<nodes>
	<node>
		<title>Stonewall Treatment Evaluation Project (STEP)</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this project is to conduct a systematic program evaluation of the Stonewall Project, which is currently deployed in four community settings by the San Francisco AIDS Foundation. The Stonewall Project is an innovative, outpatient substance abuse treatment program for methamphetamine-using MSM that is implementing evidence-based interventions (i.e., the Matrix Model) in a real world clinical setting. In collaboration with the Stonewall Project, we will conduct a comprehensive treatment outcome evaluation with 150 participants who are newly initiating services. Participants in the treatment outcome evaluation will complete quantitative assessments at baseline as well as three and six months follow-up to examine changes in substance use and HIV risk-taking behavior. We will also build the capacity of the Stonewall Project to conduct ongoing evaluation efforts by developing a web-based assessment system. This system will automate existing self-monitoring activities that participants complete prior to each counseling session at the Stonewall Project to facilitate ongoing evaluation of treatment outcomes.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Carrico_STEP_2010.pdf</url>
	</node>
	<node>
		<title>Evaluation and Technical Assistance Center (ETAC) for the SPNS Culturally Appropriate Interventions of Outreach, Access and Retention among Latino/a Populations Initiative</title>
		<tax>1737</tax>
		<content><![CDATA[The Evaluation and Technical Assistance Center (ETAC) at UCSF will provide leadership and support to demonstration sites implementing interventions to enhance HIV testing and diagnosis among out-of-care Latina/os, and to link and retain these populations in high quality HIV care.
Over the course of the five year Initiative, the ETAC will:
<ol>
 	<li>provide technical assistance (TA) to the demonstration sites regarding the development of innovative models for providing HIV and support services, as well as TA regarding methodological (both quantitative and qualitative) research design;</li>
 	<li>conduct a rigorous multi-site evaluation of the implementation and outcomes of all interventions and the multi-site cohort as a whole; and</li>
 	<li>lead and coordinate the efforts for publication and dissemination of findings and lessons learned from the Initiative.</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/Myers-and-Steward.-HRSA-SPNS-ETAC.pdf</url>
	</node>
	<node>
		<title>Formative Research to Assess HIV Risk among MSM in Nepal</title>
		<tax>1737</tax>
		<content><![CDATA[This study aims to meet the need for in-depth formative research to develop an evidence-based and theory-driven HIV prevention intervention with MSM in Nepal. The study will be conducted in collaboration with the Blue Diamond Society, the only CBO currently serving MSM in Nepal. We will conduct five interviews with key informants who are service providers knowledgeable about HIV risk among MSM to identify sub-populations of MSM, gather initial HIV risk data, assist in the refinement of an interview guide for MSM and assess feasibility of a larger study. Based on this data, we will conduct in-depth interviews with 20 MSM to explore identity, sexual networks, risk perception and stigma. Finally, we will conduct interviews with five key informants who are leaders in HIV prevention among MSM in Nepal and South Asia. These last interviews will help the research team develop relationships with leaders in South Asian MSM HIV prevention and assess feasibility for a larger study. We will engage community members at the beginning and end of this study for their input and engagement as potential community advisory board members in a future study.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Wilson_E-HIVRiskamongMSMinNepal2009.pdf</url>
	</node>
	<node>
		<title>HIV Prevention Intervention for HIV-Positive Men in China</title>
		<tax>1737</tax>
		<content><![CDATA[In China, sexual transmission has become the major driving force behind the HIV epidemic, accounting for more than half (52%) of the estimated 700,000 people currently living with HIV. Men who have sex with men (MSM) may contribute to the rapid acceleration of the epidemic throughout China. Studies with Chinese MSM have documented an increasing HIV prevalence, a high HIV incidence, and high rates of unprotected intercourse and sexually transmitted infections (e.g., syphilis) known to facilitate sexual transmission of HIV. Moreover, our work found that HIV-transmission risk behavior is highly prevalent among HIV-positive MSM in China. Nonetheless, no HIV prevention interventions have targeted HIV-positive Chinese MSM. Several interventions have demonstrated efficacy in reducing sexual risk beh aviors among HIV-positive MSM in the U.S. Adapting such interventions for HIV-positive MSM in China would help accelerate the process of developing an efficacious intervention for this risk group. The proposed three-year study (R34) will adapt and pilot-te st currently available evidence-based behavioral interventions to reduce HIV-transmission risk behavior among HIV-positive MSM in Chongqing, China. This study will be implemented in five phases, guided by Wainberg et al.’s intervention adaptation model.
<ul>
 	<li>In Step 1, we will identify core components of efficacious interventions (e.g., key theoretical constructs, intervention messages, delivery modes) through the review of the literature.</li>
 	<li>In Step 2, we will explore cultural, psychosocial, and contextual factors associated with sexual risk behaviors and generate ideas for intervention strategies for HIV-positive MSM by conducting 15 key informant interviews with individuals knowledgeable about HIV-positive MSM and 30 in-depth interviews with HIV-positive MSM.</li>
 	<li>In Step 3, we will adapt efficacious interventions through reviewing the core elements of efficacious interventions identified in Step 1 and collating those elements with qualitative data collected in Step 2 with an intervention adaptation working group of 10 health professionals and MSM lay workers who serve HIV-positive MSM.</li>
 	<li>In Step 4, we will pilot-test the adapted intervention with 16 HIV-positive MSM and refine the intervention if necessary .</li>
 	<li>In Step 5, we will test the feasibility of implementing and ass essing the intervention refined in Step 4 by conducting the intervention with 50 HIV-positive MSM and having these 50 men complete baseline and 3-month surveys .</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Choi.-HIV-Prevention-Intervention-for-HIV-Positive-Men-in-China.pdf</url>
	</node>
	<node>
		<title>Influence of Stigma and Discrimination on HIV Risk among Men in China</title>
		<tax>1737</tax>
		<content><![CDATA[This is a three-phase study to identify the specific mechanisms by which MSM stigma affect sexual risk behaviors among MSM in Beijing, China.
<ul>
 	<li>In Phase 1, we will explore the range of management strategies used to cope with MSM stigma via 30 in-depth qualitative interviews with MSM.</li>
 	<li>In Phase 2, we will develop, using Phase 1 qualitative data and adapting existing quantitative scales, culturally-relevant measures of explanatory constructs of interest (e.g., MSM stigma management) to establish reliability and validity (N=170).</li>
 	<li>In Phase 3, we will examine potential mediators (e.g., stigma management strategies, psychological distress, sexual contexts/situations) that explain how MSM stigma are linked to sexual risk for HIV with a respondent-driven sample of 500 MSM who will complete baseline and two follow-up assessments at 6 and 12 months.</li>
</ul>
We will also conduct 20 in-depth qualitative individual interviews with a subset of men selected from the Phase-3 participants to examine the acceptability of potential intervention components to address the link between MSM stigma and HIV risk.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Choi_China-Stigma-MSM_2010.pdf</url>
	</node>
	<node>
		<title>ASHA Improving Health and Nutrition of Indian Women with AIDS and Their Children</title>
		<tax>1737</tax>
		<content><![CDATA[The overall goal of this study is to enhance the physical and mental health of rural Indian women living with AIDS and their children. We will achieve these goals through the use of trained village women as Accredited Social Health Activists (ASHA) to enhance the health of women and children through improved ART adherence, CD4 levels, and physical and mental health. This Indo-US collaboration between University of California, Los Angeles, University of California, San Francisco and All India Institutes of Medical Sciences (AIIMS) builds on our previous work with rural women living with AIDS and our successful ASHA program. Specific objectives include: Using a 2x2 factorial design, we plan to assess the effects of nutrition training and/or food supplements on primary outcomes for rural women living with AIDS in improving body composition and immune status (CD4 levels) as assessed at 6-, 12- and 18-month follow-up. Examining the effects of the program arms and their interaction on adherence to ART, psychological health, nutritional adequacy, and lipid profile over time.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/06/ASHA-Nutrition-Summary_CAPS_website_FINAL.pdf</url>
	</node>
	<node>
		<title>Barriers to and Retention in Support Services among HIV+ Transwomen</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this study is to examine barriers to and retention in support services among HIV+ transwomen (women who were assigned a male sex at birth) and to explore the challenges and potential benefits of integrating HIV+ transwomen into services for HIV+ non-transgender women. This study will collect qualitative data with 14 HIV+ transwomen and 10 support services providers in Alameda County, CA. This study will provide preliminary data to inform an R01 application responding to an RFA to examine the test, treat and retain paradigm.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Wilson_Transwomen_2010.pdf</url>
	</node>
	<node>
		<title>HIV Prevention Intervention for HIV-Positive Men in China</title>
		<tax>1737</tax>
		<content><![CDATA[In China, sexual transmission has become the major driving force behind the HIV epidemic, accounting for more than half (52%) of the estimated 700,000 people currently living with HIV. Men who have sex with men (MSM) may contribute to the rapid acceleration of the epidemic throughout China. Studies with Chinese MSM have documented an increasing HIV prevalence, a high HIV incidence, and high rates of unprotected intercourse and sexually transmitted infections (e.g., syphilis) known to facilitate sexual transmission of HIV. Moreover, our work found that HIV-transmission risk behavior is highly prevalent among HIV-positive MSM in China. Nonetheless, no HIV prevention interventions have targeted HIV-positive Chinese MSM. Several interventions have demonstrated efficacy in reducing sexual risk behaviors among HIV-positive MSM in the U.S. Adapting such interventions for HIV-positive MSM in China would help accelerate the process of developing an efficacious intervention for this risk group. The proposed three-year study (R34) will adapt and pilot-test currently available evidence-based behavioral interventions to reduce HIV-transmission risk behavior among HIV-positive MSM in Chongqing, China. This study will be implemented in five phases, guided by Wainberg et al.’s intervention adaptation model. In Step 1, we will identify core components of efficacious interventions (e.g., key theoretical constructs, intervention messages, delivery modes) through the review of the literature. In Step 2, we will explore cultural, psychosocial, and contextual factors associated with sexual risk behaviors and generate ideas for intervention strategies for HIV-positive MSM by conducting 15 key informant interviews with individuals knowledgeable about HIV-positive MSM and 30 in-depth interviews with HIV positive MSM. In Step 3, we will adapt efficacious interventions through reviewing the core elements of efficacious interventions identified in Step 1 and collating those elements with qualitative data collected in Step 2 with an intervention adaptation working group of 10 health professionals and MSM lay workers who serve HIV-positive MSM. In Step 4, we will pilot-test the adapted intervention with 16 HIV-positive MSM and refine the intervention if necessary. In Step 5, we will test the feasibility of implementing and assessing the intervention refined in Step 4 by conducting the intervention with 50 HIV-positive MSM and having these 50 men complete baseline and 3-month surveys.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Choi.-HIV-Prevention-Intervention-for-HIV-Positive-Men-in-China.pdf</url>
	</node>
	<node>
		<title>Positive Prevention in Mozambique</title>
		<tax>1737</tax>
		<content><![CDATA[Facilitated by The Twinning Center, the UCSF School of Nursing has partnered with the Ministry of Health in Mozambique in order to adapt, pilot, and implement an US evidence-based Positive Prevention (PP) intervention within rural Mozambique. The purpose of this project is to develop a PP intervention that will effectively address the needs of people living with HIV (PLHIV) in Mozambique through advancing understanding among healthcare providers, counseling and testing staff, and peer educators. Beginning in 2006, this intervention is taking place in two sites in Maputo Province in Mozambique. The first site focuses on building healthcare provider skills around effective risk assessment and prevention messages for their HIV-infected patients. The second site focuses on implementing similar needs assessment and prevention messages within one community–based Voluntary counseling and testing center and an accompanying peer support group. Collaboration among US and Mozambican partners (including healthcare providers, counseling and testing counselors, and PLHIV peer counselors) has guided the development of this PP intervention. The intervention currently includes case studies developed by Mozambican partners and a peer-led support group with enhanced one-to-one risk reduction counseling by counselors and PLHIV peers. Case studies are used in each setting to illustrate concepts such as assessment of transmission risk, behavioral risk reduction approaches, encouragement of partner testing and disclosure, prevention of mother-to-child transmission, and family planning.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Dawson_C-PosPrevMozambique2009.pdf</url>
	</node>
	<node>
		<title>Technology-based Adaptive Treatment Strategies for Antiretroviral Adherence</title>
		<tax>1737</tax>
		<content><![CDATA[The Achilles heel of successful HIV treatment is adherence to antiretroviral (ARV) therapy, as non-adherence remains one of the strongest predictors of progression to AIDS and death. The U.S. Department of Health and Human Services, the British HIV Association, and the World Health Organization acknowledge the supportive role of technology for adherence. This recognition underscores the importance of the need for stronger evidence of the effectiveness of these technologies. As a result and because forgetting to take ARVs is the most commonly stated reason for non-adherence, several studies have examined and are assessing the efficacy of electronic reminder devices (such as timers and pagers) on ARV adherence. However, most studies regarding reminder devices have not revealed clinically significant improvements in adherence; which may be because they have primarily investigated the role of a single method, i.e., reminder devices, irrespective of patient-specific reasons for non-adherence. Thus, instead of using tailored technology-based methods to address distinct non-adherence reasons, most studies compel the participant to “fit” the technology. This can lead to ineffective interventions, unaddressed and unresolved adherence problems, and a misuse of resources. While it is likely that reminder devices are useful for memory-impaired individuals, the underlying cause of “forgetfulness” may be due to other issues such as stigma, depression, lack of social support, etc. Therefore, to most effectively use technology to improve adherence, customized interventions that focus on the patients’ specific ARV non-adherence reasons need to be considered. The goal of this project is to develop individually-tailored approaches to improve ARV adherence and treatment engagement of HIV+ individuals, particularly among racial/ethnic minorities. With support from my mentoring team, I am proposing a series of research projects that have significant personal and public health implications in the area of ARV adherence. The overarching research objectives of this K23 proposal is to identify technology-based approaches that have the potential to overcome specific reasons for ARV non-adherence in youth; in other words, to delineate technology-based methods that would “fit” the unique adherence problem of each individual.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Saberi.-tech-based-adaptive-treatment-strategies-for-ARV-adherence.pdf</url>
	</node>
	<node>
		<title>Transgender Evaluation and Technical Assistance Center (TETAC)</title>
		<tax>1737</tax>
		<content><![CDATA[The TETAC provides the HRSA Enhancing Engagement and Retention in Quality HIV Care for Transgender Women of Color initiative with expert leadership in the multi-site evaluation and dissemination of findings and technical assistance (TA) and capacity building to improve the timely entry, engagement, and retention in HIV primary care for transwomen of color. The project is guided by four primary goals:
<ul>
 	<li><strong>Goal 1 (Evaluation)</strong> To provide support to the demonstration sites as they design and implement their site-specific evaluation plans, and to conduct rigorous, cross-site evaluation research that will make a significant contribution to improving the timely entry, engagement, and retention (from the cascade of care model) in quality HIV primary care for transwomen of color.</li>
 	<li><strong>Goal 2 (TA)</strong> To provide TA tailored to the specific needs of each demonstration site through teleconferences, a website, webinars, site visits, and meetings in a variety of domains including (1) program development, implementation, and sustainability; (2) clinical consultation; (3) multi-site and location evaluation; (4) human research protection; (5) IRBs; and (6) intervention manuals.</li>
 	<li><strong>Goal 3 (Capacity Building)</strong> To provide capacity building assistance (CBA) relating to the provision of quality clinical and culturally competent HIV primary care and social services to transwomen of color.</li>
 	<li><strong>Goal 4 (Dissemination)</strong> To synthesize and disseminate findings from demonstration projects to optimize impact on the timely entry, engagement, and retention in quality HIV primary care for transwomen of color.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>http://transhealth.ucsf.edu/trans?page=programs-tetac</url>
	</node>
	<node>
		<title>International HIV Prevention Research at the Center for AIDS Prevention Studies, University of California San Francisco</title>
		<tax>1737</tax>
		<content><![CDATA[The principal objective of the International Core at the Center for AIDS Prevention Studies (CAPS) is to facilitate high quality international research by creating effective and productive partnerships between CAPS scientists and HIV prevention researchers from developing countries. The International Core brings together CAPS scientists and alumni of the Collaborative Prevention Research in Developing Countries Program, a training program for new developing country researchers (described below). CAPS has successfully developed a broad portfolio of small-scale international research projects conducted by CAPS scientists and Program alumni. Together we have made important contributions toward understanding how to prevent HIV transmission and how to care for the HIV-infected in the developing world.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/InternationalS2C.pdf</url>
	</node>
	<node>
		<title>Word on the Street – July 2016</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What You Should Know from the Community</h3>
"Word on the Street" is disseminated quarterly to inform CAPS/UCSF PRC of new developments, issues, programs, policy agendas, etc. that are happening in, affecting, and are of interest to the community.

In this issue:
<ol>
 	<li>Prevention and Care Integration and the "Getting to Zero" Initiative</li>
 	<li>UCSF PRC Prevention Forum (PRC-PF)</li>
 	<li>Oakland TGA Collaborative Community Planning Council (CCPC)</li>
 	<li>San Francisco EMA HIV Community Planning Council (HCPC)</li>
 	<li>Bay Area State of Emergency (BASE)</li>
 	<li>29th Annual East Bay HIV Update</li>
</ol>]]></content>
		
		<type>
			6
		</type>
			<url>http://conta.cc/29HvPvO</url>
	</node>
	<node>
		<title>Mother-to-child transmission (MTCT)</title>
		<tax>1737</tax>
		<content><![CDATA[In 2012, there were 2.3 million new HIV infections globally. A large proportion of people newly diagnosed with HIV worldwide are in their reproductive years and these men and women are likely to want children in the future. Addressing the sexual and reproductive health and rights of this population is critical to addressing the spread of HIV because HIV infection in childbearing women is the main cause of HIV infection in children. Treatment for those who are already infected is also central to stopping the spread of HIV to infants and to uninfected sexual partners.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/11/MTCT-Revised-Sept-2015.pdf</url>
	</node>
	<node>
		<title>Needle exchange programs (NEP)</title>
		<tax>1737</tax>
		<content><![CDATA[More than a million people in the US inject drugs frequently, at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion a year. People who inject drugs imperil their own health. If they contract HIV or hepatitis, their needle-sharing partners, sexual partners and offspring may become infected. It is estimated that half of all new HIV infections in the US are occurring among injection drug users (IDUs). For women, 61% of all AIDS cases are due to injection drug use or sex with partners who inject drugs. Injection drug use is the source of infection for more than half of all children born with HIV. Injection drug use is also the most common risk factor in persons with hepatitis C infection. Up to 90% of IDUs are estimated to be infected with hepatitis C, which is easily transmitted and can cause chronic liver disease. Hepatitis B is also transmitted via injection drug use. Needle exchange programs (NEPs) distribute clean needles and safely dispose of used ones for IDUs, and also generally offer a variety of related services, including referrals to drug treatment and HIV counseling and testing.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/nepFS.pdf</url>
	</node>
	<node>
		<title>Sex education</title>
		<tax>1737</tax>
		<content><![CDATA[Sex and HIV education programs have multiple goals: to decrease unintended pregnancy, to decrease STDs including HIV and to improve sexual health among youth. In 2005, almost two-thirds (63%) of all high school seniors in the US had engaged in sex, yet only 21% of all female students used birth control pills before their last sex and only 70% of males used a condom during their last sexual intercourse. In 2000, 8.4% of 15-19 year old girls became pregnant, producing one of the highest teen pregnancy rates in the western industrial world. Persons aged 15-24 had 9.1 million new cases of STDs in 2000 and made up almost half of all new STD cases in the US. There are numerous factors affecting adolescent sexual behavior and use of protection. Some of these factors have little to do with sex, such as growing up in disadvantaged communities, having little attachment to parents or failing at school. Other factors are sexual in nature, such as beliefs, values, perceptions of peer norms, attitudes and skills involving sexual behavior and using condoms or contraception. It is these sexual factors that sex/HIV education programs can potentially affect, thereby impacting behavior. Sex/HIV education programs alone cannot totally reduce sexual risk-taking, but they can be an effective part of a more comprehensive initiative.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revsexedFS.pdf</url>
	</node>
	<node>
		<title>Notificación de parejas</title>
		<tax>1737</tax>
		<content><![CDATA[A más de 20 años del inicio de la epidemia y a pesar de los avances en conocimiento, tratamiento, y aceptación del VIH, la experiencia de recibir un diagnóstico VIH+ aún puede resultar traumática. La gente VIH+ debe asimilar la realidad de su propia infección al tiempo de preocuparse por la posible infección de parejas pasadas y futuras. Es difícil hablar con la pareja sobre el VIH, pues aunque puede controlarse, aún no tiene cura. La ayuda con la notificación de parejas (conocida como servicios de asesoramiento y referencia para parejas o PCRS en inglés) es una serie de servicios voluntarios y confidenciales para personas VIH+ y para sus parejas sexuales y/o de inyección de drogas. Estos servicios son costo-efectivos y tienen un papel crítico tanto identificando individuos a mayor riesgo de infección como remitiendo oportunamente a servicios médicos a quienes estén infectados. La mayoría de las personas VIH+ deciden por su cuenta si revelan o no su condición a sus parejas, pero muchas veces necesitan apoyo para hablar directamente con éstas o para que cuidadosa y confidencialmente lo haga un profesional. En un estudio, las personas que recibieron ayuda con la notificación triplicaron la probabilidad de informar a sus parejas sobre el riesgo contraído. En años recientes, los programas de consejería y pruebas del VIH en los EE.UU. han cambiado de aplicar la prueba a todo mundo, a identificar y ofrecer pruebas a los más vulnerables a infectarse. En los sitios generales de pruebas del VIH cerca de un 1% resulta VIH+, comparado con el 8 al 39% que resulta de los programas de notificación de parejas.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/notificacionFS.pdf</url>
	</node>
	<node>
		<title>Intercambio de jeringas</title>
		<tax>1737</tax>
		<content><![CDATA[Más de un millón de personas en los EEUU se inyectan drogas con frecuencia, con un alto costo a la sociedad de más de 50 billones de dólares al sector salud, pérdidas de productividad, accidentes y crímenes. Quienes se inyectan drogas se exponen a contraer el VIH o la hepatitis arriesgando así su propia salud, la de las personas con las que comparten agujas/jeringas, sus parejas sexuales y sus descendientes.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/agujasFS.pdf</url>
	</node>
	<node>
		<title>Educación sexual</title>
		<tax>1737</tax>
		<content><![CDATA[Los programas educativos sobre la sexualidad y el VIH tienen varias metas: disminuir los embarazos no planeados, reducir las enfermedades de transmisión sexual (ETS) incluyendo la del VIH y mejorar la salud sexual de los jóvenes. En 2005 en los EE.UU., el 63% de todos los alumnos del último año de preparatoria (high school) habían tenido relaciones sexuales, pero sólo el 21 % de las alumnas usaron pastillas anticonceptivas antes del último coito y sólo el 70 % de los varones usaron condón en el último coito. En el 2000, el 8.4 % de las chicas entre 15 y 19 años se embarazaron, produciendo una de las tasas más altas de embarazo adolescente en el mundo occidental industrializado. Casi la mitad de los nuevos casos de ETS en EE.UU. del año 2000 (9.1 millones) se presentaron en jóvenes entre los 15 y los 24 años de edad. Algunos de los numerosos factores que influyen en la conducta sexual y el uso de protección entre los adolescentes tienen poco que ver con las relaciones sexuales, por ejemplo: la crianza en una comunidad desfavorecida, la falta de apego a los padres o el fracaso escolar. Otros factores de naturaleza sexual como las creencias, los valores, las percepciones de normas de los pares, las actitudes y habilidades relacionadas con la conducta sexual y con el uso del condón o de anticonceptivos, son factores en los que los programas de enseñanza potencialmente pueden incidir para generar cambios de conducta. Estos programas no pueden por sí solos eliminar las conductas sexuales riesgosas, pero sí pueden ser una pieza eficaz dentro de una iniciativa integral.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revensenanzaFS.pdf</url>
	</node>
	<node>
		<title>Heterosexual men</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are Heterosexual Men’s HIV Prevention Needs?</h3>
<h3>revised 4/01</h3>
<h4>Are heterosexual men at risk?</h4>
Yes. In the US, new AIDS cases are increasing among people who were infected through injecting drug use (IDU) and heterosexual sexual contact.<sup>1</sup> The rise in IDU infections in heterosexual men has led to the rise in HIV infections in women, as more women become infected from men who are IDUs. For this reason, sexual behavior change among heterosexual men will be key to controlling the HIV epidemic for heterosexual men, women and children.

Over one-fourth (28%) of all AIDS cases among men in the US occurred through injection drug use and heterosexual sexual contact. Over three-fourths of those cases were among men of color, with African-American men comprising more than half (55%). AIDS and HIV cases are classified by drug use and sexual act, and not by self-identification. Heterosexually-identified men that engage in sex with other men are classified as “men who have sex with men.” However, they may not relate to programs targeting gay men.

Prevention programs in the US have addressed the drug-using risks of heterosexual men. However, few have addressed their sexual behavior. Women have been the primary focus of sexual behavior change among heterosexuals. If heterosexually-identified men are reached, often it is by default because the intervention was targeting another audience.
<h4>What puts men at risk?</h4>
Injection drug use poses the highest risk to heterosexual men.<sup>2</sup> Use of other non-injected substances such as methamphetamines, crack cocaine and alcohol can increase sexual risk taking, which increases risk of HIV infection. A study of out-of-treatment IDUs in California found that heterosexual men who used methamphetamines reported more sex partners, more sexual activityincluding anal intercourse with men and womenand less condom use than men who did not use methamphetamines. In addition, half of their regular female partners did not inject drugs.<sup>3</sup>

Men can get infected from having unprotected intercourse with an HIV+ woman, although the risk is much lower than the risk from sharing infected injection equipment or having sex with an HIV+ man. The risk increases when men or their female partners have STD infections.<sup>4</sup> The greatest sexual risk behavior for heterosexual men is unprotected anal sex with an HIV+ man. Because of homophobia and fear of rejection, men may be unlikely to report having sex with men, identifying sex with women as their only risk factor.<sup>5</sup>

Men in certain settings are at greater risk. In the US, 90% of prisoners are men. Among the incarcerated, rates of HIV are 8-10 times higher than in the general population.<sup>6</sup> Injection drug use, other illicit drug use, tattooing and unprotected anal sex with other men are all risk behaviors for HIV in prison or jail. Clean needles are not available in jail and prisons in the US and condoms are only available in a few.
<h4>What makes prevention difficult?</h4>
Men in this society are not trained or coached to develop a health plan for themselves. Between childhood vaccinations and post-middle age checks for prostate cancer, many heterosexual men typically do not visit a doctor’s office.<sup>7</sup> Heterosexual men and African Americans in particular, are least likely to be tested for HIV, enter into treatment, and keep medical appointments.<sup>8,9</sup>

Many heterosexual men do not have enough knowledge about HIV and other STDs, and do not believe it concerns them. HIV is still seen as a “gay white man’s” problem because of the lack of materials targeted to straight men and lack of heterosexual peer educators. Men may be reluctant to use HIV/AIDS services that are run by or targeted to gay men.<sup>10</sup>

Men wear the (male) condom and ultimately have the power to use them or not. Men may be concerned about pregnancy, STD and HIV prevention, but may have difficulty bringing up the subject of condoms with their partners. Some men wait for the female partner to begin that discussionif she doesn’t, they often do not mention condoms themselves.

Young men of color often see themselves as an “endangered species.”<sup>11</sup> For many inner-city youth, the dangers and concerns of daily survival far outweigh any future concerns such as HIV. The realities of poverty, violence and addiction enforce Black men’s belief that they will not live past the age of 25. For many inner-city youth, the likelihood of being shot or sent to prison is their greatest concern.<sup>11</sup>
<h4>How can heterosexual men be reached?</h4>
Peer educators can help address HIV prevention to heterosexual men, yet very few heterosexual men are involved in HIV prevention. Fear and misunderstanding about gay culture further inhibit involvement. Sensitivity training is necessary for all men to understand and respect sexual cultures and boundaries.

Recruiting heterosexual men can be a difficult task. For instance, approaching African American men individually may not be as effective as recruiting them through their employer, mentor, religious leader or social group.<sup>12</sup> Heterosexual men also may need encouragement from girlfriends or wives to participate in HIV prevention programs.<sup>12</sup>

Campaigns that target heterosexual men should focus on general health issues, not sexual issues. Campaigns should encourage men to talk about and take responsibility for their health and well-being, instead of highlighting the negative side of sex (HIV kills, sex with a minor can land you in jail). Education should begin before adolescence to help young men protect themselves as they are confronted with the world of sexuality and substance use.
<h4>What’s being done?</h4>
A video-based, skills-building HIV prevention program for African American heterosexual men in Atlanta, GA, helped increase rates of condom use and lower unprotected vaginal intercourse. The program showed videotaped HIV information, questions and answers about HIV and condom use demonstrations. It also incorporated live facilitators. Because men were unlikely to participate in sexual role-playing with other men, the program used clips from popular movies and asked the men to suggest dialogue for safer sex.<sup>13</sup>

Le Penseur Youth Services reaches out to young people and families in Southeast Chicago, IL. One program targets young male gang members by using gang leaders as peer educators. Le Penseur trained gang leaders and members to deliver safer sex messages. A key component of the program is giving young men clear roles and opportunities for advancement and leadership. Using gang members drove home the point that HIV affects heterosexual men, and increased awareness of HIV in the community.<sup>14</sup>

In Baltimore, MD, the health department opened a free Men’s Health Center to address the health care needs of uninsured men ages 19-64. The clinic provides primary and dental care, substance abuse counseling, job placement and prevention education. The doctor, nurse and physician’s assistant are all men. When it opened, it was the only clinic targeting uninsured men in the US. The Center focuses on helping men stay healthy, which will help build healthier families.<sup>15</sup>
<h4>What should be done?</h4>
Heterosexual men are still in need of basic HIV/AIDS information. Programs are needed for heterosexual men that address their health and well-being and teach them how to advocate for their own health care. Programs also need to acknowledge that heterosexual men may engage in sex with men, and encourage safer sex in all sexual encounters. Finally, programs for heterosexual men need to be developed in conjunction with women, so that female partners’ needs and concerns are incorporated.

Drug treatment and access to sterile syringes through needle exchange programs and pharmacy exchanges are crucial for heterosexual men. Incarcerated men need access to drug treatment, condoms, clean syringes, HIV prevention education and transitional case management to help ease risks both while incarcerated and upon release.

Heterosexual men need to take more responsibility for trying to stop the spread of HIV. Because men have not traditionally been involved in health care and prevention issues, training and support for heterosexual men will be necessary to ensure and sustain their involvement in HIV prevention.

<hr />

<h3>Says who?</h3>
1. CDC. HIV/AIDS Surveillance Report . 1995;7:10.
2. CDC. HIV/AIDS Surveillance Report . 2001;13:16.
3.. Molitor F, Ruiz JD, Flynn N, et al. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users . American Journal of Drug and Alcohol Abuse. 1999;25:475-493.
4. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases . Sexually Transmitted Diseases. 1992;19:61-77.
5. Sternberg S. ‘Secret’ bisexuality among Black men contributes to rising number of AIDS cases in Black women. USA Today. March 15, 2001.
6. Hammett TM, Harmon P, Maruschak L. 1996-1997 Update: HIV/AIDS, STDs and TB in correctional facilities. Abt Associates, Inc .: Cambridge, MA; 1999.
7. Sandman D, Simantov E, An C. O . Published by The Commonwealth Fund. March 2000.
8. Fichtner RR, Wolitski RJ, Johnson WD, et al. Influence of perceived and assessed risk on STD clinic clients’ acceptance of HIV testing, return for test results, and HIV serostatus. Psychology, Health &amp; Medicine. 1996;1:83-98.
9. Israelski D, Gore-Felton G, Wood MJ, et al. Factors associated with keeping medical appointments in a public health AIDS clinic. Presented at the 8th International AIDS Conference, Durban, South Africa. Abst# WePeD4570.
10. Carter JA, McNair LD, Corbin WR. Gender differences related to heterosexual condom use: the influence of negotiation styles . Journal of Sex &amp; Marital Therapy. 1999;25:217-225.
11. Parham TA, McDavis RJ. Black men, an endangered species: Who’s really pulling the trigger? Journal of Counseling &amp; Development. 1987;66:24-27.
12. Summerrise R, Wilson W. “The Black Print” model for recruitment of African-American males. Published by the Chicago, IL, Prevention Planning Group. 2000.
13. Kalichman SC, Cherry C, Brown-Sperling F. Effectiveness of a video-based motivational skills-building HIV risk-reduction intervention for inner-city African American men . Journal of Consulting and Clinical Psychology. 1999;67:959-966.
14. Summerrise R. Valuing the lives of men: HIV prevention for heterosexual men. Presented at the US Conference on AIDS, Atlanta, GA. October, 2000.
15.Sugg DK. A first for men: clinic opens in Baltimore . The Baltimore Sun. May 11, 2000.

<hr />

<strong>Prepared by Reginald Summerrise* and Pamela DeCarlo**
*Le Penseur Youth Services, Chicago, IL; **CAPS</strong>

April 2001. Fact Sheet #22ER

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 2001, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revhetmenFS.pdf</url>
	</node>
	<node>
		<title>HIV+ persons</title>
		<tax>1737</tax>
		<content><![CDATA[Over 1 million persons in the US are living with HIV/AIDS. Advances in the early diagnosis, treatment and care of HIV+ persons have helped many people enjoy increased health and longer life. Some HIV+ persons have experienced a renewed interest in sexual or drug-using activity. This can place them at risk for acquiring additional STD infections and for transmitting HIV to their uninfected partners. Many HIV+ persons, therefore, require programs to help them stay safe. Most HIV+ persons are concerned about not infecting others and make efforts to prevent transmission. However, a significant percentage of HIV+ persons struggle with prevention: from 20-50% of HIV+ persons report unprotected sex with partners who are HIV- or whose HIV status they do not know. For many HIV+ persons, the same structural, inter-personal and behavioral challenges that put them at risk for HIV persist beyond their HIV diagnosis and play a role in their inability to prevent HIV transmission. Prevention with HIV+ persons may include education and skills building interventions, efforts to test more persons who are HIV+ but do not know their status, support and testing for partners of HIV+ persons and integrating prevention into routine medical care.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revPWPFS.pdf</url>
	</node>
	<node>
		<title>Injection drug users (IDUs)</title>
		<tax>1737</tax>
		<content><![CDATA[Injecting drug use accounts for nearly one-third (36%) of cumulative AIDS cases in the US, and for 28% of the 42,156 new AIDS cases reported in 2000. These cases include injecting drug users (IDUs), their sexual partners and children born to them. African Americans and Latinos are disproportionately affected by IDU-associated AIDS. In 2000, the proportion of IDU-associated AIDS cases was 26% for African Americans, 31% for Latinos and 19% for whites. Women are also disproportionately affected. Overall, 62% of AIDS cases among women have been attributed to IDUs and sex with IDU partners, compared with 34% of cases among men. IDUs are at even greater risk for other serious drug use-related illnesses, including hepatitis C and overdose. Injecting drug use accounts for 60% of hepatitis C infections in the US. Rates of hepatitis C infection among young IDUs are 4 to 100 times higher than rates of HIV infection. Drug overdose is a major cause of death among heroin users, even in areas with high rates of IDU HIV.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/IDUFS.pdf</url>
	</node>
	<node>
		<title>Substance abusers</title>
		<tax>1737</tax>
		<content><![CDATA[Although sharing used needles is a high risk for HIV transmission, substance abuse and HIV goes beyond the issue of needles. People who abuse alcohol, speed, crack cocaine, poppers or other non-injected drugs are more likely than non-substance users to be HIV positive and to become seropositive. People with a history of non-injection substance abuse are also more likely to engage in high-risk sexual activities.

Many injection drug users (IDUs) use other non-injected drugs primarily. When an IDU is HIV-positive, needle sharing may be the primary risk factor, but other non-injected drug use may have a great effect on risk behaviors. For example, a study of high risk clients in a methadone treatment program found that those at highest risk for HIV infection were also crack cocaine users.

A survey of heterosexuals in alcohol treatment programs in San Francisco, CA, found HIV infection rates of 3% for men who were not homosexually active or IDUs and 4% for women who were not IDUs. This was considerably higher than rates of 0.5% for men and 0.2% for women found in a similar population survey.

In Boston, MA, a study of gay men found a strong relationship between use of nitrite inhalants or “poppers” and HIV infection. Men who always used poppers while engaging in unprotected anal sex were 4.2 times more likely to be HIV positive than men who never used poppers and engaged in unprotected anal sex.

Crack cocaine use has been shown to be strongly associated with the transmission of HIV. A study of young adults in three inner-city neighborhoods who smoked crack and had never injected drugs found a 15.7% HIV rate. Women who had recently had unprotected sex in exchange for money or drugs, and men who had anal sex with other men were most likely to be infected.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/substanceFS.pdf</url>
	</node>
	<node>
		<title>Personas VIH+</title>
		<tax>1737</tax>
		<content><![CDATA[Más de 1 millón de personas en los Estados Unidos tienen el VIH o el SIDA. Los avances en el diagnóstico oportuno, el tratamiento y la atención para individuos VIH+ ya permiten que muchos gocen de mejor salud y más años de vida. Algunos han renovado su interés por la actividad sexual o por el consumo de drogas, lo cual aumenta su riesgo de adquirir otras ITS y de trasmitir el VIH a sus parejas no infectadas.2 Por ello, muchas personas VIH+ requieren programas que les ayuden a mantenerse protegidas.

La mayoría de las personas VIH+ se preocupan por no infectar a otros y toman medidas para evitarlo. Sin embargo, para un porcentaje importante la prevención es una lucha: entre el 20-50% reportan haber tenido contacto sexual sin protección con sus parejas VIH- o con las de condición de VIH desconocida.4 Para muchas personas seropositivas, los mismos desafíos estructurales, interpersonales y conductuales que las pusieron en riesgo de contraer el VIH persisten después de ser HIV+ y dichos desafíos afectan su capacidad de prevenir la transmisión del VIH.

La prevención para personas VIH+ puede incluir intervenciones educativas y de fomento de habilidades, esfuerzos para realizar pruebas a más personas que ignoran ser VIH+, apoyo y pruebas para las parejas de individuos VIH+ y la incorporación de la prevención en la atención médica de rutina.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revVIH+FS.pdf</url>
	</node>
	<node>
		<title>Usuarios de drogas inyectables (UDI)</title>
		<tax>1737</tax>
		<content><![CDATA[El uso de drogas inyectables representa casi la tercera parte (el 36%) de los casos acumulados de SIDA en EE.UU. Estos casos incluyen usuarios/as de drogas inyectables (UDI), sus parejas sexuales y los hijos nacidos de estas parejas.

Los afroamericanos y los latinos están desproporcionadamente afectados por el SIDA asociado al UDI. En el año 2000, de los casos de SIDA asociados al UDI, el 26% eran afroamericanos, el 31% latinos y el 19% caucásicos.1 Las mujeres también han sido afectadas en forma desproporcionada. En general, el 62% de los casos de SIDA entre mujeres se han atribuido a los UDI y al sexo con parejas UDI, en comparación con el 34% de los casos masculinos.

Las personas UDI corren un riesgo aun mayor de contraer otras enfermedades graves vinculadas al uso de drogas, entre ellas la hepatitis C y la sobredosis; y constituyen el 60% de las infecciones de hepatitis C en EE.UU.Las tasas de infección por hepatitis C entre jóvenes UDI son de 4 a 100 veces mayores que las tasas de infección por VIH. La sobredosis de drogas es una de las principales causas de muerte entre los usuarios de heroína, incluso en áreas con altas tasas de UDI con VIH.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/UDIFS.pdf</url>
	</node>
	<node>
		<title>Usuarios de drogas</title>
		<tax>1737</tax>
		<content><![CDATA[A pesar del alto riesgo de transmisión del VIH al compartir jeringas, la relación que existe entre el VIH y el uso de drogas va mucho mas allá del tema de las jeringas. Las personas adictas al alcohol, al “speed” y a la cocaína-crack, los “poppers” o cualquier otra droga no inyectada, están más propensos que aquellos que no usan drogas a ser portadores del VIH y a convertirse en seropositivos. Aún aquellos personas que no usan drogas intravenosas están mas propensas a participar en actividades sexuales de alto riesgo.

Muchos de los usuarios de drogas intravenosas (UDIs) primordialmente usan otras drogas no inyectadas. Cuando un UDI porta el VIH, compartir jeringas puede ser el factor de mayor riesgo, pero el uso de drogas no inyectadas, puede además propiciar conductas de riesgo. Por ejemplo, en un estudio de clientes en programas de tratamiento con “Methadone” que presentaban conductas de alto riesgo, se descubrió que los de mayor riesgo de infectarse con el VIH eran los que usaban cocaína-crack.

Al hacer una encuesta a heterosexuales en programas de tratamiento de alcohol en San Francisco, CA se encontraron tasas de infección del 3% entre hombres no UDIs y no homosexuales y del 4% entre mujeres no UDIs. Estas tasas resultan considerablemente altas en comparación con otra encuesta a una población similar en la que los resultados fueron del 0.5% entre hombres y el 0.2% entre mujeres.

Un estudio realizados a hombres homosexuales de la ciudad de Boston, MA encontró una estrecha relación entre el uso de inhalantes o “poppers” y la infección del VIH. Los hombres que tuvieron sexo anal bajo los efectos del inhalante estaban 4.2 veces más propensos a ser VIH positivos que los que no estaban bajo estos efectos al tener sexo anal.

La cocaína-crack siempre ha estado estrechamente ligada con la transmisión del VIH. Al realizarse un estudio entre jóvenes adultos de 3 vecindarios urbanos que fumaban crack y que nunca se habían inyectado drogas, se obtuvieron tasas de infección del 15.7%. Los más propensos a tener la infección eran las mujeres que habían accedido a tener sexo sin protección a cambio de drogas o dinero y los hombres que tuvieron sexo anal con otros.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/usariosFS.pdf</url>
	</node>
	<node>
		<title>Black men</title>
		<tax>1737</tax>
		<content><![CDATA[Black and African American men cannot be lumped into a one-size-fits-all category. They are the fathers, brothers, uncles and sons in Black communities. They are doctors and lawyers, barbers and bus drivers; they are Christians and Muslims and speak many languages. However, not every person who looks Black or African American will identify with these labels. In the US, Black men represent a diverse group, including, but not limited to, Afro-Cuban, Caribbean, Brazilian and African national men.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2011/01/BlackmenFS.pdf</url>
	</node>
	<node>
		<title>Latino gay men in the US</title>
		<tax>1737</tax>
		<content><![CDATA[The ever changing mosaic of Latino demographics in the US creates unique challenges to address health disparities of the population, especially when it comes to HIV prevention needs. Latinos are the largest and fastest growing ethno racial minority group in the US, experiencing a 43% growth between 2000 and 2010.

Data also show that Latinos are one of the fastest growing populations at risk for HIV transmission:
<ul>
 	<li>Latino men who have sex with men (MSM*) represent 81% of new infections among Latino men, and 19% among all MSM2</li>
 	<li>Latinos are 16% of the US population, but make up 17% of living HIV/ AIDS cases and 20% of new HIV infections each year</li>
 	<li>Youth (ages 13-29) accounted for 45% of new HIV infections among Latino MSM. In light of these data there is a need to identify culturally-specific health concerns of Latino gay men so that effective interventions may be developed to address current and prevent future disparities.</li>
</ul>
The US National HIV/AIDS Strategy highlights the call for HIV programs that reduce health inequities among both ethnoracial and sexual minority populations. Latino gay men have distinct cross-cultural identities that place them into both prioritized categories.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2012/09/Latino-gay-men-in-the-US.pdf.pdf</url>
	</node>
	<node>
		<title>Hombres negros</title>
		<tax>1737</tax>
		<content><![CDATA[Los hombres negros y los afroamericanos no se pueden encasillar en una sola categoría “unitalla”. Ellos son padres, hermanos, tíos e hijos en las comunidades negras. Son médicos, abogados, barberos y conductores de autobuses; son cristianos y musulmanes y hablan muchos idiomas. Sin embargo, no toda persona de aspecto negro o afroamericano se identifica con estas etiquetas. En EEUU, los hombres negros son un grupo diverso que abarca, entre otros, a afrocubanos, caribeños, brasileños y africanos.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/hombresnegrosFS.pdf</url>
	</node>
	<node>
		<title>Mujeres negras</title>
		<tax>1737</tax>
		<content><![CDATA[Desde el inicio de la epidemia, el VIH ha azotado a los hombres y mujeres negros radicados en EE.UU. A pesar de componer sólo el 12% de la población femenina del país, en el 2006 las mujeres negras representaban el 61% de los casos nuevos entre mujeres. Se diagnostica el VIH a mujeres negras con 15 veces más frecuencia que a mujeres caucásicas. Las mujeres negras también tienen altas tasas de infecciones transmitidas sexualmente (ITS), lo cual puede promover la transmisión del VIH. En el 2006, la tasa de clamidia entre mujeres negras era 7 veces mayor, la de gonorrea 14 veces mayor y la de sífilis 16 veces mayor que entre mujeres caucásicas. Estas cifras y estadísticas no terminan de revelar toda la riqueza y diversidad de las vidas de las mujeres negras, un grupo que abarca a oficinistas y obreras, cristianas y musulmanas, habitantes de áreas urbanas y de suburbios, descendientes de esclavos e inmigrantes caribeñas recién llegadas. Ellas trabajan, estudian, crían a sus familias, se enamoran. El VIH entre las mujeres negras no se debe exclusivamente a su conducta individual, sino a un sistema complejo de aspectos sociales, culturales, económicos, geográficos, religiosos y políticos los cuales se entrelazan para afectar a su salud.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/MujeresNegrasFS.pdf</url>
	</node>
	<node>
		<title>Hombres gays Latinos en los Estados Unidos</title>
		<tax>1737</tax>
		<content><![CDATA[El panorama siempre cambiante de los antecedentes demográficos de los latinos radicados en EE.UU. nos plantea retos singulares para resolver las disparidades de salud de esta población, especialmente con respecto a sus necesidades de prevención del VIH. Los latinos son el grupo etno-racial minoritario más numeroso y con mayor velocidad de crecimiento en EE.UU., con un crecimiento del 43% entre el 2000 y el 2010. Los datos también indican que los latinos son una de las poblaciones con aumento más rápido de riesgo de transmisión del VIH.
<ul>
 	<li>Los hombres latinos que tienen sexo con hombres (HSH o MSM por sus siglas en inglés*) representan el 81% de las nuevas infecciones entre hombres latinos y el 19% de todos los HSH en general.</li>
 	<li>Los latinos componen el 16% de la población de EE.UU. pero representan el 17% de las personas vivas con VIH/SIDA y el 20% de nuevas infecciones cada año.</li>
 	<li>Los jóvenes (13-29 años de edad) son el 45% de las nuevas infecciones de VIH entre los latinos MSM.</li>
</ul>
Estos datos señalan la necesidad de identificar las necesidades de salud culturalmente específicas de los hombres latinos homosexuales con el fin de crear intervenciones eficaces que respondan a las disparidades actuales de salud y eviten otras futuras. La Estrategia Nacional de EE.UU. contra el VIH/SIDA subraya la necesidad de programas de VIH que reduzcan las inequidades entre poblaciones minoritarias etno-raciales y sexuales. Los hombres latinos gay tienen identidades multiculturales distintas que los ubican en ambas categorías priorizadas.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2013/02/Latino-MSM-Spanish-2013.pdf</url>
	</node>
	<node>
		<title>HIV vaccine</title>
		<tax>1737</tax>
		<content><![CDATA[Vaccines are among the most powerful and cost-effective disease prevention tools available. A vaccine that could prevent HIV infection or stop progression of the disease would greatly help in the fight against the AIDS pandemic. Vaccines have been pivotal in worldwide smallpox elimination efforts, have nearly eliminated polio and have drastically reduced the incidence of infectious diseases like measles and pertussis in the US. A crucial question is whether a vaccine based on one strain of HIV would be effective for populations in which a different strain is predominant.

There are also questions about how an HIV vaccine would protect individuals: the vaccine might not be able to actually prevent infection, but could prevent or delay progression to disease, or simply reduce the infectiousness of people who do become infected with HIV. HIV prevention education and counseling are important components of vaccine programs. Even after the release of a vaccine, there will be an ongoing need for effective behavioral prevention programs. An HIV vaccine will not be a “magic bullet” but it could play an extremely powerful role as part of a package of prevention interventions.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revvaccineFS.pdf</url>
	</node>
	<node>
		<title>Vacuna</title>
		<tax>1737</tax>
		<content><![CDATA[Las vacunas son una de las herramientas más poderosas y costo-efectivas que tenemos para evitar las enfermedades. Una vacuna que impidiera la infección por VIH o que detuviera la progresión de la enfermedad ayudaría considerablemente en la lucha contra la pandemia del SIDA. Una pregunta crucial es si una vacuna basada en una determinada cepa del VIH sería eficaz para poblaciones en las cuales predomina otra cepa.

También existen dudas sobre cómo una vacuna contra el VIH protegería a los individuos: aunque no evitara la transmisión de la infección, tal vez la vacuna pudiera evitar o retrasar el desarrollo de la enfermedad, o simplemente reducir la infecciosidad de las personas que contraigan el VIH. La educación y consejería de prevención del VIH son componentes importantes de los programas de vacunación. Incluso después de la comercialización de una vacuna, todavía continuará la necesidad de programas eficaces de prevención conductual. La vacuna contra el VIH no será una panacea universal, pero podría jugar un papel poderoso como parte de un conjunto de intervenciones preventivas.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/vacunaFS.pdf</url>
	</node>
	<node>
		<title>Sex education</title>
		<tax>1737</tax>
		<content><![CDATA[Sex and HIV education programs have multiple goals: to decrease unintended pregnancy, to decrease STDs including HIV and to improve sexual health among youth. In 2005, almost two-thirds (63%) of all high school seniors in the US had engaged in sex, yet only 21% of all female students used birth control pills before their last sex and only 70% of males used a condom during their last sexual intercourse. In 2000, 8.4% of 15-19 year old girls became pregnant, producing one of the highest teen pregnancy rates in the western industrial world. Persons aged 15-24 had 9.1 million new cases of STDs in 2000 and made up almost half of all new STD cases in the US.

There are numerous factors affecting adolescent sexual behavior and use of protection. Some of these factors have little to do with sex, such as growing up in disadvantaged communities, having little attachment to parents or failing at school. Other factors are sexual in nature, such as beliefs, values, perceptions of peer norms, attitudes and skills involving sexual behavior and using condoms or contraception. It is these sexual factors that sex/HIV education programs can potentially affect, thereby impacting behavior. Sex/HIV education programs alone cannot totally reduce sexual risk-taking, but they can be an effective part of a more comprehensive initiative.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revsexedFS.pdf</url>
	</node>
	<node>
		<title>Educación sexual</title>
		<tax>1737</tax>
		<content><![CDATA[Los programas educativos sobre la sexualidad y el VIH tienen varias metas: disminuir los embarazos no planeados, reducir las enfermedades de transmisión sexual (ETS) incluyendo la del VIH y mejorar la salud sexual de los jóvenes. En 2005 en los EE.UU., el 63% de todos los alumnos del último año de preparatoria (high school) habían tenido relaciones sexuales, pero sólo el 21 % de las alumnas usaron pastillas anticonceptivas antes del último coito y sólo el 70 % de los varones usaron condón en el último coito. En el 2000, el 8.4 % de las chicas entre 15 y 19 años se embarazaron, produciendo una de las tasas más altas de embarazo adolescente en el mundo occidental industrializado. Casi la mitad de los nuevos casos de ETS en EE.UU. del año 2000 (9.1 millones) se presentaron en jóvenes entre los 15 y los 24 años de edad.

Algunos de los numerosos factores que influyen en la conducta sexual y el uso de protección entre los adolescentes tienen poco que ver con las relaciones sexuales, por ejemplo: la crianza en una comunidad desfavorecida, la falta de apego a los padres o el fracaso escolar. Otros factores de naturaleza sexual como las creencias, los valores, las percepciones de normas de los pares, las actitudes y habilidades relacionadas con la conducta sexual y con el uso del condón o de anticonceptivos, son factores en los que los programas de enseñanza potencialmente pueden incidir para generar cambios de conducta. Estos programas no pueden por sí solos eliminar las conductas sexuales riesgosas, pero sí pueden ser una pieza eficaz dentro de una iniciativa integral.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revensenanzaFS.pdf</url>
	</node>
	<node>
		<title>Stigma</title>
		<tax>1737</tax>
		<content><![CDATA[HIV-related stigma is a significant problem globally. HIV stigma inflicts hardship and suffering on people living with HIV and interferes with research, prevention, treatment, care and support efforts. HIV-related stigma refers to negative beliefs, feelings and attitudes towards people living with HIV, their families and people who work with them. HIV stigma often reinforces existing social inequalities based on gender, race, ethnicity, class, sexuality and culture. Stigma against many vulnerable populations who are disproportionately affected by HIV (such as the stigma of homosexuality, drug use, poverty, migration, transgender status, mental illness, sex work and racial, ethnic and tribal minority status) predates the epidemic and intersects with HIV stigma, which compounds the stigma and discrimination experienced by people living with HIV (PLWH) who belong to such groups.1 HIV-related discrimination, also known as enacted HIV stigma, refers to the unfair and unjust treatment of someone based on their real or perceived HIV status. Discrimination also affects family members and friends, caregivers, healthcare and lab staff who care for PLWH. The drivers of HIV-related discrimination usually include misconceptions regarding casual transmission of HIV and pre-existing prejudices against certain populations, behaviors, sex, drug use, illness and death. Discrimination can be institutionalized through laws, policies and practices that unjustly affect PLWH and marginalized groups.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/11/StigmaFSUpdatefinal_20161020.pdf</url>
	</node>
	<node>
		<title>Testing &amp; link to care</title>
		<tax>1737</tax>
		<content><![CDATA[Despite major progress against HIV, 21% of HIV+ people in the US are unaware that they are positive and an estimated 33% of those who know they are HIV+ are not engaged in care and treatment for their infection.Another 38% of newly diagnosed HIV+ individuals test so late that they receive an AIDS diagnosis at the same time as, or within one year of, learning they are positive. There were an estimated 56,300 new HIV infections per year between 1996 and 2006. Clearly, the US can and must do better in responding to the HIV/AIDS epidemic.

One way to increase the percentage of HIV+ people engaged in care and treatment for their infection and improve their health outcomes is to focus on coordinating or co-locating HIV testing, care and treatment, social services and prevention programs. Increasing the percentage of HIV+ people who know their serostatus and are receiving care and antiretroviral treatment could also have benefits for HIV prevention.

The National HIV/AIDS Strategy places testing and linkage to care, treatment and support services at the heart of the effort to improve the health outcomes of HIV+ individuals and prevent new infections. What is the scientific basis for this approach, how might it actually be implemented, and will it have the desired results in the real world?]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/TLCplusFS.pdf</url>
	</node>
	<node>
		<title>Black Gay Men and the Church</title>
		<tax>1737</tax>
		<content><![CDATA[Many Black men in the US grow up in families that are significantly involved with the Black church. As a long-standing institution developed for and by Black people, the Black church provides religious education and spiritual formation, and buffers against societal oppressions. The church has been a vital and trusted institution in the Black community, providing support, defining values, and building community.

Using the biblical themes of social justice and inherent dignity of all people, the Black church helped restore and promote the self esteem and self-worth of Black people who were victims of racial and other kinds of oppression. However, some Black gay men feel alienated from Black religious congregations. These men experience various homophobic and AIDS-phobic messages that increase their feelings of shame, diminish their religious identity, and are separated from important resources of the Black church.

The Black church is a part of many Black gay men’s lives, and, unfortunately, so is HIV. The HIV/AIDS epidemic has had a devastating effect on Black gay men in the US. Black gay and bisexual men are the most heavily impacted population in the Black community. Among all men who have sex with men (MSM), black MSM accounted for 10,600 (36%) estimated new HIV infections in 2010. From 2008 to 2010, new HIV infections increased 22% among young (aged 13-24) MSM and 12% among MSM overall—an increase largely due to a 20% increase among young black MSM. At the end of 2010, of the estimated 872, 990 persons living with an HIV diagnosis, 440,408 (50%) were among MSM with 31% of those living with the disease being African American.

Black men who have sex with other men may self-identify as gay, same gender-loving, bisexual, straight, or may refuse to be categorized at all. For this Fact Sheet, we use the term “Black gay men” to refer to all Black men who have sex with men.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2013/04/BlackchurchandgaymenFSdraft3.pdf</url>
	</node>
	<node>
		<title>Estigma</title>
		<tax>1737</tax>
		<content><![CDATA[El estigma relacionado con el VIH/SIDA es un concepto complejo que se refiere al prejuicio, la exclusión, el desprestigio y la discriminación dirigidos hacia personas percibidas como infectadas por el SIDA o el VIH, y también hacia sus parejas, amistades, familias y comunidades.

Muchas veces el estigma del VIH/SIDA reafirma las desigualdades sociales basadas en el sexo, la raza, el grupo étnico, la clase social, la sexualidad y la cultura de las personas. En EE.UU. por mucho tiempo ha existido el estigma hacia muchas poblaciones excesivamente afectadas por el VIH. El mismo VIH ha agravado el estigma de la homosexualidad, del consumo de drogas, de la pobreza, del trabajo sexual y de la condición de minoría racial.

El estigma del VIH/SIDA es un problema no sólo en EE.UU. sino en todo el mundo, y tiene varias formas, entre ellas: 1) el ostracismo, el rechazo y el soslayo de las personas con SIDA; 2) la discriminación contra las personas con SIDA por parte de sus familias, proveedores médicos, comunidades y gobiernos; 3) la realización de pruebas obligatorias del VIH sin consentimiento previo ni la debida protección de la privacidad; 4) la puesta en cuarentena de personas VIH+; y 5) la violencia contra personas que parecen tener SIDA, ser VIH+ o pertenecer a “grupos de alto riesgo”.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/estigmaFS.pdf</url>
	</node>
	<node>
		<title>[possible dublicate] Black Gay Men and the Church</title>
		<tax>1737</tax>
		<content><![CDATA[Many Black men in the US grow up in families that are significantly involved with the Black church. As a long-standing institution developed for and by Black people, the Black church provides religious education and spiritual formation, and buffers against societal oppressions. The church has been a vital and trusted institution in the Black community, providing support, defining values, and building community.

Using the biblical themes of social justice and inherent dignity of all people, the Black church helped restore and promote the self esteem and self-worth of Black people who were victims of racial and other kinds of oppression. However, some Black gay men feel alienated from Black religious congregations. These men experience various homophobic and AIDS-phobic messages that increase their feelings of shame, diminish their religious identity, and are separated from important resources of the Black church.

The Black church is a part of many Black gay men’s lives, and, unfortunately, so is HIV. The HIV/AIDS epidemic has had a devastating effect on Black gay men in the US. Black gay and bisexual men are the most heavily impacted population in the Black community. Among all men who have sex with men (MSM), black MSM accounted for 10,600 (36%) estimated new HIV infections in 2010. From 2008 to 2010, new HIV infections increased 22% among young (aged 13-24) MSM and 12% among MSM overall—an increase largely due to a 20% increase among young black MSM.2 At the end of 2010, of the estimated 872, 990 persons living with an HIV diagnosis, 440,408 (50%) were among MSM with 31% of those living with the disease being African American.

Black men who have sex with other men may self-identify as gay, same gender-loving, bisexual, straight, or may refuse to be categorized at all. For this Fact Sheet, we use the term “Black gay men” to refer to all Black men who have sex with men.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2013/04/BlackchurchandgaymenFSdraft3.pdf</url>
	</node>
	<node>
		<title>A Pilot RCT of Expressive Writing with HIV-Positive Methamphetamine Users</title>
		<tax>1737</tax>
		<content><![CDATA[It is well established that HIV-positive persons who use stimulants such as methamphetamine are at increased risk for transmitting medication-resistant strains HIV. Mental health co-morbidities such as symptoms of post-traumatic stress disorder and HIV-specific traumatic stress may substantially contribute to increased stimulant use among HIV-positive persons. Consequently, adjuvant mental health interventions designed to address traumatic stress could ultimately improve substance abuse treatment outcomes and reduce transmission risk behavior among HIV-positive methamphetamine-using men. In particular, expressive writing is a self-administered, exposure-based intervention to address trauma that could be easily disseminated to substance abuse treatment programs without placing significant additional burden on staff for training or intervention delivery. Over the past 20 years, numerous randomized controlled trials (RCTs) have examined the efficacy of self-administered expressive writing interventions where participants are asked write about traumatic events for 15-30 minutesover 1-5 days. Findings from meta-analyses observed that expressive writing interventions improve psychological adjustment, physiological functioning, and self-reported physical health in various populations. However, to our knowledge no published research has examined the efficacy of expressive writing with active drug users. The proposed formative clinical research will examine the safety, feasibility, and potential clinical utility of delivering a self-administered, expressive writing intervention to HIV-positive methamphetamine-using men. In order to evaluate expressive writing, we will conduct a pilot RCT with 90 HIV-positive methamphetamine-using men. In addition to providing data on safety and feasibility, this RCT will provide an opportunity to examine the potential clinical utility of expressive writing with respect to measures of psychological adjustment (primary outcome) as well as substance use and HIV transmission risk behavior (secondary outcomes). Establishing that expressive writing is safe, feasible, and potentially efficacious with this population represents a crucial first step to inform a planned clinical research program. Subsequent clinical research will examine whether expressive writing can serve as an efficacious adjuvant to substance abuse treatment with HIV-positive methamphetamine-using men. Improving the effectiveness of substance abuse treatment for HIV-positive methamphetamine-using men would alleviate human suffering and could ultimately reduce HIV transmission rates.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Carrico.-A-Pilot-RCT-of-Expressive-Writing-with-HIV-Positive-Methamphetamine-Users.pdf</url>
	</node>
	<node>
		<title>Disclosure</title>
		<tax>1737</tax>
		<content><![CDATA[Disclosure of HIV+ status is a complex, difficult and very personal matter. Disclosing one’s HIV+ status entails communication about a potentially life threatening, stigmatized and transmissible illness. Choices people make about this are not only personal but vary across different age groups, in different situations and contexts, and with different partners, and may change with time, depending on one’s experiences. Disclosure may have lifelong implications since more people are living longer, and often asymptomatically, with HIV.

Public health messages have traditionally urged disclosure to all sexual and drug using partners. In reality, some HIV+ persons may choose not to disclose due to fears of rejection or harm, feelings of shame, desires to maintain secrecy, feelings that with safer sex there is no need for disclosure, fatalism, perceived community norms against disclosure, and beliefs that individuals are responsible for protecting themselves. This Fact Sheet primarily focuses on disclosure in the context of sex.

Discussing and disclosing HIV status is a two-way street. Be it right or wrong, most people feel that when a person knows that he/she is HIV+ then he/she has an obligation to tell the other person, and counselors are encouraged to help people with this process. Also, laws in some areas require disclosure of HIV+ status prior to sex. However, both partners should be responsible for knowing their own status, disclosing their own status when it seems important, and asking their partner about their status if they want to know.

Most HIV+ persons disclose their status to some, but not all, of their partners, friends and family. Disclosure generally becomes easier the longer someone has been living with HIV, as he/she becomes more comfortable with an HIV+ status. Disclosure to sex partners is more likely in longer-term, romantic relationships than in casual relationships (one-night stands, anonymous partners, group scenes, etc.). Disclosure also varies depending on perceived HIV status of partners, level of HIV risk of sex activities, sense of responsibility to protect partners (personal vs. shared responsibility) and alcohol or drug use.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/disclosureFS.pdf</url>
	</node>
	<node>
		<title>Revelación del estatus de VIH</title>
		<tax>1737</tax>
		<content><![CDATA[La revelación de la condición de ser VIH+ es un asunto complejo, delicado y muy personal. Se trata de hablar sobre una enfermedad estigmatizada, transmisible y potencialmente mortal. Las decisiones al respecto no sólo son personales sino que varían según la edad, la situación, el contexto y la pareja, y pueden cambiar durante el transcurso del tiempo y según las experiencias de la persona.

Históricamente, los mensajes de salud pública han exhortado la revelación del estatus de VIH a toda pareja sexual y de drogas. En la realidad, algunas personas VIH+ tal vez prefieran no revelar su estatus por varios motivos: temor al rechazo o daño, sentimientos de culpabilidad, el deseo de mantenerlo en secreto, creer que al protegerse durante el acto sexual ya no es necesario revelarla, fatalismo, la percepción de normas comunitarias en contra de la revelación y creer que los otros tienen la responsabilidad de protegerse. Esta hoja se centra en la revelación del estatus de VIH dentro del contexto sexual.

Comentar y revelar el estatus de VIH es una vía de doble sentido. Ya sea correcto o no, la mayoría de las personas creen que cuando una persona se sabe VIH+ entonces le incumbe informar a su pareja, y a los consejeros se les anima a ayudarles en este proceso. Además, en algunas áreas las leyes requieren la revelación del estatus de VIH+ antes de iniciar el contacto sexual. Sin embargo, ambos integrantes de la pareja deben compartir la responsabilidad de conocer su propia condición, de revelarla cuando lo estimen importante y de preguntar a su pareja sobre la condición del otro si desean enterarse.

La mayoría de las personas VIH+ revelan su estatus a algunas pero no a todas sus parejas, amistades y familiares. Generalmente, entre más tiempo se viva con el VIH, más fácil se hace aceptar y revelar dicha estatus. La revelación del estatus de VIH a parejas sexuales es más común en las relaciones románticas de largo plazo que en las casuales (aventuras de una noche, parejas anónimas, sesiones grupales, etc.). La revelación también varía según la percepción del estatus de VIH de las parejas, el nivel de riesgo de VIH de los actos sexuales, el sentido de responsabilidad de proteger a las parejas (responsabilidad personal vs. compartida) y el consumo de alcohol o drogas.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revelacionFS.pdf</url>
	</node>
	<node>
		<title>Disclosure assistance (PCRS)</title>
		<tax>1737</tax>
		<content><![CDATA[After more than 20 years of the HIV epidemic, with advances in treatment and increases in understanding and acceptance of HIV, getting an HIV+ diagnosis still can be a traumatic experience. HIV+ persons must come to terms with their own infection and be concerned with possible infection in past and future partners. Talking to partners about HIV is especially hard because even though it is a manageable disease, HIV still is not curable.

Disclosure assistance services (also known as partner counseling and referral services or PCRS) are an array of voluntary and confidential services available to persons living with HIV and their exposed sex and/or needle-sharing partner(s). Disclosure assistance is cost effective and can play a critical role in identifying those individuals most at risk for HIV infection, and linking those who are infected to early medical care and treatment.

Most HIV+ persons make the decision to disclose or not disclose to their partners on their own. But HIV+ persons may want support for telling their partners about HIV, whether by encouragement for self-disclosure or by having someone who is well-trained carefully and confidentially notify a partner for them. In one study, persons who received disclosure assistance were over three times more likely to have informed a partner of their risk.

In the past few years, HIV counseling and testing programs across the US have shifted their emphasis from testing anyone, to finding and testing persons at greatest risk for HIV infection. At general HIV testing sites, around 1% of clients tested are found to be HIV+, whereas 8-39% of clients tested through disclosure assistance are found to be HIV+.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revPCRSFS.pdf</url>
	</node>
	<node>
		<title>HIV counseling and testing</title>
		<tax>1737</tax>
		<content><![CDATA[HIV counseling and testing (C&amp;T) is an important part of a continuum of HIV prevention and treatment services. C&amp;T is one of the main times when a comprehensive individual risk assessment is taken, making it the best opportunity for accurate referrals to more intensive services. C&amp;T is also one of the primary entry points into prevention and other services. C&amp;T uses short, client-centered counseling that can be effective in increasing condom use and preventing sexually transmitted diseases (STDs).

Knowing one’s HIV status, whether HIV- or HIV+, is key to preventing the spread of HIV and accessing counseling and medical care. It is estimated that one-fourth of all HIV+ persons in the US do not know they’re infected. A survey of young men who have sex with men (MSM), found that 14% of young Black MSM were HIV+. Among those, 93% were unaware of their infection, and 71% reported it was unlikely they were HIV+.

Recently, the Centers for Disease Control and Prevention (CDC) announced an initiative aimed at expanding C&amp;T in the US. Their Strategic Plan for 2005 strives to decrease by 50% the number of people who don’t know their HIV status. If this goal is met by 2010, an estimated 130,000 new HIV infections may be prevented, saving over $18 billion.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/C&amp;TFS.pdf</url>
	</node>
	<node>
		<title>Consejería y prueba de VIH</title>
		<tax>1737</tax>
		<content><![CDATA[La consejería y prueba (C&amp;P) del VIH es un componente importante en la gama de servicios de prevención y tratamiento del VIH. Ya que la visita para la C&amp;P incluye una evaluación individual integral de riesgo, ésta ofrece la mejor oportunidad para remitir al cliente a otros servicios más intensivos. Por otra parte, la C&amp;P es una de las entradas a los servicios de prevención y a otros servicios. La consejería breve y enfocada en el cliente que la C&amp;P proporciona puede incrementar el uso de condones y evitar la propagación de las enfermedades de transmisión sexual (ETS).

Conocer la condición de VIH, ya sea VIH- o VIH+, es clave para evitar la transmisión del VIH y para obtener consejería y atención médica. Se calcula que la cuarta parte de las personas VIH+ en los EE.UU. no saben que están infectadas. Una encuesta entre hombres jóvenes que tienen sexo con hombres (HSH) encontró que el 14% de los jóvenes negros HSH eran VIH+. El 93% de éstos desconocían estar infectados y el 71% afirmaron que era poco probable que fueran VIH+.

Hace poco los Centros para el Control y Prevención de Enfermedades (CDC, siglas en inglés) anunciaron una iniciativa para expandir la C&amp;P en EE.UU. Su plan estratégico del año 2005 pretende reducir en un 50% el número de personas que ignoran su condición de VIH. Si se cumple esta meta para el año 2010, se calcula que se prevendrán unas 130,000 nuevas infecciones de VIH, ahorrándose así más de $18 mil millones.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/C&amp;PFS.pdf</url>
	</node>
	<node>
		<title>Black women</title>
		<tax>1737</tax>
		<content><![CDATA[Black women and men in the US are hard hit by HIV, and have been since the beginning of the epidemic. In 2006, Black women accounted for 61% of new HIV cases among women, but make up only 12% of US female population. The rate of HIV diagnoses for Black women is 15 times the rate for White women.

Black women also have high rates of sexually transmitted diseases (STDs), which can facilitate transmission of HIV. Among Black women in 2006, the rate of chlamydia was 7 times higher, gonorrhea 14 times higher, and syphilis 16 times higher than the rate among White women.

These numbers and statistics, however, don’t show the richness and diversity of Black women’s lives. Black women can be White collar and working class, Christians and Muslims. They live in inner-city and suburban neighborhoods, are the descendants of slaves and recent Caribbean immigrants. They work, go to school, raise families, fall in love. HIV among Black women is not simply about individual behavior, but a complex system of social, cultural, economic, geographic, religious and political factors that combine to affect health.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/BlackwomenFS.pdf</url>
	</node>
	<node>
		<title>Childhood sexual abuse (CSA)</title>
		<tax>1737</tax>
		<content><![CDATA[Childhood sexual abuse may be defined in many ways, but this fact sheet refers to unwanted sexual body contact prior to age 18, the age of consent to engage in sex. CSA is a painful experience on many levels that can have a profound and devastating effect on later physiological, psychosocial and emotional development.

CSA experiences can vary with respect to duration (multiple experiences with the same perpetrator), degree of force/coercion or degree of physical intrusion (from fondling to digital penetration to attempted or completed oral, anal or vaginal sex). The identity of the perpetrator–ranging from a stranger to a trusted figure or family member–may also impact the long-term consequences for individuals. To distinguish CSA from exploratory sexual experimentation, the contact should be unwanted/coerced or there should be a clear power difference between the victim and perpetrator, often defined as the perpetrator being at least 5 years older than the victim.

Many more children are sexually abused than are reported to authorities. Estimates of the prevalence of CSA in the US are about 33% for females under the age of 18 and 10% in males under 18 years of age. Men are significantly less likely than women to report CSA when it occurs.

CSA is more likely to occur in families under duress. Children are at risk for CSA in families that experience stress, poverty, violence and substance abuse and whose parents and relatives have histories of CSA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/CSAFS.pdf</url>
	</node>
	<node>
		<title>Abuso sexual infantil</title>
		<tax>1737</tax>
		<content><![CDATA[El abuso sexual infantil (ASI) tiene muchas definiciones, pero en esta hoja informativa nos referimos al contacto corporal no deseado antes de los 18 años, que es la edad en que se considera que una persona puede dar su consentimiento para tener contacto sexual. El ASI es una experiencia dolorosa a muchos niveles que puede tener, posteriormente, efectos profundos y devastadores en el desarrollo psicológico, psicosocial y emocional.

Las experiencias de ASI pueden variar respecto a: duración (varios incidentes con el mismo agresor), grado de fuerza/coerción o grado de intrusión física (desde una caricia, a la penetración digital o al sexo oral, anal o vaginal intentado o consumado). La identidad del agresor/a (que podría ser un desconocido, una persona de confianza o un familiar) también puede influir en las consecuencias a largo plazo para las víctimas. Lo que distingue el ASI de la experimentación sexual exploratoria es el contacto indeseado o forzado o la clara desproporción de poder; comúnmente, se determina como agresor/a alguien que resulte por lo menos 5 años mayor que la víctima.

El número de abusos sexuales infantiles excede el número de casos reportados a las autoridades. Se calcula que la prevalencia del ASI en EE.UU. es del 33% entre chicas menores de 18 años y del 10% entre chicos menores de 18 años. Los hombres son considerablemente menos propensos a reportar un incidente de ASI que las mujeres.

La probabilidad de que el ASI ocurra aumenta en familias que sufren mucha tensión. Los niños están en riesgo de ser abusados sexualmente en familias que padecen estrés, pobreza, violencia y consumo de alcohol o drogas y cuyos padres y parientes tienen antecedentes de ASI.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/AbusoFS.pdf</url>
	</node>
	<node>
		<title>Application of Weighted Time-Series to Address Bias in Evaluation of Clinic- and Community-Level Research</title>
		<tax>1737</tax>
		<content><![CDATA[This study will use simulation to develop, test and apply new analytic methods (weighted time-series) for evaluation of community-level interventions. It will then compare results using weighted time-series and conventional methods within the context of a clinic-level intervention to provide family-centered HIV care, voluntary counseling and testing (VCT) and prevention services at Family AIDS Care and Education Services (FACES), a community-based organization in Kenya. Because FACES includes observational data on virtually all patients in care at participating clinics, it provides an excellent platform to evaluate the effectiveness of this intervention using both cohort and time-series methods. The results of this study will be used to seek funding to test the broader application of these methods in both community- and clinic-level interventions.

The specific aims of the proposed project are:
<ul>
 	<li>To provide the rationale and framework for applying weighted time-series to serial cross-sectional data.</li>
 	<li>To use simulation (created data) to apply and test the use of weighted time-series in a setting where the distribution of demographic characteristics and the health status of the population changes over time.</li>
 	<li>To use existing clinical data to compare the effect of introducing family-centered HIV care, VCT and prevention services on the transmission of HIV among the families served by participating clinics using cohort analysis, time-series analysis and weighted time-series.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Shade_S-WeightedTimeSeriestoAddressBias2009.pdf</url>
	</node>
	<node>
		<title>Assessment of Economic Factors Associated with the Psychological Well-Being of HIV+ Persons in Kenya</title>
		<tax>1737</tax>
		<content><![CDATA[The specific aim of this study is to conduct a preliminary assessment of the association between measures of economic context and material well-being on the one hand, and positive and negative psychological wellbeing on the other. We postulate that positive psychological well-being is a key determinant of effective and sustainable care and treatment for HIV+ persons, with potential to help reduce situations of HIV transmission.

The study will include 100 HIV+ men and 100 HIV+ women receiving care in Kenya. The total number of respondents will be equally distributed between the cities of Nairobi and Kisumu. A convenience sampling approach—stratified by gender—will be used in Kisumu. Oversampling of persons currently employed in the formal or informal sectors will be applied in Nairobi. Survey administration will be conducted simultaneously at both sites over a six month period.

We will conduct three types of analyses:
<ol>
 	<li>Assess and select measures for the degree of variation they exhibit.</li>
 	<li>Conduct bivariate measures of association in order to assess unadjusted associations between the psychological well-being measures and those economic factors that demonstrate sufficient variation.</li>
 	<li>Conduct logistic or multinomial logistic regressions in order to assess the extent of the relationship between the psychological well-being and the economic factors after accounting for potential confounders and effect modifiers.</li>
</ol>
Information drawn from this study will help fill the gap in understanding the connections between structural factors and psychological well-being of HIV+ persons.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Arnold_M-EconomicfactWellBeingHIVposKenya2009.pdf</url>
	</node>
	<node>
		<title>Disclosure Intervention for Zimbabwean Parents</title>
		<tax>1737</tax>
		<content><![CDATA[We propose a randomized controlled trial of a disclosure intervention in which 300 PLH are randomized to either an: 1) experimental condition, a disclosure intervention (n = 150 parents) or 2) attention control condition, a nutrition intervention (n = 150). The intervention's impact will be assessed over two years (recruitment, 3, 6, 12, 18, &amp; 24 months). The 3-session, culturally tailored disclosure intervention will be delivered by local nurses and address planning for developmentally appropriate disclosure (how and when to disclose), responding to children's reactions, building a supportive family environment, and custody planning. The attention control condition will be relevant to PLH, also delivered by nurses and address nutrition. Therefore, the Specific Aims are to: 1) Primary Aim: Assess the efficacy of the intervention to increase the frequency and timing of parental disclosure. We hypothesize that PLH randomized to the disclosure intervention will be significantly more likely to disclose their own HIV status to their children (parental disclosure) and disclose sooner than PLH randomized to the control condition. 2) Primary Aim: Assess the longitudinal impact of disclosure on parent (medical, psychological, social), child (psychological, behavioral, social) and family outcomes. We hypothesize that parent (health status, depression, anxiety, social support), child (depression, anxiety, HIV-transmission risk behaviors, social support) and family outcomes (family relationships, custody planning) will be significantly better for families in the intervention than families randomized to the control condition. 3) Secondary Aim: Assess the efficacy of the intervention to increase pediatric disclosure. We hypothesize that PLH randomized to the disclosure intervention will be significantly more likely to disclose to a child that s/he is HIV-positive (pediatric disclosure) than PLH randomized to the control condition. The proposed study addresses a neglected and profoundly understudied area that is of high importance to millions of families affected by HIV. If successful, the proposed study will provide evidence for a sustainable model and efficacious disclosure intervention in low-income settings.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Lightfoot.-Disclosure-Intervention-for-Zimbabwean-Parents1.pdf</url>
	</node>
	<node>
		<title>HIV Prevention among Township Men Who Have Sex with Men in South Africa</title>
		<tax>1737</tax>
		<content><![CDATA[This project has two aims: 1
<ol>
 	<li>To describe collective and individual belief systems of low-income township men who have sex with men (MSM) related to their sexuality, sexual health, choice of sexual partners, use of drugs and alcohol, use of condoms, utilization of health services, HIV voluntary counseling and testing (VCT) and disclosure of HIV status, in order to describe prevailing cultural norms around these subjects’ behaviors</li>
 	<li>To assess the prevalence of HIV risk factors and HIV infection among MSM from Soweto township.</li>
</ol>
This study is the first of its kind in South Africa. Through in-depth interviews, focus group discussions, and structured observations of MSM social venues, we have been able to describe the gender identities and sexualities that are prevalent in township MSM communities. We will estimate the prevalence of risk behaviors and HIV infection in Soweto using respondent-driven sampling methodology. This will be the first HIV prevalence data for an MSM community in South Africa.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lane_T-TownshipMSMinSAfrica2009.pdf</url>
	</node>
	<node>
		<title>Enhancing HIV Treatment Adherence in South India: The Chetana Study</title>
		<tax>1737</tax>
		<content><![CDATA[The study brings together researchers from the University of California, San Francisco and St. John’s National Academy of Health Sciences in Bangalore, India. The overall goal of this study is to evaluate the impact of a promising Antiretroviral Therapy (ART) adherence-enhancing intervention grounded in Social Cognitive Theory (SCT) that addresses the needs of people living with HIV (PLHIV). This intervention targets not only medication adherence, but also other culturally-relevant topics designed to enhance physical and mental health among PLHIV, including yoga/meditation, nutrition, legal services, and assistance accessing local resources. We are testing this promising intervention in a Randomized Controlled Trial (RCT) among 500 sub-optimally adherent patients, comparing it to a time-matched active control condition, consisting of the non-adherence specific components of the intervention.

Specifically, we propose:
<ol>
 	<li>To evaluate the impact of the Chetana intervention on antiretroviral medication adherence and treatment outcome, as measured by self-report, viral load, Wisepill wireless monitoring, and medical chart review. We hypothesize that participants in the intervention arm will show a significant reduction in missed pills as well as a reduced number of treatment interruptions and improved viral suppression, compared to participants in the time-matched active control group.</li>
 	<li>To evaluate the impact of the Chetana intervention on reported adherence barriers. We hypothesize that participants in the intervention arm will report a significant reduction in number of adherence barriers, compared to participants in the time-matched active control group.</li>
 	<li>To examine wireless adherence monitoring as a predictor of treatment outcome. We hypothesize that this ongoing, objective real-time measure of adherence will better predict subsequent viral load than our self-reported Optimal Adherence measure that combines past month adherence and treatment interruptions.</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/11/Chetana-summary.pdf</url>
	</node>
	<node>
		<title>Word on the Street – November 2016</title>
		<tax>1737</tax>
		<content><![CDATA["Word on the Street" is disseminated quarterly to inform CAPS/UCSF PRC of new developments, issues, programs, policy agendas, etc. that are happening in, affecting, and are of interest to the community.

In this issue:
<ol>
 	<li>San Francisco EMA HIV Community Planning Council (HCPC)</li>
 	<li>Oakland TGA Collaborative Community Planning Council (CCPC)</li>
 	<li>California Department of Public Health Office of AIDS</li>
 	<li>Get Screened Oakland and Global Network of Black People working in HIV</li>
</ol>]]></content>
		
		<type>
			6
		</type>
			<url>http://myemail.constantcontact.com/Word-on-the-Street---November-2016---CAPS-UCSF-PRC.html?soid=1114093349314&amp;aid=IUCwQItk0xw</url>
	</node>
	<node>
		<title>Word on the Street – January 2017</title>
		<tax>1737</tax>
		<content><![CDATA[“Word on the Street” is disseminated quarterly to inform CAPS/UCSF PRC of new developments, issues, programs, policy agendas, etc. that are happening in, affecting, and are of interest to the community.

In this issue:
<ol>
 	<li>CA Department of Public Health Office of AIDS (CDPH–OA)</li>
 	<li>San Francisco EMA HIV Community Planning Council (HCPC)</li>
 	<li>Oakland Transitional Grant Area Community Collaborative Planning Council (CCPC)</li>
</ol>]]></content>
		
		<type>
			6
		</type>
			<url>http://conta.cc/2l0kAQI</url>
	</node>
	<node>
		<title>Word on the Street – February 2017</title>
		<tax>1737</tax>
		<content><![CDATA[“Word on the Street” is disseminated quarterly to inform CAPS/UCSF PRC of new developments, issues, programs, policy agendas, etc. that are happening in, affecting, and are of interest to the community.

In this issue:
<ol>
 	<li>CA Department of Public Health Office of AIDS (CDPH–OA)</li>
 	<li>San Francisco EMA HIV Community Planning Council (HCPC)</li>
 	<li>Oakland Transitional Grant Area Community Collaborative Planning Council (CCPC)</li>
 	<li>Other: Stay in the know!</li>
</ol>
<em>If you have questions or need more information, please contact Barbara:</em>

<strong>Barbara Green-Ajufo, DrPH, MPH</strong>
Research Partnership Manager
Community Engagement (CE) Core
Phone: (415) 476-6362
Email: <a href="mailto:barbara.green-ajufo@ucsf.edu">barbara.green-ajufo@ucsf.edu</a>]]></content>
		
		<type>
			6
		</type>
			<url>http://conta.cc/2n7B64h</url>
	</node>
	<node>
		<title>STYLE/M+ Implementation Resources</title>
		<tax>1737</tax>
		<content><![CDATA[This PRC project is focused on evaluating the adaptation of the STYLE (“Strength Through Youth Livin’ Empowered”) intervention, developed 10+ years ago in North Carolina, to a community-based clinic in Oakland, CA. APEB is calling their STYLE adaptation “M+.” They will develop social and standard marketing materials for the program. Clients who enroll in M+ will attend an orientation and educational session focused on health literacy and self advocacy skills. Participants may choose which social support programs to attend.

<a href="/sites/prevention.ucsf.edu/files/about/prc-projects/mplus/" target="_blank" rel="noopener noreferrer">Check out the M+ Implementation Resources Page here.</a><strong>*</strong>

<a href="/sites/prevention.ucsf.edu/files/about/prc-projects/" target="_blank" rel="noopener noreferrer">Check out UCSF PRC's Project STYLE  here.</a>

<em>*Please note that these resources are incomplete and currently under development and are continuously being updated as needed</em>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/about/prc-projects/mplus/</url>
	</node>
	<node>
		<title>Word on the Street – March 2017</title>
		<tax>1737</tax>
		<content><![CDATA[“Word on the Street” is disseminated quarterly to inform CAPS/UCSF PRC of new developments, issues, programs, policy agendas, etc. that are happening in, affecting, and are of interest to the community.

In this issue:
<ol>
 	<li>CA Department of Public Health Office of AIDS (CDPH–OA)</li>
 	<li>San Francisco EMA HIV Community Planning Council (HCPC)</li>
 	<li>Other: Stay in the know!</li>
</ol>
<em>If you have questions or need more information, please contact Barbara:</em>

<strong>Barbara Green-Ajufo, DrPH, MPH</strong>
Research Partnership Manager
Community Engagement (CE) Core
Phone: (415) 476-6362
Email: <a href="mailto:barbara.green-ajufo@ucsf.edu">barbara.green-ajufo@ucsf.edu</a>]]></content>
		
		<type>
			6
		</type>
			<url>http://conta.cc/2p458Yb</url>
	</node>
	<node>
		<title>Word on the Street – April 2017</title>
		<tax>1737</tax>
		<content><![CDATA[“Word on the Street” is disseminated quarterly to inform CAPS/UCSF PRC of new developments, issues, programs, policy agendas, etc. that are happening in, affecting, and are of interest to the community.

In this issue:
<ol>
 	<li>CA Department of Public Health Office of AIDS (CDPH–OA)</li>
 	<li>Oakland Transitional Grant Area Community Collaborative Planning Council (CCPC)</li>
 	<li>San Francisco EMA HIV Community Planning Council (HCPC)</li>
 	<li>Other: Stay in the know!</li>
</ol>
<em>If you have questions or need more information, please contact Barbara:</em>

<strong>Barbara Green-Ajufo, DrPH, MPH</strong>
Research Partnership Manager
Community Engagement (CE) Core
Phone: (415) 476-6362
Email: <a href="mailto:barbara.green-ajufo@ucsf.edu">barbara.green-ajufo@ucsf.edu</a>]]></content>
		
		<type>
			6
		</type>
			<url>http://conta.cc/2rUphhr</url>
	</node>
	<node>
		<title>RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users</title>
		<tax>1737</tax>
		<content><![CDATA[In the era of HIV treatment as prevention (TasP), efforts are needed to identify evidence-based combination prevention approaches that achieve greater decreases HIV viral load among populations that are more likely to engage in HIV transmission risk behavior. Because methamphetamine-using men who have sex with men (MSM) are at greater risk for acquiring and transmitting medication-resistant strains of HIV, interventions targeting stimulant use in this population of high-risk men could boost the effectiveness of TasP. At present, only conditional cash transfer approaches such as contingency management (CM) have demonstrated short-term efficacy in reducing stimulant use among substance-using MSM who are not actively seeking formal treatment. The proposed RCT will examine the efficacy of a positive affect intervention that is designed to optimize the effectiveness of CM to achieve long-term reductions in stimulant use and HIV viral load in this population. Our team will examine the efficacy of this integrative intervention in a randomized controlled trial (RCT) with 230 HIV-positive, methamphetamine-using MSM. After enrolling in CM, participants will be randomized to receive either: 1) the positive affect intervention; or 2) an attention-matched control condition. Follow-up data will be collected at 2, 3, 6, and 12 months post-randomization. This RCT will provide an opportunity to examine the efficacy of an integrative intervention designed to promote long-term reductions in HIV viral load as the primary outcome. Secondary outcomes that will be examined include: increases positive affect, reductions in stimulant use, improvements in T-helper (CD4+) count, and decreases HIV transmission risk behavior. Identifying an efficacious intervention approach to decrease HIV viral load among methamphetamine-using MSM would substantially support the goals of the National HIV/AIDS Strategy to reduce HIV incidence and mitigate HIV-related health disparities]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Carrico.-RCT-of-an-Integrative-Intervention-for-Non-Treatment-Seeking-Meth-Users.pdf</url>
	</node>
	<node>
		<title>Study Targeting Affect Regulation (STAR)</title>
		<tax>1737</tax>
		<content><![CDATA[The STAR study will develop and pilot test a multi-component intervention to promote affect regulation among HIV+ methamphetamine-using MSM. In Phase 1a of this study, the intervention will be pilot tested with 10 HIV+ methamphetamine-using MSM to obtain initial feedback that will assist with refining the protocol. In Phase 1b, we will conduct a pilot randomized controlled trial to examine the feasibility, acceptability and potential clinical utility of this affect regulation intervention with 70 HIV+ methamphetamine-using MSM.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Carrico_STAR_2010.pdf</url>
	</node>
	<node>
		<title>The Acute UFO Study: Acute HCV Infection in Young Injectors</title>
		<tax>1737</tax>
		<content><![CDATA[Young injection drug users (IDU) constitute a distinctive high risk and understudied group with high rates of hepatitis C virus (HCV) infection. The Acute UFO study has identified 135 incident HCV infections, 95 of which are being followed prospectively. In this study we are: Studying the epidemiology of acute HCV infection. Assessing immunological responses to acute HCV (the spectrum of cytotoxic T lymphocyte (CTL) responses and evolution within CTL targets (“epitopes”) to identify early correlates of viral resolution. Examining HCV transmission and risk behavior among injecting partnerships using epidemiological and molecular virology methods. Assessing candidacy and factors to facilitate access to early antiviral treatment for acute HCV]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Page_k-AcuteUFO2009.pdf</url>
	</node>
	<node>
		<title>UFO Presents!</title>
		<tax>1737</tax>
		<content><![CDATA[UFO Presents! is a CDC-funded program aimed at the meeting the broader needs of youth and young adults with injection risk. We will provide hepatitis prevention and care education, and develop and implement programmatic materials for hepatitis C virus (HCV) counseling and education. Educational materials and protocols are being developed with input from community groups in health care, HIV and HCV prevention, and with input from young IDU who are accessing the program.

The program will:
<ul>
 	<li>Increase hepatitis B virus (HBV) vaccination in young adult IDU.</li>
 	<li>Increase the capacity of public health professionals to perform risk reduction counseling and service delivery to prevent new HCV infections in young adult IDU.</li>
 	<li>Educate current young adult IDU at increased risk for HCV infection.</li>
 	<li>Counsel persons with acute and chronic HCV infection and refer them for medical management.</li>
</ul>
UFO Presents! is an exciting program aimed at young IDU in San Francisco, CA and is accessed at locations in the Tenderloin and the Haight-Ashbury neighborhoods.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Page_K-UFOPresents2009.pdf</url>
	</node>
	<node>
		<title>Ballroom Community Project: Social Networks and Social Support for Young African American MSM</title>
		<tax>1737</tax>
		<content><![CDATA[This research investigates the relationship between social networks, social support, and HIV-related risk behavior among young African American MSM who participate in the Ballroom community. The Ballroom community consists of houses, figurative and sometimes literal homes, for queer youth of color, and the elaborate balls they host and compete in. The Ballroom community exists in urban centers across the US, and provides African American queer youth with support for same-sex desire and identity, along with multiple forms of support for HIV prevention.

This research looks at the forms of social support that young men receive through their involvement in the community, particularly with regard to HIV-related risk behavior.

The study will be carried out in three phases:
<ol>
 	<li>An ethnographic phase to determine the forms social networks and social support take with young. African American MSM in the Ballroom community,</li>
 	<li>A phase to develop and adapt appropriate scales of social networks and social support for a young  African American MSM population, and</li>
 	<li>A cross sectional survey of social networks within young African American MSM Ballroom communities to determine the association of social networks and social support with HIV-related risk behavior.</li>
</ol>
The data accumulated during this study will be used as the basis for developing an intervention tailored specifically to the Ballroom community. Approximately 300 young African American MSM will be recruited into the study, which will take place in the San Francisco Bay Area.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Arnold_E-BallroomCommunityProject2009.pdf</url>
	</node>
	<node>
		<title>Bruthas Project Randomized Controlled Trial</title>
		<tax>1737</tax>
		<content><![CDATA[This study is a collaboration between CAPS and the California Prevention and Education Project (CAL-PEP) in Oakland, CA, with valuable contributions from our research consultant at Brown University. Our collaborative research team has spent the past three years developing and testing the acceptability and feasibility of the <a href="https://projectreporter.nih.gov/project_info_description.cfm?aid=8710344&amp;icde=32501553">Bruthas Project, an enhanced HIV counseling intervention focused on African American men who have sex with men and women (MSMW)</a>, as part of a community collaborative research project funded by the California HIV/AIDS Research Program (CHRP). Our team works out of a shared understanding that service providers, researchers, and community members must work collaboratively to create solutions that can mitigate the spread of HIV/AIDS in the African American community.

This study rigorously tests the Bruthas Project in a randomized controlled trial, comparing the Bruthas Project to a standard program involving HIV counseling and testing, and referral to general case management services. A sample of 400 African American MSMW who do not identify as gay will be recruited from the San Francisco Bay Area. After receiving HIV counseling and testing, half will be randomly assigned to the enhanced intervention condition and half will be randomly assigned to the standard program. All participants will complete baseline, post-intervention, and three-month post intervention behavioral risk assessments using an audio computer-assisted interview (ACASI) that has been specifically developed for this population.

The Bruthas Project consists of four enhanced counseling intervention sessions:
<ul>
 	<li>Session 1 - HIV testing and behavioral risk reduction counseling.</li>
 	<li>Session 2 - Risk and dynamics with female partners.</li>
 	<li>Session 3 - Risk and dynamics with male partners.</li>
 	<li>Session 4 - Motivators, personal justifications and context for high risk sex</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Arnold_E-Bruthas2009.pdf</url>
	</node>
	<node>
		<title>Community-Level HIV Prevention Intervention for Young Black MSM</title>
		<tax>1737</tax>
		<content><![CDATA[This project will test the efficacy of a community-level intervention (an adaptation of the Mpowerment Project) in reducing sexual risk behavior and increasing testing among young Black men who have sex with men. We will implement the Black Mpowerment Project for two years in Dallas, TX. Houston, TX will be the comparison community. We will conduct cross-sectional surveys of young Black men who have sex with men before and after the intervention in both communities to determine the efficacy of the intervention in:
<ul>
 	<li>Reducing the proportion and frequency of sexual behaviors that are likely to transmit HIV, including reducing the number of sex partners.</li>
 	<li>Increasing the proportion of men who know their HIV serostatus.</li>
 	<li>Modifying psychosocial mediating variables that may be related to HIV risk reduction.</li>
 	<li>Changing psychosocial factors that are indicators of positive mental health and well-being.</li>
</ul>
Additionally, we will conduct process evaluations of the intervention to assess how the Black Mpowerment Project is implemented and to assess the perceptions of the project at both the individual- and community-level. We will also look for changes in sexually transmitted infection rates in both communities.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Kegeles_S-CommLevelHIVPrevYoungBLMSM2009.pdf</url>
	</node>
	<node>
		<title>Faith-Based HIV Prevention for Young Black MSM</title>
		<tax>1737</tax>
		<content><![CDATA[The goal of this project, which was originally conducted in collaboration with the Unity Fellowship Church Movement, was to determine what approaches to HIV prevention for young Black men who have sex with men could be implemented by faith-based organizations.

We assessed the capacity, interest and attitudes of certain Black churches towards HIV prevention by conducting 22 semi-structured telephone interviews with representatives of select Black churches in California. Additionally, we conducted six focus groups with young Black MSM:
<ul>
 	<li>Two groups with young Black MSM who did not attend church to discuss their attitudes towards. churches running HIV prevention programs.</li>
 	<li>Two groups with HIV- or unknown HIV status young Black MSM to discuss their opinions and experiences regarding HIV testing and the role that church-based interventions could play in encouraging testing.</li>
 	<li>Two groups with HIV+ young Black MSM to discuss issues related to HIV treatment and support for. positive people, particularly through church-based interventions.</li>
</ul>
After analyzing the results of the focus groups and interviews, we collaborated with two Boards of Cultural. Experts, men and women from faith-based organizations, who helped interpret the study’s findings and made recommendations about the foundations for HIV prevention interventions for Black faith-based organizations.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Kegeles_S-FaithBasedHIVPrevYouBlMSM2009.pdf</url>
	</node>
	<node>
		<title>Men of Asia and the Pacific Testing for HIV (MATH)</title>
		<tax>1737</tax>
		<content><![CDATA[The Men of Asia Testing for HIV (MATH) study is a national collaboration between several community-based organizations, health centers, academic institutions, laboratories, and health agencies. Funded by the National Institute of Child Health and Human Development, this project will study the HIV prevalence, incidence, and behavioral correlates of HIV infection among 2,000 Asian and Pacific Islander (API) men who have sex with men (MSM). In other words, we are studying the scope of the HIV epidemic among API MSM and who is at risk for becoming infected.

Participants are recruited into the study by community partners, and participants also refer other eligible people; they may be residents of any of five US metropolitan areas (New York, Boston, Philadelphia, San Francisco Bay Area, and Los Angeles). The study visit involves completing a behavioral survey and taking an oral rapid HIV test; those who preliminarily test positive also have blood drawn for confirmatory testing and virological studies.

Our major research questions include:
<ul>
 	<li>Which social and cultural risk and resiliency factors are associated with HIV infection among API. MSM?
<ul>
 	<li>How do international travel and immigration patterns affect HIV risk?.</li>
</ul>
</li>
 	<li>Who gets tested for HIV and what sociocultural factors impact HIV testing patterns (including being aware of one’s HIV status and late stage HIV testing)?</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Bangi_A-MATH2009.pdf</url>
	</node>
	<node>
		<title>Multilevel Prevention in Culture and Context with Latino MSM</title>
		<tax>1737</tax>
		<content><![CDATA[We are in the process of evaluating data of an HIV prevention program for Latino men who have sex with men (MSM) who do not self-identify as gay. The project relies on an established community collaborative relationship between CAPS and the City of Berkeley, CA AIDS Office, Department of Public Health. To evaluate the program we used both a survey and qualitative questions.

The goals for this project are to:
<ul>
 	<li>Design a program in dialogue with the target community of Latino MSM who do not self-identify as. gay to ensure a culturally sensitive, multi-level approach that will address critical aspects of HIV prevention both for the individual and for the environment of public places where sex takes place.</li>
 	<li>Implement a 2-month program for the individual by providing multiple, one-on-one intensive. conversations about the participant’s social support system. The conversations were recorded and played back at the second sessions to help participants assess what kinds of changes they wanted to make in their lives to ensure their health and safe behaviors. The third session assessed how the participant’s plan for change worked and developed strategies for ways to ensure success.</li>
 	<li>Conduct an evaluation of the program by administering a survey to 100 men just prior to their. participation in the program and a follow-up interview three months after the last intervention session.</li>
 	<li>Throughout the developmental phase of the intervention, we conducted qualitative interviews to. evaluate the process of crafting an intervention and continued conducting interviews through the implementation stages. All providers were interviewed at multiple junctures of the developmental and implementation phases.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Binson_D-MultiLevelPrevCultContextLatinoMSM2009.pdf</url>
	</node>
	<node>
		<title>Partner Management among Latino MSM</title>
		<tax>1737</tax>
		<content><![CDATA[Literature on risk has historically focused on individual behavior (“How many partners have you had? How often do you use a condom? etc.); however recent studies have begun to recognize the need to acknowledge the social and sexual context of risk behavior. For example, studies have examined the role of partner preferences, sexual situations, partner selection, sexual stereotypes and, most recently, seroadaptive behaviors. Additionally, studies of sexual risk behaviors integrate social influences that may impact sexual negotiations (homophobia, sexual silence, cultural influences, etc.). Building from this body of literature, the PI has introduced the term of “partner management” to describe a process in which men initiate behaviors to maximize their sexual pleasure and minimize the risk involved. We will conduct 36 in-depth interviews with participants to explore the partner management processes of Latino MSM (LMSM). The specific research aims of this study are to: Understand the factors (social, cultural, psychological) that influence partner management among LMSM. Describe the impact of acculturation processes (sexual scripts, cultural values, negotiated identities). on the partner management process of LMSM. Characterize the ways in which partner management is operationalized when LMSM negotiate. sexual situations]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Galindo_Partner-Management_2010.pdf</url>
	</node>
	<node>
		<title>HIV Prevention among Township Men Who Have Sex with Men in South Africa</title>
		<tax>1737</tax>
		<content><![CDATA[This project has two aims:
<ol>
 	<li>To describe collective and individual belief systems of low-income township men who have sex with men (MSM) related to their sexuality, sexual health, choice of sexual partners, use of drugs and alcohol, use of condoms, utilization of health services, HIV voluntary counseling and testing (VCT) and disclosure of HIV status, in order to describe prevailing cultural norms around these subjects’ behaviors</li>
 	<li>To assess the prevalence of HIV risk factors and HIV infection among MSM from Soweto township.</li>
</ol>
This study is the first of its kind in South Africa. Through in-depth interviews, focus group discussions, and structured observations of MSM social venues, we have been able to describe the gender identities and sexualities that are prevalent in township MSM communities. We will estimate the prevalence of risk behaviors and HIV infection in Soweto using respondent-driven sampling methodology. This will be the first HIV prevalence data for an MSM community in South Africa.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lane_T-TownshipMSMinSAfrica2009.pdf</url>
	</node>
	<node>
		<title>Archival Analysis of the Urban Men’s Health Study 2002</title>
		<tax>1737</tax>
		<content><![CDATA[This study will utilize data from the Urban Men’s Health Study 2002, a probability-based survey of 879 men who have sex with men (MSM) in San Francisco. These data provide a unique, cost-effective opportunity to examine psychological correlates of stimulant use among MSM who were recruited through probability-based sampling methods. Informed by Stress and Coping Theory, the study will utilize structural equation modeling to examine psychological correlates of engaging in any stimulant use during the past 6 months with 711 MSM who completed a mail-in questionnaire that assessed psychological factors and substance use.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Carrico_UMHS_2010.pdf</url>
	</node>
	<node>
		<title>Assessment of the Adaptation and Implementation of the Mpowerment Project</title>
		<tax>1737</tax>
		<content><![CDATA[The objective of this project is to better understand how 12 community-based organizations (CBOs), funded under CDC’s program announcement 06-618, are implementing and adapting the Mpowerment Project (MP) for young men of color who have sex with other men and young transgendered people of color.

This project’s specific goals are to:
<ol>
 	<li>Review and summarize all available background information about the MP at these 12 CBOs (e.g., grantee original applications, progress reports, site visit reports, PEMS data)</li>
 	<li>Develop site visit protocols tailored to each CBO, and conduct the site visits to observe the implementation of the MP and to meet with program staff, supervisors, and participants.</li>
 	<li>Analyze and summarize data about common themes across CBOs, including fidelity, adaptation, and intervention context</li>
 	<li>Convene a stakeholder consultation meeting to review the findings and discuss outcome monitoring options</li>
 	<li>Develop an MP outcome monitoring evaluation protocol</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/AAIM.pdf</url>
	</node>
	<node>
		<title>Evaluation of SFAF’s Magnet Program</title>
		<tax>1737</tax>
		<content><![CDATA[In this project, funded as a community collaborative by the California HIV/AIDS Research Program (CHRP), CAPS and the San Francisco AIDS Foundation (SFAF) seek to evaluate Magnet, a clinic and community center located in the Castro District of San Francisco, the City’s primary gay and lesbian neighborhood. The primary study will consist of a large survey of gay men in San Francisco. Data from the work will enable us to examine the characteristics of men in the city who use Magnet and other sexual health services, and to determine if their use of Magnet is associated with HIV risk reduction practices (like condom use). In addition, we will conduct a preliminary study involving qualitative interviews with gay men. The interviews will allow us to explore the facilitators and barriers of using sexual health services, and to develop a comprehensive list of all such resources available in the Bay Area. This work will ensure that the main study’s survey fully covers the types and organization of resources available to gay men.

Magnet offers sexual health services out of a storefront facility located in the heart of San Francisco’s Castro District. But it is also more than just a clinic. The center is intended to empower men with the information, skills, and confidence they need to make informed decisions during sex. The founders of Magnet placed it in an inviting location in the heart of the Castro in the hopes that would encourage men to think and talk about sexual health. Magnet has become very popular, with 4600 clients in 2007 alone. But it is unknown to what degree Magnet is influencing decisions about safer sex and other HIV prevention practices among men in the local community, a gap this study aims to fill.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Steward_Magnet_2010.pdf</url>
	</node>
	<node>
		<title>Exploring the Core of High-Risk Networks</title>
		<tax>1737</tax>
		<content><![CDATA[Research shows that most men who use multiple types of public venues (bathhouses, sex clubs, parks, bars, etc.) to meet and engage other men reported high-risk behavior. These findings lead us to hypothesize that these high-risk men are a significant proportion of the core of high-risk networks; yet we know little about them. The purpose of this study is to narrow the focus of research to this core, to learn more about their intimate encounters. The specific aims are to examine How particular venues influence intimate encounters. The interaction dynamics within the intimate encounter. What casual intimacy means to core members. We will draw a probability sample of men exiting two San Francisco sex clubs (n=300). Using audio-assisted computer self-interview (ACASI), men will complete a brief survey on site. This exit survey will identify a subsample of men who are core members and they will be invited to participate in a face-to-face qualitative interview (n=50) at a later date at the study offices. The exit survey data provide an opportunity to learn of club behavior of patrons. As such we will explore the following secondary aims: On-site and overall risk behavior of club patron. The use of the Internet to meet men]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Binson-Woods-ExploringtheCoreHighRiskNetworks2009.pdf</url>
	</node>
	<node>
		<title>Gay Couples Study</title>
		<tax>1737</tax>
		<content><![CDATA[The Gay Couples Study Continuation is a five year longitudinal study that seeks to identify and examine relationship dynamics in gay couples and how those dynamics affect sexual risk behaviors with primary and outside partners. Relationship dynamics include issues such as communication style, power dynamics, interpersonal relations, and agreements around sex. Other objectives include exploring broken agreements, internal (or safety) agreements, and HIV testing rates for gay couples. The study will have a preliminary, exploratory qualitative phase as well as a longitudinal quantitative phase.

For the Qualitative Phase, 20 gay couples will participate in face-to-face, in-depth, semi-structured interviews. Interviews will focus on broken agreements, internal (or safety) agreements, and HIV testing rates for gay couples. Themes from the interviews will help inform the development of a new quantitative survey instrument to be used during the Longitudinal Phase. For the Longitudinal Phase, 500 gay couples will be surveyed every six months for three years. Couples from the original Gay Couples Study will be invited to participate and we estimate that approximately 100 couples will continue. In the final year, we will test the feasibility and acceptability of prevention intervention designs and content concepts with gay couples. Findings will be used for an intervention with gay couples to be pilot tested in 2014.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Darbes.-Gay-Couples-Study.pdf</url>
	</node>
	<node>
		<title>HIV Prevention for Middle Adulthood Gay Men: A Formative Research Project</title>
		<tax>1737</tax>
		<content><![CDATA[We are conducting an exploratory, qualitative study of middle-adulthood gay and bisexual men, ages 30-49. The study’s objective is to identify the significant psychosocial needs of gay and bisexual men in middle adulthood that might be addressed as part of a culturally grounded, targeted HIV-prevention effort. We will recruit 15 to 25 men from community venues in the San Francisco Bay area known to be frequented by gay and bisexual men such as bars, clubs, parks, gyms, cafés, and the Internet. Volunteers will be invited to participate in a two-hour qualitative interview, during which we will elicit their personal narratives as gay and bisexual men and as members of society. Some participants will also be selected to participate in two focus group discussions.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Rebchook_G-HIVprevMidAdultGayMen2009.pdf</url>
	</node>
	<node>
		<title>International Travel Research to Inform Prevention (I-TRIP)</title>
		<tax>1737</tax>
		<content><![CDATA[I-TRIP studies sexual risk behavior in the context of international travel among gay and bisexual men from the San Francisco Bay Area. The specific aims are: To measure the prevalence of sexual risk behavior during international travel among gay and bisexual men from the Bay Area. To document the prevalence of ART drug resistance among gay and bisexual international travelers from the Bay Area. To examine the informational, motivational and behavioral skills correlates of safer sex disinhibition during international travel. Our study will employ a mixed-methods approach combining quantitative and qualitative components to assess sexual risk behavior and potential correlates of behavioral disinhibition. We will use Respondent-Driven Sampling (RDS) to recruit a representative cross-sectional survey of 1,000 gay and bisexual men in San Francisco and the greater Bay Area who travel internationally.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Truong_H-ITRIP2009.pdf</url>
	</node>
	<node>
		<title>Power and Risk Among Gay Couples</title>
		<tax>1737</tax>
		<content><![CDATA[In recent years, HIV prevention efforts among gay men in the US have broadened in scope to incorporate the social, cultural,interpersonal, and contextual factors associated with HIV infection and transmission. Findings from a recent study that supports incorporating these factors show that an examination of relationship dynamics is needed to help explain higher rates of HIV among young Black and Latino gay men since factors such as the number of sexual partners, specific sexual behaviors, and drug use did not explain their higher rates of HIV infection relative to White men. The Principal Investigator (PI) of the proposed research and her team have been examining relationship dynamics associated with HIV risk among gay couples for the past five years. Their initial study, which is ongoing, was designed to be broad in scope to both capture the breadth of variables in gay male relationships and how these variables are associated with HIV risk. One variable of interest is the power differentials that may exist between partners in a relationship. Scale instruments that are currently available to detect and measure power differentials were developed for heterosexual couples only and are therefore limited in their applicability to gay male couples. In the PI's ongoing study, one of the existing scales, the Sexual Relationship Power Scale (SRPS), was modified and adapted for use. We found that certain dimensions of relationship power (e.g., power in decision-making, lack of power about barebacking, and power in condom negotiation) are associated with HIV risk in a manner similar to many other relationship factors. Although the adapted SRPS scale lent some insight into the power dynamics at work within gay male relationships, it remains unclear what role race plays and how it may affect HIV risk. What is clear, however, is that Black and White MSM make up the largest proportion of HIV infections in the US. Yet, we know very little about race in gay male relationships. When one considers couple HIV status (i.e., the HIV status of both partners in the relationship), another layer of complexity emerges. For example, concordant negative couples have different experiences and expectations than discordant couples. Recognizing the crucial association of relationship power with HIV risk among gay couples and the dearth of research on it, we propose to conduct a comprehensive mixed-methods study to understand and define the dimensions of relationship power among Black, White and biracial Black and White couples (hereafter referred to as biracial B&amp;W couples) who are HIV concordant negative or discordant. An important component of this effort will involve the development and testing of a comprehensive quantitative scale to measure dimensions of relationship power in gay male couples. Following this, we want to study the associations of the different dimensions of relationship power with HIV risk and known psychosocial correlates of HIV risk (e.g., relationship satisfaction, agreement investment, social support, and experiences of racism and homophobia) In the future we hope to expand the cultural and racial component of the scale and apply it Latino and Asian gay couples. Including them at this time is beyond the scope of one study. We envision all of this research as leading to the development of an empirically based HIV prevention trial for gay male couples in the US.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Neilands.-Power-and-Risk-Among-Gay-Couples.pdf</url>
	</node>
	<node>
		<title>Serosorting among Men at Risk for HIV</title>
		<tax>1737</tax>
		<content><![CDATA[This study will obtain cross-sectional and longitudinal data on “HIV serosorting” among MSM in San Francisco. We broadly define HIV serosorting as diverse strategies to reduce HIV acquisition or transmission by intentionally selecting sexual partners of the same serostatus or by modifying sexual practices depending on the partner’s serostatus. We will recruit a community-based cohort of HIV- and HIV+ MSM using a probability-based time-location sampling method with longitudinal follow-up over the Internet.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/McFarland_Serosorting_2010.pdf</url>
	</node>
	<node>
		<title>Social Sexual Networks and HIV Risk: Men of Color</title>
		<tax>1737</tax>
		<content><![CDATA[This study will advance theoretical understandings of HIV risk behaviors by examining potential mechanisms (i.e., social networks and sexual partnerships) through which social discrimination impacts sexual risk among MSM of color and offer valuable insights for possible interventions involving both individual and structural changes. In three phases, we will describe sexual partnership patterns and explain the association between social discrimination, social networks, sexual partnerships and HIV risk among African American, Asian and Pacific Islander (API), and Latino men who have sex with men (MSM) in Los Angeles, CA.
<ul>
 	<li>Phase 1. We will conduct in-depth individual interviews and focus groups to explore the nature of sexual partnership formation and examine the key domains hypothesized to influence social networks, sexual partnerships and HIV risk in our working model.</li>
 	<li>Phase 2. We will utilize qualitative data to develop measures of the constructs of interest and test these new scales to establish their reliability and validity. Based upon these new measures and existing measures in the research literature, we will develop a quantitative survey instrument.</li>
 	<li>Phase 3. We will conduct a cross-sectional survey to describe sexual partnership patterns and examine our working model of HIV risk. A chain-referral sample of 1200 men will complete audio computer-assisted self-interviews using a standardized questionnaire developed in Phase 2.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Choi_K-SocialSexualNetworksRiskMofC2009.pdf</url>
	</node>
	<node>
		<title>Stonewall Treatment Evaluation Project (STEP)</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this project is to conduct a systematic program evaluation of the Stonewall Project, which is currently deployed in four community settings by the San Francisco AIDS Foundation. The Stonewall Project is an innovative, outpatient substance abuse treatment program for methamphetamine-using MSM that is implementing evidence-based interventions (i.e., the Matrix Model) in a real world clinical setting. In collaboration with the Stonewall Project, we will conduct a comprehensive treatment outcome evaluation with 150 participants who are newly initiating services. Participants in the treatment outcome evaluation will complete quantitative assessments at baseline as well as three and six months follow-up to examine changes in substance use and HIV risk-taking behavior. We will also build the capacity of the Stonewall Project to conduct ongoing evaluation efforts by developing a web-based assessment system. This system will automate existing self-monitoring activities that participants complete prior to each counseling session at the Stonewall Project to facilitate ongoing evaluation of treatment outcomes.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Carrico_STEP_2010.pdf</url>
	</node>
	<node>
		<title>Structural Intervention to Improve HIV Test Counseling</title>
		<tax>1737</tax>
		<content><![CDATA[This study has three components:
<ol>
 	<li>Describe the strategies HIV rapid test counselors use to manage multiple roles during the test session.</li>
 	<li>Develop a computer assisted survey that is self-administered by the client before they see the counselor (PalmPal).</li>
 	<li>Enhance counselor training and supervision using time charts.</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/Sheon_N-StructuralInterventionHIVTestCouns2009.pdf</url>
	</node>
	<node>
		<title>Assessment of Economic Factors Associated with the Psychological Well-Being of HIV+ Persons in Kenya</title>
		<tax>1737</tax>
		<content><![CDATA[The specific aim of this study is to conduct a preliminary assessment of the association between measures of economic context and material well-being on the one hand, and positive and negative psychological well-being on the other. We postulate that positive psychological well-being is a key determinant of effective and sustainable care and treatment for HIV+ persons, with potential to help reduce situations of HIV transmission.

The study will include 100 HIV+ men and 100 HIV+ women receiving care in Kenya. The total number of respondents will be equally distributed between the cities of Nairobi and Kisumu. A convenience sampling approach—stratified by gender—will be used in Kisumu. Oversampling of persons currently employed in the formal or informal sectors will be applied in Nairobi. Survey administration will be conducted simultaneously at both sites over a six month period. We will conduct three types of analyses:
<ol>
 	<li>Assess and select measures for the degree of variation they exhibit.</li>
 	<li>Conduct bivariate measures of association in order to assess unadjusted associations between the psychological well-being measures and those economic factors that demonstrate sufficient variation.</li>
 	<li>Conduct logistic or multinomial logistic regressions in order to assess the extent of the relationship between the psychological well-being and the economic factors after accounting for potential confounders and effect modifiers.</li>
</ol>
Information drawn from this study will help fill the gap in understanding the connections between structural factors and psychological well-being of HIV+ persons.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Arnold_M-EconomicfactWellBeingHIVposKenya2009.pdf</url>
	</node>
	<node>
		<title>Balance Project: A Randomized Clinical Trial of an HIV Treatment Side Effects Coping Intervention</title>
		<tax>1737</tax>
		<content><![CDATA[The Balance Project is a randomized controlled trial that tests a counseling intervention to help HIV+ men and women achieve an active role in their health care. The intervention is designed to help individuals cope with the challenges of taking medications, deal with side effects, and maintain an active collaboration with their health care providers. We enrolled 250 HIV+ adults taking antiretroviral medications, and will evaluate the impact of the intervention on quality of life and medication adherence. This study involves two phases:
<ul>
 	<li>Phase 1. is conducted over 12 months and includes two one-hour interviews with questions about personal life, family, friends, medications and medication side effects. After the first interview, participants may be invited to participate in Phase 2, which lasts 18 months.</li>
 	<li>Phase 2. participants complete five two to three-hour interviews occurring at baseline and Months three, six, 12 and 18. Interviews include questions about personal life, friends, family, health-related activities, drug-using behaviors, emotions, mental state and educational background.</li>
</ul>
Participants are assigned randomly to one of two treatment groups:
<ul>
 	<li>Group 1. participants receive five individual sessions of cognitive behavioral coping training, beginning after the Month 3 interview. 90-minute sessions focus on coping with stress, dealing with medication side effects and staying on track with medications.</li>
 	<li>Group 2. participants receive standard care and one group session of coping training, which is held after the Month 18 interview. The group session covers the same material that is covered in the individual sessions.</li>
</ul>
After the last follow-up interview, some participants may also be asked to complete an exit interview about thoughts and feelings on study participation.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Johnson_M-BalanceProject2009.pdf</url>
	</node>
	<node>
		<title>Duo Project: Relationship Factors and HIV Treatment Adherence</title>
		<tax>1737</tax>
		<content><![CDATA[The DUO Project investigates how relationship factors are associated with adherence to antiretroviral therapy (ART). Based on recruitment feasibility and the epidemiology of the HIV epidemic in the San Francisco area, HIV+ seroconcordant and serodiscordant male couples are included in the study’s three phases:
<ul>
 	<li>Phase 1. We conducted a qualitative investigation of relationship dynamics and partner tactics related to HIV medication adherence.</li>
 	<li>Phase 2. We developed a medication adherence-specific measure of partner support, including specific tactics informed by Phase 1.</li>
 	<li>Phase 3. We are conducting computer-assisted structured interviews of 300 couples to Validate the adherence-specific measure of partner support developed in Phase 2 and.</li>
</ul>
Test hypotheses of the inter-relationships among individual-level variables (quality of life,. psychological well-being, substance use) and couple-level variables (relationship satisfaction, conflict, adherence-specific partner support), and ART adherence and clinical variables. Clinical status is assessed by viral load and CD4 count.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Johnson_M-DuoProject2009.pdf</url>
	</node>
	<node>
		<title>Enhancing HIV Treatment Adherence in South India: The Chetana Study</title>
		<tax>1737</tax>
		<content><![CDATA[The study brings together researchers from the University of California, San Francisco and St. John’s National Academy of Health Sciences in Bangalore, India. The overall goal of this study is to evaluate the impact of a promising Antiretroviral Therapy (ART) adherence-enhancing intervention grounded in Social Cognitive Theory (SCT) that addresses the needs of people living with HIV (PLHIV). This intervention targets not only medication adherence, but also other culturally-relevant topics designed to enhance physical and mental health among PLHIV, including yoga/meditation, nutrition, legal services, and assistance accessing local resources. We are testing this promising intervention in a Randomized Controlled Trial (RCT) among 500 sub-optimally adherent patients, comparing it to a time-matched active control condition, consisting of the non-adherence specific components of the intervention.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/11/Chetana-summary.pdf</url>
	</node>
	<node>
		<title>Focus Project: A Mindfulness Approach to HIV Treatment Side Effects</title>
		<tax>1737</tax>
		<content><![CDATA[The Focus Project, funded by the National Center for Complementary and Alternative Medicine at the NIH, is a randomized controlled trial to test the efficacy of a Mindfulness-Based Stress Reduction (MBSR) intervention in reducing HIV treatment side effects and side effect-related distress. The intervention is a standardized series of eight weekly MBSR sessions, two to three hours long, held at the Osher Center for Integrative Medicine. The course also includes daily home assignments of formal and informal meditation practice. The findings from this study will provide evidence that MBSR may allow more conscious and adaptive coping behavior that reduces HIV treatment side effect-related distress. We will enroll 100 HIV+ adults taking antiretroviral medications, and will evaluate the impact of the MBSR intervention on side effects, quality of life and medication adherence. Participants are assessed at baseline and at three- and six-month follow-up periods. Psychosocial and behavioral variables are assessed via computerized (ACASI/CAPI) interviews at the CAPS project offices. MBSR is a program that provides systematic training in mindfulness meditation as a self-regulation approach to reduction of stress and medical and psychological symptoms. MBSR draws on centuries-old meditation practices, particularly Buddhist Vipassana and Zen practices, but adapts these practices to a Western audience. It aims to teach participants to respond to stressful situations “mindfully” – a state in which one focuses on the present moment, accepting and acknowledging it without getting caught up in thoughts that are about the situation or emotional reactions – to enable people to respond to the situation making conscious choices instead of automatic responses]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Johnson_M-FocusProject2009.pdf</url>
	</node>
	<node>
		<title>iAspire</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this project is to evaluate an existing HIV prevention intervention, the Employment Services Program, a vocational rehabilitation program for HIV+ persons at the Positive Resource Center (PRC) in San Francisco. The Employment Services Program is an innovative and comprehensive program that helps clients overcome structural barriers (poverty, homelessness) to HIV prevention and care. This outcome evaluation will examine the effects of vocational rehabilitation on improved ART adherence and reduced HIV transmission risk. Our team will recruit 200 HIV+ persons who are newly initiating services at the PRC. Participants will complete a baseline assessment and 6-month and 12-month follow-up assessments to examine changes in HIV-related health behaviors as well as evaluate plausible mechanisms (enhanced psychological adjustment and increased socio-economic status) whereby the PRC achieves beneficial outcomes. We also plan to conduct in-depth qualitative interviews at baseline and 12-month follow-up with a subset of 20 participants. Qualitative interviews will examine the perceptions of PRC clients regarding important components of the Employment Services Program as well as barriers to continuing to receive services at the PRC.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Carrico_iAspire_2010.pdf</url>
	</node>
	<node>
		<title>IMPACT (Investigating Motivations for Participation in Anal Cancer Prevention Trials)</title>
		<tax>1737</tax>
		<content><![CDATA[This project is designed to provide information that will be critical to the performance of a pivotal RCT of screening and treatment of anal intraepithelial neoplasia (AIN) to prevent anal cancer. This project will study determinants of participation in an RCT in which 50% of participants with AIN will be screened and treated, and 50% will be observed without treatment. At the end of a 5-year period, the number of anal cancer cases will be compared in both arms. The IMPACT study will conduct focus groups with ethnically and geographically diverse populations in cities across the US in order to: Identify and assess the determinants of provider willingness to refer eligible participants. Identify and assess the determinants of patient willingness, motivations, barriers, concerns and. incentives to participate in the RCT. Determine the optimum study design, sample size and recruitment strategies based on what we. learn Information gathered from these focus groups and interviews with health care providers will be analyzed and used to develop a national survey for collecting further data relevant to preparation of the RCT. Given the complexities of the underlying clinical issues that might govern willingness to participate, the increasing proportion of underrepresented minorities that comprise the HIV epidemic, and the varying issues around participation that racial and ethnic groups might have, a rigorous study to measure these determinants is critical.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Sheon_IMPACT_2010.pdf</url>
	</node>
	<node>
		<title>Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting</title>
		<tax>1737</tax>
		<content><![CDATA[Drug and alcohol use is not always addressed with patients in medical care settings, including HIV primary care settings. The screening, brief intervention, and referral to treatment (SBIRT) strategy has demonstrated an effective model to introduce screening for substance use, and standardized guidelines in a number of clinical populations, but SBIRT for drug and alcohol use has not been tested in an HIV primary care setting. This is remarkable because several studies suggest that HIV+ and at-risk individuals have high rates of substance use. Therefore, the goal of this project is to assess the impact of SBIRT for harmful alcohol use, illicit drug use, and opioid analgesic use in an HIV primary care setting at San Francisco General Hospital’s Positive Health Program (PHP). Specifically, the project aims to examine and compare the feasibility, acceptability and impact of introducing SBIRT into this clinic population. In addition, this study will compare two different modes of SBIRT administration: A self-administered, web-based Personal Health Record. A provider-administered protocol during clinic appointments. A randomized, two-arm cohort methodology will be used. Three hundred HIV+ clinic patients will be enrolled, and will receive the SBIRT either through the web-based system (called myHERO), or from a provider. Participants will be seen for four study visits (baseline, 1 Month, 3 Months, 6 Months). SBIRT will be conducted at baseline and at six Months. The screening instruments will include the “Alcohol, Smoking and Substance Involvement Screening Test” and “The Alcohol Use Disorders Identification Test.” The screening tool scores and interpretation will be added to the Active Problem List in the patient’s electronic medical record, and will alert the provider to the need for follow-up. The brief intervention and referral to treatment will be delivered by a clinic- based social worker trained in substance use counseling and motivational interviewing techniques. Participants will be assessed at all four visits for the outcome indicators including alcohol and drug use, HIV transmission risk behaviors, and antiretroviral medication adherence.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Dawson-Rose_SBIRT_2010.pdf</url>
	</node>
	<node>
		<title>Intervention Development for Re-Engagement in Care</title>
		<tax>1737</tax>
		<content><![CDATA[This research complements improvements in HIV services being developed in San Francisco under the auspices of the CDC’s Enhanced Comprehensive HIV Prevention Planning (ECHPP), and augments ECHPP-related evaluations already being supported through the NIH-supported Centers for AIDS Research. It involves three partnering organizations – the UCSF Center for AIDS Prevention Studies (CAPS), UCSF Positive Health Program (PHP), the San Francisco Department of Pub lic Health (SFDPH), all three of which are units with the GIVI UCSF Center for AIDS Research (CFAR). Specifically the aims of the study are: (1) to determine the outcomes among patients at the PHP who have been lost to follow-up and, for those who are shown to be out of care, to assess the feasibility and acceptability of potential strategies for re-engaging them in care at the UCSF PHP; (2) to match patients lost to follow-up at the PHP with surveillance system records to determine the proportion that show evidence of receiving care elsewhere; and (3) to identify potential intervention strategies to enhance re-engagement and retention in HIV care among at risk patient populations at PHP. Aim 1 will be accomplished by tracking and surveying 150 PHP patient s who have been lost to follow-up to understand the reasons they are no longer receiving services at PHP (e.g., in care elsewhere, fallen out of care completely) and, then, by conducting in-depth qualitative interviews with up to 30 of those patients who h ave fallen out of care completely to understand the feasibility of potential strategies to help retain and re-engage them in care. For Aim 2, we will link our tracking data with records at the surveillance section of DPH to determine if the surveillance system contains evidence of the same patients having received care elsewhere in the city (e.g., viral load or CD4 testing). The findings from this aim will allow us to examine the degree to which surveillance records can supplement clinic based efforts to determine patients’ engagement-in-care outcomes and identify which tracking efforts/elements were most beneficial. Finally, for Aim 3, we will convene a consensus development panel with representatives of the three partnering institutions – CAPS, PHP Ward 8 6, SFDPH – to identify behavioral interventions that could enhance retention and re-engagement in care among at risk patient populations in San Francisco that utilize the PHP for HIV care.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Morin.-Intervention-Development-for-Re-Engagement-in-Care.pdf</url>
	</node>
	<node>
		<title>PATH Project: A Randomized Controlled Trial Preparing Patients to Start Antiretroviral Therapy</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of The PATH Project is to develop and test an intervention to prepare HIV+ men and women who, based on current treatment guidelines, should be but are not currently taking antiretroviral therapy (ART). The immediate goal of the intervention is to address obstacles to ART uptake. The intervention is grounded in the Information, Motivation, and Behavioral Skills (IMB) Model and will consist of:
<ul>
 	<li>One-on-one session.</li>
 	<li>Small group workshop led by cross-disciplinary experts and peers.</li>
 	<li>Follow-up one-on-one session.</li>
 	<li>Booster session provided either at 6 months if a participant has not initiated ART, and/or at the first. sign of initiating ART.</li>
</ul>
We will enroll 300 HIV+ men and women in the San Francisco and the East Bay with CD4 counts at or less than 350 who are not on ART. Participants will be assessed at baseline and at three, six and 12 months post randomization. Psychological and behavioral variables will be assessed via computerized (ACASI/CAPI) interviews.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Johnson_M-PathProject2009.pdf</url>
	</node>
	<node>
		<title>AIDS Stigma Among Health Professionals in Puerto Rico</title>
		<tax>1737</tax>
		<content><![CDATA[The stigma related to HIV/AIDS poses a challenge to the lives of people living with HIV/AIDS (PLWHA). These are worsened when people who are important in the lives of PLWHA manifest it, such as health professionals. This is particularly true for physicians who represent the first line of contact for treatment and the basis of knowledge of effective strategies to treat the disease. When physicians stigmatize PLWHA access to effective treatment can be hindered. Previous studies carried out by the research team in Puerto Rico show that health professionals, particularly physicians, manifest high levels of HIV/AIDS stigma. Scientifically tested strategies to reduce such stigma are urgently needed and should be provided during their professional training since they are open to learning new ideas about the physician's role in the lives of people who are ill. Still, a review of the published literature on HIV/AIDS stigma reduction evidences a lack of scientifically tested interventions targeting medical students. This five-year R01 study aims to revise and test the efficacy of an intervention to reduce HIV/AIDS stigma among medical students through a randomized control trial. The specific aims of the proposed research are: Aim 1: Revise and implement an intervention based on Social Cognitive Theory to reduce HIV/AIDS stigma and evaluate its acceptability among medical students in their last year of training. Aim 2: Evaluate the intervention's efficacy in reducing HIV/AIDS stigma attitudes and behaviors immediately after the intervention, at six months, and 12 months time. Aim 3: Evaluate whether proposed mechanisms of stigma change, specifically HIV information, skills for identifying stigma and interacting with PLWHA, and self-efficacy for such skills, explain stigma reduction after the intervention. These aims will be carried out though a randomized control trial implemented in two stages. In Stage 1, we will revise an existing intervention to reduce HIV/AIDS stigma among health professionals based on our previous research. This pilot intervention has been tested and shows promising results in reducing HIV/AIDS stigma with statistically significant reductions in our stigma measurements. In stage two, the intervention will be implemented among a sample of 500 medical students who will be randomly assigned to intervention (n=250) and control groups (n=250) and subjected to a process and impact evaluation administering a quantitative questionnaire before, immediately after, at six months, and 12 months after the intervention. This study will entail the first HIV/AIDS stigma reduction intervention targeting medical students in Puerto Rico that will be experimentally tested with random samples and long term assessment of change. Reducing HIV/AIDS stigma among this population can foster the provision of stigma free services and provide a framework for future interventions. This study will entail the first HIV/AIDS stigma reduction intervention targeting Latino medical students that will be experimentally tested with random samples and long term assessment of change, as we have been unable to find others in the published scientific literature. If proven effective it will be disseminated and will contribute to AIDS stigma reduction among several medical training programs in Puerto Rico, and other applicable Spanish speaking scenarios. Reducing HIV/AIDS stigma among this population can foster the provision of stigma free services which research has shown to better the lives of people with HIV/AIDS.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Neilands.-AIDS-Stigma-Among-Health-Professionals-in-Puerto-Rico.pdf</url>
	</node>
	<node>
		<title>Disclosure Intervention for Zimbabwean Parents</title>
		<tax>1737</tax>
		<content><![CDATA[We propose a randomized controlled trial of a disclosure intervention in which 300 PLH are randomized to either an: 1) experimental condition, a disclosure intervention (n = 150 parents) or 2) attention control condition, a nutrition intervention (n = 150). The intervention's impact will be assessed over two years (recruitment, 3, 6, 12, 18, &amp; 24 months). The 3-session, culturally tailored disclosure intervention will be delivered by local nurses and address planning for developmentally appropriate disclosure (how and when to disclose), responding to children's reactions, building a supportive family environment, and custody planning. The attention control condition will be relevant to PLH, also delivered by nurses and address nutrition.

Therefore, the Specific Aims are to: 1) Primary Aim: Assess the efficacy of the intervention to increase the frequency and timing of parental disclosure. We hypothesize that PLH randomized to the disclosure intervention will be significantly more likely to disclose their own HIV status to their children (parental disclosure) and disclose sooner than PLH randomized to the control condition. 2) Primary Aim: Assess the longitudinal impact of disclosure on parent (medical, psychological, social), child (psychological, behavioral, social) and family outcomes. We hypothesize that parent (health status, depression, anxiety, social support), child (depression, anxiety, HIV-transmission risk behaviors, social support) and family outcomes (family relationships, custody planning) will be significantly better for families in the intervention than families randomized to the control condition. 3) Secondary Aim: Assess the efficacy of the intervention to increase pediatric disclosure. We hypothesize that PLH randomized to the disclosure intervention will be significantly more likely to disclose to a child that s/he is HIV-positive (pediatric disclosure) than PLH randomized to the control condition. The proposed study addresses a neglected and profoundly understudied area that is of high importance to millions of families affected by HIV. If successful, the proposed study will provide evidence for a sustainable model and efficacious disclosure intervention in low-income settings.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Lightfoot.-Disclosure-Intervention-for-Zimbabwean-Parents1.pdf</url>
	</node>
	<node>
		<title>Reducing AIDS Stigma among Health Professionals in South India</title>
		<tax>1737</tax>
		<content><![CDATA[This study brings together researchers from the University of California, San Francisco; Research Triangle Institute in Washington DC; St. John’s National Academy of Health Sciences in Bangalore, India; and the All India Institute of Medical Sciences in New Delhi, India to evaluate the efficacy of a promising intervention designed to reduce HIV stigma among Indian health professionals. The intervention builds on results of our previous research, identifying prevalence and drivers of stigma and discrimination in Indian healthcare settings among PLHIV, health care providers and uninfected patients.

Specifically, the study will:
<ol>
 	<li>Adapt our pilot-tested 3-session stigma reduction intervention for partial tablet-based delivery to increase its long-term sustainability in healthcare settings. The two tablet-administered sessions of the intervention use interactive touch screen methodology and video vignettes tailored to situations likely to be encountered by Indian nurses and ward attendants. The third session focuses on skills-building in a group format and is co-facilitated by a PLHIV.</li>
 	<li>Evaluate the efficacy of the intervention in 24 hospitals in North and South India on:
a) behavioral manifestations of HIV stigma, including endorsement of coercive policies, behavioral intentions to discriminate, and non/stigmatizing provider-patient interactions.
b) the factors underlying stigma proposed by our conceptual model and targeted in the intervention modules, including fears and misconceptions regarding casual transmission (instrumental stigma), and negative attitudes toward marginalized, vulnerable groups (symbolic stigma)</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/EKSTRAND-DRISTI-summary-for-CAPS-site-me-9-22-14_aes-me.pdf</url>
	</node>
	<node>
		<title>Ecosystems Therapy for Men Reintegrating into Their Family</title>
		<tax>1737</tax>
		<content><![CDATA[Structural Ecosystems Therapy (SET) is an intervention designed to mobilize participants’ families and other ecosystem members (such as service providers) to support and motivate behavior change. In this study, the SET intervention was adapted with the goal of reducing HIV transmission risk behavior and increasing medical adherence among HIV+ men being released from prison. In the intervention, participants and their ecosystem members met with the intervention staff in sessions designed to restructure interactions and communication patterns among ecosystem members with the goal of supporting participants’ positive behavior change. We recruited a total of 162 men from San Quentin State Prison, the California Medical Facility (CMF), and San Francisco County Jail. Participants were randomly assigned to receive either SET or an individually-focused comparison intervention that reduced sexual risk behavior in a previous study. Each intervention was four months in length. Participants were assessed before treatment, and at four, eight and twelve months after their release from prison.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Comfort_M-EcosystemsTherapy2009.pdf</url>
	</node>
	<node>
		<title>Homeless Female Offenders Returning to the Community: Improving Hopeful Futures</title>
		<tax>1737</tax>
		<content><![CDATA[The goals of the study are to reduce drug and alcohol use and recidivism among homeless female offenders (HFOs) in California. To achieve these goals, our team of UCLA and UCSF researchers plan to utilize our successful community participatory approaches to refine a gender-sensitive intervention program, Female Ex-Offender Mentoring in Care (FEM-CARE), with the help of a community advisory board. This study is based upon our team’s history of research promoting theoretically-based, culturally-sensitive nurse-led interventions that have resulted in significant reductions in drug and alcohol use among homeless persons, many of whom have had a history of incarceration. We will assess the impact of the FEM-CARE or Health Promotion (HP) control program on reduction of drug and alcohol use and recidivism.

Specific objectives include:
<ul>
 	<li>Guided by a Community Advisory Board (CAB) made up of HFOs and addiction staff, further conceptualize our community-based program, FEM-CARE, to address the needs of HFOs enrolled in a residential drug treatment programs (RDT) and then refine the program in focus group discussions with 12 HFOs.</li>
 	<li>Conduct a pilot randomized clinical trial (RCT) to assess the impact of the FEM-CARE program for 65 HFOs at six-month follow-up compared with 65 HFOs receiving a control Health Promotion (HP) program, in terms of a) self-reported and objective measures of drug and alcohol use; and b) prevalence of recidivism and number of days to first reincarceration.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/06/FemCare-Summary_CAPS_website_FINAL.pdf</url>
	</node>
	<node>
		<title>Navigator-Enhanced Case Management for Jail Inmates Transitioning to the Community</title>
		<tax>1737</tax>
		<content><![CDATA[While some community-based services exist, there remains a critical need to improve linkages to care and adherence to care plans among HIV+ adults as they move between community and jail. An effective service delivery model used in similar high-needs populations exists, but has not been tested with HIV+ drug users leaving jails. The model is called navigator case management and is based on harm reduction, motivational interviewing and general social work principles. Case managers work with paraprofessional peer navigators to help clients make better use of available resources, more effectively communicate with providers, sustain care over time and successfully connect with multiple service provider sectors.

In this study, we propose to:
<ul>
 	<li>Tailor the navigator case management approach to meet the needs of HIV+ individuals with. substance use and mental health disorders.</li>
 	<li>Pilot test the intervention and assessment procedures.</li>
 	<li>Conduct a randomized study with 360 HIV+ men and women leaving jail. Participants will receive either navigator case management delivered by the non-profit San Francisco Pre-Trial Diversion project, or the standard of care currently provided to transitioning inmates: 90-days of as-needed case management provided by the San Francisco Department of Public Health’s Forensic AIDS Project.</li>
 	<li>Test the effectiveness of the intervention in reducing sexual and drug-related HIV transmission risk,. increasing HIV medication adherence, reducing drug dependence and reducing reincarceration.</li>
 	<li>Characterize both the navigator and Forensic AIDS Project intervention processes and conduct. exploratory analyses of the mediators of HIV transmission risk and risk reduction and HIV-related adherence among HIV+ individuals leaving jail.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Myers_Navigator-Jail_2010.pdf</url>
	</node>
	<node>
		<title>Project Relate: HIV Risk among Male Parolees and Their Female Partners</title>
		<tax>1737</tax>
		<content><![CDATA[This study explores HIV risk among men who were released from prison within the last year and are currently on parole and the women who are in sexual relationships with them. Couples are recruited from community sites in Oakland, CA for participation in a quantitative survey. The couple comes to an appointment together and then each person is interviewed separately by a gender-matched interviewer. 200 couples will participate in the survey; a sub-sample of 44 couples will also be asked to participate in a qualitative interview to provide more in-depth contextual information about HIV risk and risk reduction among couples affected by incarceration.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Comfort_M-ProjectRelate2009.pdf</url>
	</node>
	<node>
		<title>Barriers to and Retention in Support Services among HIV+ Transwomen</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this study is to examine barriers to and retention in support services among HIV+ transwomen (women who were assigned a male sex at birth) and to explore the challenges and potential benefits of integrating HIV+ transwomen into services for HIV+ non-transgender women. This study will collect qualitative data with 14 HIV+ transwomen and 10 support services providers in Alameda County, CA. This study will provide preliminary data to inform an R01 application responding to an RFA to examine the test, treat and retain paradigm.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Wilson_Transwomen_2010.pdf</url>
	</node>
	<node>
		<title>Culturally Relevant HIV Prevention for Transgender Women</title>
		<tax>1737</tax>
		<content><![CDATA[Transgender women (people who were assigned ‘male’ at birth but identify as female) are disproportionately impacted by HIV, especially transgender women of color.

The specific aims of this research are:
<ul>
 	<li>Conduct 15 qualitative interviews to describe the influence of transgender women’s unique 1. cultural context on their HIV-related risk and behaviors and protective factors.</li>
 	<li>Create new and adapt existing quantitative measures to more accurately assess psychosocial 2. dimensions and behavior relevant to transgender women’s HIV risk and protective factors based on the qualitative data collected for Specific Aim 1</li>
 	<li>Survey 150 transgender women to identify psychosocial influences on HIV-related sexual and 3. injection risk behaviors and protective factors, using the new and adapted quantitative measures created in Specific Aim 2</li>
 	<li>Develop and test the feasibility and acceptability of a theory-driven, culturally grounded HIV 4. prevention intervention for transgender women, based on the qualitative and quantitative data collected in Specific Aims 1 and 3</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Sevelius_J-CultRelevHIVPrevTransgenderWomen2009.pdf</url>
	</node>
	<node>
		<title>Characterizing the Social Environment for STI Testing and Treatment for Young, Minority Men in San Francisco</title>
		<tax>1737</tax>
		<content><![CDATA[This project characterizes the STI testing and treatment environment for young, African American men in San Francisco, CA, by exploring STI services use, barriers to care, and preferences for future diagnostic technologies and testing strategies. This cross sectional study is conducted among 100 men aged 15-24 using a street intercept survey in predominantly minority, low income neighborhoods in San Francisco. Recruitment for the study is conducted as part of outreach efforts undertaken by the city’s STD branch at the department of public health. Participation includes completion of a structured, self-administered survey using a web-based interviewing tool. By eliciting questions regarding STI services use, STI-related knowledge, perception of gender norms and social stigma related to STI, and acceptability of varied diagnostic methods and test settings, we hope to generate data to better understand the testing and treatment environment for young African American men. The data generated will inform a future intervention proposal that aims to increase is the reach of effective STI prevention strategies, given the disproportionate burden of STI/HIV that young African Americans bear.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Lippman_STI_2010.pdf</url>
	</node>
	<node>
		<title>Computer-Based vs Interpersonal HIV Preventive Intervention for At-Risk Youth</title>
		<tax>1737</tax>
		<content><![CDATA[Building on the results of three efficacious HIV prevention programs with those at high HIV risk (LIGHT, Adolescent LIGHT, &amp; Street Smart), this study aims to examine the relative efficacy of LIGHT in an interpersonal or a computerized delivery format, in contrast to a standard care HIV prevention condition. The project has proceeded in two phases. During Phase 1, we further enhanced the existing computerized LIGHT prevention program to ensure acceptability; finalized and programmed assessment measures on a combination ACASI/CAPI program; finalized recruitment scripts and tracking programs; and conducted orientation sessions for all school personnel, parents, and stakeholders. The main intervention trial, Phase 2, utilizes a complete randomized block design with youth recruited over a two-year period. Twenty four schools (n=960 students) in the Los Angeles Department of Education were randomly assigned into one of three experimental conditions: Interpersonal Light in 8 schools 1. Computerized Light in 8 schools (n=320 youth) 2. A standard HIV control condition 3. Youth in each condition are assessed at a baseline interview, and reassessed longitudinally at three, six and 12 months.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lightfoot_M-ComptVsInterpersHIVPrevIntervYouth2009.pdf</url>
	</node>
	<node>
		<title>Maintenance Strategies for Homeless Youth’s Reductions in HIV Risk</title>
		<tax>1737</tax>
		<content><![CDATA[Street Smart (SS) is an effective HIV preventive intervention for homeless youth selected by the CDC as part of Replicating Effective Programs. However, substantial relapse diminishes the program’s effects over two years. This study examines a computerized strategy for maintaining the efficacy of the SS intervention for 400 homeless youth in Los Angles, CA. A two-stage sampling strategy (agency level and then youth within agency) was conducted in a randomized controlled trial examining the efficacy and cost-effectiveness of SS for reducing risk for HIV among homeless youth aged 12-20 years in three conditions:
<ul>
 	<li>SS, but no maintenance strategy</li>
 	<li>SS and a 2. computerized internet-based strategy for behavioral maintenance (Computerized SS; n=100)</li>
 	<li>A one-session AIDS video Control Condition (CC; n=100)</li>
</ul>
Based on a social learning theory, the maintenance strategy provides skill training, social support, informational updates, and access to an expert for consultation, referrals, and coping with emerging crises. Youth are assessed at recruitment, and at three-, six-, 12-, 18-, &amp; 24 month intervals in three domains:
<ul>
 	<li>Youth’s substance use and sexual behaviors.</li>
 	<li>Youth’s and staff members perceptions of the program’s acceptability and quality and program. utilization over time.</li>
 	<li>Generalization of the program’s effects on youth’s problem behaviors (sex work, delinquent acts,. conduct problems, school truancy/unemployment, emotional distress, and chronic homelessness).</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lightfoot_M-MaintStratHomelessYouth2009.pdf</url>
	</node>
	<node>
		<title>Qualitative Study of HIV Prevalence Patterns among Youth in Botswana</title>
		<tax>1737</tax>
		<content><![CDATA[Three recent independent national datasets suggest that the rate of new HIV infections in Botswana appears to be declining, as evidenced by decreased prevalence among pregnant women aged 15-49. However, it is still uncertain why these declines have been observed and the extent to which behavioral changes (e.g., monogamy, condom use) have been causally associated with the decline. The goal of this study is to use qualitative research methods to lend additional depth to existing surveillance data that suggest that HIV prevalence among young people in Botswana is declining. Focus group discussions and individual in-depth interviews are conducted with Local. youth service providers Youth between the ages of 18-24. Adult key informants in three districts selected for regional diversity and variation of trends in HIV. prevalence By gathering information from young people and key informants who provide health-related services to young Batswana, we will gain valuable insight into the behavioral and contextual factors that may assist in explaining the observed decreases in HIV prevalence. Qualitative methods will allow us to explore the meanings and variations of the sexual experiences of young Batswana. This work may also lead to the development of innovative behavior change strategies to help support the decreased spread of HIV in Botswana.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Rutherford_G-QualitStudyHIVPrevelYouthBotswana2009.pdf</url>
	</node>
	<node>
		<title>Regulating Emotion to Reduce HIV Risk in Delinquent Youth</title>
		<tax>1737</tax>
		<content><![CDATA[This study will develop a computerized intervention to train youth to regulate their emotions. This strategy is based on our previous successful experiences developing computerized interventions. We will develop a computerized intervention to reduce HIV risk behaviors grounded in a framework that augments Social Cognitive strategies by increasing the adolescents’ skills to manage affect and self-regulate. The CARE (Controlling and Regulating Emotions) intervention will target situations in which sexual risk behaviors occur and develop skills that allow adolescents to recognize intense affect, build strategies for tolerating intense affect and interrupt cycles of maladaptive expressions of affect in those situations.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lightfoot_M-RegEmotionReduceHIVRiskYouth2009.pdf</url>
	</node>
	<node>
		<title>Studying Youth in Northern California: The SYNC Project</title>
		<tax>1737</tax>
		<content><![CDATA[Studying Youth in Northern California (SYNC) is a public health research study assessing narcotic and stimulant use among 14-25 year-olds in five Northern California counties with an emphasis on how such factors and forces place this population at risk for HIV and related health problems. The SYNC Study is a multidisciplinary collaboration of researchers and public health experts from SFSU, UCSF, &amp; the counties of Alameda, Contra Costa, San Francisco, San Joaquin and San Mateo funded by the California Department of Health Services/Office of AIDS (CDHS/OA). SYNC hopes to provide information to complement previously collected data from the Young Women’s Survey (YWS) and HEYMAN studies, which were also collaborative efforts of the CDHS/OA and CAPS. This study will help to inform future public health interventions and policy targeting youth. The SYNC Study will be conducted in two phases: A formative qualitative information gathering phase regarding drug use in youth and risk of HIV 1. An epidemiological study of the prevalence of narcotics and stimulant use in 2. youth and young adults in the 5 counties. All the information we get will be used to assist county public health agencies and organizations to improve services for the treatment and care of youth at risk, and to develop better methods of helping young people prevent drug use and disease and promote good health.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lightfoor_M-SYNC2009.pdf</url>
	</node>
	<node>
		<title>Technology to Connect At-Risk Youth to Testing</title>
		<tax>1737</tax>
		<content><![CDATA[Among the numerous health disparities disproportionately burdening people of color, HIV/AIDS is among the highest. In the African American community the HIV/AIDS epidemic is one of the most urgent public health issues. In order to address the health disparity in HIV/AIDS, detection of HIV in the African American community is crucial. The benefits for early detection of HIV include potentially prolonged duration and quality of life for those living with the virus. HIV testing has also been proposed as a HIV preventive strategy. Detection of HIV has a number of potential preventive benefits, including reduced transmission risk behaviors by those infected9 and reduced viral load by those taking antiretroviral medications, whereby potentially reducing transmission. The proposed study makes a significant public health impact by developing and pilot testing an innovative strategy to increase the number of high-risk adolescents receiving HIV screening. In response to PA-09-146 (Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials [r34]), we propose a pilot study to examine the acceptability and feasibility of a peer-driven, HIV-testing campaign. Peer education and outreach strategies have been successful at reducing sexual risk behavior and increasing the use of health resources in adolescents and other at-risk groups, including adults residing in census tracts where STI rates are high. A potential vehicle for outreach to adolescents is socially interactive technologies (e.g., text messages). The proposed study makes a scientific impact in examining the effectiveness of messaging diffused through the social network of adolescents. A total of 100 current patients at an urban adolescent health clinic serving predominately African Americans will be recruited to disseminate at least 5 text messages to friends they believe are sexually active. Youth will be provided with a brief guide to help them develop their messages. The youth generated text messages will encourage their friends to visit the clinic and get tested. The specific aims of this project are to: Aim 1: Develop protocols and a theory-informed message guide for a peer-driven text message intervention for adolescents recruited from an adolescent health clinic. Aim 2: Examine the acceptability and feasibility of sending text messages related to obtaining HIV/STI testing. We will obtain participant feedback and examine the recruitment rate, number of youth failing to meet inclusion criteria, number of youth verified to have sent text messages, and number of text messages sent. We will also obtain feedback from the clinic providers regarding impact on patient and services flow, provider reactions, and impact on clinical visit. Aim 3: Preliminarily examine the efficacy of a youth generated messaging intervention to increase the: 1) number of high-risk youth seeking services and 2) clinic volume as measured by: a) number of new patients at clinic, b) increase in rate of new patient appointments, and c) number of STI tests conducted. If successful, the proposed study will significantly contribute to the field of HI prevention by examining the acceptability, feasibility and potential impact of an innovative strategy for delivering messages to high-risk youth, which encourage connection with the healthcare system and screening for HIV. This trial will fill a critical need to improve the sexual health outcomes of high-risk African American youth and lay the groundwork for a subsequent R01 proposal with a larger sample and that would include control sites. PUBLIC HEALTH RELEVANCE: Adolescents exhibit high rates of STI/HIV, which have implications for a myriad of other sexual health issues, including reproductive health. Further, African American youth are disproportionately impacted by HIV. The proposed study will significantly contribute to the field of HIV/STI prevention by examining the impact of an innovative strategy for delivering telehealth messages to high-risk youth that encourage connection with the healthcare system and screening for HIV. This trial will fill a critical need t improve the sexual health outcomes of high-risk youth.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/10/Lightfoot.-Technology-to-Connect-At-Risk-Youth-to-Testing.pdf</url>
	</node>
	<node>
		<title>Examining the impact of the HIV-related state budget cuts: Comparing Alameda, Fresno, and Los Angeles Counties</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Problem</strong>: During  the  summer  of  2009,  the  State  of  California  experienced  an  unprecedented  budget  crisis,  resulting  in  cuts  to  social  services  across  the  state.  Approximately  $85  million  was  eliminated  from the budget of the State Office of AIDS  (OA)  for  FY  2009‐2010,  about  half  of  the  allocation of $167 million in FY 2008‐2009. Following  the  cuts,  reports  in  the  local  media  and  press  releases  indicated  that  several  community‐based  organizations  (CBOs)  and  AIDS  service  organizations  (ASOs) had to close their doors or drastically  reduce  the  level  of  HIV‐related  services,  including  activities  such  as  HIV  testing  and  counseling.  The  UCSF  AIDS  Policy  Center  Rapid Response Team conducted this study  to  gather  more  details  on  the  impact  of  these budget reductions.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/RAP1pager_budgetcuts.pdf</url>
	</node>
	<node>
		<title>Crime and Punishment: Is There a Role for Criminal Law in HIV Prevention Policy?</title>
		<tax>1737</tax>
		<content><![CDATA[The Until There's A Cure Foundation has provided financial support for the UCSF AIDS Policy Research Center since 1998. One of the primary goals of this funding is to research and publish a monograph analyzing an area of current HIV/AIDS public policy.  Previous monographs have focused on the development an AIDS vaccine and the validity of abstinence-only education.  This year’s project, funded by Until There's A Cure Foundation, explores what role, if any, criminal law should have in addressing HIV transmission and what the scope of that role should be.  This monograph reviews the criminal law approach to HIV transmission, including the history and policy background to criminalization of intentional HIV exposure and the reasons that states may use such laws.  It then analyzes in detail the statutes that states have adopted to criminalize intentional HIV exposure, focusing on the specific statutory and its implications to highlight how criminal HIV exposure laws can support or undermine public health prevention efforts.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/criminalization-descrip1.doc</url>
	</node>
	<node>
		<title>Abstinence Only vs. Comprehensive Sex Education: What are the Arguments? What is the Evidence?</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/abstinence-only.doc</url>
	</node>
	<node>
		<title>Discovering Global Success: Future Directions for HIV Prevention in the Developing World</title>
		<tax>1737</tax>
		<content><![CDATA[The National Institutes of Health’s Fogarty International Center in collaboration with a number of other agencies sponsored the Fogarty Workshop on International HIV/AIDS Prevention Research Opportunities on April 18-20, 1998. The AIDS Research Institute at the University of California, San Francisco hosted the Workshop. The purpose of the workshop was to identify a package of effective HIV prevention interventions and develop a list of priority research goals that combine biomedical, behavioral and social interventions for HIV prevention in developing countries. The goal was to encourage research that would be feasible and relevant for developing countries with limited resources.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/intlmono.pdf</url>
	</node>
	<node>
		<title>Designing Primary Prevention for People Living with HIV</title>
		<tax>1737</tax>
		<content><![CDATA[This monograph is based largely on presentations and discussion at the June, 1999 policy forum Primary HIV Prevention: Designing Effective Programs for People Living with HIV. The Forum was hosted by the AIDS Research Institute at UCSF and the National Association of People with AIDS. The Forum was sponsored by the National Institute of Mental Health (NIMH), the NIH Office of AIDS Research (OAR), and the Centers for Disease Control and Prevention (CDC).]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/pozmono.pdf</url>
	</node>
	<node>
		<title>Paving the Road to an HIV Vaccine: Employing Tools of Public Policy to Overcome Scientific, Economic, Social and Ethical Obstacles</title>
		<tax>1737</tax>
		<content><![CDATA[In June 1996, the Center for AIDS Prevention Studies published the second occasional paper in this monograph series, entitled Sustaining Support for Domestic HIV Vaccine Research: Social Issues Over the Long Haul of Human Trials. Authored by Chris Collins, the research was supported by grants from the National Institute of Mental Health, National Institutes of Health and the University of California, San Francisco. This new report is intended to function as an update to the 1996 monograph. Most of the social and ethical issues discussed in the original paper have not changed during the past two years. Therefore, you will find many of the previously identified challenges and stages of vaccine research and development, concerns about the design of HIV vaccine efficacy trials, goals of community education, potential benefits and harms for impacted communities, and levels of industry involvement, among others, retained. As a progress report on the state of HIV vaccine research, this paper attempts to highlight, generally, both the progress and lack of progress toward the primary recommendations laid out in the earlier paper. By focusing, up front, on the latest activities of government, affected communities, and industry, a clearer landscape of the state of HIV vaccine efforts comes into view; gaps in certain areas point to the work which remains to be done.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/vaccines98.pdf</url>
	</node>
	<node>
		<title>Motivators and Barriers To Use Of Combination Therapies In Patients With HIV Disease</title>
		<tax>1737</tax>
		<content><![CDATA[The successful two-drug combination therapy in 1994 and protease inhibitors in 1995 set the stage for a new era in treatment of HIV disease, creating a burst of optimism over the prospect that HIV might be a controllable disease. Initial studies of protease containing triple-drug regimens suggested that these combinations could, in some cases, slow clinical progression of the disease and prolong the lives of patients. In anecdotal reports, physicians and patients described a kind of "Lazarus" effect in which previously disabled individuals found themselves regaining lost functions, returning to work and planning their futures, instead of preparing for death.

There are still many unknowns about these multi-drug regimens, including their durability of effect and how many individuals for whom they will be effective. Nonetheless, the drugs have proven quite effective in clinical trials and are helping many people stay alive longer and experience better quality of life while they are alive.

We thought it important to understand better why people do and do not take advantage of these therapeutic advances. Developing the medications may be only half of the battle; the other half involves making sure that HIV infected individuals have access to the drugs and that they make thoughtful decisions about whether or not to take them. If some of the barriers to taking the drugs can be addressed, they should.

We conducted in-depth qualitative interviews with 114 individuals in the HIV community--75 HIV infected men and women, 18 hotline operators and supervisors, 11 case managers, and 10 physicians and nurse practitioners.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/combotherapymono.pdf</url>
	</node>
	<node>
		<title>Do As I Say…Should We Teach Only Abstinence in Sex Education?</title>
		<tax>1737</tax>
		<content><![CDATA[Politics rather than scientific evidence is driving the debate over abstinence-only vs. comprehensive sexuality education programs. It is an approach to making policy that may satisfy the needs of some adults, but does nothing to address the crucial needs of young people.

In health promotion, as in medical care, the informed practitioner usually chooses a proven effective strategy over one for which there is no indication of effectiveness. Anything else is malpractice. If policy makers were physicians, they would prescribe what the current sexuality education research indicates actually works: tested comprehensive sexuality education programs. They would not be willing to take a chance on an unproven therapy (i.e., abstinence-only sexuality education), outside of limited studies designed specifically to test the intervention’s effectiveness.

The U.S. Congress recently approved one quarter billion dollars in new sexuality education funding. But the money comes with strict restrictions on program content. The mandated “abstinence-only” approach dictated by Congress has not been proven effective in scientific studies, runs counter to the sexuality education approaches of most states, and is based on assumptions inconsistent with the behavior of the majority of the youth in this country.

The costs of unprotected adolescent sex are clear. American teens have the highest rates of unplanned pregnancies and sexually transmitted diseases in the industrialized world. One in four sexually active adolescents acquires a sexually transmitted disease (STD) in any given year. This adds up to three million adolescent STD cases annually. Every 30 minutes another person under 20 becomes newly infected with HIV. Nearly one in ten high school seniors reports becoming pregnant or getting someone else pregnant. About 406,000 teens have abortions annually, 134,000 miscarry, and 313,000 unmarried teens give birth to a child.

In order to address these problems more effectively, it is not necessary to settle any of the political debates that whirl around the issue of sexuality education. What is needed is a commitment to results. Elected officials, teachers, school boards and parents need to choose: is the function of sexuality education in public schools primarily to prevent disease and unplanned pregnancy or to promote traditional ideology?

We need to use the information currently available to set responsible sexuality education policy focused on improved outcomes for youth. Quality research on program effectiveness, along with a close analysis of the needs of young people at especially high risk, provides important guidance.

Comprehensive sexuality education programs discourage teens from having sex before they are ready, and encourage condom and contraceptive use for teens who choose to have sex. The substantial body of current behavioral research indicates that some of these programs have been effective at delaying the onset of sexual intercourse, decreasing the number of sexual partners, and increasing condom and contraceptive use among young people. To date, no published, peer reviewed research has been able to demonstrate positive outcomes for abstinence-only sexuality education programs like those recently funded by Congress.

It makes scientific sense that the more comprehensive programs would demonstrate promising results. Even the most effective behavioral interventions succeed with only a portion of their intended audience. And given that two thirds of high school seniors report having had intercourse, it is fanciful to expect that abstinence-only programs will be able to bring an absolute end to adolescent sexual activity.

Given that a large percentage of young people are destined to be sexually active, it follows that they will need to know how to protect themselves in sexual situations, and have access to condoms and other contraceptives. Abstinence-only programs fail to deliver these protections. They ignore the complexity of risk factors relating to youth STD and pregnancy rates. And abstinence-only programs are typically silent or condemning on subjects that are critical to many of the young people at highest risk, including gay sex, dynamics with older sexual partners, and abortion.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/doasisay.pdf</url>
	</node>
	<node>
		<title>Dangerous Inhibitions: How America Is Letting AIDS Become an Epidemic of the Young</title>
		<tax>1737</tax>
		<content><![CDATA[This monograph was produced as part of the Marketing HIV Prevention project, a collaborative project between the Center for AIDS Prevention Studies at the University of California, San Francisco (Thomas J. Coates, , Director) and the Harvard AIDS Institute (Richard Marlink, MD, Executive Director). We would like to thank SmithKline Beecham Consumer Health Care, makers of OraSure, for its unrestricted grant in support of the Marketing HIV Prevention project. We would also like to acknowledge the support of the Office of AIDS, National Institute of Mental Health, National Institutes of Health, for its ongoing support of the Center for AIDS Prevention Studies under grant number MH42459. The author would like to thank Thomas Coates and Mario Cooper for their significant contributions to this report. I am also indebted to several colleagues who reviewed earlier drafts of the paper, including: Paula Brewer, James Colgrove, Peggy Dolcini, Kevin Filocamo, Katherine Haynes-Sanstad, Lisa Heft, Susan Kegeles, Clark Moore, Ric Marlink, Maureen Michaels, James Riggs, Mark Steitz, Jeff Stryker, and Steve Wakefield. And thanks to Susan Lausten for the design and layout of this piece.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/DangerInhib.pdf</url>
	</node>
	<node>
		<title>Sustaining Support for Domestic HIV Vaccine Research</title>
		<tax>1737</tax>
		<content><![CDATA[By the time Kevin Shancady walked into the Denver Department of Public Health to enroll in an HIV vaccine trial, he'd managed to put most of his fears behind him: fears of a government hostile to gay men, fears that researchers might inject volunteers with a dangerous vaccine. "So many people have died," he said, "and I feel an obligation to advance prevention research. I'm willing to take some risk. And if the vaccine works, then I'll have protection." It's that mix of optimism, altruism and hope for personal benefit that has made it possible for the National Institute of Allergy and Infectious Diseases (NIAID) to recruit over 4800 Americans into a cohort being readied for HIV vaccine trials. But what Kevin heard when he sat down with a study counselor shows why recruiting volunteers is just the first step on the long and difficult road of HIV vaccine testing. In the best tradition of public health, the study counselor warned him of the possible risks of trial participation. "He told me participants in this trial might not be able to join other vaccine trials," Kevin said, "and if a different vaccine is eventually developed later, it might not work as well in me as in people who had not been in one of these early vaccine studies. I felt blindsided, actually."]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/vaccinemono96.pdf</url>
	</node>
	<node>
		<title>UFO Presents! A viral hepatitis prevention and education program for young adult IDUs</title>
		<tax>1737</tax>
		<content><![CDATA[Young injection drug users (IDU) are at high risk for viral infections, such as HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV), due to frequent injecting, needle/syringe and other drug preparation equipment sharing, high numbers of sexual partners, and exchange of sex for money or drugs. Street youth who inject have high unemployment, poor education, and mental health issues. In San Francisco, young IDU are typically homeless runaways who often are involved in an illegal street economy, including prostitution, drug sales, theft, panhandling, pornography and selling stolen property. They experience a large number of negative and traumatic events prior to leaving home. Many fear and mistrust authority and consequently avoid or delay contact with the public health system. The combination of youth, drugs, survival sex and disenfranchisement make this group extremely vulnerable to multiple negative health outcomes.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/UFOPresentsS2C.pdf</url>
	</node>
	<node>
		<title>Studying Youth in Northern California (SYNC)</title>
		<tax>1737</tax>
		<content><![CDATA[Substance use among youth and young adults continues to pose a variety of public health challenges. Young people who use opiates (heroin) and methamphetamine are more likely to have high risk sexual and injection practices, as well as more likely to be HIV+. Drug use among youth may be associated with a variety of problems including family trauma, academic difficulties, mental and physical health problems, sexual abuse, incarceration, poor peer relationships and violence. Youth in Northern California who are at risk for drug use, HIV and related health problems need to be better understood and targeted for prevention programs.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/SYNCS2C.pdf</url>
	</node>
	<node>
		<title>A novel condom distribution program for county jail prisoners</title>
		<tax>1737</tax>
		<content><![CDATA[Correctional facilities concentrate populations that are at risk for HIV infection: persons of color, persons with substance abuse histories, and persons living in poverty.1,2 As a result, the prevalence of HIV among US incarcerated populations is five to seven times that of the general US population.3,4 Furthermore, about 25% of people living with HIV in the US have been incarcerated.5 These statistics support the need for access to effective means of HIV prevention and harm reduction strategies in correctional facilities.

Condoms are highly effective at preventing the transmission of HIV.6 Despite the fact that there is a growing consensus that in-custody HIV transmission is not trivial,7 condoms are made available to only a minute fraction of the US prisoner population. The manner in which condoms are currently made available to prisoners in California varies widely. In the Los Angeles County Jail, the Center for Health Justice distributes condoms to a segregated gay male population only, one condom per week by request. In San Francisco, prior to this project, condoms were distributed by request through the Forensic AIDS Project’s public health staff in one-on-one health counseling sessions, one per person, per request.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/PrisoncondomS2C.pdf</url>
	</node>
	<node>
		<title>HIV prevention for women visiting their incarcerated partners: the HOME Project</title>
		<tax>1737</tax>
		<content><![CDATA[CAPS and Centerforce, a community-based organization that has been providing services to prisoners and their families for thirty years, have been collaborating since 1993 to design and evaluate HIV prevention interventions for incarcerated men and their female partners. Our previous work with male prisoners includes the evaluation of a peer-led HIV education orientation for arriving prisoners; development and evaluation of a prerelease intervention for men leaving prison; development and evaluation of a health promotion intervention for HIV+ prisoners preparing for release;3 and a multi-site study to conduct formative research and develop and test an HIV, STD and hepatitis intervention for young men preparing for release from prison.

Early in the course of these studies, men expressed a need for HIV prevention interventions specifically tailored for the needs of the women with whom they were in romantic and sexual relationships. In response, we conducted formative research with women visiting men imprisoned in a California state prison and we piloted a single session intervention designed for this population that was taught by a peer educator.

Our formative work with women visiting incarcerated men indicated that it was feasible to engage women in intervention and research evaluation activities. However, a single-session intervention did not have a measurable effect on the HIV risk behavior of study participants. We decided to develop a multi-component intervention targeting the specific needs of women with incarcerated male partners. We designed and evaluated Health Options Mean Empowerment (HOME), an intervention to reduce HIV risk among women whose male partner was being released from state prison.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/HOMES2C.pdf</url>
	</node>
	<node>
		<title>The CHANGES Project: Coping Effectiveness Training for HIV+ gay men</title>
		<tax>1737</tax>
		<content><![CDATA[HIV+ persons confront a unique set of challenges and chronic stressors, including stigmatization, alienation from family and friends, complex treatment regimens, and, often, debilitating side effects as they attempt to manage the psychologic and physiological consequences of their condition. For persons living with HIV, elevated distress and low social support take on added importance because they can accelerate disease progression. Helping HIV+ people to reduce stress and adhere to their medical care may in turn help to reduce their risky behavior. The ability to cope successfully with a chronic illness such as HIV disease is influenced by a number of social and psychological factors. Stress and coping theory provides a framework for studying these factors and for intervention. Coping research draws attention to the co-occurrence of positive and negative psychological states and recognizes the importance of encouraging coping processes that help to sustain positive psychological states in the context of stress. We evaluated a coping intervention, Coping Effectiveness Training (CET), designed to assist HIV+ gay men in sustaining psychological health despite the ongoing stress associated with HIV infection. The study was a randomized clinical trial of an innovative, theory-based coping intervention. The research questions addressed the problems of maintaining intervention effects, evaluating intervention effects on quality of life, health care utilization and adherence to medical care, and testing new advances in stress and coping theory.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/CHANGES-S2C.pdf</url>
	</node>
	<node>
		<title>Seroconversion Narratives for AIDS Prevention (The SNAP Project)</title>
		<tax>1737</tax>
		<content><![CDATA[As people are living longer and healthier lives with HIV, the risk of HIV transmission through unprotected sexual intercourse or sharing injection equipment continues to grow. While the general consensus is that most people who know they are HIV+ are careful to avoid transmitting the virus, it is estimated that one third of HIV+ gay/bisexual men continue to engage in unprotected sex. There is now a growing call to develop targeted and effective prevention strategies addressing the specific needs of people living with HIV.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/SNAPS2C.pdf</url>
	</node>
	<node>
		<title>What Providers Think about HIV Prevention: The Implicit Theory Project</title>
		<tax>1737</tax>
		<content><![CDATA[The Implicit Theory project was designed to capture how HIV prevention providers delivering services think behavior change in their clients happens, what we refer to as providers’ implicit theories. This is important for many reasons. To begin with, the providers work directly with clients and were often peers of these clients. They are directly interacting with their clients and may be able to even witness when change has occurred. The providers’ position as peer or former peer, as the practice of hiring from the community that one wants to serve is very popular among HIV prevention organizations, is also key. This position provides insight and familiarity about the context and complexities of clients’ lives that is unique to providers. But the most compelling reason to capture this is that this is what providers are actually doing. Regardless of what researchers are studying or what funders are funding, we found that the providers we interviewed are out in the field acting on what they believe helps change behavior. Providers’ implicit theories drive their services, and therefore, it’s important to understand these implicit theories.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/ITS2C.pdf</url>
	</node>
	<node>
		<title>Collaborative Research to Prevent HIV among Prisoners and their Families</title>
		<tax>1737</tax>
		<content><![CDATA[There are more than two million adults incarcerated in the US and four million more on probation or parole. Rates of HIV are 8 to 10 times higher for incarcerated persons than for the general US population, hepatitis C rates are 9 to 10 times higher, and sexually transmitted disease (STD) rates among men entering jails are as high as 35%. Because many prisoners are serving short sentences for parole violation, and return to prison is common, at-risk individuals move frequently between prisons and their home communities. (National Commission on Correctional Health Care, 2002) There is an urgent need to develop effective, accessible HIV prevention programs and population-specific HIV education materials for prisoners and their partners. Despite this, institutional barriers have impeded development and evaluation of such programs. Prisoners in the US have virtually no access to condoms, bleach, clean syringes, comprehensive HIV prevention education or support for transitioning out of prison. Rules protecting the security of the institution also limit access by community-based organizations (CBOs) and researchers. Staff at Centerforce, a CBO, have provided comprehensive HIV prevention education at San Quentin State Prison since 1986. Since 1992 they have been evaluating many of these programs in collaboration with the Center for AIDS Prevention Studies (CAPS), UCSF.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/CenterforceS2C.pdf</url>
	</node>
	<node>
		<title>Investigación Conjunta para la Prevención del VIH con Poblaciones Encarceladas y sus Familias</title>
		<tax>1737</tax>
		<content><![CDATA[En los EE.UU. existen más de 2 millones de personas adultas encarceladas y 4 millones más en libertad condicional. Las tasas de VIH son de 8 a 10 veces más altas para los encarcelados que para la población en general; las tasas de hepatitis C son de 9 a 10 veces más altas y las de enfermedades de transmisión sexual (ETS) entre hombres que recién ingresan a la cárcel alcanzan hasta un 35%. Muchos internos tienen sentencias cortas por infringir su libertad condicional y el regreso a la prisión es común, por lo que dichas personas transitan frecuentemente entre la prisión y su comunidad aumentando su condición de riesgo y la de sus familias. (National Commission on Correctional Health Care, 2002) Existe la necesidad urgente de desarrollar programas de prevención del VIH eficientes y accesibles así como materiales educativos específicos para las personas en prisión y sus parejas. Sin embargo, las barreras institucionales han impedido el desarrollo y la evaluación de dichos programas. En EE.UU. los internos prácticamente no tienen acceso a condones, cloro, jeringas limpias, información sobre las formas de transmisión y prevención del VIH o apoyo para la transición al salir de prisión. Las reglas de seguridad de las instituciones limitan el acceso de las organizaciones de servicio comunitarias (OSC) e investigadores. Desde 1986, Centerforce, una OSC, ha proporcionado educación preventiva del VIH en la prisión estatal de San Quintín y desde 1992, ha evaluado varios de sus programas en colaboración con el Centro de Estudios de Prevención del SIDA (CAPS sus siglas en inglés) de UCSF.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/encarceladaS2C.pdf</url>
	</node>
	<node>
		<title>Project START: HIV/STD/Hepatitis Prevention for Young Men Being Released from Prison</title>
		<tax>1737</tax>
		<content><![CDATA[By the end of 2002, over 2 million adults were incarcerated in the US, and 93% of those were men. African Americans and Latinos were incarcerated at greater rates than Whites in the US, 7.6 times greater for African Americans and 2.6 times greater for Latinos. Nearly 40% of incarcerated men were under the age of 30. Young men of color are at high risk of incarceration and the health problems related to incarceration. These young men also are our neighbors, frequently passing in and out of jail and prison and returning back to the community. Men who are incarcerated have disproportionate rates of HIV, sexually transmitted diseases (STDs) and hepatitis. Rates of HIV are 8-10 times higher for incarcerated persons than for the general US population; hepatitis C rates are 9-10 times higher, and STD rates among men entering jails are as high as 35%. Men leaving prison face numerous challenges that may impede their ability to protect themselves against these diseases. Men often must re-establish relationships, find employment and housing and deal with addictions and mental health issues. Prisons present a unique opportunity for HIV/STD education and skills building to help men avoid risk after their release from prison.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/STARTS2C.pdf</url>
	</node>
	<node>
		<title>Prevention Strategies of HIV Positive Injection Drug Users (VENUS Study)</title>
		<tax>1737</tax>
		<content><![CDATA[New HIV infections are decreasing among IDUs. This decrease has been related to the practice of injection risk reduction among IDUs such as the use of needle exchange programs where available. However, recent research has found that sexual risk behavior among IDUs may account for more new HIV infections than injection practices.2 We need to know more about the sexual practices of IDUs. To date, most HIV prevention efforts have focused on how HIV negative people can stay negative. This has overlooked the important role that HIV positive individuals can play in the prevention of new HIV infections. HIV positive people also need support to not spread the virus and to keep themselves healthy (avoid STDs, Hepatitis C, abscesses, etc.). The need for prevention efforts targeting HIV positive individuals has only recently been addressed.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/venusS2C.pdf</url>
	</node>
	<node>
		<title>Project Access: Barriers to HIV Counseling and Testing, and the Prevention Strategies of Drug Users Community</title>
		<tax>1737</tax>
		<content><![CDATA[Project Access is a qualitative study of barriers to HIV counseling and testing, and the personal HIV prevention strategies of drug users.

Main Findings:
<ul>
 	<li>Drug users’ risk behavior was not directly related to the number of times they had previously tested for HIV.</li>
 	<li>Personal prevention strategies and HIV testing patterns are shaped by public health messages, institutional practices, and the concrete realities of living and surviving in impoverished communities.</li>
 	<li>Many low-income drug users approach HIV as a chronic illness, one of many life threatening diseases facing their communities. HIV infection was seen as random and unpredictable, the virus was believed to lay dormant and completely undetectable within the body for years, and routine screening (HIV testing) was believed to be a primary means of managing HIV.</li>
 	<li>Race, class, and gender inflect individuals’ perceptions, their responses to the threat of HIV, and their motivations for HIV testing.</li>
 	<li>Health and social service referrals can play an important role in linking these populations to needed services.</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/AccessS2C.pdf</url>
	</node>
	<node>
		<title>Study of HIV Sexual Risk among Disenfranchised African American MSM Community</title>
		<tax>1737</tax>
		<content><![CDATA[HIV transmission is disproportionately on the rise among economically poor, African American men who have sex with men (MSM) in the United States . Although this trend has been observed for over a decade, prevention efforts have apparently been unable to adequately address the needs of this population. Existing support systems for MSM have often failed to consider cultural and family differences, perceptions of sexual orientation, economic disparity, and differential access to education and information among African American MSM . Disenfranchised African American MSM are often isolated both by homophobia in the African American community and racism in the predominantly white gay community . In addition to this, many African American MSM self-identify as either bisexual or heterosexual, thus possibly eluding HIV prevention efforts which target gay men. The crisis of HIV in the African American community and in communities of color cannot be separated from the crises of poverty, racism, and drugs . The presence of crack and other drugs plays a continuing role in the social disintegration of many of these communities. However, relatively little is known about the role of substance use in HIV sexual risk behaviors.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/TESS2C.pdf</url>
	</node>
	<node>
		<title>The Legacy Project: Lessons Learned About Conducting Community-Based Research</title>
		<tax>1737</tax>
		<content><![CDATA[Since 1991, the Center for AIDS Prevention Studies (CAPS) has conducted collaborative research with local community-based HIV prevention organizations within a consortium model. Community-based research (CBR) refers to research that is conducted by or with the participation of community members. As conducted by CAPS, CBR was a full partnership, with the CBO partner taking the lead on developing the research question, delivering the intervention, and collecting the data. The academic researcher took the lead on developing the instrument, consent procedures, data collection protocol, and data analysis. Together, the academic/CBO team trained intervention and evaluation staff, interpreted the data, crosstrained on service and research issues, and disseminated the findings. We developed a model which supported joint work and negotiation of research activities, as opposed to a model where the academic researcher conducts a study on the CBO’s clients, with the CBO mainly providing access to clients.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/LegacyS2C.pdf</url>
	</node>
	<node>
		<title>Collaborative HIV Prevention Research in Minority Communities</title>
		<tax>1737</tax>
		<content><![CDATA[HIV has spread dramatically in minority communities, with African Americans currently being five times as likely as whites to contract HIV, and the disproportion continues to increase. Historically, few minority investigators have been funded by the NIH. Culturally appropriate measurements and methods are needed to successfully involve respondents and accurately measure their beliefs, values, and behaviors. Investigators who are members of minority groups often have more access to the minority community and more credibility within that community. In addition, they may have a greater understanding of the cultural issues that could influence behavior, and they often have language fluency]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/MinorityS2C.pdf</url>
	</node>
	<node>
		<title>The Voluntary HIV-1 Counseling and Testing Efficacy Study: A Randomized Controlled Trial in Three Developing Countries</title>
		<tax>1737</tax>
		<content><![CDATA[The Voluntary HIV-1 Counseling and Testing Efficacy Study was designed to measure the efficacy of HIV VCT in developing country and resource poor settings where access to antiretrovirals and other expensive medications is difficult or impossible.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/VCTS2C.pdf</url>
	</node>
	<node>
		<title>Systematic Reviews Demystified: Conducting Systematic Reviews on HIV Infection and AIDS</title>
		<tax>1737</tax>
		<content><![CDATA[Physicians, researchers, public health practitioners and patients are deluged with unmanageable amounts of information about the best approaches to prevention, treatment and health care delivery. Over the last 30 years, there has been an exponential rise in the number of published scientific articles across health fields. There have been 131,000 randomized controlled trials (RCTs) completed since 1948,1 over 2 million articles are published annually in the biomedical literature in over 20,000 journals,2 and over 3,330 journals are indexed in MEDLINE.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/CochraneS2C.pdf</url>
	</node>
	<node>
		<title>Smoking Cessation Interventions in San Francisco’s Queer Communities</title>
		<tax>1737</tax>
		<content><![CDATA[Rates of smoking among lesbian, gay, and bisexual adolescents and adults appear to be higher than rates for the general population (Gruskin, et al., 2001; Ryan, et al., 2001; Stall, et al., 1999). Smoking is also likely problematic among transgender people, many of whom face poverty, homelessness, stressful living and work environments, and depression in their daily lives. Despite the fact that smoking negatively impacts or complicates health issues of particular importance to LGBT persons (e.g., hormone therapy for transgender people, HIV/AIDS), tobacco companies target these communities. Yet, there is little research on smoking cessation by and for LGBT persons.

Community activists in San Francisco started working more than a decade ago to address these problems. In the early 1990’s, Lyon-Martin Women’s Health Services initiated “The Last Drag,” the first stop-smoking group for LGBT and HIV positive smokers. The California Lavender Smokefree Project (CLSP), funded by the state in the mid-90’s, counteracted tobacco industry targeting of LGBT communities. In 1996, the Coalition of Lavender Americans on Smoking and Health (CLASH), with the help of Progressive Research and Training for Action (PRTA), (a community-based organization specializing in LGBT technical assistance), held Alive with Pleasure! the first federally funded conference on tobacco use among California’s LGBT population. In 1998, at the urging of CLASH members, the Center for AIDS Prevention Studies (CAPS) launched its first tobacco study with gay/bisexual men.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/Q-TIPS2C.pdf</url>
	</node>
	<node>
		<title>Stress and Coping in Gay Male Caregivers of Men with AIDS</title>
		<tax>1737</tax>
		<content><![CDATA[Traditionally, responsibility for providing care in the home for people with serious illness has fallen to women as wives, mothers, or daughters of the afflicted individual. Among the many societal repercussions of the HIV/AIDS epidemic has been the creation of a new group of caregivers—gay men who are the primary caregivers for their partners with AIDS. In the 1980s and early 1990s, before the advent of protease inhibitors and the new antiretroviral treatments, AIDS was a pernicious, essentially uncontrollable terminal illness that manifested horrendous opportunistic infections. Caregiving during this period was challenging at every level: emotional, psychological, physical, and even spiritual. The tasks were daunting, highly stressful, and unremitting. The only predictable aspect of the disease was that it would claim its victim sooner rather than later.

How could these caregivers, many of whom were themselves infected with HIV, maintain their own sanity, and for those who were HIV+, sustain their own physical health, while facing the extraordinary challenges of AIDS caregiving? These were the questions that led us to design a study about this new group of caregivers. We felt that there was a great deal these men could teach us about coping with profound psychological stress that would help other AIDS caregivers as well as anyone who was faced with the profound stress of caring for someone with a serious illness.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/CopingS2C.pdf</url>
	</node>
	<node>
		<title>National Gay Men’s HIV/AIDS Awareness Day – September 27, 2016</title>
		<tax>1737</tax>
		<content><![CDATA[This brochure lists research projects with gay men and helpful resources produced by CAPS/PRC.

You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects.</li>
</ul>
Lead researchers (PIs) are listed for each study. Contact us below to connect.

Questions? Comments? Contact Daryl Mangosing at 415-514-4590 or Daryl.Mangosing@ucsf.edu

This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2016/09/2016GayMenAwareness-booklet.pdf</url>
	</node>
	<node>
		<title>National HIV Testing Day – June 27, 2016 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[This brochure lists research focusing on HIV testing and helpful resources produced by CAPS/PRC.

You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Use the materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects.</li>
</ul>
Lead researchers (PIs) are listed for each study. Questions? Comments?

Contact Daryl Mangosing at 415-514-4590 or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

This brochure was prepared by the <a href="/sites/prevention.ucsf.edu/files/about/caps-structure-and-cores/community-engagement-ce-core/">Community Engagement (CE) Core</a>, previously known as the Technology and Information Exchange (TIE) Core: “Tying research and community together.”]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2016/06/2016-National-HIV-Testing-Day-booklet.pdf</url>
	</node>
	<node>
		<title>National Black HIV/AIDS Awareness Day — February 7, 2016 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with African Americans and helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing at 415-514-4590 or Daryl.Mangosing@ucsf.edu

<em>This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core. </em>
<h4>Acronyms</h4>
<strong>MSM</strong>: Men who have sex with men

<strong>PI</strong>: Principal Investigator (lead researcher on the study)]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2016/02/NBHAAD2016.pdf</url>
	</node>
	<node>
		<title>National Women and Girls HIV/AIDS Awareness Day—March 11, 2011</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2011/03/NBHAAD2011_non-booklet.pdf</url>
	</node>
	<node>
		<title>National Black HIV/AIDS Awareness Day —February 7, 2011</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/NBHAAD2011_non-booklet.pdf</url>
	</node>
	<node>
		<title>National Black HIV/AIDS Awareness Day—February 7, 2010</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/2010NBHAAD_non-booklet.pdf</url>
	</node>
	<node>
		<title>National Women and Girls HIV/AIDS Awareness Day—March 10, 2010</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/NWGHAAD2010.pdf</url>
	</node>
	<node>
		<title>National HIV Testing Day—June 27, 2010</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/2010TestingDay-non-booklet.pdf</url>
	</node>
	<node>
		<title>National Gay Men’s HIV/AIDS Awareness Day—September 27, 2010</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/2010GayMenAwarenessnon-booklet.pdf</url>
	</node>
	<node>
		<title>Proceedings of the National Roundtable on Evaluation of Mutlilevel/Combination HIV Prevention Interventions</title>
		<tax>1737</tax>
		<content><![CDATA[The National Roundtable on Evaluation of Multilevel/Combination HIV Prevention Interventions had the goals of examining the present state of the art of multilevel and combination HIV prevention interventions, both domestically and internationally; to define the significant challenges and scientific gaps in current evaluation methods and identify the most promising methodological approaches to address these gaps; and to guide the future agenda for HIV prevention research.

To address these methodological gaps, we must combine the methodological and statistical rigor associated with clinical trials, the conceptual framework of implementation science, the on-the-ground strategies of programmatic monitoring and evaluation, and the strengths of pre- and post-intervention mathematical modeling.

In looking at the HIV epidemic in the US, the group discussed current initiatives guided by the National HIV/AIDS Strategy and the increased optimism over treatment as prevention. We noted that considerable progress has been made in developing core metrics to evaluate outcomes along the “treatment-as-prevention cascade” that could be captured through public health surveillance—number of new HIV cases detected and proportion linked to care, retained in care, on active treatment, and virally suppressed. Our understanding of the optimum package of interventions with regard to both effectiveness and efficiency remains incomplete. Progress was reported, however, in the collection of process data at the local level to better assess how to improve programs. Devising epidemic impact measures to quantify reductions in HIV incidence attributable to combination interventions remains challenging, mostly due to barriers to testing impact through methods like community cluster randomization in the US.

Looking globally, the group discussed a number of planned clinical trials of combination interventions also spurred by optimism over treatment as prevention. Common elements of combination approaches included expansion of voluntary counseling and testing, adult male circumcision, prevention of mother-to-child transmission, and management of sexually transmitted infections, along with expanding ART treatment. Outcome measures were generally framed in terms of the treatment-as-prevention cascade, though these data are not available from current surveillance systems, pointing to the need to create improved systems of data collection. The most common approach to measuring epidemic impact was clustered community randomization, with incident infections measured through cohorts or newer cross-sectional, multi-assay algorithms.

Recommendations from the roundtable include the following:
<ul>
 	<li>A new coalition of interventionists, implementation scientists, public health program and surveillance specialists, mathematical modelers, and behavioral scientists is needed to adequately address the evaluation of multilevel/combination HIV interventions at the community-level.</li>
 	<li>The use of the conceptual frameworks of the HIV prevention continuum and engagement-in-HIV-care cascade should be used in structuring evaluation of combination HIV interventions.</li>
 	<li>Common public health surveillance systems to evaluate combination HIV prevention interventions at the community level are recommended, and this capacity should be further developed internationally.</li>
 	<li>Mathematical modeling before, during, and after multilevel/combination HIV interventions should be incorporated in the design, implementation, and interpretation of intervention results.</li>
 	<li>Because an emphasis on efficiency as well as effectiveness from implementation science is helpful, costing and cost-effectiveness evaluations of combination HIV prevention interventions are recommended and are important to policy makers.</li>
 	<li>Use of innovative trial and observational study designs outside of the traditional randomized, controlled trial paradigm should be used to account for the complex multilevel and combination nature of new HIV prevention interventions, and emerging design and analysis methods (e.g., stepped-wedge designs, adaptive trial designs, causal inference modeling of “natural experiments”) should be considered to address the challenges of community-level effectiveness evaluation.</li>
 	<li>Because social factors and human behaviors are integral factors all along the HIV care and treatment cascade, it is crucial to include social and behavioral science in the design, implementation, and evaluation of combination interventions (e.g., community engagement and mobilization interventions).</li>
 	<li>Mixed methods, including qualitative data collection (e.g., key informant interviews with implementers, in-depth interviews with target population members), are recommended to increase our understanding of how and why interventions are successful or not.</li>
 	<li>Increased funding opportunities for methods development, whether as standalone projects or as supplements to large trials, is recommended as is funding for career development in methods research (e.g., methods-focused K awards).</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/National-Roundtable-Summary.pdf</url>
	</node>
	<node>
		<title>Community acceptance and implementation of HIV prevention interventions for injection drug users</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Background</strong>: In 1997, the National Institutes of Health (NIH) reviewed evidence of the effectiveness of HIV prevention programs for injection drug users (IDUs) and recommended that three types of interventions be implemented to prevent transmission of HIV among IDUs: 1) community-based outreach, 2) expanded syringe access (including needle exchange programs [NEP] and pharmacy sales), and 3) drug treatment. Progress on increasing the acceptance and feasibility of implementing these programs has been made at the national level, but their implementation has been varied at the local level.

<strong>Objective</strong>: To study the acceptance and implementation of the three interventions by communities and to identify the factors that contributed to the success or failure of communities to implement these programs on the local level.

<strong>Methods</strong>: Forty-three in-depth qualitative interviews were conducted with key informants in six U.S. cities. Informants included AIDS prevention providers, political leaders, activists, substance abuse and AIDS researchers, health department directors, and law enforcement officials. Cities were classified according to when they initiated interventions as 1) early adopters, 2) middle adopters, and 3) late or never adopters.

<strong>Results</strong>: Conditions that facilitated or deterred the adoption of interventions were identified. Coalition building and community consultation were key to the acceptance and sustainability of new interventions. Leadership from politicians, public health officials, and program directors provided necessary authority, legitimacy, and access to resources. Grassroots activists took initiative and risks in the face of opposition, but often lacked the resources to sustain their efforts. Researchers played an important role in initiating interventions and legitimizing them by providing access to the scientific information supporting their safety and effectiveness. Successful implementers worked with or avoided the opposition rather than creating polarized positions. Changes in funding and structure of publicly supported drug treatment programs have limited the implementation of new programs. Lack of leadership in the political and public health sectors, and, indeed, fear of adopting or even discussing needle exchange because of perceived political opposition, were the biggest barriers to implementation of syringe exchange programs.

<strong>Conclusion</strong>: Understanding the conditions under which communities accept and implement interventions can help guide effective strategies to foster the implementation of these interventions in areas where programs do not currently exist.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/IDUacceptance.pdf</url>
	</node>
	<node>
		<title>Report Back from the MSM IDU Forum</title>
		<tax>1737</tax>
		<content><![CDATA[This forum grew out of an interest in having dialogues between researchers, providers and community members (these categories are not mutually exclusive groups). This would serve the dual purpose of giving research legs so that it can inform programs and helping ensure that program and life experience inform research studies.

Another factor for calling this meeting was the high prevalence of HIV among men who have sex with men and are also injection drug users (MSM IDUs). In San Francisco, the prevalence of HIV among MSM IDUs is 35%. MSM IDUs make up 9% of the cumulative AIDS cases in California, and 6% of the cumulative AIDS cases in the US. Currently, the San Francisco Community Planning Group has listed MSM IDUs as a top priority for prevention programs and funding.

Despite the high prevalence rates and interest in serving this population, there are few services, limited infrastructure and scant research specifically addressing MSM IDUs. Most of the funding is divided between MSM-specific and IDU-specific, as well divided between care and prevention, HIV+ and HIV-.

As a result of this first informal meeting, CAPS is providing this Report Back on the forum, and a roster of participants to encourage ongoing discussion and networking among service providers, researchers and others working with MSM IDUs.

<strong>NOTE</strong>: The ground rules of this meeting were that specific comments were not attributed to specific people. This Report is intended to be a summary of the different views and ideas from the forum; not every point made is included. This Report is not a consensus.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/MSMIDUreport.pdf</url>
	</node>
	<node>
		<title>The San Francisco Department of Public Health and AIDS Research Institute/UCSF Response to the Updated Estimates of HIV Infection in San Francisco, 2000</title>
		<tax>1737</tax>
		<content><![CDATA[There have been many reactions to the release of preliminary data suggesting a significant increase in HIV incidence in San Francisco. Many are alarmed, some are saddened, and more than a few have a great deal of anger. The one reaction nobody has had is surprise. While a few don’t like the numbers and will argue about the analysis of them, there has been little shock that there appears to be a range of 750 – 900 new infections this year. That the majority of these infections are occurring in men who have sex with men (MSM) is also not surprising to most observers of or members of the San Francisco gay community.

The increase in numbers is based on several realities:

The AIDS epidemic changed forever when new treatments were unveiled in Vancouver in 1996. The perception of AIDS as a death sentence, already suspect among many gay men, is gone. If people see HIV as a death sentence, they make certain choices about risk. We know that when the perception of HIV becomes one of a chronic, manageable illness, people make different choices.

The perception of HIV has changed on the streets and in the minds of MSM. Most HIV prevention efforts have not caught up with that change. Prevention and health education efforts, which rely on death or danger-avoidance for motivation, may no longer resonate with gay men. Studies indicate that high risk sexual behavior is increasing among MSM in San Francisco.

Another factor contributing to the higher estimate of HIV incidence is that the population of gay men in San Francisco is larger than was previously thought. Because of recently improved data collection, such as survey work done for the Gay Men’s Health Study and some groundbreaking work with homeless gay men in San Francisco, we now know that gay men comprise between 15-20% of the adult male population of San Francisco. This is a significant increase from the data available in 1997.

In San Francisco, one can look at gay men’s communities as being divided into three distinct groups, all of whom need HIV prevention. The first group is those who have eliminated high-risk behavior from their lives. These people have a thorough knowledge of HIV transmission and risk reduction techniques. They have chosen to eliminate risk based on personal decisions about their risk and need.

Despite many years of risk reduction education and media, a second group of people have engaged in high-risk behavior throughout the epidemic. This has not changed. For these men, decisions about perceived risk are outweighed by their needs for identity, intimacy, pleasure, or other considerations. They know about risk, have made choices, and engage in behavior at the level of risk that they believe to be appropriate.

A third group of MSM has increased their risk behavior recently. This group makes situational decisions about risk behavior. These decisions are based on their knowledge 3 and understanding of HIV transmission, the perceived risk of the behavior in question, and the stated or presumed HIV status of their partner.

For nearly 20 years, we have conducted HIV prevention and education based on several theories, including cognitive learning theory. However, there are many issues that mediate people’s risk assessment and behavior. The behaviors in questions are basic, often urgent, and engaged in without complex cognitive analysis. A brochure can be informative on Tuesday morning; in a moment of intense passion on Friday night, a different analysis occurs.

Substance use before and during sex is also a factor. Additionally, for some individuals chronic loneliness, isolation, and alienation lead to remedies, which may include highrisk behavior. The pursuit of pleasure in a society where discrimination can make life painful can be another motivation for pre-cognitive, high-risk behavior.

There are many complicated and compelling reasons why a person chooses his own acceptable level of risk. In the era of HAART (highly active anti-retroviral therapy), many men make an assessment based on their firm belief that living with HIV is an acceptable option. Others make a determination about the potential for transmission from a given partner based on information (or perception) about his HIV status or viral load.

The fact is, there is an increase in risk behavior amongst MSM in San Francisco. The AIDS epidemic has entered a new and complex era. It is time for prevention efforts to be based on these new realities.

In the next section, we will outline an 11-point Action Plan to revitalize the HIV prevention programs of the City and County of San Francisco. No increase in HIV infections is acceptable, regardless of the reason. This new plan will allow us to break this epidemic by realistically equipping MSM to take control of their health.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/HIVEstimatesReport.pdf</url>
	</node>
	<node>
		<title>A Survey of AIDS Prevention Funders: Which Programs Are Funded, and Why?</title>
		<tax>1737</tax>
		<content><![CDATA[Because of threats to government funding, community based organizations that provide HIV prevention programs diversify their sources of income by seeking non-governmental funding, including funding from foundations.

This survey of foundations across the United States asked questions about the amount of money they spend on AIDS and HIV prevention, the types of prevention projects and populations their grants served, and the sources of AIDS information used by the foundation staff. The results were then compared to the types of projects known to be effective and to the populations most at risk for HIV infection.

These organizations funded a diverse range of HIV prevention programs, with a total of 583 grants worth over $8.1 million. This represents almost a quarter of all AIDS-related funding by foundations in the United States.
<ul>
 	<li>HIV prevention grants represented 52% of all AIDS-related grants</li>
 	<li>The average HIV prevention grant was for almost $14,000, ranging from $750 to $1.4 million.</li>
 	<li>Public policy, capacity building, outreach and technical assistance were among the most frequently funded HIV prevention programs.</li>
 	<li>Some useful HIV prevention programs, such as condom distribution and needle exchange, were rarely funded. • Women and youth received 25% of the funding for HIV prevention.</li>
 	<li>More grants targeted the general population than drug users, gay men or ethnic minorities, although these groups contain more people at risk for HIV infection.</li>
 	<li>Print media, site visits and colleagues were the main sources of AIDS related information for funders.</li>
 	<li>Better sources of information are available to help funders gauge the effectiveness of proposed programs.</li>
 	<li>Several factors (such as using culturally relevant language, providing creative rewards for participants, designing flexible programs and creating a forum for open discussion) that make HIV prevention programs more effective are provided for use when evaluating programs.</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/fundersreport.pdf</url>
	</node>
	<node>
		<title>The Public Health Impact of Needle Exchange Programs in the United States and Abroad: Summary, Conclusions, and Recommendations</title>
		<tax>1737</tax>
		<content><![CDATA[[S]ubstance use plays a major role in the transmission of HIV disease-indeed, a much larger role than has been generally recognized. Clearly, our nation's drug control policies must recognize this inextricable linkage between drugs and HIV disease and be designed to address the two aggressively and simultaneously.

-National Commission on AIDS, The Twin Epidemics of Substance Use and HIV, 1991[1]

Because neither a vaccine nor a cure for HIV infection appears likely in the near future, planning is needed for the long term to limit the spread of HIV among drug injectors, their sexual partners, and their potential offspring.

-National Research Council, AIDS: The Second Decade, 1990[2]]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/NEPReportSummary1993.pdf</url>
	</node>
	<node>
		<title>Spring 2016 [E-Newsletter]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>CAPS/UCSF PRC leading PrEP research!</h3>
Welcome to our new quarterly e-newsletter! This issue focuses on PrEP or pre-exposure prophylaxis. Read about our work on PrEP uptake and implementation in Oakland, Sacramento, San Francisco, Texas, and internationally. There are also CAPS updates to share, so take a look!

In this issue:
<ol>
 	<li>The Trans Community and PrEP</li>
 	<li>Local black MSM and PrEP Access</li>
 	<li>Black MSM in TX and PrEP Use</li>
 	<li>iPrex Open Label Extension</li>
 	<li>International HIV/STI Programs for Transgender People</li>
 	<li>CAPS Technical Assistance</li>
 	<li>Mpowerment Summit 2016</li>
 	<li>Updates</li>
</ol>]]></content>
		
		<type>
			6
		</type>
			<url>http://conta.cc/1sZ8ISc</url>
	</node>
	<node>
		<title>Spring 2011 [E-Newsletter]</title>
		<tax>1737</tax>
		<content><![CDATA[In This Issue:
<ul>
 	<li>California budget cuts</li>
 	<li>Seroadaptation</li>
 	<li>Kenya, China</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>http://archive.constantcontact.com/fs067/1103384405113/archive/1104653321222.html</url>
	</node>
	<node>
		<title>Fall 2010</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Center for AIDS Prevention Studies (CAPS) Newsletter - </strong>Fall 2010
<div>
<table border="0" width="100%" cellspacing="0" cellpadding="3">
<tbody>
<tr>
<td colspan="1" rowspan="1" align="left" bgcolor="#71a5bf" height="20"><span style="color: #ffffff; font-family: 'Arial Narrow', 'Arial MT Condensed Light', sans-serif; font-size: large;"><b>In This Issue</b></span></td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left" width="100%"><a href="http://archive.constantcontact.com/fs067/1103384405113/archive/1103724135254.html#LETTER.BLOCK6" shape="rect"><span style="color: #333333; font-family: Arial, Helvetica, sans-serif; font-size: small;">Alameda County Research</span></a></td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left" width="100%"><a href="http://archive.constantcontact.com/fs067/1103384405113/archive/1103724135254.html#LETTER.BLOCK10" shape="rect"><span style="color: #333333; font-family: Arial, Helvetica, sans-serif; font-size: small;">CAPS at the White House</span></a></td>
</tr>
<tr>
<td colspan="1" rowspan="1" align="left" width="100%"><a href="http://archive.constantcontact.com/fs067/1103384405113/archive/1103724135254.html#LETTER.BLOCK11" shape="rect"><span style="color: #333333; font-family: Arial, Helvetica, sans-serif; font-size: small;">Adherence in India</span></a></td>
</tr>
</tbody>
</table>
</div>]]></content>
		
		<type>
			6
		</type>
			<url>http://archive.constantcontact.com/fs067/1103384405113/archive/1103724135254.html</url>
	</node>
	<node>
		<title>Great HIV Prevention Campaigns Are Not Just Born The Convergence of Research and Service in the Making of the “Families Change, Families Grow” Campaign</title>
		<tax>1737</tax>
		<content><![CDATA[When the latest HIV prevalence consensus report was released in San Francisco in 1997, statistics revealed increasing HIV rates among gay and bisexual men of color. Among gay men of color, Latinos had the highest rates of HIV infection. In response to this, the STOP AIDS Project decided to heighten their HIV prevention efforts for Latino gay and bisexual men.

STOP AIDS convened a meeting for all of the agencies in San Francisco providing HIV prevention services for Latino gay and bisexual men. “We wanted to bring all of the providers to the same table to increase communication between the agencies and to learn what types of HIV prevention activities each of the agencies were doing.” said Héctor Carillo, former STOP AIDS Project Deputy Director and current CAPS researcher. Another aim was to get a sense of which segments of the gay Latino community each agency was reaching. “What we discovered in that meeting was that we were all reaching a part of this diverse community. There was overlap, but each agency had access to a specific segment of the community,” Héctor said.

Acknowledging and integrating each community based organizations’ expertise strengthened the campaign. “Every organization was valued and every group was covered and it made folks feel less defensive.” said Robert Pérez, former Communications Director of STOP AIDS.

At that meeting, the agencies realized that there was no unified media to reach the community as a whole, and decided to pursue a media campaign. The STOP AIDS Project had the experience in developing media campaigns and access to funds for the project, while the other agencies had access to each of the various segments of the gay Latino community. Representatives from all of the agencies involved formed a planning committee to create the media campaign. The result is “Families Change, Families Grow/Las Familias Cambian, Las Familias Crecen”– a research-grounded media campaign created through this collaborative effort involving Mission Neighborhood Health Center, Proyecto ContraSIDA por Vida, El Ambiente and the STOP AIDS Project.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/CEsummer2000.pdf</url>
	</node>
	<node>
		<title>Habilitando a los Jóvenes</title>
		<tax>1737</tax>
		<content><![CDATA[La escena: San Francisco; la época: 1989. El STOP AIDS Project acaba de cerrar sus puertas porque los cambios generalizados en la conducta de la comunidad gay han originado una marcada reducción en las infecciones de VIH. Sin embargo, Bob Hays, investigador del CAPS, empieza a observar informes anecdóticos de que los jóvenes gay todavía adoptan conductas riesgosas.

Bob se comunica con Susan Kegeles (otra investigadora del CAPS) y ambos llaman al Instituto Nacional de Salud Mental (National Institute of Mental Health) para indagar si financiarían un estudio. Juntos redactan una encuesta sobre la conducta y la distribuyen en tres pequeños poblados, Santa Cruz y Santa Bárbara, en California, y Eugene, en Oregon. La gente devuelve por correo sus respuestas y descubren que un escandaloso 43% de jóvenes gay está sosteniendo relaciones sexuales por vía anal, sin protección.

Cuando los resultados se publicaron en la revista AIDS en 1990, constituyeron la primera mención, en una publicación científica, de que los hombres gay más jóvenes corrían el riesgo de contraer VIH. Bob y Susan emprendieron el desarrollo y la prueba de una intervención para jóvenes gay. Así fue como nació el Project MPowerment, una intervención al interior de la comunidad que ofrece habilidades para reducir el riesgo de contraer VIH entre los jóvenes gay.

"Sabíamos que las intervenciones a nivel de la comunidad eran la mejor manera de tratar de contactar o alcanzar a los jóvenes, y deseábamos intentar algo innovador", dice Bob.

El Projecto MPowerment opera promoviendo una norma de sexo más seguro entre jóvenes gay y bisexuales, a través de labores de promoción y actividades sociales entre grupos pequeños, las cuales fueron diseñadas y conducidas por los propios jóvenes. El programa tiene cuatro componentes: la promoción formal entre iguales en eventos y con un equipo de promoción; pequeños grupos conducidos por pares denominados "M-groups"; labores de promoción informal de iguales en que los jóvenes gay instan a otros hombres a tener relaciones sexuales más protegidas o seguras; así como una campaña publicitaria (ver el recuadro para contar con un esquema del programa).

MPowerment se basa en cuatro principios: 1) Para muchos jóvenes gay y bisexuales, la prevención del VIH posiblemente no sea la cosa más importante en sus vidas; encontrar amistades, parejas y una comunidad puede ser más apremiante. 2) Los promotores pueden gozar de mucho poder para influir a sus contemporáneos. 3) Las intervenciones que facilitan la habilitación/autogestión (haciendo que los participantes se dediquen a identificar, encontrar e instrumentar soluciones a sus problemas) ofrecen cambios más duraderos. 4) El cambio social ocurre cuando una masa crítica adopta prácticas innovadoras.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/CEEspanolweb.pdf</url>
	</node>
	<node>
		<title>Healthy Living Project</title>
		<tax>1737</tax>
		<content><![CDATA[Healthy Living is a 3-module/15-session intervention that is delivered one-on-one to people living with HIV. Each of the 3 modules consists of 5 sessions, and each is designed to improve quality of life in a different broad area of health: physical, mental, and sexual. HLP is one of the CDC’s <a href="https://www.cdc.gov/hiv/pdf/HLP_BEST_RR_GOOD_MA.pdf" target="_blank">Best-Evidence Interventions</a>. (posted 1/09)
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Reference_Guide.pdf">HLP Reference Guide</a> (Warning: This is a large PDF file to download – 1.1 MB)</li>
 	<li>HLP Intervention Manual
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Intervention_Manual.pdf">Entire curriculum</a> (Warning: This is a large PDF file to download – 1.6 MB)</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Intervention_Cover_ToC_Intro.pdf">Cover, ToC, Intro</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Intervention_Module1.pdf">Module 1</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Intervention_Module2.pdf">Module 2</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Intervention_Module3A.pdf">Module 3A</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Intervention_Module3B.pdf">Module 3B</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Session_Forms.pdf">Session Forms</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Main_Tabs.pdf">Tabs</a></li>
</ul>
</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/curricula/pdf/HLP_Reference_Guide.pdf</url>
	</node>
	<node>
		<title>Project Accept</title>
		<tax>1737</tax>
		<content><![CDATA[Project Accept is an HIV prevention trial in which 34 communities in Africa (in South Africa, Tanzania, and Zimbabwe) and 14 communities in Thailand are being randomized to receive either a community-based HIV voluntary counseling and testing (CBVCT) intervention plus standard clinic-based VCT (SVCT), or SVCT alone. The CBVCT intervention has three major strategies: (1) to make VCT more available in community settings; (2) to engage the community through outreach; and (3) to provide post-test support. These strategies are designed to change community norms and reduce risk for HIV infection among all community members, irrespective of whether they participated directly in the intervention. (posted 7/10)
<blockquote>The <a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept" target="_blank">HIV InSite website</a> provides curricula, training guides, participant and interventionist manuals, evaluation forms, logs, worksheets, guidelines, etc for the following:</blockquote>
<ul>
 	<li><a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept-summary" target="_blank">Protocol Summary</a></li>
 	<li><a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept#S3.1.1X" target="_blank">Community Preparedness</a></li>
 	<li><a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept#S3.1.2X" target="_blank">Community Mobilization</a></li>
 	<li><a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept#S3.1.3X" target="_blank">Community-based Voluntary Counseling &amp; Testing</a></li>
 	<li><a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept#S3.1.4X" target="_blank">Post-test Support Services</a></li>
 	<li><a href="http://hivinsite.ucsf.edu/InSite?page=pr-accept#S3.1.5X" target="_blank">Utilization</a></li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>http://hivinsite.ucsf.edu/InSite?page=pr-accept-summary</url>
	</node>
	<node>
		<title>Mpowerment Project</title>
		<tax>1737</tax>
		<content><![CDATA[The Mpowerment Project is a community-level HIV prevention intervention designed to reduce the frequency of unprotected anal intercourse among young gay/bisexual men, ages 18-29, by mobilizing young gay men to support each other about safer sex and to build a stronger, healthier young gay men’s community. It is the only scientifically developed and empirically tested intervention that has been shown to reduce HIV sexual risk taking behaviors among young gay men.
<ul>
 	<li>Please see the <a href="https://web.archive.org/web/20161029004657/http://www.mpowerment.org/" target="_blank">Mpowerment website</a> for full curriculum and replication materials.</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>http://www.mpowerment.org/</url>
	</node>
	<node>
		<title>Project Explore</title>
		<tax>1737</tax>
		<content><![CDATA[Explore is a nationwide HIV prevention behavioral trial involving nearly 4,300 men who have sex with men. Explore is one of the largest behavioral studies of its kind, and includes participants recruited from six cities: Boston, Chicago, Denver, New York, San Francisco, and Seattle. (posted 8/06)
<ul>
 	<li><a href="https://www.hptn.org/sites/default/files/2016-05/hivnet_015.pdf" target="_blank">EXPLORE Protocol</a></li>
 	<li><a href="https://web.archive.org/web/20150905224601/http://www.hptn.org/Web%20Documents/ExploreDocuments/EXPLORE_CounselingDeliveryManualGuide.pdf" target="_blank">Counseling Delivery Manual</a></li>
 	<li><a href="http://www.hptn.org/Web%20Documents/ExploreDocuments/EXPLORE_CounselingDeliveryManualGuide.pdf" target="_blank">Counseling Delivery Manual</a><a href="https://web.archive.org/web/20161029004657/http://www.hptn.org/Web%20Documents/ExploreDocuments/EXPLORE_CounselingDeliveryManualGuide.pdf"> Guide</a></li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>https://web.archive.org/web/20150905224601/http:/www.hptn.org/research_studies/HIVNET015StudyDocuments.htm</url>
	</node>
	<node>
		<title>Draw the Line, Respect the Line</title>
		<tax>1737</tax>
		<content><![CDATA[CAPS and ETR Associates researchers developed a curriculum to assist sixth, seventh and eighth grade students in postponing sexual activity and using protection if they are sexually active. The curriculum has many characteristics that are shared by successful HIV prevention and sex education curricula.
<ul>
 	<li>Curricula available through <a href="http://pub.etr.org/ProductDetails.aspx?id=10000&amp;prodid=S028" target="_blank">ETR Associates</a> for purchase</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>http://pub.etr.org/ProductDetails.aspx?id=100000005&amp;itemno=Z002</url>
	</node>
	<node>
		<title>Healthy Oakland Teens</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>NOTE: The HOT Project ended in 1995. For a list of more recent, effective school-based sexuality/HIV education programs, please see:</strong>
<ul>
 	<li><a href="http://pub.etr.org/pages.aspx?docid=135" target="_blank">ETR Associates’ Evidence-Based Programs</a></li>
 	<li><a href="http://www.cdc.gov/hiv/topics/research/prs/subset-best-evidence-interventions.htm#link2" target="_blank">CDC’s Best Evidence Interventions</a></li>
 	<li>CDC’s DEBI programs for youth: <a href="http://www.effectiveinterventions.org/en/HighImpactPrevention/Interventions/CLEAR.aspx" target="_blank">CLEAR</a>, <a href="http://www.effectiveinterventions.org/en/HighImpactPrevention/Interventions/FOY.aspx" target="_blank">Focus on Youth</a>, <a href="http://www.effectiveinterventions.org/en/HighImpactPrevention/Interventions/StreetSmart.aspx" target="_blank">Street Smart</a>, <a href="http://www.effectiveinterventions.org/en/HighImpactPrevention/Interventions/TLC.aspx" target="_blank">TLC</a></li>
</ul>
The Healthy Oakland Teens Project (HOT) began in the fall of 1992 at an urban, ethnically diverse junior high school. The project’s goal is to reduce adolescents’ risk for HIV infection by using peer role models to advocate for responsible decision making, healthy values and norms, and improved communication skills. (posted 4/98)
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/HOT/pdf/HealthyOaklandTeensPeercurriculum.pdf">Peer Curriculum</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/HOT/pdf/HealthyOaklandTeensAdult.pdf">Adult Curriculum</a></li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/projects/HOT/pdf/HealthyOaklandTeensPeercurriculum.pdf</url>
	</node>
	<node>
		<title>African-American Men&#039;s Health Study</title>
		<tax>1737</tax>
		<content><![CDATA[Many Black gay men are at high risk for HIV, yet few programs exist for them, and even fewer have been evaluated for effectiveness. The African-American Men’s Health Study (AAMHS) represents the first published attempt to develop and evaluate the impact of a culturally appropriate, community-based, HIV risk reduction intervention designed to change high-risk sexual behaviors among African-American homosexual and bisexual men in the San Francisco Bay area. (posted 9/96)
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/AAMHS/pdf/AF-AMtrainingmanual.pdf">Intervention Facilitator’s Training Manual</a></li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/projects/AAMHS/pdf/AF-AMtrainingmanual.pdf</url>
	</node>
	<node>
		<title>HIV Counseling and Testing Developing Countries</title>
		<tax>1737</tax>
		<content><![CDATA[In developing countries where health resources are severely limited, debate continues regarding the relative amount that should be spent on HIV counseling and testing. While HIV counseling and testing has been promoted as effective for prevention, few controlled studies have been conducted.The Voluntary HIV Counseling and Testing Efficacy study was a randomized clinical trial of the effectiveness of HIV counseling and testing for the prevention of new HIV infections. The study was conducted at three sites: Nairobi, Kenya; Dar-Es- Salaam, Tanzania; and Port-of-Spain, Trinidad. (posted 9/98)
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/pdf/VCTcounselortrainingmanual.pdf">Counselor Training Manual</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/pdf/VCTinterviewertrainingmanual.pdf">Interviewer Training Manual</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/pdf/VCTintervention.pdf">Intervention Manual</a></li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/projects/VCT/pdf/VCTcounselortrainingmanual.pdf</url>
	</node>
	<node>
		<title>Mental Health for HIV+ Gay Men</title>
		<tax>1737</tax>
		<content><![CDATA[The CHANGES Project: A Clinical Trial of Coping Effectiveness Training for HIV+ Gay Men is an innovative, theory-based coping intervention. The intervention–Coping Effectiveness Training–is designed to assist HIV+ gay men stay mentally healthy despite ongoing stress of HIV infection. The study will look at the problems of maintaining intervention effects, evaluating effects on quality of life and adherence to medical care, and testing new advances in stress and coping theory. (posted 10/04)
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/CHANGES/pdf/CET%20Facilitator%27s%20Manual.pdf">Facilitator Manual</a> (Warning: This is a large PDF file to download -4.85 MB)</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/CHANGES/pdf/CET%20Workbook.pdf">Participant Workbook</a> (Warning: This is a large PDF file to download -1.2 MB)</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/projects/CHANGES/pdf/CET%20Facilitator%27s%20Manual.pdf</url>
	</node>
	<node>
		<title>Action Point</title>
		<tax>1737</tax>
		<content><![CDATA[Action Point Center is a storefront medication adherence program for homeless people with HIV. Most clients also suffer from mental illness and/or substance use. Program components include: medication storage/dispensing, pharmacist consultation, acupuncture, adherence devices, monetary incentives, case management, and nursing services. Action Point is independent of any health care facility. Clients receive primary HIV care from a wide variety of providers in both community and private clinic settings. Action Point is a collaborative effort between the Department of Public Health and the San Francisco AIDS Foundation. (posted 4/03)
<ul>
 	<li><a href="http://hivinsite.ucsf.edu/pdf/actionpoint.pdf" target="_blank">Action Point Program Manual</a></li>
 	<li><a href="http://hivinsite.ucsf.edu/pdf/ap2.pdf" target="_blank">Action Point Proceedures Manual</a></li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>http://hivinsite.ucsf.edu/pdf/actionpoint.pdf</url>
	</node>
	<node>
		<title>Good Questions Better Answers</title>
		<tax>1737</tax>
		<content><![CDATA[Good Questions Better Answers: A Formative Research Handbook for California HIV Prevention Programs is for community agencies and service providers. The handbook shows how agencies and departments of health can formalize the research process and use it to guide and improve their services. It uses examples from programs throughout California to demonstrate how community agencies conduct formative research all the time, sometimes without realizing that what they are doing is “research.” Funded by the California State Office on AIDS and Northern California Grantmakers.Manual in PDF
A Buenas Preguntas… ¡Mejores Respuestas! (manual in Spanish)]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/manuals/pdf/GQBA.pdf</url>
	</node>
	<node>
		<title>Working Together</title>
		<tax>1737</tax>
		<content><![CDATA[Working Together: A Guide to Collaborative Research in HIV Prevention is for service providers, researchers and funders who are interested in working on a collaborative research project. It provides a wealth of information drawn from research and years of experience and is full of hands-on, practical strategies for successful collaboration. Working Together outlines a step-by-step process for collaborative research from conceptualizing a research question to analyzing data to disseminating research findings.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/manuals/pdf/WorkingTogether.pdf</url>
	</node>
	<node>
		<title>A Buenas Preguntas… ¡Mejores Respuestas!</title>
		<tax>1737</tax>
		<content><![CDATA[A Buenas Preguntas… ¡Mejores Respuestas!: Un manual de investigación formativa para los programas de prevención de VIH de California que muestra cómo las organizaciones y los departamentos de salud pueden formalizar el proceso de investigación y usarlo para guiar y mejorar sus servicios. La investigación formativa ofrece la oportunidad de formular las preguntas que permiten indagar información clave sobre lo que se quiere o lo se está llevando. Se ofrecen ejemplos de programas a lo largo de California para demostrar cómo es que las organizaciones comunitarias realizan investigación formativa en todo momento, incluso sin advertir que lo que están haciendo es investigación.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/manuals/pdf/BPMR.pdf</url>
	</node>
	<node>
		<title>Samples of Consent Forms provided by the Committee of Human Research, UCSF</title>
		<tax>1737</tax>
		<content><![CDATA[These templates are appropriate for studies that require <a href="http://irb.ucsf.edu/levels-review">expedited or full committee review</a>. There are separate <a href="http://irb.ucsf.edu/exempt-consent-templates-and-guidance">consent templates for exempt research.</a>
<ul>
 	<li>Review the <a href="http://irb.ucsf.edu/consent-form-guidelines-and-suggested-wording">Consent Guidelines and Standard Wording</a> before writing your consent form.</li>
 	<li>Keep the upper right-hand corner blank and use at least a 1.25" top margin.</li>
 	<li>See the <a href="http://www.nccn.org/clinical_trials/informed_consent.aspx" target="_blank">NCNN Informed Consent Language Database</a> for lay language terms.</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>http://irb.ucsf.edu/consent-and-assent-form-templates#consent-templates</url>
	</node>
	<node>
		<title>Explanation of Consent Form standards by Committee of Human Research, UCSF</title>
		<tax>1737</tax>
		<content><![CDATA[As part of the Committee on Human Research (CHR) process improvement project analysis, we discovered that poorly-prepared submissions negatively impacted the review and approval times of well-prepared submissions by diverting significant time and resources to a small fraction of poorly prepared submissions. Consequently, the CHR office is implementing consistent minimum submission standards. Instituting this new procedure will enable CHR staff to focus on well-prepared applications, resulting in faster reviews and approvals overall.]]></content>
		
		<type>
			6
		</type>
			<url>http://irb.ucsf.edu/news/minimum-submission-standards-implemented</url>
	</node>
	<node>
		<title>Sample Consent Form provided by the Society for Science</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>https://member.societyforscience.org/document.doc?id=654</url>
	</node>
	<node>
		<title>Developing and Sustaining Community-Based Participatory Research Partnerships: A Skill-building Curriculum</title>
		<tax>1737</tax>
		<content><![CDATA[First published in 2006, this curriculum is intended as a tool for use by community-institutional partnerships that are using or planning to use a CBPR approach to improving health. Over the years, we have incorporated feedback and updates into the curriculum. We welcome your comments and suggestions on the curriculum and encourage submissions of content to be incorporated into the curriculum.]]></content>
		
		<type>
			6
		</type>
			<url>http://cbprcurriculum.info/</url>
	</node>
	<node>
		<title>Community-Based Research Toolkit: Resources and Tools for Doing Research with Community for Social Change</title>
		<tax>1737</tax>
		<content><![CDATA[The tools, templates and resources in this toolkit were compiled and developed by the CBR team at Access Alliance based on half a decade of implementing CBR projects. The CBR team at Access Alliance realized early on that having solid CBR training and tools was crucial to the success of its CBR projects. Thus, the team made it a priority to build CBR training and tools. In 2006, we created a part-time in-house researcher trainer position whose task was to develop innovative CBR training materials and tools and to deliver CBR training to peer researchers and other partners as per the need of our CBR projects. We also hired a consultant from the Catalyst Centre (Matthew Adams) to ground our CBR training and tools in a popular education framework.]]></content>
		
		<type>
			6
		</type>
			<url>http://accessalliance.ca/wp-content/uploads/2015/03/CBR_Toolkit_Jan2012.pdf</url>
	</node>
	<node>
		<title>Community-Engaged Research</title>
		<tax>1737</tax>
		<content><![CDATA[This Quick-Start Guide is intended for community-based organizations that may be interested in partnering with academic researchers at UCSF to conduct community-based research. The Guide is a product of the Community Engagement Program of the UCSF Clinical &amp; Translational Science Institute (CTSI). One of the Program’s primary aims is to assist both community-based organizations and UCSF-based researchers in the process of developing effective and mutually-satisfying collaborations on community-based research.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2013/05/guide_for_cbos.pdf</url>
	</node>
	<node>
		<title>Comprehensive Cancer Control Branch Program Evaluation Toolkit</title>
		<tax>1737</tax>
		<content><![CDATA[This toolkit is a “how to” guide for planning and implementing evaluation activities in cancer prevention and control programs.

The Comprehensive Cancer Control Branch (CCCB) is part of the Centers for Disease Control and Prevention’s (CDC’s) Division of Cancer Prevention and Control (DCPC). CCCB developed this toolkit to help funded programs meet the evaluation requirements established for their cooperative agreements. This toolkit provides general guidance on evaluation principles and techniques, as well as practical templates and tools; therefore, grantees can continue to use the toolkit to support their evaluation efforts even as the program evolves and priorities change.]]></content>
		
		<type>
			6
		</type>
			<url>http://www.cdc.gov/cancer/ncccp/pdf/CCC_Program_Evaluation_Toolkit.pdf</url>
	</node>
	<node>
		<title>Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention (RAND)</title>
		<tax>1737</tax>
		<content><![CDATA[Molly Morgan Jones, a Research Leader in RAND Europe, discusses how antiretroviral (ARV)-based HIV prevention strategies need to be closely tailored to local contexts and cultures in order to make an impact on new HIV infections globally.]]></content>
		
		<type>
			6
		</type>
			<url>http://www.rand.org/multimedia/video/2013/06/19/mapping-pathways.html</url>
	</node>
	<node>
		<title>Measuring Coalition Functioning: Refining Constructs Through Factor Analysis</title>
		<tax>1737</tax>
		<content><![CDATA[Internal and external coalition functioning is an important predictor of coalition success that has been linked to perceived coalition effectiveness, coalition goal achievement, coalition ability to support evidence-based programs, and coalition sustainability. Understanding which aspects of coalition functioning best predict coalition success requires the development of valid measures of empirically unique coalition functioning constructs. The goal of the present study is to examine and refine the psychometric properties of coalition functioning constructs in the following six domains: leadership, interpersonal relationships, task focus, participation benefits/costs, sustainability planning, and community support. The authors used factor analysis to identify problematic items in our original measure and then piloted new items and scales to create a more robust, psychometrically sound, multidimensional measure of coalition functioning. Scales displayed good construct validity through correlations with other measures. Discussion considers the strengths and weaknesses of the refined instrument.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2013/05/Pages-from-HEB-proofs-3.pdf</url>
	</node>
	<node>
		<title>Partnership Perspectives</title>
		<tax>1737</tax>
		<content><![CDATA[In an effort to equip community and institutional leaders from the health professions with the skills and knowledge to sustain community-campus partnerships, we are pleased to provide you with a copy of Partnership Perspectives-a magazine designed to foster greater awareness of critical issues impacting upon partnerships between communities and health professions schools. Partnership Perspectives is an informational resource drawing upon the diverse perspectives of leaders representing higher education, such as health professions institutions, 4-year undergraduate level universities and community colleges, health policy organizations, and civic groups. The purpose of Partnership Perspectives is to bring to the forefront the wide range of issues and perspectives that shape and influence the development of community-campus partnerships across the country. Partnership Perspectives brings to its readers a new look into the impact of partnerships and relationship building in our changing society.

The goals of Partnership Perspectives are to:
<ul>
 	<li>showcase thought provoking articles that address efforts to improve and promote community health, education and development through innovative approaches and best practices.</li>
 	<li>promote a diverse range of multidisciplinary perspectives from within the community and educational sectors.</li>
 	<li>advance new thinking and awareness about health and its connection to community and economic development.</li>
 	<li> highlight ways in which communities and educational institutions value each other’s assets and strengths to collaborate and improve community health together.</li>
 	<li>promote the CCPH principles of community-campus partnerships</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2013/05/ccph-partnership-perspectives.pdf</url>
	</node>
	<node>
		<title>Memorandum of Understanding</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2013/05/MEMORANDUM-OF-UNDERSTANDING-v3.pdf</url>
	</node>
	<node>
		<title>Power-Privilege Resource List</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2013/05/PowerPrivilegeResourceList.pdf</url>
	</node>
	<node>
		<title>Alameda AIDS Research Coalition Resources</title>
		<tax>1737</tax>
		<content><![CDATA[This page has many more publications and resources that may be of use in facilitating CBPR.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/research/alameda-aids-research-coalition/</url>
	</node>
	<node>
		<title>Across the Board: How multilevel interventions can improve the health of our communities</title>
		<tax>1737</tax>
		<content><![CDATA[As the social ecological framework shows there are several levels -- including intrapersonal, interpersonal, organizational, community, and policy— and that determinants within these levels interact with one another to influence behavior and health outcomes. Studies have shown multilevel interventions which address determinants at a number of levels and mutually reinforce one another produce longer and more sustained effects than interventions that target only one level. Join us March 19th as we explore multilevel interventions, how to design them, and how to implement them in communities.]]></content>
		
		<type>
			6
		</type>
			<url>https://researchtoreality.cancer.gov/cyber-seminars/across-board-how-multilevel-interventions-can-improve-health-our-communities</url>
	</node>
	<node>
		<title>The Adaptation Effect: Engaging Community Partners to Adapt and Implement Evidence-based Interventions</title>
		<tax>1737</tax>
		<content><![CDATA[This cyber-seminar will highlight three of the R2R Mentorship Program projects that are working with community partners to adapt and implement evidence-based interventions.  Kiameesha Evans is adapting and implementing the diet and nutrition program, <em>Body and Soul</em>, to include a physical activity component and is piloting the intervention with several faith-based organizations in New Jersey.  Venice Haynes has partnered with a local foundation to provide technical assistance in the adaptation of a cervical cancer program, <em>Con Amor Aprendemos </em>(With Love We Learn), for African American faith-based communities in Atlanta. Finally, Charlene Mitchell adapted a sun safety program, <em>Pool Cool</em>, for implementation at rural Idaho public pools.  Kiameesha, Venice, and Charlene will each share an overview of their projects, outcomes, and lessons learned about partnership, adaptation, and implementation relevant to other communities and researchers interested in these types of cancer control interventions.]]></content>
		
		<type>
			6
		</type>
			<url>https://researchtoreality.cancer.gov/cyber-seminars/adaptation-effect-engaging-community-partners-adapt-and-implement-evidence-based</url>
	</node>
	<node>
		<title>Developing, Maintaining, and Sustaining Partnerships</title>
		<tax>1737</tax>
		<content><![CDATA[Launched in 2003, Cancer Control P.L.A.N.E.T.(Plan, Link, Act, Network with Evidence-based Tools) and its satellite site, Research-tested Intervention Programs (RTIPs), were developed to address the needs of public health professionals seeking evidence-based resources for their cancer control planning activities. A collaboration between AHRQ, CDC, SAMHSA and NCI was established and as a result the “one stop shop” of Cancer Control P.L.A.N.E.T. was born.]]></content>
		
		<type>
			6
		</type>
			<url>https://researchtoreality.cancer.gov/node/170</url>
	</node>
	<node>
		<title>HINTS: Moving from Data to Reality</title>
		<tax>1737</tax>
		<content><![CDATA[Disseminating evidence-based programs and policies requires that researchers, policy makers, and practitioners take active roles in the process. While their perspectives, systems, and practices vary, their goal remains the same: to reduce the burden of disease and move from "research to reality."

The Health Information National Trends Survey (HINTS) is a data collection program created to monitor changes in the rapidly evolving field of health communication. Survey researchers are using the data to understand how adults 18 years and older use different communication channels, including the Internet, to obtain vital health information for themselves and their loved ones. Public health practitioners are using the data to overcome barriers to health information usage across populations and are obtaining the data they need to create more effective communication strategies.]]></content>
		
		<type>
			6
		</type>
			<url>http://www.inspirenet.ca/seminar/hints-moving-data-reality</url>
	</node>
	<node>
		<title>Howdy, Partner! Using the PARTNER Tool to Track and Analyze Community Partnerships</title>
		<tax>1737</tax>
		<content><![CDATA[A major challenge facing public health researchers and practitioners today is how to partner with other organizations, agencies, and groups to collaboratively address public health goals while effectively leveraging resources. The process by which organizations have engaged partners in collaboration has varied, with few ways to measure the success of these partnerships. Public leaders are eager to understand how to analyze these collaborations to determine whether the time and resources spent building these partnerships are worth the investment.]]></content>
		
		<type>
			6
		</type>
			<url>https://researchtoreality.cancer.gov/cyber-seminars/howdy-partner-using-partner-tool-track-and-analyze-community-partnerships</url>
	</node>
	<node>
		<title>Using Systems Thinking and Tools to Solve Public Health Problems</title>
		<tax>1737</tax>
		<content><![CDATA[Public health researchers and practitioners often work to solve complex population and health issues, such as obesity and chronic disease, which are deeply embedded within the fabric of society. As such, the solutions often require intervention and engagement with key stakeholders and organizations across many levels ranging from local entities (schools, churches, and work environments) to regional systems (health departments and hospital networks) to entire countries (national agencies). This multi-level, multi-participant view is at the heart of systems thinking, a process of understanding how parts influence one another within a whole.]]></content>
		
		<type>
			6
		</type>
			<url>https://researchtoreality.cancer.gov/cyber-seminars/using-systems-thinking-and-tools-solve-public-health-problems</url>
	</node>
	<node>
		<title>Writing Implementation Research Grant Proposals: 10 Key Ingredients</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>http://www.youtube.com/watch?v=SxvxbVBSf3Q</url>
	</node>
	<node>
		<title>Community-Engaged Scholarship for Health</title>
		<tax>1737</tax>
		<content><![CDATA[A free, online mechanism for peer-reviewing, publishing and disseminating products of health-related community-engaged scholarship that are in forms other than journal articles.]]></content>
		
		<type>
			6
		</type>
			<url>http://www.ces4health.info/index.aspx</url>
	</node>
	<node>
		<title>Linkage to Database of Best Practices</title>
		<tax>1737</tax>
		<content><![CDATA[Resources for exploring promising approaches to promote community health and development.]]></content>
		
		<type>
			6
		</type>
			<url>http://ctb.ku.edu/en/promisingapproach/databases_best_practices.aspx</url>
	</node>
	<node>
		<title>University of Kansas Community Toolbox</title>
		<tax>1737</tax>
		<content><![CDATA[The Community Tool Box is a free, online resource for those working to build healthier communities and bring about social change. It offers thousands of pages of tips and tools for taking action in communities.

Want to learn about community assessment, planning, intervention, evaluation, advocacy, and other aspects of community practice? Then help yourself to over 300 educational modules and other free tools.

Under continuous development since 1994, the Community Tool Box is widely used in teaching, training, and technical support. Currently available in English, Spanish, and Arabic and with millions of user sessions annually, it has reached those working in over 230 countries around the world.]]></content>
		
		<type>
			6
		</type>
			<url>http://ctb.ku.edu/en/default.aspx</url>
	</node>
	<node>
		<title>QGIS Module 1 of 4: GIS Workshop Concept and Practice</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>http://www.slideshare.net/CAPSUCSF/qgis-final-session-1</url>
	</node>
	<node>
		<title>QGIS Module 2 of 4: Attribute Tables and Adding Data to QGIS</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>http://www.slideshare.net/CAPSUCSF/qgis-final-session2</url>
	</node>
	<node>
		<title>QGIS Module 3 of 4: Mapping and Related Concepts</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>http://www.slideshare.net/CAPSUCSF/qgis-final-session-3</url>
	</node>
	<node>
		<title>QGIS Module 4 of 4: Metadata, Clipping Layers &amp; Coordinates, Finalizing Maps and Priority Setting</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>http://www.slideshare.net/CAPSUCSF/qgis-final-session-4</url>
	</node>
	<node>
		<title>Condom Use among Hispanics</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/library/condom-use-among-hispanics-female/" target="_blank">Condom use for females in English</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/library/condom-use-among-hispanics-male/" target="_blank">Condom use for males in English</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/library/condom-use-among-hispanics-mujeres/" target="_blank">Uso de condones para mujeres en Español</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/resources/survey-instruments/condom-use-among-hispanics-hombres/" target="_blank">Uso de condones para hombres en Español</a></li>
</ul>
<strong>Scoring:</strong> Please read the <a href="/sites/prevention.ucsf.edu/files/library/caps-instruments/">detailed description of the instruments</a>.
<strong>Reliability and/or validity:</strong> “<a href="/sites/prevention.ucsf.edu/files/library/hispanic-condom-use/">Condom use among Hispanic men with secondary female sexual partners</a>” by Barbara VanOss Marin, Cynthia A. Gomez, and Jeanne M. Tschann, printed in <em>Public Health Reports;</em> also in Gómez C, Marín BV (1996). Gender, culture, and power: Barriers to safe sex. Journal of Sex Research, 33(4), 355–362.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Latino Gay/Bisexual Men</title>
		<tax>1737</tax>
		<content><![CDATA[The following Spanish-language survey has been used to assess risk behavior. It was developed through the Hermanos de Luna y Sol program, a culturally appropriate HIV risk–reduction intervention that targeted immigrant, Spanish-speaking gay and bisexual men in San Francisco.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/luna-y-sol.pdf</url>
	</node>
	<node>
		<title>Measures of Sexual Attitudes and Behavior of Latino Adults</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/unmarriedLatina.pdf">Questionnaire for unmarried Latina women</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/unmarriedLatino.pdf">Questionnaire for unmarried Latino men</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Latinasnocasadas.pdf">Cuestionario para mujeres latinas solteras</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Latinosnocasados.pdf">Cuestionario para hombres latinos solteros</a></li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity: </strong>Please see a <a href="/sites/prevention.ucsf.edu/files/library/married-unmarried-latinos/">description of the instruments</a>. Marín BV, Tschann J, Gómez C, Gregorich SE (1998). Self-efficacy to use condoms in unmarried Latino adults. American Journal of Community Psychology. 26(1), 53–71.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>National Sexual Health Survey (NSHS)</title>
		<tax>1737</tax>
		<content><![CDATA[NSHS is national telephone survey of adults 18 years and older residing in the 48 contiguous states. Measures were developed to assess a wide range of HIV-related and human sexuality topics including, but not limited to, the following: condom attitudes, condom slips and breaks, HIV-related caregiving, HIV testing and home testing use, STD histories, perceived risk for HIV and other STDs and optimistic bias assessments, extramarital sex, sexual development, sexual abuse and rape, and sexual dysfunctions. The survey also employed various psychological scales (sensation-seeking, machismo) and collected family assessments and history, health information and demographics, and a detailed assessment of sexual activities with each of the respondent’s sexual partners in the past year up to a total of 10 partners. In addition, demographic, geographic, and HIV/STD risk characteristics of sexual partners were determined.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_EngScreen.pdf">Screening questionnaire</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_ENGcover.pdf">Questionnaire guidelines</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_MAP.pdf">Questionnaire map</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_%20Quex_English.pdf">National Sexual Health Survey (NSHS)</a> <em>(Warning: This is a large, 118-page survey; 4.4 MB PDF)</em></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_SPscreen.pdf">Cuestionario de selección</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_SPcover.pdf">Información sobre el cuestionario de NSHS</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/NSHS_%20Quex_Spanish.pdf">Cuestionario NSHS</a> <em>(Warning: This is a large, 118-page survey; 4.4 MB PDF)</em></li>
</ul>
<strong>Supporting documentation:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/contents.pdf">Table of contents</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/introduction.pdf">Introduction</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/sample-design.pdf">Sample design &amp; proceedures</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/dispositions.pdf">Disposition codes</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/data_map.pdf">Variables &amp; univariate statistics</a> <em>(Warning: This is a large file; 6.8 MB PDF)</em></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/derived.pdf">Derived variables</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/contact.pdf">Contact information</a></li>
</ul>
<strong>Scoring:</strong> Included<strong>
Reliability and/or validity: </strong>Catania JA, Coates TJ, Stall R, Turner HA, Peterson J, Hearst N, Dolcini MM, Hudes E, Gagnon J, Wiley J, Groves R (1992). Prevalence of AIDS-related risk factors and condom use in the United States. Science, 258, 1101–1106.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Teen Peer Educators</title>
		<tax>1737</tax>
		<content><![CDATA[The following surveys were used with the <a href="/sites/prevention.ucsf.edu/files/library/healthy-oakland-teens-hot/">Healthy Oakland Teens</a> project at an urban, ethnically diverse junior high school. The project’s goal is to reduce adolescents’ risk for HIV infection by using peer role models to advocate for responsible decision making, healthy values and norms, and improved communication skills. Adult and student evaluations of peer educators were conducted, but these are unfortunately unavailable.

<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOT%20survey.pdf">Teen knowledge, attitude, behavior, belief (KABB) questionnaire</a><strong>
Scoring:</strong> Please read the <a href="/sites/prevention.ucsf.edu/files/library/healthy-oakland-teens-2/">detailed description of the instruments</a>. <strong>
Reliability and/or validity:</strong> Ekstrand ML, Siegel D, Nido V, Faigeles B, Krasnovsky F, Battle R, Cummings G, Chiment E, and Coates TJ (1996). Peer-led AIDS prevention delays sexual debut among U.S. junior high school students. Oral presentation to the XI International Conference on AIDS, Vancouver, Canada.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>HIV Counseling and Testing in Developing Countries</title>
		<tax>1737</tax>
		<content><![CDATA[The following surveys were used with the <a href="/sites/prevention.ucsf.edu/files/library/voluntary-hiv-counseling-and-testing-efficacy-study/">Voluntary HIV Counseling and Testing Efficacy study</a>, a randomized clinical trial of the effectiveness of HIV counseling and testing for the prevention of new HIV infections. The study was conducted at three sites: Nairobi, Kenya; Dar-Es- Salaam, Tanzania; and Port-of-Spain, Trinidad.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/baseline%20C&amp;T.pdf">Baseline survey</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/6-month%20C&amp;T.pdf">6-month follow-up survey</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/6-month%20counselor.pdf">6-month counselor questionnaire</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/STD%20test%20form.pdf">6-month STD test</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/12-month%20C&amp;T.pdf">12-month follow-up survey</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/12-month%20counselor.pdf">12-month counselor questionnaire</a></li>
</ul>
<strong>Scoring:</strong> See <a href="/sites/prevention.ucsf.edu/files/uploads/tools/data/VCT/variable%20recodes.txt">variable recodes</a>.<strong>
Reliability and/or validity:</strong> Coates T J, Grinstead OA, Gregorich SE, Heilbron DC, et al. (2000). “Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial.” Lancet V356(N9224): 103–112.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Qualitative Survey: HIV Testing and Counseling among Injection Drug Users</title>
		<tax>1737</tax>
		<content><![CDATA[The following survey was used with <a href="/sites/prevention.ucsf.edu/files/library/project-access-barriers-to-hiv-counseling-and-testing-and-the-prevention-strategies-of-drug-users-community/">Project Access</a>, a qualitative needs assessment commissioned by the California State Office of AIDS and the Centers for Disease Control and Prevention to examine counseling and testing utilization and prevention programs through the perspective of drug-using clients. The instrument is designed to assess: 1) the behavioral, psychosocial, and social risk factors that influence high-risk drug users’ decisions to test for HIV; 2) the service delivery factors that influence high-risk drug users’ decision to test for HIV; 3) how high-risk drug users employ HIV testing in personal prevention strategies; and 4) how knowledge of HIV test results affects risk behavior.

<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/library/qualitative-interview-instrument/">Qualitative interview instrument</a>
<strong>Scoring:</strong> N/A
<strong>Reliability and/or validity: </strong>N/A]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Self-Report Adherence to Medications</title>
		<tax>1737</tax>
		<content><![CDATA[This questionnaire was developed by the AIDS Clinical Trials Group (ACTG) Recruitment, Adherence, and Retention Subcommittee, Margaret A. Chesney, PhD, and Jeannette Ickovics, PhD, co-chairs. Please read the two <a href="/sites/prevention.ucsf.edu/files/library/adherence-abstracts/">abstracts on adherence in clinical trials and practice</a>.

<strong>Instruments</strong>:
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/2098.4186.pdf">ACTG adherence baseline questionnaire</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/2098.4188.pdf">ACTG adherence follow-up questionnaire</a></li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity:</strong> Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, and Wu AW (2000). “Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee &amp; Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).” AIDS Care 12(3): 255–66.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Focus Group Questions for Sexual Negotiations</title>
		<tax>1737</tax>
		<content><![CDATA[The following two outlines of focus group questions are taken from the Sexual Negotiations among Young Adults in the Era of AIDS research study. Prepared by Diane Binson, PI. Funded by the Universitywide AIDS Research Program, R94-SF-050.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/goodquestions/section3/3c5_women.htm">Focus group questions for young women who have sex with men</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/goodquestions/section3/3c6_men.html">Focus group questions for young gay/bisexual men</a></li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity:</strong> N/A]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Sexual Behavior for Students at Public Middle Schools</title>
		<tax>1737</tax>
		<content><![CDATA[Barbara Marín and Cynthia Gómez at the Center for AIDS Prevention Studies at UCSF and Karin Coyle and Doug Kirby at ETR Associates developed this questionnaire as part of an evaluation study. These questionnaires are available both in English and Spanish. <a href="/sites/prevention.ucsf.edu/files/library/middle-school-pregnancystdhiv-prevention-program/">Please read a description of the questionnaires</a>.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/marinschoolquest.pdf">Student health questionnaire</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/encuestamarin.pdf">Encuesta de salud estudiantil</a></li>
</ul>
<strong>Scoring: </strong>See <a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Marinadultscales.pdf">scales</a>.<strong>
Reliability and/or validity:</strong> Marín BV, Coyle K, Gómez C, Carvajal S, Kirby D (2000). Older Boyfriends and Girlfriends Increase Risk of Sexual Initiation in Young Adolescents. Journal of Adolescent Health, 27, 409–418.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Prevention Services for HIV+ Patients</title>
		<tax>1737</tax>
		<content><![CDATA[The following exit survey instruments were developed to assess frequency and variation of prevention services as reported by HIV-positive patients at Ryan White CARE Act–funded clinics across the US.
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/RyanwhiteEngQ.pdf">Ryan White Prevention Project patient exit survey (English)</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/RyanwhteSpanQ.pdf">Ryan White Prevention Project patient exit survey (Spanish)</a></li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity:</strong> Learn more about the <a href="/sites/prevention.ucsf.edu/files/library/prevention-services-for-hiv-patients-methods/">methods used</a>.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Risk Behavior for Gay Men</title>
		<tax>1737</tax>
		<content><![CDATA[These questionnaires were used with the <a href="/sites/prevention.ucsf.edu/files/library/project-explore/">EXPLORE Project</a> and cover social activity, attitude, PEP, drug use, and sexual behavior.

<strong>Instruments:</strong>
<ul>
 	<li><a href="http://www.hptn.org/Web%20Documents/ExploreDocuments/Explore_RiskAssessment_screen.pdf" target="_blank">Baseline risk assessment</a> (PDF)</li>
 	<li><a href="http://www.hptn.org/Web%20Documents/ExploreDocuments/Explore_RiskAssessment_6to12.pdf" target="_blank">6 &amp; 12-month risk assessement</a> (PDF)</li>
 	<li><a href="http://www.hptn.org/Web%20Documents/ExploreDocuments/Explore_RiskAssessment_18to48.pdf" target="_blank">18 to 48-month risk assessment</a> (PDF)</li>
 	<li><a href="http://www.hptn.org/Web%20Documents/ExploreDocuments/ExploreFeedbackSurvey.gen.pdf" target="_blank">Feedback survey</a> (PDF)</li>
</ul>
<strong>Scoring: </strong>See data collection section of the <a href="http://www.hptn.org/Web%20Documents/HIVNET_Protocols/HIVNET_015.pdf" target="_blank">EXPLORE study protocol</a>.<strong>
Reliability and/or validity:</strong> BA Koblin, MA Chesney, MJ Husnik, et al. <a href="http://www.hptn.org/web%20documents/Publications/bkbaselineajph.pdf" target="_blank">High-Risk Behaviors among Men Who Have Sex with Men in 6 US Cities: Baseline Data from the EXPLORE Study</a>. American Journal of Public Health. 2003 93: 926–932.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Risk Behavior and Health Care for HIV+ Injection Drug Users (INSPIRE Study)</title>
		<tax>1737</tax>
		<content><![CDATA[These instruments were used to measure the effectiveness of the multisite INSPIRE Study (known as <a href="/sites/prevention.ucsf.edu/files/uploads/projects/Voice/index.php">VOICE</a> in San Francisco) and cover medication use and adherence, health care utilization, substance abuse, injection behavior, sexual behavior, partner relationships, and more.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/INSPIRE_screener.pdf">Screening questionnaire</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/mw_inspirebaseline_20070529135554.pdf">Baseline survey</a> <em>(Warning: This is a large file; 7.4 MB PDF)</em></li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity:</strong> Purcell DW, Metsch LR, Latka M, Santibanez S, Gómez CA, Eldred L, Latkin CA, INSPIRE Study Group. <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=ShowDetailView&amp;TermToSearch=15385907&amp;ordinalpos=3&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum">Interventions for seropositive injectors—research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction</a>. J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S110–8.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Risk Behavior and Health Care for HIV+ Injection Drug Users (SUDIS Study)</title>
		<tax>1737</tax>
		<content><![CDATA[These instruments were used with the SUDIS Study and cover medication use and adherence, health care utilization, disclosure, alcohol and drug use, sexual behavior, partner relationships, social support, and more.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/mw_sudiscreener_20070529140932.pdf">Screening questionnaire</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/mw_sudis_frmale_20070529141905.pdf">Female questionnaire</a><em> (Warning: This is large file; 7.9 MB PDF)</em></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/mw_sudisquest_male_20070529141230.pdf">Male questionnaire</a><em> (Warning: This is large file; 7.9 MB PDF)</em></li>
</ul>
<strong>Scoring:</strong> Included in instruments.
<strong>Reliability and/or validity:</strong> Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gómez CA, Seropositive Urban Injectors Study Team. <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=ShowDetailView&amp;TermToSearch=15843119&amp;ordinalpos=2&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum">Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention</a>. AIDS Educ Prev. 2005 Feb;17(1 Suppl A):76–88.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Women with Incarcerated Male Partners</title>
		<tax>1737</tax>
		<content><![CDATA[These instruments were used with the <a href="/sites/prevention.ucsf.edu/files/archives/survey-instruments/">HOME Study</a>.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOMELongitudinalbaseline.2.1.05.pdf">Longitudinal survey: baseline</a>. We administered these surveys to women visiting their incarcerated partners at the prison under study. Women completed the baseline while their partner was incarcerated, and completed the follow-up 30 days after their partner was released from custody.</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOMELBFUfieldversion.pdf">Longitudinal survey: follow-up</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOMECross-sectionalsurveyFinal2006.pdf">Cross-sectional survey</a>. We administered this survey to women visiting incarcerated men at the prison under study before our intervention began and after our intervention ended, to measure community impact.</li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity:</strong> See instruments.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Attitudes and Risk Behavior for Healthcare Providers and Their HIV+ Patients</title>
		<tax>1737</tax>
		<content><![CDATA[These instruments were used with the <a href="/sites/prevention.ucsf.edu/files/library/enhancing-prevention-with-positives-evaluation-center-eppec/">EPPEC Project</a>.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/EPPEC-PatientAssessment.pdf">Patient assessment</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/EPPEC-ProviderAssessment.pdf">Provider assessment</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/EPPEC-PatientGuide.pdf">Patient program evaluation</a> (qualitative)</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/EPPEC-PIProjectDirectorGuide.pdf">PI and project director implementation</a> (qualitative)</li>
</ul>
<strong>Scoring:</strong> N/A
<strong>Reliability and/or validity: </strong>RISK ASSESSMENT QUESTIONS: Morin et al. Predicting HIV Transmission Risk among HIV-infected MSM: Findings from the Healthy Living Project. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):226–233. STIGMA QUESTIONS: Westbrook LE and Bauman LJ (1996). Perceived Stigma of HIV/AIDS Scale. Bronx, New York: Albert Einstein College of Medicine. Purcell DW, Metsch L, Latka M, et al. Behavioral prevention trial with HIV-seropositive injection drug users: rationale and methods of the INSPIRE Study. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S110–S118. ATTITUDINAL QUESTIONS: Myers et al. Written clinic procedures enhance delivery of HIV “prevention with positives” counseling in primary health care settings. J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S95–S100. Morin et al. Missed Opportunities: Prevention with HIV+ Patients in Clinical Care Settings. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):960–966. Steward et al. Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings. AIDS Behav. 2006 Jan;10(1):3–12. TREATMENT OPTIMISM QUESTIONS: Vanable PA, Ostrow DG, McKirnan DJ (2003). Viral load and HIV treatment attitudes as correlates of sexual risk behavior among HIV-positive gay men. J of Psychosomatic Research 54:263–269.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Risk Behavior for Jail Inmates and Jail Staff</title>
		<tax>1737</tax>
		<content><![CDATA[These instruments were used with the <a href="/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2007/Prev6.pdf">Innovative Condom Distribution Study</a> to gauge attitudes toward and awareness of condoms and sexual activity in jail.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/FINALPrisonerSurvey.pdf">Pre-intervention prisoner survey</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Follow-UpPrisonerSurvey.pdf">Follow-up prisoner survey</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/PrisonStaffInterviewGuide.pdf">Prison staff interview guide</a></li>
</ul>
<strong>Scoring: </strong>N/A
<strong>Reliability and/or validity:</strong> N/A]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Ways of Coping</title>
		<tax>1737</tax>
		<content><![CDATA[The Ways of Coping questionnaire by Susan Folkman and Richard S. Lazarus is used to identify the thoughts and actions an individual has used to cope with a specific stressful encounter.

<strong>Instruments:</strong>
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Ways%20of%20coping.pdf">Ways of coping</a> (English)</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/SpanRelig.php">Ways of coping</a> (Spanish)</li>
</ul>
<strong>Scoring: </strong>Included in English instrument<strong>
Reliability and/or validity:</strong> Folkman S, Lazarus RS, Gruen RJ, and DeLongis A (1986). “Appraisal, coping, health status, and psychological symptoms.” Journal of Personality &amp; Social Psychology 50(3): 571–579.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Female Condom Attitudes Scale</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Femalecondomatt.pdf">Attitudes toward the female condom</a><strong>
Scoring: </strong>Included in article<strong>
Reliability and/or validity: </strong>Neilands TB, Choi KH. <a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Femalecondomval.pdf">A validation and reduced form of the Female Condom Attitudes Scale</a>. AIDS Education and Prevention. 2002 Apr;14(2):158–71.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/Femalecondomatt.pdf</url>
	</node>
	<node>
		<title>Coping Self-Efficacy Scale</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/CopingSelf-EfficacyScale.pdf">Coping self-efficacy scale</a>
<strong>Scoring: </strong>See <a href="/sites/prevention.ucsf.edu/files/library/coping-self-efficacy-scale-scoring/">scoring information</a>. <strong>
Reliability or validity: </strong>Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S.  <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1602207">A validity and reliability study of the coping self-efficacy scale</a>. Br J Health Psychol 2006 Sep; 11(3): 421–37.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/CopingSelf-EfficacyScale.pdf</url>
	</node>
	<node>
		<title>SECope: Coping with HIV Treatment Side Effects</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/SECope.pdf">SECope</a><strong>
Scoring: </strong>Included in article.<strong>
Reliability or validity: </strong>Johnson MO, Neilands TB. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17436074" target="_blank">Coping with HIV Treatment Side Effects: Conceptualization, Measurement, and Linkages</a>. AIDS and Behavior. 2007 Jul;11(4):575–85.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/SECope.pdf</url>
	</node>
	<node>
		<title>HIV Treatment Adherence Self-Efficacy Scale</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HIV-ASES.pdf">HIV treatment adherence self-efficacy scale</a><strong>
Scoring: </strong>Included in article
<strong>Reliability or validity: </strong>Johnson MO, Neilands TB, Dilworth SE, Morin SF, Remien RH, Chesney MA. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17588200" target="_blank">The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES)</a>. J Behav Med. 2007 Jun 23.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HIV-ASES.pdf</url>
	</node>
	<node>
		<title>Modified Schedule of Sexist Events (SSE-LM)</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/SES-LM.pdf">SSE-LM</a><strong>
Scoring: </strong>Included in article<strong>
Reliability or validity:</strong> Bowleg L, Neilands TB, Choi K-H. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18681099?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Evaluating the Validity and Reliability of a Modified Schedule of Sexist Events: Implications for Public Health Research on Women’s HIV Risk Behaviors</a>. Women &amp; Health, Vol. 47(2) 2008.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/SES-LM.pdf</url>
	</node>
	<node>
		<title>China MSM Stigma Scale</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/China_MSM_Stigma_Scale.pdf">China MSM stigma scale</a><strong>
Scoring: </strong>Included in article.<strong>
Reliability or validity:</strong> Neilands TB, Steward WT, Choi K-H. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18274889?ordinalpos=7&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum">Assessment of Stigma towards Homosexuality in China: A Study of Men Who Have Sex with Men</a>. Arch Sex Behav. 2008 Oct;37(5):838-44.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/China_MSM_Stigma_Scale.pdf</url>
	</node>
	<node>
		<title>India HIV-Related Stigma Scales</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Instrument: </strong><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/India-stigma-scales.pdf">India HIV-related stigma scales</a><strong>
Scoring: </strong>Included in article.<strong>
Reliability or validity: </strong>Steward WT, Herek GM, Ramakrishna J, Bharat S, Chandy S, Wrubel J, Ekstrand ML. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18599171?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum" target="_blank">HIV-related stigma: Adapting a theoretical framework for use in India.</a> Social Science &amp; Medicine 67 (2008) 1225–1235.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/India-stigma-scales.pdf</url>
	</node>
	<node>
		<title>Population Council Technical &amp; Research Services</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>http://www.popcouncil.org/contact</url>
	</node>
	<node>
		<title>The Measurement Group Evaluation &amp; Research Tools</title>
		<tax>1737</tax>
		<content><![CDATA[The following are examples of evaluation reports by The Measurement Group. We customize our dissemination strategies to meet the needs of our clients, their
stakeholders, and the intended audience for evaluation reports and presentations. Additional work samples are available upon request.]]></content>
		
		<type>
			6
		</type>
			<url>http://themeasurementgroup.com/reports/</url>
	</node>
	<node>
		<title>Club drugs</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How do club drugs impact HIV prevention?</h3>
<h4>What are club drugs?</h4>
Club drugs are illegal drugs that are often, although not exclusively, used at dance clubs, raves and circuit parties. Drugs often referred to as club drugs include: MDMA (ecstasy), methamphetamine (crystal meth, speed), GHB (liquid X), Ketamine (special K) and less often, Viagra and amyl nitrites (poppers)<sup>1</sup>. These drugs also are often used outside of clubs and parties.

Raves are large parties featuring house or techno music and visual effects. Mostly younger people attend raves. Circuit parties are a series of large, predominantly gay parties lasting several days and nights in a row that are frequented mostly by younger and older middle-class white men. They occur annually in different cities.<sup>2</sup>

Some of the physical and psychological effects of club drugs include: elevated mood, increased empathy, altered vision, sensations and emotions, increased alertness, decreased appetite, relaxation, increased physical energy and/or self-confidence. Many people use drugs recreationally with few or no immediate repercussions. Misuse of club drugs can lead to problems with toxicity (from the drugs themselves or from interactions with other drugs), with legal issues and sometimes with addiction. Persons using one or more club drugs during sex often report engaging in extremely high HIV risk behaviors.<sup>3</sup>

Club drugs can cause a variety of non-HIV-related health risks. This fact sheet will focus on sexual and drug-using HIV risk behaviors that can occur with club drug use.
<h4>Who uses club drugs?</h4>
Most of the research on club drugs has been with gay men, mainly because HIV prevalence and risk of infection are high among gay men. Use of club drugs varies by different populations and by geography.<sup>4</sup>

A survey of gay male circuit party attenders in San Francisco found that 80% used ecstasy, 66% ketamine, 43% methamphetamines, 29% GHB, 14% Viagra and 12% poppers during their most recent out-of-town weekend party. Half (53%) used four or more drugs.<sup>5</sup>

A study of rave attenders in Chicago found that 48.9% had used any club drugs, 29.8% used LSD, 27.7% ecstasy and 8.5% methamphetamine. Rave attenders used club drugs with other drugs such as marijuana (87%), alcohol (65.2%) and cocaine/crack (26.1%).<sup>6</sup>
<h4>What is the risk?</h4>
There are many negative physical and psychological side effects of club drugs. The reason club drugs present a potential HIV risk is because they can lower inhibitions, impair judgment, increase sexual endurance and encourage sexual risk-taking. With injected drugs, there is also a potential risk from sharing injection equipment.

The risk for HIV occurs mainly when drug use occurs during sexual activity. For example, methamphetamine is often used to initiate, enhance and prolong sexual encounters, allowing individuals to have sexual intercourse with numerous partners. Poppers are used for receptive anal sex, to relax the anal sphincter. Speed is also dehydrating, which may make men and women more prone to tears in the anus, vagina or mouth, and therefore more prone to HIV/STD infections.<sup>3,7</sup>

In one study, HIV- heterosexual methamphetamine users reported an average of 9.4 sex partners over two months. The number of unprotected sexual acts in two months averaged 21.5 for vaginal sex, 6.3 for anal sex and 41.7 for oral sex. Most users (86%) reported engaging in “marathon sex” while high on methamphetamine. Over one-third (37%) of users reported injecting, and of those, almost half had shared and/or borrowed needles.<sup>7</sup>

Unprotected sex with a partner whose HIV status is unknown is a high-risk activity. A survey of gay men found that 21% of HIV+ and 9% of HIV- men reported unprotected anal sex with a partner of unknown status at their most recent circuit party.<sup>5</sup>

A study of gay men at raves in New York City found that about one-third (34%) used ecstasy at least once a month. Men who used ecstasy were more likely to report recent unprotected anal intercourse than men who used other drugs, including alcohol.<sup>8</sup>
<h4>Why do people use club drugs?</h4>
For many people, straight or gay, drug use and sex are a natural occurrence at raves and circuit parties, and one of the appeals of these parties. These parties are popular social activities for some groups of youth and gay men, and there can be strong peer pressure to use drugs and be sexually active.<sup>9</sup> While circuit parties and raves may not themselves cause drug use, they may attract persons who are more inclined to use drugs.<sup>10</sup>

People use club drugs for many reasons. Some people use club drugs to have fun, dance and loosen inhibitions. Others use them to escape their problems and to counter feelings of depression or anxiety. Parental drug use, childhood sexual abuse and depression are some of the factors that may lead to drug use.<sup>4</sup>
<h4>What’s being done?</h4>
A drug treatment program for gay methamphetamine users in Los Angeles, CA, sought to reduce drug use and HIV-related sexual risk behaviors. Treatment options included: 1) cognitive behavioral therapy, a 90-minute group session delivered three times a week; 2) contingency management, a behavioral intervention that offered increasingly valuable vouchers for abstinence from drug use; and 3) cognitive behavioral therapy culturally tailored to gay issues. All men reduced their drug use, and those using contingency management reduced drug use longer. The highest reduction in sexual risk-taking occurred in men who used the culturally tailored program.<sup>11</sup>

DanceSafe promotes health and safety within the rave and nightclub community, with local chapters throughout the US and Canada. DanceSafe trains volunteers to be health educators and drug abuse prevention counselors at raves and nightclubs. They use a harm reduction approach and primarily target non-addicted, recreational drug users. DanceSafe offers information on drugs, safer sex and staying healthy, and in some venues offers pill testing to make sure drugs do not contain harmful substitutes.<sup>12</sup>

Twelve Step programs such as Crystal Meth Anonymous (CMA), Narcotics Anonymous (NA) and Alcoholics Anonymous (AA) are for people for whom drug use has become a problem. Twelve Step advocates abstinence from crystal meth, alcohol and other illicit drugs. Twelve Step meetings occur in many cities across the US.<sup>13</sup>

The PROTECT project at the South Florida Regional Prevention Center aims to reduce club-drug use among young gay men. PROTECT trains police officers, teachers and other community stakeholders on club drugs, particularly ecstasy. They also developed a web site with a chat room monitored by peer counselors.<sup>14</sup>

Stepping Stone, in San Diego, CA, is a residential drug treatment facility for gay men and lesbians. Most of their clients are poly drug users and most are dually diagnosed with psychiatric disorders. They address sexual behaviors and mental health issues in the context of drug abuse treatment. Stepping Stone sponsors a harm reduction social marketing campaign to increase awareness of the dangers of club drugs and alcohol.15
<h4>What needs to be done?</h4>
Several organizations are currently addressing the negative effects of club drugs at raves and parties across the country. More education is needed about the toxicity of club drugs, poly drug use and the connection between drug use and unsafe sex. Referrals for mental health counseling should also be made available at these venues.

The gay community needs to address the very real pressures in some sub-communities to party and be highly sexually active, and ask the question “is drug use worth the risks men are taking?”<sup>3</sup> It is not enough to attempt to reduce drug use and abuse at circuit parties without also addressing the powerful sexual motivations to using drugs.<sup>3,9</sup>

When prescribing Viagra, physicians should counsel men on safer sex and the harmful effects of combining Viagra with methamphetamines, poppers and ecstasy. Physicians should inquire about club drug use among their HIV+ patients and counsel them on the danger of combining them with HIV treatment drugs.<sup>16</sup> Physicians should be aware that club drug use can affect adherence to HIV drugs.
<h3>Says who?</h3>
1. Freese TE, Miotto K et al. The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment. 2002;23:151-156.
2. Swanson J, Cooper A. Dangerous liaison: club drug use and HIV/AIDS. IAPAC Monthly. 2002;8:1-15.
3. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality. 2001;41:17-35.
4. Stall R, Paul JP, Greenwood G et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men’s Health Study. Addiction. 2001;96:1589-1601.
5. Colfax GN, Mansergh G, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. Journal of Acquired Immune Deficiency Syndromes. 2001;28:373-379.
6. Fendrich M, Wislar JS, Johnson TP et al. A contextual profile of club drug use among adults in Chicago. Addiction. 2003;98:1693-1703.
7. Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addictive Behavior. 2004;29:807-810.
8. Klitzman RL, Pope HG, Hudson JI. MDMA (“ecstacy”) abuse and high-risk sexual behaviors among 169 gay and bisexual men. American Journal of Psychiatry. 2000;157:1162-1164.
9. Task Force on Crystal, Syphilis and HIV. Confronting crystal methamphetamine use in New York City. Public policy recommendations. Gay Men’s Health Crisis, New York, NY. July 2004.
http://www.gmhc.org/policy/nyc/crystaltaskforce04.php
10. Adlaf EM, Smart RG. Party subculture or dens of doom? An epidemiological study of rave attendance and drug use patterns among adolescent students. Journal of Psychoactive Drugs. 1997;29:193-198.
11. Shoptaw S, Reback CJ. Drug and sex risk behavior reductions with behavioral treatments for methamphetamine dependence among gay/bisexual men. Presented at the National HIV Prevention Conference, Atlanta, GA. 2003. Abstract #T3-D1004.
12. www.dancesafe.org
13. www.crystalmeth.org, www.na.org, www.aa.org
14. Rothaus S. Workshop targets young gays with a penchant for club drugs. Miami Herald. July 16, 2003.
15. Johnson SB. Stepping Stone: a catalyst for change. Presented at Methamphetamine Use and Gay Men Meeting. Sacramento, CA. April 24, 2003.
16. Romanelli F, Smith KS, Pomeroy C. Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men. Topics in HIV Medicine. 2003;11:25-32.
<h4>Other internet resources:</h4>
www.lifeormeth.com
www.tweaker.org
www.crystalrecovery.com
www.freevibe.com
www.crystalneon.org

<hr />

<strong>Prepared by Mike Pendo*, Pamela DeCarlo**
*San Francisco Department of Public health, **CAPS</strong><strong>July 2004. Fact Sheet #55E</strong>

Special thanks to the following reviewers of this Fact Sheet: Michael Thomas Angelo, Grant Colfax, Viva Delgado, Paul Galatowitsch, Rob Guzman, Perry Halkitis, Manuel Laureano-Vega, Gary Leigh, Phil Reichert, Frank Romanelli, Mike Siever, Steve Shoptaw, Steven Tierney, Dan Wohlfeiler.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©July 2004, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/ClubDrugsFS.pdf</url>
	</node>
	<node>
		<title>Crack cocaine</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are the HIV prevention needs of crack cocaine users?</h3>
Prepared by Margaret R. Weeks PhD, Institute for Community Research
and Pamela DeCarlo, CAPS

Fact Sheet 66, December 2009
<h4>Is crack cocaine an issue?</h4>
Yes. Although many people think of it as a drug of the 80s, crack cocaine is still around. HIV prevention has traditionally focused on injecting drug use and other stimulants like methamphetamine. But many people use more than one drug and may be using these drugs in different ways, for example, smoking crack and injecting heroin. Crack use alone and crack use combined with other drugs present real risks for HIV transmission and acquisition.

Crack cocaine is a powerfully addictive stimulant drug. Crack is a rock crystal, which can be smoked or dissolved and injected. It is relatively cheap and readily available on the street in mainly low-income urban areas. Crack is highly addictive and the effects of the drug are short-lived (about 5 minutes), making it necessary to use more to maintain a high.

Recent studies of crack users show high rates of HIV infection. In Harlem, New York, 23.9% of users and sellers of crack were HIV+<sup>1</sup>; in Los Angeles, California, 24% of older low-income MSM were HIV+<sup>2</sup>; and 22.4% of female street sex workers in Miami, Florida were HIV+<sup>3</sup>.
<h4>Who uses crack?</h4>
While crack use may vary geographically by race, age and sexual orientation, most crack use is concentrated in inner city communities that are impoverished and disadvantaged and have limited access to many services. These are the same neighborhoods with high rates of unemployment, homelessness, violence, substance abuse, HIV, sexually transmitted diseases (STDs) and other risks. However, some crack users do not fit these characteristics and are still at very high risk of health related consequences of crack use.
<h4>How does crack affect HIV transmission risk?</h4>
Risk of HIV and other sexually transmitted diseases can vary by level of crack use and addiction. Crack’s short-lived high and addictiveness can create a compulsive cycle in which users quickly exhaust their resources and turn to other ways to get the drug, including exchanging sex for money or drugs (such as a “hit” of crack)<sup>4</sup>. Trading sex in these circumstances often creates extremely risky situations that may include high numbers of partners, sex while under the influence and drug-related violence. This environment makes it hard to engage in safer behaviors and contributes to inconsistent condom use.<sup>5,6</sup> In one study, HIV infection was associated with intensive, daily crack smoking among women engaged in survival sex.<sup>5,7</sup>

Crack use is also associated with very high rates of other STDs, including syphilis, gonorrhea, and chlamydia. Lesions and abrasions associated with these infections increase opportunities for infection with HIV, especially during repeated or protracted sex, common among crack users.<sup>8</sup>

Crack is often smoked in make-shift pipes that use a glass pipette (tube) or a broken car antenna as a mouthpiece. These crack pipes can lead to cuts and burns on the lips, which are associated with HIV transmission.<sup>9</sup> It is not known if this is due to sharing pipes between users or sexual transmission during oral sex. Some research shows possible risk of pneumonia and tuberculosis transmission through sharing of crack pipes as well.<sup>10</sup>
<h4>How does crack affect HIV+ persons?</h4>
Crack use affects HIV+ persons on many levels: biological, social and behavioral. On a biological level, crack use can accelerate HIV disease progression.<sup>11</sup> One study found that persistent crack users were over three times as likely to die from AIDS-related causes as non-users.<sup>12</sup>

On a social level, most crack users who are HIV+ live in disadvantaged and impoverished communities, which present a variety of barriers to health. Crack users with HIV are less likely than HIV+ non-users to have access to basic medical services and more likely never to have been in HIV primary care.<sup>13</sup> They are less likely to have a regular healthcare provider and to initiate medical care and treatment.<sup>14</sup>

On a behavioral level, crack users have low rates of adherence to HIV therapy once they have begun treatment.<sup>15</sup> And HIV+ crack users are more likely than HIV+ non-users to continue to engage in high risk sexual behaviors with HIV- or unknown status partners after learning their HIV status.<sup>13</sup>
<h4>What’s being done?</h4>
The Risk Avoidance Partnership (RAP) Project in Hartford, Connecticut, trained active drug injectors and crack users to deliver an HIV, hepatitis, and STD prevention intervention to hard-to-reach drug users both inside and outside of their networks. The Peer Health Advocates (PHAs) received training in risk reduction and health promotion, communication skills and the importance of health advocacy. Crack users in RAP helped to design special “crack kits” they distributed to encourage use of rubber tips on crack pipes; kits also included male and female condoms and “dental dams” (flat latex sheets for use when performing oral sex on women). Study participants reported significant risk reduction.<sup>16</sup>

Using a harm reduction model, a needle exchange program in Ottawa, Canada distributes safety kits to crack users to reduce the risk of cuts and burns and potential transmission from sharing crack pipes and to decrease needle sharing. The kits include glass stems, rubber mouthpieces, brass screens, chopsticks, lip balm and chewing gum. Recipients reported less injecting and less sharing of pipes.<sup>10,17</sup>

JEWEL (Jewelry Education for Women Empowering their Lives) was an economic empowerment and HIV prevention project for crack-using women involved in prostitution in Baltimore, Maryland. The JEWEL intervention used six 2-hour sessions that taught HIV prevention and the making, marketing and selling of jewelry. Women participants significantly reduced trading drugs or money for sex, the number of sex trade partners, and daily crack use.<sup>18</sup>

Two separate intervention trials compared a standard National Institute on Drug Abuse HIV prevention intervention to woman-focused, culturally-specific interventions for female African-American crack cocaine users. The two interventions were grounded in motivation and empowerment theories and addressed the reality of the daily lives of women and the violence and poverty of their inner-city neighborhoods. Women in the culturally-specific interventions reported more reductions in sexual risk behaviors<sup>19</sup> as well as improvements in employment and housing status.<sup>20</sup>
<h4>What still needs to be done?</h4>
While there is still no medical treatment for crack or cocaine abuse and dependence, several behavioral treatments have demonstrated efficacy for helping people to initiate abstinence and to prevent relapse to cocaine use. These include contingency management, cognitive behavioral therapy, and motivational interviewing.<sup>21</sup> Currently available treatment for crack dependence tends to be limited to 12-step programs, which have little evidence of efficacy. Further development and testing of efficacious behavioral and medical treatments are needed to help crack users overcome the intense cravings associated with crack addiction.

Federal sentencing laws currently give far harsher penalties for crack cocaine than for powdered cocaine.<sup>22</sup> Using a 100-to-1 ratio, a person who sells a small amount of crack receives the same sentencing as a person who sells 100 times that amount of powder cocaine, resulting in prisons packed with low-level, predominantly African American offenders. In 2008, over 80% of offenders sentenced for crack-related federal crimes were Black and 10% were White. Activists and legislators are working to change the legislation, and to make it retroactive for those currently incarcerated.<sup>23</sup> Stronger public policy around sentencing guidelines are needed.

Substance use is complicated and HIV prevention has tended to simplify efforts into either reducing needle sharing and needle use, or reducing sexual risk. However, many IDUs also use crack, and often smoke crack when they’ve stopped injecting. Programs for IDUs should address poly-drug use, including crack use, and sexual risk reduction in the context of complex psychological and social needs and pressures associated with addiction.

Crack users face a variety of barriers to remaining healthy, and programs need to take a more holistic approach to prevention.<sup>24</sup> Crack users often need basic services such as childcare, safe shelter, food security, basic necessities and substance abuse treatment before they can think about HIV prevention.<sup>25</sup> Interventions should not simply focus on drug and sex risks, but should address these basic survival needs as well as education, employment, housing and job training.

<hr />

<h3>Says who?</h3>
1. Davis WR, Johnson BD, Randolph D , et al. Risks for HIV infection among users and sellers of crack, powder cocaine and heroin in central Harlem: Implications for interventions. <em>AIDS Care</em>. 2006;18:158-165.

2. Ober A, Shoptaw S, Wang PC, et al. Factors associated with event-level stimulant use during sex in a sample of older, low-income men who have sex with men in Los Angeles. <em>Drug &amp; Alcohol Dependence</em>. 2009;102:123-129.

3. Inciardi JA, Surratt HL, Kurtz SP. HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami, Florida.<em> AIDS and Behavior.</em>2006;10:139-147.

4. Edwards JM, Halpern CT, Wechsberg W. Correlates of exchanging sex for drugs or money among women who use crack cocaine. <em>AIDS Education and Prevention</em>. 2006;18:420-429.

5. Sharpe TT. Behind the eight-ball: Sex for crack cocaine exchange and poor Black women. Taylor and Francis, New York. 2005

6. Sterk CE, Elifson KW, Theall KP. Individual action and community context: The health intervention project. <em>American Journal of Preventive Medicine.</em>2007;32:S177-S181.

7. Shannon K, Bright V, Gibson K, et al. Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada.<em>Canadian Journal of Public Health</em>. 2007;98:465-469.

8. Miller M, Liao Y, Wagner M, et al. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs. <em>Sexually Transmitted Diseases</em>. 2008;35:696-702.

9. Theall KP, Sterk CE, Elifson KW, et al. Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence. <em>Public Health Reports.</em> 2003;118:415-424.

10. Johnson J, Malchy L, Mulvogue T, et al. Lessons learned from the SCORE project: A document to support outreach and education related to safer crack use. June 2008.

11. Baum MK, Rafie C, Lai S, et al. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. <em>Journal of AIDS</em>. 2009;50:93-99.

12. Cook JA, Burke-Miller JK, Cohen MH, et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. <em>AIDS</em>. 2008; 22:1355-1363.

13. Metsch LR, Bell C, Pereyra M, et al. Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. <em>American Journal of Public Health</em>. 2009;99:1045-1049.

14. Cunningham CO, Sohler NL, Berg KM, et al. Type of substance use and access to HIV-related health care. <em>AIDS Patient Care and STDs</em>. 2006; 20:399-407.

15. Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study.<em>Clinical Infectious Diseases.</em> 2004;39:1190-1198.

16. Weeks MR, Li J, Dickson-Gomez J, et al. Outcomes of a peer HIV prevention program with injection drug and crack users: the Risk Avoidance Partnership.<em>Substance Use &amp; Misuse</em>. 2009;44:253-281.

17. Leonard L, DeRubeis E, Pelude L, et al. “I inject less as I have easier access to pipes” Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. <em>Int’l Journal of Drug Policy</em>. 2008; 19:255-264.

18. Sherman SG, German D, Cheng Y, et al. The evaluation of the JEWEL projects: An innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. <em>AIDS Care.</em>2006;18:1-11.

19. Sterk CE, Theall KP, Elifson KW, et al. HIV risk reduction among African-American women who inject drugs: a randomized controlled trial. <em>AIDS and Behavior</em>. 2003;7:73-86.

20. Wechsberg WM, Lam WK, Zule WA, et al. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. <em>American Journal of Public Health.</em> 2004;94:1165-1173.

21. National Institute on Drug Abuse. Research Report Series. <em>Cocaine: Abuse and Addiction.</em> May 2009.

22. Sentencing. Stiff sentence for HIV+ crack user affirmed on appeal. <em>AIDS Policy &amp; Law</em>. 2007;22:8.

23. Emery T. Will crack-cocaine sentencing reform help current cons? <em>Time Magazine</em>. August 7, 2009.

24. Schlabig Williams J. Researchers adapt HIV risk prevention program for African-American women. <em>NIDA Notes</em>. April 2004.

25. MacMaster SA. Social service delivery preferences among African American women who use crack cocaine: What women say they need before they can be open to HIV prevention services? <em>Journal of HIV/AIDS &amp; Social Services.</em>2006;5:161-179.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Susan Boyd, Michael Campsmith, Judith Cook, Tom Donohoe, Waleska Maldonado, Lisa Metsch, Kate Shannon, Steve Shoptaw, Claire Sterk, Bill Stewart, Tanya Telfair Sharpe.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©December 2009, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.Web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/crackFS.pdf</url>
	</node>
	<node>
		<title>Injection drug users (IDUs)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are injection drug users (IDU) HIV prevention needs?</h3>
<h4>Are IDUs at risk?</h4>
Yes. Injecting drug use accounts for nearly one-third (36%) of cumulative AIDS cases in the US, and for 28% of the 42,156 new AIDS cases reported in 2000. These cases include injecting drug users (IDUs), their sexual partners and children born to them.<sup>1</sup>

African Americans and Latinos are disproportionately affected by IDU-associated AIDS. In 2000, the proportion of IDU-associated AIDS cases was 26% for African Americans, 31% for Latinos and 19% for whites.<sup>1</sup> Women are also disproportionately affected. Overall, 62% of AIDS cases among women have been attributed to IDUs and sex with IDU partners, compared with 34% of cases among men.<sup>2</sup>

IDUs are at even greater risk for other serious drug use-related illnesses, including hepatitis C and overdose. Injecting drug use accounts for 60% of hepatitis C infections in the US. Rates of hepatitis C infection among young IDUs are 4 to 100 times higher than rates of HIV infection. Drug overdose is a major cause of death among heroin users, even in areas with high rates of IDU HIV.<sup>5</sup>
<h4>What puts IDUs at risk?</h4>
Sharing injection equipment to either inject or split drugsincluding syringes, cookers, water and cottonis a high risk factor for IDUs.<sup>6</sup> Sharing mainly occurs because there are not enough needles and syringes available or they are not affordable to IDUs.

Unprotected sexual activity with an HIV+ partner is also a high risk factor for IDUs, especially male IDUs who have sex with men, women IDUs who trade sex for money and women with IDU partners.<sup>7</sup> Risk varies depending on drug use; for example, speed (methamphetamines) increases sexual desire and has been shown to lead to unsafe sex.<sup>8</sup>

IDUs often struggle with multiple health risks due to social, economic and psychological factors. HIV prevention may not be their top concern since they face other more pressing daily challenges such as addiction, poverty, incarceration, homelessness, stigma,
depression, mental illness and past trauma.<sup>9</sup>
<h4>What about drug treatment?</h4>
Quitting drug use through drug abuse treatment can be an effective HIV prevention intervention. However, only about 15% of IDU are currently in treatment, and there is no medical treatment for speed addiction.

Increasing the amount of quality drug treatment alone is not enough. Drug dependence is a chronic, relapsing disease. Some drug users are unwilling to seek treatment and those who do often find there are no treatment services available or affordable. Also, most people who go through drug treatment relapse several times before quitting for good. Because of this, it is important to take a harm reduction approach to HIV prevention for IDUs.<sup>10</sup>

A harm reduction approach recognizes that some IDUs are unable or unwilling to stop using drugs; therefore, harm reduction helps IDUs in a nonjudgmental way to reduce negative consequences of drug use. This can be done through promoting safer use, managed use or quitting drug use. In the US, harm reduction methods include street outreach to active drug users, syringe exchange and pharmacy access to sterile syringes.<sup>11</sup> Internationally, harm reduction initiatives include safe injecting rooms and medical dispensing of illicit drugs.<sup>12</sup>
<h4>What can help?</h4>
Peers, such as recovering IDUs, can be effective in motivating behavior change. However, recovering IDUs used as peer educators need support to avoid relapse to drug use. IDUs are more likely to use condoms when members of their social network discuss general health concerns and condom use, and when they have broader financial support.<sup>13</sup>

Access to quality medical care and STD/HIV treatment can help promote safer behaviors. A study in Baltimore, MD, found that informal caregivers were more likely to promote prevention messages in the community when their friends and family had access to HIV treatment, giving them hope for the future.<sup>14</sup>
<h4>What’s being done?</h4>
Methadone maintenance treatment for heroin dependency can help reduce injection risk behavior and HIV seroconversion.<sup>15</sup> In Connecticut, the Department of Mental Health and Addiction Services works with community-based Drug Treatment Advocates (DTAs) to help drug users get into drug abuse and mental health facilities. Each day, the Department faxes the available treatment slots to the DTAs so that their outreach and referrals are guaranteed.<sup>16</sup>

Syringe exchange helps reduce the risk of sharing infected needles by exchanging used syringes with new, sterile syringes. It is estimated that the use of a syringe exchange has a two- to six-fold protective effect against HIV risk behaviors.<sup>17</sup> In Oakland, CA, high-risk IDUs who used the syringe exchange were significantly more likely to quit sharing syringes than IDUs who never used the exchange.<sup>18</sup> However, only about 20 million syringes are exchanged annually in the US, equivalent to only about 15 syringes per drug user per year, not nearly enough to meet the number needed for effective HIV prevention.<sup>19</sup>

Community-based prevention programs can be effective. These programs address not just individual IDUs needs, but the health and welfare of the entire community. In Harlem, NY, a community advisory board comprised of researchers, health providers and community members identified three public health problems to be addressed: substance use, infectious diseases and asthma. In order to reduce barriers to receiving care and social services, they created a “survival guide” for substance users. They also began a peer training program for IDUs to deliver HIV and hepatitis C prevention interventions at local community-based organizations.

The UFO Study in San Francisco, CA, offered a spectrum of services for young IDUs, including HIV and hepatitis B and C testing and counseling and overdose prevention education. The Study had a drop-in site for young IDUs with phones, food and clothes, as well as on-site peer counselors and clinicians. Clients could also receive hepatitis A and B vaccinations. The study also provided a directory of youth-friendly services in several large cities in the US.<sup>20</sup>

Yet another prevention approach calls for treating HIV+ IDU with highly active antiretroviral therapy and helping them adhere to it. Bringing HIV+ IDUs’ viral loads to undetectable levels could slow transmission of HIV. In San Francisco, CA, Action Point, a storefront drop-in center, offers adherence support for the urban poor with active drug or alcohol addiction. Action Point is open 5 days a week and operates on a harm reduction principle that encourages any positive change in health. The program offers adherence case management, medication dispensing, nursing care, acupuncture and referrals to mental health and substance abuse services.<sup>21</sup>
<h4>What still needs to be done?</h4>
The biggest barrier to reducing HIV transmission among IDUs is the failure to implement effective prevention programs. Increasing access to quality drug treatment and sterile injection equipment would greatly affect this epidemic among IDUs. However, political attitudes and the criminalization of drug use have hampered prevention efforts in the US.<sup>22</sup> Federal and state governments should act quickly to legalize syringe exchange programs and fund more drug treatment.

It is often erroneously assumed that IDUs are not comfortable discussing sexual issues. Prevention programs for IDUs need to address sexual behavior as well as injecting behavior. Handing out condoms is not enough; service providers need to initiate discussions about sex. This is especially important for drug use-based interventions, such as syringe exchange programs, drug treatment and 12-step programs.

Programs should be multi-faceted and address other non-HIV needs of IDUs. Collaboration between HIV prevention, drug treatment, hepatitis C prevention and mental health services is crucial. Case managers can then give effective referrals to these services, housing or medical care, and help with follow-up and retention. Programs for IDUs should also incorporate a harm reduction approach and be aware that relapse is a common event for IDUs.

<hr size="2" />

<strong>Says who?</strong>

1. Drug-associated HIV transmission in the United States. Fact Sheet published by the Center for Disease Control and Prevention. 2002.http://www.cdc.gov/hiv/pubs/facts/idu.htm
2. CDC. HIV/AIDS Surveillance Report-cases reported through December 2001. 2002;13:tbl 22,23. http://www.cdc.gov/hiv/stats/hasr1302.htm
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV- related chronic disease. Morbidity and Mortality Weekly Report. 1998;47(RR19):1-39.
4. Garfein RS, Doherty MC, Monterroso ER, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of AIDS and Human Retrovirology. 1998;18:S11-19.
5. Darke S, Hall W. Heroin overdose: research and evidence-based intervention. Journal of Urban Health. 2003;80:189-200.
6. Access to sterile syringes. Published by the National Center for HIV, STD and TB Prevention. January 2002. www.cdc.gov/idu/facts/
7. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
8. Bull SS, Piper P, Rietmeijer C. Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors. Journal of Homosexuality. 2002;42:31-51.
9. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness and incarceration. Public Health Reports. 2002;117: S135-S145.
10. Day D. Health emergency 2003: the spread of drug-related AIDS and hepatitis C among African Americans and Latinos. Published by Dogwood Center. 2003. www.dogwoodcenter.org/2003/HE2003.pdf
11. Hilton BA, Thompson R, Moore-Dempsey L, et al. Harm reduction theories and strategies for control of HIV: a review of the literature. Journal of Advanced Nursing. 2001;33:357-370.
12. Is there a more effective social policy with respect to the problems of substance misuse in British Columbia? Presentation to the Vancouver Area Network of Drug Users. 2000. www.vandu.org
13. Latkin CA, Forman V, Knowlton A, et al. Norms, social networks, and HIV-related behaviors among urban disadvantaged drug users. Social Science &amp; Medicine. 2003;56:465-476.
14. .Knowlton AR. Social network approaches to HIV prevention and care: theoretical and methodological considerations of intervention. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. ThOrE1501.
15. Gibson DR, Flynn NM, McCarthy JJ. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 1999,13:1807-1818.
16. Alcohol and drug use and HIV. NASTAD HIV Prevention Fact Sheet.http://www.nastad.org/documents/public/pub_prevention/200145AlcoholandDrugUseandHV.pdf
17. Gibson DR, Brand R, Anderson K, et al. Two- to six-fold decreased odds of risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiencies Syndrome. 2002;31:237-242.
18. Bluthenthal RN, Kral AH, Gee L, et al. The effect of syringe exchange on high-risk injection drug users: a cohort study. AIDS. 2000;14:605-611.
19. Galea S, Factor SH, Bonner S, et al. Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. Public Health Reports. 2001;116:530-539.
20. The UFO Study. /sites/prevention.ucsf.edu/files/uploads/ufostudy/
21. Bamberger JD, Unick J, Klein P, et al. Helping the urban poor stay with antiretroviral HIV drug therapy. American Journal of Public Health. 2000;90:699-701.
22. Des Jarlais DC, Friedman SR. Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports. 1998;113:182-188.

<hr size="2" />

<strong>Prepared by Pamela DeCarlo and David R. Gibson</strong><strong>
</strong><strong>CAPS</strong>

<strong>September 2003. Fact Sheet #51E</strong>

Special thanks to the following reviewers of this Fact Sheet: Cyril Colonius, Carol Dawson-Rose, Dawn Day, Pam Klein, Alex Kral, Pam Ling, Kim Shafer, Claire Sterk, Karin Tobin.

<hr size="2" />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/IDUFS.pdf</url>
	</node>
	<node>
		<title>Methamphetamine</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How does methamphetamine use affect HIV prevention?</h3>
<h4>what is methamphetamine?</h4>
Methamphetamine (meth, also called crystal, speed, Tina, ice, crank) is a powerful, illegal stimulant and is similar to amphetamine. It can be taken orally, snorted, smoked, injected and inserted rectally and can affect the user for several hours or more depending on how much is used.<sup>1</sup> Meth is cheap, widely available and has a high potential for abuse and addiction.

Meth users describe the positive effects to be feelings of euphoria, loss of appetite, heightened self esteem and increased desire for and intensity of sex. However, meth also has many negative short and long-term effects, including damaging brain neurons, high blood pressure, oral hygiene problems, depression, anxiety, paranoia and psychotic symptoms such as paranoid delusions and hallucinations. Symptoms of overdose include chest pain, elevated body temperature, rapid heart rate and rapid shallow breathing.

Meth is widely used, both nationally and internationally, with over one million users in the US.<sup>2</sup> Although lifetime meth use has increased dramatically since the early 1990s, the number of abusers has remained steady and meth abuse is far less common than cocaine abuse.<sup>3</sup> In recent years, meth use has increased in some locales and sub-populations, particularly on the East Coast.
<h4>how does meth use affect HIV?</h4>
Meth use can heighten one’s HIV risk through unsafe injection and sexual behaviors. If a person injects meth, sharing needles and injection equipment can transmit HIV.

Many users consider meth a sexual drug, using it specifically to intensify and prolong sex and increase disinhibition. Meth tends to dry out the skin on the penis, anus and vagina, which may lead to tears and cuts and HIV transmission, especially with extended sex play, multiple partners and more aggressive sex associated with meth use.

Meth can both increase sex drive and decrease men’s ability to get and maintain an erection. As a result, some men using meth may choose receptive anal sex (“bottoms”), or may choose to combine meth with erectile dysfunction drugs such as Viagra. Both meth and Viagra use are independently associated with unprotected anal sex.<sup>4</sup>
<h4>how does meth use affect HIV risk?</h4>
Meth use and abuse is a very real concern among gay men and other men who have sex with men (MSM). Research on meth use in other populations, such as heterosexuals, is limited. Gay and bisexual men report using meth and other stimulants at rates 10 times greater than the general population.<sup>5</sup> This is particularly concerning because HIV is more common in this population than among heterosexuals. The use of meth for sexual reasons has been found to be more common among HIV+ men.<sup>6,7</sup> The reasons for meth use among MSM vary, and may include strong cultural expectations of sexual prowess in some parts of the gay community.<sup>8</sup>

Several studies of MSM (primarily gay-identified men) have found that users are 2-3 times more likely than non-users to engage in unprotected anal sex, have condoms break or slip off, acquire a sexually transmitted disease, or become infected with HIV.<sup>9</sup> In fact, these elevated risks occur among frequent and occasional users alike.<sup>10</sup>

A study of HIV- MSM found that men using stimulants were twice as likely to become infected as non-users, even when accounting for specific risky sexual behavior like unprotected anal sex with HIV+ partners.<sup>11</sup> This suggests that meth use may contribute to HIV infection above and beyond increasing the likelihood that users will engage in risky behavior.

While there is ample evidence of the link between HIV risk and meth use among MSM, some studies also show high levels of HIV risk behavior among heterosexuals. In one study, 86% of users reported engaging in “marathon sex” while high on meth. More than a third reported injecting, and of those, 47% had shared and/or borrowed needles.<sup>12</sup>
<h4>how does meth affect HIV+ persons?</h4>
Meth use and abuse can have negative consequences for HIV+ persons. HIV protease inhibitors (particularly ritonavir) may increase the potential for adverse reactions or overdose. Being high on meth may cause HIV+ persons to forget to take–or be unconcerned with taking–their medications. Meth use may also affect HIV+ persons’ overall health by increasing dehydration, sleeplessness and weight loss.<sup>13</sup>
<h4>what’s being done?</h4>
The high potential for addiction to meth and the intentional combination of meth and sex pose unique challenges for sexual risk-reduction efforts for meth users. However, a variety of approaches are available.

Meth and HIV prevention efforts should focus on: 1) preventing initial use of meth among non-users by influencing community norms, 2) discouraging occasional users from becoming regular users, 3) minimizing health risks for current users, and 4) increasing drug treatment capacity and getting meth abusers into accessible programs.

There have been several social marketing campaigns addressing the prevention of meth use. “Crystal Mess” and “Got Meth?” addressed negative consequences of meth use among gay men and youth, respectively. “Silence=Meth” calls for the gay community to take action around meth use.<sup>14</sup>

A harm-reduction approach may be better suited to those currently not choosing to cease meth use entirely, such as is offered at the Stonewall Project for MSM in San Francisco, CA.<sup>15</sup> Those injecting meth should be referred to needle exchange programs and provided education and counseling on safer injection and sex practices.

Life in the FASTLANE is a harm reduction-based program to reduce sexual risk among heterosexual active meth users. Using four weekly 90-minute one-on-one counseling sessions, FASTLANE increased intentions for safer sex and protected sex acts.<sup>16</sup>

For meth users ready to quit using, several programs are available. Some users may benefit from 12-step programs like Crystal Meth Anonymous, Narcotics Anonymous and LifeRing.<sup>17</sup> The Positive Reinforcement Opportunity Project (PROP), uses positive conditioning to help gay and bisexual men stay off meth. Participants get urine tests 3 times a week for 12 weeks. Each time the test is negative for meth, they get positive reinforcement and vouchers good for food, medical bills, personal care items and more.<sup>17</sup>

Perhaps the best studied meth treatment approach is the Matrix Model, which is a behavioral intervention using 48 group and individual sessions over 16 weeks.<sup>18</sup> Another study with MSM compared a variation of this model with contingency management (providing vouchers of increasing value for meth-negative urine), a combination of both approaches, and a gay-specific version of Matrix.<sup>19</sup> All groups showed substantial reductions in meth use and sexual risk behavior one year later.

While there are no medications currently approved to treat meth dependence, this may prove to be an effective approach. Currently, several studies, such as BUMP, are testing the feasibility of providing the antidepressant bupropion to meth-dependent MSM.<sup>20</sup>
<h4>what are next steps?</h4>
The gay community needs to address the very real pressure in some sub-communities to party and be highly sexually active<sup>21</sup>, and to ask the question “is drug use worth the risks men are taking?” It is not enough to attempt to reduce drug and alcohol use and abuse without also addressing the powerful sexual reasons why MSM use drugs, and explore ways to develop a healthy and satisfying sex life without drugs.

Research into potentially effective treatment, counseling, medication and harm reduction approaches continues. Counselors and health care providers should be trained on the symptoms and effects of meth use and how to discuss meth and other substance use with clients and patients in a non-judgmental way. Providers can refer users to locally accessible meth harm reduction, treatment and HIV prevention programs when appropriate.

<hr />

<h3>Says who?</h3>
1. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA. Treatment of methamphetamine abuse: research findings and clinical directions. Journal of Substance Abuse Treatment. 2003;24:267-277.

2. SAMHSA. Methamphetamine use, abuse and dependence: 2002, 2003 and 2004. The NSDUH Report. September 2005.

3. King RS. The next big thing? Methamphetamine use in the US. Report prepared by The Sentencing Project. June 2006.www.sentencingproject.org/pdfs/methamphetamine_report.pdf

4. Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sexually Transmitted Infections. 2006;82:131-134.

5. Stall R, Paul JP, Greenwood G, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men. Addiction. 2001;96:1589-1601.

6. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. Journal of Substance Abuse and Treatment. 2002;22:149-156.

7. Halkitis PN, Shrem MT, Martin FW. Sexual behavior patterns of methamphetamine-using gay and bisexual men. Substance Use &amp; Misuse. 2005;40:703–719.

8. Diaz RM, Heckert AL, Sanchez J. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. Journal of Urban Health. 2005;82:i71-78.

9. CDC. Methamphetamine use and HIV risk behaviors among heterosexual menpreliminary results from five northern California counties. Morbidity and Mortality Weekly Report. 2006;55:273-277.

10. Colfax G, Vittinghoff E, Husnik MJ, et al. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. American Journal of Epidemiology. 2004;159:1002-1012.

11. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20:731-739.

12. Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addictive Behavior. 2004;29:807-810.

13. New York State Department of Health AIDS Institute. Methamphetamine and HIV: basic facts for service providers. March 2006.www.nyhealth.gov/diseases/aids/harm_reduction/crystalmeth/

14. www.crystalmess.net;
www.justthinktwice.com/gotmeth/;
http://www.gaycenter.org/news/press/News.2006-06-07.9724110679/news_view

15. www.tweaker.org

16. Patterson TL, Mausbach B, Semple SJ, et al. Life in the fastlane: testing the efficacy of a behavioral intervention to reduce high risk sexual behaviors among HIV-negative, heterosexual methamphetamine users. Presented at the International AIDS Conference, Toronto, Canada, August 2006. #MOAC0205

17. www.na.org;
www.unhooked.com;
www.crystalmeth.org;
www.propsf.com

18. Rawson RA, Marinelli-Casey P, Anglin MD, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99:708-717.

19. Shoptaw S, Reback CJ, Peck JA, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence. 2005;78:125-134.

20. www.sfbump.com

21. Green IA, Halkitis PN. Crystal methamphetamine and sexual sociality in an urban gay subculture: An elective affinity. Culture, Health and Sexuality. 2006;8:317-333.

*All websites accessed July 2006

<hr />

<strong>Prepared by Robert Guzman MPH, San Francisco DPH; Pamela DeCarlo, CAPS</strong>

<strong>September 2006 . Fact Sheet #61E</strong>

Special thanks to the following reviewers of this Fact Sheet: David Celentano, Grant Colfax, Perry Halkitis, Mark Hammer, Jeff Klausner, David Knapp Whittier, Jennifer Lorvick, Alix Lutnick, Jean Malpas, Gordon Mansergh, Tim Matheson, Tracey Packer, Joseph Palamar, Jimmy Palmieri, Jim Peck, Brady Ralston, Cathy Reback, Steve Shoptaw, Michael Siever, Hanne Thiede, Steven Tierney, Chad Upham, Will Wong.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2006, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/methFS.pdf</url>
	</node>
	<node>
		<title>Needle exchange programs (NEP)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Does HIV Needle Exchange Work?</h3>
<h3>revised 12/98</h3>
<h4>Why do we need needle exchange?</h4>
More than a million people in the US inject drugs frequently, at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion a year.<sup>1</sup> People who inject drugs imperil their own health. If they contract HIV or hepatitis, their needle-sharing partners, sexual partners and offspring may become infected.

It is estimated that half of all new HIV infections in the US are occurring among injection drug users (IDUs)<sup>2</sup>. For women, 61% of all AIDS cases are due to injection drug use or sex with partners who inject drugs. Injection drug use is the source of infection for more than half of all children born with HIV.<sup>3</sup>

Injection drug use is also the most common risk factor in persons with hepatitis C infection. Up to 90% of IDUs are estimated to be infected with hepatitis C, which is easily transmitted and can cause chronic liver disease. Hepatitis B is also transmitted via injection drug use.<sup>4</sup>

Needle exchange programs (NEPs) distribute clean needles and safely dispose of used ones for IDUs, and also generally offer a variety of related services, including referrals to drug treatment and HIV counseling and testing.
<h4>Why do drug users share needles?</h4>
The overwhelming majority of IDUs are aware of the risk of the transmission of HIV and other diseases if they share contaminated equipment. However, there are not enough needles and syringes available and even these are often not affordable to IDUs.

Getting IDUs into treatment and off drugs would eliminate needle-related HIV transmission. Unfortunately, not all drug injectors are ready or able to quit. Even those who are highly motivated may find few services available. Drug treatment centers frequently have long waiting lists and relapses are common.

Most US states have paraphernalia laws that make it a crime to possess or distribute drug paraphernalia “known to be used to introduce illicit drugs into the body.”<sup>5</sup> In addition, ten states and the District of Columbia have laws or regulations that require a prescription to buy a needle and syringe. Consequently, IDUs often do not carry syringes for fear of police harassment or arrest. Concern with arrest for carrying drug paraphernalia has been associated with sharing syringes and other injection supplies.<sup>6</sup>

In July 1992, the state of Connecticut passed laws permitting the purchase and possession of up to ten syringes without a prescription and making parallel changes in its paraphernalia law. After the new laws went into effect, the sharing of needles among IDUs decreased substantially, and there was a shift from street needle and syringe purchasing to pharmacy purchasing.<sup>7</sup> However, even where over-the-counter sales of syringes are permitted by law, pharmacists are often unwilling to sell to IDUs, emphasizing the need for education and outreach to pharmacists.
<h4>What’s being done?</h4>
Around the world and in more than 80 cities in 38 states in the US, NEPs have sprung up to address drug-injection risks. There are currently 113 NEPs in the US. In Hawaii, the NEP is funded by the state Department of Health. In addition to needle exchange, the program offers a centralized drug treatment referral system and a methadone clinic, as well as a peer-education program to reach IDUs who do not come to the exchange. Rates of HIV among IDUs have dropped from 5% in 1989 to 1.1% in 1994-96. From 1993-96, 74% of NEP clients reported no sharing of needles, and 44% of those who did report sharing reported always cleaning used needles with bleach.<sup>8</sup>

Harm Reduction Central in Hollywood, CA, is a storefront NEP that targets young IDUs aged 24 and under. The program provides needle exchange, arts programming, peer-support groups, HIV testing and case management and is the largest youth NEP in the US. Over 70% of clients reported no needle-sharing in the last 30 days, and young people who used the NEP on a regular basis were more likely not to share needles.<sup>9</sup>
<h4>Does needle exchange reduce the spread of HIV? Encourage drug use?</h4>
It is possible to significantly limit HIV transmission among IDUs. One study looked at five cities with IDU populations where HIV prevalence had remained low. Glasgow, Scotland; Lund, Sweden; New South Wales, Australia; Tacoma, WA; and Toronto, Ontario, all had the following prevention components: beginning prevention activities when levels of HIV infection were still low; providing sterile injection equipment including through NEPs; and conducting community outreach to IDUs.<sup>10</sup>

A study of 81 cities around the world compared HIV infection rates among IDUs in cities that had NEPs with cities that did not have NEPs. In the 52 cities without NEPs, HIV infection rates increased by 5.9% per year on average. In the 29 cities with NEPs, HIV infection rates decreased by 5.8% per year. The study concluded that NEPs appear to lead to lower levels of HIV infection among IDUs.<sup>11</sup>

In San Francisco, CA, the effects of an NEP were studied over a five-year period. The NEP did not encourage drug use either by increasing drug use among current IDUs, or by recruiting significant numbers of new or young IDUs. On the contrary, from December 1986 through June 1992, injection frequency among IDUs in the community decreased from 1.9 injections per day to 0.7, and the percentage of new initiates into injection drug use decreased from 3% to 1%.<sup>12</sup>

Hundreds of other studies of NEPs have been conducted, and all have been summarized in a series of eight federally funded reports dating back to 1991. Each of the eight reports has concluded that NEPs can reduce the number of new HIV infections and do not appear to lead to increased drug use among IDUs or in the general community.<sup>13-15</sup> These were the two criteria that by law had to be met before the federal ban on NEP service funding could be lifted. This is a degree of unanimity on the interpretation of research findings unusual in science. Five of the studies recommended that the federal ban be lifted and two made no recommendations. In the eighth report the Department of Health and Human Services decided that the two criteria had been met, but failed to lift the ban. The Congress has since changed the law, continuing to ban federal funding for NEPs, regardless of whether the criteria are met.
<h4>Is needle exchange cost-effective?</h4>
Yes. The median annual budget for running a program was $169,000 in 1992. Mathematical models based on those data predict that needle exchanges could prevent HIV infections among clients, their sex partners, and offspring at a cost of about $9,400 per infection averted.<sup>16</sup> This is far below the $195,188 lifetime cost of treating an HIV-infected person at present.<sup>17</sup> A national program of NEPs would have saved up to 10,000 lives by 1995.<sup>13</sup>
<h4>What must be done?</h4>
Efforts to increase the availability of sterile needles must be a part of a broader strategy to prevent HIV among IDUs, including expanded access to drug treatment and drug-use prevention efforts. Although the US federal government has acknowledged that NEPs<sup>15</sup> reduce rates of HIV infection and do not increase drug use rates, it still refuses to provide funding for NEPs. Therefore, advocacy activity at the state and local community level is critical. However, the federal government should play a more active role in advocating for NEPs publicly, even if it doesn’t fund them.

States with prescription laws should repeal them; those with paraphernalia laws should revise them insofar as they restrict access to needles and syringes. Local governments, Community Planning Groups and public health officials should work with community groups to develop comprehensive approaches to HIV prevention among IDUs and their sexual partners, including NEPs and programs to increase access to sterile syringes through pharmacies.

<hr />

<h3>Says who?</h3>
1. Rice DP, Kelman S, Miller LS. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988 . Public Health Reports. 1991;106:280-92.

2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas . American Journal of Public Health. 1996;86:642-654.

3. CDC. HIV/AIDS Surveillance Report . 1998;9:12.

4. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998; 18(Suppl 1):S6-10.

5. Gostin LO, Lazzarini Z, Jones TS, et al. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles . Journal of the American Medical Association. 1997;277:53-62.

6. Bluthenthal RN, Kral AH, Erringer EA, et al. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Journal of Drug Issues. (in press).

7. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993 . Journal of Acquired Immune Deficiency Syndromes. 1995;10:82-89.

8. Vogt RL, Breda MC, Des Jarlais DC, et al. Hawaii’s statewide syringe exchange program . American Journal of Public Health. 1998;88:1403-1404.

9. Kipke MD, Edgington R, Weiker RL, et al. HIV prevention for adolescent IDUs at a storefront needle exchange program in Hollywood, CA. Presented at 12th World AIDS Conference, Geneva, Switzer-land. 1998. Abstract #23204.

10. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users . Journal of the American Medical Association. 1995;274:1226-1231.

11. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection . Lancet. 1997;349:1797-1800.

12. Watters JK, Estilo MJ, Clark GL, et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users . Journal of the American Medical Association. 1994; 271:115-120.

13. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA . Lancet. 1997;349:604-608.

14. Report from the NIH Consensus Development Conference. February 1997.

15. Goldstein A. Clinton supports needle exchanges but not funding. Washington Post. April 21, 1998:A1.

16. Lurie P, Reingold AL, Bowser B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad . Prepared for the Centers for Disease Control and Prevention. October 1993.

17. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997;16:54-62.

<hr />

<strong>Prepared by Peter Lurie, MD MPH*,** and Pamela DeCarlo**
*Public Citizen’s Health Research Group **CAPS</strong>

Updated December 1998. Fact Sheet #5Er

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © December 1998, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/nepFS.pdf</url>
	</node>
	<node>
		<title>Substance abusers</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are Substance Abusers’ HIV Prevention Needs?</h3>
<h4>Are Substance Abusers Who Don’t Inject At High Risk Of Infection?</h4>
Yes. Although sharing used needles is a high risk for HIV transmission, substance abuse and HIV goes beyond the issue of needles. People who abuse alcohol, speed, crack cocaine, poppers or other non-injected drugs are more likely than non-substance users to be HIV positive and to become seropositive. People with a history of non-injection substance abuse are also more likely to engage in high-risk sexual activities.<sup>1</sup>

Many injection drug users (IDUs) use other non-injected drugs primarily. When an IDU is HIV-positive, needle sharing may be the primary risk factor, but other non-injected drug use may have a great effect on risk behaviors. For example, a study of high risk clients in a methadone treatment program found that those at highest risk for HIV infection were also crack cocaine users.<sup>2</sup>

A survey of heterosexuals in alcohol treatment programs in San Francisco, CA, found HIV infection rates of 3% for men who were not homosexually active or IDUs and 4% for women who were not IDUs. This was considerably higher than rates of 0.5% for men and 0.2% for women found in a similar population survey.<sup>3</sup>

In Boston, MA, a study of gay men found a strong relationship between use of nitrite inhalants or “poppers” and HIV infection. Men who always used poppers while engaging in unprotected anal sex were 4.2 times more likely to be HIV positive than men who never used poppers and engaged in unprotected anal sex.<sup>4</sup>

Crack cocaine use has been shown to be strongly associated with the transmission of HIV. A study of young adults in three inner-city neighborhoods who smoked crack and had never injected drugs found a 15.7% HIV rate. Women who had recently had unprotected sex in exchange for money or drugs, and men who had anal sex with other men were most likely to be infected.<sup>5</sup>
<h4>Why Are They At Higher Risk?</h4>
There are probably a lot of reasons why substance abusers are at higher risk for HIV. The reasons most likely vary by drug and social context-crack abusers may have different risks than alcohol abusers, for example. For non-injecting substance abusers, HIV infection is not caused by drug use but by unsafe sexual behavior.

Recently, observers have found an association between HIV infection, heavy crack use and unprotected fellatio among prostitutes. This may be due to poor oral hygiene and oral damage from crack pipes, high frequency of fellatio, and inconsistent condom use.<sup>6</sup>

Gay male substance abusers in San Francisco, CA, identified a number of factors that made safe sex difficult for them, including: perceived disinhibiting effect of alcohol and other drugs, learned patterns of association between substance use and sex (especially methamphetamine use and anal sex), low self-esteem, lack of assertiveness, and perceived powerlessness.<sup>7</sup>

Post Traumatic Stress Disorder (PTSD) may account for high sexual risk-taking activities among female crack users in the South Bronx, NY. In one study, 59% of women interviewed were diagnosed with PTSD due to violent traumas such as assault, rape or witness to murder, and non-violent traumas such as homelessness, loss of children or serious accident.<sup>9</sup>

It is often believed that having unprotected sex while under the influence of drugs or alcohol accounts for substance abusers’ HIV risk. However, sexual networks and sexual mixing might better explain risk.<sup>9</sup> Many people who are in treatment or using drugs or alcohol are primarily selecting sexual partners from similar networks. They might include people who have used needles, have traded sex for money or drugs, have been victims of trauma, or have been incarcerated. All of these populations may have higher rates of HIV infection, making transmission more likely.
<h4>What Are Obstacles To Prevention?</h4>
In American social culture, drug use and sex have become hopelessly linked. For many people, straight or gay, bars are the main method for meeting people. Ads and commercials portray alcohol as seductive. Honest conversations about sexuality, including homosexuality, are lacking in schools, homes and the media. This can lead to greater sexual inhibitions that might be eased through drinking or using drugs.

The goals of HIV prevention and substance treatment are often conflicting. Many treatment programs focus on stopping substance abuse altogether, and 12 Step programs often advocate sexual abstinence while in recovery. On the other hand, many prevention programs focus on safer sex and harm reduction, acknowledging that relapse could occur. These conflicting cultures may make it difficult to integrate HIV prevention interventions into substance abuse programs.
<h4>What’s Being Done?</h4>
New Leaf (formerly 18th Street Services) in San Francisco, CA, provides substance abuse treatment for gay/bisexual men, and offers a safer sex intervention. Although evaluation of the intervention showed little difference between men who participated in the safer sex program, and men who only went through treatment, both groups showed significant reductions in sexual risk.<sup>10</sup> Getting and retaining substance abusers in treatment is an effective preventive method; adding a safer sex program may also help.

Some prevention efforts teach safer sex behaviors regardless of drug use. In “Sex, Games, and Videotapes,” a program for homeless mentally ill men in New York City, NY, the men suggested taping condoms to their crack pipes as a reminder for sexual encounters that are often quick and public. They also compete to see which man can put a condom on a banana fastest (without tearing the condom), which teaches important skills for using a condom quickly. The program allows for sex issues to be brought up in a non-judgmental way, and reduced sexual risk behavior threefold.<sup>11</sup>

Many substance abusers receive treatment only after they have been arrested and are offered treatment as an alternative to jail or prison, or while they are incarcerated. The Delaware correctional system has instituted a therapeutic community (TC) treatment program in prison and a transitional TC outside the prison for parolees. The drug-free residential program includes rehabilitation, peer education group counseling and social services. Participants in the TC program had lower rates of drug relapse and re-arrest than non-participants, and reported reduced HIV risk behaviors.<sup>12</sup>
<h4>What Still Needs To Be Done?</h4>
Gender specific programs are needed that address women’s substance use needs. Women have a higher physical vulnerability to alcohol and higher levels of traumatic events associated with substance use than men.<sup>13</sup> Gay and lesbian-specific treatment is also needed. In addition, specific treatment is needed for drugs such as crack cocaine and new drugs as they arrive on the scene.

Prevention programs for substance abusers need to be integrated into existing services. The HIV epidemic has closely paralleled the epidemics of substance use and incarceration. Substance treatment agencies and prisons and jails need training and authority to incorporate HIV prevention education into their programs. Funders should increase funds and require substance abuse programs to expand treatment to include HIV education.

Prevention programs don’t need to depend on causality-that drug abuse causes risk behaviors.<sup>14</sup> A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. Because of high rates of HIV and risk behaviors among substance abusers, programs are urgently needed in this population.

<em>Prepared by Pamela DeCarlo, Ron Stall, PhD, MPH, Robert Fullilove EdD</em>

**********
<h3>Says Who?</h3>
1. Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV. American Psychologist. 1993;48:1035-1045.

2. Grella CE, Anglin MD, Wugalter SE. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients . Drug and Alcohol Dependence. 1995;37:15-21.

3. Avins AL, Woods WJ, Lindan CP, et al . HIV infection and risk behaviors among heterosexuals in alcohol treatment programs . Journal of the American Medical Association. 1994;271:515-518.

4. Seage GR, Mayer KH, Horsburgh CR, et al. The relation between nitrite inhalants, unprotective receptive anal intercourse, and the risk of human immunodeficiency virus infection . American Journal of Epidemiology. 1992;135:1-11.

5. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics – crack cocaine use and HIV infection among inner-city young adults . New England Journal of Medicine. 1994;331:1422-1427.

6. Wallace JI, Bloch D, Whitmore R, et al. Fellatio is a significant risk activity for acquiring AIDS in New York City street walking sex workers. Presented at the Eleventh International Conference on AIDS, Vancouver BC; 1996. Abs #Tu.C.2673.

7. Paul JP, Stall R, Davis F. Sexual risk for HIV transmission among gay/bisexual men in substance-abuse treatment . AIDS Education and Prevention. 1993;5:11-24.

8. Fullilove MT, Fullilove RE, Smith M, et al. Violence, trauma and post-traumatic stress disorder among women drug users . Journal of Traumatic Stress. 1993;6:533-543.

9. Renton A, Whitaker L, Ison C, et al. Estimating the sexual mixing patterns in the general population from those in people acquiring gonorrhoea infection: theoretical foundation and empirical findings. Journal of Epidemiology and Community Health. 1995;49:205-213.

10. Stall RD, Paul JP, Barrett DC, et al. Substance abuse treatment lowers sexual risk among gay male substance abusers. Presented at Eleventh International Conference on AIDS, Vancouver, BC; 1996. Abs #We.C.3490.

Contact: Ron Stall, 415/597-9155.

11. Susser E, Valencia E, Torres J. Sex, games and videotapes: an HIV-prevention intervention for men who are homeless and mentally ill. Psychosocial Rehabilitation Journal. 1994;17:31-40.

Contact: Ezra Susser, 212/960-5763.

12. Martin SS, Butzin CA, Inciardi JA. Assessment of a multistage therapeutic community for drug-involved offenders . Journal of Psychoactive Drugs. 1995;27:109-116.

Contact: Steve Martin, 302/831-2091-fax.

13. el-Guebaly N. Alcohol and polysubstance abuse among women . Canadian Journal of Psychiatry. 1995;40:73-79.

14. Stall R, Leigh B. Understanding the relationship between drug or alcohol use and high risk sexual activity for HIV transmission: where do we go from here ? Addiction. 1994;89:131-134.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©1996, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/substanceFS.pdf</url>
	</node>
	<node>
		<title>Drogas de club o discoteca</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el impacto de las drogas de club en la prevención del VIH?</h3>
<h4>¿cuáles son éstas drogas?</h4>
Entre las llamadas drogas de club o fiesta se incluyen la MDMA (éxtasis), la metanfetamina (cristal, speed), el GHB (X líquido o ácido gammahidroxibutirato), la ketamina (K especial), y a veces también los nitratos de amilo (poppers) y la Viagra<sup>1</sup>. Con frecuencia estas drogas se consumen (aunque no exclusivamente) en clubes nocturnos/discotecas, en las fiestas rave y en las de circuito.

Los raves son fiestas grandes con música house o tecno acompañada de efectos visuales; la mayoría de los asistentes son jóvenes. Las fiestas de circuito son una serie de fiestas grandes que duran varios días y noches y se organizan anualmente en diferentes ciudades<sup>2</sup>. Sus asistentes son predominantemente hombres gay blancos de la clase media, tanto jóvenes como mayores.

Entre los efectos físicos y psicológicos de las drogas de club se encuentran: estado de ánimo elevado; mayor empatía, alteración en las percepciones visuales, sensuales y emocionales; agudeza mental; disminución del apetito; relajamiento; mayor energía física y autoestima elevada. Muchas personas consumen drogas recreativamente con pocas o ninguna consecuencia inmediata. El mal uso de las drogas de club puede producir toxicidad (por las drogas mismas o por sus interacciones con otras drogas o fármacos), problemas legales y a veces problemas de adicción. Muchas personas que usan una o más de estas drogas en las relaciones sexuales mencionan haber participado en conductas que aumentan considerablemente su riesgo de VIH.

Las drogas de club plantean otros riesgos para la salud, pero aquí sólo comentaremos sus posibles efectos sobre las prácticas que facilitan el contagio del VIH.
<h4>¿quiénes las usan?</h4>
Gran parte de las investigaciones sobre las drogas de club se ha realizado entre hombres homosexuales, principalmente por la alta prevalencia del VIH y riesgo de infección que existen en esta población. El consumo de drogas de club varía según la población y el área geográfica<sup>3</sup>.

Un estudio de fiestas rave en Chicago encontró que el 48.9% de los asistentes había consumido alguna droga de club, el 29.8% LSD, el 27.7% éxtasis y el 8.5% metanfetamina. Ellos consumieron drogas de club junto con otras drogas tales como marihuana (el 87%), alcohol (el 65.2%) y cocaína/crack (el 26.1%).<sup>4</sup>

Una encuesta de hombres homosexuales que asistían a fiestas de circuito en San Francisco demostró que el 80% consumió éxtasis, el 66% ketamina, el 43% metanfetaminas, el 29% GHB, el 14% Viagra y el 12% poppers. La mitad (el 53%) consumió cuatro drogas o más.<sup>5</sup>
<h4>¿cuál es el riesgo?</h4>
Estas drogas tienen muchas consecuencias físicas y psicológicas que aumentan el riesgo de contraer el VIH: pueden disminuir las inhibiciones, afectar el juicio, incrementar la resistencia sexual y promover conductas riesgosas durante el sexo. El consumo de drogas inyectables también puede aumentar el riesgo de VIH si los equipos de inyección se comparten.

El riesgo de VIH ocurre principalmente cuando el consumo de drogas coincide con el contacto sexual. Por ejemplo, la metanfetamina (speed) se usa a menudo para iniciar, intensificar y prolongar los encuentros sexuales, de modo que es posible tener relaciones sexuales con varias parejas. Las drogas inhaladas poppers se usan para relajar el esfínter anal durante el sexo anal receptivo. Por ser deshidratante, la metanfetamina también puede promover desgarros en los
tejidos del ano, vagina o boca, aumentando así el riesgo de contraer el VIH/ITS.<sup>6,7</sup>

En un estudio, consumidores heterosexuales VIH- reportaron un promedio de 9.4 parejas sexuales durante dos meses. El promedio de actos sexuales desprotegidos durante este lapso era de 21.5 para el sexo vaginal, de 6.3 para el sexo anal y de 41.7 para el sexo oral. El 86% de los participantes mencionaron haber tenido sexo maratónico mientras estaban bajo los efectos de la metanfetamina. El 37% dijo que se había inyectado la droga; casi la mitad compartió jeringas o las pidió prestadas.<sup>7</sup>

El sexo desprotegido con una pareja sexual cuya condición de VIH se desconoce es una actividad de alto riesgo. Una encuesta de hombres homosexuales encontró que el 21% de los hombres VIH+ y el 9% de los VIH- reportaron sexo anal desprotegido en la fiesta de circuito más reciente sin conocer la condición de VIH de su pareja.<sup>5</sup>

Un estudio de hombres homosexuales en fiestas rave en la Ciudad de Nueva York reveló que el 34% consumía éxtasis por lo menos una vez al mes. Los consumidores de éxtasis mencionaron más incidentes de sexo anal desprotegido que los consumidores de otras drogas y de alcohol.<sup>8</sup>
<h4>¿por qué se consumen?</h4>
Para muchas personas, tanto homosexuales como heterosexuales, el consumo de drogas y el sexo son una parte integral y un atractivo principal de las fiestas rave y de circuito. Estas actividades sociales son importantes para algunos grupos de jóvenes y hombres homosexuales, quienes pueden sentirse presionados por sus compañeros a consumir drogas y a tener sexo en este ambiente. Las fiestas rave y de circuito en sí tal vez no producen el consumo de drogas, pero pueden atraer a personas más propensas a consumirlas.<sup>9</sup>

Las drogas de club se consumen por varias razones: para divertirse, bailar, disminuir las inhibiciones, escaparse de los problemas y combatir la depresión o la ansiedad, entre otras. Algunos factores que pueden llevar al consumo de drogas son la depresión, el consumo de drogas de los padres y el abuso sexual infantil.<sup>10</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Un programa de tratamiento de drogas para consumidores gay de metanfetamina en Los Ángeles, CA, buscó reducir el consumo de drogas y las prácticas sexuales arriesgadas relacionadas con el VIH. Ofreció terapia conductual cognitiva (una sesión grupal de 90 minutos tres veces por semana), ayuda para el manejo de contingencias (intervención conductual que ofrece bonos cuyo valor incrementa al abstenerse de las drogas) y terapia conductual cognitiva diseñada especialmente para la cultura gay. Todos los hombres redujeron su consumo de drogas, y quienes participaron en el manejo de contingencias mantuvieron la reducción por más tiempo. La mayor reducción de prácticas sexuales riesgosas ocurrió entre los participantes de la terapia dirigida a la cultura gay.<sup>11</sup>

“DanceSafe” capacita a voluntarios que sirven como promotores de salud y de prevención del consumo de drogas en las fiestas rave y clubes nocturnos en todo EE.UU. y Canadá. Estos programas emplean un método de reducción de daños y dirigen sus servicios principalmente a consumidores recreacionales de drogas que no son adictos. DanceSafe ofrece información sobre las drogas, el sexo protegido y cómo mantenerse sano; en algunos clubes y fiestas ofrecen examinar las pastillas para comprobar que no contengan sustitutos peligrosos.<sup>12</sup>

Por medio de reuniones regulares, los programas de 12 pasos como “Crystal Meth Anonymous,” “Narcotics Anonymous” y “Alcoholics Anonymous” promueven la abstención entre personas con problemas causados por el consumo de alcohol, metanfetamina y otras drogas.<sup>13</sup>

El proyecto “PROTECT” del South Florida Regional Prevention Center pretende reducir el consumo de drogas de club entre homosexuales jóvenes. PROTECT capacita a policías, maestros y otros actores comunitarios sobre las drogas de club, particularmente el éxtasis. Su sitio web incluye una sala de conversación monitoreada por consejeros jóvenes.<sup>14</sup>

“Stepping Stone,” en San Diego, CA, es un programa residencial de tratamiento de drogas para homosexuales y lesbianas; la mayoría son policonsumidores (que combinan drogas) con algún trastorno psiquiátrico. Las conductas sexuales y las necesidades de salud mental se abordan en el contexto del tratamiento para dejar las drogas. Stepping Stone auspicia una campaña de mercadotecnia social sobre la reducción de daños para concientizar al público sobre los peligros de las drogas de club y el alcohol.<sup>15</sup>
<h4>¿qué queda hacer?</h4>
Varias organizaciones están respondiendo a los efectos perjudiciales de las drogas de club en fiestas en EE.UU. Se necesita más sensibilización sobre la toxicidad de estas drogas, el policonsumo y la relación entre el consumo de drogas y la falta de protección en el sexo. En estas fiestas también se deben ofrecer recomendaciones a servicios de salud mental.

La comunidad homosexual necesita responder a las presiones reales que existen en algunos subgrupos sobre consumir drogas y ser muy activos sexualmente y debe preguntarse “si el consumo de drogas vale el riesgo que estos hombres corren.” No es suficiente intentar reducir el uso y abuso de drogas en las fiestas de circuito sin abordar simultáneamente las poderosas motivaciones sexuales de su consumo.<sup>6</sup>

Al recetarles Viagra, los médicos deben informar a los hombres sobre los efectos dañinos de combinar el Viagra con metanfetaminas, poppers y éxtasis. También deben preguntar a sus pacientes VIH+ si ellos usan drogas de club, y explicarles sobre los peligros de combinarlas con los medicamentos contra el VIH.<sup>16</sup> Los médicos necesitan saber que el consumo de drogas de club puede afectar la adherencia (apego) al tratamiento del VIH.

<hr />

<h3>¿Quién Lo Dice?</h3>
1. Freese TE, Miotto K et al. The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment. 2002;23:151-156.
2. Swanson J, Cooper A. Dangerous liaison: club drug use and HIV/AIDS. IAPAC Monthly. 2002;8:1-15.
3. Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. Journal of Homosexuality. 2001;41:17-35.
4. Stall R, Paul JP, Greenwood G et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men’s Health Study. Addiction. 2001;96:1589-1601.
5. Colfax GN, Mansergh G, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. Journal of Acquired Immune Deficiency Syndromes. 2001;28:373-379.
6. Fendrich M, Wislar JS, Johnson TP et al. A contextual profile of club drug use among adults in Chicago. Addiction. 2003;98:1693-1703.
7. Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addictive Behavior. 2004;29:807-810.
8. Klitzman RL, Pope HG, Hudson JI. MDMA (“ecstacy”) abuse and high-risk sexual behaviors among 169 gay and bisexual men. American Journal of Psychiatry. 2000;157:1162-1164.
9. Task Force on Crystal, Syphilis and HIV. Confronting crystal methamphetamine use in New York City. Public policy recommendations. Gay Men’s Health Crisis, New York, NY. July 2004.
http://www.gmhc.org/policy/nyc/crystaltaskforce04.html
10. Adlaf EM, Smart RG. Party subculture or dens of doom? An epidemiological study of rave attendance and drug use patterns among adolescent students. Journal of Psychoactive Drugs. 1997;29:193-198.
11. Shoptaw S, Reback CJ. Drug and sex risk behavior reductions with behavioral treatments for methamphetamine dependence among gay/bisexual men. Presented at the National HIV Prevention Conference, Atlanta, GA. 2003. Abstract #T3-D1004.
12. www.dancesafe.org
13. www.crystalmeth.org, www.na.org, www.aa.org
14. Rothaus S. Workshop targets young gays with a penchant for club drugs. Miami Herald. July 16, 2003.
15. Johnson SB. Stepping Stone: a catalyst for change. Presented at Methamphetamine Use and Gay Men Meeting. Sacramento, CA. April 24, 2003.
16. Romanelli F, Smith KS, Pomeroy C. Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men. Topics in HIV Medicine. 2003;11:25-32.

<strong>Otros recursos en español:</strong>
Drogas de club, NIDA
AZ libre de drogas

<strong>Otros recursos en inglés:</strong>
www.lifeormeth.com
www.crystalrecovery.com
www.drugabuse.com
www.freevibe.com
www.crystalneon.org

<hr />

<strong>Preparado por Mike Pendo*, Pamela DeCarlo**
*SF Dept of Public Health, **CAPS</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Enero 2005. Hoja Informativa 55S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/drogasclubFS.pdf</url>
	</node>
	<node>
		<title>Cocaína crack</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/CocainaCrackFS.pdf</url>
	</node>
	<node>
		<title>Usuarios de drogas inyectables (UDI)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los usuarios de drogas inyectables (UDI) para evitar el VIH?</h3>
<h4>¿corren riesgo los UDI?</h4>
Sí. El uso de drogas inyectables representa casi la tercera parte (el 36%) de los casos acumulados de SIDA en EE.UU. Estos casos incluyen usuarios/as de drogas inyectables (UDI), sus parejas sexuales y los hijos nacidos de estas parejas.<sup>1</sup>

Los afroamericanos y los latinos están desproporcionadamente afectados por el SIDA asociado al UDI. En el año 2000, de los casos de SIDA asociados al UDI, el 26% eran afroamericanos, el 31% latinos y el 19% caucásicos.<sup>1</sup> Las mujeres también han sido afectadas en forma desproporcionada. En general, el 62% de los casos de SIDA entre mujeres se han atribuido a los UDI y al sexo con parejas UDI, en comparación con el 34% de los casos masculinos.<sup>2</sup>

Las personas UDI corren un riesgo aun mayor de contraer otras enfermedades graves vinculadas al uso de drogas, entre ellas la hepatitis C y la sobredosis; y constituyen el 60% de las infecciones de hepatitis C en EE.UU.<sup>3</sup> Las tasas de infección por hepatitis C entre jóvenes UDI son de 4 a 100 veces mayores que las tasas de infección por VIH.<sup>4</sup> La sobredosis de drogas es una de las principales causas de muerte entre los usuarios de heroína, incluso en áreas con altas tasas de UDI con VIH.<sup>5</sup>
<h4>¿qué pone a los UDI en riesgo?</h4>
El uso compartido de equipos para inyectarse (jeringas, cucharas u otros recipientes para cocinar drogas, agua, algodón, etc.) o para dividir las drogas es un factor de alto riesgo para los UDI.:6 Los UDI comparten sus equipos principalmente por la falta de disponibilidad de agujas y jeringas o por falta de dinero para comprarlas.

La actividad sexual sin protección con una pareja VIH+ es otro factor de alto riesgo para los UDI, especialmente para los hombres que tienen sexo con hombres, para las mujeres UDI que intercambian el sexo por dinero y para las mujeres con una pareja UDI.<sup>7</sup> El riesgo varía según el tipo de droga; por ejemplo, el speed (“arranque” o metanfetaminas) aumenta el deseo sexual y se ha comprobado que lleva a la falta de protección durante el acto sexual.<sup>8</sup>

Muchos UDI tienen que lidiar con una multitud de riesgos médicos debido a factores sociales, económicos y psicológicos. En la vida diaria, la prevención del VIH podría quedar en segundo plano, pues ellos se enfrentan con otros problemas más apremiantes como la adicción, pobreza, encarcelamiento, falta de hogar, estigma, depresión, enfermedad mental y antecedentes de trauma.<sup>9</sup>
<h4>¿y el tratamiento para dejar las drogas?</h4>
Dejar las drogas con la ayuda de un programa de tratamiento para personas adictas puede ser una intervención eficaz en la prevención del VIH. Sin embargo, en la actualidad sólo un 15% de los UDI reciben algún tratamiento y no existe tratamiento médico contra la adicción a la metanfetamina.

No es suficiente ampliar el número y la calidad de los programas para dejar las drogas. La drogo-dependencia es una enfermedad crónica que implica recaídas. Algunos usuarios de drogas se niegan a buscar tratamiento y muchos de aquellos que lo buscan se encuentran con servicios escasos o incosteables. Además, la mayoría de las personas que reciben tratamiento para dejar las drogas reinciden varias veces antes de dejarlas definitivamente. Por esta razón, es importante emplear un método de reducción de daños en los servicios de prevención del VIH destinados a los UDI.<sup>10</sup>

El método de reducción de daños reconoce que algunos UDI son reacios o incapaces de renunciar a las drogas; la reducción de daños los ayuda, sin juzgarlos, a reducir las consecuencias negativas de su consumo de drogas ya sea promoviendo prácticas de consumo más seguras, controlando dicho consumo o dejando de consumirlas. En EE.UU., los métodos de reducción de daños incluyen trabajadores de salud que salen a la calle para entrar en contacto con usuarios activos de drogas, así como el intercambio de jeringas y el acceso en farmacias a jeringas esterilizadas.<sup>11</sup> Algunas iniciativas internacionales de reducción de daños incluyen salones para la inyección de drogas en forma segura y la provisión de drogas ilícitas por medio de profesionales médicos.<sup>12</sup>
<h4>¿qué podría ayudar?</h4>
Los UDI en recuperación pueden motivar y generar cambios de conducta en otros UDI. No obstante, los UDI en recuperación que trabajan como educadores de pares necesitan apoyo para no recaer ellos mismos en el uso de drogas. Los UDI están más propensos a usar condones si los miembros de su red social hablan entre ellos sobre la salud en general y sobre el uso de condones, así como cuando disponen de más recursos económicos.<sup>13</sup>

El acceso a una alta calidad de servicios médicos y tratamiento contra las enfermedades de transmisión sexual (ETS) y el VIH puede ayudar a promover prácticas más seguras. Un estudio realizado en Baltimore, MD, encontró que los cuidadores informales eran más propensos a promover los mensajes de prevención en la comunidad cuando sus amigos y familiares tenían acceso al tratamiento del VIH, lo cual les brindó esperanza por el futuro.<sup>14</sup>
<h4>¿qué se está haciendo actualmente?</h4>
El tratamiento de mantenimiento con metadona contra la dependencia de la heroína puede ayudar a reducir las prácticas riesgosas de inyección y la seroconversión del VIH. En Connecticut, el Department of Mental Health and Addiction Services colabora con el programa comunitario Drug Treatment Advocates (DTA) para ayudar a los usuarios de drogas a inscribirse en programas de salud mental y de tratamiento de la drogadicción. Todos los días, el departamento envía al DTA por fax una lista actualizada de los espacios disponibles para que los trabajadores de salud remitan a sus clientes garantizándoles el cupo.<sup>16</sup>

El intercambio de jeringas ayuda a disminuir el riesgo de usar jeringas compartidas al reemplazar las jeringas usadas por otras esterilizadas. Se calcula que el uso de un programa de intercambio de jeringas multiplica entre 2 y 6 veces el efecto protector contra las prácticas de riesgo.<sup>17</sup> Sin embargo, sólo se intercambian unas 20 millones de jeringas anualmente en EE.UU., el equivalente a 15 jeringas por UDI al año, muchísimas menos de las necesarias para lograr una prevención eficaz del VIH.

Los programas comunitarios de prevención pueden lograr buenos resultados al tomar en cuenta no solamente las necesidades individuales de los UDI, sino también la salud y el bienestar de toda la comunidad. En Harlem, NY, un consejo comunitario integrado por investigadores, proveedores de servicios médicos y habitantes de la comunidad, identificó tres problemas de salud pública que debían resolverse: el uso de alcohol y drogas, las enfermedades infecciosas y el asma. Con el fin de reducir los obstáculos a la obtención de servicios médicos y sociales, ellos crearon una “guía de sobrevivencia” para los usuarios de drogas. También iniciaron un programa de capacitación de pares que permitió a los UDI llevar a cabo intervenciones de prevención del VIH y de la hepatitis C en las organizaciones comunitarias locales.<sup>18</sup>

El Estudio UFO realizado en San Francisco, CA, ofreció varios servicios a los jóvenes UDI, desde pruebas y consejos sobre el VIH y la hepatitis B y C, hasta información sobre cómo evitar las sobredosis. Este estudio disponía de un lugar adonde los jóvenes UDI podían llegar sin cita previa, usar el teléfono, obtener comida y ropa y consultar con consejeros y profesionales clínicos. Los clientes también podían recibir vacunas contra la hepatitis A y B así como un directorio de servicios para jóvenes en varias ciudades grandes de EE.UU.<sup>19</sup>
<h4>¿qué queda por hacer?</h4>
El mayor obstáculo a la reducción de la transmisión del VIH entre los UDI es la falta de implementación de programas eficaces de prevención. La expansión del acceso al tratamiento de alta calidad contra la drogadicción y a equipos de inyección esterilizados tendrían un efecto considerable sobre esta epidemia entre los UDI. Sin embargo, las actitudes políticas y la criminalización del uso de drogas han afectado los esfuerzos de prevención en EE.UU.<sup>20</sup> Los gobiernos federal y estatales deben actuar pronto para legalizar los programas de intercambio de jeringas y designar más fondos al tratamiento de la drogadicción.

Muchas veces se supone incorrectamente que los UDI no se sienten cómodos de hablar sobre asuntos sexuales. No es suficiente repartir condones; los proveedores de servicios deberán iniciar conversaciones sobre el sexo. Esto tiene especial importancia en las intervenciones destinadas a usuarios de drogas, tales como los programas de intercambio de jeringas, los de tratamiento de la drogadicción y los de los 12 pasos.

Los programas deben ser multifacéticos y tomar en cuenta otras necesidades de los UDI aparte de las asociadas al VIH. Es fundamental que colaboren los servicios de prevención del VIH, del tratamiento de drogadicción, de prevención de la hepatitis C y de salud mental. De esta manera, los trabajadores sociales podrán remitir a sus clientes a estos servicios, y a otros de vivienda o atención médica, con la confianza de que ellos de hecho los recibirán. Los programas para UDI también deben incorporar una filosofía de reducción de daños y reconocer que las recaídas
ocurren frecuentemente entre los UDI.

<hr />

<h4>¿quién lo dice?</h4>
1. Drug-associated HIV transmission in the United States. Fact Sheet published by the Center for Disease Control and Prevention. 2002.http://www.cdc.gov/hiv/pubs/facts/idu.htm
2. CDC. HIV/AIDS Surveillance Report-cases reported through December 2001. 2002;13:tbl 22,23. http://www.cdc.gov/hiv/stats/hasr1302.htm
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV- related chronic disease. Morbidity and Mortality Weekly Report. 1998;47(RR19):1-39.
4. Garfein RS, Doherty MC, Monterroso ER, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of AIDS and Human Retrovirology. 1998;18:S11-19.
5. Darke S, Hall W. Heroin overdose: research and evidence-based intervention. Journal of Urban Health. 2003;80:189-200.
6. Access to sterile syringes. Published by the National Center for HIV, STD and TB Prevention. January 2002. www.cdc.gov/idu/facts/
7. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
8. Bull SS, Piper P, Rietmeijer C. Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors. Journal of Homosexuality. 2002;42:31-51.
9. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness and incarceration. Public Health Reports. 2002;117: S135-S145.
10. Day D. Health emergency 2003: the spread of drug-related AIDS and hepatitis C among African Americans and Latinos. Published by Dogwood Center. 2003. www.dogwoodcenter.org/2003/HE2003.pdf
11. Hilton BA, Thompson R, Moore-Dempsey L, et al. Harm reduction theories and strategies for control of HIV: a review of the literature. Journal of Advanced Nursing. 2001;33:357-370.
12. Is there a more effective social policy with respect to the problems of substance misuse in British Columbia? Presentation to the Vancouver Area Network of Drug Users. 2000. www.vandu.org
13. Latkin CA, Forman V, Knowlton A, et al. Norms, social networks, and HIV-related behaviors among urban disadvantaged drug users. Social Science &amp; Medicine. 2003;56:465-476.
14. .Knowlton AR. Social network approaches to HIV prevention and care: theoretical and methodological considerations of intervention. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. ThOrE1501.
15. Gibson DR, Flynn NM, McCarthy JJ. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 1999,13:1807-1818.
16. Alcohol and drug use and HIV. NASTAD HIV Prevention Fact Sheet.http://www.nastad.org/documents/public/pub_prevention/200145AlcoholandDrugUseandHV.pdf
17. Gibson DR, Brand R, Anderson K, et al. Two- to six-fold decreased odds of risk behavior associated with use of syringe exchange. Journal of Acquired Immune Deficiencies Syndrome. 2002;31:237-242.
18. Bluthenthal RN, Kral AH, Gee L, et al. The effect of syringe exchange on high-risk injection drug users: a cohort study. AIDS. 2000;14:605-611.
19. Galea S, Factor SH, Bonner S, et al. Collaboration among community members, local health service providers, and researchers in an urban research center in Harlem, New York. Public Health Reports. 2001;116:530-539.
20. The UFO Study. /sites/prevention.ucsf.edu/files/uploads/ufostudy/
21. Bamberger JD, Unick J, Klein P, et al. Helping the urban poor stay with antiretroviral HIV drug therapy. American Journal of Public Health. 2000;90:699-701.
22. Des Jarlais DC, Friedman SR. Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports. 1998;113:182-188.

<hr />

<strong>Preparado por Pamela DeCarlo y David R. Gibson, CAPS; Traducción Rocky Schnaath
</strong><strong>CAPS
</strong>

<strong>Septiembre 2003. Fact Sheet #51S</strong>

Special thanks to the following reviewers of this Fact Sheet: Cyril Colonius, Carol Dawson-Rose, Dawn Day, Pam Klein, Alex Kral, Pam Ling, Kim Shafer, Claire Sterk, Karin Tobin.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/UDIFS.pdf</url>
	</node>
	<node>
		<title>Metanfetamina</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el efecto del consumo de metanfetamina en la prevención del VIH?</h3>
<h4>¿qué es la metanfetamina?</h4>
La metanfetamina (metanfeta meth en ingléstambién conocida como cristal, speed, Tina, hielo, tiza, vidrio) es un potente estimulante ilícito parecido a la anfetamina. Puede ser ingerida, inhalada, fumada, inyectada o introducida en el recto, y sus efectos pueden durar varias horas o más según la cantidad consumida.<sup>1</sup> La metanfeta es barata, ampliamente disponible y tiene un alto potencial de abuso y adicción.

Los consumidores de metanfeta describen efectos positivos de euforia, supresión del apetito, mayor autoestima y deseo sexual y también relaciones sexuales más intensas. Sin embargo, la metanfeta también produce muchos efectos negativos a corto y a largo plazo, entre ellos: daño a las neuronas cerebrales, presión arterial alta, problemas de higiene oral, depresión, ansiedad, paranoia y síntomas psicóticos como los delirios paranoicos y las alucinaciones.

La metanfeta se usa extensamente alrededor del mundo, con más de un millón de consumidores en los Estados Unidos.<sup>2</sup> Aunque el consumo de metanfeta en algún momento de la vida de los consumidores ha aumentado en forma dramática desde la primera parte de la década de 1990, el número de consumidores se ha mantenido constante y su consumo es mucho menos frecuente que el de la cocaína.<sup>3</sup> Durante los últimos años, el consumo de metanfeta se ha incrementado en
ciertos lugares y grupos, especialmente en la costa este de EE.UU.
<h4>¿cuál es el efecto sobre el VIH?</h4>
El consumo de metanfeta puede aumentar el riesgo de contraer el VIH por falta de protección durante la inyección de drogas y el contacto sexual. Se puede transmitir el VIH al inyectarse metanfeta compartiendo jeringas y otros equipos de inyección.

Muchos consumidores consideran la metanfeta como una droga sexual y la usan precisamente para intensificar y prolongar el acto sexual y para desinhibirse. La metanfeta tiende a resecar la piel del pene, del ano y de la vagina, lo cual puede producir desgarros y cortaduras que facilitan la transmisión del VIH, especialmente si existen otros aspectos vinculados con su consumo (prolongación de los juegos sexuales, sexo con varias parejas y contacto sexual más agresivo).

La metanfeta puede aumentar el deseo sexual y también disminuir la capacidad de lograr y mantener una erección. Consecuentemente, es posible que algunos hombres que consumen metanfeta elijan el sexo anal receptivo o que combinen la metanfeta con medicamentos para los trastornos eréctiles, por ejemplo el Viagra. Los consumos de metanfeta y de Viagra están vinculados por separado con el sexo anal desprotegido.<sup>4</sup>
<h4>¿cuál es el efecto sobre el riesgo del VIH?</h4>
El consumo y el abuso de metanfeta es una preocupación muy real entre los homosexuales y otros hombres que tienen sexo con hombres (HSH). Hay pocos estudios sobre el consumo de metanfeta en otras poblaciones, por ejemplo la heterosexual. Los hombres homo y bisexuales reportan el consumo de metanfeta y otros estimulantes con 10 veces más frecuencia que la población general.<sup>5</sup> Este dato es especialmente preocupante dado que el VIH se da más en esta población que en la heterosexual. Se ha comprobado que el consumo de metanfeta por motivos sexuales es más frecuente entre los hombres VIH+.<sup>6,7</sup> Las razones para consumir metanfeta pueden variar para los HSH y pueden incluir las fuertes expectativas culturales en algunos sectores de la comunidad gay con respecto a la proeza sexual.<sup>8</sup>

Varios estudios de HSH (principalmente entre hombres que se auto identifican como homosexuales) han encontrado que los consumidores de metanfeta tienen una probabilidad de dos a tres veces mayor que los no consumidores de no protegerse durante el sexo anal, de tener una rotura o deslizamiento del condón, de adquirir una enfermedad de transmisión sexual o de resultar infectados por el VIH.<sup>9</sup> De hecho, estos riesgos elevados se dan tanto entre los consumidores frecuentes como entre los eventuales.<sup>10</sup>

Aunque existen amplias evidencias del vínculo entre el riesgo de VIH y el consumo de metanfeta entre los HSH, algunos estudios también demuestran altos niveles de conductas riesgosas con respecto al VIH entre los heterosexuales. En un estudio, el 86% de los consumidores reportaron haber participado en un “maratón sexual” mientras estaban bajo los efectos de la metanfeta. Más de un tercio informó haberse inyectado metanfeta y de este grupo el 47% había compartido jeringas o las había usado después de otra persona.<sup>11</sup>
<h4>¿cómo afecta a las personas VIH+?</h4>
El consumo y la adicción a la metanfeta pueden perjudicar a las personas VIH+. Los inhibidores de proteasa del VIH (el ritonavir en particular) podrían aumentar la posibilidad de reacciones adversas o de sobredosis. Drogarse con metanfeta podría hacer que las personas VIH+ se olviden de tomar sus medicamentos o que no les importe tomarlos. Su consumo también podría afectar la salud general de las personas VIH+ al aumentar la deshidratación, el insomnio y el delgazamiento.<sup>12</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Los esfuerzos de prevención del VIH y del consumo de metanfeta deben enfocarse en: 1) evitar el consumo inicial de metanfeta por no consumidores promoviendo cambios en las normas comunitarias al respecto, 2) desalentar a los consumidores eventuales para que no se envicien, 3) minimizar los riesgos de salud para los consumidores actuales y 4) aumentar el cupo de los programas de desintoxicación así como el número de adictos ingresados en éstos.

Se han llevado a cabo varias campañas de mercadotecnia social sobre la prevención del consumo de metanfeta. Las campañas “Crystal Mess” y “Got Meth?” expusieron los peligros del consumo de metanfeta para los hombres y jóvenes homosexuales. “Silence= Meth” hace un llamado a la comunidad gay para que actúe ante el consumo de metanfeta.<sup>13</sup>

Un método de reducción de daños como el programa del Stonewall Project en San Francisco, CA podría ser el más adecuado para los que eligen no cesar su consumo de metanfeta.<sup>14</sup> Los que se inyectan metanfeta deberían ser remitidos a programas de intercambio de jeringas y recibir orientación y asesoramiento sobre prácticas sexuales y de inyección más seguras.

Life in the FASTLANE es un programa de reducción de daños que busca reducir el riesgo sexual entre consumidores activos de metanfeta heterosexuales. Mediante cuatro sesiones semanales de consejería individual de 90 minutos de duración, FASTLANE aumentó las intenciones de practicar el sexo en forma más segura y con protección.<sup>15</sup>

Existen varios programas para ayudar a los consumidores de metanfeta que desean dejarla, entre ellos los programas de 12 pasos como Crystal Meth Anonymous, Narcotics Anonymous y LifeRing. El Positive Reinforcement Opportunity Project (PROP) emplea el acondicionamiento positivo para ayudar a los hombres gay a abstenerse de la metanfeta. Se hacen análisis de orina 3 veces por semana a lo largo de 12 semanas y por cada resultado negativo reciben respaldo positivo y bonos para comprar comida, servicios médicos, artículos personales y otros.<sup>16</sup>

Quizás el modelo de tratamiento más estudiado sea el Matrix Model, una intervención conductual con 48 sesiones grupales e individuales durante el transcurso de 16 semanas.<sup>17</sup> Otro estudio sobre los HSH comparó una variación de este modelo con otro de manejo de contingencias (el cual provee bonos cuyo valor aumenta por cada resultado negativo de metanfetaminas en orina), una combinación de ambos métodos, y una versión del Matrix específicamente para hombres homosexuales.<sup>18</sup> Todos los grupos demostraron reducciones importantes del consumo de metanfeta y de la conducta sexual de riesgo un año más tarde.

Aunque en la actualidad no existe ningún medicamento aprobado para tratar la dependencia de metanfeta, eso podría resultar eficaz. Se están realizando varios estudios, como el de “BUMP,” para probar la factibilidad del antidepresivo bupropion en los HSH adictos a la metanfeta.<sup>19</sup>
<h4>¿qué queda por hacer?</h4>
La comunidad gay necesita responder ante la presión muy real en algunas sub-comunidades para festejar con alcohol y drogas y para llevar una vida sexual muy activa<sup>20</sup>, y debe preguntarse: “¿Vale la pena consumir drogas dados los riesgos que conllevan?” No es suficiente intentar reducir el consumo de drogas y alcohol sin también considerar los poderosos motivos sexuales por los cuales los HSH consumen drogas y explorar formas para desarrollar una vida sexual sana y plena sin drogas.

Los consejeros y proveedores médicos deberían capacitarse sobre los síntomas y efectos del consumo de metanfeta y sobre cómo comentarlos sin hacer juicios, y pueden remitir a los consumidores de metanfeta a programas locales de reducción de daños, tratamiento y prevención.

<hr />

<h3>¿Quién lo dice?</h3>
1. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA. Treatment of methamphetamine abuse: research findings and clinical directions. Journal of Substance Abuse Treatment. 2003;24:267-277.

2. SAMHSA. Methamphetamine use, abuse and dependence: 2002, 2003 and 2004. The NSDUH Report. September 2005.

3. King RS. The next big thing? Methamphetamine use in the US. Report prepared by The Sentencing Project. June 2006.www.sentencingproject.org/pdfs/methamphetamine_report.pdf

4. Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sexually Transmitted Infections. 2006;82:131-134.

5. Stall R, Paul JP, Greenwood G, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men. Addiction. 2001;96:1589-1601.

6. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. Journal of Substance Abuse and Treatment. 2002;22:149-156.

7. Halkitis PN, Shrem MT, Martin FW. Sexual behavior patterns of methamphetamine-using gay and bisexual men. Substance Use &amp; Misuse. 2005;40:703–719.

8. Diaz RM, Heckert AL, Sanchez J. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. Journal of Urban Health. 2005;82:i71-78.

9. CDC. Methamphetamine use and HIV risk behaviors among heterosexual menpreliminary results from five northern California counties. Morbidity and Mortality Weekly Report. 2006;55:273-277.

10. Colfax G, Vittinghoff E, Husnik MJ, et al. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. American Journal of Epidemiology. 2004;159:1002-1012.

11. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20:731-739.

12. Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addictive Behavior. 2004;29:807-810.

13. New York State Department of Health AIDS Institute. Methamphetamine and HIV: basic facts for service providers. March 2006.www.nyhealth.gov/diseases/aids/harm_reduction/crystalmeth/

14. www.crystalmess.net; www.justthinktwice.com/gotmeth/;http://www.gaycenter.org/news/press/News.2006-06-07.9724110679/news_view

15. www.tweaker.org

16. Patterson TL, Mausbach B, Semple SJ, et al. Life in the fastlane: testing the efficacy of a behavioral intervention to reduce high risk sexual behaviors among HIV-negative, heterosexual methamphetamine users. Presented at the International AIDS Conference, Toronto, Canada, August 2006. #MOAC0205

17. www.na.org; www.unhooked.com; www.crystalmeth.org; www.propsf.com

18. Rawson RA, Marinelli-Casey P, Anglin MD, et al. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99:708-717.

19. Shoptaw S, Reback CJ, Peck JA, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug and Alcohol Dependence. 2005;78:125-134.

20. www.sfbump.com

21. Green IA, Halkitis PN. Crystal methamphetamine and sexual sociality in an urban gay subculture: An elective affinity. Culture, Health and Sexuality. 2006;8:317-333.

*All websites accessed July 2006

<hr />

<strong>Preparado por Robert Guzmán MPH, San Francisco DPH</strong>

<strong>Traducido por Rocky Schnaath</strong>

<strong>Enero 2007. Hoja de Dato #61S</strong>

Se autoriza la reproducción (citando a UCSF) mas no la venta de copias este documento. También disponibles en inglés. Para recibir las Hojas de Datos por correo electrónico escriba a listserv@listserv.ucsf.edu con el mensaje “subscribe CAPSFS nombre apellido” ©Enero 2007, UCSF.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/metanfetaminaFS.pdf</url>
	</node>
	<node>
		<title>Intercambio de jeringas</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Sirve el intercambio de jeringas?</h3>
(revisado 4/99)
<h4>¿por qué es necesario el intercambio de agujas/jeringas?</h4>
Más de un millón de personas en los EEUU se inyectan drogas con frecuencia, con un alto costo a la sociedad de más de 50 billones de dólares al sector salud, pérdidas de productividad, accidentes y crímenes.<sup>1</sup> Quienes se inyectan drogas se exponen a contraer el VIH o la hepatitis arriesgando así su propia salud, la de las personas con las que comparten agujas/jeringas, sus parejas sexuales y sus descendientes.

Se calcula que en los EEUU la mitad de los nuevos casos de infección con VIH se presentan en Usuarios de Drogas Intravenosas (UDIs).<sup>2</sup> En la mujer, el 61% de todos los casos de SIDA se debe al uso de drogas inyectadas o por tener sexo con parejas UDIs. El uso de drogas inyectadas son la fuente de infección de la mitad de todos los casos de bebés con VIH en los recién nacidos.<sup>3</sup>

La forma más común de contraer la infección con hepatitis C se debe al uso de drogas inyectadas. Se calcula que hasta un 90% de UDIs están infectados con hepatitis C, la cual se transmite facilmente y puede dañar al hígado permanentemente.<sup>4</sup> La hepatitis B se transmite a su vez por medio del uso de drogas inyectadas.

Los programas de intercambio de agujas/jeringas (NEPs por sus siglas en Inglés) distribuyen agujas/jeringas limpias y se deshacen de las usadas por UDIs y generalmente ofrecen una variedad de servicios relacionados al caso, incluyendo servicios de referencia a programas de tratamientos por uso de drogas, consejería y pruebas de detección del VIH.
<h4>¿por qué comparten jeringas los UDIs?</h4>
La gran mayoría de los UDIs saben que al compartir el equipo de inyección se arriesgan a contraer el VIH y otras enfermedades. Sin embargo, no hay sufucientes agujas/jeringas disponibles y las que hay son muy costosas para los UDIs.

Si lográramos rehabilitar a los UDIs, se eliminarían los casos de transmisión del VIH por uso de agujas/jeringas. Desafortunadamente, no todos los UDIs son capaces o están listos a tomar ese paso. Aún aquellos que tienen la motivación pueden encontrarse con escasos servicios disponibles. Los programas de tratamiento de drogas tienen largas listas de espera y es muy común la recaída.

La mayoría de los estados en Norteamérica poseen leyes de paraphernalia la cual convierte en crímen la distribución de este equipo conocido como “el mecanismo para introducir drogas ilícitas al cuerpo.”<sup>5</sup> Adicionalmente, diez estados y el Distrito de Columbia poseen leyes o regulaciones que exigen una receta médica para obtener agujas/jeringas. Los UDIs no cargan agujas/jeringas por temor al acoso o arresto policial. El temor a ser arrestado por cargar este equipo ha sido asociado al motivo por el cual comparten jeringas/agujas o cualquier otro equipo de inyección.<sup>6</sup>

En Julio de 1992, el estado de Connecticut aprobó leyes que permiten la compra y posesión de un máximo de diez jeringas sin receta logrando cambios paralelos a las leyes de paraphernalia. Después que estas leyes entraron en vigor la práctica de compartir agujas/jeringas diminuyó sustancialmente en UDIs y se efectuó un cambio de comprar agujas/jeringas en la calle a comprarlas en farmacias.<sup>7</sup> Sin embargo, aunque legalmente sea permitido vender agujas/jeringas sin receta médica, los farmacistas, a menudo, resisten vendérselas a UDIs.
<h4>¿qué se está haciendo?</h4>
En EEUU, más de 80 ciudades de 38 estados y en el resto del mundo, han surgido NEPs para tratar el caso de los riesgos asociados con el uso de drogas inyectadas. Actualmente existen 113 NEPs en los EEUU. En Hawaii, el NEP opera con fondos del Departamento de Salud. Además de intercambiar agujas/jeringas, el programa cuenta con un sistema central de servicios de referencia a programas de tratamiento de drogas y una clínica de tratamiento con Metadona, además de un componente educativo dirigido por miembros del este grupo para aquellos UDIs que no asisten al programa. La tasas de VIH en UDIs han disminuido de un 5% a 1,1% de 1994-96. Desde 1993-96, 74% de los clientes del NEP reportaron no compartir agujas/jeringas.<sup>8</sup>

El “Harm Reduction Central” en Hollywood, California es un NEP para jóvenes UDIs menores de 24 años que encabeza la lista. Este programa ofrece el intercambio de agujas/jeringas, programas de arte, grupos de apoyo, pruebas de detección del VIH y la administración de los casos, es además el NEP más grande para jóvenes en los EEUU. Más del 70% de los clientes reportaron no compartir agujas/jeringas en los últimos 30 días y aquellos jóvenes que asistieron al NEP regularmente presentaban menos posibilidades de compartir agujas/jeringas.<sup>9</sup>
<h4>¿intercambiar agujas/jeringas reduce la transmisión del VIH? ¿promueve el uso de drogas?</h4>
Es posible limitar la transmisión del VIH en UDIs significativamente. Se hizo un estudio a cinco ciudades con poblaciones de UDIs que han mantenido una baja prevalencia del VIH: Glasgow, Escocia; Lund, Suecia; Nuevo Sur de Gales, Australia; Tacoma, EEUU; y Toronto, Canada. Todos estos presentaban los siguientes componentes de prevención: comenzaron actividades de prevención cuando los niveles de infección eran aún bajos, brindaron equipo de inyección y esterilización hasta por medio de los NEPs, llevaron a cabo programas de reclutamiento de UDIs.<sup>10</sup>

Un estudio a nivel mundial comparó las tasas de infección de UDIs con VIH en 81 ciudades con NEPs y en ciudades que no tenían NEPs. En las 52 ciudades sin NEP, la tasa de infección aumentó un promedio del 5,9% anual. En las 29 ciudades con NEP, la tasa de infección con VIH se redujo en un 5,8% anuales. El estudio concluyó que aparentemente los NEPs tienden a reducir los niveles de infección con VIH en UDIs.<sup>11</sup>

En San Francisco, CA, los efectos de un NEP fue estudiado por un período mayor de cinco años. El NEP no promovió ni el uso de drogas, ni aumentó el uso de drogas entre los UDIs dentro del programa, ni entre los nuevos reclutados. Por el contrario, desde 12/86 hasta 6/92, decayó la frecuencia con la que los UDIs de esta comunidad se inyectaban del 1,9% por día al 0,7%, y el porcentaje de nuevos iniciados al mundo de las drogas bajó del 3% al 1%.<sup>12</sup>

Se han estudiado otro centenar de NEPs, estos reportes que datan de 1991 se encuentran recopilados en una serie de ocho reportes auspiciados por fondos federales. Cada uno de estos ocho reportes ha concluido que los NEPs pueden reducir la cantidad de nuevas infecciones y aparentemente no incrementan el uso de drogas en UDIs o en la comunidad en general.<sup>13-15</sup> Estos fueron los dos criterios que debían cumplirse ante la ley para levantar la prohibición de los NEPs. Este nivel unánime de interpretación a proyectos de estudio es inusual en el área científica. Cinco de los estudios recomendaron levantar la prohibición federal y dos no hicieron recomendación alguna. El octavo reporte el Departamento de Salud y Servicios Humanos concluyó que los dos criterios se habían cumplido, pero esto no evitó la prohibición.<sup>15</sup> El Congreso cambió la ley desde entonces, la cual continúa prohibiendo fondos federales para los NEPs, a pesar de haber cumplido los dos criterios exigidos.
<h4>¿son costosos los NEPs?</h4>
No. El presupuesto anual mediano de un NEP en 1992 fue de $169,000. Los modelos matemáticos creados en base a estos datos estiman que los programas de intercambio de jeringas/agujas pueden prevenir la infección del VIH a sus clientes, sus parejas sexuales y a sus descendientes a un costo de $9,400 por cada infección que se evite.<sup>16</sup> Esto es mucho menor al costo actual por tratar a una persona infectada con el VIH de por vida de $195,188.<sup>17</sup> Un programa nacional de NEP hubiera podido salvar 10,000 vidas hasta 1995.<sup>13</sup>
<h4>¿qué se debe hacer?</h4>
Una estrategia más amplia para prevenir la infección del VIH en UDIs debe incluir esfuerzos para incrementar la disponibilidad de agujas esterilizadas, y un mayor acceso a programas de tratamiento de drogas y esfuerzos de prevención para el uso de las mismas. A pesar que el gobierno federal Estadounidense ha reconocido que los NEPs reducen los índices de infección con VIH y no incrementan el índice del uso de drogas, continúa negándose a otorgar fondos a los NEPs. Por esta razón resulta vital hacer campañas comunitarias estatales y locales. Sin embargo, el gobierno federal debe jugar un papel más activo y abogar públicamente en pro de los NEPs, aunque no les otorgue fondos.

Los estados que poseen leyes que exigen recetas médicas deben rechazarlas; aquellos que poseen leyes de paraphernalia deberán revisarlas a fondo ya que restringen el acceso a jeringas/agujas. Los gobiernos locales, Grupos de Planificación Comunitaria y oficiales del sector salud deben trabajar en conjunto con los grupos comunitarios para crear métodos más eficaces en la prevención del VIH en UDIs y a sus respectivas parejas sexuales, incluyendo NEPs y programas para incrementar el acceso de jeringas/agujas por medio de las farmacias.

<hr />

<h4>¿quién lo dice?</h4>
1. Rice DP, Kelman S, Miller LS. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988 . Public Health Reports. 1991;106:280-92.

2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas . American Journal of Public Health. 1996;86:642-654.

3. CDC. HIV/AIDS Surveillance Report . 1998;9:12.

4. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998; 18(Suppl 1):S6-10.

5. Gostin LO, Lazzarini Z, Jones TS, et al. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles . Journal of the American Medical Association. 1997;277:53-62.

6. Bluthenthal RN, Kral AH, Erringer EA, et al. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Journal of Drug Issues. (in press).

7. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993 . Journal of Acquired Immune Deficiency Syndromes. 1995;10:82-89.

8. Vogt RL, Breda MC, Des Jarlais DC, et al. Hawaii’s statewide syringe exchange program . American Journal of Public Health. 1998;88:1403-1404.

9. Kipke MD, Edgington R, Weiker RL, et al. HIV prevention for adolescent IDUs at a storefront needle exchange program in Hollywood, CA. Presented at 12th World AIDS Conference, Geneva, Switzer-land. 1998. Abstract #23204.

10. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users . Journal of the American Medical Association. 1995;274:1226-1231.

11. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection . Lancet. 1997;349:1797-1800.

12. Watters JK, Estilo MJ, Clark GL, et al. Syringe and needle exchange as HIV/AIDS prevention for injection drug users . Journal of the American Medical Association. 1994; 271:115-120.

13. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA . Lancet. 1997;349:604-608.

14. Report from the NIH Consensus Development Conference. February 1997.

15. Goldstein A. Clinton supports needle exchanges but not funding. Washington Post. April 21, 1998:A1.

16. Lurie P, Reingold AL, Bowser B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad . Prepared for the Centers for Disease Control and Prevention. October 1993.

17. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997;16:54-62.

<hr />

<strong>Preparado por Peter Lurie, MD, MPH** y Pamela DeCarlo*, Traducción Romy Benard-Rodríguez*
*Public Citizen’s, Health Research Group **CAPS</strong>

Abril 1999. Hoja Informativa 5SR.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/agujasFS.pdf</url>
	</node>
	<node>
		<title>Usuarios de drogas</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Qué necesitan los usarios de drogas en la prevención del VIH?</h3>
<h4>¿están los usuarios de drogas que no se inyectan a riesgo de infectarse?</h4>
Si. A pesar del alto riesgo de transmisión del VIH al compartir jeringas, la relación que existe entre el VIH y el uso de drogas va mucho mas allá del tema de las jeringas. Las personas adictas al alcohol, al “speed” y a la cocaína-crack, los “poppers” o cualquier otra droga no inyectada, están más propensos que aquellos que no usan drogas a ser portadores del VIH y a convertirse en seropositivos. Aún aquellos personas que no usan drogas intravenosas están mas propensas a participar en actividades sexuales de alto riesgo.<sup>1</sup>

Muchos de los usuarios de drogas intravenosas (UDIs) primordialmente usan otras drogas no inyectadas. Cuando un UDI porta el VIH, compartir jeringas puede ser el factor de mayor riesgo, pero el uso de drogas no inyectadas, puede además propiciar conductas de riesgo. Por ejemplo, en un estudio de clientes en programas de tratamiento con “Methadone” que presentaban conductas de alto riesgo, se descubrió que los de mayor riesgo de infectarse con el VIH eran los que usaban cocaína-crack.<sup>2</sup>

Al hacer una encuesta a heterosexuales en programas de tratamiento de alcohol en San Francisco, CA se encontraron tasas de infección del 3% entre hombres no UDIs y no homosexuales y del 4% entre mujeres no UDIs. Estas tasas resultan considerablemente altas en comparación con otra encuesta a una población similar en la que los resultados fueron del 0.5% entre hombres y el 0.2% entre mujeres.<sup>3</sup>

Un estudio realizados a hombres homosexuales de la ciudad de Boston, MA encontró una estrecha relación entre el uso de inhalantes o “poppers” y la infección del VIH. Los hombres que tuvieron sexo anal bajo los efectos del inhalante estaban 4.2 veces más propensos a ser VIH positivos que los que no estaban bajo estos efectos al tener sexo anal.<sup>4</sup>

La cocaína-crack siempre ha estado estrechamente ligada con la transmisión del VIH. Al realizarse un estudio entre jóvenes adultos de 3 vecindarios urbanos que fumaban crack y que nunca se habían inyectado drogas, se obtuvieron tasas de infección del 15.7%. Los más propensos a tener la infección eran las mujeres que habían accedido a tener sexo sin protección a cambio de drogas o dinero y los hombres que tuvieron sexo anal con otros.<sup>5</sup>
<h4>¿por qué están a mayor riesgo?</h4>
Probablemente sean múltiples las razones por las que el riesgo a contraer el VIH sea mayor entre las personas que usan o abusan de las drogas. Estas razones varían mucho y dependen del tipo de drogas y el ambiente que les rodea. Por ejemplo, es posible que aquellos que usan crack experimenten diferentes niveles de riesgo que los que abusan del alcohol. Entre los usuarios de drogas no inyectadas, contraer el VIH no ocurre a causa del solo hecho de usar drogas sino por tener sexo sin protección.

Recientemente, los observadores han encontrado un asociación entre la infección del VIH, el uso intenso del crack, y la práctica del sexo oral sin protección entre las prostitutas. Esto puede ser atribuido a la poca higiene bucal y al daño que sufre la boca al usar las pipas en las que fuman crack, a la alta frecuencia del sexo oral y al uso inconsistente del condón.<sup>6</sup>

En San Francisco, CA, los hombres homosexuales que abusan de las drogas identificaron una serie de factores que les dificultaba las relaciones sexuales seguras, entre ellas: la desinhibición percibida ocasionada por el alcohol u otras drogas, la adquisición de los patrones existentes que relacionan al sexo con las drogas (especialmente entre las anfetaminas y el sexo anal), la baja auto-estima, la falta de seguridad y la falta de poder (percibida).<sup>7</sup>

Se cree que el hecho de tener relaciones sexuales bajo los efectos del alcohol o drogas es lo que les expone a riesgo de contraer el VIH. Cabe mencionar que el riesgo se hace aún más latente cuando ocurren relaciones sexuales mixtas dentro de estos grupos.<sup>8</sup> La mayoría de las personas que participan en programas de tratamiento de drogas o de alcohol escogen parejas sexuales que pertenecen al mismo círculo. Estas pueden ser personas que se han inyectado, han intercambiado sexo por drogas o dinero, que han sido víctimas de algún trauma, o han estado en la cárcel. Estas poblaciones pueden poseer tasas de VIH mucho más altas, acrecentando así las posibilidades de transmisión del virus.
<h4>¿cuáles son los obstáculos?</h4>
Para la cultura de la sociedad Americana, el sexo y las drogas van de la mano. Para muchas personas homosexuales, o no, el método más eficaz para hacer amistades es en los bares o cantinas. Hace falta la conversación franca y abierta acerca de la homosexualidad en las escuelas, hogares y en el medio noticioso. Esta falta de communicación puede ocasionar una mayor inhibición frente a la sexualidad las cuales se liberan al usar drogas o alcohol.

Muchas veces, las metas de prevención del VIH y de los programas de tratamiento de drogas son contradictorias. Muchos de estos programas creen que los participantes deben cortar las drogas al unísono, el programa de los 12 pasos está a favor de la abstinencia sexual durante la etapa rehabilitadora. Por otro lado, muchos programas de prevención cuyo objetivo es el de promover la reducción del riesgo por medio del sexo seguro, advierten que hay posibilidades de una recaída. Es posible que estos conceptos contradictorios sean un obstáculo al tratar integrar las intervenciones de prevención del VIH en los programas para el tratamiento de drogas.
<h4>¿qué se está haciendo?</h4>
El programa “New Leaf” (previamente conocido como “18th Street Services”) en San Francisco, CA, ofrece programas de rehabilitación a hombres bisexuales y homosexuales y un componente sobre el sexo seguro. Al evaluar este estudio se encontró poca diferencia entre aquellos que recibieron la parte del sexo seguro y los que recibieron solo la rehabilitación, aunque en ambos grupos se observó una reducción en el nivel de riesgo sexual. Reclutar y mantener a los clientes en rehabilitación se puede considerar como un método efectivo en las tareas de prevención; agregar un componente sobre sexo seguro puede ayudar un poco más.

Algunos programas ofrecen información sobre sexo seguro sin tomar en cuenta el uso de las drogas. En “Juegos, Sexo y Videos”, un programa para enfermos mentales desamparados de la ciudad de Nueva York, los hombres sugirieron pegar un condon en las pipas, esto les ayuda recordar a usar el condón aún cuando los encuentros sexuales son a menudo rápidos y en público. Estos tambien compiten entre ellos para ver quien le pone un condón a una banana más rápido (sin romperlo) lo cual les enseña a usar el condón en situaciones comprometidas. El programa les permite tratar temas sexuales sin ser juzgados por ello, reduciendo en gran parte las conductas sexuales de alto riesgo.<sup>10</sup>

Muchos usuarios de drogas reciben el tratamiento después de haber sido arrestados, entonces se les ofrece como alternativa al ir a la cárcel o mientras están en la prisión. El sistema correccional de Delaware ha instituido un programa Terapeútico Comunitario (TC) dentro de las cárceles y otro para los que están bajo libertad condicional. Este programa residencial en el que no se permiten drogas incluye: rehabilitación, educación en grupo impartida por miembros del grupo en cuestión, consejería y servicios sociales. Los participantes resultaron estar menos propensos a tener una recaída o a quedar arrestados nuevamente, además de reportar bajos niveles de conductas de riesgo.<sup>11</sup>
<h4><strong>¿qué queda por hacer?</strong></h4>
Los programas diseñados en base al género son necesarios, especialmente los que tratan las necesidades de la mujer usuaria de drogas. La mujer más que el hombre, es más vulnerable al daño físico ocasionado por el alcohol y a eventos traumáticos asociados con el uso de substancias o drogas.<sup>12</sup> Otros de los programas necesarios son los que cumplen con las necesidades de la población homosexual (hombre y/o mujer).

Los programas de prevención para los usuarios de drogas requieren ser integrados en los servicios existentes. Las agencias que proveen tratamiento y los reclusorios necesitan entrenamiento y la autoridad para exigir que la prevención del VIH forme parte de sus programas. Las agencias que financian estos programas deberán incrementar los fondos y exigir la extensión de los programas de rehabilitación e incluir la prevención del VIH.

Los programas preventivos no deben partir de las causantes, es decir, que no es necesario que los programas se basen en la creencia de que el abuso de las drogas conlleva a conductas de alto riesgo. Un programa de prevención completo y eficaz utiliza múltiples elementos para proteger a la mayor cantidad de personas a riesgo posible. Es urgente implementar programas para los usuarios de drogas debido a la alta incidencia en el VIH y a las conductas de alto riesgo.

<hr size="2" />

<strong>¿quién lo dice?</strong>

1. Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV. American Psychologist. 1993;48:1035-1045.

2. Grella CE, Anglin MD, Wugalter SE. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients . Drug and Alcohol Dependence. 1995;37:15-21.

3. Avins AL, Woods WJ, Lindan CP, et al . HIV infection and risk behaviors among heterosexuals in alcohol treatment programs . Journal of the American Medical Association. 1994;271:515-518.

4. Seage GR, Mayer KH, Horsburgh CR, et al. The relation between nitrite inhalants, unprotective receptive anal intercourse, and the risk of human immunodeficiency virus infection . American Journal of Epidemiology. 1992;135:1-11.

5. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics – crack cocaine use and HIV infection among inner-city young adults . New England Journal of Medicine. 1994;331:1422-1427.

6. Wallace JI, Bloch D, Whitmore R, et al. Fellatio is a significant risk activity for acquiring AIDS in New York City street walking sex workers. Presented at the Eleventh International Conference on AIDS, Vancouver BC; 1996. Abs #Tu.C.2673.

7. Paul JP, Stall R, Davis F. Sexual risk for HIV transmission among gay/bisexual men in substance-abuse treatment . AIDS Education and Prevention. 1993;5:11-24.

8. Fullilove MT, Fullilove RE, Smith M, et al. Violence, trauma and post-traumatic stress disorder among women drug users . Journal of Traumatic Stress. 1993;6:533-543.

9. Renton A, Whitaker L, Ison C, et al. Estimating the sexual mixing patterns in the general population from those in people acquiring gonorrhoea infection: theoretical foundation and empirical findings. Journal of Epidemiology and Community Health. 1995;49:205-213.

10. Stall RD, Paul JP, Barrett DC, et al. Substance abuse treatment lowers sexual risk among gay male substance abusers. Presented at Eleventh International Conference on AIDS, Vancouver, BC; 1996. Abs #We.C.3490.

Contact: Ron Stall, 415/597-9155.

11. Susser E, Valencia E, Torres J. Sex, games and videotapes: an HIV-prevention intervention for men who are homeless and mentally ill. Psychosocial Rehabilitation Journal. 1994;17:31-40.

Contact: Ezra Susser, 212/960-5763.

12. Martin SS, Butzin CA, Inciardi JA. Assessment of a multistage therapeutic community for drug-involved offenders . Journal of Psychoactive Drugs. 1995;27:109-116.

Contact: Steve Martin, 302/831-2091-fax.

13. el-Guebaly N. Alcohol and polysubstance abuse among women . Canadian Journal of Psychiatry. 1995;40:73-79.

14. Stall R, Leigh B. Understanding the relationship between drug or alcohol use and high risk sexual activity for HIV transmission: where do we go from here ? Addiction. 1994;89:131-134.

<hr size="2" />

<strong>Preparado por Ron Stall, PhD, Robert Fullilove, EdD,</strong> <strong>
Traducción Romy Benard-Rodríguez</strong>
Enero 1997. Hoja Informativa 21S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/usariosFS.pdf</url>
	</node>
	<node>
		<title>Adherence</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of adherence in HIV treatment?</h3>
<h4>Why is adherence important?</h4>
The introduction of highly active antiretroviral therapy (HAART) has extended and improved the quality of life for people living with HIV by reducing viral load, often to undetectable levels. However, the initial enthusiasm for these drugs has been dampened somewhat by the discovery that they require near perfect adherence to prevent virus replication and mutation. Studies have shown that 95% adherence is needed for viral suppression and that even a small decrease in adherence can greatly increase viral load.<sup>1</sup>

If the virus is allowed to mutate into drug resistant strains, the treatment regimen can become ineffective, which reduces treatment options both for the non-adherent individuals and for any partners they may infect with these strains.<sup>2</sup>
<h4>How do you measure adherence?</h4>
Adherence is usually measured through self-report, pill count, electronic pill bottle caps (MEMS caps) and laboratory tests.<sup>3</sup> Self-report through doctor’s office visits, questionnaires, structured interviews or diaries provides a simple and practical way of determining the self-perceived level of adherence.<sup>4</sup> However, many individuals forget whether or not they took all their pills or may forget to complete their diary every day, and others may misrepresent their adherence in order to please the interviewer or clinician. Diaries may also not be feasible in settings where literacy is an issue.

Pill count, particularly if unannounced, may provide a more accurate assessment of adherence rates than self-report. However, it is labor intensive and may be perceived as intrusive, especially if conducted during unannounced home visits. In such situations, in-clinic pill count may work better. MEMS caps record each time the bottle cap is removed by the patient. They have been found to correlate highly with concurrent viral load. However, they are expensive to use and may under-report adherence in patients who remove more than one dose at a time for using medi-sets pill organizers.<sup>6</sup> All of these methods assume that patients have actually taken all missing pills.

Laboratory tests, an indirect measure of adherence, can include viral load, CD4 counts, and blood levels of drug metabolites. These measures are less commonly used and very expensive. The results give no specific information about number of doses missed or adherence to medication schedule. They can also be influenced by other factors, such as the presence of drug resistant virus. Still, lab measures are often considered a useful adherence measure when combined with patient self-report and/or pill counts.
<h4>What are barriers?</h4>
Adhering to medications is hard to do. Most people have a problem finishing even a 5-day dose of antibiotics. Adherence is even more difficult when taking multiple drugs with different dosing requirements and severe, unpleasant side effects such as diarrhea, nerve damage and changes in body composition. Many people with HIV also have other complicating factors in their lives, including mental health issues, economic worries, lack of stable housing and alcohol or drug use, making it difficult to prioritize adherence.

Adherence barriers are often divided into regimen-specific, social/psychological and institutional. Regimen-specific issues, such as the complexity of the treatment and taking many pills at different times, as well as side effects of the medication, can lead persons to miss doses.<sup>8</sup> Scheduling demands such as work, travel and mealtimes can also be barriers.

Social and psychological factors influence adherence. Mental health issues (such as depression or psychological distress), attitudes toward treatment and toward HIV, and support from health care workers, family and friends are key to adherence.<sup>9</sup> Positive responses promote adherence and negative responses (lack of support, pessimism, etc.) can make it more difficult to adhere to treatment regimens.

Institutional factors such as incarceration, clinic setting and access to reliable health care and medication affect adherence. Factors that promote adherence are pleasantness of the clinic, convenience of scheduling, confidentiality and availability of transportation and childcare.<sup>10</sup>
<h4>What’s being done?</h4>
Action Point, a storefront drop-in center in San Francisco, CA, offers adherence support for the urban poor with active drug or alcohol addiction. Located in an area of high rates of drug-related arrests and deaths, Action Point is open 6 days a week and operates on a harm reduction principle that encourages any positive change in health. The program offers adherence case management, prescription dispensing, nursing care, acupuncture and referrals to mental health and substance abuse services. After one month of enrollment, clients are offered a pager that receives e-mail messages to remind clients to take their medications. After six months, 61% of Action Point clients were taking HAART and 81% reported greater than 90% adherence.<sup>11</sup>

In New York, patients who had not previously been on HAART were offered an individualized, three-module program on basic understanding of HIV, adherence and regimen options. Counselors discussed with each patient in detail potential adherence barriers, anticipated toxicities, pill burdens, dosing intervals and drug preferences. These were evaluated, reported to their provider and used to select an individualized regimen. Patients were given tools such as pillboxes, dose cards and beepers, if needed. They also provided intensive coaching and a dedicated phone line for patients. The program increased adherence and enhanced virologic response.<sup>12</sup>

One promising new adherence strategy is directly observed therapy (DOT) for antiretrovirals, or DAART. Based on DOT for tuberculosis, DAART has been used in settings where patients have frequent interactions with health care workers, such as prisons and methadone maintenance clinics. Some complications of using DAART include the fact that medications need to be taken for a lifetime and dosing is usually more than once a day.<sup>13</sup>
<h4>What can we do?</h4>
Because adherence to HAART is a complex process, interventions to improve adherence are best designed to be multifaceted. Factors to consider include regimen complexity, side effects, patient-related factors and even the patient-health care worker relationship, each of which affects adherence to medications. Overall, the better that a regimen “fits” with a patient’s lifestyle, the greater adherence is likely to be.<sup>14</sup>

Health care workers can help increase adherence by: involving the patient in selecting a regimen with tolerable dosing schedules; preparing for and managing side effects; addressing and treating mental health and drug use issues; addressing concrete issues such as lack of transportation and homelessness; providing memory aids and anticipating treatment fatigue.<sup>15</sup>

Patients can help by: learning about HIV disease and anti-HIV drugs and what they do; finding treatment goals that are not HIV-related (seeing children grow up, remaining healthy and looking good); recruiting friends or family to act as adherence monitors and anticipating changes in routine such as travel.<sup>15</sup>
<h4>What needs to be done?</h4>
Everyone can be adherent with proper support. HIV+ persons may combat not just HIV disease, but drug addiction, homelessness and/or incarceration. Many of the barriers to adherence can be overcome with treatment and the right tools. For example, depression and other mental health problems that get in the way of optimal adherence are often treatable and should be diagnosed and treated.

Because adherence is complex, it often requires an “adherence team.” Collaboration between the patient, physician, nurse, case manager, social worker, pharmacist, counselor and family or friends is essential.

<hr />

<h4>Says who?</h4>
1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000;133:21-30.

2. Bangsberg DR, Deeks SD. Is average adherence to HIV antiretroviral therapy enough? Journal of General Internal Medicine. 2002;17:812-813.

3. Fogarty L, Roter D, Larson S et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Education and Counseling. 2002;46:93-108.

4. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care. 2000;12:255-266.http://www.fstrf.org/qol/adult/ql0702.pdf

5. Samet JH, Sullivan LM, Traphagen ET, et al. Measuring adherence among HIV-infected persons: is MEMS consummate technology? AIDS and Behavior. 2001;5:21-30.

6. Wendel CS, Mohler MJ, Kroesen K, et al. Barriers to use of electronic adherence monitoring in an HIV clinic. The Annals of Pharmacotherapy. 2001;35:1010-1015.

7. Ickovics JR, Meade CS. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care. 2002;14:309-318.

8. Altice FL, Mostashari F, Friedland GH. Trust and acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2001;28:47-58.

9. Gordillo V, Del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-1769.

10. Ciccarone D, Bangsberg D. , Bamberger J, et al. HIV-Related hospitalization before and during participation in ‘Action Point’ an adherence case management program. Presented at the American Public Health Association Conference. 2003.

11. Bamberger JD, Unick J, Klein P et al. Helping the urban poor stay with antiretroviral HIV drug therapy. American Journal of Public Health. 2000;90:699-701.

12. Esch L, Hardy H, Wynn H, et al. Intensive adherence interventions improve virologic response to antiretroviral therapy (ART) in naive patients. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL. 2001. Abst #481.

13. Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? AIDS Patient Care and STDs. 2002;16:527-535.

14. Chesney MA, Malow RM. Adherence in Chronic Diseases: Lessons learned from HIV/AIDS. World Health Organization volume on Adherence in Chronic Diseases. in press

15. Bartlett JA. Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndromes. 2002;29:S2-S10.

For information on how this affects prevention, please see Fact Sheet #27 “Do new HIV drugs affect HIV prevention?”

<hr />

<strong>Prepared by Maria Ekstrand, Michael Crosby and Pamela DeCarlo, CAPS</strong>

<strong>January 2003. Fact Sheet #47E</strong>

Special thanks to the following reviewers of this Fact Sheet: Margaret Chesney, Linda Fogarty, Celia Friedrich, Jeanette Ickovics, James L. Sorensen.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/adherenceFS.pdf</url>
	</node>
	<node>
		<title>Effect of treatment on prevention</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the effect of HIV treatment on HIV prevention?</h3>
<h3>revised 9/03</h3>
<h4>Why HIV treatment and prevention?</h4>
Traditionally, HIV prevention efforts have focused on uninfected persons at risk, encouraging them to adopt and maintain safer sex and drug-using behavior that would keep them uninfected. Less attention was paid to prevention among persons who were already infected, where the priority was maintaining their health in the face of a devastating disease. Providers and programs for prevention and care were distinct and separate. While such a division was always short-sighted (naturally the behavior of both HIV+ and HIV- persons influence transmission), in today’s era of more effective treatment for HIV, it is even more important that prevention and care be permanently linked.

More effective treatment, also known as highly active anti-retroviral therapy or HAART, can have differing effects on HIV prevention. On the one hand, HAART has dramatically improved the length of survival and the physical well-being of persons living with HIV/ AIDS, and with it has increased the opportunities for transmission of the virus to others. On the other hand, treatment may decrease the opportunity for HIV transmission by lowering the amount of HIV virus shed through blood and genital secretions.

The availability and use of HAART also may have produced changes in attitudes that can help or hinder HIV prevention. Prevention efforts must therefore carefully weigh and address the potential positive and negative effects of HAART on HIV transmission.
<h4>Can treatment benefit prevention?</h4>
There is a variety of evidence supporting HAART’s beneficial effect on HIV prevention, both in the acquisition of infection among HIV- persons and in the transmission of infection from HIV+ persons to others.

First, the provision of anti-retroviral treatment to HIV+ women and their infants around the time of delivery has been shown to reduce mother-to-child transmission.<sup>1</sup> Treatment is thought to work by reducing the mother’s infectiousness and/or by blocking the
establishment of infection in the infant.

Second, follow-up of healthcare workers exposed to HIV through needlestick injuries or other accidental contact with body fluids found that persons taking anti-retroviral post-exposure prophylaxis (PEP) were less likely to become infected compared to those who did not.<sup>2</sup> The concept has been extended to the provision of PEP to prevent HIV infection resulting from episodes of unprotected sex or needle-sharing.<sup>3</sup>

A third argument is indirect. HAART can dramatically reduce the levels of virus in the blood, often to the point of becoming undetectable by current tests. Although not a one-to-one relation, lower blood levels of virus tend to correlate with lower genital fluid levels of virus.<sup>4,5</sup> At least one study in Africa observed that low blood viral load translated to low likelihood of sexual transmission; no HIV transmissions were observed among discordant couples when the partner’s blood viral load was under 1500 copies per ml.<sup>6</sup> If treatment can reduce blood levels of virus to below this level, the reasoning goes, then it can prevent HIV transmission. This conclusion, while appealing, has not been proven.

Even in patients on HAART, virus remains in many tissues of the body, inside cells and in the blood despite being undetectable with tests.<sup>7</sup> While it is probably true that a low viral load makes someone less infectious, viral loads fluctuate over time due to changes in adherence, the development of drug resistance or the natural history of infection. While the evidence suggests treatment can reduce infectiousness, it does not eliminate it at all points in time. Until the conditions when someone is not infectious are well-defined, it is safest to assume that an HIV+ person remains potentially infectious for life.

On a different level, HAART can help prevention by providing hope to persons affected by AIDS. There is greater incentive to seek HIV testing (and therefore risk reduction counseling) when effective HIV treatment is available and greater disincentive when it is not, especially where high stigma of HIV exists. Moreover, communities devastated by friends and families getting sick and dying may view HIV infection as inevitable and self care and prevention take low priority. A study in Baltimore, MD, found that informal caregivers were more likely to promote prevention messages in the community when their friends and family had access to HIV treatment, giving them hope for the future.<sup>8</sup>
<h4>Can treatment harm prevention?</h4>
HIV+ persons and HIV- persons have been having sex and/or injecting drugs since the beginning of the epidemic, before the advent of HAART. In the past few years, however, there have been increases in sexually transmitted diseases (STDs) and sexual risk behavior in the US and across the developed world.<sup>9-12</sup> These increases might be a sign of upcoming increases in HIV infection. It is difficult to determine if this is due to improved treatment or not.

Outbreaks of syphilis among men who have sex with men (MSM) have occurred in several cities across the US. Around half of the men in these outbreaks were HIV+, with many receiving treatment. In San Francisco, CA, acquiring an STD after AIDS diagnosis was associated with the use of HAART.<sup>10</sup> STDs can promote HIV transmission by increasing HIV infectiousness in HIV+ persons and increasing susceptibility to HIV in HIV- persons.<sup>13</sup>

Internationally, increases in sexual risk behavior and STDs have been documented among both HIV- and HIV+ MSM in the last few years. In London, Manchester and Brighton, England, Amsterdam, the Netherlands and Sydney, Australia, high-risk sexual behavior increased since 1996, especially among MSM.<sup>14</sup>

These increases in sexual risk behavior in recent years have led to heated discussion on the role of “treatment optimism” in HIV transmission. Treatment optimism means that people are more likely to engage in sexual risk behavior because they believe treatment will make them or their partners less infectious or they believe that HIV is less serious a disease than before. In fact, a recent review of studies on treatment optimism in three continents found few gay men were optimistic overall and the association between optimism and sexual risk behavior was inconsistent.<sup>14</sup> That is, treatment optimism may be causing an increase in sexual risk behavior among some communities or segments of communities of gay men, but not among others.

The trade-offs between the potential benefits of HAART in reducing the likelihood of HIV transmission and potential harm resulting from increased risk behavior have been included in many complex mathematical models of the epidemic. The models suggest that HIV transmission can increase in a community where greater than 50% of infected persons are on HAART if risk behavior increases on the order of 10% or more.<sup>15</sup>
<h4>What needs to be done?</h4>
HIV care programs provide opportunities for treatment and prevention to work together. Health care providers can take a greater role in HIV prevention, making prevention activities an expected part of medical care. Key prevention components can include regular risk reduction counseling and STD screening. Training and support are needed for HIV care providers unfamiliar with these roles.

Programs outside medical care settings are needed to help HIV+ and HIV- persons avoid transmission.<sup>16</sup> These prevention programs should incorporate a variety of strategies, including counseling and training on when and how to disclose HIV status, how to maintain consistent condom use in the absence of disclosure, how to address HIV-related stigma, and how to keep intimacy in serodiscordant and seroconcordant relationships. This should be available for HIV+ and HIV- persons in the context of managing a healthy sex life. Communities impacted by HIV need better understanding of and access to research on when and how persons are infectious and how to best use HIV treatment to reduce the risk of transmission, so that they can make appropriate informed decisions.

Persons who know they are HIV-, know they are HIV+, or do not know their serostatus all need community-level prevention messages that address sexual and drug-related behavior. New HIV tests that are easier to use and give faster results should facilitate increased testing for those who do not know their status. HIV testing should be made more widely available through as many outlets as possible, including anonymous and confidential test sites and home collection kits.

The fight against the HIV/AIDS epidemic should not be divided into treatment for HIV+’s and prevention for HIV-’s. Treatment will not eliminate the epidemic in the absence of prevention programs for HIV- and HIV+ persons; prevention will not work unless relevant to those infected and uninfected.

<hr />

<h3>Says who?</h3>
1. Mofenson LM. Technical Report: Perinatal Human Immunodeficiency Virus Testing and Prevention of Transmission. Pediatrics. 2000;106:E88.
2. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine. 1997;337: 1485-1490.
3. Kahn JO, Martin JN, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injecting drug use exposure: the San Francisco PEP study. Journal of Infectious Diseases. 2001;183: 707-714.
4. Barroso PF, Schechter M, Gupta P, et al. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. Journal of Acquired Immune Deficiency Syndromes. 2003;32:435-440.
5. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases. 1998;177:1100-1103.
6. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and risk of heterosexual transmission of HIV-1 among sexual partners. Presented at the Conference on Retroviruses and Opportunistic Infections. Jan 30-Feb 2;2000. Abst# 193.
7. Zhu T, Wang N, Carr A, et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. Journal of Virology. 1996;70:3098-3107.
8. Knowlton AR. Social network approaches to HIV prevention and care: theoretical and methodological considerations of intervention. Presented at the International AIDS Conference, Barcelona, Spain. 2002. ThOrE1501.
9. Valdiserri RO. Preventing new HIV infections in the US: what can we hope to achieve? Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA. February 10-14, 2003.
10. Scheer S, Chu PL, Klausner JD, et al. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001 Feb 10;357(9254):432-5.
11. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men in San Francisco. American Journal of Public Health. 2002;92:388-394.
12. Stolte IG, Coutinho RA. Risk behaviour and sexually transmitted diseases are on the rise in gay men, but what is happening with HIV? Current Opinions in Infectious Diseases. 2002;15:37-41.
13. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections. 1999;75:3-17.
14. Elford J, Bolding G, Sherr L. HIV optimism: fact or fiction? FOCUS. 2001;8:1-3.
15. Blower S, Schwartz EJ, Mills J. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines. AIDS Reviews. 2003;5:113-125.
16. Collins C, Morin SF, Shriver MD, et al. Designing Primary Prevention for People Living with HIV. Monograph published by the AIDS Policy Research Center &amp; Center for AIDS Prevention Studies. March, 2000.prevention.ucsf.edu/uploads/publications/pozmono.pdf (Accessed 4/20/06)

<hr />

<strong>Prepared by Willi McFarland* and Pamela DeCarlo**
*San Francisco Department of Public Health, **CAPS</strong>

<strong>September 2003. Fact Sheet #27ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Angela Kashuba, Mitch Katz, Jeffrey Klausner, Kimberly Page-Shafer, Jack Summerside, Dan Wohlfeiler.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/treatmenteffectsFS.pdf</url>
	</node>
	<node>
		<title>Healthcare workers</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Can Healthcare Workers Help in HIV Prevention?</h3>
<h3>revised 4/99</h3>
<h4>Are healthcare providers important in prevention?</h4>
Yes. Healthcare providers have many opportunities to help foster the behavior changes needed to stem the spread of HIV infection. In the US in 1996, the average adult visited a physician 3 times a year. Overall, 82% of visits were in physician offices and 10% in emergency departments.<sup>1</sup> Visits with healthcare providers or other encounters with the healthcare system are “teachable moments”-opportunities for discussing sexual and drug-use risks in a manner relevant to individual patients’ lives.

Healthcare providers in environments with large numbers of high-risk patients such as emergency departments, sexually transmitted disease (STD) clinics, methadone maintenance clinics and prison or jail clinics, can be crucial for HIV prevention. For example, men, women and adolescents who have been incarcerated have high rates of HIV, STDs and tuberculosis, as well as substance abuse problems, and would benefit from preventive information and medical services.<sup>2</sup>

In a nationwide survey of adults, only 20% of patients had discussed HIV risks with their doctors in the previous five years. Only 21% of those who did talk to a physician said the physician initiated the discussion. And only 23% of those who reported a behavioral risk for HIV had spoken to their physician about AIDS.<sup>3</sup>
<h4>What are barriers to discussing HIV?</h4>
HIV prevention requires the ability to talk about sexuality and drugs in an open manner, which may be uncomfortable. Healthcare providers need training in initiating discussions, negotiating awkward moments, responding to fears and expectations, encouraging patient feedback and being empathic. Ways to help foster these skills include instructors acting as patients for role-play and videotaped feedback on clinical performance.<sup>4</sup>

Lack of time can be a huge barrier to discussing HIV risks for healthcare providers. Many hospitals, clinics and health maintenance organizations (HMOs) require healthcare providers to address prevention in many other areas such as diet and exercise, smoking, depression, diabetes, heart disease and cancer. With a limited amount of time allotted each patient, healthcare providers may feel there is not enough time to also discuss sensitive issues such as sexuality and drug use.
<h4>What can healthcare providers do?</h4>
Assessing HIV risk behaviors should be a standard part of new patient intake. In-depth AIDS prevention education is not necessary for each and every patient. However, healthcare providers should ask all patients about condom use, number of sexual partners, sexual orientation and injection drug use to assess a patient’s risk for HIV. These quick questions may lead to longer discussions and counseling about safer sex or drug use practices. Healthcare providers who don’t have the time or comfort for these discussions can refer patients to toll-free hotlines or community-based public health programs.

Healthcare providers can provide HIV counseling and testing to patients who request it, and recommend testing to patients at high risk for HIV. These include patients with STDs, especially adolescents, injection drug users (IDUs), women whose partners may be IDUs and patients who are unsure of their partner’s HIV status.<sup>5</sup>

Helping patients get into drug treatment can be an effective HIV prevention tool. Healthcare providers can have a profound effect on patients’ lives by showing an interest in drug-using patients and encouraging willing patients to enter a drug or alcohol treatment program. Because relapse is common in treating addictions, healthcare providers should use a non-judgmental attitude.<sup>6</sup>

Healthcare providers who work with HIV+ patients can help prevent HIV transmission by assessing patients’ risky sexual and needle-use behaviors and counseling them to reduce those unsafe behaviors.<sup>7</sup> This is especially important with the advent of more effective treatments for HIV. For example, HIV+ patients may believe that if they have a low or undetectable viral load, they cannot transmit HIV. Opportune moments for counseling are: at diagnosis, at onset of symptoms and when beginning drug treatment.<sup>8</sup>
<h4>Can treatment promote prevention?</h4>
Yes. Diagnosing and treating STDs such as syphilis and gonorrhea can help protect against HIV transmission. Early detection and treatment of STDs can be crucial, as STD infections make it easier to both get HIV and transmit it to others. In areas and populations with high rates of STDs and low rates of HIV infection, treating STDs is an effective means to prevent HIV infection.<sup>9</sup>

In recent years, great advances have been made in preventing HIV transmission from mother to infant. Healthcare providers should offer HIV testing to all pregnant women. Treating HIV+ mothers and their babies with AZT has been shown to reduce transmission by two-thirds. HIV+ mothers should also be counseled on the risk of breastfeeding and provided with alternates to breast milk if needed.<sup>10</sup>

Post-exposure prophylaxis (PEP) is a method for potentially preventing HIV transmission by administering AZT and other anti-HIV drugs within 72 hours of an accidental exposure to HIV. Studies of occupational PEP have found that HIV transmission can be prevented by post-exposure treatment, and PEP is now recommended by the Centers for Disease Control and Prevention (CDC) for occupational exposure among healthcare workers.<sup>11</sup> PEP is currently being piloted for exposure via sexual or drug use activities, including sexual assault. The CDC has not yet endorsed this due to lack of research data directly from drug and sexual exposure.<sup>12</sup>
<h4>What’s being done?</h4>
Healthcare providers need access to training and medical updates. One program trained rural healthcare providers in HIV/AIDS information, how to conduct risk assessments, advances in treatments, and sensitivity to diverse populations. The most effective training was achieved with a self-study booklet which helped increase prevention, early intervention and health promotion among rural health care providers. This booklet is now available free of charge on the Internet. Interactive teleconference training and personal training from visiting educators were also effective.<sup>13</sup>

Healthcare providers need to address the multiple needs of patients. In Bangalore, India, the Well Woman Clinic was established as part of an HIV control program. Poor women, especially commercial sex workers, had been underserved, had high rates of STDs and were at high risk for HIV. Because women are conditioned to ignore or tolerate health problems, patients at the Clinic are automatically screened for STDs without having to admit to any symptoms.<sup>14</sup>

Healthcare providers need to take advantage of community-based services. Children’s Hospital Los Angeles teamed with community-based prevention organizations to provide an integrated care model for youth with and at high risk for HIV infection. The model offers a general medical clinic for youth and psychosocial services such as counseling and case management. Peer educators also conduct extensive street outreach where high-risk youth congregate. The program developed a computerized referral system for local youth services available on the Internet.<sup>15</sup>
<h4>Will enhancing healthcare providers’ involvement be enough?</h4>
Enhancing healthcare providers’ involvement is only one aspect of a broad prevention policy. A comprehensive HIV-prevention strategy uses multiple elements to protect as many people at risk of HIV infection as possible. HIV prevention is not a “one-shot” effort; it is an ongoing process that demands the involvement of many sectors of society. This includes the physicians, nurses, health educators, therapists, dentists and other healthcare providers to whom people look for advice on how to stay healthy.

<hr />

<h3>Says who?</h3>
1. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996 . Vital and Health Statistics. 1998;134:1-37.
2. Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings . Health Education and Behavior. 1998;25:99-120.
3. Gerbert B, Bleecker T, Bernzweig J . Is anybody talking to physicians about acquired immunodeficiency syndrome and sex? A national survey of patients. Archives of Family Medicine. 1993;2:45-51.
4. Epstein RM, Morse DS, Frankel RM, et al. Awkward moments in patient-physician communication about HIV risk. Annals of Internal Medicine. 1998;128:435-442.
5. American Medical Association. Physician Guide to HIV Prevention. June 1996.
6. Herman M, Gourevitch MN. Integrating primary care and methadone maintenance treatment: implementation issues . Journal of Addictive Diseases. 1997;16:91-102.
7. Gerbert B, Brown B, Volberding P, et al. Physicians’ transmission assessment and counseling practices with their HIV-seropositive patients. AIDS Education and Prevention. In press.
8. Gerbert B, Love C, Caspers N et al. “ Making all the difference in the world”: how physicians can help HIV-seropositive patients become more involved in their healthcare . AIDS Patient Care and STDs. 1999;13:29-39.
9. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases-United States . Morbidity and Mortality Weekly Report. 1998;47(RR-12):1-25.
10. Centers for Disease Control and Prevention. Update: perinatally acquired HIV/AIDS-United States, 1997 . Morbidity and Mortality Weekly Report. 1997;46:1086-1092.
11. Centers for Disease Control and Prevention. Management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis . Morbidity and Mortality Weekly Report. 1998;47(RR-7):1-33.
12. Centers for Disease Control and Prevention. Management of possible sexual, injecting drug-use, or other non-occupational exposure to HIV, including considerations related to antiretroviral therapy . Morbidity and Mortality Weekly Report. 1998;47(RR-17):1-14.
13. Martin SJ. HIV/AIDS prevention, early intervention and health promotion: results of training for rural health care providers. Presented at the 9th National AIDS Update Conference, San Francisco, CA. March 19, 1997. Contact: Sara Martin (303) 315-2516. www.uchsc.edu/sm/aids/begin.htm
14. Baksi CM, Harper I, Raj M. A `Well Woman Clinic’ in Bangalore: one strategy to attempt to decrease the transmission of HIV infection . International Journal of STDs &amp; AIDS. 1998;9:418-423.
15. Schneir A, Kipke MD, Melchior LA, et al. Children’s Hospital Los Angeles: a model of integrated care for HIV-positive and very high risk youth. Journal of Adolescent Health. 1998;23(2Suppl):59-70. Computerized referral system:www.caars.net

<hr />

<strong>Prepared by Pamela DeCarlo*, Barbara Gerbert, PhD** and the Center for Health Improvement and Prevention Studies**
*CAPS, **Division of Behavioral Sciences, UCSF</strong>

April 1999. Fact Sheet #6ER

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 1999, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/providersFS.pdf</url>
	</node>
	<node>
		<title>Hepatitis C</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Can hepatitis C (HCV) transmission be prevented?</h3>
Prepared by Alice Asher RN, MS, CNS and Kimberly Page PhD MPH

Fact Sheet: 46 September 2010
<h4>What is the hepatitis C virus (HCV)?</h4>
Hepatitis C virus is blood borne virus affects the liver. It is principally acquired and transmitted by blood-to-blood contact, most commonly among injection drug users (IDU). Other common infectious viruses that affect the liver are Hepatitis A and B which have other routes of infection. Unlike hepatitis A and B, there is no vaccine for HCV.

About 3.2 – 4 million Americans are estimated to be infected with HCV.<sup>1</sup> In the US, 8,000 to 10,000 deaths per year are attributed to HCV-associated liver disease and that is expected to triple in the next 10-20 years.
<h4>Who’s at risk for HCV?</h4>
The population at highest risk for HCV are people who inject drugs; principally through sharing of syringes directly or through sharing of drug preparation equipment. Among newly reported HCV cases with known risk factors, 50%-60% are attributable to injecting drugs. However, this may be underestimated due to underreporting both due to the illicit nature of IDU and lack of HCV surveillance in high risk groups.<sup>2</sup> HCV is usually acquired rapidly after a person first starts injecting drugs. As a result, prevalence of HCV among IDU is very high, ranging from 40-90%, depending on a person’s age and number of years injecting.<sup>3</sup>

Persons who received blood transfusions or an organ transplant before 1992 and hemophiliacs who received clotting factor concentrates before 1987 are also at risk for HCV. At moderate risk are persons receiving continual care (hemodialysis) for kidney failure. Others at risk include healthcare workers exposed to needlesticks with HCV+ blood.and, rarely, infants born to infected mothers.

Sexual transmission of HCV is uncommon, although recent studies of HIV+ gay men show that it does occur.<sup>4</sup>Rough sex, fisting, sex with multiple partners and having a sexually transmitted disease (STD) or HIV appear to increase a person’s risk of HCV.<sup>5</sup> This is likely due to blood contact during sex.
<h4>What does HCV infection look like?</h4>
HCV infection can range of in severity from a mild illness lasting a few weeks to a serious, lifelong illness that damages the liver.5 The majority of people infected with HCV do not experience symptoms related to their infection. Because of this, testing is the only way to confirm HCV infection.

The first period after HCV infection is referred to as the “acute” period. Acute HCV infection generally lasts about 6 months after someone is infected with the virus. About 25% of people who become infected with HCV will spontaneously clear the virus on their own in the first 6 months. Studies have shown that women are more likely to spontaneously clear the virus than men. Even for those who have cleared HCV, re-infection can occur. While many who become re-infected will clear the virus again, this is not guaranteed, and a subsequent infection may become chronic. Those who do not clear or resolve their HCV infection are considered chronically infected.

Most people with chronic infection remain asymptomatic for 20-30 years, and some will never develop symptoms of advanced disease. However, 60-70% of people with chronic HCV ultimately will develop some degree of liver disease.<sup>5</sup> People with chronic infection whose liver disease has started to progress often report increasing levels of fatigue and stomach pain. The symptoms of chronic HCV are often are vague and unspecific and may go undiagnosed. This again underlines the importance of testing for anyone at risk of HCV.

Chronic HCV infection causes liver damage that can turn into cirrhosis (scarring of the liver) and liver cancer.<sup>5</sup> Up to 20% of chronically infected individuals will develop cirrhosis and 5% will develop liver cancer. Alcohol and drugs</sup>including marijuana and even tobacco</sup>can speed up the rate of liver damage significantly.
<h4>Can HCV be treated?</h4>
The short answer is yes, there is a treatment for HCV, but currently available treatments will not work for everybody. Before starting a treatment regimen, it is important to stabilize any mental or other health problems. Undergoing antiviral treatment for HCV is a long, difficult and expensive process, so determining whether treatment is the right choice is a decision that should be made between a patient and a care provider.

There are two approved antiviral medications used for the treatment of HCV: pegylated interferon alpha (often referred to as “peg”) and ribavirin. Peg interferon is taken by injection once a week. Ribavirin is an oral tablet that is taken daily. When taken together, the medications are effective in clearing the HCV virus 40-80% of the time, depending on the genotype of the virus.<sup>7</sup> Hepatitis C has 6 chemical types (1-6), called genotypes, and they differ in how they respond to treatment.

People of color, especially African-Americans and Latinos, have lower response rates to treatment, compared to other groups.<sup>7</sup> New drugs are being developed that may be more effective than currently available treatments and may be available in the very near future. Treatment during the acute phase of infection is significantly more likely to be effective<sup>8</sup>, so identifying HCV early can be beneficial. While herbal remedies are popular among people living with HCV, none have been proven effective at clearing the HCV virus or in improving liver health.<sup>9</sup>

HCV treatment can be successful for active drug users. Nonetheless, daily drug and alcohol use can adversely affect treatment eligibility and completion. Engaging in drug or alcohol treatment programs while being treated for HCV can be helpful.
<h4>How does HCV affect HIV?</h4>
About one-quarter of all people in the US living with HIV are also infected with HCV. Persons who are both HIV+ and HCV+ (coinfected), can experience a much faster progression of liver disease and have higher HCV viral loads and higher rates of cirrhosis than do people who have HCV but not HIV.<sup>10</sup> Liver damage from HCV infection also can increase the toxicity of medications used to treat HIV.

As persons living with HIV who are on effective medications lead longer lives, liver disease has become the leading cause of non-AIDS-related deaths among HIV+ persons, due to HCV and HBV infection.<sup>11</sup> Treatment for HCV infection in an HIV+ person can be effective. Side effects and drug interactions, however, can be hard to manage. It is important the coinfected person be on well-managed HIV treatment before starting treatment for HCV.
<h4>How can HCV be prevented?</h4>
HCV prevention can take many forms.<sup>12</sup> Currently, targeted prevention strategies and harm reduction programs, including increased availability of clean syringes and increased access to drug treatment programs have the greatest potential to slow transmission of HCV. Educating those at risk, especially about the risks associated with shared injecting and ancillary equipment is very important. Encouraging the use of condoms, lubrication and gloves during high-risk sexual practices also can help reduce HCV transmission.

Behavioral risk reduction prevention programs have had mixed results in decreasing risks associated with HCV transmission. Two peer-led interventions were effective in reducing injection risk behaviors in HIV negative and positive IDUs. The Study to Reduce Intravenous Exposures (STRIVE) and Drug Users Intervention Trials (DUIT) both provided information, enhanced risk-reduction skills, and motivated behavior change through peer education training. Although participants in these programs reported decreases in sharing syringes and drug preparation equipment,<sup>13,14</sup> rates of new HCV infections among HCV negative participants in the DUIT Study did not decrease (neither did HIV infections).

The UFO Study conducts HCV-related research and provides hepatitis, HIV and STD prevention services including testing, counseling, support and education tailored to young adult IDUs under age 30 in San Francisco, CA. Young injection drug users comprise a group for whom few health-related resources or programs are targeted.<sup>15</sup>

For persons who are infected with HCV or at risk of becoming infected with HCV, it is important to get regular healthcare. A healthcare provider can help monitor HCV infection and liver health and make important decisions about prevention and treatment. Support and education groups are valuable in learning more about HCV infection and about the experience of living with HCV, treating HCV and preventing HCV transmission to others. People infected with HCV should be screened and vaccinated for HBV and should be strongly encouraged to stop or decrease alcohol use.
<h4>What needs to be done?</h4>
Over the next 15 years, the global costs associated with HCV infection are projected to increase from $30 billion to $85 billion.<sup>16</sup> Development of an HCV vaccine will significantly decrease rates of new HCV infections. Research is needed on the development of a vaccine and effective models for delivery. Increasing access to HCV testing and screening, HCV treatment, drug treatment, clean syringes and effective behavioral interventions is crucial.

<hr />

<h3>Says who?</h3>
1. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine. 2006;144:705-714.

2. Hagan H, Snyder N, Hough E, et al. Case-reporting of acute hepatitis B and C among injection drug users. Journal of Urban Health. 2002;79:579-585.

3. Hagan H, Pouget ER, Des Jarlais DC, et al. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. American Journal of Epidemiology. 2008;168:1099-1109.

4. Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009;23:F1-7.

5. Hepatitis C Fact Sheet. Prepared by the Centers for Disease Control and Prevention.

6. Page K, Hahn JA, Evans J, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. Journal of Infectious Diseases. 2009;200:1216-1226.

7. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of Hepatitis C: An update. Hepatology. 2009;49:1335-1374.

8. Kamal SM. Acute hepatitis C: a systematic review. American Journal of Gastroenterology. 2008;103:1283-1297

9. Liu JP, Manheimer E, Tsutani K, et al. Medicinal herbs for hepatitis C virus infection. Cochrane Database of Systematic Reviews. 2001;4.

10. Verucchi G, Calza L, Manfredi R, et al. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32:33-46.

11. Tuma P, Jarrin I, Del Amo J, et al. Survival of HIV-infected patients with compensated liver cirrhosis. AIDS. 2010;24:745-753.

12. Page-Shafer K, Hahn J, Lum PJ. Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough. AIDS. 2007;21:1967-1969.

13. Latka MH, Hagan H, Kapadia F, et al. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. American Journal of Public Health. 2008;98:853-861.

14. Garfein RS, Golub ET, Greenberg AE, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007;21:1923-1932.

15. Lum PJ, Ochoa KC, Hahn JA, et al. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. American Journal of Public Health. 2003;93:919-23.

16. Shah BB, Wong JB. The economics of hepatitis C virus. Clinics in Liver Disease. 2006;10:717-34.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Laura Mae Alpert, Orlando Chavez, Myrna Cozen, Richard Garfein, Holly Hagan, Judy Hahn, Emalie Huriaux, Steve Livingston, Megan Mahoney, Brian McMahon, Jay Ryan, Jim Stillwell, Leslie Tobler, Anouk Urbanus.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©September 2010, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.Web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revHCVFS.pdf</url>
	</node>
	<node>
		<title>HIV vaccine</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>Can an HIV Vaccine make a Difference?</h2>
<h3>why do we need an HIV vaccine?</h3>
Vaccines are among the most powerful and cost-effective disease prevention tools available. A vaccine that could prevent HIV infection or stop progression of the disease would greatly help in the fight against the AIDS pandemic. Vaccines have been pivotal in worldwide smallpox elimination efforts, have nearly eliminated polio and have drastically reduced the incidence of infectious diseases like measles and pertussis in the US.

A crucial question is whether a vaccine based on one strain of HIV would be effective for populations in which a different strain is predominant. There are also questions about how an HIV vaccine would protect individuals: the vaccine might not be able to actually prevent infection, but could prevent or delay progression to disease, or simply reduce the infectiousness of people who do become infected with HIV.

HIV prevention education and counseling are important components of vaccine programs. Even after the release of a vaccine, there will be an ongoing need for effective behavioral prevention programs. An HIV vaccine will not be a “magic bullet” but it could play an extremely powerful role as part of a package of prevention interventions.
<h3>has progress been made?</h3>
Twenty-two years into the epidemic, researchers are still struggling with the daunting scientific challenges involved in HIV vaccine research: 1) traditional approaches to vaccine design (i.e. use of inactivated or attenuated viruses) are considered too dangerous with HIV; 2) the virus is highly variable and mutates rapidly; 3) the viral infection is permanent, full recovery from HIV has not been documented, and thus, it is unclear how the body could mount an effective immune response and 4) there is no perfect animal model for use in AIDS vaccine research.<sup>1</sup>

There is still no HIV vaccine that has been tested and found to be effective. There have been over 70 small-scale human clinical trials of over 35 different candidate HIV vaccines, but only one product, AIDSVAX, produced by VaxGen, has been tested in a large-scale (Phase III) trial. Unfortunately, two separate trials of AIDSVAX conducted in 1) North America, Puerto Rico and the Netherlands<sup>2</sup> and 2) Thailand, found that the vaccine did not prevent HIV infection in the overall study populations and did not slow progression of disease among participants who became HIV-infected during the trial.<sup>3</sup>

A successful HIV vaccine would train the immune system to recognize HIV before it does extensive damage. Vaccine concepts now in development use a variety of methods to train the immune system to recognize parts of HIV without exposing people to HIV itself. Early AIDS vaccine research focused on developing bio-engineered vaccines that represent a portion of HIV’s outer surface (envelope) protein. Different vaccine approaches are currently in development, none of which include the actual virus (HIV) and none of which can cause a recipient to acquire HIV from the vaccine itself.
<h3>what is the impact on HIV prevention?</h3>
An effective HIV vaccine cannot take the place of HIV prevention efforts, any more than prevention efforts can take the place of a vaccine. The best way to address the HIV pandemic is using multiple interventions at multiple levels, and the protective power of a vaccine could one day be of enormous benefit in HIV prevention.

There have been increases in sexual risk behavior in men who have sex with men (MSM) since the advent of ART (antiretroviral treatment).<sup>4</sup> There is concern that when a vaccine becomes available there could be similar increases in risk behavior among people who receive the HIV vaccine because they feel they can’t become infected with HIV.

In the VaxGen efficacy trial in North America, younger participants and MSM who believed they had received the actual vaccine rather than a placebo were more likely to report unprotected anal intercourse during the trial. Overall, self-reported risk behavior did not increase throughout the trial.<sup>5</sup> In the VaxGen efficacy trial in Thailand, injecting drug users reported decreases in injection drug use and needle sharing during the first 12 months of the trial.<sup>6</sup> This may have been due to the prevention education and risk-reduction counseling received.
<h3>what are the ethical issues?</h3>
HIV vaccines can only be tested for safety and effectiveness if thousands of individuals are willing to participate in clinical trials. These trials raise concerns about the potential harm to trial participants. Certain HIV vaccines may cause trial volunteers to test HIV+ on standard HIV antibody tests, even though they are not infected with the virus. A positive HIV test result could expose individuals to discrimination in health insurance, employment and immigration, or lead to social stigma. The simple act of participating in an HIV vaccine trial may result in someone being labeled as a “high risk” individual, a gay person or a drug user, and discrimination against these and other groups is a very real issue in many places. It is the responsibility of researchers to ensure that vaccine trial participants receive assistance to alleviate the risks of discrimination or other harm that may result.<sup>7</sup> Communities must be closely involved in clinical trial design and implementation.

Researchers also need to ensure that true informed consent is acquired before individuals are enrolled in a vaccine trial. Community members and potential volunteers need to be fully informed about the vaccine trial process and must understand such concepts as “placebo,” “randomization” and “blinding” to be able to truly evaluate whether participation is right for them. Using community educators and peers to help with the community education that accompanies HIV vaccine research will also help increase participants’ understanding and acceptance of vaccine trials.<sup>8</sup>
<h3>what are barriers?</h3>
Much of the expertise to develop and manufacture HIV vaccines rests in private-sector pharmaceutical and biotechnology companies. Yet industry commitment to HIV vaccines has not matched the enormity of the public health need.<sup>9,10</sup> An HIV vaccine will only bring the pandemic under control if it is widely available in the
developing world, where more than 95% of new HIV infections are occurring. People in resource-poor countries have often had to wait a decade or more for vaccines after they have been licensed for use in industrialized nations.<sup>11,12</sup>

There are numerous challenges to HIV vaccine access in addition to price. Marginal health care infrastructures in some developing countries may make it difficult to distribute a vaccine. Even countries that can afford vaccines may not see them as a high priority and may not allocate adequate resources to fund research or vaccine purchase.

Vaccination programs generally focus on children. With HIV, it is sexually active adolescents and adults who will need a vaccine most immediately, necessitating new approaches to immunization. Vaccine acceptance may be problematic in communities where there is a distrust of government or stigma in being associated with HIV/AIDS.
<h3>what needs to be done?</h3>
Public sector funding for research on HIV vaccines has increased in recent years, and additional resources are needed. The private sector must be encouraged to invest in HIV and other priority vaccines through a range of incentives, including direct funding, public support for clinical research infrastructure and product manufacture, and through public/private partnerships.<sup>9</sup> Wealthy governments should commit in advance to purchase AIDS vaccines for people in the developing world. Continued political leadership is needed to prioritize resources for vaccines.

Vaccine trials conducted to date have included HIV prevention education and risk reduction counseling. Vaccine trials can further benefit participants by offering drug treatment services and STD screening and treatment. Combining medical, behavioral and psychological efforts as part of a vaccine initiative can be a powerful tool for combatting the HIV pandemic.

Vaccines are an integral part of an effective disease prevention strategy, and vaccine development is critical in arresting the spread of HIV. Yet, a vaccine alone will not eliminate the social and structural conditions that created and fuel the epidemic. Even when HIV vaccines are available, communities will continue to need quality behavioral interventions to control the HIV epidemic and policies that ensure access to vaccines.

<strong>Prepared by Chris Collins, MPP, AIDS Vaccine Advocacy Coalition</strong>

<hr />

<h2>Says who?</h2>
1. National Institute of Allergy and Infectious Diseases. Challenges in designing AIDS vaccines. May 2003. www.niaid.nih.gov/factsheets/challvacc.htm
2. AIDS Vaccine Advocacy Coalition. Understanding the results of the AIDSVAX trial. May 2003. www.avac.org/pdf/ UnderstandingAIDSVAX.pdf
3. VaxGen Announces Results of its Phase III HIV Vaccine Trial in Thailand: Vaccine Fails to Meet Endpoints. Press release from VaxGen.
www.vaxgen.com/pressroom/
4. Valdiserri RO. Preventing new HIV infections in the US: what can we hope to achieve? Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA. February 10-14, 2003.
5. Bartholow B. Risk behavior and HIV seroincidence in the US trial of AIDSVAX B/B. Presented at the AIDS Vaccine 2003 Conference, New York, NY. September 2003.
6. Vanichseni S, van Griensven F, Phasithiphol B, et al. Decline in HIV risk behavior among injection drug users in the AIDSVAX B/E vaccine trial in Bangkok, Thailand. Presented at the XIV International AIDS Conference, Barcelona, Spain. July 2002.
7. UNAIDS. Guidance Document on Ethical Considerations in HIV Preventive Vaccine Research. June 2002.
8. van Loon KV, Lindegger GC, Slack CM. Informed consent: A review of the experiences of South African clinical trial researchers. Presented at the XIV International AIDS Conference, Barcelona, Spain. July 2002. Abst #TuOrG1170.
9. AIDS Vaccine Advocacy Coalition. How Do You Fight a Disease of Mass Destruction? And Other Questions on the Road to an AIDS Vaccine. May 2003.www.avac.org/pdf/reports/ DiseaseofMassDestruction.pdf
10. Klausner RD, Fauci AS, Corey L, et al. The need for a global HIV vaccine enterprise. Science. 2003;300:2036-2039.
11. Public health considerations for the use of a first generation HIV vaccine: Report from a WHO-UNAIDS-CDC Consultation, Geneva, 20-21 November 2002. AIDS. 2003;17:W1-W10.
12. International AIDS Vaccine Initiative. AIDS Vaccines for the New World: Preparing Now to Assure Access. July 2000. www.iavi.org

<strong>Resources</strong>

AIDS Vaccine Advocacy Coalition (AVAC)
101 West 23rd St. #2227
New York, NY 10011
212/367-1021
www.avac.org

HIV InSite: Vaccine Overview http://hivinsite.ucsf.edu/InSite?page=kb-08-01-11
HIV Vaccine Trials Network http://www.hvtn.org

International AIDS Vaccine Initiative (IAVI)
110 William Street
New York, NY 10038-3901 212/847-1111
www.iavi.org

IAVI vaccine trials database www.iavi.org/trialsdb/basicsearchform.asp

National Institute of Allergy and Infectious Diseases (NIAID)
Division of AIDS Vaccines www.niaid.nih.gov/aidsvaccine
NIAID Vaccine Research Center
www.vrc.nih.gov

<hr />

<strong>January 2004. Fact Sheet #38ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Barbara Adler, Emily Bass, Mark Boaz, Susan Buchbinder, Jose Esparza, Jorge Flores, Paula Frew, Ingelise Gordon, Ashraf Grimwood, Margaret McCluskey, Catherine Slack, Robert Smith, Steven Tierney, Steven Wakefield, Doug Wassenaar, Sandra Wearins, Dan Wohlfeiler.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2004, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revvaccineFS.pdf</url>
	</node>
	<node>
		<title>HIV+ persons</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are HIV+ persons’ HIV prevention needs?</h3>
<h3>revised 9/05</h3>
<h4>do HIV+ persons need prevention?</h4>
Yes. Over 1 million persons in the US are living with HIV/AIDS.<sup>1</sup> Advances in the early diagnosis, treatment and care of HIV+ persons have helped many people enjoy increased health and longer life. Some HIV+ persons have experienced a renewed interest in sexual or drug-using activity. This can place them at risk for acquiring additional STD infections and for transmitting HIV to their uninfected partners.<sup>2</sup> Many HIV+ persons, therefore, require programs to help them stay safe.

Most HIV+ persons are concerned about not infecting others and make efforts to prevent transmission.<sup>3</sup> However, a significant percentage of HIV+ persons struggle with prevention: from 20-50% of HIV+ persons report unprotected sex with partners who are HIV- or whose HIV status they do not know. For many HIV+ persons, the same structural, inter-personal and behavioral challenges that put them at risk for HIV persist beyond their HIV diagnosis and play a role in their inability to prevent HIV transmission.<sup>4</sup>

Prevention with HIV+ persons may include education and skills building interventions, efforts to test more persons who are HIV+ but do not know their status, support and testing for partners of HIV+ persons and integrating prevention into routine medical care.<sup>5</sup>
<h4>how is it different?</h4>
HIV prevention programs with HIV+ persons are different than programs with HIV- persons in that they must address clinical, mental and social support needs as well as build skills to prevent HIV transmission to current and future partners.

<strong>Stigma. </strong>Pre-existing stigma towards gay men, women, drug users, sex workers and persons of color has helped fuel the HIV epidemic in this country by creating social conditions that foster HIV transmission.<sup>6</sup> Added to this is the additional stigma of living with HIV. Previous experience of stigma (coming out as gay or as a drug user) may lead to trauma that impacts the ability to cope with HIV transmission.<sup>7</sup> It is important to address these structural factors to build strength and resiliency in HIV+ communities.

<strong>Disclosure. </strong>One of the foremost concerns for HIV+ persons is how, when, where and to whom to disclose their HIV status.<sup>8</sup> The traditional message has been that HIV+ persons should always disclose their HIV status to partners. In reality, disclosure is complex and difficult. Some HIV+ persons decide not to disclose and not engage in risk behavior. HIV+ persons often fear that disclosure may bring partner or familial rejection, limit sexual opportunities or increase risk for physical and sexual violence. A survey of HIV+ persons found that 42% of gay men, 19% of heterosexual men and 17% of women had sex without disclosing their HIV status.<sup>9</sup> HIV+ persons may disclose differently with doctors, family, friends, work colleagues and sexual and injecting partners.

<strong>Responsibility.</strong> Persons with HIV live with both the experience of being infected (sometimes by someone they love and trust) and the tremendous responsibility of knowing that they can infect other people. Although the subject of responsibility is complex, prevention programs can provide support to HIV+ persons to explore and understand what it means for them individually.<sup>10</sup>
<h4>what can HIV+ persons do?</h4>
Many HIV+ persons are using strategies that limit HIV transmission. One strategy is having sex mainly with other known HIV+ persons.<sup>11</sup> Knowing that your sexual partner is also HIV+ avoids the risk of transmission and allows for sex without consistent condom use. There have been recent concerns about superinfection among HIV+ couples, where one HIV+ person might acquire another strain of HIV from their HIV+ partner. However, superinfection among such couples appears to be rare.<sup>12</sup>

Another strategy is switching from high-risk to lower risk activities. HIV+ persons can avoid high-risk activities such as being an insertive partner (top) during anal and vaginal sex, having sex while menstruating, breastfeeding and sharing syringes. Lower risk activities can be having oral sex and being a receptive partner (bottom).<sup>11</sup>
<h4>what can my agency/clinic do?</h4>
HIV+ persons are a diverse group and require prevention programs that fit their specific needs. Programs need to see the whole person, not just sex and drug use. Relationships, employment, healthcare, housing, stigma and discrimination should be addressed as needed. Listening to HIV+ persons and involving them in the design, delivery and evaluation of programs ensures that programs are relevant and useful.<sup>13</sup>

Prevention programs with HIV+ persons can require institutional change and adjustment for agencies and clinics that may be integrating care and prevention services for the first time. Healthcare clinics may train providers and staff to deliver prevention counseling, link with prevention and social service agencies or provide referrals to agencies. Prevention programs may train staff in treatment and care issues, forge relationships with clinics and service agencies or provide referrals.

It is critical for healthcare providers to maintain a non-judgmental tone about situations and behaviors with HIV+ clients.<sup>14</sup> It is equally important to work in collaboration with HIV+ persons to develop a concrete risk reduction plan based on the client’s needs and abilities.<sup>14</sup> Providers should be supportive, empathic, goal-oriented and focus on a client’s strengths and resiliencies. Prevention programs need to provide clients with the knowledge, skills and resources (such as condoms, clean needles and a plan to decrease alcohol and drug use) to put the risk reduction plan in place.
<h4>what’s being done?</h4>
There are currently many programs and interventions addressing prevention with HIV+ persons in service agency and clinical settings across the US. The following programs are part of the CDC’s Replicating Effective Programs initiative.<sup>15</sup>

Healthy Relationships is a five-session risk-reduction group intervention for men and women. The program focuses on developing decision-making and problem-solving skills for making informed and safe decisions about disclosure and behavior. The groups allow HIV+ persons to interact, examine their risks, develop skills to reduce their risks and receive feedback from others. Participants reported significantly less unprotected intercourse and greater condom use at six-month follow-up.<sup>16</sup>

Choosing Life: Empowerment, Action, Results (CLEAR) offers HIV+ youth 18 one-on-one 90-minute sessions with a counselor. CLEAR seeks to build motivation and enhance self-esteem so that youth can learn to choose healthy activities over self destructive behaviors. CLEAR is divided into three modules: substance use, sexual decision-making and self care. Youth also can choose telephone sessions instead of in person sessions. Youth participating reported having fewer sexual partners, using fewer drugs and feeling less emotional distress.<sup>17</sup> CLEAR is now known as Street Smart.

Partnership for Health trained staff in HIV medical clinics to provide brief, safer-sex counseling supplemented by written information and clinic posters. The program found that counseling emphasizing the negative consequences of unsafe sex helped reduce risky behaviors with patients who reported 2 or more partners.<sup>18</sup>
<h4>what needs to be done?</h4>
Prevention programs with HIV+ persons need to pay attention to structural barriers to safer sexual and drug use behavior. For some HIV+ persons, barriers may include housing instability, lack of access to HIV care and repeated incarceration. The challenges of sexual and drug risk behavior, disclosure and responsibility need to be placed in social and structural contexts that are meaningful to HIV+ persons.

There is a need to further examine how early childhood and adult trauma, sexual abuse, coming out, racism and homophobia affect an HIV+ person’s ability to maintain safer behaviors. More emphasis should be placed on couples and sexual partners, both in research and in prevention programs, because sexual risk behavior among HIV+ persons is often a shared risk decision within couples/partners.<sup>19</sup>

Prevention with positives programs present the opportunity and challenge of forging relationships and integrating services in areas that have not traditionally worked together. Treatment, prevention and social services need to work in tandem, helping clients deal with the multiple issues they may face. Involving HIV+ persons is key.

<strong>Prepared by Kelly Knight MEd and Carol Dawson-Rose RN PhD, CAPS</strong>

<hr />

<h3>Says who?</h3>
1. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #595.
2. Janssen RS, Valdiserri RO. HIV prevention in the Unites States: increasing emphasis on working with those living with HIV. Journal of AIDS. 2004;37:S119-S121.
3. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. Journal of AIDS. 2005;39:446-453.
4. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological and medical findings. AIDS. 2002;16:135-149.
5. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic – United States, 2003. Morbidity and Mortality Weekly Report. 2003;52:329-332.
6. Herek GM, Capitanio JP, Widaman KF. Stigma, social risk, and health policy: public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychology. 2003;22:533-540.
7. Knight KR. With a little help from my friends: community affiliation and perceived social support. In HIV+ Sex. PN Halkitis, CA Gómez, RJ Wolitsky, eds. American Psychological Association; Washington DC. 2005.
8. Parsons JT, Missildine W, Van Ora J, et al. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care and STDs. 2004;18:457-469.
9. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. American Journal of Public Health. 2003;93:949-954.
10. Wolitski RJ, Bailey CJ, O’Leary A, et al. Self-perceived responsibility of HIV-seropositive men who have sex with men for preventing HIV transmission. AIDS and Behavior. 2003;7:363-372.
11. Parsons JT, Schrimshaw EW, Wolitski RJ, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19:S13-S25.
12. Grant RM, McConnell JJ, Herring B, et al. No superinfection among seroconcordant couples after well-defined exposure. Presented at the International Conference on AIDS. 2004. Abst #ThPeA6949.
13. National Association of People with AIDS. Principles of HIV prevention with positives. www.napwa.org/pdf/PWPPrinciples.pdf (Accessed 4/20/06)
14. Dawson-Rose C, Shade SB, Lum P, et al. The healthcare experience of HIV positive injection drug users. Journal of Multicultural Nursing and Health. 2005;11:23-30.
15. www.cdc.gov/hiv/projects/rep/ www.effectiveinterventions.org (Accessed 4/20/06)
16. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine. 2001;21:84-92.
17. Rotheram-Borus MJ, Swendeman D, Comulada WS, et al. Prevention for substance-using HIV-Positive young people: telephone and in-person delivery. Journal of AIDS. 2004;37:S68-S77.
18. Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS.2004;18:1179-1186.
19. Remien RH, Wagner G, Dolezal C, et al. Factors associated with HIV sexual risk behavior in male couples of mixed HIV status. Journal of Psychology and Human Sexuality. 2001;13:31-48.

<hr />

<strong>September 2005. Fact Sheet #37ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Latoya Conner, Keith Folger, Mari Gasiorowicz, Trevor Hart, Gregory Herek, Jessica Merron-Brainerd, Katie Mosack, Judith Moskowitz, Lisa Orban, Robert Remien, Kurt Schroeder, Stephen Trujillo, Tim Vincent.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©Sepetmber 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revPWPFS.pdf</url>
	</node>
	<node>
		<title>Informal caregivers</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Are Informal Caregivers Important in AIDS Care?</h3>
<h4>What do caregivers do?</h4>
Informal caregivers of people with AIDS (PWAs) provide practical help and nursing care at home. They are often the lovers, spouses, friends, or family of someone with AIDS and are not professional care providers. The service they provide is essential to the scope of AIDS care services and saves society great expense.

AIDS care services in the US have shifted from hospital-based care to community-based and in-home care. Rising health care costs and many people’s preference to receive health care, and, when possible, to die at home, have driven this trend. The percentage of AIDS deaths in hospitals decreased from 92% in 1983 to 57% in 1991.<sup>1</sup> Informal caregivers have helped make this shift possible.

Caregivers provide practical support such as shopping, housekeeping, and transportation to clinics, as well as more basic assistance such as help with bathing, going to the bathroom, and feeding. As symptoms worsen, caregivers are also likely to take on more clinical roles such as keeping track of medications, giving injections, inserting catheters, and cleaning wounds.<sup>2</sup> Caregivers often provide front-line medical and mental assessment, being the first to note changes in health and to decide when to go for help. One study found the value of personal care tasks and housework performed by caregivers equaled a per capita value of over $25,000 a year for caregiving.<sup>3</sup>
<h4>Who are AIDS caregivers?</h4>
A national survey found that 3.2% of the entire US adult population have provided care to a friend, spouse, relative, or lover with AIDS. Almost three-fourths of caregivers were under 40 years old. Caregiving was equally distributed across gender, race and ethnic groups among the general population.<sup>4</sup>

Traditionally, parents, spouses and adult daughters have been the caregivers of people with terminal illnesses. With AIDS, family members still provide care in many cases. However, with gay men, it is more often the partners and friends who provide care. A study of 265 British men with AIDS found that 87% had a close friend or partner as primary caregiver.<sup>5</sup>
What are caregiver burdens?

AIDS is prevalent in young and middle-aged people; one in every four new HIV infections occurs in young people under the age of 22.<sup>6</sup> Caregivers, also, are often in their 20s, 30s and 40s. At that age most people are traditionally building relationships and developing careers, not caring for sick people or preparing for the loss of their partner. The stress involved in this “off-time” caregiving can be enormous.<sup>2</sup>

Unlike professional care providers, informal caregivers are often on call 24-hours a day and are not protected by a limited work day or professional distance. Many informal caregivers have never cared for a seriously ill person, nor have they seen someone die. Also, caregivers must learn skills such as how to give shots or insert catheters, often under extremely stressful circumstances.<sup>2</sup>

Many caregivers of AIDS patients are also their sexual partners. This puts them at risk for HIV infection. For HIV-positive caregivers, disease progression symbolizes the loss of their partner as well as their own changing health status. Caregiving also raises the question of who will care for them when they become ill.

Informal caregivers may experience numbness, compassion fatigue, or burnout from losing multiple friends and loved ones to AIDS, or from caring for someone who has been ill for a very long time.

In some communities there is still fear and stigma surrounding HIV disease. In addition, people greatly affected by AIDS are often already stigmatized populations: gay men, injection drug users, African-Americans and Latinos. Caregivers may fear social rejection, loss of job and/or housing and may thus conceal their caregiving status from family, friends, and co-workers.<sup>7</sup>

For women with HIV, having responsibility for children at home may pose a barrier to obtaining caregiving support for themselves. A study of HIV-infected mothers across the US found 46% were the sole caretakers of children. Only 30% knew about child care assistance services, and only 8% had contacted those services.<sup>8</sup> Caregiving for mothers with HIV must include the children as well as the sick mother, and address the welfare of the children after a parent dies. According to one estimate, there could be over 80,000 AIDS orphans in the US by the year 2000.<sup>9</sup>
<h4>What can be done to help?</h4>
Helping caregivers benefits both the caregiver and the patient. Professional clinicians can include the caregiver in the “triad of care”-doctor, patient, caregiver-and train them in simple medical procedures to help improve patient care.<sup>10</sup> Caregivers can benefit from psychological help (like support groups) to help them cope with the emotional roller coaster involved in caring for a terminally ill person. Caregivers may also need support in grieving the death of a loved one.

Some people may be unsure how to act around a person with AIDS, or confused about the best way to show love and support. A study of PWAs identified what they see as helpful and unhelpful actions in caregiving. Helpful actions included expressing love or concern, acting naturally, providing an opportunity for reciprocity and providing encouragement. Unhelpful actions included avoiding interaction, acting embarrassed or ashamed, breaking confidentiality, and criticizing their medical care decisions.<sup>11</sup>

Doctors and clinical staff have an excellent opportunity for primary and secondary prevention with caregivers during medical appointments or home visits.<sup>12</sup> Informal caregivers may benefit from prevention education and assistance in staying HIV-negative. HIV-positive caregivers need information on early treatment of HIV in order to stay healthier longer.

Many organizations have emerged to provide care for AIDS caregivers. Kairos Support for Caregivers and Home Care Companions Inc. in San Francisco, CA, and Gay Men’s Health Crisis in New York City, NY, provide training, educational and emotional support to caregivers with support groups, workshops, and classes. Some religious organizations, such as the HIV/AIDS Ministries Network and the National Episcopal AIDS Coalition, also provide support to caregivers.<sup>13</sup>

In Africa, many different community responses have helped AIDS caregivers. In Rwanda, a Red Cross project trains volunteers to train family caregivers in nursing skills, and to give emotional support. In Kamwokya, Uganda, where 20-30% of people 20-45 years old are HIV-positive, the religious community provides medical and material support to caregivers and also helps break down social tensions and unfounded fears in the community.<sup>14</sup>

The UCSF Coping Project, in San Francisco, CA, has been studying the physical and psychological well-being of gay male caregivers for over five years. The project found that while caregivers experience stress and depression, they also experience positive feelings associated with loving, caring and comforting. To sustain this positive well-being, the Coping Project suggests three techniques: define what is personally meaningful and valued by the caregiver; facilitate intimacy and conversation between caregivers and their partners; and help caregivers tune in to “brief human moments” that create positive feelings.<sup>2</sup> The UCSF Care Study has also been following the caregiving experiences of over 600 friends, partners and family members.<sup>15</sup>

Prepared by Pamela DeCarlo and Susan Folkman, PhD
<h4>**********
Says Who?</h4>
1. Kelly JJ, Chu SY, Buehler JW. AIDS deaths shift from hospital to home . American Journal of Public Health. 1993;83:1433-1437.

2. Folkman S, Chesney MA, Christopher-Richards A. Stress and coping in caregiving partners of men with AIDS . Psychiatric Manifestations of HIV Disease. 1994;17:35-53.

Contact: Susan Folkman 415/597-9156.

3. Ward D, Brown MA. Labor and cost in AIDS family caregiving . Western Journal of Nursing Research. 1994;16:10-22.

4. Turner HA, Catania JA, Gagnon J. The prevalence of informal caregiving to persons with AIDS in the United States: caregiver characteristics and their implications . Social Science and Medicine. 1994;38:1543-1552.

5. McCann K, Wadsworth E. The role of informal carers in supporting gay men who have HIV related illness. What do they do and what are their needs? AIDS Care. 1992;4:25-34.

6. Rosenberg PS, Biggar RJ, Goedert JJ. Declining age at HIV infection in the United States . New England Journal of Medicine. 1994;330:789-790.

7. Raveis VH, Siegel K. The impact of care giving on informal or familial care givers. AIDS Patient Care. 1991;39-43.

8. Schable B, Diaz T, Chu SY, et al. Who are the primary caretakers of children born to HIV-infected mothers? Results from a multi-state surveillance project . Pediatrics. 1995;95:511-515.

9. Michaels D, Levine C. Estimates of the number of motherless youth orphaned by AIDS in the United Sates. Journal of the American Medical Association. 1992;268:3456-3461.

10. Rabkin J, Remien R, Wilson C. Good Doctors, Good Patients: Partners in HIV Treatment. New York: NCM Publishers, Inc.;1994.

Contact: Robert Remien 212/966-2375.

11. Hays RB, Magee RH, Chauncey S. Identifying helpful and unhelpful behaviours of loved ones: the PWA’s perspective . AIDS Care. 1994;6:379-392.

12. D’Arrigo,T. When the caregiver has HIV: early intervention through home care . Caring. 1994;13:4,7,80.

Contact: Caring Magazine 202/547-5277.

13. Contacts:

Kairos Support for Caregivers 415/861-0877;
Home Care Companions, Inc 415/824-3269;
Gay Men’s Health Crisis 212/337-3524;
HIV/AIDS Ministries Network 212/870-3909;
National Episcopal AIDS Coalition 202/628-6628.

14. Anderson S. Community responses to AIDS . International Nursing Review. 1994;41:57-60.

<strong>Contact:</strong>

UCSF Care Study, Joe Mullan 800/350-8660.

Other caregiver resources:

Shelby D. If A Partner Has AIDS: Guide to Clinical Intervention for Relationships in Crisis. Binghamton, NY: Harrington Park Press;1992.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©1996, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/caregiverFS.pdf</url>
	</node>
	<node>
		<title>Prevention in health care settings</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How can HIV prevention be integrated into health care settings?</h3>
Prepared by Carol Dawson-Rose RN PhD, Janet Myers PhD MPH, and Karen McCready MA; CAPS
Fact Sheet 68, July 2010
<h4>Why is HIV prevention important in health care settings?</h4>
HIV prevention is an important part of health care for all individuals. It is particularly key for those at risk of becoming infected, as well as for those who are already infected, who can then avoid transmitting HIV to others and stay healthy themselves. Many strategies can be used in health care settings to optimize HIV prevention, including: assessing HIV risk; enhancing access to HIV testing; providing HIV-infected patients with disclosure and partner services; screening and treating patients for problem drinking, drug use and sexually transmitted infections (STIs); and providing the best possible care to HIV-infected individuals including access to anti-retroviral therapy (ARVs) and adherence counseling.
<h4>Do health care settings have a role in finding new infections?</h4>
Health care settings are important sites for providing access to HIV testing and prevention messages, for finding new infections and for linking infected individuals into HIV care. In 2006, the CDC issued guidelines for primary health care providers suggesting expanded access to HIV testing for all patients 13 to 64 years old.<sup>1</sup> Providing HIV testing as a routine part of care has been most productive in emergency room and labor and delivery settings,<sup>2,3</sup> although community health centers have also provided important new access.<sup>4</sup> Testing programs have also proven effective in helping pregnant women to not transmit HIV to their babies.<sup>3</sup>

One key strategy for expanding testing is rapid test technology.<sup>5</sup> Rapid tests allow providers to perform a test and deliver the results in under an hour, although a confirmatory test is required for positive rapid test results. Appropriate follow-up care can be planned before the patient leaves the health care facility.

Especially when HIV testing is newly introduced, providers in health care settings need to learn how to integrate HIV testing into regular care, and to refer patients for additional support services if needed. Providers should also be trained in documenting test results to ensure they are shared with other health care providers and to maintain the confidentiality of client information.

Providers must ensure that HIV-infected persons get the care and support they need. Linkage to care is an important and often overlooked piece of integrating HIV testing into health care. Individuals who are just finding out they are infected often need a great deal of help and support to find an HIV provider, to make an appointment and to show up at that appointment. Intensive case management models show promise in enhancing linkages to care for newly-diagnosed individuals.<sup>6</sup>
<h4>What other HIV prevention strategies work in health care settings?</h4>
<strong>Risk assessment.</strong> Assessing HIV risk behaviors should be a standard part of new patient intake, regardless of HIV status. In-depth HIV prevention education is not necessary for every patient. However, health care providers should ask all patients about their sexual behavior, condom use, number of sexual partners, and alcohol and illicit drug use to assess a patient’s risk for acquiring or transmitting HIV. These quick questions may lead to longer discussions and counseling about safer sex or alcohol and drug use practices.<sup>7</sup>

<strong>Drug treatment.</strong> Helping patients get into alcohol or drug treatment can be an effective HIV prevention tool and can help HIV-infected persons stay healthy. Health care providers can have a profound effect on patients’ lives by showing an interest in drug-using patients and encouraging willing patients to enter drug or alcohol treatment programs. Because relapse is common in treating addictions, health care providers should use a non-judgmental approach.

<strong>Screening and treating for STIs.</strong> Providers should encourage screening for STIs. They should also provide STI education, emphasize the link between HIV and STIs, and encourage screening for partners.<sup>9</sup>
<h4>How does positive prevention work in health care settings?</h4>
<strong>Prevention counseling.</strong> Brief prevention counseling delivered in health care settings at every visit has been shown to decrease the likelihood that HIV-infected individuals transmit HIV to others, particularly if interventions are tailored to sub-populations of HIV-infected patients.<sup>10</sup> Important messages include: helping people understand the relative risks of their actions and the effectiveness of different prevention strategies such as using condoms; disclosing HIV status to sex and drug using partners; and understanding their responsibility with regard to prevention. Formal provider training is important to facilitate these approaches.<sup>11,12</sup>

<strong>Viral suppression.</strong> A unique component that health care settings play in HIV prevention is helping HIV-infected persons find and adhere to an effective ARV regimen to help keep their viral load low. Some research has demonstrated that keeping the viral load below a threshold that is detectable with lab tests can help prevent up to 60% of new STIs.<sup>13</sup> New research suggests that effective detection of HIV and treatment to reduce the viral load could reduce the overall community viral load and have a population-level impact on HIV transmission.<sup>14</sup>
<h4>How can HIV prevention capacity be increased in health care settings?</h4>
<strong>Risk assessment.</strong> Knowing how to assess risk among patients is key to HIV prevention of any kind. Having risk assessment tools and training providers to use them is critical.

<strong>Written protocols.</strong> It is important to make sure that procedures are in place to guide testing efforts in health care settings.<sup>15</sup> Having a “prevention plan” tailored to the clinic size, the service delivery model, the types of providers and the patient population is critical.

<strong>Leadership. </strong>Successful clinic programs often have identified staff leaders who function as counselors or team leaders for positive prevention.<sup>16</sup>

<strong>Training.</strong> Underlying all of these important components is training. Training can facilitate buy-in from clinic providers and can address provider attitudes and beliefs about risk reduction and counseling.<sup>17</sup> Training should outline staff responsibilities and anticipate changes to clinic flow.<sup>16</sup>
<h4>What are effective models for use in health care settings?</h4>
Positive STEPs<sup>17</sup> is a training intervention to help HIV care providers deliver prevention counseling to their patients. The model was effective in improving provider attitudes, comfort, self-efficacy and frequency of delivering prevention counseling.

Partnership for Health<sup>18</sup> is an EBI (CDC’s Effective Behavioral Intervention) for providers in HIV clinics. Medical providers are trained to deliver brief risk-reduction counseling to their patients. All clinic staff are trained to integrate prevention messages into the clinic setting, and counseling is supplemented with written information for all patients. The intervention was effective in reducing unprotected intercourse by 38% among patients who had two or more sexual partners.

Positive Choice<sup>19</sup> is an interactive “Video Doctor.” Patients at HIV clinics completed an in-depth computerized risk assessment and received tailored risk-reduction counseling from a “Video Doctor” via laptop computer and a printed educational worksheet. Providers received a Cueing Sheet on reported risks for discussion during the clinical encounter.

Provider-Delivered Counseling.<sup>10,16</sup> In a large federal demonstration project, brief counseling messages delivered by primary care providers in clinic settings were most effective in reducing risk among HIV-infected patients, although there were also benefits in programs delivered by prevention specialists and HIV-infected peers.
<h4>What needs to be done?</h4>
Health care providers need more and repeated training on how HIV prevention can be integrated into the care they deliver. There are still significant misperceptions among health care providers about who should be tested for HIV and when to implement rapid testing. Provider attitudes, beliefs and self-efficacy can affect whether or not they address prevention through HIV testing or by providing risk-reduction counseling. Methods that enhance provider uptake of HIV prevention in health care delivery settings need attention and further research.

Leaders in health care settings can establish written protocols that guide HIV prevention practices, including HIV testing in their clinics. Establishing protocols, documentation and quality assurance practices can enhance testing and prevention practices in all types of health care settings.

<hr />

<h3>Says who?</h3>
1. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.Morbidity and Mortality Weekly Report. 2006;55:1-17.

2. Haukoos JS, Hopkins E, Byyny RL, et al. Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings. Annals of Emergency Medicine. 2008;51:303-309.

3. Tepper NK, Farr SL, Danner SP, et al. Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study. American Journal of Obstetrics and Gynecology. 2009;201:31-36.

4. Myers JJ, Modica C, Bernstein C, Kang M, McNamara K. Routine rapid HIV screening in six Community Health Centers serving populations at risk. Journal of General Internal Medicine. 2009;24:1269–1274.

5. Branson BM. State of the art for diagnosis of HIV infection. Clinical Infectious Diseases. 2007;15:S221-225.

6. Christopoulos K, Koester K, Weiser S, et al. A comparative evaluation of the development and implementation of three emergency department HIV testing programs (forthcoming)

7. Schechtel J, Coates T, Mayer K, et al. HIV risk assessment: physician and patient communication. Journal of General Internal Med. 1997;12:722-723.

8. Bruce RD. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy. 2010;21:122-124.

9. McClelland RS, Baeten JM. Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals. Journal of Antimicrobial Chemotherapy. 2006;57:163-166.

10. Myers JJ, Shade S, Dawson Rose C, et al. Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV. AIDS and Behavior. 2010;14:483-492.

11. Gilliam PP, Straub DM. Prevention with positives: A review of published research, 1998-2008. Journal of the Association of Nurses in AIDS Care. 2009;20:92-109.

12. Harder &amp; Co. Community Research. Prevention with positives: Best practices Guide. Prevention with Positives Workgroup. 2009.

13. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81-88.

14. Das M, Chu PL, Santos G-M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5:e11068.

15. Myers JJ, Steward, WT, Koester KA, et al. Written procedures enhance delivery of HIV “prevention with positives” counseling in primary health care settings. Journal of AIDS. 2004;37:S95-S100.

16. Koester KA, Maiorana A, Vernon K, et al. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: Challenges and lessons learned. AIDS and Behavior. 2007;1:S17-S29.

17. Thrun M, Cook PF, Bradley-Springer LA, et al. Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs. AIDS Education and Prevention. 2009;21:55-66.

18. Richardson J, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS. 2004;18:1179-1186.

19. Gilbert P, Ciccarone D, Gansky SA, et al. Interactive “Video Doctor” counseling reduces drug and sexual risk behaviors among HIV+ patients in diverse outpatient settings. PLoS One. 2008;3.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Lucy Bradley-Springer, Kimberly Carbaugh, Mark Cichocki, Renata Dennis, Josh Ferrer, Mark Molnar, Quentin O’Brien, Jim Sacco.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©July 2010, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.Web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/healthcaresettingsFS.pdf</url>
	</node>
	<node>
		<title>Superinfection</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What do we know about HIV superinfection?</h3>
revised 5/06
<h4>what is dual infection, co-infection, superinfection?</h4>
Dual infection is when a person is infected with two or more strains of HIV. That person may have acquired both strains simultaneously from a dually infected partner or from multiple partners. A different strain of the virus is one that can be genetically distinguished from the first in a “family” or phylogenetic tree.

Acquisition of different HIV strains from multiple partners is often called co-infection if all the virus strains were acquired prior to seroconversion, that is, very early before any HIV infection is recognized.

Acquisition of different HIV strains from multiple partners is called superinfection if the second virus is acquired after seroconversion when the first virus strain already has been established.<sup>1</sup> Superinfection and re-infection mean the same thing.

Dual infections can be sequentially expressed, which can make co-infection look like superinfection. Sequentially Expressed Dual Infections (SEDI) may occur because immune responses against the predominant virus may allow other virus strains in the body to be expressed. Random shifts in evolving virus populations can also occur, which could look like superinfection even though dual infection was present from the beginning.
<h4>why does superinfection matter?</h4>
Superinfection is a concern because it may be a way for someone who is HIV+ to acquire drug resistance, and it may lead to more rapid disease progression.<sup>2,3</sup> Research on when superinfection may or may not occur could identify types of immune responses that may protect against infection. This could guide the development of HIV vaccines.

People who are HIV+ and have HIV+ partners often ask about superinfection. Public health officials need information about superinfection in order to craft messages that help people understand the possible risks of unprotected sexual intercourse among HIV+ persons, without creating undue anxiety that could undermine rewarding relationships between HIV+ persons and disclosure of HIV status with prospective new partners.
<h4>does superinfection occur?</h4>
Many scientists believe that superinfection can occur. Research in monkeys has indicated that superinfection with viruses like HIV can occur.<sup>4,5</sup> Sixteen people with SEDI (apparent superinfection) have been reported in the scientific literature, including injection drug users in Asia, women in Africa, and men in Europe and the US. Laboratory analysis in some of these reports suggested that the second virus that appeared in these individuals was not present earlier in the course of infection, which suggests superinfection. The sensitivity of these laboratory assays is limited, and source partners have not been identified, so there is no way to know for sure when the second virus was acquired.
<h4>who is at highest risk?</h4>
Ninety-five percent of apparent superinfection cases have occurred during the first three years of infection.<sup>6-9</sup> Studies have found evidence of superinfection in 2 to 5% of persons in the first year of infection. Intermittent treatment in acute or recent HIV infection may prolong superinfection susceptibility.<sup>10-11</sup>

In contrast, studies in persons with longer term infection have found no evidence of superinfection. One study found no cases after 1,072 person-years of observation.<sup>12</sup> Another found none after 215 person-years of observation among intravenous drug users.<sup>13</sup> A third found none after 233 person-years and 20,859 exposures through unprotected sex.<sup>14</sup>

It is possible that people with very low viral load in their blood may be more susceptible to superinfection. Low viral load in the blood can occur during combination antiretroviral therapy or in “healthy non-progressors.” Antiviral immune responses and viral interference is lower in persons with low viral load, so superinfection may occur more frequently.<sup>15</sup> More research is needed to know for sure.
<h4>is it bad to have more than one virus?</h4>
Dual infection can have a harmful effect on the health of HIV+ persons. Superinfected individuals may have higher viral loads and lower CD4 counts, which causes more rapid disease progression.<sup>2,3</sup> Disease progression can accelerate after a second virus appears.<sup>1</sup>

Superinfection may also affect treatment of HIV, as it increases the likelihood of drug resistance.<sup>16</sup> HIV+ persons with dual infection may not respond as well to available antiretroviral medication due to resistant strains.
<h4>what don’t we know?</h4>
There is a lot we still do not know about superinfection. First of all, we need to be more sure whether superinfection actually occurs between HIV+ persons. A definitive case of superinfection has not been documented, which would require that the timing of the second infection be traced to initiation of a relationship with a new sexual partner.

Second, we need to understand how and when superinfection occurs. Among researchers some consensus is developing about the idea that HIV+ persons in early infection–and particularly the first year of infection–may be at higher risk for superinfection than HIV+ persons with chronic infection.<sup>17</sup> We also should determine whether persons with suppressed viral load on treatment are susceptible to superinfection.

Third, we need to know how to protect against superinfection. If superinfection is rare, or if it only happens in recent infection, it is important to determine what mechanisms make an HIV+ person immune to acquiring a second virus. It would be important to know if exposure to different viral strains may provide protective immunity against superinfection.<sup>18</sup>

Lastly, we must continue to provide up-to-date scientific data on superinfection, its causes and consequences to HIV+ persons and healthcare professionals who work with them.
<h4>what can we recommend right now?</h4>
Counseling about superinfection should be based on understanding the individual’s sexual relationships. Before providing advice about superinfection, the counselor should know whether the individual is in a continuing relationship with another HIV+ partner, whether the person routinely seeks out other HIV+ partners for unprotected sex, and whether there is disclosure of HIV status with prospective partners. This background should inform the discussion about the risks and benefits of sex among HIV+ partners. If the counselor does not have time to consider these personal issues, it would probably be best to simply say that “There is not enough information available about superinfection. If superinfection occurs at all, it probably occurs in the first few years after infection. After that, it may be rare.”

Even less is known about superinfection as a result of sharing needles, although it is reasonable to expect that the same pattern of initial high risk followed by low risk during chronic infection may occur. However, because intravenous drug users are at high risk of hepatitis C infections from sharing needles, efforts to obtain clean needles through needle exchange should always be emphasized.

Interested persons should be referred to on-going research studies so that important gaps in information can be filled.<sup>19</sup>

People with multiple sexual partners, or partners with multiple partners, should be counseled regarding the risks of other sexually transmitted infections. Vaccination for hepatitis B and periodic testing for syphilis is warranted.

<hr />

<h3>Says who?</h3>
1. Smith DM, Richman DD, Little SJ. HIV superinfection . Journal of Infectious Diseases. 2005;192:438-444.

2. Gottlieb GS, Nickle DC, Jensen MA, et al. Dual HIV-1 infection associated with rapid disease progression . The Lancet. 2004;363:610-622.

3. Grobler J, Gray CM, Rademeyer C, et al. Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype c-infected female sex workers . Journal of Infectious Diseases. 2004;190:1355-9.

4. Otten RA, Ellenberger DL, Adams DR, et al. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina model . Journal of Infectious Diseases. 1999;180:673-84.

5. Fultz PN, Srinivasan A, Greene CR, et al. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus . Journal of Virology. 1987;61:4026-4029.

6. Angel JB, Hu YW, Kravcik S, et al. Virological evaluation of the ‘Ottawa case’ indicates no evidence for HIV-1 superinfection . AIDS. 2004;18:331-334.

7. Smith DM, Wong JK, Hightower GK, et al. Incidence of HIV superinfection following primary infection . Journal of the American Medical Association. 2004;292:1177-1178.

8. Hu DJ, Subbarao S, Vanichseni S, et al. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand . AIDS. 2005;19:303-308.

9. Grant R, McConnell J, Marcus J, et al. High frequency of apparent HIV-1 superinfection in a seroconverter cohort. 12th Conference on Retroviruses and Opportunistic Infections. 2005. Abst #287.

10. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus . Nature. 2002;420:434-439.

11. Jost S, Bernard M, Kaiser L, et al. A patient with HIV-1 super-infection . New England Journal of Medicine. 2002;347:731-736.

12. Gonzales MJ, Delwart E, Rhee SY, et al. Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation . Journal of Infectious Diseases. 2003;188:397-405.

13. Tsui R, Herring BL, Barbour JD, et al. Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure . Journal of Virology. 2004;78:94-103.

14. Grant R, McConnell J, Herring B, et al. No superinfection among seroconcordant couples after well-defined exposure. International Conference on AIDS, Bangkok, Thailand, 2004. Abst #ThPeA6949.

15. Marcus J, McConnell J, Liegler T, et al. Highly divergent viral lineages in blood DNA appear frequently during suppressive therapy in persons exposed to superinfection. 13th Conference on Retroviruses and Opportunistic Infections. 2006. Abst #297.

16. Smith DM, Wong JK, High-tower GK, et al. HIV drug resistance acquired through superinfection . AIDS. 2005;19:1251-1256.16. Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity. AIDS. 2004;18:1513-1520.

17. Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity . AIDS. 2004;18:1513-1520.

18. McConnell J, Liu Y, Kreis C, et al. Broad neutralization of HIV-1 variants in couples without evidence of systemic superinfection. 13th Conference on Retroviruses and Opportunistic Infections. 2006. Abst #92.

19. HIV+ persons who have HIV+ partners residing or visiting San Francisco can call the Positive Partners Study 1-415-734-4878.

<hr />

Prepared by Robert M. Grant MD, J. Jeff McConnell MA

Gladstone Institute of Virology and Immunology, UCSF

<strong>May 2006 . Fact Sheet #56ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Jonathan Angel, Michael Carter, Mark Cichocki, Eric Delwart, Keith Folger, Geoffrey Gottlieb, Luc Perrin, Travis Porco, Peter Shalit, David Spach, Carolyn Williamson, Zenda Woodman.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © May 2006, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revsuperinfectionFS.pdf</url>
	</node>
	<node>
		<title>Apego a tratamientos</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el papel del apego en el tratamiento del VIH?</h3>
<h4>¿por qué es importante el apego?</h4>
La introducción de la terapia antirretroviral sumamente activa o altamente activa, TARSA o TARAA respectivamente (HAART, siglas en inglés) ha extendido y mejorado la calidad de vida de las personas con VIH al disminuir la carga viral, hasta niveles muchas veces imperceptibles. Sin embargo, tras descubrir que estos medicamentos requieren un apego (o adherencia) casi perfecto para evitar la replicación y mutación del virus, el entusiasmo inicial se ha menguado en cierto grado. Estudios han demostrado que la TARSA requiere un apego del 95% para lograr la supresión viral, y que incluso una disminución mínima del apego puede aumentar enormemente la carga viral.<sup>1</sup>

Si se permite la mutación del virus en cepas resistentes a medicamentos, el régimen de tratamiento puede perder su eficacia, lo cual limita las opciones de tratamiento tanto para los individuos con poco apego como para las parejas a quienes les transmitan estas cepas.<sup>2</sup>
<h4>¿cómo se mide el apego?</h4>
Por lo general, el apego se mide mediante el autoinforme del paciente, el recuento de pastillas, el uso de dispositivos electrónicos en la tapa del frasco de medicamentos (tapas MEMS, siglas en inglés) y los análisis de laboratorio.<sup>3</sup> El autoinforme que el paciente provee en visitas médicas, en cuestionarios, en entrevistas o en registros diarios de medicamentos es una manera sencilla y práctica de determinar autopercepción del apego.<sup>4</sup> Pero muchos individuos no recuerdan si tomaron todas las pastillas, o se les olvida anotarlo en el registro todos los días. Otros pueden fingir un mayor apego para quedar bien con el entrevistador o con el proveedor médico. Asimismo, los registros podrían tener poca utilidad entre personas analfabetas.

El recuento de pastillas, especialmente si se hace sin aviso previo, puede ofrecer una evaluación más exacta del nivel de apego que el autoinforme. Sin embargo, este método demanda mucho tiempo y puede percibirse como una intromisión, especialmente si se realiza durante una visita no programada a la casa del paciente. En estos casos, podría ser mejor contar las pastillas en la clínica. Las tapas MEMS registran cada ocasión en la que el paciente quita la tapa al frasco. Se ha demostrado una correlación estrecha entre la carga viral concurrente y el número de veces que se abre la tapa. Sin embargo, son costosas y pueden subestimar el apego en pacientes que saquen más de una dosis a la vez para guardarlas en organizadores de pastillas (Medi-sets).<sup>6</sup> Todos estos métodos suponen que los pacientes de hecho se han tomado todas las pastillas extraídas del frasco.

Los análisis de laboratorio miden el apego indirectamente y pueden incluir la carga viral, el recuento de las células CD4 y los niveles sanguíneos de metabolitos de los medicamentos. Estas mediciones son menos frecuentes y muy costosas. Los resultados no indican concretamente el número de dosis omitidas ni el apego al horario de los medicamentos, y pueden ser afectadas por otros factores tales como la presencia de un virus resistente a medicamentos. No obstante, muchas veces los análisis de laboratorio se consideran útiles para medir el apego cuando se usan en combinación con el autoinforme del paciente o el recuento de pastillas.
<h4>¿cuáles son los obstáculos?</h4>
Es difícil seguir estrictamente un régimen de medicamentos. La mayoría de las personas tienen problemas hasta para terminar una dosis de antibióticos de 5 días. El apego se dificulta aun más cuando se toman varios medicamentos con dosis diferentes y efectos secundarios intensos y molestos como la diarrea, los daños nerviosos y los cambios en la composición corporal. La vida de muchas personas con VIH se complica por otros factores que les impiden dar prioridad al apego, tales como los trastornos de la salud mental, los problemas económicos y el uso de alcohol o drogas.

Se destacan comúnmente tres tipos de obstáculos al apego: los que son específicos del régimen, los sociales/psicológicos y los institucionales.<sup>7</sup> Las dificultades debidas al régimen, como la complejidad del tratamiento y la necesidad de tomar numerosas pastillas en diferentes horarios, así como los efectos secundarios de los medicamentos, pueden causar que se pierdan algunas dosis.<sup>8</sup> Las exigencias del tiempo, tales como el trabajo, los viajes y el horario de las comidas también pueden ser barreras.

El apego se ve afectado por factores sociales y psicológicos. Los trastornos de la salud mental (como la depresión o la angustia); las actitudes hacia el tratamiento y hacia el VIH; y el apoyo de los trabajadores de salud, familiares y amigos juegan un papel clave.<sup>9</sup> Las reacciones positivas fomentan el apego mientras que las negativas (la falta de apoyo, el pesimismo) pueden impedirlo.

Los factores institucionales como el encarcelamiento, el ambiente de la clínica y el acceso a servicios médicos y medicamentos confiables afectan al apego. Los factores que promueven el apego son un ambiente clínico agradable, un horario conveniente de citas, la confidencialidad, y la disponibilidad del transporte y del cuidado infantil.<sup>10</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Action Point, un centro de servicios sin cita previa en San Francisco, CA, promueve el apego en personas pobres con adicción activa a las drogas o al alcohol. Ubicado en un local que da a la calle en una zona donde los arrestos y muertes relacionadas con las drogas son muy frecuentes, Action Point opera 6 días por semana empleando un principio de reducción de daños que alienta cualquier cambio que mejore la salud. El programa ofrece manejo de casos de apego, surtido de recetas médicas, servicios de enfermería, acupuntura y recomendaciones a servicios de salud mental y del abuso de drogas o alcohol. Un mes después de la inscripción, los clientes reciben un localizador (pager) con correo electrónico para recordarles de tomar sus medicamentos. Después de seis meses, el 61% de los participantes de Action Point tomaban la terapia TARSA y el 81% de éstos reportaron un apego superior al 90%.<sup>11</sup>

En Nueva York, pacientes que nunca habían tomado TARSA participaron en un programa de tres módulos: conocimientos básicos del VIH, apego y opciones de tratamiento. Los consejeros hablaron a fondo con cada paciente sobre los posibles obstáculos al apego, las toxicidades esperadas, el trabajo de tomar las pastillas, los intervalos de las dosis y las preferencias de medicamentos. Luego de evaluar esta información, la reportaron al proveedor médico quien la aprovechó para formular un régimen individualizado. Los pacientes recibieron herramientas tales como pastilleros, tarjetas de dosificación y localizadores (bípers), según la necesidad. Tuvieron seguimiento intensivo y una línea telefónica para consultas. El programa incrementó el apego y mejoró la respuesta virológica.<sup>12</sup>

Una estrategia prometedora para promover el apego es la terapia de observación directa o TOD (DOT, siglas en inglés) que para los antirretrovirales sería TODARSA (DAART, siglas en inglés). Basada en la TOD para la tuberculosis, la TODARSA se ha usado con pacientes que tienen contacto frecuente con los trabajadores de salud, como por ejemplo en las prisiones y clínicas de metadona. Una de las complicaciones del uso de la TODARSA es la necesidad de tomar los medicamentos de por vida y por lo general más de una vez al día.<sup>13</sup>
<h4>¿qué podemos hacer?</h4>
El apego a la TARSA es un proceso complicado, por lo que las intervenciones que logren aumentarlo tendrán un diseño multifacético. Se deben considerar, entre otros factores, la complejidad del régimen, los efectos secundarios, los factores asociados al paciente y hasta la relación paciente-trabajador médico, ya que todos juegan un papel en el apego al tratamiento. En general, cuanto más el régimen “se ajuste” al estilo de vida del paciente, mayor será el apego.<sup>14</sup>

Los trabajadores de salud pueden ayudar a incrementar el apego haciendo lo siguiente: involucrar al paciente en la selección de un régimen con horarios tolerables de dosificación; anticipar y manejar los efectos secundarios, identificar y tratar los problemas de salud mental y uso de drogas; responder a obstáculos concretos tales como la falta de transporte o vivienda; proporcionar recursos que estimulen la memoria y anticipar la fatiga debido al tratamiento prolongado.<sup>15</sup>

Los pacientes pueden ayudar aprendiendo más sobre el VIH, los medicamentos para tratarlo, y cómo funcionan éstos; fijándose metas no relacionadas con el VIH (ver crecer a sus hijos, mantenerse sanos y luciendo bien, etc.); reclutando amigos o familiares que vigilen su apego y anticipando los cambios de rutina, como por ejemplo los viajes.<sup>15</sup>
<h4>¿qué queda por hacer?</h4>
Con el apoyo adecuado, toda persona VIH+ puede apegarse al tratamiento. Muchas personas VIH+ no sólo combaten el VIH, sino también la drogadicción, la falta de vivienda o el encarcelamiento. Con el tratamiento y las herramientas adecuadas, muchos de los obstáculos al apego se pueden superar. Por ejemplo, la depresión y otros trastornos mentales que impiden el apego óptimo deben ser diagnosticados y tratados, lo cual es posible en muchos casos.

La complejidad del apego muchas veces requiere “un equipo de apego”. La colaboración entre pacientes, médicos, manejadores de casos, trabajadores sociales, farmacéuticos, consejeros y familiares o amigos es esencial.

<hr />

<h4>¿quién lo dice?</h4>
1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine. 2000;133:21-30.

2. Bangsberg DR, Deeks SD. Is average adherence to HIV antiretroviral therapy enough? Journal of General Internal Medicine. 2002;17:812-813.

3. Fogarty L, Roter D, Larson S et al. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Education and Counseling. 2002;46:93-108.

4. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care. 2000;12:255-266.

5. Samet JH, Sullivan LM, Traphagen ET, et al. Measuring adherence among HIV-infected persons: is MEMS consummate technology? AIDS and Behavior. 2001;5:21-30.

6. Wendel CS, Mohler MJ, Kroesen K, et al. Barriers to use of electronic adherence monitoring in an HIV clinic. The Annals of Pharmacotherapy. 2001;35:1010-1015.

7. Ickovics JR, Meade CS. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care. 2002;14:309-318.

8. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 2001;28:47-58.

9. Gordillo V, Del Amo J, Soriano V, et al. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-1769.

10. Ciccarone D, Bangsberg D. , Bamberger J, et al. HIV-Related hospitalization before and during participation in ‘Action Point’ an adherence case management program. Presented at the American Public Health Association Conference. 2003.

11. Bamberger JD, Unick J, Klein P et al. Helping the urban poor stay with antiretroviral HIV drug therapy. American Journal of Public Health. 2000;90:699-701.

12. Esch L, Hardy H, Wynn H, et al. Intensive adherence interventions improve virologic response to antiretroviral therapy (ART) in naive patients. Presented at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL. 2001. Abst #481.

13. Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? AIDS Patient Care and STDs. 2002;16:527-535.

14. Chesney MA, Malow RM. Adherence in Chronic Diseases: Lessons learned from HIV/AIDS. World Health Organization volume on Adherence in Chronic Diseases. in press

15. Bartlett JA. Addressing the challenges of adherence. Journal of Acquired Immune Deficiency Syndromes. 2002;29:S2-S10.

Información sobre cómo el apego afecta en la prevención en la Hoja Informativa #27 “¿Las nuevas medicinas afectan la prevención del VIH?”

<hr />

<strong>Preparado por Maria Ekstrand, Michael Crosby y Pamela DeCarlo, CAPS</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Abril 2003. Hoja Informativa 47S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/apegoFS.pdf</url>
	</node>
	<node>
		<title>Efecto del tratamiento en la prevención</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué efecto tiene el tratamiento en la prevención del VIH?</h3>
<h4>¿porqué tratamiento con prevención?</h4>
Tradicionalmente, los programas de prevención del VIH se han centrado en las personas no infectadas que corren riesgo de contraer el VIH, motivándolas a adoptar y mantener prácticas más seguras en las relaciones sexuales y en el consumo de drogas para que continúen sin infectarse. Se ha puesto menos atención a la prevención entre las personas ya infectadas, pues la prioridad de su atención médica ha sido mantener su salud frente a una enfermedad devastadora. Los programas de prevención y sus prestadores de servicios eran distintos y separados de los del tratamiento. Aunque tal división siempre ha sido miope (naturalmente, la conducta tanto de las personas VIH+ como las de VIH- influye en la transmisión), hoy en día cuando existen mejores tratamientos contra el VIH, es aun más importante compaginar la prevención y la atención médica.

El uso del tratamiento más eficaz, conocido como terapia antirretroviral (por sus siglas en español TAR o en inglés ART–término que está sustituyendo al de “terapia antirretroviral sumamente activa o altamente activa” conocido en español como TARSA o TARAA y en ingles como HAART) puede tener diferentes efectos sobre la prevención del VIH. Por una parte, la TAR ha ampliado radicalmente el tiempo de supervivencia y el bienestar físico de la gente con VIH/SIDA; aumentando así, las oportunidades de transmisión del virus a otros. Por otra parte, el tratamiento podría disminuir la transmisión del VIH al reducir la cantidad del virus en la sangre y las secreciones genitales.

La disponibilidad y uso de la TAR también puede haber producido cambios de actitud que pueden tanto ayudar como impedir la prevención del VIH. Los esfuerzos de prevención deberán realizar una cuidadosa evaluación y consideración de los posibles efectos positivos y negativos de la TAR en la transmisión del VIH.
<h4>¿beneficia el tratamiento a la prevención?</h4>
Existen muchas evidencias sobre el efecto benéfico de la TAR en la prevención del VIH, tanto en la adquisición de la infección entre personas VIH- como en su transmisión entre personas VIH+. Primero, se ha comprobado que la provisión cercana al parto del tratamiento antirretroviral a mujeres VIH+ y a sus bebés reduce la transmisión madre-hijo<sup>1</sup>. Se piensa que el tratamiento funciona al disminuir la infecciosidad de la madre o al impedir que la infección se establezca en el bebé.
Segundo, un seguimiento a trabajadores médicos expuestos al VIH por pinchazos de agujas u otro contacto accidental con líquidos corporales encontró que las personas que tomaron antirretrovirales por medio de la profilaxis postexposición (PPE sus siglas en español/PEP en inglés) tenían menos probabilidades de resultar infectadas que quienes no la tomaron.<sup>2</sup> Esta idea se extiende al uso de la PPE para prevenir el VIH en episodios de sexo sin protección o al compartir jeringas.<sup>3</sup>

El tercer planteamiento es indirecto. La TAR puede causar una reducción dramática en los niveles de virus en la sangre, al grado de que resulta indetectable a las pruebas actuales. Aunque no existe una relación uno-a-uno, los niveles reducidos de VIH en la sangre tienden a coincidir con niveles reducidos del virus en las secreciones genitales.<sup>4,5</sup> Un estudio en África observó que una carga viral baja se traducía en una reducción de la posibilidad de transmisión sexual; cuando la pareja infectada tenía una carga viral inferior a 1500 copias por ml. no se observó ninguna transmisión del VIH entre parejas discordantes.<sup>6</sup> Se especula que si el tratamiento logra disminuir los niveles sanguíneos del virus hasta por debajo de este nivel, también podrá evitar la transmisión del VIH. Aunque atractiva, esta conclusión no ha sido comprobada.

Aun cuando el VIH sea indetectable en pacientes que reciben TAR, éstos mantienen residuos del VIH en muchos tejidos corporales, en las células y en la sangre.<sup>7</sup> Si bien una carga viral baja probablemente reduce la infecciosidad, las cargas virales varían al paso del tiempo debido a los cambios en el apego (o adherencia) al tratamiento, al desarrollo de resistencia medicamentosa o a la evolución natural de la infección. Aunque las evidencias sugieren que el tratamiento puede disminuir la infecciosidad, no la elimina en todo momento. Hasta que no se definan bien las condiciones en las que una persona VIH+ no resulte infecciosa, vale más partir del supuesto de que potencialmente será infecciosa de por vida.<sup>8</sup>

En otro plano, la TAR ayuda a la prevención al brindar esperanza a las personas afectadas por el SIDA. Existe un mayor incentivo para hacerse la prueba del VIH (y por tanto a la consejería de la reducción del riesgo) cuando el tratamiento eficaz del VIH está disponible; y un mayor desincentivo, cuando éste no se ofrece, especialmente donde existe mucho estigma en torno al VIH. Sin tratamiento, las comunidades devastadas por la muerte y la enfermedad pueden creer que la infección por VIH es inevitable y dar poca prioridad al cuidado personal y a la prevención. Un estudio realizado en Baltimore, MD, encontró que los cuidadores informales tendían más a promover mensajes de prevención en la comunidad cuando sus amigos y familiares tenían acceso al tratamiento del VIH, lo cual les brindó esperanza por el futuro.
<h4>¿puede el tratamiento perjudicar la prevención?</h4>
Tanto las personas VIH+ como las VIH- han venido teniendo relaciones sexuales o inyectándose drogas desde el comienzo de la epidemia, antes de la introducción de la TAR. Sin embargo en los últimos años, se han visto aumentos en las enfermedades de transmisión sexual (ETS) en los EE.UU. y otros países desarrollados <sup>9-12</sup>lo que podría señalar un futuro incremento en las infecciones de VIH. Es difícil determinar si ésto se debe o no a los avances en el tratamiento.

En varias ciudades de los EE.UU., han ocurrido brotes de sífilis entre hombres que tienen sexo con hombres (HSH). Casi la mitad de los hombres afectados por estos brotes eran VIH+ y muchos recibían tratamiento. En San Francisco, CA, la adquisición de una ETS posterior al diagnóstico de SIDA fue asociada al uso de la TAR<sup>10</sup>. Las ETS pueden promover la transmisión del VIH al aumentar la infecciosidad del virus de las personas VIH+ y al incrementar la susceptibilidad al virus en las personas VIH-.<sup>13</sup>

En los últimos años, internacionalmente se han documentado aumentos en las prácticas sexuales de riesgo y en el número de ETS tanto entre los HSH VIH- como en los VIH+. Desde 1996 en Londres, Manchester y Brighton, Inglaterra; en Ámsterdam, Holanda y en Sydney, Australia, dichas prácticas se han incrementado especialmente entre los HSH.<sup>12</sup>

Éste incremento de conductas sexuales arriesgadas ha generado una acalorada discusión sobre el papel que el “optimismo suscitado por el tratamiento” juega en la transmisión del VIH. Dicho optimismo significa que las personas están más propensas a participar en actividades riesgosas por creer que el tratamiento las vuelve a ellas (o a sus parejas) menos infecciosas, o que el VIH es ahora una enfermedad menos peligrosa. De hecho, un repaso reciente de investigaciones en tres continentes sobre el optimismo suscitado por el tratamiento encontró que pocos hombres homosexuales se sentían optimistas en general y que la asociación entre el optimismo y las prácticas sexuales riesgosas era inconstante.<sup>14</sup> Posiblemente el optimismo suscitado por el tratamiento esté causando un incremento de actividad sexual de riesgo en algunas comunidades o segmentos de comunidades de hombres homosexuales pero no en otras.

Muchos modelos matemáticos complejos de la epidemia comparan los posibles beneficios de la TAR en la reducción de la probabilidad de transmisión del VIH con sus posibles perjuicios debidos al incremento de conductas riesgosas. Los modelos sugieren que la transmisión del VIH puede aumentar en una comunidad en la cual más del 50% de las personas infectadas tomen la TAR si las prácticas riesgosas se incrementan por lo menos un 10%.<sup>15</sup>
<h4>¿qué queda por hacer?</h4>
Los programas de atención del VIH brindan oportunidades para que el tratamiento y la prevención interactúen. Los profesionales médicos pueden tener un mayor papel en la prevención del VIH al integrarla permanentemente en sus servicios de atención médica. Los componentes clave de la prevención pueden incluir consejería periódica sobre reducción de riesgos y pruebas de detección de ETS. Se necesita capacitar y apoyar a los proveedores de atención de VIH que no conozcan estos componentes.

Para ayudar a las personas VIH+ y a las VIH- a evitar la transmisión, se necesitan programas en lugares que no sean instituciones médicas.<sup>16</sup> Estos programas de prevención deben incorporar varias estrategias como consejería y capacitación sobre cuándo y cómo divulgar la condición de VIH, cómo usar condones habitualmente si no se revela la condición de VIH, cómo afrontar el estigma en torno al VIH y cómo mantener la intimidad en las relaciones tanto de parejas serodiscordantes como de las seroconcordantes. Dicho apoyo debe ofrecerse a la gente VIH+ y VIH- en el contexto de llevar una vida sexual sana. Para tomar decisiones bien fundamentadas, las comunidades afectadas por el VIH necesitan mejor conocimiento y acceso a estudios sobre cuándo y cómo las personas son infecciosas y sobre cómo aprovechar mejor el tratamiento del VIH con el fin de reducir el riesgo de transmisión. Las pruebas del VIH anónimas, confidenciales y/o caseras deben hacerse ampliamente accesibles.

En la lucha contra la epidemia del VIH/SIDA, no debe existir una división entre el tratamiento para personas VIH+ y la prevención para las persona VIH-. El tratamiento no pondrá fin a la epidemia en la ausencia de programas de prevención tanto para gente VIH- como VIH+ y la prevención no servirá si no refleja la realidad de las personas infectadas y de las no infectadas.

<hr />

<h4>¿quién lo dice?</h4>
1. Mofenson LM. Technical Report: Perinatal Human Immunodeficiency Virus Testing and Prevention of Transmission. Pediatrics. 2000;106:E88.
2. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. New England Journal of Medicine. 1997;337: 1485-1490.
3. Kahn JO, Martin JN, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injecting drug use exposure: the San Francisco PEP study. Journal of Infectious Diseases. 2001;183: 707-714.
4. Barroso PF, Schechter M, Gupta P, et al. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. Journal of Acquired Immune Deficiency Syndromes. 2003;32:435-440.
5. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases. 1998;177:1100-1103.
6. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and risk of heterosexual transmission of HIV-1 among sexual partners. Presented at the Conference on Retroviruses and Opportunistic Infections. Jan 30-Feb 2;2000. Abst# 193.
7. Zhu T, Wang N, Carr A, et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. Journal of Virology. 1996;70:3098-3107.
8. Knowlton AR. Social network approaches to HIV prevention and care: theoretical and methodological considerations of intervention. Presented at the International AIDS Conference, Barcelona, Spain. 2002. ThOrE1501.
9. Valdiserri RO. Preventing new HIV infections in the US: what can we hope to achieve? Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA. February 10-14, 2003.
10. Scheer S, Chu PL, Klausner JD, et al. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet 2001 Feb 10;357(9254):432-5.
11. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men in San Francisco. American Journal of Public Health. 2002;92:388-394.
12. Stolte IG, Coutinho RA. Risk behaviour and sexually transmitted diseases are on the rise in gay men, but what is happening with HIV? Current Opinions in Infectious Diseases. 2002;15:37-41.
13. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections. 1999;75:3-17.
14. Elford J, Bolding G, Sherr L. HIV optimism: fact or fiction? FOCUS. 2001;8:1-3.
15. Blower S, Schwartz EJ, Mills J. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines. AIDS Reviews. 2003;5:113-125.
16. Collins C, Morin SF, Shriver MD, et al. Designing Primary Prevention for People Living with HIV. Monograph published by the AIDS Policy Research Center &amp; Center for AIDS Prevention Studies. March, 2000.prevention.ucsf.edu/uploads/publications/pozmono.pdf (Accessed 4/20/06)

<hr />

<strong>Preparado por Willi McFarland* y Pamela DeCarlo**
*San Francisco Department of Public Health, **CAPS</strong>

<strong>Revised January 2004. Fact Sheet #27SR</strong>

<strong>Traducción Rocky Schnaath</strong>

Special thanks to the following reviewers of this Fact Sheet: Angela Kashuba, Mitch Katz, Jeffrey Klausner, Kimberly Page-Shafer, Jack Summerside, Dan Wohlfeiler.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/tratamientoFS.pdf</url>
	</node>
	<node>
		<title>Proveedores de salud</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Pueden los proveedores de salud ayudar en la prevención del VIH?</h3>
(revisado 4/99)
<h4>¿son los trabajadores de salud importantes en la prevención?</h4>
Sí. Los proveedores de salud tienen muchas oportunidades para promover los cambios de comportamiento necesarios para detener nuevas infecciones de VIH. En los EEUU en 1996, el adulto promedio visitó al médico 3 veces al año. 82% de las visitas fueron en consultas médicas y 10% en salas de emergencia.<sup>1</sup> Las visitas médicas proveen oportunidades para que el paciente pueda expresar su propria experiencia con respecto al riesgo sexual y el uso de drogas.

Los proveedores de salud que trabajan en areas con altos índices de pacientes de alto-riesgo-como en salas de emergencia, clínicas de enfermedades transmitidas sexualmente (ETS), clínicas de mantenimiento con metadona y clínicas en cárceles o prisiones-juegan un papel crítico en la prevención del VIH. Por ejemplo, hombres, mujeres, y adolescentes que han sido encarcelados tienen altos índices de VIH, ETS, y tuberculosis, así como problemas de alcoholismo y narco-dependencia, y se beneficiarían de información preventiva y servicios médicos.<sup>2</sup>

En una encuesta nacional de adultos en los EEUU, solamente un 20% de los pacientes había discutido su riesgo relacionado con el VIH con su médico. Solamente 21% de los que sí habían hablado del tema con su médico reportaron que el médico había iniciado el tema. Y solamente 23% de los que reportaron un riesgo con respecto a el VIH había hablado con su médico sobre el SIDA.<sup>3</sup>
<h4>¿cuáles son las barreras para hablar del VIH?</h4>
La prevención del VIH requiere la habilidad de hablar abiertamente sobre la sexualidad y las drogas-lo cual puede ser incómodo. Los proveedores de salud necesitan entrenamiento sobre como iniciar discusiones, saber manejar los temas incómodos, responder a temores y expectativas, estimular respuestas del paciente y comprender al paciente. Hay varios formas de enseñar estas técnicas incluyendo practicar discusiones en las cuales los instructores juegan el papel del paciente y se graba la sección en video para que el proveedor pueda criticar su actuación.<sup>4</sup>

La falta de tiempo puede ser un gran obstaculo para discutir los riesgos del VIH. Muchos proveedores de salud practican la prevención en muchas otras áreas de la salud como la nutricion y el ejercicio, fumar, depresión, diabetes, enfermedades del corazón y cáncer. Con una cantidad de tiempo programado para cada paciente, proveedores de salud pueden sentir que no hay suficiente tiempo para discutir temas tan delicados como la sexualidad o el uso de drogas.
<h4>¿qué pueden hacer?</h4>
La evaluación de los comportamientos de riesgo relacionados con el VIH debe ser parte habitual de la evaluación inicial con cada nuevo paciente. No todos los pacientes requieren educación preventiva intensiva. Sin embargo, los proveedores de salud deben preguntarle a todo paciente sobre el uso de condones, número de parejas sexuales, orientación sexual y uso de drogas inyectables para evaluar el riesgo de contraer el VIH. Los que no tienen tiempo o no se sienten cómodos discutiendo estos temas pueden canalizar a sus pacientes a líneas informativas gratuitas o programas comunitarios de salud pública.

Los proveedores de salud pueden proveer consejería sobre el VIH y proveer o recomendar la prueba de detección del VIH a pacientes de alto riesgo para el VIH. Esto incluye pacientes con ETS, especialmente adolescentes, usuarios de drogas inyectables (UDI), mujeres cuyas parejas pueden ser UDIs y pacientes que no saben si su pareja es VIH- o VIH+. Los proveedores de salud pueden tener un efecto profundo en la vida del paciente cuando demuestran interés en sus pacientes que usan drogas y alentarlos a empezar un programa para el alcoholismo o la narco-dependencia. Recaer en el uso de alcohol o drogas ocurre frecuentemente al tratar adicción. Es importante que en dichos casos los proveedores de salud no demuestren una actitud prejuiciosa hacia el paciente.<sup>6</sup>

Los proveedores de salud que trabajan con pacientes VIH+ pueden prevenir la transmisión de VIH ayudándoles a evaluar sus comportamientos de riesgo y aconsejándoles que reduzcan dichos comportamientos.<sup>7</sup> Esto es de suma importancia con los nuevos tratamientos efectivos contra el VIH. Por ejemplo, pacientes VIH+ pueden creer que tener un conteo bajo o indetectable del virus impide la transmitir del virus. Los momentos oportunos para ofrecer consejería son: en el diagnóstico, al inicio de los síntomas y al empezar un nuevo tratamiento.<sup>8</sup>
<h4>¿el tratamiento puede promover la prevención?</h4>
Sí. El diagnóstico y tratamiento de ETS tales como la sífilis y la gonorrea pueden proteger contra la transmisión del VIH. La detección temprana y el tratamiento de ETS puede ser crucial ya que las infecciones de ETS facilitan la infección y la transmisión del VIH. En zonas y poblaciones con altos índices de ETS y bajos índices de infecciones de VIH, el tratamiento de ETS es una forma eficaz de prevenir infecciones de VIH.<sup>9</sup>

En años recientes, ha habido muchos adelantos en la prevención de la transmisión del VIH de madre a hijo. Los proveedores de salud deben ofrecer la prueba del VIH a toda mujer embarazada. El tratamiento con AZT a madres VIH+ y sus bebés ha reducido la transmision en dos-tercios. A las madres VIH+ también se les debe ofrecer consejería sobre los riesgos al amamantar así como alternativas a la leche materna si fuera necesario.<sup>10</sup>

PEP es un método que potencialmente prevendría la transmisión del VIH al administrar AZT y otras drogas anti-VIH en las primeras 72 horas después de haber estado expuesto al virus.<sup>11</sup> Estudios ocupacionales han encontrado que la transmisión de VIH puede ser prevenida con el tratamiento pos-exposición, y ahora es recomendado por los Centers for Disease Control and Prevention (CDC) para los trabajadores del sector de salud que accidentalmente han estado expuestos al virus. Actualmente, se hacen estudios sobre el uso de PEP para exposición a través del sexo o uso de drogas inyectables, incluyendo asalto sexual. El CDC todavía no ha aprobado el uso de PEP en estos casos ya que no hay datos sobre su efecto en las exposiciones de este tipo.<sup>12</sup>
<h4>¿qué se está haciendo?</h4>
Los proveedores de salud necesitan acceso a entrenamiento y a información médica actualizada. Proveedores de salud en áreas rurales recibieron entrenamiento sobre VIH/SIDA. Aprendieron información básica, como evaluar el riesgo, los adelantos en tratamientos, y como ser sensibles a las poblaciones diversas. El entrenamiento más eficaz para los proveedores de salud en áreas rurales fue un folleto auto-didáctico que ayudó a incrementar la prevención, a intervenir temprano y a promover salud en el área rural. Dicho folleto está disponible gratuitamente en la Internet. Entrenamientos interactivos por medio de teleconferencias y entrenamiento de personal por medio de educadores también fueron eficaces.<sup>13</sup>

Los proveedores de salud tienen que prestar atención a las múltiples necesidades de sus pacientes. En Bangalore, India, se estableció la Clínica de la Mujer Sana como parte de un programa de control del VIH. Mujeres de bajos ingresos, en su mayoría prostitutas, habían sido indebidamente atendidas, tenían altos índices de ETS y tenían alto riesgo de contraer el VIH. Debido a que las mujeres están condicionadas a ignorar o tolerar problemas de salud, las pacientes de la Clínica automáticamente reciben pruebas de detección de ETS sin tener que admitir ningún síntoma.<sup>14</sup>

Los proveedores de salud deben utilizar los servicios disponibles en sus comunidades. El Hospital de Niños de Los Angeles colaboró con organizaciones de prevención de la comunidad para proveer un modelo de cuidado integral para jóvenes con/o en riesgo de contraer el VIH. El modelo ofrece una clínica de medicina general y servicios psicosociales tales como consejería y manejo de casos. Educadores del mismo grupo también proveen reclutamiento extensivo en los sitios donde se reúnen jóvenes de alto riesgo. El programa desarrolló un sistema de canalización de servicios locales para jóvenes que puede obtenerse en la Internet.<sup>15</sup>
<h4>¿es suficiente incrementar la participación de proveedores de salud?</h4>
Incrementar la participación de proveedores de salud es solamente uno de los aspectos de un plan de prevención amplio. Una estrategia completa utiliza múltiples elementos para proteger del VIH a la mayor cantidad de personas posible. La prevención del VIH no se logra de un “solo golpe”; es un proceso contínuo que requiere la participación de varios sectores de la sociedad. Esto incluye doctores, enfermeras, educadores de salud, terapeutas, dentistas y otros proveedores de salud a quienes la poblacion consulta sobre como mantener la salud.

<hr />

<h4>¿quién lo dice?</h4>
1. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1996 . Vital and Health Statistics. 1998;134:1-37.
2. Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings . Health Education and Behavior. 1998;25:99-120.
3. Gerbert B, Bleecker T, Bernzweig J . Is anybody talking to physicians about acquired immunodeficiency syndrome and sex? A national survey of patients. Archives of Family Medicine. 1993;2:45-51.
4. Epstein RM, Morse DS, Frankel RM, et al. Awkward moments in patient-physician communication about HIV risk. Annals of Internal Medicine. 1998;128:435-442.
5. American Medical Association. Physician Guide to HIV Prevention. June 1996.
6. Herman M, Gourevitch MN. Integrating primary care and methadone maintenance treatment: implementation issues . Journal of Addictive Diseases. 1997;16:91-102.
7. Gerbert B, Brown B, Volberding P, et al. Physicians’ transmission assessment and counseling practices with their HIV-seropositive patients. AIDS Education and Prevention. In press.
8. Gerbert B, Love C, Caspers N et al. “ Making all the difference in the world”: how physicians can help HIV-seropositive patients become more involved in their healthcare . AIDS Patient Care and STDs. 1999;13:29-39.
9. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases-United States . Morbidity and Mortality Weekly Report. 1998;47(RR-12):1-25.
10. Centers for Disease Control and Prevention. Update: perinatally acquired HIV/AIDS-United States, 1997 . Morbidity and Mortality Weekly Report. 1997;46:1086-1092.
11. Centers for Disease Control and Prevention. Management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis . Morbidity and Mortality Weekly Report. 1998;47(RR-7):1-33.
12. Centers for Disease Control and Prevention. Management of possible sexual, injecting drug-use, or other non-occupational exposure to HIV, including considerations related to antiretroviral therapy . Morbidity and Mortality Weekly Report. 1998;47(RR-17):1-14.
13. Martin SJ. HIV/AIDS prevention, early intervention and health promotion: results of training for rural health care providers. Presented at the 9th National AIDS Update Conference, San Francisco, CA. March 19, 1997. Contact: Sara Martin (303) 315-2516. www.uchsc.edu/sm/aids/begin.htm
14. Baksi CM, Harper I, Raj M. A `Well Woman Clinic’ in Bangalore: one strategy to attempt to decrease the transmission of HIV infection . International Journal of STDs &amp; AIDS. 1998;9:418-423.
15. Schneir A, Kipke MD, Melchior LA, et al. Children’s Hospital Los Angeles: a model of integrated care for HIV-positive and very high risk youth. Journal of Adolescent Health. 1998;23(2Suppl):59-70. Computerized referral system:www.caars.net

<hr />

<strong>Preparado por Pamela DeCarlo*, Barbara Gerbert, PhD y el Center for Health Improvement and Prevention Studies; *CAPS
Traducido por Sandra Gálvez, CAPS</strong>

Septiembre 1999. Hoja Informativa 6SR.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/proveedoresFS.pdf</url>
	</node>
	<node>
		<title>Hepatitis C (VHC)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Se puede prevenir la transmisión del hepatitis C (VHC)?</h3>
<h4>¿qué es la hepatitis “C” (VHC)?</h4>
En los EEUU, la hepatitis “C” es la enfermedad viral crónica sanguínea mas común y la mayor causante de las enfermedades hepáticas. Se transmite principalmente por contacto sanguíneo. La transmisión sexual del VHC es poco común. Se estima que cerca de 4 millones de personas en los EEUU están infectadas con VHC. Anualmente se registran 8,000-10,000 muertes relacionadas con las enfermedades hepáticas de VHC y se estima que se triplique durante los próximos 10 a 20 años.

Muchas personas con VHC no presentan síntomas en muchos años por lo tanto desconocen portar el virus. El 60% a 70% de los pacientes con VHC desarrollan la hepatitis crónica en un período de 20 a 30 años, un 20% a 30% desarrollan cirrosis hepática y del 1% a 5% cáncer hepático. VHC es la causa principal de los transplantes de hígado en los EEUU.
<h4>¿cómo se expone a riesgo?</h4>
En los EEUU, el 60% de todos los casos nuevos de infección con VHC son atribuidos al uso de drogas inyectadas, al compartir jeringas/agujas o alguno de los utensilios utilizados para este fin. Entre los Usuarios de Drogas Indovenosas (UDIs) la transmisión del VHC ocurre al momento de aplicarse la droga. Por tal razón, la prevalencia del VHC en UDIs es muy alta, se estima en un 90%. Los índices de infección en UDIs jóvenes son de 4 a 100 veces mayores que los índices de infección con VIH.

Las personas que recibieron transfusiones de sangre y transplante de órganos antes de 1992 y los hemofílicos que recibieron concentrados de factor coagulante producidos antes de 1987 están a riesgo de estar infectados con VHC.
<h4>¿se puede tratar el VHC?</h4>
Muchas personas con VHC desconocen tener la enfermedad debido a la ausencia de síntomas. La prueba de detección de anticuerpos del VHC se puso en práctica por primera vez en 1990, al mismo tiempo empezaron a hacerse las pruebas de VHC en donantes de sangre. Sin embrago, muchas personas apenas ahora están descubriendo que estuvieron expuestas al VHC, y la mayoría de los que están a mayor riesgo aún no se hacen la prueba.

Existen dos alternativas para el tratamiento del VHC: con Interferon-Alpha por sí sólo o en combinación con Ribavirín. El uso del Interferón-Alpha por sí sólo se usa si es administrada por vía indovenosa 3 veces por semana durante un período de 12 meses eliminando el virus eficazmente en 10% a 20% de los pacientes que reciben el tratamiento. Cuando se combina el Interferón-Alpha con Ribavirín se usa la vía oral, se ingiere a diario y elimina el virus en un 30% a 40% de las personas que son tratadas con la combinación. Los efectos secundarios de ambos medicamentos pueden ser sustanciales. Los remedios a base de hierbas como la Leche de Cardos no ha sido aprobada como tratamiento pero es popular en muchos pacientes con hepatitis crónica.

En 1997 el Institutos Nacionales de la Salud llevó a cabo un conferencia para llegar a un acuerdo en cuanto al manejo y desarrollo del VHC. En esta conferencia se acordó que “deberá postponerse el tratamiento en pacientes que consumen cantidades significativas de alcohol o que activamente usan drogas ilícitas hasta que hayan eliminado este hábito por lo menos 6 meses.” Esto puede estar basado en la preocupación de una re-infección dado el contínuo consumo de drogas ilícitas vía indovenosa y el daño al hígado por el consumo contínuo de alcohol y por no seguir las instrucciones lo cual limita la efectividad del tratamiento. Otros proveedores de salud han abogado por ofrecer el tratamiento a todas las personas además de el contínuo apoyo para tratar estos problemas. El apoyo puede incluir un tratamiento por abuso concurrente de drogas, acceso a jeringas/agujas esterilizadas y educación sobre como inyectarse de forma segura.
<h4>¿en qué se parece el VHC al VIH?</h4>
Algunas autoridades de salud pública se refieren al VHC como “el nuevo VIH” dada a la similitud entre ambas. La mayoría de las personas una vez infectadas con VIH o VHC quedan infectadas de por vida. El VHC y el VIH se transmiten por medio de la sangre y ambas evolucionan hacia un curso crónico. En ambas enfermedades aún no existe cura ni vacuna preventiva. Sin embargo existen diferencias que las distinguen. Comparado al VIH, 15% a 20% de las personas infectadas con VHC logran, aparentemente, la recuperación total. El VHC se transmite más facilmente que el VIH por medio de las agujas, pero con menor facilidad por vía perinatal o sexual. El VHC no se transmite por medio de la lactancia en cambio el VIH sí.
<h4>¿qué pasa con la co-infección con VIH?</h4>
Las personas a riesgo de infectarse con VHC, se involucran en actividades que les pone a riesgo de infectarse con VIH. Se estima que 40% de los individuos VIH+ en los EEUU se co-infectan con VHC y muchos desconocen esta condición. Los mayores índices de co-infección se presentan en UDIs y hemofílicos.

Aparentemente el VIH afecta el curso del VHC, acelerando a veces el progreso de la enfermedad del hígado y la cirrosis. Además, el enfermedad del hígado de VHC puede limitar la aceptación de las medicinas para el tratamiento del VIH. La infección del VHC está siendo directamente asociada con el aumento en la mortalidad de las personas infectadas con VIH.
<h4>¿cómo puede prevenirse el VHC?</h4>
Debido a que la transmisión del VHC ocurre más facilmente por medio de jeringas/agujas para el uso de drogas indovenosas, la distribución de equipo esterilizado por medio de programas de intercambio de jeringas/agujas (NEP) ha sido uno de los mayores esfuerzos de prevención. Sin embargo un estudio previo realizado en Tacoma, WA demostró la eficacia de los programas de intercambio de jeringas/agujas como una intervención preventiva, un estudio más reciente reveló que estos programas de intercambio no registraron efecto alguno en la transmisión del VHC. Esto pudo deberse al hecho de que los UDIs adquieren la infección del VHC en el momento en que se inyectan, es decir, antes de haber recibido los servicios de los programas de intercambio de jeringas/agujas.

El VHC es prevalente en UDIs y se transmite fácilmente, por lo tanto es difícil prevenirlo. Es posible que la transmisión ocurra de varias formas: compartiendo jeringas/agujas; compartiendo los utensilios que se utilizan para inyectarse drogas como los cookers, popotes/pajillas/paja, isopos/palillos de oídos, torniquetes y algodón; y al compartir la misma jeringa con varias personas; al pincharse accidentalmente y al ser inyectado por otra persona. Los programasde prevención necesitan tomar en cuenta todas estas actividades como posibles riesgos.

En las penitenciarías correcionales del estado de Rhode Island se llevó a cabo un programa de prevención y tratamiento de VHC. Los reos reciben educación sanitaria sobre VHC, aquellos que soliciten un análisis clínico o tratamiento son sometidos a un proceso de eligilidad para determinar si pueden recibir el tratamiento. La eligibilidad depende en parte del período de tiempo que permanezcan en la carcel (tiempo suficiente para completar este largo tratamiento) y no haber usado drogas inyectadas en los últimos 12 meses. De esta forma se logran resultados eficaces a bajo costo.
<h4>¿qué se debe hacer?</h4>
Para entender los métodos de transmisión y prevención del VHC se necesita un mayor conocimiento de lo que ocurre dentro de la cultura de las personas a riesgo, particularmente los UDIs. Es necesario conducir mas estudios con jóvenes e identificar los factores que les empujan a UDI y como promover el uso seguro de la inyección entre los que inician esta práctica. Debemos, además, tener un mejor conocimiento de la historia natural del VHC. La mayoría de los estudios que se han realizado han sido con personas que ya han desarrollado la enfermedad, pero pueden haber muchos que a pesar de estar infectados no reciben asistencia médica.

El VHC tiene una alta prevalencia en los EEUU y es extremadamente transmisible por la vía sanguínea. Sin embargo, la mayoría de las personas infectadas con VHC desconocen estarlo y continúan sin hacerse la prueba de detección. Los bancos de sangre están enviando notificaciones a toda persona que recibió transfusiones de sangre, pero llevar a cabo pruebas de detección de VHC en otros grupos de alto riesgo constituirá un enorme costo a salud pública. El gobierno federal y el CDC (Centros de Control De Enfermedades) necesitan asignar mas fondos monetarios para esta labor.

Lo mismo que ocurre en los programas de prevención de VIH/ETS debiera ocurrir con los programas de VHC “trabajar con una meta en común”. Los programas de prevención del VIH, especialmente los dirigidos a UDIs, deben incorporar la prevención del VHC, consejería y pruebas de detección, incluyendo la vacunación contra la hepatitis A y B en personas infectadas con VHC. El cuidado estándar en todo esfuerzo de prevención de enfermedades infecciosas debe incluir pruebas de detección, consejería relacionadas al VIH, ETS y hepatitis B y C.
<h3>¿quién lo dice?</h3>
1. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease . Morbidity and Mortality Weekly Report. 1998;47(RR19):1-39.
2. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. New England Journal of Medicine. 1992;327:1899-1905.
3. Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injection drug users in the United States . Journal of Acquired Immune Deficiency Syndromes. 1998;18:S6-S10.
4. Garfein RS, Doherty MC, Monterroso ER, et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;18:S11-19.
5. Crofts N, Aitken CK, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not . Medical Journal of Australia. 1999;170:220-221.
6. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C . New England Journal of Medicine. 1998;339:1485-1492.
7. Flora K, Hahn M, Rosen H, et al. Milk thistle (silybum marianum) for the therapy of liver disease . American Journal of Gastro-enterology. 1998;93:139-143.
8. Management of Hepatitis C. NIH Consensus Statement 1997 Mar 24-26;15:1-41.
9. Tolmachoff R. When you have HIV and hepatitis C. Women Organized to Respond to Life-Threatening Diseases (WORLD). October 1998 Newsletter; p.3-5.
10. Soto B, Sanchez-Quijano A, Rodrigo L, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis . Journal of Hepatology. 1997;26:1-5.
11. Pol S, Lamorthe B, Thi NT, et al. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users . Journal of Hepatology. 1998;28:945-50
12. Piroth L, Duong M, Quantin C, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12: 381-811.
13. Hagan H, McGough JP, Thiede H, et al. Syringe exchange and risk of infection with hepatitis B and C viruses . American Journal of Epidemio-logy. 1999;149:201-213.
14. Kral AH, Bluthenthal RN, Erringer EA, et al. Risk factors among IDUs who give injections to or receive injections from other drug users . Addiction. 1999;94:675-683.
15. Spaulding A, Green C, Davidson K, et al. Hepatitis C in state correctional facilities . Preventive Medicine. 1998;28:92-100.
16. Making sense of hepatitis C (editorial). Lancet. 1998;352:1485.

<strong>PREPARADO POR PAULA LUM, MD Y PAMELA DECARLO.
TRADUCIDO POR ROMY BENARD RODRÍGEZ, CAPS</strong>

Agosto 2000. Hoja Informativa 35S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/hepaCFS.pdf</url>
	</node>
	<node>
		<title>Vacuna</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>¿Puede una vacuna contra el VIH lograr cambios significativos?</h2>
<h3>¿por qué necesitamos una vacuna?</h3>
Las vacunas son una de las herramientas más poderosas y costo-efectivas que tenemos para evitar las enfermedades. Una vacuna que impidiera la infección por VIH o que detuviera la progresión de la enfermedad ayudaría considerablemente en la lucha contra la pandemia del SIDA.

Una pregunta crucial es si una vacuna basada en una determinada cepa del VIH sería eficaz para poblaciones en las cuales predomina otra cepa. También existen dudas sobre cómo una vacuna contra el VIH protegería a los individuos: aunque no evitara la transmisión de la infección, tal vez la vacuna pudiera evitar o retrasar el desarrollo de la enfermedad, o simplemente reducir la infecciosidad de las personas que contraigan el VIH.

La educación y consejería de prevención del VIH son componentes importantes de los programas de vacunación. Incluso después de la comercialización de una vacuna, todavía continuará la necesidad de programas eficaces de prevención conductual. La vacuna contra el VIH no será una panacea universal, pero podría jugar un papel poderoso como parte de un conjunto de intervenciones preventivas.
<h3>¿ha habido avances?</h3>
Veinte años después del inicio de la epidemia, los investigadores continúan sus esfuerzos para superar los desafíos científicos planteados por los estudios de vacunas contra el VIH: 1) los métodos convencionales de diseño de vacunas (es decir, el empleo de virus inactivados o atenuados) se consideran muy peligrosos con el VIH; 2) el virus es sumamente variable y de mutación rápida; 3) la infección viral es permanente, no existe ningún caso documentado de curación del VIH y por lo tanto, no queda claro cómo el cuerpo podría montar una respuesta inmunológica eficaz y 4) falta un modelo animal perfecto que se pueda utilizar en los estudios de vacunas contra el SIDA.<sup>1</sup>

Todavía no existe una vacuna contra el VIH cuya eficacia haya sido comprobada. Se han realizado más de 70 pequeños ensayos clínicos en humanos de más de 35 diferentes vacunas experimentales contra el VIH, pero sólo un producto, AIDSVAX, fabricado por VaxGen, se ha estudiado en un ensayo de escala grande (de fase III). Lamentablemente, dos ensayos diferentes de AIDSVAX realizados 1) en Norteamérica, Puerto Rico y los Países Bajos<sup>2</sup> y 2) en Tailandia, encontraron que la vacuna no evitó la infección por VIH en la población general del estudio y tampoco retrasó la progresión de la enfermedad entre aquellos participantes que contrajeron el VIH durante el ensayo.<sup>3</sup>

Una vacuna exitosa contra el VIH enseñaría al sistema inmunológico a reconocer al VIH antes de que éste causara un daño extenso. Los conceptos de vacunas que se desarrollan actualmente utilizan varios métodos para entrenar al sistema inmunológico a reconocer partes del VIH sin exponer a las personas al VIH mismo. Los primeros estudios de vacunas contra el SIDA se centraron en la creación de vacunas biotecnológicas que representan una porción de las proteínas que se encuentran en la superficie externa (envoltura) del VIH. Actualmente se están desarrollando diferentes estrategias; ninguna de éstas emplea el virus mismo del VIH y ninguna puede causar que un participante adquiera el VIH por la vacuna misma.
<h3>¿cuál es el efecto sobre la prevención?</h3>
Una vacuna eficaz contra el VIH no sustituye los esfuerzos de prevención del VIH, de la misma manera que la prevención no puede reemplazar una vacuna. La mejor manera de combatir la pandemia del VIH es utilizar diversas intervenciones a varios niveles y el poder protector de una vacuna puede ser un beneficio en la prevención del VIH.

Desde la introducción del tratamiento antirretroviral (por sus siglas en español TAR o en inglés ART – término que está sustituyendo al de “tratamiento o terapia antirretroviral sumamente activa o altamente activa” conocido en español como TARSA o TARAA y en inglés como HAART), han aumentado las prácticas de riesgo de los hombres que tienen sexo con hombres (HSH).<sup>4</sup> Existe la preocupación de que similarmente, quienes reciban una vacuna contra el VIH aumenten sus
conductas de riesgo por sentirse invulnerables a la infección.

En el ensayo de eficacia de VaxGen realizado en Norteamérica, los participantes más jóvenes y los HSH que creían haber recibido la vacuna y no un placebo fueron más propensos a afirmar que habían tenido sexo anal sin protección durante el ensayo. Las prácticas de riesgo declaradas por los participantes no aumentaron durante el transcurso del ensayo. En el ensayo<sup>5</sup> de eficacia de VaxGen en Tailandia, los usuarios de drogas inyectables reportaron reducciones en su consumo de drogas y en su uso de agujas compartidas durante los primeros 12 meses.<sup>6</sup> Esto puede deberse a la educación y consejería sobre la prevención y la reducción de riesgos que recibieron.
<h3>¿cuáles son las cuestiones éticas?</h3>
Sólo es posible probar la seguridad y eficacia de las vacunas contra el VIH si miles de individuos están dispuestos a participar en ensayos clínicos, dichos ensayos plantean inquietudes sobre los posibles perjuicios para los participantes. Aunque los voluntarios no estén infectados, ciertas vacunas contra el VIH pueden arrojar un resultado VIH+ en las pruebas convencionales para detectar los anticuerpos del VIH. Un resultado positivo de la prueba del VIH puede conducir a la estigmatización social o discriminación en el seguro médico, en el empleo y en asuntos de inmigración. Simplemente por haber participado en el ensayo de una vacuna contra el VIH, el individuo podría ser considerado “de alto riesgo”, homosexual o usuario de drogas; la discriminación en contra de estos y otros grupos es una realidad patente en muchos lugares. A los investigadores les incumbe asegurar que los participantes de los ensayos de vacunas reciban la asistencia necesaria para aliviar los riesgos de discriminación u otros perjuicios que su participación pudiera conllevar.<sup>7</sup> Se debe involucrar a las comunidades para que participen de cerca en el diseño de los ensayos clínicos y en su implementación.

Los investigadores también necesitan comprobar que los participantes den un consentimiento con pleno conocimiento de causa antes de inscribirse en un ensayo de vacuna. La comunidad y los posibles voluntarios necesitan recibir información detallada sobre el proceso del ensayo y deberán entender conceptos tales como “placebo,” “asignación aleatoria” y “estudio ciego” para poder evaluar las ventajas y desventajas de la participación. La asignación de educadores comunitarios y de pares que ayuden con la orientación comunitaria que acompaña a la investigación de vacunas contra el VIH también ampliará los conocimientos de los participantes sobre los ensayos de vacunas así como su aceptación de éstos.<sup>8</sup>
<h3>¿cuáles son los obstáculos?</h3>
Gran parte de los conocimientos especializados sobre el diseño y la fabricación de las vacunas contra el VIH se concentran en las compañías farmacéuticas y biotecnológicas del sector privado. Sin embargo, el compromiso de estas industrias por las vacunas contra el VIH no ha igualado la enorme necesidad de la salud pública.<sup>9,10</sup> Una vacuna contra el VIH sólo logrará controlar la pandemia si se hace disponible ampliamente en los países en vías de desarrollo, donde ocurren más del 95% de las nuevas infecciones. La gente de países con escasos recursos ha tenido que esperar una década o más para recibir vacunas cuyo uso ya está aprobado en las naciones industrializadas.<sup>11,12</sup>

Además del costo, existen numerosos obstáculos al acceso a las vacunas contra el VIH. Las infraestructuras marginales de algunos países en vías de desarrollo pueden impedir la distribución de una vacuna. Incluso los países que pueden costear las vacunas tal vez no les den alta prioridad ni asignen suficientes recursos para investigarlas o comprarlas.

Los programas de vacunación generalmente se enfocan en los niños. En el caso del VIH, son los adultos y los adolescentes sexualmente activos quienes tendrán la necesidad más inmediata de una vacuna. Se requieren nuevas formas de abordar la inmunización. Puede haber poca aceptación de las vacunas en comunidades en las cuales existe desconfianza al gobierno o estigma por asociación con el VIH/SIDA.
<h3>¿qué queda por hacer?</h3>
En años recientes, el sector público ha incrementado los fondos para la investigación y el acceso a las vacunas contra el VIH, pero se necesitan más recursos. Se deberá motivar la inversión del sector por medio de incentivos como el financiamiento indirecto, el apoyo público en la infraestructura de la investigación clínica y la fabricación de productos, y fomentando las colaboraciones públicas y privadas.<sup>9</sup> Los gobiernos de los países desarrollados o con recursos financieros podrían hacer un compromiso para comprar vacunas contra SIDA para la gente de países en desarrollo. Se requiere de un liderazgo político constante para priorizar los recursos para las vacunas.

Los ensayos de vacunas realizados hasta la fecha han incluido educación sobre la prevención del VIH y consejería para reducir los riesgos. Dichos ensayos pueden beneficiar aun más a los participantes si ofrecieran servicios de tratamiento de drogas y pruebas de detección y tratamiento de las ETS. La combinación de los esfuerzos médicos, conductuales y psicológicos como parte de una iniciativa de vacunas puede ser una herramienta poderosa contra el VIH.

Las vacunas son un componente integral de una estrategia eficaz de prevención de enfermedades; su producción se hace imprescindible para detener la propagación del VIH. No obstante, una vacuna no eliminará por sí sola las condiciones sociales y estructurales que generaron y continúan alimentando la epidemia. Aun cuando las vacunas contra el VIH estén disponibles, las comunidades todavía necesitarán intervenciones conductuales de alta calidad para controlar la epidemia del VIH, así como normas que permitan que todos tengan acceso a las vacunas.

<strong>Preparado por Chris Collins, MPP AIDS Vaccine Adv. Coal.; Traducción R. Schnaath</strong>

<hr />

<h3>¿quien lo dice?</h3>
1. National Institute of Allergy and Infectious Diseases. Challenges in designing AIDS vaccines. May 2003. www.niaid.nih.gov/factsheets/challvacc.htm
2. AIDS Vaccine Advocacy Coalition. Understanding the results of the AIDSVAX trial. May 2003. www.avac.org/pdf/ UnderstandingAIDSVAX.pdf
3. VaxGen Announces Results of its Phase III HIV Vaccine Trial in Thailand: Vaccine Fails to Meet Endpoints. Press release from VaxGen.
www.vaxgen.com/pressroom/
4. Valdiserri RO. Preventing new HIV infections in the US: what can we hope to achieve? Presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA. February 10-14, 2003.
5. Bartholow B. Risk behavior and HIV seroincidence in the US trial of AIDSVAX B/B. Presented at the AIDS Vaccine 2003 Conference, New York, NY. September 2003.
6. Vanichseni S, van Griensven F, Phasithiphol B, et al. Decline in HIV risk behavior among injection drug users in the AIDSVAX B/E vaccine trial in Bangkok, Thailand. Presented at the XIV International AIDS Conference, Barcelona, Spain. July 2002.
7. UNAIDS. Guidance Document on Ethical Considerations in HIV Preventive Vaccine Research. June 2002.
8. van Loon KV, Lindegger GC, Slack CM. Informed consent: A review of the experiences of South African clinical trial researchers. Presented at the XIV International AIDS Conference, Barcelona, Spain. July 2002. Abst #TuOrG1170.
9. AIDS Vaccine Advocacy Coalition. How Do You Fight a Disease of Mass Destruction? And Other Questions on the Road to an AIDS Vaccine. May 2003.www.avac.org/pdf/reports/ DiseaseofMassDestruction.pdf
10. Klausner RD, Fauci AS, Corey L, et al. The need for a global HIV vaccine enterprise. Science. 2003;300:2036-2039.
11. Public health considerations for the use of a first generation HIV vaccine: Report from a WHO-UNAIDS-CDC Consultation, Geneva, 20-21 November 2002. AIDS. 2003;17:W1-W10.
12. International AIDS Vaccine Initiative. AIDS Vaccines for the New World: Preparing Now to Assure Access. July 2000. www.iavi.org

<strong>Resources</strong>

AIDS Vaccine Advocacy Coalition (AVAC)
101 West 23rd St. #2227
New York, NY 10011
212/367-1021
www.avac.org

HIV InSite: Vaccine Overview http://hivinsite.ucsf.edu/InSite?page=kb-08-01-11
HIV Vaccine Trials Network http://www.hvtn.org

International AIDS Vaccine Initiative (IAVI)
110 William Street
New York, NY 10038-3901 212/847-1111
www.iavi.org

IAVI vaccine trials database www.iavi.org/trialsdb/basicsearchform.asp

National Institute of Allergy and Infectious Diseases (NIAID)
Division of AIDS Vaccines www.niaid.nih.gov/aidsvaccine
NIAID Vaccine Research Center
www.vrc.nih.gov

<hr />

<strong>Febrero 2004. Fact Sheet #38SR</strong>

Special thanks to the following reviewers of this Fact Sheet: Barbara Adler, Emily Bass, Mark Boaz, Susan Buchbinder, Jose Esparza, Jorge Flores, Paula Frew, Ingelise Gordon, Ashraf Grimwood, Margaret McCluskey, Catherine Slack, Robert Smith, Steven Tierney, Steven Wakefield, Doug Wassenaar, Sandra Wearins, Dan Wohlfeiler.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/vacunaFS.pdf</url>
	</node>
	<node>
		<title>Personas VIH+</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuáles son las necesidades de prevención de la gente VIH+?</h3>
<h3>revisado 9/05</h3>
<h4>¿necesitan prevenir las personas VIH+?</h4>
Sí. Más de 1 millón de personas en los Estados Unidos tienen el VIH o el SIDA.<sup>1</sup> Los avances en el diagnóstico oportuno, el tratamiento y la atención para individuos VIH+ ya permiten que muchos gocen de mejor salud y más años de vida. Algunos han renovado su interés por la actividad sexual o por el consumo de drogas, lo cual aumenta su riesgo de adquirir otras ITS y de trasmitir el VIH a sus parejas no infectadas.<sup>2</sup> Por ello, muchas personas VIH+ requieren programas que les ayuden a mantenerse protegidas.

La mayoría de las personas VIH+ se preocupan por no infectar a otros y toman medidas para evitarlo.<sup>3</sup> Sin embargo, para un porcentaje importante la prevención es una lucha: entre el 20-50% reportan haber tenido contacto sexual sin protección con sus parejas VIH- o con las de condición de VIH desconocida.4 Para muchas personas seropositivas, los mismos desafíos estructurales, interpersonales y conductuales que las pusieron en riesgo de contraer el VIH persisten después de ser HIV+ y dichos desafíos afectan su capacidad de prevenir la transmisión del VIH.<sup>4</sup>

La prevención para personas VIH+ puede incluir intervenciones educativas y de fomento de habilidades, esfuerzos para realizar pruebas a más personas que ignoran ser VIH+, apoyo y pruebas para las parejas de individuos VIH+ y la incorporación de la prevención en la atención médica de rutina.<sup>5</sup>
<h4>¿en qué difieren los programas?</h4>
Los programas de prevención del VIH para personas VIH+ difieren de los programas para personas VIH- en que deben responder a las necesidades clínicas, mentales y de apoyo social al tiempo que aumentan la capacidad del individuo para evitar la transmisión del VIH a sus parejas actuales y futuras.

<strong>Estigma.</strong> El estigma hacia los hombres homosexuales, las mujeres, los consumidores de drogas, los trabajadores sexuales y las personas de minorías etnicas/raciales ha alimentado la epidemia del VIH en los Estados Unidos al crear condiciones sociales favorables para la transmisión del VIH.6 A esto se suma el estigma adicional de vivir con el VIH. Las víctimas del estigma (por haber revelado su orientación homosexual o consumo de drogas) pueden sufrir un trauma que les impide lidiar con la transmisión del VIH.<sup>7</sup> Es importante tomar en cuenta estos factores estructurales con el fin de promover la fuerza y la capacidad de resistencia de las comunidades VIH+.

<strong>Revelación.</strong> Una de las mayores preocupaciones de las personas VIH+ es cómo, cuándo y a quién revelar su condición de VIH.<sup>8</sup> El mensaje tradicional ha sido que las personas VIH+ siempre deben revelar su condición de VIH a sus parejas. En la realidad, la revelación es un asunto difícil y complejo. Algunas personas VIH+ deciden no revelar su condición y no participar en conductas riesgosas. Muchas veces las personas VIH+ temen que la revelación provoque el rechazo de su pareja o de su familia, limite sus oportunidades sexuales o aumente el riesgo de violencia física y sexual. Una encuesta de personas VIH+ encontró que el 42% de los hombres homosexuales, el 19% de los heterosexuales y el 17% de las mujeres había tenido sexo sin revelar su condición de VIH<sup>9</sup>. Las personas VIH+ pueden revelar su condición de forma diferente a sus médicos, familiares, amigos, compañeros de trabajo, parejas sexuales y compañeros de inyección de drogas.

<strong>Responsabilidad.</strong> Las personas con VIH viven con el hecho de haber sido infectadas (a veces por una persona de confianza a la que aman) y con la enorme responsabilidad de saber que pueden infectar a otros. Es una responsabilidad compleja, pero los programas de prevención deben ayudar a las personas VIH+ a explorarla y a comprender su significado a nivel personal.<sup>10</sup>
<h4>¿qué pueden hacer las personas VIH+?</h4>
Muchas personas VIH+ emplean estrategias que limitan la transmisión del VIH, por ejemplo, tener relaciones sólo con otras personas VIH+<sup>11</sup>. Al saber que la pareja sexual también es VIH+ se evita el riesgo de transmisión y permite el contacto sexual sin uso de condón constante. Recientemente han surgido inquietudes sobre la súper infección entre parejas VIH+ (la posible transmisión de otra cepa del virus entre las personas VIH+), pero ésta parece suceder rara vez.<sup>12</sup>

Otra estrategia es la de cambiar las actividades de alto riesgo por otras de menor riesgo. Por ejemplo, las personas VIH+ pueden evitar: ser la pareja insertiva durante el sexo anal y vaginal, el contacto sexual durante la menstruación, la lactancia materna y el uso compartido de jeringas. Algunas actividades menos riesgosas incluyen tener sexo oral y ser la pareja receptiva del pene.<sup>11</sup>
<h4>¿qué puede hacer su organización o clínica?</h4>
Las personas VIH+ son un grupo diverso que requiere programas de prevención que se ajusten a sus necesidades específicas y tomen en cuenta a la persona en su totalidad sin limitarse a su conducta sexual o su consumo de drogas. Las relaciones personales, el empleo, la atención de salud, la vivienda, el estigma y la discriminación son temas que deben ser abarcados según la necesidad. Escuchar a las personas VIH+ e involucrarlas en el diseño, la provisión y la evaluación de programas asegurará que éstos sean relevantes y útiles.<sup>13</sup>

Los programas de prevención con las personas VIH+ pueden exigir cambios y ajustes institucionales en las organizaciones y clínicas que integren por primera vez los servicios de atención y de prevención. Las clínicas pueden capacitar a los profesionales de salud para proporcionar consejería sobre la prevención del VIH, enlazar con servicios sociales y preventivos así como remitir pacientes a otras organizaciones. Los programas de prevención pueden capacitar a su personal sobre tratamiento y cuidado del VIH, formar vínculos con clínicas y organizaciones para VIH+ de servicios, o remitir a sus pacientes a estos servicios.

Es crítico que los profesionales médicos mantengan un tono sin juicios con respecto a las situaciones y conductas de los clientes VIH+.<sup>14</sup> Es igualmente importante colaborar con las personas VIH+ para crear un plan de reducción de riesgos basado sus necesidades y capacidades.<sup>13</sup> Los proveedores deben adoptar una actitud de apoyo y empatía enfocándose en el logro de metas, los puntos fuertes y las capacidades de resistencia del paciente. Los programas de prevención para gente positiva deben brindar los conocimientos, las capacidades y los recursos (como condones, jeringas esterilizadas y una estrategia para disminuir el consumo de alcohol y drogas) necesarios para poner en práctica un plan de reducción de riesgos.
<h4>¿qué se está haciendo al respecto?</h4>
En los EE.UU. existen varios programas preventivos para VIH+ que han probado eficacia.<sup>15</sup> Healthy Relationships, intervención de reducción de riesgos de cinco sesiones grupales para hombres y mujeres. Fomenta el desarrollo de capacidades para la toma de decisiones y resolución de problemas. Los grupos permiten que las personas VIH+ interactúen, examinen los riesgos, desarrollen habilidades para limitar sus riesgos y reciban comentarios de otras personas. En un seguimiento realizado a los seis meses de haber iniciado el programa, los participantes reportaron una reducción importante en el coito sin protección y un mayor uso de condones.<sup>16</sup>

Choosing Life: Empowerment, Action, Results (CLEAR) ofrece a jóvenes VIH+ 18 sesiones individuales de 90 minutos con un consejero. CLEAR fomenta la motivación y aumenta la autoestima para aprender a preferir las actividades saludables sobre las autodestructivas. CLEAR tiene tres módulos: toma de decisiones sexuales, auto cuidado y consumo de alcohol y drogas. La participación también puede ser vía telefónica. Los jóvenes reportaron tener menos parejas sexuales, usar menos drogas y sentirse menos afligidos.<sup>17</sup> A CLEAR se le conoce como Street Smart.

Partnership for Health capacitó al personal de clínicas de VIH en ofrecer consejería breve sobre relaciones sexuales más protegidas, la cual fue complementada con materiales escritos y carteles en las clínicas. La consejería sobre las consecuencias negativas del sexo sin protección ayudó a reducir las conductas riesgosas de los pacientes con dos o más parejas.<sup>18</sup>
<h4>¿qué queda por hacer?</h4>
Los programas de prevención con personas VIH+ necesitan poner atención a los obstáculos estructurales que se interponen a la protección durante las relaciones sexuales y el consumo de drogas. Dichos obstáculos pueden incluir vivienda inestable, falta de acceso a la atención médica y encarcelamiento repetido.

Es necesario examinar más a fondo cómo los traumas sufridos durante la infancia y la adultez, el abuso sexual, revelarse como homosexual, el racismo y la homofobia afectan la capacidad de una persona VIH+ para mantener conductas más seguras. Puesto que la conducta sexual de riesgo entre personas VIH+ frecuentemente es una decisión y un riesgo compartido con la pareja,<sup>19</sup> se requiere más énfasis en el trabajo con parejas (homo o heterosexuales) tanto en programas de prevención como en la investigación.

Los programas de prevención con personas VIH+ presentan la oportunidad y el reto de establecer relaciones e integrar servicios en áreas con las que tradicionalmente no se ha colaborado. Es clave involucrar a las personas VIH+ en el diseño de los programas. Los programas de tratamiento, de prevención y de servicios sociales deben trabajar conjuntamente para realmente ayudar a los pacientes a afrontar múltiples problemas.

<strong>Preparado por Kelly Knight MEd and Carol Dawson-Rose RN PhD, CAPS</strong>

<hr />

<h4>¿quién lo dice</h4>
1. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #595.
2. Janssen RS, Valdiserri RO. HIV prevention in the Unites States: increasing emphasis on working with those living with HIV. Journal of AIDS. 2004;37:S119-S121.
3. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. Journal of AIDS. 2005;39:446-453.
4. Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological and medical findings. AIDS. 2002;16:135-149.
5. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic – United States, 2003. Morbidity and Mortality Weekly Report. 2003;52:329-332.
6. Herek GM, Capitanio JP, Widaman KF. Stigma, social risk, and health policy: public attitudes toward HIV surveillance policies and the social construction of illness. Health Psychology. 2003;22:533-540.
7. Knight KR. With a little help from my friends: community affiliation and perceived social support. In HIV+ Sex. PN Halkitis, CA Gómez, RJ Wolitsky, eds. American Psychological Association; Washington DC. 2005.
8. Parsons JT, Missildine W, Van Ora J, et al. HIV serostatus disclosure to sexual partners among HIV-positive injection drug users. AIDS Patient Care and STDs. 2004;18:457-469.
9. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. American Journal of Public Health. 2003;93:949-954.
10. Wolitski RJ, Bailey CJ, O’Leary A, et al. Self-perceived responsibility of HIV-seropositive men who have sex with men for preventing HIV transmission. AIDS and Behavior. 2003;7:363-372.
11. Parsons JT, Schrimshaw EW, Wolitski RJ, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19:S13-S25.
12. Grant RM, McConnell JJ, Herring B, et al. No superinfection among seroconcordant couples after well-defined exposure. Presented at the International Conference on AIDS. 2004. Abst #ThPeA6949.
13. National Association of People with AIDS. Principles of HIV prevention with positives. www.napwa.org/pdf/PWPPrinciples.pdf (Accessed 4/20/06)
14. Dawson-Rose C, Shade SB, Lum P, et al. The healthcare experience of HIV positive injection drug users. Journal of Multicultural Nursing and Health. 2005;11:23-30.
15. www.cdc.gov/hiv/projects/rep/ www.effectiveinterventions.org (Accessed 4/20/06)
16. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine. 2001;21:84-92.
17. Rotheram-Borus MJ, Swendeman D, Comulada WS, et al. Prevention for substance-using HIV-Positive young people: telephone and in-person delivery. Journal of AIDS. 2004;37:S68-S77.
18. Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS.2004;18:1179-1186.
19. Remien RH, Wagner G, Dolezal C, et al. Factors associated with HIV sexual risk behavior in male couples of mixed HIV status. Journal of Psychology and Human Sexuality. 2001;13:31-48.

<hr />

<strong>Septiembre 2005 . Hoja #37SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revVIH+FS.pdf</url>
	</node>
	<node>
		<title>Ayudantes de enfermos</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Son importantes los ayudantes de enfermos con SIDA?</h3>
<h4>¿cuál es la labor de los que cuidan de enfermos?</h4>
Aquellas personas que de manera informal cuidan a otras infectadas con el SIDA (PWA por sus siglas en inglés) llevan lo que se conoce como ayuda práctica y cuidados de salud hasta los hogares. Usualmente es la pareja, el esposo(a), el amigo, o los familiares de alguien con SIDA y el personal médico. Este tipo de servicios es esencial en lo que respecta a servicios de salud para personas con SIDA, ya que le ahorra un gasto sustancial a la sociedad.

En los EEUU los servicios médicos en torno al SIDA han pasado de manos del hospital a manos de la comunidad y al cuidado en casa. El móbil de este nuevo giro ha sido la contínua alza en los costos de cuidados médicos y la preferencia de la mayoría por recibir estos servicios en casa mientras sea posible. El porcentaje de muertes por SIDA en los hospitales pasó del 92% en 1983 al 57% en 1991.<sup>1</sup> Este giro se debe a las personas que cuidan a los enfermos.

Los asistentes de los enfermos proveen necesidades prácticas como hacer compras, los quehaceres, el transporte a las clínicas y otras aún más básicas como ayudarles a bañarse, ir al inodoro y a alimentarse. A medida que los síntomas empeoran, los ayudantes llegan a desempeñar un papel más clínico como es estar al tanto de los medicamentos, inyectarlos, aplicarles la sonda y limpiarles las llagas.<sup>2</sup> Los ayudantes muchas veces proveen cuidados de primer auxilio y hasta asesoran el estado mental ya que son los primeros en notar los cambios de salud por lo tanto deciden cuándo es necesaria la ayuda. Un estudio demostró que el valor de las tareas de cuidado personal y de los quehaceres que desempeñan estos asistentes tienen un valor equivalente a los $25,000 anuales per cápita.<sup>3</sup>
<h4>¿quiénes son los ayudantes?</h4>
Una encuesta nacional encontró que el 3.2% de la población adulta de los EEUU ha brindado ayuda a algún pariente, amigo(a), esposo(a) o a la pareja infectada con SIDA. Casi tres cuartos de estos ayudantes tenían menos de 40 años de edad. El tipo de población que ha brindado esta ayuda estuvo distribuida equitativamente en cuanto a género, raza o grupo étnico.<sup>4</sup>

Tradicionalmente los padres, esposos e hijas adultas han sido los que ayudan a cuidar a personas con enfermedades terminales. En lo que respecta al SIDA son los familiares los que brindan la ayuda en la mayoría de los casos. Sin embargo, entre el hombre homosexual es más frecuente que sea la pareja o los amigos los que brinden esta ayuda. En un estudio a 265 hombres Británicos con SIDA se encontró que el 87% tenían a un amigo cercano o a su pareja como principal ayudante.<sup>5</sup>
<h4>¿cuál es el precio por ayudar?</h4>
El SIDA prevalece entre la gente joven y el joven-adulto; una de cada cuatro nuevas infecciones ocurrre entre jóvenes menores de 22 años.<sup>6</sup> Los ayudantes de las personas enfermas con SIDA tienen entre 20, 30, y 40 años de edad. A esta edad la gran mayoría está apenas construyendo sus relaciones y llevando a cabo una carrera, no cuidando enfermos o preparándose para perder a un ser querido. La presión que se experimenta durante este tiempo es de una enorme magnitud.<sup>2</sup>

Muchas veces es la pareja sexual la que cuida a la persona con SIDA, lo cual significa exponerse al riesgo de contraer el virus. Con respecto a los ayudantes VIH+, la progresión de la enfermedad en la pareja simboliza no solo la pérdida de ésta sino el deterioro de salud que ellos están experimentando. Para estas personas la otra pregunta es: ¿Quien va a cuidar de mi cuando me enferme?.

Los ayudantes pueden experimentar síntomas de insensibilidad ante tanto dolor, y agotamiento al perder amigos o seres queridos a causa del SIDA, o al cuidar personas enfermas por un largo período de tiempo.

En algunas comunidades aún se mantiene el miedo y el estigma que rodean al VIH. Vale agregar que la gran mayoría de los afectados por el SIDA son poblaciones que han padecido el estigma por el hecho de ser minorías: los hombres homosexuales, los usuarios de drogas intravenosas, los Afro-americanos y los Latinos. Los ayudantes muchas veces temen el rechazo social y la pérdida del trabajo y debido a esto en ocasiones esconden la condición de estar cuidando a alguien con SIDA a sus familares, amigos o compañeros de trabajo.<sup>7</sup>

Las mujeres VIH+ que cargan con la responsabilidad de los hijos pueden encontrar obstáculos obteniendo la ayuda y el apoyo necesarios. En un estudio a madres infectadas con el VIH se encontró que el 46% cuidaban por si solas a sus hijos. Solo el 30% conocía la existencia de la asistencia para el cuidado de los niños. Solamente el 8% había hecho uso de estos servicios.<sup>8</sup> Los servicios de cuidados para madres con VIH deberían incluir a los hijos, además de tratar de solucionar el bienestar de estos al morir la madre. Se estima que para el año 2,000 habrá más de 80,000 niños huérfanos a causa del SIDA en los EEUU.<sup>9</sup>
<h4>¿qué puede hacerse?</h4>
Al ayudar a los que que auxilian a los enfermos se está ayudando al paciente. En la profesión clínica el ayudante debería ser agregado al trío-doctor, paciente, ayudante-y ser entrenados en cuanto a los procedimientos médicos básicos que ayudan a la mejoría del paciente.<sup>10</sup> Los ayudantes pueden beneficiarse de la ayuda psicológica (como los grupos de apoyo) para ayudarles a llevar la carga emocional que acarrea el cuidar a una persona con una enfermedad terminal.

Algunas personas no sabrán como actuar frente a alguien con SIDA, o estarán confusas sobre cuál es la mejor manera de demostrar amor y apoyo. En un estudio a personas con SIDA (PWAs) se identificaron las acciones que ayudan y las que no. Las acciones consideradas de ayuda para expresar amor son: actuar con naturalidad, mostrarse receptivo y dar ánimo. Las acciones contraproducentes son: evitar la comunicación, mostrarse apenados, romper la confidencialidad o criticar sus decisiones médicas.<sup>11</sup>

Los doctores y el personal clínico tienen la excelente oportunidad de ofrecer educación preventiva primaria y secundaria al que cuida al enfermo cuando el doctor está visitando al enfermo en casa como en el hospital.<sup>12</sup> Aquellas personas que cuidan enfermos pueden beneficiarse de la educación preventiva para mantener su estado VIH-. Los ayudantes VIH+ necesitan recibir información acerca de los tratamientos existentes para tratar la etapa inicial de la enfermedad y lograr mantenerse saludables por largo tiempo.

Han surgido muchas organizaciones que brindan ayuda a quienes cuidan a personas con SIDA. “Kairos Support for Care Givers” y “Home Care Companions, Inc.” en San Francisco, CA y el “Gay Men Health Crisis” en la ciudad de Nueva York ofrecen entrenamiento, apoyo educativo y emocional a quienes cuidan enfermos por medio de su participación en grupos de apoyo, talleres, y clases. Algunas organizaciones religiosas tales como “HIV/AIDS Ministry Network” y “National Episcopal AIDS Coalition” también ofrecen apoyo a estas personas.<sup>13</sup>

En el Africa, muchas de las respuestas obtenidas por parte de la comunidad han servido de gran ayuda a quienes cuidan enfermos con SIDA. En Ruanda, Africa, un proyecto de la Cruz Roja se encarga de entrenar a voluntarios, estos a su vez entrenan a familiares encargados de cuidar enfermos. Estos aprenden principios de enfermería y sobre como brindar apoyo emocional. En Kamwokya, Uganda, donde el 20 al 30 por ciento de las personas entre los 20 y 45 años son VIH positivos, la comunidad provee ayuda médica y material a aquellos que cuidan enfermos además de ayudar a reducir la tensión social y los temores infundados de la comunidad.<sup>14</sup>

El proyecto “Coping” de la ciudad de San Francisco, CA, es un programa que ha estado dedicado al estudio del estado físico y psicológico de los que cuidan enfermos. El proyecto encontró que además de experimentar tensión y depresión también existen sentimientos positivos asociados con cuidar, dar amor, cariño y apoyo. Para poder mantener el bienestar emocional, el proyecto “Coping” sufiere tres técnicas: valorar y definir el significado individual que conlleva cuidar a un enfermo; fomentar la conversación entre el ayudante y sus parejas; y ayudar a sintonizar “momentos humanos” capaces de generar sentimientos positivos.<sup>2</sup> El proyecto “Care Study” de la Universidad de California, San Francisco también ha estado siguiendo las experiencias obtenidas de más de 600 amigos, parejas, y familiares.<sup>15</sup>

Preparado por Pamela DeCarlo y la Dra. Susan Folkman, Tradución Romy Benard-Rodríguez

**********
<h4>¿quién lo dice?</h4>
1. Kelly JJ, Chu SY, Buehler JW. AIDS deaths shift from hospital to home . American Journal of Public Health. 1993;83:1433-1437.

2. Folkman S, Chesney MA, Christopher-Richards A. Stress and coping in caregiving partners of men with AIDS . Psychiatric Manifestations of HIV Disease. 1994;17:35-53.
<ul>
 	<li>Contact: Susan Folkman 415/597-9156.</li>
</ul>
3. Ward D, Brown MA. Labor and cost in AIDS family caregiving . Western Journal of Nursing Research. 1994;16:10-22.

4. Turner HA, Catania JA, Gagnon J. The prevalence of informal caregiving to persons with AIDS in the United States: caregiver characteristics and their implications . Social Science and Medicine. 1994;38:1543-1552.

5. McCann K, Wadsworth E. The role of informal carers in supporting gay men who have HIV related illness. What do they do and what are their needs? AIDS Care. 1992;4:25-34.

6. Rosenberg PS, Biggar RJ, Goedert JJ. Declining age at HIV infection in the United States . New England Journal of Medicine. 1994;330:789-790.

7. Raveis VH, Siegel K. The impact of care giving on informal or familial care givers. AIDS Patient Care. 1991;39-43.

8. Schable B, Diaz T, Chu SY, et al. Who are the primary caretakers of children born to HIV-infected mothers? Results from a multi-state surveillance project . Pediatrics. 1995;95:511-515.

9. Michaels D, Levine C. Estimates of the number of motherless youth orphaned by AIDS in the United Sates. Journal of the American Medical Association. 1992;268:3456-3461.

10. Rabkin J, Remien R, Wilson C. Good Doctors, Good Patients: Partners in HIV Treatment. New York: NCM Publishers, Inc.;1994.
<ul>
 	<li>Contacto: Robert Remien 212/966-2375.</li>
</ul>
11. Hays RB, Magee RH, Chauncey S. Identifying helpful and unhelpful behaviours of loved ones: the PWA’s perspective . AIDS Care. 1994;6:379-392.

12. D’Arrigo,T. When the caregiver has HIV: early intervention through home care . Caring. 1994;13:4,7,80.
<ul>
 	<li>Contacto: Caring Magazine 202/547-5277.</li>
</ul>
Contactos:
<ul>
 	<li>Kairos Support for Caregivers 415/861-0877;</li>
 	<li>Home Care Companions, Inc 415/824-3269;</li>
 	<li>Gay Men’s Health Crisis 212/337-3524;</li>
 	<li>HIV/AIDS Ministries Network 212/870-3909;</li>
 	<li>National Episcopal AIDS Coalition 202/628-6628.</li>
</ul>
14. Anderson S. Community responses to AIDS . International Nursing Review. 1994;41:57-60.

Contacto:
<ul>
 	<li>UCSF Care Study, Joe Mullan 800/350-8660.</li>
</ul>
Otros recursos:

Shelby D. If A Partner Has AIDS: Guide to Clinical Intervention for Relationships in Crisis. Binghamton, NY: Harrington Park Press;1992.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/ayudantesFS.pdf</url>
	</node>
	<node>
		<title>Barrier methods</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Can Barrier Methods Help in HIV Prevention?</h3>
<h4>Why barrier methods?</h4>
Barrier methods are a relatively low-cost, accessible and important part of the pregnancy and sexually transmitted disease (STD) prevention landscape. Barrier methods can be physical or chemical substances which prevent pregnancy and/or block the spread of STDs including HIV. They do not include hormonal contraceptive methods. People have successfully used contraceptive physical barriers for centuries.<sup>1</sup>

Since the beginning of the HIV epidemic, the latex male condom has been the exclusive prevention tool. After two decades, there is a call to create a greater selection of barrier methods to combat HIV. Because HIV rates continue to increase among women and among men who have sex with men (MSM)<sup>2,3</sup>, it is time to strengthen both current condom use programs and develop other barrier methods that optimize usage and choice in prevention.
<h4>What methods are available?</h4>
Currently, the male and female condoms are used for the prevention of HIV, STDs and unintended pregnancy.<sup>4,5</sup> The female condom, made of polyurethane plastic, is also used for receptive anal sex, but it was not designed for that purpose.<sup>6</sup> The diaphragm, cervical cap and sponge are often used with a spermicide and block the cervix to prevent conception. Although studies have shown that these cervical blocking methods may also prevent certain STDs<sup>7</sup>, research has not been conducted to show that they prevent HIV. Dental dams are latex sheets used to provide a barrier in oral/anal and oral/vaginal sex.

Spermicides (gels, creams, foams, or films that can be inserted into the vagina) are available for preventing pregnancy. One of the most widely used spermicides, Nonoxynol 9 (N-9), was recently tested for its ability to prevent HIV. The study of female sex workers in Thailand, South Africa, Cote d’Ivoire and Benin, randomly assigned women to use either a gel containing 52.5 mg of N-9 or a placebo, a vaginal moisturizer known as Replens. Preliminary results showed that there were more new HIV infections among the N-9 group than in the Replens group.<sup>8</sup> In August, 2000, the CDC recommended against N-9 as a sole barrier method for HIV prevention.<sup>9</sup>

This study documented the harmful effects of a relatively large dose of N-9 on HIV infection. N-9 is commonly used in much smaller amounts as part of a condom lubricant. The impact of small doses of N-9 is not clear.
<h4>Why do we need alternatives to male condoms?</h4>
Male condoms are an extremely effective means of HIV, STD and pregnancy prevention. What most often limits condoms’ effectiveness is user failure rather than product failure. For example, users may fail to either put on a condom before genital contact or completely unroll the condom. In addition, some people fail to use a condom with every act of sexual intercourse. Some don’t use condoms because they reduce sexual sensation. For others, using condoms is seen as a barrier to intimacy.

Male condom use requires male participation or negotiation. Female-controlled and receptive-partner-controlled options (such as female condoms or future microbicides) may be used without the participation or consent of the insertive partner. These methods are still detectable by sexual partners and partners can still refuse to use them. Female- and receptive-partner-controlled options can be used in situations where it is difficult to negotiate condom use such as in an abusive relationship, where there is economic disincentive to use a condom<sup>10</sup> or where the insertive partner refuses to use a condom.<sup>5</sup> Female-controlled HIV/STD prevention methods can be empowering<sup>11</sup> and are vital in an HIV epidemic that is increasingly infecting women, especially in developing countries.

Finally, there is no barrier method that allows women to protect themselves from HIV and still get pregnant. Hopefully, a barrier method can be developed that separates the control of fertility from the prevention of STDs. This is an important consideration for many women.<sup>2</sup>
<h4>What are the drawbacks?</h4>
Barrier methods can provide protection against HIV and STDs, yet they are not an option for everyone. Although some methods are low-cost, others, such as the female condom, may have limited accessibility because of their cost. Most barrier methods require application before each act of sexual intercourse, making consistent use more difficult. Barrier methods may not protect against STDs that are transmitted via skin-to-skin contact such as herpes and human papilloma virus (HPV). Products may be messy or may require adequate cleaning and storage, which may not be available to some people. Some barrier methods are inserted into the vagina which requires comfort and familiarity with one’s body. Diaphragms and cervical caps require a health care worker to fit the devices. Further, individuals may have sensitivities to products’ chemicals or materials, such as latex allergies.<sup>1</sup> Barrier methods under development are addressing some of these limitations.
<h4>What about microbicides?</h4>
Microbicides are topically-applied chemical barriers that prevent HIV and/or STD transmission. They are not currently available, but are under development and being tested for efficacy as an alternative to current methods. Microbicides may come in the form of gels, creams, foams or films that can be inserted into the vagina or rectum. Development is currently focused on creating products which destroy or immobilize germs or viruses through a variety of mechanisms: breaking down the outer cell membranes of pathogens, enhancing normal vaginal defenses, providing a physical coating to the vagina or the rectum, inhibiting HIV from entering cells or preventing HIV replication if HIV does enter a cell.<sup>12</sup> Studies show that there is large potential demand for microbicides from women in the US and internationally.<sup>13</sup> People are also willing to participate in efficacy trials, as studies in women and MSM have shown.<sup>14,15</sup>
<h4>What’s being done?</h4>
Male condoms are currently the best comprehensive prevention method. Education and prevention campaigns must be continued to optimize condom usage while also searching for alternatives. HIV prevention efforts may be more effective among certain populations if condom use and HIV are addressed together with STD and unintended pregnancy prevention. Some STD and family planning clinics are encouraging condom use for both STDs and HIV prevention with great success.<sup>16</sup>

New physical barrier methods currently being researched include the disposable diaphragm, alternative types of cervical shields, caps and sponges and alternative types of condoms, both male and female. New materials are also under development, including various plastics and silicone rubber.<sup>2</sup> It is also important to examine the potential for adapting current products and testing existing products for HIV prevention. As these products are already FDA approved, the testing process is not as lengthy.
<h4>What are the next steps?</h4>
The development of alternative barrier methods must be a priority among private and public researchers alike. With over 50 microbicides in the research pipeline, one should be on the market by the year 2005. Advocacy groups have played a large role in increasing awareness and attention to microbicides and should continue advocating for accessible barrier methods.<sup>16</sup> Although US government funding for microbicides has increased, in the 1998 fiscal year, microbicide-related research received only 1% of the National Institutes of Health AIDS research budget.<sup>17</sup>

There is no single solution to HIV and STD prevention. Prevention requires continued work on many levels, including increasing access to products, advocating for social change to eliminate unsafe situations that many people are in, and developing stronger prevention and treatment alternatives. Barrier methods are an integral part of these prevention alternatives and must be developed to their fullest potential to enhance health and prevent disease.

<strong>Says who?</strong>

1. Feldblum P, Joanis C. Modern barrier methods: effective contraception and disease prevention. Family Health International. 1994.
2. The Population Council and International Family Health. The case for microbicides: a global priority . 2000.
3. Microbicides: a new weapon against HIV. American Foundation for AIDS Research (AmFAR) Report. www.amfar.org .
4. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission . Social Science and Medicine. 1997;44:1303-1312.
5. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV . AIDS. 1996;3:S43-51.
6. Gibson S, McFarland W, Wohlfeiler D, et al. Experiences of 100 men who have sex with men using the REALITY condom for anal sex . AIDS Education and Prevention. 1999;11:65-71.
7. Rosenberg MJ, Davidson AJ, Chen JH, et al. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms . American Journal of Public Health. 1992; 82:669-674.
8. UNAIDS. Nonoxynol-9 not effective microbicide, trial shows. Search continues for effective product, UNAIDS chief says. UNAIDS Press Release, June 13, 2000.http://www.unaids.org/whatsnew/press/eng/geneva130600.php
9. Gayle H. Dear Colleague. Centers for Disease Control and Prevention. August 4, 2000.
10. Abdool Karim Q, Abdool Karim SS, Soldan K, et al. Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers . American Journal of Public Health. 1995;85:1521-1525.
11. Gollub EL. The female condom: tool for women’s empowerment . American Journal of Public Health. 2000;90:1377-1381.
12. Heise L. Topical microbicides: new hope for STI/HIV prevention. Center for Health and Gender Equity (CHANGE). Takoma Park, MD.
13. Darroch JE, Frost JJ. Women’s interest in vaginal microbicides . Family Planning Perspectives. 1999;31:16-23
14. Hammet TR, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities . Sexually Transmitted Diseases. 2000;27:119-126.
15. Gross M, Buchbinder SP, Celum C, et al. Rectal microbicides for U.S. gay men: are clinical trials needed? Are they feasible? Sexually Transmitted Diseases. 1998;39:55-61.
16. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group . Journal of the American Medical Association. 1998;280:1161-1167.
17. Harrison PF. A new model for collaboration: the alliance for microbicide development . International Journal of Gynecology and Obstetrics. 1999;67:S39-S53.

<strong>PREPARED BY Beth Freedman MPH, Nancy Padian PhD, CAPS, ARI</strong>

December 2000. Fact Sheet #39E

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © December 2000, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/barrierFS.pdf</url>
	</node>
	<node>
		<title>Condoms</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of male condoms in HIV prevention?</h3>
revised 01/05
<h4>do condoms work?</h4>
Yes. The condom is one of the only widely available and highly effective HIV prevention tools in the US.<sup>1</sup> When used consistently and correctly, latex male condoms can reduce the risk of pregnancy and many sexually transmitted infections (STIs), including HIV by about 80-90%<sup>1-6</sup>. Condoms, including female condoms, are the only contraceptive method that is effective at reducing the risk of both STIs and pregnancy.

When placed on the penis before any sexual contact, the male condom prevents direct contact with semen, sores on the head and shaft of the penis and discharges from the penis and vagina. Condoms thus should effectively reduce the transmission of STIs that are transmitted primarily through genital secretions such as gonorrhea, trichomoniasis, chlamydia, hepatitis B and HIV.<sup>1-6</sup> Because condoms only cover the penis, they provide less protection from STIs primarily transmitted through skin-to-skin contact such as genital herpes, syphilis, chancroid and genital warts.

Abstinence, mutual monogamy between uninfected partners, reducing the number of sexual partners and correctly and consistently using condoms during intercourse are all essential to slowing the spread of HIV/STIs.<sup>7</sup>

Condom effectiveness depends heavily on the skill level and experience of the user. Appropriate education, counseling and training on partner negotiation skills can greatly increase the ability of a person to use a condom correctly and consistently.<sup>2</sup>
<h4>what are the advantages?</h4>
<strong>Accessibility. </strong>Using condoms does not require medical examination, prescription or fitting. Condoms can be bought at drug stores, grocery stores, vending machines, gas stations, bars and the internet, and are distributed free at many STI and HIV clinics.

<strong>Sexual enhancement.</strong> Using condoms can help delay premature ejaculation. Lubricated condoms can make intercourse easier and more pleasurable for women. And condoms do away with the “wet spot” left by semen leakage after sex. Using condoms helps reduce anxiety and fears of pregnancy and STIs so that men and women can enjoy sex more.

<strong>Protect fertility.</strong> Some STIs can affect a woman’s ability to get pregnant; condoms can protect against some STIs and therefore help reduce the risk of infertility.<sup>8</sup>
<h4>what are the disadvantages?</h4>
<strong>Lack of cooperation.</strong> Women cannot directly control whether a condom is used and have to rely upon male cooperation. When men refuse, condom use may be impossible.

<strong>Physical problems.</strong> Many men and their partners complain that condoms reduce sensitivity. Proper condom use requires an erect penis. Some men cannot consistently maintain an erection so condom use becomes difficult. Trying different kinds of condoms (such as thinner condoms) and using water-based lubricant can help increase sensation.

<strong>Embarrassment.</strong> Some men and women may be embarrassed to buy condoms at a store, or take free condoms from a clinic. Others may be embarrassed to suggest or initiate using condoms because they perceive condom use implies a lack of trust or intimacy.<sup>9</sup>
<h4>how are they used?</h4>
The most important key messages for condom use are quite simple: 1) Use a new condom every time, with every act of intercourse, if there is a risk of pregnancy or STIs. 2) Before penetration, carefully unroll the condom onto the erect penis, all the way to the base. Put it on before the penis comes in contact with the partner’s vagina or anus. 3) After ejaculation (while the penis is still erect), hold the rim of the condom against the base of the penis during withdrawal.<sup>2,10</sup>

Even with adequate training and access to condoms, people won’t always use condoms perfectly. In the real world, people may fall in love, or make mistakes, or get drunk or simply decide not to use condoms. Having sex under the influence of alcohol and/or drugs greatly increases the chances of condom non-use, misuse and failure.<sup>11</sup>
<h4>what are concerns?</h4>
<strong>Condom education/distribution in schools.</strong> Although schools can be an important source of information on HIV/STIs, only 2% of public schools have school-based health centers, and only 28% of those make condoms available to students.<sup>13</sup> In 2000, persons aged 15-24 had 9.1 million new cases of STIs and made up almost half of all new STI cases in the US. 47% of US high school students have had sexual intercourse.<sup>15</sup>

<strong>Condom breakage and slippage (condom failure). </strong>Condom quality has been improving<sup>16</sup> and for most users condom failure is relatively rare. About 4% of condoms break or slip off.<sup>2</sup> However some persons report much higher rates. In one study, gay men who were unemployed and reported amphetamine and/or heavy alcohol use were more likely to report condom failure. Men who were frequent users of condoms and used lubricant reported less failure<sup>11</sup>. Counseling and education on condom use can greatly reduce condom failure.<sup>2</sup>

<strong>Effectiveness of N-9. </strong>Condoms lubricated with the spermicide nonoxynol-9 (N-9) often cost more, have no proven protective advantage over condoms without N-9, have a shorter shelf life and might be harmful if used excessively. Many manufacturers have discontinued N-9 condoms.<sup>2,16</sup>
<h4>what works?</h4>
The following programs have been documented as effective by the Centers for Disease Control and Prevention, and are currently being replicated nationwide.<sup>17</sup>

<strong>Training on condom use and negotiation.</strong> The SISTA Project is a social skills training intervention for African American women designed to increase their comfort with and use of condoms. In small group sessions, women learn sexual assertion skills and proper condom use and discuss cultural and gender triggers that affect condom negotiation. Homework activities involve their male partners. Participants reported more condom use.<sup>18</sup>

<strong>Changing community norms.</strong> The Mpowerment Project is a community-level program developed by and for young gay men that increases peer support and acceptance for safer sex. Peer-led M-groups use a gay-positive and sex-positive approach to teach men negotiation and condom use and train and motivate them to conduct informal outreach with their friends. Participants reported decreased rates of unprotected anal intercourse.<sup>19</sup>

<strong>Combining HIV prevention with STI and unintended pregnancy prevention.</strong>The VOICES/VOCES program was implemented in an STI clinic and uses culturally-specific videos and skills building to increase condom use and negotiation among African American and Latino/a heterosexuals. The program is bilingual and includes education about different types of condoms and condom distribution. Participants reported more condom use and fewer repeat STIs.<sup>20</sup>
<h4>what needs to be done?</h4>
Better marketing and increased accessibility to condoms is needed in the US. Although condom use has increased in the past decade, there are still unacceptably high rates of STIs among sexually active adolescents and young adults and among gay men, two populations that are also at increased risk for HIV. New approaches to condom promotion are needed, ideally before the onset of sexual activity. For adolescents to use them, condoms must be easily and anonymously accessible, widely available and low cost. Distributing free condoms can also help increase condom use.<sup>21</sup>

To effectively address HIV prevention, all persons should have accurate and complete information about different prevention options. But the emphasis needs to be different for different groups. For example, while young people who have not started sexual activity need information and access to condoms, the first priority should be to encourage abstinence and delay of sexual intercourse. When targeting those at highest risk for HIV, the first priority should be to encourage correct and consistent condom use along with avoiding high-risk behaviors and partners.<sup>7</sup>

Are condoms foolproof? No. Neither are seat belts, helmets, abstinence pledges or vaccines. But in the real world we drive to work, vaccinate our children, and hope to get through the day unscathed. No public health strategy can guarantee perfect protection. The real question is not are condoms 100% effective, but how can we more effectively use condoms and other approaches to help reduce the risk of disease.

<hr />

<h3>Says who?</h3>
1. Scientific evidence on condom effectiveness for STD prevention. Report from the NIAID. July 2001.
2. Warner L, Hatcher RA, Steiner MJ. Male Condoms. In: Hatcher RA, Trussel J, Stewart F, et al, editors. Contraceptive Technology. New York: Ardent Media Inc. 2004:331-353.
3. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization. 2004;82:454-461.
4. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Systematic Review. 2002;(1):CD003255.
5. Hearst N, Chen S. Condom promotion for AIDS prevention in the developing world: is it working? Studies in Family Planning. 2004;35:39-47.
6. CDC. Male latex condoms and STDs.
7. Halperin DT, Steiner MJ, Cassell MM, et al. The time has come for common ground on preventing sexual transmission of HIV. Lancet. 2004;364:1913-1915.
8. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. American Journal of Public Health. 2004;94:1327-1329.
9. Miller LC, Murphy ST, Clark LF, et al. Hierarchical messages for introducing multiple HIV prevention options: promise and pitfalls. AIDS Education and Prevention. 2004;16:509-25.
10. ASHA. The right way to use a male condom. 1/30/05.
11. Stone E, Heagerty P, Vittinghoff E, et al. Correlates of condom failure in a sexually active cohort of men who have sex with men. Journal of AIDS. 1999;20:495-501.
12. McElderry DH, Omar HA. Sex education in the schools: what role does it play? International Journal of Adolescent Medical Health. 2003;15:3-9.
13. Santelli JS, Nystrom RJ, Brindis C, et al. Reproductive health in school-based health centers: findings from the 1998-99 census of school-based health centers. Journal of Adolescent Health. 2003;32:443-451.
14. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6-10.
15. Youth risk behavior surveillance–US, 2003. Morbidity and Mortality Weekly Report. 2004;53:1-98.
16. Condoms: extra protection. Consumer Reports. Feb 2005.
17. www.effectiveinterventions.org
18. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk reduction intervention for young African-American women. Journal of the American Medical Association. 1995;274:271-276.
19. Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study. AIDS. 1999;13: 1753–1762.
20. O’Donnell CR, O’Donnell L, San Doval A, et al. Reductions in STD infections subsequent to an STD clinic visit: using video-based patient education to supplement provider interactions. Sexually Transmitted Diseases. 1998;25:161–168.
21. Cohen DA, Farley TA. Social marketing of condoms is great, but we need more free condoms. Lancet. 2004;364:13.

<strong>Prepared by Markus Steiner PhD* and Pamela DeCarlo**
*Family Health International, **CAPS</strong>

<strong>January 2005. Fact Sheet #2ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Barb Adler, Daniel Bao, Willard Cates, Bill Cayley Jr, Rick Crosby, Scott Dougherty, Ralph DiClemente, Paul Feldblum, Steve Gibson, Daniel Halperin, Norman Hearst, Mary Hoban, John James, Doug Kirby, Andrzej Kulczycki, Kay Stone, Koray Tanfer, Lee Warner, Dan Wohlfeiler.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/condomFS.pdf</url>
	</node>
	<node>
		<title>Disclosure</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How does disclosure affect HIV prevention?</h3>
<h4>why is disclosure important in HIV?</h4>
Disclosure of HIV+ status is a complex, difficult and very personal matter. Disclosing one’s HIV+ status entails communication about a potentially life threatening, stigmatized and transmissible illness. Choices people make about this are not only personal but vary across different age groups, in different situations and contexts, and with different partners, and may change with time, depending on one’s experiences. Disclosure may have lifelong implications since more people are living longer, and often asymptomatically, with HIV.

Public health messages have traditionally urged disclosure to all sexual and drug using partners. In reality, some HIV+ persons may choose not to disclose due to fears of rejection or harm, feelings of shame, desires to maintain secrecy, feelings that with safer sex there is no need for disclosure, fatalism, perceived community norms against disclosure, and beliefs that individuals are responsible for protecting themselves.<sup>1</sup> This Fact Sheet primarily focuses on disclosure in the context of sex.

Discussing and disclosing HIV status is a two-way street. Be it right or wrong, most people feel that when a person knows that he/she is HIV+ then he/she has an obligation to tell the other person, and counselors are encouraged to help people with this process. Also, laws in some areas require disclosure of HIV+ status prior to sex.<sup>2</sup> However, both partners should be responsible for knowing their own status, disclosing their own status when it seems important, and asking their partner about their status if they want to know.

Most HIV+ persons disclose their status to some, but not all, of their partners, friends and family. Disclosure generally becomes easier the longer someone has been living with HIV, as he/she becomes more comfortable with an HIV+ status. Disclosure to sex partners is more likely in longer-term, romantic relationships than in casual relationships (one-night stands, anonymous partners, group scenes, etc.).<sup>3</sup> Disclosure also varies depending on perceived HIV status of partners, level of HIV risk of sex activities, sense of responsibility to protect partners (personal vs. shared responsibility) and alcohol or drug use.
<h4>does disclosure affect sexual relationships?</h4>
The relationship between disclosure, sexual risk behaviors and potential transmission of HIV varies. Research findings have presented a mixed picture.<sup>4</sup> Some studies have found that increased disclosure is associated with reduced sexual risk behavior.<sup>5</sup> Other studies show that disclosure doesn’t always alter risk taking behaviors.<sup>6</sup> Even with disclosure, unsafe sex sometimes occurs. Some people engage in safer sex behaviors without any discussion of HIV status.<sup>7</sup>

Disclosure can provide psychological benefits. In one study, HIV+ injection drug users who disclosed their status experienced increased intimacy with partners and reaffirmation of their sense of self.<sup>8</sup> Many HIV+ persons who disclose their status find that it reduces anxiety about transmission, so sex can be much more comfortable and relaxed.

A challenging issue for many people is the timing of disclosure. If it’s not done relatively early, it can become more difficult as time goes on, and can cause significant disruption to an ongoing relationship if the disclosed-to partner feels betrayed due to the lack of an earlier disclosure. HIV+ persons who have thought through a disclosure plan and have a consistent strategy for managing disclosure are less likely to engage in risky sexual behaviors than those who do not disclose or have inconsistent disclosure strategies.<sup>5</sup>
<h4>does disclosure affect social relationships?</h4>
Yes. Disclosure to significant others can help increase support for HIV+ persons. A study of Latino gay men found that disclosure was related to greater quality of social support, greater self-esteem, and lower levels of depression.<sup>9</sup> Disclosure also can lead to support that facilitates initiation of, and adherence to, HIV treatment and medications.<sup>10,11</sup>

Disclosing HIV+ status can and sometimes does result in rejection, discrimination or violence. Disclosing to certain persons also can be more of a burden than a benefit. One study found that friends were disclosed to most often and perceived as more supportive than family members, and mothers and sisters were disclosed to more often than fathers and brothers and perceived as more supportive than other family members.<sup>12</sup>
<h4>what are the controversies?</h4>
There is debate around whether partners have a right to know if their partner is HIV+, in order to be able to make a fully informed decision about what sexual behavior to engage in. Some HIV+ persons believe that if they only have protected sex, there is no need for disclosure, especially with casual partners, and that encouraging disclosure only serves to further stigmatize HIV+ persons. These issues can be complicated by complex gender role norms and local laws—23 states have laws that make it a crime for a person to engage in certain risk behaviors without disclosing their HIV status.<sup>2</sup>

People may use disclosure as a way to limit their partners to only persons of the same status, be it HIV+ or HIV- (sometimes known as serosorting). The success of serosorting as a prevention strategy depends upon honest and accurate disclosure on the part of any two sexual partners.<sup>13</sup>

Even when persons do choose to disclose, their awareness of their own HIV status may not be accurate.<sup>14</sup> For example, some people who think that they are HIV- may be, in fact, in the acute stage of HIV infection. If an individual is in the acute stage of HIV infection, which are the initial weeks to months after acquiring HIV when the body has not yet produced a detectable antibody response, then he or she will have a negative result on a standard HIV test. This is especially concerning because when people are in this stage of infection, they more readily transmit the virus during unprotected sex than at other times.<sup>15</sup>
<h4>what’s being done?</h4>
Because many experts believe that HIV+ status disclosure helps prevent HIV transmission and increases social support for HIV+ individuals, there are efforts to develop programs to encourage disclosure and make it a constructive experience. Most programs to support HIV status disclosure have been part of overall prevention and well-being programs for HIV+ persons. Programs may include discussions of the benefits of disclosure, when to disclose and to whom. Programs should include practicing skills to discuss HIV status in the context of sexual negotiation and dating.

The Healthy Living Project is a 15-session, individually delivered, cognitive behavioral intervention to help HIV+ persons cope with the challenges of living with HIV. The project addressed issues of stress, coping and adjustment, safer behavior, including disclosure to partners, and health-related behaviors. Participants reported fewer unprotected sexual risk acts with persons of HIV- or unknown status.<sup>16</sup>

Healthy Relationships is a 5-session, small-group skills-building program for HIV+ persons, and is one of the CDC’s Diffusion of Effective Interventions (DEBI). It is designed to reduce participants’ stress related to safer sexual behaviors and disclosure of their HIV status to family, friends and sex partners. Participants reported significantly less unprotected intercourse and greater condom use at follow-up.<sup>17</sup>

Other disclosure approaches have aimed at encouraging both HIV+ and HIV- persons to not make assumptions about their partner’s HIV status, to get tested, to disclose their own status and practice safer sex with all partners. The Department of Public Health in San Francisco, CA, created the Disclosure Initiative social marketing campaign which aims to normalize the disclosure of HIV status for both HIV+ and HIV- men.<sup>18</sup>
<h4>what needs to be done?</h4>
We need to normalize and facilitate comfortable discussions about HIV, so that disclosure of HIV+ status isn’t such a difficult thing to do. The more HIV is talked about, and the more people come out about being HIV+, the less stigma there will be.

Disclosure is a two-way street. That means it is up to both people who are having sex with each other to address the issue. People living with HIV often are much happier in their relationships (long and short-term) when their HIV status is known by their partner.

There’s no simple answer or policy for disclosure of HIV. Clinicians, counselors and programs need to be sensitive to the complexity of disclosure, and understand that disclosure is not for all people in all contexts. However, disclosing one’s HIV status can facilitate support for HIV+ persons and may lead to better communication, including discussion of risk reduction practices between sexual partners.

<hr />

<h3>Says who?</h3>
1. Wolitski RJ, Parsons JT, Gómez CA, et al. Prevention with HIV-seropositive men who have sex with men: lessons from the Seropositive Urban Men’s Study and the Seropositive Urban Men’s Intervention Trial. Journal of AIDS. 2004;37:S101-109.

2. Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS and Behavior. 2006;10:451-461.

3. Duru OK, Collins RL, Ciccarone DH, et al. Correlates of sex without serostatus disclosure among a national probability sample of HIV patients. AIDS and Behavior. 2006;10:495-507.

4. Simoni JM, Pantalone D. Secrets and safety in the age of AIDS: does HIV disclosure lead to safer sex? Topics in HIV Medicine. 2004;12:109-118.

5. Parsons JT, Schrimshaw EW, Bimbi DS, et al. Consistent, inconsistent, and non-disclosure to casual sex partners among HIV-seropositive gay and bisexual men. AIDS. 2005;19:S87-S97.

6. Crepaz N, Marks G. Serostatus disclosure, sexual communication and safer sex in HIV-positive men. AIDS Care. 2003;15:379-387.

7. Klitzman R, Exner T, Correale J, et al. It’s not just what you say: Relationships of HIV dislosure and risk reduction among MSM in the post-HAART era. AIDS Care. 2007;19:749-756.

8. Parsons JT, VanOra J, Missildine W, et al. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Education and Prevention. 2004;16:459-475.

9. Zea MC, Reisen CA, Poppen PJ, et al. Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS and Behavior. 2005;9:15-26.

10. Stirratt MJ, Remien RH, Smith A, et al. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS and Behavior. 2006;10:483-493.

11. Klitzman RL, Kirshenbaum SB, Dodge B, et al. Intricacies and inter-relationships between HIV disclosure and HAART: a qualitative study. AIDS Care. 2004;16:628-640.

12. Kalichman SC, DiMarco M, Austin J, et al. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. Journal of Behavioral Medicine. 2003;26:315-332.

13. Cairns G. New directions in HIV prevention: serosorting and universal testing. IAPAC Monthly. February 2006:42-45.

14. MacKellar DA, Valleroy LA, Behel S, et al. Unintentional HIV exposures from young men who have sex with men who disclose being HIV-negative. AIDS. 2006;20:1637-1644.

15. Pilcher CD, Eron JJ, Galvin S, et al. Acute HIV revisited: new opportunities for treatment and prevention. Journal of Clinical Investigation. 2004;113:937-945.

16. The Healthy Living Project Team. Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the Healthy Living Project randomized controlled study. Journal of AIDS. 2006; 44:213-221.

17. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine. 2001;21: 84-92. Program information

18. hivdisclosure.com, www.disclosehiv.org

<em>All websites accessed July 2007.</em>

<hr />

<strong>Prepared by Robert H. Remien and Mark Bradley
HIV Center for Clinical &amp; Behavioral Studies, NY State Psychiatric Institute and Columbia University</strong>

<strong>July 2007. Fact Sheet #64E</strong>

Special thanks to the following reviewers of this fact sheet: Mark Cichocki, Joe Imbriani, Phebe Lam, Jennifer Lewis, Bradford McIntyre, Bob Munk, Michael Paquette, Tom Patterson, Steve Pinkerton, Jane Simoni, Jef St De Lore, David Vance, John K. Williams.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©July 2007, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/disclosureFS.pdf</url>
	</node>
	<node>
		<title>Disclosure assistance (PCRS)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of disclosure assistance services in HIV prevention?</h3>
<h4>why assistance for disclosure?</h4>
After more than 20 years of the HIV epidemic, with advances in treatment and increases in understanding and acceptance of HIV, getting an HIV+ diagnosis still can be a traumatic experience. HIV+ persons must come to terms with their own infection and be concerned with possible infection in past and future partners. Talking to partners about HIV is especially hard because even though it is a manageable disease, HIV still is not curable.

Disclosure assistance services (also known as partner counseling and referral services or PCRS) are an array of voluntary and confidential services available to persons living with HIV and their exposed sex and/or needle-sharing partner(s). Disclosure assistance is cost effective and can play a critical role in identifying those individuals most at risk for HIV infection, and linking those who are infected to early medical care and treatment.<sup>1,2,3</sup>

Most HIV+ persons make the decision to disclose or not disclose to their partners on their own. But HIV+ persons may want support for telling their partners about HIV, whether by encouragement for self-disclosure or by having someone who is well-trained carefully and confidentially notify a partner for them. In one study, persons who received disclosure assistance were over three times more likely to have informed a partner of their risk.<sup>4</sup>

In the past few years, HIV counseling and testing programs across the US have shifted their emphasis from testing anyone, to finding and testing persons at greatest risk for HIV infection.<sup>5</sup> At general HIV testing sites, around 1% of clients tested are found to be HIV+, whereas 8-39% of clients tested through disclosure assistance are found to be HIV+.<sup>2</sup>
<h4>what is disclosure assistance?</h4>
Often, disclosure assistance or PCRS mistakenly has been seen as only provider disclosure, but there are three forms of assistance:

<strong>Self disclosure–</strong>The client chooses to notify a partner him/herself. The disclosure assistance provider guides and prepares the client before disclosure. Currently, most HIV+ persons choose this method.

<strong>Dual disclosure–</strong>The client chooses to notify a partner in the presence of a provider. The provider supports the client during disclosure and acts as a resource for the partner. This method is rarely chosen and requires highly skilled providers.

<strong>Provider disclosure (anonymous third party)–</strong>The client prefers a professional to notify a partner, and gives his/her provider identifying and locating information for partner(s). Most often, providers give this info to Disease Intervention Specialists (DIS) who then locate and notify the named partners, keeping client identity strictly confidential. This method is chosen less often, yet it is the only one with client anonymity.

For the partners of an HIV+ client, disclosure assistance services can include: being notified of exposure to HIV, HIV prevention counseling, HIV testing options, referrals for HIV medical evaluation if positive and referrals for other social or medical services.<sup>6</sup>
<h4>how does it work?</h4>
Disclosure assistance services are first offered when a person receives a positive HIV test result. It is not a one-time only service, but should be offered as clients’ risk circumstances and needs change. The main element is helping HIV+ persons tell their sexual and/or needle-sharing partners about possible HIV exposure.

The quality and use of disclosure assistance services can vary widely. Services differ from state to state: some have legal mandates to provide it, some offer it through HIV, STD or combined HIV/STD programs, and states can receive referrals from clinicians, health departments or testing sites.<sup>7</sup>

Services can be provided by HIV service agencies, health departments and most clinics and hospitals. Most service agencies can provide coaching and support for self or dual disclosure and gather partner identifying and locating information which is forwarded to DIS staff. Most notification of partners has been done by DIS at local health departments because they have the capacity, expertise, trained staff and protection from liability.

Good provider disclosure depends on DIS staff who are properly trained and have enough experience and knowledge of the populations they serve. DIS staff should be evaluated regularly to assure quality and be provided with support and ongoing training.<sup>6</sup>
<h4>what are the concerns?</h4>
Public health messages have traditionally urged disclosure to all sexual and drug using partners. In reality, disclosure is complex and difficult. Some HIV+ persons may fear that disclosure will bring partner or familial rejection, limit sexual opportunities, reduce access to drugs of addiction or increase risk for physical and sexual violence. Because of this, some HIV+ persons choose not to disclose. Programs need to accept that not disclosing is a valid option.

Many HIV service agencies and testing and counseling sites routinely offer self disclosure and dual disclosure, working with HIV+ clients by preparing and supporting them to disclose to partners on their own.

Although provider disclosure services have been used for many years with other STDs, there is a wide variety in rates of acceptance of provider disclosure in HIV: in North Carolina, 87% of newly diagnosed HIV+ persons accepted provider disclosure,<sup>8</sup> in Florida 63.1%,<sup>9</sup> Los Angeles, CA 60%,<sup>10</sup> New York State 32.9%,<sup>12</sup> Seattle, WA 32% and among anonymous testers in San Francisco, CA 3.1%.<sup>13</sup> In Los Angeles, the most common reasons for refusal were: already notified partner (23.4%), not being ready to disclose (15.3%), being abstinent (15%) and having an anonymous partner (11%).<sup>10</sup>

Disclosing HIV status to partners can be scary, but also can be empowering. In one study, HIV+ injection drug users who disclosed their status found increased social support and intimacy with partners, reaffirmation of their sense of self and the chance to share experiences and feelings with sexual partners. Another study of HIV+ persons and their partners who received disclosure assistance found that emotional abuse and physical violence decreased significantly after notification.<sup>15</sup>
<h4>what’s being done?</h4>
Florida utilizes trained DISs to deliver disclosure assistance for all reported new HIV infections. In 2004, 63.1% of all newly infected HIV+ persons accepted provider disclosure, identifying 4,460 sex or needle-sharing partners. Among those, 21.8% had previously tested HIV+. Of the 2,518 persons notified, 84.2% agreed to counseling and testing and 11.5% were HIV+.<sup>9</sup>

The Massachusetts Department of Public Health piloted a client-centered model of disclosure assistance that is integrated into the client’s routine prevention, care and support services. The program required significant changes to the standard model of DIS provider disclosure, building close relationships between service providers and DIS to better support clients’ disclosure needs while protecting confidentiality.<sup>16</sup>

California instituted a voluntary disclosure assistance program that includes counseling and preparing HIV+ persons for self disclosure; anonymous third party provider notification; counseling, testing and referrals for notified partners; and training and technical assistance to providers in public and private medical sites. About one-third of patients opted for provider disclosure and 85% referred partners. Of the partners located, 56% tested for HIV and half had never tested before. Overall, 18% of partners tested HIV+.<sup>4</sup>
<h4>what needs to be done?</h4>
New HIV testing technologies can be useful with disclosure assistance services. Improved rapid testing is a potential invaluable tool for offering HIV tests in the field to notified partners. Nucleic acid amplification testing (NAAT) can determine acute infections, that is, new HIV infections that do not show up during the window period of other HIV tests. Combining these testing strategies with disclosure assistance can help identify newly infected persons and provide immediate counseling, support and referrals to medical or social services as needed.<sup>17</sup>

Disclosure assistance services, and particularly provider disclosure, may need extensive changes from the traditional DIS model in order to work well and be accepted within HIV services. Health departments could forge closer ties between their STD and HIV programs and with outside service agencies. HIV staff also can be trained to be DIS providers to broaden access to and comfort with disclosure services.

Disclosure assistance services should be made available not only upon HIV diagnosis, but on an ongoing basis as HIV+ persons’ circumstances and needs change. It is not the role of providers to decide if a client will need or want disclosure assistance, but to offer clients support and choices, whether or not a client chooses to disclose.

<strong>Prepared by Fern Orenstein MEd, CA STD Control Branch, Prevention Training Center</strong>

<hr />

<h3>Says who?</h3>
1. Landis SE, Schoenbach VJ, Weber DJ, et al. Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. New England Journal of Medicine. 1992;326: 101-106.

2. Golden MR. Editorial: HIV partner notification, a neglected prevention intervention. Sexually Transmitted Diseases. 2002;29:472-475.

3. Varghese B, Peterman TA, Holtgrave DR. Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS. 1999;13:1745-1751.

4. Eckert V. Utilization of voluntary HIV partner counseling and referral services. California Office of AIDS &amp; STD Control Branch. Presented at the Statewide PCRS Conference, May 2004.

5. Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic – US, 2003. Morbidity and Mortality Weekly Report. 2003:52;329-332.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5215a1.htm (accessed April 2006).

6. HIV partner counseling and referral services guidance. Centers for Disease Control and Prevention. 1998. www.cdc.gov/hiv/pubs/pcrs.htm

7. Aldridge C, Randall L. Implementing partner counseling and referral services programs. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #TO-057.

8. Centers for Disease Control and Prevention. Partner counseling and referral services to identify persons with undiagnosed HIV–North Carolina, 2001. Morbidity and Mortality Weekly Report. 2003;52:1181-1184.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5248a4.htm (accessed April 2006).

9. George D. Partner counseling and referral services (PCRS): the Florida experience. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #M3-B1605.

10. Aynalem G, Hawkins K, Smith LV, et al. Who and why? Partner counseling and referral service refusal: implication for HIV infection prevention in Los Angeles. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #MP-036.

11. Birkhead G. HIV partner counseling and referral services in New York state. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #M3-B1603.

12. Golden MR. Partner notification: where do we stand and outstanding barriers. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #T3-D1302.

13. Schwarcz S, McFarland W, Delgado V, et al. Partner notification for persons recently infected with HIV: experience in San Francisco. Journal of Acquired Immune Deficiency Syndrome. 2001;28:403-404.

14. Parsons JT, Vanora J, Missildine W, et al. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Education and Prevention. 2004;16:459-475.

15. Kissinger PJ, Niccolai LM, Magnus M, et al. Partner notification for HIV and syphilis: effects on sexual behaviors and relationship stability. Sexually Transmitted Diseases. 2003;30:75-82.

16. Cranston K. Planning for HIV partner counseling and referral services in the third decade. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #T3-D1301.

17. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. New England Journal of Medicine. 2005;352:1873-1883.

<hr />

<strong>September 2005. Fact Sheet #53ER</strong>

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©Sepetmber 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revPCRSFS.pdf</url>
	</node>
	<node>
		<title>HIV counseling and testing</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Is the Role of Counseling and Testing in HIV Prevention?</h3>
<h4>why is C&amp;T important?</h4>
HIV counseling and testing (C&amp;T) is an important part of a continuum of HIV prevention and treatment services. C&amp;T is one of the main times when a comprehensive individual risk assessment is taken, making it the best opportunity for accurate referrals to more intensive services. C&amp;T is also one of the primary entry points into prevention and other services. C&amp;T uses short, client-centered counseling that can be effective in increasing condom use and preventing sexually transmitted diseases (STDs).<sup>1</sup>

Knowing one’s HIV status, whether HIV- or HIV+, is key to preventing the spread of HIV and accessing counseling and medical care. It is estimated that one-fourth of all HIV+ persons in the US do not know they’re infected.<sup>2</sup> A survey of young men who have sex with men (MSM), found that 14% of young Black MSM were HIV+. Among those, 93% were unaware of their infection, and 71% reported it was unlikely they were HIV+.<sup>3</sup>

Recently, the Centers for Disease Control and Prevention (CDC) announced an initiative aimed at expanding C&amp;T in the US.<sup>4</sup> Their Strategic Plan for 2005 strives to decrease by 50% the number of people who don’t know their HIV status.<sup>5</sup> If this goal is met by 2010, an estimated 130,000 new HIV infections may be prevented, saving over $18 billion.<sup>6</sup>
<h4>how is C&amp;T done?</h4>
C&amp;T has three distinct components: risk assessment and counseling before the blood or oral sample is taken, testing of the sample, and counseling and referral with the test results.<sup>7</sup> C&amp;T can be confidential-a person’s name is recorded with the test results-or anonymous-no name is recorded with the test. Publicly funded HIV C&amp;T takes place in testing centers, community health clinics, community-based organizations, outreach programs, mobile vans, STD and family planning clinics and local health departments, among other venues.

Although public health workers are trained in C&amp;T procedures, most HIV testing in the US occurs in private doctors’ offices. Many people prefer being tested as part of a routine check-up, instead of public health sites. However, testing in private venues does not offer anonymity, and patients who get tested as part of routine medical care may not receive adequate counseling or referrals.<sup>8</sup>

Other venues also test for HIV, such as emergency rooms, jails/prisons, military recruitment sites and Job Corps. HIV testing in the US is mandatory to get some insurance and medical benefits, apply for some jobs, join the military, give blood or enter the US as an immigrant. HIV testing is compulsory for federal prison inmates and sex offenders in some states.
<h4>what about rapid testing?</h4>
The standard testing method for the past 20 years has been a needle blood draw. In the past 10 years, a mouth swab (OraSure) that tests cells from inside the cheek has also been available. Results are sent to a lab for the ELISA test and a Western Blot to confirm an initially positive result, with an average wait of 1-2 weeks between sample collection and the provision of results. With this method, many persons don’t return for their test results, and nationally 31% of persons who test HIV+ don’t return to find out their results.<sup>4</sup>

Rapid testing is now available with a finger stick (OraQuick). With this method, results are known in 20 minutes, eliminating the need for a return visit for results. However, if a client’s tests is reactive, he receives a preliminary positive result. A second blood test (needle draw or OraSure) is required to confirm the result with a standard Western Blot. Final confirmation still takes 1-2 weeks. National data indicate that with rapid testing, 95% of clients who received a preliminary positive result returned for their confirmatory results.<sup>9</sup>

Rapid testing will change the way C&amp;T is conducted, although clients can still opt to get their results later. Because the client needs to wait for 20 minutes for the results, the counselor takes the blood early in the session and has a “captive audience” for risk assessment and counseling. Test counselors can conduct the blood test themselves, or a separate staff person can do the finger stick and read results. Counseling with rapid testing can be more intense and client-focused due to the immediacy of getting results. It is hoped that rapid testing will dramatically increase the number of persons who know their results.
<h4>what makes good C&amp;T?</h4>
Good C&amp;T depends on counselors who are properly trained and have enough experience. Counselors must protect the confidentiality of client information, obtain informed consent before testing and provide effective counseling services and appropriate referrals. Counselors should establish relationships with key service
agencies to make sure the referrals they give clients reflect their needs, priorities, culture, age, sexual orientation and language. C&amp;T counselors should be evaluated
regularly to assure quality and be provided with support and ongoing training.<sup>7</sup>

With rapid testing, counselors need different training as they can be both the counselor and the lab. Rapid testing requires stable temperatures, adequate lighting, and careful attention to detail. Also, rapid testing is not rapid counseling. Counselors need to work closely with clients to develop a reasonable risk reduction step and to make sure their clients are actually ready to receive the test results. It is also important to obtain a second blood sample for confirmation if a client tests positive.<sup>10</sup>
<h4>what’s being done?</h4>
The Department of Public Health (DPH) in Florida made a deliberate effort to improve their C&amp;T services and increase the number of people who know they are HIV+. State funded testing sites targeted venues with high-risk persons, including CBOs, prisons/jails and outreach settings. They also began using OraSure for testing in the field. In 2002, the DPH reported a 2% seropositive rate for blood draws and 3.2% for OraSure. In jails they found a 3.6% seropositive rate. They also used partner counseling and referral services (PCRS) and in 2002, 80% of HIV+ people gave names of partners, 64% of partners were located and counseled, and 13% of partners who tested were HIV+.<sup>11</sup>

In Minneapolis, MN, rapid testing was offered at a variety of agencies serving primarily African American clients. Venues included drug treatment programs,
homeless shelters, teen clinics, sex offender groups and halfway houses. Almost all (99.7%) of clients received their test results and counseling, and 95% reported they would rather have a finger stick than a blood draw.<sup>12</sup>

Wisconsin’s AIDS/HIV Program wanted to increase the number of high-risk persons accessing testing. In the early 90s, tests jumped from 6000 per year to between 20,000-30,000. The number of high-risk persons tested, however, remained the same while seroprevalence rates dropped from 3.5% to 0.5%. In the late 90s, the program shifted its philosophy from one of public education to case finding. Publicly funded sites were reduced from 126 to 55 serving the greatest percentage of high-risk persons and persons of color. In one year, the seroprevalence rate improved to .75%, the number of low-risk persons tested decreased 42%, high-risk persons tested increased 6%, and testing among persons of color improved 18%.<sup>13</sup>
<h4>what is the future of C&amp;T?</h4>
As rapid testing becomes more widely used, it is hoped that the number of people not returning for their test results will decrease. Rapid testing can allow for more
targeted outreach to communities and persons at risk, as C&amp;T occurs in venues that are more accessible and acceptable. Rapid testing should be implemented carefully to allow time for agencies to gain experience and clients to understand the new testing process.

Greater efforts may be necessary to refer clients to effective services. Behavior change is a slow and difficult process, and many persons make changes incrementally. Linkages to other services and follow-up with clients may substantially increase the impact of the initial counseling. While training and quality assurance has traditionally centered on counseling in C&amp;T, referrals may be the weakest part and need most improvement.

Simply increasing the number of persons who know they are HIV+ will not slow the HIV epidemic sufficiently. As more persons in the US discover their HIV status, it is crucial to ensure that more prevention, social and treatment services are available both to HIV+ and HIV- persons. In addition to primary HIV prevention interventions, these should include access to quality drug and alcohol treatment, housing and employment services, STD testing and treatment, syringe exchange programs, quality medical care and adherence support to insure effective use of AIDS medications.

<strong>Prepared by Steven R. Truax, PhD*, Pamela DeCarlo**
*California State Office of AIDS, **CAPS</strong>

<hr />

<h3>Says who?</h3>
1. Kamb ML, Fishbein M, Douglas JM,et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases. Journal of the American Medical Association. 1998;280:1161-1167.

2. Fleming P, Byers RH, Sweeney PA, et al. HIV prevalence in the United States, 2000. Presented at the 9th Conference on Retroviruses and Opportunistic Infections, Seattle, WA; February 24-28, 2002.

3. Centers for Disease Control and Prevention. Unrecognized HIV infection, risk behaviors and perceptions of risk among young black men who have sex with men – six US cities, 1994-1998. Morbidity and Mortality Weekly Reports. 2002;33:733-736.

4. Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic – US, 2003. Morbidity and Mortality Weekly reports. 2003:52;329-332. www.cdc.gov/hiv/partners/ahp.htm

5. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005. www.cdc.gov/hiv/partners/ psp.htm

6. Holtgrave DR, Pinkerton SD. Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States. Journal of Acquired Immune Deficiency Syndromes. 2003;33:171-174.

7. Centers for Disease Control and Prevention. Revised Guidelines for HIV Counseling, Testing, and Referral. Morbidity and Mortality Weekly Reports. 2001;50.

8. Haidet P, Stone DA, Taylor WC, et al. When risk is low: primary care physicians’ counseling about HIV prevention. Patient Education and Counseling. 2002;46:21-29.

9. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045-1051.

10. Fournier J, Morris P. Speed bumps and roadblocks on the road to rapid testing: a look at the integration of HIV rapid testing in an agency and community. Presented at the US Conference on AIDS, New Orleans, LA, 2003.

11. Liberti T. Florida’s HIV counseling, testing and referral program. Presented at the US Conference on AIDS, New Orleans, LA, 2003.

12. Keenan PA. HIV outreach in the African American community using OraQuick rapid testing. Presented at the National HIV Prevention Conference, Atlanta, GA. 2003.

13. Stodola J. Restructuring Wisconsin’s HIV CTR program: targeting CTR services. Presented at the US Conference on AIDS, New Orleans, LA, 2003.

<hr />

<strong>January 2004. Fact Sheet #3ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Jena Adams, Barbara Adler, Chris Aldridge, Teri Dowling, Barbara Gerbert, Paul Haidet, Sydney Harvey, Willi McFarland, Patrick Keenan, Kathryn Phillips, Jim Stodola, Brenda Storey, Ed Wolf.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2004, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/C&amp;TFS.pdf</url>
	</node>
	<node>
		<title>Mother-to-child transmission (MTCT)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Is Mother-to-Child HIV Transmission Preventable?</h3>
<strong>Prepared by Sarah A. Gutin, MPH*
*CAPS, Community Health Systems- School of Nursing, UCSF</strong>

<strong>Fact Sheet #34ER – September 2015</strong>

Special thanks to the following reviewers of this Fact Sheet: Yvette Cuca, Carol Dawson Rose, Shannon Weber

In 2012, there were 2.3 million new HIV infections globally [1]. A large proportion of people newly diagnosed with HIV worldwide are in their reproductive years and these men and women are likely to want children in the future [2-4]. Addressing the sexual and reproductive health and rights of this population is critical to addressing the spread of HIV because HIV infection in childbearing women is the main cause of HIV infection in children [5]. Treatment for those who are already infected is also central to stopping the spread of HIV to infants and to uninfected sexual partners.
<h4>How does transmission occur?</h4>
Perinatal transmission of HIV, also called vertical transmission, occurs when HIV is passed from an HIV-positive woman to her baby during pregnancy, labor and delivery or breastfeeding. For an HIV-positive woman not taking HIV medications, the chance of passing the virus to her child ranges from about 15 to 45% during pregnancy, labor and delivery. If she breastfeeds her infant, there is an additional 35 to 40% chance of transmission [6].
<h4>Is the risk of perinatal transmission always the same?</h4>
No. Global societal and economic inequities create a wide gap between women in developing nations and women in developed nations with regard to HIV prevention, voluntary counseling and testing and access to drugs which treat HIV infection and can prevent perinatal transmission.

<strong>Developed countries</strong>- In many developed countries, pediatric HIV has been virtually eliminated [7]. In the US in 1994, the Public Health Service recommended HIV counseling and voluntary testing and AZT therapy for all pregnant women after the clinical trial known as “076” showed that AZT reduced rates of MTCT by two-thirds. Since then, a combination of interventions that includes treatment with ART to control the virus and make it undetectable, cesarean delivery, and avoidance of breastfeeding has helped further reduce perinatal transmission in the US, from an estimated 1,500 cases in 1992 to an estimated 162 perinatal infections in 2010 [8]. Although the estimated number of perinatal HIV infections in the US continues to decline, women of color, especially black/African American women are disproportionately affected by HIV infection and as a result, perinatal HIV infection is highest among blacks/African Americans (63%), followed by Hispanics/Latinas (22%) [8]. Although effective interventions have led to a significant reduction in the number of perinatal infections in the US, <strong>perinatal</strong> transmission still occurs. To close the final gap, the CDC has proposed a new framework to eliminate mother-to-child HIV transmission (EMCT) in the US [8]. This framework focuses on key areas including: comprehensive reproductive health care (that includes both family planning (FP) and preconception care) and comprehensive case-finding of pregnancies in HIV-infected women that is conducted through comprehensive clinical care and case management services for women and infants; case review and community action; continuous quality research in prevention and long-term monitoring of HIV-exposed infants; and thorough data reporting for HIV surveillance at the state and local health department levels [8 9].

<strong>Developing countries</strong>- Unfortunately, perinatal transmission of HIV continues to plague many developing countries despite recent prevention acceleration. In 2008, an estimated 1.4 million pregnant women in low and middle-income countries were living with HIV, of whom about 90% were in sub-Saharan African countries [7]. In 2012, UNAIDS reported that approximately 210,000 children became HIV infected [1].
<h4>Can perinatal transmission of HIV be reduced?</h4>
Yes. Perinatal transmission encompasses a variety of highly effective interventions that have huge potential to improve maternal and child health. Advances in treatment and new classes of drugs have provided the opportunity to greatly reduce rates of perinatal transmission worldwide. Also, perinatal transmission can be reduced by preventing unintended pregnancies. Preventing unintended pregnancies is one of the most effective ways to prevent HIV infection in infants and stop spread of the epidemic to children [10]. For that reason, preventing unintended pregnancies among women living with HIV and offering family planning to delay, space or end childbearing is one of the four WHO pillars in the comprehensive approach to preventing perinatal transmission [7]. However, we have still not addressed the root cause of perinatal transmission, mainly heterosexual HIV transmission. The best way to prevent perinatal HIV transmission is to prevent HIV transmission in the mother and father.

In order to reduce perinatal transmission, all pregnant women should have access to free or low-cost prenatal care and voluntary HIV testing and counseling. If a pregnant woman is HIV-positive, she should have access to lifelong ART to treat HIV and improve her own health and to decrease the chances of HIV infection in her infant. In June 2013, the WHO published updated guidelines on the diagnosis of HIV, the care of people living with HIV(PLHIV) and the use of ART for treating and preventing HIV infection [1]. In the US, the Department of Health and Human Services recommends that all HIV-infected pregnant women should be given ART during pregnancy to prevent perinatal transmission of HIV, regardless of whether ART is indicated for the woman’s own health [11]. Perinatal transmission can be reduced to less than 2% if a woman is on ART, has a low or undetectable viral load, follows the recommended treatment regimen and does not breastfeed [7 8]. Careful management during labor and delivery can also help reduce perinatal transmission, for example by avoiding unnecessary instrumentation and not prematurely rupturing membranes [12].

Also, although universal prenatal HIV testing is the standard in the US, if prenatal care has not been provided, the patient has HIV, or her HIV status is undocumented, it is critical for hospitals to determine a laboring patient’s HIV status upon admission. Even without the use of ART during the pregnancy, the use of ART during labor and for the infant can reduce the risk of perinatal transmission to between 6 to 13% [13]. It is therefore recommended that rapid HIV testing be performed in Labor and Delivery units on pregnant women with no HIV test during their pregnancy or with risk factors for infection since their last test [14].

In developing countries, perinatal transmission has been a priority since 1998, following the success of short-course zidovudine and single-dose nevirapine clinical trials [7]. In recent years, single-dose nevirapine as the primary antiretroviral medicine option for HIV-positive pregnant women to prevent transmission to their infants has been phased out, in favor of more effective and simplified triple ART regimens [1]. The WHO now recommends that all pregnant and breastfeeding women with HIV, regardless of CD4 count or clinical stage, should initiate a triple ART regimen which should be maintained for the duration of perinatal transmission risk, which includes pregnancy, delivery and throughout the breastfeeding period (this is known as Option B). In countries were more than one percent of the population has HIV (these are known as generalized epidemics) and where there is often limited access to tests that indicate the severity of HIV illness (such as CD4 testing), limited partner testing, long duration of breastfeeding and high rates of fertility, the WHO recommends that women meeting treatment eligibility criteria should continue lifelong ART (this strategy is referred to as Option B+) [12]. There are many benefits to lifelong treatment for all pregnant and breastfeeding women and these include increased coverage of those needing ART for their own health, a reduction in the number of women stopping and starting ART during repeat pregnancies, early protection against perinatal transmission in future pregnancies, reduced risk of infecting a partner who is HIV-negative and decreased risk of medication failure or the development of resistance [12].

The ultimate goal is to find the most effective and sustainable regimens for HIV treatment and the prevention of perinatal transmission worldwide. Economics, politics, poor infrastructure, access to healthcare and medications, stigma and cultural norms all pose significant challenges to providing this standard of care everywhere and not all PLHIV have equal access to treatment.
<h4>What are the barriers to the prevention of perinatal transmission?</h4>
Pregnant women face many difficult decisions, including decisions around HIV testing, treatment options and infant feeding. Understanding the barriers that women face and addressing barriers at various levels can help in realizing the full potential of prevention of perinatal transmission programs. A recent review article found that barriers to the prevention of perinatal transmission often fell into three broad categories that included the individual, their partners and community, and health systems [15]. At the individual level, studies suggest that a lower maternal education level, younger maternal age, and poor knowledge of HIV transmission and ART are associated with not receiving and/or not taking ART in order to treat and prevent the spread of HIV [15].

Additionally, a woman’s male partner(s), extended family, greater community and health care setting all influence her decision and ability to take advantage of prevention of perinatal transmission programs. Many qualitative studies have found that stigma regarding HIV status and fear of disclosure to partners and family members is a major barrier to the uptake of perinatal prevention interventions [15]. Women living with HIV also continue to report that stigma and discrimination, especially in health care settings, continue to be a barrier to accessing adequate information and services [1]. In various studies, PLHIV have reported negative staff attitudes and this has been cited as a barrier to returning to facilities for care [15].

In developing countries, health systems issues are also a barrier to greater prevention uptake. Key barriers that have been identified include a shortage of trained clinic staff, high patient volumes, long wait times, and brief and poor counseling sessions [15]. In addition, a lack of access or shortages of medications, including ART, as well as stock-outs of HIV test kits and condoms have been reported. Poor access to healthcare overall (long distances to facilities) and poor integration of services also contributes to low ART uptake.
<h4>What about breastfeeding?</h4>
Breastfeeding is usually the healthiest choice for both infants and mothers. However, HIV transmission can occur during breastfeeding, with chances of transmission increasing the longer the infant is breastfed. In the countries with the highest perinatal HIV rates, it is estimated that more than half of the children newly infected with HIV acquire it during the breastfeeding period [1]. However, the risk of transmitting HIV to infants through breastfeeding is low in the presence of ART [12]. Therefore, providing ART to mothers throughout the breastfeeding period is a critical step needed to further reduce rates of perinatal transmission [1]. It is recommended that HIV-positive mothers do not breastfeed when formula feeding is safe, well accepted and readily available. In the US, both the Centers for Disease Control and Prevention and the American Academy of Pediatrics recommends that HIV-infected women refrain from breastfeeding regardless of their ART status to avoid postnatal transmission of HIV to their infants through breast milk [16 17].

However, formula feeding requires clean water for mixing formula. Many women in developing countries do not have access to clean water or sanitation and cannot afford formula, and therefore cannot avoid breastfeeding. In developing countries where breastfeeding is the norm, formula feeding may also alert a woman’s family or community that she is HIV-positive, which may result in stigma or other negative repercussions. Therefore, the WHO recommends that when breastfeeding is unavoidable, mothers should take ART while breastfeeding and that infants should receive 6 weeks of prophylaxis with once-daily nevirapine [12]. The WHO further recommends that mothers known to be infected with HIV (and whose infants are HIV uninfected or of unknown status) should exclusively breastfeed for the first 6 months of life, introducing appropriate complementary foods thereafter, and continue breastfeeding for the first 12 months of life. It is recommended that breastfeeding should only stop when a nutritionally adequate and safe diet without breast-milk can be provided [12]. Access to ARVs during this extended breastfeeding period is critical [12].
<h4>What’s being done?</h4>
<strong>Primary prevention of HIV among men and women of childbearing age:</strong>

Various tools are now available to prevent HIV infections in men and women of childbearing age. Pre-exposure prophylaxis (PrEP), which is a special course of HIV treatment that aims to prevent people from becoming infected with HIV, has been found to protect against HIV-1 infection in heterosexual men and women and reduce HIV transmission by 67 to 75% [18 19]. PrEP is intended for people at-risk of becoming infected with HIV, for example in the case of couples where one partner is HIV-positive and the other is HIV-negative. In countries with generalized HIV epidemics, voluntary medical male circumcision for HIV-negative male partners in relationships with a positive partner has been shown to reduce the risk of HIV-acquisition in men by between 38% to 66% [20]. Using ART to decrease the chance of HIV transmission, a concept known as treatment as prevention, has also recently been found to be very efficacious, with studies in heterosexual populations showing that adherence to ART is very effective at preventing transmission of HIV to HIV-negative partners [21-23]. Couples-testing with treatment for infected partners in discordant partnerships is also a promising approach. Integrating couples counseling and partner testing into routine clinic and community services can increase the number of couples in which the status of both partners is known and can help identifying sero-discordant couples [24].

<strong>Preventing unintended pregnancies and Safer Conception Options:</strong>

Preventing unintended pregnancies among women living with HIV (WLHIV) is a powerful prevention strategy. One study found that even modest reductions in the numbers of pregnancies among WLHIV could avert HIV-positive births at the same rates as the use of ART for PMTCT [25]. One targeted approach to strengthening FP programs is to integrate FP within HIV services. In Kenya, a recent cluster-randomized trial tried to determine whether integrating FP services into HIV care was associated with increased use of more effective contraceptive methods such as sterilization, IUDs, implants, injectables and oral contraceptives. Women seen at integrated sites were significantly more likely to use more effective methods of FP at the end of the study [26]. This makes the case for integrating FP within HIV care. Reducing the unmet need for FP will reduce new HIV infections among children and improve overall maternal and infant health.

For HIV-positive or serodiscordant couples who would like to have children, there are many options available to make conception safer. When offering preconception care, HIV-positive couples will have specific needs, many of which can be addressed during their routine HIV care. When offering preconception counseling for HIV-positive women, the CDC recommends that health care providers should discuss a variety of topics, including: reproductive options and actively assessing women’s pregnancy intentions on an ongoing basis; Counseling on safe sexual practices that prevent HIV transmission to sexual partners, protect women from acquiring sexually transmitted diseases, and reduce the potential to acquire more virulent or resistant strains of HIV; Using ART to attain a stable, maximally suppressed maternal viral load prior to conception to decrease the risk of perinatal transmission and of HIV transmission to an uninfected partner; and encouraging sexual partners to receive counseling and HIV testing and, if infected, to seek appropriate HIV care[11].

For couples who want to conceive, in which one or both are HIV-positive, the positive partner should be on ART and have achieved maximal suppression of HIV infection. ART for the positive partner may not be fully protective against sexual transmission of HIV and so the administration of PrEP for the HIV-negative partner may offer an additional tool to reduce the risk of transmission. For discordant couples, when the positive partner is a woman, the safest conception option is artificial insemination. In discordant couples where the positive partner is male, the safest conception option is the use of donor sperm from an HIV-uninfected male with artificial insemination. When the use of donor sperm is unacceptable, the use of sperm preparation techniques together with either intrauterine insemination or <em>in vitro </em>fertilization is an option [11].

<strong>Preventing HIV transmission from WLHIV to infants:</strong>

Increasing access to ART for WLHIV is critical to saving the lives of women and their children. The number of pregnant WLHIV receiving ART for their own health has increased from 25% in 2009 to 60% in 2012 [1]. One of the greatest success stories has been in Malawi where a policy of providing lifelong ART to all pregnant and breastfeeding women (irrespective of CD4 count or clinical status– a strategy referred to as Option B+) was enacted in 2011. Since then, Malawi increased the estimated coverage of women in need of ART from 13% in 2009 to 86% in 2012. The implementation of Option B+ has resulted in a 748% increase in the number of pregnant and breastfeeding women starting ART, from 1,257 in the second quarter of 2011 to 10,663 in the third quarter of 2012 [27]. As a result of Option B+, the perinatal transmission rate for women on ART is expected to be reduced, from approximately 40% without intervention to less than 5%. By decentralizing treatment services and offering lifelong HIV treatment to all pregnant and breastfeeding women, Malawi has been able to increase ART coverage both during pregnancy and the breastfeeding period [1].

<strong>Providing treatment, care and support to WLHIV and their children and families:</strong>

Increasing access to ART for pregnant women living with HIV for their own health is critical to saving the lives of women and their children. Even developing countries, which at first lagged behind in reducing the number of children newly infected with HIV, have made great gains in recent years. In 2013, UNAIDS reported that in 7 high burden countries where access to treatment has increased, the rates of HIV transmission to children has fallen by 50% or more [1].
<h4><strong>What still needs to be done?</strong></h4>
HIV is a preventable disease. Perinatal transmission is best prevented by effective, accessible and sustainable HIV prevention, access to HIV testing, early diagnosis and linkage to treatment programs for women, men and their children, access to family planning and abortion services to prevent unintended pregnancies, and access to an ongoing supply of ARVs to improve the health of women and their children. Structural interventions are also needed that increase access to health centers, improve health care infrastructure, provide food supplementation, and HIV treatments.

Women are the key to the HIV response and the number of women acquiring HIV has to be reduced. All women have a right to be treated for HIV infection, not simply because they are bearing a child. All women living with HIV who are eligible for ART need to have access to it. Unfortunately, too many women are still lost along the prevention cascade and never get the care or treatment they need and deserve. Providing women with access to high quality healthcare for themselves and their families, whether they are HIV-positive or not, is imperative.
<div>

<hr size="1" />

</div>
<strong>Says who?</strong>

1. UNAIDS. AIDS by the numbers. Geneva, Switzerland, 2013.

2. Kanniappan S, Jeyapaul MJ, Kalyanwala S. Desire for motherhood: exploring HIV-positive women’s desires, intentions and decision-making in attaining motherhood. AIDS care 2008;<strong>20</strong>(6):625-30 doi: 10.1080/09540120701660361[published Online First: Epub Date]|.

3. Beyeza-Kashesya J, Kaharuza F, Mirembe F, et al. The dilemma of safe sex and having children: challenges facing HIV sero-discordant couples in Uganda. African health sciences 2009;<strong>9</strong>(1):2-12

4. Cooper D, Moodley J, Zweigenthal V, et al. Fertility intentions and reproductive health care needs of people living with HIV in Cape Town, South Africa: implications for integrating reproductive health and HIV care services. AIDS and behavior 2009;<strong>13 Suppl 1</strong>:38-46 doi: 10.1007/s10461-009-9550-1[published Online First: Epub Date]|.

5. UNAIDS. We Can Prevent mothers fom dying and babies from becoming infected with HIV. Geneva, Switzerland, 2010.

6. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA : the journal of the American Medical Association 2000;<strong>283</strong>(9):1175-82

7. WHO. PMTCT Strategic Vision 2010-2015: Preventing mother-to-child transmission of HIV to reach the UNGASS and Millenium Development Goals. Geneva, Switzerland, 2010.

8. CDC. HIV Among Pregnant Women, Infants, and Children in the United States. Atlanta, 2012.

9. Nesheim S, Taylor A, Lampe MA, et al. A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics 2012;<strong>130</strong>(4):738-44 doi: 10.1542/peds.2012-0194[published Online First: Epub Date]|.

10. Nakayiwa S, Abang B, Packel L, et al. Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS and behavior 2006;<strong>10</strong>(4 Suppl):S95-104 doi: 10.1007/s10461-006-9126-2[published Online First: Epub Date]|.

11. Department of Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. In: Bureau HA, ed. Washington, DC, 2014.

12. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva, Switzerland, 2013.

13. Kourtis AP, Lee FK, Abrams EJ, et al. Mother-to-child transmission of HIV-1: timing and implications for prevention. The Lancet infectious diseases 2006;<strong>6</strong>(11):726-32 doi: 10.1016/S1473-3099(06)70629-6[published Online First: Epub Date]|.

14. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2006;<strong>55</strong>(RR-14):1-17; quiz CE1-4

15. Gourlay A, Birdthistle I, Mburu G, et al. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society 2013;<strong>16</strong>(1):18588 doi: 10.7448/IAS.16.1.18588[published Online First: Epub Date]|.

16. American Academy of Pediatrics Committee on Pediatric A. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008;<strong>122</strong>(5):1127-34 doi: 10.1542/peds.2008-2175[published Online First: Epub Date]|.

17. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Secondary Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf.

18. Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Current opinion in infectious diseases 2012;<strong>25</strong>(1):51-7 doi: 10.1097/QCO.0b013e32834ef5ef[published Online First: Epub Date]|.

19. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England journal of medicine 2012;<strong>367</strong>(5):399-410 doi: 10.1056/NEJMoa1108524[published Online First: Epub Date]|.

20. Siegfried N, Muller M, Deeks JJ, et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. The Cochrane database of systematic reviews 2009(2):CD003362 doi: 10.1002/14651858.CD003362.pub2[published Online First: Epub Date]|.

21. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;<strong>375</strong>(9731):2092-8 doi: 10.1016/S0140-6736(10)60705-2[published Online First: Epub Date]|.

22. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England journal of medicine 2010;<strong>363</strong>(27):2587-99 doi: 10.1056/NEJMoa1011205[published Online First: Epub Date]|.

23. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine 2011;<strong>365</strong>(6):493-505 doi: 10.1056/NEJMoa1105243[published Online First: Epub Date]|.

24. Medley A, Baggaley R, Bachanas P, et al. Maximizing the impact of HIV prevention efforts: Interventions for couples. AIDS care 2013 doi: 10.1080/09540121.2013.793269[published Online First: Epub Date]|.

25. Sweat MD, O’Reilly KR, Schmid GP, et al. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. Aids 2004;<strong>18</strong>(12):1661-71

26. Grossman D, Onono M, Newmann SJ, et al. Integration of family planning services into HIV care and treatment in Kenya: a cluster-randomized trial. Aids 2013;<strong>27 Suppl 1</strong>:S77-85 doi: 10.1097/QAD.0000000000000035[published Online First: Epub Date]|.

27. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV–Malawi, July 2011-September 2012. MMWR. Morbidity and mortality weekly report 2013;<strong>62</strong>(8):148-51]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/11/MTCT-Revised-Sept-2015.pdf</url>
	</node>
	<node>
		<title>Post-exposure prevention (PEP)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Is Post-Exposure Prevention (PEP)?</h3>
<h4>Why PEP now?</h4>
There is still no cure for AIDS. Prevention remains the most effective way to halt the epidemic. The best way to avoid HIV infection is to avoid exposure in the first place through sexual abstinence, having only uninfected sex partners, consistent condom use, injection drug use abstinence, and consistent use of sterile injection equipment.<sup>1</sup>

However, recently we have learned a lot about treating HIV and understanding the progression of HIV disease. Protease inhibitors used in combination with other HIV drugs have been extremely effective in reducing the levels of HIV in the blood and restoring health to many patients.<sup>2</sup> For HIV-uninfected persons who are exposed to HIV, there may be a window of opportunity in the first few hours or days after exposure in which these highly active drugs may prevent HIV infection.

A study of health care workers showed that treatment with AZT after needlestick exposure to HIV-infected blood reduced the odds of HIV infection by 81%.<sup>3,4</sup> The study was not designed to test the efficacy of AZT for post-exposure treatment and has some limitations. Following consultations, the findings from this study and other data led the Centers for Disease Control and Prevention (CDC) to recommend post-exposure prevention (more commonly known as post-exposure treatment, post-exposure prophylaxis or PEP) for some health care workers who are accidentally exposed to HIV-infected body fluids. Since PEP is recommended for health care workers, it is only logical that PEP be considered for people exposed to HIV through sex or injection drug use, especially since these are more common sources of HIV infection.
<h4>What are components of PEP?</h4>
There are no federal recommendations governing PEP for sexual or injection drug use exposure although the CDC is currently studying the matter. Many physicians and clinics across the country currently offer PEP in widely varying forms.<sup>5</sup> Most forms of PEP involve providing one or several anti-HIV drugs within 72 hours of possible exposure. These drugs are then taken for a 4-6-week period.

Before PEP is implemented, a thorough risk assessment should be conducted to determine a patient’s level and frequency of risk-taking, as well as the HIV status of the patient’s partner. Patients should be informed of the potential side effects and difficulty taking the drugs and should be assisted to develop strategies to successfully take the drugs as prescribed. Partner notification and counseling can be part of a PEP program.

One of the potential advantages of PEP is the opportunity to reach and counsel people at high risk for HIV. PEP programs should include a behavioral counseling component to help patients develop skills for avoiding future exposure to HIV and to deal with the fear of becoming infected. Referrals to HIV prevention, substance abuse, medical, mental health and housing programs should also be included to help patients address important risk factors.<sup>6</sup>

Unprotected sexual intercourse can result not only in HIV infection, but in other sexually transmitted diseases (STDs) and unintended pregnancy. PEP programs should offer testing and treatment for other STDs and testing for pregnancy. STD infection has been shown to increase the risk of HIV transmission 2- to 5-fold, and treating STDs is an effective HIV prevention intervention.<sup>7</sup>
<h4>Does PEP work?</h4>
No one knows for sure. The idea of providing potent anti-HIV drugs to prevent infection makes sense biologically, but some people believe the study of health care workers and AZT is not definitive, and there have been no studies on PEP for sexual or injection exposure. The potency of the new anti-HIV drugs, however, is a compelling, if unproven, reason to offer PEP treatment after exposure to a life threatening disease.<sup>8</sup>
<h4>What are disadvantages of PEP?</h4>
One of the biggest fears about PEP is that people will return to unsafe sexual and drug using practices if they believe that PEP will prevent them from becoming infected. There is some evidence that treatment advances, including PEP, may be leading to increasing incidence of unsafe sex in the US.<sup>9</sup> For example, rates of gonorrhea among men who have sex with men have recently increased for the first time since the early 1980s.<sup>10</sup>

Another fear is that misuse of PEP drug therapies may cause a person to develop a resistant strain of HIV. If PEP drug therapy is unsuccessful and a person does develop a drug-resistant virus, the new anti-HIV drugs may not be as effective for treating that person. This can occur not only with PEP, but with any combination therapy treatment.

PEP regimens can be both complicated and prohibitively expensive to follow. PEP drugs need to be taken at specific times of the day on a regular schedule. About one-third of the health care workers who received PEP never finished the regimen because of difficulty taking the drugs. Side effects of the drugs can be severe and debilitating, and long-term effects are still unknown. A typical dosage for four weeks can cost $600-1,000 including the medicine, blood tests and clinic visits.

Prescribing PEP can be a complicated decision for clinicians, and should be done on an individual basis. Many believe that a person with single case of unprotected sexual- or needle-related exposure to an HIV+ partner would be a good candidate for PEP. However, many people worry that providing PEP repeatedly to a person with ongoing high-risk behavior may cause disinhibition for unsafe sex and could also be toxic.
<h4>What programs exist?</h4>
San Francisco, CA has recently implemented a project to determine the safety and feasibility of PEP. The study offers intensive behavioral counseling, HIV testing and anti-HIV medication to persons who have been exposed within the last 72 hours. The project will not look at the effectiveness of PEP; rather it will look at whether participants comply with treatments, if there are significant side effects, and if clients change their risk behavior following the exposure.<sup>11</sup>

Internationally, many countries are moving ahead with PEP. In France, the Secretary of State for Health announced in August that PEP would be made available to all accidental exposures to HIV, whether occupational, sexual or injection. In London, England, PEP is available through clinics and private physicians. In British Columbia, Canada, PEP is available in emergency rooms for patients with possible exposure.
<h4>How can PEP help?</h4>
PEP can help strengthen HIV prevention strategies by serving as a bridge between prevention and treatment, similar to STD prevention. Traditional STD prevention includes education, testing, early treatment, counseling, partner notification and follow-up. In San Francisco, one PEP program is located in an STD clinic. Many people have advocated the integration of HIV and STD strategies. PEP is a step in that direction.

No one expects PEP to be 100% effective. No prevention tool is 100% effective for any medical condition, whether it be HIV, unwanted pregnancy or cancer. The best prevention effort requires a “myriad of imperfect, cumulatively effective”<sup>12</sup> interventions. A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. PEP offers the opportunity to expand the range of prevention activities, thereby expanding the possibility of saving lives.

<hr />

<h4>Says who?</h4>
1. Centers for Disease Control and Prevention. Backgrounder: CDC-sponsored external consultants meeting on post-exposure therapy (PET) for non-occupational exposures to HIV. Fact sheet prepared by the CDC. July 1997.

2. Deeks SG, Smith M, Holodniy M, et al. HIV-1 protease inhibitors: a review for clinicians . Journal of the American Medical Association. 1997;277:145-153.

3. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposures to HIV-infected blood-France, United Kingdom, and United States, January 1988-August 1994 . Morbidity and Mortality Weekly Report. 1995;44:929-933.

4. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure . New England Journal of Medicine. 1997;337:1485-1490.

5. Zuger A. `Morning after’ treatment for AIDS. The New York Times. June 10, 1997.

6. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use . New England Journal of Medicine. 1997;336:1097-1100.

7. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases . Sexually Transmitted Diseases. 1992;19:61-77.

8. Henderson DK. Postexposure treatment of HIV-taking some risks for safety’s sake . New England Journals of Medicine. 1997;337:1542.

9. Dilley JW, Woods WJ, McFarland W. Are advances in treatment changing views about high-risk sex? (letter) . New England Journal of Medicine. 1997;337:501-502.

10. Centers for Disease Control and Prevention. Gonorrhea among men who have sex with men-selected sexually transmitted diseases clinics, 1993-1996 . Morbidity and Mortality Weekly Report. 1997;46:889-892.

11. Perlman D. Morning-after HIV experiment starts in SF. San Francisco Chronicle. October 14, 1997.

12. Cates W. Contraception, unintended pregnancies, and sexually transmitted diseases: why isn’t a simple solution possible? American Journal of Epidemiology. 1996;143:311-318.

<hr />

<strong>Prepared by Pamela DeCarlo*, Thomas J. Coates, PhD*
*CAPS, UCSF</strong>

December 1997. Fact Sheet #32E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © December 1997, University of California	]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/02/PEPFS.pdf</url>
	</node>
	<node>
		<title>Pre-exposure prophylaxis (PrEP) - 2012</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is pre-exposure prophylaxis (PrEP) and is it effective in preventing HIV?</h3>
<strong>Prepared by Stephanie Cohen, MD &amp; Al Liu, MD; SF DPH | Gabriel R. Galindo DrPH; CAPS</strong>
<h4>What is PrEP?</h4>
PrEP stands for pre-exposure prophylaxis and it is a promising biomedical HIV intervention. It is an approach to prevention where HIV-negative people take HIV drugs in order to prevent HIV infection. PrEP is started<em> <strong>before</strong></em> possible exposure to HIV, and is taken on an ongoing basis.  PrEP is not a vaccine, and it is different from post-exposure prophylaxis (PEP), where the medication is started soon after exposure to HIV, and continued for 28 days only. Taking a medication before exposure has been shown to be effective in preventing other infectious diseases. Likewise, providing antiretroviral therapy to pregnant women and their infants has been used effectively for many years to prevent mother-to-child transmission of HIV [<sup>1</sup>]. PrEP can be in the form of a pill taken by mouth, known as “oral PrEP”.[<sup>2,3,4 </sup>] In clinical trials PrEP has been provided in combination with other HIV prevention interventions, such as condom distribution, behavioral counseling, HIV testing, and screening of other sexually transmitted infections (STIs).
<h4>Why is PrEP important?</h4>
Globally there are 2.6 million new HIV infections each year, and in the US, there are an estimated 56,000 new HIV infections annually.[<sup>5</sup>] While risk reduction counseling, condoms, male circumcision and other methods have been shown to reduce HIV infections, by themselves they are not enough, and new approaches to HIV prevention are urgently needed – especially for men who have sex with men (MSM) and transgender women, the groups who disproportionately bear the greatest HIV burden in the US [<sup>6</sup>].
<h4>What drugs are currently being tested for PrEP?</h4>
Recently completed and ongoing studies of <strong>oral PrEP</strong> have tested the HIV drug tenofovir (also known as Viread®) alone or in combination with emtricitabine.   The combination of tenofovir and emtricitabine is known as Truvada®. These medications were chosen because they only have to be taken once daily, they have few side effects, they don’t interact with most other medications, and they have been shown to be safe and effective in animal studies of PrEP.  Different topical formulations are currently being studied in clinical trials and other forms of <strong>topical PrEP</strong>, including a vaginal ring and a gel formulated for rectal use, are also under development.[<sup>7</sup>]
<h4>How effective is PrEP in preventing HIV infection?</h4>
For MSM and transgender women, the iPrEx study results, released in November 2010, demonstrated for the first time that daily oral Truvada®  is effective for HIV prevention.[<sup>2</sup>] The iPrEx study enrolled nearly 2500 MSM (1.2% of participants were transgendered women) participants from 6 countries, and included two cities in the US. All participants received frequent HIV testing, risk reduction counseling, condoms and lubricants, and screening and treatment for STIs. Half of the participants were randomly assigned to receive Truvada®, and the other half a placebo. The participants who received Truvada® had 44% fewer HIV infections than the participants who received the placebo. This means that PrEP prevented almost half of the infections that would have occurred if the medication was not provided. The protective effect of PrEP was even higher for those who were able to take the drug more consistently, including those who had evidence of Truvada® in their blood.

The effectiveness of PrEP in other populations, such as heterosexual men and women, and injection drug users, is currently unknown as clinical trials have had mixed results. Still, there are several ongoing studies happening around the world in these populations, and those results will further enhance our understanding of PrEP’s efficacy [<sup>9,10</sup>]. For detailed information on PrEP trials occurring globally, click here for a table of ongoing and planned studies [<sup>11</sup>], and here for a PrEP trials timeline [<sup>12</sup>].
<h4>Is PrEP safe?</h4>
The iPrEx trial found that Truvada® was safe and generally well-tolerated by participants in the study. There were a few mild side effects related to Truvada®, such as nausea, which were infrequent and decreased with time. While a small amount of bone loss was seen in men receiving PrEP, a finding commonly seen in HIV-positive individuals starting similar antiretroviral treatment regimens, these changes had no apparent negative health impact.  Drug resistance was not seen among those who became HIV-infected during the iPrex study. Still, HIV testing and medical evaluation before starting, and while using PrEP, are important to prevent resistance and to monitor side effects on an individual level.

Like the iPrex study, there were also no significant safety concerns raised in the trials of PrEP that have been conducted among heterosexual men and women. However, it is important to note that the follow-up in these studies was relatively short. Therefore, evaluating the longer-term safety of oral PrEP is important and will require further investigation in ongoing studies. Additional research is also needed to determine how frequently people taking PrEP will need to be seen by a health care provider and how often they will need to have laboratory monitoring, including HIV testing and monitoring of kidney function.
<h4>What are current recommendations for PrEP?</h4>
In January 2011, the Centers for Disease Control and Prevention (CDC) issued interim guidance on the use of PrEP for HIV prevention in MSM.[<sup>13</sup>] The CDC emphasizes that:
<ul>
 	<li>PrEP should only be considered for MSM at high risk for HIV infection (and not other populations until additional data are available).</li>
 	<li>PrEP should only be used in individuals with negative HIV antibody test(s) confirmed immediately prior to starting PrEP.  If symptoms of recent HIV infection are present, PrEP should be deferred and testing for acute HIV infection should be performed.</li>
 	<li>PrEP should <strong>never</strong> be seen as the first line of defense against HIV. PrEP should be delivered as a part of a comprehensive prevention package that includes risk-reduction and adherence counseling, encouragement of condom use, and diagnosis and treatment of STIs.</li>
 	<li>PrEP should be taken daily. Only the regimen tested in iPrEx (daily Truvada®) should be used, and not other antiretroviral medications or other dosing regimens (such as intermittent or occasional use).</li>
 	<li>PrEP should be obtained and used in close collaboration with healthcare providers to monitor side effects, adherence, safety, and risk behaviors at regular intervals.</li>
</ul>
Individuals taking PrEP should undergo regular HIV testing and should stop taking PrEP if they test HIV-positive. Those interested in PrEP should discuss this with their physicians and should not use PrEP on their own. Comprehensive guidelines for PrEP use will be developed by the United States Public Health Service through expert consultation and community input.
<h4>What are the next steps for PrEP?</h4>
In July 2012 the U.S. Food and Drug Administration approved Truvada® to reduce the risk of HIV infection in uninfected individuals who are at high risk and who may engage in sexual activity with HIV-infected partners. Recognizing that no infectious disease has ever been eliminated through medications alone, we need to carefully consider how to best use this tool in combination with other prevention strategies to make the largest impact on HIV/AIDS in the US and worldwide. In the iPrEx, Partners PrEP and TDF-2 studies, PrEP was shown to be partially effective when used in combination with regular HIV testing, condoms and other proven prevention methods, like individual risk reduction counseling.  Combination prevention approaches that integrate biomedical, behavioral and structural components are necessary to optimize HIV prevention efforts.[<sup>14</sup>] As such, the effectiveness of PrEP depends not just on the effectiveness and safety of the drugs, but also on several other implementation factors, including good adherence to the drug, maintaining safer sex behaviors, and access to clinical and social support services. Interventions and programs that help HIV-negative individuals access PrEP, take the pills on a regular schedule, manage potential side effects, undergo regular HIV testing, and maintain safer sex and drug-using practices are key to maximizing PrEP’s effectiveness and acceptance.[<sup>15,16</sup>] Additional studies, community-wide discussions, and advocacy work are underway to try to address and assess many of these important considerations.

<hr />

<h3><strong>Says Who?</strong></h3>
<ol>
 	<li>WHO. Guidance on global scale-up of the prevention of mother-to-child-transmission of HIV: Towards universal access for women, infants and young children and eliminating HIV and AIDS among children. The Interagency Task Team on Prevention of HIV Infection in Pregnant Women, Mothers and Their Children, 2007.</li>
 	<li>Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. NEJM 2010;363(27):2587-99. Epub 2010 Nov 23.</li>
 	<li>Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74.</li>
 	<li>Centers for Disease Control and Prevention. CDC Trials: Pre-Exposure Prophylaxis for HIV Prevention.  February 2011.  http://www.cdc.gov/hiv/prep/pdf/PrEP_TrialsFactSheet.pdf</li>
 	<li>Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008;300(5):520-9</li>
 	<li>Centers for Disease Control and Prevention. Estimates of new HIV infections in the United States. CDC Fact Sheet, 2008. Available at: http://www.cdc.gov/nchhstp/newsroom/docs/Fact-Sheet-on-HIV-Estimates.pdf.</li>
 	<li>Stone A, Harrison PF.  Microbicides – Ways Forward. Alliance for Microbicide Development: Silver Spring, MD, USA. 2010.</li>
 	<li>Buchbinder SP, Liu A. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS and Behavior. 2011:15,S1:72-79.</li>
 	<li>Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007;2:e27.</li>
 	<li>Grohskopf L, Gvetadze R, Pathak S, et al. Preliminary analysis of biomedical data from the phase II clinical safety trial of tenofovir disoproxil fumarate (TDF) for HIV-1 pre-exposure prophylaxis (PrEP) among U.S. men who have sex with men (MSM). Abstract no. FRLBC102, International AIDS Society 2010, Vienna.</li>
 	<li>AIDS Vaccine Advocacy Coalition. (2012, April). Ongoing and planned pre-exposure prophylaxis (PREP) trials.            Retrieved from http://www.avac.org/ht/a/GetDocumentAction/i/3113</li>
 	<li>AIDS Vaccine Advocacy Coalition. (2011, May). Oral and topical PrEP trials timeline. Retrieved from http://www.avac.org/ht/d/sp/a/GetDocumentAction/i/3618</li>
 	<li>Smith DK, Grant RM, Weidle PJ, et al. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report. 2011;60:65-68.</li>
 	<li>Centers for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP) for HIV prevention: Promoting safe and effective use in the United States.  February 2011.  http://www.cdc.gov/hiv/prep/pdf/PrEPfactsheet.pdf</li>
 	<li>Underhill K, Operario D, Skeer MR, et al. Packaging PrEP to prevent HIV: An integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. JAIDS.2010;55:8-13.</li>
 	<li>16. Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation Science of Pre-exposure Prophylaxis: Preparing for Public Use. Curr HIV/AIDS Rep 2010;7:210-9.</li>
</ol>

<hr />

Fact Sheet 19, October 2012

<strong>Prepared by Stephanie Cohen, MD &amp; Al Liu, MD; SF DPH | Gabriel R. Galindo DrPH; CAPS </strong>

Special thanks to the following reviewers of this Fact Sheet: David Abbott, Tom Aloisi, Susan Buchbinder, Katerina Christopoulos, Chris Collins, Jen Hect, Quarrasha Abdool Karim, Delia Molloy, Stephen Morin, Don Operario, Kristen Underhill and Dana Van Gorder.

<hr size="2" />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Francisco should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © July 2012, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2012/10/PrEPFS-final1.pdf</url>
	</node>
	<node>
		<title>Structural interventions</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of structural interventions in HIV prevention?</h3>
<h4>What are structural interventions?</h4>
Most HIV prevention interventions deal with individuals, one by one. Many of these interventions have been very successful. However, they often require a lot of staff time and reach a limited number of persons. Furthermore, those who do receive interventions may face pressures to continue high-risk behaviors from their peers who do not receive the intervention. Structural interventions change or influence social, political, or economic environments in ways that help many people all at onceperhaps without their even knowing it.<sup>1</sup>

The term “structural interventions” means many things. Structural interventions include programs that change legal environments (often with community pressure or input) to make safer behavior easier, such as allowing syringes to be sold over the counter. They can also target the immediate social context of sexual or injection behaviors by changing the physical or normative environments within which they occur. Examples include Thai brothels that require condom use or European public health safer injection rooms. Structural interventions also include programs to reduce or abolish income inequality, racism, and other inequities and oppressions which create vulnerability to HIV/AIDS.
<h3>What structures create risk?</h3>
How can we know what social, political or economic structures or processes need changing? Generally, we learn this by studying naturally-occurring variation among areas or groups, or naturally-occurring experiments in which conditions change for reasons other than HIV-related interventions.

Studies of naturally-occurring variation have shown that: 1) poor countries are more likely to have generalized HIV epidemics; 2) countries with more income inequality have higher HIV rates; 3) policies matter: localities where syringes can be bought legally have lower rates of HIV prevalence and incidence among injection drug users (IDUs).<sup>2</sup>

Studies of natural experiments indicate that: 1) otherwise-positive social and political transitions like the end of apartheid in South Africa in the 1990s, the break-up of the Soviet Union in the 1990s, and the ending of the dictatorship in Indonesia in the late 1990s were followed by large HIV outbreaks; 2) wars cause the spread of HIV, STDs, prostitution, rape, sexual bondage and high-risk substance use and lead to increased numbers of sexual partners and rates of sexual partner change.<sup>3</sup>
<h4>Why structural interventions?</h4>
Structural interventions often address issues that seem to be unrelated to HIV. When people think about preventing HIV, they don’t normally consider eliminating income inequalities or stopping war. But these social, political and economic realities greatly influence high-risk behaviors. Issues that are not directly related to HIV often create conditions that encourage the spread of HIV, making structural interventions necessary.

For example, the New York City government closed fire stations in poor minority sections of the city in the 1970s. As a result, uncontrolled fires destroyed many buildings. The social lives of building residents were severely traumatized. Great overcrowding took place in surrounding poor minority areas. Injection drug use (and later crack), alcoholism, sex trading, gangs and demoralization spread widelyfollowed later by outbreaks of STDs, HIV, tuberculosis and many other ills.<sup>4</sup>

The governments of wealthy countries, including the USA, as well as banks, corporations and other economic elites have aggressively pursued an organized global policy of social welfare cutbacks, privatization and competition. This has led many developing countries into massive debt, and increased income inequality and the growth of massive cities based around giant slums. Also, International Monetary Fund-imposed “structural adjustment programs” have forced large-scale cuts in health and education services in many African, Asian and Latin American countries. These policies and progams have greatly hampered these countries from providing effective prevention interventions and/or antiretroviral therapy or other medical care for their infected populations.<sup>5,6</sup>
<h4>Examples of structural interventions</h4>
In many countries, sex workers have high rates of HIV and other STDs. Thailand and the Dominican Republic have instituted “100% condom” campaigns mandating that brothel owners enforce the use of condoms during all sex acts. These campaigns enlist the support of brothel owners and sex workers and, when possible, their customers. These programs have reduced HIV and STD transmission considerably by changing the immediate social context of sexual behaviors to reduce unprotected sex.<sup>7,8</sup>

Most US states have laws that make it a crime to possess or distribute needles and many have laws that require a prescription to buy a needle and syringe. Consequently, IDUs often do not carry syringes for fear of police harassment or arrest. To address this on a legal level, the Connecticut legislature passed a partial repeal of needle prescription and drug paraphernalia laws. This resulted in dramatic reductions in needle sharing, and increases in pharmacy purchase of syringes by IDUs. Sharing dropped from 52% to 31% after the new laws, pharmacy purchase rose from 19% to 78%, and street purchase fell from 74% to 28%.<sup>9</sup>
<h4>How can we impact harmful policies?</h4>
It is not easy to avoid or end wars, urban development policies that hurt the poor and minorities and repressive sexual and drug policies that create underground environments. However, individuals and communities can make a difference. Grassroots or community-based movements are often a necessary step to larger structural interventions. The formation of such movements can sometimes be a structural intervention if this leads to changes in power relationships or group norms.

“Chico Chats,” a program of the STOP AIDS Project in San Francisco, CA, offered workshops on community organizing and mobilization techniques. Participants formed an activist group called <em>¡Ya Basta!</em> (Enough Already) and designed a video and workshop examining the issues of sexual silence and coming out in Latino families. The video is being shown throughout Latino communities in San Francisco.<sup>10</sup>

Community organizations and individuals began operating needle exchange programs (NEPs) in many states with high rates of HIV among IDUs. The NEPs were often illegal and unsupported. The people working at NEPs and other politically active groups worked with public officials to invoke “state of emergency” policies to allow NEPs to exist legally in many states.<sup>11</sup>

Calcutta sex workers were aided by public health authorities to organize a community union that has enabled them to insist upon condom use. HIV prevalence among Calcutta sex workers has remained lower than in other Indian cities.<sup>12</sup>
<h4>What still needs to be done?</h4>
The relationship between structural factors such as economic, political and social marginalization and behaviors that place persons at risk for contracting or spreading HIV/AIDS and STDs cannot be ignored.<sup>13,14</sup> Nor can high-risk behaviors be seen as operating outside of social, political and economic contexts. A more focused discussion of these issues is sorely needed in HIV/AIDS circles.

One way to reduce the likelihood of negative repurcussions when structural factors change, is to legally mandate that economic, urban development and foreign policy programs conduct scientific “HIV/AIDS impact statements.” A first step might be for HIV prevention agencies to produce and publicize such HIV/AIDS impact statements themselves.<sup>15</sup>

Funders need to take into account the broad range of activities that constitute HIV prevention. Many community-based organizations find themselves responding to all issues affecting HIV, including ones that may seem unrelated. Addressing these larger issues of war, poverty, restrictive laws and social inequalities such as racism and homophobia is a part of what many agencies do on a daily basis. Helping organize and support these efforts may lead to needed structural HIV prevention interventions.

<hr />

<h4>Says who?</h4>
1. Friedman SR, O’Reilly K. Sociocultural interventions at the community level.AIDS. 1997; 11:S201-S208.

2. Friedman SR, Perlis T, Lynch J, et al. Economic inequality, poverty, and laws against syringe access as predictors of metropolitan area rates of drug injection and HIV infection. 2000 Global Research Network Meeting on HIV Prevention in Drug-Using Populations. Third Annual Meeting Report. Durban, South Africa, July 5 -7, 2000. 147-149.

3. Hankins CA, Friedman SR, Zafar T, et al. Transmission and prevention of HIV and STD in war settings: implications for current and future armed conflicts.AIDS. 2002:16(17):2245-52.

4. Wallace R. Urban desertification, public health and public order: ‘planned shrinkage’, violent death, substance abuse and AIDS in the Bronx. Social Science and Medicine. 1990;31:801-813.

5. Lurie P, Hintzen P, Lowe RA. Socioeconomic obstacles to HIV prevention and treatment in developing countries: the roles of the International Monetary Fund and the World Bank. AIDS. 1995;9:539-546.

6. Farmer P. Infections and Inequalities: the Modern Plagues. University ofCalifornia Press: Los Angeles. 1999.

7. Celentano DD, Nelson KE, Lyles CM, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS. 1998;12:F29-F36.

8. Roca E, Ashburn K, Moreno L, et al. Assessing the impact of environmental-structural interventions. Presented at the International AIDS Conference,Barcelona, Spain. 2002. Abst #TuPeC4831.

9. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting drug users and police officers–Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes.1995;10:82-89.

10. The STOP AIDS Project. Q Action, ¡Ya Basta! San Francisco, CA. 415/865-0790 x303

11. Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. Journal of Acquired Immune Deficiency Syndromes. 1998;18:S60-70.

12. Piot P, Coll Seck AM. International response to the HIV/AIDS epidemic: planning for success. Bulletin of the World Health Organization. 2001;79:1106-1112.

13. Diaz RM, Ayala G, Marin BV. Latino gay men and HIV: risk behavior as a sign of oppression. Focus. 2000;15:1-5.

14. Friedman SR, Aral S. Social networks, risk potential networks, health and disease. Journal of Urban Health. 2001;78:411-418.

15. Friedman SR, Reid G. The need for dialectical models as shown in the response to the HIV/AIDS epidemic. International Journal of Sociology and Social Policy. (in press).

<hr />

<strong>Prepared by Sam Friedman*, Kelly Knight**
*National Development and Research Institutes, ** CAPS</strong>

<strong>January 2003. Fact Sheet #46E</strong>

Special thanks to the following reviewers of this Fact Sheet: Abu Abdul-Quader, Sevgi Aral, Judith Auerbach, Kim Blankenship, John Encandela, Mindy Fullilove, Carl Latkin, Peter Lurie.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/structuralFS.pdf</url>
	</node>
	<node>
		<title>Testing &amp; link to care</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>Can HIV testing plus linking HIV+ people to care and treatment reduce HIV transmission?</h2>
<h3>Why is this an important question?</h3>
Despite major progress against HIV, 21% of HIV+ people in the US are unaware that they are positive<sup>1</sup> and an estimated 33% of those who know they are HIV+ are not engaged in care and treatment for their infection.<sup>2</sup> Another 38% of newly diagnosed HIV+ individuals test so late that they receive an AIDS diagnosis at the same time as, or within one year of, learning they are positive.<sup>3</sup> There were an estimated 56,300 new HIV infections per year between 1996 and 2006.<sup>4</sup> Clearly, the US can and must do better in responding to the HIV/AIDS epidemic.

One way to increase the percentage of HIV+ people engaged in care and treatment for their infection and improve their health outcomes is to focus on coordinating or co-locating HIV testing, care and treatment, social services and prevention programs. Increasing the percentage of HIV+ people who know their serostatus and are receiving care and antiretroviral treatment could also have benefits for HIV prevention.<sup>5</sup>

The National HIV/AIDS Strategy places testing and linkage to care, treatment and support services at the heart of the effort to improve the health outcomes of HIV+ individuals and prevent new infections.<sup>6</sup> What is the scientific basis for this approach, how might it actually be implemented, and will it have the desired results in the real world?
<h3>Can HIV testing and linking HIV+ persons to care plus treatment reduce HIV incidence?</h3>
Although it is not proven conclusively, there are strong data showing that HIV treatment reduces an individual’s viral load and thus the potential for them to transmit HIV.<sup>7,8</sup> A Swiss study concluded that HIV+ individuals whose virus was suppressed at or below 50 copies for more than six months and who had no STIs were very unlikely to transmit the virus to HIV- partners through sexual contact.<sup>8</sup>

A study of over 3,000 serodiscordant heterosexual couples in Africa found a much lower transmission rate when the HIV+ partner was receiving treatment (only 1 seroconversion for a rate of 0.37 per 100 person years), compared to couples where the HIV partner was not receiving treatment (102 seroconversions, for a rate of 2.24 per 100 person years).<sup>9</sup>

Mathematical models predict some level of reduction in new HIV cases from high levels of participation in testing and treatment.<sup>10</sup> A study in San Francisco found that expansion of HIV treatment was linked to a reduction in “community viral load,” the estimated average viral load of all HIV+ persons in a community. This reduction was thought to be at least partly responsible for declines in new HIV cases in San Francisco in recent years.<sup>11</sup>Additionally, studies in British Columbia, Canada have suggested that reductions in the number of new HIV infections among injection drug users may also be linked to expanded HIV treatment.<sup>12</sup>
<h3>How can this be accomplished?</h3>
One possible approach is called Testing and Linkage to Care Plus, or TLC+, a framework for integrating HIV testing, care and treatment, social services and prevention-with-positives activities into a comprehensive initiative that can be implemented by individual providers or jurisdictions.<sup>13</sup> This approach is not new; many providers and jurisdictions have been implementing TLC+ in whole or part for some time. TLC+ proponents have argued that this approach should be replicated nationwide. A study is being conducted in Washington, DC and the Bronx, NY on the feasibility of the TLC+ approach in highly impacted urban settings.<sup>14</sup>

TLC+ is a reframing of the “Test &amp; Treat” concept, which generally seeks to achieve near universal knowledge of serostatus and treatment of all individuals found to be HIV+ in order to improve health outcomes and reduce incidence.<sup>13</sup> The TLC+ approach emphasizes informed patient choice in HIV care decisions and the importance of securing social services in order to successfully engage and retain HIV+ people in care and treatment.<sup>15</sup> TLC+ acknowledges that supporting HIV+ persons’ participation in primary medical care and needed social services is more likely to engage them in addressing HIV than immediately encouraging them to start HIV treatment.

Elements of TLC+ include:
<ul>
 	<li>Expanding and promoting HIV testing both as a routine part of medical care population-wide and through programs targeting individuals who are members of high-risk groups or engaging in high-risk behaviors</li>
 	<li>Linking newly diagnosed HIV+ individuals ASAP to a primary care provider, and innovative programs to re-engage previously diagnosed individuals who have fallen out of care or treatment</li>
 	<li>Assessing and meeting the social services needs of HIV+ people in order to support their initial engagement in care</li>
 	<li>Measuring CD4s and viral load and thoroughly counseling patients about the role of HIV treatment in assuring individual health and preventing transmission of HIV, as well as options for when to start treatment</li>
 	<li>Testing for STIs, TB and hepatitis B and C</li>
 	<li>Supporting retention in care and treatment adherence by ensuring ongoing linkage to needed social services and support</li>
 	<li>Prevention-for-positives counseling and linkage to services that support engagement in safe behaviors</li>
</ul>
<h3>Should HIV+ people be on treatment to prevent HIV transmission?</h3>
The potential benefits of HIV treatment, both for the individual and community, have much to do with when an individual decides to initiate HIV treatment and how much support they have to remain adherent to treatment. Earlier treatment might benefit both individual and community health.

Federal treatment guidelines recommend starting treatment at 500 CD4s or below, and support consideration of treatment at 500 or above.<sup>16</sup> Some providers, notably the San Francisco Department of Public Health, are now offering HIV treatment to all diagnosed HIV+ people, and even encouraging consideration of treatment at 500 CD4s and above. Providers should fully inform their HIV+ patients about the risks and benefits of either treatment strategy. A current study called START seeks to determine the risks and benefits of initiating HIV treatment at different CD4 thresholds.

It is essential that HIV+ people make treatment decisions primarily to benefit their own health, with secondary consideration of the possible benefits for prevention. In keeping with values of patient empowerment and informed choice, providers can explain to an HIV+ person that engaging in treatment might help them in their goal of preventing transmission, but the choice of whether, when and why they decide to take medications must be left in the patient’s hands.
<h3>What are concerns about TLC+?</h3>
Concerns have been raised that expanded HIV testing and treatment of HIV+ people as a prevention intervention is intended to replace behavioral prevention programs. However, behavioral counseling and other forms of support for safe behaviors are an important component of the TLC+ model. Additionally, successful HIV prevention must take many forms and should include educational, behavioral, structural and biomedical interventions.

Concerns have also been raised that describing the possible benefits of treatment for prevention may cause HIV+ people who are taking medications to abandon safe sex and syringe use behaviors. However, a range of studies have shown that HIV+ people on treatment do not exhibit increased sexual risk behavior, even when they achieved an undetectable viral load.<sup>17</sup>

Most HIV+ people are concerned about not infecting others and make efforts to prevent transmission.<sup>18</sup> Nevertheless, it is essential to counsel HIV+ patients to practice safe sex, including condom use, whether on treatment or not and whether they achieve undetectable viral loads or not.
<h3>What steps needs to be take place to implement TLC+ nationally?</h3>
The concepts behind TLC+ are contained in the National HIV/AIDS Strategy, and it is critical that the federal government achieve unprecedented coordination in the planning and funding of this approach across all agencies, as well as with state and local governments and AIDS service organizations.

TLC+ may take several years to be fully implemented because it depends upon the thoughtful coordination of surveillance, testing, care and treatment, social services and prevention programs and their funding streams to support it. TLC+ also demands improved reimbursement and targeting of HIV testing activities, and increased coverage of the cost of care and treatment, which could be achieved largely through effective implementation of national health care reform.

The Ryan White Program will need to be reconfigured to support the high level of staffing necessary to link HIV+ people to care, treatment and social services when it is reauthorized by Congress in 2013.

<hr />

<h2>Says who?</h2>
1. Centers for Disease Control and Prevention. HIV in the United States. Fact Sheet. July 2010.

2. HRSA. HIV/AIDS Bureau. Outreach: Engaging people in HIV care. August 2006.

3. Valdiserri RO. Late HIV diagnosis: Bad medicine and worse public health. PLoS Medicine. 2007; 4:e200.

4. Hall HI, Song R, Rhodes P, et al. Estimation of HIV Incidence in the United States. JAMA. 2008;300:520-529.

5. Cohen J. Treatment as Prevention. Science. 2010;327:1196-1197.

6. Office of the White House. National HIV/AIDS Strategy for the United States.July 2010.

7. CDC. Effect of antiretroviral therapy on risk of sexual transmission of HIV infection and superinfection. Fact sheet. August 2009.

8. Engsig F, Omland L, Larsen M, et al. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months. HIV Medicine. 2010.

9. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-2098.

10. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.

11. Das M, Chu PL, Santos G-M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5:e11068.

12. Montaner J, Wood E, Kerr T, et al. Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among injection drug users in British Columbia, Canada. Presented at the CROI. 2010.

13. Project Inform. TLC+: Testing, Linkage to Care and Treatment.

14. El-Sadr W. TLC-Plus: Feasibility of an enhanced test, link-to-care plus treat approach for HIV prevention in the US.

15. Statement on ART as prevention: Scaling down HIV requires scaling up human rights, testing and treatment. Sign-on letter from the International Council of AIDS Service Organizations. 2009.

16. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.Department of Health and Human Services. 2009;1-161.

17. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review. JAMA. 2004;292:224-236.

18. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States. Journal of AIDS. 2005;39:446-453.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Julia Dombrowski, Reuben Granich, Peter Kilmarx, Kim Koester, Monica Ruiz, George Rutherford, Allison Zerbe.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©October 2010, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.Web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/TLCplusFS.pdf</url>
	</node>
	<node>
		<title>Métodos de barrera</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Pueden las barreras ayudar en la prevención del VIH?</h3>
<h4>¿por qué los métodos de barrera?</h4>
Los métodos de barrera son relativamente bajos en costo, de fácil acceso y juegan un papel importante en la prevención de embarazos y de Enfermedades de Transmisión Sexual (ETS). Las barreras físicas (como el diafragma, el condón, etc.) son efectivas para la prevención de embarazos y algunas de ellas para la prevención del VIH/ETS; las barreras químicas (espermicidas) previenen primordialmente el embarazo. Los métodos hormonales anticonceptivos (la pastilla, etc.) no se incluyen en ésta categoría de métodos de barrera. Durante siglos, la gente ha utilizado con éxito las barreras físicas.<sup>1</sup>

Desde el inicio de la epidemia del VIH el condón de látex para hombres ha sido el instrumento exclusivo para la prevención. Dos décadas mas tarde, se hace un llamado para crear una mayor selección de métodos de barrera para combatir el VIH. Dado el continuo incremento en las tasas de infección por VIH entre mujeres y entre hombres que tienen sexo con hombres (HSH),<sup>2,3</sup> es necesario fortalecer los programas actuales para el uso del condón y crear otros métodos de barrera que optimicen el uso y las opciones en la prevención.
<h4>¿qué métodos están disponibles?</h4>
Actualmente, tanto el condón femenino (Reality) como el masculino son utilizados para prevenir VIH/ETS y embarazos no deseados.<sup>4,5</sup> El condón femenino, hecho a base de plástico poliuretano, también es utilizado en las relaciones anales receptivas a pesar de no haber sido diseñado para ese propósito.<sup>6</sup> La esponja, el diafragma y el capuchón cervical son a menudo utilizados con espermicidas y bloquean el cuello del útero para impedir la concepción. A pesar de que los estudios han demostrado que los métodos que bloquean el cuello del útero (cerviz) pueden a su vez prevenir algunas ETS<sup>7</sup>, no hay investigaciones que demuestren que previenen el VIH. Las barreras dentales son unas películas de látex utilizadas para en el sexo oral-anal y oral-vaginal.

Los espermicidas (gelatinas, cremas, espumas o películas que se introducen en la vagina) asisten en la prevención de embarazos. Uno de los espermicidas más utilizados, el Nonoxynol 9 (N-9), recientemente se sometió a estudios para comprobar su efectividad respecto al VIH. Un estudio con trabajadoras sexuales en Tailandia, Sudáfrica, Costa de Marfil y Benin; asignó aleatoriamente quienes usarían 5.5 mg de N-9 y quienes usarían un placebo – la crema vaginal humectante “Replens.” Los resultados preliminares demostraron que hubo una mayor cantidad de nuevas infecciones entre el grupo que usó el N-9 que entre el grupo del placebo.<sup>8</sup> En Agosto del 2000, el CDC hizo una recomendación en contra del uso de N-9 como único método para prevenir el VIH.<sup>9</sup>

Este mismo estudio documentó los efectos dañinos de una dosis relativamente alta de N-9 sobre la infección del VIH. El N-9 se utiliza como lubricante de condones en escalas mucho menores. El impacto de dosis en baja escala aún se desconoce.
<h4>¿por qué necesitamos métodos alternos al condón masculino?</h4>
Los condones masculinos son muy eficaces para prevenir VIH/ETS y embarazos. Generalmente lo que limita la efectividad de los condones son fallas por parte del usuario más que las del producto mismo. Por ejemplo, el colocarse el condón después de haber iniciado el contacto genital, el no desenrollarlo totalmente, ó el no usarlo en todo acto sexual son fallas. Algunos no usan condones porque les reduce la sensibilidad, otros los consideran un obstáculo para la intimidad.

Los condones masculinos requieren de la negociación con el hombre para su uso. Las opciones controladas por mujeres o parejas receptoras pueden ser utilizadas en situaciones en las que la negociación del uso de condón se dificulta, como en las relaciones de abuso, donde las cuestiones económicas, como costo del condón, son un pretexto para no usarlo<sup>10</sup> o cuando la pareja que penetra se rehusa a usarlo<sup>5</sup>. Los métodos de prevención del VIH/ETS controlados por la mujer ofrecen una forma de autopoder<sup>11</sup> y son vitales dado el incremento de mujeres infectadas por la epidemia del VIH, especialmente en los países en vías de desarrollo.

Finalmente, no existe un método de barrera que le permita a la mujer protegerse del VIH y al mismo tiempo poder embarazarse. El que se desarrolle un método que separe el control de la natalidad de la prevención de ETS es una consideración importante para muchas mujeres.<sup>2</sup>
<h4>¿cuáles son los obstáculos ?</h4>
Los métodos de barrera pueden ofrecer protección contra el VIH/ETS, sin embargo no son una alternativa para todo mundo. A pesar del bajo costo de algunos métodos, los precios de otros no son tan accesibles (como el de los condones femeninos). La mayoría de los métodos de barrera requieren ser aplicados antes de cada acto sexual, lo cual dificulta el uso constante. Es posible que no protejan en contra de aquellas ETS que se transmiten por medio del contacto con la piel como el herpes y el Virus del Papiloma Humano (VPH). Los productos que resultan complicados o que requieren de cierta limpieza o almacenamiento, se vuelven inaccesibles para algunas personas. Las barreras que se introducen en la vagina requieren de que la persona se familiarice con su cuerpo y sienta cómoda haciéndolo. Con el diafragma y el capuchón cervical es un médico quien debe tomar la medida adecuada para cada persona. Algunas personas son sensibles a ciertos químicos ó materiales, como quienes presentan alergias al latex. Estas limitaciones se están considerando para el desarrollo de nuevas barreras.
<h4>¿qué son los microbicidas?</h4>
Los microbicidas son barreras químicas de aplicación tópica para prevenir la transmisión del VIH/ETS que aún se encuentran en proceso de desarrollo y bajo pruebas de ensayo para asegurar su eficacia como método alterno. Quizá serán presentados en forma de gelatinas, cremas, espumas o películas para introducirse en la vagina o el recto. Las investigaciones se están enfocando en crear productos que destruyan o inmovilicen gérmenes o virus por medio de mecanismos como romper las membranas externas de las células de los patógenos, o proveer un recubrimiento a las paredes de la vagina o el recto, ó inhibir la inserción del VIH en las células, lo que previene la reproducción del mismo. Los estudios han demostrado que existe una demanda potencial de microbicidas a nivel nacional y mundial para las mujeres. Estudios realizados con mujeres y con HSH demostraron que hay personas dispuestas a participar en estudios clínicos para probar la eficacia de estos productos.
<h4>¿qué se está haciendo?</h4>
Actualmente, el condón masculino es el método de prevención más completo que existe. Deben continuar las campañas de prevención en las que se optimice el uso del condón mientras se consiguen otras alternativas. Las labores de prevención podrían ser más efectivas para ciertas poblaciones si se incluyera el tema del condón y del VIH en las campañas de prevención de embarazos y ETS. Algunas clínicas de ETS y de planificación familiar promueven con mucho éxito el uso del condón para prevenir el VIH/ETS.

Se están investigando nuevos métodos de barrera como los diafragmas deshechables, alternativas de escudos cervicales, capuchones, esponjas y condones femeninos y masculinos. También se están desarrollando nuevos materiales incluyendo varias clases de plástico y silicón.2 De igual importancia es examinar el potencial para adaptar y probar productos ya existentes en la prevención del VIH; los cuales al ya haber sido aprobados por la FDA (Food and Drug Administration) no tendrían un proceso tan largo de pruebas.
<h4>¿cuáles son los próximos pasos?</h4>
Desarrollar métodos de barrera alternos debe ser la prioridad entre científicos públicos y privados. Con más de 50 microbicidas en vías de investigación quizá uno saldrá al mercado para el 2005. Los grupos que han sido claves en la lucha para despertar el interés y atención por los microbicidas deben continuar abogando por tener métodos de barrera accesibles. A pesar de que el gobierno Estadounidense incrementó los fondos destinados a los microbicidas, en el año fiscal 1998 el porcentaje para la investigación de éstos fue sólo del 1% del presupuesto de los Institutos Nacionales de Salud de Investigación de SIDA

La solución para prevenir el SIDA y las ETS no es sencilla. La prevención requiere un trabajo continuo a muchos niveles incluyendo aumentar el acceso a los productos y desarrollar alternativas para la prevención y tratamientos más fuertes. Los métodos de barrera son una parte integral de estos métodos de prevención alternos y deben desarrollarse a su máxima capacidad.

<hr />

<strong>¿quién lo dice?</strong>

1. Feldblum P, Joanis C. Modern barrier methods: effective contraception and disease prevention. Family Health International. 1994.
2. The Population Council and International Family Health. The case for microbicides: a global priority . 2000.
3. Microbicides: a new weapon against HIV. American Foundation for AIDS Research (AmFAR) Report. www.amfar.org .
4. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission . Social Science and Medicine. 1997;44:1303-1312.
5. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV . AIDS. 1996;3:S43-51.
6. Gibson S, McFarland W, Wohlfeiler D, et al. Experiences of 100 men who have sex with men using the REALITY condom for anal sex . AIDS Education and Prevention. 1999;11:65-71.
7. Rosenberg MJ, Davidson AJ, Chen JH, et al. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms . American Journal of Public Health. 1992; 82:669-674.
8. UNAIDS. Nonoxynol-9 not effective microbicide, trial shows. Search continues for effective product, UNAIDS chief says. UNAIDS Press Release, June 13, 2000.http://www.unaids.org/whatsnew/press/eng/geneva130600.html
9. Gayle H. Dear Colleague. Centers for Disease Control and Prevention. August 4, 2000.
10. Abdool Karim Q, Abdool Karim SS, Soldan K, et al. Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers . American Journal of Public Health. 1995;85:1521-1525.
11. Gollub EL. The female condom: tool for women’s empowerment . American Journal of Public Health. 2000;90:1377-1381.
12. Heise L. Topical microbicides: new hope for STI/HIV prevention. Center for Health and Gender Equity (CHANGE). Takoma Park, MD.
13. Darroch JE, Frost JJ. Women’s interest in vaginal microbicides . Family Planning Perspectives. 1999;31:16-23
14. Hammet TR, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities . Sexually Transmitted Diseases. 2000;27:119-126.
15. Gross M, Buchbinder SP, Celum C, et al. Rectal microbicides for U.S. gay men: are clinical trials needed? Are they feasible? Sexually Transmitted Diseases. 1998;39:55-61.
16. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group . Journal of the American Medical Association. 1998;280:1161-1167.
17. Harrison PF. A new model for collaboration: the alliance for microbicide development . International Journal of Gynecology and Obstetrics. 1999;67:S39-S53.

<hr />

<strong>Preparado por Beth Freedman, MPH, Nancy Padian, PhD, CAPS/ARI Traducción: Romy Benard-Rodríguez, Revisión: Maricarmen Arjona, CAPS</strong>

Abril 2001. Fact Sheet #39S]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/barrerasFS.pdf</url>
	</node>
	<node>
		<title>Condones</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el papel de los condones masculinos en la prevención del VIH?</h3>
<h3>revisado 5/05</h3>
<h4>¿funcionan los condones?</h4>
Sí. El condón es una de las únicas herramientas ampliamente disponibles y altamente eficaz para la prevención del VIH en los EE.UU.<sup>1</sup> Cuando se usan correcta y habitualmente, los condones masculinos de látex pueden reducir en un 80-90% el riesgo de embarazo y de muchas infecciones de transmisión sexual (ITS), incluyendo el VIH.<sup>1-6</sup> Los condones masculino y femenino son el único método anticonceptivo que disminuye el riesgo tanto de las ITS como del embarazo.

Cuando el condón masculino se coloca en el pene antes de cualquier contacto sexual, se evita el contacto directo con el semen, las llagas en el pene y las secreciones del pene y de la vagina; de forma que los condones pueden reducir eficazmente el contagio de la gonorrea, la tricomonosis, la clamidia, la hepatitis B, el VIH y otras ITS transmitidas por las secreciones genitales.<sup>1-6</sup> Debido a que el condón solamente cubre el pene, ofrece menos protección contra las ITS transmitidas principalmente por el contacto de piel contra piel, tales como el herpes genital, la sífilis, los chancroides y las verrugas genitales.

La abstinencia, la monogamia mutua entre parejas no infectadas, la limitación del número de parejas sexuales y el uso correcto y habitual del condón durante el coito son todos elementos esenciales para disminuir la propagación del VIH/ITS.<sup>7</sup>

Gran parte de la eficacia del condón depende del nivel de destreza y experiencia del usuario. La educación, consejería y capacitación en habilidades de negociación entre parejas pueden aumentar en gran medida la capacidad de la persona de usar el condón correcta y habitualmente.<sup>2</sup>
<h4>¿cuáles son las ventajas?</h4>
<strong>Accesibilidad. </strong>El uso del condón no requiere examen médico, receta o prueba. Los condones se pueden comprar en farmacias, tiendas, máquinas dispensadoras, gasolineras, bares y en internet. Muchas clínicas para ITS y VIH también los distribuyen gratis.

<strong>Acto sexual más placentero. </strong>El uso del condón puede retrasar la eyaculación precoz. Los condones lubricados pueden facilitar y aumentar el placer del coito para las mujeres. Los condones evitan “mojar las sábanas” con el goteo de semen después del sexo y también reducen la ansiedad y el miedo a un embarazo o ITS de forma que la pareja disfrute más del sexo.

<strong>Protección de la fertilidad. </strong>Algunas ITS pueden afectar la capacidad de las mujeres para embarazarse; los condones protegen contra ciertas ITS y por ende reducen el riesgo a la infertilidad.<sup>8</sup>
<h4>¿cuáles son las desventajas?</h4>
<strong>Falta de cooperación. </strong>Sin la cooperación del varón el uso del condón puede ser imposible, pues las mujeres no pueden controlar el uso del condón directamente.

<strong>Problemas físicos. </strong>Muchos hombres y sus parejas se quejan de que los condones reducen la sensibilidad. El uso correcto del condón requiere de un pene erecto. Algunos hombres no pueden mantener una erección duradera, lo cual dificulta el uso del condón. Probar diferentes clases de condones (más delgados) y usar lubricantes a base de agua puede ayudar a aumentar la sensación.

<strong>Vergüenza. </strong>Algunos hombres y mujeres pueden sentir vergüenza de comprar condones o de adquirirlos gratuitamente de una clínica. Otros pueden sentir pena al sugerir o iniciar el uso de condones porque perciben que esto implicaría falta de confianza o de intimidad.<sup>9</sup>
<h4>¿cómo se usan?</h4>
Los mensajes más importantes sobre el uso del condón son muy sencillos: 1) Use un condón nuevo en cada coito si existe riesgo de embarazo o de ITS. 2) Antes de la penetración, desenrolle el condón cubriendo el pene erecto hasta su base y póngaselo antes de que el pene entre en contacto con la vagina o el ano de su pareja. 3) Después de eyacular (con el pene todavía erecto), sostenga el borde del condón contra la base del pene mientras se retira de la vagina o ano.<sup>2,10</sup>

Aun con la capacitación adecuada y con acceso a los condones, las personas no siempre van a usarlos a la perfección. En la vida real, uno se puede enamorar, cometer errores, alcoholizarse o simplemente decidir no usarlos. El tener relaciones sexuales bajo los efectos del alcohol u otras drogas aumenta grandemente la posibilidad de no usar condones, de usarlos mal o de que fallen.<sup>11</sup>
<h4>¿cuáles son las preocupaciones?</h4>
<strong>Información y distribución de condones en las escuelas. </strong>Aunque las escuelas pueden ser una fuente importante de información sobre el VIH/ITS<sup>12</sup>, sólo el 2% de las escuelas públicas cuentan con centros de salud en sus instalaciones y sólo el 28% de ellas ponen condones a disposición de los estudiantes<sup>13</sup>. En el año 2000, hubo 9.1 millones de nuevos casos de ITS entre jóvenes de 15 a 24 años de edad, siendo éstos casi la mitad de todos los casos nuevos de ITS en EE.UU.<sup>14</sup> El 47% de los estudiantes de preparatoria (high school) en los EE.UU. han tenido coito.<sup>15</sup>

<strong>Ruptura y deslizamiento (falla del condón). </strong>La calidad del condón ha mejorado<sup>16</sup> y para la mayoría de los usuarios el deslizamiento del condón es relativamente raro. Cerca del 4% de los condones se rompen o se deslizan,<sup>2</sup> pero algunas personas reportan tasas más altas. En un estudio, hombres gay desempleados que reportaron consumo de anfetaminas o de mucho alcohol fueron más susceptibles a reportar fallas de condones; los que usaron condones con frecuencia y usaron lubricante reportaron menos fallas.<sup>11</sup> La consejería y orientación sobre el uso del condón puede reducir notablemente la falla del condón.<sup>2</sup>

<strong>Eficacia del N-9. </strong>Por lo general, los condones lubricados con el espermicida nonoxinol-9 (N-9) cuestan más, no poseen ventajas comprobadas de protección sobre los condones sin N-9, tienen una vida en anaquel más limitada y pueden ser dañinos si se usan en exceso. Varios fabricantes han descontinuado los condones con N-9.<sup>2,16</sup>
<h4>¿qué funciona?</h4>
Los Centros de Control y Prevención de Enfermedades en EE.UU. han documentado la eficacia de los siguientes programas, que se están duplicando en todo el país.<sup>17</sup>

<strong>Capacitar para la negociación y el uso condón.</strong> El Proyecto SISTA ofrece capacitación sobre destrezas sociales para mujeres afroamericanas con el fin de incrementar su confianza y uso del condón. Las mujeres aprenden cómo ser proactivas en la relación sexual y cómo usar el condón correctamente, al tiempo que comentan aspectos culturales y de género que influyen en la negociación sobre el uso del condón. Los participantes reportaron mayor uso de condón.<sup>18</sup>

<strong>Cambiar las normas comunitarias.</strong> El Proyecto Mpowerment es un programa comunitario diseñado por y para hombres jóvenes gay para aumentar el apoyo entre pares y la aceptación del sexo más seguro. Grupos liderados por jóvenes usan un enfoque positivo sobre el sexo y la homosexualidad para enseñar a sus pares cómo negociar y usar el condón, capacitándolos y motivándolos para que hagan campañas informales con sus amigos. Los participantes reportaron una disminución del sexo anal sin protección.<sup>19</sup>

<strong>Combinar la prevención del VIH, ITS y embarazos no deseados.</strong> El programa VOICES/ VOCES fue implementado en una clínica de ITS y se dirige a la población heterosexual afroamericana y latina empleando videos específicos a cada cultura y promoviendo el desarrollo de destrezas que aumenten la negociación y el uso del condón. Esta programa es bilingüe e incluye educación sobre los diferentes tipos de condones y su distribución. Los participantes reportaron mayor uso de condón y menor repetición de ITS.<sup>20</sup>
<h4>¿qué queda por hacer?</h4>
Se necesita mejorar la comercialización y la accesibilidad de los condones en EE.UU. Aunque en la última década el uso del condón ha aumentado, todavía hay tasas altas inaceptables de ITS entre adolescentes y adultos jóvenes sexualmente activos y entre hombres gay; dos grupos que tienen también un riesgo alto de contraer el VIH. Se necesitan nuevas formas de promover el condón, idealmente antes de la iniciación sexual. A fin de que los adolescentes los usen, los condones deben ser accesibles en forma fácil y anónima, ampliamente disponibles y a bajo precio. La distribución de condones gratis también puede contribuir a un uso mayor.<sup>21</sup>

Para lograr una prevención eficaz del VIH, todas las personas necesitan información correcta y completa sobre las diferentes opciones de prevención. No obstante, el énfasis debe modificarse según el grupo. Por ejemplo, si bien la gente joven que no es sexualmente activa necesita información y acceso a los condones, la prioridad debe ser la promoción de la abstinencia y el retraso de la iniciación sexual. Cuando el objetivo sean personas en alto riesgo de adquirir el VIH, se debe priorizar el uso correcto y habitual del condón junto con la omisión de comportamientos y parejas de alto riesgo.<sup>7</sup>

¿Son infalibles los condones? No. Tampoco lo son el cinturón o el casco de seguridad, la promesa de abstinencia o las vacunas. Sin embargo, en la vida real, manejamos al trabajo, vacunamos a los niños y esperamos concluir cada día ilesos. Ninguna estrategia de salud pública puede garantizar la protección perfecta. Realmente no se trata de saber si los condones son eficaces al 100%, sino cómo maximizar el beneficio del condón y otros métodos para reducir el riesgo de enfermedad.

<hr />

<h3>Says who?</h3>
1. Scientific evidence on condom effectiveness for STD prevention. Report from the NIAID. July 2001.
2. Warner L, Hatcher RA, Steiner MJ. Male Condoms. In: Hatcher RA, Trussel J, Stewart F, et al, editors. Contraceptive Technology. New York: Ardent Media Inc. 2004:331-353.
3. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization. 2004;82:454-461.
4. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Systematic Review. 2002;(1):CD003255.
5. Hearst N, Chen S. Condom promotion for AIDS prevention in the developing world: is it working? Studies in Family Planning. 2004;35:39-47.
6. CDC. Male latex condoms and STDs.
7. Halperin DT, Steiner MJ, Cassell MM, et al. The time has come for common ground on preventing sexual transmission of HIV. Lancet. 2004;364:1913-1915.
8. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. American Journal of Public Health. 2004;94:1327-1329.
9. Miller LC, Murphy ST, Clark LF, et al. Hierarchical messages for introducing multiple HIV prevention options: promise and pitfalls. AIDS Education and Prevention. 2004;16:509-25.
10. ASHA. The right way to use a male condom. 1/30/05.
11. Stone E, Heagerty P, Vittinghoff E, et al. Correlates of condom failure in a sexually active cohort of men who have sex with men. Journ al of AIDS. 1999;20:495-501.
12. McElderry DH, Omar HA. Sex education in the schools: what role does it play? International Journal of Adolescent Medical Health. 2003;15:3-9.
13. Santelli JS, Nystrom RJ, Brindis C, et al. Reproductive health in school-based health centers: findings from the 1998-99 census of school-based health centers. Journal of Adolescent Health. 2003;32:443-451.
14. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6-10.
15. Youth risk behavior surveillance–US, 2003. Morbidity and Mortality Weekly Report. 2004;53:1-98.
16. Condoms: extra protection. Consumer Reports. Feb 2005.
17. www.effectiveinterventions.org
18. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk reduction intervention for young African-American women. Journal of the American Medical Association. 1995;274:271-276.
19. Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study. AIDS. 1999;13: 1753–1762.
20. O’Donnell CR, O’Donnell L, San Doval A, et al. Reductions in STD infections subsequent to an STD clinic visit: using video-based patient education to supplement provider interactions. Sexually Transmitted Diseases. 1998;25:161–168.
21. Cohen DA, Farley TA. Social marketing of condoms is great, but we need more free condoms. The Lancet. 2004;364:13.

<strong>Preparado por Markus Steiner PhD* y Pamela DeCarlo**
*Family Health International, **CAPS</strong>

<strong>Mayo 2005. Fact Sheet #2SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/condonesFS.pdf</url>
	</node>
	<node>
		<title>Revelación del estatus de VIH</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el efecto de la revelación del estatus de VIH en la prevención del VIH?</h3>
<h4>¿por qué es importante en el VIH?</h4>
La revelación de la condición de ser VIH+ es un asunto complejo, delicado y muy personal. Se trata de hablar sobre una enfermedad estigmatizada, transmisible y potencialmente mortal. Las decisiones al respecto no sólo son personales sino que varían según la edad, la situación, el contexto y la pareja, y pueden cambiar durante el transcurso del tiempo y según las experiencias de la persona.

Históricamente, los mensajes de salud pública han exhortado la revelación del estatus de VIH a toda pareja sexual y de drogas. En la realidad, algunas personas VIH+ tal vez prefieran no revelar su estatus por varios motivos: temor al rechazo o daño, sentimientos de culpabilidad, el deseo de mantenerlo en secreto, creer que al protegerse durante el acto sexual ya no es necesario revelarla, fatalismo, la percepción de normas comunitarias en contra de la revelación y creer que los otros tienen la responsabilidad de protegerse.<sup>1</sup> Esta hoja se centra en la revelación del estatus de VIH dentro del contexto sexual.

Comentar y revelar el estatus de VIH es una vía de doble sentido. Ya sea correcto o no, la mayoría de las personas creen que cuando una persona se sabe VIH+ entonces le incumbe informar a su pareja, y a los consejeros se les anima a ayudarles en este proceso. Además, en algunas áreas las leyes requieren la revelación del estatus de VIH+ antes de iniciar el contacto sexual.<sup>2</sup> Sin embargo, ambos integrantes de la pareja deben compartir la responsabilidad de conocer su propia condición, de revelarla cuando lo estimen importante y de preguntar a su pareja sobre la condición del otro si desean enterarse.

La mayoría de las personas VIH+ revelan su estatus a algunas pero no a todas sus parejas, amistades y familiares. Generalmente, entre más tiempo se viva con el VIH, más fácil se hace aceptar y revelar dicha estatus. La revelación del estatus de VIH a parejas sexuales es más común en las relaciones románticas de largo plazo que en las casuales (aventuras de una noche, parejas anónimas, sesiones grupales, etc.).<sup>3</sup> La revelación también varía según la percepción del estatus de VIH de las parejas, el nivel de riesgo de VIH de los actos sexuales, el sentido de responsabilidad de proteger a las parejas (responsabilidad personal vs. compartida) y el consumo de alcohol o drogas.
<h4>¿afecta las relaciones sexuales?</h4>
La relación entre la revelación del estatus de VIH, las conductas sexuales de riesgo y la posible transmisión del VIH varía. Las investigaciones presentan un cuadro mixto al respecto.<sup>4</sup> Algunos estudios han encontrado que el aumento de la revelación del estatus de VIH se asocia con una reducción de conductas sexuales riesgosas.<sup>5</sup> Otros indican que no siempre produce cambios en la conducta riesgosa.<sup>6</sup> Incluso en casos de revelación del estatus de VIH, el sexo sin protección ocurre a veces. Algunas personas practican el sexo más seguro sin mencionar el estatus de VIH.<sup>7</sup>

La revelación del estatus de VIH puede brindar beneficios psicológicos. Un estudio entre consumidores de drogas inyectables VIH+ que revelaron su estatus encontró que sintieron mayor intimidad con sus parejas y reafirmación de su sentido de sí mismos.<sup>8</sup> Muchas personas VIH+ que revelan su estatus notan que disminuye su ansiedad sobre la transmisión, lo cual les permite sentirse más tranquilas y relajadas durante el acto sexual.

Para muchos es delicado escoger el momento de la revelación del estatus de VIH. Si no se hace oportunamente, la revelación puede ser más difícil con el paso de tiempo, pudiendo así trastornar la relación si la pareja recién informada se sintiera traicionada por la demora. Las personas VIH+ que han planeado la revelación del estatus y mantienen una estrategia congruente son menos propensas a tener conductas sexuales riesgosas que quienes no revelan su estatus o tienen estrategias incongruentes.<sup>5</sup>
<h4>¿afecta las relaciones sociales?</h4>
Sí. La revelación del estatus de VIH a los seres queridos puede aumentar el apoyo que reciben las personas VIH+. Un estudio entre hombres latinos homosexuales encontró que la revelación del estatus de VIH se vinculaba a mayor calidad de apoyo social, mayor auto estima y menores niveles de depresión.<sup>9</sup> La revelación del estatus de VIH también puede llevar a apoyo que facilite el inicio y el apego de tratamiento y medicamentos contra el VIH.<sup>10,11</sup>

A veces la revelación del estatus de VIH+ produce rechazo, discriminación o violencia. Informar a ciertas personas también puede resultar más pesado que benéfico. Un estudio encontró que era más frecuente informar a los amigos y recibir su apoyo en comparación con los familiares. Entre los familiares, se informó a más madres y hermanas que a padres y hermanos; y se percibió que las mujeres les brindaron más apoyo que otros miembros de la familia.<sup>12</sup>
<h4>¿cuáles son las polémicas al respecto?</h4>
Existe un debate en torno a si las parejas tienen derecho a saber si su pareja es VIH+, lo cual les permitiría tomar una decisión plenamente informada sobre qué actividades sexuales realizar. Algunas personas VIH+ creen que si sólo tienen relaciones sexuales protegidas, no hay necesidad de revelar su condición, especialmente con las parejas casuales, y que fomentar la revelación del estatus de VIH sólo sirve para aumentar el estigma contra la gente VIH+. Estos temas pueden complicarse debido a normas complejas sobre los papeles de género y a leyes locales—en EE.UU. las leyes de 23 estados criminalizan la participación en ciertas conductas de riesgo sin revelación previa la condición de VIH.<sup>2</sup>

Las personas pueden usar la revelación del estatus de VIH para limitarse a elegir parejas de su misma estatus, ya sea ésta VIH+ o VIH- (proceso conocido también como seroselección). El éxito de la seroselección como estrategia de prevención depende de la revelación del estatus de VIH sincera y precisa de ambos integrantes de la pareja sexual.<sup>13</sup>

Aunque alguien tuviera disposición por revelar el estatus del VIH, es posible que no tenga conciencia sobre su situación.<sup>14</sup> Por ejemplo, algunas personas que se consideran VIH- pueden estar en la etapa aguda de infección por VIH (las semanas o meses iniciales de la adquisición del VIH). Durante este lapso, el cuerpo todavía no produce una respuesta detectable a los anticuerpos, pudiendo el individuo obtener un resultado negativo de la prueba estándar del VIH. Lo preocupante es que durante esta etapa de la infección cuando hay relaciones sexuales sin protección, es mucho más fácil transmitir el virus que en cualquier otro momento.<sup>15</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Muchos expertos creen que la revelación del estatus de VIH+ ayuda a impedir la transmisión del VIH y amplía el apoyo social para los individuos VIH+. Esto ha generado el diseño de programas que promueven la revelación del estatus de VIH y buscan hacer de ésta una experiencia constructiva. La mayoría de los programas que apoyan la revelación del estatus de VIH están integrados en los servicios generales de prevención y bienestar para personas VIH+. Los programas pueden incluir conversaciones sobre los beneficios de revelar su estatus, el mejor momento para hacerlo y a quiénes. Los programas deben incluir practicar las habilidades para hablar sobre la condición de VIH en el contexto de la negociación sexual y de las citas románticas.

El Healthy Living Project es una intervención conductual cognitiva de 15 sesiones individuales que ayuda a personas VIH+ a afrontar los retos de convivir con el VIH. Aborda temas como: el estrés, maneras para afrontar y adaptarse a la realidad, conductas más protegidas (incluyendo revelación a parejas) y prácticas relacionadas con la salud. Los participantes reportaron menos actos sexuales desprotegidos con personas VIH- o cuya condición de VIH desconocían.<sup>16</sup>

Healthy Relationships es un programa de 5 sesiones en grupos pequeños para aumentar las habilidades de las personas VIH+ y es una intervencion seleccionada por el CDC como parte de Dissemination of Effective Interventions (DEBI). Su propósito es reducir el estrés de los participantes con respecto a las conductas sexuales más seguras y a la revelación del estatus de VIH a sus familiares, amistades y parejas sexuales. Los participantes reportaron considerablemente menos sexo sin protección y mayor uso de condones en las sesiones de seguimiento.<sup>17</sup>

Otros métodos relacionados con la revelación del estatus de VIH han buscado estimular tanto a las personas VIH+ como a las VIH- a evitar hacer suposiciones sobre la condición de VIH de su pareja, a hacerse la prueba del VIH, a revelar su propia estatus de VIH y a protegerse en sus relaciones sexuales con toda pareja. El Departamento de Salud Pública de San Francisco, CA creó la Disclosure Initiative, una campaña de mercadeo social para normalizar la revelación del estatus de VIH para hombres VIH+ y VIH-.<sup>18</sup>
<h4>¿qué queda por hacer?</h4>
Necesitamos normalizar y facilitar discusiones cómodas sobre el VIH para que no sea tan difícil revelar la condición de ser VIH+. Entre más conversaciones tengamos sobre el VIH y más personas que revelen ser VIH+, menor será el estigma. La revelación del estatus de VIH es una vía de doble sentido. Esto significa que ambos participantes del encuentro sexual deben afrontar el tema. Muchas personas que viven con el VIH son más felices en sus relaciones (a largo y a corto plazo) cuando su condición de VIH es conocida por sus parejas.

No existe una respuesta o normativa sencilla con respecto a la revelación del estatus de VIH. Los profesionales médicos, consejeros y programas deben ser sensibles a su complejidad y entender que ésta no es lo mejor para todas las personas en todos los contextos. Sin embargo, revelar el estatus de VIH puede facilitar la provisión de apoyo a personas VIH+ y generar una mejor comunicación incluyendo la reducción de prácticas de riesgo entre parejas sexuales.

<hr />

<h3>¿Quién lo dice?</h3>
1. Wolitski RJ, Parsons JT, Gómez CA, et al. Prevention with HIV-seropositive men who have sex with men: lessons from the Seropositive Urban Men’s Study and the Seropositive Urban Men’s Intervention Trial. Journal of AIDS. 2004;37:S101-109.

2. Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS and Behavior. 2006;10:451-461.

3. Duru OK, Collins RL, Ciccarone DH, et al. Correlates of sex without serostatus disclosure among a national probability sample of HIV patients. AIDS and Behavior. 2006;10:495-507.

4. Simoni JM, Pantalone D. Secrets and safety in the age of AIDS: does HIV disclosure lead to safer sex? Topics in HIV Medicine. 2004;12:109-118.

5. Parsons JT, Schrimshaw EW, Bimbi DS, et al. Consistent, inconsistent, and non-disclosure to casual sex partners among HIV-seropositive gay and bisexual men. AIDS. 2005;19:S87-S97.

6. Crepaz N, Marks G. Serostatus disclosure, sexual communication and safer sex in HIV-positive men. AIDS Care. 2003;15:379-387.

7. Klitzman R, Exner T, Correale J, et al. It’s not just what you say: Relationships of HIV dislosure and risk reduction among MSM in the post-HAART era. AIDS Care. 2007;19:749-756.

8. Parsons JT, VanOra J, Missildine W, et al. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Education and Prevention. 2004;16:459-475.

9. Zea MC, Reisen CA, Poppen PJ, et al. Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS and Behavior. 2005;9:15-26.

10. Stirratt MJ, Remien RH, Smith A, et al. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS and Behavior. 2006;10:483-493.

11. Klitzman RL, Kirshenbaum SB, Dodge B, et al. Intricacies and inter-relationships between HIV disclosure and HAART: a qualitative study. AIDS Care. 2004;16:628-640.

12. Kalichman SC, DiMarco M, Austin J, et al. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. Journal of Behavioral Medicine. 2003;26:315-332.

13. Cairns G. New directions in HIV prevention: serosorting and universal testing. IAPAC Monthly. February 2006:42-45.

14. MacKellar DA, Valleroy LA, Behel S, et al. Unintentional HIV exposures from young men who have sex with men who disclose being HIV-negative. AIDS. 2006;20:1637-1644.

15. Pilcher CD, Eron JJ, Galvin S, et al. Acute HIV revisited: new opportunities for treatment and prevention. Journal of Clinical Investigation. 2004;113:937-945.

16. The Healthy Living Project Team. Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the Healthy Living Project randomized controlled study. Journal of AIDS. 2006; 44:213-221.

17. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. American Journal of Preventive Medicine. 2001;21: 84-92. Program information

18. hivdisclosure.com, www.disclosehiv.org

<hr />

<strong>Preparado por Robert H. Remien y Mark Bradley
HIV Center for Clinical &amp; Behavioral Studies, NY State Psychiatric Institute y Columbia University</strong>

<strong>Traducción: Rocky Schnaath</strong>

Diciembre 2007. Hoja de Dato #64S]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revelacionFS.pdf</url>
	</node>
	<node>
		<title>Consejería y prueba de VIH</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el papel de la consejería y prueba en la prevención del VIH?</h3>
<h4>¿por qué es tan importante la C&amp;P?</h4>
La consejería y prueba (C&amp;P) del VIH es un componente importante en la gama de servicios de prevención y tratamiento del VIH. Ya que la visita para la C&amp;P incluye una evaluación individual integral de riesgo, ésta ofrece la mejor oportunidad para remitir al cliente a otros servicios más intensivos. Por otra parte, la C&amp;P es una de las entradas a los servicios de prevención y a otros servicios. La consejería breve y enfocada en el cliente que la C&amp;P proporciona puede incrementar el uso de condones y evitar la propagación de las enfermedades de transmisión sexual (ETS).<sup>1</sup>

Conocer la condición de VIH, ya sea VIH- o VIH+, es clave para evitar la transmisión del VIH y para obtener consejería y atención médica. Se calcula que la cuarta parte de las personas VIH+ en los EE.UU. no saben que están infectadas.<sup>2</sup> Una encuesta entre hombres jóvenes que tienen sexo con hombres (HSH) encontró que el 14% de los jóvenes negros HSH eran VIH+. El 93% de éstos desconocían estar infectados y el 71% afirmaron que era poco probable que fueran VIH+.<sup>3</sup>

Hace poco los Centros para el Control y Prevención de Enfermedades (CDC, siglas en inglés) anunciaron una iniciativa para expandir la C&amp;P en EE.UU.<sup>4</sup> Su plan estratégico del año 2005 pretende reducir en un 50% el número de personas que ignoran su condición de VIH.<sup>5</sup> Si se cumple esta meta para el año 2010, se calcula que se prevendrán unas 130,000 nuevas infecciones de VIH, ahorrándose así más de $18 mil millones.<sup>6</sup>
<h4>¿cómo se realiza la C&amp;P?</h4>
La C&amp;P tiene tres componentes: 1) la evaluación de riesgos y consejería antes de obtener la muestra de sangre o bucal, 2) el análisis de la muestra y 3) la consejería y remisión a otros servicios a la entrega de los resultados.<sup>7</sup> La C&amp;P puede ser confidencial (el nombre de la persona se registra con el resultado) o anónima (el nombre no se registra con el resultado). Los servicios de C&amp;P financiados con fondos públicos se realizan en centros de pruebas, clínicas y organizaciones comunitarias, programas de alcance comunitario, unidades móviles, clínicas de planificación familiar y de ETS y en departamentos de salud locales, entre otros lugares.

Aunque los trabajadores de salud pública están capacitados para implementar los procedimientos de C&amp;P, la mayoría de las pruebas del VIH en EE.UU. se realizan en consultorios médicos privados. Muchas personas prefieren hacerse la prueba del VIH como parte de un chequeo médico regular en lugar de ir a un centro de salud pública. Sin embargo, las pruebas de los consultorios privados no son anónimas y es posible que los pacientes no reciban la consejería o las remisiones adecuadas.<sup>8</sup>

Las pruebas del VIH también se efectúan en otros lugares como las salas de emergencia, las cárceles y prisiones, los centros de reclutamiento militar y en el Cuerpo de Trabajo. En EE.UU., la prueba es obligatoria para recibir algunos beneficios de seguro y médicos, así como para solicitar ciertos trabajos, ingresar a las fuerzas armadas, donar sangre o entrar al país como inmigrante.
<h4>¿qué tal las pruebas rápidas?</h4>
En los últimos 20 años el método general ha sido obtener una muestra por venipunción (sacar sangre). Desde hace 10 años, también se obtienen muestras de la mucosa bucal (OraSure) para analizar las células. Los resultados se envían a un laboratorio que realiza la prueba ELISA seguida por la Western Blot para confirmar un resultado inicialmente positivo. El tiempo de espera entre la toma de la muestra y la provisión de los resultados suele ser de una a dos semanas. Con este método, muchas personas no regresan para recoger sus resultados. En EE.UU., el 31% de las personas con pruebas VIH+ no vuelven por sus resultados.<sup>4</sup>

La prueba rápida por medio de una punción del dedo (OraQuick) ya está disponible. Este método entrega resultados en 20 minutos. Sin embargo, si la prueba resulta reactiva, el cliente recibirá un resultado preliminar positivo y deberá tomársele otra muestra confirmatoria (por venipunción o con OraSure) para realizar la prueba habitual (Western Blot) cuyos resultados tardarán 1-2 semanas. Los datos nacionales indican que el 95% de los clientes con un resultado preliminar VIH+ a la prueba rápida regresaron por sus resultados confirmatorios.<sup>9</sup>

Aunque la gente sigue teniendo la opción de las pruebas tradicionales, la prueba rápida cambiará la C&amp;P. Ya que se necesita esperar 20 minutos para recibir los resultados, una vez que el consejero obtiene la muestra de sangre en la primera parte de la sesión, se dispone de un “público cautivo” para realizar la evaluación de riesgos y la consejería. Los consejeros mismos pueden efectuar la prueba de sangre, o en su defecto otro trabajador de salud puede hacer la punción y lectura los resultados. Debido a los resultados inmediatos, la consejería de la prueba rápida puede ser más intensa y enfocada en el cliente. Se espera que la prueba rápida produzca un incremento dramático en el número de personas que conocen sus resultados.
<h4>¿en qué consiste la buena C&amp;P?</h4>
La buena C&amp;P depende de consejeros con la preparación y la experiencia adecuadas. Los consejeros deben proteger la confidencialidad de los datos del cliente, obtener el consentimiento con conocimiento de causa antes de la prueba y proporcionar servicios de consejería eficaces y remisiones apropiadas. Es importante establecer vínculos con prestadores de servicios clave para remitir a los clientes a servicios adecuados a sus necesidades, prioridades, cultura, edad, orientación sexual e idioma. Los consejeros de C&amp;P deben ser evaluados periódicamente para asegurar la calidad de sus servicios y deben recibir apoyo y capacitación constante.<sup>7</sup>

Para la prueba rápida, los consejeros necesitan otro tipo de capacitación, ya que también pueden actuar como técnicos de laboratorio. La prueba rápida requiere una temperatura estable, iluminación adecuada y una atención esmerada al detalle. Cabe señalar que la prueba rápida no equivale a la consejería rápida. Los consejeros necesitan colaborar de cerca con los clientes para formular un objetivo razonable respecto a la reducción de riesgos y asegurarse que realmente estén preparados para conocer sus resultados. Asimismo, es importante obtener otra muestra de sangre para confirmar todo resultado positivo.<sup>10</sup>
<h4>¿qué se está haciendo al respecto?</h4>
El Departamento de Salud Pública (DPH, siglas en inglés) de la Florida se propuso mejorar sus servicios de C&amp;P y aumentar el número de personas que conocen su condición de VIH+. Los programas subvencionados por el gobierno estatal se enfocaron en ofrecer la prueba del VIH a personas de alto riesgo en las ONG, en las prisiones y cárceles, así como en programas de alcance comunitario. También utilizaron la OraSure fuera de los centros médicos. En el 2002, el DPH reportó una tasa de seropositividad del 2% para las muestras por venipunción y del 3.2% para las pruebas de OraSure. En las cárceles encontraron una tasa del 3.6% con OraSure. También ofrecieron servicios de consejería y remisión para parejas (PCRS, siglas en inglés). En el año 2002, el 80% de los clientes VIH+ dieron los nombres de sus parejas: el 64% de éstas fueron localizadas y recibieron consejería, y el 13% de las que se hicieron la prueba resultaron VIH+.<sup>11</sup>

En Minneapolis, MN, se ofreció la prueba rápida en organizaciones con clientela principalmente afroamericana en lugares como centros para dejar las drogas, refugios para desamparados, clínicas para adolescentes, grupos terapéuticos para agresores sexuales y residencias de transición. Casi todos los clientes (el 99.7%) recibieron los resultados de la prueba y servicios de consejería y el 95% indicaron que preferían la punción del dedo a la de la vena.<sup>12</sup>

El programa de SIDA/VIH de Wisconsin buscó incrementar el número de personas de alto
riesgo que se hacían la prueba. Al principio de los años ‘90, las pruebas realizadas ascendieron anualmente de 6 mil a entre 20 y 30 mil. Al final de los ‘90, el programa cambió su filosofía de la educación pública a la búsqueda de casos. Los lugares subvencionados con fondos públicos se redujeron de 126 a los 55 que servían al mayor porcentaje de personas de alto riesgo y personas no caucásicas. En un año, la tasa de seroprevalencia disminuyó al .75%. Se registró una reducción del 42% en el número de personas de bajo riesgo que se hicieron la prueba y hubo incrementos de pruebas del 6% entre individuos de alto riesgo y del 18% entre personas no caucásicas.<sup>13</sup>
<h4>¿cuál es el futuro de la C&amp;P?</h4>
A medida que se extiende el uso de la prueba rápida, se espera una disminución del número de personas que no regresan por sus resultados. La prueba rápida debe ser introducida cuidadosamente y gradualmente para que las organizaciones obtengan experiencia con el nuevo proceso y sus clientes lo vayan conociendo.

Puede ser necesario hacer un mayor esfuerzo para remitir a los clientes a servicios eficaces. El cambio conductual es un proceso paulatino y difícil, y muchas personas realizan los cambios incrementalmente. Al remitir a los clientes a otros servicios y darles seguimiento, se puede ampliar considerablemente los efectos de la consejería inicial. Los métodos de capacitación y de control de calidad en la C&amp;P tradicionalmente se han centrado en la consejería, por lo que las remisiones pueden ser el aspecto más débil y necesitado de mejoras.

El simple incremento del número de personas enteradas sobre su condición VIH+ no disminuirá lo suficiente esta epidemia. Mientras que más personas en EE.UU. conocen su condición VIH, es imperativo disponer de más servicios de prevención, sociales y de tratamiento tanto para las personas VIH+ como para las VIH-. Además de las intervenciones primarias de prevención del VIH, estos servicios deben incluir el acceso a tratamiento de calidad para dejar las drogas y el alcohol, a servicios de vivienda y de empleo, a pruebas y tratamiento de las ETS, a programas de intercambio de jeringas, a servicios médicos de calidad así como al apoyo para apegarse al tratamiento que asegure el aprovechamiento eficaz de los medicamentos contra el SIDA.

<hr />

<h4>¿quién lo dice?</h4>
1. Kamb ML, Fishbein M, Douglas JM,et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases . Journal of the American Medical Association. 1998;280:1161-1167.

2. Fleming P, Byers RH, Sweeney PA, et al. HIV prevalence in the United States, 2000. Presented at the 9th Conference on Retroviruses and Opportunistic Infections, Seattle, WA; February 24-28, 2002.

3. Centers for Disease Control and Prevention. Unrecognized HIV infection, risk behaviors and perceptions of risk among young black men who have sex with men – six US cities, 1994-1998. Morbidity and Mortality Weekly Reports. 2002;33:733-736.

4. Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic – US, 2003 . Morbidity and Mortality Weekly reports. 2003:52;329-332.

5. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005. www.cdc.gov/hiv/partners/psp.htm

6. Holtgrave DR, Pinkerton SD. Economic implications of failure to reduce incident HIV infections by 50% by 2005 in the United States . Journal of Acquired Immune Deficiency Syndromes. 2003;33:171-174.

7. Centers for Disease Control and Prevention. Revised Guidelines for HIV Counseling, Testing, and Referral. Morbidity and Mortality Weekly Reports. 2001;50.

8. Haidet P, Stone DA, Taylor WC, et al. When risk is low: primary care physicians’ counseling about HIV preven tion. Patient Education and Counseling. 2002;46:21-29.

9. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling . AIDS. 1997;11:1045-1051.

10. Fournier J, Morris P. Speed bumps and roadblocks on the road to rapid testing: a look at the integration of HIV rapid testing in an agency and community. Presented at the US Conference on AIDS, New Orleans, LA, 2003.

11. Liberti T. Florida’s HIV counseling, testing and referral program. Presented at the US Conference on AIDS, New Orleans, LA, 2003.

12. Keenan PA. HIV outreach in the African American community using OraQuick rapid testing. Presented at the National HIV Prevention Conference, Atlanta, GA. 2003.

13. Stodola J. Restructuring Wisconsin’s HIV CTR program: targeting CTR services. Presented at the US Conference on AIDS, New Orleans, LA, 2003.

<hr />

<strong>Preparado por Steven R. Truax, PhD, CA State Office of AIDS; Pam DeCarlo, CAPS</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Enero 2005. Hoja Informativa 3SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/C&amp;PFS.pdf</url>
	</node>
	<node>
		<title>Prevención Posexposición</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Que es la prevención pos-exposición (PEP)?</h3>
<h4>¿por qué PEP ahora?</h4>
Aún no se descubre la cura del SIDA. La prevención continúa siendo la mejor forma de detener esta epidemia. La mejor forma de no contraer el VIH es evitando la exposición en primer lugar: abstinerse sexualmente, tener solo parejas sanas, hacer uso constante del condón, abstenerse de usar drogas inyectables y la esterilización constante del equipo de inyeción.<sup>1</sup>

Recientemente hemos aprendido mucho sobre el tratamiento del VIH y la progresión de la misma. El uso de los inhibidores de la Proteasa en combinación con otros medicamentos para tratar el VIH han sido altamente eficaces reduciendo los niveles de VIH en la sangre y restaurando la salud de muchos pacientes.<sup>2</sup> Para aquellas personas que no están infectadas con el VIH y que se exponen a este virus, es posible que durante las primeras horas o días de haber estado expuestas estas medicinas de alto poder activo logren prevenir la infección con VIH.

En un estudio a trabajadores del sector de salud quedó demostrado que el tratamiento con AZT después de haber estado en contacto con agujas expuestas a sangre infectada con VIH redujo las posibilidades de infección en un 81%.<sup>3,4</sup> El estudio no fue diseñado para comprobar la eficacia del tratamiento con AZT después de haber estado expuesto lo cual presenta ciertas limitaciones. A partir de numerosas consultas, resultados de estudios, y otros datos el Centro de Prevención y Control de las Enfermedades (CDC por sus siglas en Inglés) se inclinó por recomendar la Prevención Pos-Exposición (PEP por sus siglas en Inglés) para algunos trabajadores del sector salud que accidentalmente han estado expuestos a fluidos corporales infectados con VIH. Si el PEP fue recomendado a trabajadores de la salud lo más lógico es que se tomen en consideración aquellas personas que han estado expuestas por medio del sexo, uso de drogas inyectables, especialmente siendo éstas son las formas más comunes de contraer la infección con VIH.
<h4>¿cuáles son los componentes del PEP?</h4>
Aún no existen recomendaciones federales que regulen el uso del PEP en personas que han estado expuestas al VIH por medio del sexo o uso de drogas inyectables, aunque el CDC actualmente estudia este caso. Actualmente, muchos doctores y clínicas a lo largo de la nación Estadounidense ofrecen el PEP en formas diversas.<sup>5</sup> En la mayoría de los casos el PEP se aplica dentro de un período de 72 horas del posible contacto utilizando una o varias drogas anti-VIH. Este tratamiento dura un período de 4 a 6 semanas.

Antes de implementar el PEP, es necesario determinar cautelosamente el nivel y la frecuencia con la que el paciente se expone al riesgo, al igual que el estado de la pareja del paciente con respecto al VIH. Los pacientes deberán ser informados sobre los posibles efectos negativos y la difícil tarea de cumplir con el medicamento a cabalidad, por lo tanto será necesario ayudarles a crear las estrategias para lograr el cumplimiento de las indicaciones del tratamiento. También pueden formar parte de un programa del PEP la notificación de la pareja del paciente.

Una de las potenciales ventajas que ofrece PEP es la oportunidad de alcanzar y aconsejar personas con alto riesgo de contraer el VIH. Los programas PEP deben incluir un componente de consejería conductual que ayude a los pacientes a encontrar la forma de no exponerse al VIH en el futuro y a manejar el temor de la posible infeción. Incluir servicios de referencia a programas de prevención del VIH, de tratamiento por abuso de drogas, y salud mental y física puede contribuir a la resolución de ciertos factores de riesgo que son de vital importancia.<sup>6</sup>

Al tener relaciones sexuales sin protección no solo se está exponiendo al riesgo de infección con VIH, sino a otras ETS y a embarazos no planeados. Los programas PEP deben ofrecer pruebas de detección de embarazos y de ETS con su respectivo tratamiento. Está demostrado que las personas infectadas con algun ETS tienen de 2 a 5 veces mas probabilidad de infectarse con VIH que las personas sin ETS. El tratamiento de las ETS es una intervención exitosa para prevenir el VIH.<sup>7</sup>
<h4>¿funciona el PEP?</h4>
Nadie está seguro. La idea de prevenir la infección por medio de poderosas drogas anti-VIH hace sentido biologicamente hablando, aunque algunas personas opinan que el estudio del AZT y el personal de salud es inconcluso y que no se han realizado estudios del PEP en personas que han estado expuestas al VIH por uso de drogas inyectables o contacto sexual. La potencia de los nuevos drogas anti-VIH es sorprendente, y hasta que se demuestre lo contrario, razón demás para ofrecer el PEP después de haber estado expuesto a una enfermedad que puede ocasionar la muerte.<sup>8</sup>
<h4>¿cuáles son las desventajas?</h4>
Uno de los temores del PEP es que las personas retornen a la prácticas riesgosas si estos asumen que el PEP va a prevenir la infección. Hay evidencias de que los avances en el tratamiento del VIH, incluyendo el PEP, pueden ya estar aumentando el índice de sexo sin protección en los EEUU.<sup>9</sup> Por ejemplo, las tasas de gonorrea en hombres que tienen sexo con otros hombres se han elevado por primera vez desde comienzos de los 1980′s.<sup>10</sup>

Otro de los temores es que el uso indebido de las terapias con PEP ocasione que las personas desarrollen un tipo de VIH más resistente a estas medicinas. Si la terapia no tiene éxito y la persona desarrolla este virus más resistente, es posible que los nuevos tratamientos no funcionen para esta persona. Esto no solo puede ocurrir con la terapia del PEP, sino que con cualquier otro tratamiento de combinación de terapias.

Seguir este régimen puede ser a su vez complicado y prohibido por su costo. Las medicinas necesitan ser ingeridas a horas específicas y con mucha regularidad. Cerca de un tercio de los tarabajadores de salud que recibieron el PEP no pudieron cumplir con el el régimen por lo difícil que resulta seguirlo. Los efectos secundarios de estos medicamentos pueden ser severos y debilitantes y se desconocen los efectos a largo plazo. Una dosis tipica de cuatro semanas puede tener un costo de $600-1000 incluyendo el medicamento, pruebas de sangre y las visitas a la clínica.

Recetar el PEP puede ser una decisión muy complicada para los doctores y debe hacerse de acuerdo a cada caso. Muchos opinan que un buen candidato para el PEP es aquella persona que haya estado expuesta al sexo sin protección o que haya compartido jeringas con una pareja VIH+. Sin embargo a muchas personas les preocupa que proveer repetidamente el PEP a personas que repiten conductas de alto riesgo puede dar licensia a las practicas riesgosas, o resultar en intoxicación por las medicinas.
<h4>¿qué programas existen?</h4>
San Francisco, CA recién implementó un proyecto para determinar que tan seguro y factible es el PEP. Este estudio ofrece consejería conductual intensiva, pruebas de detección del VIH y medicinas anti-VIH a personas que hayan estado expuestas al VIH dentro de un período de 72 horas. El proyecto no determinará la efectividad del PEP; determinará si los participantes cumplen o no con los tratamientos, si presentan efectos secundarios significantes y si estos cambian su comportamiento de alto riesgo después de haber estado expuesto.<sup>11</sup>

A nivel internacional, muchos países han implementado el PEP. En Francia, el Secretario de Salud anunció en Agosto de 1997 que el PEP estará a la disposición de todas aquellas personas que accidentalmente hayan estado expuestas al VIH por razón ocupacional, sexual o por inyección. En Londres, Inglaterra el PEP esta disponible a través de las clínicas y doctores privados. En Colombia Británica, Canadá el PEP está disponible en las salas de emergencia para aquellos pacientes que hayan estado posiblemente expuestos.
<h4>¿cómo puede ayudar el PEP?</h4>
El PEP puede ayudar a reforzar las labores de prevención al servir de puente entre la prevención y el tratamiento, similar a lo que hace la prevención de las ETS. Tradicionalmente la prevención de las ETS ha incluído educación, pruebas de detección, notificación de pareja y seguimiento. En San Francisco, uno de los programas del PEP está localizado en una clínica de ETS. Muchas personas han abogado por la integración del VIH y las ETS en labores de prevención. El PEP lleva ese rumbo.

Nadie espera que el PEP sea 100% eficaz. Hasta hoy, dentro de lo que es prevención no existe un instrumento capaz de garantizar un 100% de efectividad ante cualquier condición médica así sea cáncer, embarazos o VIH. La mejor forma de prevención requiere “una miríada de intervenciones imperfectas de efectividad acumulativa.” Un programa de prevención completo, utiliza muchos elementos para proteger del VIH a la mayor cantidad de personas posible. PEP ofrece la oportunidad de ampliar la extensa gama de actividades de prevención, ampliando así la posibilidad de salvar vidas.

<strong>¿quién lo dice?</strong>

1. Centers for Disease Control and Prevention. Backgrounder: CDC-sponsored external consultants meeting on post-exposure therapy (PET) for non-occupational exposures to HIV. Fact sheet prepared by the CDC. July 1997.

2. Deeks SG, Smith M, Holodniy M, et al. HIV-1 protease inhibitors: a review for clinicians . Journal of the American Medical Association. 1997;277:145-153.

3. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposures to HIV-infected blood-France, United Kingdom, and United States, January 1988-August 1994 . Morbidity and Mortality Weekly Report. 1995;44:929-933.

4. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure . New England Journal of Medicine. 1997;337:1485-1490.

5. Zuger A. `Morning after’ treatment for AIDS. The New York Times. June 10, 1997.

6. Katz MH, Gerberding JL. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use . New England Journal of Medicine. 1997;336:1097-1100.

7. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases . Sexually Transmitted Diseases. 1992;19:61-77.

8. Henderson DK. Postexposure treatment of HIV-taking some risks for safety’s sake . New England Journals of Medicine. 1997;337:1542.

9. Dilley JW, Woods WJ, McFarland W. Are advances in treatment changing views about high-risk sex? (letter) . New England Journal of Medicine. 1997;337:501-502.

10. Centers for Disease Control and Prevention. Gonorrhea among men who have sex with men-selected sexually transmitted diseases clinics, 1993-1996 . Morbidity and Mortality Weekly Report. 1997;46:889-892.

11. Perlman D. Morning-after HIV experiment starts in SF. San Francisco Chronicle. October 14, 1997.

12. Cates W. Contraception, unintended pregnancies, and sexually transmitted diseases: why isn’t a simple solution possible? American Journal of Epidemiology. 1996;143:311-318

<strong>Preparado por Pamela DeCarlo* Thomas J. Coates, PhD*, Traducción Romy Benard Rodríguez* </strong><strong>
</strong><strong>*CAPS</strong>

Agosto 1998. Hoja Informativa 32S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/PEPesFS.pdf</url>
	</node>
	<node>
		<title>Profilaxis pre-exposición (PrEP)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué es la profilaxis previa a la exposición (PrEP) y es eficaz en la prevención del VIH?</h3>
<strong>Preparado por </strong>

<strong>Stephanie Cohen, MD y Al Liu, MD; SF DPH | Gabriel R. Galindo DrPH; CAPS </strong>
<h4>¿Qué es PrEP?</h4>
PrEP (por sus siglas en inglés) significa profilaxis previa a la exposición y es una intervención biomédica prometedora contra el VIH en la cual personas VIH negativas toman medicamentos anti VIH para evitar contraer la infección. PrEP se inicia <strong><em>antes</em></strong> de la posible exposición al VIH y se toma en forma continua. PrEP no es una vacuna y se distingue de la profilaxis post exposición (PEP por sus siglas en inglés) que se inicia poco después de la exposición al VIH y sólo se toma durante 28 días. Se ha comprobado que tomar medicamentos antes de exponerse al contagio es eficaz para la prevención de otras enfermedades infecciosas. Asimismo, desde hace muchos años la provisión de terapia antirretroviral a mujeres embarazadas y sus bebés ha logrado evitar la transmisión del VIH de madre a hijo[<sup>1</sup>]. PrEP puede tomarse por vía oral en forma de una pastilla conocida como “PrEP oral”.[<sup>2,3,4 </sup>] En ensayos clínicos, PrEP se ha brindado en combinación con otras intervenciones de prevención del VIH, como la distribución de condones, consejería conductual, pruebas del VIH y pruebas para detectar otras infecciones transmitidas sexualmente (ITS).
<h4>¿Por qué es importante PrEP?</h4>
Cada año suceden 2.6 millones de nuevas infecciones de VIH en el mundo y se calcula que 56,000 de esta se dan en EE.UU.[<sup>5</sup>] Aunque el asesoramiento sobre la reducción de riesgos, los condones, la circuncisión masculina y otros métodos han mostrado reducir las infecciones de VIH, por sí solos no son suficientes y urgen nuevos abordajes a la prevención del VIH, especialmente para hombres que tienen sexo con hombres (HSH) y mujeres transgénero, los grupos más desproporcionadamente afectados por el VIH en EE.UU.[<sup>6</sup>].
<h4>¿Qué medicamentos se están poniendo a prueba para PrEP?</h4>
Estudios concluidos recientemente y otros actuales sobre <strong>PrEP</strong> <strong>oral </strong>han puesto a prueba el medicamento tenofovir (también conocido como Viread®) ya sea solo o combinado con emtricitabina para combatir el VIH. La combinación de tenofovir y emtricitabina se conoce como Truvada®. Estos medicamentos fueron seleccionados porque sólo es necesario tomarlos una vez al día, tienen pocos efectos secundarios, no interactúan con otros medicamentos y han mostrado ser inocuos y eficaces en estudios sobre la PrEP realizados en animales. Actualmente se están investigando diferentes formulaciones tópicas en ensayos clínicos y otras formas de <strong>PrEP tópica</strong>, entre ellas un aro vaginal y un gel formulado para uso rectal, también están en vías de desarrollo.[<sup>7</sup>]
<h4>¿Qué tan eficaz es PrEP para evitar la infección del VIH?</h4>
Para los HSH y las mujeres transgénero, los resultados del estudio iPrEx, publicados en noviembre del 2010, demostraron por primera vez que Truvada® oral diaria es eficaz en la prevención del VIH.[<sup>2</sup>] El estudio iPrEx inscribió a casi 2500 HSH (el 1.2% de los participantes eran mujeres transgénero) provenientes de 6 países e incluyó dos ciudades estadounidenses. Todos los participantes recibieron con frecuencia pruebas del VIH, asesoramiento sobre la reducción de riesgos, condones y lubricantes, y pruebas de detección y tratamiento de ITS. A la mitad de los participantes se les asignó aleatoriamente recibir Truvada® y la otra mitad un placebo. Los que recibieron Truvada® tuvieron un 44% menos infecciones de VIH que los que tomaron el placebo, lo cual significa que PrEP evitó casi la mitad de las infecciones que hubieran ocurrido de no haberse tomado el medicamento. El efecto protector de PrEP fue aun mayor para los participantes que pudieron tomar el medicamento más habitualmente, incluidos los que tenían evidencia de Truvada® en la sangre.

La eficacia de PrEP en otras poblaciones, como los hombres y mujeres heterosexuales y los consumidores de drogas inyectables, se desconoce actualmente debido a los resultados mixtos obtenidos en ensayos clínicos. Aun así, se están realizando varios estudios alrededor del mundo en estos grupos y los resultados de éstos profundizarán nuestros conocimientos sobre la eficacia de PrEP [<sup>9,10</sup>]. Para más detalles sobre los ensayos clínicos a nivel mundial, pulse <a href="https://web.archive.org/web/20161029012223/http://www.avac.org/ht/d/sp/a/GetDocumentAction/i/3618">aquí</a> para ver una tabla de estudios actuales y planeados [<sup>11</sup>], y <a href="https://web.archive.org/web/20161029012223/http://www.avac.org/ht/a/GetDocumentAction/i/3113">aquí</a> para un cronograma de ensayos clínicos de la PrEP[<sup>12</sup>].
<h4>¿Es segura PrEP?</h4>
El ensayo iPrEx encontró que Truvada® fue inocua y generalmente bien tolerada por los participantes del estudio. Hubo algunos efectos secundarios leves relacionados con Truvada®, como náusea, los cuales fueron infrecuentes y disminuyeron con el tiempo. Aunque se observó una pequeña cantidad de pérdida ósea en los hombres que recibieron PrEP, un hallazgo común en individuos VIH positivos que inician otros regímenes de tratamiento con antirretrovirales similares, estos cambios no tuvieron ningún efecto negativo evidente sobre la salud. La resistencia al medicamento no se observó entre los participantes que se infectaron con el VIH durante el estudio iPrex. Aun así, es importante realizarse una prueba del VIH y una valoración médica antes de comenzar a tomar PrEP y durante el transcurso de la terapia para vigilar los efectos secundarios a nivel individual.

Al igual que en el estudio iPrex, tampoco han surgido preocupaciones de seguridad significantes durante los ensayos de PrEP realizados en hombres y mujeres heterosexuales. Sin embargo, cabe destacar que el seguimiento en estos estudios fue relativamente corto, por lo cual la evaluación de la seguridad a más largo plazo de PrEP oral es importante y requerirá de más investigación en los estudios actuales. También se necesita investigar más para determinar con qué frecuencia las personas que toman PrEP deben ser atendidas por un proveedor médico y con qué frecuencia necesitarán análisis de laboratorio, entre ellos la prueba de VIH y la vigilancia de la función hepática.
<h4>¿Cuáles son las recomendaciones actuales para PrEP?</h4>
En enero del 2011, los Centros para el Control y la Prevención de Enfermedades (CDC) de EE.UU. emitió lineamientos provisionales sobre el uso de PrEP en la prevención del VIH en los HSH.[<sup>13</sup>] Los CDC señalan que:
<ul>
 	<li>PrEP sólo debe considerarse para los HSH en alto riesgo de contraer el VIH (y no para otras poblaciones hasta que dispongamos de datos adicionales).</li>
 	<li>PrEP debe usarse solamente en individuos con una o más pruebas negativas de anticuerpos del VIH confirmadas inmediatamente antes de iniciar PrEP. Si existen síntomas de una infección reciente de VIH, se debe aplazar PrEP y realizar una prueba para detectar una infección aguda de VIH.</li>
 	<li>PrEP <strong>nunca</strong> debe considerarse como la primera línea de defensa contra el VIH. PrEP debe brindarse como parte de un paquete integral de prevención que incluya asesoramiento sobre la reducción de riesgos y la adherencia al tratamiento, promoción del uso del condón y el diagnóstico y tratamiento de ITS.</li>
 	<li>PrEP debe tomarse todos los días. Sólo el régimen puesto a prueba en el estudio iPrEx (Truvada® diaria) debe usarse y ningún otro medicamento antirretroviral o régimen de dosificación (como el uso intermitente o eventual).</li>
 	<li>PrEP debe obtenerse y usarse en estrecha colaboración con proveedores médicos para vigilar en intervalos regulares los efectos secundarios, el apego al tratamiento, la seguridad y los comportamientos de riesgo.</li>
</ul>
Los individuos que toman PrEP deben someterse a pruebas regulares del VIH y descontinuar PrEP si salen VIH positivos. Los interesados en PrEP deben consultarlo con su médico y no deben tomarla sin supervisión médica. El Servicio de Salud Pública de EE.UU. formulará lineamientos integrales solicitando los consejos de expertos en el tema y comentarios de la comunidad.
<h4>¿Cuáles son los próximos pasos para PrEP?</h4>
En julio del 2012 la Administración de Alimentos y Fármacos de EE.UU. aprobó Truvada® para reducir el riesgo de infección de VIH en individuos no infectados que se encuentran en algo riesgo y que podrían tener contacto sexual con una pareja VIH positiva. Reconociendo que ninguna enfermedad infecciosa jamás se ha eliminado por medio del uso de medicamentos exclusivamente, necesitamos considerar cuidadosamente cómo utilizar mejor esta herramienta en combinación con otras estrategias de prevención con el fin de lograr el mayor impacto contra el VIH/SIDA en EE.UU. y en todo el mundo. En los estudios iPrEx, Partners PrEP (parejas PrEP) y TDF-2, PrEP se mostró parcialmente eficaz cuando se usó en combinación con pruebas del VIH regulares, condones y otros métodos comprobados para evitar el VIH como la consejería individual sobre la reducción de riesgos. La combinación de abordajes para la prevención que integran componentes biomédicos, conductuales y estructurales son necesarios para optimizar los esfuerzos de prevención del VIH.[<sup>14</sup>] Como tal, la eficacia de PrEP depende no sólo de la eficacia y seguridad de los medicamentos, sino también de otros factores de implementación, entre ellos un buen apego al régimen de medicamentos, el mantenimiento de conductas de sexo más seguro y el acceso a servicios clínicos y de apoyo social. Las intervenciones y programas que ayudan a las personas VIH negativas a obtener PrEP, tomar las pastillas en un horario regular, manejar los posibles efectos secundarios, hacerse pruebas del VIH regularmente y mantener prácticas de sexo más seguro y de consumo de drogas son clave para maximizar la eficacia y la aceptación de PrEP.[<sup>15,16</sup>] Se están realizando estudios adicionales, diálogos a escala comunitaria y trabajo de promoción de derechos para intentar abordar y evaluar muchas de estas consideraciones importantes.

<strong>Referencias:</strong>

1.            WHO. Guidance on global scale-up of the prevention of mother-to-child-transmission of HIV: Towards universal access for women, infants and young children and eliminating HIV and AIDS among children. The Interagency Task Team on Prevention of HIV Infection in Pregnant Women, Mothers and Their Children, 2007.

2.            Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. NEJM 2010;363(27):2587-99. Epub 2010 Nov 23.

3.            Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74.

4.            Centers for Disease Control and Prevention. CDC Trials: Pre-Exposure Prophylaxis for HIV Prevention.  February 2011.  <a href="https://web.archive.org/web/20161029012223/http://www.cdc.gov/hiv/prep/pdf/PrEP_TrialsFactSheet.pdf">http://www.cdc.gov/hiv/prep/pdf/PrEP_TrialsFactSheet.pdf</a>

5.            Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008;300(5):520-9

6.            Centers for Disease Control and Prevention. Estimates of new HIV infections in the United States. CDC Fact Sheet, 2008. Available at: <a href="https://web.archive.org/web/20161029012223/http://www.cdc.gov/nchhstp/newsroom/docs/Fact-Sheet-on-HIV-Estimates.pdf">http://www.cdc.gov/nchhstp/newsroom/docs/Fact-Sheet-on-HIV-Estimates.pdf</a>.

7.            Stone A, Harrison PF.  Microbicides – Ways Forward. Alliance for Microbicide Development: Silver Spring, MD, USA. 2010.

8.            Buchbinder SP, Liu A. Pre-exposure prophylaxis and the promise of combination prevention

approaches. AIDS and Behavior. 2011:15,S1:72-79.

9.            Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007;2:e27.

10.          Grohskopf L, Gvetadze R, Pathak S, et al. Preliminary analysis of biomedical data from the phase II clinical safety trial of tenofovir disoproxil fumarate (TDF) for HIV-1 pre-exposure prophylaxis (PrEP) among U.S. men who have sex with men (MSM). Abstract no. FRLBC102, International AIDS Society 2010, Vienna.

11.          AIDS Vaccine Advocacy Coalition. (2012, April). Ongoing and planned pre-exposure prophylaxis (PREP) trials.            Retrieved from http://www.avac.org/ht/a/GetDocumentAction/i/3113

12.          AIDS Vaccine Advocacy Coalition. (2011, May). Oral and topical PrEP trials timeline. Retrieved from http://www.avac.org/ht/d/sp/a/GetDocumentAction/i/3618

13.          Smith DK, Grant RM, Weidle PJ, et al. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbidity and Mortality Weekly Report. 2011;60:65-68.

14.          Centers for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP) for HIV prevention: Promoting safe and effective use in the United States.  February 2011.  <a href="https://web.archive.org/web/20161029012223/http://www.cdc.gov/hiv/prep/pdf/PrEPfactsheet.pdf">http://www.cdc.gov/hiv/prep/pdf/PrEPfactsheet.pdf</a>

15.          Underhill K, Operario D, Skeer MR, et al. Packaging PrEP to prevent HIV: An integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. JAIDS.2010;55:8-13.

16.          Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation Science of Pre-exposure Prophylaxis: Preparing for Public Use. Curr HIV/AIDS Rep 2010;7:210-9.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2013/02/PrEP-Spanish-2013.pdf</url>
	</node>
	<node>
		<title>Intervenciones estructurales</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué papel juegan las intervenciones estructurales en la prevención del VIH?</h3>
<h4>¿qué son las intervenciones estructurales?</h4>
La mayoría de las intervenciones de prevención del VIH tratan con los individuos de a uno por uno. Aún cuando muchas obtienen excelentes resultados, requieren mucho tiempo del personal y benefician a un número limitado de personas. Además, los beneficiarios de las intervenciones pueden sentirse presionados por parte de sus pares (que no reciben las intervenciones) para continuar participando en actividades de alto riesgo. Las intervenciones estructurales modifican o influencian el ambiente social, político o económico de manera que muchas personas se beneficien al mismo tiempo, quizás sin saberlo.<sup>1</sup>

El término “intervenciones estructurales” significa muchas cosas. Las intervenciones estructurales incluyen programas que efectúan cambios en el campo jurídico (frecuentemente con presión o participación comunitaria) para facilitar las conductas seguras, como la venta libre de jeringas. También pueden enfocarse en el contexto social inmediato de la actividad sexual o inyección de drogas, modificando el entorno físico o normativo en el cual éstas suceden. Como ejemplo tenemos los prostíbulos tailandeses que exigen el uso de condones. Las intervenciones estructurales abarcan también los programas que buscan reducir o eliminar la desigualdad de ingresos, el racismo y otras inequidades y formas de opresión que crean vulnerabilidad al VIH/SIDA.
<h4>¿qué estructuras producen riesgo?</h4>
¿Cómo podemos identificar las estructuras o procesos sociales, políticos o económicos que deberán modificarse? Por lo general, lo hacemos estudiando la variación natural entre áreas o grupos, o los experimentos naturales en los cuales las condiciones cambian por motivos que no sean intervenciones relacionadas con el VIH.

Los estudios de la variación natural (naturally-occurring variation) han demostrado que: 1) los países pobres son los más propensos a tener una epidemia generalizada del VIH; 2) los países con mayor desigualdad de ingresos tienen tasas altas del VIH; 3) las políticas importan: los lugares en donde las jeringas se pueden comprar legalmente tienen tasas menores de prevalencia y de
incidencia del VIH entre los usuarios de drogas inyectables (UDI).<sup>2</sup>

Los estudios sobre experimentos naturales indican que: 1) las transiciones sociales y políticas que de otra manera resultarían provechosas (ej. sucesos de los ’90 como la eliminación del sistema de apartheid en Sudáfrica y la terminación de la dictadura en Indonesia) fueron seguidas por grandes brotes del VIH; 2) las guerras aumentan el VIH, las enfermedades transmitidas sexualmente (ETS), la prostitución, la violación, la esclavitud sexual y el uso arriesgado de alcohol y drogas. También llevan a incrementos en el número de parejas sexuales y en la frecuencia de cambio de pareja sexual.<sup>3</sup>
<h4>¿por qué las intervenciones estructurales?</h4>
Muchas veces las intervenciones estructurales abarcan temas que parecen completamente ajenos VIH. Al pensar en la prevención del VIH, por lo general no se considera ni la eliminación de las desigualdades de ingresos la ni de la guerra. Pero estas realidades sociales, políticas y económicas ejercen una influencia enorme sobre las conductas de alto riesgo. Circunstancias sin relación directa con el VIH con frecuencia crean condiciones que promueven la propagación del mismo, haciendo de las intervenciones estructurales una necesidad imprescindible.

Por ejemplo, en los años ‘70 el gobierno de la ciudad de Nueva York cerró las estaciones de bomberos en los barrios pobres habitados por grupos minoritarios. Como consecuencia, los incendios incontrolados destruyeron numerosos edificios, lo cual tuvo efectos muy traumáticos sobre la vida social de los residentes. El uso de drogas inyectables (y después de crack), el alcoholismo, el intercambio sexual, las pandillas y la desmoralización, se extendieron ampliamente. Posteriormente se presentaron brotes de ETS, VIH, tuberculosis y muchas otras enfermedades.<sup>4</sup>

Los gobiernos de los países ricos, incluyendo el de EE.UU., así como los bancos, las grandes empresas y otros integrantes de la élite económica, han perseguido agresivamente una política mundial organizada basada en recortes a la asistencia pública, privatización y competencia. Esto ha provocado el endeudamiento masivo de muchos países en vías de desarrollo, aumentado la desigualdad de ingresos y fomentado la formación de macrociudades en torno a enormes barrios de tugurios. Asimismo, debido a los “programas de ajuste estructural” impuestos por el Fondo Monetario Internacional, muchos países africanos, asiáticos y latinoamericanos se han visto
obligados a recortar substancialmente los servicios de salud y educación. Estas políticas y programas han impedido en gran medida la provisión eficaz de intervenciones preventivas, terapias antirretrovirales y otros servicios médicos para las poblaciones infectadas.<sup>5,6</sup>
<h4>ejemplos de intervenciones estructurales</h4>
En muchos países, gran número de trabajadores sexuales tiene VIH y otras ETS. Tailandia y la República Dominicana han instituido campañas de “condones al 100%” que exigen a los propietarios de los prostíbulos que hagan cumplir el uso de condones durante todo acto sexual. Las campañas buscan el apoyo de los dueños de prostíbulos, de los trabajadores sexuales y, en cuanto sea posible, de los clientes. Estos programas han limitado considerablemente la transmisión del VIH y de las ETS al modificar el contexto social inmediato de la conducta sexual para reducir los incidentes de sexo sin protección.<sup>7,8</sup>

Las leyes de la mayoría de los estados de EE.UU. prohíben la posesión o distribución de jeringas, y muchos estados requieren receta médica para comprar jeringas. Consecuentemente, muchos UDI no llevan jeringas consigo por miedo a ser hostigados o detenidos por la policía. Para encontrar una solución jurídica a este problema, la legislatura de Connecticut aprobó la revocación parcial de las leyes sobre la receta de jeringas y la posesión de artículos para el uso de drogas. El resultado fue que los UDI redujeron en forma dramática su uso de jeringas compartidas y compraron más jeringas en farmacias. Después de la entrada en vigor de las nuevas leyes, el uso de jeringas compartidas bajó del 52% al 31%, la compra en farmacias subió del 19% al 78%, y la compra callejera disminuyó del 74% al 28%.<sup>9</sup>
<h4>¿podemos cambiar las políticas dañinas?</h4>
No es fácil evitar o terminar las guerras, ni las políticas de desarrollo urbano que perjudican a los pobres y a los grupos minoritarios, ni tampoco las políticas sexuales y de drogas que crean ambientes marginados. Sin embargo, los individuos y las comunidades pueden efectuar cambios. Los movimientos de las bases o comunitarios muchas veces son pasos iniciales necesarios para proceder a intervenciones estructurales más amplias. A veces, incluso la formación de dichos movimientos puede ser una intervención estructural.

“Chico Chats,” un programa del Proyecto STOP AIDS en San Francisco, CA, ofreció talleres informativos sobre técnicas de organización y movilización comunitaria. Los participantes formaron un grupo activista llamado ¡Ya Basta! y diseñaron un video y un taller que examinaban el silencio en torno al sexo y la revelación de la homosexualidad en la familia latina. El video se está presentando en comunidades latinas en todo San Francisco.<sup>10</sup>

Organizaciones comunitarias e individuos de varios estados de EE.UU. con tasas altas de VIH entre los UDI, han creado programas de intercambio de jeringas (PIJ). Muchos PIJ han operado ilegalmente y sin apoyo. Las personas que trabajan en los PIJ y otros grupos de activistas políticos han colaborado con los oficiales públicos para invocar políticas “bajo estado de emergencia” que permitan la existencia legal de los PIJ en muchos estados.<sup>11</sup>

Los trabajadores/as sexuales de Calcuta recibieron ayuda de las autoridades de salud pública para organizar un sindicato comunitario que les permite insistir a sus clientes sobre el uso de condón. La prevalencia del VIH entre los trabajadores/as sexuales de Calcuta se ha mantenido menor que en otras ciudades de la India.<sup>12</sup>
<h4>¿qué queda por hacer?</h4>
No se puede ignorar la relación que existe entre los factores estructurales como la marginalización económica, política y social y entre las conductas que ponen a las personas en riesgo de contraer o transmitir el VIH/SIDA y las ETS.<sup>13, 14</sup> Tampoco podemos considerar a las conductas de alto riesgo como si operaran fuera de los contextos social, político y económico. Se necesita un diálogo mas profundo sobre estos temas entre los profesionales del VIH/SIDA.

Una manera de reducir posibles consecuencias negativas por el cambio de los factores estructurales, es exigir que por ley que los programas económicos, de desarrollo urbano y de política extranjera realicen anticipadamente “informes científicos sobre el impacto del VIH/SIDA”. Un primer paso posible es que las propias organizaciones de prevención del VIH investigen y publiquen sus propias “informes de impacto.”<sup>15</sup>

Las instituciones financiadoras deberán tomar en cuenta la amplísima variedad de actividades que constituyen la prevención del VIH. Muchas organizaciones comunitarias responden a todo tema relacionado con el VIH, incluyendo algunos que parecen ajenos. Parte de lo que muchas organizaciones comunitarias atienden diariamente son problemáticas mayores relacionadas con guerra, pobreza, desigualdades sociales (ej. racismo y homofobia) y leyes restrictivas. La ayuda para apoyar y organizar estos esfuerzos puede llevar a la creación de intervenciones estructurales necesarias en la prevención del VIH.

<hr />

<h4>¿quién lo dice?</h4>
1. Friedman SR, O’Reilly K. Sociocultural interventions at the community level.AIDS. 1997; 11:S201-S208.

2. Friedman SR, Perlis T, Lynch J, et al. Economic inequality, poverty, and laws against syringe access as predictors of metropolitan area rates of drug injection and HIV infection. 2000 Global Research Network Meeting on HIV Prevention in Drug-Using Populations. Third Annual Meeting Report. Durban, South Africa, July 5 -7, 2000. 147-149.

3. Hankins CA, Friedman SR, Zafar T, et al. Transmission and prevention of HIV and STD in war settings: implications for current and future armed conflicts.AIDS. 2002:16(17):2245-52.

4. Wallace R. Urban desertification, public health and public order: ‘planned shrinkage’, violent death, substance abuse and AIDS in the Bronx. Social Science and Medicine. 1990;31:801-813.

5. Lurie P, Hintzen P, Lowe RA. Socioeconomic obstacles to HIV prevention and treatment in developing countries: the roles of the International Monetary Fund and the World Bank. AIDS. 1995;9:539-546.

6. Farmer P. Infections and Inequalities: the Modern Plagues. University ofCalifornia Press: Los Angeles. 1999.

7. Celentano DD, Nelson KE, Lyles CM, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS. 1998;12:F29-F36.

8. Roca E, Ashburn K, Moreno L, et al. Assessing the impact of environmental-structural interventions. Presented at the International AIDS Conference,Barcelona, Spain. 2002. Abst #TuPeC4831.

9. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting drug users and police officers–Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes.1995;10:82-89.

10. The STOP AIDS Project. Q Action, ¡Ya Basta! San Francisco, CA. 415/865-0790 x303

11. Gostin LO. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. Journal of Acquired Immune Deficiency Syndromes. 1998;18:S60-70.

12. Piot P, Coll Seck AM. International response to the HIV/AIDS epidemic: planning for success. Bulletin of the World Health Organization. 2001;79:1106-1112.

13. Diaz RM, Ayala G, Marin BV. Latino gay men and HIV: risk behavior as a sign of oppression. Focus. 2000;15:1-5.

14. Friedman SR, Aral S. Social networks, risk potential networks, health and disease. Journal of Urban Health. 2001;78:411-418.

15. Friedman SR, Reid G. The need for dialectical models as shown in the response to the HIV/AIDS epidemic. International Journal of Sociology and Social Policy. (in press).

<hr />

P<strong>reparado por Sam Friedman*, Kelly Knight**
*National Development and Research Institutes, ** CAPS</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Enero 2003. Hoja Informativa 46S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/estructuralesFS.pdf</url>
	</node>
	<node>
		<title>Black men</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are Black Men’s HIV prevention Needs?</h3>
<h4>Who are black men?</h4>
Black and African American men cannot be lumped into a one-size-fits-all category. They are the fathers, brothers, uncles and sons in Black communities. They are doctors and lawyers, barbers and bus drivers; they are Christians and Muslims and speak many languages. However, not every person who looks Black or African American will identify with these labels. In the US, Black men represent a diverse group, including, but not limited to, Afro-Cuban, Caribbean, Brazilian and African national men.
<h4>Why is HIV a concern?</h4>
HIV is currently a major health crisis among Black and African American men of every age and sexual orientation.<sup>1</sup> In 2000, AIDS was the leading cause of death among Black men 35-44 and the third leading cause of death for all Black men 25-44.<sup>2</sup> Rates of HIV are higher among young African American men who have sex with men (MSM) than among any other racial or ethnic group.<sup>2</sup>

HIV/AIDS is not the first health crisis faced by Black men and will not be the last one. Black men face many health disparities and are overrepresented in many diseases such as hypertension, cancer and heart disease. HIV presents a different challenge because it is transmitted through sex and drug use, topics that are difficult to discuss and often stigmatized in many communities.
<h4>What are HIV risk factors?</h4>
The leading cause of HIV infection among African American men is sex with men or women.<sup>1</sup> In this country, we have often confused the sexual behavior and sexual identification of Black men.<sup>3</sup> For example, a Black man who has had sex with women and men may be seen by the CDC’s risk classification as “male-to-male sexual contact,” by researchers as “bisexual” or “MSM,” by newspaper articles as “on the down low,” by activist groups as “same gender loving” or by his partners as “straight.”

Injection drug use is the second most common cause of HIV infection among Black men.<sup>1</sup> Drug abusers often face addiction, poverty, homelessness, stigma, depression, mental illness and past trauma; all of which affect HIV risk such as sharing injection equipment.<sup>4</sup>
<h4>What affects HIV risk?</h4>
We know how HIV is transmitted, be it among Black men or any other man: through unprotected anal or vaginal intercourse with an HIV+ person or sharing injection equipment with an HIV+ person. We know much less about how psychosocial, contextual, political and historical forces influence Black men’s risk taking. Education, employment and incarceration must be addressed, especially with financially marginalized men.

Black and African American men face discrimination in education and employment. Black male children in schools are often characterized as disruptive and are channeled into “special education” classes. This results in fewer Black male youth entering high school.<sup>5</sup> Because of this, Black men often cannot obtain gainful employment, putting them at a significant disadvantage in our technological economy. Lack of employment is linked to increased involvement in activities that can increase risk of HIV infection such as substance use, commercial sex, homelessness and incarceration.

Nearly one-third of all Black men have been incarcerated either as adolescents or adults.<sup>6</sup> Cycling in and out of the prison system can negatively affect Black men’s ability to keep and maintain jobs and relationships. Fewer available Black men in the community means Black couples have less opportunity for long-term monogamy and more chance for multiple partnerships, which may increase the risk of HIV/STD transmission.<sup>7</sup>

In the US there has been a significant history of sexual exploitation and objectification of the Black male. Black men often are referred to by their presumed sexual preoccupation and/or prowess rather than being seen as complex multi-dimensional beings with strengths as well as weaknesses.<sup>8</sup>
What are protective factors?

Many organizations across the country promote strength and bonding among Black men. Fraternities, barber shops, civic groups such as 100 Black Men and others build on the strength of Black men by providing positive role models, promoting African American history and culture and collaborating with businesses and institutions of higher learning.<sup>9</sup>

Family, community and spirituality are important support systems that can protect Black youth from HIV risk. Strong families where parents and adult caregivers
monitor and talk to their children are key to promoting healthy behaviors.<sup>10</sup> The Black church can provide guidance and HIV prevention education, and can set an example by addressing and destigmatizing drug users, homosexuals and HIV+ persons.<sup>11</sup>
<h4>What’s being done?</h4>
African American adolescents in Philadelphia, PA were offered an HIV prevention program addressing both abstinence and safer sex. Abstinence intervention
participants reported less sexual intercourse after 3 months, but not at 6- or 12- month follow-ups. For youth who reported prior sexual experience, those in the safer sex intervention reported less sexual intercourse than those in the abstinence intervention at 3-, 6- and 12-month follow-ups. Both approaches reduced HIV sexual risk behaviors in the short-term, but safer sex interventions may have longer-lasting effects than abstinence interventions, and may be more effective for sexually experienced youth.<sup>12</sup>

People of Color in Crisis (POCC) in Brooklyn, NY, has been active in providing HIV/AIDS prevention and intervention efforts to Black men and women for many years. “Many Men, Many Voices” is an interactive and experiential group intervention designed for gay men of color. Trained facilitators lead six weekly group sessions to help men feel safe and accepted with positive social support.<sup>13</sup>

Concerned Black Men (CBM) is a service organization for males founded and run by Black men to provide positive role models for Black children. CBM has 21 chapters across the US that offer programs for preventing violence, substance use, school drop-out, pregnancy and STDs/HIV, as well as promoting self-esteem, conflict resolution and planning for higher education.<sup>14</sup>

The Down Low Barbershop Project works with barbers/stylists in Black communities to provide Black men with HIV education and condoms, and referrals for free HIV counseling and testing. Barbers receive two 8-hour HIV prevention trainings, then recruit ten of their clients for a 4-hour training. Barbershop owners, barbers and clients are all paid for their involvement and clients who attend receive a coupon for a free haircut. The Down Low Barbershop Project takes place through Brother to Brother in Seattle, WA and Us Helping US in Washington, DC.<sup>15</sup>
What needs to be done?

HIV prevention agencies must acknowledge underlying cultural and social factors in the Black community.<sup>16</sup> There is a broadening gap between haves and have-nots, with the majority of HIV risk and infections occurring in low-income communities. Programs need to address issues of employment, education, incarceration, addiction and stigma in addition to sexual and drug risk behaviors.

In order to provide a comfortable atmosphere for open discussion about sensitive sexual and drug use issues, research and prevention programs should take place in familiar settings away from clubs, bars or other sexually-identified venues. <sup>17</sup> Collaborating with cultural, religious and civic organizations that historically reach Black men can help recruit and involve Black men.<sup>18</sup>

Prevention programs should link with other programs such as drug treatment, violence prevention, scholastic enrichment, family planning, cultural strengthening and business organizations to help support Black men as a whole, working with the richness and complexities of modern Black male life.
<h4>Says who?</h4>
1.Centers for Disease Control and Prevention. HIV/AIDS among African Americans. 2003.http://www.cdc.gov/hiv/topics/aa/resources/factsheets/aa.htm
2. Key Facts: African Americans and HIV/AIDS. Report published by the Kaiser Family Foundation. September 2003.http://www.kff.org/hivaids/hiv6090chartbook.cfm
3. Beatty LA, Wheeler D, Gaiter J. HIV prevention research for African Americans: current and future directions. Journal of Black Psychology. 2004;30:40-58.
4. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness and incarceration. Public Health Reports. 2002;117: S135-S145.
5. Davis JE. Early schooling and academic achievement of African American males. Urban Education. 2003;38:515-537.
6. Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. American Journal of Public Health. 2003;93:759-763.
7. Adimora A, Schoenbach VJ. Contextual factors and the Black-White disparity in heterosexual HIV transmission. Epidemiology. 2002;13:707-712.
8. Whitehead TL. Urban low-income African American men, HIV/AIDS, and gender identity. Medical Anthropology Quarterly. 1997;11:411-447.
9. Bailey DF, Paisley PO. Developing and nurturing excellence in African American male adolescents. Journal of Counseling and Development. 2004;82:10-17.
10. “This is my reality–the price of sex: an inside look at Black urban youth sexuality and the role of the media.” Report published by Motivational Educational Entertainment. January 2004.http://www.meeproductions.com/store/youthSexuality.cfm
11. Miller RL. African American churches at the crossroads of AIDS. FOCUS. 2001;10:1-5.
12. Jemmott JB III, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial. Journal of the American Medical Association. 1998;279:1529-1536. http://www.cdc.gov/hiv/pubs/hivcompendium/section1-20.htm
13. People of Color in Crisis (POCC), Brooklyn, NY. http://www.pocc.org/
14. Concerned Black Men, Washington, DC. http://www.cbmnational.org/
15. Sanders E. Seattle HIV program enlists barbershops: Black men get a trim and a frank discussion. The Boston Globe. January 1, 2004.
The Down Low Barbershop Program: www.ushelpingus.com.
16. Darbes LA, Kennedy GE, Peersman G, et al. Systematic review of HIV behavioral prevention research in African Americans. The Cochrane Review. March 2002.
17. Malebranche DJ. Black men who have sex with men and the HIV epidemic: next steps for public health. American Journal of Public Health. 2003;93:862-865.
18. Summerrise R, Wilson W. “The Black Print” model for recruitment of African-American males. Published by the Chicago, IL, Prevention Planning Group. 2000.

Prepared by Darrell P. Wheeler, PhD, MPH, ACSW; Hunter College, NY

July 2004. Fact Sheet #54E

Special thanks to the following reviewers of this Fact Sheet: Juan Battle, Leonard Dawson, Jr, Beth Freedman, David Malebranche, JE Miles, Jr, Robert
Miller, Greg Millet, Stephen Oxendine, George Roberts, Dan Wohlfeiler.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © July 2004, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2011/01/BlackmenFS.pdf</url>
	</node>
	<node>
		<title>Gay men (MSM)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3><strong>What are men who have sex with men’s (MSM) HIV prevention needs?</strong></h3>
<h3>What do MSM need?</h3>
Men who have sex with men (MSM) are not a single homogenous group, but represent a wide variety of people, lifestyles and health needs. From middle class gay men, to homeless runaways, to injection drug users (IDUs) to incarcerated men, MSM have many different identities and associated risks for HIV and other infectious diseases. MSM refers to any man who has sex with a man, whether he identifies as gay, bisexual or heterosexual. Despite success in changing sexual behaviors, MSM continue to be disproportionately affected by HIV/AIDS. MSM account for the largest percentage of persons with AIDS in the US (53%), even as the percentage of AIDS cases among IDUs (25%) and heterosexuals (10%) has increased.1 In 1997, the prevalence rate of HIV for MSM in 4 urban communities was 17% overall, 29% for African-American MSM and 40% for MSM-IDUs.2 HIV is not an issue that exists by itself, but is woven into many aspects of men’s lives. Risk for HIV is embedded in many other core issues such as dating and intimacy, sexual desire and love, as well as alcohol and recreational drug use, homophobia, abuse and coercion, racism and self-esteem.3 HIV prevention programs must be informed by of all these elements
<h3>Sexual health</h3>
There is not enough sexuality education for young people in the US, and almost no samegender sexuality education. Like many teenagers, young MSM may only learn about sex through distorted media or pornographic images. In general, men in today’s society are pressured to prove their manhood through sexual activity and aggressiveness, while women receive messages on moderation and caretaking. Given this, many MSM face additional challenges learning about dating, intimacy and forming relationships, or about desire, sexual functioning and arousal. Discomfort with one’s sexuality and identity can lead to sexual risk taking.4 In Minnesota, “Man-to-Man: Sexual Health Seminars” are based on the sexual health model. This model assumes that if MSM are more sexually literate, comfortable and competent, they are more likely to be able to reduce risk in the context of sexual behaviors and relationships. The program uses comprehensive sexuality education, cultural specificity and empirical research to help MSM reduce HIV risk long-term. The program was effective in reducing internalized homonegativity and unprotected anal intercourse.5 HIV is not the only sexual health concern for MSM. Other sexually transmitted diseases (STDs) such as herpes and genital warts can negatively affect health and sexuality. Several states have seen an increase in drug-resistant gonorrhea among MSM, making it more difficult to treat.6
<h3>Homophobia, racism and self esteem</h3>
Homophobia and racism are prevalent in the US. Internal and external homophobia and racism can lead to low self-esteem, which can lead to increased risk behavior such as sexual aggression, difficulty negotiating safer sex, and drug or alcohol abuse. MSM of color are disproportionately affected by many social and health-related ills such as HIV. African American and Latino MSM are more likely than their White counterparts to engage in high-risk activities and to be HIV-infected. Social and cultural factors may limit the ability of MSM of color to protect themselves from HIV. A study of Latino gay men in urban centers found that men who reported high-risk behavior also reported significantly higher rates of financial hardship, experiences of racism and homophobia, incidence of domestic violence and a history of coercive childhood sexual abuse.7 Hermanos de Luna y Sol, an HIV prevention intervention for Latino gay/bisexual men in San Francisco, CA, deals with the common history of oppression among Latino gay men, including issues of homophobia, machismo, sexual abuse, racism and separation from family and culture.8 In Washington, DC, US Helping US (UHU) is a multi-modal prevention program for Black MSM that addresses the psychological and emotional stress that they may experience as racially and sexually oppressed minorities. UHU provides mental health services, community building and anti-homophobia social marketing.9
<h3>Alcohol and recreational drug use</h3>
The prevalence of drug use is higher among MSM than among heterosexuals,10 although decreases recently have been noted in all alcohol and drug use categories except amphetamines.11 In many areas of the US, gay bars--often sex-charged environments where alcohol and drugs are prevalent--are the only venues for MSM to meet and socialize with each other. Drug use may vary greatly by region and subculture. Substance use puts MSM at risk for HIV for several reasons: 1) MSM-IDUs are at risk if they share infected injection equipment; 2) substance use is associated with high risk sexual behavior; 3) background HIV prevalence rates are higher for MSM-IDUs and MSM who abuse drugs but do not inject, increasing the likelihood of transmission.12 Substance use can serve as a trigger or an excuse for unprotected sex. Some MSM have trouble having sex without getting high first; others prefer having sex while high, believing recreational drugs increase their libido. For some MSM, drug use provides a sense of community and bonding at gay clubs and circuit parties. A survey of MSM who attend circuit parties found that serodiscordant unprotected anal sex was more likely to occur among men who used amphetamines (speed), Viagra and amyl nitrites (poppers).13 For many MSM-IDUs, drug use, rather than sexual orientation, forms their personal identity. Many MSM-IDUs identify as heterosexual. Too often MSM-IDUs are missed in prevention programs that target MSM but leave out IDUs, or programs that target IDUs but don’t address sexual orientation. MSM-IDUs have high rates of HIV infection, high frequency of unprotected sex and high rates of poverty, addiction and its related social and physical ills.12 The Stonewall Project in San Francisco, CA is a harm reduction program for MSM who use speed. The project provides education and assistance and has been successful at reaching MSM of different sexual and social identities.14 Across the US, several cities have opened social centers for gay men where no alcohol is served and drugs are not allowed. One HIV prevention program for young gay men helps develop community centers where young men can socialize without alcohol.15
<h3>What is sexual risk?</h3>
The perception of sexual risk for HIV varies among MSM and may change from one sexual situation to another. Throughout the HIV epidemic, MSM have engaged in sophisticated decision-making about what they consider to be risky.16 Some men decide for themselves it is OK to not use a condom if they are the top (insertive partner), if they are having oral sex or if their or their partner’s viral load is undetectable. MSM may make these decisions because the scientific evidence of HIV risk is cloudy, or simply because they are comfortable with some level of risk. HIV prevention programs should help MSM to make realistic and healthy choices based on factual information. MSM have engaged in a hierarchy of strategies for maintaining safer sex that are fluid and context-dependent. Most MSM are able to manage sexual risk with effective strategies such as monogamy with concordant partners, consistent condom use with repeated testing, condom use outside of relationship or abstinence. Other MSM use strategies that are not known to be effective (see above paragraph). A small minority of MSM choose to engage in known risk activities such as unprotected anal intercourse without knowledge of partner serostatus. Unprotected anal intercourse between an HIV+ and an HIV- man remains the greatest risk for HIV transmission among MSM. This has proven to be the biggest challenge for HIV prevention. The intimacy of skin-to-skin contact during intercourse is a powerful and important draw. Many MSM feel their sexual identity, as well as the hard-won goals of gay sexual liberation, are based on having sex--including anal intercourse--in a free and unconstricted manner. A majority of MSM consistently manage sexual risk, yet there is little understanding or research of men who are largely safe, and how their values of nurturance and caretaking, ethics, hopes for collective survival, or relations with friends and community help support them. Only recently have HIV+ MSM been targeted with messages and programs featuring “prevention altruism” that make use of MSM’s strengths. HIV prevention efforts need broader, more emotionally-resonant concepts that build on what is good in MSM’s lives.17

<hr />

<h3>Says who?</h3>
<ol>
 	<li>Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2000;12.</li>
 	<li>Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men. American Journal of Public Health. in press.</li>
 	<li>Seal DW, Kelly JA, Bloom FR, et al. HIV prevention with young men who have sex with men: what young men themselves say is needed. AIDS Care. 2000;12:5-26.</li>
 	<li>Robinson BE, Bockting W, Rosser BRS, et al. The sexual health model: a sexological approach to long-term HIV risk reduction. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #ThPeD5613.</li>
 	<li>Rosser BRS, Bockting WO, Rugg DL, et al. A sexual health approach to long-term HIV risk reduction among men who have sex with men: results from a randomized controlled intervention trial. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #WePeD4718.</li>
 	<li>Altman LK. Gonorrhea shows its resistant side; disease control agency tells doctors of new recommendations. Milwaukee Journal Sentinel. October 2, 2000. p. 5G.</li>
 	<li>Diaz RD, Ayala G, Bein E. Social oppression, resiliency and sexual risk: findings from the national Latino gay men’s study. Presented at the National HIV Prevention Conference, Atlanta, GA, Aug 29-Sep 1, 1999. Abst#287</li>
 	<li>Díaz RM. Latino Gay Men and HIV: Culture, Sexuality, &amp; Risk Behavior. NY:Routledge. 1998.</li>
 	<li>Simmons R. Towards developing a comprehensive program for effective HIV prevention among racially oppressed gay men, bisexuals and MSM. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #TuPeD3839.</li>
 	<li>Stall R, Wiley J. A comparison of alcohol and drug use patterns of homosexual and heterosexual men: the San Francisco men’s health study. Drug Alcohol Dependency. 1988;22:63-73.</li>
 	<li>Crosby M, Stall R, Paul J, et al. Alcohol and drug use patterns have declined between generations of younger gay/bisexual men in San Francisco. Drug and Alcohol Dependence. 1998;52:177-182.</li>
 	<li>Rhodes F, Deren S, Wood MM, et al. Understanding HIV risks of chronic drug-using men who have sex with men. AIDS Care. 1999;11:629-648.</li>
 	<li>Colfax G, Mansergh G, Vittinghoff E, et al. Drug use and high-risk sexual behavior among circuit party participants. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #TuPeC3422.</li>
 	<li>Stonewall Project. 415/502- 1999.</li>
 	<li>Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study. AIDS. 1999;13:1753-1762.</li>
 	<li>Williams AM. Condoms, risk and responsibility. Presented at the HIV Prevention Summit, Half Moon Bay, CA, June 2000.</li>
 	<li>Nimmons D. In this together: the limits of prevention based on self-interest and the role of altruism in HIV safety. Journal of Psychology &amp; Human Sexuality. 1998;10:75-87</li>
</ol>

<hr />

Prepared by Michael Crosby PhD and Pamela Decarlo, CAPS

<strong>December 2000</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/MSMFS.pdf</url>
	</node>
	<node>
		<title>Latino gay men in the US</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are the HIV prevention needs of Latino gay men in the US?</h3>
Fact Sheet 28, March 2012
<h4>Why focus on Latino gay men?</h4>
The ever changing mosaic of Latino demographics in the US creates unique challenges to address health disparities of the population, especially when it comes to HIV prevention needs.  Latinos are the largest and fastest growing ethnoracial minority group in the US, experiencing a 43% growth between 2000 and 2010<sup>1</sup>. Data also show that Latinos are one of the fastest growing populations at risk for HIV transmission:
<ul>
 	<li>Latino men who have sex with men (MSM<sup>*</sup>) represent 81% of new infections among Latino men, and 19% among all MSM<sup>2,3</sup></li>
 	<li>Latinos are 16% of the US population, but make up 17% of living HIV/ AIDS cases and 20% of new HIV infections each year<sup>3 </sup></li>
 	<li>Youth (ages 13-29) accounted for 45% of new HIV infections among Latino MSM<sup>4</sup></li>
</ul>
In light of these data there is a need to identify culturally-specific health concerns of Latino gay men so that effective interventions may be developed to address current and prevent future disparities. The US National HIV/AIDS Strategy highlights the call for HIV programs that reduce health inequities among both ethnoracial and sexual minority populations<sup>5</sup>.  Latino gay men have distinct cross-cultural identities that place them into both prioritized categories<sup>6</sup>.
<h4>What are the prevention challenges?</h4>
Most work related to Latino gay men has been based on a sociocultural model of health, which shows that experiences of social discrimination, defined as racism, homophobia and poverty, are strong predictors of mental health outcomes<sup>7</sup>. Mental health outcomes, such as psychological distress, have been shown to increase sexual risk and decrease sexual resiliency. A recent study of Latino MSM living in New York and Los Angeles<sup>8</sup> reported that:
<ul>
 	<li>Over 40% of the participants reported experiences of both racism and homophobia in the past year</li>
 	<li>Low self-esteem and decreased levels of social support among Latino gay men are associated with increased rates of sexual risk behaviors, including unprotected anal sex</li>
 	<li>Men who had both homophobic and racist experiences were more likely than men who reported no form of discrimination to engage in unprotected anal sex as a bottom, and to also be binge drinkers</li>
</ul>
Late testing (that is, those individuals who have an AIDS diagnosis within one year of testing HIV-positive) and lack of access to health insurance also create challenges to prevention, treatment and care.
<ul>
 	<li>38% of Latinos test late in their illness<sup>9</sup>.</li>
 	<li>In a study of 21 major US cities, 46% of Latino MSM who tested positive for HIV were unaware of their infection<sup>3</sup>.</li>
 	<li>HIV+ Latinos are more likely than Whites to postpone care due to issues such as lack of transportation, and more likely to delay initiation of care after their diagnosis<sup>9</sup>.</li>
 	<li>24% of Latinos living with HIV/ AIDS are uninsured, compared to 17% of Whites; and only 23% of HIV+ Latinos have private health insurance, compared to 44% of Whites<sup>10</sup>.</li>
</ul>
Reviews of research with Latino gay and bisexual men also report that cultural influences and socioeconomic forces impact sexual well being. For example, residency status, HIV-related stigma, machismo, immigration and migration patterns, language, insurance status and educational attainment have all been associated barriers to HIV prevention services and programming<sup>11, 12</sup>
<h4>What other factors affect sexual risk and resiliency?</h4>
Latino gay men are often faced with unique socio-sexual situations that place them at risk for HIV transmission. Prior work with MSM populations, including Latino gay men, has documented that various factors are associated with sexual-risk:
<ul>
 	<li>Serosorting (choosing sexual partners based on perceived HIV status), seropositioning (choosing sexual roles [e.g., top or bottom] based on the perceived HIV status of each partner), and sexual stereotypes and preferences<sup>13</sup></li>
 	<li>Alcohol and drug use (including methamphetamine and injection use), as well as having had a history of STDs, like syphilis and gonorrhea<sup>14,15</sup></li>
 	<li>High rates of condomless anal sex (“barebacking”) and multiple partners<sup>16</sup></li>
 	<li>Childhood sexual abuse and a social context of discrimination<sup>17</sup></li>
</ul>
Defined as adopting cultural ways of mainstream society, work on acculturation suggests that: Latinos who are less acculturated to mainstream US culture are protected by traditional Latino (sexual) values; and that acculturation of US mainstream values serves as a protective barrier because it increases a sense of individualism and self-determination<sup>18</sup>

Understanding the role of sociocultural factors helps to refine definitions of sexual resiliency among Latino gay men. Innovative work exploring protective factors among Latino gay men notes that:

HIV prevalence was higher among US born than non-US born Latinos in San Francisco, while in Chicago the opposite was true<sup>19</sup>
<ul>
 	<li>Community involvement moderates sexual risk behaviors<sup>20</sup></li>
 	<li>Volunteering with HIV/ AIDS organizations can decrease psychological stressors<sup>20</sup></li>
</ul>
As the majority of these data came from quantitative surveys, more public health focused qualitative studies are needed to further examine the context of the sexual situations in which Latino gay men find themselves, as well as the cultural factors and sexual scripts<sup>21</sup> that influence their harm reduction behaviors.
<h4>What is being done?</h4>
<ul>
 	<li>Hermanos de Luna y Sol, born out of the Mission District in San Francisco, CA is a longstanding HIV prevention intervention for immigrant Spanish speaking Latino gay and bisexual men that is based on empowerment education and social support, and has been successful in increasing condom use among participants<sup>22</sup>.</li>
 	<li>Latinos D (based in Queens, NY<sup>23</sup>) and Somos Latinos Salud (based in Ft. Lauderdale, FL<sup>24</sup>) are dynamic and promising adaptations of the MPowerment program, an effective community-level, evidence-based HIV intervention for young gay and bisexual men<sup>25</sup>.</li>
 	<li>SOMOS, a homegrown and culturally responsive NYC-based HIV prevention program, has been shown to lower risk behaviors and decrease number of sexual partners among Latino gay men<sup>26</sup>.</li>
</ul>
Still, even with these programs and CDC recommendations to address Latino MSM health disparities, most adaptations of evidence-based interventions have largely been linguistically, but not necessarily culturally, translated versions of established programs.
<h4>What are the recommendations?</h4>
<ul>
 	<li>Celebrate the diversity of Latino cultures in programming. Different experiences of historical events, political environments, immigration patterns and regional cultures exist within Latino communities (e.g., Chicanos in Los Angeles, Nuyoricans in New York, Tejanos in San Antonio).</li>
 	<li>Conduct more research on structural and environmental influences on Latino gay men’s sexual health including issues relating to undocumented HIV+ Latinos.</li>
 	<li>Understand that serving populations is not the same as being culturally competent. Including Latino participation does not equate to providing appropriate services.</li>
 	<li>Cultivate Latino gay community collaboration and empowerment by ensuring that Latino gay men participate in local HIV prevention and care planning councils.</li>
 	<li>Develop programs that address the unique concerns of both immigrants and U.S. born Latino gay men. Assuming that all Latino gay men are monolingual Spanish speakers minimizes the needs of bicultural (but not necessarily bilingual) Latino gay men.</li>
 	<li>Reduce gay-related and HIV-related stigmas in Latino communities. Breaking sexual silences will help promote healthy sexual identity development.</li>
 	<li>Work with policy makers and political stakeholders to advocate for sustainable health care access.</li>
 	<li>Highlight social norms and cultural values that enhance sexual resiliency. Focusing solely on risk factors leads to limited insights and opportunities for interventions.</li>
 	<li>Foster programs that address the impact of isolation and identity validation. Lessening stressors that Latino gay men face will improve their overall well-being.</li>
</ul>

<hr size="2" />

<h3><strong>Says who?</strong></h3>
1 US Census Bureau (2011).  Overview of Race and Hispanic Origin: 2010 – U.S. Census Bureau. http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.

2 CDC. (2011). CDC Fact Sheet: HIV and AIDS among Latinos. http://www.cdc.gov/nchhstp/newsroom/docs/FastFacts-Latinos-FINAL508COMP.pdf.

3 CDC. (2008).  HIV Surveillance in Men Who Have Sex with Men (MSM). http://www.cdc.gov/hiv/topics/surveillance/resources/slides/msm/index.htm.

4 Prejean J, et al. (2011). Estimated HIV Incidence in the United States, 2006-2009. PLoS ONE.

5 ONAP. (2010). National HIV/AIDS Strategy: Federal Implementation Plan. http://www.whitehouse.gov/files/documents/nhasimplementation.pdf.

6 Diaz, RM (1998). Latino gay men and HIV: culture, sexuality, and risk behavior. Routledge.

7 Díaz RM, et al. (2001). The impact of homophobia, poverty, and racism on the mental health of gay and bisexual Latino men: findings from 3 US cities. Am J Public Health. 91(6):927-932.

8 Mizuno Y, et al. (2011). Homophobia and Racism Experienced by Latino Men Who Have Sex with Men in the United States: Correlates of Exposure and Associations with HIV Risk Behaviors. AIDS Behav. [Epub ahead of print]

9 CDC. (2011). HIV Surveillance Report, Vol. 21.

10 RAND. (2011). HIV Cost and Services Utilization Study (HCSUS). http://www.rand.org/health/projects/hcsus.html.\

11 Zea MC, et al. (2004). Methodological issues in research on sexual behavior with Latino gay and bisexual men.  Am J Community Psychol. 31(3-4):281-291.

12 National Latino AIDS Awareness Day. HIV/ AIDS and Latino/ Hispanic men who have sex with men. http://www.nlaad.org/resources/key_facts_latino_msm.php.

13 Rosenberg ES, et al. (2011). Number of casual male sexual partners and associated factors among men who have sex with men: results from the National HIV Behavioral Surveillance system. BMC Public Health. 25: 11-89.

14 CDC. (2010). HIV among Hispanics/ Latinos. http://www.cdc.gov/hiv/hispanics/resources/factsheets/pdf/hispanic.pdf.

15 Balan IC, et al. (2009). Intentional Condomless Anal Intercourse Among Latino MSM Who Meet Sexual Partners on the Internet. AIDS Educ Prev. 21(1): 14-24.

16 Diaz RM et al. (2005). Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. Journal of Urban Health. 82(Supp1): 71-78.

17 Arreola SG, et al. (2009). Childhood sexual abuse and the sociocultural context of sexual risk among adult Latino gay and bisexual men. Am J Pub Hlth. 99 Suppl 2:S432-8.

18 Abraído-Lanza AF, et al. (2005). Do healthy behaviors decline with greater acculturation? Implications for the Latino mortality paradox. Soc Sci Med. 61:1243–1255.

19 Ramirez-Valles J, et al. (2008) HIV Infection, Sexual Risk, and Substance Use among Latino Gay and Bisexual Men and Transgender Persons. American Journal of Public Health. 98: 1036-1042.

20 Ramirez-Valles J (2002). The proactive effects of community inolvment for HIV risk behavior: A conceptual framework. Health Education Research. 17(4): 389-403.

21 Carrillo H, et al. (2008). Risk across borders: Sexual contexts and HIV prevention challenges among Mexican gay and bisexual immigrant men. Findings and recommendations from the Trayectos Study (Monograph). San Francisco: UCSF and SFSU. /sites/prevention.ucsf.edu/files/uploads/projects/Trayectos/monograph/index.html.

22 Hermanas de Luna y Sol. /sites/prevention.ucsf.edu/files/resources/project-websites/hermanos-de-luna-y-sol.

23 Latinos Diferentes. https://www.facebook.com/LatinosD.

24 Latinos Salud – Somos. http://www.latinossalud.org

25 Mpowerment. http://mpowerment.org.

26 Vega MY, et al. (2011). SOMOS: evaluation of an HIV prevention intervention for Latino gay men. Health Educ Res. 26(3):407-418.

<hr size="2" />

<strong>Prepared by Gabriel R. Galindo DrPH, UCSF Center for AIDS Prevention Studies</strong>

Fact Sheet 28, March 2012

Special thanks to the following reviewers of this Fact Sheet: Ana F. Abraido-Lanza, Sonya Arreola, Maricarmen Arjona, George Ayala, Alida Bouris, Hector Carrillo, Rafael Diaz, Lizette Rivera, Ramon Ramirez and Jesus Ramirez-Valles.

<hr size="2" />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Francisco should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © July 2012, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2012/09/Latino-gay-men-in-the-US.pdf.pdf</url>
	</node>
	<node>
		<title>Transgender men</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are transgender men’s HIV prevention needs?</h3>
Prepared by Jae Sevelius, CAPS; Ayden Scheim and Broden Giambrone,
Gay/Bi/Queer Trans Men’s Working Group, Ontario Gay Men’s Sexual Health Alliance

Fact Sheet 67 – Revised September 2015
<h4>Who are transmen?</h4>
Transgender (‘trans’) is an umbrella term for people whose gender identity and expression do not conform to norms and expectations traditionally associated with their sex assigned at birth. Transgender men, or transmen, are people who were assigned ‘female’ at birth and have a male gender identity and/or masculine gender expression. Transgender people may self-identify and express their gender in a variety of ways and often prefer certain terms and not others. Some who transition from female to male do not identify as transgender at all, but simply as men. In general, transmen should be referred to with male pronouns. However, if you are unsure it is best to respectfully ask a person what terms and pronouns they prefer.

Accurate information about the diversity of transmen’s bodies is not widely available. Transmen have different types of bodies, depending on their use of testosterone and gender confirmation surgeries (which may include chest reconstruction, hysterectomy, metoidioplasty, phalloplasty<sup>1</sup>, etc.; see www.ftmguide.org for further information). Transmen use a broad range of terms and language to identify their sex/gender, describe their body parts, and disclose their trans status to others. For instance, some transmen are not comfortable with the terms ‘vagina’ and ‘vaginal sex’ and may prefer ‘front hole’ and ‘front sex’ or ‘front hole sex’, although this is not true for all transmen. This diversity creates unique needs and barriers for negotiating and adhering to safer sex practices that are not addressed by current HIV prevention programs.
<h4>What do we know about HIV and transmen?</h4>
The transgender community is diverse and not enough research has been conducted with trans people in general. We have very limited information about transmen in particular. To date, research related to HIV among trans people has almost exclusively focused on transwomen (people who were assigned ‘male’ at birth and have a female gender identity and/or feminine gender expression). However, there is evidence that there is a significant subgroup of transmen that engage in unprotected sex with non-trans men (trans MSM), including some transmen who engage in sex work.

Several cities have conducted needs assessments that focus on or are inclusive of transmen and HIV risk, such as Philadelphia, Washington D.C, San Francisco, and the province of Ontario. The few published studies that report HIV rates among samples of transmen have reported 0–3% prevalence.<sup>2,4</sup> These rates are self-reported, however, and are based on small, non-representative samples, so we do not have conclusive data about the actual rates. Due to the assumption of low rates of HIV among transmen relative to other high-risk groups, there has not been much research on risk behaviors among transmen.

We do know that HIV prevention messages are not reaching most transmen.<sup>5</sup> We also know that many trans MSM seek services at gay men’s organizations, where there is little to no education for transmen and their non-trans male partners.<sup>4</sup> Providers are generally not trained to identify or serve gay and bisexual transmen in culturally sensitive ways or understand their specific risks and prevention needs.
<h4>What <em>don’t</em> we know about HIV and transmen?</h4>
We do not have enough information about HIV and transmen. Data collection methods at testing sites do not accurately identify and track transmen or capture their experiences, which contributes to the lack of clarity around HIV rates among transmen.

Rates of HIV and sexual risk behaviors among transmen are also not well understood because transmen are often assumed to be primarily having sex with non-trans women. However, transmen, like other men, can be of any sexual orientation and may have sex with different types of partners, including (but not limited to) non-trans men, transgender women, and transgender men.<sup>6,7</sup>
<h4>What puts transmen at risk?</h4>
In one study, a majority of trans MSM reported not using condoms consistently during receptive anal and/or frontal (vaginal) sex with non-trans male partners and low rates of HIV testing and low perception of risk.<sup>4</sup> In urban areas where HIV prevalence rates among non-trans MSM are estimated to be 17-40% and STI rates are increasing, trans MSM who engage in unprotected receptive anal and/or frontal (vaginal) intercourse with non-trans MSM may be especially vulnerable to HIV/STIs.<sup>8,9</sup>

Transmen may face complicated power and gender dynamics in their sexual relationships with non-trans men.<sup>4</sup> For some trans MSM, having sex with a non-trans gay male partner is a powerful validation of their gay/queer male identity, especially in the early years of transition, and may be more important than insisting on condom use. Some transmen who use testosterone have reported increased sex drive and increased interest in sex with non-trans men after beginning hormone use, which may contribute to their willingness to take sexual risks.<sup>4,10</sup> Transmen on testosterone and/or who have had a hysterectomy may have frontal (vaginal) dryness, which increases their risk for frontal (vaginal) trauma during penetration, thus increasing their risk for STIs, including HIV.<sup>10</sup>

Low self-esteem may contribute to sexual risk-taking among transmen. Rates of depression, substance use, and suicide attempts are high in this population, but multiple barriers exist to accessing culturally competent support and treatment.<sup>3,11</sup>

Drug and alcohol use is a major risk factor for every community, regardless of their gender identity. Transmen may use alcohol or drugs to enhance sexual experiences or help to relieve anxiety about their bodies during sex.<sup>4</sup> Some transmen may feel pressure to use drugs in order to fit into some gay men’s communities or subcultures. Although we have very little information about needle sharing for hormone or drug use among transmen, it may also be a risk factor for some.
<h4>What can help?</h4>
<strong>Online dating.</strong> Many transmen meet their non-trans male sexual partners on the Internet. Meeting partners through personal ads may allow transmen to describe their body and gender identity upfront (if they choose to do so) and discuss safer sex with potential partners before meeting in person.<sup>4</sup>

<strong>Educational materials for non-trans partners.</strong> Transmen’s non-trans male partners often do not have experience with transmen nor access to education about sex with transmen, which can lead to misconceptions about safer sex. For non-trans gay men, safe sex often simply means condom use with anal sex and they may not be aware of the risks associated with frontal (vaginal) sex. See the next section for information on available materials.

<strong>Greater visibility in the gay community.</strong> Gay and bisexual men need to be educated about the presence of transmen in their community. Increasing visibility and knowledge about transmen may help create a welcoming environment, help increase inclusivity, and help transmen feel more powerful in their relationships with non-trans men.<sup>7</sup>
<h4>What’s being done?</h4>
tm4m (tm4m.org) is a San Francisco-based project for transmen who play with men (or want to). They provide information, education, and support to transmen who have sex with men through monthly educational workshops and discussion groups, informational materials and continuously working to foster acceptance and build community. tm4m is a collaborative effort co-sponsored by Eros, Trannywood Pictures and TRANS:THRIVE (a program of the API Wellness Center).

The Gay/Bi/Queer Trans Men’s Working Group in Ontario has conducted a needs assessment with trans MSM, developed a sexual health resource<sup>12</sup>, and a website at www.queertransmen.org. They are also providing training and consultation about trans MSM inclusion for prevention workers serving gay men across the province.

All Gender Health Online is a study exploring the sexual health of non-transgender men who have sex with transgender people. The results will be used to develop an online intervention to prevent the spread of HIV and promote the sexual health of transgender people and their partners.

The STOP AIDS Project in San Francisco, CA strives to include transmen in their programming and community education. They include transgender men in their mission statement and have changed their data collection methods to better reflect varying bodies and gender identities in gay men’s communities.
<h4>What needs to be done?</h4>
We need to implement more inclusive data collection methods to better capture subgroups of transgender people. HIV prevention and care providers should not assume that all men they see were assigned ‘male’ at birth. You cannot tell if a guy is trans just by looking at him. The best method for data collection is a two-part question: 1) ask about current gender identity and 2) ask what sex was assigned at birth.<sup>13</sup> If unsure, programs should ask transmen for their preferred name and pronoun and use those terms.

If rates of HIV among transmen are indeed low, we now have the opportunity to engage in true prevention work to keep those numbers low. Gaining a better understanding of transmen’s risk behaviors and the different ways that they protect themselves will aid in providing appropriate and effective HIV prevention education to transmen and their sexual partners.

<hr />

<h3>Says who?</h3>
1. It is important to note that few transmen have fully functional penises, primarily due to the relatively low rates of surgical success, high rates of complications, and the extremely high cost.

2. Herbst J, Jacobs E, Finlayson T, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: A systematic review.AIDS and Behavior. 2007.

3. Clements-Nolle K, Marx R, Guzman R, et al. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: Implications for public health intervention. American Journal of Public Health. 2001;91:915-921.

4. Sevelius J. ‘‘There’s no pamphlet for the kind of sex I have’’: HIV-related risk factors and protective behaviors among transgender men who have sex with non-transgender men. Journal of the Association of Nurses in AIDS Care. 2009;20:398-410.

5. Hein D, Kirk M. Education and soul-searching: The Enterprise HIV prevention group. In: Bockting W, &amp; Kirk, S., editor. Transgender and HIV: Risks, prevention, and care. Binghamton, NY: The Haworth Press; 2001. p. 101-117.

6. Schleifer D. Make me feel mighty real: Gay female-to-male transgenderists negotiating sex, gender, and sexuality. Sexualities 2006;9(1):57-75.

7. Bockting W, Benner A, Coleman E. Sexual identity development among gay and bisexual female-to-male transsexuals: Emergence of a transgender sexuality. Archives of Sexual Behavior. 2009;38(5).

8. Colfax G, Coates T, Husnik M, Huang Y, Buchbinder S, Koblin B, et al.Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health. 2005;82:i62-i70.

9. CA Department of Health Services. California HIV counseling and testing annual report: January – December 2003. Sacramento, CA: Office of AIDS; 2006.

10. Gorton N, Buth J, Spade D. Medical therapy and health maintenance for transgender men: A guide for health care providers: Lyon-Martin Women’s Health Services; 2005.

11. Newfield E, Hart S, Dibble S, Kohler L. Female-to-male transgender quality of life. Quality of Life Research 2006;15(9):1447-57.

12. Gay/Bi/Queer Transmen’s Working Group of the Ontario Gay Men’s HIV Prevention Strategy. Primed: The Back Pocket Guide for Transmen &amp; The Men Who Dig Them. Toronto, Ontario; 2007.

13. Center of Excellence for Transgender HIV Prevention. Recommendations for Inclusive Data Collection of Trans People in HIV Prevention, Care, and Services. San Francisco, CA: University of California, San Francisco; 2009.
www.transhealth.ucsf.edu

<hr />

Special thanks to the following reviewers of this Fact Sheet: Walter Bockting, Luis Gutierrez-Mock, AJ King, Niko Kowell, Dan Lentine, Vel McKleroy, Sarah Morgan, Emily Newfield, David Schleifer, Hale Thompson, Erin Wilson.

&nbsp;

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©January 2010, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.Web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2011/01/TransmenFS-Sept2015.pdf</url>
	</node>
	<node>
		<title>Young gay men</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are the HIV Prevention Needs of Young Men Who Have Sex with Men?</h3>
revised 4/01
<h4>Are young MSM at risk for HIV?</h4>
Yes. Over half of all the reported HIV and AIDS cases among males aged 13-24 in the US were due to male-male sexual contact.<sup>1</sup> Various studies found that 26% to 50% of young men who have sex with men (MSM) report recent unprotected anal intercourse, and much of this unprotected sex occurred with a partner of unknown or different HIV status.<sup>2-4</sup> Rates of sexual risk-taking among young MSM are also increasing.<sup>5</sup> The term young MSM includes men who self-identify as gay or bisexual, as well as non-gay/bi-identified MSM under 30 years old.<sup>6</sup>

A large number of urban young MSM are already infected with HIV. A study of 15- to 22-year-old young MSM in seven cities (Baltimore, MD; Dallas, TX; Los Angeles, CA; Miami, FL; New York, NY; San Francisco Bay Area, CA and Seattle, WA) showed a high overall HIV prevalance: 7%, ranging from 2% -12%. Moreover, 82% of the HIV+ men had no idea they were HIV+ before this testing.

Young MSM of color, especially African American men, are disproportionately impacted. In the multi-city study, 14% of the African Americans tested HIV+, compared to 13% among mixed race men, 7% among Hispanics, 3% among Asians and 3% among whites.<sup>6</sup>
<h4>Why do young MSM take risks?</h4>
Unfortunately, there are no simple answers to this question. The explanations for unsafe sex are complex and multi-faceted.<sup>3,7</sup> Adolescence and young adulthood are often characterized by experimentation and exploration of sexuality and drug using. While most young MSM will engage in some HIV risk behaviors at some point in their lives, only a small percentage are consistent risk takers. Many young MSM struggle with individual, interpersonal and societal stressors that may interfere with their ability to protect themselves.<sup>8</sup>

For some young MSM, individual factors can lead to unsafe sex, such as: feeling invulnerable to HIV; having high levels of optimism about HIV antiviral medications; perceiving that unsafe sex is more pleasurable than safer sex; being depressed or sad; having conflicting allegiance with either their racial or sexual identity; and using alcohol or other drugs (e.g. speed/crystal, poppers).<sup>8</sup>

Protecting one’s health is not necessarily a young MSM’s top concern. Interpersonal motivations may be more pressingwanting to fit in, to find companionship and intimacy. However, interpersonal issues can also contribute to unsafe sex, such as finding it difficult to communicate or negotiate safer sex with a sexual partner. Young MSM who are in a relationship are more likely to have unsafe sex than single young MSM.<sup>4</sup>

Societal factors may also influence the risk-taking of young MSM. Many young MSM find themselves isolated or rejected by traditional sources of support like family, school, or religious community.<sup>9</sup> Homophobia, racism and poverty also place young MSM at risk. Some young MSM, especially those living on the street, are struggling with daily needs like avoiding violence, finding a place to live, or obtaining food. These pressing needs may overshadow the concern for safer sex and injection practices.

Young MSM have few public places to meet each other. Gay bars and public cruising areas are some of the more visible and accessible places, offering anonymity for young men exploring their sexual identity. These venues are also associated with high levels of risk-taking. They are highly sex-charged and the bar scene’s emphasis on alcohol sets the stage for engaging in sex while intoxicated. This is consistently found to contribute to unsafe sex.<sup>10</sup>

Little is known about the Internet’s role in the lives of young MSM, including how young MSM use the Internet to obtain social support, make new friends, find romantic partners, and/or cruise for sex.
<h4>What’s being done?</h4>
The Mpowerment Project is a multilevel, sex- and gay-positive, peer-based intervention in which young men take charge. Because HIV may not be particularly compelling for many young MSM, the project focuses on young MSM’s social concerns. The young men plan and coordinate activities to create a stronger and healthier community for themselves in which safer sex becomes the mutually accepted norm. Participants in the Project have reduced rates of unprotected anal intercourse with casual partners and boyfriends. Mpowerment, proven effective as an HIV prevention intervention, provides CBOs with training and a manual for replication.<sup>11</sup>

The COLOURS Organization in Philadelphia, PA targets young MSM of color with support groups, peer educator training and individual case management. They do street outreach at sex clubs and bars frequented by MSM of color, providing condoms and counseling to young MSM who partner with older men. They also promote gay-friendly drug and alcohol treatment services for young MSM.<sup>12</sup>

The American Psychological Association has implemented the Healthy Schools Project for Lesbian and Gay Students. The Project trains school psychologists, counselors, nurses and social workers to work effectively with gay, lesbian and bisexual students. The goal is to make schools a friendlier environment for these students and make HIV prevention education more relevant to them.<sup>13</sup>

“Chico Chats,” a program of the STOP AIDS Project in San Francisco, CA, consists of a one-month intensive series of workshops. Participants get to know each other while engaging in facilitated conversations about body image, relationships and identity and how these issues relate to HIV. Learning community organizing and mobilization techniques is a key component of these workshops as well. Participants formed an activist group called ¡Ya Basta! (Enough Already) and designed a video and workshop examining the issues of sexual silence and coming out in Latino families. The video is being shown throughout Latino communities in San Francisco.<sup>14</sup>
<h4>What else needs to happen?</h4>
Effective programs for young MSM must address the context of their lives and the individual, interpersonal and societal factors that put them at risk. Comprehensive health and sexuality education must target both those who identify as gay or bisexual and those who do not. Unfortunately, many school-based programs focus on reproduction or abstinence until marriage, further marginalizing young MSM.

There is an urgent need to create prevention and wellness programs specifically for young MSM of color. Existing programs for older MSM of color should also be accessible to young MSM. These programs should address issues of sexuality, gay identity, culture, race/ethnicity, racism, homophobia, poverty and violence. Programs must also consider the HIV prevention needs of both HIV positive and HIV negative young MSM. Special attention is necessary to reach marginalized young MSM, such as those who are homeless, engaged in commercial sex work or involved with the criminal justice system. These young men may not identify as gay or bisexual, and may have immediate needs for food and shelter to address.

Programs are needed that foster support for young MSM and involve them directly in planning and implementation. Support might encompass creating safe places for young MSM to socialize and access services, developing school-based sexuality and gay-awareness programs and helping young MSM advocate for greater acceptance by schools, families, religious communities, the gay community at large and communities of color.<sup>15</sup>

Societal homophobia may impede implemention of prevention programs for young MSM and may discourage young MSM from accessing prevention services.<sup>16</sup> Political concerns must not be allowed to interfere with HIV prevention services for young MSM. Targeting young MSM with HIV prevention messages and services is an appropriate response to a grave public health threat. Unless action is taken quickly, we will lose many young men to HIV.

<hr />

<h3>Says who?</h3>
<ol>
 	<li>Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . 2000;12.</li>
 	<li>Molitor F, Facer M, Ruiz JD. Safer sex communication and unsafe sexual behavior among young men who have sex with men in California. Archives of Sexual Behavior. 1999;28:335-343.</li>
 	<li>Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study . AIDS. 1999;12:1753-1762.</li>
 	<li>Hays RB, Kegeles SM, Coates TJ. Unprotected sex and HIV risk-taking among young gay men within boyfriend relationships . AIDS Education and Prevention. 1997;9:314-329.</li>
 	<li>Ekstrand ML, Stall RD, Paul JP et al. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status . AIDS. 1999;13:1525-1533.</li>
 	<li>Valleroy LA, MacKellar DA, Karon JM et al. HIV prevalence and associated risks in young men who have sex with men . Young Men’s Survey Study Group. Journal of the American Medical Association. 2000;284:198-204.</li>
 	<li>Strathdee SA, Hogg RS, Martindale SL et al. Determinants of sexual risk-taking among young HIV-negative gay and bisexual men . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;19:61-66.</li>
 	<li>Choi KH, Kumekawa E, Dang Q et al. Risk and protective factors affecting sexual behavior among young Asian and Pacific Islander men who have sex with men: Implications for HIV prevention . Journal of Sex Education &amp; Therapy. 1999;24:47-55.</li>
 	<li>Beeker C, Kraft JM, Peterson JL, et al. Influences on sexual risk behavior in young African-American men who have sex with men. Journal of the Gay and Lesbian Medical Association. 1998;2:59-67.</li>
 	<li>Greenwood GL, White EW, Page-Shafer K, et al . Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men’s Health Study . Drug and Alcohol Dependence. 2001:61:105-112.</li>
 	<li>CDC. Compendium of HIV prevention interventions with evidence of effectiveness . 1999.</li>
 	<li>The COLOURS Organization, Inc . Philadelphia, PA. 215/496-0330.</li>
 	<li>Clay RA. Healthy Schools project hoped to ease discrimination . APA Monitor. 1999;30.</li>
 	<li>The STOP AIDS Project . Q Action, ¡Ya Basta! San Francisco, CA. 415/865-0790×303.</li>
 	<li>Seal DW, Kelly JA, Bloom FR, et al. HIV prevention with young men who have sex with men: what young men themselves say is needed . AIDS Care. 200;12:5-26.</li>
 	<li>Stokes JP, Peterson JL. Homophobia, self-esteem, and risk for HIV among African American men who have sex with men . AIDS Education and Prevention. 1998;10:278-292.</li>
</ol>

<hr />

<strong>Prepared by Pilgrim Spikes MPH Phd, Bob Hays PhD, Greg Rebchook PhD, Susan Kegeles PhD, CAPS
</strong>

April 2001. Fact Sheet 8ER

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 2001, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revYMSMFS.pdf</url>
	</node>
	<node>
		<title>Hombres negros</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los hombres negros para evitar el VIH?</h3>
<h4>¿quiénes son los hombres negros?</h4>
Los hombres negros y los afroamericanos no se pueden encasillar en una sola categoría “unitalla”. Ellos son padres, hermanos, tíos e hijos en las comunidades negras. Son médicos, abogados, barberos y conductores de autobuses; son cristianos y musulmanes y hablan muchos idiomas. Sin embargo, no toda persona de aspecto negro o afroamericano se identifica con estas
etiquetas. En EEUU, los hombres negros son un grupo diverso que abarca, entre otros, a afrocubanos, caribeños, brasileños y africanos.
<h4>¿por qué el VIH es una preocupación?</h4>
Actualmente, el VIH es una crisis de salud mayúscula entre los hombres negros y afroamericanos de cualquier edad u orientación sexual.<sup>1</sup> En el año 2000, el SIDA fue la primera causa de muerte entre los hombres negros de 35-44 años de edad y la tercera causa de muerte de hombres negros entre 25 y 44 años de edad.<sup>2</sup> Las tasas del VIH entre afroamericanos jóvenes que tienen sexo con otros hombres (HSH) son más elevadas que entre cualquier otro grupo racial o étnico.<sup>2</sup>

El VIH/SIDA no es la primera crisis de salud que encaran los hombres negros, ni será la última. Los hombres negros afrontan muchas disparidades médicas y están desproporcionadamente afectados por muchas enfermedades como la hipertensión, el cáncer y las cardiopatías. El VIH plantea otro tipo de desafío debido a su transmisión por medio del contacto sexual y del consumo de drogas, temas difíciles de tocar y cargados de estigma en muchas comunidades.
<h4>¿cuáles son los factores de riesgo del VIH?</h4>
La primera causa de infección por VIH entre los hombres afroamericanos es el sexo, ya sea con hombres o con mujeres.<sup>1</sup> En EE.UU. hemos confundido la conducta sexual con la identificación sexual de los hombres negros.<sup>3</sup> Por ejemplo, un hombre negro que tiene sexo con hombres y mujeres puede pertenecer a la clasificación de riesgo de los CDC (centros de control de enfermedades) de “contacto sexual de hombre a hombre;” por los investigadores como “bisexual” o “HSH,” por la prensa como “incógnitos” o que tienen relaciones con otros hombres discretamente (on the down low), por grupos activistas como “amante del mismo sexo” o por sus parejas como “heterosexual.”

El consumo de drogas inyectables es la segunda causa de infección por VIH entre hombres negros<sup>1</sup>. Muchos consumidores de drogas padecen adicción, pobreza, falta de vivienda, estigma, depresión, enfermedad mental y trauma anterior, todas éstas situaciones que favorecen la transmisión del VIH, por ejemplo al compartir equipos de inyección.<sup>4</sup>
<h4>¿qué afecta al riesgo del VIH?</h4>
Sabemos que el VIH se transmite entre hombres (sean negros o no) por medio del sexo anal o vaginal sin protección con una persona VIH+ o por usar los equipos de inyección de una persona VIH+. Sabemos mucho menos sobre el efecto de las fuerzas psicosociales, contextuales, políticas e históricas sobre las prácticas de riesgo de los hombres negros. Es necesario resolver los problemas de educación, empleo y encarcelamiento, especialmente entre los hombres marginados económicamente.

Los hombres negros y afroamericanos son discriminados en la educación y en el empleo. En la escuela, muchos niños negros son etiquetados como “problemáticos” y son remitidos a clases de “educación especial,” lo cual reduce el número de varones negros que ingresan a la escuela secundaria.<sup>5</sup> Consecuentemente, muchos hombres negros no consiguen empleo bien remunerado y quedan sumamente desfavorecidos en nuestra economía tecnológica. La falta de empleo está vinculada con condiciones que pueden aumentar el riesgo del VIH, tales como el consumo de alcohol y drogas, el sexo comercial, la falta de vivienda y el encarcelamiento.

Casi la tercera parte de los hombres negros han estado encarcelados como adolescentes o adultos.<sup>6</sup> El ciclo de entrar, salir y regresar a la cárcel puede perjudicar la capacidad de los hombres negros de encontrar y mantener tanto empleo como relaciones personales. Entre menos hombres negros haya en la comunidad, menos oportunidades tendrán las parejas negras para la monogamia a largo plazo y mayores serán las posibilidades de tener múltiples parejas, lo que puede aumentar el riesgo de transmitir el VIH/ETS.<sup>7</sup>

En EE.UU. existe una larga historia de explotación y objetivización sexual del varón negro. Con frecuencia a los hombres negros se les describe según su supuesta afición o proeza sexual en lugar de reconocerlos como seres complejos y multidimensionales con sus fortalezas y debilidades.<sup>8</sup>
<h4>¿cuáles son los factores protectores?</h4>
Muchas organizaciones en todo el país promueven la fuerza y la unidad entre hombres negros. Grupos fraternales, barberías y grupos cívicos, como “100 Black Men” y otros, fortalecen a los hombres negros ofreciéndoles modelos positivos a seguir, promoviendo la historia y cultura afroamericana y colaborando con empresas y universidades.<sup>9</sup>

Los sistemas de apoyo familiares, comunitarios y espirituales son importantes para proteger a los jóvenes negros contra el VIH. Las familias unidas con padres que vigilen a sus hijos y hablen con ellos son la clave para promover conductas saludables.<sup>10</sup> Las iglesias negras pueden ofrecer información sobre la prevención del VIH; también pueden poner el ejemplo respondiendo a las necesidades de los consumidores de drogas, homosexuales y personas VIH+ sin estigmatizarlos.<sup>11</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Se implementó un programa de prevención el VIH con adolescentes afroamericanos en Filadelfia, PA, que abarcaba tanto la abstinencia sexual como la protección durante las relaciones sexuales. Los participantes de la intervención de abstinencia reportaron menos actos sexuales después de 3 meses, pero no en las encuestas de seguimiento realizadas a los 6 y 12 meses después. Entre los jóvenes con experiencia sexual anterior al programa, aquellos que participaron en la intervención sobre el sexo más seguro reportaron menos actos sexuales que los participantes de la intervención de abstinencia según las encuestas de seguimiento realizadas a los 3, 6 y 12 meses. Ambos métodos redujeron a corto plazo las conductas riesgosas con respecto al VIH, pero es posible que las intervenciones enfocadas en la protección en el sexo tengan efectos más duraderos que las intervenciones sobre la abstinencia, y que también logren mejores resultados entre jóvenes con previa experiencia sexual.<sup>12</sup>

Desde hace muchos años, “People of Color in Crisis” (POCC) en Brooklyn, NY ofrece actividades de prevención del VIH/SIDA y otras intervenciones para hombres y mujeres negras. “Many Men, Many Voices” es una intervención grupal interactiva y experiencial para hombres homosexuales no caucásicos. Sus facilitadores capacitados dirigen seis sesiones semanales para ayudar a los hombres a sentirse protegidos y aceptados con un apoyo social positivo.<sup>13</sup>

“Concerned Black Men” (CBM) es una organización de servicio establecida y dirigida por hombres negros con el fin de ofrecer modelos positivos a seguir a los niños negros. CBM tiene 21 sedes a lo largo de EE.UU. que brindan programas de prevención de la violencia, el consumo del alcohol y drogas, del embarazo y de ETS/VIH, al tiempo que promueven la autoestima, resolución de conflictos y plantación para asistir a la universidad.<sup>14</sup>

El “Down Low Barbershop Project” colabora con barberos y estilistas en comunidades negras para brindar a los hombres negros información sobre el VIH, condones y recomendaciones para pruebas y consejería de VIH gratuitas. Los barberos participan en dos capacitaciones de 8 horas sobre la prevención del VIH y luego reclutan a diez clientes para que asistan a una capacitación de 4 horas. La participación de los propietarios de barberías, barberos y clientes es pagada, y los clientes que asisten reciben un vale para un corte de pelo gratuito. El Down Low Barbershop Project se realiza a través de los programas “Brother to Brother” en Seattle, WA y “Us Helping US” en Washington, DC.<sup>15</sup>
<h4>¿qué queda por hacer?</h4>
Las agencias de prevención del VIH deberán reconocer las bases culturales y sociales de la comunidad negra.<sup>16</sup> La brecha entre ricos y pobres sigue creciendo y la mayoría de las infecciones por VIH ocurre en comunidades pobres.<sup>3</sup> Los programas deben responder a los problemas de empleo, educación, encarcelamiento, adicción y estigma, además de las conductas riesgosas relacionadas con el sexo y con el consumo de drogas.

Para contar con un ambiente de confianza que favorezca las conversaciones abiertas sobre temas delicados relacionados con el sexo y con el consumo de drogas, los programas de investigación y de prevención deben llevarse a cabo en ambientes familiares lejos de los clubes, bares y otros lugares donde prevalece el sexo.<sup>17</sup> La colaboración con organizaciones culturales, religiosas y cívicas que históricamente han llegado a los hombres negros puede ayudar a reclutar e involucrar a estos hombres.<sup>18</sup>

Los programas de prevención deben vincularse con programas de tratamiento de drogas, prevención de la violencia, enriquecimiento académico, planificación familiar, fortalecimiento cultural y organizaciones empresariales; todo esto con el fin de apoyar a los hombres negros en general tomando en cuenta la riqueza y la complejidad de la vida moderna del hombre negro.

<hr />

<h4>¿quién lo dice?</h4>
1.Centers for Disease Control and Prevention. HIV/AIDS among African Americans. 2003.http://www.cdc.gov/hiv/topics/aa/resources/factsheets/aa.htm
2. Key Facts: African Americans and HIV/AIDS. Report published by the Kaiser Family Foundation. September 2003.http://www.kff.org/hivaids/hiv6090chartbook.cfm
3. Beatty LA, Wheeler D, Gaiter J. HIV prevention research for African Americans: current and future directions. Journal of Black Psychology. 2004;30:40-58.
4. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness and incarceration. Public Health Reports. 2002;117: S135-S145.
5. Davis JE. Early schooling and academic achievement of African American males. Urban Education. 2003;38:515-537.
6. Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. American Journal of Public Health. 2003;93:759-763.
7. Adimora A, Schoenbach VJ. Contextual factors and the Black-White disparity in heterosexual HIV transmission. Epidemiology. 2002;13:707-712.
8. Whitehead TL. Urban low-income African American men, HIV/AIDS, and gender identity. Medical Anthropology Quarterly. 1997;11:411-447.
9. Bailey DF, Paisley PO. Developing and nurturing excellence in African American male adolescents. Journal of Counseling and Development. 2004;82:10-17.
10. “This is my reality–the price of sex: an inside look at Black urban youth sexuality and the role of the media.” Report published by Motivational Educational Entertainment. January 2004.http://www.meeproductions.com/store/youthSexuality.cfm
11. Miller RL. African American churches at the crossroads of AIDS. FOCUS. 2001;10:1-5.
12. Jemmott JB III, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial. Journal of the American Medical Association. 1998;279:1529-1536. http://www.cdc.gov/hiv/pubs/hivcompendium/section1-20.htm
13. People of Color in Crisis (POCC), Brooklyn, NY. http://www.pocc.org/
14. Concerned Black Men, Washington, DC. http://www.cbmnational.org/
15. Sanders E. Seattle HIV program enlists barbershops: Black men get a trim and a frank discussion. The Boston Globe. January 1, 2004.
The Down Low Barbershop Program: www.brotobro.com, www.ushelpingus.com.
16. Darbes LA, Kennedy GE, Peersman G, et al. Systematic review of HIV behavioral prevention research in African Americans. The Cochrane Review. March 2002.
17. Malebranche DJ. Black men who have sex with men and the HIV epidemic: next steps for public health. American Journal of Public Health. 2003;93:862-865.
18. Summerrise R, Wilson W. “The Black Print” model for recruitment of African-American males. Published by the Chicago, IL, Prevention Planning Group. 2000.

<hr />

<strong>Preparado por Darrell P. Wheeler, PhD, MPH, ACSW; Hunter College, NY</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Enero 2005. Hoja Informativa 54S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/hombresnegrosFS.pdf</url>
	</node>
	<node>
		<title>Hombres gay (HSH)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los HSH para la prevención del VIH?</h3>
<h3>revisado 4/01</h3>
<h4>¿qué necesitan los HSH?</h4>
Los Hombres que tienen Sexo con otros Hombres (HSH ó MSM por sus siglas en inglés) no constituyen un grupo homogéneo sino que representan una amplia gama de personas con estilos de vida y necesidades de salud distintas. El término HSH se refiere a cualquier hombre que tenga sexo con otro hombre independientemente de cómo se autodefina: gay, bisexual o heterosexual, entre otras identidades.

A pesar del éxito en los cambios de conductas sexuales, los HSH continúan siendo afectados en forma desproporcionada por el VIH/SIDA. Ellos representan el mayor porcentaje de casos con SIDA en los EEUU (53%) aún cuando los porcentajes entre usarios de drogas inyectadas (UDI) (25%) y entre heterosexuales (10%) han aumentado. En 1997, la tasa de prevalencia del VIH en HSH en cuatro comunidades urbanas fue de 17%, 29% para los HSH afroamericanos y 40% para los HSH-UDIs.

El VIH no es una cuestión que existe por sí sola sino que está ligada a los diferentes aspectos de la vida de los hombres. El riesgo relacionado con el VIH está muy arraigado a otros aspectos esenciales como son el romance y la intimidad, el deseo sexual y el amor, el uso del alcohol y drogas recreativas, la homofobia, la coerción y el abuso, el racismo y la autoestima. Los programas de prevención de VIH deben tomar en cuenta estos elementos.
<h4>la salud sexual</h4>
En los EEUU los jóvenes no reciben suficiente educación sexual y la educación sobre la sexualidad entre personas del mismo sexo es casi nula. En nuestra sociedad en general, los hombres se ven presionados a demostrar su hombría por medio de la actividad sexual y la agresividad. En este contexto, muchos HSH enfrentan retos adicionales al aprender a buscar pareja, al intimar y establecer una relación, al entender como funcionan el deseo, el sexo y la excitación sexual. La incomodidad con la propia sexualidad e identidad puede llevar a tomar riesgos sexuales.

“De Hombre a Hombre: Seminarios de Salud Sexual”, es un programa en Minnesota basado en un modelo de salud sexual que asume que si los HSH se sienten más cómodos y más competentes e informados sobre la sexualidad, tendrán mayores posibilidades de reducir el riesgo. El programa utiliza una educación sexual muy amplia y especificidad cultural. El programa tuvo éxito en la reducción de la homonegatividad interiorizada y las relaciones sexuales anales sin protección.

El VIH no es lo único que afecta la salud sexual de los HSH. Otras enfermedades de transmisión sexual (ETS) como el herpes y las verrugas genitales pueden afectar la salud y la sexualidad. En varios estados de este país se ha visto un incremento entre los HSH en los casos de la gonorrea resistente a los medicamentos, lo cual la hace más difícil de tratar.
<h4>homofobia, racismo y autoestima</h4>
La homofobia y el racismo externos e internalizados pueden provocar baja autoestima la cual puede conducir al aumento de las conductas de riesgo, la agresión sexual, la dificultad para negociar el sexo seguro y el abuso de alcohol y drogas.

Los HSH de razas de color están siendo afectados en forma desproporcionada por muchos males sociales y de salud como el VIH. Los HSH afroamericanos y los latinos son más propensos que los HSH blancos a participar en actividades de alto riesgo y a contagiarse con el VIH. En un estudio con hombres gay latinos urbanos se descubrió que quienes reportaron conductas de alto riesgo también presentaron altos índices de dificultades económicas, racismo, homofobia, violencia doméstica y un historial de abuso y coacción sexual a temprana edad.

Hermanos de Luna y Sol, es un programa de prevención de VIH para latinos inmigrantes gay/bisexuales, que confronta experiencias comunes de opresión sufridas por latinos gay como la homofobia, el machismo, el abuso sexual, el racismo y la separación de la familia y de la cultura. ”Ayudándonos a Nosotros Mismos” (UHU por sus siglas en inglés) es un programa multifacético de prevención para HSH negros en el que se analizan las tensiones provocadas por formar parte de una minoría étnica racial y sexualmente oprimida. UHU ofrece servicios para la salud mental y utiliza estrategias de mercadeo social para combatir la homofobia.
<h4>uso de alcohol y drogas recreativas</h4>
La frecuencia en el consumo de drogas es mayor entre los HSH que entre los heterosexuales, aunque recientemente se ha notado un descenso en el consumo de uso de alcohol y drogas, exceptuando las anfetaminas. El patrón de uso de drogas puede variar enormemente por región y subcultura. En varias partes de los EEUU los bares gay—donde con frecuencia hay un ambiente cargado sexualmente en el que las drogas y el alcohol están presentes—son los únicos lugares para socializar y conocer a otros HSH.

Algunos factores sobre el consumo de drogas que exponen a los HSH al VIH son 1) compartir equipo de inyección infectado; 2) el uso de drogas está asociado con conductas sexuales de alto riesgo; 3) la prevalencia de VIH es mayor entre HSH-UDI y en HSH que consumen drogas aunque no se inyecten, lo que aumenta las posibilidades de transmisión del VIH.

El uso de drogas puede ser el detonador o la excusa para no protegerse al tener relaciones sexuales. Algunos HSH tienen problemas para tener sexo sin la influencia de drogas, mientras otros prefieren el sexo bajo la influencia de drogas creyendo que así aumenta su libido. Para algunos HSH consumir drogas en los clubes gay y en las llamadas “circuit parties” les produce una sensación de comunidad y pertenencia. Una encuesta a HSH que asisten a estas fiestas reveló que es más factible que el sexo anal sin condón entre serodiscordantes (un VIH+ con un VIH-) ocurra entre quienes consumen anfetaminas (speed), Viagra y alminitratos (poppers).

Para muchos HSH-UDI lo que forma su identidad personal es el uso de drogas más que la propia orientación sexual. Muchos HSH-UDI se consideran heterosexuales. Muchas veces los programas de prevención para HSH pasan por alto a los HSH-UDI, o bien, los programas para UDI no tratan el tema de la orientación sexual. Los HSH-UDI tienen altos índices de infección de VIH, alta frecuencia para el sexo sin protección, altos índices de pobreza y una adicción que conlleva padecimientos físicos y sociales.

El Proyecto Stonewall en San Francisco es un programa de “reducción de daño” para HSH que usan speed. Este proyecto ofrece educación y asistencia y ha llegado a HSH de diversas identidades sociales y sexuales. Varias ciudades de los EEUU han abierto centros sociales para hombres gay en los que no se sirve alcohol y ni permiten las drogas. Un programa de prevención para hombres jóvenes gay ayuda a crear centros comunitarios para que éstos puedan socializar sin necesidad de usar alcohol.
<h4>¿qué significa el riesgo sexual?</h4>
Las percepciones del riesgo sexual respecto al VIH varía entre los HSH y puede cambiar de una situación sexual a otra. A lo largo de la epidemia del VIH, los HSH han tenido que tomar decisiones complicadas sobre lo que ellos consideran que es riesgoso. Algunos hombres deciden por sí mismos que es correcto no usar un condón si son quienes penetran, o si tienen sexo oral, o si la carga viral de la pareja es indetectable. Los HSH podrían estar tomando estas decisiones porque hasta hoy las evidencias científicas de la trasmisión son ambiguas o porque no les incomoda su nivel de riesgo.

La mayoría de los HSH han podido manejar el riesgo sexual con estrategias eficaces como la monogamia entre parejas concordantes, el uso constante del condón y de repetidas pruebas de detección, el uso de condones al tener sexo con otras parejas o la abstinencia. Una pequeña minoría de HSH participa en actividades sabiendo el riesgo que corre, como el de tener relaciones sexuales anales sin protección y cuando desconocen el seroestatus de la pareja.

Las relaciones sexuales anales sin protección entre hombres VIH+ y VIH- siguen constituyendo el mayor riesgo de transmisión entre los HSH. La sensación de intimidad que produce el contacto de piel con piel hace que algunas personas no usen condón durante la penetración. Muchos HSH sienten que su identidad sexual y las metas de liberación sexual obtenidas en arduas batallas dependen de poder tener sexo—incluyendo las relaciones anales—sin restricciones de ninguna clase.

Una gran mayoría de HSH se enfrenta al riesgo con frecuencia, sin embargo existe muy poco conocimiento o investigaciones sobre aquellos hombres que se mantienen sanos y seguros, y sobre cómo sus valores, su forma de cuidarse, su ética, su esperanza de sobrevivencia colectiva y sus relaciones con los demás les han apoyado. Las labores de prevención del VIH necesitan conceptos más amplios y emocionalmente resonantes que desarrollen los aspectos afirmativos de la vida de los HSH.

<hr size="2" />

<h4>¿quién lo dice?</h4>
1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2000;12.
2. Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men. American Journal of Public Health. in press.
3. Seal DW, Kelly JA, Bloom FR, et al. HIV prevention with young men who have sex with men: what young men themselves say is needed. AIDS Care. 2000;12:5-26.
4. Robinson BE, Bockting W, Rosser BRS, et al. The sexual health model: a sexological approach to long-term HIV risk reduction. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #ThPeD5613.
5. Rosser BRS, Bockting WO, Rugg DL, et al. A sexual health approach to long-term HIV risk reduction among men who have sex with men: results from a randomized controlled intervention trial. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #WePeD4718.
6. Altman LK. Gonorrhea shows its resistant side; disease control agency tells doctors of new recommendations. Milwaukee Journal Sentinel. October 2, 2000. p. 5G.
7. Diaz RD, Ayala G, Bein E. Social oppression, resiliency and sexual risk: findings from the national Latino gay men’s study. Presented at the National HIV Prevention Conference, Atlanta, GA, Aug 29-Sep 1, 1999. Abst#287.
8. Díaz RM. Latino Gay Men and HIV: Culture, Sexuality, &amp; Risk Behavior. NY:Routledge. 1998.
9. Simmons R. Towards developing a comprehensive program for effective HIV prevention among racially oppressed gay men, bisexuals and MSM. Presented at the XIII International Conference on AIDS, Durban,South Africa, July 2000. Abst #TuPeD3839.
10. Stall R, Wiley J. A comparison of alcohol and drug use patterns of homosexual and heterosexual men: the San Francisco men’s health study. Drug Alcohol Dependency. 1988;22:63-73.
11. Crosby M, Stall R, Paul J, et al. Alcohol and drug use patterns have declined between generations of younger gay/bisexual men in San Francisco. Drug and Alcohol Dependence. 1998;52:177-182.
12. Rhodes F, Deren S, Wood MM, et al. Understanding HIV risks of chronic drug-using men who have sex with men. AIDS Care. 1999;11:629-648.
13. Colfax G, Mansergh G, Vittinghoff E, et al. Drug use and high-risk sexual behavior among circuit party participants. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #TuPeC3422.
14. Stonewall Project. 415/502-1999.
15. Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study. AIDS. 1999;13:1753-1762.
16. Williams AM. Condoms, risk and responsibility. Presented at the HIV Prevention Summit, Half Moon Bay, CA, June 2000.
17. Nimmons D. In this together: the limits of prevention based on self-interest and the role of altruism in HIV safety. Journal of Psychology &amp; Human Sexuality. 1998;10:75-871. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . 2000;12.

2. Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men . American Journal of Public Health. 2001 Jun;91(6):907-14.

3. Seal DW, Kelly JA, Bloom FR, et al. HIV prevention with young men who have sex with men : what young men themselves say is needed. AIDS Care. 2000;12:5-26.

4. Robinson BE, Bockting W, Rosser BRS, et al. The sexual health model: a sexological approach to long-term HIV risk reduction. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #ThPeD5613.

5. Rosser BRS, Bockting WO, Rugg DL, et al. A sexual health approach to long-term HIV risk reduction among men who have sex with men: results from a randomized controlled intervention trial. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #WePeD4718.

6. Altman LK. Gonorrhea shows its resistant side; disease control agency tells doctors of new recommendations . Milwaukee Journal Sentinel. October 2, 2000. p. 5G.

7. Diaz RD, Ayala G, Bein E. Social oppression, resiliency and sexual risk: findings from the national Latino gay men’s study. Presented at the National HIV Prevention Conference, Atlanta, GA, Aug 29-Sep 1, 1999. Abst#287.

8. Díaz RM. Latino Gay Men and HIV: Culture, Sexuality, &amp; Risk Behavior . NY:Routledge. 1998.

9. Simmons R. Towards developing a comprehensive program for effective HIV prevention among racially oppressed gay men, bisexuals and MSM. Presented at the XIII International Conference on AIDS, Durban,South Africa, July 2000. Abst #TuPeD3839.

10. Stall R, Wiley J. A comparison of alcohol and drug use patterns of homosexual and heterosexual men: the San Francisco men’s health study . Drug Alcohol Dependency. 1988;22:63-73.

11. Crosby M, Stall R, Paul J, et al. Alcohol and drug use patterns have declined between generations of younger gay/bisexual men in San Francisco . Drug and Alcohol Dependence. 1998;52:177-182.

12. Rhodes F, Deren S, Wood MM, et al. Understanding HIV risks of chronic drug-using men who have sex with men . AIDS Care. 1999;11:629-648.

13. Colfax G, Mansergh G, Vittinghoff E, et al. Drug use and high-risk sexual behavior among circuit party participants. Presented at the XIII International Conference on AIDS, Durban, South Africa, July 2000. Abst #TuPeC3422.

14. Stonewall Project . 415/502-1999.

15. Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study . AIDS. 1999;13:1753-1762.

16. Williams AM. Condoms, risk and responsibility. Presented at the HIV Prevention Summit, Half Moon Bay, CA, June 2000.

17. Nimmons D. In this together: the limits of prevention based on self-interest and the role of altruism in HIV safety . Journal of Psychology &amp; Human Sexuality. 1998;10:75-87.

<hr size="2" />

<strong>Preparado por Michael Crosby, PhD y Pamela DeCarlo;
Traducido por Romy Benard-Rodríguez, Revisión Maricarmen Arjona, CAPS</strong>

<strong>Abril 2001. Fact Sheet #7SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/02/HSHFS.pdf</url>
	</node>
	<node>
		<title>Hombres heterosexuales</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesita el hombre heterosexual en la prevención del VIH?</h3>
<h3>revisado 4/01</h3>
<h4>¿está el hombre heterosexual en riesgo?</h4>
Sí. En los EEUU los casos nuevos de SIDA reflejan un incremento en las infecciones por uso de drogas intravenosas (UDI) y por contacto sexual heterosexual.<sup>1</sup> El aumento de infecciones en hombres heterosexuales por UDI ha elevado los casos de VIH en las mujeres ya que más mujeres se están infectando al tener sexo con hombres UDI. El cambio de conducta del hombre heterosexual es determinante para controlar la epidemia en los hombres heterosexuales, las mujeres y los niños.

Más de la cuarta parte (28%) de todos los casos de SIDA en hombres en los EEUU se producen por UDI y por relaciones sexuales heterosexuales. De estos casos, más de tres cuartos se dan en hombres de raza no blanca (caucásica), de los cuales más de la mitad (55%) son afroamericanos.<sup>2</sup> Los casos de VIH/SIDA (según el Centro de Control de Enfermedades (CDC) de EEUU) se clasifican por conductas de riesgo (consumo de drogas/práctica sexual) y no por autoidentificación de género ó preferencia sexual. A los hombres que se autoidentifican como heterosexuales y que tienen sexo con otros hombres se les categoriza como “hombres que tienen sexo con hombres”; los cuales, no necesariamente llegan a identificarse con los programas dirigidos a hombres gay.

Los programas de prevención para hombres heterosexuales en los EEUU han tocado los temas en cuanto al uso de drogas, pero pocos han considerado la conducta sexual. Las intervenciones para el cambio de conducta en heterosexuales se han dirigido principalmente a las mujeres, Si los hombres participan es secundario ya que la intervención no estaba dirigida a ellos.
<h4>¿qué pone a los hombres en riesgo?</h4>
UDI representa el mayor riesgo para el hombre heterosexual. Las drogas no inyectables como las anfetaminas, la cocaína-crack y el alcohol, incrementan que se tomen riesgos en la conducta sexual, aumentando así el riesgo de infección con VIH. Un estudio en drogadictos UDI que no están en tratamiento de desintoxicación, determinó que los hombres que consumieron metanfetaminas tuvieron más parejas sexuales, mayor actividad sexualcon penetración anal en hombres y en mujeresy menor uso del condón, que aquellos que no las consumieron.<sup>3</sup>

El hombre puede infectarse al tener sexo desprotegido con una mujer VIH+, aunque el riesgo es mucho menor que el asociado con compartir jeringas infectadas o el sexo con otro hombre VIH+. El riesgo aumenta si la pareja masculina o femenina tiene alguna enfermedad de transmisión sexual (ETS).<sup>4</sup> La conducta sexual de mayor riesgo para el heterosexual es el sexo anal desprotegido con otro hombre VIH+. Quizá por homofobia o miedo al rechazo, los hombres no se atreven a reportar el tener sexo con otros hombres, identificando el sexo con mujeres como su único factor de riesgo.<sup>5</sup>

En ciertos ambientes los hombres corren un riesgo mayor. En los EEUU, el 90% de los prisioneros son hombres. Las tasas de VIH entre los encarcelados son 8 a 10 veces mayores que en la población en general.<sup>6</sup> El uso de drogas inyectables, de otras drogas ilícitas, el tatuaje y el sexo anal desprotegido entre hombres son conductas de riesgo en las prisiones.
<h4>¿qué es lo que dificulta la prevención?</h4>
En esta sociedad a los hombres no se les educa para que cuiden su salud, muchos no reciben atención médica desde la infancia hasta la edad madura (a los 40 años aproximadamente).<sup>7</sup> Los hombres heterosexuales, y en especial los afroamericanos, son los más reacios para hacerse la prueba del VIH, recibir tratamiento y acudir a las citas médicas.<sup>8,9</sup>

Muchos hombres heterosexuales no sólo saben muy poco sobre VIH/ETS, sino que tampoco creen que les concierne. Por falta de material educativo para hombres heterosexuales y de educadores de pares, el hombre heterosexual considera al VIH como un problema exclusivo del “hombre gay blanco.” El hombre es quien porta el condón (masculino) y quien tiene el poder de usarlo o no. Aunque el embarazo, las ETS y el VIH le preocupen, al hombre le puede ser difícil hablar sobre el uso del condón con su pareja. Algunos esperan que sea la pareja femenina quien mencione el tema; si ésta no lo hacen es común que ellos tampoco.<sup>10</sup>

Los jóvenes de razas no blancas frecuentemente se perciben así mismos como una “especie en peligro de extinción.”<sup>11</sup> Para muchos jóvenes urbanos de áreas marginales, el peligro y la lucha diaria por sobrevivir rebasa las preocupaciones sobre el futuro como el VIH. La pobreza, violencia y adicción refuerzan las creencias del hombre negro de que no vivirá más 25 años. Para muchos de éstos jóvenes, el recibir un balazo o acabar en prisión son sus mayores preocupaciones.<sup>11</sup>
<h4>¿cómo involucrar al hombre heterosexual?</h4>
Los educadores de pares pueden ayudar a la prevención del VIH en el hombre heterosexual, aunque muy pocos hombres heterosexuales actualmente participan en la prevención del VIH. El temor y la concepción errónea de la cultura gay inhiben aún más su participación. Se necesita una educación que concientice a los hombres en general para entender y respetar los límites y las culturas sexuales.

Reclutar a hombres heterosexuales puede ser una tarea difícil. Por ejemplo, abordar individualmente al afroamericano no es tan eficaz como hacerlo a través de su trabajo, líder religioso o grupo social. Además, el hombre heterosexual puede necesitar la motivación de la novia o esposa para participar en programas de prevención del VIH.<sup>12</sup>

Las campañas dirigidas al hombre heterosexual deben centrarse en temas generales de salud, no sólo en temas sexuales. Las campañas deben promover que los hombres hablen y se responsabilicen de su salud y bienestar, y no resaltar el lado negativo del sexo (ej.: el VIH mata, tener sexo con un(a) menor puede llevarte a la cárcel). La educación debe empezar en la pre-adolescencia para así ayudar a los jóvenes a protegerse a sí mismos cuando se enfrenten el mundo de la sexualidad y las drogas.
<h4>¿qué se ha hecho?</h4>
Un programa de desarrollo de destrezas para la prevención del VIH basado en el uso de videos y diseñado para afroamericanos heterosexuales de Atlanta, ayudó a incrementar el uso del condón y redujo el sexo vaginal desprotegido. El programa mostró información videograbada sobre VIH, preguntas y respuestas y demostró el uso del condón. Además se incorporaron moderadores en vivo. Como los hombres se limitan a participar en demostraciones de situaciones sexuales, se les pidió que sugirieran diálogos relacionados con prácticas sexuales más seguras para escenas específicas de películas populares.<sup>13</sup>

Le Penseur Youth Services ofrece servicios educativos a jóvenes y familias del sureste de Chicago. Uno de sus programas está dirigido a miembros de pandillas e incorpora a líderes pandilleros como educadores. Le Penseur adiestró a líderes y otros miembros de pandillas para transmitir mensajes sobre sexo seguro. Un componente clave es asignar papeles definidos a estos jóvenes y oportunidades de progreso y liderazgo. Éstos jóvenes también llevaron a su casa el mensaje de que el VIH afecta al hombre heterosexual, lo que aumentó la conciencia sobre el VIH en la comunidad.<sup>14</sup>

En Baltimore, el departamento de salud abrió un Centro de Salud Masculino gratuito que sirve a hombres sin seguro médico entre las edades de 16 a 64 años. La clínica ofrece atención primaria y dental, consejería para drogodependientes, educación sobre prevención y oportunidades de empleo. El personal de salud es masculino. Cuando este centro abrió, era el único en los EEUU dirigido a los hombres sin seguro médico. El enfoque del centro es ayudar a los hombres a que se mantengan sanos, contribuyendo así a crear familias sanas.<sup>15</sup>
<h4>¿qué queda por hacer?</h4>
El hombre heterosexual aún necesita información básica sobre VIH y requiere de programas que protejan su salud y le enseñen cómo obtener servicios para su salud. Los programas deben considerar que el hombre heterosexual puede tener sexo con otros hombres y deben promover el sexo seguro en cada encuentro sexual. Finalmente, estos programas deben crearse junto con las mujeres para incorporar así las necesidades e inquietudes de la pareja femenina.

El tratamiento anti-drogas y el acceso a jeringas estériles que ofrecen los programas de intercambio de jeringas e intercambio en farmacias son cruciales para los hombres heterosexuales. Los hombres encarcelados necesitan tener acceso a tratamientos para la desintoxicación, condones, jeringas estériles, educación sobre prevención del VIH y asesoramiento para la transición de la cárcel a la calle que disminuya el riesgo dentro y fuera de la cárcel.

El hombre heterosexual debe tomar más responsabilidad para evitar el contagio del VIH. Como tradicionalmente el hombre no ha participado en asuntos de salud y prevención, hay que apoyarlo y adiestrarlo para asegurar su participación en la prevención del VIH.
<h4>¿quién lo dice?</h4>
1. CDC. HIV/AIDS Surveillance Report . 1995;7:10.
2. CDC. HIV/AIDS Surveillance Report . 2001;13:16.
3.. Molitor F, Ruiz JD, Flynn N, et al. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users . American Journal of Drug and Alcohol Abuse. 1999;25:475-493.
4. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases . Sexually Transmitted Diseases. 1992;19:61-77.
5. Sternberg S. ‘Secret’ bisexuality among Black men contributes to rising number of AIDS cases in Black women. USA Today. March 15, 2001.
6. Hammett TM, Harmon P, Maruschak L. 1996-1997 Update: HIV/AIDS, STDs and TB in correctional facilities. Abt Associates, Inc .: Cambridge, MA; 1999.
7. Sandman D, Simantov E, An C. O . Published by The Commonwealth Fund. March 2000.
8. Fichtner RR, Wolitski RJ, Johnson WD, et al. Influence of perceived and assessed risk on STD clinic clients’ acceptance of HIV testing, return for test results, and HIV serostatus. Psychology, Health &amp; Medicine. 1996;1:83-98.
9. Israelski D, Gore-Felton G, Wood MJ, et al. Factors associated with keeping medical appointments in a public health AIDS clinic. Presented at the 8th International AIDS Conference, Durban, South Africa. Abst# WePeD4570.
10. Carter JA, McNair LD, Corbin WR. Gender differences related to heterosexual condom use: the influence of negotiation styles . Journal of Sex &amp; Marital Therapy. 1999;25:217-225.
11. Parham TA, McDavis RJ. Black men, an endangered species: Who’s really pulling the trigger? Journal of Counseling &amp; Development. 1987;66:24-27.
12. Summerrise R, Wilson W. “The Black Print” model for recruitment of African-American males. Published by the Chicago, IL, Prevention Planning Group. 2000.
13. Kalichman SC, Cherry C, Brown-Sperling F. Effectiveness of a video-based motivational skills-building HIV risk-reduction intervention for inner-city African American men . Journal of Consulting and Clinical Psychology. 1999;67:959-966.
14. Summerrise R. Valuing the lives of men: HIV prevention for heterosexual men. Presented at the US Conference on AIDS, Atlanta, GA. October, 2000.
15.Sugg DK. A first for men: clinic opens in Baltimore . The Baltimore Sun. May 11, 2000.

<strong>Preparado por Reginald Summerrise* y Pamela DeCarlo**, Traducción Romy Benard y Maricarmen Arjona**
*Le Penseur Youth Services, Chicago, IL; **CAPS</strong>

Septiembre 2001. Hoja Informativa 22SR]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/hetspanFS.pdf</url>
	</node>
	<node>
		<title>Hombres gays Latinos en los Estados Unidos</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los hombres Latinos gay para la prevención del VIH en EE.UU.?</h3>
Hoja informativa 28, marzo del 2012
<h4>¿Por qué enfocarnos en los hombres latinos gay?</h4>
El panorama siempre cambiante de los antecedentes demográficos de los latinos radicados en EE.UU. nos plantea retos singulares para resolver las disparidades de salud de esta población, especialmente con respecto a sus necesidades de prevención del VIH. Los latinos son el grupo etno-racial minoritario más numeroso y con mayor velocidad de crecimiento en EE.UU., con un crecimiento del 43% entre el 2000 y el 2010<sup>1</sup>. Los datos también indican que los latinos son una de las poblaciones con aumento más rápido de riesgo de transmisión del VIH.
<ul>
 	<li>Los hombres latinos que tienen sexo con hombres (HSH o MSM por sus siglas en inglés<sup>*</sup>) representan el 81% de las nuevas infecciones entre hombres latinos y el 19% de todos los HSH en general<sup>2,3</sup></li>
 	<li>Los latinos componen el 16% de la población de EE.UU. pero representan el 17% de las personas vivas con VIH/SIDA y el 20% de nuevas infecciones cada año<sup>3 </sup></li>
 	<li>Los jóvenes (13-29 años de edad) son el 45% de las nuevas infecciones de VIH entre los latinos MSM<sup>4</sup></li>
</ul>
Estos datos señalan la necesidad de identificar las necesidades de salud culturalmente específicas de los hombres latinos homosexuales con el fin de crear intervenciones eficaces que respondan a las disparidades actuales de salud y eviten otras futuras. La Estrategia Nacional de EE.UU. contra el VIH/SIDA subraya la necesidad de programas de VIH que reduzcan las inequidades entre poblaciones minoritarias etno-raciales y sexuales<sup>5</sup>.  Los hombres latinos gay tienen identidades multiculturales distintas que los ubican en ambas categorías priorizadas<sup>6</sup>.
<h4>¿Cuáles son los desafíos para la prevención?</h4>
La mayor parte del trabajo relacionado con los hombres latinos gay se ha basado en un modelo de salud sociocultural, que demuestra que las experiencias de discriminación social, definidas como racismo, homofobia y pobreza, son pronosticadores importantes de la salud mental a futuro.<sup>7 </sup>Se ha comprobado que los trastornos de salud mental, como la angustia psicológica, aumentan el riesgo sexual y disminuyen la capacidad para elegir opciones sexuales sanas. Un estudio reciente de HSH latinos radicados en Nueva York y Los Ángeles<sup>8</sup> informó que:
<ul>
 	<li>Más del 40% de los participantes reportaron experiencias de racismo y homofobia durante el último año</li>
 	<li>La baja auto estima y los reducidos niveles de apoyo social entre hombres latinos gay se asocian con tasas más altas de comportamientos de riesgo sexual, entre ellos el sexo anal sin protección</li>
 	<li>Los hombres que habían tenido experiencias tanto homofóbicas como racistas eran más propensos que los hombres que no reportaron discriminación alguna a participar en el sexo anal sin protección como la pareja receptiva, y también a tener atracones de consumo excesivo de alcohol</li>
</ul>
Las pruebas tardías (es decir, individuos que reciben un diagnóstico de SIDA durante el primer año después de tener un resultado positivo de la prueba del VIH) y la falta de acceso a un seguro médico también plantean desafíos para la prevención, el tratamiento y el cuidado del VIH.
<ul>
 	<li>El 38% de los latinos se hacen la prueba en una etapa tardía de la enfermedad<sup>9</sup>.</li>
 	<li>En un estudio realizado en 21 ciudades grandes de EE.UU., el 46% de los HSH latinos que salieron positivos desconocían que estaban infectados con el VIH<sup>3</sup>.</li>
 	<li>En comparación con los blancos, los latinos VIH+ son más propensos a aplazar el cuidado por problemas como la falta de transporte y a demorar el inicio del cuidado médico después de ser diagnosticados<sup>9</sup>.</li>
 	<li>El 24% de los latinos que viven con VIH/SIDA no tienen seguro médico, en comparación con el 17% de los blancos; y sólo el 23% de los latinos VIH+ cuentan con un seguro médico privado, en contraste con el 44% de los blancos.</li>
</ul>
Las revisiones de investigaciones en hombres latinos gay y bisexuales también reportan que las influencias culturales y fuerzas socioeconómicas afectan al bienestar sexual. Por ejemplo, el estatus de residencia legal, el estigma relacionado con el VIH, el machismo, los patrones de inmigración y migración, el idioma, el estatus de seguro médico y el nivel de estudios son todos obstáculos asociados con los servicios y programas de prevención para el VIH<sup>11, 12</sup>
<h4>¿Qué otros factores afectan al riesgo sexual y la capacidad para elegir opciones sanas?</h4>
Muchos hombres latinos gay afrontan situaciones socio sexuales únicas que los hacen vulnerables a la transmisión del VIH. Estudios realizados anteriormente con grupos de HSH, entre ellos hombres latinos gay, han documentado que varios factores están asociados con el riesgo sexual:
<ul>
 	<li>Selección serológica (elegir a la pareja sexual basándose en su condición percibida de VIH), posicionamiento serológico (selección de roles sexuales [activo o pasivo] según la condición percibida de VIH de cada pareja) y estereotipos y preferencias sexuales<sup>13</sup></li>
 	<li>Consumo de alcohol y drogas (incluido el consumo de metanfetaminas y la inyección de drogas) así como tener antecedentes de ITS como sífilis y gonorrea<sup>14,15</sup></li>
 	<li>Tasas altas de sexo anal sin condón (“sexo a pelo”) y parejas múltiples<sup>16</sup></li>
 	<li>Abuso sexual en la niñez y un contexto social de discriminación<sup>17</sup></li>
</ul>
Definida como la adopción de las costumbres culturales de la sociedad mayoritaria, el trabajo sobre la aculturación sugiere que los latinos que son menos asimilados a la cultura mayoritaria de EE.UU. están protegidos por sus valores (sexuales) latinos tradicionales; y que la asimilación de los valores mayoritarios estadounidenses les sirve de barrera protectora porque les aumenta el sentido de individualismo y autodeterminación.<sup>18</sup>

Entender el papel que juegan los factores socioculturales nos ayuda a refinar la definición de la capacidad para elegir opciones sexuales sanas de los hombres latinos gay. El trabajo innovador que explora factores protectores entre hombres latinos gay señala que:

Entre los latinos radicados en San Francisco, la prevalencia del VIH era mayor entre los latinos nacidos en EE.UU. que los nacidos en otro país, en contraste con Chicago donde sucedió lo contrario<sup>9</sup>
<ul>
 	<li>El involucramiento comunitario modera las conductas de riesgo<sup>20</sup></li>
 	<li>Trabajar como voluntario con organizaciones de VIH/SIDA puede reducir los estresores psicológicos<sup>20</sup></li>
</ul>
Dado que la mayoría de estos datos provienen de encuestas cuantitativas, se necesitan más estudios enfocados en la salud pública para examinar más a fondo el contexto de las situaciones sexuales en las cuales los hombres latinos gay se encuentran, así como los factores culturales y guiones sexuales<sup>21</sup> que influyen en sus comportamientos de reducción de daños.
<h4>¿Qué se está haciendo al respecto?</h4>
<ul>
 	<li>Hermanos de Luna y Sol, un programa nacido en el Distrito de la Misión en San Francisco, CA es una intervención de prevención del VIH con una larga trayectoria enfocada en hombres inmigrantes latinos gay y bisexuales que hablan español. Basado en la educación sobre el empoderamiento y la fomentación del apoyo social, el programa ha logrado aumentar el uso de condones entre sus participantes<sup>22</sup>.</li>
 	<li>latinos D (basado en Queens, NY<sup>23</sup>) y Somos latinos Salud (basado en Ft. Lauderdale, FL<sup>24</sup>) son adaptaciones dinámicas y prometedoras del programa MPowerment, una eficaz intervención de VIH a nivel comunitario y basada en evidencias para hombres jóvenes gay y bisexuales<sup>25</sup>.</li>
 	<li>SOMOS, un programa de prevención de VIH surgido de la comunidad y culturalmente sensible basado en la ciudad de Nueva York, ha mostrado reducir los comportamientos de riesgo y disminuir el número de parejas entre los hombres latinos gay<sup>26</sup>.</li>
</ul>
Aun así, a pesar de estos programas y las recomendaciones de los CDC para resolver las disparidades de salud de los HSH latinos, la mayoría de las adaptaciones de intervenciones basadas en evidencias han sido versiones de programas establecidos que han sido traducidos lingüísticamente pero no necesariamente culturalmente.
<h4>¿Cuáles son las recomendaciones?</h4>
<ul>
 	<li>Honrar la diversidad dentro de las culturas latinas al momento de diseñar programas. Existen diferentes experiencias de eventos históricos, ambientes políticos, patrones inmigratorios y culturas regionales dentro de las comunidades latinas (por ejemplo, los chicanos en Los Ángeles, los “Nuyoricans” en Nueva York y los tejanos en San Antonio).</li>
 	<li>Realizar más investigaciones sobre las influencias estructurales y ambientales en la salud sexual de los hombres latinos gay, incluyendo temas relacionados con los latinos VIH+ indocumentados.</li>
 	<li>Entender que trabajar con una población no es lo mismo que tener competencia cultural. Incluir la participación latina no equivale a la provisión de servicios apropiados.</li>
 	<li>Cultivar la colaboración y empoderamiento de la comunidad gay latina logrando que los hombres latinos gay participen en los consejos locales que planifican la prevención y cuidado del VIH.</li>
 	<li>Crear programas que respondan a las necesidades particulares de los hombres latinos gay, tanto los inmigrantes como los nacidos en EE.UU. Suponer que todos los hombres latinos gay son hispanohablantes monolingües minimiza las necesidades de los hombres latinos gay biculturales (pero no necesariamente bilingües).</li>
 	<li>Reducir el estigma relacionados con la homosexualidad y el VIH en las comunidades latinas. Romper los silencios sexuales ayudará a promover la formación de una identidad sexual sana.</li>
 	<li>Colaborar con formuladores de políticas y entidades políticas interesadas para promover el acceso sostenible al cuidado de la salud.</li>
 	<li>Destacar las normas sociales y valores culturales que aumenten la capacidad para elegir opciones sexuales sanas. Enfocarse sólo en los factores de riesgo limita la identificación de nuevas percepciones y oportunidades para las intervenciones.</li>
 	<li>Fomentar programas que respondan al impacto del aislamiento y a la validación de la identidad. Disminuir los estresores que los hombres latinos gay encaran mejorará su bienestar general.</li>
</ul>

<hr size="2" />

<h3><strong>¿Quién lo dice?</strong></h3>
1 US Census Bureau (2011).  Overview of Race and Hispanic Origin: 2010 – U.S. Census Bureau. http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.

2 CDC. (2011). CDC Fact Sheet: HIV and AIDS among Latinos. http://www.cdc.gov/nchhstp/newsroom/docs/FastFacts-Latinos-FINAL508COMP.pdf.

3 CDC. (2008).  HIV Surveillance in Men Who Have Sex with Men (MSM). http://www.cdc.gov/hiv/topics/surveillance/resources/slides/msm/index.htm.

4 Prejean J, et al. (2011). Estimated HIV Incidence in the United States, 2006-2009. PLoS ONE.

5 ONAP. (2010). National HIV/AIDS Strategy: Federal Implementation Plan. http://www.whitehouse.gov/files/documents/nhasimplementation.pdf.

6 Diaz, RM (1998). Latino gay men and HIV: culture, sexuality, and risk behavior. Routledge.

7 Díaz RM, et al. (2001). The impact of homophobia, poverty, and racism on the mental health of gay and bisexual Latino men: findings from 3 US cities. Am J Public Health. 91(6):927-932.

8 Mizuno Y, et al. (2011). Homophobia and Racism Experienced by Latino Men Who Have Sex with Men in the United States: Correlates of Exposure and Associations with HIV Risk Behaviors. AIDS Behav. [Epub ahead of print]

9 CDC. (2011). HIV Surveillance Report, Vol. 21.

10 RAND. (2011). HIV Cost and Services Utilization Study (HCSUS). http://www.rand.org/health/projects/hcsus.html.\

11 Zea MC, et al. (2004). Methodological issues in research on sexual behavior with Latino gay and bisexual men.  Am J Community Psychol. 31(3-4):281-291.

12 National Latino AIDS Awareness Day. HIV/ AIDS and Latino/ Hispanic men who have sex with men. http://www.nlaad.org/resources/key_facts_latino_msm.php.

13 Rosenberg ES, et al. (2011). Number of casual male sexual partners and associated factors among men who have sex with men: results from the National HIV Behavioral Surveillance system. BMC Public Health. 25: 11-89.

14 CDC. (2010). HIV among Hispanics/ Latinos. http://www.cdc.gov/hiv/hispanics/resources/factsheets/pdf/hispanic.pdf.

15 Balan IC, et al. (2009). Intentional Condomless Anal Intercourse Among Latino MSM Who Meet Sexual Partners on the Internet. AIDS Educ Prev. 21(1): 14-24.

16 Diaz RM et al. (2005). Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users. Journal of Urban Health. 82(Supp1): 71-78.

17 Arreola SG, et al. (2009). Childhood sexual abuse and the sociocultural context of sexual risk among adult Latino gay and bisexual men. Am J Pub Hlth. 99 Suppl 2:S432-8.

18 Abraído-Lanza AF, et al. (2005). Do healthy behaviors decline with greater acculturation? Implications for the Latino mortality paradox. Soc Sci Med. 61:1243–1255.

19 Ramirez-Valles J, et al. (2008) HIV Infection, Sexual Risk, and Substance Use among Latino Gay and Bisexual Men and Transgender Persons. American Journal of Public Health. 98: 1036-1042.

20 Ramirez-Valles J (2002). The proactive effects of community inolvment for HIV risk behavior: A conceptual framework. Health Education Research. 17(4): 389-403.

21 Carrillo H, et al. (2008). Risk across borders: Sexual contexts and HIV prevention challenges among Mexican gay and bisexual immigrant men. Findings and recommendations from the Trayectos Study (Monograph). San Francisco: UCSF and SFSU. /sites/prevention.ucsf.edu/files/uploads/projects/Trayectos/monograph/index.html.

22 Hermanas de Luna y Sol. /sites/prevention.ucsf.edu/files/resources/project-websites/hermanos-de-luna-y-sol.

23 Latinos Diferentes. https://www.facebook.com/LatinosD.

24 Latinos Salud – Somos. http://www.Latinossalud.org

25 Mpowerment. http://mpowerment.org.

26 Vega MY, et al. (2011). SOMOS: evaluation of an HIV prevention intervention for Latino gay men. Health Educ Res. 26(3):407-418.

<hr size="2" />

<strong>Preparado por Gabriel R. Galindo DrPH, UCSF Center for AIDS Prevention Studies</strong>

Fact Sheet 28, March 2012

Agradecemos a los revisores de esta hoja informativa: Ana F. Abraido-Lanza, Sonya Arreola, Maricarmen Arjona, George Ayala, Alida Bouris, Hector Carrillo, Rafael Díaz, Lizette Rivera, Ramon Ramirez y Jesus Ramírez-Valles.

<hr size="2" />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Francisco should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © July 2012, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2013/02/Latino-MSM-Spanish-2013.pdf</url>
	</node>
	<node>
		<title>Hombres transgénero</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Quienes son los hombres trans?</h3>
Transgenero (‘trans’) es un término sombrilla para aquellas personas las cuales la identidad de género y expresión no conforman las normas y expectaciones tradicionales asociadas al género asignado al nacer. Hombres transgenero, también conocidos como hombres trans, son personas a las que se les asigno ‘femenino’ a la hora de nacer y tienen una identidad de género y/o una expresión de genero masculina. Personas transgenero pueden auto identificarse y expresar su género en una variedad de formas y en muchas ocasiones prefieren ciertos términos y no otros. Algunos que transicionan de mujer a hombre no se identifican para nada como transgenero sino solamente como hombres, a un hombre trans se les debe de referir con pronombres masculinos. De cualquier manera, si uno no está seguro, lo mejor es de que con respeto se les debe preguntar en qué términos y que proverbios estar personas prefieren ser referidas.

Información precisa sobre la diversidad de los cuerpos de los hombres trans no está al alcance ampliamente. Los hombres trans tienen diferentes tipos de cuerpos, dependiendo en el uso que hacen de testosteronas y cirugías usadas para la confirmación de su género (las cuales puede incluir la reconstrucción del pecho, histerectomía, metodioplastia, falloplastia,<sup>1</sup> etc.; visitar la página de internet en ingles: www.ftmguide.org para más información. Los hombres trans utilizan una amplia gama de términos y lenguajes para identificar su sexo y/o genero, describir sus partes corporales, y divulgar su estatus trans a otros. Por ejemplo, algunos hombres trans no se sienten cómodos con términos como “vagina” o “sexo vaginal” y suelen preferir llamarle “hoyo frontal” y “sexo frontal” o “sexo del hoyo frontal”, aunque esto no sea verdadero para todos los hombres trans. Esta diversidad crea necesidades únicas y barreras al negociar y adherirse a prácticas sexuales más seguras las cuales no son mencionadas en actuales programas de prevención del VIH.
<h4>¿Qué es lo que sabemos sobre el VIH y los hombres trans?</h4>
La comunidad transgenero es diversa y no se han llevado a cabo suficientes estudios con gente trans en general. En particular, tenemos información muy limitada sobre los hombres trans. Hasta la fecha, estudios relacionados con el VIH entra las personas trans han sido enfocadas casi exclusivamente en mujeres trans (personas las cuales se les asigno “masculino” al nacer y tiene una identidad de género femenina y/o una expresión de género femenina). De cualquier manera, existe evidencia que hay un subgrupo significante de hombres trans que llevan a cabo en sexo sin protección con otros hombres no-trans (trans MSM), incluyendo algunos hombres trans que están envueltos en el trabajo sexual.

Varias ciudades han llevado a cabo estudios de necesidades que se enfocan en, o son inclusivas a los hombres trans y los riesgos de contrael el VIH, como Philadelphia, Washington D.C, San Francisco, y la provincia de Ontario. Los escasos estudios publicados que muestran casos entre los hombres trans reportadan un prevalencia del 0 – 3%.<sup>2-4</sup> Estas cifras son auto-reportadas, de cualquier forma, y están basadas en muestras pequeñas y no representativas, así que no tenemos información final sobre cifras actuales. Dado a que se asume número bajos de infección del VIH entre hombres trans este es relavito a otros grupos de alto riesgo, no han habido muchos estudios sobres actividades de riesgo entre los hombres trans.

Nosotros si sabemos que los mensajes de prevención del VIH no están llegando a la mayoría de los hombres trans.<sup>5</sup> También sabemos que trans MSM buscan servicios en organizaciones donde proveen servicios a hombres gay, donde hay poca o no hay educación para los hombres trans y sus parejas non-trans.<sup>4</sup> Proveedores generalmente no están entrenados para identificar o dar servicios a los hombres trans gay o bisexuales en formas culturalmente sensitivas, ni entienden sus riesgos o necesidades de prevención especificas.
<h4>¿Qué es lo que no sabemos sobre el VIH y los hombres trans?</h4>
Nosotros no tenemos suficiente información sobre el VIH y los hombres trans. Métodos de colección de información en lugares donde se llevan a cabo estudios no identifican exactamente, no mantienen un control de los hombres trans ni capturan sus experiencias, lo cual contribuye a la falta de clarificación de las cifras de infección del HIV entre los hombres trans.

Cifras del VIH y actividades sexuales de riesgo entre los hombres trans tampoco son muy entendidas puesto que continuamente se asume que las relaciones sexuales de los hombres trans son primariamente con mujeres non-trans. De cualquier manera, como cualquier otro hombre, los hombres trans pueden ser de cualquier orientación sexual y pueden tener sexo con diferentes tipos de parejas, incluyendo (pero no limitándose a) hombres non-trans, mujeres transgenero, y hombres transgenero.<sup>6,7</sup>
<h4>¿Qué pone a riesgo a los hombres trans?</h4>
En un estudio, la mayoría de trans MSM reportaron consistentemente no usar condones durante el sexo anal receptivo y/o sexo frontal (vaginal) con otras parejas masculinas non-trans, y bajos el número de exámenes del VIH y baja percepción de riesgo.<sup>4</sup> En áreas urbanas en donde la prevalencia de números del VIH entre non-trans MSM son estimadas de ser 17-40% y los números de Infecciones Transmitidas Sexualmente (ITS) están incrementando, trans MSM quienes practican sexo anal receptivo sin protección y/o copula (penetración) con non-tran MSM pueden ser especialmente vulnerable al VIH/ITS.<sup>8,9</sup>

Los hombres trans pueden enfrontar complicados juegos de poderes y dinámicas de género en sus relaciones sexuales con otros hombres non-trans. Para un trans MSM, el tener sexo con una pareja hombre gay es una validación muy fuerte para identidad gay/queer, especialmente en los años iniciales de su transición, y puede esto ser más importante que el de insistir a usar un condón. Algunos hombres trans que usan testosteronas han reportado un incremento es su deseo sexual y un incremento en el interés sexual con hombres no trans después de comenzar el uso de hormonas, el cual puede contribuir al deseo de tomar riesgos seuxales.<sup>4,10</sup>
Los hombres trans pueden enfrontar complicados juegos de poderes y dinámicas de género en sus relaciones sexuales con otros hombres non-trans.<sup>4</sup> Para un trans MSM, el tener sexo con una pareja hombre gay es una validación muy fuerte para identidad gay/queer, especialmente en los años iniciales de su transición, y puede esto ser más importante que el de insistir a usar un condón. Algunos hombres trans que usan testosteronas han reportado un incremento es su deseo sexual y un incremento en el interés sexual con hombres no trans después de comenzar el uso de hormonas, el cual puede contribuir al deseo de tomar riesgos seuxales. <sup>4,10</sup>
Los hombres trans en testosterona y/o quienes hayan tenido una histerectomía pueden tener sequedad frontal (vaginal), lo cual incrementa sus riesgos de trauma frontal (vaginal) durante la penetración, y así incrementando sus riesgos de infección de las ITS, incluyendo el VIH<sup>10</sup>
Baja autoestima puede contribuir a practicar sexo de riesgo entre los hombres trans. Los números de depresión, uso de substancias, y atentos de suicidios son altos en esta población, pero existen múltiples barreras al tratar de obtener apoyo y tratamiento que sea culturalmente competente. <sup>3,11</sup>

El uso de drogas y alcohol es un gran factor de riesgo en cualquier comunidad, sin importar su identidad de género. Los hombres trans puede usar alcohol o drogas para realzar sus experiencias sexuales o para ayudar a aliviar o reducir ansiedades sobres sus cuerpos durante el sexo.<sup>4</sup> Algunos hombres trans pueden sentir presión de usar drogas para poder pertenecer a algunas comunidades o subculturas de hombres gay. Aunque tenemos muy poca información sobre el compartir agujas para hormonas o uso de drogas entres los hombres trans, este también puede ser un factor de riesgo para algunos de ellos.
<h4>¿Qué puede ayudar?</h4>
<strong>Noviasgo en el Internet.</strong> Varios hombres trans conocen a sus parejas sexuales no-trans en el internet. Conocer parejas por medio de anuncios personales puede permitir los hombres trans describir sus cuerpos y genero inicialmente (si ellos deciden hacerlo) y así discutir sexo más seguro con posible parejas antes de encontrarse en persona.<sup>4</sup>

<strong>Materiales educacionales para parejas no-trans.</strong> Parejas hombres no-trans de los hombres trans frecuentemente no tienen experiencia con los hombres trans ni acceso a educación sexual con ellos, lo cual los lleva a tener una idea equivocada sobre sexo más seguro. Para hombres gay no-trans, sexo más seguro frecuentemente solo significa usar condón para el sexo anal y pueden no estar consientes del riesgo asociado con el sexo frontal (vaginal). Vea la próxima sección que contiene informacion en materiales disponibles.

<strong>Gran visibilidad en la comunidad gay.</strong> Hombres gay y bisexuales necesitan ser educados sobre la presencia de los hombres trans en sus comunidades. Visibilidad incrementada y conocimiento sobre los hombres trans puede ayudar a crear un medioambiente de bienvenida, ayuda a incrementar inclusividad, y ayuda los hombres trans a sentirse con más poder es sus relaciones con otros hombres no-trans.<sup>7</sup>
<h4>¿Qué es lo que se está haciendo?</h4>
tm4m (tm4m.org) es un projecto basado en San Francisco para los hombres trans que juega con otros hombres (o que quiere jugar con ellos). Este provee información, educación, y apoyo a los hombres trans que tienen sexo con otros hombres por medio de talleres educacionales mensuales y grupos de discusión, materiales informativos y continuamente trabajan en adoptar aceptación y crear comunidad. tm4m es un esfuerzo colaborativo co-patrocinado por Eros, Trannywood Pictures y TRANS:THRIVE (un programa del Centro de Salud para Asiaticos y personas de las islas del pacifico).

El Grupo de Trabajo de Hombres Trans Gay/Bi/Queer ha conducido un estudio de necesidades con trans MSM, creado recursos de salud sexual,<sup>12</sup> y la página electrónica www.queertransmen.org También proveen entrenamiento y consulta sobre la inclusión de trabajadores de prevención a través de la provincia.

All Gender Health Online (www.allgenderhealth.org) es un estudio que explora la salud sexual de hombres no-transgenero que tienen sexo con personas transgenero. Los resultados serán usados para crear una intervención en el internet para prevenir la extensión del VIH y promover la salud sexual de personas transgeneros y sus parejas.

El proyecto STOP AIDS de San Francisco, California se esfuerza en incluir los hombres trans en su programación y educación comunitaria. Estos incluyen transgenero hombres en la declaración de la misión de su agencia y han cambiado los métodos de colectar información que mejor reflejen cuerpos en transición e identidades de géneros en comunidades de hombres gay.
<h4>¿Qué queda por hacer?</h4>
Necesitamos implementar métodos de colección de información mas inclusiva para mejor captar subgrupos de personas transgenero. Proveedores de salud no deben asumir que todos los hombres que ellos ven han sido asignados ‘hombre’ al nacer. <sup>13</sup> Uno no puede decir que alguien es trans al solo mirarlo. El mejor método para colección de información es una pregunta de dos partes: 1) pregunta sobre identidad de género actual y 2) pregunta que sexo fue asignado al nacer.

Si uno no está seguro, debería de preguntar los hombres trans por su nombre y pronombres preferidos y usar estos términos. Si los números del VIH entre los hombres trans están de hecho bajos, tenemos nosotros la oportunidad de envolvernos en un trabajo verdadero de prevención para mantener esos números bajos. Adquirir un mayor entendimiento de los comportamientos de riesgo de los
hombres trans y las diferente formas en las cuales ellos mismos se protegen, ayudara a proveer educacion apropiada y efectiva de prevención del VIH para los hombres trans y sus parejas sexuales.

<hr />

<h4>¿Quién lo dice?</h4>
1. Es importante notar que pocos hombres trans tienen penes completamente funcionales, debido primariamente a las bajas tasas del éxito de la cirujía, altos números de complicaciones y el alto costo de la cirujía.

2. Herbst J, Jacobs E, Finlayson T, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: A systematic review.
AIDS and Behavior. 2007.

3. Clements-Nolle K, Marx R, Guzman R, et al. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: Implications for public health intervention. American Journal of Public Health. 2001;91:915-921.

4. Sevelius J. ‘‘There’s no pamphlet for the kind of sex I have’’: HIV-related risk factors and protective behaviors among transgender men who have sex with
non-transgender men. Journal of the Association of Nurses in AIDS Care. 2009;20:398-410.

5. Hein D, Kirk M. Education and soul-searching: The Enterprise HIV prevention group. In: Bockting W, &amp; Kirk, S., editor. Transgender and HIV: Risks,
prevention, and care.Binghamton, NY: The Haworth Press; 2001. p. 101-117.

6. Schleifer D. Make me feel mighty real: Gay female-to-male transgenderists negotiating sex, gender, and sexuality. Sexualities 2006;9(1):57-75.

7. Bockting W, Benner A, Coleman E. Sexual identity development among gay and bisexual female-to-male transsexuals: Emergence of a transgender
sexuality. Archives of Sexual Behavior. 2009;38(5).

8. Colfax G, Coates T, Husnik M, Huang Y, Buchbinder S, Koblin B, et al. Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. Journal of Urban Health. 2005;82:i62-i70.

9. CA Department of Health Services. California HIV counseling and testing annual report: January - December 2003. Sacramento, CA: Office of AIDS; 2006.

10. Gorton N, Buth J, Spade D. Medical therapy and health maintenance for transgender men: A guide for health care providers: Lyon-Martin Women’s Health Services; 2005.

11. Newfield E, Hart S, Dibble S, Kohler L. Female-to-male transgender quality of life. Quality of Life Research 2006;15(9):1447-57.

12. Gay/Bi/Queer Transmen’s Working Group of the Ontario Gay Men’s HIV Prevention Strategy. Primed: The Back Pocket Guide for Transmen &amp; The Men Who Dig Them. Toronto, Ontario; 2007.

13. Center of Excellence for Transgender HIV Prevention. Recommendations for inclusive data collection of trans people in HIV prevention, care, and services. University of California, San Francisco. 2009. www.transhealth.ucsf.edu

<hr />

Una publicación del Centro de Estudios para la Prevención del SIDA (CAPS) y el Instituto de Investigaciones sobre SIDA (ARI), Universidad de California en San Francisco (UCSF). Se autoriza la reproducción (citando a UCSF) más no la venta de copias este documento. También disponibles en inglés - www.prevention.ucsf.edu/pubs/FS/. Para recibir las Hojas de Datos por correo electrónico escriba a listserv@listserv.ucsf.edu con el mensaje “subscribe CAPSFS nombre apellido” ©UCSF 2010

&nbsp;

&nbsp;]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/HombresTransgeneroFS.pdf</url>
	</node>
	<node>
		<title>Jóvenes HSH</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los hombres jóvenes que tienen sexo con hombres para la prevención del VIH?</h3>
<h3>revisado 4/01</h3>
<h4>¿están en riesgo de contraer VIH?</h4>
Sí. En los EEUU más de la mitad de los casos nuevos de VIH/SIDA en hombres de 13 a 24 años, ocurren por contacto sexual entre hombres.<sup>1</sup> Varios estudios encontraron que del 26% -50% de los hombres jóvenes que tienen sexo con hombres reportó haber tenido relaciones sexuales recientes sin protección, muchas de las cuales se dieron con parejas de estatus de VIH desconocido o diferente al del entrevistado.<sup>2-4</sup> El índice de conductas de riesgos que toman los jóvenes HSH también se ha incrementado.<sup>5</sup> El término de hombres jóvenes que tienen sexo con hombres (jóvenes HSH) se refiere a todo aquel menor de 30 años que se identifique como gay/bisexual, así como a quien no se identifique como tal pero que practique el sexo con otro hombre

Un gran número de jóvenes HSH urbanos está infectado con VIH. Un estudio con participantes entre los 15 y 22 años en siete ciudades (Baltimore, Dallas, Los Angeles, Miami, Nueva York, El Area de la Bahía de San Francisco y Seattle) reveló una alta prevalencia (número total de infecciones existentes) general del 7%, que varía entre 2% y 12% entre subgrupos. El 82% de los jóvenes VIH+ no sabían que estaban infectados antes participar en éste estudio.<sup>6</sup>

Los jóvenes HSH de raza no blanca (no caucásicos), especialmente los afroamericanos, están siendo mayormente afectados por el VIH. En el estudio mencionado arriba, el 14% de los afroamericanos resultaron VIH+ comparado con un 3% de asiáticos, 3% de caucásicos, 7% de hispanos y un 13% de hombres de razas mezcladas (o “mixtas” como se les denomina en EEUU).<sup>6</sup>
<h4>¿por qué corren riesgos los jóvenes HSH?</h4>
Desgraciadamente, no existe una respuesta sencilla. Las razones por las que ocurre el sexo desprotejido son complejas y múltiples.<sup>3,7</sup> La adolescencia y el inicio de la edad adulta comúnmente se caracterizan por la experimentación sexual y el consumo de drogas. Aunque la mayoría de los jóvenes HSH llegará a practicar ciertas conductas de riesgo, sólo un pequeño porcentaje tomará riesgos constantemente. Muchos jóvenes luchan con tensiones personales, interpersonales y sociales que pueden limitar su capacidad de protegerse.

Para algunos jóvenes HSH [en los EEUU] existen factores individuales capaces de impulsarles a tener sexo desprotegido, por ejemplo: sentimientos de invulnerabilidad ante el VIH, altos niveles de optimismo por los medicamentos antivirales, percepción de que el sexo desprotegido es más placentero que el sexo protegido, depresión o tristeza, conflicto con la identidad sexual o racial [que frecuentemente se ven como separadas y parte de dos comunidades diferentes] y consumo de alcohol o drogas (como cristal/speed, poppers).<sup>8</sup>

Proteger su salud no es necesariamente la preocupación principal del joven HSH como lo son las motivaciones interpersonales de querer sentirse parte de algo, querer compañía y tener intimidad. Además, existen otros factores interpersonales que pueden contribuir al sexo desprotegido como no saber comunicar o negociar relaciones sexuales más seguras con una pareja sexual. Los jóvenes HSH con pareja son más propensos que los solteros al sexo desprotejido.<sup>4</sup>

Los factores sociales también pueden influir en los riesgos que toman los jóvenes HSH. Muchos jóvenes se sienten aislados o rechazados por las fuentes de tradicionales de apoyo como la familia, la escuela o la comunidad religiosa.<sup>9</sup> La homofobia, el racismo y la pobreza también ponen en riesgo a estos jóvenes. Algunos jóvenes HSH (especialmente los indigentes) luchan con preocupaciones diarias como evitar la violencia, buscar un lugar dónde vivir o conseguir comida. Estas preocupaciones inmediatas pueden opacar la necesidad de protegerse al inyectarse drogas y al tener sexo.

Los jóvenes HSH tienen pocos lugares públicos dónde reunirse. Los bares gay y las areas públicas de encuentro o “de ligue” son sitios visibles y accesibles que ofrecen anonimato para el joven que intenta explorar su identidad sexual. Estos sitios están asociados con niveles altos para la toma de riesgos pues tienen una alta tensión sexual. Además, la escena del bar al enfatizar el consumo de alcohol, crea un escenario ideal para los encuentros sexuales bajo la influencia del mismo. Se ha encontrado que todo esto contribuye consistentemente al sexo desprotegido.<sup>10</sup>

Poco se sabe del papel de la Internet en la vida de éstos jóvenes y cómo la utilizan para obtener apoyo social, conocer nuevas amistades, tener encuentros sexuales, y conseguir pareja.
<h4>¿qué se ha hecho?</h4>
El proyecto Mpowerment es una intervención de múltiples niveles por y para jóvenes gay. Ellos mismos se encargan del programa. Debido a que el VIH puede ser un tema poco atractivo para muchos jóvenes HSH, el proyecto se concentra en sus intereses y preocupaciones sociales. Ellos coordinan y planean actividades que les permiten crear una comunidad más fuerte y más saludable en la que el sexo protegido sea la norma aceptada mutuamente. Al participar, los jóvenes del proyecto reducen sus tasas de sexo anal desprotegido con parejas casuales y con novios.<sup>3</sup> Mpowerment ha comprobado su eficacia como intervención para la prevención del VIH. Ofrece adiestramientos a agencias comunitarias y un manual sobre cómo replicar éste modelo.<sup>11</sup>

La organización COLOURS en Filadelfia ofrece grupos de apoyo, adiestramiento de pares y manejo de casos individuales para jóvenes de raza no blanca. Tienen promotores que asisten a los bares y clubes de sexo frecuentados por adultos HSH de raza no blanca y ofrecen condones y consejería a jóvenes que se relacionan con una pareja mayor. También promueven programas para el tratamiento del alcohol y drogas dirigidos a jóvenes HSH.<sup>12</sup>

La Asociación Americana de Psicología (APA sus siglas en inglés) ha implementado el proyecto Healthy Schools for Gay and Lesbian Students (escuelas sanas para estudiantes gay y lesbianas) que imparte adiestramiento a psicólogos, consejeros, enfermeras y trabajadoras sociales de las escuelas para que puedan trabajar exitosamente con estudiantes gay, lesbianas y bisexuales. La meta es crear un ambiente escolar más hospitalario y que la educación sobre prevención de VIH toque temas importantes para ellos/as.<sup>13</sup>

“Chico Chats”, un programa del proyecto STOP AIDS en San Francisco, imparte una serie de talleres intensivos durante un mes. Los participantes llegan a conocerse mientras que entablan conversaciones conducidas por un moderador sobre temas como identidad, imagen corporal, relaciones de pareja y cómo todo ésto se vincula con el VIH. Un componente clave de los talleres es aprender las técnicas sobre organización y movilización comunitaria. Los participantes formaron un grupo activista llamado ¡Ya Basta! Diseñaron un video y un taller que examina los temas del silencio sexual y la forma de “salir del closet” en el contexto de las familias latinas. El video está siendo presentado a la comunidad latina de San Francisco.<sup>14</sup>
<h4>¿qué más se necesita?</h4>
Para ser eficientes, los programas para jóvenes HSH deberán considerar el contexto de sus vidas y los factores individuales, interpersonales y sociales que los pone en riesgo. Una educación integral sobre salud y sexualidad debe dirigirse tanto a los que se identifican como gay o bisexual como a los que no lo hacen. Desgraciadamente, muchos programas escolares tienen un enfoque en la reproducción o la abstinencia hasta el momento del matrimonio, marginando aún más a los jóvenes HSH.

Hay una necesidad urgente de crear programas de prevención y bienestar para jóvenes HSH de raza no blanca. Los programas existentes para hombres mayores HSH de raza no blanca también deben estar disponibles para los jóvenes. Estos programas deben incluir los temas de la sexualidad, identidad gay, cultura, etnicidad, racismo, homofobia, pobreza y violencia. Los programas deben considerar las necesidades de prevención de VIH para jóvenes que son VIH+ y VIH-. Es necesario prestar especial atención a la forma de llegar a los jóvenes HSH marginados como los indigentes, los trabajadores sexuales o los que están bajo el sistema de justicia criminal. Es posible que ellos no se identifiquen a sí mismos como gay o bisexuales y que sus necesidades inmediatas sean la comida y un techo.

Se necesitan programas que promuevan el apoyo para jóvenes HSH y los incluyan directamente en la planificación e implementación de los mismos; por ejemplo crear lugares seguros donde los jóvenes puedan socializar y tengan acceso a servicios, implementar programas escolares que instruyan sobre la sexualidad y necesidades de gay y bisexuales; promover mayor aceptación del joven HSH en las escuelas, familias, comunidades religiosas, la comunidad gay en general y en las comunidades de razas no blancas.<sup>15</sup>

La homofobia social puede impedir la implementación de programas de prevención para jóvenes HSH y puede desalentarles para que utilicen los servicios de prevención.<sup>16</sup> La política no debe interferir con los servicios de prevención para jóvenes HSH. Dirigir mensajes de prevención y ofrecer servicios a estos jóvenes son respuestas adecuadas ante la grave amenaza que enfrenta la salud pública. Si no se toma acción inmediata muchos más hombres perderán sus vidas a causa del VIH.

<hr />

<h4>¿quién lo dice?</h4>
<ol>
 	<li>Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . 2000;12.</li>
 	<li>Molitor F, Facer M, Ruiz JD. Safer sex communication and unsafe sexual behavior among young men who have sex with men in California. Archives of Sexual Behavior. 1999;28:335-343.</li>
 	<li>Kegeles SM, Hays RB, Pollack LM, et al. Mobilizing young gay and bisexual men for HIV prevention: a two-community study . AIDS. 1999;12:1753-1762.</li>
 	<li>Hays RB, Kegeles SM, Coates TJ. Unprotected sex and HIV risk-taking among young gay men within boyfriend relationships . AIDS Education and Prevention. 1997;9:314-329.</li>
 	<li>Ekstrand ML, Stall RD, Paul JP et al. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status . AIDS. 1999;13:1525-1533.</li>
 	<li>Valleroy LA, MacKellar DA, Karon JM et al. HIV prevalence and associated risks in young men who have sex with men . Young Men’s Survey Study Group. Journal of the American Medical Association. 2000;284:198-204.</li>
 	<li>Strathdee SA, Hogg RS, Martindale SL et al. Determinants of sexual risk-taking among young HIV-negative gay and bisexual men . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;19:61-66.</li>
 	<li>Choi KH, Kumekawa E, Dang Q et al. Risk and protective factors affecting sexual behavior among young Asian and Pacific Islander men who have sex with men: Implications for HIV prevention . Journal of Sex Education &amp; Therapy. 1999;24:47-55.</li>
 	<li>Beeker C, Kraft JM, Peterson JL, et al. Influences on sexual risk behavior in young African-American men who have sex with men. Journal of the Gay and Lesbian Medical Association. 1998;2:59-67.</li>
 	<li>Greenwood GL, White EW, Page-Shafer K, et al . Correlates of heavy substance use among young gay and bisexual men: The San Francisco Young Men’s Health Study . Drug and Alcohol Dependence. 2001:61:105-112.</li>
 	<li>CDC. Compendium of HIV prevention interventions with evidence of effectiveness . 1999.</li>
 	<li>The COLOURS Organization, Inc . Philadelphia, PA. 215/496-0330.</li>
 	<li>Clay RA. Healthy Schools project hoped to ease discrimination . APA Monitor. 1999;30.</li>
 	<li>The STOP AIDS Project . Q Action, ¡Ya Basta! San Francisco, CA. 415/865-0790 x303.</li>
 	<li>Seal DW, Kelly JA, Bloom FR, et al. HIV prevention with young men who have sex with men: what young men themselves say is needed . AIDS Care. 200;12:5-26.</li>
 	<li>Stokes JP, Peterson JL. Homophobia, self-esteem, and risk for HIV among African American men who have sex with men . AIDS Education and Prevention. 1998;10:278-292.</li>
</ol>

<hr />

<strong>Preparado por Pilgrim Spikes MPH, Phd, Bob Hays PhD, Greg Rebchook PhD, Susan Kegeles PhD;
Traducción Romy Benard y Maricarmen Arjona
CAP</strong>S

Septiembre 2001. Hoja Informativa 8SR]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/HJSHFS.pdf</url>
	</node>
	<node>
		<title>Adults over 50</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are HIV Prevention Needs of Adults Over 50?</h3>
<h4>Are older adults at risk?</h4>
Yes. Over 10% of all new AIDS cases in the US occur in people over the age of 50.<sup>1</sup> In the last few years, new AIDS cases rose faster in middle age and older people than in people under 40.<sup>2</sup> While many of these AIDS cases are the result of HIV infection at a younger age, many are due to becoming infected after age 50.

It is difficult to determine rates of HIV infection among older adults, as very few persons over the age of 50 at risk for HIV routinely get tested.<sup>3</sup> Most older adults are first diagnosed with HIV at a late stage of infection-when they seek treatment for an HIV-related illness.

Cases among older people may be under reported, as HIV symptoms and infections may coincide with other diseases associated with aging, and thus be overlooked. AIDS-related dementia is often misdiagnosed as Alzheimer’s, and early HIV symptoms such as fatigue and weight loss may be dismissed as a normal part of aging.<sup>4</sup>

Older persons with AIDS get sick and die sooner than younger persons. This is due to late diagnosis of the disease as well as co-infection with other diseases that may speed the progression of AIDS. Also, new drugs for HIV treatment may interact with medications the older person is taking to treat pre-existing chronic conditions.
<h4>What puts them at risk?</h4>
A common stereotype in the US is that older people don’t have sex or use drugs. Very few HIV prevention efforts are aimed at people over 50, and most educational ad campaigns never show older adults, making them an invisible at-risk population.<sup>6</sup> As a result, older people are generally less knowledgeable about HIV/AIDS than younger people and less aware of how to protect themselves against infection. This is especially true for older injecting drug users, who comprise over 16% of AIDS cases over 50.

Men who have sex with men form the largest group of AIDS cases among adults over 50. Older gay men tend to be invisible and ignored both in the gay community and in prevention. Among the HIV risk factors for older gay men are internalized homophobia, denial of risk, alcohol and other substance use, and anonymous sexual encounters.<sup>7</sup>

Women comprise a greater percentage of all AIDS cases as age increases. While 6.1% of all AIDS cases among those aged 50-59 are women, the percentage of cases occurring among women rises to 13.2% for age 60-69 and 28.7% for those 65 and older.<sup>8</sup> Normal aging changes such as a decrease in vaginal lubrication and thinning vaginal walls can put older women at higher risk for HIV infection during intercourse.<sup>9</sup>
<h4>what are barriers to prevention?</h4>
Few Americans over age 50 who are at risk for HIV infection either use condoms or get tested for HIV. In a national survey, at-risk people over 50 were one sixth as likely to use condoms and one fifth as likely to have been tested for HIV than at-risk people in their 20s.<sup>3</sup> Factors that influence condom use in older persons are not known.

Doctors and nurses often do not consider HIV to be a risk for their older patients. A study of doctors in Texas found that most doctors rarely or never asked patients older than 50 years questions about HIV/AIDS or discussed risk factor reduction. Doctors were much more likely to rarely or never ask patients over 50 about HIV risk factors (40%) than they were to never or rarely ask patients under 30 (6.8%).<sup>10</sup>

Many older people live in assisted living communities, where there is still great stigma attached to HIV/AIDS, often associated with homosexuality and/or substance abuse. Management may be resistant to providing HIV/AIDS educational materials or presentations in their facilities.
<h4>How are older adults different?</h4>
Cultural and generational issues need to be considered in crafting HIV prevention efforts. Older persons may not be comfortable disclosing their sexual behaviors or drug use to others. This can make it difficult to find older adults who attend support groups.<sup>11</sup> Also, older adults may not view condom use as important or necessary, especially post-menopausal women who need not worry about pregnancy protection.

Older adults may have fewer surviving friends and a smaller social network to provide support and care. Also, they are more likely to be caregivers themselves, as about one third of AIDS patients are dependent on an older parent for financial, physical or emotional support.<sup>12</sup>
<h4>What’s being done?</h4>
Unfortunately, few prevention programs exist that target adults over 50. Most programs for older adults offer support for HIV+ persons, or target clinicians and caregivers of older adults. Promising prevention programs incorporate generational concerns, target high-risk groups such as older gay men and older women (especially recent widows), and involve older adults in their design and as peer educators.

Senior HIV Intervention Project (SHIP) in Florida’s Dade, Broward and Palm Beach Counties, trains older peer educators to present educational and safer sex seminars at retirement communities. Trained AIDS educators meet with health care professionals and aging services workers to help them understand the risk posed to seniors by HIV.<sup>13</sup>

In six regional senior centers in Chicago, IL, a program used peer-led “study circles” to increase HIV awareness and knowledge. Participants viewed a video, “The Forgotten Tenth,” and did their own research as to how HIV affects their lives physically, politically and economically. They then shared their knowledge at the next meetings. After the program many participants became AIDS educators.<sup>14</sup>

An HIV education program for older adults was conducted at meal sites in Florida. Based on the Health Belief Model, the program included facts and statistics on older persons and HIV, condom use instruction, HIV testing information, and case studies of older persons with AIDS. After the session, participants reported a significant increase in knowledge about AIDS and perceived susceptibility to HIV.<sup>15</sup>
<h4>What needs to be done?</h4>
There has been a striking lack of interest in people over 50 in HIV prevention efforts. Prevention programs are needed specifically for older adults. Mainstream ad campaigns need to incorporate images and issues concerning persons over 50 and encourage at-risk older adults to be routinely tested for HIV. More research on sexual and drug using behavior of older adults is needed, as well as research on disease progression and treatments, including recruiting HIV+ older persons for clinical trials.

Clinicians and service providers for older adults, including care takers and nursing home staff, need to be educated on HIV risk behaviors and symptoms of HIV infection among older adults. Clinicians need to conduct thorough sex and drug use risk assessments with their patients over 50, and challenge any assumptions that older people do not engage in these activities or will not discuss them.

Older adults need support and education to ensure that their lives over 50 are as rewarding and safe as before 50. A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. Adults over 50 are an especially important group to target with prevention messages, both for their own risk behaviors, and for their role as leaders and teachers of younger generations.

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . 1996;8:15.

2. HIV, AIDS, and older adults . Fact sheet prepared by the National Institute on Aging, National Institutes of Health.

3. Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral Surveys . Archives of Internal Medicine. 1994;154:57-63.

4. Whipple B, Scura KW. The overlooked epidemic: HIV in older adults . American Journal of Nursing. 1996;96:22-28.

5. Skiest DJ, Rubinstien E, Carley N, et al. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study . American Journal of Medicine. 1996;101:605-611.

6. Feldman MD. Sex, AIDS, and the elderly . Archives of Internal Medicine. 1994;154:19-20.

7. Grossman AH. At risk, infected, and invisible: older gay men and HIV/AIDS . Journal of the Association of Nurses in AIDS Care. 1995;6:13-19.

8. Ship JA, Wolff A, Selik RM. Epidemiology of acquired immune deficiency syndrome in persons aged 50 years or older . Journal of Acquired Immune Deficiency Syndromes. 1991;4:84-88.

9. Catania JA, Turner H, Kegeles SM, et al. Older Americans and AIDS: transmission risks and primary prevention research needs . Gerontologist. 1989;29:373-381.

10. Skiest DJ, Keiser P. Human immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians’ beliefs, practices, and knowledge . Archives of Family Medicine. 1997;6:289-294.

11. Nokes K, ed. HIV/AIDS and the older adult . Washington DC: Taylor &amp; Francis;1996.

12. Ory MG, Zablotsky D. Notes for the future: research, prevention, care, public policy. In MW Riley, MG Ory, D Zablotsky, eds. AIDS In an Aging Society. New York, NY: Springer Publishing; 1989.

13. Senior HIV Intervention Project (SHIP). Contact: Lisa Agate (954) 467-4774.

14. Dill D, Huston W. AIDS education for older adults. Healthpro UIC. 1996;Fall:18-19.

Contact: Rita Strombeck, HealthCare Education Associates (760) 323-4032.

15. Rose MA. Effect of an AIDS education program for older adults . Journal of Community Health Nursing. 1996;13:141-148.

Contact: Molly Rose (215) 503-7567.

<strong>Resources:</strong>

NY HIV Over 50 Task Force
Brookdale Center on Aging
Hunter College
425 E 25th Street
New York, NY 10010
(212) 481-7594.
<ul>
 	<li>Contact: Kathy Nokes
kathynokes@aol.com</li>
</ul>
American Association of Retired Persons (AARP)
Social Outreach and Support (SOS)
601 E Street, NW
Washington, DC 20049
(202) 434-2260
http://www.aarp.org

National Association on HIV Over Fifty (NAHOF)
Midwest AIDS Training &amp; Education Center
University of Illinois
808 S. Wood Street m/c 779
Chicago, IL 60612
(312) 996-1426
nlinsk@uic.edu

National Institute on Aging
http://www.nih.gov/nia/

<hr />

<strong>Prepared by Pamela DeCarlo* and Nathan Linsk, PhD**
*CAPS, **National Association on HIV Over 50, Midwest AIDS Training &amp; Education Center</strong>

September 1997. Fact Sheet #29E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 1997, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/over50FS.pdf</url>
	</node>
	<node>
		<title>American Indian/ Alaskan Natives (AI/AN)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are American Indian/ Alaskan Natives’ (AI/AN) HIV prevention needs?</h3>
<h4>Are AI/AN at risk for HIV?</h4>
Yes. American Indians and Alaskan Natives (AI/AN) represent a unique population within the US, not only because of their oppression suffered in the development of this country but also because of their ongoing struggle to gain recognition in the HIV/AIDS epidemic. AI/ANs are not so unique, however, that they are protected from the same behaviors that put all people at risk for HIV infection.

The long history of oppression of AI/AN in the US has had a devastating effect on the health and well-being of Native Peoples. This history, including colonization, outlawing Native languages and spiritual practices, and centuries of forced relocation, has created justified mistrust of US government programs and health institutions.<sup>1</sup> This legacy continues to shape the experience of AI/AN as they are disproportionately impacted by poverty, ill health, family violence and drug and alcohol abuse. All of these factors are associated with HIV risk.<sup>2</sup>

Through the end of 2000, AI/ANs comprised 2,337 AIDS cases and 871 HIV cases<sup>3</sup>. AI/AN constitute approximately 1% of the total US population, and just under 1% of reported AIDS and HIV cases<sup>3</sup>. Although these numbers appear small relative to other populations, the impact is considerable. Underreporting and the lack of detailed HIV surveillance of AI/AN may result in significant undercounting of HIV infections.

Further, AI/AN are often misclassified in terms of race/ethnicity on data collection forms, due to assumptions about names, skin color, residence and even intentionally misleading self reporting.<sup>4</sup> A study of STD data in Oklahoma found that 35% of chlamydia and over 60% of gonorrhea cases among AI/AN had been incorrectly attributed as Hispanic or white.<sup>5</sup>
<h4>What puts AI/ANs at risk?</h4>
HIV research among AI/AN has a short history starting in the early 1990s, with few studies on risk behavior. According to the CDC, for AI/AN men, the leading exposure category for HIV is men who have sex with men (MSM) at 51%, MSM and injection drug use (IDU) 13% and heterosexual IDU 12%. Among women, the primary exposure risk is heterosexual contacts at 41%, followed by IDU at 32%. However, this data does not include data from California, which has the largest Native population of all 50 states.<sup>6</sup>

AI/AN populations are disproportionately impacted by social, behavioral and economic factors that are associated with HIV risk. AI/AN suffer high rates of poverty and unemployment, with 32% living below poverty level, compared to 13% of the general US population. Native Americans also experience high rates of drug and alcohol use, STDs and violence. Alcohol use in the AI/AN population has resulted in the highest alcohol-related mortality rates for all US populations.<sup>9</sup>

One study of AN drug users found that alcohol use was the factor that put them at greatest risk for HIV. Many individuals reported blacking out while drinking, and later learned that they had unprotected sex with complete strangers or persons they would not otherwise accept as partners.<sup>10</sup>

This same study showed that drug using Alaskan Native women are at high risk for gonorrhea infection and HIV infection. AN women were more likely to inject drugs than any other ethnic group among women, and they were more likely to have white male injectors as sex partners. Sex pairs composed of AN women and white men were the least likely of any ethnic pair combinations to use condoms.<sup>11</sup>

In states with AI/AN populations over 20,000, gonnorhea and syphilis rates are twice as high as among other ethnic groups.<sup>7</sup> Persons with STDs are more likely both to transmit HIV and become infected with HIV if exposed.

A study of American Indian youth in over 200 reservation-based schools across the US showed that youth engaged in several risk behaviors: the use of alcohol, tobacco and other drugs, risky sexual behavior and suicidal behaviors. Drug use was most commonly associated with other risky behaviors.<sup>12</sup>
<h4>What are barriers to prevention?</h4>
HIV is often rendered invisible within AI/AN communities that are facing many other severe and more visible health and social problems such as alcoholism, diabetes and unemployment. As a result, there is often great denial about HIV as a problem in AI/AN communities.

Like in many other tight-knit communities, confidentiality can be difficult to maintain in AI/AN communities, especially in rural areas. This can be a barrier to important prevention activities such as testing for HIV, discussing sexual practices with health care providers, obtaining drug treatment, or buying condoms in local stores.

Prevention services for AI/AN MSM are severely underfunded, and those that exist may not reach MSM at risk. AI/AN MSM have a wide range of identities, from “gay” to “two-spirit” and may not access services addressed to urban gay men.<sup>13</sup> AI/AN MSM may feel isolated and not seek out needed services because of stigma and denial about homosexuality in some AI/AN communities.

The AI/AN population is highly diverse, with over 550 federally-recognized tribes. AI/AN consider themselves to belong to Indian nations that are sovereign, with complex relationships between tribal, state and federal governments. Many state and local governments erroneously assume that the IHS is solely responsible for the health- related needs of AI/AN. Less than 1% of IHS budget goes to urban populations, yet more than half of all AI/AN in the US live in urban areas. As a result, AI/AN tribes and organizations are often denied funding opportunities available to other citizens.
<h4>What’s being done?</h4>
To address the rising rates of STDs and HIV among adolescents in a rural Arizona Indian tribe, tribal health educators, school officials and public health officials collaborated to establish several programs including school health clinics, Native American HIV+ speakers, peer-produced educational dramas, community educational meetings and radio and newspaper ads. Cases of STDs and HIV peaked in 1990 and slowly declined over the next six years, for a 69% overall reduction in STDs.<sup>14</sup>

The Indigenous People’s Task Force (IPTF) in Minneapolis, MN, promotes health and education for Native persons. Their Ogitchidag Gikinooamaagad (warrior/teachers) peer education/theater program provides youth with a comprehensive HIV/AIDS prevention curriculum, theater instruction and traditional teachings. IPTF’s programs have been acknowledged by the US Surgeon General.<sup>15</sup>

The Indian Health Care Resource Center (IHCRC) of Tulsa, OK provides a biweekly social group for two-spirit Native American men to help build a sense of community, self-esteem and reduce risk behaviors. IHCRC also hosts a relationship skills-building workshop which focuses on helping the participants determine what they want out of relationships, managing triggers to risk behavior and increasing negotiating skills. Each year, IHCRC offers a 4-day retreat with social, cultural and educational activities including traditional meals, a Powwow and stomp dancing.<sup>16</sup>
<h4>What still needs to be done?</h4>
AI/AN communities, although diverse in many ways, share a sense of pride, self- determination, spirituality, and resiliency which have helped them fight HIV infection in their communities. These efforts need to be encouraged to ensure sustained HIV prevention. This can only occur with cooperation and collaboration between the many agencies who work with AI/AN, including tribal health care systems, federal, state and local health departments and non-profit agencies. For example, complex funding streams need to be simplified to allow AI/AN communities greater access to prevention resources.

HIV/AIDS must be made visible in AI/AN communities to prevent the spread of HIV. Visibility can be increased by collecting reliable HIV/AIDS data, including AI/AN in the design and delivery of HIV prevention programs, addressing AI/AN stigma about homosexuality and drug use, and linking to STD, violence, unintended pregnancy, and alcohol and drug abuse prevention programs.

<hr />

<h3>Says who?</h3>
1. National Institutes of Health. Women of color health data book: adolescents to seniors. 1999. NIH publication #99-4247.www4.od.nih.gov/orwh/WOCEnglish.pdf (accessed January 2002).

2. Vernon I. Killing Us Quietly: Native Americans and HIV/AIDS. University of Nebraska Press, 2001.

3. Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through December 2001, Year-end edition. HIV/AIDS Surveillance Report. 2001;13 (2). (accessed April 2006).

4. Rowell RM, Bouey PD. Update on HIV/AIDS among American Indians and Alaska Natives. The IHS Primary Care Provider. 1997;22:49-53. (accessed April 2006).

5. Thoroughman DA, Frederickson D, Cameron HD, et al. Racial Misclassification of American Indians in Oklahoma state surveillance data for sexually transmitted diseases. American Journal of Epidemiology. 2002;155(12): 1137-41.

6. Smith AS, Ahmed B, Sink L. US Census Bureau. An Analysis of State and County Population Changes by Characteristics: 1990-1999. Working Paper Series No. 45. (accessed April 2006).

7. Centers for Disease Control and Prevention. HIV/AIDS among American Indians and Alaskan Natives – United States, 1981-1997. Morbidity and Mortality Weekly Report. 1998;47:154-160. (accessed April 2006).

8. Morrison-Beedy D, Carey MP, Lewis BP, et al. HIV risk behavior and psychological correlates among Native American women: an exploratory investigation. Journal of Women’s Health and Gender-Based Medicine. 2001:10;487-494.

9. Indian Health Service. Trends in Indian Health–1997. U.S. Department of Health and Human Services, Public Health Service, Indian Health Service, Office of Planning, Education, and Legislation, Division of Program Statistics. 1998.

10. Baldwin JA, Maxwell CJ, Fenaughty AM, et al. Alcohol as a risk factor for HIV transmission among American Indian and Alaska Native drug users. American Indian and Alaska Native Mental Health Research. 2000;9:1-16.

11. Fisher DG, Fenaughty AM, Paschane DM, et al. Alaska Native drug users and sexually transmitted disease: results of a five-year study. American Indian Alaska Native Mental Health Research. 2000;9:47-57.

12. Potthoff SJ, Bearinger LH, Skay CL, et al. Dimensions of risk behaviors among American Indian youth. Archives of Pediatric and Adolescent Medicine. 1998;152:157-163.

13. National Native American AIDS Prevention Center. HIV Prevention for gay/bisexual/two-spirit Native American men. 1996. www.nnaapc.org (accessed April 2006).

14. Yost D, Hamstra S, Roosevelt L. HIV/AIDS and STD prevention in a rural Arizona Indian tribe. Presented at the International Conference on AIDS, Geneva, Switzerland. 1998. Abst #43162.

15. Indigenous People’s Task Force, 1433 East Franklin Ave. Suite 18A, Minneapolis, MN 55404. Contact Sharon Day 612/870-1723.www.indigenouspeoplestf.org (accessed January 2002).

16. Indian Healthcare Resource Center of Tulsa, 550 South Peoria, Tulsa, OK 74120. Contact Tommy Chesbro 918/382-1275 www.tulsaindianhealth.com(accessed January 2002).

<hr />

<strong>Prepared by Ron Rowell MPH*, Paul Bouey PhD MPH**
*San Francisco Foundation, **Pangaea Global AIDS Foundation</strong>

<strong>January 2002. Fact Sheet #43E</strong>

Special thanks to the following reviewers of this Fact Sheet: Joan Benoit, Lucy Bradley-Springer, Yvonne Davis, Sharon Day, Thomas Lee Eades, Sheila Fitzgibbons, Diane Morrison-Beady, Billy Rogers, Chris Sandoval, Delight E. Satter, Irene Vernon, Diane Williams, Charlton Wilson.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2002, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/AI-ANFS.pdf</url>
	</node>
	<node>
		<title>Asian and Pacific Islanders (APIs)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are Asian and Pacific Islanders’ HIV prevention
needs?</h3>
<h3>revised 5/07</h3>
<h4>are APIs at risk?</h4>
Asians and Pacific Islanders (APIs) are one of the fastest growing ethnic populations in the United States.1 It is projected that by 2050, APIs together will comprise 8% of the total US population, or 34 million persons.<sup>1,2</sup>

Asians and Pacific Islanders are extremely diverse and represent 49 different ethnic groups and over 100 languages. APIs include Chinese, Filipinos, Koreans, Hawaiians, Indians, Japanese, Samoans and Vietnamese, among other groups. Most APIs live in concentrated metropolitan areas such as Honolulu, HI; San Francisco, CA; New York City, NY and Los Angeles, CA.<sup>2</sup>

Between 2001 and 2004, APIs represented less than 1% of all US HIV/AIDS cases, yet APIs had the highest estimated annual percentage increase in HIV/AIDS diagnosis rates of all race/ethnicities (8.1% for males and 14.3% for females).<sup>3</sup> When populations such as APIs show low prevalence (overall numbers) but high increases in incidence (new diagnoses), prevention efforts are crucial to keep future HIV/AIDS cases low.

Underreporting and a lack of detailed HIV surveillance mask the true nature of the epidemic among APIs. One study found that API AIDS diagnoses may be underreported by as much as 33%.<sup>4</sup> This may in part be due to the misclassification of race and ethnicity in medical records, the source of information for case reports.<sup>2,5</sup> For example, persons with Filipino surnames may be mistakenly recorded as Latino. In addition, the lack of detailed demographic information on specific ethnicity and place of birth makes it difficult to track differences in the AIDS epidemic for API subpopulations and develop ethnically-targeted public health measures.<sup>2</sup>
<h4>who are APIs at risk?</h4>
HIV transmission in API men occurs mostly between men who have sex with men (MSM), followed by men who have high-risk heterosexual contact or are injection drug users (IDUs). In 2005, MSM transmission accounted for 71% of all API AIDS diagnoses to date.<sup>6</sup> Among API women, HIV transmission occurs mostly when a woman has sex with a man who is at increased risk, followed by women who are IDUs.<sup>6</sup>

While API MSM are most affected by HIV/AIDS, diagnosis rates among API women have increased (14.3%), as noted above.<sup>3</sup> The CDC does not categorize transgendered women (persons born as men but who identify and live as women), but one study showed a 13% HIV prevalence among API transgendered women in San Francisco, CA.<sup>7</sup>
<h4>what puts APIs at risk?</h4>
Among API MSM, social discrimination and the lack of family, peer and community support for sexual and racial diversity can negatively impact self-esteem and positive self-identity, thereby increasing their HIV risk. In one study, 57% of gay API men in San Francisco, CA, used alcohol prior to engaging in anal intercourse; approximately 24% reported unprotected anal intercourse. However, 85% believed they were unlikely to contract HIV.:9

APIs have significantly lower rates of HIV testing than the rest of the US population, despite reporting similar rates of risk behavior<sup>2</sup>, and often delay seeking HIV services. In one study of young API MSM in San Francisco, CA, 24.4% of participants had never tested for HIV. Additionally, 2.6% tested HIV+, of whom 61.5% were unaware they were positive, and 38.5% reported recent unprotected sex<sup>10</sup>. Untested HIV+ APIs are more likely to engage in high-risk behaviors and unknowingly infect other persons.<sup>11</sup> Those that delay seeking services are at greater risk of presenting with advanced AIDS at diagnosis and acquiring co-infections like hepatitis B, tuberculosis and PCP.<sup>5,12</sup>

Immigrant API women employed in massage parlors often engage in activities that put them at risk for HIV infection. However, for many of these women, immediate survival needs take priority over HIV prevention. Problems with the police, sex work, immigration, family planning, language barriers, and a lack of condom use policies in parlors all constitute risk factors for this population.<sup>13</sup>
<h4>what are barriers to prevention?</h4>
Although APIs are often stereotyped as the “model minority,” 17% of APIs lack health insurance and cannot receive adequate medical treatment and healthcare services.<sup>14</sup> Because of limited API health and behavioral risk data, resources are often channeled to other populations, without assessing or acknowledging API healthcare needs.<sup>14</sup>

Among APIs, the cultural avoidance of issues such as sexual behavior, illness and death creates barriers to HIV prevention, breeds stigmatization and negatively impacts the psychological and mental health of those living with the illness.<sup>15</sup>

Approximately 40% of APIs are limited English proficient (low or no English skills)<sup>14</sup>, and few culturally competent intervention programs exist for ethnically, culturally and linguistically diverse API populations. One study found that language is the most common barrier to receiving healthcare services for APIs with HIV/AIDS.<sup>12</sup>
<h4>what’s being done?</h4>
There are many national and local programs that provide HIV prevention and education services for APIs, as well as capacity building and technical assistance efforts for agencies serving APIs.<sup>17</sup> For example:

The Asian and Pacific Islander Coalition on HIV/AIDS (APICHA) developed the Bridges Project, a community-based intervention to reduce disparities in care for HIV+ APIs in New York. It created linkages with hospitals and medical providers, provided case management and advocacy services and offered cultural competency training for providers. It was effective in improving service use and reducing barriers for non-English speaking, Asian-primary-language and undocumented participants.<sup>12</sup>

Life Foundation, in Honolulu, HI, has been running community-level programs for Pacific Islander MSM and transgenders since 1999. “UTOPIA Hawai’i” is based on the Mpowerment model and has been very successful in reaching high risk Pacific Islanders that would have never accessed HIV services before.<sup>18</sup>

The Health Project for Asian Women (HPAW) addressed Asian female sex workers at massage parlors in San Francisco, CA, with two interventions: Massage Parlor Owner Education Program and Health Educator Masseuse Counseling Program. HPAW staff escorted masseuses to health clinics, handed out safer sex kits and provided translation, referrals and advocacy services. Masseuses participated in a 3-session counseling intervention and massage parlor owners received an education session.<sup>13</sup>

Asian &amp; Pacific Islander Wellness Center conducted an anti-stigma HIV media campaign targeting Chinese communities of San Francisco, CA, using bus shelter posters, newspaper advertisements and a documentary featuring local community leaders, people living with HIV and their families. They also lead the annual National Asian &amp; Pacific Islander HIV/AIDS Awareness Day with over fifteen events across the US to increase acceptance of HIV among families and A&amp;PI communities.<sup>19</sup>
<h4>what needs to be done?</h4>
We have a golden opportunity to keep numbers low among APIs, but that opportunity may be disappearing quickly as APIs have the highest increases in HIV/AIDS diagnosis rates of any racial group in the US. HIV prevention programs for APIs should focus on those at greatest risk, including MSM, women, transgenders and substance users. Programs can help APIs develop and strengthen support systems, as well as focus on prevention and healthcare needs, such as early testing for HIV, hepatitis B and TB. More culturally and linguistically-appropriate prevention and healthcare services for APIs need to be developed and evaluated.

Stigma around HIV, homosexuality, sex work and drug use should be addressed with anti-stigma campaigns that increase discussions on HIV/AIDS prevention and lead to greater acceptance of APIs living with HIV. Collaborating with policymakers and new partners such as faith-based organizations can help to address stigma among APIs.

Given the enormous diversity among APIs in the US, it is important to improve surveillance systems and quality of data and consistently collect information on subpopulation ethnicity and birthplace.<sup>3</sup> Research is needed on HIV and co-infections (hepatitis B and tuberculosis) and on acculturation and its relationship to HIV.

<hr />

<h3>Says who?</h3>
1. Choi KH, Wong F, Sy FS. HIV/ AIDS among Asians and Pacific Islanders in the United States. AIDS Education and Prevention. 2005;17:iii-v.

2. Zaidi IF, Crepaz N, Song R, et al. Epidemiology of HIV/AIDS Among Asians and Pacific Islanders in the United States. AIDS Education and Prevention. 2005;17:405-417.

3. Racial/ethnic disparities in diagnoses of HIV/AIDS33 states, 2001-2004. Morbidity and Mortality Weekly Report. 2006;55:121-125.

4. Kelly JJ, Chu SY, Diaz T, et al. Race/ethnicity misclassification of persons reported with AIDS. Ethnicity &amp; Health. 1996;1:87-94.

5. Wortley PM, Metler RP, Hu DJ, et al. AIDS among Asians and Pacific Islanders in the United States. American Journal of Preventative Medicine. 2000;18:208-214.

6. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveillance Report. 2006;17:37.

7. Operario D, Nemoto T. Sexual risk behavior and substance use among a sample of Asian Pacific Islander transgendered women. AIDS Education and Prevention. 2005;17:430-443.

8. Wilson PA, Yoshikawa H. Experiences of and responses to social discrimination among Asian and Pacific Islander gay men: Their relationship to HIV risk. AIDS Education and Prevention. 2004;16:68-83.

9. Choi KH, Operario D, Gregorich SE, et al. Substance use, substance choice, and unprotected anal intercourse among young Asian American and Pacific Islander men who have sex with men. AIDS Education and Prevention. 2005;17:418-429.

10. Do TD, Chen S, McFarland W, et al. HIV testing patterns and unrecognized HIV infection among young Asian and Pacific Islander men who have sex with men in San Francisco. AIDS Education and Prevention. 2005;17:540-554.

11. Wong F, Campsmith ML, Nakamura GV, et al. HIV testing and awareness of care-related services among a group of HIV-positive Asian Americans and Pacific Islanders in the United States: Findings from a supplemental HIV/AIDS surveillance project. AIDS Education and Prevention. 2004;16:440-447.

12. Chin JJ, Kang E, Haejin Kim J, et al. Serving Asians and Pacific Islanders with HIV/AIDS: Challenges and lessons learned. Journal of Health Care for the Poor and Underserved. 2006;17:910-927.

13. Nemoto T, Iwamoto M, Oh HJ, et al. Risk behaviors among Asian women who work at massage parlors in San Francisco: Perspectives from masseuses and owners/managers. AIDS Education and Prevention. 2005;17:444-456.

14. Ghosh C. Healthy People 2010 and Asian Americans/Pacific Islanders: Defining a baseline of information. American Journal of Public Health. 2003;93:2093-2098.

15. Kang E, Rapkin BD, Remien RH, et al. Multiple dimensions of HIV stigma and psychological distress among Asians and Pacific Islanders living with HIV illness.AIDS and Behavior. 2005;9:145-154.

16. API Capacity Building programs

17. Takahashi LM, Candelario J, Young T, et al. Building capacity for HIV/AIDS prevention among Asian and Pacific Islander organizations: The experience of a culturally appropriate capacity-building program in southern California. Journal of Public Health Management and Practice. 2007:S55-S63.

18. Utopia Hawai’i

19. API Wellness antistigma campaign

<hr />

<strong>Prepared by Roshan Rahnama, Nina Agbayani, Stacy Lavilla,* John Chin, PhD**
*Association of Asian Pacific Community Health Organizations (AAPCHO), **NY Academy of Medicine</strong>

<strong>May 2007. Fact Sheet #33ER</strong>

Special thanks to the following reviewers of this fact sheet: Vince Crisostomo, Chandak Ghosh, Erin Kahle, Saori Miyazaki, Lina Sheth, Lois Takahashi, Ed Tepporn, Peter Tuiolosega Silva.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©May 2007, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revAPIFS.pdf</url>
	</node>
	<node>
		<title>Deaf persons</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are Deaf Persons’ HIV Prevention Needs?</h3>
<h4>Are deaf persons at risk for HIV?</h4>
Yes. It is estimated that 7,000 to 26,000 deaf persons in the US are infected with HIV.<sup>1</sup> However, the Centers for Disease Control and Prevention (CDC) does not currently collect information on deafness and HIV or AIDS. Maryland was the first state to include questions about deafness in its HIV counseling and testing forms. In Maryland, 4.3% of the deaf population is HIV+ (infected with HIV).<sup>2</sup>

There are about two million deaf Americans, and one out of every ten Americans has some hearing loss. The deaf have long struggled for equal access to medical and social services, and equality in jobs and education. In the US today, there is still very little information on HIV and deafness, few prevention or treatment services and scarce research.<sup>3</sup>
<h4>What are risk factors for HIV?</h4>
High rates of substance use exist among the deaf community. One in seven (1 in 7) deaf persons has a history of substance abuse, compared to one in ten (1 in 10) in the hearing population. Substance abuse can be a riskfactor for HIV by lowering inhibitions and impairing judgement, which can lead to unsafe sexual behaviors. Sharing injection equipment is also a risk for HIV transmission.

There is very little HIV or sexuality education in schools for the deaf, especially for adolescents. Because of this, deaf persons have much less knowledge and awareness of HIV transmission, prevention and treatment. If deaf children don’t learn about HIV and other sexually transmitted diseases, they won’t have the vocabulary necessary to talk about thse topics with each other. One study of students at schools for the deaf found that adolescents in 9-12 grade had extremely limited knowledge of AIDS. Students knew correct answers to only 8 of 35 basic questions asked about AIDS.<sup>4</sup>

Deaf men who have sex with men (MSM) may face discrimination from within the deaf community. For this reason, deaf MSM often conceal their identity and may engage in furtive, anonymous and high risk sexual behaviors. Many deaf MSM also seek out hearing MSM for relationships, which makes communication about safer sex practices difficult.<sup>3</sup>

Children with disabilities, including deaf children, have been found to be at greater risk for sexual abuse, both at residential schools and at home. One study of deaf and hearing children at a language institute found that 54% of the deaf boys reported abuse, compared to 10% of hearing boys. Deaf girls reported 50% rates of abuse, compared to 25% of hearing girls. Childhood sexual abuse is a strong indicator for risky sexualand substance use behavior and HIV infection as an adult.<sup>6</sup>
<h4>What are barriers to prevention?</h4>
For the majority of deaf persons in the US, American Sign Language (ASL) is their primary language, and English the second language. ASL is a complex language of signs and gestures with its own grammar and syntax. The only way to communicate in ASL is face to face. There are only sporadic materials on HIV/AIDS available in written, graphic ASL. Although some deaf persons can read written materials such as pamphlets used in HIV prevention, for deaf persons with limited English skills, they are ineffective.<sup>7</sup>

ASL communicates largely in concepts, so many English phrases and idioms don’t make sense to persons with limited language skills. For example, there is no word for AIDS in ASL, and HIV-positive cannot be interpreted in ASL because “positive” means something good. ASL interpreters for HIV/AIDS issues may require special training to be able to address openly and frankly complex issues of sexuality and drug use.

The deaf community is very tight knit, which can offer strong support and strong condemnation at times. Confidentiality is very important in this community where news travels fast. Many deaf persons would rather go alone to an all-hearing HIV testing and counseling clinic and risk miscommunication and misunderstanding, than bring an interpreter or go to a deaf clinic and risk being recognized and losing confidentiality.<sup>8</sup> Home test kits are no more confidential, as deaf persons must use an interpreter using a regular phone or call through a Relay Service agent to get test results.
<h4>What can help in prevention?</h4>
Better understanding of the strengths of the deaf community can help HIV prevention efforts. Because the deaf community is tight knit, there is a greater degree of physical and emotional intimacy. The visual nature of ASL requires addressing sexual and drug use issues openly and frankly. When these topics are brought up, deaf persons often have greater comfort discussing sexuality and drug use, which can help in understanding and negotiating safer behaviors.<sup>8</sup>

Deaf institutions must address issues that have traditionally been hidden or taboo in their community, such as alcohol and drug abuse, childhood sexual abuse and homophobia. In 1998, the National AIDS Hotline sent over a thousand letters to state schools for the deaf offering an educational program on AIDS for deaf or hard of hearing students. Only three schools responded to the program.<sup>7</sup>
<h4>What’s being done?</h4>
A program developed by Gallaudet University’s Mental Health Center provides HIV/AIDS training to mental health professionals who work with deaf persons. The training program provides visual tools to use with the deaf community, such as captioned videos, drawings, group activities and models of how HIV attaches to cells.<sup>9</sup>

In Paris, France, a mobile AIDS prevention unit (EMIPS in French) used a variety of programs to target deaf adolescents both in and out of deaf schools. A young deaf educator visited deaf schools and presented an intervention in sign language. The program created several visual images in public ads that dealt with false beliefs about HIV risk. The program also opened a walk-in HIV testing clinic with a doctor using sign language. However, the clinic was not widely used because it was too much identified with AIDS. When the program opened a sign language HIV test center in a general clinic, it was much more successful.<sup>10</sup>

The Minnesota Chemical Dependency Program for Deaf and Hard of Hearing Individuals provides treatment for alcohol and other drugs for deaf persons in the US and Canada. All staff members are specially trained in deafness and substance abuse, and they have developed therapeutic approaches without communication barriers. The program also provides training for students and professionals working with deaf persons. They have a resource center that disseminates materials and provides funding for interpreters to attend AA/NA meetings.<sup>11</sup>
<h4>What still needs to be done?</h4>
Comprehensive education and outreach are needed in the deaf community, not just around AIDS and HIV, but around the larger issues of sexual health and substance use. Schools for the deaf need to provide education about sexuality and substance use and provide counseling for children and adolescents who have experienced abuse. Programs for the deaf should address issues specific to the deaf community, such as negotiating safer sex with a hearing partner, advocating for health care services and breaking down barriers about sexual abuse and substance abuse among deaf persons.

HIV prevention programs for deaf persons need to be as clear and as visual as possible. Programs should not be designed as presentations alone, but should incorporate physical activities, longer time for discussions, pictures, dolls, graphic manuals in ASL and captioned videos to make sure concepts are understood.<sup>12</sup> To access deaf communities, rearchers and service providers should take advantage of advances in technology such as interactive video and the Internet.<sup>13</sup>

Although there has been effort to educate the deaf community on HIV/AIDS at all levels, there continue to be great discrepancies in getting crucial information out to the target population. The CDC and states need to add questions about disabilities when collecting HIV statistics in order to document the extent of the epidemic in the deaf population. More programs are needed to help increase knowledge and dispel myths about HIV transmission and risk behaviors of deaf persons. The few popular programs that exist need to be evaluated and replicated across the country.

<hr />

<h3>Says who?</h3>
1. Friess S. Silence = Deaf . Poz Magazine. April 1998. p.60-63.
2. Personal communication. Department of Health and Mental Hygiene, State of Maryland. 1999.
3. Peinkoffer JR. HIV education for the deaf, a vulnerable minority . Public Health Reports. 1994;109:390-396.
4. Baker-Duncan N, Dancer J, Gentry B, et al. Deaf adolescents’ knowledge of AIDS. Grade and gender effects . American Annals of the Deaf. 1997;142:368-372.
5. Sullivan PM, Vernon M, Scanlan JH. Sexual abuse of deaf youth . American Annals of the Deaf. 1987;132:256-262.
6. Johnsen L, Harlow L. Childhood sexual abuse linked with adult substance use, victimization, and AIDS-risk . AIDS Education and Prevention. 1996;80:44-57.
7. Campbell D. AIDS and the deaf community. ADVANCE for Speech-Language Pathologists &amp; Audiologists. April 26, 1999; p.10-11.
8. Morrone JJ. Peer education and the deaf community. Journal of American College Health. 1993;41:264-266.
9. Sleek S. HIV/AIDS education efforts have missed deaf community. American Psychological Association Monitor. 1999.
10. Grivois L, Houette A. Outreach programs towards deaf people targeting prevention of AIDS. Presented at the 11th International Conference on AIDS, Vancouver, Canada. June 1996. Abst. #MoD240.
11. Program celebrates ten years. Steps to Recovery. Published by the Minnesota Chemical Dependency Program for Deaf and Hard of Hearing Individuals. Spring/Summer 1999.
12. Gaskins S. Special population: HIV/AIDS among the deaf and hard of hearing. Journal of the Association of Nurses in AIDS Care. 1999;10:75-78.
13. Lipton DS, Goldstein M, Wellington Fahnbulleh F, et al. The interactive video-questionnaire: a new technology for interviewing deaf persons . American Annals of the Deaf. 1999;141:370-378.
<h3>Resources:</h3>
CDC National AIDS Hotline TTY Service
American Social Health Association
1-800-243-7889 (same as) 1-800-AIDS-TTY
www.ashastd.org/nah/tty.php

<hr />

<strong>Prepared by Brian Determan* Natasha Kordus ** and Pamela DeCarlo***
*Montrose Clinic, Houston, TX, **California School for the Deaf, ***CAPS</strong>

September 1999. Fact Sheet #36E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 1999, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/deafFS.pdf</url>
	</node>
	<node>
		<title>Homeless persons</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are homeless persons’ HIV prevention needs?</h3>
<h3>revised 9/05</h3>
<h4>who are the homeless?</h4>
Homelessness is a growing problem in the US.<sup>1</sup> It is estimated that on any given day there are more than 800,000 homeless individuals in the US, while over the course of a year there are 2.3 to 3.5 million individuals who experience a period of homelessness.<sup>2</sup> In the 2004 Mayors’ report on homelessness 70% of cities surveyed registered an increase in the number of requests for emergency shelter during the preceding year.<sup>3</sup>

The US homeless population is typically divided into three major groups: single adults, members of homeless families and youth. It is estimated that single adults make up 54% of the population, families 40% and unaccompanied youth 5%.<sup>3</sup>
<h4>do homeless populations have a high prevalence of HIV infection?</h4>
People who are homeless have poorer health and higher mortality than the general population.<sup>4</sup> The prevalence of HIV/AIDS varies widely among homeless subgroups, but generally exceeds that of the non-homeless population. The elevated prevalence of infection combined with limited access to treatment and poor living conditions have contributed to HIV/AIDS becoming a leading cause of death in this population.<sup>5</sup>

A study in San Francisco, CA, reported an overall HIV prevalence of 10.5% for currently homeless and marginally housed adults, which is five times higher than that of the general San Francisco population. The same study reported an HIV prevalence of 30% among homeless men who have sex with men (MSM) and 8% among homeless injection drug users (IDUs).<sup>6</sup>

The association between homelessness and HIV appears to be a two-way street. HIV+ persons are at greater risk of homelessness due to discrimination and the high costs of housing and medical care. At the same time, homeless people have an elevated risk of contracting HIV.
<h4>what puts a homeless person at risk?</h4>
Homeless persons are in transient living situations, typically in impoverished communities with high HIV prevalence. Thus, risky behaviors they may engage in are more likely to result in infection.

Homeless persons are also more likely to evidence drug, alcohol, and mental disorders than the general population. By one estimate in 2000, 88% of homeless single men and 69% of homeless single women had one of these three disorders.<sup>7</sup> Overall, almost one-fourth of the single adult homeless population suffers from severe and persistent mental illness.<sup>2</sup> The impulsivity and impaired judgment often associated with severe mental illness or substance abuse contribute to risky behaviors such as unprotected sex, multiple partners, sharing needles or exchanging sex for drugs.

The conditions of homelessness and extreme poverty also contribute to risky behaviors. For example, most homeless shelters provide communal sleeping and bathing, are single sex, and offer limited privacy. Under these restrictions, it is more difficult to have stable sexual relationships.

Other characteristics that are common among homeless persons and associated with HIV risk behaviors include: adverse childhood experiences such as physical and sexual abuse,<sup>2,8</sup> sexual assault, partner violence and other traumatic histories and poor social support.<sup>9</sup>
<h4>what are barriers to prevention?</h4>
A common misconception is that the greatest barrier to delivering prevention services to homeless persons is finding them. The reality, however, is that homeless people are often visible by living or working in the streets or readily accessible in shelters. Forming trusting relationships, making consistent contact over time, and working through already existing social networks can help find and retain homeless persons for follow-up and services. In one HIV testing program for homeless persons with severe mental illness, 90% of those tested returned to receive their results.<sup>10</sup>

Institutional barriers and settings can restrict HIV prevention activities. Staffing at shelters is often only adequate to provide basic needs, and shelters may be reluctant to allow outside HIV prevention programs to talk explicitly about sex and drugs or to distribute condoms because those activities are forbidden in most shelters. A lack of private space for counseling and education around sensitive topics can also be a barrier.
<h4>what’s being done?</h4>
The quantity and quality of services available to homeless individuals varies greatly across the nation. Historically, services have concentrated on serving single male clients and few have formed coordinated networks of care to facilitate comprehensive on-going services.<sup>2</sup> Here we provide just a few examples of effective interventions designed specifically to serve homeless individuals at risk for or living with HIV.

Sex, Games and Videotapes is a program for homeless mentally ill men in a New York City, NY shelter that is built around activities central to shelter life: competitive games, storytelling and watching videos. For many men sex is conducted in public spaces, revolves around drug use, and must be done quickly. The program allows for sex issues to be brought up in a nonjudgmental way. One component is a competition to see who can put a condom (without tearing it) on a banana fastest–this teaches important skills for using a condom quickly. The program reduced sexual risk behavior threefold.<sup>11</sup>

Boston HAPPENS provides health education, case management, basic medical care, HIV testing, counseling and mental health care for HIV+, at-risk youth, many of whom are homeless. Boston HAPPENS’ collaborators run drop-in services and storefront clinics in places where young people hang out. Through persistent outreach and individualized case management, HAPPENS retains homeless at-risk youth in care.<sup>12</sup>

Providing homeless individuals with housing and cash benefits has been shown to reduce risk taking behaviors such as unprotected sex, drug use and needle sharing.<sup>13,14</sup>

Housing Works is an AIDS service organization that specializes in providing comprehensive care to HIV+ homeless persons in New York City. Their services include housing, healthcare, job training and placement, as well as a variety of other advocacy services for homeless HIV+ persons.<sup>15</sup>
<h4>what needs to be done?</h4>
There is an ongoing need to deliver effective prevention activities in culturally appropriate service settings that homeless persons use, such as soup kitchens, shelters, residential hotels and clinics. Staff of these organizations should be trained in HIV prevention education methods that recognize specific risk factors related to homelessness, employ realistic expectations for change and give homeless people concrete goals that they can accomplish.

Coordinated care networks need to be developed so that staff can link individuals quickly and easily to the services they need.<sup>16</sup> Group interventions that have worked in certain settings need to be broadly disseminated and adapted for use in other locations.

Efforts to prevent HIV transmission among homeless persons will flounder without a concerted effort to better address their survival needs including long term housing, jobs, income, adequate nutrition, substance abuse treatment, and regular medical and mental health services. Unfortunately, despite the announcement of new initiatives to help the homeless,<sup>1</sup> recent trends in government support in these areas are discouraging and the growing federal budget deficit does not bode well for increases in the near future. As one of the most vulnerable populations in our society, homeless persons need support, respect, protection and continued prevention efforts.

<strong>Prepared by Naomi Adler BA*, Dan Herman Phd**, Ezra Susser MD DrPh***
*CAPS, **NY State Psychiatric Inst., *** Columbia U Mailman School of Public Health</strong>

<hr />

<h3>Says who?</h3>
1. Burt M, Laudan Y, Lee E, et al. Helping America’s homeless: emergency shelter or affordable housing? Washington, D.C.: Urban Institute Press. 2001.
2. U.S. Conference of Mayors. A status report on hunger and homelessness inAmerica’s cities: 2004.www.usmayors.org/uscm/hungersurvey/2004/onlinereport/HungerAndHomelessnessReport2004.pdf(Accessed 4/20/06)
3. Burt, MR, Laudan, AY, Douglas T, et. al. 1999 Homelessness: Programs and the People They Serve – Summary Report. Washington, DC: DHUD/DHHS.http://www.huduser.org/publications/homeless/homelessness/contents.php(Accessed 4/20/06)
4. Cheung AM, Hwang SW. Risk of death among homeless women: a cohort study and review of the literature. Canadian Medical Association Journal. 2004;170:1243.
5. Robertson MJ, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. American Journal of Public Health. 2004;94:1207-1217.
6. North CS, Eyrich KM, Pollio DE, et al. Are rates of psychiatric disorders in the homeless population changing? American Journal of Public Health. 2004;94:103-108.
7. Herman DB, Susser ES, Struening EL, et al. Adverse childhood experiences: are they risk factors for adult homelessness? American Journal of Public Health. 1997;87:249-255.
8. Zlotnick C, Tam T, Robertson MJ. Adverse childhood events, substance abuse, and measures of affiliation. Addiction and Behavior. 2004;29:1177-1181.
9. Desai MM, Rosenheck RA. HIV testing and receipt of test results among homeless persons with severe mental illness. American Journal of Psychiatry. 2004;161:2287-2294.
10. Susser E, Valencia E, Berkman A, et al. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness. Archives of General Psychiatry. 1998;55:266-272.
11. Harris SK, Samples CL, Keenan PM, et al. Outreach, mental health, and case management services: can they help to retain HIV-positive and at-risk youth and young adults in care? Maternal and Child Health Journal. 2003;7:205-218.
12. Aidala A, Cross JE, Stall R, Harre D, et. al. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS and Behavior. 2005;9:1-15.
13. Riley ED, Moss AR, Clark RA, et. al. Cash benefits are associated with lower risk behavior among the homeless and marginally housed in San Francisco. Journal of Urban Health. 2005;82:142-150.
14. Housing Works www.housingworks.org (Accessed 4/20/06)
15. Woods ER, Samples CL, Melchiono MW, et. al. Initiation of services in the Boston HAPPENS Program: human immunodeficiency virus-positive, homeless, and at-risk youth can access services. AIDS Patient Care STDs. 2002;16:497-510.

<hr />

<strong>September 2005. Fact Sheet #16ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Martha Burt, Carol Caton, Travis Emery, Lillian Gelberg, Sion Harris, Daniel Kidder, Steven Metraux, Carol North, Thomas Painter, Jamie Van Leeuwen, Harris Sion, Suzanne Wenzel, Elizabeth Woods, Cheryl Zlotnick.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©Sepetmber 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revhomelessFS.pdf</url>
	</node>
	<node>
		<title>Sex Workers</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>are sex workers at risk for HIV?</h3>
Sex workers in the US may be at risk for HIV depending on the conditions of their workplace. Male, female and transgender sex workers who are most vulnerable to HIV are street-based workers, most of whom are poor or homeless, and likely to have had a history of sexual or physical abuse.<sup>1</sup> Street-based sex workers are also commonly dependent on drugs or alcohol, and at a greater risk for violence from clients and police.<sup>2</sup>

Sex work off the street (in brothels, massage parlors, private homes or escort services) is less likely to result in HIV infection for the workers because they may exercise greater control over their working conditions and sexual transactions, including condom use.

Little research has been done on rates of HIV infection among street-based sex workers across the US. In one study of drug-using female sex workers in Miami, FL, 22.4% of the women tested HIV+.<sup>3</sup> In a study of male sex workers in Houston, TX, 26% reported testing HIV+.<sup>4</sup>
<h4>what places sex workers at risk?</h4>
Sex workers who are injection drug users (IDUs) are more likely to be HIV+ than those who do not inject drugs.<sup>2</sup> Injection risks include sharing needles and injection equipment and being injected by someone else. IDU and other substance use (crack cocaine, methamphetamine, alcohol) can also impact sexual risks by compromising safe sexual behavior and communication.<sup>5</sup> Persons who use crack cocaine are more likely to enter sex work and have large numbers of partners.<sup>6</sup>

The decision and ability to use condoms is a complex one that depends on many factors.<sup>7,8</sup> Negotiating safer sex can be affected by money, if business is slow or clients offer more money for unprotected sex. Clients may use violence to enforce unsafe sex. Sex workers may use drugs before or with clients, which affects decision making and ability to use condoms. Sex workers may also be targeted by police if they are carrying condoms.5 In addition, sex workers, like many people, may choose not to use condoms with their boyfriends/girlfriends/spouses.

Sex workers have elevated rates of sexually transmitted diseases (STDs), including HIV.<sup>1</sup> One study of female, male and transgender sex workers in San Francisco, CA, reported high rates of gonorrhoea (12.4%), chlamydia (6.8%), syphilis (1.8%) and herpes (34.3%).<sup>9</sup> Active STDs increase the likelihood of acquiring HIV. Genital trauma caused by frequent or forced intercourse also increases HIV risk.<sup>1</sup>

Violence, and the trauma associated with it, is a concern for many sex workers. Violence can include physical, sexual and verbal abuse that sex workers experienced as children, and as adults from their clients and intimate partners. It can also include the violence many street-based sex workers witness daily. This history of violence leaves many sex workers with emotional trauma, and many may turn to drug use to deal with the harsh realities of their daily lives.<sup>10</sup>
<h4>what are barriers to prevention?</h4>
The illegality of sex work in the US drives the industry underground and leads to a strong distrust of both police and public health authorities among sex workers. To avoid arrest, street-based sex workers are often forced to change how they work to avoid police.<sup>11</sup> For example, sex workers may take less time to negotiate sexual transactions prior to getting into a client’s car, and may even agree to engage in riskier sexual activities. Conducting HIV prevention outreach or education in this environment can be difficult.

Desperation and poverty can often override HIV prevention concerns. Drug-addicted persons may turn to prostitution to earn money to pay for the high cost of illegal drugs. Transgender persons may use sex work to make money for hormones or surgery. Many homeless youth have no training or means of support, and rely on prostitution for survival. Attention to the more immediate concerns of food, housing, and addiction often takes priority over concerns of HIV infection.<sup>12</sup>
<h4>what is being done?</h4>
JEWEL (Jewelry Education for Women Empowering their Lives), was an economic empowerment and HIV prevention project for drug-using women involved in prostitution in Baltimore, MD. The JEWEL intervention used six 2-hour sessions that taught HIV prevention and the making, marketing and selling of jewelry. Women participants significantly reduced trading drugs or money for sex, the number of sex trade partners, and drug use, including daily crack use.<sup>13</sup>

The Health Project for Asian Women (HPAW) addressed Asian female sex workers at massage parlors in San Francisco, CA, with two interventions: Massage Parlor Owner Education Program and Health Educator Masseuse Counseling Program. HPAW staff escorted masseuses to health clinics, handed out safer sex kits and provided translation, referrals and advocacy services. Masseuses participated in a 3-session counseling intervention and massage parlor owners received an education session.<sup>14</sup>

A brief intervention for male sex workers in Houston, TX, consisted of two 1-hour sessions held a week apart. Almost two-thirds (63%) of the men who began the intervention completed it, and those that completed the intervention increased their condom use during paid anal sex.<sup>15</sup>

Breaking Free in St Paul, MN, helps primarily African American girls and women leave sex work. The program helps women in crisis stabilize, then begin an intense program of counseling and education to address the traumas associated with sex work. Breaking Free offers transitional and permanent housing, as well as an internship program to help women who may have never held a real job become employable.<sup>16</sup>

The St. James Infirmary in San Francisco, CA, a peer-based clinic for sex workers by sex workers, provides male, female and transgender sex workers with free medical services. They also offer HIV/STD screening and treatment, transgender health, harm reduction and peer counseling, psychiatric services, acupuncture, massage, support groups, food, clothing, and needle exchange. Staff conducts street and venue-based outreach to distribute safer sex supplies and offers HIV testing.<sup>9</sup>
<h4>what still needs to be done?</h4>
In the US over the past decade, there has been very little research conducted on HIV/AIDS in the sex worker population. Furthermore, past research focused largely on the role of sex workers as vectors of HIV/STDs for the general public. To prevent HIV among sex workers, it is essential not only to increase overall research efforts in this population, but to also acknowledge the greater context in which sex work is transacted, as well as the specific practice of sex workers.

Researchers, public health and law enforcement officials need to hear from sex workers what they need to keep themselves safe, and work together to achieve those goals. Laws and police attitudes towards carrying condoms must be eased to allow sex workers to protect themselves. Violence against sex workers by clients, police, and other neighborhood community members must be criminalized, while sex workers should be encouraged and supported to report violent incidents.

Street-based sex workers face a multitude of needs, from immediate concerns of housing, food and medical attention, to longer-range concerns such as mental health services, substance abuse treatment, violence prevention, job training and employment, HIV/STD prevention, quality health care, improved relationships with law enforcement and help leaving sex work. Increased funding and awareness is needed for public health programs that address this full range of issues sex workers face.

<strong>PREPARED BY ROSHAN RAHNAMA, CAPS</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revsexworkerFS.pdf</url>
	</node>
	<node>
		<title>What are transgender women’s HIV prevention needs?</title>
		<tax>1737</tax>
		<content><![CDATA[Transgender is an umbrella term for persons whose gender identity and expression does not conform to norms and expectations traditionally associated with their sex assigned at birth. Transgender persons may self-identify as transgender, female, male, trans-woman or -man, transsexual, cross-dresser, bigender, gender queer, gender questioning, MtF, FtM or one of many other transgender identities, and may express their genders in a variety of masculine, feminine and androgynous ways. Transgender persons may prefer and identify with certain terms and not others, so it is best to ask participants and clients what they prefer. For this fact sheet, we use the term transgender women.

The transgender community is diverse and more research is needed. From what we know, transgender women have higher rates of HIV and HIV-related risks than transgender men. While this fact sheet focuses on transgender women, we are developing other fact sheets on transgender men and the general transgender population.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/11/transgender-women-fact-sheet.pdf</url>
	</node>
	<node>
		<title>Personas mayores de 50</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan las personas mayores de 50 en la prevención del VIH?</h3>
<h4>¿están a riesgo las personas mayores?</h4>
Sí. En los EEUU más del 10% de todos los nuevos casos de SIDA ocurren entre personas mayores de 50 años.<sup>1</sup> En los últimos años, los nuevos casos de SIDA aumentaron más rápido entre personas de edad mediana y mayores que en personas menores de 40.<sup>2</sup> Si bien es cierto que muchas de estas personas con SIDA quedaron infectadas con el VIH a una edad más temprana, muchos se infectaron después de los 50.

Es difícil determinar los índices de infección con VIH entre personas mayores, ya que son pocas las personas mayores de 50 a riesgo de contraer el VIH que se hacen la prueba de detección rutinariamente.<sup>3</sup> A la mayoría de las personas mayores se les diagnostica el VIH a un estado muy avanzado de la enfermedad-cuando andan en búsqueda de algún tratamiento a causa de las enfermedades ocasionadas por el VIH.<sup>1</sup>

Los casos de SIDA en personas mayores pueden no estar siendo reportados ya que los síntomas y las infecciones del VIH pueden coincidir con otras enfermedades relacionadas con la edad por lo tanto pasa desapercibida. La demencia ocasionada por el SIDA es muchas veces diagnosticada como el mal de Alzheimer, y los primeros síntomas del VIH coma la fatiga y la pérdida de peso pueden estar siendo interpretadas como el proceso natural del envejecimiento.<sup>4</sup>

Las personas mayores con SIDA se enferman y mueren más rápido que las más jóvenes. Esto se debe al diagnóstico tardío del SIDA y a la combinación de infecciones y otras enfermedades que posiblemente aceleran la progresión del SIDA. Además, las nuevas medicinas para tratar el VIH pueden interferir con el tratamiento médico de enfermedades crónicas previas.
<h4>¿qué los pone a riesgo?</h4>
Una de las falsas creencias más comunes en los EEUU es que las personas mayores ni tienen sexo ni usan drogas. Muy pocas campañas de prevención son dirigidas a personas mayores, y en la mayoría de los anuncios con mensajes educativos no aparecen personas mayores, lo cual les convierte en una población a riesgo e invisible.<sup>6</sup> Esto ocasiona que las personas mayores estén generalmente menos informadas sobre el VIH que los más jóvenes y menos conscientes de como protegerse a si mismos de la infección. Esto es más real entre personas mayores usuarios de drogas inyectadas, los cuales componen el 16% de los casos de SIDA en mayores de 50 años.

El mayor grupo de casos de SIDA entre personas mayores de 50 ocurre en hombres que tienen sexo con hombres. Los hombres gay/homosexuales mayores tienden a ser un grupo invisible dentro de esta comunidad y en los esfuerzos de prevención. Dentro de los factores que presentan los gay/ homosexuales mayores están: la arraigada homofobia, la negación del riesgo, el uso del alcohol y otras drogas, y los encuentros sexuales anónimos. <sup>7</sup>

Las mujeres componen un mayor porcentaje de casos de SIDA a medida que aumenta la edad. A pesar de que solo el 6,1% de los casos de SIDA ocurre en mujeres de 50 a 59 años, el porcentaje se eleva a 13,2% en las de 60 a 69 años y a 28,7% en las mayores de 65 años de edad.<sup>8</sup> Los cambios normales que aparecen con la edad tales como la falta de lubricación vaginal y el desgaste de las paredes vaginales pueden estar poniendo a mayor riesgo de infección con VIH a las mujeres mayores durante las relaciones sexuales.<sup>9</sup>
<h4>¿cuáles son las barreras en la prevención?</h4>
Pocos norteamericanos mayores de 50 a riesgo de contraer el VIH usan condones o se hacen la prueba de detección del VIH. En una encuesta a nivel nacional, de las personas mayores a riesgo de infectarse con VIH, un sexto estaba tan propenso a usar condones y un quinto a hacerse la prueba del VIH, que las personas de 20 a 30 años a riesgo de infección.<sup>3</sup> Se desconocen los factores que influyen en el uso del condón en personas mayores.

Pocas veces doctores y enfermeras consideran al VIH un riesgo entre pacientes mayores. Un estudio hecho a doctores, reveló que la gran mayoría de estos “raras veces” o “nunca” hacían preguntas sobre VIH/SIDA o discutían el tema de la reducción del riesgo con pacientes mayores de 50. Los doctores estuvieron mucho más propensos a “raras veces” o “nunca” preguntar a sus pacientes mayores de 50 sobre el factor de riesgo con relación al VIH (40%) que a pacientes menores de 30 (6.8%).<sup>10</sup>
<h4>¿en qué se diferencian?</h4>
Es necesario tomar en cuenta el aspecto cultural y generacional al diseñar campañas de prevención. A las personas mayores les puede resultar muy incómodo revelar a otros información sobre su comportamiento sexual o su uso de drogas. Esto puede interferir con la participación de personas mayores en grupos de apoyo.<sup>11</sup> Además, las personas mayores pueden creer que el condón ni es importante ni necesario, especialmente si la mujer ya pasó la etapa de la menopausia cuando ya no hay necesidad de protegerse para evitar un embarazo.

Es posible que a estas personas les queden pocos amigos y que el círculo social que pudiera ofrecerles apoyo y cuidados sea reducido. Adicionalmente, es muy probable que ellos estén cuidando a otras personas, ya que cerca de un tercio de los pacientes con SIDA dependen de un familiar mayor para que les ayude en el aspecto económico, emocional y físico.<sup>12</sup>
<h4>¿qué se está haciendo?</h4>
El “Senior HIV Intervention Project (SHIP)” o “proyecto de intervención de VIH para mayores” en los condados de Dade, Broward y Palm Beach de la Florida capacita a personas mayores para hacer presentaciones de tipo educativo y conducir seminarios sobre sexo seguro en comunidades de jubilados. Estos educadores a su vez se reúnen con profesionales de la salud y trabajadores al servicio de personas mayores para informarles sobre el riesgo que este grupo encierra en cuanto al VIH.<sup>13</sup>

En seis centros para el cuidado de personas mayores de Chicago, Illinois, un programa utilizó “círculos de estudio”, los cuales fueron dirigidos por miembros del mismo grupo con el fin de alertar y aumentar el conocimiento sobre VIH entre los participantes. Los participantes presenciarion el video “The Forgotten Tenth” o “el 10% restante” e investigaron por cuenta propia como afecta el VIH en sus vidas: física política y economicamente. Luego compartieron lo aprendido en las reuniones subsecuentes. Al concluir el programa muchos de los participantes se convirtieron en educadores de SIDA.<sup>14</sup>

En la Florida se llevó a cabo un programma educativo sobre VIH en varios comedores para mayores. Basado en el “Modelo de Creencia de Salud”, el programa incluyó información básica y estadísticas sobre el VIH, instrucción sobre el uso del condón, información sobre las pruebas de detección, y el estudio de algunos casos de personas mayores con SIDA. Al final de esta sesión, los participantes reportaron un aumento en su conocimiento del SIDA y la susceptibilidad que estos perciben con respecto al VIH.<sup>15</sup>
<h4>¿qué queda por hacer?</h4>
Ha existido una falta notable de interés por las personas mayores de 50 en los esfuerzos de prevención. Es necesario crear programas de prevención exclusivos para gente mayor. Los medios de comunicación y los carteles de anuncios necesitan contener temas e imágenes que se identifiquen con las personas mayores de 50 y promover a su vez la prueba de detección del VIH rutinariamente en personas mayores que viven a riesgo de infección. Es necesario investigar más a fondo el comportamiento de estas personas en relación al sexo y al uso de drogas, la progresión de la enfermedad y los tratamientos, y reclutar a personas mayores VIH+ para los estudios clínicos.

El personal clínico y los proveedores de servicio para personas mayores, incluyendo a los cuidantes y el personal de asilo de ancianos, deben recibir educación sobre los comportamientos de riesgo y los síntomas del VIH en personas mayores. El personal clínico además, debe asesorar el riesgo y el uso de drogas más cuidadosamente en pacientes mayores de 50 y no asumir que los pacientes no participan en este tipo de actividades o que no hablan de ello.

Las personas mayores carecen del apoyo y la educación que les permitiría asegurarse una vida tan satisfactoria como la que tenían antes de pasar los 50 años. Un programa de prevención completo, utiliza muchos elementos para proteger del VIH a la mayor cantidad de gente posible. Los adultos mayores de 50 consituyen un grupo especial que debería recibir mensajes preventivos tanto por el riesgo ocasionado por las conductas de riesgo como por el papel de liderazgo y de maestros que estos desempeñan para futuras generaciones.

<hr />

<h4>¿quién lo dice?</h4>
1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report . 1996;8:15.

2. HIV, AIDS, and older adults . Fact sheet prepared by the National Institute on Aging, National Institutes of Health.

3. Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral Surveys . Archives of Internal Medicine. 1994;154:57-63.

4. Whipple B, Scura KW. The overlooked epidemic: HIV in older adults . American Journal of Nursing. 1996;96:22-28.

5. Skiest DJ, Rubinstien E, Carley N, et al. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study . American Journal of Medicine. 1996;101:605-611.

6. Feldman MD. Sex, AIDS, and the elderly . Archives of Internal Medicine. 1994;154:19-20.

7. Grossman AH. At risk, infected, and invisible: older gay men and HIV/AIDS . Journal of the Association of Nurses in AIDS Care. 1995;6:13-19.

8. Ship JA, Wolff A, Selik RM. Epidemiology of acquired immune deficiency syndrome in persons aged 50 years or older . Journal of Acquired Immune Deficiency Syndromes. 1991;4:84-88.

9. Catania JA, Turner H, Kegeles SM, et al. Older Americans and AIDS: transmission risks and primary prevention research needs . Gerontologist. 1989;29:373-381.

10. Skiest DJ, Keiser P. Human immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians’ beliefs, practices, and knowledge . Archives of Family Medicine. 1997;6:289-294.

11. Nokes K, ed. HIV/AIDS and the older adult . Washington DC: Taylor &amp; Francis;1996.

12. Ory MG, Zablotsky D. Notes for the future: research, prevention, care, public policy. In MW Riley, MG Ory, D Zablotsky, eds. AIDS In an Aging Society. New York, NY: Springer Publishing; 1989.

13. Senior HIV Intervention Project (SHIP). Contact: Lisa Agate (954) 467-4774.

14. Dill D, Huston W. AIDS education for older adults. Healthpro UIC. 1996;Fall:18-19.

Contact: Rita Strombeck, HealthCare Education Associates (760) 323-4032.

15. Rose MA. Effect of an AIDS education program for older adults . Journal of Community Health Nursing. 1996;13:141-148.

Contact: Molly Rose (215) 503-7567.

<strong>Recursos:</strong>

NY HIV Over 50 Task Force, Brookdale Center on Aging, Hunter College, 425 E 25th Street, New York, NY 10010, (212) 481-7594. Contact: Kathy Nokes,kathynokes@aol.com

American Association of Retired Persons (AARP), Social Outreach and Support (SOS), 601 E Street, NW, Washington, DC 20049, (202) 434-2260,http://www.aarp.org

National Association on HIV Over Fifty (NAHOF), Midwest AIDS Training &amp; Education Center, University of Illinois, 808 S. Wood Street m/c 779, Chicago. IL 60612, (312) 996-1426, nlinsk@uic.edu

National Institute on Aging, http://www.nih.gov/nia/

<hr />

<strong>Preparado por Pamela DeCarlo*, Nathan Linsk, PhD**, Traducción Romy Benard-Rodríguez*
*CAPS, **National Association on HIV Over 50, Midwest AIDS Training &amp; Education Center</strong>

Abril 1998. Hoja Informativa 29S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/mayoresFS.pdf</url>
	</node>
	<node>
		<title>Indígenas norteamericanos y nativos de Alaska</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuáles son las necesidades de los indígenas norteamericanos y nativos de Alaska (IN/NA) para la prevención del VIH?</h3>
<h4>¿están en riesgo de contraer el VIH?</h4>
Sí. Los indígenas norteamericanos y nativos de Alaska (IN/NA) son una población única dentro de los EEUU, no sólo por la opresión que han sufrido durante el desarrollo de este país, sino también por su lucha continua por ser tomados en cuenta en el combate contra la epidemia del VIH/SIDA. Sin embargo, los IN/NA no son tan únicos que sean invulnerables a las mismas conductas que ponen a todas las personas en peligro de contraer el VIH.

La larga historia de opresión de los IN/NA en los Estados Unidos ha tenido efectos devastadores sobre la salud y el bienestar de los pueblos indígenas. Esta historia, que incluye la colonización, la prohibición de los idiomas indígenas y de sus prácticas religiosas, y siglos de reubicación forzada, ha generado una desconfianza justificada de los programas e instituciones médicas del gobierno estadounidense.<sup>1</sup> Este legado sigue formando la experiencia de los IN/NA, que están excesivamente afectados por la pobreza, problemas de salud, violencia familiar y abuso de drogas y alcohol. Todos estos factores están asociados con el riesgo de VIH.<sup>2</sup>

Al final del año 2000, los IN/NA representaban 2,337 casos de SIDA y 871 casos de VIH. Los IN/NA constituyen el 1% de la población total de EEUU y un poco menos del 1% de los casos reportados de SIDA y VIH<sup>3</sup>. Aunque estas cifras parecen reducidas en relación con otros grupos, el efecto es considerable. El bajo número de casos reportados y la falta de vigilancia detallada del VIH entre los IN/NA podría estar causando un conteo muy incompleto de las infecciones por VIH.

Por otra parte, muchas veces los datos sobre la raza o grupo étnico de los IN/NA se anotan incorrectamente por las suposiciones que se hacen en base a su nombre, color de la piel y lugar de residencia, y hasta por el uso intencionado de datos engañosos por parte de la persona IN/NA.<sup>4</sup> Un estudio de datos sobre las ETS en Oklahoma encontró que el 35% de los casos de clamidia y más del 60% de los casos de gonorrea entre los IN/NA se habían reportado incorrectamente como casos hispanos o angloamericanos.<sup>5</sup>
<h4>¿cuáles son los riesgos para los IN/NA?</h4>
La investigación sobre el VIH entre los IN/NA tiene una historia corta que empezó al principio de la década de los ’90 con unos cuantos estudios sobre comportamientos arriesgados. Según los CDC, las categorías más comunes de transmisión del VIH entre los hombres IN/NA son: hombres que tienen sexo con otros hombres (HSH) 51%, HSH usuarios de drogas inyectables (UDI) 13% y UDI heterosexuales 12%. Entre las mujeres, el mayor riesgo es el contacto heterosexual (41%), seguido del UDI (32%).<sup>3</sup> Sin embargo, estos datos no incluyen información de California, que tiene la población indígena más grande de todos los 50 estados de EEUU.<sup>6</sup>

Los pueblos IN/NA están desmesuradamente afectados por factores sociales, conductuales y económicos que están asociados con el riesgo de VIH. Los IN/NA sufren más pobreza y desempleo: el 32% de ellos viven por debajo de la línea de pobreza, en comparación con el 13% de la población general de EEUU.<sup>7</sup> Los indígenas norteamericanos también tienen tasas altas de uso de drogas y alcohol, ETS y violencia.<sup>8</sup> Debido a su consumo de alcohol, los IN/NA tienen las tasas más altas de mortalidad relacionada con el alcohol entre todas las poblaciones de EEUU.<sup>9</sup>

Un estudio de usuarios de drogas NA encontró que el consumo de alcohol fue el factor que más aumentó su riesgo de contraer el VIH. Muchos individuos reportaron que habían perdido el conocimiento cuando tomaron alcohol y se enteraron más tarde que habían tenido sexo sin protección con personas completamente desconocidas o con quienes de otra manera no hubieran aceptado como pareja sexual.<sup>10</sup>

El mismo estudio demostró que las mujeres nativas de Alaska tienen un riesgo alto de infectarse por gonorrea y por VIH. Las mujeres NA estaban más propensas a inyectarse drogas que las mujeres de cualquier otro grupo étnico y sus parejas sexuales tendían ser UDI angloamericanos. Las parejas sexuales compuestas por una mujer NA y un hombre angloamericano usaron condones con menos frecuencia que otras parejas compuestas por una combinación de grupos étnicos.<sup>11</sup>

En los estados con poblaciones de IN/NA superiores a 20,000, las tasas de gonorrea y sífilis son dos veces mayores que entre otros grupos étnicos.<sup>7</sup> Las personas con ETS son más propensas tanto a transmitir el VIH como a infectarse si se exponen al virus.

Un estudio entre adolescentes indígenas en más de 200 escuelas en reservaciones a lo largo de EEUU reveló que los jóvenes practicaban varias conductas arriesgadas: el uso de alcohol, tabaco y otras drogas; actividades sexuales sin protección suficiente; y comportamientos suicidas. En la mayoría de los casos, el uso de drogas se asociaba con otros comportamientos peligrosos.<sup>12</sup>
<h4>¿cuáles son los obstáculos?</h4>
Con frecuencia el VIH se vuelve invisible dentro de las comunidades IN/NA que afrontan muchos otros problemas graves y más visibles, tales como el alcoholismo, la diabetes y el desempleo. Por lo tanto, muchas veces se niega tajantemente que el VIH sea un problema.

Al igual que en muchas otras comunidades muy unidas, puede ser difícil mantener la confidencialidad en las comunidades IN/NA, especialmente en zonas rurales. Esto puede dificultar algunas actividades importantes de prevención, como el llegar a hacerse la prueba del VIH, hablar con profesionales médicos sobre prácticas sexuales, obtener tratamiento para dejar las drogas, o comprar condones en tiendas locales.

Los HSH IN/NA tienen una amplia gama de identidades, desde “gay” hasta “doble espíritu” y pueden no responder a servicios diseñados para hombres homosexuales urbanos.<sup>13</sup> Los HSH IN/NA pueden sentirse aislados y evitar buscar los servicios que necesitan a causa del estigma y la negación que existen en torno a la homosexualidad en algunas comunidades IN/NA.

Los IN/NA consideran que ellos pertenecen a naciones indígenas soberanas, cada una con su propio gobierno. Las relaciones entre estos gobiernos tribales y los gobiernos estatales y federal son muy complejas. Muchos gobiernos estatales y locales se equivocan al suponer que el Servicio de Salud Indígena (IHS, siglas en inglés) es la única institución responsable de las necesidades médicas de los IN/NA. Menos del 1% del presupuesto del IHS se dedica a comunidades urbanas, pero más de la mitad de todos los IN/NA en EEUU viven en zonas urbanas. Como consecuencia, muchas veces se les niega a las tribus y organizaciones IN/NA las mismas oportunidades para recibir fondos que otros ciudadanos tienen.
<h4>¿qué es lo que se está haciendo?</h4>
Para responder al aumento de casos de ETS y VIH entre los adolescentes de una tribu rural de Arizona, educadores en salud tribales colaboraron con representantes de las escuelas y del departamento de salud pública para establecer varios programas. Entre ellos se incluyen clínicas, pláticas presentadas por indígenas norteamericanos VIH positivos, dramas sobre el VIH producidos por y para jóvenes, reuniones comunitarias, y anuncios de radio y en la prensa. Los casos de ETS y VIH en esta tribu alcanzaron el máximo en 1990 y en los seis años siguientes se redujeron gradualmente hasta conseguir una reducción total del 69%.<sup>14</sup>

El Grupo de Trabajo de Pueblos Indígenas (Indigenous People’s Task Force o IPTF) de Minneapolis, MN, promueve la salud y la educación para personas indígenas. Su programa de educación de pares y teatro llamado Gikinooamaagad (Guerreros/Maestros) brinda a los jóvenes instrucción integral sobre la prevención del VIH/SIDA, el teatro y enseñanzas tradicionales. Los programas del IPTF han sido reconocidos por el Cirujano General de EEUU.<sup>15</sup>

El Centro de Recursos de Salud para Indígenas Norteamericanos de Tulsa, OK, ofrece un grupo social para hombres indígenas “doble-espíritu.” El grupo les ayuda a formar un sentimiento de comunidad, aumentar su autoconfianza y reducir sus conductas arriesgadas. El programa también presenta un taller para mejorar las relaciones de pareja que ayuda a los participantes a determinar lo que quieren de sus relaciones, a reconocer y manejar las situaciones que promueven comportamientos riesgosos, y a aumentar sus habilidades de negociación.<sup>16</sup>
<h4>¿qué queda por hacer?</h4>
Si bien las comunidades IN/NA son diferentes entre sí, éstas comparten un sentido de orgullo, autodeterminación, espiritualidad y adaptabilidad que les ha ayudado a luchar contra la infección por VIH. Dichos empeños deben empujarse para asegurar que se mantenga la prevención del VIH. Esto no puede suceder sin la cooperación y colaboración de las diversas agencias que trabajan con los IN/NA, tales como los sistemas tribales de servicios de salud, los departamentos de salud gubernamentales y las organizaciones no lucrativas. Por ejemplo, para permitir que las comunidades IN/NA tengan más acceso a los recursos de prevención, es preciso simplificar el complicado sistema de canalización de fondos.

El VIH debe hacerse visible en las comunidades IN/NA para evitar su propagación. La visibilidad se puede aumentar obteniendo datos confiables sobre el VIH, incluyendo a los IN/NA en el diseño y realización de programas de prevención del VIH, respondiendo al estigma con respecto a la homosexualidad y al uso de drogas, y formando conexiones con programas de prevención de ETS, violencia, embarazos no deseados, y abuso de alcohol y drogas.

<hr />

<h4>¿quién lo dice?</h4>
1. National Institutes of Health. Women of color health data book: adolescents to seniors. 1999. NIH publication #99-4247.www4.od.nih.gov/orwh/WOCEnglish.pdf (accessed January 2002).

2. Vernon I. Killing Us Quietly: Native Americans and HIV/AIDS. University of Nebraska Press, 2001.

3. Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through December 2001, Year-end edition. HIV/AIDS Surveillance Report. 2001;13 (2). (accessed April 2006).

4. Rowell RM, Bouey PD. Update on HIV/AIDS among American Indians and Alaska Natives. The IHS Primary Care Provider. 1997;22:49-53. (accessed April 2006).

5. Thoroughman DA, Frederickson D, Cameron HD, et al. Racial Misclassification of American Indians in Oklahoma state surveillance data for sexually transmitted diseases. American Journal of Epidemiology. 2002;155(12): 1137-41.

6. Smith AS, Ahmed B, Sink L. US Census Bureau. An Analysis of State and County Population Changes by Characteristics: 1990-1999. Working Paper Series No. 45. (accessed April 2006).

7. Centers for Disease Control and Prevention. HIV/AIDS among American Indians and Alaskan Natives – United States, 1981-1997. Morbidity and Mortality Weekly Report. 1998;47:154-160. (accessed April 2006).

8. Morrison-Beedy D, Carey MP, Lewis BP, et al. HIV risk behavior and psychological correlates among Native American women: an exploratory investigation. Journal of Women’s Health and Gender-Based Medicine. 2001:10;487-494.

9. Indian Health Service. Trends in Indian Health–1997. U.S. Department of Health and Human Services, Public Health Service, Indian Health Service, Office of Planning, Education, and Legislation, Division of Program Statistics. 1998.

10. Baldwin JA, Maxwell CJ, Fenaughty AM, et al. Alcohol as a risk factor for HIV transmission among American Indian and Alaska Native drug users. American Indian and Alaska Native Mental Health Research. 2000;9:1-16.

11. Fisher DG, Fenaughty AM, Paschane DM, et al. Alaska Native drug users and sexually transmitted disease: results of a five-year study. American Indian Alaska Native Mental Health Research. 2000;9:47-57.

12. Potthoff SJ, Bearinger LH, Skay CL, et al. Dimensions of risk behaviors among American Indian youth. Archives of Pediatric and Adolescent Medicine. 1998;152:157-163.

13. National Native American AIDS Prevention Center. HIV Prevention for gay/bisexual/two-spirit Native American men. 1996. www.nnaapc.org (accessed April 2006).

14. Yost D, Hamstra S, Roosevelt L. HIV/AIDS and STD prevention in a rural Arizona Indian tribe. Presented at the International Conference on AIDS, Geneva, Switzerland. 1998. Abst #43162.

15. Indigenous People’s Task Force, 1433 East Franklin Ave. Suite 18A, Minneapolis, MN 55404. Contact Sharon Day 612/870-1723.www.indigenouspeoplestf.org (accessed January 2002).

16. Indian Healthcare Resource Center of Tulsa, 550 South Peoria, Tulsa, OK 74120. Contact Tommy Chesbro 918/382-1275 www.tulsaindianhealth.com(accessed January 2002).

<hr />

<strong>Preparado por Ron Rowell MPH*, Paul Bouey PhD MPH**
*San Francisco Foundation, **Pangaea Global AIDS Foundation</strong>

<strong>Tradución Rocky Schnaath</strong>

<strong>Abril 2002. Hoja Informativa 43S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/IN-NAFS.pdf</url>
	</node>
	<node>
		<title>Asiáticos y Isleños del Pacífico</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los asiáticos e isleños del Pacífico para prevenir el VIH?</h3>
revisado 12/07
<h4>¿corren riesgo los AIP?</h4>
Los asiáticos e isleños del Pacífico (AIP) son una de las poblaciones de minorías étnicas de mayor crecimiento en los Estados Unidos.<sup>1</sup> Se calcula que para el año 2050 este grupo alcanzará 34 millones personas y representará el 8% de la población total de EE.UU.<sup>1,2</sup>

Los asiáticos y los isleños del Pacífico tienen una diversidad considerable que abarca 49 grupos étnicos, más de 100 idiomas y personas de origen chino, filipino, coreano, hawaiano, indio-asiático, japonés, samoano, vietnamita y otros. La mayoría vive en metrópolis grandes como Honolulu, HI; San Francisco, CA; Nueva York, NY y Los Ángeles, CA.<sup>2</sup>

Entre el 2001 y el 2004 los AIP componían menos del 1% de los casos de VIH/SIDA en EE.UU., pero también tenían el mayor porcentaje del incremento anual en las tasas de diagnóstico frente a todos los otros grupos étnicos/raciales (el 8.1% para hombres y el 14.3% para mujeres).<sup>3</sup> Cuando grupos poblacionales como los AIP muestran una prevalencia baja (cifras totales) pero grandes incrementos en la incidencia (casos nuevos), se precisan esfuerzos de prevención para limitar futuros casos de VIH/SIDA.

El subregistro de casos y la falta de una vigilancia detallada del VIH ocultan la naturaleza auténtica de la epidemia entre los AIP. Un estudio encontró que el subregistro de casos de SIDA entre AIP puede alcanzar el 33 %<sup>4</sup>. Esto podría deberse en parte al registro erróneo de raza y origen étnico en los expedientes médicos, que son la fuente de datos para el reporte de registro de casos.<sup>2,5</sup> Por ejemplo, las personas con apellido hispano, como los filipinos, pueden ser registradas por error como latinas. La falta de detalles demográficos sobre el grupo étnico específico y lugar de nacimiento también impide el rastreo de diferencias entre subgrupos de AIP con respecto a la epidemia del SIDA y dificulta la creación de medidas de salud pública para etnias específicas.<sup>2</sup>
<h4>¿quiénes son los AIP que corren riesgo?</h4>
La transmisión del VIH entre los AIP masculinos se da principalmente entre hombres que tienen sexo con hombres (HSH), seguidos por hombres que tienen contacto heterosexual de alto riesgo o que se inyectan drogas (UDI). En 2005, el 71% de los casos de SIDA entre los AIP hasta esa fecha se debió a la transmisión entre HSH.<sup>6</sup> Entre las mujeres AIP, la transmisión ocurre mayormente entre mujeres que tienen coito con un hombre que tiene mayor riesgo, seguido por mujeres UDI.<sup>6</sup>

Aunque los HSH AIP son los más afectados por el VIH/SIDA, los diagnósticos entre mujeres AIP han aumentado (14.3%)<sup>3</sup>. El CDC no tiene una categoría para mujeres transgéneras (nacidos hombres pero que se consideran y viven como mujeres), sin embargo un estudio en San Francisco, CA indicó una prevalencia de VIH del 13% entre las mujeres transgéneras AIP.<sup>7</sup>
<h4>¿qué pone a los AIP en riesgo?</h4>
Entre los HSH AIP, la discriminación social y la falta del apoyo familiar, de sus semejantes y comunitario con respecto a la diversidad sexual y racial puede perjudicar la auto estima y la auto identidad positivas, lo cual aumenta el riesgo de contraer el VIH.<sup>8</sup> En un estudio, el 57% de los hombres AIP gay en San Francisco, CA, consumieron alcohol antes del sexo anal; el 24% reportó practicarlo sin protección. Sin embargo, el 85% creía tener pocas posibilidades de contraer el VIH.<sup>9</sup>

Pocos AIP se hacen la prueba del VIH en contraste con el resto de la población de EE.UU., aunque reportan tasas similares de conductas de riesgo<sup>2</sup> y con frecuencia demoran en buscar servicios de VIH. En un estudio entre jóvenes HSH AIP en San Francisco, CA, el 24.4 % de los participantes nunca se había hecho la prueba del VIH anteriormente. Además, el 2.6 % resultó VIH+; de este grupo el 61.5 % no sabía que era VIH positivo y el 38.5 % reportó un acto sexual reciente sin protección.<sup>10</sup> Los AIP VIH+ que todavía no se han hecho la prueba son más propensos a actos riesgosos y a infectar a otros sin saberlo.<sup>11</sup> Aquellos que demoran en atenderse corren un mayor riesgo de tener el SIDA avanzado en el momento del diagnóstico y de adquirir una coinfección como la hepatitis B, la tuberculosis y la PCP.<sup>5,12</sup>

Las inmigrantes AIP que trabajan en casas de masaje muchas veces realizan actividades que las exponen al VIH. Sin embargo, para muchas de ellas la sobrevivencia diaria tiene prioridad sobre la prevención del VIH. Los problemas relacionados con la policía, el trabajo sexual, la situación migratoria, la planificación familiar, el idioma y la falta de uso de condones en los centros de masaje son todos factores de riesgo para esta población.<sup>13</sup>
<h4>¿cuáles son los obstáculos?</h4>
A pesar del estereotipo de los AIP como “minoría étnica modelo”, el 17% no tiene seguro médico y no puede recibir tratamiento y otros servicios de salud adecuados.<sup>14</sup> Debido a los escasos datos sobre la salud y los riesgos conductuales de los AIP, muchos recursos se destinan a otros grupos sin evaluar o reconocer las necesidades de los AIP.<sup>14</sup>

La norma cultural de evitar temas como la actividad sexual, la enfermedad y la muerte plantea barreras a la prevención del VIH, genera estigmas y perjudica la salud psicológica y mental de los AIP que viven con esta enfermedad.<sup>15</sup>

El 40% de los AIP habla poco o nada de inglés<sup>14</sup> y pocos programas de intervención reflejan la diversidad cultural y lingüística de esta población. Un estudio encontró que el idioma es el obstáculo más común al acceso a servicios médicos para los AIP con VIH/SIDA.<sup>12</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Existen muchos programas nacionales y locales que brindan servicios y orientación sobre la prevención del VIH para AIP.<sup>16</sup> Otros ofrecen desarrollo de capacidades y asistencia técnica para organizaciones que los atienden.<sup>17</sup> Por ejemplo:
La Asian and Pacific Islander Coalition on HIV/AIDS (AIPCHA) desarrolló Project Bridges, una intervención comunitaria para reducir las disparidades de atención para AIP VIH+ en Nueva York. Formó enlaces con proveedores médicos y brindó manejo de casos, promoción de derechos y capacitación sobre la competencia cultural para los proveedores. Se logró aumentar la utilización de servicios y reducir las barreras a servicios para los participantes que tenían un idioma asiático como lengua principal, los que no hablaban inglés y los indocumentados.<sup>12</sup>

Life Foundation, en Honolulu, HI, ha ofrecido programas comunitarios para HSH y transgéneros de las islas del Pacífico desde 1999. “UTOPIA Hawai’i” está basado en el modelo Mpowerment y ha logrado grandes éxitos en alcanzar a isleños del Pacífico que nunca habían utilizado servicios de VIH anteriormente.<sup>18</sup>

El Health Project for Asian Women (HPAW) para las trabajadoras sexuales asiáticas de casas de masaje en San Francisco, CA, brindó dos intervenciones: una orientó a los dueños de estos negocios y otra informó a las masajistas sobre temas de salud. El personal del HPAW acompañó a las masajistas a clínicas médicas, repartió materiales para una práctica sexual más segura, y les ofreció servicios de interpretación, remisiones y promoción de derechos. Las masajistas recibieron tres sesiones de consejería y los dueños asistieron a una sesión informativa.<sup>13</sup>

El Asian &amp; Pacific Islander Wellness Center realizó una campaña anti estigma sobre el VIH. La campaña se destinó a las comunidades chinas de San Francisco, CA por medio de carteles en las paradas de autobús, anuncios en los periódicos y un documental con la participación de dirigentes comunitarios locales, personas VIH+ y sus familias. También lideró el Día Nacional AIP para la Concienciación del VIH/SIDA, en el que organizó más de 15 eventos a lo largo de EE.UU. para aumentar la aceptación del VIH/SIDA entre familias y comunidades AIP.<sup>19</sup>
<h4>¿qué queda por hacer?</h4>
Tenemos una oportunidad de oro para mantener bajas las cifras de VIH entre los AIP, pero podríamos perderla pronto, pues tienen el mayor aumento en las tasas de diagnóstico de VIH/SIDA que cualquier otro grupo racial en EE.UU. Los programas de prevención del VIH para AIP deben centrarse en las personas que corren mayor riesgo: HSH, mujeres, transgéneros y consumidores de drogas. Los programas pueden ayudar a los AIP a crear y fortalecer sistemas de apoyo y enfocar la prevención y la atención médica, como pruebas para detectar el VIH, la hepatitis B y la tuberculosis. Se necesita diseñar y evaluar más programas que se ajusten mejor a los aspectos culturales y lingüísticos de los AIP.

Para combatir el estigma en torno al VIH, a la homosexualidad, al trabajo sexual y al consumo de drogas se necesitan campañas informativas que profundicen el diálogo sobre la prevención de VIH/SIDA y la aceptación de los AIP VIH+. El trabajo conjunto entre los formuladores de políticas y nuevos colaboradores, como lo son ahora las organizaciones religiosas, puede reducir el estigma entre los AIP. Dada la enorme diversidad entre los AIP radicados en EE.UU., es importante mejorar los sistemas de vigilancia y la calidad de los datos recogidos, registrando siempre el origen étnico y el lugar de nacimiento de cada subgrupo.<sup>3</sup> Se necesitan investigaciones sobre el VIH y las coinfecciones (la hepatitis B y la tuberculosis) y sobre la relación entre la aculturación y el VIH.

<hr />

<h3>¿Quién lo dice?</h3>
1. Choi KH, Wong F, Sy FS. HIV/ AIDS among Asians and Pacific Islanders in the United States. AIDS Education and Prevention. 2005;17:iii-v.

2. Zaidi IF, Crepaz N, Song R, et al. Epidemiology of HIV/AIDS Among Asians and Pacific Islanders in the United States. AIDS Education and Prevention. 2005;17:405-417.

3. Racial/ethnic disparities in diagnoses of HIV/AIDS33 states, 2001-2004. Morbidity and Mortality Weekly Report. 2006;55:121-125.

4. Kelly JJ, Chu SY, Diaz T, et al. Race/ethnicity misclassification of persons reported with AIDS. Ethnicity &amp; Health. 1996;1:87-94.

5. Wortley PM, Metler RP, Hu DJ, et al. AIDS among Asians and Pacific Islanders in the United States. American Journal of Preventative Medicine. 2000;18:208-214.

6. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveillance Report. 2006;17:37.

7. Operario D, Nemoto T. Sexual risk behavior and substance use among a sample of Asian Pacific Islander transgendered women. AIDS Education and Prevention. 2005;17:430-443.

8. Wilson PA, Yoshikawa H. Experiences of and responses to social discrimination among Asian and Pacific Islander gay men: Their relationship to HIV risk. AIDS Education and Prevention. 2004;16:68-83.

9. Choi KH, Operario D, Gregorich SE, et al. Substance use, substance choice, and unprotected anal intercourse among young Asian American and Pacific Islander men who have sex with men. AIDS Education and Prevention. 2005;17:418-429.

10. Do TD, Chen S, McFarland W, et al. HIV testing patterns and unrecognized HIV infection among young Asian and Pacific Islander men who have sex with men in San Francisco. AIDS Education and Prevention. 2005;17:540-554.

11. Wong F, Campsmith ML, Nakamura GV, et al. HIV testing and awareness of care-related services among a group of HIV-positive Asian Americans and Pacific Islanders in the United States: Findings from a supplemental HIV/AIDS surveillance project. AIDS Education and Prevention. 2004;16:440-447.

12. Chin JJ, Kang E, Haejin Kim J, et al. Serving Asians and Pacific Islanders with HIV/AIDS: Challenges and lessons learned. Journal of Health Care for the Poor and Underserved. 2006;17:910-927.

13. Nemoto T, Iwamoto M, Oh HJ, et al. Risk behaviors among Asian women who work at massage parlors in San Francisco: Perspectives from masseuses and owners/managers. AIDS Education and Prevention. 2005;17:444-456.

14. Ghosh C. Healthy People 2010 and Asian Americans/Pacific Islanders: Defining a baseline of information. American Journal of Public Health. 2003;93:2093-2098.

15. Kang E, Rapkin BD, Remien RH, et al. Multiple dimensions of HIV stigma and psychological distress among Asians and Pacific Islanders living with HIV illness.AIDS and Behavior. 2005;9:145-154.

16. API Capacity Building programs

17. Takahashi LM, Candelario J, Young T, et al. Building capacity for HIV/AIDS prevention among Asian and Pacific Islander organizations: The experience of a culturally appropriate capacity-building program in southern California. Journal of Public Health Management and Practice. 2007:S55-S63.

18. Utopia Hawai’i

19. Campaña anti estigma sobre el VIH

<hr />

<strong>Preparado por Roshan Rahnama, Nina Agbayani, Stacy Lavilla,* John Chin, PhD**
*Association of Asian Pacific Community Health Organizations (AAPCHO), **NY Academy of Medicine</strong>

<strong>Traducción: Rocky Schnaath</strong>

Diciembre 2007. Hoja de Dato #33SR]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revasiaticosFS.pdf</url>
	</node>
	<node>
		<title>Sordos</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesítan los sordos en la prevención del VIH?</h3>
<h4>¿están a riesgo de contraer el VIH?</h4>
Si. Se estima que en los EEUU existen de 7,000 a 26,000 personas carentes del sentido auditivo infectadas con el VIH.<sup>1</sup> Sin embargo, los Centros para el Control de Enfermedades (CDC por sus siglas en Inglés) actualmente no recopilan información acerca de los que padecen de sordera y VIH o SIDA. Maryland fue el primer estado en incluir preguntas relacionadas con el sentido auditivo en el área de consejería y al realizar pruebas de detección. En Maryland, el 4.3% de la población sorda padecen de la infección con VIH.<sup>2</sup>

Existen cerca de dos millones de personas que no pueden oir, y una de cada 10 Norteamericanos padecen de problemas auditivos. Las personas que carecen del sentido auditivo han luchado por mucho tiempo por obtener igualdad en acceso a servicios sociales y médicos, educación y empleos. Actualmente en los EEUU, existe poca información sobre VIH y sordera, pocos servicios de prevención o tratamiento, y escasa investigación para los sordos.<sup>3</sup>
<h4>¿cuáles son los factores de riesgo?</h4>
Existen altos índices de abuso de substancias en la communidad sorda. Una de cada siete personas (1 de 7) que no oyen tiene una historia de abuso de sustancias versus una de cada diez (1 de 10) reportada por la población sin problemas auditivos.<sup>3</sup> El abuso de las sustancias puede ser un factor de riesgo para contraer el VIH ya que reduce la inhibición y altera el juicio, lo cual puede conducir a conductas sexuales poco seguras. Compartir el equipo de inyección es otro de los riesgos de transmisión del VIH.

Existe muy poca educación sobre el VIH o sobre sexualidad en las escuelas para sordos, especialmente en escuelas para adolescentes. Debido a esto, las personas sordas poseen un menor conocimiento y están menos concientes de los riesgos de transmisión del VIH, tratamiento y prevención. Si los niños sordos no aprenden sobre el VIH u otras enfermedades de transmisión sexual, no van a tener el vocabulario adecuado para hablar del tema entre ellos. Un estudio entre estudiantes de una escuela para sordos descubrió que los adolescentes del 9 al 12 grado tenían un conocimiento extremadamente limitado sobre el SIDA. Los estudiantes solamente acertaron 8 de la 35 preguntas básicas sobre SIDA.<sup>4</sup>

Los hombres sordos que tienen sexo con hombres pueden sufrir discriminación dentro de la comunidad de sordos. Por este motivo, los hombres sordos que tienen sexo con hombres esconden a menudo su identidad y pueden llegar a presentar comportamientos sexuales furtivos, anónimos y de mucho riesgo. Muchos hombres sordos que tienen sexo con hombres también desean tener relaciones con hombres no sordos, lo cual dificulta aún mas la comunicación sobre la práctica segura del sexo.<sup>3</sup>

Se ha descubierto que los niños discapacitados, incluyendo a niños sordos, están a mayor riesgo de sufrir abuso sexual tanto en la escuela como en el hogar. En un estudio a niños sordos y no sordos de un instituto de lenguaje se descubrió que el 54% de los varones sordos reportó abuso, comparado con el 10% reportado por los no-sordos. Las niñas sordas reportaron índices de abuso del 50% comparado con el 25% reportado por las niñas no sordas. El abuso sexual a temprana edad es un fuerte indicador de los comportamientos sexuales de alto riesgo, del abuso de sustancias, e infección con VIH en la edad adulta.<sup>6</sup>
<h4>¿cuáles son las barreras en la prevención?</h4>
Para la mayoría de las personas sordas en los EEUU, el Lenguaje Americano de Signos (ASL) es su primer idioma, Inglés o Español el segundo. El ASL es un lenguaje complejo de gestos y señales con su propia gramática y sintaxis. La única forma de comunicarse en ASL es cara a cara. El material escrito sobre VIH en ASL Gráfico disponible es escaso. Aunque algunas personas sordas pueden leer material escrito tales como los panfletos utilizados en la prevención del VIH, para algunas personas sordas con un nivel de Inglés o Español limitado, estos panfletos son ineficaces.<sup>7</sup>

La comunidad sorda es un grupo muy unido, esto a veces significa que así como se recibe un fuerte apoyo a veces lo que se recibe es una fuerte condena. La privacidad es muy importante en esta comunidad donde las noticias vuelan muy rápido. Muchas personas sordas prefieren ir solas a hacerse la prueba de detección del VIH y a recibir consejería totalmente oral ya que traer a un intérprete o ir a una clínica para sordos pone a riesgo su privacidad aunque también a la misma vez exponen la comunicación y la comprensión.<sup>8</sup> El hacerse la prueba usando un equipo casero de detección del VIH tampoco ofrece la solución al problema de la privacidad ya que estas personas necesitan a un intérprete por medio del teléfono o a través de un intermediario para conocer los resultados.
<h4>¿qué puede ayudar en la prevención?</h4>
Conocer las áreas mas fuertes de esta comunidad puede ser muy útil en los esfuerzos de prevención. El hecho de que esta comunidad sea tan unida significa que existe un mayor grado de intimidad física y emociónal. La naturaleza visual del ASL requiere tratar temas como el sexo y el uso de las drogas abiertamente y con mucha franqueza. Cuando estos temas salen a la luz, las personas sordas a menudo se sienten mas cómodas al hablar del los temas, logrando al unísono un mayor entendimiento y una mejor negociación en cuanto al comportamiento seguro.<sup>8</sup>

Las instituciones para sordos deben tratar temas que tradicionalmente han estado tapados o que han sido tabú en esta comunidad, tales como el abuso de la drogas y el alcohol, el abuso sexual a temprana edad y la homofobia. En 1998, la Línea Nacional del SIDA del CDC envió más de un millar de cartas a escuelas estatales para sordos ofreciendo programas educacionales sobre SIDA para estudiantes sordos o con problemas auditivos. De éstas solamente 3 escuelas respondieron.:7
<h4>¿qué se está haciendo?</h4>
Un programa creado por el Centro de Salud Mental de la Universidad Gallaudet ofrece entrenamiento sobre VIH/SIDA a profesionales de salud mental que trabajan con la comunidad sorda, utilizando videos con subtítulos o leyendas, dibujos, actividades de grupo y modelos sobre como el VIH se adhiere a las células.<sup>9</sup>

En París, Francia, la Unidad Móvil de Prevención de SIDA (EMIPS) utilizó una variedad de programas para llevar el mensaje a los adolescentes sordos dentro y fuera de las escuelas para sordos. Un joven educador sordo visitó escuelas para sordos y presentó una intervención en lenguaje por señas. El programa creó varias anuncios públicos exponiendo las falsas creencias del riesgo que envuelve al VIH. El programa también abrió una clínica que no requiere de cita previa en la que el Doctor(a) se comunica por medio del lenguaje por señas. Sin embargo, la clínica no estuvo muy concurrida ya que estaba demasiado identificada con el SIDA. Cuando el programa abrió un centro de detección de VIH dentro de una clínica general se obtuvo mayor éxito.<sup>10</sup>

En Minnesota, el programa para personas que carecen o tienen dificultades auditivas que dependen de sustancias químicas y otras drogas ofrecen tratamiento para los adictos al alcohol y otras drogas en los EEUU y Canadá. El personal está capacitado específicamente para tratar a personas con problemas auditivos parcial o total y en tratar el abuso de sustancias, además, han desarrollado métodos terapeúticos sin problemas de comunicación. Por otra parte, el programa ofrece entrenamiento a estudiantes y profesionales que trabajan con personas sordas, tienen además un centro de recursos para diseminar material y proveen fondos para intérpretes que asisten a reuniones de AA/NA (Alcohólicos Anónimos/Narcóticos Anónimos).<sup>11</sup>
<h4>¿qué queda por hacer?</h4>
Crear material educativo y buscar la forma de llegar a esta comunidad, no solo alrededor del tema del VIH o del SIDA también sobre temas tan amplios como la salud sexual y el uso de sustancias psicotrópicas. Las escuelas para sordos necesitan ofrecer educación sobre sexualidad y sobre el uso de sustancias y proveer consejería a niños y adolescentes que hayan experimentado abuso. Los programas para sordos deben tratar temas específicos de esta comunidad, tales como negociar el sexo seguro con una pareja no sorda, abogar por los servicios del cuidado de salud y derribar las barreras que impiden tratar el problema del abuso sexual y abuso de drogas.

Los programas de prevención de VIH para personas sordas deben ser lo mas claro y visuales posibles. Los programas no deben ser diseñados a manera de presentación sólamente, deben además dedicar mayor tiempo a debatir el tema, incorporar actividades físicas, fotos, muñecos, manuales gráficos en ASL y videos con subtítulos.<sup>12</sup> Para poder llegar a las comunidades de sordos tanto investigadores como proveedores de servicios deben aprovechar los avances tecnológicos tales como los videos interactivos y la internet.<sup>13</sup>

Si bien es cierto que ya se han hecho esfuerzos a todo nivel para educar a la comunidad sorda sobre el tema del VIH/SIDA, todavía existen discrepancias sobre el tipo de información crucial que debe recibir la población que realmente lo necesita. Cada estado al igual que el CDC necesita añadir preguntas sobre discapacidades al recaudar datos estadísticos para poder determinar el alcance de la epidemia en la población sorda. Se necesitan más programas que ayuden a desarrollar un mayor conocimiento y disipar los mitos acerca de la transmisión del VIH y las conductas de riesgo de las personas sordas. Los pocos programas populares que existen deben ser evaluados y replicados en toda la nación.

<hr />

<h4>¿quién lo dice?</h4>
1. Friess S. Silence = Deaf . Poz Magazine. April 1998. p.60-63.
2. Personal communication. Department of Health and Mental Hygiene, State of Maryland. 1999.
3. Peinkoffer JR. HIV education for the deaf, a vulnerable minority . Public Health Reports. 1994;109:390-396.
4. Baker-Duncan N, Dancer J, Gentry B, et al. Deaf adolescents’ knowledge of AIDS. Grade and gender effects . American Annals of the Deaf. 1997;142:368-372.
5. Sullivan PM, Vernon M, Scanlan JH. Sexual abuse of deaf youth . American Annals of the Deaf. 1987;132:256-262.
6. Johnsen L, Harlow L. Childhood sexual abuse linked with adult substance use, victimization, and AIDS-risk . AIDS Education and Prevention. 1996;80:44-57.
7. Campbell D. AIDS and the deaf community. ADVANCE for Speech-Language Pathologists &amp; Audiologists. April 26, 1999; p.10-11.
8. Morrone JJ. Peer education and the deaf community. Journal of American College Health. 1993;41:264-266.
9. Sleek S. HIV/AIDS education efforts have missed deaf community. American Psychological Association Monitor. 1999.
10. Grivois L, Houette A. Outreach programs towards deaf people targeting prevention of AIDS. Presented at the 11th International Conference on AIDS, Vancouver, Canada. June 1996. Abst. #MoD240.
11. Program celebrates ten years. Steps to Recovery. Published by the Minnesota Chemical Dependency Program for Deaf and Hard of Hearing Individuals. Spring/Summer 1999.
12. Gaskins S. Special population: HIV/AIDS among the deaf and hard of hearing. Journal of the Association of Nurses in AIDS Care. 1999;10:75-78.
13. Lipton DS, Goldstein M, Wellington Fahnbulleh F, et al. The interactive video-questionnaire: a new technology for interviewing deaf persons . American Annals of the Deaf. 1999;141:370-378.
<h4>Recursos:</h4>
<strong>Línea Nacional del SIDA de los CDC,
Servicio Para Sordos Y Personas Con Dificultad En Oír</strong>
American Social Health Association
1-800-243-7889 o1-800-AIDS-TTY
www.ashastd.org/nah/spantty.html

<hr />

<strong>PREPARADO POR BRYAN DETERMAN** NATASHA KORDUS** Y PAMELA DECARLO***
*CLINICA MONTROSE, HOUSTON, TX, **ESCUELA PARA SORDOS DE CALIFORNIA,***CAPS</strong>

Agosto 2000. Hoja Informativa 36S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/sordosFS.pdf</url>
	</node>
	<node>
		<title>Desamparados</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los desamparados para evitar el VIH?</h3>
<h3>revisado 9/05</h3>
<h4>¿quiénes son los desamparados?</h4>
El desamparo es un problema creciente en EE.UU. donde cada día más de 800,000 personas están sin hogar. Entre 2.3 y 3.5 millones de individuos se encuentran desamparados en algún momento del año.<sup>2</sup> Según el informe sobre el desamparo preparado en el 2004 por los alcaldes estadounidenses, el 70% de las ciudades encuestadas habían registrado un aumento en el número de solicitudes de albergue de emergencia durante el año previo.<sup>2</sup>

La población de desamparados en EE.UU. se divide normalmente en tres grupos: adultos solteros, familias y jóvenes. Se calcula que los adultos solteros componen el 54% de esta población, las familias el 40% y los jóvenes no acompañados un 5%.
<h4>¿existe una prevalencia alta de VIH en las poblaciones desamparadas?</h4>
Los desamparados tienen peor salud y mayor mortalidad que la población en general.<sup>3</sup> La prevalencia del VIH/SIDA varía mucho entre los subgrupos de personas sin hogar, pero por lo general excede a la de quienes cuentan con vivienda. La elevada prevalencia de infección, el acceso limitado a tratamiento y las pobres condiciones de vida han contribuido a que el VIH/SIDA ya sea una principal causa de muerte en esta población.<sup>4</sup>

Un estudio en San Francisco, CA reportó una prevalencia total del VIH del 10.5% entre adultos actualmente desamparados o con vivienda marginal, una tasa cinco veces mayor que la de la población general de San Francisco. El mismo estudio encontró una prevalencia del VIH del 30% entre los hombres desamparados que tienen sexo con otros hombres (HSH) y del 8% entre los desamparados usuarios de drogas inyectables (UDI).<sup>5</sup>

La relación entre el desamparo y el VIH parece ser un camino de doble sentido. Las personas VIH+ corren mayor riesgo de convertirse en desamparados debido a la discriminación y al alto costo de la vivienda y de la atención médica. Al mismo tiempo, los desamparados corren más riesgo de contraer el VIH.
<h4>¿cuáles son los riesgos para una persona desamparada?</h4>
Los desamparados viven en situaciones transitorias, por lo general en comunidades pobres con una alta prevalencia del VIH. Por lo tanto, si participan en conductas riesgosas la probabilidad de resultar infectado es mayor.

Los desamparados también están más afectados por problemas relacionados con las drogas, el alcohol y la salud mental que el resto de la población. Según un cálculo realizado en el año 2000, el 88% de los hombres solteros desamparados y el 69% de las solteras desamparadas tenía uno de estos tres trastornos.<sup>6</sup> Casi un cuarto de toda la población adulta de solteros desamparados padece de enfermedad mental grave y persistente.<sup>1</sup> La impulsividad y la imprudencia que muchas veces se asocian con la enfermedad mental grave o con el abuso de drogas y alcohol contribuyen a conductas riesgosas tales como el contacto sexual sin protección y con múltiples parejas, el uso compartido de jeringas o el intercambio de sexo por drogas.

Las condiciones del desamparo y de la pobreza extrema también favorecen las conductas riesgosas. Por ejemplo, la mayoría de los albergues tienen áreas comunales para dormir y bañarse son exclusivamente para hombres o para mujeres y ofrecen poca privacidad. Estas restricciones impiden las relaciones sexuales estables.

Otras características comunes entre los desamparados y que están asociadas con las conductas de riesgo del VIH incluyen: experiencias adversas en la niñez tales como abuso físico y sexual,<sup>1,7</sup> acoso sexual, violencia por parte de la pareja y otros historiales traumáticos, así como la falta de apoyo social.<sup>8</sup>
<h4>¿cuáles son los obstáculos?</h4>
Una concepción falsa es que el mayor obstáculo en la prestación de servicios de prevención es el de localizar a los desamparados. En realidad, muchos de ellos son visibles por trabajar o vivir en la calle o son fáciles de encontrar en los albergues. Al formar relaciones de confianza, visitarlos continuamente durante un tiempo y aprovechar las redes sociales existentes, es posible encontrar y retener a los desamparados para atenderlos y darles seguimiento. En un programa de pruebas del VIH para desamparados con enfermedad mental grave, el 90% de los que se hicieron la prueba regresaron por los resultados.:9

Las barreras y entornos institucionales pueden restringir las actividades de prevención del VIH. Muchos albergues sólo disponen del personal suficiente para brindar servicios básicos. Algunos son reacios a permitir que programas externos de prevención del VIH los visiten para hablar explícitamente sobre el sexo y las drogas o para distribuir condones a sus clientes, ya que estas actividades se prohíben en la mayoría de los albergues. La falta de lugares privados para ofrecer pruebas y consejería sobre asuntos delicados también puede ser un obstáculo.
<h4>¿qué se está haciendo al respecto?</h4>
La cantidad y calidad de los servicios para desamparados varía mucho a través de los EE.UU. Históricamente, estos programas han atendido a hombres solteros y pocos han formado redes de atención coordinada que faciliten la provisión de servicios integrales y continuos.<sup>1</sup> A continuación presentamos unos ejemplos de intervenciones eficaces diseñadas específicamente para atender a los desamparados con VIH o en riesgo de contraerlo.

Sex, Games and Videotapes es un programa para hombres desamparados con enfermedad mental en un albergue de la ciudad de Nueva York, NY. Este programa se basa en las actividades centrales de la vida en albergue: juegos competitivos, cuentos relatados y videos. Para muchos de estos hombres el sexo ocurre en lugares públicos, en forma apresurada y gira alrededor del consumo de drogas. Este programa permite comentar temas sexuales sin temor a reproches. Uno de los componentes es un concurso para ver quién coloca más rápido un condón (sin desgarrarlo) sobre un plátano, lo cual enseña habilidades importantes en el uso del condón. El programa triplicó la reducción de conductas sexuales de riesgo.<sup>10</sup>

Boston HAPPENS provee educación en salud, manejo de casos, atención médica básica, pruebas del VIH, consejería y servicios de salud mental para jóvenes VIH+ vulnerables, muchos de ellos desamparados. Los colaboradores de Boston HAPPENS ofrecen servicios sin cita previa y clínicas que dan a la calle en áreas donde los jóvenes se reúnen. Por medio del trabajo persistente de alcance comunitario y del manejo individualizado de casos, HAPPENS retiene a los jóvenes desamparados vulnerables.<sup>11</sup>

Se ha comprobado que la provisión de vivienda e incentivos económicos reduce las conductas riesgosas tales como el sexo desprotegido, el consumo de drogas y el uso compartido de jeringas.<sup>12,13</sup> Housing Works se especializa en la atención integral para desamparados VIH+ en la ciudad de Nueva York. Sus servicios abarcan las áreas de vivienda, atención médica, capacitación y colocación laboral, así como la promoción y defensa de derechos.<sup>14</sup>
<h4>¿qué queda por hacer?</h4>
Sigue siendo necesario brindar actividades de prevención eficaces en entornos de servicio culturalmente adecuados adonde acudan los desamparados, por ejemplo: comedores gratuitos, albergues, hoteles residenciales y clínicas. El personal de estas organizaciones debe recibir capacitación sobre métodos de prevención del VIH que tomen en cuenta los factores de riesgo concretos vinculados al desamparo, tener expectativas realistas de cambios y permitir que los desamparados se fijen metas concretas y factibles.

Es necesario formar redes coordinadas para que el personal remita a las personas rápida y fácilmente a los servicios que necesitan.<sup>15</sup> Las intervenciones grupales que han funcionado en ciertos ámbitos deben diseminarse ampliamente y ser adaptadas para su uso en otros entornos.

Los intentos para evitar la transmisión del VIH entre los desamparados fracasarán si no se hace un esfuerzo concertado para responder mejor a sus necesidades de supervivencia, entre ellas las de vivienda a largo plazo, empleo, ingresos, nutrición adecuada, tratamiento contra las drogas y el alcohol, así como servicios médicos y de salud mental regulares.

Lamentablemente, a pesar del anuncio de nuevas iniciativas para socorrer a los desamparados, las tendencias recientes de apoyos gubernamentales son desalentadoras y el creciente déficit presupuestario federal no augura los aumentos necesarios en el futuro próximo. Como una de las poblaciones más vulnerables de nuestra sociedad, los desamparados necesitan apoyo, respeto, protección y esfuerzos de prevención constantes.

<strong>Preparado por Naomi Adler BA*, Dan Herman Phd**, Ezra Susser MD DrPh***</strong>

<strong>*CAPS, **NY State Psychiatric Inst., *** Columbia U Mailman School of Public Health</strong>

<strong>Septiembre 2005. Hoja #16SR</strong>

**********
<h3>¿quién lo dice?</h3>
1. Burt M, Laudan Y, Lee E, et al. Helping America’s homeless: emergency shelter or affordable housing? Washington, D.C.: Urban Institute Press. 2001.
2. U.S. Conference of Mayors. A status report on hunger and homelessness inAmerica’s cities: 2004.www.usmayors.org/uscm/hungersurvey/2004/onlinereport/HungerAndHomelessnessReport2004.pdf(Accessed 4/20/06)
3. Burt, MR, Laudan, AY, Douglas T, et. al. 1999 Homelessness: Programs and the People They Serve – Summary Report. Washington, DC: DHUD/DHHS.http://www.huduser.org/publications/homeless/homelessness/contents.html(Accessed 4/20/06)
4. Cheung AM, Hwang SW. Risk of death among homeless women: a cohort study and review of the literature. Canadian Medical Association Journal. 2004;170:1243.
5. Robertson MJ, Clark RA, Charlebois ED, et al. HIV seroprevalence among homeless and marginally housed adults in San Francisco. American Journal of Public Health. 2004;94:1207-1217.
6. North CS, Eyrich KM, Pollio DE, et al. Are rates of psychiatric disorders in the homeless population changing? American Journal of Public Health. 2004;94:103-108.
7. Herman DB, Susser ES, Struening EL, et al. Adverse childhood experiences: are they risk factors for adult homelessness? American Journal of Public Health. 1997;87:249-255.
8. Zlotnick C, Tam T, Robertson MJ. Adverse childhood events, substance abuse, and measures of affiliation. Addiction and Behavior. 2004;29:1177-1181.
9. Desai MM, Rosenheck RA. HIV testing and receipt of test results among homeless persons with severe mental illness. American Journal of Psychiatry. 2004;161:2287-2294.
10. Susser E, Valencia E, Berkman A, et al. Human immunodeficiency virus sexual risk reduction in homeless men with mental illness. Archives of General Psychiatry. 1998;55:266-272.
11. Harris SK, Samples CL, Keenan PM, et al. Outreach, mental health, and case management services: can they help to retain HIV-positive and at-risk youth and young adults in care? Maternal and Child Health Journal. 2003;7:205-218.
12. Aidala A, Cross JE, Stall R, Harre D, et. al. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS and Behavior. 2005;9:1-15.
13. Riley ED, Moss AR, Clark RA, et. al. Cash benefits are associated with lower risk behavior among the homeless and marginally housed in San Francisco. Journal of Urban Health. 2005;82:142-150.
14. Housing Works www.housingworks.org (Accessed 4/20/06)
15. Woods ER, Samples CL, Melchiono MW, et. al. Initiation of services in the Boston HAPPENS Program: human immunodeficiency virus-positive, homeless, and at-risk youth can access services. AIDS Patient Care STDs. 2002;16:497-510.

3p\(18px; “&gt;18. Lombardi E. Enhancing transgender health care. American Journal of Public Health. 2001;91:869-872.

<hr />

<strong>Preparado por Joanne Keatley, MSW* y Kristen Clements-Nolle, MPH**
*CAPS, **SF Departamento de Salud Pública</strong>

<strong>Tradución Mateo Rutherford y Roy Rojas</strong>

<strong>Febrero 2002. Hoja Informativa 41S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revdesamparadosFS.pdf</url>
	</node>
	<node>
		<title>Prostitutas</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan las/los trabajadores sexuales en la prevención del VIH?</h3>
revisado 4/08
<h4>¿corren riesgo de contraer el VIH?</h4>
Los trabajadores sexuales en EEUU pueden ser vulnerables al VIH según cuál sea su lugar de trabajo. Hombres, mujeres y transgéneros que trabajan en la calle, en su mayoría pobres o desamparados con antecedentes de abuso sexual o físico, corren el mayor riesgo de contraer el VIH.<sup>1</sup> Muchos sexo servidores que trabajan en la calle también dependen de las drogas o alcohol y corren un mayor riesgo de sufrir violencia a manos de sus clientes y de la policía.<sup>2</sup>

El servicio de sexo fuera de la calle–en prostíbulos, casas de masaje o por medio de servicios de acompañante–supone menos riesgo de infección por VIH porque los trabajadores sexuales pueden controlar mejor sus condiciones laborales y transacciones sexuales, incluido el uso de condones.

Se han realizado pocas investigaciones sobre las tasas de infección de VIH entre sexo servidores que trabajan en la calle a lo largo de EEUU. En un estudio de sexo servidoras consumidoras de drogas en Miami, FL el 22.4 % resultó ser VIH+.<sup>3</sup> Otro estudio de trabajadores sexuales masculinos en Houston, TX encontró que el 26 % afirmaron ser VIH+.<sup>4</sup>
<h4>¿qué los pone en riesgo?</h4>
Los sexo servidores que son usuarios de drogas inyectables (UDI) tienen más probabilidades de resultar VIH+ que los no usuarios. Los riesgos por inyección incluyen compartir agujas/ jeringas y otro equipo de inyección previamente usados, así como ser inyectados por otra persona. La inyección y otras formas de consumo de drogas (cocaína en roca, etanfetamina, alcohol) también pueden aumentar los riesgos sexuales al disminuir la protección y la comunicación sexuales.<sup>5</sup> Las personas que usan cocaína en roca (crack) son más propensas a entrar al sexo servicio y a tener numerosas parejas sexuales.<sup>6</sup>

La decisión y la capacidad de usar condones es un asunto complejo y depende de muchos factores.<sup>7,8</sup> La necesidad económica, la falta de clientes y los clientes que ofrecen pagar más por tener relaciones sin protección pueden perjudicar la negociación del sexo más seguro. Además, hay clientes que pueden recurrir a la violencia para conseguir relaciones sin condón. Si los trabajadores sexuales se drogan junto con sus clientes o antes de atender a ellos, esto afecta su capacidad para tomar decisiones y usar condones.<sup>5</sup> También pueden ser un blanco de la policía si cargan con condones. Asimismo, al igual que muchas otras personas, los trabajadores sexuales pueden optar por no usar condones con sus novios/novias/esposos.

Los sexo servidores tienen tasas más altas de infecciones de transmisión sexual (ITS), entre ellas el VIH. Un estudio en San Francisco, CA reportó tasas altas de gonorrea (el 12.4 %), clamidia (el 6.8 %), sífilis (el 1.8 %) y herpes (el 34.3 %) entre los trabajadores sexuales (hombres, mujeres y transgéneros).<sup>9</sup> La presencia de una ITS activa aumenta la probabilidad de adquirir el VIH, como hace también el trauma genital producido por el coito frecuente o forzado.<sup>1</sup>

La violencia, y el trauma que conlleva, es una preocupación para muchos trabajadores sexuales. La violencia puede incluir el abuso físico, sexual y verbal ocurrido en la niñez, o bien en la edad adulta a manos de clientes y parejas íntimas. También abarca la violencia diaria presenciada por muchos trabajadores sexuales de la calle. El historial de violencia deja a muchos trabajadores sexuales con trauma emocional, y muchos pueden recurrir al consumo de drogas para ayudarles a afrontar la dura realidad de la vida diaria.<sup>10</sup>
<h4>¿cuáles son los obstáculos?</h4>
La naturaleza ilícita del trabajo sexual en EEUU lo ha convertido en una industria clandestina y ha creado en los trabajadores sexuales una fuerte desconfianza hacia las autoridades policiales y de salud pública. Muchos sexo servidores que trabajan en la calle se ven obligados a cambiar sus prácticas laborales con el fin de evitar ser detenidos por la policía.<sup>11</sup> Por ejemplo, pueden dedicar menos tiempo a la negociación de las transacciones sexuales antes de subirse al vehículo del cliente o incluso aceptar participar en actividades más riesgosas. Puede ser difícil realizar actividades de prevención, extensión y orientación sobre el VIH en este ambiente.

La desesperación y la pobreza muchas veces anulan la prevención del VIH. Los adictos pueden recurrir a la prostitución como fuente de dinero para comprar drogas. Las personas transgénero pueden usar el trabajo sexual para cubrir los gastos de hormonas o cirugía. Muchos jóvenes sin hogar no tienen capacitación laboral u otra manera de generar ingresos, por lo que recurren a la prostitución para sobrevivir. Responder a las necesidades más inmediatas de alimentación, vivienda y adicción con frecuencia toma precedencia sobre la preocupación de infectarse por VIH.<sup>12</sup>
<h4>¿qué se está haciendo al respecto?</h4>
JEWEL (<em>Jewelry Education for Women Empowering their Lives</em>), fue un proyecto de empoderamiento económico y prevención del VIH para prostitutas consumidoras de drogas en Baltimore, MD. JEWEL presentó seis sesiones de dos horas con orientación sobre la prevención del VIH y sobre la fabricación, comercialización y venta de joyería. Las participantes disminuyeron considerablemente el intercambio de sexo por drogas o dinero, el número de parejas de intercambio sexual y su consumo de drogas, incluido el uso diario de crack.<sup>13</sup>

El <em>Health Project for Asian Women</em> (HPAW) brindó dos intervenciones para trabajadoras sexuales asiáticas de casas de masaje en San Francisco, CA: una orientada a educar a los dueños y otra de consejería e orientación para las masajistas. El personal del proyecto acompañó a las masajistas a los centros de salud, les entregó materiales de protección sexual y les brindó servicios de interpretación, de remisiones a otros servicios y de defensa de derechos. Las masajistas asistieron a tres sesiones de consejería y los dueños de las casas de masaje recibieron una sesión educativa.<sup>14</sup>

Una intervención breve para trabajadores sexuales masculinos en Houston, TX presentó dos sesiones de una hora realizadas con una semana de intervalo. Casi los dos tercios (el 63 %) de los hombres que iniciaron la intervención la completaron y también aumentaron su uso de condones para la penetración anal remunerada.<sup>15</sup>

<em>Breaking Free</em>, ubicado en St. Paul, MN, ayuda principalmente a muchachas y mujeres afroamericanas a dejar el sexo servicio. Las mujeres que se encuentran en crisis reciben ayuda para estabilizarse, luego participan en un programa intensivo de consejería y orientación sobre los traumas asociados con el trabajo sexual. <em>Breaking Free</em> ofrece vivienda transicional y permanente, así como un programa de prácticas laborales para aumentar las posibilidades de las mujeres, algunas con poca o nula experiencia previa, de conseguir un empleo convencional.<sup>16</sup>

St. James Infirmary en San Francisco, CA, es una clínica organizada para y por trabajadores sexuales la cual provee servicios médicos gratis a hombres, mujeres y transgéneros. También ofrece pruebas y tratamiento de VIH/ITS, servicios médicos especializados para transgéneros, consejería de pares y sobre reducción de daños, servicios psiquiátricos, acupuntura, masaje, grupos de apoyo, alimentos, ropa e intercambio de jeringas. El personal realiza trabajo de extensión en la calle y en lugares concretos para repartir materiales de protección sexual y ofrecer pruebas de VIH.<sup>9</sup>
<h4>¿qué queda por hacer?</h4>
Durante la última década se ha realizado poca investigación en EEUU sobre el VIH/SIDA entre los sexo servidores. Además, los estudios anteriores se enfocaron principalmente en el papel de los trabajadores sexuales como vectores de transmisión del VIH y de ITS al público general. Para evitar el VIH entre los trabajadores sexuales, es fundamental no sólo expandir la investigación sobre este grupo sino también reconocer el contexto más amplio en el cual el trabajo sexual se transacciona y también la práctica específica de los sexo servidores.

Los investigadores, las autoridades de salud pública y las policiales necesitan escuchar a los trabajadores sexuales acerca de sus propios necesidades para mantenerse protegidos, y deben trabajar en conjunto para realizar estas metas. Las leyes y las actitudes de la policía en cuanto que los sexo servidores porten condones deben ser indulgentes para permitirles que se protejan. La violencia en contra de los trabajadores sexuales a manos de los clientes, de la policía y de otros en la comunidad deberá criminalizarse, al tiempo que se estimule y apoye a las víctimas para denunciar ante la policía los incidentes violentes.

Los sexo servidores que trabajan en la calle enfrentan numerosas necesidades que van desde las inmediatas (vivienda, comida, atención médica) hasta otras de más largo plazo (salud mental, desintoxicación de drogas, prevención de la violencia, capacitación laboral y empleo, prevención del VIH/ITS, atención médica de alta calidad, mejores relaciones con las autoridades policiacas y ayuda para abandonar el trabajo sexual). Es necesario aumentar la financiación y el reconocimiento de los programas de salud pública que respondan a toda la amplia gama de necesidades encaradas por los trabajadores sexuales.

<hr />

<h3>¿Quién lo dice?</h3>
1. Rekart ML. Sex-work harm reduction. The Lancet. 2005:366: 2123-2134.

2. Vanwesenbeeck I. Another decade of social scientific work on sex work: a review of research 1990- 2000. Annual Review of Sexuality Research. 2001;12:242-289.

3. Inciardi JA, Surratt HL, Kurtz SP. HIV, HBV, and HCV infections among drug-involved, inner-city, street sex workers in Miami, Florida. AIDS and Behavior. 2006;10:139-147.

4. Timpson SC, Ross MW, Williams ML, et al. Characteristics, drug use, and sex partners of a sample of male sex workers. The American Journal of Drug and Alcohol Abuse. 2007;33: 63-69.

5. Alexander P. Sex work and health: A question of safety in the workplace. Journal of the American Medical Women’s Association. 1998;53: 77-82.

6. Maranda MJ, Han C, Rainone GA. Crack cocaine and sex. Journal of Psychoactive Drugs. 2004;36: 315-122.

7. McMahon JM, Tortu S, Pouget ER, et al. Contextual determinants of condom use among female sex exchangers in East Harlem, NYC: an event analysis. AIDS and Behavior. 2006;10:731-741.

8. Roxburgh A, Degenhardt L, Larance B, et al. Mental health, drug use and risk among street-based sex workers in greater Sydney. NDARC Technical Report No. 237. Sydney: National Drug and Alcohol Research Centre, University of New South Wales. 2005.

9. Cohan D, Lutnick A, Davidson P, et al. Sex worker health: San Francisco style.Sexually Transmitted Infections. 2006;82:418-422.

10. Romero-Daza N, Weeks M, Singer M. “Nobody gives a damn if I live or die”: violence, drugs, and street-level prostitution in inner-city Hartford, Connecticut.Medical Anthropology. 2003;22:233-259.

11. Blankenship KM, Koester S. Criminal law, policing policy, and HIV risk in female street sex workers and injection drug users. Journal of Law, Medicine &amp; Ethics. 2002;30:548-559.

12. Yahne CE, Miller WR, Irvin-Vitela L, et al. Magdalena Pilot Project: motivational outreach to substance abusing women street sex workers. Journal of Substance Abuse Treatment. 2002;23:49-53.

13. Sherman SG, German D, Cheng Y, et al. The evaluation of the JEWEL projects: An innovative economic enhancement and HIV prevention intervention study targeting drug using women involved in prostitution. AIDS Care. 2006;18:1-11.

14. Nemoto T, Iwamoto M, Oh HJ, et al. Risk behaviors among Asian women who work at massage parlors in San Francisco: Perspectives from masseuses and owners/managers. AIDS Education and Prevention. 2005;17:444-456.

15. Williams ML, Bowen AM, Timpson SC, et al. HIV prevention and street-based male sex workers: an evaluation of brief interventions. AIDS Education and Prevention. 2006;18:204-215.

16. Valandra. Reclaiming their lives and breaking free: an Afrocentric approach to recovery from prostitution. Journal of Women and Social Work. 2007;22:195-208.www.breakingfree.net

<hr />

<strong>Preparado por Roshan Rahnama, MPH, CAPS</strong>

<strong>Traducido por Rocky Schnaat</strong>h

Septiembre 2008. Hoja de Dato #19SR]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revprostitutasFS.pdf</url>
	</node>
	<node>
		<title>What are African-Americans’ HIV prevention needs?</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are African-Americans’ HIV Prevention Needs?</h3>
<h3>revised 9/99</h3>
<h4>Are African-Americans at risk for HIV?</h4>
Yes. Many African-Americans are at high risk for HIV infection, not because of their race or ethnicity, but because of the risk behaviors they may engage in. As with other ethnic/racial groups, HIV risk depends not on who you are, but on whether you engage in risk-taking behaviors with an HIV+ partner, and whether you have access to care, education and prevention services. The majority of AIDS cases among African-Americans occur among persons aged 25-44, and among men.

While African-Americans comprise 13% of the US population, they are disproportionately affected by HIV, accounting for 37% of total AIDS cases in the US. In 1998, almost two-thirds (62%) of AIDS cases among all women were among African-Americans. Likewise, African-Americans accounted for over half (53%) of all AIDS cases among injection drug users (IDUs). In 1998, 62% of all children with AIDS were African-American.
<h4>Who are African-Americans at risk?</h4>
African-Americans, like many ethnic/racial groups, represent a diverse population. Their diversity is evident in their immigrant status, religion, socioeconomic status, geographic locales and the languages they speak. For example, African-Americans are White collar and working class, Christians and Muslims. They reside in inner-city and rural neighborhoods, are the descendants of slaves and recent Caribbean immigrants. Current epidemiological surveillance data do not record these social, cultural, economic, geographic, religious and political identities that may more accurately predict risk.

HIV transmission in African-American communities is primarily viewed as a problem among heterosexual IDUs and their sexual partners. Among African-American men, however, the cumulative proportion of AIDS cases attributed to homosexual/bisexual activity (38%) is greater than that attributed to injection drug use (35%).

African-American adolescents have, with few exceptions, markedly higher seroprevalence rates compared to White adolescents. Some sexually-active young African-American women are at especially high risk for HIV infection, especially those from poorer neighborhoods. A study of disadvantaged out-of-school youth in the US Job Corps found that young African-American women had the highest rate of HIV infection in the study. Women 16-18 years old had 50% higher rates of infection than young men.
<h4>What puts African-Americans at risk?</h4>
Injection drug use has played a major role in HIV infection among African-Americans. Although the majority of IDUs in the US are White, HIV infection is higher for Black IDUs than White IDUs. Unemployment and poverty are significant co-factors which may have led to high rates of addiction and high rates of risk behaviors such as sharing needles. In fact, the HIV and drug use epidemic among African-Americans is focused in a small number of inner-city urban neighborhoods of color, an indication that the epidemic may have more to do with geography and poverty than race.

While attitudes in the African-American community are slowly changing, homophobia and negative attitudes toward gay men still exist. For young African-American men who have sex with men (MSM), these negative attitudes may cause low self-esteem , lack of community and psychological distress, all of which contribute to risk-taking behaviors.

Many African-American women, especially adolescent women, are at high risk for heterosexually acquired HIV. African-American women may not want to or may not be able to negotiate condom use because they may think it would interfere with physical and emotional intimacy, imply infidelity by themselves or their partner or result in physical abuse. Some women may also be in denial or be unaware of their own risk. Over one-third (35%) of AIDS cases among African-American women reported in 1998 were classified as “risk not reported or identified.” It is thought that a majority of these women are infected through heterosexual sex with IDUs and/or gay or bisexual partners.
<h4>What are obstacles to prevention?</h4>
Communities of color in this country, including African-Americans, have experienced persistent inequalities in social benefits, health care, education and job opportunities. Economic disparities continue to exacerbate the health status of African-Americans and other communities of color in the US. As a result, African-Americans report high rates of diseases and mortality. In addition, many African-Americans hold a distrust of government programs and health institutions. Some African-Americans believe that the effects of AIDS on the community are the results of deliberate efforts and omission of responsibility by the US government. Effective community-based prevention programs must address these concerns.

AIDS has been seen as a primarily gay issue in the African-American community. In addition, homophobia exists in the African-American family, church and community on both a personal and institutional level. Many homosexually active African-American men may have been reluctant to respond to the AIDS epidemic for fear of alienation.
<h4>What’s being done?</h4>
African-American adolescents in Philadelphia, PA were offered an HIV prevention program addressing both abstinence and safer sex. Abstinence intervention participants reported less sexual intercourse after 3 months, but not at 6- or 12- month follow-ups. For youth who reported prior sexual experience, those in the safer sex intervention reported less sexual intercourse than those in the abstinence intervention at 3-, 6- and 12-month follow-ups. Both safer sex and abstinence-only approaches reduced HIV sexual risk behaviors in the short-term, but safer sex interventions may have longer-lasting effects and may be more effective for sexually experienced youth.

Some faith communities are responding to HIV in innovative ways. In Tennessee, the Metropolitan Interdenominational Church began an outreach program to IDUs in four poor, predominantly African-American neighborhoods. The program provides sterile needles, condoms, case management and prevention education. They are developing a church-based harm reduction program model for use in other faith communities.

The Well is a community-based drop-in center for African-American women that promotes self-help and wellness in a low income housing project in Los Angeles, CA. The Well offers peer support “sister circles”, exercise classes, community health education, a lounge/library, a nurse practitioner’s office, and a partnerships with other community health organizations. The well incorporates HIV/STD education into general education that addresses all aspects of women’s lives.

In 1999, in response to the disproportionate impact of HIV on communities of color in the US, the Congressional Black Caucus (CBC) Initiative earmarked $186 million to be spent on community-based HIV prevention programs for communities of color.
<h4>What needs to be done?</h4>
Researchers and service providers need a better understanding of the role of cultural and socioeconomic factors in the transmission of HIV, as well as the effect of racial inequality on public health. In addition, public health officials should consider changing epidemiological surveillance to include other demographic information such as social, economic and cultural factors. These efforts need to influence the design of HIV prevention messages, services and programs.

In the second decade of the AIDS epidemic, homophobia and AIDS denial have yet to be fully countered. Public health institutions should seek out partnerships with African-American faith communities and incorporate spiritual teachings on compassion to ignite a community response. HIV prevention for African-Americans must occur at the community level. Comprehensive programs should link with other health services, such as substance abuse programs, family planning services and STD clinics.
<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. HIV/AIDS Sur-veillance Report . 1998;10:1-43.
2. National Commission on AIDS. The challenge of HIV/AIDS in communities of color. 1994.
3. Moss N, Krieger N. Measuring social inequalities in health: report on the conference of the National Institutes of Health . Public Health Reports. 1995;110:302-305.
4. Valleroy LA, MacKellar DA, Karon JM, et al. HIV infection in disadvantaged out-of-school youth: prevalence for US Job Corps entrants, 1990 through 1996 . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;19:67-73.
5. Substance Abuse and Mental Health Services Administration . Preliminary results from the 1997 national household survey on drug abuse . US Department of Health and Human Service: Rockville, MD; 1999.
6. Fullilove, RE, Fullilove MT. HIV prevention and intervention in the African American community: a public health perspective. In: AIDS Knowledge Base. PT Cohen, ed. Lippincott, Williams &amp; Wilkins. 1999.
7. Stokes JP, Peterson JL. Homophobia, self-esteem, and risk for HIV among African American men who have sex with men . AIDS Education and Prevention. 1998;10: 278-292.
8. Wingood GM, DiClemente RJ. Pattern influences and gender-related factors associated with noncondom use among young adult African American women . American Journal of Community Psychology. 1998;26:29-52.
9. Wingood GM, DiClemente RJ. The effects of having a physically abusive partner on the condom use and sexual negotiation practices of young adult African-American women . American Journal of Public Health. 1997;87:1016-1018.
10. Dalton HL. AIDS in blackface . Daedalus. 1989:118:205-227.
11. Thomas SB, Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community . American Journal of Public Health. 1991;81: 1498-1506.
12. Peterson JL. AIDS-related risks and same-sex behaviors among African American men. In AIDS, Identity and Community. Herek GM, Greene B, eds. Sage Publications: Thousand Oaks, CA; 1995:85-104.
13. Jemmott JB III, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial . Journal of the American Medical Association. 1998;279:1529-1536.
14. Sander E. Church based harm reduction programs. Presented at the 12th World AIDS Conference, June 1998,Geneva, Switzerland. Abst. #33380.
15. Elliott Brown KA, Jemmott FE, Mitchell HJ, et al. The Well: a neighborhood-based health promotion model for black women . Health and Social Work. 1998;23:146-152.

<strong>Prepared By John Peterson Phd*, Gina Wingood ScD, MPH**, Ralph Diclemente PhD**, Pamela Decarlo***, Kathleen Quirk MA***
*Department Of Psychology, Georgia State University, **Rollins School Of Public Health, Emory University, ***CAPS</strong>

September 1999. Fact Sheet #15ER

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 1999, University of California.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/afamFS.pdf</url>
	</node>
	<node>
		<title>Black Gay Men and the Church</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of the Black church for Black gay men and HIV prevention?</h3>
<h4>Why the Black church?</h4>
Many Black men in the US grow up in families that are significantly involved with the Black church. As a long-standing institution developed for and by Black people, the Black church provides religious education and spiritual formation, and buffers against societal oppressions. The church has been a vital and trusted institution in the Black community, providing support, defining values, and building community.<sup>1</sup>

Using the biblical themes of social justice and inherent dignity of all people, the Black church helped restore and promote the self esteem and self-worth of Black people who were victims of racial and other kinds of oppression. However, some Black gay men feel alienated from Black religious congregations. These men experience various homophobic and AIDS-phobic messages that increase their feelings of shame, diminish their religious identity, and are separated from important resources of the Black church.<sup>1</sup>

The Black church is a part of many Black gay men’s lives, and, unfortunately, so is HIV. The HIV/AIDS epidemic has had a devastating effect on Black gay men in the US. Black gay and bisexual men are the most heavily impacted population in the Black community. Among all men who have sex with men (MSM), black MSM accounted for 10,600 (36%) estimated new HIV infections in 2010. From 2008 to 2010, new HIV infections increased 22% among young (aged 13-24) MSM and 12% among MSM overall—an increase largely due to a 20% increase among young black MSM.<sup>2</sup> At the end of 2010, of the estimated 872, 990 persons living with an HIV diagnosis, 440,408 (50%) were among MSM with 31% of those living with the disease being African American.<sup>2</sup>

Black men who have sex with other men may self-identify as gay, same gender-loving, bisexual, straight, or may refuse to be categorized at all. For this Fact Sheet, we use the term “Black gay men” to refer to all Black men who have sex with men.
<h4>How has the church positively affected Black gay men?</h4>
Churches have traditionally occupied a special place in the African American experience.<sup>3 </sup>For many Black gay men, church is a part of their identity. Often, generations of families are involved in the church: their great grandparents helped build the church, their grandparents provided leadership, their parents work and volunteer at the church. For many, going to church was a requirement as children and they may have gone to Sunday school, sang in the choir or participated in other church activities. As adults, Black gay men are often involved in church leadership positions.

Spirituality is a resource for HIV- and HIV+ Black gay men.<sup>4</sup> Spirituality has been used to cope with life-threatening events, physical illness and emotional and psychological stresses. Belief in God is an important strength for many Black Americans. Religious participation also provides positive health benefits, increased life satisfaction, and is especially supportive in crisis moments.
<h4>How has the church negatively affected Black gay men?</h4>
Many religious traditions view homosexuality as a sin and have strictly defined visions of masculinity and femininity. Black gay men experience homophobia and AIDS phobia that is sanctioned by the Black church. These oppressions and messages experienced in church increase Black gay men’s internalized homophobia, which can increase risk taking and decrease access to support.<sup>5</sup>

Many Black gay men attend church knowing that homosexuality is considered a sin, and pastors may know or believe that they have gay men in their congregations. The common yet contradictory scene of gay men singing in the choir while homosexuality is denounced in the pulpit, creates an “open closet” at the center of church life.<sup>6</sup> This contradiction in the church has a damaging effect on gay men’s personal and sexual lives.<sup>7</sup>

The Black church’s views on homosexuality also negatively affect the Black community at-large. These views and attitudes influence the entire congregation, increasing stigma against homosexuality in the community,<sup>6 </sup>and presenting potential problems for friends and family of gay men who are torn between their personal love for the men and their religious beliefs. These tensions play a role in reducing the amount of social support gay men receive from the community.
<h4>How can the church help in HIV prevention?</h4>
Within the context of the Black church, religion is an extraordinary opportunity to expose oppression and marginalization (homophobia and heterosexism) and create a framework for all people to be validated by virtue of their humanity, regardless of their sexual orientation. The Black church can also be a practical setting for health promotion interventions and can serve key roles in developing and/or delivering interventions.<sup>8</sup>Using the justice and liberation themes of religion, HIV prevention messages can be framed in validating and life-affirming ways to everyone, including Black gay men. Thus, religion can encourage Black gay men and couples to engage in sexual behaviors that promote their emotional, psychological, and sexual well being, maximizing HIV prevention efforts.
<h4>What can gay men do?</h4>
Most Black gay men do not regularly engage in HIV risk behaviors such as having unsafe sex, but may cycle in and out of risk at different times in their lives.<sup>9</sup> Similar to many people, risk for Black gay men often occurs during periods of stress and life changes—death of a family member or friend, loss of employment, relationship breakdowns, or depression.<sup>10</sup> In times of profound crisis, spirituality and support from the church can protect Black gay men from falling into risky behaviors. Despite negative views on homosexuality, Black gay men have forged many ways to deal with the condemnation of the Black church and move in and out of these different paths.<sup>1</sup>

Some Black gay men reject their homosexual identity and pray to God to help change them.

Some Black gay men co-exist with church doctrine. They may participate actively in the church and socialize with other gay members of the congregation, yet remain “in the closet,” never publicly identifying as gay within the church.<sup>11</sup>

Some Black gay men reject their religious identity, unable to accept a religion that labels them as sinners. However, to walk away from the church is to walk away from family, and the absence of religious affiliations can be a void in their lives. Many may reject religious traditions but remain deeply spiritual.

Some Black gay men are able to integrate their own identity with the teachings of the bible, developing a personal relationship with a higher power that may or may not include traditional religious institutions, but incorporate religious communion in more affirming and welcoming environments.<sup>12</sup> These gay men remain deeply spiritual, but seek to express their spirituality, including prayer, music and fellowship via other outlets, believing that God created them as worthy and capable of living healthy loving lives that include sexually fulfilling relationships.<sup>12</sup>
<h4>What can the Black church do?</h4>
HIV/AIDS has posed a significant challenge to Black churches and their congregations. Each church is different—some may be able to create change and address AIDS and homophobia and some may not be able or willing to.<sup>13</sup> HIV prevention programs need to respect the philosophical differences between the church and public health and be open to negotiation.

A number of programs and organizations exist to address HIV/AIDS within the Black Church. For example, the Balm in Gilead Inc. provides support for faith-based institutions to address HIV and other health challenges.<sup>14</sup> The Ark of Refuge is a faith-based HIV prevention program that provides HIV/AIDS education and prevention services for African Americans.<sup>15</sup> Project Bridge is a faith-based substance abuse and HIV/AIDS prevention program for African American adolescents.<sup>16</sup> YOUR Blessed Health (YBH) is a program designed to increase the capacity of faith-based organizations and faith leaders to prevent HIV/AIDS among African American youth in their organizations.<sup>17</sup>

In response to the homophobia of many traditional Black churches, several inclusive churches have arisen across the country. For example, the Unity Fellowship Church was founded in 1982 for openly gay and lesbian African Americans.<sup>18</sup> The Fellowship, a coalition of Christian churches and ministries, supports mostly Black churches and faith organizations to move towards radical inclusivity of all marginalized populations.<sup>18</sup> The Metropolitan Community Church was founded in 1968 as a Christian church for LGBT persons of all races.<sup>19</sup>

A survey of Black churches in California that excluded the most conservative churches found a range of institutions with four patterns of acceptance for homosexuality and HIV prevention: non-condemning, accepting, open and affirming, and radically inclusive. Churches classified as gay friendly and radically inclusive tended to be racially diverse.<sup>12</sup>
<h4>What needs to be done?</h4>
The growing disparities in HIV/AIDS and other health problems, particularly among African American and other poor racial/ethnic groups, coupled with dwindling financial resources requires even greater attention to and help from religious and faith-based organizations.<sup>20</sup>

While some Black churches may continue to struggle with interpreting scripture related to same sex behavior, others have found success utilizing community based participatory research (CBPR) approaches to fully involve church leaders in the development, implementation, and evaluation of HIV intervention strategies.<sup>21</sup> Community-level interventions have strong effects on normative and structural influences on HIV-risk behavior and can work across broad segments of the MSM population.<sup> 22</sup> Mobilizing Black churches against HIV/AIDS require active involvement of community members, putting them in control of the questions and issues investigated.<sup>23</sup> Due to the institution’s elevated social standing in the lives of many Black gay men, the Black church represents a logical, yet largely untapped venue for HIV intervention programming.

HIV continues to ravage Black gay men—an already disenfranchised and highly stigmatized population. Given its mandate for love, justice and mercy, the Black church has a history of confronting injustice and oppression. Black church leadership and Black gay men must develop a strategy that values the lives of Black gay men. HIV+ and HIV- Black gay men are a vulnerable population who are entitled to compassionate and courageous support. HIV related anti-stigma efforts by church leaders, as well as the mobilization of community utilizing themes of compassion for prevention and outreach, may be effective ways for the church to use their teachings to engage with this population.
<h2><strong>Says Who?</strong></h2>
1. Miller RL Jr.  Legacy denied: African American gay men, AIDS, and the black church. Social Work. 2007;52:51-61.

2. HIV Among Gay and Bisexual Men Fact Sheet, Centers for Disease Control, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. March 2013

3. Francis SA, Liverpool J. A review of faith-based HIV prevention programs. J Relig Health. 2009;48(1):6–15. doi: 10.1007/s10943-008-9171-4.

4. Miller RL Jr. An appointment with God: AIDS, place, and spirituality. Journal of Sexuality Research. 2005;42:35-45.

5. Peterson JL, Jones KT. HIV prevention for Black men who have sex with men in the US. American Journal of Public health. 2009;99:976-980.

6. Fullilove MT, Fullilove RE. Stigma as an obstacle to AIDS action: The case of the African American community. American Behavioral Scientist. 1999;42:1117-1129.

7. Yakushko O. Influence of social support, existential well-being, and stress over sexual orientation on self-esteem of gay, lesbian and bisexual individuals. International Journal for the Advancement of Counseling. 2005;27:131-1143.

8. Kim, K., Linnan, L., Campbell, M., Brooks, C.,Koenig, H., &amp; Wiesen, C. (2008). The WORD (Wholeness, Oneness, Righteousness, Deliverance): A faith-based weight-loss program utilizing a community-based participatory research approach. Health Education &amp; Behavior, 35, 634-650.

9. Elam G, Macdonals N Hickson FCI, et al. Risky sexual behaviour in context: qualitative results from an investigation into risk factors for seroconversion among gay men who test for HIV. Sexually Transmitted Infections. 2008;84:473-477.

10. Grinstead O. Seroconversion narratives and insights for HIV prevention. FOCUS. 2006;21:1-4.

11. Pitt RN.”Still looking for my Jonathan”: gay Black men’s management of religious and sexual identity conflicts. Journal of Homosexuality. 2010;57:39-53.

12. Foster ML, Arnold E, Rebchook G, Kegeles SM. ‘It’s my inner strength’: spirituality, religion and HIV in the lives of young African American men who have sex with men. Cult Health Sex. 2011 Oct;13(9):1103-17. Epub 2011 Aug 9.

13. Francis SA, Liverpool J. A review of faith-based HIV prevention programs. Journal of Religious Health. 2009;48:6-15.

14. Balm in Gilead (http://www.balmingilead.org)

15. The Ark of Refuge (http://www.arkofrefuge.org) or (http://www.sfrefuge.org)

16. Marcus MT, et al. Community-based participatory research to prevent substance abuse and HIV/AIDS in African-American adolescents. Journal of Interprofessional Care. 2004;18:347-59.

17. YOUR Blessed Health (YBH) (http://www.kellogghealthscholars.org/news/2009_Annual_Meeting/OnePager-Pichon-YOUR%20Blessed%20Health.pdf)

18. Unity Fellowship Church, The Fellowship, Metoropolitan Community Church

19. Metropolitan Community Churches (http://mccchurch.org)

20. Agatha N. Eke, Aisha L. Wilkes &amp; Juarlyn Gaiter. Organized religion and the fight against HIV/AIDS in the Black community: the role of the Black church. African Americans and HIV/AIDS, 2010, pp 53-68.

21. Berkley-Patton J, Bowe-Thompson C, Bradley-Ewing A, Hawes S, Moore E, Williams E, Martinez D, Goggin, K. Taking it to the pews: A CBPR-guided HIV awareness and screening project with black churches. AIDS Education and Prevention. 2010;22(3):218–237.

22. Peterson JL, Jones KT. HIV prevention for Black men who have sex with men in the United States. Am J Public Health 2009;99(6):976–980.

23. Hill WA, McNeely C. HIV/AIDS disparity between African-American and Caucasian men who have sex with men: Intervention strategies for the Black church. Journal of Religion and Health 2011

&nbsp;

Special thanks to the following reviewers of this Fact Sheet: Michael Foster, Shelley Francis, Susan Kegeles, Eddie Kornegay, Joan Liverpool, Maureen Miller, Richard Pitt Jr., Sylvia Rhue, Leo Wilton

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. ©2009, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2013/04/BlackchurchandgaymenFSdraft3.pdf</url>
	</node>
	<node>
		<title>Black women</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are Black women’s HIV prevention needs?</h3>
<h4>Are Black women affected by HIV?</h4>
Yes. Black women and men in the US are hard hit by HIV, and have been since the beginning of the epidemic. In 2006, Black women accounted for 61% of new HIV cases among women, but make up only 12% of US female population.<sup>1</sup> The rate of HIV diagnoses for Black women is 15 times the rate for White women.<sup>1</sup>

Black women also have high rates of sexually transmitted diseases (STDs), which can facilitate transmission of HIV. Among Black women in 2006, the rate of chlamydia was 7 times higher, gonorrhea 14 times higher, and syphilis 16 times higher than the rate among White women.<sup>2</sup>

These numbers and statistics, however, don’t show the richness and diversity of Black women’s lives. Black women can be White collar and working class, Christians and Muslims. They live in inner-city and suburban neighborhoods, are the descendants of slaves and recent Caribbean immigrants. They work, go to school, raise families, fall in love. HIV among Black women is not simply about individual behavior, but a complex system of social, cultural, economic, geographic, religious and political factors that combine to affect health.<sup>3</sup>
<h4>Who are the women at risk?</h4>
Having STDs other than HIV, having unprotected vaginal and anal intercourse with an HIV+ person, and sharing injection drug equipment with an HIV+ person are the highest risk factors for HIV transmission for Black women or anyone. Another risk is not knowing your partner’s risks, such as injection drug use, having other current sex partners or unknown HIV status. In 2005, 80% of Black women were infected with HIV through heterosexual contact and 18% through injection drug use.<sup>4</sup>

Young women and teens are particularly affected. In 2004, HIV was the leading cause of death for Black women aged 25-34 years.<sup>5</sup> Black teenagers (ages 13-19) accounted for 69% of new AIDS cases among teens in 2006, but make up only 16% of US teenagers.<sup>6</sup>
<h4>What affects risk?</h4>
When it comes to having safer sex, women are often more concerned about pregnancy prevention than HIV/STD prevention, and are less likely to use two methods of protection (such as the pill and condoms). Black teenage girls are more likely to use implant and injectable contraception (the patch, Norplant) than White teenage girls, making them less likely to use condoms that protect against HIV.<sup>7</sup> Similarly, Black women, especially women living in low income areas, are more likely to use sterilization as contraception.<sup>6</sup>

HIV prevention often takes a back seat when women are struggling to secure jobs, food, housing or child care. Most HIV/AIDS cases among Black women occur in inner city and rural areas where many women live in poverty and have unstable employment and housing.<sup>9</sup> Women in these neighborhoods are more likely to be homeless and trade sex for money or shelter, use substances (alcohol, crack, heroin), be dependent on a man for support, and experience violence or trauma. All of these affect a woman’s ability to refuse sex, use condoms or clean needles and protect herself from HIV.

High incarceration rates in the African American community also affect HIV risk. Incarceration decreases the number of men in the community, which disrupts stable partnerships and promotes higher-risk concurrent partnerships (having more than one sexual partner in a given period and going back and forth between them).<sup>10</sup>

The ratio of men to women is much lower among African Americans than among any other ethnic group in the US. High rates of death among Black men due to disease and violence as well as high rates of incarceration impact the community in many ways, including reducing the number of potential partners. This promotes women with low-risk behaviors partnering with men with high-risk behaviors.<sup>3</sup>
<h4>Do Black women know their risk?</h4>
It’s been reported that many Black women don’t know that they are at risk for HIV, because many women report no or unknown transmission category when testing for HIV. Black communities traditionally have a high degree of social mixing between higher and lower risk individuals,<sup>11</sup> which means that Blacks are more likely to know and date a partner with a risk history. Ultimately, it may not be that Black women aren’t aware of their risks, but that risk is more accepted because of this social mixing.

Black women understand they are at risk, as shown by HIV testing rates that are higher than any other racial group. Almost two thirds (65%) of Black women ages 15-44 have ever been tested for HIV. Black women are twice as likely to be tested for HIV in the past 12 months (25%) than are White women (13%).<sup>12</sup>

Because of the disproportionately high rates of STDs and HIV in the Black community, the likelihood of being exposed to an infected person is much higher for Black women and men than it is for people living in other communities. This means that even though Black women are engaging in fewer risk behaviors than White women,<sup>3</sup> in order to not get infected, Black women have to do so much more than other women to protect themselves.<sup>3</sup>
<h4>What’s being done?</h4>
There are currently 11 interventions for Black women and adolescents that have been approved by the CDC as best or promising evidence or are in the Diffusion of Effective Behavioral Interventions (DEBI) project.<sup>13</sup> In addition, many agencies across the US provide innovative HIV prevention services with and for Black women that see women as a whole, not just their sex and drug use, and as part of a community.

Supporting women with incarcerated partners is important. HOME (Health Options Mean Empowerment) worked with women whose male partner was being released from state prison. HOME trained women visitors to be peer health educators, both for other women visitors and women in their communities. HOME included community-building activities (group lunches for women waiting to enter the prison); general-health workshops (on diabetes, blood pressure, obesity and smoking cessation); sexual-health workshops on HIV/STDs; health fairs; and facilitated community referrals and support services geared to the needs of women who visit men in prison. Women who participated reported decreased unprotected sex, increased HIV testing and increased communication with their partners about HIV-related topics.<sup>14</sup>

A recent large, multisite trial described the Eban HIV/STD Risk Reduction Intervention, a program for African American couples who are HIV-serodiscordant. Eban addresses individual, interpersonal, and community-level factors that contribute to HIV risk behaviors at mulitple levels in 8 weekly 2-hour sessions. Four sessions focus on communication, problem solving and decision making around safer sex within the couple. Four group sessions focus on changing peer attitudes and norms, de-stigmatizing serodiscordant couples and increasing support for couples in the community.<sup>15</sup>

To reach Black women in their own communities, many agencies have implemented HIV prevention interventions in beauty salons and nail parlors, which provide a safe environment to access HIV information and condoms. In Durham County, NC, Project StraightTalk has been training barbers and beauticians to educate their clients about STDs/HIV since 1988. The project offers annual trainings, gives condoms and educational materials to each salon twice a month, and produces personalized posters for the salons.<sup>16</sup>
<h4>What needs to be done?</h4>
The African American community will continue to be severely affected by HIV unless prevention and care efforts are combined with efforts to address the root causes of disease.<sup>3</sup> Black girls, teenagers and women need to be supported within their social environment to build stronger relationships, families, neighborhoods and communities and reduce their risk for HIV and other diseases. HIV prevention programs for women’s male partners can benefit both men and women.

Effective HIV prevention programs should be developed and run by Black women and provide job training, couples counseling, food banks, housing assistance, mental health services, substance abuse treatment and family services. Government and other funding agencies need to understand that all of these things are HIV prevention and should be funded as such.

<hr />

<h3>Says who?</h3>
1. CDC. Subpopulation Estimates from the HIV Incidence Surveillance System—United States, 2006. Morbidity and Mortality Weekly Report. 2008;57;985-989.

2. CDC. Sexually Transmitted Disease Surveillance, 2006. November 2007.

3. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372:337-340.

4. Rose MA, Telfair Sharpe T, Raleigh K, et al. An HIV/AIDS crisis among African American women: A summary for prevention and care in the 21st century. Journal of Women’s Health. 2008;17:321-324.

5. HIV/AIDS among women. Fact sheet prepared by the CDC. August 2008.

6. Black Americans and HIV/AIDS. Fact sheet by the Kaiser Family Foundation. October 2008.

7. Abma JC, Martinez GM, Mosher WD, et al. Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2002. Vital and Health Statistics. 2004;23.

8. Mosher WD, Deang LP, Bramlett MD. Community environment and women’s health outcomes: Contextual data. Vital and Health Statistics. 2003;23.

9. Fullilove RE. African Americans, health disparities and HIV/AIDS. Report prepared by the National Minority AIDS Council. November 2006.

10. Harawa N, Adimora A. Incarceration, African Americans and HIV: advancing a research agenda. Journal of the National Medical Association. 2008;100:57-62.

11. Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the Southern United States: sexual networks and social context. Sexually Transmitted Diseases. 2006;33:S39-S45.

12. Anderson JE, Chandra A, Mosher WD. HIV Testing in the United States, 2002. Advance Data for Vital and Health Statistics. 2005;363:16.

13. Centers for Disease Control and Prevention. Updated Compendium of Evidence-Based Interventions, 2007.

14. Grinstead O, Comfort M, McCartney K, et al. Bringing it home: design and implementation of an HIV/STD intervention for women visiting incarcerated men. AIDS Education and Prevention. 2008;20:285-300.

15. NIMH Multisite HIV/STD Prevention Trial for African American Couples Group. Eban HIV/STD Risk Reduction Intervention: Conceptual basis and procedures. Journal of AIDS. 2008;49:S15–S27.

16. Lewis YR, Shain L, Crouse Quinn S, et al. Building community trust: lessons from an STD/HIV peer educator program with African American barbers and beauticians. Health Promotion Practice. 2002;3:133-143.

<hr />

<strong>Prepared by Prepared by Pamela DeCarlo and Olga Grinstead Reznick PhD, MPH; CAPS</strong>

<strong>March 2009. Fact Sheet #65E</strong>

Special thanks to the following reviewers of this Fact Sheet: Victoria Cargill, Deidra Carrol, Marcia Glasgow, Bridget Hughes, Sharon Johnson, Marlene LaLota, Marianne Marcus, Leisha McKinley-Beach, Maureen Miller, Adeline Nyamathi, Tara Regan, Celeste Watkins-Hayes, Wendee Wechsberg.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©March 2009, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/BlackwomenFS.pdf</url>
	</node>
	<node>
		<title>Latina/os</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are U.S. Latinos’ HIV Prevention Needs?</h3>
<h3>revised 4/02</h3>
<h4>Are Latinos at risk for HIV?</h4>
HIV continues to be a major health threat for Latinos in the US, many of whom are disadvantaged due to racism, economic disparities and language barriers. Latinos in the US (including residents of Puerto Rico) are disproportionately affected by HIV, accounting for 18% of total AIDS cases while comprising 14% of the US population.<sup>1</sup>

The majority of AIDS cases among the Latino population in 2000 were concentrated among those born in the continental US (35%) and Puerto Rico (25%), followed by those born in Mexico (13%), Central or South America (8%) and Cuba (2%). An additional 18% were reported from Latinos with unknown place of birth (15%) or born elsewhere (3%).<sup>2</sup>
<h4>What puts Latinos at risk?</h4>
Latinos in the US include a diverse mixture of racial and ethnic groups and cultures. Latinos share common factors with other ethnic groups that increase vulnerability to HIV, such as discrimination,<sup>3</sup> poverty, lack of information, substance use and negative attitudes toward condoms.

AIDS case rates and risk behaviors among Latinos in the US vary by region. In the Northeast and along the eastern seaboard, where many Latinos from Puerto Rico live, Latino rates are up to three times higher than the national average.<sup>4</sup> In this region, the main risk for transmission is injection drug use, believed to be fueled by the concentration of heroin availability. By comparison, in the West and Southwest, the majority of AIDS cases occurs among men who have sex with men (MSM), although cases are also high among injection drug users (IDUs) in certain areas.

In 2000, 47% of AIDS cases among Latino men were attributed to sex with men, 33% to injection drug use, and 14% to sex with women. In the same year, 65% of AIDS cases among Latina women were attributed to sex with men, and 32% to injection drug use.<sup>1</sup> Thus, among both male and female Latinos, as with most other groups, unprotected sex with an HIV+ man is the most common route for becoming infected with HIV, followed by the sharing of an unclean syringe/needle with an HIV+ person.

HIV risk dynamics among immigrant and migrant Latinos can be more complex than among US born Latinos, as they are dealing with conflicting cultural norms while trying to adjust to life in a new country. For some, this results in higher risk; for others, lower risk. Levels of acculturation, poverty, employment, migrant labor conditions and connection to traditional Latino values can influence HIV risk.<sup>6</sup>
<h4>What are barriers to prevention?</h4>
The social and political climate in the US today poses serious problems for effective HIV prevention in Latino communities. Racial and ethnic discrimination, anti- immigrant attitudes, policies on mandatory testing for immigrants, and fear of deportation for undocumented immigrants can prevent many Latinos from receiving and accessing adequate resources and services for HIV prevention, including HIV counseling and testing.

Traditionally in Latino cultures, sex and sexuality are not discussed. For some Latina women, this sexual silence dictates that they should not know about or talk to men about sex because it suggests promiscuity. Therefore, their ability, comfort and success in insisting on condom use with male partners may be limited. Sexual silence can prevent MSM from discussing their sexual preference, instilling low self-esteem and personal shame. In addition, the lack of parental discussions and education regarding sex and condoms seems to contribute to the disproportionate number of unintended pregnancies, sexually transmitted diseases and HIV cases among Latino youth.<sup>9</sup>

Injection drug use is one of the main risk factors for HIV transmission, yet many IDUs do not have access to clean needles and drug treatment. Access is even more difficult for monolingual, immigrant Latino IDUs who may not use needle exchange sites or other public services due to lack of knowledge and fear of being recognized or deported.
<h4>How does culture affect prevention?</h4>
Familismo is a traditional Latino commitment to family and a central support to family members. Familismo can be a powerful incentive in helping heterosexual Latino men reduce unprotected sex with casual partners outside of primary partnerships. However, for many Latino MSM, familismo and homophobia can create conflict because families may perceive homosexuality as wrong. MSM are forced to separate their sexual identity from their family life, leading to low self-esteem and personal shame.<sup>8</sup>

Machismo may lead men to view sex as a way to prove masculinity. This can mean that frequency and type of sex are most often determined by men, leaving women in fear of violence or abandonment if they resist male sexual advances.7Machismo may also be used as an excuse for unprotected sex.
<h4>What’s being done?</h4>
Prevention Point Philadelphia, in collaboration with other AIDS organizations, operated a full service needle exchange site from a van that traveled to an area with many shooting galleries. The van offered needle exchange, oral HIV testing, bilingual social service and drug treatment referrals and medical care. The van reached many homeless, Spanish-speaking Puerto Rican IDUs who were regular shooting gallery users. Many of them had never accessed preventive medical care or social services.

In San Antonio, TX, a three-session small group intervention was offered to English-speaking Mexican-American women who had a sexually transmitted disease (STD). The intervention sought to help women recognize their risk for HIV and other STDs, make a plan to change and then build skills to help reduce those risks. The intervention significantly reduced rates of subsequent STDs.<sup>11</sup>

Hermanos de Luna y Sol, is an ongoing intervention for Latino gay/bisexual men at Mission Neighborhood Health Center in San Francisco, CA, based on empowerment education and social support. The program provides outreach, six structured discussion sessions and ongoing support to maintain behavior change. Sessions deal with the common history of oppression among Latino gay men, social support and community and emotional issues around sex and sexuality. The impact of AIDS and HIV transmission are discussed in the final two sessions. The program has been successful in recruiting men and increasing condom use among participants.<sup>12</sup>

Mujeres Unidas y Activas is a community education, organizing and advocacy project created by and for Latina immigrant and refugee women in San Francisco, CA. The project includes components such as information meetings, friendship circles, workshops and advocacy. Although the project was not developed to specifically target HIV risk behaviors, women who attended up to nine types of activities showed increases in sexual communication comfort, were less likely to maintain traditional sexual gender norms and reported changes in decision-making power.<sup>13</sup>
<h4>What still needs to be done?</h4>
Latinos are concerned about the HIV epidemic and are motivated to learn and to teach their children about prevention.<sup>14</sup> Providers and social service agencies should capitalize on this by providing Spanish-language or bilingual education and services such as anonymous and confidential HIV testing. Incorporating HIV prevention messages into general health services, Spanish media and religious settings would decrease stigma and increase access to HIV prevention programs.

As Latinos, we must attempt to break the silence around sexuality in our communities and overcome homophobia. Latinos can encourage healthy sexuality by discussing gender role expectations, teaching children about sexuality and accepting diversity in our own community. Programs can build upon the protective aspects of Latino culture and emphasize resiliency. Larger societal factors such as poverty, racism and homophobia must also be addressed in order to reduce their impact on risk behavior.
<h3>Says who?</h3>
1.Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, Midyear Edition. 2001;13. http://www.cdc.gov/hiv/stats/hasr1301.htm
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, Year End Edition. 2000;12. http://www.cdc.gov/hiv/stats/hasr1202.htm
3. Díaz RM, Ayala G. Social discrimination and health: the case of Latino gay men and HIV risk. National Gay and Lesbian Task Force.
4. Kaiser Family Foundation. Key Facts: Latinos and HIV/AIDS. November 2001.
5. Klevens RM, Díaz T, Fleming PL, et al. Trends in AIDS among Hispanics in the United States, 1991-1996. American Journal of Public Health. 1999;89:1104-1106.
6. Organista K, Carrillo H, Ayala G. HIV prevention with Mexican migrants: review, critique and recommendations. Journal of Acquired Immune Deficiency Syndrome. 2004;37:S227-39
7. Gómez CA, Marín BV. Gender, culture and power: barriers to HIV prevention strategies for women. The Journal of Sex Research. 1996;33:355-362.
8. Díaz RM. Latino Gay Men and HIV: Culture, Sexuality and Risk Behavior. New York: Routledge Press, 1998.
9. The National Campaign to Prevent Teen Pregnancy. Whatever Happened to Childhood? The Problem of Teen Pregnancy in the United States. 1997.
10. Porter J, Perez G. Taking it to the street: shooting gallery needle exchange site for drug injectors at highest risk for HIV. Presented at the International Conference on AIDS, Geneva, Switzerland; 1998. Abst #33402.
11. Shain RN, Piper JM, Newton ER, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. New England Journal of Medicine. 1999;340:93-100.
12. Hermanos de Luna y Sol. Contact: 415/552-1013 x296
13. Gómez CA , Hernandez M, Faigeles B. Sex in the New World: An Empowerment Model for HIV Prevention among Latina Immigrant Women. Health Education &amp; Behavior. 1999;26:200-212.
14. Kaiser Family Foundation. Latinos’ View of the HIV/AIDS Epidemic at 20 Years: Findings from a National Survey. 2001.
15. Ortiz-Torres B, Serrano-Garcia I, Torres-Burgos N. Subverting culture: promoting HIV/AIDS prevention among Puerto Rican and Dominican women. American Journal of Community Psychology. 2000;28:859-881.
16. Raj A, Amaro H, Reed E. Culturally tailoring HIV/AIDS prevention programs: Why, when and how. In: Kazarian &amp; Evans (Eds) Handbook of Cultural Health Psychology. San Diego: Academic Press, 2001; 195-239.

<hr />

<strong>Prepared by Cynthia Gómez, PhD, CAPS</strong>

<strong>April 2002. Fact Sheet #17ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Hortensia Amaro, George Ayala, Jaime Calderón-Soto, Alejandra Cano, Dennis De Leon, José Ramón Fernandez-Peña, Francisco Gonzales, Barbara Marín, Kurt Organista, Prisci Quijada, Carlos Soles, Carlos Velazquez, Luis Villanueva.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2001, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/LatinorevFS.pdf</url>
	</node>
	<node>
		<title>Mexican immigrants</title>
		<tax>1737</tax>
		<content><![CDATA[<h1>What are the HIV prevention needs of Mexican immigrants in the US?</h1>
<h2>Why do Mexicans migrate?</h2>
The most common motivation for Mexicans to move to the US is economic, followed by a desire to reunite with spouses, parents or other immediate family, particularly among women and children. However, for some an additional important reason to leave Mexico is the need to find a new social space where they can redefine their sexual and gender identities.<sup>1,2</sup> This phenomenon–labeled “sexual migration”–is known to happen among Mexican women and among men who are sexually attracted to other men (MSM). Sexual migration is of particular interest in terms of HIV risk.

Contrary to what is often assumed, the population of Mexicans who move to the US is considerably diverse. Mexicans are from cities and rural areas, poor and middle-class, undocumented and legal immigrants, monolingual and bilingual. Some emigrate permanently or come for a short period and then return to Mexico.
<h2>Who is at risk for HIV infection?</h2>
There are an estimated 3 to 6 million Mexican undocumented residents in the US, and most of them live in California and Texas.<sup>3</sup> Many Mexicans frequently travel back and forth over the border. One-fourth of the AIDS cases in Mexico are among persons who have spent prolonged periods in the US.<sup>4</sup> AIDS statistics in Mexico report a slight trend toward the “ruralization” of AIDS that might be linked to male migration to the US.<sup>5</sup>

The limited data on HIV infection in Mexicans living in the US suggests that the groups that have been most greatly affected are MSM, heterosexuals-some of whom have injecting drug user (IDU) partners-and IDUs. Of the US AIDS cases reported in 2000 among persons born in Mexico, 44% were among MSM, 14% among heterosexuals, 9% among IDUs, and 3% among MSM IDUs.<sup>6</sup> The cause of transmission was not known for 29% of cases.
<h2>What puts them at risk?</h2>
Different subgroups of Mexicans living in the US confront different challenges in terms of HIV risk. Among other factors, such challenges depend on 1) how their identities and behaviors (sexual and drug-related) change after moving to the US; 2) their access to health services, appropriate HIV education, and condoms; 3) norms about safe sex and drug use in their new communities; 4) the nature of their relationships with sexual partners in the US and in Mexico; and 5) the degree to which they experience racism, discrimination, and poverty in the US.

One study of 374 young Latino MSM in the San Diego/Tijuana region found high rates of HIV: 19% in Tijuana, Mexico and 35% in San Diego, CA.<sup>7</sup> In Tijuana, only half had ever received HIV prevention information and less than half had ever been tested for HIV. Young MSM in Tijuana were more likely to report sex with females and injection drug use than young MSM in San Diego. In San Diego, young MSM were more likely to report unprotected sex with men.

HIV risk also exists among heterosexual Mexican migrants, especially among male urban day laborers and those working in agriculture. Often these men come without a spouse and are young, lonely, and isolated, making them likely to seek sex. In addition, they often are not well educated, speak little English, and have limited access to healthcare, making it difficult for them to receive HIV prevention messages<sup>8</sup>. Some of these men engage in sex work, regularly have unprotected sex with female sex workers, or have spouses in Mexico with whom they use no condoms.<sup>9</sup>

Many married Mexican women, whether they are living in the US or in border towns, or living in Mexico with a spouse who migrates to the US, believe strongly in marital fidelity and have negative beliefs about condom use. In one study, many women acknowledged that men who spend long periods of time away from home are at risk for HIV, but most believed that it did not pertain to their marriages or their spouses.<sup>10</sup> Both younger and older women said they did not want to know about any extra-marital affairs their spouses may have had, and did not want to infer infidelity by using condoms.
<h2>Does acculturation affect HIV risk?</h2>
Research is somewhat contradictory about whether HIV risk increases or decreases as immigrants adopt norms and values of mainstream communities in the US. Some studies argue that acculturation is protective because it promotes individuality, self-esteem and self-empowerment. Others argue that acculturation increases HIV risk because immigrants adopt sexual and drug-related behaviors that were not part of their more conservative, previous worldviews. What is clear is that immigrants change over time in the US, that the changes are complex, and that they have to be taken into account when designing HIV prevention programs for immigrant populations.
<h2>What’s being done?</h2>
Few HIV prevention programs for Mexican immigrants currently exist, although the number of programs is increasing. In addition, cooperation between the Mexican and American governments in addressing HIV/AIDS has increased.

In San Francisco, CA, Hermanos de Luna y Sol has been designed to address the HIV prevention needs of Latin American MSM who have migrated to the US. The program deals with the common history of oppression among Latino gay men, social support, and community and emotional issues around sex and sexuality. This program explicitly ties HIV prevention to other developmental and identity-related needs in ways that contextualize safe sex in the participants’ larger lives.

In El Paso, TX, prevention case management services (PCMS) are provided in a large homeless shelter serving undocumented immigrants. PCMS uses a holistic approach to address homelessness, being HIV+, an IDU, a sex worker, or a partner of any of the above. The program concentrates on survival needs first, providing referrals for housing, food banks and medical and mental health treatment. PCMS also locates clinics to give free Pap smears to undocumented women.

The Promotoras de Salud Project, sponsored by the Farmworker Justice Fund and Centro de Salud Familiar la Fe, trains farmworker women as health educators or promotoras to provide counseling and education about HIV prevention, care and services in their communities. The promotoras link farmworker women with healthcare facilities, often accompanying the women and interpreting for them. They also provide condoms and emotional support for women using them.
<h2>What needs to be done?</h2>
Prevention programs for immigrant Mexicans need to contextualize HIV risk in the lives of participants in order to ensure that potential safety measures are relevant and that participants can strategize realistic ways of adopting them. Programs should address the challenges of being a Mexican immigrant living in the US; experiences of racism and homophobia; and barriers that may be imposed by poverty and social marginality. These factors may influence sexual and drug-related behaviors.

In addition to prevention programs in US cities with large concentrations of Mexicans, such as Los Angeles, CA and Chicago, IL, border cities such as Ciudad Juárez and Tijuana, Mexico, El Paso, TX, and San Diego, CA are key locations for HIV prevention efforts. Similarly, there is a need for programs focusing on rural areas that attract Mexican migrant workers.

Access to basic needs such as healthcare, housing, and jobs, may help reduce HIV risk in Mexican immigrant populations. Culturally-relevant educational and training materials in Spanish, as well as educational programs tailored for the needs of specific subgroups of immigrants, are also needed. HIV surveillance must be improved to understand the scope of HIV among both documented and undocumented immigrants. Because many Mexicans travel back and forth between the US and Mexico, bi-national cooperation is key in addressing these issues.

Fostering participation of Mexican immigrants in HIV Prevention Community Planning is key to further identifying effective prevention interventions, and to expanding funding and availability of prevention services for this population.

<hr />

<h1>Says who?</h1>
1. Hogdagneu-Sotelo P. Gendered transitions: Mexican experiences of immigration. University of California Press: Berkeley, CA, 1994.
2. Cantú, L. Border crossings: Mexican men and the sexuality of migration. Doctoral Dissertation. University of California, Irvine, 1999.
3. Lowell BL, Suro R. How many undocumented: the numbers behind the US-Mexico migration talks. Report by the Pew Hispanic Center. March 2002
4. Rangel G, Lozada R. Factores de riesgo de infección por VIH en migrantes mexicanos: el caso de los migrantes que llegan a la Casa del Migrante “Centro Escalabrini y Ejército de Salvación. El Colegio de la Frontera Norte, ISESALUD/COMUSIDA.
5. Magis-Rodríguez C et al. La situación del SIDA en México a finales de 1998. Enfermedades Infecciosas y Microbiológicas. 1998; 18, 6: 236-244.
6. CDC. HIV AIDS Surveillance Report. 2001. Volume 12, No.2http://www.cdc.gov/hiv/stats/hasr1202/table18.htm
7.Ruiz JD. HIV prevalence, risk behaviors and access to case among young Latino MSM in San Diego, California, and Tijuana, Mexico. Presented at the Binational Conference on HIV/AIDS. Oakland, CA, 2002.
8. Bronfman N, Moreno L. Perspectives on HIV/AIDS prevention among immigrants on the US-Mexico border. In: Mishra S, Conner R, Magaña R (eds) AIDS crossing borders: The spread of HIV among migrant Latinos. Westview Press: Boulder, CO, 1996. 49-76.
9. Organista KC, Organista PB. Migrant laborers and AIDS in the United States: A review of the literature. AIDS Education and Prevention. 1997; 9:83-93.
10. Hirsch JS, Higgins J, Bentley ME, et al. The social constructions of sexuality: marital infidelity and sexually transmitted disease-HIV risk in a Mexican migrant community. American Journal of Public Health. 2002; 92:1227-1237
11. Flaskerud JH, et al. Sexual practices, attitudes, and knowledge related to HIV transmission in low income Los Angeles Hispanic women. The Journal of Sex Research. 1996: 33:343-353.
12. Marín BV, Flores E. Acculturation, sexual behavior, and alcohol use among Latinas. International Journal of the Addictions. 1994; 29:1101-1114
13. Díaz RM. Latino gay men and HIV. New York and London: Routledge. 1998. prevention.ucsf.edu/uploads/projects/hlsindex.php
14. Moore EF. Sub-culturally competent HIV prevention case management on the Mexican-American border. Presented at the National AIDS Prevention Conference, Atlanta, GA. 1999. Abs#659.
15. Hernández A. Promovision/ USMBHA: Proyecto para fortaleces la capacidad de la comunidad en la prevención del VIH/SIDA. Presented at the United States-Mexico Border Health Association (USMBHA) Conference, Las Cruces, New Mexico. 2001.
http://www.usmbha.org/english/projects/promovision/
16. US-Mexico Border Health Association. The State of Latinos in HIV Prevention Community Planning. 2002.
http://www.usmbha.org/english/projects/enlaces/publications.htm

<strong>Prepared by Héctor Carrillo, DrPH and Pamela DeCarlo, CAPS</strong>

<strong>April 2003. Fact Sheet #48E</strong>

Special thanks to the following reviewers of this Fact Sheet: María Chaparro, Frank Galvan, Apolonia Hernández, Barbara Marin, Octavio Vallejo.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/mexicansFS.pdf</url>
	</node>
	<node>
		<title>Afroamericano/as</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesítan los afro-americanos en la prevención del VIH?
(revisado 8/00)</h3>
<h4>¿corren el riesgo de contraer el VIH los afro-americanos?</h4>
Sí. Muchos Afro-Americanos corren alto riesgo de infectarse con VIH, no por razones étnicas o raciales, sino por los comportamientos de riesgo en los que pueden estar participando. Igual que ocurre en otros grupos raciales/étnicos, el riesgo de infección con VIH no solo depende de la identidad, sino del tipo de conductas riesgos que se estén llevando a cabo con una pareja VIH+, y si se tiene acceso a servicios médicos y prevención. La mayoría de los casos de SIDA en Afro-Americanos ocurre en personas de 25 a 44 años de edad y en hombres.

A pesar de contar con el 13% de la población total estadounidense, los Afro-Americanos se ven desproprocionadamente afectados por el VIH ya que cuentan con el 37% de todos los casos de SIDA. En 1998, casi dos tercios (62%) de los casos de SIDA entre mujeres estuvo compuesto por Afro-Americanas. Al unísono, el 37% de todos los casos de SIDA en la categoría de Usuarios de Drogas Intravenosas (UDIs) pertenecia a Afro-Americanos. En 1998, los niños Afro-Americanos representaron el 62% de todos los casos de SIDA infantil.
<h4>¿cuáles afro-americanos están a riesgo?</h4>
Los Afro-Americanos, igual que otros grupos raciales o étnicos, representan una población diversa. Su diversidad se evidencia en el estado migratorio, religioso, nivel económico, posicióngeográfica y el idioma que hablan. Por ejemplo, los Afro-Americanos incluyendo a oficinistas y la clase trabajadora, Musulmanes y Cristianos. Pueden residir en el centro de la ciudad y en áreas rurales, pueden ser descendientes de esclavos o Caribeños recién emigrados. Los datos de vigilancia epidemiológica actuales, no registran la identidad social, cultural, económica, geográfica, política y religiosa que pudiera predecir con mayor exactitud el nivel de riesgo.

Dentro de las comunidades Afro-Americanas, la transmisión del VIH se toma como un problema de los heterosexuales UDIs y de sus parejas sexuales. Sin embargo, la proporción acumulativa de casos de SIDA atribuida a la actividad homosexual/bisexual (38%) es mayor que la atribuida al uso de drogas inyectadas (35%).

En general, los adolescentes Afro-Americanos registran tasas de seroprevalencia mucho mayores que las de los adolescentes Anglo-Sajones. Las jóvenes Afro-Americanas, especialmente las sexualmente activas y de los barrios pobres son las que tienen un mayor nivel de riesgo de infección con VIH. En un estudio a jóvenes desertores escolares de bajo nivel económico en los “Job Corps” (Cuerpos de Trabajo) se descubrió que las mujeres entre los 16 a 18 años de edad tenían tasas de infección 50% mayores a las de los varones Afro-Americanos.
<h4>¿cómo se exponen al riesgo?</h4>
El uso de drogas inyectadas ha sido el factor determinante de la infección con VIH entre los Afro-Americanos. Si bien es cierto que la mayoría de los UDIs en los EEUU son Blancos, las tasas de infección son mayores en UDIs Negros. El desempleo y la probreza son co-factores significativos que pueden estar contribuyendo al aumento en los índices de adicción y comporta-mientos de riesgo. En efecto, la epidemia del VIH y del uso de drogas en Afro-Americanos se concentra en un número reducido de barrios urbanos del centro de la ciudad, lo cual indica que la epidemia puede estar mas ligada a la geografía y a la pobreza que a la raza o etnia.

Si bien las actitudes en la comunidad Afro-Americana cambian poco a poco, la homofobia y las actitudes negativas hacia el hombre homosexual continúan vigentes. Para los hombres jóvenes Afro-Americanos que tienen sexo con otros hombres, estas actitudes negativas pueden ocasionar una baja auto-estima, falta de conección comunitaria y malestares psicológicos, factores que a su vez contribuyen a las conductas de riesgo.

Muchas mujeres Afro-Americanas, las adolescentes en especial, presentan alto riesgo de adquirir el VIH por la vía heterosexual. Las mujeres Afro-Americanas pueden no querer o no estar aptas para negociar el uso del condón puesto que pueden pensar que esto va a interferir con la intimidad física y emocional; puede implicar infifelidad propia o de su pareja o puede ocasionar abuso físico. Algunas mujeres pueden, además, estar en un estado de negación o hasta desconocer el riesgo que corren. Más de un tercio (35%) de los casos de SIDA en mujeres Afro-Americanas reportados en 1998 se clasificaron como “riesgo no reportado” o “no identificado”. Se creee que la mayoría de estas mujeres se infectan por medio del sexo heterosexual con UDIs y/o parejas “gay” o bisexuales.
<h4>¿cuáles son los obstáculos en la prevención?</h4>
Las comunidades de color de este país, incluyendo a la Afro-Americana, han experiementado persistentes desigualdades en beneficios sociales, cuidados médicos, educación y oportunidades de trabajo. Las disparidades económicas continúan deteriorando el estado de salud de los Afro-Americanos y de otras comunidaes de color en los EEUU. Dando como resultado altos índices de muerte y enfermedeades en la comunidad Afro-Americana. Adicionalmente, muchos Afro-Americanos mantienen una desconfianza hacia los programas gubernamentales y hacia las intituciones de salud. Algunos Afro-Americanos piensan que los efectos del SIDA en la comunidad forman parte de los esfuerzos deliberados y de omisión de responsablidad por parte del gobierno estadounidense. La eficacia de los programas de prevención de índole comunitaria deben tomar en cuenta estos factores.

El problema del SIDA dentro de la comunidad Afro-Americana se entiende como un problema principalmente “gay”. Adicionalmente, la homofobia está presente en la familia, la iglesia y la comunidad Afro-Americanas tanto a nivel personal como institucional. Muchos homosexuales Afro-Americanos sexualmente activos pueden estar renuentes a responder ante la epidemia del SIDA por temor a ser alienados.
<h4>¿qué se está haciendo?</h4>
A los jóvenes Afro-Americanos de Filadelfia, PA, se les ofreció un programa de prevención que integraba intervenciones de abstinencia y de sexo seguro. Los participantes en las intervenciones de abstinencia reportaron menos relaciones sexuales 3 meses después, pero no a los 6 o 12 meses de seguimiento. De los jóvenes que reportaron previa experiencia sexual, los que recibieron la intervención de sexo seguro reportaron menos relaciones sexuales que los que recibieron la intervención de abstinencia a 3-, 6-, y 12-meses de seguimiento. Ambas alternativas, el sexo seguro y la abstinencia redujeron las conductas sexuales de riesgo a corto plazo, pero las intervenciones de sexo seguro pueden tener efectos más duraderos y pueden ser más eficaces para los jóvenes con previa experiencia sexual.

Algunas comunidades que promulgan la fé están respondiendo al VIH de forma innovadora. En Tennessee, la Iglesia Interdenominacional inició un programa para atraer a UDIs de 4 barrios pobres predomantemente Afro-Americanos. El programa ofrece agujas esterilizadas, condones, manejo de casos y educación preventiva. Ellos están creando un programa modelo de reducción de riesgo con base en la iglesia para ser utilizado en otras comunidades de este tipo.

“The Well,” un centro para mujeres Afro-Americanas al que se acude sin previo aviso, diseñado para esta comunidad, promueve la auto-eficacia y el bienestar en un proyecto de viviendas para personas de bajos ingresos en Los Angeles, CA. Este centro ofrece servicios de apoyo por parte de personas que reciben los servicios en “círculos de hermanas”, clases de ejercicio, educación sobre salud comunitaria, una sala/biblioteca, una oficina de enfermería y mantiene asociaciones con otras organizaciones comunitarias de salud. “The Well” mezcla la educación sobre VIH/ETS con la educación general que trata todos los aspectos de la vida de estas mujeres.
<h4>¿qué es necesario hacer?</h4>
Los científicos y proveedores de servicio necesitan conocer más a fondo cual es el papel de la cultura y los factores socio-económicos en la transmisión del VIH asi como la desigualdad racial en salud pública. Adicionalmente, las autoridades de salud pública deben considerar un cambio al sistema de vigilancia epidemiológica para que incluya otros tipos de información demográfica tales como los factores culturales, sociales y económicos. Estos esfuerzos necesitan tener una influencia en el diseño de los mensajes de prevención del VIH, servicios y programas.

En la segunda década de la epidemia del SIDA, falta por tomar en cuenta la homofobia y la negación de la problemática del SIDA. Las instituciones de salud pública deben buscar formas de establecer asociaciones con las comunidades Afro-Americanas que promulgan la fé e incorporar la compasión a la enseñanza espiritual que logre despertar la respuesta de la comunidad. La prevención del VIH para los Afro-Americanos debe llevarse a cabo a nivel de comunidad. Los programas complejos deben establecer nexos con otros servicios de salud tales como los programas de abuso de sustancias ilícitas, servicios de planificación familiar y clínicas de ETS.

<hr />

<h3>¿quién lo dice?</h3>
1. Centers for Disease Control and Prevention. HIV/AIDS Sur-veillance Report . 1998;10:1-43.
2. National Commission on AIDS. The challenge of HIV/AIDS in communities of color. 1994.
3. Moss N, Krieger N. Measuring social inequalities in health: report on the conference of the National Institutes of Health . Public Health Reports. 1995;110:302-305.
4. Valleroy LA, MacKellar DA, Karon JM, et al. HIV infection in disadvantaged out-of-school youth: prevalence for US Job Corps entrants, 1990 through 1996 . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;19:67-73.
5. Substance Abuse and Mental Health Services Administration . Preliminary results from the 1997 national household survey on drug abuse . US Department of Health and Human Service: Rockville, MD; 1999.
6. Fullilove, RE, Fullilove MT. HIV prevention and intervention in the African American community: a public health perspective. In: AIDS Knowledge Base. PT Cohen, ed. Lippincott, Williams &amp; Wilkins. 1999.
7. Stokes JP, Peterson JL. Homophobia, self-esteem, and risk for HIV among African American men who have sex with men . AIDS Education and Prevention. 1998;10: 278-292.
8. Wingood GM, DiClemente RJ. Pattern influences and gender-related factors associated with noncondom use among young adult African American women . American Journal of Community Psychology. 1998;26:29-52.
9. Wingood GM, DiClemente RJ. The effects of having a physically abusive partner on the condom use and sexual negotiation practices of young adult African-American women . American Journal of Public Health. 1997;87:1016-1018.
10. Dalton HL. AIDS in blackface . Daedalus. 1989:118:205-227.
11. Thomas SB, Quinn SC. The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community . American Journal of Public Health. 1991;81: 1498-1506.
12. Peterson JL. AIDS-related risks and same-sex behaviors among African American men. In AIDS, Identity and Community. Herek GM, Greene B, eds. Sage Publications: Thousand Oaks, CA; 1995:85-104.
13. Jemmott JB III, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial . Journal of the American Medical Association. 1998;279:1529-1536.
14. Sander E. Church based harm reduction programs. Presented at the 12th World AIDS Conference, June 1998,Geneva, Switzerland. Abst. #33380.
15. Elliott Brown KA, Jemmott FE, Mitchell HJ, et al. The Well: a neighborhood-based health promotion model for black women . Health and Social Work. 1998;23:146-152.

<hr />

<strong>PREPARADO POR JOHN PETERSON PHD*, GINA WINGWOOD SCD, MPH**, RALPH DICLEMENTE PHD**, KATHLEEN QUIRK MA***; TRADUCIDO POR ROMY BENARD RODRÍGUEZ***
*DEPARTMENT OF PSYCHOLOGY, GEORGIA STATE UNIVERSITY, ** ROLLINS SCHOOL OF PUBLIC HEALTH, EMORY UNIVERSITY, ***CAPS</strong>

Agosto 2000. Hoja Informativa 15SR.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/Afro-AmFS.pdf</url>
	</node>
	<node>
		<title>Latino/as</title>
		<tax>1737</tax>
		<content><![CDATA[El VIH sigue siendo una gran amenaza para la salud de los latinoamericanos en EEUU. Muchos de ellos se encuentran en desventaja debido al racismo, a las desigualdades económicas y a barreras lingüísticas. En EE.UU., los latinos (incluyendo los habitantes de Puerto Rico) se ven desproporcionadamente afectados por el VIH, ya que representan el 18% de todos los casos de SIDA aún cuando sólo son el 14% de la población. En el año 2001, la mayoría de los casos de SIDA entre latinos en EE.UU. la componían personas nacidas en la parte continental de EE.UU. (35%) y Puerto Rico (25%), seguidos por personas nacidas en México (13%), Centro o Sudamérica (8%) y Cuba (2%). Otro 18% lo componían latinos con un lugar de nacimiento desconocido (15%) o nacidos en otra parte (3%).]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/splatinorevFS.pdf</url>
	</node>
	<node>
		<title>Inmigrantes mexicano/as</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuáles son las necesidades de prevención de inmigrantes mexicanos/as en EE.UU.?</h3>
<h4>¿por qué emigran?</h4>
Entre la gente en México, el motivo principal para emigrar a Estados Unidos es la necesidad económica, seguido por el deseo (especialmente por parte de mujeres y niños) de reunirse con su pareja, sus padres u otros familiares cercanos. Sin embargo, algunas personas tienen otra razón importante: la necesidad de encontrar un entorno social que les permita redefinir su identidad
sexual y de género.::1,2— Esta “migración sexual” se ha observado en mujeres mexicanas y en hombres con atracción sexual por otros hombres (HSH). La migración sexual es de particular interés en relación con el riesgo de VIH.

Contrariamente a lo que con frecuencia se supone, hay mucha diversidad entre los mexicanos y mexicanas que se mudan a EE.UU., ya que provienen tanto de zonas rurales como urbanas, y pueden ser de cualquier nivel socioeconómico, documentados o indocumentados, monolingües o bilingües. Algunas personas emigran permanentemente. Otras se quedan por poco tiempo y luego regresan a México.
<h4>¿quién corre riesgo de contraer el VIH?</h4>
Se calcula que entre 3 y 6 millones de mexicanos indocumentados viven actualmente en EE.UU., la mayoría en California y Texas.::3— Muchos mexicanos cruzan con frecuencia de un lado a otro de la frontera. La cuarta parte de los casos de SIDA en México ocurren en personas que han pasado periodos largos en EE.UU.::4— Las estadísticas sobre el SIDA en México señalan una leve tendencia hacia la “ruralización” del SIDA, la cual podría estar ligada a la migración masculina a EE.UU.::5—

Los escasos datos sobre las infecciones por VIH entre mexicanos radicados en EE.UU. sugieren que los grupos más afectados son los HSH, los heterosexuales (algunos con parejas que usan drogas inyectables, llamados UDI), y los UDI mismos. De los casos de SIDA reportados en EE.UU. en el año 2000 entre personas nacidas en México, el 44% ocurrió entre HSH, el 14% entre heterosexuales, el 9% entre UDI y el 3% entre HSH que son también UDI.::6— Se desconocía la causa de transmisión en el 29% de los casos.
<h4>¿qué los pone en riesgo?</h4>
Los subgrupos de mexicanos/as radicados en EE.UU. afrontan diferentes desafíos relacionados con el riesgo de transmisión del VIH. Entre otros factores, estos desafíos dependen de: 1) los cambios en su identidad y conducta (sexual y de consumo de drogas) después de llegar a EE.UU.; 2) el acceso a servicios de salud, a información adecuada sobre el VIH y a condones; 3) las normas de su nueva comunidad sobre la protección sexual y el consumo de drogas; 4) la naturaleza de sus relaciones con parejas sexuales en EE.UU. y en México; y 5) el grado en que son afectados por el racismo, la discriminación y la pobreza en EE.UU.

Un estudio de 374 jóvenes HSH latinos en la región de San Diego/Tijuana encontró altas tasas de infección por VIH: 19% en Tijuana, México y 35% en San Diego, CA.::7— En Tijuana, sólo la mitad de los jóvenes HSH había recibido alguna información sobre la prevención del VIH y menos de la mitad se había hecho la prueba del VIH. Más jóvenes HSH en Tijuana reportaron contacto sexual con mujeres y uso de drogas inyectables que sus pares en San Diego. En San Diego, los jóvenes HSH reportaron más sexo con hombres sin protección.

El riesgo de transmisión del VIH también existe entre migrantes mexicanos/as heterosexuales, especialmente entre hombres que son jornaleros urbanos o trabajadores del campo. Muchos de estos hombres emigran sin su pareja, son jóvenes y están solos y aislados, por lo que es probable que busquen sexo. Asimismo, es común que tengan un nivel bajo de escolaridad, hablen poco inglés y tengan poco acceso a servicios médicos, todo lo cual les puede impedir recibir mensajes de prevención del VIH.::8— Algunos se prostituyen, tienen sexo sin protección con trabajadoras sexuales, o tienen una esposa en México con quien tienen relaciones sexuales sin condón.::9—

Muchas mexicanas casadas, que viven ya sea en EE.UU., en pueblos fronterizos, o en México con un esposo que ha emigrado a EE.UU., tienen fuertes creencias sobre la fidelidad matrimonial y sentimientos negativos sobre el uso de condones. En un estudio, muchas mujeres reconocieron que los hombres con largas ausencias corren riesgo de contraer el VIH, pero la mayoría creía que esto no le ocurriría a su esposo.::10— Tanto las jóvenes como las mujeres mayores dijeron que no querían saber de las aventuras extramaritales del esposo, y que tampoco querían sugerir con el uso de condón que sospechaban de infidelidad.
<h4>¿influye la aculturación en el riesgo?</h4>
Los estudios son algo contradictorios sobre si el riesgo de contraer el VIH se incrementa o se reduce a medida que los inmigrantes adoptan las normas y los valores de las comunidades dominantes de EE.UU. Algunos estudios argumentan que la aculturación es protectora, puesto que promueve la individualidad, la autoestima y el apoderamiento personal.::11— Otros sostienen que la aculturación aumenta el riesgo de contraer el VIH porque los inmigrantes adoptan comportamientos sexuales y de consumo de drogas que antes no tenían, cuando eran más conservadores. Lo evidente es que quien inmigra cambia durante su estancia en EE.UU., que los cambios son complejos y que deben tomarse en cuenta al diseñar programas de prevención del VIH para grupos inmigrantes.
<h4>¿qué se está haciendo al respecto?</h4>
El número de programas de prevención del VIH destinados a los inmigrantes mexicanos/as está incrementando. La cooperación entre los gobiernos de México y EE.UU. para afrontar el VIH/SIDA también ha aumentado.

En San Francisco, CA, el programa Hermanos de Luna y Sol fue diseñado para satisfacer las necesidades de prevención del VIH entre HSH inmigrantes.::13— El programa trata experiencias de opresión que son comunes entre hombres latinos gay, el apoyo social, y temas comunitarios y emocionales en torno al sexo y la sexualidad. Se hace una conexión explícita entre la prevención del VIH y otras necesidades relacionadas con el desarrollo y la identidad, de tal manera que el sexo protegido se contextualice dentro del marco más amplio de la vida de los participantes.

En El Paso, TX, un refugio para inmigrantes indocumentados brinda servicios de prevención basados en manejo de casos.::14— El manejo de casos usa un método integral para tratar la indigencia, así como la condición de ser VIH+, UDI o trabajador sexual, o de tener una pareja con cualquiera de estas condiciones. El programa se concentra primero en necesidades de sobrevivencia: da referencias para servicios de alojamiento y vivienda, bancos de comida, tratamiento médico y de salud mental. También busca clínicas que ofrezcan exámenes de Papanicolaou gratis a mujeres indocumentadas.

El Proyecto Promotoras de Salud, patrocinado por el Farm Workers Justice Fund y por el Centro de Salud Familiar la Fe, capacita a mujeres campesinas como promotoras de salud para proveer consejería y orientación sobre la prevención, la atención y otros servicios de VIH en sus comunidades.::15— Las promotoras sirven de enlace entre los servicios de salud y las campesinas; muchas veces las acompañan a las citas y sirven de intérpretes. También proporcionan condones y apoyan emocionalmente a las mujeres que los usan.
<h4>¿qué queda por hacer?</h4>
Los programas de prevención para inmigrantes mexicanos/as necesitan contextualizar el riesgo del VIH en la vida de los participantes de manera que identifiquen medidas de protección que les sean pertinentes y estrategias realistas para adoptarlas. Se deben considerar los retos de ser inmigrante mexicano/a radicado/a en EE.UU., de experimentar el racismo y la homofobia, y de las posibles barreras debidas a la pobreza y a la marginación social.::13— Estos factores pueden influir en las conductas sexuales y de consumo de drogas.

Además de los programas de prevención en ciudades estadounidenses con grandes concentraciones de población mexicana (como Los Ángeles, CA y Chicago, IL), las ciudades fronterizas tales como Ciudad Juárez y Tijuana, México; El Paso, TX; y San Diego, CA son lugares clave para los servicios de prevención del VIH. Asimismo, se necesitan programas enfocados en zonas rurales que atraen a trabajadores migrantes mexicanos/as.

El acceso a servicios de salud, vivienda y trabajo, entre otras necesidades básicas, podría disminuir el riesgo del VIH en poblaciones mexicanas de inmigrantes. También se necesitan materiales culturalmente adecuados de orientación y capacitación en español, así como programas educativos adaptados a las necesidades de subgrupos específicos de inmigrantes. Se debe mejorar la vigilancia epidemiológica para entender la dimensión del VIH entre inmigrantes documentados e indocumentados. Debido a que muchos inmigrantes mexicanos viajan continuamente entre EE.UU. y México, se requiere una estrecha cooperación binacional al abordar estos temas. Fomentar la participación de inmigrantes mexicanos/as en el proceso de Planificación Comunitaria para la Prevención del VIH de EE.UU. es crucial para seguir identificando intervenciones de prevención efectivas y para incrementar los fondos y la disponibilidad de servicios para esta población.::16—

<hr />

<strong>¿quién lo dice?</strong>

1. Hogdagneu-Sotelo P. Gendered transitions: Mexican experiences of immigration. University of California Press: Berkeley, CA, 1994.
2. Cantú, L. Border crossings: Mexican men and the sexuality of migration. Doctoral Dissertation. University of California, Irvine, 1999.
3. Lowell BL, Suro R. How many undocumented: the numbers behind the US-Mexico migration talks. Report by the Pew Hispanic Center. March 2002
4. Rangel G, Lozada R. Factores de riesgo de infección por VIH en migrantes mexicanos: el caso de los migrantes que llegan a la Casa del Migrante “Centro Escalabrini y Ejército de Salvación. El Colegio de la Frontera Norte, ISESALUD/COMUSIDA.
5. Magis-Rodríguez C et al. La situación del SIDA en México a finales de 1998. Enfermedades Infecciosas y Microbiológicas. 1998; 18, 6: 236-244.
6. CDC. HIV AIDS Surveillance Report. 2001. Volume 12, No.2http://www.cdc.gov/hiv/stats/hasr1202/table18.htm
7.Ruiz JD. HIV prevalence, risk behaviors and access to case among young Latino MSM in San Diego, California, and Tijuana, Mexico. Presented at the Binational Conference on HIV/AIDS. Oakland, CA, 2002.
8. Bronfman N, Moreno L. Perspectives on HIV/AIDS prevention among immigrants on the US-Mexico border. In: Mishra S, Conner R, Magaña R (eds) AIDS crossing borders: The spread of HIV among migrant Latinos. Westview Press: Boulder, CO, 1996. 49-76.
9. Organista KC, Organista PB. Migrant laborers and AIDS in the United States: A review of the literature. AIDS Education and Prevention. 1997; 9:83-93.
10. Hirsch JS, Higgins J, Bentley ME, et al. The social constructions of sexuality: marital infidelity and sexually transmitted disease-HIV risk in a Mexican migrant community. American Journal of Public Health. 2002; 92:1227-1237
11. Flaskerud JH, et al. Sexual practices, attitudes, and knowledge related to HIV transmission in low income Los Angeles Hispanic women. The Journal of Sex Research. 1996: 33:343-353.
12. Marín BV, Flores E. Acculturation, sexual behavior, and alcohol use among Latinas. International Journal of the Addictions. 1994; 29:1101-1114
13. Díaz RM. Latino gay men and HIV. New York and London: Routledge. 1998. prevention.ucsf.edu/uploads/projects/hlsindex.html
14. Moore EF. Sub-culturally competent HIV prevention case management on the Mexican-American border. Presented at the National AIDS Prevention Conference, Atlanta, GA. 1999. Abs#659.
15. Hernández A. Promovision/ USMBHA: Proyecto para fortaleces la capacidad de la comunidad en la prevención del VIH/SIDA. Presented at the United States-Mexico Border Health Association (USMBHA) Conference, Las Cruces, New Mexico. 2001.
http://www.usmbha.org/english/projects/promovision/
16. US-Mexico Border Health Association. The State of Latinos in HIV Prevention Community Planning. 2002.
http://www.usmbha.org/english/projects/enlaces/publications.htm

<hr />

<strong>Preparado por Héctor Carrillo, DrPH y Pamela DeCarlo, CAPS</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Abril 2003. Hoja Informativa 48S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/mexicanosFS.pdf</url>
	</node>
	<node>
		<title>Criminalization</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Is there a role for criminal law in HIV prevention?</h3>
<h4>why criminal law for HIV exposure?</h4>
Throughout the AIDS epidemic in the US, there has been repeated debate over the need for laws that punish individuals who know they are HIV+ and expose another person to HIV (sometimes referred to as intentional or knowing HIV exposure). Much of this debate has been at the extremes – criminalization of all HIV exposures or none at all. But a sounder position in this debate may be found between the extremes.

The primary means by which HIV is spread (sexual behavior and drug use) are already controversial areas in both the legal and public health fields. Research, social norms, and personal values about sex and drug use – and consequently about HIV and its prevention – vary greatly. Not surprisingly, the issue of using criminal law to punish HIV exposure is hotly contested.

Analysis of laws, cases and public opinion polls shows support for legislation that condemns at least some behaviors that expose others to HIV, such as laws that add extra penalties to violent crimes like rape or assault when the perpetrator is HIV+. Yet the way many HIV exposure laws are currently written could have serious negative impacts on HIV+ people. Justification for some of these laws has been based on incorrect perceptions of transmission risk, thus potentially criminalizing behavior that poses little or no threat of spreading HIV. Further, no evidence exists that using criminal law is an effective approach to HIV prevention.

The question that arises, then, is how criminal HIV transmission laws and public health efforts can work in greater harmony to achieve the best possible outcomes for a given community.
<h4>what are the laws?</h4>
While there are no federal laws on HIV exposure, Congress has provided explicit support for such efforts at the state level. In 1990, the Ryan White CARE Act, which provides states funds for AIDS treatment and care, required every state to certify that its criminal laws were “adequate to prosecute any HIV infected individual” who knowingly exposes a person to HIV. (The requirement was removed in 2000 after all states had certified that they had such laws.)<sup>1</sup>

States have taken three general approaches to making HIV exposure by a person who knows they are HIV+ a crime: 1) Adopt HIV-specific laws; 2) Rely on existing STD laws; and 3) Use general criminal statutes such as assault or reckless endangerment.

HIV-specific laws: As of May 2005, 24 states have laws that specifically punish HIV exposure as a separate crime; however, there is substantial variation among these laws. Many HIV-specific laws address sexual activity, needle sharing and blood donation. Less often, these laws address other activities such as biting and spitting that have little or no risk of spreading HIV. Most of these laws do not require that the HIV+ person actually infect someone else – only that that person engage in a behavior knowing that it could put someone else at risk for contracting HIV. Penalties for breaking the law range from a minimum of one year to a maximum of life in prison.<sup>2,3</sup>

Twelve of these states also have laws that specifically identify HIV exposure as grounds for enhancing a sentence for an existing crime (such as sexual assault or prostitution). Three additional states have these enhancement laws, but do not have laws that identify HIV exposure as a separate crime.

The wide range of behaviors addressed and possible penalties show the challenge of creating HIV-exposure laws. While laws that are more broadly worded allow for more flexibility, more specific laws may provide for protection against misuse. Finding a balance is particularly hard in a field such as HIV/AIDS, where knowledge about the virus, its transmission and how to prevent transmission continues to advance and change.

STD laws and general statutes: Six states rely on existing STD laws and 17 states have neither HIV nor STD laws and instead rely on general criminal laws. However, HIV does not always fit easily within the scope of general criminal laws.<sup>4</sup> For example, assault is generally defined in the law as an unwanted touching, and is poorly suited to the consensual nature of the behaviors that can result in exposure to HIV.
<h4>why use the law?</h4>
Criminal law reflects society’s interest in protecting people from serious harm.<sup>5</sup> In the case of HIV exposure, criminal law may be used to deter HIV+ people from behaviors that would expose others to HIV and thus create a potential harm. This kind of potentially harmful behavior is similar to other actions prohibited by criminal laws.

Criminal laws are sometimes used to reflect a community’s standards for socially acceptable behavior. Some HIV exposure laws require that an HIV+ person disclose her/his HIV status to a partner before engaging in any high-risk activities. In this way, the law is used to establish an expected standard of behavior for a particular group, and may share goals with public health policies.<sup>6</sup>

Criminal laws may be used to encourage HIV+ persons to stop engaging in high-risk behaviors that expose others to HIV. However, at present there is no published evidence that criminal laws have been able to achieve any goal but retribution in the context of intentional HIV exposure.
<h4>what are concerns?</h4>
At present, no studies show that criminalizing HIV transmission is an effective HIV prevention approach.<sup>7</sup> In addition, many people do not know about HIV laws in their state. Unless people are aware of the laws, the statutes will not affect behavior.

Among those people who are aware of such laws, the statutes may create greater stigma against a disease about which much fear and misunderstanding already exists. In addition, the threat of criminal prosecution may discourage people from HIV testing, counseling and treatment.<sup>8</sup> In this way, criminal laws could work against public health efforts, because people who do not know their HIV status may be more likely to engage in high-risk behaviors, and, therefore, may increase the spread of HIV.<sup>9</sup>

There are also concerns about stigma and discrimination in sentencing for HIV exposure convictions. Under some of the more extreme criminal HIV exposure laws, sentences can be as long as 10 to 25 years. Some people prosecuted for exposing others to HIV have received these long sentences, even when the victim was not infected.<sup>10</sup>

Many laws specifically punish someone for failing to disclose his/her HIV+ status to a partner. But HIV+ people may be taking steps to prevent the spread of HIV even if they do not disclose their status. Also, many factors may influence a person’s ability to disclose HIV infection in a relationship. One survey of HIV+ persons found that 42% of gay men, 19% of heterosexual men, and 17% of women reported having sex without disclosing their HIV.<sup>11</sup> In addition, research shows that disclosing HIV status is not necessarily associated with using condoms or other risk reduction activities.<sup>12</sup>
<h4>how can we find a balance?</h4>
Laws used to punish HIV exposure vary widely from state to state. While some aspects of the laws support public health efforts, other parts may contradict them. There must be a balance between criminal law and public health goals, so that both may function as effectively as possible.

For community agencies and those who serve HIV+ people, it is important to raise awareness that such laws exist. Increased awareness of the laws may support the laws’ goal of deterring risky behaviors, and may allow HIV+ individuals to have a greater voice in the development of laws that affect them directly.

Among legislators and policy makers, several steps can be taken to find a balance. In states that do not have HIV-specific laws, creation of such laws is not necessary. Numerous states have been able to take legal action on this issue using general statutes. In fact, UNAIDS specifically recommends against singling out HIV in this way.<sup>13</sup>

For those states with HIV-specific laws, legislators can strike a balance by supporting laws that reflect prevention measures and accurate medical knowledge about HIV transmission. At present many laws establish punishable behaviors without considering prevention guidelines issued by the CDC (such as condom usage). Additional protections could be incorporated by having laws that target only persistent offenders after less restrictive public health measures fail to achieve behavior change.

<hr />

<h3>Says who?</h3>
1. McKinney MM, Marconi K. Delivering HIV services to vulnerable populations: a review of CARE Act funded research. Public Health Reports. 2002;117:99-113.

2. Wolf LE, Vezina R. Crime and punishment: is there a role for criminal law in HIV prevention policy? Whittier Law Review. 2004;25: 821-886.

3. HIV Criminal Law and Policy Project. www.hivcriminallaw.org. Accessed March 2005.

4. Sullivan KM, Field MA. AIDS and the coercive power of the state. Harvard Civil Rights &amp; Civil Liberties Law Review. 1988;23: 139-197.

5. Gostin LO. Public health law in a new century: part I: law as a tool to advance the community’s health. Journal of the American Medical Association. 2000;283: 2837-2841.

6. Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13:297-306.

7. Lazzarini Z, Klitzman R. HIV and the law: integrating law, policy, and social epidemiology. Journal of Law and Medical Ethics. 2002;30:533-547.

8. Lazzarini Z, Bray S, Burris S. Evaluating the impact of criminal laws on HIV risk behavior. Journal of Law and Medical Ethics. 2002; 30:239-253.

9. Gostin LO, Hodge JG. The “names debate”: the case for national HIV reporting in the United States. Albany Law Review. 1998;61: 679-742.

10. In Brief: Maximum Sentence. AIDS Policy &amp; Law. 1998;13:16.

11. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. American Journal of Public Health. 2003;93:949-954.

12. Stein MD, Freedberg KA, Sullivan LM, et al. Sexual ethics. Disclosure of HIV-positive status to partners. Archives of Internal Medicine. 1998;158:253-257.

13. United Nations Program on AIDS (UNAIDS). Handbook for Legislators on HIV/AIDS, Law and Human Rights. 1999:51.

<hr />

<h3>Prepared by Leslie E. Wolf, JD, MPH and Richard Vezina, MPH, CAPS</h3>
<strong>May 2005 . Fact Sheet #57E</strong>

Special thanks to the following reviewers of this Fact Sheet: Scott Burris, James Chalmers, Dan Ciccarone, Bill Hirsch.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © May 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/criminalizationFS.pdf</url>
	</node>
	<node>
		<title>Ley penal</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Hay un papel para la ley penal dentro de la prevención del VIH?</h3>
<h4>¿por qué una ley penal?</h4>
Durante el transcurso de la epidemia del SIDA en EE.UU., se ha debatido constantemente la necesidad de leyes que castiguen a individuos que se saben VIH+ y exponen a otra persona al VIH (llamado a veces exposición intencional al VIH o con conocimiento). Gran parte del debate se ha polarizado entre la criminalización de toda exposición al VIH y ninguna criminalización. Una postura más razonable tal vez se encuentra entre los dos extremos.

Las formas principales de transmisión del VIH (actividad sexual y consumo de drogas) ya son áreas controversiales en el campo legal así como en el de la salud pública. Las investigaciones, las normas sociales y los valores personales en torno al sexo y al consumo de drogas (y por lo tanto al VIH y a su prevención) varían muchísimo. No es de extrañarse que la discusión sobre el uso de la ley o derecho penal (criminal law) para castigar la exposición al VIH sea tan acalorada.

Un análisis de leyes, casos y encuestas de opinión pública indica que existe apoyo para leyes que condenen por lo menos algunos comportamientos que exponen a otros al VIH, por ejemplo, leyes que imponen castigos adicionales por delitos violentos tales como violación o asalto cuando el agresor es VIH+. Sin embargo, la forma en que están redactadas las leyes actuales sobre la exposición al VIH podría perjudicar gravemente a las personas VIH+. La justificación de algunas de estas leyes se ha basado en percepciones erróneas sobre el riesgo de transmisión, lo cual puede criminalizar actos con poco o ningún riesgo de propagar el VIH. Asimismo, no existe evidencia de que el uso de la ley penal sea una estrategia eficaz para la prevención del VIH.

La pregunta que surge es: ¿Cómo pueden colaborar con mayor armonía el derecho penal sobre la transmisión del VIH y los esfuerzos de salud pública para lograr mejores resultados en la comunidad?
<h4>¿cuáles son las leyes?</h4>
Aunque en EE.UU. no existen leyes federales sobre la exposición al VIH, el Congreso ha proporcionado apoyo explícito a esfuerzos estatales. En 1990, la ley de Ryan White CARE (que provee fondos para la atención del SIDA) requirió que cada estado certificara que sus leyes criminales eran “adecuadas para enjuiciar a cualquier individuo infectado con VIH” que con conocimiento exponga al VIH a otra persona. (Este requisito fue eliminado en el 2000 cuando todos los estados certificaron que tenían dichas leyes.)

Los gobiernos estatales han respondido de tres maneras generales para convertir en delito la exposición al VIH por una persona que se sabe infectada: 1) Adoptar leyes específicas sobre el VIH; 2) Depender de leyes que regulan las enfermedades de transmisión sexual (ETS) y 3) Aplicar estatutos penales generales contra el asalto o la imprudencia temeraria.<sup>1</sup>

Leyes específicas al VIH: Desde mayo del 2005, 24 estados tienen leyes que castigan específicamente la exposición al VIH como delito por separado, pero estas leyes varían significativamente. Muchas abarcan la actividad sexual, el uso de jeringas compartidas y la donación de sangre. Con menos frecuencia, mencionan otras actividades como morder y escupir que tienen poco o ningún riesgo de propagar el VIH. La mayoría de estas leyes no requieren que la persona VIH+ llegue a infectar a otro, sino que simplemente realice con conocimiento algún acto que pudiera poner a otra persona en riesgo de contraer el VIH. Los castigos por violar la ley varían entre un año en prisión, como mínimo, hasta la condena perpetua como máximo.<sup>2,3</sup>

Doce de estos estados también tienen leyes que identifican específicamente la exposición al VIH como una razón para aumentar la condena por un delito existente (por ejemplo, asalto sexual o prostitución). Otros tres estados tienen estas leyes de condena aumentada pero no tienen leyes que identifiquen la exposición al VIH como delito por separado.

La amplia gama de conductas y los posibles castigos muestran la complejidad para crear leyes sobre la exposición al VIH. Si bien las leyes más ambiguas permiten mayor flexibilidad, las más específicas pueden impedir la aplicación inadecuada. Es especialmente difícil encontrar el equilibrio en un campo como el VIH/SIDA, en el cual el conocimiento sobre el virus, la transmisión y la prevención avanza y cambia constantemente.

Leyes sobre las ETS y estatutos generales: Seis estados de EE.UU. se apoyan en leyes existentes sobre las ETS y 17 estados carecen de regulaciones tanto para VIH como para ETS por lo que aplican leyes penales generales.<sup>4</sup> Sin embargo los casos de VIH no siempre se encajan fácilmente en los estatutos generales. Por ejemplo, la definición legal general del asalto como el contacto físico no deseado, escasamente contempla la naturaleza del consentimiento involucrado en conductas que pueden resultar en una exposición al VIH.
<h4>¿por qué hacer uso de la ley?</h4>
El derecho penal refleja el interés de la sociedad por proteger a las personas contra daños graves.<sup>5</sup> En el caso de la exposición al VIH, las leyes penales se pueden aplicar para impedir que las personas VIH+ realicen actos que pudieran exponer a otros al VIH y posiblemente hacerles daño. Estos actos potencialmente dañinos son similares a otros actos prohibidos por dichas leyes.

Las leyes penales se usan a veces para reflejar las normas de la comunidad sobre el comportamiento socialmente aceptable. Algunas leyes sobre la exposición al VIH requieren que la persona VIH+ revele su condición a su pareja antes de realizar cualquier actividad de alto riesgo. De esta manera, la ley sirve para establecer una norma de conducta para cierto grupo en particular y podría compartir las metas de las políticas de salud pública.<sup>6</sup>

Las leyes penales se pueden emplear para alentar que las personas VIH+ dejen de participar en actividades de alto riesgo que exponen a otros al VIH.<sup>7</sup> Sin embargo, actualmente no existe evidencia publicada de que las leyes penales hayan logrado otra meta que no sea el castigo en el contexto de la exposición intencional al VIH.
<h4>¿cuáles son las preocupaciones?</h4>
Actualmente, ningún estudio ha comprobado que la criminalización de la transmisión del VIH sea un método eficaz de prevención del VIH.<sup>7</sup> Además, muchas personas desconocen las leyes vigentes sobre el VIH en su estado, lo que impide que éstas influyan en su comportamiento.

Entre quienes conocen dichas leyes, los estatutos podrían aumentar el estigma contra una enfermedad ya muy temida y muy malentendida. Además, la amenaza de un juicio penal puede desalentar a las personas a recibir pruebas, consejería y tratamiento del VIH.<sup>8</sup> De esta manera, las leyes penales podrían contrarrestar los esfuerzos de salud pública porque las personas que desconocen su condición de VIH podrían ser más propensas a participar en comportamientos de alto riesgo y por lo tanto aumentar la propagación del VIH.<sup>9</sup>

Existen preocupaciones también sobre el estigma y la discriminación en las condenas por la exposición al VIH. Bajo algunas de las leyes penales más extremas sobre la exposición al VIH, las sentencias pueden ser tan largas como de 10 a 25 años. Algunas personas enjuiciadas por haber expuesto a otros al VIH han recibido estas extensas condenas aunque la víctima no resultara infectada.<sup>10</sup>

Muchas leyes castigan el fallo de revelar la condición de VIH+ a la pareja sexual, sin embargo las personas VIH+ pueden tomar medidas para evitar el contagio del VIH sin señalar su condición. Además, muchos factores pueden influir en la capacidad de la persona para revelar su infección de VIH en el contexto de su relación de pareja. Una encuesta de personas VIH+ encontró que el 42% de los hombres homosexuales, el 19% de los heterosexuales y el 17% de las mujeres reportaron haber tenido sexo sin revelar su condición de VIH.<sup>11</sup> Asimismo, los estudios muestran que la revelación de la condición de VIH no se asocia necesariamente con el uso de condones u otra actividad para reducir el riesgo.<sup>12</sup>
<h4>¿cómo encontrar equilibrio?</h4>
Las leyes usadas para castigar la exposición al VIH varían ampliamente según el estado en los EE.UU. Aunque algunos aspectos de las leyes apoyen los esfuerzos de salud pública, otros pueden contradecirlos. Es necesario equilibrar la ley penal y las metas de salud pública de manera que ambas tengan la mayor eficacia posible.

Es importante aumentar la conciencia de la existencia de estas leyes entre las organizaciones comunitarias y otras que atienden a personas VIH+. Ésto puede apoyar la meta de dichas leyes (impedir el comportamiento de riesgo) y permitir que los individuos VIH+ tengan una mayor voz en la creación de leyes que los afectan directamente.

Los legisladores y formuladores de normas y políticas pueden tomar varias medidas para lograr esta justa medida. En los estados que no tienen leyes específicas sobre el VIH, no hace falta crearlas. Numerosos estados han podido tomar acción legal al respecto valiéndose de los estatutos generales. De hecho la ONUSIDA específicamente recomienda no destacar al VIH de esta manera.<sup>13</sup>

Para los estados que ya tienen leyes específicas sobre el VIH, los legisladores pueden encontrar el punto medio apoyando leyes que reflejen medidas de prevención y conocimientos exactos sobre la transmisión del VIH. Actualmente muchas leyes establecen conductas condenables sin considerar las normas de prevención emitidas por los CDC (tales como el uso del condón). Se podrían incorporar protecciones adicionales al formular leyes dirigidas únicamente a infractores persistentes después de que las medidas menos restrictivas de salud pública hayan fallado en lograr cambios de conducta.

<hr />

<h3>¿Quién Lo Dice?</h3>
1. McKinney MM, Marconi K. Delivering HIV services to vulnerable populations: a review of CARE Act funded research. Public Health Reports. 2002;117:99-113.

2. Wolf LE, Vezina R. Crime and punishment: is there a role for criminal law in HIV prevention policy? Whittier Law Review. 2004;25: 821-886.

3. HIV Criminal Law and Policy Project. www.hivcriminallaw.org. Accessed March 2005.

4. Sullivan KM, Field MA. AIDS and the coercive power of the state. Harvard Civil Rights &amp; Civil Liberties Law Review. 1988;23: 139-197.

5. Gostin LO. Public health law in a new century: part I: law as a tool to advance the community’s health. Journal of the American Medical Association. 2000;283: 2837-2841.

6. Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13:297-306.

7. Lazzarini Z, Klitzman R. HIV and the law: integrating law, policy, and social epidemiology. Journal of Law and Medical Ethics. 2002;30:533-547.

8. Lazzarini Z, Bray S, Burris S. Evaluating the impact of criminal laws on HIV risk behavior. Journal of Law and Medical Ethics. 2002; 30:239-253.

9. Gostin LO, Hodge JG. The “names debate”: the case for national HIV reporting in the United States. Albany Law Review. 1998;61: 679-742.

10. In Brief: Maximum Sentence. AIDS Policy &amp; Law. 1998;13:16.

11. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. American Journal of Public Health. 2003;93:949-954.

12. Stein MD, Freedberg KA, Sullivan LM, et al. Sexual ethics. Disclosure of HIV-positive status to partners. Archives of Internal Medicine. 1998;158:253-257.

13. United Nations Program on AIDS (UNAIDS). Handbook for Legislators on HIV/AIDS, Law and Human Rights. 1999:51.

<hr />

<strong>Preparado por Leslie Wolf, JD, MPH y Richard Vezina, MPH, CAPS</strong>
<strong> Traducción Rocky Schnaath</strong>

<strong>Septiembre 2005. Hoja Informativa 57S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/leypenalFS.pdf</url>
	</node>
	<node>
		<title>Estigma</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el efecto del estigma en el tratamiento y prevención del VIH?</h3>
<h4>¿qué es el estigma del VIH/SIDA?</h4>
El estigma relacionado con el VIH/SIDA es un concepto complejo que se refiere al prejuicio, la exclusión, el desprestigio y la discriminación dirigidos hacia personas percibidas como infectadas por el SIDA o el VIH, y también hacia sus parejas, amistades, familias y comunidades.<sup>1,2</sup>

Muchas veces el estigma del VIH/SIDA reafirma las desigualdades sociales basadas en el sexo, la raza, el grupo étnico, la clase social, la sexualidad y la cultura de las personas. En EE.UU. por mucho tiempo ha existido el estigma hacia muchas poblaciones excesivamente afectadas por el VIH. El mismo VIH ha agravado el estigma de la homosexualidad, del consumo de drogas, de la pobreza, del trabajo sexual y de la condición de minoría racial.<sup>3</sup>

El estigma del VIH/SIDA es un problema no sólo en EE.UU. sino en todo el mundo, y tiene varias formas, entre ellas: 1) el ostracismo, el rechazo y el soslayo de las personas con SIDA; 2) la discriminación contra las personas con SIDA por parte de sus familias, proveedores médicos, comunidades y gobiernos; 3) la realización de pruebas obligatorias del VIH sin consentimiento previo ni la debida protección de la privacidad; 4) la puesta en cuarentena de personas VIH+; y 5) la violencia contra personas que parecen tener SIDA, ser VIH+ o pertenecer a “grupos de alto riesgo”.<sup>1</sup>
<h4>¿cómo puede afectar a la prevención?</h4>
El estigma del VIH/SIDA se suma al estrés que sienten las personas VIH+ y plantea desafíos para los esfuerzos de prevención del VIH.

<strong>Pruebas del VIH. </strong>El temor a las consecuencias de una prueba positiva del VIH puede impedir que algunas personas se la hagan. Un estudio de hombres y mujeres en siete ciudades estadounidenses reveló que el estigma se asociaba con una menor probabilidad de hacerse la prueba del VIH.<sup>4</sup> Es menos probable que las personas que son VIH+ sin saberlo intenten evitar transmitir el VIH a otros.&lt;sup5

<strong>Conductas más protegidas.</strong> Algunas personas VIH+ pueden temer que la revelación de su condición de VIH o el uso de condones cause el rechazo de su pareja, limite su oportunidad de tener relaciones sexuales o aumente el riesgo de violencia física y sexual. Un estudio de hombres rurales que tienen sexo con hombres (HSH) encontró que los hombres que pensaban que los proveedores médicos en su comunidad eran intolerantes hacia las personas VIH+ también reportaron más conductas sexuales de alto riesgo.<sup>6</sup>

<strong>Programas de prevención. </strong>El estigma en torno al VIH, a la homosexualidad, al comercio sexual y al consumo de drogas dificulta la provisión de servicios de prevención del VIH en una variedad de ambientes. La idea de integrar la prevención del VIH en un contexto sanitario y comunitario más extenso es ampliamente aceptada, pero muchos lugares comunitarios (iglesias, negocios, cárceles, prisiones y escuelas) se han resistido a dialogar francamente sobre el VIH.<sup>7</sup>
<h4>¿cómo puede afectar al tratamiento?</h4>
El estigma del VIH/SIDA también puede perjudicar la salud y el bienestar de las personas VIH+.

<strong>Tratamiento</strong>. Las personas VIH+ tal vez eviten buscar tratamiento o se demoren en acudir al médico debido a la discriminación real o percibida. En un estudio nacional de adultos VIH+, el 36 % reportaron haber sido discriminado por un profesional médico, incluyendo el 8 % a quienes se les negó atención médica.<sup>8</sup>

<strong>Apoyo.</strong> Algunas personas VIH+ no tienen una red de apoyo adecuada por temor a que sus amigos o familiares las abandonen o sean objetos del mismo estigma. Un estudio de asiáticos e isleños del Pacífico (AIP) con VIH reveló altos niveles de estigma interiorizado. Los AIP no buscaron apoyo por temor a revelar su condición de VIH+, y tampoco creyeron que merecían apoyo.<sup>9</sup>

<strong>Apego o adherencia al tratamiento</strong>. El rechazo social, la desaprobación y la discriminación relacionadas con el VIH pueden mermar la motivación de las personas VIH+ para mantenerse sanas. Un estudio de mujeres y hombres VIH+ encontró que aquellos que habían experimentado el estigma también eran más propensos a faltar a sus citas médicas del VIH y a tener problemas para seguir su régimen de medicamentos.<sup>10</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Los programas y las capacitaciones de reducción del estigma se realizan en todo EE.UU. y alrededor del mundo. Sin embargo, resulta difícil determinar la eficacia, por lo que existen pocos estudios publicados sobre programas exitosos que reduzcan el estigma. La mayoría de los programas cuentan con varios componentes que afrontan el estigma, entre ellas la educación, el desarrollo de habilidades y el contacto a nivel individual y comunitario con personas VIH+.<sup>11</sup>

En Texas, un programa escolar para estudiantes de preparatoria que viven en sectores urbanos pobres invitó a oradores VIH+ con el fin de disminuir las actitudes negativas hacia el VIH/SIDA. Los oradores resultaron ser un éxito entre alumnos y maestros, y tuvieron un efecto positivo sobre sus actitudes a corto plazo. La combinación de oradores VIH+ con un programa multifacético de prevención y educación del VIH tuvo un impacto aún mayor.<sup>12</sup>

El South Carolina HIV/AIDS Council (SCHAC) instituyó un programa tripartito contra el estigma. 1) Convocó reuniones comunitarias legislativas sobre temas de VIH en los condados rurales. 2) Produjo una obra de teatro educativa sobre las realidades del estigma del VIH para las comunidades y sus dirigentes. 3) Diseñó una campaña de publicidad estatal sobre el estigma del VIH/SIDA en la cual se difundieron anuncios de servicio público, carteles y artículos editoriales.<sup>13</sup>

El AIDS Institute (AI) del Departamento de Salud del Estado de Nueva York ha aprovechado intervenciones multinivel para evitar el estigma y la discriminación relacionados con el VIH. El AI ha promulgado leyes y políticas que protejan los derechos de las personas VIH+ o quienes sean vistas como tal, incluyendo leyes de confidencialidad y la inclusión del VIH/ SIDA en la ley actual contra la discriminación. También ofrece foros y consejos asesores para discutir normas y políticas, y ha establecido una oficina que gestiona reclamos de discriminación. A nivel programático, el AI provee capacitaciones sobre la diversidad y la confidencialidad para proveedores médicos, capacitación en liderazgo para personas VIH+ y métodos de mercadotecnia social para actividades de educación y concientización comunitaria.<sup>14</sup>
<h4>¿qué queda por hacer?</h4>
Tener conocimientos sobre la prevención, la transmisión y la atención del VIH puede compensar el estigma originado por la mala información y la ignorancia. Todavía se necesitan (y se necesitarán para futuras generaciones de jóvenes) programas educativos en muchas áreas y poblaciones.<sup>5</sup>

El estigma existe no simplemente en los actos de los individuos, sino dentro de amplios contextos sociales y culturales que deben tomarse en cuenta al diseñar programas para reducir el estigma. Las organizaciones y las comunidades deberán considerar los valores, las normas y los juicios morales que contribuyen al estigma de las personas VIH+ colaborando con las organizaciones religiosas, instituciones clave y líderes de opinión que ayuden a formar y a reafirmar los valores sociales.<sup>15</sup> Los legisladores y otras autoridades necesitan considerar las implicaciones de las leyes si no desean aumentar involuntariamente el estigma relacionado con el VIH/SIDA.

Las personas VIH+ deben ser involucradas en el diseño, la operación y la evaluación de los programas de reducción del estigma. Un método es capacitar y apoyar a personas VIH+ para que se movilicen y promuevan sus propios derechos.<sup>16</sup> Los programas para la prevención, enfrentarse al diagnóstico y la adherencia al tratamiento para personas VIH+ deben afrontar directamente el estigma y sus efectos sobre la salud y el bienestar de las personas VIH+.

Los programas también pueden ofrecer capacitación sobre la competencia cultural, la confidencialidad y la concientización para trabajadores de salud, consejeros y el personal de servicios sociales incluyendo los de desintoxicación, de vivienda y de salud mental. La capacitación es especialmente importante en áreas de elevado estigma como las zonas rurales y en organizaciones con pocos clientes VIH+.

Es poco probable que el estigma del VIH/SIDA desaparezca pronto.<sup>16</sup> Se están realizando investigaciones nacionales e internacionales,<sup>17</sup> pero hacen falta otras más que midan los efectos del estigma y nos ayuden a entender qué intervenciones sirven mejor y en qué comunidades. Los programas prometedores de concientización y reducción del estigma necesitan ser evaluados y publicados para permitir la amplia reproducción de los programas eficaces.

<hr />

<h2>¿Quién lo dice?</h2>
1. Herek GM. AIDS and stigma. <em>American Behavioral Scientist. </em>1999;42:1102-1112.

2. Goffman E. <em>Stigma: note on the management of spoiled identity </em>. Prentice-Hall: Englewood, NJ. 1963.

3. Parker R, Aggleton P. HIV/AIDS-related stigma and discrimination: a conceptual framework and agenda for action. Report prepared by the Population Council, May 2002. www.popcouncil.org/pdfs/horizons/sdcncptlfrmwrk.pdf

4. Fortenberry JD, McFarlane M, Bleakley A, et al. Relationships of stigma and shame to gonorrhea and HIV screening . <em>American </em><em>Journal of Public Health.</em>2002;92(3):378-381.

5. Valdiserri RO. HIV/AIDS stigma: an impediment to public health . <em>American Journal of Public Health. </em>2002;92(3):341-342.

6. Preston DB, D’Augelli AR, Kassab CD, et al. The influence of stigma on the sexual risk behavior of rural men who have sex with men. <em>AIDS Education and Prevention </em>. 2004;16(4):291-303.

7. Brooks RA, Etzel MA, Hinojos E, et al. Preventing HIV among Latino and African American gay and bisexual men in a context of HIVrelated stigma, discrimination and homophobia: perspectives of providers . <em>AIDS Patient Care and STDs.</em>2005;19(11):737-744.

8. Schuster MA, Collins R, Cunningham WE, et al. Perceived discrimination in clinical care in a nationally representative sample of HIV-infected adults receiving health care . <em>Journal of General Internal </em><em>Medicine. </em>2005;20:807-813.

9. Kang E, Rapkin BD, Remien RH, et al. Multiple dimensions of HIV stigma and psychological distress among Asians and Pacific Islanders living with HIV illness .<em>AIDS and Behavior. </em>2005;9(2):145-154.

10. Vanable PA, Carey MP, Blair DC, et al. Impact of HIV-related stigma on health behaviors and psychological adjustment among HIV-positive men and women .<em>AIDS and Behavior. </em>2006;10:____.

11. Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we learned? <em>AIDS Education and Prevention </em>. 2003;15(1):49-69.

12. Markham C, Baumler E, Richesson R, et al. Impact of HIV-positive speakers in a multicomponent, school-based HIV/STD prevention program for inner-city adolescents . <em>AIDS Education and Prevention. </em>2000;12(5):442-454.

13. Ford Foundation HIV/AIDS anti-stigma initiative:a framework for addressing HIV/AIDS related stigma in the US.www.hivaidsstigma.org/documents/antistigmafactsheet.pdf

14. Klein SJ, Karchner WD, O’Connell DA. Interventions to prevent HIV-related stigma and discrimination: findings and recommendations for public health practice . <em>Journal of Public Health Management and Practice. </em>2002;8(6):44-53.

15. Ogden J, Nyblade L. Common at its core: HIV-related stigma across contexts. Report prepared by the International Center for Research on Women. 2005. http://www.icrw.org/docs/2005_report_stigma_synthesis.pdf

16. Anderson T. Stigma mitigation components in HIV/AIDS programs. In:<em>HIV/AIDS Stigma: Theory, Reality and Response </em>, J Holloway, R Seaton and J Crowley, eds. Health Resources and Services Administration: Rockville, MD. 2004.www.ask.hrsa.gov/detail.cfm?PubID=HAB00353

<hr />

<strong>Preparado por Maria Ekstrand PhD, CAPS y el National AIDS Fund</strong>

<strong>Traducción: Rocky Schnaath</strong>

Septiembre 2006. Hoja de Dato #60S]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/estigmaFS.pdf</url>
	</node>
	<node>
		<title>What works in HIV prevention</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>We Know What Works in HIV Prevention -Why Aren’t We Doing More of It?</h2>
<h3>What have we learned?</h3>
Fifteen years ago, the first AIDS cases were diagnosed among 5 gay men in Los Angeles, CA. Since then, AIDS has spread to over half a million people in the US and is the leading cause of death for all Americans aged 25-44. Fifteen years have also seen great leaps in understanding how to prevent the spread of HIV. But these fifteen years have not seen the widespread implementation of effective HIV prevention programs in the US. If we know what works, why aren’t we doing more of it?

HIV prevention does not have to be perfect to be effective. Epidemiological models have shown that simply cutting rates of risky behavior in half can halt the epidemic.<sup>1</sup> The programs listed below are some of the interventions that have shown signs of success and should be replicated, even without 100% reduction in risk behavior.
<h3>What has shown signs of working?</h3>
The majority of the estimated 41,000 annual new HIV infections in the US are occurring among injection drug users (IDUs), their sexual partners, and their offspring.<sup>2</sup> We know what works to prevent the spread of HIV among IDUs: starting HIV prevention efforts when rates of HIV are still low, providing sterile injecting equipment through needle exchange programs and over-the-counter pharmacy sales, conducting community outreach to IDUs, and providing drug treatment on demand.<sup>3</sup>

In Tacoma, WA, where prevention efforts for IDUs began in 1988, the prevalence of HIV among IDUs has remained steady at 3-4%. In New York City, NY, where prevention efforts for IDUs met with early opposition, HIV among IDUs increased from 10% to more than 50% in five years.<sup>3</sup>

Connecticut implemented the ideal HIV prevention program: it cost the state nothing and was highly effective. A partial repeal of needle prescription and drug paraphernalia laws resulted in dramatic reductions in needle sharing, and increases in pharmacy purchase of syringes by IDUs. Sharing dropped from 52% to 31% after the new laws, pharmacy purchase rose from 19% to 78%, and street purchase fell from 74% to 28%.<sup>4</sup>

Gay and bisexual men account for a majority of total current HIV infections, and 25% of annual new infections in the US.<sup>2</sup> We know what intervention strategies work for gay and bisexual men: small group counseling and skills training, peer outreach, counseling and testing, hot lines, media programs, and community interventions.

One effective program in several medium-sized towns trained the most popular people in social settings to deliver AIDS risk-reduction messages to friends and acquaintances in gay bars. As a result, fewer gay men practiced unprotected sex.<sup>5</sup> Another successful program promoted a norm for safer sex among young gay men through a variety of social, outreach and small group activities such as dances, picnics, and volleyball games. As a result, rates of unprotected intercourse dropped from 40% to 31%.<sup>6</sup>

One fourth of all new HIV infections in the US occur in young people under the age of 22. We know what works for adolescents: effective sex education programs in schools. Although the popular belief is that teaching kids about sex will lead to promiscuity, in fact, the opposite is true. A comprehensive review of 23 school-based programs found that teens who received specific AIDS education were less likely to engage in sex, and those who did were more likely to have sex less often and use contraception.<sup>7</sup>

Sex education is most effective when it is begun before students have initiated sexual activity. A program in Oakland, CA, used peer educators to teach seventh graders about sexuality and HIV/AIDS. After one year, students in the program were less likely to initiate activities such as deep kissing, genital touching, and sexual intercourse.<sup>8</sup>

Voluntary HIV testing and treatment with AZT for HIV-positive pregnant women reduced the risk of maternal-fetal HIV transmission by two-thirds in clinical trials.<sup>9</sup> Long-term effects on mother and child have yet to be determined.
<h3>How is prevention being held back?</h3>
The US government still bans the use of federal funds for needle exchange programs, even though six government-sponsored reports have shown that those programs help stop the spread of HIV and do not lead to increased drug use. Similarly, ten states and the District of Columbia still have laws requiring a doctor’s prescription to buy a syringe, even though four government-sponsored studies have recommended repealing those laws.<sup>10</sup> Meanwhile, drug treatment centers frequently have long waiting lists, and fewer than 15% of IDUs in the US are in treatment at any given time.<sup>11</sup>

In recent years, many states have passed laws that restrict sex education. For example, eight states require or recommend teaching that homosexuality is not an acceptable lifestyle, even though gay teens are at highest risk for HIV and most in need of education. Twenty-six states require abstinence instruction, even though a review of abstinence programs showed no proof of effectiveness in delaying the onset of intercourse.<sup>7</sup> Only 14 of the 26 states also require sex education curricula to include information on contraception, sexually transmitted diseases and HIV.<sup>12</sup>

Funding for HIV prevention has not always flowed where it is most needed. For example, in California in 1991, gay and bisexual men accounted for 88% of all AIDS cases, yet received only 5% of total state spending on prevention.<sup>13</sup>

Success preventing maternal-fetal transmission has prompted the federal government to recommend universal counseling and voluntary HIV testing to all pregnant women. However, getting tested does not guarantee treatment if a women should test positive. A study of publicly funded HIV test sites found that almost half of all clients had no health insurance, and racial minorities were more likely to be uninsured.<sup>14</sup> Lack of insurance may block many women from preventive services such as prenatal care.

Prevention programs that have been evaluated and shown to be effective are sometimes perceived as too complicated or expensive to work “in the field.” Researchers and service providers can collaborate to better understand how to adapt effective programs to different populations, and to determine the cost-effectiveness of programs.
<h3>What can we do?</h3>
The federal government needs to repeal the ban on funding for needle exchange programs. State governments need to repeal needle prescription and paraphernalia laws. Federal and state governments need to dramatically increase methadone maintenance programs, as well as drug treatment programs for cocaine and crack.

State governments should pass laws requiring all children to receive explicit and age-appropriate sexuality, drug, and HIV/AIDS education in schools that includes discussions of homosexuality and contraception.

State health departments and their Community Planning groups need to prioritize funding for prevention programs that more accurately reflect the epidemiology of HIV in their communities. Highest priority should be given to programs for populations with the greatest need: IDUs in and out of treatment; gay and bisexual men who are young, substance users, and men of color; female partners of IDUs; and high-risk youth.

The federal government needs to ensure early access to care and treatment for those who test positive. New medications and therapies can be prohibitively expensive for those without health insurance. Recent advances in HIV treatment can dramatically lower the amount of HIV virus during early phases of infection, which may reduce the risk of transmission. In the future, good HIV treatment may be key for HIV prevention.

A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. Prevention does not have to be perfect to make a difference. We know what works in HIV prevention. We need to apply that knowledge more completely, more fairly, and more consistently.

<em>Prepared by Thomas J. Coates, PhD and Pamela DeCarlo</em>

<hr />

<h3>Says Who?</h3>
1. Blower SM, McLean AR. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco . Science. 1994;265:1451-1454.

2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas . American Journal of Public Health. 1996;86:642-654.

3. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users . Journal of the American Medical Association. 1995;274:1226-1231.
<ul>
 	<li>Contact: Don Des Jarlais 212/387-3870 X3808.</li>
</ul>
4. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993 . Journal of Acquired Immune Deficiency Syndromes. 1995;10:82-89.
<ul>
 	<li>Contact: Beth Weinstein 203/509-7800.</li>
</ul>
5. Kelly JA, St. Lawrence JS, Stevenson LY, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities . American Journal of Public Health. 1992;82:1483-1489.
<ul>
 	<li>Contact: Jeff Kelly 414/287-4680.</li>
</ul>
6. Hays RB, Rebchook, GM, Kegeles SM. The Mpowerment project: a community-level HIV prevention intervention for young gay and bisexual men . American Journal of Public Health. 1996;86:1-8.
<ul>
 	<li>Contact: Susan Kegeles 415/597-9159.</li>
</ul>
7. Kirby D, Short L, Collins J, et al. School-based programs to reduce sexual risk behaviors: a review of effectiveness. Public Health Reports. 1994;109:339-360.

8. Ekstrand ML, Siegel D, Nido V, et al. Peer-led AIDS prevention delays initiation of sexual behaviors among US junior high school students. Presented at 11th International Conference on AIDS, Vancouver, BC. 1996.
<ul>
 	<li>Contact: Maria Ekstrand 415/597-9160.</li>
</ul>
9. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment . New England Journal of Medicine. 1994;331:1173-1180.

10. Lurie P, Drucker E. An opportunity lost: estimating the number of HIV infections due to the US failure to adopt a national needle exchange policy. Presented at 11th International Conference on AIDS, Vancouver, BC. 1996.

11. Wiley J, Samuel M. Prevalence of HIV infection in the USA . AIDS. 1989;3(Suppl. 1):71-78.

12. Sexuality Education in America: A State-by-State Review. Report prepared by the NARAL Foundation. Washington, DC: 1995.

13. Lee PR, Franks P, Haynes-Sanstad K, et al. HIV Prevention in California: HIV Education and Prevention Evaluation. Report prepared for the Office of AIDS, California Department of Health Services, 1993.

14. Valdiserri RO, Gerber AR, Dillon BA, et al. Clients without health insurance at publicly funded HIV counseling and testing sites: implications for early intervention . Public Health Reports. 1995;110:47-52.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©1996, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/whatworksFS.pdf</url>
	</node>
	<node>
		<title>Lo que funciona en la prevención</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Si sabemos lo que funciona al prevenir el VIH — ¿porqué no sacamos mayor provecho?</h3>
<h4>¿qué hemos aprendido?</h4>
Hace quince años, en Los Angeles, CA, se diagnosticaron los primeros 5 casos de SIDA entre hombres homosexuales. Desde entonces el SIDA se ha extendido a más de medio millón de personas en los EEUU y actualmente es la causa líder de muertes entre los Norteamericanos de 25 a 44 años de edad. Estos quince años han sido testigos del gran avance logrado tratando de entender como detener esta enfermedad. Sin embargo, en estos quince años no se ha visto la implementación de programas eficaces de prevención a gran escala en las tareas de prevención del VIH en los EEUU. Si sabemos lo que funciona, ¿porqué no lo ponemos a prueba?

No es necesario que la tarea de prevención sea perfecta para ser efectiva. Los modelos epidemiológicos demuestran que el simple hecho de reducir por mitad el número de conductas de riesgo puede detener esta epidemia.<sup>1</sup> Los programas que a continuación mencionamos son algunas de las intervenciones que han dado muestras de eficacia y que deberían ser replicadas aunque no se haya obtenido un 100% en la reducción de las conductas de riesgo.
<h4>¿cuáles programas parecen funcionar?</h4>
Se estima que la mayoría de los 41,1000 nuevos casos anuales de infección con VIH son atribuidas a los Usuarios de Drogas Intravenosas (UDIs), a sus parejas sexuales y a su descendencia.<sup>2</sup> Ya sabemos como detener la transmisión del VIH entre los UDIs: comenzar las tareas de prevención apenas se registren los primeros brotes de infección, proveer el material que se usa para inyectarse esterilizado por medio de los programas de intercambio de jeringuillas o a través de las farmacias, crear programas capaces de reclutar a los UDIs en esta lucha, y proveer programas de rehabilitación de drogas de acuerdo a las circunstancias.<sup>3</sup>

En Tacoma Washington, ciudad donde los esfuerzos de prevención para los UDIs empezaron en el año 1988, la prevalencia del VIH entre los ellos se ha mantenido entre el 3-4%. En la ciudad de Nueva York, en donde los esfuerzos de prevención para los UDIs encontraron resistencia en sus inicios, nos encontramos con un incremento del 10% hasta más del 50% en cinco años.<sup>3</sup>

Connecticut implementó el programa ideal de prevención del VIH: sin costo alguno al estado y con resultados sumamente positivos. Esto se logro haciendo un simple cambio sustancial a las leyes que giran en torno a la paraphernalia y a la compra de jeringas lo cual produjo una dramática reducción en el uso de jeringas usadas y un incremento en las ventas de jeringas nuevas entre los UDIs. A raíz de la implementación de estas nuevas leyes se observó una reducción en el uso de jeringas usadas del 52% al 31%, la venta en las farmacias subió del 19% al 78%, y las ventas en las calles cayeron del 74% al 28%.<sup>4</sup>

Actualmente, el hombre gay y/o bisexual cuenta con la mayoría de los casos de infección con VIH, y con el 25% anual de nuevas infecciones en los EEUU. Sabemos cuales son las estrategias de intervención que funcionan entre el hombre gay y bisexual: pequeños grupos de apoyo, la práctica de ciertas destrezas o la creación de estas, proveer consejería, pruebas del VIH y programas de recultamiento llevados a cabo por miembros del grupo en cuestión, líneas telefónicas de asistencia, programas televisivos e intervenciones a nivel comunitario.

Uno de los programas exitosos fue implementado en varias ciudades de tamaño mediano. En este programa se entrenó a las personas más populares del ámbito social para transmitir mensajes de reducción de riesgo en bares de homosexuales. Debido a esto, se redujeron las relaciones sexuales sin protección.<sup>5</sup> Otro de los programas exitosos usó la estrategia de promover una norma o patrón de conducta por medio de fiestas, días de campo y juegos de voliból. Esto ocasionó un descenso en las relaciones sexuales sin protección del 40% al 31%.<sup>6</sup>

Un cuarto de todas las nuevas infecciones en los EEUU ocurre entre los jóvenes menores de 22 años. Sabemos cuales son las estrategias para tratar el caso de los adolescentes: los programas eficaces de educación sexual en las escuelas. En una revisión a 23 programas implementados en las escuelas se descubrió que aquellos jóvenes que participaron en estos programas estaban menos propensos a participar en actividades sexuales y aquellos que estaban teniendo relaciones sexuales lo hacían con menos frecuencia usando métodos anticonceptivos.<sup>7</sup>

La prueba voluntaria del VIH y el tratamiento con AZT a las mujeres embarazadas VIH positivas redujo en dos tercios el riesgo de transmisión del VIH de la madre al feto.<sup>8</sup> Aunque los efectos secundarios que esta medicina ocasiona aún están por verse.
<h4>¿comó se limita la prevención?</h4>
Hasta hoy, el gobierno Estadounidense no permite el uso de fondos federales para programas de intercambio de jeringas, a pesar de que 6 reportes auspiciados por el gobierno demostraron que estos programas ayudan a detener la transmisión del VIH sin que se haya observado un incremento en el uso de las drogas.<sup>9</sup> Simultáneamente, diez estados y el DC tiene hasta hoy leyes que requieren una receta del doctor para comprar jeringas, a pesar de que 4 estudios auspiciados por el gobierno han recomendado abolir estas leyes. Mientras tanto, los centros para el tratamiento de drogas tienen con frecuencia largas listas de espera, y menos del 15% de los UDIs en los EEUU están bajo tratamiento en un momento dado.<sup>10</sup>

Hasta hace pocos años, muchos estados han logrado crear/pasar leyes que restringen la educación sexual. Por ejemplo, en ocho estados se requiere o se recomienda enseñar que la homosexualidad no es un estilo de vida aceptable en la sociedad a pesar de que los jóvenes gay/homosexuales son los que corren mayor riesgo de contraer el VIH y por lo tanto son los que necesitan más educación. A pesar de que en 26 estados se exige promover la abstinencia en las escuelas, una revisión de estos programas no comprobó la efectividad de estos en cuanto a retrasar las actividades sexuales. Solamente en 14 de los 26 estados se exige como requisito incluir en el currícula de educación sexual información acerca de los anticonceptivos, sobre las enfermedades transmitidas sexualmente y sobre el VIH.<sup>11</sup>

Los fondos monetarios designados para los esfuerzos de prevención del VIH no siempre se canalizan donde más se necesitan. Por ejemplo, en el estado de California, en el año 1991 en donde el 88% de todos los casos de SIDA era atribuido a hombres homosexuales y bisexuales, solamente designaron el 5% del presupuesto para la prevención en esta población.<sup>12</sup>

El éxito obtenido al prevenir la transmisión materno-fetal ha provocado que el gobierno federal recomiende servicios de consejería y pruebas voluntaria del VIH a toda mujer embarazada. Eso si, el hecho de hacerse la prueba no garantiza recibir el tratamiento en caso de resultar positiva. Un estudio a los centros públicos donde se hacen pruebas del VIH, encontró que casi la mitad de los clientes no tenían seguro de salud siendo las minorías raciales las que poseían menos posibilidades de tener seguro de salud.<sup>13</sup> La falta de un seguro puede impedir que las mujeres reciban servicios preventivos tales como el cuidado prenatal.
<h4>¿qué podemos hacer?</h4>
El gobierno federal deberá revocar las leyes que impiden que los programas de intercambio de jeringas obtengan fondos para operar. Los gobiernos estatales necesitan revocar las leyes de paraphernalia y de prescripción en cuanto a las jeringas. Ambos gobiernos necesitan incrementar programas de mantenimiento con “Methadone”, asimismo los programas de rehabilitación de drogas como la cocaína y el crack.

Los gobiernos estatales deberán implementar leyes que requieran que todo joven reciba educación más explícita sobre la sexualidad, las drogas y el VIH/SIDA de acuerdo con la edad en las escuelas, incluyendo el tema de la homosexualidad y los anticonceptivos.

Los departamentos de salubridad del estado y los Grupos Comunitarios de Planeamiento a cargo de distribuir los fondos deberán darle prioridad a los programas de prevención que reflejen con mayor exactitud la epidemiología del VIH en sus comunidades. La mayor prioridad deberá estar centrada en aquellos programas dirigidos a las poblaciones que más lo necesitan: los UDIs dentro y fuera de los programas de tratamiento; hombres homosexuales y bisexuales jóvenes, UDIs y minorías; las parejas femeninas de los UDIs; y los jóvenes que corren alto riesgo.

El gobierno federal necesita asegurar el acceso al cuidado médico durante la etapa inicial a aquellas personas que resulten VIH-positivas. El alto costo de los nuevos medicamentos y del tratamiento se hace inaccesible para aquellos que no poseen seguro médico. Los recientes avances en el tratamiento del VIH pueden reducir dramaticamente la cantidad de virus si se hace durante la etapa inicial, lo cual reduce el riesgo de transmisión. En el futuro, un buen tratamiento puede ser la clave para el éxito de los esfuerzos de prevención.

Un programa de prevención completo y eficaz utiliza múltiples elementos para proteger a la mayor cantidad de personas a riesgo posible. La estrategia de prevención no necesariamente debe ser perfecta para obtener éxito. Sabemos lo que funciona al hacer prevención. Necesitamos aplicar este conocimiento mas plena, justa, y consistentemente.

<hr />

<h4>¿quién lo dice?</h4>
1. Blower SM, McLean AR. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco . Science. 1994;265:1451-1454.

2. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas . American Journal of Public Health. 1996;86:642-654.

3. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users . Journal of the American Medical Association. 1995;274:1226-1231.
<ul>
 	<li>Contact: Don Des Jarlais 212/387-3870 X3808.</li>
</ul>
4. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993 . Journal of Acquired Immune Deficiency Syndromes. 1995;10:82-89.
<ul>
 	<li>Contact: Beth Weinstein 203/509-7800.</li>
</ul>
5. Kelly JA, St. Lawrence JS, Stevenson LY, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities . American Journal of Public Health. 1992;82:1483-1489.
<ul>
 	<li>Contact: Jeff Kelly 414/287-4680.</li>
</ul>
6. Hays RB, Rebchook, GM, Kegeles SM. The Mpowerment project: a community-level HIV prevention intervention for young gay and bisexual men . American Journal of Public Health. 1996;86:1-8.
<ul>
 	<li>Contact: Susan Kegeles 415/597-9159.</li>
</ul>
7. Kirby D, Short L, Collins J, et al. School-based programs to reduce sexual risk behaviors: a review of effectiveness. Public Health Reports. 1994;109:339-360.

8. Ekstrand ML, Siegel D, Nido V, et al. Peer-led AIDS prevention delays initiation of sexual behaviors among US junior high school students. Presented at 11th International Conference on AIDS, Vancouver, BC. 1996.
<ul>
 	<li>Contact: Maria Ekstrand 415/597-9160.</li>
</ul>
9. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment . New England Journal of Medicine. 1994;331:1173-1180.

10. Lurie P, Drucker E. An opportunity lost: estimating the number of HIV infections due to the US failure to adopt a national needle exchange policy. Presented at 11th International Conference on AIDS, Vancouver, BC. 1996.

11. Wiley J, Samuel M. Prevalence of HIV infection in the USA . AIDS. 1989;3(Suppl. 1):71-78.

12. Sexuality Education in America: A State-by-State Review. Report prepared by the NARAL Foundation. Washington, DC: 1995.

13. Lee PR, Franks P, Haynes-Sanstad K, et al. HIV Prevention in California: HIV Education and Prevention Evaluation. Report prepared for the Office of AIDS, California Department of Health Services, 1993.

14. Valdiserri RO, Gerber AR, Dillon BA, et al. Clients without health insurance at publicly funded HIV counseling and testing sites: implications for early intervention . Public Health Reports. 1995;110:47-52.

<hr />

<strong>Preparado por Thomas J. Coates, PhD, Pamela DeCarlo;
Traducción Romy Benard-Rodríguez</strong>
Enero 1997. Hoja Informativa 20S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/funcionaFS.pdf</url>
	</node>
	<node>
		<title>Childhood sexual abuse (CSA)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How does childhood sexual abuse affect HIV prevention?</h3>
<h4>What is childhood sexual abuse?</h4>
Childhood sexual abuse may be defined in many ways, but this fact sheet refers to unwanted sexual body contact prior to age 18, the age of consent to engage in sex. CSA is a painful experience on many levels that can have a profound and devastating effect on later physiological, psychosocial and emotional development.

CSA experiences can vary with respect to duration (multiple experiences with the same perpetrator), degree of force/coercion or degree of physical intrusion (from fondling to digital penetration to attempted or completed oral, anal or vaginal sex). The identity of the perpetrator–ranging from a stranger to a trusted figure or family member–may also impact the long-term consequences for individuals. To distinguish CSA from exploratory sexual experimentation, the contact should be unwanted/coerced or there should be a clear power difference between the victim and perpetrator, often defined as the perpetrator being at least 5 years older than the victim.

Many more children are sexually abused than are reported to authorities.<sup>1</sup> Estimates of the prevalence of CSA in the US are about 33% for females under the age of 18 and 10% in males under 18 years of age.<sup>2</sup> Men are significantly less likely than women to report CSA when it occurs.<sup>3</sup>

CSA is more likely to occur in families under duress. Children are at risk for CSA in families that experience stress, poverty, violence and substance abuse and whose parents and relatives have histories of CSA.
<h4>Does CSA affect HIV risk?</h4>
Yes. Because childhood and early adolescence are critical times in a person’s sexual, social and personal development, CSA can distort survivors’ physical, mental and sexual images of themselves. These distortions, combined with coping mechanisms adopted to offset the trauma of CSA, can lead CSA survivors into high-risk sexual and drug-using behaviors that increase the likelihood of HIV infection.<sup>4</sup>

Persons who experience CSA may feel powerless over their sexuality and sexual communication and decision-making as adults because they were not given the opportunity to make their own decisions about their sexuality as children or adolescents. As a result, they may engage in more high-risk sexual behavior, be unable to refuse sexually aggressive partners and have less sexual satisfaction in relationships.

CSA survivors may have difficulties forming attachments and long term relationships and may dissociate from their feelings, resulting in having multiple sexual partners, “one night stands” and short-term sexual relationships. Adults who perceive positive aspects of their own CSA (such as gaining attention) may also use sex as a soothing or comforting strategy, which can lead to promiscuity and compulsive sexual patterns.<sup>5</sup>

The effects of CSA may be different for adult men and women. Female survivors of CSA may have lower condom self-efficacy with partners, use condoms less frequently, exhibit more sexual passivity and attract or be attracted to overly controlling partners.<sup>6</sup> Male survivors of CSA may experience higher levels of eroticism, exhibit aggressive, hostile behavior and victimize others.<sup>7</sup>

Adults with CSA histories may use dissociation and other coping efforts to avoid negative thoughts, emotions and memories associated with the abuse. One of the most common dissociation methods is alcohol and drug abuse. A study of men and women with a history of substance abuse found that 34% had experienced CSA. CSA survivors with substance abuse problems were more likely than substance abusers who had not experienced CSA to exchange sex for money or drugs, have an HIV+ or high-risk partner and not use condoms.<sup>8</sup>

Sexual revictimization can also influence high-risk sexual behavior. One study of African American and white women found that CSA survivors who experience revictimization as adults had more unintended pregnancies, abortions, STDs and high-risk sexual behaviors than those who experienced only CSA.<sup>9</sup>
<h4>What’s being done?</h4>
There are many resources for CSA survivors, but few programs exist to reduce HIV-related sexual and drug-using risk behaviors and increase psychological well being. Most of these programs focus on women; there are even fewer programs for male CSA survivors.
Good-Touch/Bad-Touch is a comprehensive child abuse prevention intervention designed for pre-school and kindergarten through sixth grade students. The program uses a variety of materials to teach children prevention skills including personal body safety rules, what abuse is and what action to take if threatened.<sup>10</sup>

The Children’s Medical Center in Dallas, TX, provides HIV/STD prevention for young female sexual abuse victims at a child abuse clinic. Adolescent females between 12 and 16 years old receive one-on-one evaluation and personalized education from an adolescent-focused HIV/STD counselor. Providing sensitive counseling close to the time of recognition of abuse can be a good method for prevention education.<sup>11</sup>

At Stanford University, CA, a trauma-focused group therapy intervention seeks to reduce HIV risk behavior and revictimization among adult women survivors of CSA. The groups focus on survivors’ memories of CSA to see if this helps increase safer behaviors and reduce stress. The women also receive case management.<sup>12</sup>

The Visiting Nurse Service of New York offers comprehensive in-home services to HIV-infected families. The children in these families are at high risk for repeating the histories and behaviors of their parents, including HIV infection, substance abuse, sexual abuse and mental illness. The program provides home-based interventions that include play therapy, health and safe sex education, family and individual counseling, relapse prevention for the parent and drug awareness and prevention for the children. Helping the child deal with anger and resentment towards the parent lessens the likelihood that their anger will be displaced on themselves, thus repeating the behavior of the parent. Supporting each family member is key to breaking the cycle of HIV and abuse in these families.<sup>13</sup>

At the University of California, Los Angeles, and King-Drew University, CA, a psychoeducational intervention aims to increase healthy behavior and decrease HIV risk behaviors in HIV+ women with histories of CSA. Women are taught communication and problem-solving tools and link CSA experiences to past and current areas of risk.<sup>14</sup>
<h4>What needs to be done?</h4>
Although dealing with CSA may seem like a daunting task for many HIV prevention programs, there are a variety of usable approaches to address CSA in adults. Programs can: include questions on abuse during routine client screening, reassess clients over time, provide basic education on the effects of CSA and offer referrals for substance abuse and mental health services. Program staff need basic training and support to help cope with the effects of CSA counseling and the relative high prevalence in certain populations.<sup>15</sup>

Persons who are likely to interact with CSA survivors such as medical and other health professionals, religious and peer counselors, including alcohol, substance abuse and rape counselors, and probation officers need to be educated on the effects of CSA on sexual and drug risk behaviors. They also need training on how to recognize symptoms of CSA and how to address these issues or provide appropriate referrals for treatment.

Professionals should look beyond CSA symptoms and inquire about other childhood experiences that may have been problematic. CSA survivors often are forced to contend with other types of abuse and a dysfunctional family environment. A poor family environment may set the tone for abuse to occur and leave the survivor with little support to cope with the experience.

<hr />

<h3>Says who?</h3>
1. Green AH. Overview of child sexual abuse. In SJ Kaplan (ed.), Family violence: A clinical and legal guide. Washington, DC: American Psychiatric Press. 1996;73-104.
2. Finkelhor D. The international epidemiology of child sexual abuse. Child Abuse &amp; Neglect. 1994;18:409-417.
3. Roesler TA, McKenzie N. Effects of childhood trauma on psychological functioning in adults sexually abused as children. Journal of Nervous and Mental Disease. 1994;182:145-150.
4. Prillo KM, Freeman RC, Collier C, et al. Association between early sexual abuse and adult HIV-risky behaviors among community-recruited women. Child Abuse &amp; Neglect. 2001;25:335-346.
5. Paul, J. Understanding childhood sexual abuse as a predictor of sexual risk-taking among men who have sex with men: The Urban Men’s Health Study. Child Abuse &amp; Neglect. 2001;125:557-584.
6. Watkins B, Bentovim A. The sexual abuse of male children and adolescents: a review of current research. Journal of Child Psychology &amp; Psychiatry &amp; Allied Disciplines. 1992;33:197–248.
7. Wyatt GE, Guthrie D, Notgrass CM. Differential effects of women’s child sexual abuse and subsequent revictimization. Journal of Consulting and Clinical Psychology. 1992;60:167-173.
8. Morrill AC, Kasten L, Urato M, et al. Abuse, addiction and depression as pathways to sexual risk in women and men with a history of substance use. Journal of Substance Abuse. 2001;13:169-184.
9. Wyatt GE, Myers HF, Williams JK, et al. Does a history of trauma contribute to HIV risk for women of color? Implications for prevention and policy. American Journal of Public Health. 2002;92:1-7.
10. Harvey P, Forehand R, Brown C, et al. The prevention of sexual abuse: Examination of the effectiveness of a program with kindergarten-age children. Behavior Therapy. 1988;19:429-435.
11. Squires J, Persaud DI, Graper JK. HIV and STD prevention counseling for adolescent girls seen in a child abuse clinic. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. Abst # TuPeF5249.
12. Group Interventions to Prevent HIV in High Risk Women.www.med.stanford.edu/school/ Psychiatry/PSTreatLab/TraumaStudy.php
13. Mills R, Samuels KD, Bob-Semple N, et al. Breakin the cycle: multigenerational dysfunction in families affected with HIV/AIDS. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. Abst #. ThPeE7828.
14. Wyatt GE, Myers H, Longshore D, et al. Examining the effects of trauma on HIV risk reduction: the women’s health intervention. Presented at the International Conference on AIDS, Barcelona, Spain. 2002. Abst# WePeF6853.
15. Paul JP. Coerced childhood sexual episodes and adult HIV prevention. FOCUS. 2003;18:1-4

<hr />

<strong>Prepared by Gail Wyatt PhD, Tamra Loeb PhD, Inna Rivkin PhD, Jennifer Carmona PhD, Dorothy Chin PhD, John Williams MD, Hector Myers PhD, Douglas Longshore PhD and Charlotte Sykora PhD
UCLA Women’s Health Project</strong>

<strong>September 2003. Fact Sheet #52E</strong>

Special thanks to the following reviewers of this Fact Sheet: Ruth Kelley, Jay Paul, Elizabeth Radhert.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/CSAFS.pdf</url>
	</node>
	<node>
		<title>Abuso sexual infantil</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el efecto del abuso sexual infantil en la prevención del VIH?</h3>
<h4>¿qué es el abuso sexual infantil?</h4>
El abuso sexual infantil (ASI) tiene muchas definiciones, pero en esta hoja informativa nos referimos al contacto corporal no deseado antes de los 18 años, que es la edad en que se considera que una persona puede dar su consentimiento para tener contacto sexual. El ASI es una experiencia dolorosa a muchos niveles que puede tener, posteriormente, efectos profundos y devastadores en el desarrollo psicológico, psicosocial y emocional.

Las experiencias de ASI pueden variar respecto a: duración (varios incidentes con el mismo agresor), grado de fuerza/coerción o grado de intrusión física (desde una caricia, a la penetración digital o al sexo oral, anal o vaginal intentado o consumado). La identidad del agresor/a (que podría ser un desconocido, una persona de confianza o un familiar) también puede influir en las consecuencias a largo plazo para las víctimas. Lo que distingue el ASI de la experimentación sexual exploratoria es el contacto indeseado o forzado o la clara desproporción de poder; comúnmente, se determina como agresor/a alguien que resulte por lo menos 5 años mayor que la víctima.

El número de abusos sexuales infantiles excede el número de casos reportados a las autoridades.<sup>1</sup> Se calcula que la prevalencia del ASI en EE.UU. es del 33% entre chicas menores de 18 años y del 10% entre chicos menores de 18 años.<sup>2</sup> Los hombres son considerablemente menos propensos a reportar un incidente de ASI que las mujeres.<sup>3</sup>

La probabilidad de que el ASI ocurra aumenta en familias que sufren mucha tensión. Los niños están en riesgo de ser abusados sexualmente en familias que padecen estrés, pobreza, violencia y consumo de alcohol o drogas y cuyos padres y parientes tienen antecedentes de ASI.
<h4>¿afecta el riesgo de contraer el VIH?</h4>
Sí. Ya que la niñez y el comienzo de la adolescencia son etapas críticas del desarrollo sexual, social y personal, el ASI puede distorsionar la autoimagen física, mental y sexual de las víctimas. Estas distorsiones, junto con los mecanismos de defensa adoptados para compensar el trauma del ASI, pueden conducir a sus sobrevivientes a prácticas de alto riesgo en el sexo y al consumir drogas, las cuales aumentan sus probabilidades de contraer el VIH.<sup>4</sup>

Quienes han sufrido el ASI pueden sentirse sin poder respecto a su sexualidad, la comunicación sexual y la toma de decisiones en la edad adulta, pues no tuvieron la oportunidad de tomar decisiones propias sobre su sexualidad durante su niñez o adolescencia. Consecuentemente, es posible que estas personas participen en prácticas sexuales de alto riesgo, sean incapaces de rechazar a una pareja sexual agresiva y sientan menos satisfacción sexual en sus relaciones.

Los sobrevivientes del ASI pueden disociarse de sus sentimientos y tener dificultades para formar lazos afectivos y relaciones a largo plazo, por lo cual llegan a tener varias parejas sexuales, “aventuras de una sola noche” y relaciones sexuales cortas. Los adultos que perciben algún aspecto positivo de su propio ASI (por ejemplo, la atención que recibieron) pueden usar el sexo como una manera de consolarse o reconfortarse, una conducta que puede llevar a la promiscuidad y a patrones sexuales compulsivos.<sup>5</sup>

El ASI puede tener efectos diferentes en hombres y en mujeres. Las mujeres sobrevivientes del ASI pueden usar condones con menos frecuencia, ser menos eficaces para establecer el uso de condones con sus parejas sexuales, demostrar más pasividad sexual y atraer o sentirse atraída a parejas exageradamente controladoras.<sup>6</sup> Los hombres que sobreviven al ASI pueden sentir un mayor grado de erotismo, exhibir una conducta agresiva y hostil y agredir a otros.<sup>7</sup>

Los adultos con historial de ASI pueden valerse de la disociación y de otros mecanismos para evitar los pensamientos, emociones y recuerdos negativos asociados con el abuso. Uno de los métodos más comunes de disociación es el abuso del alcohol y drogas. Un estudio de hombres y mujeres con antecedentes de alcoholismo y drogadicción encontró que el 34% fueron víctimas del ASI. En comparación con otros consumidores de alcohol o drogas que no fueron víctimas, los
sobrevivientes del ASI con problemas de alcohol o drogas tenían más probabilidades de tener sexo por dinero o drogas, de tener una pareja VIH + o de alto riesgo y de no usar condón durante el sexo.<sup>8</sup>

La revictimización sexual también puede influir en la conducta sexual de alto riesgo. Un estudio de mujeres afroamericanas y caucásicas encontró que las sobrevivientes del ASI revictimizadas ya siendo adultas tuvieron más embarazos indeseados, abortos terapéuticos, enfermedades de transmisión sexual (ETS) y prácticas sexuales de alto riesgo que quienes sólo fueron abusadas sexualmente en la niñez.<sup>9</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Existen muchos recursos para quienes sobreviven el ASI, pero escasean los programas que aumenten el bienestar psicológico y reduzcan las prácticas riesgosas relacionadas con el VIH en el sexo y en el uso de drogas. La mayoría de estos programas se enfocan en la mujer; los programas destinados a los sobrevivientes masculinos son aun más escasos.

Good-Touch/Bad-Touch es una intervención integral de prevención del abuso infantil diseñada para los niños de preescolar y kindergarten hasta los del sexto año de primaria. El programa utiliza una variedad de materiales para enseñar a los niños métodos de prevención que incluyen las reglas de la seguridad corporal, en qué consiste el abuso y qué hacer si se sienten amenazados.<sup>10</sup>

En una clínica para víctimas del ASI, el Children’s Medical Center en Dallas, TX, ofrece prevención del VIH/ETS para jovencitas víctimas del abuso sexual. Las adolescentes entre 12 y 16 años reciben una evaluación individual y educación personalizada de una consejera de VIH/ ETS especializada en las necesidades de las jóvenes. La provisión de consejería sensible y cercana al momento en que se reconoce el abuso, puede ser un buen método de educación preventiva.<sup>11</sup>

En la Universidad de Stanford, CA, una intervención de terapia grupal sobre el trauma busca reducir las conductas de riesgo del VIH y la revictimización entre mujeres adultas sobrevivientes al ASI. Los grupos se centran en los recuerdos que las sobrevivientes tienen del ASI para ver si éstos les ayudan a aumentar conductas más seguras y a reducir el estrés. Las mujeres también reciben servicios de manejo de casos.<sup>12</sup>

El Visiting Nurse Service de Nueva York ofrece servicios integrales a domicilio para familias infectadas con el VIH. Los niños de estas familias corren un alto riesgo de repetir las historias y conductas de sus padres, incluyendo la adquisición del virus, el abuso de drogas o alcohol, el abuso sexual y la enfermedad mental. El programa proporciona intervenciones realizadas en el hogar que incluyen terapia del juego, educación en salud y protección sexual, consejería familiar e individual, prevención de recaídas para los padres y concientización y prevención del uso de drogas para los hijos. Al ayudar al niño a afrontar el enojo y resentimiento que sienta hacia el padre, es menos probable que dirija ese enojo hacia sí mismo y que termine repitiendo la conducta de los padres. Para romper el ciclo del VIH y del abuso en estas familias, es fundamental apoyar a cada uno de los miembros de la familia.<sup>13</sup>

En la Universidad de California, Los Ángeles, y en la Universidad King-Drew, CA, una intervención psicoeducativa pretende incrementar las conductas sanas y disminuir las prácticas de riesgo del VIH en mujeres VIH+ con antecedentes de ASI. Las mujeres aprenden técnicas de comunicación y de resolución de problemas y vinculan sus experiencias de ASI con riesgos pasados y actuales.<sup>14</sup>
<h4>¿qué queda por hacer?</h4>
Aunque abordar el ASI parezca una tarea de enormes proporciones para muchos programas de prevención del VIH, existe una variedad de métodos utilizables para tratar el tema del ASI en adultos. Los programas pueden: incorporar preguntas sobre el abuso en la evaluación inicial de todos los clientes, hacer reevaluaciones periódicas, brindarles información básica sobre los efectos del ASI y remitirlos a programas de tratamiento de abuso de drogas y alcohol así como a servicios de salud mental. El personal de prevención del VIH necesita capacitación básica y apoyo para ayudar a sobrellevar los efectos de la consejería sobre el ASI y su prevalencia relativamente alta en ciertas poblaciones.<sup>15</sup>

El personal que probablemente tenga contacto con sobrevivientes del ASI como serían los profesionales médicos, consejeros religiosos, de pares, de abuso de drogas y de víctimas de violación, así como los policías para los delincuentes en libertad condicional, debe ser orientado de los efectos del ASI sobre las prácticas de riesgo en el sexo y en el uso de drogas. Estas personas también necesitan capacitación para reconocer los síntomas del ASI, afrontar la situación y remitir adecuadamente a los servicios de tratamiento existentes.

Los profesionales deben mirar más allá de los síntomas del ASI e indagar sobre otras experiencias que tal vez fueron problemáticas durante la niñez. Muchas veces, los sobrevivientes del ASI son obligados a sufrir otras formas de abuso y un ambiente familiar disfuncional. Un ambiente familiar problemático puede crear condiciones favorables para el abuso y dejar al sobreviviente con poco apoyo para sobrellevar la experiencia.

<strong>Preparado por Gail Wyatt PhD, Tamra Loeb PhD, Inna Rivkin PhD, Jennifer Carmona PhD, Dorothy Chin PhD, John Williams MD, Hector Myers PhD, Douglas Longshore PhD and Charlotte Sykora PhD. UCLA Women’s Health Project. Traducción: Rocky Schnaath.</strong>

<strong>September 2003. Fact Sheet #52S</strong>

<hr />

<h3>¿quien lo dice?</h3>
1. Green AH. Overview of child sexual abuse. In SJ Kaplan (ed.), Family violence: A clinical and legal guide. Washington, DC: American Psychiatric Press. 1996;73-104.
2. Finkelhor D. The international epidemiology of child sexual abuse. Child Abuse &amp; Neglect. 1994;18:409-417.
3. Roesler TA, McKenzie N. Effects of childhood trauma on psychological functioning in adults sexually abused as children. Journal of Nervous and Mental Disease. 1994;182:145-150.
4. Prillo KM, Freeman RC, Collier C, et al. Association between early sexual abuse and adult HIV-risky behaviors among community-recruited women. Child Abuse &amp; Neglect. 2001;25:335-346.
5. Paul, J. Understanding childhood sexual abuse as a predictor of sexual risk-taking among men who have sex with men: The Urban Men’s Health Study. Child Abuse &amp; Neglect. 200;125:557-584.
6. Watkins B, Bentovim A. The sexual abuse of male children and adolescents: a review of current research. Journal of Child Psychology &amp; Psychiatry &amp; Allied Disciplines. 1992;33:197–248.
7. Wyatt GE, Guthrie D, Notgrass CM. Differential effects of women’s child sexual abuse and subsequent revictimization. Journal of Consulting and Clinical Psychology. 1992;60:167-173.
8. Morrill AC, Kasten L, Urato M et al. Abuse, addiction and depression as pathways to sexual risk in women and men with a history of substance use. Journal of Substance Abuse. 2001;13:169-184.
9. Wyatt GE, Myers HF, Williams JK, et al. Does a history of trauma contribute to HIV risk for women of color? Implications for prevention and policy. American Journal of Public Health. 2002;92:1-7.
10. Harvey P, Forehand R, Brown C, et al. The prevention of sexual abuse: Examination of the effectiveness of a program with kindergarten-age children. Behavior Therapy. 1988;19:429-435.
11. Squires J, Persaud DI, Graper JK. HIV and STD prevention counseling for adolescent girls seen in a child abuse clinic. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. Abst # TuPeF5249.
12. Group Interventions to Prevent HIV in High Risk Women.www.med.stanford.edu/school/ Psychiatry/PSTreatLab/TraumaStudy.html
13. Mills R, Samuels KD, Bob-Semple N, et al. Breakin the cycle: multigenerational dysfunction in families affected with HIV/AIDS. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. Abst #. ThPeE7828.
14. Wyatt GE, Myers H, Longshore D, et al. Examining the effects of trauma on HIV risk reduction: the women’s health intervention. Presented at the International Conference on AIDS, Barcelona, Spain. 2002. Abst# WePeF6853.
15. Paul JP. Coerced childhood sexual episodes and adult HIV prevention. FOCUS. 2003;18:1-4.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Ruth Kelley, Jay Paul, Elizabeth Radhert.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/AbusoFS.pdf</url>
	</node>
	<node>
		<title>HIV/STD/unintended pregnancy</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How Do HIV, STD and Unintended Pregnancy Prevention Work Together?</h3>
<h4>Why is it important?</h4>
HIV is a sexually transmitted disease (STD). HIV, other STDs (such as gonorrhea, syphilis, herpes, chlamydia and trichomoniasis), and unintended pregnancy are all adverse consequences of sexual behavior. If someone is at risk for unintended pregnancy or common STDs, that means they are engaging in an activity that could also put them at risk for HIV. In addition, these STDs may increase the likelihood of HIV acquisition.

STDs are the most frequently reported diseases in the US. Every year in the US, about 12 million new cases of STDs occur, 3 million of them among teenagers.<sup>1</sup>

In 1996, for the first time in the US, the number of AIDS deaths decreased. However, new cases continue to occur, and the largest proportionate increase in AIDS incidence in 1996 occurred among men and women who acquired AIDS through heterosexual contact (28% increase for men, 23% for women).<sup>2</sup>

Over half of the 6.4 million pregnancies in the US in 1988 were unintended (56%). As many of those pregnancies ended in abortion (44%) as in birth (43%).<sup>3</sup> In 1996, over half a million young women under age 20 gave birth, and two-thirds of those were unintended.<sup>4</sup> Unintended pregnancy has great personal and social consequences.
<h4>Do STDs affect HIV?</h4>
Absolutely. First, an HIV- person who has an STD is 2- to 5-times more susceptible to HIV acquisition because the lesions and immune response associated with STDs make it easier for HIV to enter the body. Second, an HIV+ person who has an STD can be more infectious and more easily transmit HIV to an uninfected partner. Third, an HIV+ person may be more likely to acquire other STDs. This “epidemiological synergy” may be responsible for the explosive growth of HIV in some populations.<sup>5</sup>

Many research studies have shown the connection between HIV and STDs. A study in Malawi found that HIV+ men with gonorrhea had concentrations of HIV in their semen eight times higher than HIV+ men who did not have another STD. After treatment for the STD, HIV concentration in semen decreased to levels not significantly different from pre-STD levels. This suggests that STDs increase the infectiousness of HIV, and that detecting and treating STDs in HIV+ persons may help prevent HIV transmission.<sup>6</sup>

Clients at urban STD clinics in Miami, FL who had at least two HIV tests were found to have high rates of HIV and syphilis. Among clients tested twice, 10% acquired syphilis and 4% HIV in the interval. African-Americans accounted for 77% of HIV seroconversions and the rate was highest in women, especially 15-19 year olds. The majority of HIV infections were acquired heterosexually. A total of 18% of all seroconversions were associated with syphilis acquired between two HIV tests.<sup>7</sup>
<h4>Are STD and HIV prevention connected?</h4>
Yes and no. While the epidemics of STD and HIV have grown in parallel, prevention efforts to combat the adverse consequences of sexual behavior have not always worked in tandem. In the US HIV epidemic, heterosexual transmission is an increasing cause of infection, and people of color and younger people are increasingly infected. This is also true of STDs in the Southeast and selected large cities across the US, where syphilis, gonorrhea and HIV epidemics clearly overlap, especially among young African-American women.<sup>8</sup>

HIV prevention efforts may be more effective among certain populations if condom use and HIV are addressed together with STD or pregnancy prevention. Young people are much more likely to know someone who has had an STD or an unintended pregnancy than they are to know someone with HIV. HIV prevention programs, as well as family planning and STD clinics, might create a more effective and realistic message by putting all three together-HIV, STDs and unintended pregnancy-and saying condoms can protect against all three.<sup>9,10</sup>
<h4>What’s working?</h4>
In rural Tanzania, a community-level program focused on improving diagnosis and treatment of STDs as means to prevent HIV infection. The program included training existing health center staff in STD management, ensuring availability of effective antibiotics for STDs, and providing periodic outreach to educate on STDs and increase health care use. Individuals in the intervention communities had lower HIV incidence (by about 40%) compared to persons in non-intervention communities.<sup>11</sup>

Project RESPECT was a randomized HIV counseling and testing program conducted at STD clinics in five cities in the US with high HIV seroprevalence. The program evaluated whether interactive counseling is more effective than informational messages in reducing risk behaviors and preventing HIV and other STD transmission. The program found relatively little difference between 4-session and 2-session interactive counseling interventions, but found lower rates of new STDs, including HIV, among those groups compared to groups that only received information. Reported condom use increased across all groups. Project RESPECT demonstrated that brief risk-reduction counseling strategies can be effectively conducted in busy public clinic settings, and that counseling interventions can change STD rates in high-risk populations.<sup>12</sup>

An HIV prevention program was implemented at an STD clinic in the South Bronx, NY, due to the clinic’s access to large numbers of high-risk men and women. The program was designed to have minimal disruption on clinical services while providing culturally-appropriate counseling. Patients had access to either a video on condom use in English or Spanish, or both the video and an interactive group session. Patients were given coupons for free condoms at a pharmacy several blocks from the clinic. Clients who saw the video were more likely to redeem coupons than those who did not, and clients who saw the video and participated in group sessions were even more likely to redeem coupons.<sup>13</sup>

People of Color Against AIDS Network (POCAAN) in Seattle, WA found that because of the stigma of HIV, prevention educators were not always successful at reaching at-risk populations, especially young African-American and Latino males ages 13-35. In 1990 POCAAN decided to educate about STDs and sexual health since these messages were more acceptable to the target population. The program uses street outreach and presentations in various settings such as juvenile facilities, middle and high schools, ESL classes and drug treatment centers. They offer referral vouchers that ensures clients will be seen at an STD clinic and that it will be free. In addition, POCAAN continually updates and educates its staff about STDs and works hard to integrate STD prevention messages into all its HIV-related activities.<sup>14</sup>
<h4>What still needs to be done?</h4>
It is time to further integrate STD, HIV and unintended pregnancy efforts, both on a programmatic and a research level. Wherever and whenever feasible, HIV prevention behavior change programs, STD clinics, family planning clinics and primary care facilities need to incorporate all three-HIV, STDs and unintended pregnancy-in their education, testing, counseling and treatment services.<sup>10</sup> Research on HIV, both clinical and behavioral, needs to include the effects of STD and pregnancy.

Although funding for HIV, STDs and family planning have traditionally been separate, government agencies and foundations need to provide funds for improved coordination or integration. Workers in STD, HIV and family planning should be cross-trained. Community Planning Groups should consider STD and unintended pregnancy prevention plans as well in areas where the epidemiology warrants. A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. As funding for social services grow more scarce, it is important to not pit STDs and unintended pregnancy against HIV in the fight for money, but to adopt new approaches to fight these overlapping epidemics.

<hr />

<h3>Says who?</h3>
1. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC : National Academy Press; 1997.

2. Centers for Disease Control and Prevention. Update: trends in AIDS incidence-United States, 1996 . Morbidity and Mortality Weekly Report. 1997;46:861-867.

3. Forrest JD . Epidemiology of unintended pregnancy and contraceptive use . American Journal of Obstetrics and Gynecology. 1994;170:1485-1489.

4. Centers for Disease Control and Prevention. State-specific birth rates for teenagers-United States, 1990-1996 . Morbidity and Mortality Weekly Report. 1997;46:837-842.

5. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases . Sexually Transmitted Diseases. 1992;19:61-77.

6. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 . The Lancet. 1997;349:1868-1873.

7. Otten MW, Zaidi AA, Peterman TA, et al. High rate of seroconversion among patients attending urban sexually transmitted disease clinics . AIDS. 1994;8:549-553.

8. St. Louis ME, Wasserheit JN, Gayle HD. Editorial: Janus considers the HIV pandemic-harnessing recent advances to enhance AIDS prevention . American Journal of Public Health. 1997;87:10-12.

9. Cates W. Sexually transmitted diseases and family planning. Strange or natural bedfellows, revisited . Sexually Transmitted Diseases. 1993;20:174-178.

10. Stein Z. Family planning, sexually transmitted diseases, and the prevention of AIDS-divided we fail? American Journal of Public Health. 1996;86:783-784.

11. Grosskurth H, Mosha F, Todd J, et al . Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial . The Lancet. 1995;346:530-536.

12. Kamb ML, Bolan G, Zenilman J, et al. Does HIV/STD prevention counseling work? Results from a multi-center randomized trial. Presented at 12th Meeting of the International Society of Sexually Transmitted Diseases Research, Seville, Spain. 1997.
<ul>
 	<li>Contact: Mary Kamb (404) 639-2080.</li>
</ul>
13. O’Donnell LN, San Doval A, Duran R, et al. Video-based sexually transmitted disease patient education: its impact on condom acquisition . American Journal of Public Health. 1995;85:817-822
<ul>
 	<li>Contact: Lydia O’Donnell, Education Development Center, (617) 969-7100 X2368.</li>
</ul>
14. US Conference of Mayors. Sexual Health and STDs: an avenue to HIV prevention services. AIDS Information Exchange. 1995:12:6-8.
<blockquote>Contact: Kevin Harris (206) 322-7061 x233.</blockquote>

<hr />

<h3><strong>Prepared by Pamela DeCarlo* and Nancy Padian PhD**
*CAPS, **UCSF Department of Obstetrics, Gynecology and Reproductive Sciences</strong></h3>
December 1997. Fact Sheet #31E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Francisco should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © December 1997, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/STD-HIVFS.pdf</url>
	</node>
	<node>
		<title>VIH/ETS/embarazos no planeados</title>
		<tax>1737</tax>
		<content><![CDATA[<h3><strong>¿Como trabajan: la prevención de las ETS, del VIH y de los embarazos no planeados?</strong></h3>
<strong>¿por qué es importante?</strong>

El VIH es una enfermedad de transmisión sexual (ETS). El VIH, otras ETS (como la gonorrea, la sífilis, el herpes, la clamidia y la tricomoniasis), y los embarazos no planeados son consecuencias adversas del comportamiento sexual. Si alguien está a riesgo de un embarazo no planeado, o de alguna ETS común, significa que está participando en una actividad que adicionalmente le pone a riesgo de contraer el VIH. Estas ETS, a su vez, pueden aumentar las posibilidades de adquirir el VIH.

En los EEUU, las enfermedades que se reportan con mayor frecuencia son las ETS. Cada año ocurren cerca de 12 millones de nuevos casos de ETS, 3 millones de estos entre los jóvenes.<sup>1</sup>

En 1996, por primera vez en los EEUU se experimentó un descenso en la cantidad de muertes a causa del SIDA. Sin embargo, continúan apareciendo nuevos casos, en 1996 se observó el mayor incremento proporcional de casos de SIDA entre hombres y mujeres que adquirieron el SIDA por contacto heterosexual (28% para hombres, 23%, en mujeres).<sup>2</sup>

En los EEUU, un poco más de los 64 millones de embarazos en 1998 no fueron planeados (56%). Una cantidad casi igual de embarazos terminaron en abortos (44%) así como en nacimientos (43%).<sup>3</sup> En 1996, un poco más de medio millón de mujeres menores de 20 años dieron a luz, y dos tercios de estos no fueron planeados. Los embarazos no planeados<sup>4</sup> tienen graves consecuencias personales y sociales.

<strong>¿las ETS afectan al VIH?</strong>

Indudablemente. Primero, una persona VIH- con una ETS tiene de 2 a 5 veces más posibilidades de contraer el VIH debido a las lesiones y a la respuesta del sistema inmune ante la presencia de una ETS; lo cual facilita la entrada del VIH. Segundo, una persona VIH+ con una ETS es más infecciosa, por lo tanto transmite más facilmente el VIH a su pareja VIH-. Tercero, una persona VIH+ puede tener más posibilidades de contraer otras ETS. Esta “sinergia epidemiológica” puede ser la responsable del aumento de VIH en algunas poblaciones.<sup>5</sup>

Muchos estudios han demostrado la conección entre el VIH y las ETS. Un estudio en Malawi descubrió que los hombres infectados con VIH y gonorrea tenían una concentración de VIH en el sémen 8 veces mayor a la de hombres VIH positivos que no estaban infectados con ninguna otra ETS. Después del tratamiento para las ETS, la concentración de VIH en el sémen declinó a niveles no muy diferentes a los que tenían previos a la ETS. Esto indica que las ETS incrementan los niveles infecciosos del VIH y que la detección y tratamiento de las ETS en personas VIH positivas puede contribuir a prevenir la transmisión del VIH.<sup>6</sup>

<strong>¿existe alguna conneción entre la prevención de las ETS y las del VIH?</strong>

Si y no. A pesar de que tanto la epidemia de las ETS como la del VIH han crecido paralelamente, la labor de prevención al combatir las consecuencias adversas del comportamiento sexual no siempre ha funcionado en tándem. En los EEUU, la transmisión del VIH por vía heterosexual sigue creciendo al igual que en personas de color y los jóvenes. Lo mismo ocurre con las ETS en el Sureste y en ciertas urbes a lo largo de los EEUU, en donde la gonorrea y el VIH convergen claramente, especialmente entre la mujer joven Afro-Americana.<sup>7</sup>

La labor de prevención del VIH podría ser más eficaz en ciertas poblaciones si el uso del condón y el VIH formara parte de las campañas de prevención de embarazos y de ETS. Los jóvenes tienen mayores posibilidades de conocer a alguien con una ETS o que haya tenido un embarazo no planeado que conocer a alguien con VIH. Los programas de prevención del VIH, al igual que las clínicas de ETS y planificación familiar pueden desarrollar o crear un mensaje más eficaz y realista si se combinaran los tres elementos-VIH, ETS, embarazos no planeados -usando el mensaje que los condones les protegen en contra de los tres.<sup>8,9</sup>

<strong>¿qué está funcionando?</strong>

En una área rural de Tanzania, un programa a nivel comunitario se esforzó por mejorar el diagnóstico y tratamiento de las ETS como una forma de prevenir la infección del VIH. El programa capacitó al personal de salud existente en cuanto al manejo de casos de ETS y asegurando la disponibilidad de antibióticos eficaces para combatir las ETS; además educó a la comunidad en cuanto a las ETS y promovió el cuidado de la salud. Se reportaron menores índices de SIDA entre las personas que participaron en la intervención comunitaria (como en un 40%) en comparación con las personas que no participaron en dicha intervención.<sup>10</sup>

El “Proyecto RESPECT” (RESPETO), un programa aleatorio, ofreció consejería y pruebas de detección de VIH en clínicas de ETS de 5 ciudades estadounidenses con altos índices de seroprevalencia del VIH. El programa evaluó si la consejería interactiva era más eficaz que los mensajes informativos en cuanto a reducir conductas de alto riesgo y prevenir el VIH u otras ETS. El programa registró un impacto relativamente mínimo-entre las intervenciones de consejería interactiva de 2 y 4 sesiones. Sin embargo se presentaron menos casos de ETS, incluyendo el VIH, entre esos grupos al compararse con los grupos que solo recibieron los mensajes informativos. Se reportó un aumento en el uso del condón en todos los grupos. El”Proyecto RESPECT” demostró que la estrategia de una breve consejería puede ser muy útil en clínicas públicas y que las intervenciones con consejería pueden tener un impacto en las tasas de ETS en poblaciones de alto riesgo (de contagio).<sup>11</sup>

Un programa de prevención del VIH fue implementado en una clínica de ETS al Sur del Bronx, New York, debido a la alta concentración de hombres y mujeres a riesgo de contagio. El programa fue diseñado para interrumpir en lo más mínimo con los servicios clínicos, mientras se impartía consejería apropiada al medio cultural del paciente. Estos tenían acceso a un video, en Español o Inglés, sobre el uso del condón, o a una combinación de video y sesión de grupo interactivo. Los pacientes recibieron cupones para condones gratis válidos en una farmacia cercana a la clínica. Los clientes que vieron el video usaron más los cupones (que los que no lo vieron), y los que vieron el video y participaron en la sesión de grupo aún más.<sup>12</sup>

En Seattle, Washington la organización de “People of Color Against AIDS Network” o POCAAN, descubrió que debido al estigma que rodea al VIH, los educadores de prevención no siempren tuvieron éxito atrayendo a las poblaciones a mayor riesgo especialmente a los hombres Afro-Americanos y Latinos entre los 13 y 35 años de edad. En 1990, POCAAN decidió enviar el mensaje enseñando sobre ETS y salud sexual ya que esta población era más receptiva a este tipo de intervención. El programa hace uso del reclutamiento y concientización en las calles y al hacer presentaciones en diferentes sitios tales como centros de detención juvenil, en escuelas secundarias, en clases de Inglés como segunda lengua (ESL) y en centros para el tratamiento de droga-adicción. Este programa aseguró servicios gratis en una clínica de ETS para los participantes. Adicionalmente, POCAAN continuamente educa y pone al día a su personal en lo que a ETS se refiere y se esfuerzan mucho por integrar el tema de las ETS en mensajes de prevención y en toda actividad relacionada con el VIH.<sup>13</sup>

<strong>¿qué queda por hacer?</strong>

Es hora de integrar aún más las ETS, el VIH y los embarazos no planeados en esfuerzos programáticos y científicos. Siempre y cuando sea factible, los programas de prevención del VIH, las clínicas para las ETS, las de planificación familiar, y las que ofrecen cuidado primario, necesitan incorporar estos tres elementos-VIH, ETS y embarazos no planeados-en sus servicios de educación, de la prueba de detección, de consejería, y de tratamiento.<sup>9</sup> Los estudios sobre VIH, tanto clínicos como conductuales, deben incluir los efectos de las ETS y de los embarazos.

Aunque los recursos para combatir el VIH, los embarazos no planeados, y las ETS se hacen tradicionalmente por separado, las agencias del gobierno y las fundaciones deben designar fondos para mejorar la coordinación o integración de estos. Los trabajadores de ETS, VIH y planificación familiar deben recibir el mismo entrenamiento. Los grupos de planificación comunitaria (de programas de VIH locales) deben tomar en cuenta aquellos grupos que muestran altos indices de ETS y de embarazos no planeados ademas del VIH en su programación. A medida que los fondos para servicios escasean, es importante que los servicios para combatir las ETS, los embarazos no planeados, y el VIH no tengan que competir por fondos; más bien sería adoptar nuevas formas de lucha para combatir estas epidemias convergentes.

<hr />

<strong>¿quién lo dice?</strong>

1. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC : National Academy Press; 1997.

2. Centers for Disease Control and Prevention. Update: trends in AIDS incidence-United States, 1996 . Morbidity and Mortality Weekly Report. 1997;46:861-867.

3. Forrest JD . Epidemiology of unintended pregnancy and contraceptive use . American Journal of Obstetrics and Gynecology. 1994;170:1485-1489.

4. Centers for Disease Control and Prevention. State-specific birth rates for teenagers-United States, 1990-1996 . Morbidity and Mortality Weekly Report. 1997;46:837-842.

5. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases . Sexually Transmitted Diseases. 1992;19:61-77.

6. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 . The Lancet. 1997;349:1868-1873.

7. Otten MW, Zaidi AA, Peterman TA, et al. High rate of seroconversion among patients attending urban sexually transmitted disease clinics . AIDS. 1994;8:549-553.

8. St. Louis ME, Wasserheit JN, Gayle HD. Editorial: Janus considers the HIV pandemic-harnessing recent advances to enhance AIDS prevention . American Journal of Public Health. 1997;87:10-12.

9. Cates W. Sexually transmitted diseases and family planning. Strange or natural bedfellows, revisited . Sexually Transmitted Diseases. 1993;20:174-178.

10. Stein Z. Family planning, sexually transmitted diseases, and the prevention of AIDS-divided we fail? American Journal of Public Health. 1996;86:783-784.

11. Grosskurth H, Mosha F, Todd J, et al . Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial . The Lancet. 1995;346:530-536.

12. Kamb ML, Bolan G, Zenilman J, et al. Does HIV/STD prevention counseling work? Results from a multi-center randomized trial. Presented at 12th Meeting of the International Society of Sexually Transmitted Diseases Research, Seville, Spain. 1997.
<ul>
 	<li>Contact: Mary Kamb (404) 639-2080.</li>
</ul>
13. O’Donnell LN, San Doval A, Duran R, et al. Video-based sexually transmitted disease patient education: its impact on condom acquisition . American Journal of Public Health. 1995;85:817-822
<ul>
 	<li>Contact: Lydia O’Donnell, Education Development Center, (617) 969-7100 X2368.</li>
</ul>
14. US Conference of Mayors. Sexual Health and STDs: an avenue to HIV prevention services. AIDS Information Exchange. 1995:12:6-8.

Contact: Kevin Harris (206) 322-7061 x233.

<hr size="2" />

<strong>Preparado por Pamela DeCarlo*, Nancy Padian PhD**; Traducción Romy Benard-Rodriguez*</strong> <strong>
*CAPS, **UCSF Department of Obstetricts, Gynecology and Reproductive Services</strong>

Agosto 1998. Hoja Informativa 31S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/ETSFS.pdf</url>
	</node>
	<node>
		<title>Mental health</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How Does Mental Health Affect HIV Prevention?</h3>
<h4>What does mental health have to do with HIV prevention?</h4>
A s much as the HIV epidemic has changed over the past 20 years, most reasons for continued high risk behavior have remained very much the same. Some factors that contribute to these behaviors are: loneliness, depression, low self-esteem, sexual compulsivity, sexual abuse, marginalization, lack of power and oppression. These issues do not have quick fixes. Addressing these basic issues requires time and effort and may extend beyond the capabilities of most HIV prevention programs.

One thing we have learned from HIV prevention research is that “one size does not fit all.” Programs need different components to address the different needs of clients. Increasing knowledge, skills building and increasing access to condoms and syringes are good methods, but don’t work for everyone or on their own. For many, the barriers to behavior change are mental health problems. This fact sheet focuses on non-acute mental health issues and does not address the effect of severe mental illness or brain disorders on HIV prevention.

What people do and what they experience affects their mental health. Substance use and abuse, discrimination, marginalization and poverty are all factors that impact mental health and, in turn, can place people at risk for HIV infection.
<h4>Do mental health issues affect HIV risk?</h4>
Yes. The decision to engage in risky sexual or drug using practices may not always be a consciously made “decision.” Rather, it is based on an attempt to satisfy some other need, for example:

<strong>LOW SELF-ESTEEM.</strong> For many men who have sex with men (MSM), low self-esteem and internalized homophobia can impact HIV risk-taking. Internalized homophobia is a sense of unhappiness, lack of self-acceptance or self-condemnation of being gay. In one study, men who experienced internalized homophobia were more likely to be HIV+, had less relationship satisfaction and spent less social time with gay people.<sup>1</sup>

Male-to-female transgender persons (MTFs) identify low self-esteem, depression, feelings of isolation, rejection and powerlessness as barriers to HIV risk reduction. For example, many MTFs state that they engage in unprotected sex because it validates their female gender identity and boosts their self-esteem.<sup>2</sup>

<strong>ANXIETY AND DEPRESSION. </strong>Young adults who suffer from anxiety and depression are much more likely to engage in high risk activities such as prostitution, both injection and non-injection drug use and choosing high risk partners. One study that followed inner-city youths for several years found that change in risk behavior was not associated with knowledge, access to information, counseling or knowing someone with AIDS. Reducing symptoms of depression and other mental health issues were, however, associated with reductions in HIV-related risk behaviors.<sup>3</sup>

<strong>SEXUAL ABUSE.</strong> Persons who experience incidents of sexual abuse during childhood and adolescence are at a significantly higher risk of mental health problems and HIV risk behavior. A study of adult gay and bisexual men found that those who had been abused were much more likely to engage in unprotected anal intercourse and injecting drug use.<sup>4</sup>

For many women, sexual abuse is combined with physical and/or emotional abuse in childhood or adolescence. HIV risk is only one of the consequences of this abuse for women. Women may turn to drug use as a way of coping with abuse experience(s). They may also have difficulty adjusting sexually, causing difficulty negotiating condom use with partners and increasing the likelihood of sexual risk taking.<sup>5</sup> Women who have been abused have higher rates of sexually transmitted diseases (STDs) including HIV.<sup>6</sup>

<strong>POST-TRAUMATIC STRESS DISORDER (PTSD).</strong> PTSD may account for high sexual risk-taking activities. In one study among female crack users in the South Bronx, NY, 59% of women interviewed were diagnosed with PTSD due to violent traumas such as assault, rape or witness to murder, and non-violent traumas such as homelessness, loss of children or serious accident.<sup>7</sup>  A national study of veterans found that substance abusers who suffered from PTSD were almost 12 times more likely to be HIV-infected than veterans who were not substance abusers nor suffering from PTSD.<sup>8</sup>
<h4>What factors impact mental health?</h4>
Many persons who suffer from mental health problems turn to substance use as a means of coping. Substance use has been shown to decrease inhibitions and impair judgement, which can contribute to HIV risk-taking. Injection drug users (IDUs) who suffer from depression are at higher risk for needle sharing.<sup>9</sup>

Environmental factors such as poverty, racism and marginalization can lead to mental health problems such as low self-esteem which can in turn, lead to substance use and other HIV risk behaviors. Inner-city young adults with high rates of HIV risk behaviors also experience higher rates of suicidality, substance misuse, antisocial behavior, stressful events and neighborhood murders.<sup>10</sup>
<h4>What’s being done?</h4>
Addressing mental health issues does not only mean getting clients to see an individual counselor or therapist. Community-level and structural programs can also address mental health needs. For example, a program can hire a trained facilitator and offer support groups for survivors of sexual abuse. Open houses or drop-in centers where individuals can meet each other can serve to combat loneliness and depression. Offering mobile vans that deliver syringe exchange as well as clothing or food can reach isolated groups that are at high risk for mental health problems and HIV.

The Bodyworkers Program in New York, NY, provides MSM sex workers with free HIV prevention and mental health counseling, peer counseling and access to medical services. Male body workers, escorts, street hustlers, porn stars, go-go dancers and others cited several mental health issues that are barriers to accessing prevention and medical services. They are: mistrust, shame, isolation, fear of personal relationships, sexual compulsivity, depression, low self-esteem, substance abuse and a history of physical/sexual abuse.<sup>11</sup>

The HAPPENS (HIV Adolescent Provider and Peer Education Network for Services) Program in Boston, MA, provides a network of youth-specific care to HIV+, homeless and at-risk youth. The program conducts street outreach, offers individual HIV risk reduction counseling and links youth to appropriate social, medical and mental health services. All health care visits include a mental health intake and mental health services are offered both on a regular basis and at times of crisis.<sup>12</sup>

A program in New Haven, CT, used a street-based interactive case management model to reach drug-using women with or at risk for HIV. Case managers traveled in mobile health units to provide intensive one-on-one counseling on-site. Counseling often included discussions among members of the client’s family and peers. Case managers also provided transportation, crisis intervention, court accompaniment, family assistance and donated food and clothing.<sup>13</sup>
<h4>What are the implications for prevention programs?</h4>
Persons working in HIV prevention need to be aware of the close association between mental health, social and environmental factors and an individual’s ability to make and maintain behavior changes. Prevention program staff should be trained to look for and identify mental health problems in clients. If mental health staff are not available on-site, programs can provide referrals to counselors as needed. Some service agencies have integrated mental health services into their overall services and can provide counseling as part of their prevention interventions.

Mental health issues are often overlooked because of stigma on an institutional and individual level. These issues may vary across communities and by geographic region. Addressing mental health problems is an integral part of health promotion and should be a part of HIV prevention. It is not about labeling or putting people down, but aboutproviding accurate diagnoses and treatments for mental and physical health.

<hr />

<h3>Says who?</h3>
1. Ross MW, Rosser BR. Measurement and correlates of internalized homophobia: a factor analytic study. Journal of Clinical Psychology. 1996;52:15-21.

2. Clements-Nolle K, Wilkinson W, Kitano K. HIV Prevention and Health Service Needs of the Transgender Community in San Francisco. in W. Bockting &amp; S Kirk editors: Transgender and HIV: Risks, prevention and care. Binghampton, NY: The Haworth Press, Inc. 2001; in press.

3. Stiffman AR, Dore P, Cunningham RM, et al. Person and environment in HIV risk behavior change between adolescence and young adulthood. Health Education Quarterly. 1995;22:211-226.

4. Bartholow BN, Doll LS, Joy D, et al. Emotional, behavioral and HIV risks associated with sexual abuse among adult homosexual and bisexual men. Child Abuse and Neglect. 1994;9:747-761.

5. Miller M. A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care. 1999;1:3-20.

6. Petrak J, Byrne A, Baker M. The association between abuse in childhood and STD/HIV risk behaviors in female genitourinary (GU) clinic attendees. Sexually Transmitted Infections. 2000;6:457-461.

7. Fullilove MT, Fullilove RE, Smith M, et al. Violence, trauma and post-traumatic stress disorder among women drug users. Journal of Traumatic Stress. 1993;6:533-543.

8. Hoff RA, Beam-Goulet J, Rosenheck RA. Mental disorder as a risk factor for HIV infection in a sample of veterans. Journal of Nervous and Mental Disease. 1997;185:556-560.

9. Mandel W, Kim J, Latkin C, et al. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. American Journal of Drug and Alcohol Abuse. 1999;25:117-127.

10. Stiffman AR,Doré P, Earls F, et al. The influence of mental health problems on AIDS-related risk behaviors in young adults. Journal of Nervous and Mental Disease. 1992;180:314-320.

11. Baney M, Dalit B, Koegel H, et al. Wellness program for MSM sex workers. Presented at the International Conference on AIDS, Durban, South Africa. 2000. Abstract #MoOrD255.

12. Woods ER, Samples CL, Melchiono MW, et al. Boston HAPPENS Program: a model of health care for HIV-positive, homeless and at-risk youth. Journal of Adolescent Health. 1998;23:37-48.

13. Thompson AS, Blankenship KM, Selwyn PA, et al. Evaluation of an innovative program to address the health and social service needs of drug-using women with or at risk for HIV infection. Journal of Community Health. 1998;23:419-421.

<hr />

<strong>PREPARED BY JIM DILLEY, MD*, PAMELA DECARLO**
*AIDS HEALTH PROJECT, **CAPS</strong>

September 2001. Fact Sheet #42E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2001, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/mentalFS.pdf</url>
	</node>
	<node>
		<title>Salud mental</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo afecta la salud mental en la prevención del VIH?</h3>
<h4>¿qué tienen que ver la salud mental y la prevención del VIH?</h4>
A unque la epidemia del VIH ha cambiado mucho durante los últimos 20 años, poco han cambiado las razones para los comportamientos de alto riesgo. Algunos factores que contribuyen a estos comportamientos son: la soledad, la depresión, la baja autoestima, la compulsividad sexual, el abuso sexual, la marginalización, la falta de poder y la opresión. Estas circunstancias no tienen soluciones fáciles. Resolverlas puede requerir más tiempo y esfuerzo de lo que muchos programas de prevención del VIH disponen.

Algo que hemos aprendido de las investigaciones sobre la prevención del VIH es que “no hay una respuesta única.” El aumentar los conocimientos y capacidades de las personas para evitar el VIH y ofrecerles más acceso a condones y jeringas son buenos métodos, pero no sirven para todo el mundo y ningún método es suficiente por sí solo. Para muchas personas los obstáculos para cambiar su conducta se deben a problemas de salud mental. Esta hoja informativa se enfoca en los trastornos “no agudos” de salud mental; sin abarcar el efecto de los trastornos severos o cerebrales sobre la prevención del VIH.

Lo que las personas hacen y lo que experimentan afecta a su salud mental. El uso y abuso de drogas y alcohol, la discriminación, la marginalización y la pobreza son todos factores que influyen en la salud mental y al mismo tiempo pueden poner a las personas en riesgo de contraer el VIH.
<h4>¿puede la salud mental afectar el riesgo de contraer el VIH?</h4>
Sí. La decisión de participar en prácticas sexuales riesgosas o de usar drogas tal vez no siempre sea una “decisión” tomada con conciencia, sino para satisfacer otra necesidad, como por ejemplo:

<strong>LA BAJA AUTOESTIMA.</strong> Para muchos hombres que tienen sexo con hombres (HSH), la baja autoestima y la homofobia internalizada pueden afectar la conducta arriesgada respecto al VIH. La homofobia internalizada lleva al individuo a sentirse infeliz, a recriminarse o no aceptarse a sí mismo/a por ser gay. En un estudio, los hombres que padecían la homofobia internalizada tenían más posibilidades de ser VIH+, estaban menos satisfechos en sus relaciones de pareja y pasaban menos tiempo con gente homosexual.<sup>1</sup>  Las transexuales de masculino a femenino (MAF) identifican la baja autoestima, la depresión y los sentimientos de aislamiento, rechazo e impotencia como barreras a la reducción de su riesgo. Muchas MAF mencionan que no se protegen durante el sexo porque el no hacerlo valida su identidad femenina y aumenta su autoestima.<sup>2</sup>

<strong>LA ANSIEDAD Y LA DEPRESIÓN.</strong> Los adultos jóvenes que sufren ansiedad y depresión están mucho más propensos a participar en actividades de alto riesgo como la prostitución, el uso de drogas inyectadas o no inyectadas y la selección de parejas sexuales de alto riesgo. Un estudio que hizo un seguimiento a jóvenes urbanos a lo largo de varios años encontró que ellos no cambiaron su comportamiento arriesgado por haber obtenido más conocimientos, ni más acceso a información o consejería. En cambio, sí hubo una asociación entre la reducción de sus síntomas de depresión y otros problemas de salud mental, y la reducción de las actividades riesgosas.<sup>3</sup>

<strong>EL ABUSO SEXUAL.</strong> Las personas que sufren abuso sexual durante su niñez o juventud tienen un riesgo mucho mayor de tener problemas de salud mental y comportamientos arriesgados con respecto al VIH. Un estudio entre hombres homo y bisexuales encontró que aquellos que habían sido abusados estaban mucho más propensos a tener sexo anal sin protección y a inyectarse drogas.<sup>4</sup>

Para muchas mujeres, el abuso sexual se combina con el maltrato físico o emocional en la niñez o juventud. El riesgo de contraer el VIH es sólo una de las consecuencias de estos maltratos. Las mujeres pueden empezar a usar drogas para ayudarles a sobrellevar los maltratos. También pueden tener dificultades en su vida sexual que les impiden negociar con su pareja sobre el uso de con-dones, lo cual aumenta la posibilidad ponerse en riesgo durante el sexo.<sup>5</sup> Las mujeres que han sido abusadas tienen tasas más altas de enfermedades de transmisión sexual (ETS), incluido el VIH.<sup>6</sup>

EL TRASTORNO DE ESTRÉS POSTRAUMÁTICO (PTSD siglas en inglés). El PTSD puede llevar a actividades sexuales de alto riesgo. En un estudio de usuarias de crack en el South Bronx, Nueva York, el 59% de las participantes tenían PTSD debido a traumas violentos (como el asalto, la violación o el haber visto un homicidio) y no violentos (como la falta de vivienda, la pérdida de los hijos o un accidente grave).<sup>7</sup> Un estudio nacional entre veteranos encontró que quienes usaban drogas o alcohol y sufrían PTSD tenían una posibilidad casi 12 veces mayor de tener VIH que otros veteranos que no usaban drogas ni tenían PTSD.<sup>8</sup>
<h4>¿qué factores afectan a la salud mental?</h4>
Muchas personas que sufren problemas de salud mental empiezan a usar drogas o alcohol para aliviar su dolor. Se ha comprobado que el uso de drogas o alcohol reduce las inhibiciones e impide el buen juicio, lo cual puede contribuir a la participación en actividades arriesgadas con respecto al VIH. Por ejemplo, los usuarios de drogas inyectables que sufren de depresión corren más riesgo de compartir agujas.<sup>9</sup>

Varios factores ambientales como la pobreza, el racismo y la marginalización pueden conducir a problemas de salud mental tales como la baja autoestima, la cual a su vez puede llevar al uso de drogas y alcohol y a otros comportamientos riesgosos con respecto al VIH. Los adultos jóvenes del área urbana con altos niveles de conducta arriesgada con respecto al VIH también tienen tasas más altas de suicidio, consumo de drogas y alcohol conducta antisocial, incidentes estresantes y homicidios en su barrio.<sup>10</sup>
<h4>¿qué se está haciendo al respecto?</h4>
La solución de los problemas de salud mental no consiste únicamente en convencer la persona para que hable con un consejero o psicólogo. Los programas comunitarios y estructurales también pueden tomar en cuenta las necesidades de salud mental. Por ejemplo, se puede ofrecer grupos de apoyo para quienes han sufrido abuso sexual. Los centros recreativos y de convivencia sirven para conocer a otras personas y pueden ayudar a combatir la soledad y la depresión. Por medio de servicios móviles se pueden proveer el intercambio de jeringas así como ropa o alimentos a grupos aislados que están en alto riesgo de tener problemas de salud mental y VIH.

El programa Bodyworkers en Nueva York brinda a los trabajadores sexuales HSH consejería gratuita para la prevención del VIH y para la salud mental, consejería de pares y acceso a servicios médicos. Masajistas, acompañantes, prostitutos que trabajan en la calle, estrellas de porno, bailarines de go-go y otros mencionaron varios problemas de salud mental que les dificultan obtener servicios médicos y de prevención. Estas barreras son: la desconfianza, la vergüenza o pena, el miedo a las relaciones personales, la compulsividad sexual, la depresión, la baja autoestima, el uso de drogas y alcohol y una historia de abuso físico/sexual.<sup>11</sup>

El programa HAPPENS en Boston, Massachusetts, provee una variedad de servicios especializados para jóvenes VIH+, sin hogar y en riesgo. El personal del programa va a la calle a encontrarse con los jóvenes y ofrecerles consejería individualizada sobre la reducción de riesgos con respecto al VIH. También conecta a los jóvenes con servicios sociales, médicos y de salud mental. Todas las visitas médicas incluyen una evaluación de su salud mental, y se ofrecen servicios de salud mental tanto en forma continua como en tiempos de crisis.<sup>12</sup>

Otro programa en New Haven, Connecticut, usó un modelo de manejo interactivo de casos en la calle para ayudar a mujeres drogodependientes que tenían VIH o estaban en riesgo de tenerlo. Trabajadores sociales encargados de casos viajaron en unidades móviles y proporcionaron consejería intensiva individualizada en el mismo sitio donde encontraron a las clientes. Muchas veces la consejería incluía conversaciones entre los miembros de la familia y los amigos de la cliente. Los encargados de casos también brindaron transporte, intervención en tiempos de crisis, compañía a las citas en la corte, asistencia familiar, ropa y alimentos donados.<sup>3</sup>
<h4>¿qué implica esto para los programas de prevención?</h4>
Quienes trabajan en la prevención del VIH deben tener consciencia de la asociación cercana entre los factores de salud mental, sociales y ambientales y la capacidad del individuo para hacer y mantener cambios en su conducta. El personal de los programas de prevención debe capacitarse para identificar problemas de salud mental al hablar con sus clientes. Si un programa no ofrece servicios de salud mental, se puede remitir al cliente a otra agencia o consejero. Algunas agencias han integrado los servicios de salud mental a sus servicios generales y ofrecen consejería como parte de sus intervenciones preventivas.

Con frecuencia las necesidades de salud mental pasan desapercibidas debido al estigma que éstas tienen entre los individuos y en las instituciones. Estas necesidades pueden variar según la comunidad y región geográfica. Responder a los problemas de salud mental es una parte integral de la promoción de la salud y debe ser parte también de la prevención del VIH. No se trata de etiquetar a las personas ni de menospreciarlas, sino de darles un diagnóstico exacto y el tratamiento adecuado para su salud mental y física.

<hr />

<h4>¿quién lo dice?</h4>
1. Ross MW, Rosser BR. Measurement and correlates of internalized homophobia: a factor analytic study. Journal of Clinical Psychology. 1996;52:15-21.

2. Clements-Nolle K, Wilkinson W, Kitano K. HIV Prevention and Health Service Needs of the Transgender Community in San Francisco. in W. Bockting &amp; S Kirk editors: Transgender and HIV: Risks, prevention and care. Binghampton, NY: The Haworth Press, Inc. 2001; in press.

3. Stiffman AR, Dore P, Cunningham RM, et al. Person and environment in HIV risk behavior change between adolescence and young adulthood. Health Education Quarterly. 1995;22:211-226.

4. Bartholow BN, Doll LS, Joy D, et al. Emotional, behavioral and HIV risks associated with sexual abuse among adult homosexual and bisexual men. Child Abuse and Neglect. 1994;9:747-761.

5. Miller M. A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care. 1999;1:3-20.

6. Petrak J, Byrne A, Baker M. The association between abuse in childhood and STD/HIV risk behaviors in female genitourinary (GU) clinic attendees. Sexually Transmitted Infections. 2000;6:457-461.

7. Fullilove MT, Fullilove RE, Smith M, et al. Violence, trauma and post-traumatic stress disorder among women drug users. Journal of Traumatic Stress. 1993;6:533-543.

8. Hoff RA, Beam-Goulet J, Rosenheck RA. Mental disorder as a risk factor for HIV infection in a sample of veterans. Journal of Nervous and Mental Disease. 1997;185:556-560.

9. Mandel W, Kim J, Latkin C, et al. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. American Journal of Drug and Alcohol Abuse. 1999;25:117-127.

10. Stiffman AR,Doré P, Earls F, et al. The influence of mental health problems on AIDS-related risk behaviors in young adults. Journal of Nervous and Mental Disease. 1992;180:314-320.

11. Baney M, Dalit B, Koegel H, et al. Wellness program for MSM sex workers. Presented at the International Conference on AIDS, Durban, South Africa. 2000. Abstract #MoOrD255.

12. Woods ER, Samples CL, Melchiono MW, et al. Boston HAPPENS Program: a model of health care for HIV-positive, homeless and at-risk youth. Journal of Adolescent Health. 1998;23:37-48.

13. Thompson AS, Blankenship KM, Selwyn PA, et al. Evaluation of an innovative program to address the health and social service needs of drug-using women with or at risk for HIV infection. Journal of Community Health. 1998;23:419-421.

<hr />

<strong>PREPARADO POR JIM DILLEY, MD*, PAMELA DECARLO**
*AIDS Health Project **CAPS</strong>

<strong>TRADUCIÓN ROCKY SCHNAATH</strong>

<strong>Febrero 2002. Hoja Informativa 42S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/saludmentalFS.pdf</url>
	</node>
	<node>
		<title>Sexual networks</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How do sexual networks affect HIV/STD prevention?</h3>
<h4>What are sexual networks?</h4>
Focusing on risk behavior alone does not explain why some persons and communities continue to be infected with HIV and other sexually transmitted diseases (STDs) more than others. Networks help explain why persons can have the same risk behavior and yet one may have a much greater risk of contracting or transmitting HIV.

Sexual networks are groups of persons who are connected to one another sexually. The number of persons in a network, how central high-risk persons are within it, the percentage in monogamous relationships and the number of “links” each has to others all determine how quickly HIV/STDs can spread through a network.<sup>1</sup> Sexual networks are distinct from, but often overlap with social networks.
<h4>How do networks affect transmission?</h4>
The different ways persons select partners affect how quickly HIV/STDs can spread. <strong>Exclusively monogamous</strong> persons are, by definition, not part of a sexual network. If both are HIV-negative they remain so.

<strong>Serial monogamists</strong> are persons who go from relationship to relationship one at a time. If they have unprotected sex, they have a higher risk of HIV/STDs than exclusively monogamous persons. Earlier partners’ risk may affect later partners.

<strong>Concurrent relationships</strong> involve having more than one sexual partner in a given period and going back and forth between them. This increases the probability for transmission, because earlier partners can be infected by later partners. Further, they can serve as “nodes”, connecting all persons in a dense cluster, creating highly connected networks that facilitate transmission. Concurrent partners can connect each of their respective clusters and networks as well. Concurrency alone can fuel an epidemic even if the average number of partners is relatively low.<sup>2</sup><img src="/sites/prevention.ucsf.edu/files/uploads/pubs/FS/images/network.gif" alt="" width="375" height="70" />

The two networks above show that what matters is not simply risk behavior, but risk configuration. Each has 8 persons (circles) connected into 9 relationships. Two persons each have 3 partners, and the other six each have 2 partners. Yet transmission will be less efficient in network A, and prevention will be more difficult in network B. In A, in just two steps from the index person, half the network can be infected and half spared; in B, two steps can result in everyone being infected except for the person on the extreme right. In A, sparing half the population from exposure requires cutting one bridge, while in B, it requires cutting three bridges. In a word, for epidemics, network structure is destiny.<sup>3</sup>
<h4>What are key concepts of networks?</h4>
<strong>Number of partners.</strong> Programs can focus on persons with the largest number of ties to others in a network. With HIV/STDs, this suggests that in addition to promoting condom usage, programs seek to identify those with a high number of unprotected partners.

<strong>Random spread broadens transmission.</strong> An infection spreads quickest when partnering is random.<sup>4</sup> When partners select one another within groups such as age, ethnicity, class, religion or other characteristics, diseases may not spread to all subgroups. When partnering is anonymous or random, a disease can spread more quickly through all groups.

<strong>Core groups.</strong> Core group members have high levels of risky behaviors. They contribute a disproportionate share of HIV/STDs, and can fuel sustained transmission.

<strong>Centrality.</strong> How central an HIV+ person is to a network deeply influences transmission rates in a community. In Colorado Springs, CO, network analysts found that HIV+ persons had high levels of risk behavior but were located in peripheral areas of risk networks.<sup>5</sup> This network configuration may have explained the relatively low HIV transmission levels. In contrast, HIV+ persons in New York City, NY occupied central positions within their needle-sharing and sexual risk networks, which helped explain the high observed levels of infection.<sup>6</sup>
<h4>Can sexual networks help explain racial differences in HIV/STD rates?</h4>
Yes. Sexual networks and partner selection help explain racial differences in HIV/STD infection rates. For example, African American gay and bisexual men may take no more risk than white men, but appear to get infected much faster.<sup>7</sup> In the same way, Asian American gay and bisexual men report similar risk levels but get infected at lower rates.<sup>8</sup>

In one national study, it was shown that heterosexual African-Americans were getting infected with bacterial STDs at rates almost five times faster than whites after controlling for individual level risk factors. Sexually transmitted infections remain in African American populations because their partner choices are more segregated than other groups. In addition, non-core African-Americans (with few partners) are more likely to choose “core” sexual partners. <sup>9</sup>
<h4>What interventions influence networks?</h4>
<strong>Partner notification.</strong> Many public health departments have developed highly confidential and sound techniques of partner notification and, through network analysis, have learned to trace “up” the chain of transmission to the transmitter rather than “down” the chain to those infected.<sup>10</sup> This allows transmitters to be identified for treatment and HIV/STD prevention counseling.

<strong>Message development.</strong> In addition to promoting condom use and counseling, media messages can be tailored to encourage network fragmentation by encouraging serial monogamy (“one partner at a time”) rather than overlapping partners.

<strong>Community dialogue.</strong> Community-based organizations (CBOs) can play a key role in facilitating community dialogue about difficult questions about networks: How should communities balance sexual freedoms of all–including those at highest risk–with the health and future of their entire community? What community and cultural norms contribute to risky sexual networking? Additionally, CBOs should distinguish between traditionally-defined “risk groups” and those individuals with the very highest levels of risk to focus resources on them.

<strong>Addressing venues which facilitate partner mixing</strong>. In many settings, identification of partners may be impossible. However, by focusing on venues which facilitate sexual mixing between members of both high- and low-risk networks, HIV/STD prevention workers may be able to reduce transmission. For example, many men with syphilis report meeting partners over the internet and in commercial sex venues.<sup>11,12</sup> Working with bathhouse and sex club managers and internet service providers to negotiate respective roles in promoting safer behaviors should be a priority for HIV/STD intervention workers.

In San Francisco, CA, AIDS educators and sex club owners developed a shared set of guidelines to reduce risky behavior in the clubs.<sup>13</sup> In the Netherlands, the gay dating internet site www.dateguide.nl provides interactive safer sex education for every man as he logs on.<sup>14</sup>
<h4>What still needs to be done?</h4>
At the beginning of the epidemic, network analysis helped explain some of the most important features of AIDS and helped explain its causes.15 It can still be useful now for agencies, communities, and researchers to work together to encourage sexual networks that discourage HIV/STD transmission. It has long been known and understood that some individuals contribute much more to the spread of HIV/STDs than others. Ignoring that fact, and ignoring the role of sexual networks in fueling the epidemic, hampers our ability to slow HIV/STD transmission.

<hr />

<h3>Says who?</h3>
1. Potterat JJ, Muth SQ, Brody S. Evidence undermining the adequacy of the HIV reproduction number formula. Sexually Transmitted Diseases. 2000;27:644-645.
2. Morris M. Sexual networks and HIV. AIDS. 1997;11:S209-216.
3. Klovdahl AS, Potterat JJ, Woodhouse D, et al. HIV infection in a social network: A progress report. Bulletin de Methodologie Sociologique. 1992;36:24-33.
4. Laumann EO, Gagnon J, Michael R, Michaels S. The Social Organization of Sexuality. Chicago: The University of Chicago Press, 1994.
5. Rothenberg RB, Potterat JJ, Woodhouse DE, et al. Social network dynamics and HIV transmission. AIDS. 1998;12:1529-1536.
6. Friedman SR, Neaigus A, Jose B, et al. Sociometric risk networks and risk for HIV infection. American Journal of Public Health. 1997;87:1289-1296.
7. Centers for Disease Control and Prevention. HIV Incidence Among Young Men Who Have Sex With Men—-Seven U.S. Cities, 1994-2000. Morbidity and Mortality Weekly Report. 2001;50:440-444.
8. Choi KH, Operario D, Gregorich S, et al. Age and race mixing patterns of sexual partnerships among Asian men who have sex with men: implications for HIV transmission and prevention. AIDS Education and Prevention. 2003;15:S53-65.
9. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sexually Transmitted Diseases. 1999;26:250-61.
10. Ghani AC, Ison CA, Ward H, et al. Sexual partner networks in the transmission of sexually transmitted diseases. An analysis of gonorrhea cases in Sheffield, UK. Sexually Transmitted Diseases. 1996;23:498-503.
11. Klausner JD, Wolf W, Fischer-Ponce L, et al. Tracing a syphilis outbreak through cyberspace. Journal of the American Medical Association. 2000;284: 447-449.
12. Williams LA, Klausner JD, Whittington WL, et al. Elimination and reintroduction of primary and secondary syphilis. American Journal of Public Health. 1999;89:1093-1097.
13. Wohlfeiler D. Structural and environmental HIV prevention for gay and bisexual men. AIDS. 2000;14:S52-S56.
14. Harternik P, van Berkel M, van den Hoek K, et al. e-Dating: a developing field for HIV prevention. Published by the Dutch AIDS Fund. www.dateguide.nl
15. Auerbach DM, Darrow WW, Jaffe HW, et al. Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. American Journal of Medicine. 1984;76:487-92.

<strong>Prepared by Prepared by Dan Wohlfeiler*, John Potterat
*UCSF</strong>

<strong>April 2003. Fact Sheet #50E</strong>

Special thanks to the following reviewers of this Fact Sheet: Buzz Bense, Peggy Dolcini, Paul Etkind, Sam Friedman, Azra Ghani, Jed Herman, Ed Laumann, Virginia Loo, Robin Miller, Michael Samuel, Tom Valente, Russell Westacott.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/networksFS.pdf</url>
	</node>
	<node>
		<title>Redes sexuales</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo afectan las redes sexuales a la prevención del VIH/ETS?</h3>
<h4>¿qué son las redes sexuales?</h4>
El comportamiento de riesgo no es suficiente para explicar por qué algunas personas y comunidades (más que otras) siguen infectándose por el VIH y otras enfermedades de transmisión sexual (ETS). Las redes ayudan a explicar cómo dos personas pueden tener la misma conducta riesgosa y sin embargo una puede tener un riesgo mucho mayor de contraer o de transmitir el VIH.

Las redes sexuales son grupos de personas interconectadas sexualmente. El número de personas en la red, la centralidad de las personas de alto riesgo, el porcentaje de relaciones monógamas y el número de “enlaces” que cada individuo tiene con los otros, son todos determinantes de la rapidez con la cual el VIH y las ETS pueden ser transmitidas por la red.<sup>1</sup> Las redes sexuales son distintas a las redes sociales, aunque muchas veces se traslapan.
<h4>¿cómo afectan las redes en la transmisión?</h4>
Las diferentes maneras de elección de parejas afectan la rapidez de propagación del VIH y las ETS. Por definición, las personas exclusivamente monógamas no forman parte de ninguna red sexual. Si ambas personas son VIH-negativas, permanecerán así.

Los <strong>monógamos seriales</strong> son personas que terminan una relación antes de pasar a la próxima. Si tienen sexo sin protección, corren más riesgo de contraer el VIH o una ETS que las personas exclusivamente monógamas. El riesgo de las parejas anteriores puede afectar a las parejas posteriores.

En las <strong>relaciones concurrentes</strong>, se tiene más de una pareja sexual en el mismo periodo y se tienen relaciones sexuales con una y otra alternativamente; lo cual aumenta la probabilidad de transmisión, pues las parejas anteriores pueden ser infectadas por las parejas posteriores. Además, las relaciones concurrentes pueden servir como “puntos o nodos” que conectan a todas las personas de la red en una densa agrupación, creando redes ampliamente conectadas que facilitan la transmisión. Las parejas concurrentes también pueden conectar a cada una de sus agrupaciones y redes respectivas. La concurrencia por sí sola puede generar una epidemia aunque el número promedio de parejas sea relativamente reducido.<sup>2</sup>

<img src="/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/images/redes.gif" alt="" width="377" height="70" />
Las dos redes representadas arriba demuestran que no solo importa la conducta de riesgo sino también de la configuración del riesgo. Cada red tiene 8 personas (círculos) interconectadas que forman 9 relaciones. Dos personas tienen 3 parejas cada una, y las otras seis tienen 2 parejas cada una, pero la transmisión será menos eficiente en la red A y la prevención será más difícil en la red B. En la red A, a tan sólo dos pasos de la persona índice, la mitad de los integrantes de la red se pueden infectar mientras que la mitad puede permanecer libre de infección; en la B, a dos pasos todos pueden resultar infectados menos la persona situada al extremo derecho. Para evitar la exposición de la mitad de la población de la red A, es necesario cortar un solo enlace, mientras que en la red B se deberán cortar tres enlaces. En otras palabras, cuando se trata de una epidemia, el destino de las personas depende de la estructura de su red sexual.<sup>3</sup>
<h4>¿cuáles son los conceptos clave?</h4>
<strong>Número de parejas</strong>: Los programas se pueden enfocar en las personas con el mayor número de enlaces en la red. Con respecto al VIH/ETS, esto sugiere que además de promover el uso de condones, los programas deben identificar a las redes con un alto número de parejas desprotegidas.

<strong>La difusión aleatoria amplifica la transmisión:</strong> La infección se propaga con más rapidez cuando la formación de parejas se hace aleatoriamente.<sup>4</sup> Cuando las parejas se eligen por compartir ciertas características (como edad, grupo étnico o clase socioeconómica), es posible que la enfermedad no llegue a transmitirse a todos los subgrupos. Cuando la elección se realiza en forma aleatoria o anónima, la enfermedad se puede transmitir más rápidamente entre todos los grupos.

<strong>Grupos centrales:</strong> Los integrantes del grupo central tienen un comportamiento de riesgo alto, contribuyen desproporcionadamente a la transmisión del VIH/ETS y pueden alimentar una transmisión sostenida.

<strong>Centralidad:</strong> El grado de centralidad de una persona VIH+ dentro de la red tiene una influencia profunda sobre las tasas de transmisión en la comunidad. En Colorado Springs, CO, un análisis de redes reveló que las personas VIH+ tenían niveles altos de conducta riesgosa pero se situaban en la periferia de las redes de riesgo.<sup>5</sup> Esta configuración de red puede haber explicado los niveles relativamente reducidos del VIH. En contraste, las personas VIH+ en la ciudad de Nueva York, NY ocupaban posiciones centrales dentro de sus redes de uso de jeringas compartidas y de riesgo sexual, lo cual ayudó a explicar los elevados niveles de infección observados entre ellas.<sup>6</sup>
<h4>¿pueden las redes sexuales ayudar a explicar diferencias raciales en las tasas de VIH/ETS?</h4>
Sí. Las redes sexuales y la selección de parejas ayudan a explicar las diferencias raciales en las tasas de VIH y ETS. Por ejemplo, aunque no se arriesguen más que los caucásicos los hombres afroamericanos gay y bisexuales, parecen infectarse mucho más rápidamente.<sup>7</sup> De la misma manera, los hombres asiáticos gay y bisexuales reportan niveles parecidos de riesgo pero se infectan con menos frecuencia.<sup>8</sup>

Un estudio nacional demostró que los afroamericanos heterosexuales se infectaban con ETS casi cinco veces más rápidamente que los caucásicos después de controlar los factores de riesgo individuales. Las infecciones transmitidas sexualmente permanecen en las poblaciones afroamericanas porque la elección de parejas se hace en forma más segregada que en otros grupos. Además, los afroamericanos “no centrales” (con pocas parejas sexuales) son más propensos a elegir parejas sexuales “centrales”. En cambio, los caucásicos no centrales tienden a elegir parejas no centrales.<sup>9</sup>
<h4>¿qué intervenciones influyen en las redes?</h4>
<strong>Notificación de pareja:</strong> Muchos departamentos de salud pública han desarrollado técnicas sumamente confidenciales y confiables de notificación de parejas y, mediante el análisis de redes, han aprendido a rastrear “subiendo” por la cadena de transmisión hacia el transmisor en lugar de “bajar” por la cadena hacia las parejas infectadas.<sup>10</sup> Esto les permite identificar a los transmisores y remitirlos a servicios de tratamiento y de asesoramiento sobre la prevención del VIH y las ETS.

<strong>Formulación de mensajes:</strong> Además de la promoción del uso de condones y la consejería, se pueden difundir mensajes específicos en los medios de comunicación para fomentar la fragmentación de la red, lo cual se hace promoviendo la monogamia serial (“una pareja la vez”) en lugar de tener parejas concurrentes.

<strong>Diálogo comunitario: </strong>Las organizaciones comunitarias (OC) pueden ser clave para facilitar el diálogo sobre las preguntas difíciles acerca de las redes en la comunidad: ¿Cómo deben las comunidades equilibrar las libertades sexuales de todos (incluyendo las personas de alto riesgo) con la salud y el futuro de la comunidad entera? ¿Qué normas comunitarias y culturales contribuyen a la formación de redes sexuales riesgosas? Las OC también deben distinguir entre los tradicionalmente definidos “grupos de riesgo” y aquellos individuos de más alto riesgo, con el fin de canalizar recursos hacia estos últimos.

<strong>Lugares que facilitan el intercambio sexual de parejas:</strong> En muchos ambientes, la identificación de parejas puede ser imposible. Sin embargo, es posible que al focalizar lugares en donde las redes de alto riesgo se mezclan sexualmente con las de bajo riesgo, los promotores de la prevención del VIH y las ETS puedan reducir la transmisión. Por ejemplo, muchos hombres con sífilis informan haber conocido a parejas en internet y lugares de comercialización sexual.<sup>11,12</sup> Los trabajadores de intervenciones contra el VIH y las ETS deben priorizar la colaboración con los gerentes de baños públicos y de clubes sexuales y con los proveedores de servicios de internet para negociar sus papeles respectivos en la promoción de conductas más seguras.

En San Francisco, CA, los educadores de SIDA y los propietarios de clubes sexuales establecieron una serie de normas compartidas para reducir las prácticas riesgosas en los clubes.<sup>13</sup> En los Países Bajos, el sitio en internetwww.dateguide.nl para hombres gay que buscan pareja proporciona a quien entre al sitio una educación interactiva sobre cómo protegerse en el sexo.<sup>14</sup>
<h4>¿qué queda por hacer?</h4>
Al principio de la epidemia, el análisis de redes ayudó a explicar algunos de los aspectos más importantes del SIDA así como sus causas, y puede ser útil todavía en las colaboraciones entre organizaciones, comunidades e investigadores para fomentar la formación de redes
sexuales que impidan la transmisión del VIH y las ETS.<sup>15</sup> Hace tiempo que se sabe y se entiende que algunos individuos contribuyen mucho más a la transmisión del VIH y las ETS que otros. No darle importancia a este hecho y al papel de las redes sexuales en alimentar la epidemia impide nuestra capacidad para desacelerar la transmisión del VIH y las ETS.

<hr />

<h4>¿quién lo dice?</h4>
1. Potterat JJ, Muth SQ, Brody S. Evidence undermining the adequacy of the HIV reproduction number formula. Sexually Transmitted Diseases. 2000;27:644-645.
2. Morris M. Sexual networks and HIV. AIDS. 1997;11:S209-216.
3. Klovdahl AS, Potterat JJ, Woodhouse D, et al. HIV infection in a social network: A progress report. Bulletin de Methodologie Sociologique. 1992;36:24-33.
4. Laumann EO, Gagnon J, Michael R, Michaels S. The Social Organization of Sexuality. Chicago: The University of Chicago Press, 1994.
5. Rothenberg RB, Potterat JJ, Woodhouse DE, et al. Social network dynamics and HIV transmission. AIDS. 1998;12:1529-1536.
6. Friedman SR, Neaigus A, Jose B, et al. Sociometric risk networks and risk for HIV infection. American Journal of Public Health. 1997;87:1289-1296.
7. Centers for Disease Control and Prevention. HIV Incidence Among Young Men Who Have Sex With Men—-Seven U.S. Cities, 1994-2000. Morbidity and Mortality Weekly Report. 2001;50:440-444.
8. Choi KH, Operario D, Gregorich S, et al. Age and race mixing patterns of sexual partnerships among Asian men who have sex with men: implications for HIV transmission and prevention. AIDS Education and Prevention. 2003;15:S53-65.
9. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sexually Transmitted Diseases. 1999;26:250-61.
10. Ghani AC, Ison CA, Ward H, et al. Sexual partner networks in the transmission of sexually transmitted diseases. An analysis of gonorrhea cases in Sheffield, UK. Sexually Transmitted Diseases. 1996;23:498-503.
11. Klausner JD, Wolf W, Fischer-Ponce L, et al. Tracing a syphilis outbreak through cyberspace. Journal of the American Medical Association. 2000;284: 447-449.
12. Williams LA, Klausner JD, Whittington WL, et al. Elimination and reintroduction of primary and secondary syphilis. American Journal of Public Health. 1999;89:1093-1097.
13. Wohlfeiler D. Structural and environmental HIV prevention for gay and bisexual men. AIDS. 2000;14:S52-S56.
14. Harternik P, van Berkel M, van den Hoek K, et al. e-Dating: a developing field for HIV prevention. Published by the Dutch AIDS Fund. www.dateguide.nl
15. Auerbach DM, Darrow WW, Jaffe HW, et al. Cluster of cases of the acquired immune deficiency syndrome. Patients linked by sexual contact. American Journal of Medicine. 1984;76:487-92.

<hr />

<strong>Preparado por Dan Wohlfeiler*, John Potterat. *UCSF</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Septiembre 2003. Hoja Informativa 50S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/redesFS.pdf</url>
	</node>
	<node>
		<title>Stigma (fact sheet)</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>How does stigma affect HIV prevention and treatment?</h2>
<strong>Prepared by Pamela DeCarlo and Maria Ekstrand, PhD</strong>

<strong>Community Engagement (CE) Core | October 2016</strong>
<h3>What is HIV/AIDS stigma?</h3>
HIV-related stigma is a significant problem globally.  HIV stigma inflicts hardship and suffering on people living with HIV and interferes with research, prevention, treatment, care and support efforts.

<strong>HIV-related stigma</strong> refers to negative beliefs, feelings and attitudes towards people living with HIV, their families and people who work with them. HIV stigma often reinforces existing social inequalities based on gender, race, ethnicity, class, sexuality and culture. Stigma against many vulnerable populations who are disproportionately affected by HIV (such as the stigma of homosexuality, drug use, poverty, migration, transgender status, mental illness, sex work and racial, ethnic and tribal minority status) predates the epidemic and intersects with HIV stigma, which compounds the stigma and discrimination experienced by people living with HIV (PLWH) who belong to such groups.<sup>1</sup>

<strong>HIV-related discrimination</strong>, also known as enacted HIV stigma, refers to the unfair and unjust treatment of someone based on their real or perceived HIV status. Discrimination also affects family members and friends, caregivers, healthcare and lab staff who care for PLWH. The drivers of HIV-related discrimination usually include misconceptions regarding casual transmission of HIV and pre-existing prejudices against certain populations, behaviors, sex, drug use, illness and death. Discrimination can be institutionalized through laws, policies and practices that unjustly affect PLWH and marginalized groups.<sup>1</sup>
<h3>How is HIV stigma harmful?</h3>
Stigma and discrimination add barriers which weaken the ability of people and communities to protect themselves from HIV and to stay healthy if they are living with HIV.

<strong>To persons living with HIV.</strong> Fear of stigma, discrimination and potential violence, may keep people from disclosing their status to family, friends and sexual partners. This can increase isolation and undermine their ability to access and adhere to treatment, and undermine prevention efforts such as using condoms and not sharing drug equipment. Enacted stigma can result in losing housing and jobs, being ostracized by family, and being treated badly in healthcare facilities, among other effects.

<strong>To vulnerable populations.</strong> The way people experience stigma varies across countries and communities. Stigma discourages people from seeking information and programs, for fear it will make others think they have HIV, are promiscuous or unfaithful, or are members of populations associated with HIV, like people who inject drugs, sex workers and gay men. It can make people less likely to get tested for HIV, use condoms, ask their partners about their status, use clean needles and injection equipment, or access biomedical prevention options such as male circumcision and pre-exposure prophylaxis (PrEP).
<h3>How do people cope with stigma?</h3>
Several factors help individuals cope with HIV-related stigma, and respond to feelings of worthlessness, depression, and anger associated with their diagnosis. Many people learn to manage or cope with stigma quite well and have very positive relationships not impacted greatly by stigma, especially if they have supportive family and friends.

<strong>Social support.</strong> For many PLWH, social support can help buffer the impact of any stigma. A study of African American PLWH found many had experienced stigma and discrimination, but the impact was softened by having non-PLWH in their social networks express interest and take the initiative to offer help. Connection with other PLWH gave them an opportunity to share their feelings and to fight for their rights.<sup>2</sup> A study of young African American men who have sex with men (MSM) found that stigma of racism and homophobia was associated with delayed HIV testing, but that men with peer support tested earlier.<sup>3</sup>

<strong>Adapting and coping. </strong>Although it can be difficult for persons in already stigmatized communities to identify as HIV-positive, many PLWH do accept their HIV status and successfully form an identity of being pro-active and choosing to live. Adequate treatment for depression and anxiety, along with acceptance of one’s diagnosis, provide a protective buffer against stigma and promote acceptance of lifelong HIV treatment.<sup>4</sup>
<h3>How is HIV stigma addressed?</h3>
Stigma exists, and should be targeted at multiple levels: individual, interpersonal (family, friends, social networks), organizational, community and public policy.5 Involving PLWH in the design, creation, implementation and evaluation of stigma reduction programs is critical to success.

<strong>Individual level</strong>

Increasing individual knowledge about HIV transmission, prevention and care, as well as access to services and legal rights is important. One study in South Africa found that while some PLWH experienced stigma through insults and arguments with family members during conflict, they knew that disclosing someone’s status without their consent was a crime. In these instances, threatening to go to the police, or sometimes actually calling the police, allowed PLWH to fight back and maintain their self-esteem.<sup>6</sup>

<strong>Interpersonal level</strong>

The We Are Family campaign from Greater Than AIDS and the Georgia Department of Public Health, reinforces the importance of social support for PLWH. The video campaign features a grandmother and her grown son, a college student and his parents, a pastor and his congregation, a recovering addict and his mother, a transgender woman and her sister, and childhood best friends, all supporting one another following an HIV diagnosis.<sup>7</sup>

<strong>Organizational level</strong>

Healthcare providers are often named by PLWH as important sources of stigma.<sup>8</sup> Programs for training healthcare workers<sup>9</sup> should address culturally-specific stigma drivers, including personal fears of infection, prejudice towards vulnerable groups, and misconceptions or lack of knowledge about HIV transmission, prevention, treatment and universal precautions.<sup>10</sup> Programs also should address how the effect of stigma, discrimination, breaches of confidentiality and negative attitudes can negatively impact patients’ lives, health, and ability to follow treatment regimens.

Biomedical and behavioral approaches to HIV prevention, such as PrEP, routine HIV testing, starting treatment soon after diagnosis (test and treat), and treatment for PLWH to viral suppression, have been successful in the US and several countries in reducing new HIV infections and improving the life and health of PLWH. However, HIV stigma and discrimination can greatly impact the success of these interventions. Stigma surrounding PrEP use, including assumptions about promiscuity, can negatively affect PrEP access and uptake.<sup>11</sup> Prejudice among healthcare workers may result in drug users, young adults, women<sup>12</sup> and other marginalized populations not being offered either PrEP or HIV testing.

<strong>Community level</strong>

The Let’s Stop HIV Together campaign, launched by the Centers for Disease Control and Prevention (CDC), raises awareness about HIV and its impact on the lives of all Americans, and fights stigma by showing that persons with HIV are real people—mothers, fathers, friends, brothers, sisters, sons, daughters, partners, wives, husbands, and co-workers. The campaign offers facts about HIV, links to testing sites across the US, guidance for taking action against stigma, and online stories about PLWH, and the people who care for them.<sup>13</sup>

<strong>Policy level</strong>

In Ghana, the Commission on Human Rights and Administrative Justice, the Ghana AIDS Commission and the Health Policy Project developed a web-based mechanism for PLWH to report discrimination in employment, health care, education and other areas. Reports can be anonymous, and all reports result in mediation, investigation and legal resolution by human rights and legal organizations.<sup>14</sup>
<h3>What needs to be done?</h3>
Both the US White House and UNAIDS reports recommend focusing on key populations that have high and disproportionate rates of HIV, and are at higher risk for transmitting and acquiring HIV.<sup>1,15</sup> Reducing stigma for other conditions common among persons at risk for or living with HIV—such as substance use, mental health problems, sex work and homelessness—and addressing homophobia are important efforts to improve health outcomes. However, promotion of disclosure of HIV status must be accompanied by protections for PLWH. This calls for a continued commitment to civil rights enforcement.

<hr />

<h2>Says who?</h2>
1. UNAIDS. Reduction of HIV-related stigma and discrimination. Guidance Note. 2014. www.unaids.org/en/resources/documents/2014/ReductionofHIV-relatedstigmaanddiscrimination

2. Mosack KE, Stevens PE, Brouwer AM, et al. Shared illness and social support within two HIV-affected African American communities. Qualitative Health Research. 2015 Oct 28.

3. Scott HM, Pollack L, Rebchook GM, et al. Peer social support is associated with recent HIV testing among young black men who have sex with men. AIDS and Behavior. 2014;1:913-920.

4. Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. Journal of the International AIDS Society. 2013, 16(Suppl 2):18640.

5. Stangl AL, Lloyd JK, Brady LM, et al. A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? Journal of the International AIDS Society. 2013;16(Suppl 2):18734.)

6. Abrahams N, Jewkes R. Managing and resisting stigma: a qualitative study among people living with HIV in South Africa. Journal of the International AIDS Society. 2012;15:17330.

7. We Are Family. www.greaterthan.org/we-are-family-love-saves-lives/

8. UNAIDS. Key programmes to reduce stigma and discrimination and increase access to justice in national HIV responses. Guidance Note. 2012. www.unaids.org/en/media/unaids/ contentassets/documents/document/2012/Key_Human_Rights_Programmes_en_ May2012.pdf

9. Kidd R and Clay S. Understanding and challenging HIV stigma: Toolkit for action. International Center for Research on Women. 2003. www.icrw.org/publications/understanding-and-challenging-hiv-stigma-toolkit-action

10. Ekstrand ML, Ramakrishna J, Bharat S, et al. Prevalence and drivers of HIV stigma among health providers in urban India: implications for interventions. Journal of International AIDS Society. 2013;16:18717.

11. Calabrese SK, Underhill K. How Stigma Surrounding the Use of HIV Preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize “Truvada whores.” American Journal of Public Health. 2015;105:1960–1964.

12. Auerbach JD, Kinsky S, Brown G, et al. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care and STDs. 2015. 29:102-110.

13. CDC. Let’s Stop HIV Together. www.cdc.gov/actagainstaids/campaigns/lsht/

14. UNAIDS. On the Fast-Track to end AIDS by 2030: Focus on location and population. 2015. www.unaids.org/en/resources/documents/2015/FocusLocationPopulation

15. The White House. The National HIV/AIDS Strategy: Updated to 2020. July 2015. www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf

<hr />

<strong>Prepared by Pamela DeCarlo and Maria Ekstrand PhD, CAPS</strong>

<strong>*CAPS</strong>

<strong>October 2016 .</strong>

Special thanks to the following reviewers of this Fact Sheet: Sarah Calabrese, Barbara Green-Ajufo, Cynthia Grossman, William Holzemer, Sebastian Kevany, Daryl Mangosing, Cynthia Tucker.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. ©2016, University of CA. Comments and questions about this Fact Sheet may be e-mailed to <a href="mailto:CAPS.web@ucsf.edu">CAPS.web@ucsf.edu. </a>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/11/StigmaFSUpdatefinal_20161020.pdf</url>
	</node>
	<node>
		<title>Adapting programs</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Can HIV Prevention Programs Be Adapted?</h3>
<h4>Why adapt?</h4>
We know that many HIV prevention interventions have made a difference, and that prevention efforts have helped to lower rates of HIV infection in many different populations.<sup>1</sup> But as the HIV epidemic changes, so too do the number and groups of people at risk for HIV. Adapting interventions allows us to use principles we know are effective to address the needs of those newly at risk, who may not have been studied yet.

Developing new interventions is expensive and time consuming, and it makes good sense to adapt programs that have been demonstrated to be effective.<sup>2</sup> Using existing tools and theories of successful programs can save time and money. In an age when money for prevention is limited, adapting interventions can be cost-effective.
<h4>Aren’t all populations different?</h4>
Yes and no. While each community or population is unique, there are many similarities between populations and their social, political and emotional environments. While injecting drug users in Chicago, IL may have very different needs than young gay men in Eugene, OR, both may benefit from similar aspects of programs. For example, using peer educators to help spread the message and change community norms can be effective for both groups.<sup>3,4</sup>

HIV prevention is more than simply teaching safer sex and safe drug use nuts and bolts. Prevention programs need to take into account the life context in which a person applies safer sex, and the relationship to the HIV epidemic of the person. Prevention programs need to be tailored to these different situations, not reinvented entirely.
<h4>What helps with adaptation?</h4>
Program planners can choose from a variety of elements of prevention programs that can address their own local population, setting or intervention needs. Staff training and technical assistance to understand and effectively implement programs is key for successful adaptation.

Understanding the community is integral to adapting programs.<sup>5</sup> Service organizations often know their populations best, whether through outreach or needs assessment. Before adapting an intervention, it is essential to understand the characteristics of the original program and its audience, and how they are different or similar to the new environment.

Theory gives a background for behavior change, and may also be useful in assessing whether an intervention is appropriate for a different target group. For example, the Social Cognitive theory of behavior calls for learning through interactions with other people and using physical and social environments to produce change.<sup>6</sup> Role playing, community building, interactive videos and job training can all be components of a program using this theory.

Peer education has been an important element of prevention programs and serves as a powerful motivator especially for disenfranchised people. Such programs recruit peer educators who are at high risk, and teach them how to educate and help save the lives of their friends and colleagues.<sup>7</sup> This recognizes that people in their own communities have tremendous power of persuasion and can be effective agents of change.

Another successful prevention element involves addressing notions of family, community and ethnic pride.<sup>8</sup> For example, offering parenting and communicating classes often attracts more participation from parents than offering classes specifically about HIV. Appealing to protecting and supporting the community or family-children, spouses, relatives-can be more encouraging than simply protecting oneself.
<h4>What are some examples?</h4>
The STOP AIDS project in San Francisco, CA, has served as a model for HIV prevention across the country.<sup>9</sup> The model, based on community mobilization and outreach and small group meetings, has been adapted and used for gay men across the country.<sup>9</sup> The STOP AIDS model has been used in Los Angeles, CA, West Palm Beach, FL, Phoenix, AZ and Chicago, IL, among other cities. In San Francisco, clients have been recruited on the streets and at bars, while in Chicago, the program has gone into schools. They have found that HIV prevention programs work better when high levels of local commitment are established in a city.

Healthy Oakland Teens (HOT), a peer-based sex education program at a junior high school in Oakland, CA, trained ninth graders to lead classes on sexuality and HIV/AIDS to seventh graders. After one year, students in the program were less likely to initiate activities such as deep kissing, genital touching, and sexual intercourse.<sup>10</sup> HOT was then adapted to address Balinese youth who were perceived at risk for HIV due to increasing HIV seroprevalence and an extensive tourist and sex industry in Bali.

In Bali, researchers found that among members of traditional Balinese youth groups, only 14% of those who were sexually active had used condoms. Although most still lived at home, only 33% reported feeling comfortable discussing sexuality with their parents, while 75% felt comfortable discussing it with their peers. The HOT model of peer education was therefore seen to be appropriate, and the setting was changed from public schools to traditional Balinese youth groups which reach all Balinese youth regardless of socioeconomic status or educational level.<sup>11</sup>

One successful prevention program for gay men in small cities recruited popular opinion leaders from bars, and trained them to deliver and model prevention messages to their peers.<sup>12</sup> This program was then adapted to address minority women in inner city housing developments. However, the program didn’t work there. The reason? Women didn’t know their neighbors, and because of high crime rates in the housing developments, were reluctant to open their doors to someone they didn’t know.

This program was then reworked, starting by helping women in the housing developments establish a sense of community through potluck dinners and music festivals. As a result, not only did the women increase condom use and communication, but the community began to tackle other issues besides HIV such as drugs and violence in the housing development.<sup>13</sup>
<h4>What needs to be done?</h4>
Service organizations need to commit time and resources to training staff in effective use of prevention programs, including using theory, conducting needs assessments and reaching out to researchers and other organizations to find out what interventions have been shown to be effective.

Community planning groups (CPGs) need to facilitate better communication and stable relationships between researchers, community based organizations and Health Departments. CPG Program Coordinators can help link CPGs with local researchers to help community-based prevention planners determine the best adaptations to make.

Researchers need to move from small scale efficacy studies to wide scale field trials. Many interventions are effective in what can be a very controlled research environment (clients often receive payment, staff is well paid and often have advanced degrees). These interventions then need to be tested in the “real world” to see how they may need to be adapted or modified to ensure effectiveness under different conditions and with different populations.

Funders need to commit funds to adaptation and pilot testing new programs at the community level. A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. Adapting existing interventions can be a money-saving and effective prevention strategy.

<hr />

<h3>Says who?</h3>
<ol>
 	<li>Office of Technology Assessment. The Effectiveness of AIDS Prevention Efforts. 1995.</li>
 	<li>Holtgrave DR, Qualls NL, Curran JW, et al. An overview of the effectiveness and efficiency of HIV prevention programs . Public Health Reports. 1995;110:134-146.</li>
 	<li>Weibel W, Jimenez A, Johnson W, et al. Positive effect on HIV seroconversion of street outreach intervention with IDUs in Chicago. Presented at the 9th International Conference on AIDS. Berlin, Germany, 1993. Abstract WSC152.</li>
 	<li>Hays RB, Rebchook, GM, Kegeles SM. The Mpowerment project: a community-level HIV prevention intervention for young gay and bisexual men . American Journal of Public Health. 1996;86:1-8.
<ul>
 	<li>Contact: Susan Kegeles 415/597-9159.</li>
</ul>
</li>
 	<li>Herek GM, Greene B, eds. AIDS, identity, and community : the HIV epidemic and lesbians and gay men . Thousand Oaks, CA: Sage Publications; 1995.</li>
 	<li>Bandura A. Social cognitive theory and exercise of control over HIV infection. In DiClemente RJ, ed. Preventing AIDS: Theories and Methods of Behavioral interventions . New York, NY: Plenum Press; 1994.</li>
 	<li>Grinstead OA, Zack B, Faigeles B. Effectiveness of peer HIV education for prisoners. Presented at the Biopsychosocial Conference on AIDS; Brighton, England. 1994.
<ul>
 	<li>Contact: Barry Zack, Marin AIDS Project 415/457-2487.</li>
</ul>
</li>
 	<li>Díaz RM. HIV risk in Latino gay/bisexual men: a review of behavioral research. Report prepared for the National Latino/a Lesbian and Gay Organization. 1995.
<ul>
 	<li>Contact: Jose Ramón Fernández-Peña, Mission Neighborhood Health Center, 415/552-1013 X386.</li>
</ul>
</li>
 	<li>Wohlfeiler D. Community Organizing and Community Building Among Gay and Bisexual Men. In Minkler M, ed. Community Organizing and Community Building for Health . Rutgers University Press. (in press).
<ul>
 	<li>Contact: Dan Wohlfeiler 415/575-1545.</li>
</ul>
</li>
 	<li>Ekstrand ML, Siegel D, Nido V, et al. Peer-led AIDS prevention delays initiation of sexual behaviors among US junior high school students. Presented at 11th International Conference on AIDS, Vancouver, BC. 1996.
<ul>
 	<li>Contact: Maria Ekstrand 415/597-9160.</li>
</ul>
</li>
 	<li>Merati T, Wardhana M, Ekstrand M, et al. HIV risk taking among youth participating in peer-led AIDS education programs in traditional Balinese youth groups. Presented at the 11th International Conference on AIDS; Vancouver BC. 1996. Th.C.4411.</li>
 	<li>Kelly JA, St. Lawrence JS, Stevenson LY, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities . American Journal of Public Health. 1992;82.1483-1489.
<ul>
 	<li>Contact: Jeff Kelly 414/287-4680.</li>
</ul>
</li>
 	<li>Sikkema KJ, Kelly J, Heckman T, et al. Effects of community-level behavior change intervention for women in low-income housing developments. Presented at the 11th International Conference on AIDS; Vancouver BC. 1996. Tu.C.453.</li>
</ol>
<blockquote>Contact: Kathy Sikkema 414/287-6100.</blockquote>
<em>Prepared by Pamela DeCarlo and Jeff Kelly</em>

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©1996, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/adaptFS.pdf</url>
	</node>
	<node>
		<title>Adaptación de programas</title>
		<tax>1737</tax>
		<content><![CDATA[<h3><strong>Se pueden adaptar los programas de prevención del VIH?</strong></h3>
<strong>¿para qué adaptarlos?</strong>

Sabemos que muchas intervenciones de prevención del VIH han logrado hacer la diferencia y que los esfuerzos de prevención han ayudado a reducir las tasas de infección con VIH en diferentes poblaciones.<sup>1</sup> Así como la epidemia del VIH cambia, igual ocurre con las cantidades y los grupos poblacionales afectados por el este virus. Adaptar intervenciones nos permite usar los principios que han comprobado ser eficaces y luego ser aplicadarlos a aquellos grupos que recién entran a formar parte del riesgo y que por lo tanto no han sido analizados.

Crear intervenciones consume tiempo y dinero, por esta razón adaptar programas que han demostrado su eficacia es lo más sensato.<sup>2</sup> Usando las herramientas y teorías de otros programas exitosos puede ahorrarnos tiempo y dinero. En una época en la que los fondos de prevención escasean, adaptar intervenciones puede ser lo más apropiado para el bolsillo.

<strong>¿acaso son iguales los diferentes grupos poblacionales?</strong>

Sí y no. A pesar de que cada comunidad o población es única, existen muchas semejanzas entre ellas, incluyendo el entorno social, político y emocional. Si bien es cierto que los usuarios de drogas intravenosas de Chicago, IL y los jóvenes gay de Eugene, OR tienen diferentes necesidades, ambos pueden beneficiarse de ciertos aspectos que ofrecen los programas de intervención. Por ejemplo, ambas poblaciones pueden usar personas del mismo grupo para transmitir mensajes y cambiar normas de grupo.<sup>3,4</sup>

La prevención del VIH va más allá de la enseñanza del sexo seguro y del uso responsable de las drogas. Los programas de prevención necesitan tomar en cuenta el contexto de la vida de la persona que practica el sexo seguro y la relación de esta persona con respecto a la epidemia. Los programas de prevención pueden ser adaptados de acuerdo a las circunstancias que se presentan, no necesariamente reinventarlo totalmente.

<strong>¿cómo se logra esta adaptación?</strong>

Para adaptar un programa, es esencial conocer bien a la comunidad a intervenir.<sup>5</sup> Las organizaciones que ofrecen servicios a nivel comunal son quienes mejor conocen a su población, a través del reclutamiento o del estudio de sus necesidades. Antes de adaptar un programa de intervención es necesario entender muy bien las características del programa original, a su audiencia habrá también que identificar las diferencias y semejanzas con relación al ambiente al que será adaptado.

La teoría nos brinda las bases para ejercer el cambio conductual, esta a su vez puede ser muy útil para darse cuenta si la intervención es apropiada para el grupo que será intervenido. Por ejemplo, la teoría Social Cognitiva nos conduce al aprendizaje por medio de la interacción con otras personas, utilizando el entorno social y físico para producir el cambio.<sup>6</sup> Las dramatizaciones, la creación de la conciencia a nivel comunitario, los juegos interactivos, la enseñanza de un oficio, todos estos elementos pueden formar parte de un programa basado en esta teoría.

La educación impartida por personas del mismo grupo al que se va a tratar puede ser un elemento exitoso y sirve de gran motivación, especialmente entre las personas en desventaja. Estos programas reclutan a aquellas personas que están a riesgo y se les entrena para que puedan educar y salvar las vidas de aquellos que corren el mismo riesgo.<sup>7</sup> Esto pone en evidencia que hay miembros dentro de la comunidad que pueden actuar como agentes que tienen la capacidad de lograr el cambio.

Otro elemento exitoso consiste en utilizar principios de familia, el orgullo por la raza y despertar el sentido de comunidad.<sup>8</sup> Por ejemplo, se obtiene mayor participación de los padres de familia al ofrecer clases de comunicación entre padres e hijos que si se ofrecieran clases específicas sobre el VIH. Hacer un llamado a la comunidad para que proteja a la familia, a los hijos, esposos y esposas y a que se apoyen entre sí, puede ser más estimulante que hacer un llamado para protegerse a sí mismo.

<strong>¿algunos ejemplos?</strong>

El proyecto “STOP AIDS” de San Francisco, CA ha servido de modelo en la prevención del VIH en toda la nación.<sup>9</sup> El modelo, basado en la movilización de la comunidad, el reclutamiento y las pequeñas reuniones de grupo, ha sido adaptado y usado por hombres gay a lo largo del país. El modelo de “STOP AIDS” se ha usado en los Angeles, CA, West Palm Beach, FL, Phoenix, AZ y en Chicago, IL, entre otras. En San Francisco, los clientes han sido reclutados en la calle y en los bares, mientras que en Chicago el programa se ha hecho en las escuelas. Se ha descubierto que los programas de prevención funcionan mejor si ya existe un sentido de responsabilidad comunitario en la ciudad que se piensa intervenir.

El “Healthy Oakland Teens” (HOT), un programa de educación sexual impartido por los estudiantes de una escuela en la ciudad de Oakland, CA, entrenó a jóvenes del noveno grado para impartir clases de sexualidad y de VIH/SIDA a los estudiantes del séptimo grado. Un año más tarde, los participantes del programa estuvieron menos propensos a iniciar actividades tales como los besos apasionados, tocarse los genitales o iniciar relaciones sexuales.<sup>10</sup> HOT fue adaptado para jóvenes Balineses ya que ha habido un incremento en la seroprevalencia debido al incremento del turismo y a la industria del sexo en Balí, Indonesia.

En Balí, los investigadores descubrieron que entre los grupos de jóvenes tradicionales, sólo el 14% de los activos sexualmente habían usado condones. A pesar de que la mayoría aún vivía con sus padres, solo el 33% reportó sentir confianza al hablar sobre la sexualidad con sus padres, mientras que el 75% sentía más confianza hablando de sexo con sus amigos. El modelo inicialmente usado por HOT pareció ser el más apropiado para lograr la adaptación, solo que esta vez las bases no iban a ser en las escuelas, sino que se adiestró a grupos tradicionales, que llevaran el mensaje a todo jóven Balinés sin importar el nivel educacional o socio-económico.<sup>11</sup>

Otro de los programas que resultó exitoso, reclutó a líderes del gusto popular que asistía a los bares, a estos se les adiestró para diseminar mensajes de prevención a este grupo.<sup>12</sup> Este programa se adaptó a un grupo de mujeres de minoría racial residentes en viviendas gubernamentales. Sin embargo, el programa no funcionó en este ambiente. ¿El motivo? Las mujeres no se conocían entre sí, y por a las altas tasas de crimen registradas en este tipo de viviendas, no existía la confianza de para abrir las puertas a desconocidos.

Este programa volvió a intentarse, esta vez comenzando ayudando a las mujeres a crear conciencia comunitaria, organizando festivales, música y cenas a la que cada una traía un platillo. El resultado fue el incremento del uso del condón y una mayor comunicación. Entre otras cosas se logró tratar temas que afectaban a la comunidad en estos complejos de vivienda tales como las drogas y la violencia.<sup>12</sup>

<strong>¿qué se puede hacer?</strong>

Las organizaciones que ofrecen servicios deben invertir tiempo y dinero en la capacitación del personal sobre cómo aprovechar los programas de prevención al máximo, esto incluye: el uso de la teoría, el estudio de las necesidades de la población a la que se piensa intervenir tanto como cultivar la relación entre ivestigadores y organizaciones para estar enterados sobre el tipo de programas que han demostrado su eficacia.

Los grupos de planificación comunitaria (CPGs) pudieran crear y mantener una relación estable entre los investigadores, las organizaciones a nivel comunitario y el Departamento de Salud. Los coordinadores de programas de los CPGs, además, deberían poner en contacto a los CPGs con los investigadores locales, ambos a su vez pueden ayudar a los planificadores de prevención a nivel comunitario a determinar cuáles son las adaptaciones más apropiadas.

Los investigadores necesitan pasar de los estudios con eficacia en menor escala a los de mayor escala. Muchas intervenciones son eficaces en un área de mucho control (los clientes son remunerados, el personal bien pagado y con un nivel alto de educación). Estas intervenciones deben ser puestas a prueba en el “mundo real”, solo así se sabrá cuáles son las modificaciones que habrán de hacerse para poder asegurar la efectividad bajo circunstancias diferentes.

Los administradores de estos fondos deberán comprometerse a designar dinero para la adaptación de programas y para llevar a cabo programas piloto a nivel comunitario. Un programa de prevención completo, utiliza muchos elementos para proteger del VIH a la mayor cantidad de gente posible. Adaptar los programas de intervención existentes puede ahorrar dinero además de ser una estrategia eficaz en la prevención.

<hr size="2" />

<strong>¿quién lo dice?</strong>
<ol>
 	<li>Office of Technology Assessment. The Effectiveness of AIDS Prevention Efforts. 1995.</li>
 	<li>Holtgrave DR, Qualls NL, Curran JW, et al. An overview of the effectiveness and efficiency of HIV prevention programs . Public Health Reports. 1995;110:134-146.</li>
 	<li>Weibel W, Jimenez A, Johnson W, et al. Positive effect on HIV seroconversion of street outreach intervention with IDUs in Chicago. Presented at the 9th International Conference on AIDS. Berlin, Germany, 1993. Abstract WSC152.</li>
 	<li>Hays RB, Rebchook, GM, Kegeles SM. The Mpowerment project: a community-level HIV prevention intervention for young gay and bisexual men . American Journal of Public Health. 1996;86:1-8.</li>
</ol>
<ul>
 	<li>Contact: Susan Kegeles 415/597-9159.</li>
</ul>
<ol>
 	<li>Herek GM, Greene B, eds. AIDS, identity, and community : the HIV epidemic and lesbians and gay men . Thousand Oaks, CA: Sage Publications; 1995.</li>
 	<li>Bandura A. Social cognitive theory and exercise of control over HIV infection. In DiClemente RJ, ed. Preventing AIDS: Theories and Methods of Behavioral interventions . New York, NY: Plenum Press; 1994.</li>
 	<li>Grinstead OA, Zack B, Faigeles B. Effectiveness of peer HIV education for prisoners. Presented at the Biopsychosocial Conference on AIDS; Brighton, England. 1994.</li>
</ol>
<ul>
 	<li>Contact: Barry Zack, Marin AIDS Project 415/457-2487.</li>
</ul>
<ol>
 	<li>Díaz RM. HIV risk in Latino gay/bisexual men: a review of behavioral research. Report prepared for the National Latino/a Lesbian and Gay Organization. 1995.</li>
</ol>
<ul>
 	<li>Contact: Jose Ramón Fernández-Peña, Mission Neighborhood Health Center, 415/552-1013 X386.</li>
</ul>
<ol>
 	<li>Wohlfeiler D. Community Organizing and Community Building Among Gay and Bisexual Men. In Minkler M, ed. Community Organizing and Community Building for Health . Rutgers University Press. (in press).</li>
</ol>
<ul>
 	<li>Contact: Dan Wohlfeiler 415/575-1545.</li>
</ul>
10.  Ekstrand ML, Siegel D, Nido V, et al. Peer-led AIDS prevention delays initiation of sexual behaviors among US junior high school students. Presented at 11th International Conference on AIDS, Vancouver, BC. 1996.
<ul>
 	<li>Contact: Maria Ekstrand 415/597-9160.</li>
</ul>
11.  Merati T, Wardhana M, Ekstrand M, et al. HIV risk taking among youth participating in peer-led AIDS education programs in traditional Balinese youth groups. Presented at the 11th International Conference on AIDS; Vancouver BC. 1996. Th.C.4411.

12.  Kelly JA, St. Lawrence JS, Stevenson LY, et al. Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities . American Journal of Public Health. 1992;82.1483-1489.
<ul>
 	<li>Contact: Jeff Kelly 414/287-4680.</li>
</ul>
13.  Sikkema KJ, Kelly J, Heckman T, et al. Effects of community-level behavior change intervention for women in low-income housing developments. Presented at the 11th International Conference on AIDS; Vancouver BC. 1996. Tu.C.453.

Contact: Kathy Sikkema 414/287-6100.

<hr size="2" />

<strong>Preparado por Pamela DeCarlo y Jeff Kelly, Traducción Romy Benard-Rodríquez</strong>
Mayo 1997. Hoja Informativa 23S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/adaptarFS.pdf</url>
	</node>
	<node>
		<title>Technical Assistance (TA) Services</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>CAPS/PRC Technical Assistance</h3>
<h4>How can we assist your organization?</h4>
CAPS/PRC is funded to provide technical assistance (TA) to community based organizations and local and state health departments to assist in the access, use and implementation of HIV science to strengthen programmatic and research processes, develop stronger grant proposals and develop evidence based policies.
<h4>Scientific Assistance</h4>
<ul>
 	<li>Consult with a Researcher</li>
 	<li>Review of Program Materials</li>
 	<li>Targeted Review for Grant Proposals and Surveys</li>
 	<li>Assistance in facilitating research/community partnerships</li>
 	<li>Science to Inform Policy</li>
</ul>
<h4>Access and use of HIV Science</h4>
<ul>
 	<li>Intervention Curricula</li>
 	<li>Assessments and measurement tools</li>
 	<li>Fact Sheets, Reports, Research Summaries and Instruments</li>
 	<li>Science Access (Journal Articles searches, etc)</li>
 	<li>Recommend Resources in Spanish</li>
 	<li>Interpreting and applying HIV science to community programs</li>
</ul>
<h4>Community Collaboration</h4>
<ul>
 	<li>Community Advisory Board TA</li>
 	<li>Partnership Development</li>
 	<li>Community Engagement</li>
 	<li>Evaluation Resources</li>
</ul>
<h4>Dissemination and Engagement</h4>
<ul>
 	<li>Dissemination and Diffusion Strategies</li>
 	<li>Social Media for Public Health</li>
 	<li>Utilizing Web Metric and Analytics</li>
</ul>
<h4>CAPS is also a CDC Capacity Building Assistance (CBA) Provider</h4>
UCSF provides capacity building assistance to community-based organizations to improve the effectiveness of community-based high-impact HIV prevention activities. CBA can be accessed by using the CBA Request Information System (CRIS).
<h4>Recent Technical Assistance Provided:</h4>
<ul>
 	<li>Strategize web marketing for an Open-Access GIS system self-teaching curriculum</li>
 	<li>Connect Community-Based Organizations with Survey Instruments</li>
 	<li>Assist in the development and implementation of a Community Advisory Board (CAB)</li>
</ul>
<h4>Contact the Community Engagement (CE) Core with questions or requests at:</h4>
<a href="/sites/prevention.ucsf.edu/files/about/contact-us/" target="_blank" rel="noopener noreferrer">Web contact form</a> / Phone: 415-476-6326 / Email: <a href="mailto:caps.web@ucsf.edu">caps.web@ucsf.edu</a>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Cost effectiveness</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Can cost-effectiveness analysis help in HIV prevention?</h3>
<h4>Why invest in HIV prevention?</h4>
HIV prevention is still our best hope for fighting the HIV/AIDS epidemic. The estimated lifetime cost of care and treatment for just one HIV+ person is about $195,000.<sup>1</sup> Given 40,000 new infections a year, it will cost more than $6 billion in future years to care for everyone who gets infected this year alone.<sup>2</sup> By keeping people from becoming infected, HIV prevention not only saves lives and slows down the epidemic, it also reduces the number of persons who require expensive medical regimens to combat their HIV disease.

The cost of the AIDS epidemic is incurred not only in dollars, but also in the suffering and death of friends, family and loved ones. The loss to society is untold. We lose productivity and creativity, as well as health and social service dollars.

AIDS has a high cost to society because it predominantly affects young adults in their prime for work and childbearing. In 1998, HIV was the fifth leading cause of death in the US for persons aged 25-44, the leading cause of death for African American men aged 25-44 and the third leading cause of death for African American women in the same age group.<sup>3</sup>
<h4>What is cost-effectiveness analysis?</h4>
The term <strong>cost-effectiveness analysis</strong> refers to the economic analysis of an intervention. In HIV prevention, one measure of cost-effectiveness is the cost per HIV infection averted. This is affected by many factors: intervention cost, number of people reached, their risk behaviors and HIV incidence, and the effectiveness of the intervention in changing behavior. The purpose of cost-effectiveness analysis is to quantify how these factors combine to determine the overall value of a program.

Cost-effectiveness analysis can determine if an intervention is <strong>cost-saving</strong>(cost per HIV infection averted is less than the lifetime cost of providing HIV/AIDS treatment and care) or <strong>cost-effective</strong> (cost per HIV infection averted compares favorably to other health care services such as smoking cessation or diabetes detection).

Community-based organizations (CBOs), community planning groups (CPGs) and health departments often face the difficult task of choosing from a spectrum of HIV prevention strategies in order to best address the HIV prevention needs of the riskiest populations in their community. Knowing the cost-effectiveness of programs can help them decide how to save the most lives with the limited resources available.<sup>4</sup>

Cost-effectiveness analyses also break down the costs and resources needed to implement interventions—personnel, training, supplies, transportation, rent, overhead, volunteer services, etc. This can help CBOs decide if they can implement an intervention.
<h4>What are the limitations?</h4>
Cost-effectiveness is an important consideration but is only one of many factors that should be considered when making program decisions. Cost-effectiveness models do not take everything into account—sometimes they omit important but hard to quantify factors like family stability, freedom from HIV-related stigma and social justice. In addition to helping clients reduce their HIV risk, many interventions also help clients get into stable housing, out of abusive relationships or into drug treatment programs. These outcomes are not easily quantifiable in cost-effectiveness models.

HIV prevention cost-effectiveness estimates cannot be generalized easily because the effectiveness of programs is determined by rates of infection and risk behaviors that may vary greatly across populations. Unlike a surgical procedure, which is likely to be as effective in Cleveland as it is in Dallas, HIV prevention programs can be more or less effective depending on the status of the epidemic in a community at risk.<sup>5</sup>

More and more, HIV prevention programs are being asked to “prove their worth” by showing they are cost-saving or cost-effective. Just because a program doesn’t save society money, doesn’t mean it’s not good or needed. A program that does not save money might still be cost-effective; or, it might not be cost-saving or cost-effective yet still be something that society wants and needs.
<h4>What programs are cost-effective?</h4>
A variety of intervention strategies for injection drug users were shown to be cost-effective: needle exchange (typically $4,000-40,000 per HIV infection averted, or HIA), HIV testing and counseling ($5,000-10,000 per HIA) and drug treatment ($40,000 per HIA which may not include important benefits like crime reduction).<sup>6</sup>

Project LIGHT, a randomized, controlled multisite HIV prevention trial, tested a seven-session small group intervention based on cognitive-behavioral therapy. Project LIGHT found the multi-session intervention to be more effective at reducing sexual risk than a comparison 1-hour videotape session. However, the seven-session intervention was also more expensive to implement. Cost-effectiveness analysis showed that the multi-session intervention was not only more effective than the videotape session in reducing risk, but also was more cost-effective.<sup>7</sup>

Safer Choices, a school-based HIV, STD and pregnancy prevention program, achieved a 15% increase in condom use and an 11% increase in contraceptive use among sexually active students. By preventing cases of HIV, chlamydia, gonorrhea, pelvic inflammatory disease and pregnancies, Safer Choices saved $2.65 in medical and social costs for every dollar spent on the program.<sup>8</sup>

The Mpowerment Project is a community-level HIV prevention intervention run by and for young gay and bisexual men. Mpowerment took place in a mid-sized city with low HIV prevalence and used community building and peer influence to alter the norms of the gay community. The program proved to be cost-effective even with resource- intensive components such as personnel, renting a community space and running social events. Mpowerment was estimated to avert 5-6 HIV infections over 5 years, with cost per HIA of $14,600-18,300.<sup>9</sup>

In the developing world, where the need for aggressive HIV prevention efforts is profound, interventions have been found to be very cost-effective. This is because the epidemic is very severe, and because program costs (such as personnel) are low in these countries. Estimates of cost-effectiveness include: STD control and condom promotion in commercial sex workers ($8-10 per HIA), female condom promotion in high-risk women (cost-saving), voluntary counseling and testing (about $70 per HIA in HIV-discordant couples, $300 overall), community STD control ($350 per HIA), and mother-to-child transmission reduction with nevirapine ($300-500 per HIA).<sup>10</sup>
<h4>What does cost-effective analysis show?</h4>
<ul>
 	<li>All other things being equal, <strong>interventions targeted to high-seroprevalence areas tend to be more cost-effective than interventions that are not targeted</strong>.</li>
 	<li><strong>Low cost doesn’t mean cost-effective</strong>. If a client needs an intensive intervention, spending the money may be the most cost-effective choice in the long run.</li>
 	<li><strong>Reaching more clients for the same money isn’t always the best thing to do</strong>. Giving everyone a brochure produces little behavior change, whereas working intensively to help high-risk clients use condoms correctly, communicate safer sex desires to their partners and learn to recognize and avoid high-risk situations can result in pronounced behavior change.<sup>113</sup></li>
</ul>
<h4>What still needs to be done?</h4>
Cost-effectiveness analyses can help determine how to save the most lives with limited funding. Neglecting cost-effectiveness information may waste scarce prevention dollars, and thereby miss the opportunity to save lives.<sup>12</sup> To this end, simpler cost-effectiveness models and improved technical assistance are needed to help public health decision-makers make better use of cost-effectiveness information.<sup>13</sup>

<hr />

<h3>Says who?</h3>
1. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes. 1997;16:54-62.

2. Holtgrave DR, Pinkerton SD. The economics of HIV primary prevention. In JL Peterson &amp; RJ DiClemente (eds). Handbook of HIV Prevention. New York: Plenum Press, 2000; 285-296.

3. Centers for Disease Control and Prevention. Mortality slide series.http://www.cdc.gov/hiv/graphics/mortalit.htm.

4. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? American Journal of Public Health. 1996;86:1709-1712.

5. Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, et al. Using cost-effective league tables to compare interventions to prevent sexual transmission of HIV. AIDS. 2001;15:917-928.

6. Kahn JG. Economic evaluation of primary HIV prevention in intravenous drug users. In Holtgrave DR, ed. Handbook of Economic Evaluation of HIV Prevention Programs. New York:Plenum Press, 1998.

7. Pinkerton SD, Holtgrave DR, Johnson-Masotti AP, et al. Cost-effectiveness of the NIMH Multisite HIV Prevention intervention. AIDS and Behavior. 2002;6:83-96.

8. Wang LY, Davis M, Robin L, et al. Economic evaluation of Safer Choices. Archives of Pediatric and Adolescent Medicine. 2000;154:1017-1024.

9. Kahn JG, Kegeles SM, Hays R, et al. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men. Journal of Acquired Immune Deficiency Syndromes. 2001;27:482-491.

10. Marseille EA, Hofmann PB, Kahn JG. HIV prevention should be funded before HAART in Sub-Saharan Africa. Lancet. In press

11. Centers for Disease Control and Prevention. Compendium of HIV Prevention Interventions with Evidence of Effectiveness. November 1999.

12. Institute of Medicine. No time to lose – getting more from HIV prevention. Washington, DC: National Academy Press; 2000.www.nap.edu/books/0309071372/html/

13. Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS &amp; Behavior. 1998;2:189-201.
<h3>Further reading:</h3>
DR Holtgrave (ed). Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Publishers, 1998.

Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost- effectiveness in Health and Medicine. New York: Oxford University Press, 1996.

<hr />

<strong>Prepared by James G. Kahn*, Steven D. Pinkerton**, David R. Holtgrave***
*Institute for Health Policy Studies, UCSF; **Center for AIDS Intervention Research, Medical College of Wisconsin; ***Rollins School of Public Health, Emory University</strong>

<strong>January 2002. Fact Sheet #12ER</strong>

Special thanks to the reviewers of this Fact Sheet: Kim Compoc, Karin Coyle, Paul Farnham, Susan Fernyak, Celia Friedrich, Anne Haddix, Ana Johnson-Masotti, Susan Klein, Frank Laufer, Rani Marx, David Perlman, Katherine Phillips, Ron Stall, Mike Sweat, Gary Zarkin.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © February 2002, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/costeffectiveFS.pdf</url>
	</node>
	<node>
		<title>Análisis de costo-efectividad</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Puede el análisis de costo-efectividad ayudar en la prevención del VIH?</h3>
<h4>¿por qué invertir en la prevención?</h4>
La prevención del VIH sigue siendo nuestra mejor esperanza en la lucha contra la epidemia del VIH/SIDA. Se calcula que el costo de la atención médica y otros cuidados para una sola persona VIH+ es de $195,000 (en dólares estadunidenses) durante el transcurso de su vida.<sup>1</sup> Dadas las 40,000 nuevas infecciones que ocurren cada año, el cuidado de todas las personas que se infecten solamente este año costará más de 6 mil millones de dólares.<sup>2</sup> Al evitar el contagio, la prevención del VIH no sólo salva vidas y retrasa la epidemia, sino que también reduce el número de personas que requieren atención médica costosa para combatir su enfermedad del VIH.

El costo de la epidemia del SIDA no se mide en dólares solamente, sino en el sufrimiento y la muerte de amigos, familiares y seres queridos. Lo que la sociedad pierde no se puede medir. Se ha perdido productividad y creatividad así como el dinero gastado en servicios médicos y sociales.

El SIDA tiene un alto costo para la sociedad, ya que afecta principalmente a adultos jóvenes que están en la mejor edad para trabajar y tener hijos. En los EEUU en 1998, entre las personas de 25-44 años, el VIH fue la quinta causa de muerte, la primera causa de muerte para hombres afroamericanos y la tercera para mujeres afroamericanas.<sup>3</sup>
<h4>¿qué es el análisis de costo-efectividad?</h4>
El término <strong>análisis de costo-efectividad</strong> se refiere al análisis económico de una intervención. En la prevención del VIH, el costo de cada infección que se evite representa una medida de costo-efectividad. Aquí entran en juego varios factores: el costo de la intervención, el número de personas alcanzadas, sus conductas riesgosas e incidencia de VIH, y la eficacia de la intervención para cambiar la conducta. El propósito del análisis de costo-efectividad es cuantificar cómo estos factores se combinan para determinar el valor general de un programa.

El análisis de costo-efectividad puede determinar si una intervención <strong>reduce costos </strong>(el costo por infección evitada es inferior al costo del tratamiento y cuidado de por vida de la persona con VIH/SIDA) o si es <strong>costo-efectiva</strong> (es decir el costo por infección evitada es favorable en comparación con otros servicios de salud como los programas para dejar de fumar o detectar la diabetes).

Muchas veces las organizaciones comunitarias, los grupos de planificación comunitaria y los departamentos de salud tienen la difícil tarea de escoger, entre una amplia gama de estrategias para evitar el VIH, aquellas intervenciones que se ajusten mejor a las necesidades de los grupos de mayor riesgo en su comunidad. Conocer la costo-efectividad de los programas puede ayudarles a decidir cómo salvar el mayor número de vidas con recursos limitados.<sup>4</sup>
<h4>¿cuáles son las limitaciones?</h4>
El análisis de costo-efectividad es una consideración importante, pero es sólo uno de muchos factores que deben tenerse en cuenta al tomar decisiones programáticas. Los modelos de costo-efectividad no toman todo en cuenta. A veces omiten factores importantes pero difíciles de cuantificar como la estabilidad familiar, el estigma relacionado con el VIH y la justicia social. Además de ayudar a los clientes a reducir su riesgo de contraer el VIH, muchas intervenciones también los ayudan a conseguir vivienda estable, dejar relaciones abusivas o ingresar a programas para dejar las drogas. Esto no es fácil de medir usando los modelos de costo-efectividad.

Los cálculos de costo-efectividad de los programas de prevención del VIH no se pueden generalizar fácilmente, pues dependen de tasas de infección y conductas arriesgadas que pueden variar mucho entre grupos y comunidades. A diferencia de una cirugía, que tiene las mismas posibilidades de obtener buenos resultados en Cleveland que en Dallas, la eficacia de los programas de prevención del VIH puede variar de acuerdo con las características de la epidemia en una comunidad en riesgo.<sup>5</sup>

Cada vez más se les pide a los programas de prevención del VIH que “comprueben su valía” demostrando que reducen costos o que son costo-efectivos. El hecho de que un programa no le ahorre dinero a la sociedad no significa sea inadecuado o innecesario. Un programa que no ahorra dinero puede seguir siendo costo-efectivo; o bien, puede ser un servicio que la sociedad necesita y desea aún cuando no reduzca costos ni sea costo-efectivo.
<h4>¿qué programas son costo-efectivos?</h4>
Se ha comprobado la costo-efectividad de varias estrategias de intervención para usuarios de drogas inyectables: el intercambio de jeringas (unos $4,000-40,000 por infección de VIH evitada, o IVE), pruebas del VIH y consejería ($5,000-10,000 por IVE) y tratamiento de la drogadicción ($40,000 por IVE, una cifra que tal vez no incluya otros beneficios importantes como la reducción de la delincuencia).<sup>6</sup>

El proyecto LIGHT, un ensayo clínico de prevención del VIH con selección al azar y un grupo de control que se realizó en varios sitios, puso a prueba una intervención de siete sesiones de grupo. El proyecto LIGHT encontró que la intervención de varias sesiones fue más eficaz para reducir el riesgo sexual comparada con la de ver una sola vez un video de una hora. Sin embargo, la intervención de siete sesiones también fue la más costosa de implementar. El análisis de costo- efectividad demostró que la intervención de varias sesiones no sólo fue más eficaz que la sesión de video para reducir el riesgo, sino que también fue la más costo-efectiva.<sup>7</sup>

Safer Choices (Opciones Más Seguras) es un programa escolar para prevenir el VIH, las ETS y el embarazo. Este programa logró un incremento del 15% en el uso de condones y un incremento del 11% del uso de métodos anticonceptivos entre los estudiantes sexualmente activos. Al evitar casos de VIH, clamidia, gonorrea, enfermedad pélvica inflamatoria y embarazo, Safer Choices ahorró $2.65 en costos médicos y sociales por cada dólar gastado en el programa.<sup>8</sup>

El proyecto Mpowerment es una intervención comunitaria dirigida por y para hombres jóvenes gay y bisexuales. Mpowerment se realizó en una ciudad mediana con pocos casos de VIH. Los jóvenes emplearon el fortalecimiento comunitario y la influencia de pares para cambiar las normas de la comunidad homosexual. El programa resultó ser costo-efectivo a pesar de tener componentes que consumen muchos recursos como el personal, el alquiler de un espacio y el tiempo dedicado a la organización de funciones sociales. Se calcula que Mpowerment evitó 5-6 infecciones de VIH durante el transcurso de 5 años, con un costo por IVE de $14,600-18,300.<sup>9</sup>

En los países en vías de desarrollo, donde hay una enorme necesidad de campañas agresivas de prevención del VIH, se ha comprobado que las intervenciones son costo-efectivas. Esto se debe a la gravedad de la epidemia y a los bajos costos de los programas y de personal en estos países. Algunos cálculos de intervenciones costo-efectivas incluyen: control de ETS entre trabajadores sexuales comerciales ($8-10 por IVE), promoción del uso de condones femeninos entre mujeres con alto riesgo (reduce costos), pruebas del VIH y consejería hechas en forma voluntaria (unos $70 por IVE en parejas VIH-discordantes, $300 en general), control comunitaria de ETS ($350 por IVE) y reducción con nevirapina de la transmisión madre-a-hijo ($300-500 por IVE).<sup>10</sup>
<h4>¿qué demuestra el análisis de costo-efectividad?</h4>
<ul>
 	<li>Suponiendo que todos los otros factores sean iguales, <strong>las intervenciones dirigidas a áreas de alta seroprevalencia tienden a ser más costo-efectivas</strong> que otras intervenciones no dirigidas.</li>
 	<li><strong>Bajo costo no significa costo-efectivo</strong>. Si un cliente necesita una intervención intensiva, gastar el dinero en esa intervención podría ser la opción más costo-efectiva a largo plazo.</li>
 	<li><strong>Alcanzar a más clientes por la misma cantidad de dinero no necesariamente produce el mejor resultado</strong>. Repartir folletos a todo mundo genera pocos cambios de comportamiento. En cambio, se pueden producir cambios de conducta notables al trabajar intensivamente con personas de alto riesgo en cómo usar condones correctamente, cómo hablar con sus parejas sexuales sobre su deseo de protegerse en el sexo y a que reconozcan y eviten situaciones riesgosas.<sup>11</sup></li>
</ul>
<h4>¿qué queda por hacer?</h4>
Los análisis de costo-efectividad pueden ayudar a determinar cómo salvar el máximo número de vidas con fondos limitados. De no tomarse en cuenta la información sobre estos análisis, se puede malgastar los escasos fondos de prevención y por lo tanto perder la oportunidad de salvar vidas.<sup>12</sup> Con este fin, se necesitan modelos más sencillos de costo-efectividad y mejor asistencia técnica para ayudar a quienes toman las decisiones sobre la salud pública a sacar el mejor provecho de ésta información.<sup>13</sup>

<hr />

<h4>¿quién lo dice?</h4>
1. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes. 1997;16:54-62.

2. Holtgrave DR, Pinkerton SD. The economics of HIV primary prevention. In JL Peterson &amp; RJ DiClemente (eds). Handbook of HIV Prevention. New York: Plenum Press, 2000; 285-296.

3. Centers for Disease Control and Prevention. Mortality slide series.http://www.cdc.gov/hiv/graphics/mortalit.htm.

4. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? American Journal of Public Health. 1996;86:1709-1712.

5. Pinkerton SD, Johnson-Masotti AP, Holtgrave DR, et al. Using cost-effective league tables to compare interventions to prevent sexual transmission of HIV. AIDS. 2001;15:917-928.

6. Kahn JG. Economic evaluation of primary HIV prevention in intravenous drug users. In Holtgrave DR, ed. Handbook of Economic Evaluation of HIV Prevention Programs. New York:Plenum Press, 1998.

7. Pinkerton SD, Holtgrave DR, Johnson-Masotti AP, et al. Cost-effectiveness of the NIMH Multisite HIV Prevention intervention. AIDS and Behavior. 2002;6:83-96.

8. Wang LY, Davis M, Robin L, et al. Economic evaluation of Safer Choices. Archives of Pediatric and Adolescent Medicine. 200;154:1017-1024.

9. Kahn JG, Kegeles SM, Hays R, et al. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men. Journal of Acquired Immune Deficiency Syndromes. 2001;27:482-491.

10. Marseille EA, Hofmann PB, Kahn JG. HIV prevention should be funded before HAART in Sub-Saharan Africa. Lancet. In press

11. Centers for Disease Control and Prevention. Compendium of HIV Prevention Interventions with Evidence of Effectiveness. November 1999.

12. Institute of Medicine. No time to lose – getting more from HIV prevention. Washington, DC: National Academy Press; 2000.www.nap.edu/books/0309071372/html/

13. Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS &amp; Behavior. 1998;2:189-201.
<h3>Otras lecturas:</h3>
DR Holtgrave (ed). Handbook of Economic Evaluation of HIV Prevention Programs. New York: Plenum Publishers, 1998.

Gold MR, Siegel JE, Russell LB, Weinstein MC (eds). Cost- effectiveness in Health and Medicine. New York: Oxford University Press, 1996.

<hr />

<strong>Preparado por James G. Kahn*, Steven D. Pinkerton**, David R. Holtgrave***
*Institute for Health Policy Studies, UCSF; **Center for AIDS Intervention Research, Medical College of Wisconsin; ***Rollins School of Public Health, Emory University</strong>

<strong>Tradución Rocky Schnaath</strong>

<strong>Abril 2002. Hoja Informativa 12SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/costo-efectividadFS.pdf</url>
	</node>
	<node>
		<title>Evaluation</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How does evaluation help in HIV prevention?</h3>
<h4>what is evaluation?</h4>
Most HIV prevention service providers conduct evaluation and data collection activities on a regular basis, although they may not consider it evaluation. Writing case notes during a prevention case management session, discussing client feedback on program services, watching needle exchange in action, taking notes at staff meetings: these are all examples of “informal” data collection that happen every day. Evaluation provides systems for collecting data, and then helps providers make sense of the data they collect so that they can use it in their work. Evaluation can help providers increase their knowledge, better understand the populations they serve, improve programs and make decisions.

Evaluation is a way to identify program strengths and areas for improvement.<sup>1</sup> It is a way for service providers to be responsible to the communities in which they work, to show accountability to funders, and to ensure that programs have the intended result.

Evaluation can be integrated into all phases of planning and implementing an intervention:
<ul>
 	<li><strong>Before (formative evaluation, needs assessment):</strong> To understand the context of the lives of community members and what puts them at risk, how they avoid risk, and what kinds of resources they need to reduce risk and maintain health and wellness. This can help shape the program and provide baseline data to help measure any change.</li>
 	<li><strong>During (process monitoring and evaluation, quality assurance):</strong> To find out what actually occurs in practice and if the program is operating as planned; document interactions with participants; discover which components work best and if the program meets the needs of the participants. This can help develop any changes to the program.</li>
 	<li><strong>After (outcome and impact evaluation):</strong> To determine what, if any, effect (short and long-term) the program has had on the participants, their partners/families, program staff and the community. At this time, program staff can reassess their objectives and use findings to further refine their programs.<img class="aligncenter" src="/sites/prevention.ucsf.edu/files/uploads/pubs/FS/images/EvalChart.jpg" alt="" width="400" height="226" /></li>
</ul>
<h4>why do evaluation?</h4>
Evaluation can help agencies work more efficiently and improve their programs. It is not a substitute for staff and providers’ experience and knowledge, but can offer complementary information. Using systematic data collection to design an intervention or program can help agencies make smart choices about what elements to incorporate and what behaviors, influences and life issues to address.<sup>1</sup>

Evaluation can help agencies successfully compete for funds and be precise in seeking funding. Funders often require agencies to show that they have systematically thought through current and proposed interventions.<sup>2</sup> Evaluation can also help agency staff know exactly what services best serve their program participants, so that they don’t respond to all grant proposals, but only ones that specifically relate to their participants’ needs.<sup>1</sup>
<h4>what’s a good evaluation question?</h4>
Good evaluation questions come from well-written program objectives that are both realistic and measurable. When agencies design program activities based on a desired outcome (example: conduct outreach—increase the number of women tested for HIV), forming an evaluation is much easier.<sup>3</sup> It is hard to evaluate programs that lack direction.

The mark of a good evaluation question is that you care about the answer. Is it more helpful to know the number of condoms handed out in a month, or what clients do with the condoms after they take them? A good question should also be answerable. Many agencies may want to know if their programs are effective, but broad questions like that may require more time, money and staff than are possible. For example, instead of asking, “Has our agency lowered HIV rates among gay men?” a more helpful and more easily answerable question might be, “Have the men who attended our living room discussion program reduced their use of methamphetamine or increased their use of condoms?”
<h4>what are perceptions of evaluation?</h4>
A common perception of evaluation is that it is only used by funders to pass judgment, to “prove” that a program worked or failed. It is no wonder that many agencies are wary of the idea of evaluation.<sup>4,5</sup> Yet evaluation is a way for providers to know for themselves what works, what doesn’t work, what adjustments might improve their program, and whether what they are doing makes a difference for their clients and community.

Another perception of evaluation is that it is often “done to” an agency. However, evaluation can be incorporated into regular program planning and all agency members can be active participants. This strengthens the process and ensures that results will be understood and used. Evaluators, front line staff, representative community members or program participants should be included in all phases: designing evaluation questions, reviewing forms or guides, discussing results and brainstorming action points.<sup>6</sup>
<h4>how is evaluation conducted?</h4>
There are many ways for agencies to conduct evaluation. One way is to train staff in evaluation or hire an internal staff person with experience doing research to be in charge of evaluation and data. This approach may work best at a large agency with many resources. For example, AIDS Project Los Angeles’s evaluation team worked with their Commercial Sex Venues (CSV) initiative to design and evaluate risk-reduction activities in nine CSVs in Los Angeles County. Program and evaluation staff collaboratively developed and implemented formative research, pre/post evaluations, outreach forms, program evaluation and an annual needs assessment of patrons. CSV patrons reported decreased unprotected sex in CSVs at one-year follow-up.<sup>7</sup>

Another example is for an agency to hire an external evaluator either for a one-time or ongoing evaluation. This approach can be less expensive than hiring a staff person, can build agency capacity to conduct some aspects of evaluation internally, and may be perceived by funders as having less bias than an internal evaluator. Agencies have had both positive and negative experiences with external evaluators. These evaluations are more likely to be successful when there is a strong partnership; agreement about roles, responsibilities, and expectations; and a dedication to collaboration between the evaluator and the agency. When hiring an evaluator, agencies can look for someone with a history of successful collaboration, extensive skills and experience with evaluation in a service setting, and knowledge or experience with the program population.<sup>8</sup>

A third example is for an agency and a local evaluator to work collaboratively to develop evaluation approaches and build agency capacity. Chicago HIV Prevention and Adolescent Mental Health Project (CHAMP), is a long-term collaboration between researchers at the University of Chicago and parents, schools and community agencies. Together, they have designed, implemented and evaluated an HIV prevention program for Black youth and families. The collaboration began in 1995 and continues today.<sup>9</sup>

As HIV prevention service providers have become more involved in evaluation, technical assistance and capacity building assistance (CBA) programs for providers have increased. The Centers for Disease Control and Prevention (CDC) has funded capacity building that integrates program planning, monitoring and evaluation activities in agencies. A national network of CBA providers builds organizational, HIV prevention program and evaluation capacity in agencies that serve Asian &amp; Pacific Islanders, Latino/as, American Indians/Alaska Natives and African Americans.<sup>10</sup>
<h4>what still needs to be done?</h4>
Without specific time and money set aside, evaluation can get lost in the crisis-oriented world of client services. Agencies should be encouraged to foster an atmosphere of learning along with service provision. Agencies can write evaluation time into job descriptions and allow time for staff to read and discuss what they’ve learned in regular meetings. Funders need to cover all costs related to evaluation, so that it can be appropriately staffed. Often-overlooked costs include staff time and training, data entry, data analysis, write-up of findings and dissemination costs.

Making sure that evaluation findings are shared is crucial. Agency staff need to write about their findings and present them at regional and national conferences. Funders need to share reports with agencies and other funders, and synthesize the lessons learned for all their grantees. Health departments can organize regional report-backs and encourage networking among agencies with similar evaluation needs.

<hr />

<h3>Says who?</h3>
1. Gandelman AA, DeSantis LM, Rietmeijer CA. Assessing community needs and agency capacity—an integral part of implementing effective evidence-based interventions. AIDS Education and Prevention. 2006;18:32-43.

2. Holtgrave DR, Gilliam A, Gentry D et al. Evaluating HIV prevention efforts to reduce new infections and ensure accountability. AIDS Education and Prevention. 2002;14SA:1-

3. Nu’Man J, King W, Bhalakia A, et al. A framework for building organizational capacity integrating planning, monitoring, and evaluation. Journal of Public Health Management and Practice. 2007;Suppl:S24-32.

4. Kegeles SM, Rebchook GM. Challenges and facilitators to building program evaluation capacity among community-based organizations. AIDS Education and Prevention. 2005;17:284-299.

5. Napp D, Gibbs D, Jolly D, et al. Evaluation barriers and facilitators among community-based HIV prevention programs. AIDS Education and Prevention. 2002;14:38-48.

6. Gilliam A, Davis D, Barrington T, et al. The value of engaging stakeholders in planning and implementing evaluations. AIDS Education and Prevention. 2002;14:5-17.

7. Mutchler M, Colemon L. A model for community-based participatory evaluation: Benefits, challenges and lessons of evaluating HIV prevention in commercial sex venues. Presented at the 2005 Nat’l HIV Prevention Conf, Atlanta, GA. #M3-D0601.

8. Center for AIDS Prevention Studies. Working Together: A Guide to Collaborative Research in HIV Prevention. 2001.

9. Baptiste DR, Paikoff RL, McKay MM, et al. Collaborating with an urban community to develop an HIV and AIDS prevention program for black youth and families. Behavior Modification. 2005;29:370-416.

10. Taveras S, Duncan T, Gentry D, et al. The evolution of the CDC HIV Prevention Capacity-building Assistance Initiative. Journal of Public Health Management &amp; Practice. 2007;13S:S8-S15.
<h4>Evaluation resources:</h4>
<h3>Manuals</h3>
<ul>
 	<li>Good Questions, Better Answers: A Formative Research Handbook</li>
 	<li>Program Evaluation, NMAC</li>
</ul>
<h3>Researchers</h3>
<ul>
 	<li>Behavioral and Social Science Volunteer Program (BSSV)</li>
</ul>
<h3>Training</h3>
<ul>
 	<li>STD/HIV Prevention Training Centers</li>
</ul>
<h3>Tools</h3>
<ul>
 	<li>AETC National Evaluation Center</li>
 	<li>American Evaluation Association</li>
 	<li>CDC Program Evaluation Resources</li>
 	<li>The Community Toolbox</li>
 	<li>Virtual Program Evaluation Consultant (VPEC)</li>
</ul>
<em>*All websites accessed 10/2007</em>

<hr />

<strong>Prepared by Dara Coan,* Oscar Macias,* Janet Myers,** Kevin Khamarko***
*San Francisco Public Health Department, **CAPS, ***AETC Evaluation Center</strong>

<strong>December 2007. Fact Sheet #44ER</strong>

Special thanks to the following reviewers of this fact sheet: Carl Bell, Alice Gandelman, Ellen Goldstein, Carol Kong, Gene Shelley, Stacy Vogan, Duane Wilkerson.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©December 2007, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revevaluationFS.pdf</url>
	</node>
	<node>
		<title>Evaluación</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo ayuda la evaluación en la prevención del VIH?</h3>
<h4>¿qué es la evaluación?</h4>
La mayoría de los proveedores de servicios de prevención del VIH realizan actividades periódicas de evaluación y recolección de datos, aunque tal vez no consideren que sea una evaluación. Tomar notas durante reuniones de manejo de casos de prevención, comentar las opiniones de los clientes sobre los servicios que han recibido, observar un sitio de intercambio de jeringas, tomar notas en juntas del personal: todos son ejemplos de la recolección “informal” de datos que sucede a diario.

La evaluación provee sistemas para obtener datos, luego ayuda a los proveedores a entenderlos y aplicarlos en el trabajo. La evaluación puede profundizar los conocimientos de los proveedores, su entendimiento de los grupos poblacionales que sirven, aumentar la eficacia de los programas que ofrecen y las decisiones que se toman.

La evaluación es una manera de identificar los puntos programáticos fuertes y débiles<sup>1</sup> y facilita que los programas obtengan los resultados que desean. También permite que los proveedores se responsabilicen ante las comunidades en que trabajan y ante las entidades que los financian.

La evaluación puede integrarse en todas las fases de planificación y ejecución de una intervención.
<ul>
 	<li><strong>Antes (evaluación formativa, valoración de necesidades): </strong>Para entender el contexto de las vidas de los miembros de la comunidad y lo que los pone en riesgo, cómo evitan el riesgo o qué recursos necesitan para reducirlo y mantener la salud y el bienestar. Esto puede ayudar a darle forma al programa y proveer datos basales que ayuden a medir cualquier cambio.</li>
 	<li><strong>Durante (monitoreo y evaluación del proceso, control de calidad): </strong>Para averiguar exactamente qué sucede en la práctica y si el programa opera tal y como fue planeado; para documentar las interacciones con los participantes; para identificar los componentes que sirven mejor y para saber si el programa satisface las necesidades de los participantes. Esta información puede ayudar a desarrollar cambios al programa.</li>
 	<li><strong>Después (evaluación del impacto y los resultados):</strong> Para determinar si el programa tuvo algún efecto a corto y a largo plazo sobre los participantes, sus parejas y familias, sobre el personal del programa y la comunidad. En ese momento, el personal puede reevaluar los objetivos del programa y aprovechar los datos obtenidos para refinar más los programas.</li>
</ul>
<img class="aligncenter" src="/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/images/EvalChartesp2.gif" alt="" width="401" height="314" />
<h4>¿por qué hay que evaluar?</h4>
La evaluación puede aumentar la eficiencia y la calidad de los programas. No sustituye la experiencia ni los conocimientos del personal pero sí puede brindar información complementaria. El uso de datos recolectados sistemáticamente para el diseño de una intervención o programa puede ayudar a tomar decisiones inteligentes sobre qué elementos incorporar y qué conductas, influencias y circunstancias de vida se deben tomar en cuenta.<sup>1</sup>

La evaluación puede ayudar a las organizaciones a solicitar fondos con mayor éxito, claridad y precisión. Muchos financiadores requieren que los solicitantes demuestren que han pensado sistemáticamente en las intervenciones que brindan actualmente y las que proponen.<sup>2</sup> La evaluación también puede ayudar a identificar exactamente qué servicios benefician más a los participantes, lo cual permite que en vez de responder a toda convocatoria de financiación, se trabaje sólo en las que concretamente respondan a las necesidades de los participantes.<sup>1</sup>
<h4>¿cuál es una buena pregunta de evaluación?</h4>
Las buenas preguntas de evaluación se derivan de objetivos programáticos bien formulados que sean realistas y medibles. Al diseñar actividades programáticas basadas en un resultado deseado (por ejemplo: realizar extensión comunitaria para aumentar el número de mujeres que reciben la prueba del VIH), es mucho más fácil articular la evaluación.<sup>4</sup> Por el contrario, es difícil evaluar programas que carecen de dirección.

El indicador de una buena pregunta de evaluación es que a uno le importe la respuesta. ¿Qué es más útil conocer: el número de condones repartidos en un mes, o lo que hacen los clientes después de recibirlos? Asimismo, una pregunta buena también debe poder ser respondida. Muchas organizaciones tal vez quieran saber si sus programas son eficaces, pero estas preguntas tan amplias requieren de más tiempo, dinero y personal de los que disponen. Por ejemplo, en vez de preguntar, “¿Hemos reducido las tasas de VIH entre los hombres homosexuales?” otra pregunta más útil y más fácil de contestar podría ser: “¿Han reducido su consumo de metanfetamina o aumentado su uso de condones los hombres que asistieron a nuestro programa de pláticas grupales?”
<h4>¿cuáles son las percepciones?</h4>
Una percepción común sobre la evaluación es qué ésta se usa únicamente por financiadores para “comprobar” el éxito o fracaso de los programas. No es de extrañar que muchas organizaciones desconfíen al respecto.<sup>4,5</sup> Sin embargo, la evaluación permite que los proveedores descubran por sí mismos qué funciona y qué no, qué ajustes se necesitan para mejorar el programa y si sus servicios están logrando cambios en las vidas de sus usuarios y en la comunidad.

Otra percepción es que la evaluación “se le hace a” la organización por alguien ajeno a ésta, cuando en realidad puede incorporarse en la planificación programática con la participación plena de todos los miembros de la propia organización. Esto fortalece el proceso y asegura que los resultados se entiendan y se aprovechen. Los evaluadores, el personal de atención al público, los representantes de la comunidad o participantes del programa deben ser incluidos en todas las fases: el diseño de las preguntas de evaluación, la revisión de formularios o guías y las discusiones sobre resultados y puntos de acción.<sup>6</sup>
<h4>¿cómo se realiza la evaluación?</h4>
Las organizaciones pueden realizar la evaluación de muchas maneras. Una es capacitar al personal para que la efectúe o contratar a algún miembro del propio personal con experiencia en investigación para que se encargue de la evaluación y de los datos. Este método puede ser el más apto para una organización grande con muchos recursos. Por ejemplo, el equipo de evaluación del AIDS Project Los Angeles colaboró con la iniciativa Commercial Sex Venues (CSV) para diseñar y evaluar actividades de reducción de riesgos en nueve CSV en el condado de Los Ángeles. El personal del programa y el de evaluación diseñaron e implementaron conjuntamente investigaciones formativas, pre y postevaluaciones, formularios de extensión comunitaria, la evaluación del programa y una valoración anual de las necesidades de los usuarios. Los usuarios de los CSV reportaron una reducción en encuentros sexuales sin protección en el seguimiento realizado un año más tarde.<sup>7</sup>

Otro ejemplo es que la propia organización contrate a un evaluador externo para que realice este trabajo ya sea una sola vez o en forma continua. Este método puede resultar menos costoso que la contratación de personal de plantilla, puede promover la ejecución de algunos aspectos de la evaluación con recursos internos y puede ser visto por los financiadores como un proceso menos subjetivo que el realizado por un evaluador interno. Las experiencias de las organizaciones con los evaluadores externos han sido positivas y negativas. Estas evaluaciones suelen ser más exitosas cuando existe una colaboración fuerte; concordancia sobre los roles, responsabilidades y expectativas; y una solidaridad absoluta entre el evaluador y la organización. Al contratar a un evaluador, las organizaciones pueden buscar a un profesional con un historial de colaboración exitosa, amplia habilidad y experiencia de evaluación en ambientes de prestación de servicios y conocimientos o experiencia con la población beneficiada por el programa.<sup>8</sup>

Un tercer ejemplo es la colaboración entre una organización y un evaluador para desarrollar los métodos de evaluación y aumentar la capacidad de la organización. En Chicago, el HIV Prevention and Adolescent Mental Health Project (CHAMP), es una colaboración a largo plazo entre investigadores de la Universidad de Chicago, padres de familia, escuelas y organizaciones comunitarias. Conjuntamente han diseñado, implementado y evaluado este programa de prevención del VIH para jóvenes negros y sus familias. Iniciaron su colaboración en 1995 y la continúan hasta la fecha.<sup>9</sup>

Los Centros para el Control y Prevención (CDC siglas en inglés) han otorgado fondos para proyectos de fomento de capacidad (CBA en inglés) que integran las actividades de planificación, vigilancia y evaluación programática en las organizaciones. Una red nacional de proveedores CBA fomenta la capacidad organizacional, de prevención del VIH y de evaluación en organizaciones con usuarios asiáticos e isleños del Pacífico, latinos, indígenas americanos, nativos de Alaska y afroamericanos.<sup>10</sup>
<h4>¿qué queda por hacer?</h4>
Si no se le asignan tiempo y fondos concretos, la evaluación puede perderse en el mundo de los servicios a usuarios el cual gira en torno a las crisis. Se debe alentar a las organizaciones a promover un ambiente de aprendizaje junto con la provisión de servicios. Las organizaciones pueden incorporar en los perfiles de sus puestos el tiempo necesario para realizar la evaluación y pueden asignar al personal el tiempo necesario para comentar lo que han aprendido en reuniones periódicas. Los financiadores necesitan cubrir todos los gastos relacionados con la evaluación para que ésta cuente con suficiente personal. Con frecuencia se pasa por alto los costos del tiempo y capacitación del personal, el registro de datos, el análisis de datos y la redacción y divulgación del informe sobre los resultados de la evaluación.

Es esencial difundir los resultados de la evaluación. El personal de la organización necesita redactar informes sobre los hallazgos y presentarlos en congresos regionales y nacionales. Los financiadores necesitan compartir informes con las organizaciones y con otros financiadores y sintetizar las lecciones aprendidas para todos sus financiados. Los departamentos de salud pueden organizar reuniones regionales para difundir resultados y fomentar vínculos entre organizaciones con necesidades de evaluación similares.

<hr />

<h3>¿Quién lo dice?</h3>
1. Gandelman AA, DeSantis LM, Rietmeijer CA. Assessing community needs and agency capacity—an integral part of implementing effective evidence-based interventions. AIDS Education and Prevention. 2006;18:32-43.

2. Holtgrave DR, Gilliam A, Gentry D et al. Evaluating HIV prevention efforts to reduce new infections and ensure accountability. AIDS Education and Prevention. 2002;14SA:1-

3. Nu’Man J, King W, Bhalakia A, et al. A framework for building organizational capacity integrating planning, monitoring, and evaluation. Journal of Public Health Management and Practice. 2007;Suppl:S24-32.

4. Kegeles SM, Rebchook GM. Challenges and facilitators to building program evaluation capacity among community-based organizations. AIDS Education and Prevention. 2005;17:284-299.

5. Napp D, Gibbs D, Jolly D, et al. Evaluation barriers and facilitators among community-based HIV prevention programs. AIDS Education and Prevention. 2002;14:38-48.

6. Gilliam A, Davis D, Barrington T, et al. The value of engaging stakeholders in planning and implementing evaluations. AIDS Education and Prevention. 2002;14:5-17.

7. Mutchler M, Colemon L. A model for community-based participatory evaluation: Benefits, challenges and lessons of evaluating HIV prevention in commercial sex venues. Presented at the 2005 Nat’l HIV Prevention Conf, Atlanta, GA. #M3-D0601.

8. Center for AIDS Prevention Studies. Working Together: A Guide to Collaborative Research in HIV Prevention. 2001.

9. Baptiste DR, Paikoff RL, McKay MM, et al. Collaborating with an urban community to develop an HIV and AIDS prevention program for black youth and families. Behavior Modification. 2005;29:370-416.

10. Taveras S, Duncan T, Gentry D, et al. The evolution of the CDC HIV Prevention Capacity-building Assistance Initiative. Journal of Public Health Management &amp; Practice. 2007;13S:S8-S15.

<strong>Recursos</strong>

Manuales
<ul>
 	<li>A Buenas Preguntas… ¡Mejores Respuestas!: Un manual de investigación formativa, CAPS</li>
 	<li>Evaluacion de Programas, NMAC</li>
 	<li>Manual de Evaluación, Fundación W.K. Kellogg</li>
</ul>
Herramientas
<ul>
 	<li>Caja de Herramientas Comunitarias</li>
</ul>

<hr />

<strong>Preparado por Dara Coan,* Oscar Macias,* Janet Myers,** Kevin Khamarko***
*San Francisco Public Health Department, **CAPS, ***AETC Evaluation Center</strong>

<strong>Traducción: Rocky Schnaath</strong>

Abril 2008. Hoja de Dato #44SR]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/evaluacionFS.pdf</url>
	</node>
	<node>
		<title>Levels of prevention</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How does HIV prevention work on different levels?</h3>
<h4>what are levels?</h4>
HIV prevention is not just about changing individual behavior. Many other factors also influence HIV transmission, such as relationships with family and friends, community norms, access to health care and local laws. Working on different levels means addressing all these factors through multiple approaches: individual, couple/family, community, medical and legal.<sup>1</sup>

HIV prevention programs for injecting drug users (IDUs) in the US have included interventions on many different levels. These programs have incorporated interventions such as: intensive street outreach to educate IDUs, drug treatment, syringe exchange, community-building and empowerment efforts and adherence programs for HIV+ IDUs. Where these efforts are in place, rates of HIV among IDUs have remained stable.<sup>1</sup>

Prevention efforts addressing multiple levels have reversed HIV epidemics in Uganda and Thailand, and averted an epidemic in Senegal. Senegal, for example, used prevention programs on the individual level (HIV counseling and testing), community level (HIV education in schools, condom promotion among sex workers), medical level (treatment of sexually transmitted diseases [STDs]), and structural/political level (mobilizing religious and political leaders to talk openly about HIV) to maintain one of the lowest rates of HIV infection in Sub-Saharan Africa.<sup>3</sup>
<h4>individual level</h4>
Many prevention programs help individuals change risky behavior. Project EXPLORE was a randomized trial of an individually-based counseling intervention for men who have sex with men. EXPLORE recognized that different men experience different individual, interpersonal and situational factors associated with risk. The program tailored the intervention to each man’s needs. Ten counseling modules used motivational interviewing to assess risk behavior, enhance sexual communication, understand substance use and recognize triggers to unsafe sex.<sup>4</sup>

Project RESPECT was a randomized HIV counseling trial conducted at STD clinics in five cities in the US with high HIV seroprevalence. The program evaluated whether interactive counseling is more effective than informational messages in reducing risk behaviors and preventing HIV and other STDs. The program found relatively little difference between 4- and 2-session interactive counseling interventions, but found lower rates of new STDs among the interactive counseling groups compared to groups that only received information. Reported condom use increased in all groups, with significantly greater protection among those in interactive counseling.<sup>5</sup>
<h4>couple/family level</h4>
The Visiting Nurse Service of New York offers comprehensive in-home services to families affected by HIV, substance abuse, sexual abuse and mental illness. The
children in these families are at high risk for repeating the histories and behaviors of their parents. The program provides home-based interventions that include play therapy, health and safe sex education, family and individual counseling, relapse prevention for the parent and drug awareness and prevention for the children. Helping children deal with anger and resentment towards their parents lessens the likelihood that their anger will be displaced on themselves, thus repeating the behavior of the parent. Supporting each family member is key to breaking the cycle of dysfunction in these families.<sup>6</sup>

Interventions that promote safer sexual behaviors for both members of a couple can also be important. Project Connect was a six-session relationship-based intervention for women in a heterosexual relationship. Women attended separately or with their partners. The sessions emphasized communication, negotiation and how gender roles affect relationship dynamics. Project Connect helped decrease risky behaviors for couples receiving the intervention together and for couples where the woman attended alone.<sup>7</sup>
<h4>community level</h4>
Community-level programs can reach large numbers of people and can therefore be cost-effective. The Mpowerment Project promoted a norm of safer sex among young gay men through a variety of social, outreach and small group activities designed and run by young men themselves. They found that young men engaging in unsafe sex who were unlikely to attend workshops were more likely to be reached through outreach activities such as dances, movie nights, picnics and volleyball games. Rates of unprotected anal intercourse fell from 40% to 31% after the intervention.<sup>8</sup>

A community-level intervention with ethnically-diverse adolescents living in low-income housing, uses skills training, modeling, peer norm and social reinforcement to reduce sexual risk. Using social events and peer leaders nominated for training and team building, the program attracted neighborhood youth. The peer leaders developed small media prevention messages and planned community-wide events. Workshops for parents were also offered. The community intervention was shown to be more effective in delaying onset of first intercourse than education or skills building only.<sup>9</sup>
<h4>medical level</h4>
In the past few years, various medical approaches have been shown to be effective in HIV prevention. For example, antiretroviral drugs used to treat HIV have also been used to help prevent mother to child transmission (MTCT) of HIV, and to prevent transmission after accidental exposures (post-exposure prophylaxis or PEP). Neither of these approaches completely prevents transmission, but MTCT can reduce the risk of transmission by one half to two-thirds. Similarly, because antiretroviral drugs can greatly reduce the viral load in HIV+ persons, it is possible that widespread use could decrease the sexual transmission of HIV.<sup>3</sup>

Children’s Hospital Los Angeles teamed with community-based prevention organizations to provide an integrated care model for youth with and at high risk for HIV infection. The model offered a general medical clinic for youth and psychosocial services such as counseling and case management. Peer educators also conducted
extensive street outreach where high-risk youth congregate. The program developed a computerized referral system for local youth services available on the Internet.<sup>11</sup>
<h4>policy/legal level</h4>
HIV infection is closely linked to and often fueled by structural factors such as poverty, discrimination and lack of power for women. The Center for Young Women’s Development is a peer-run organization in San Francisco, CA that promotes self-sufficiency, community safety and youth advocacy among young women aged 14-18 who are involved in the juvenile justice, foster care systems and/or have lived on the streets. The Center provides employment, leadership and training for young women to educate others in their community. Equipped with the knowledge and opportunity to train others, young women are more likely to incorporate these skills into their own lives.<sup>12</sup>

Political and legislative factors can also hamper HIV prevention. For example, there is currently a ban on federal funding for needle exchange programs in the US. Connecticut addressed the problem of access to clean needles through a program that cost the state nothing and was highly effective. A partial repeal of needle prescription and drug paraphernalia laws resulted in dramatic reductions in needle sharing, and increases in pharmacy purchase of syringes by IDUs. Needle sharing dropped from 52% before the new laws to 31% after implementation, street purchase fell from 74% to 28%, and pharmacy purchase rose from 19% to 78%.<sup>13</sup>
<h4>what have we learned?</h4>
Prevention is more than a single program or intervention. A comprehensive HIV prevention strategy addresses multiple levels to protect as many people at risk for HIV as possible. We should learn from and promote the effectiveness of HIV prevention programs already in place, as well as continue to evaluate these programs.

<hr />

<h3>Says who?</h3>
1. Kelly JA, Kalichman SC. Behavioral research in HIV/AIDS primary and secondary prevention: recent advances and future directions. Journal of Consulting and Clinical Psychology. 2002;70:629-639.
2. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American Journal of Epidemiology. 2001;154:S70-77.
3. Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nature Medicine. 2003;9:881-886.
4. Chesney MA, Koblin BA, Barresi PJ, et al. An individually tailored intervention for HIV prevention: Baseline data from EXPLORE study. American Journal of Public Health. 2003;93:933-938.
5. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. Journal of the American Medical Association. 1998;280:1161-1167.
6. Mills R, Samuels KD, Bob-Semple N, et al. Breakin’ the cycle: multigenerational dysfunction in families affected with HIV/AIDS. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. Abst #ThPeE7828.
7. El-Bassel N, Witte SS. Gilbert L, et al. The efficacy of a relationship-based HIV/STD prevention program for heterosexual couples. American Journal of Public Health. 2003;93:963-969.
8. Hays RB, Rebchook GM, Kegeles SM. The Mpowerment Project: community-building with young gay and bisexual men to prevent HIV1. American Journal of Community Psychology. 2003;31:301-312.
9. Sikkema KJ, Hoffmann RG, Brondino MJ, et al. Outcomes of a community-level intervention among adolescents in inner-city housing developments. Presented at the International Conference on AIDS, Barcelona, Spain. July 2002. Abst# WeOrD1276.
10. Fuchs J, Colfax G. A shot or a pill: exploring biomedical approaches to HIV prevention. Focus. 2004;19:1-4.
11. Schneir A, Kipke MD, Melchior LA, et al. Children’s Hospital Los Angeles: a model of integrated care for HIV-positive and very high risk youth. Journal of Adolescent Health. 1998;23(2Suppl):59-70. Computerized referral system:www.caars.net
12. Center for Young Women’s Development. www.cywd.org
13. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes. 1995;10:82-89.

<hr />

<strong>Prepared by The Center for AIDS Prevention Studies, University of California, San Francisco</strong>

<strong>July 2004. Fact Sheet #1ER</strong>

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © July 2004, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/LevelsFS.pdf</url>
	</node>
	<node>
		<title>Niveles de prevención</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo opera la prevención del VIH a diferentes niveles?</h3>
<h4>¿qué queremos decir con niveles?</h4>
La prevención del VIH no depende exclusivamente de lograr cambios en la conducta individual. Hay muchos otros factores que influyen en la transmisión del VIH como las relaciones entre familiares, entre amistades, los valores comunitarios, el acceso a servicios médicos y las leyes locales. Trabajar a diferentes niveles significa responder a todos estos factores por medio de estrategias múltiples: individual, de pareja/familia, comunitaria, médica y legal.<sup>1</sup>

En EE. UU. los programas de prevención del VIH para usuarios de drogas inyectables (UDI) han incluido intervenciones a muchos niveles: campañas intensivas de educación para UDI en la calle, tratamiento para dejar las drogas, intercambio de jeringas, empoderamiento comunitario y programas de apego (adherencia) para UDI VIH+. Las localidades que cuentan con estos servicios tienen tasas estables de infección por VIH entre los UDI.<sup>2</sup>

Los esfuerzos de prevención a varios niveles han invertido el curso de las epidemias del VIH en Uganda y Tailandia. También han evitado una epidemia en Senegal, en donde los programas preventivos a nivel individual (consejería y pruebas del VIH), comunitario (información en las escuelas, promoción del uso de condones entre trabajadores sexuales), médico (tratamiento de enfermedades de transmisión sexual, ETS) y estructural/político (movilización de dirigentes religiosos y políticos para hablar abiertamente sobre el VIH) han mantenido una de las tasas más bajas de infección por VIH en el África subsahariana.<sup>3</sup>
<h4>nivel individual</h4>
Muchos programas de prevención ayudan a los individuos a cambiar sus conductas riesgosas. El Proyecto EXPLORE fue un ensayo aleatorio de consejería individual para hombres que tienen sexo con hombres. EXPLORE reconoció que los factores individuales, interpersonales y situacionales asociados con el riesgo son diferentes para diferentes hombres. El programa individualizó la intervención adaptando los diez módulos de consejería motivacional para evaluar la conducta de riesgo, aumentar la comunicación sexual, entender el consumo de drogas y alcohol e identificar las situaciones que provocan el sexo desprotegido.<sup>4</sup>

El Proyecto RESPECT fue un ensayo aleatorio de consejería del VIH realizado en clínicas de ETS en cinco ciudades estadounidenses con alta seroprevalencia del VIH. El programa evaluó la eficacia de la consejería interactiva en comparación con los mensajes informativos para reducir las prácticas de riesgo y evitar el VIH y otras ETS. El programa descubrió relativamente poca diferencia entre las intervenciones de 2 y las de 4 sesiones de consejería interactiva, pero encontró tasas más bajas de ETS entre los grupos que recibieron consejería interactiva en comparación con otros grupos que sólo recibieron información. Todos los grupos reportaron un aumento en el uso de condones y quienes recibieron consejería interactiva mostraron notablemente tener una mayor protección.<sup>5</sup>
<h4>nivel de pareja/familiar</h4>
El Visiting Nurse Service de Nueva York ofrece servicios integrales a domicilio para familias afectadas por el VIH, las drogas, el alcohol, el abuso sexual y la enfermedad mental. Los niños de estas familias están en alto riesgo de repetir las historias y conductas de sus padres. El programa les ofrece intervenciones a domicilio que incluyen terapia del juego, educación sobre la salud y el sexo protegido, consejería familiar e individual, prevención de recaídas para los padres e información y prevención del consumo de drogas para los niños. Al ayudarles a afrontar sus sentimientos de ira y resentimiento hacia sus padres se reduce la probabilidad de que los niños dirijan la ira hacia sí mismos y repitan la conducta de sus padres. La clave para romper el ciclo de disfunción en estas familias es brindarle apoyo a cada miembro de la familia.<sup>6</sup>

Las intervenciones que promueven conductas con mayor protección sexual para ambos miembros de la pareja también pueden ser importantes. El Proyecto Connect fue una intervención basada en la relación heterosexual de pareja en la cual las mujeres asistieron a 6 sesiones con o sin sus compañeros. Las sesiones se enfocaron en la comunicación, la negociación y los efectos de los papeles masculinos y femeninos en la dinámica de pareja. El Proyecto Connect ayudó a disminuir las conductas riesgosas entre las parejas que participaron juntas en la intervención y en las que sólo asistió la mujer.<sup>7</sup>
<h4>nivel comunitario</h4>
Los programas a nivel comunitario pueden alcanzar a muchas personas y por lo tanto pueden ser costo-efectivos. El Proyecto Mpowerment promovió una norma de protección en el sexo entre jóvenes gay mediante diversas actividades (sociales, de alcance comunitario y en grupos pequeños) diseñadas y llevadas a cabo por los jóvenes mismos. Mpowerment notó que las actividades de promoción como bailes, noches de cine, días de campo y partidos de voleibol funcionaban mejor para alcanzar a los jóvenes que tenían sexo desprotegido y no asistían a charlas. La tasa de sexo anal sin protección cayó del 40% al 31% después de la intervención.<sup>8</sup>

Una intervención a nivel comunitario con adolescentes de diversos grupos étnicos que vivían en residencias para familias de bajos ingresos combinó el desarrollo de habilidades, el modelaje de comportamientos, las normas sociales entre jóvenes y el fortalecimiento social en la reducción del riesgo sexual. Para atraer a los jóvenes del vecindario, el programa los invitó a funciones sociales e involucró a líderes jóvenes que realizaron capacitaciones y fomentaron el trabajo en equipo. Los jóvenes lideres diseñaron breves mensajes de prevención para los medios de comunicación y organizaron eventos para toda la comunidad. También se ofrecieron talleres para los padres. La intervención comunitaria fue más eficaz para aplazar el primer coito que la educación o el desarrollo de habilidades por sí solos.<sup>9</sup>
<h4>nivel médico</h4>
En años recientes se ha comprobado la eficacia de varios métodos médicos de prevención del VIH.<sup>10</sup> Por ejemplo, los medicamentos antirretrovirales (AR) usados para tratar el VIH también han ayudado a evitar la transmisión del VIH de madre a hijo (TMH) así como después de una exposición accidental (profilaxis posterior a la exposición, PPE). Ninguno de estos métodos impide la transmisión totalmente pero el uso de AR puede reducir el riesgo de la TMH a la mitad o dos terceras partes. De igual forma ya que los AR pueden reducir la carga viral en las personas VIH+ es posible que un uso más amplio disminuya la transmisión sexual del VIH.<sup>3</sup>
El Children’s Hospital de Los Ángeles colaboró con organizaciones comunitarias de prevención en un programa modelo con servicios integrados para jóvenes con VIH o en alto riesgo de contraerlo. Se les ofreció una clínica de medicina general para jóvenes junto con servicios psicosociales como consejería y manejo de casos. Educadores de pares también llevaron a cabo esfuerzos intensivos de contacto callejero. El programa creó un sistema computarizado de referencia con servicios locales para jóvenes disponible vía Internet.<sup>11</sup>
<h4>nivel político/legal</h4>
La infección por VIH está muy vinculada a y con frecuencia es alimentada por factores estructurales como la pobreza, la discriminación y la falta de poder de las mujeres. El Center for Young Women’s Development es una organización dirigida por mujeres jóvenes en San Francisco, CA que promueve la autosuficiencia, la seguridad comunitaria y la defensa de los derechos de la gente joven entre jovencitas de 14-18 años de edad que han vivido en la calle o están involucradas en los sistemas de justicia juvenil o de crianza temporal. El centro provee empleo, oportunidades de liderazgo y capacitaciones para que las jóvenes eduquen a otros en su comunidad. Las jóvenes que obtienen estos conocimientos y la oportunidad de enseñarlos a otros están más propensas a incorporar dichas habilidades en su propia vida.<sup>12</sup>

Los factores políticos y legislativos también pueden impedir la prevención del VIH. Por ejemplo, en EE.UU. se prohíbe el uso de fondos federales para programas de intercambio de jeringas. En Connecticut la falta de acceso a jeringas limpias se resolvió con un programa muy eficaz que no le costó nada al estado. Al revocar parcialmente las leyes que prohibían recetar jeringas y usar equipo de inyección de drogas, hubo reducciones dramáticas en el uso compartido de jeringas e incrementos en la compra en farmacias de jeringas por UDI. El uso de jeringas compartidas cayó del 52% antes de las nuevas leyes al 31% después de su entrada en vigor. Asimismo, la compra de jeringas en la calle se redujo del 74% al 28% y el porcentaje de jeringas compradas en farmacias aumentó del 19% al 78%.<sup>13</sup>
<h4>¿qué hemos aprendido?</h4>
La prevención va más allá de un solo programa o intervención. Una estrategia integral de prevención del VIH abarca varios niveles para proteger al mayor número posible de personas en riesgo. Debemos aprender de los programas actuales de prevención del VIH y fomentar su eficacia al tiempo que continuamos evaluándolos.

<hr />

<h3>Quien lo dice?</h3>
1. Kelly JA, Kalichman SC. Behavioral research in HIV/AIDS primary and secondary prevention: recent advances and future directions. Journal of Consulting and Clinical Psychology. 2002;70:629-639.
2. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American Journal of Epidemiology. 2001;154:S70-77.
3. Valdiserri RO, Ogden LL, McCray E. Accomplishments in HIV prevention science: implications for stemming the epidemic. Nature Medicine. 2003;9:881-886.
4. Chesney MA, Koblin BA, Barresi PJ, et al. An individually tailored intervention for HIV prevention: Baseline data from EXPLORE study. American Journal of Public Health. 2003;93:933-938.
5. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. Journal of the American Medical Association. 1998;280:1161-1167.
6. Mills R, Samuels KD, Bob-Semple N, et al. Breakin’ the cycle: multigenerational dysfunction in families affected with HIV/AIDS. Presented at the 14th International AIDS Conference, Barcelona, Spain. 2002. Abst #ThPeE7828.
7. El-Bassel N, Witte SS. Gilbert L, et al. The efficacy of a relationship-based HIV/STD prevention program for heterosexual couples. American Journal of Public Health. 2003;93:963-969.
8. Hays RB, Rebchook GM, Kegeles SM. The Mpowerment Project: community-building with young gay and bisexual men to prevent HIV1. American Journal of Community Psychology. 2003;31:301-312.
9. Sikkema KJ, Hoffmann RG, Brondino MJ, et al. Outcomes of a community-level intervention among adolescents in inner-city housing developments. Presented at the International Conference on AIDS, Barcelona, Spain. July 2002. Abst# WeOrD1276.
10. Fuchs J, Colfax G. A shot or a pill: exploring biomedical approaches to HIV prevention. Focus. 2004;19:1-4.
11. Schneir A, Kipke MD, Melchior LA, et al. Children’s Hospital Los Angeles: a model of integrated care for HIV-positive and very high risk youth. Journal of Adolescent Health. 1998;23(2Suppl):59-70. Computerized referral system:www.caars.net
12. Center for Young Women’s Development. www.cywd.org
13. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993. Journal of Acquired Immune Deficiency Syndromes. 1995;10:82-89.

<hr />

<strong>Preparado por The Center for AIDS Prevention Studies, University of California, San Francisco</strong>

<strong>Julio 2004. Fact Sheet #1SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/NivelesFS.pdf</url>
	</node>
	<node>
		<title>Research/service provider collaboration</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How Can Service Providers and Researchers Collaborate in HIV Prevention?</h3>
<h4>Why collaborate?</h4>
<blockquote>“Research on HIV prevention—no matter how good—does not stop HIV infection. HIV behavioral research can only stop HIV infection when results of the research can be used to make applied programs better.”<sup>1</sup> -Jeff Kelly</blockquote>
Everyone working in HIV prevention wants to know that their efforts make a difference towards halting the spread of HIV. When researchers and community-based organizations (CBOs) collaborate, the outcome can be better community programs and better science, resulting in improved HIV prevention.

Researchers need to learn about how health education and community organizing programs function in order to evaluate or create interventions that are feasible in real world settings. They also need to gain access to research participants (clients of CBOs) and disseminate research findings in the most useful way. Working with CBOs and their clients can improve research.”<sup>2</sup>

The mission of most CBOs is program delivery, not evaluation. CBOs may need to collaborate with a researcher when using tested interventions, evaluating ongoing programs and incorporating theory into intervention design. Working with researchers can improve programs.”<sup>3</sup> Federal, state, local and private funders are increasingly requiring CBOs both to use theory in designing programs and to evaluate their programs.
<h4>What does collaboration involve?</h4>
Researchers and service providers can work together in many ways and the degree of collaboration can vary. Collaboration can be a simple act that is not very time consuming, such as CBOs getting help with questions on a survey or researchers learning more about client populations. Even if the relationship between a researcher and service provider is limited, there are ways to bring the expertise of all participants together and optimize outcomes of their joint work.

Collaboration can also be relatively complex and time- and resource-intensive. Service providers and researchers may collaborate on program evaluation, program design, data analysis or research. Typically, these collaborations involve 1) selecting the researcher and CBO partner; 2) developing a relationship; 3) deciding on a research or programmatic question; 4) conducting the research or evaluation; 5) analyzing and interpreting the data; and 6) disseminating the findings.”<sup>4</sup> The last step in the collaboration would involve developing programs based on the research findings.
<h4>What are barriers to collaboration?</h4>
Collaboration can be understood as a cross-cultural experience: a meeting of the culture of research and the culture of CBOs. Researchers and providers have distinct work cultures including norms, incentives, jargon, sense of time, resources, training, education, and expectations, that are often at odds with each other.”<sup>5</sup> For example, CBO staff often must respond to clients with immediate needs. Researchers, on the other hand, often work on 2-5 year grants with more long-term objectives. While their common goal may be slowing the epidemic, each has different contributions and strategies for achieving that end.

Often CBOs mistrust researchers. Researchers are seen as “using” the CBO, collecting data with no return of information and taking all of the credit.”<sup>6</sup> Service providers often see researchers as over-resourced. For example, CBO staff may be paid far less than the researchers they collaborate with. On the other hand, researchers are often frustrated by the fast pace, limited staff time and lack of prioritization of research activities found in CBOs.

An inherent power imbalance exists when researchers and CBOs work together on research projects. Researchers are often seen as “experts” by virtue of their academic degree. The expertise of CBO staff—knowledge of the community, understanding how interventions work and access to the population—is often overlooked and undervalued by researchers.
<h4>What’s being done?</h4>
One simple yet vital method of collaboration is making sure that data collected by the researcher is available to CBOs to use. The University of British Columbia in Canada conducted a large-scale study of health care and community resources used by persons living with HIV/AIDS. After the study, they hired a Community Liaison Researcher to work with CBOs to jointly determine their information needs, and conduct tailored analyses of the large and valuable database for use in CBO programs.”<sup>7</sup>

Another more complex method of collaboration involves working together from the beginning to develop programs. The San Francisco AIDS Foundation (SFAF) wanted to understand why gay/bisexual men were continuing to become HIV-infected. They initiated a collaboration with CAPS, UCSF to conduct qualitative research among high-risk men. SFAF and research staff met weekly to discuss the research question, design the instrument and discuss the transcripts. This led to the agencies collaboratively developing and evaluating two interventions and a media campaign. The programs, Gay Life and Black Brothers Esteem, are ongoing.”<sup>8</sup>

Collaborations often require a solid infrastructure for support. In San Francisco, CA, the CAPS collaboration initiative provided funding, training, supervision, technical assistance and researcher pairing for CBOs to conduct program evaluation. This initiative was jointly funded through the university and private funders. CBOs developed research questions and conducted evaluation with the aid of researchers. Findings were disseminated through public forums and a special issue of a journal. This collaborative model has been replicated across the US.”<sup>9</sup>
<h4>What are best practices?</h4>
Although collaborating can be a resource and labor-intensive activity, the benefits for the CBO, researcher and the field of HIV prevention are worth the investment. The following recommendations can help ensure a successful experience:<sup>10,11</sup>
<ul>
 	<li>Choose CBO or researcher partners carefully. Interview several different individuals or agencies. Always ask for and check references.</li>
 	<li>Establish buy-in, input and ownership from agency staff and directors.</li>
 	<li>Define roles and responsibilities clearly and repeatedly.</li>
 	<li>Plan and budget for time for CBO-researcher communication and meetings.</li>
 	<li>Address conflict when it arises.</li>
 	<li>Allow flexibility to modify or change the scope of research.</li>
 	<li>Expect staff turnover and allow time to orient and train new staff.</li>
 	<li>Support agencies to build capacity before engaging in outcome research. Formative, descriptive and theory-development research are useful; outcome evaluation is not always the best choice for new interventions or new CBOs.</li>
 	<li>Build a safety net into the research design. If you are evaluating a new intervention, make sure to include alternative research questions from the start.</li>
 	<li>Plan for community dissemination strategies throughout all stages of research.</li>
 	<li>Jointly monitor for research quality control.</li>
 	<li>Secure adequate resources and support for intervention and evaluation time.</li>
</ul>
<h4>What supports collaboration?</h4>
There are some recent initiatives that support collaborative work, including federal, foundation and university grants. Funders, however, still need to set aside money for researchers and CBOs to work together, and the requirement for this should be structured into the grant.”<sup>12</sup> This way, much-needed program funds aren’t diverted into research. Local and state health departments can help by matching CBOs and researchers and then fostering the collaboration.

In addition to requiring adequate funding, collaboration requires time, energy and commitment. Without support for these basic requirements, the ultimate goal of collaboration—more effective HIV prevention—will not be achieved.

<hr />

<h3>Says who?</h3>
1. Kelly JA, Somlai AM, DiFranceisco WJ, et al. Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers . American Journal of Public Health. 2000;90:1082-1088.

2. Schensul JJ. O rganizing community research partnerships in the struggle against AIDS . Health Education &amp; Behavior. 1999; 26:266-283.

3. Holtgrave DR, Qualls NL, Curran JW, et al. An overview of the effectiveness and efficiency of HIV prevention programs . Public Health Reports. 1995;110:134-146.

4. Harper GW, Salinan DD. Building collaborative partnerships to improve community-based HIV prevention research: The university-CBO collaborative partnership (UCCP) model. Journal of Prevention &amp; Intervention in the Community. 2000;19:1-20.

5. Gomez C, Goldstein E. The HIV prevention evaluation initiative: a model for collaborative and empowerment evaluation. In: The Empowerment Evaluation: Knowledge and Tools for Self-Assessment and Accountability . Fetterman, Wandersman and Kaftarian, eds. Sage Publications, 1995.

6. Perkins DD, Wandersman A. “You’ll have to overcome our suspicions”: the benefits and pitfalls of research with community organizations. Social Policy. 1990;21:32-41.

7. James S, Hanvelt R, Copley T. The role of the Community Liaison Researcher- returning research to the community. Presented at the AIDS Impact Conference, Ottawa. July 15-18, 1999.

8. Bey J, Durazzo R, Headlee J, et al. Prevention among african american gay and bisexual men. Presented at the 8th International AIDS Conference, Durban, South Africa. Abst# WePeD4523.

9. Haynes Sanstad K, Stall R, Goldtsein E, et al. Collaborative Community Research Consortium: a model for HIV prevention. Health Education &amp; Behavior. 1999;26:171-184.

10. Goldstein E, Freedman B, Richards A, et al. The Legacy Project: lessons learned about conducting community-based research. Published by the AIDS Research Institute, University of California San Francisco, Science to Community series. 2000. prevention.ucsf.edu/uploads/bibindex.php .

11. Acuff C, Archambeault J, Greenberg B, et al. Mental health care for people living with or affected by HIV/AIDS: A practical guide. Published by the Research Triangle Institute. 1999. #6031.

12. DiFranceisco W, Kelly JA, Otto-Salaj L. Factors influencing attitudes within AIDS service organizations toward the use of research-based HIV prevention interventions . AIDS Education and Prevention. 1999;11:72-86.

<strong>Resources:</strong>

<strong>Behavioral and Social Science Volunteer Program (BSSV)</strong>
American Psychological Association
750 First Street, N.E.
Washington, D.C., 20002-4242
202/218-3993 Fax: 202/336-6198
e-mail: bssv@apa.org
www.apa.org/pi/aids/bssv.php

<strong>HIV Community-Based Research</strong>
www.cbrc.net

<strong>Loka Institute</strong>
PO Box 355
Amherst, MA 01004
413/559-5860
www.loka.org

<hr />

<strong>PREPARED BY Ellen Goldstein MA*, Beth Freedman MPH*, Dan Wohlfeiler MPH**
*CAPS, **STD Prevention Training Center</strong>

April 2001. Fact Sheet #40E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. ©April 2001, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/collabFS.pdf</url>
	</node>
	<node>
		<title>Colaboración entre proveedores e investigadores</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo pueden colaborar los proveedores de servicio y los investigadores?</h3>
<h4>¿por qué colaborar?</h4>
<blockquote><em>“La investigación sobre la prevención del VIH-por muy buena que sea-no detiene la infección del VIH. La investigación del comportamiento sobre el VIH sólo puede detener la infección del VIH si sus resultados se utilizan en el mejoramiento de programas ya implementados.”<sup>1</sup> -Jeff Kelly</em></blockquote>
Toda persona que trabaja en el área de prevención de VIH quiere lograr disminuir la propagación del VIH. Cuando los investigadores y las agencias comunitarias (CBO por sus siglas en inglés) colaboran es posible mejorar los programas comunitarios, las investigaciones científicas y por consiguiente los esfuerzos de prevención del VIH.

Para evaluar y realizar programas de prevención que sean útiles en las comunidades, los investigadores han de comprender cómo funcionan los programas de educación para la salud y de organización comunitaria, cómo tener acceso a las poblaciones que estudian (las mismas que atienden las CBO), y las maneras mas útiles de divulgación de resultados. Estos recursos se obtienen al colaborar con las CBO y pueden contribuir al mejoramiento de las investigaciones.<sup>2</sup>

La misión de muchas CBO es impartir programas, no evaluarlos. Éstas podrían requerir de colaborar con investigadores al utilizar intervenciones ya comprobadas, evaluar programas en operación o para incorporar elementos teóricos en el diseño de una intervención. Trabajar con los investigadores puede ayudar a mejorar los programas.<sup>3</sup> En EEUU los financiamientos federales, estatales, locales y privados requieren cada vez más que las CBO utilicen la teoría en el diseño de sus programas y que evaluen estos programas.
<h4>¿qué implica la colaboración?</h4>
Los investigadores y proveedores de servicio pueden trabajar juntos de muchas formas, y el grado de colaboración puede variar. La colaboración puede ser una acción simple y de corta duración, como ayudar a una CBO en la formulación de preguntas para una encuesta o cuando los investigadores quieren saber más sobre la población que las CBO sirven. Aún si la relación entre investigador y proveedor de servicios es limitada, hay maneras de combinar la experiencia y las habilidades de ambos y de optimizar los resultados del trabajo en conjunto.

La colaboración también puede ser relativamente compleja y requerir de tiempo y recursos. Los proveedores de servicio y los investigadores pueden colaborar en la evaluación de programas, diseño de programas, y/o en el análisis datos. Generalmente, esta colaboración implica 1) seleccionar al colaborador (ya sea el investigador o la CBO); 2) crear la relación entre sí; 3) decidir qué se va a investigar (la pregunta de investigación); 4) conducir la investigación o la evaluación; 5) analizar e interpretar la información; 6) divulgar los resultados.<sup>4</sup> El último paso en la colaboración podría implicar la creación de programas basados en los resultados de la investigación.
<h4>¿qué obstáculos enfrenta la colaboración?</h4>
La colaboración puede ser interpretada como el encuentro entre dos culturas: la cultura de la investigación y la de las CBO. Tanto investigadores como proveedores de servicio poseen culturas de trabajo particulares que incluyen ciertas normas, incentivos, lenguaje, percepción de tiempos, recursos, capacitación, educación y expectativas que a menudo difieren entre sí.<sup>5</sup> Por ejemplo, las CBO deben resolver las necesidades inmediatas de sus afiliados mientras que los investigadores generalmente trabajan en proyectos de 2-5 años de duración con objetivos a largo plazo.

A menudo las CBO desconfían de los investigadores pues se sienten “usadas” por los mismos para la recolección sus datos, toman todo el crédito y no proporcionan la información a cambio.<sup>6</sup> También llegan a sentir que los investigadores tienen un exceso de recursos; por ejemplo, el personal de una CBO llega a recibir salarios muy por debajo de los que sus colaboradores investigadores reciben.

Por otro lado los investigadores a menudo se frustran por el ritmo acelerado de las CBO, la falta de personal y la falta de prioridad para las actividades de investigación. Cuando la CBO y el investigador colaboran en un proyecto, existe un desbalance de poder inherente. A los investigadores se les percibe como “expertos” por su grado académico. La sabiduría de las CBO-conocimiento de la comunidad, del funcionamiento de intervenciones y su acceso a la población-algo que los investigadores subestiman y pasan por alto.
<h4>¿qué se está haciendo?</h4>
Un método sencillo pero vital de colaboración es asegurarse que los datos recolectados por el investigador estén a disponibilidad de la CBO. La Universidad de British Columbia en Canadá, realizó un estudio a gran escala sobre cómo utilizan los sistemas de salud y los recursos comunitarios las personas que viven con VIH/SIDA. Después del estudio, se contrató a un investigador de enlace comunitario para que trabajara con las CBO y juntos determinaran las necesidades de información de las mismas y analizaran la enorme y valiosa base de datos del estudio para ser usada en los programas de las CBO.<sup>7</sup>

Otro método de colaboración más complejo, implica trabajar juntos desde el inicio para el desarrollo de programas. La Fundación de SIDA de San Francisco (SFAF sus siglas en inglés) quería entender porqué los hombres gay/bisexuales continuaban infectándose con el VIH, por lo que inició una investigación cualitativa con hombres de alto riesgo en colaboración con CAPS-UCSF. La SFAF y los investigadores se reunían semanalmente a comentar la pregunta de investigación, el diseño del instrumento y a discutir las transcripciones de entrevistas. Desarrollaron y evaluaron dos intervenciones y una campaña publicitaria. Como producto de esta colaboración, los programas Gay Life y Black Brothers Esteem continúan operando.<sup>8</sup>

La colaboración a menudo requiere del apoyo de una infraestructura sólida. En San Francisco, la iniciativa de colaboración de CAPS brindó fondos, capacitación, supervisión, asistencia técnica y compaginó investigadores con CBO para efectuar la evaluación de programas. Esta iniciativa fue financiada conjuntamente por la universidad y fundaciones privadas. Las CBO formularon las preguntas de investigación y realizaron la evaluación con ayuda de los investigadores. Los resultados fueron divulgados en foros públicos y a través de un ejemplar especial de una revista científica. Este modelo colaborativo ha sido replicado a lo largo de los EEUU.<sup>9</sup>
<h4>¿cuáles son las mejores prácticas?</h4>
Aunque colaborar puede ser una actividad intensa de trabajo y de recursos, los beneficios para la CBO, el investigador y el campo de la prevención del VIH ameritan la inversión. Las siguientes recomendaciones pueden ayudar a asegurar una experiencia satisfactoria:<sup>10,11</sup>
<ul>
 	<li>Escoger cuidadosamente al colaborador (CBO o investigador). Entrevistar varios individuos y agencias. Pedir y revisar sus referencias.</li>
 	<li>La agencia debe generar un interés y sentido de pertenencia entre sus directivos y su personal hacia el proyecto.</li>
 	<li>Definir roles y responsabilidades clara y repetidamente.</li>
 	<li>Planear y presupuestar el tiempo empleado por el investigador y la CBO para comunicarse y reunirse.</li>
 	<li>Resolver conflictos en la medida que surjan.</li>
 	<li>Tener flexibilidad en cuanto a posibles cambios en el ámbito y/o amplitud de la investigación.</li>
 	<li>Anticipar cambios de personal y anticipar tiempo para orientar y adiestrar al nuevo personal.</li>
 	<li>Ayudar a capacitar a la agencia antes de iniciar una investigación .La investigación formativa, la descriptiva y la de desarrollo teórico son de mucha utilidad; la evaluación de los resultados no es siempre la mejor opción para nuevas intervenciones o nuevas CBO.</li>
 	<li>Diseñar una investigación que tenga “una protección”, es decir, si se está evaluando una nueva intervención, quizá se deba incluir desde el inicio preguntas de investigación alternas.</li>
 	<li>Planear estrategias de divulgación a la comunidad en todas las fases de la investigación.</li>
 	<li>Monitorear conjuntamente el control de calidad de la investigación.</li>
 	<li>Asegurar que se tengan los recursos y apoyo adecuados para el momento de la intervención y de la evaluación.</li>
</ul>
<h4>¿qué sostiene a la colaboración?</h4>
Existen algunas iniciativas recientes por medio de becas y subvenciones federales, privadas y universitarias. Sin embargo los proveedores de fondos deben continuar designando dinero para el trabajo conjunto entre investigadores y CBO, y este requisito deberá estar estructurado dentro de la propuesta de solicitud de fondos (grant);<sup>12</sup> así los fondos tan requeridos para los programas no irán sólo hacia la investigación. La colaboración, además de requerir de fondos adecuados requiere de tiempo, energía y compromiso. Sin éstos requerimientos básicos la meta final de la colaboración-una prevención del VIH más efectiva-no se logrará.

<hr />

<h4>¿quién lo dice?</h4>
1. Kelly JA, Somlai AM, DiFranceisco WJ, et al. Bridging the gap between the science and service of HIV prevention: transferring effective research-based HIV prevention interventions to community AIDS service providers . American Journal of Public Health. 2000;90:1082-1088.

2. Schensul JJ. O rganizing community research partnerships in the struggle against AIDS . Health Education &amp; Behavior. 1999; 26:266-283.

3. Holtgrave DR, Qualls NL, Curran JW, et al. An overview of the effectiveness and efficiency of HIV prevention programs . Public Health Reports. 1995;110:134-146.

4. Harper GW, Salinan DD. Building collaborative partnerships to improve community-based HIV prevention research: The university-CBO collaborative partnership (UCCP) model. Journal of Prevention &amp; Intervention in the Community. 2000;19:1-20.

5. Gomez C, Goldstein E. The HIV prevention evaluation initiative: a model for collaborative and empowerment evaluation. In: The Empowerment Evaluation: Knowledge and Tools for Self-Assessment and Accountability . Fetterman, Wandersman and Kaftarian, eds. Sage Publications, 1995.

6. Perkins DD, Wandersman A. “You’ll have to overcome our suspicions”: the benefits and pitfalls of research with community organizations. Social Policy. 1990;21:32-41.

7. James S, Hanvelt R, Copley T. The role of the Community Liaison Researcher- returning research to the community. Presented at the AIDS Impact Conference, Ottawa. July 15-18, 1999.

8. Bey J, Durazzo R, Headlee J, et al. Prevention among african american gay and bisexual men. Presented at the 8th International AIDS Conference, Durban, South Africa. Abst# WePeD4523.

9. Haynes Sanstad K, Stall R, Goldtsein E, et al. Collaborative Community Research Consortium: a model for HIV prevention. Health Education &amp; Behavior. 1999;26:171-184.

10. Goldstein E, Freedman B, Richards A, et al. The Legacy Project: lessons learned about conducting community-based research. Published by the AIDS Research Institute, University of California San Francisco, Science to Community series. 2000.

11. Acuff C, Archambeault J, Greenberg B, et al. Mental health care for people living with or affected by HIV/AIDS: A practical guide. Published by the Research Triangle Institute. 1999. #6031.

12. DiFranceisco W, Kelly JA, Otto-Salaj L. Factors influencing attitudes within AIDS service organizations toward the use of research-based HIV prevention interventions . AIDS Education and Prevention. 1999;11:72-86.
<h4>Recursos:</h4>
<strong>Behavioral and Social Science Volunteer Program (BSSV)</strong>
American Psychological Association
750 First Street, N.E. Washington, D.C., 20002-4242
202/218-3993 Fax: 202/336-6198
e-mail: bssv@apa.org
www.apa.org/pi/aids/bssv.html

<strong>HIV Community-Based Research</strong>
www.cbrc.net

<strong>Loka Institute</strong>
PO Box 355
Amherst, MA 01004
413/559-5860
www.loka.org

<hr />

<strong>Preparado por Ellen Goldstein MA*, Beth Freedman MPH*, Dan Wohlfeiler MPH**;
Traducción Romy Benard-Rodríguez y Maricarmen Arjona
*CAPS, **STD Prevention Training Center</strong>

Septiembre 2001. Hoja Informativa 40S]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/colaboracionFS.pdf</url>
	</node>
	<node>
		<title>Theory</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of theory in HIV prevention?</h3>
<h4>What is theory and how can it help?</h4>
A theory describes what factors or relationships influence behavior and/or environment and provides direction on how to impact them. Theories used in HIV prevention are drawn from several disciplines, including psychology, sociology and anthropology. A theory becomes formalized when it is carefully tested with the results repeatable in a number of different settings, and generalizable to various communities.<sup>1</sup>

Both formal and informal (or implicit) theories first begin with an individual’s observation about a person or phenomenon. Informal theories—those conceived by service providers— are not usually “tested,” yet these intuitive beliefs about why people do what they do are very useful and often similar to concepts found in formal theories conceived by academics.

Theories can help providers frame interventions and design evaluation. When designing or choosing an intervention, theory can show what factors should be targeted and where to focus interventions. Theories can help define the expected outcome of an intervention for evaluation purposes. Also, basing programs on a tested theory gives it scientific support, especially if the program hasn’t been evaluated.<sup>2</sup>

HIV prevention providers are frequently required to use theory in the development of prevention interventions. It’s common, though, for providers to pick a theory based on their intervention. Because many providers are not trained or supported in using theory, they can miss the opportunity to use it as a process for thinking critically about a community in the development of programs.
<h4>How can theory guide programs?</h4>
Answering the questions in the framework below can help in selecting the most appropriate theories and interventions for a particular community:<sup>3</sup>
<ol>
 	<li>Which communities/populations are targeted for services?</li>
 	<li>What are the specific behaviors that put them at risk for HIV/STDS?</li>
 	<li>What are the factors that impact risk-taking behaviors?</li>
 	<li>Which factors are the most important and can be realistically addressed?</li>
 	<li>What theory(ies) or models best address the identified factors?</li>
 	<li>What kind of intervention can best address above factors?</li>
</ol>
Behaviors that place people at risk for STDS/HIV acquisition and transmission are often the result of many complex factors operating at multiple levels. Theories of behavior change usually address one or more these levels and include individual, interpersonal, community, and structural and environmental factors. Many researchers and providers use a combination of factors from several theories to guide their programs. Following are select theories and models and examples of programs that use them.
<h4>Structural and policy level</h4>
These theories look at societal and environmental influences on health, including laws, policies, customs, economic conditions and social inequalities (e.g. racism, classism, sexism). <strong>Social Disorganization Theory</strong> states that where social institutions, norms and values are no longer functioning, high rates of violence, drug abuse, poverty and disease occur. <strong>Theory of Gender and Power</strong> views the differences in labor, power dynamics, and relationship-investment between women and men as structures that can produce inequalities for women and increase women’s risk and vulnerability to HIV.<sup>5</sup>

Family to Family is a structural intervention that strengthens family functioning and the bonds that connect families to each other in Harlem, NY. Designed to address a broad range of social issues, the program seeks to foster strong relationships in a community with high rates of violence, drug abuse and HIV infection, thus influencing the social determinants of individual risk behavior.<sup>6</sup>
<h4>Community level</h4>
<strong>Empowerment Education Theory</strong>, based on Paulo Freire’s popular education model, engages groups to identify and discuss problems.<sup>7</sup> Once the issue is fully understood by community members, solutions are jointly proposed, agreed, and acted upon. This seeks to promote health by increasing people’s feelings of power and control over their lives. <strong>Diffusion of Innovation</strong> helps understand how new ideas or behaviors are introduced to, and are spread into and then accepted by a community.<sup>8</sup>

Voices of Women of Color Against HIV/AIDS (VOW) in New York City, is a community organizing intervention based on empowerment theory that aims to increase the involvement of women of color in all aspects of HIV prevention. Women meet monthly to discuss HIV/AIDS issues. VOW organizes trainings on topics of highest concern, and helps women advocate for formulating or changing policies. VOW has met with legislators, given public testimony and organized a women’s policy conference.<sup>9</sup>
<h4>Interpersonal level</h4>
<strong>Social Cognitive Theory</strong> views the adoption of behaviors as a social process influenced by interactions with a person and others in their environment.<sup>10</sup> Two primary components of this theory are: 1) modeling of behaviors we see others performing, and 2) self-efficacy, a person’s belief that s/he is capable of performing the new behavior in the proposed situation. <strong>Social Support/Social Networks</strong> describes the impact of social relationships on health and well-being, where social networks refers to a web of social relationships and social support is the aid and assistance received through those relationships.<sup>11</sup>

Lista Para Accion is an intervention in Long Beach, CA, that works with Latino gay men and is based on social support and social cognitive theories. The program features four skills-based workshops held in a local Latino dance club. Participants who complete all four workshops can become “Compadres” or community leaders who serve as a support network or “second family” for new workshop participants.<sup>12</sup>
<h4>Individual level</h4>
The <strong>Health Belief Model</strong> proposes that in order for persons to change their behaviors they must first believe they are susceptible to a particular condition, and that the severity of that condition is serious.<sup>13</sup> <strong>Stages of Change</strong>explains the process of incremental behavior change, from having no intentions to changing, to maintaining safer behaviors.<sup>14</sup> The five stages are: Precontemplation, Contemplation, Preparation, Action and Maintenance. <strong>Theory of Reasoned Action</strong> sees intention as the main influence on behavior.<sup>15</sup> Intentions are a combination of attitudes toward the behavior as well as perceived opinions of peers, both heavily influenced by social norms.

Students Together Against Negative Decisions (STAND) is a peer educator training in a rural Georgia county that is based on stages of change and diffusion of innovations theories. HIV prevention training topics are sequenced to match each of the stages of change. STAND prepares teens to initiate conversations with their peers about sexual risk reduction, then assess a person’s stage of change and suggest specific activities. Peer educators reported a sevenfold larger increase in condom use and a 30% decrease in unprotected intercourse.<sup>16</sup>
<h4>What else is there?</h4>
Besides tested and implicit theories, there are strategies that are used as frameworks for programs. <strong>Harm Reduction</strong> accepts that while harmful behaviors exist, the main goal is to reduce their negative effects.<sup>17</sup> <strong>Community Organizing/Mobilization</strong> approaches encourage communities to advocate for healthier conditions in their lives.<sup>18</sup>

Providers have tremendous insight into what puts their clients at risk for HIV and why. Funders need to accept both tested and implicit theories as a valid base for programs, which often go beyond HIV prevention to address violence, poverty and drug abuse.

<hr />

<h3>Says who?</h3>
1. Goldman KD, Schmalz KJ. Theoretically speaking: overview and summary of key health education theories. Health Promotion Practice. 2001:2;277-281.

2. Centers for Disease Control and Prevention. Evaluating CDC-Funded Health Department HIV Prevention Programs. December 1999.http://www.cdc.gov/hiv/aboutdhap/perb/hdg.htm

3. Freeman A, Vogan S, Rietmeijer K, et al. Bridging theory and practice: a course on apply-ing behavioral theory to STD/HIV prevention. Presented at National HIV Prevention Conference, Atlanta, GA; 1999. Abst #263.

4. Elliott MA, Merrill FE. Social disorganization. New York, NY: Harper; 1961.

5. Wingood GM, DiClemente RJ. Application of the theory of gender and power to examine HIV-related exposures, risk factors and effective interventions for women. Health Education and Behavior. 2000;27:539-565.

6. Fullilove RE, Green L, Fullilove MT. The Family to Family pro-gram: a structural intervention with implications for the prevention of HIV/AIDS and other community epidemics. AIDS. 2000;14S1;S63-S67.

7. Wallerstein N. Powerlessness, empowerment and health: implications for health promotion programs. American Journal of Health Promotion. 1992;6:197-205.

8. Rogers EM. Diffusion of Innovations. Third edition. New York, NY: The Free Press:1983.

9. Elcock S, Goodman D. Women of color doing it for ourselves: HIV prevention policies. Presented at the National HIV Prevention Conference, Atlanta , GA. 1999, Abst. #443.

10. Bandura A. Social cognitive theory and exercise of control over HIV infection. In DiClemente RJ (ed) Preventing AIDS: Theories and Methods of Behavioral Interventions. New York, NY: Plenum Press; 1994.

11. Glanz K, Marcus Lewis F, Rimer BK, Eds. Health Behavior and Health Education: Theory, Research and Practice. 2nd Edition. San Francisco: Jossey-Bass, Inc. 1997.

12. Buitron M, Corby N, Rhodes F. Creating a culturally appropriate behavioral prevention intervention for Spanish speaking gay men from an existing risk-reduction program. Presented at the International Conference on AIDS, Geneva, Switzerland, 1998. Abst # 335553.

13. Rosenstock IM, Strecher VJ, Becker MH. The health belief model and HIV risk behavior change. In DiClemente RJ (ed) Preventing AIDS: Theories and Methods of Behavioral Interventions. New York, NY: Plenum Press; 1994.

14. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. American Psychologist. 1992;47:1102-1114.

15. Fishbein M, Middlestadt SE. Using the theory of reasoned action as a framework for under-standing and changing AIDS-related behaviors. In Wasserheit JN (ed) Primary Prevention of AIDS: Psychological Approaches. 1989.

16. Smith MU, DiClemente RJ. STAND: A peer educator training curriculum for sexual risk reduction in the rural South. Preventive Medicine. 2000;30:441-449.

17. Brettle RP. HIV and harm reduction for injection drug users. AIDS. 1991;5:125-136.

18. Community organizing and community building for health. M Minkler, ed. New Brunswick, NJ: Rutgers University Press. 1997.

<hr />

<strong>PREPARED BY ALICE GANDELMAN MPH*, BETH FREEDMAN MPH**
*California HIV/STD Prevention Training Center,**CAPS</strong>

<strong>January 2002. Fact Sheet #14ER</strong>

Special thanks to the following reviewers of this Fact Sheet: David Cotton, Pat Coury-Doniger, Ann Freeman, Andy Handler, Julie Lifshay, Matthew Staley, Javid Syed.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © February 2002, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/theoryFS.pdf</url>
	</node>
	<node>
		<title>Teoría</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué papel juega la teoria en la prevención del VIH?</h3>
<h4>¿qué es la teoría y en qué puede ayudar?</h4>
Una teoría describe los factores o las relaciones que influencian la conducta o el ambiente, y sirve de guía para modificar estos últimos. Las teorías empleadas en la prevención provienen de varios campos que incluyen la psicología, sociología y antropología. Las teorías se formalizan por medio de un proceso de comprobación cuidadosa. Los resultados de esta comprobación deben ser repetibles en varios ambientes diferentes y generalizables a varias comunidades.<sup>1</sup>

Tanto las teorías formales como las informales (o implícitas) comienzan con observaciones sobre personas o fenómenos. Por lo general las teorías informales (aquellas ideadas por proveedores de servicios) no se comprueban formalmente. Sin embargo, estas creencias intuitivas sobre por qué las personas hacen lo que hacen son muy útiles y muchas veces son similares a los conceptos de las teorías formales ideadas por académicos.

Las teorías pueden ayudar a enmarcar las intervenciones y a diseñar evaluaciones. Al diseñar o escoger una intervención, la teoría puede dar una idea de los factores que se deben tomar en cuenta y en qué aspectos se debe enfocar. Las teorías pueden ayudar a definir el resultado que se espera de la intervención para fines de evaluación. También, basar el programa en una teoría comprobada le da apoyo científico, especialmente si el programa no ha sido evaluado.<sup>2</sup>

Muchos financiadores de proyectos requieren que los proveedores de servicios de prevención del VIH empleen la teoría para crear intervenciones preventivas. Sin embargo, es común que los proveedores escojan una teoría en función de su intervención. Ya que muchos proveedores no están capacitados ni apoyados para usar la teoría, ellos pueden perder la oportunidad de usarla como un proceso para pensar críticamente sobre una comunidad durante la creación de programas.
<h4>¿cómo puede la teoría guiar programas?</h4>
Contestar las siguientes preguntas puede ayudar a escoger las teorías e intervenciones más adecuadas para una comunidad en particular:<sup>3</sup>
<ol>
 	<li>¿Qué comunidades o grupos se beneficiarán con los servicios?</li>
 	<li>¿Cuales son las conductas concretas los ponen en riesgo de contraer el VIH/las ETS?</li>
 	<li>¿Qué factores tienen algún efecto sobre estas conductas riesgosas?</li>
 	<li>¿Cuáles son los factores más importantes que realmente se pueden modificar?</li>
 	<li>¿Qué teoría(s) o modelo(s) servirán mejor para los factores identificados?</li>
 	<li>¿Qué tipo de intervención servirá mejor para estos factores?</li>
</ol>
Frecuentemente, las conductas que ponen a las personas en riesgo de contraer y transmitir las ETS/el VIH son el resultado de muchos factores complicados que operan en varios niveles. Las teorías de cambio conductual usualmente abordan uno o más de estos niveles e incluyen factores individuales, interpersonales/grupales, comunitarios, estructurales y ambientales. Muchos investigadores y proveedores usan una combinación de factores de varias teorías para guiar sus programas. A continuación describimos algunas teorías y modelos así como ejemplos de programas que los emplean. Las teorías están organizadas por nivel de implementación, pero muchas se pueden usar en varios niveles diferentes.
<h4>nivel estructural y politico</h4>
Estas teorías examinan las influencias sociales y ambientales sobre la salud, incluyendo leyes, normas, costumbres, condiciones económicas y desigualdades sociales. L<strong>a Teoría de Desorganización Social</strong> sostiene que cuando las instituciones, normas y valores sociales dejan de funcionar, ocurren altas incidencias de violencia, abuso de drogas, pobreza y enfermedades.<sup>4</sup> <strong>La Teoría de Ecología Social</strong> afirma que los ambientes sociales, culturales y físicos forman la conducta, por lo tanto las intervenciones no deben enfocarse en el individuo sino en estos ambientes.<sup>5</sup> <strong>La Teoría de Género y Poder</strong> considera las diferencias entre hombres y mujeres con respecto al trabajo, la dinámica de poder y la inversión en relaciones como estructuras que pueden generar desigualdades para la mujer y aumentar su riesgo y vulnerabilidad con respecto al VIH.<sup>6</sup>

“Family to Family” es una intervención estructural que fortalece el funcionamiento de la familia y los lazos entre familiares en Harlem, NY. Diseñado para responder a una amplia gama de situaciones sociales, el programa busca promover relaciones fuertes en una comunidad con altas tasas de violencia, abuso de drogas e infección por VIH. De esta manera el programa busca influenciar los determinantes sociales de la conducta arriesgada de los individuos.<sup>7</sup>
<h4>nivel comunitario</h4>
<strong>La Teoría de la Educación de Apoderamiento</strong>, basada en el modelo de educación popular de Paulo Freire, involucra a grupos para que identifiquen y comenten problemas sociales.<sup>8</sup> Una vez que los miembros de la comunidad entiendan el tema completamente, ellos proponen y concuerdan soluciones y las ponen en práctica. Este método buscar promover la salud al incrementar los sentimientos de poder y control que tienen las personas sobre su vida. <strong>La Difusión de Innovaciones</strong> explica cómo ideas o conductas nuevas son introducidas en la comunidad y cómo la comunidad las difunde hasta llegar a aceptarlas.<sup>9</sup>

Las Voces de Mujeres de Color Contra el VIH/SIDA (VOW, siglas en inglés) en la ciudad de Nueva York, es una intervención de organización de comunidades basada en la teoría de apoderamiento que busca aumentar la participación de mujeres de color en todos los aspectos de la prevención del VIH. Las mujeres se reúnen cada mes para hablar sobre el VIH/SIDA. VOW organiza capacitaciones y ayuda a las mujeres a promover la creación o modificación de políticas y normas. VOW se ha reunido con legisladores, ha dado testimonio público y ha organizado un congreso para mujeres sobre la política pública.<sup>10</sup>
<h4>nivel interpersonal/grupal</h4>
Según<strong> la Teoría Social Cognitiva</strong>, la adopción de conductas es un proceso social influenciado por las interacciones entre el individuo y otras persona en su entorno.<sup>11</sup> Dos componentes principales de esta teoría son: 1) la imitación de conductas que vemos en otras personas: y 2) la autoeficacia: la creencia de que uno es capaz de realizar la nueva conducta en la situación propuesta. <strong>La Teoría de Redes Sociales/Apoyo Social</strong> describe el efecto de las relaciones sociales sobre la salud y el bienestar. Redes Sociales se refiere a una red de relaciones sociales y el Apoyo Social es la ayuda que se obtiene por medio de estas relaciones.<sup>5</sup>

Listo Para Acción es una intervención en Long Beach, CA entre hombres homosexuales latinos que está basada en las teorías de apoyo social y cognitiva social. El programa ofrece en una discoteca latina cuatro talleres para desarrollar habilidades. Los participantes que completen los cuatro talleres pueden convertirse en “compadres” o líderes que luego sirven como una red de apoyo o segunda familia para los nuevos participantes de los talleres.<sup>12</sup>
<h4>nivel individual</h4>
<strong>El Modelo de Creencias sobre la Salud</strong> propone que antes de poder cambiar su conducta, las personas deben creer primero que son vulnerables a cierta condición y percibirla como una condición grave.<sup>13</sup> <strong>Los Estadíos de Cambio</strong>explica el proceso de cambios incrementales, desde no tener ninguna intención de cambiar, hasta lograr mantener conductas más seguras.<sup>14</sup> Los cinco estadíos son: Precontemplación, Contemplación, Preparación, Acción y Mantenimiento. <strong>La Teoría de Acción Razonada</strong> ve la intención como la influencia primordial sobre la conducta.<sup>15</sup> Las intenciones son una combinación de actitudes hacia la conducta y percepciones de las opiniones de los pares. Las normas sociales tienen una influencia muy fuerte sobre ambas.

Estudiantes Unidos Contra las Decisiones Negativas (STAND, siglas en inglés) es un programa de capacitación de pares en un condado de Georgia. STAND se basa en las teorías de estadíos de cambio y difusión de innovaciones. Presentando temas de capacitación en prevención del VIH en secuencia de acuerdo con cada estadío de cambio, STAND prepara a los jóvenes para que inicien conversaciones con sus pares sobre cómo reducir el riesgo durante el sexo, y después evalúen su estadío de cambio y les sugieran actividades concretas. Los participantes reportaron un aumento en su uso de condones y una reducción de la penetración sexual sin protección.<sup>16</sup>
<h4>¿qué más hay?</h4>
Aparte de las teorías comprobadas y las implícitas, existen estrategias que se usan como marcos para los programas. La Reducción de Daños acepta que mientras existan los comportamientos dañinos, el objetivo principal es reducir sus efectos negativos.<sup>17</sup> La Organización/Movilización de Comunidades anima a las comunidades a defender sus derechos de vivir en condiciones más saludables.<sup>18</sup>

Los proveedores tienen mucha información sobre los peligros que sus clientes corren con respecto al VIH y las razones de estos riesgos. Por lo tanto, ellos deben asegurarse de que sus programas se basen en sus propias teorías o en otras teorías comprobadas, y quienes financian los programas deben aceptar ambos tipos de teoría como una base válida para los programas.

<hr />

<h4>¿quién lo dice?</h4>
1. Goldman KD, Schmalz KJ. Theoretically speaking: overview and summary of key health education theories. Health Promotion Practice. 2001:2;277-281.

2. Centers for Disease Control and Prevention. Evaluating CDC-Funded Health Department HIV Prevention Programs. December 1999.http://www.cdc.gov/hiv/aboutdhap/perb/hdg.htm

3. Freeman A, Vogan S, Rietmeijer K, et al. Bridging theory and practice: a course on apply-ing behavioral theory to STD/HIV prevention. Presented at National HIV Prevention Conference, Atlanta, GA; 1999. Abst #263.

4. Elliott MA, Merrill FE. Social disorganization. New York, NY: Harper; 1961.

5. Wingood GM, DiClemente RJ. Application of the theory of gender and power to examine HIV-related exposures, risk factors and effective interventions for women. Health Education and Behavior. 2000;27:539-565.

6. Fullilove RE, Green L, Fullilove MT. The Family to Family pro-gram: a structural intervention with implications for the prevention of HIV/AIDS and other community epidemics. AIDS. 2000;14S1;S63-S67.

7. Wallerstein N. Powerlessness, empowerment and health: implications for health promotion programs. American Journal of Health Promotion. 1992;6:197-205.

8. Rogers EM. Diffusion of Innovations. Third edition. New York, NY: The Free Press:1983.

9. Elcock S, Goodman D. Women of color doing it for ourselves: HIV prevention policies. Presented at the National HIV Prevention Conference, Atlanta , GA. 1999, Abst. #443.

10. Bandura A. Social cognitive theory and exercise of control over HIV infection. In DiClemente RJ (ed) Preventing AIDS: Theories and Methods of Behavioral Interventions. New York, NY: Plenum Press; 1994.

11. Glanz K, Marcus Lewis F, Rimer BK, Eds. Health Behavior and Health Education: Theory, Research and Practice. 2nd Edition. San Francisco: Jossey-Bass, Inc. 1997.

12. Buitron M, Corby N, Rhodes F. Creating a culturally appropriate behavioral prevention intervention for Spanish speaking gay men from an existing risk-reduction program. Presented at the International Conference on AIDS, Geneva, Switzerland, 1998. Abst # 335553.

13. Rosenstock IM, Strecher VJ, Becker MH. The health belief model and HIV risk behavior change. In DiClemente RJ (ed) Preventing AIDS: Theories and Methods of Behavioral Interventions. New York, NY: Plenum Press; 1994.

14. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. American Psychologist. 1992;47:1102-1114.

15. Fishbein M, Middlestadt SE. Using the theory of reasoned action as a framework for under-standing and changing AIDS-related behaviors. In Wasserheit JN (ed) Primary Prevention of AIDS: Psychological Approaches. 1989.

16. Smith MU, DiClemente RJ. STAND: A peer educator training curriculum for sexual risk reduction in the rural South. Preventive Medicine. 2000;30:441-449.

17. Brettle RP. HIV and harm reduction for injection drug users. AIDS. 1991;5:125-136.

18. Community organizing and community building for health. M Minkler, ed. New Brunswick, NJ: Rutgers University Press. 1997.

<hr />

<strong>Preparado por Alice Gandelman MPH* y Beth Freedman MPH**
*California HIV/STDS Prevention Training Center,**CAPS</strong>

<strong>Tradución Rocky Schnaath</strong>

<strong>Abril 2002. Hoja Informativa 14SR</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/teoriarevFS.pdf</url>
	</node>
	<node>
		<title>Using science</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How Is Science Used in HIV Prevention?</h3>
<h4>Is science needed?</h4>
Yes. While prevention science will not give “the answer,” science fills in critical pieces of the prevention puzzle. Science used in conjunction with an agency’s experience with clients can strengthen, inspire, target, and best use limited resources in HIV prevention programs. This fact sheet will cover some of the basic elements of prevention science, what they mean, and their implications for service.

Using science in prevention is now mandated in many areas. In 1994, the Centers for Disease Control and Prevention (CDC) radically changed how it makes prevention program awards. The CDC’s guidance recommends that HIV Prevention Community Planning Groups (CPGs) use epidemiology, evaluation and behavioral science theories, findings, and methodologies in developing programs.<sup>1</sup>
Science that is applicable to HIV prevention can be broken down into five general categories:
<ul>
 	<li>epidemiology,</li>
 	<li>basic behavioral science,</li>
 	<li>behavior change theory,</li>
 	<li>intervention science, and</li>
 	<li>evaluation methodology.</li>
</ul>
<h4>How is epidemiology useful?</h4>
Epidemiology is the study of the occurrence of infections or disease in a population. It can tell you how many people are newly infected with HIV, what subpopulations have been infected, and who might be expected to be infected by HIV in the future. Behavioral epidemiology can tell you about the frequency of risk behaviors.<sup>2</sup> Using local epidemiology can help program planners target specific audiences and behavior risks that are most in need of prevention in their community. It can also help planners be more thoughtful about how to best use limited resources. Health departments and the CDC can help by collecting local data for all populations.<sup>3</sup>
<h4>How is behavioral science useful?</h4>
Basic behavioral science explores the social, behavioral and cultural influences that help explain why people put themselves at risk, and why people continue to get infected with HIV. Research on human sexuality is key to understanding how people change risky sexual behaviors and can help in program design.<sup>4</sup> It does not tell service providers what to do, but can suggest new ways of thinking about program elements.

For example, recent research has shown that childhood sexual abuse is a predictor for risky sexual behavior in adulthood.<sup>5</sup> Knowing this, program managers can incorporate questions on early abuse into needs assessments, add a segment on childhood abuse to multi-session education interventions, develop new programs for adults who were abused and/or give special training to direct service staff on sexual abuse issues.
<h4>How is behavior change theory useful?</h4>
Behavior change theory provides a framework to ideas on why and how people change behaviors that put them at risk for HIV infection. Using behavior change theories can help when crafting an intervention, to support each component in a model as the intervention is designed.<sup>6,7</sup>

For example, Paulo Freire’s theory of Popular Education states that teachers and students should learn from one another.<sup>8</sup> Using this theory, a program can use discussion groups as opposed to lectures. This format can strengthen the intervention by empowering people to personally develop their own solutions to change their environment.
<h4>How is intervention science useful?</h4>
Intervention science explores which components of programs are more effective and which programs work well in certain populations. For example, in a recent study, the riskiest people did not attend small group educational sessions. A program for gay/ bisexual men in Portland, OR conducted outreach in bars and at community events, home meetings, and safer sex workshops. While most men attended outreach activities, few men were likely to attend safer sex workshops.<sup>9</sup>

Scientific study of the program showed that outreach was most likely to reach the riskiest men-younger men and men who reported unprotected anal intercourse. Interventions aimed at high risk-taking populations can rely on intensive individual outreach/counseling and/or innovative, minimally structured community-level social activities to help draw their intended audience.
<h4>How is evaluation methodology useful?</h4>
Evaluation encourages critical thinking about the process of designing interventions, and should not only occur at the end of an intervention. Good evaluation produces information about needs, service use patterns, impacts and outcomes. It also gives a voice to clients’ experiences, and allows service providers to learn about their programs so that they can make necessary changes to increase their effectiveness.<sup>10</sup> An agency can hire a consultant or researcher for evaluation, or can conduct its own evaluation.

For example, Tri-City Health Center in Fremont, CA surveyed suburban street youth to evaluate the effectiveness of their program of outreach and educational workshops. In response to youth feedback, Tri-City cancelled their scheduled workshops and added a drop-in center providing HIV education as well as support in areas such as dropping out of school, joblessness, substance abuse, abusive relationships and living with HIV.<sup>11</sup>
<h4>How do people access science?</h4>
No one should need an advanced degree to understand prevention science. Several organizations exist to help translate and summarize research into understandable and usable forms. CPGs are directed to incorporate prevention science in their comprehensive plans, which are available through local and state health departments.<sup>12</sup> Local universities (especially schools of public health and social work, departments of sociology, psychiatry/psychology, or anthropology) are an excellent contact for research assistance.<sup>13</sup> Mailing lists and newsletters from organizations that specialize in prevention science and technical assistance can also be invaluable resources.<sup>14</sup>
<h4>What still needs to be done?</h4>
To more closely link the efforts of researchers and service providers: 1) Researchers should share findings with local CBOs and with the CDC and DPHs, as well as become active members of CPGs. 2) CBOs should be more aggressive and proactive in using information outside of their agencies. 3) State DPHs and the CDC should recognize and act upon their role as translators of science. 4) National Institutes of Health, the CDC and private funders should provide adequate funding for integrating prevention science into prevention programs. 5) CBOs and researchers should forge long term partnerships to conduct collaborative projects.<sup>15</sup>

Using science in service provision is a specialized field. Most scientists are not trained in the real world application of research. Likewise, most service providers are not trained in research methods. A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. By closing the gap between HIV prevention science and prevention practice, we can ensure that our best efforts won’t be wasted, and we can make a difference in the fight against HIV.

<hr />

<h3>Says who?</h3>
<ol>
 	<li>Valdiserri RO, Aultman TV, Curran JW. Community planning: a national strategy to improve HIV prevention programs. Journal of Community Health. 1995;20:87-100.</li>
 	<li>Rothman KJ. Modern Epidemiology. Boston, MA: Little, Brown and Company; 1986.</li>
 	<li>A database of epidemiological data for states and some cities is available on the Internet at: http://hivinsite.ucsf.edu/cgi-msql/usa_db1.pl</li>
 	<li>Kelly JA, Kalichman SC. Increased attention to human sexuality can improve HIV-AIDS prevention efforts: key research issues and directions. Journal of Consulting and Clinical Psychology. 1995;63:907-918.</li>
 	<li>Jinich S, Stall R, Acree M, et al. Childhood sexual abuse predicts HIV risk sexual behavior in adult gay and bisexual men. Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Mo.D.1718.</li>
 	<li>Valdiserri RO, West GR, Moore M, et al. Structuring HIV prevention service delivery systems on the basis of social science theory. Journal of Community Health. 1992;17:259-269.</li>
 	<li>Herlocher T, Hoff C, DeCarlo P. Can theory help in HIV prevention? Fact sheet prepared by the Center for AIDS Prevention Studies, UCSF. August 1995.</li>
 	<li>Wallerstein N. Powerlessness, empowerment, and health: implications for health promotion programs. American Journal of Health Promotion. 1992;6:197-205.</li>
 	<li>Hoff CC, Kegeles S., Acree M, et al. Gay men at highest risk are best reached through outreach in bars and community events. Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Tu.D.360.</li>
 	<li>San Francisco HIV Prevention Plan. Report prepared by the San Francisco HIV Prevention Planning Council and the Department of Public Health AIDS Office. 1996.</li>
 	<li>Carver LJ, Harper GW. Responding to the HIV prevention needs of suburban street youth. Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Th.D.4921.</li>
 	<li>For information on your local or state Community Planning group, please contact Lynne Greabell at NASTAD (202) 434-8090.</li>
 	<li>13. A directory of universities is available on the Internet at http://info.risc.uni-linz.ac.at/CGI/ scripts/ph.cgi/lookup?.</li>
 	<li>CDC (800) 458-5231 (www.cdc.gov/nchstp/hiv_aids/dhap.htm)
<ul>
 	<li>American Psychological Association (202) 336-6042</li>
 	<li>National Minority AIDS Council (202) 483-6622</li>
 	<li>National Association of People With AIDS (202) 898-0414</li>
 	<li>Academy for Educational Development (202) 884-8700</li>
 	<li>National Alliance of State and Territorial AIDS Directors (202) 434-8090</li>
 	<li>Council of State &amp; Territorial Epidemiologist (770) 458-3811</li>
 	<li>The US Conference of Mayors (202) 293-7330</li>
 	<li>GMHC Education Department (212) 807-7517 (www.gmhc.org)</li>
 	<li>CAPS (415) 597-9100 (www.prevention.ucsf.edu)</li>
 	<li>Rural Prevention Center (812) 855-1718 (www.indiana.edu/~aids)</li>
</ul>
</li>
 	<li>Goldstein E, Wrubel J, Faigeles B, et al. Is research important for non-governmental organizations in the United States? Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Th.C.4779.</li>
</ol>

<hr />

<strong>Prepared by Ellen Goldstein and Pamela DeCarlo</strong>
January 1997. Fact Sheet #25E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 1997, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/scienceFS.pdf</url>
	</node>
	<node>
		<title>Utilizando la ciencia</title>
		<tax>1737</tax>
		<content><![CDATA[<h3><strong>¿Cómo se utiliza la ciencia en la prevención del VIH?</strong></h3>
<strong>¿es necesaria la ciencia?</strong>

Sí. Aunque la ciencia de la prevención por si sola no ofrece la respuesta, esta posee algunas piezas críticas del rompecabezas de la prevención. La ciencia en conjunto con la experiencia de algunas agencias en el manejo de clientes además de reforzar el programa sirve de inspiración y guía para hacer un mejor uso de los escasos fondos que enfrentan los programas de prevención. Esta hoja informativa intentará abordar algunos de los elementos básicos que ofrecen las ciencias de la prevención, su significado, y su implicaciones en la práctica.

Actualmente, es un requisito usar la ciencia de la prevención en muchas áreas. En 1994, el CDC cambió radicalmente su criterio para designar los programas que serían subsidiados. El CDC recomienda que los Grupos de Planificación Comunitaria (CPGs por sus siglas en Inglés) tomen en cuenta la epidemiología, la evaluación, las teorías científicas del comportamiento, descubrimientos y la metodología en la creación de estos programas.<sup>1</sup>

La ciencia aplicable a la prevención del VIH puede dividirse en cinco categorías generales: la ciencia de la epidemiología, la ciencia conductual básica, la ciencia básica del cambio conductual, la ciencia de la intervención y la metodología de la evaluación.

<strong>la epidemiología</strong>

La epidemiología es el estudio de los casos de infección u otras enfermedades dentro de la población. Nos informa sobre la cantidad de nuevos casos de infección con VIH, la subpoblación afectada, y las que pueden llegar a infectarse. La epidemiología conductual puede indicar la frecuencia de las conductas de riesgo.<sup>2</sup> La epidemiología local puede servir de mucho a los planificadores de programas de prevención ya que les permite identificar la comunidad y las conductas de riesgo que necesitan ser tratadas. Esto a su vez puede ser muy útil para hacer mejor uso de los recursos limitados. El departamento de salud y el CDC pueden ayudar recopilando datos de los diferentes grupos poblacionales.<sup>3</sup>

<strong>la ciencia conductual básica</strong>

Los elementos básicos de esta ciencia exploran la influencia que los factores sociales, culturales y conductuales ejercen sobre las personas. Esto nos permite entender el porque las personas se exponen al riesgo y porque sigue en aumento la cantidad de infectados con VIH. El estudio de la sexualidad es un elemento clave que ayuda a entender los cambios en las conductas riesgo con relación al sexo y facilita la tarea del diseño del programa.<sup>4</sup> No señala exactamente lo que habrá de hacerse, sino que sugiere diferentes formas de pensar en cuanto a los elementos que el programa debe tener.

Por ejemplo, recientemente se descubrió una estrecha relación entre el abuso sexual a temprana edad y las conductas de riesgo en la adultez.<sup>5</sup> Con estos antecedentes, los planificadores del programa pueden agregar preguntas sobre abuso sexual a temprana edad para asesorar las necesidades del caso. Se puede también agregar un segmento sobre abuso infantil a las intervenciones con sesiones educativas múltiples o crear programas para los que fueron abusados y/o capacitar al personal sobre el tema del abuso sexual.

<strong>la ciencia de los cambios de conducta</strong>

La teoría del cambio conductual nos brinda un marco de ideas sobre como y por que ocurren estos cambios de conducta que exponen a las personas a riesgo de contraer el VIH. Para lograr mantener unidos cada uno de los componentes del modelo al diseñar una intervención puede ayudar usar las Teorías de cambio conductual.<sup>6</sup>

Por ejemplo, la teoría de Paulo Freire sobre la Educación Popular propone que el alumno y el maestro aprendan el uno del otro.<sup>7</sup> Si se usa esta teoría, un programa puede reemplazar las lecturas por discusiones de grupo. De esta forma la intervención se hace más fuerte puesto que las personas adquieren por si mismas el poder o la responsabilidad que les permitirá cambiar el ambiente que les rodea.

<strong>la ciencia de la intervención</strong>

La ciencia de la intervención analiza los componentes más eficaces del programa e identifica los programas que han logrado un cambio en ciertas poblaciones. Por ejemplo, en un estudio reciente, las personas que estaban a mayor riesgo no asistieron a los talleres de sexo seguro. Un programa para hombres gay/bisexuales de Portland, OR, hizo su campaña en bares, organizando eventos comunitarios y reuniones en casas, y ofreciendo talleres de sexo seguro. Mientras la mayoría de los hombres asistió a la mayor parte de las actividades, pocos asistieron a los talleres.<sup>8</sup>

El estudio científico del programa indicó que la mayoría de los hombres atraídos por el programa eran jóvenes los que presentaban mayor riesgo o los hombres que reportaron sexo anal sin protección.<sup>8</sup> Las intervenciones que intentan trabajar con poblaciones de alto riesgo pueden obtener la atención de esta audiencia con un programa a nivel comunitario intensivo, innnovador, que ofrezca actividades sociales y consejería, con una estructura no complicada.

<strong>la metodología de la evaluación</strong>

La evaluación estimula el pensamiento crítico en el proceso del diseño de la intervención y no necesariamente debe ocurrir al final de la intervención. Una buena evaluación genera información acerca de las necesidades que tiene el grupo a ser intervenido, el tipo de servicios necesarios, el impacto del programa y los resultados del mismo. Esto a la vez que permite conocer la opinión del cliente, les brinda la oportunidad a los proveedores del servicio de ajustar el programa para aumentar su efectividad.<sup>9</sup>

Por ejemplo, el Centro de Salud Tri-City de Fremont, CA, encuestó a jóvenes de la calle para evaluar la efectividad del programa en cuanto a los talleres educativos y a la forma de atraer a los necesitados. En base a la opinión de los jóvenes, el Tri-City reemplazó los talleres con horas establecidas por un servicio disponible a cualquier hora. Este nuevo servicio ofreció educación sobre VIH, apoyo en áreas tales como la deserción escolar, el desempleo, el abuso de drogas, las relaciones abusivas y como vivir con el VIH.<sup>10</sup>

<strong>¿cómo se obtiene el acceso a la ciencia?</strong>

No se requiere un nivel de educación avanzado para comprender la ciencia de la prevención. Existen algunas organizaciones que interpretan y resumen los resultados de la investigación a un lenguaje claro y conciso. La función de los CPGs es la de incorporar la ciencia de la prevención en todos sus planes, los cuales están disponibles a través de los departamentos de salud estatales y locales.<sup>11</sup> Las universidades locales son un excelente punto de contacto en cuanto a la asistencia con las investigaciones.<sup>12</sup> Pertenecer a listas de envío por correo y a Boletines Informativos especializados en las ciencias de la prevención puede ser un recurso invaluable.<sup>13</sup>

<strong>¿qué queda por hacer?</strong>

Estrechar aún más los esfuerzos de los investigadores y de los proveedores de servicio: 1) Los investigadores deben compartir datos reveladores con los CBO locales, con el CDC y con el departamento de salud pública. También es necesario ejercer una participación activa en los CPG. 2) Los CBO locales deben ser más agresivos y pro-activos haciendo uso de la información que existe fuera de las agencias. 3) Los departamentos de salud pública estatales y el CDC deben reconocer y poner en práctica su papel de traductores de esta ciencia. 4) Los Institutos Nacionales de Salud, el CDC y las Fundaciones Privadas deberán integrar la ciencia en los programas de prevención y proveer los fondos para este fin.<sup>14</sup>

El uso de la ciencia en la aplicación del servicio es un campo especializado. La mayoría de los investigadores no están capacitados para aplicar sus proyectos de investigación en el mundo real. Así como la mayoría de los proveedores de servicio no están capacitados para aplicar los métodos de investigación. Un programa de prevención completo utiliza muchos elementos para proteger del VIH a la mayor cantidad de personas posible. Si logramos acortar la distancia entre la ciencia y la práctica de la prevención , nos aseguraríamos que nuestros esfuerzos no van a ser en vano y haremos la diferencia en la lucha contra el VIH.

<hr size="2" />

<strong>¿quién lo dice?</strong>

1. Valdiserri RO, Aultman TV, Curran JW. Community planning: a national strategy to improve HIV prevention programs. Journal of Community Health. 1995;20:87-100.

2. Rothman KJ. Modern Epidemiology. Boston, MA: Little, Brown and Company; 1986.

3. Si desea encontrar información con datos epidemiológicos los puede encontrar por estado y por ciudad (ciertas) en la internet: http://hivinsite.ucsf.edu/cgi-msql/usa_db1.pl

4. Kelly JA, Kalichman SC. Increased attention to human sexuality can improve HIV-AIDS prevention efforts: key research issues and directions. Journal of Consulting and Clinical Psychology. 1995;63:907-918.

5. Jinich S, Stall R, Acree M, et al. Childhood sexual abuse predicts HIV risk sexual behavior in adult gay and bisexual men. Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Mo.D.1718.

6. Valdiserri RO, West GR, Moore M, et al. Structuring HIV prevention service delivery systems on the basis of social science theory. Journal of Community Health. 1992;17:259-269.

7. Wallerstein N. Powerlessness, empowerment, and health: implications for health promotion programs. American Journal of Health Promotion. 1992;6:197-205.

8. Hoff CC, Kegeles S., Acree M, et al. Gay men at highest risk are best reached through outreach in bars and community events. Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Tu.D.360.

9. San Francisco HIV Prevention Plan. Report prepared by the San Francisco HIV Prevention Planning Council and the Department of Public Health AIDS Office. 1996.

10. Carver LJ, Harper GW. Responding to the HIV prevention needs of suburban street youth. Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Th.D.4921.

11. Para mayor información sobre su Grupo Comunitario local o estatal, póngase en contacto con Lynne Greabell de NASTAD (202) 434-8090.

12. Un directorio de universidades está disponible en la internet en:http://www.uiuc.edu/cgi-bin/ph/ lookup?Query=.

13.
<ul>
 	<li>CDC (800) 458-5231 (www.cdc.gov/nchstp/hiv_aids/dhap.htm)</li>
 	<li>American Psychological Association (202) 336-6042</li>
 	<li>National Minority AIDS Council (202) 483-6622</li>
 	<li>National Association of People With AIDS (202) 898-0414</li>
 	<li>Academy for Educational Development (202) 884-8700</li>
 	<li>National Alliance of State and Territorial AIDS Directors (202) 434-8090</li>
 	<li>Council of State &amp; Territorial Epidemiologist (770) 458-3811</li>
 	<li>The US Conference of Mayors (202) 293-7330</li>
 	<li>GMHC Education Department (212) 807-7517 (www.gmhc.org)</li>
 	<li>CAPS (415) 597-9100 (www.prevention.ucsf.edu)</li>
 	<li>Rural Prevention Center (812) 855-1718 (www.indiana.edu/~aids)</li>
</ul>
14. Goldstein E, Wrubel J, Faigeles B, et al. Is research important for non-governmental organizations in the United States? Presented at the 11th International Conference on AIDS, Vancouver, BC. 1996. Abstract Th.C.4779.

<hr size="2" />

<strong>Preparado por Pamela DeCarlo y Ellen Goldstein, Traducción Romy Benard-Rodríguez</strong>

Septiembre 1997. Hoja Informativa 25S.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/cienciaFS.pdf</url>
	</node>
	<node>
		<title>Health care settings</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How can HIV prevention be integrated into health care settings?</h3>
<h4>Why is HIV prevention important in health care settings?</h4>
HIV prevention is an important part of health care for all individuals. It is particularly key for those at risk of becoming infected, as well as for those who are already infected, who can then avoid transmitting HIV to others and stay healthy themselves. Many strategies can be used in health care settings to optimize HIV prevention, including: assessing HIV risk; enhancing access to HIV testing; providing HIV-infected patients with disclosure and partner services; screening and treating patients for problem drinking, drug use and sexually transmitted infections (STIs); and providing the best possible care to HIV-infected individuals including access to anti-retroviral therapy (ARVs) and adherence counseling.
<h4>Do health care settings have a role in finding new infections?</h4>
Health care settings are important sites for providing access to HIV testing and prevention messages, for finding new infections and for linking infected individuals into HIV care. In 2006, the CDC issued guidelines for primary health care providers suggesting expanded access to HIV testing for all patients 13 to 64 years old.<sup>1</sup> Providing HIV testing as a routine part of care has been most productive in emergency room and labor and delivery settings,<sup>2,3</sup> although community health centers have also provided important new access.<sup>4</sup> Testing programs have also proven effective in helping pregnant women to not transmit HIV to their babies.<sup>3</sup>

One key strategy for expanding testing is rapid test technology.<sup>5</sup> Rapid tests allow providers to perform a test and deliver the results in under an hour, although a confirmatory test is required for positive rapid test results. Appropriate follow-up care can be planned before the patient leaves the health care facility.

Especially when HIV testing is newly introduced, providers in health care settings need to learn how to integrate HIV testing into regular care, and to refer patients for additional support services if needed. Providers should also be trained in documenting test results to ensure they are shared with other health care providers and to maintain the confidentiality of client information.

Providers must ensure that HIV-infected persons get the care and support they need. Linkage to care is an important and often overlooked piece of integrating HIV testing into health care. Individuals who are just finding out they are infected often need a great deal of help and support to find an HIV provider, to make an appointment and to show up at that appointment. Intensive case management models show promise in enhancing linkages to care for newly-diagnosed individuals.<sup>6</sup>
<h4>What other HIV prevention strategies work in health care settings?</h4>
<strong>Risk assessment.</strong> Assessing HIV risk behaviors should be a standard part of new patient intake, regardless of HIV status. In-depth HIV prevention education is not necessary for every patient. However, health care providers should ask all patients about their sexual behavior, condom use, number of sexual partners, and alcohol and illicit drug use to assess a patient’s risk for acquiring or transmitting HIV. These quick questions may lead to longer discussions and counseling about safer sex or alcohol and drug use practices.<sup>7</sup>

<strong>Drug treatment.</strong> Helping patients get into alcohol or drug treatment can be an effective HIV prevention tool<sup>8</sup> and can help HIV-infected persons stay healthy. Health care providers can have a profound effect on patients’ lives by showing an interest in drug-using patients and encouraging willing patients to enter drug or alcohol treatment programs. Because relapse is common in treating addictions, health care providers should use a non-judgmental approach.

<strong>Screening and treating for STIs.</strong> Providers should encourage screening for STIs. They should also provide STI education, emphasize the link between HIV and STIs, and encourage screening for partners.<sup>9</sup>
<h4>How does positive prevention work in health care settings?</h4>
<strong>Prevention counseling.</strong> Brief prevention counseling delivered in health care settings at every visit has been shown to decrease the likelihood that HIV-infected individuals transmit HIV to others, particularly if interventions are tailored to sub-populations of HIV-infected patients.<sup>10</sup> Important messages include: helping people understand the relative risks of their actions and the effectiveness of different prevention strategies such as using condoms; disclosing HIV status to sex and drug using partners; and understanding their responsibility with regard to prevention. Formal provider training is important to facilitate these approaches.<sup>11,12</sup>

<strong>Viral suppression.</strong> A unique component that health care settings play in HIV prevention is helping HIV-infected persons find and adhere to an effective ARV regimen to help keep their viral load low. Some research has demonstrated that keeping the viral load below a threshold that is detectable with lab tests can help prevent up to 60% of new STIs.<sup>13</sup> New research suggests that effective detection of HIV and treatment to reduce the viral load could reduce the overall community viral load and have a population-level impact on HIV transmission.<sup>14</sup>
<h4>How can HIV prevention capacity be increased in health care settings?</h4>
<strong>Risk assessment.</strong> Knowing how to assess risk among patients is key to HIV prevention of any kind. Having risk assessment tools and training providers to use them is critical.

<strong>Written protocols.</strong> It is important to make sure that procedures are in place to guide testing efforts in health care settings.<sup>15</sup> Having a “prevention plan” tailored to the clinic size, the service delivery model, the types of providers and the patient population is critical.

<strong>Leadership. </strong>Successful clinic programs often have identified staff leaders who function as counselors or team leaders for positive prevention.<sup>16</sup>

<strong>Training.</strong> Underlying all of these important components is training. Training can facilitate buy-in from clinic providers and can address provider attitudes and beliefs about risk reduction and counseling.<sup>17</sup> Training should outline staff responsibilities and anticipate changes to clinic flow.<sup>16</sup>
<h4>What are effective models for use in health care settings?</h4>
Positive STEPs<sup>17</sup> is a training intervention to help HIV care providers deliver prevention counseling to their patients. The model was effective in improving provider attitudes, comfort, self-efficacy and frequency of delivering prevention counseling.

Partnership for Health<sup>18</sup> is an EBI (CDC’s Effective Behavioral Intervention) for providers in HIV clinics. Medical providers are trained to deliver brief risk-reduction counseling to their patients. All clinic staff are trained to integrate prevention messages into the clinic setting, and counseling is supplemented with written information for all patients. The intervention was effective in reducing unprotected intercourse by 38% among patients who had two or more sexual partners.

Positive Choice<sup>19</sup> is an interactive “Video Doctor.” Patients at HIV clinics completed an in-depth computerized risk assessment and received tailored risk-reduction counseling from a “Video Doctor” via laptop computer and a printed educational worksheet. Providers received a Cueing Sheet on reported risks for discussion during the clinical encounter.

Provider-Delivered Counseling.<sup>10,16</sup> In a large federal demonstration project, brief counseling messages delivered by primary care providers in clinic settings were most effective in reducing risk among HIV-infected patients, although there were also benefits in programs delivered by prevention specialists and HIV-infected peers.
<h4>What needs to be done?</h4>
Health care providers need more and repeated training on how HIV prevention can be integrated into the care they deliver. There are still significant misperceptions among health care providers about who should be tested for HIV and when to implement rapid testing. Provider attitudes, beliefs and self-efficacy can affect whether or not they address prevention through HIV testing or by providing risk-reduction counseling. Methods that enhance provider uptake of HIV prevention in health care delivery settings need attention and further research.

Leaders in health care settings can establish written protocols that guide HIV prevention practices, including HIV testing in their clinics. Establishing protocols, documentation and quality assurance practices can enhance testing and prevention practices in all types of health care settings.

<hr />

<h3>Says who?</h3>
1. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.Morbidity and Mortality Weekly Report. 2006;55:1-17.

2. Haukoos JS, Hopkins E, Byyny RL, et al. Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings. Annals of Emergency Medicine. 2008;51:303-309.

3. Tepper NK, Farr SL, Danner SP, et al. Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study. American Journal of Obstetrics and Gynecology. 2009;201:31-36.

4. Myers JJ, Modica C, Bernstein C, Kang M, McNamara K. Routine rapid HIV screening in six Community Health Centers serving populations at risk. Journal of General Internal Medicine. 2009;24:1269–1274.

5. Branson BM. State of the art for diagnosis of HIV infection. Clinical Infectious Diseases. 2007;15:S221-225.

6. Christopoulos K, Koester K, Weiser S, et al. A comparative evaluation of the development and implementation of three emergency department HIV testing programs (forthcoming)

7. Schechtel J, Coates T, Mayer K, et al. HIV risk assessment: physician and patient communication. Journal of General Internal Med. 1997;12:722-723.

8. Bruce RD. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy. 2010;21:122-124.

9. McClelland RS, Baeten JM. Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals. Journal of Antimicrobial Chemotherapy. 2006;57:163-166.

10. Myers JJ, Shade S, Dawson Rose C, et al. Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV. AIDS and Behavior. 2010;14:483-492.

11. Gilliam PP, Straub DM. Prevention with positives: A review of published research, 1998-2008. Journal of the Association of Nurses in AIDS Care. 2009;20:92-109.

12. Harder &amp; Co. Community Research. Prevention with positives: Best practices Guide. Prevention with Positives Workgroup. 2009.

13. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81-88.

14. Das M, Chu PL, Santos G-M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE. 2010;5:e11068.

15. Myers JJ, Steward, WT, Koester KA, et al. Written procedures enhance delivery of HIV “prevention with positives” counseling in primary health care settings. Journal of AIDS. 2004;37:S95-S100.

16. Koester KA, Maiorana A, Vernon K, et al. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: Challenges and lessons learned. AIDS and Behavior. 2007;1:S17-S29.

17. Thrun M, Cook PF, Bradley-Springer LA, et al. Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs. AIDS Education and Prevention. 2009;21:55-66.

18. Richardson J, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. AIDS. 2004;18:1179-1186.

19. Gilbert P, Ciccarone D, Gansky SA, et al. Interactive “Video Doctor” counseling reduces drug and sexual risk behaviors among HIV+ patients in diverse outpatient settings. PLoS One. 2008;3.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Lucy Bradley-Springer, Kimberly Carbaugh, Mark Cichocki, Renata Dennis, Josh Ferrer, Mark Molnar, Quentin O’Brien, Jim Sacco.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©July 2010, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.Web@ucsf.edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/healthcaresettingsFS.pdf</url>
	</node>
	<node>
		<title>Establecimientos de salud</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo puede integrarse la prevención del VIH en los establecimientos de atención de salud?</h3>
<h4>¿Por qué es importante la prevención de la infección por el VIH en los establecimientos de atención de salud?</h4>
La prevención de la infección por el VIH es una parte importante de la atención de la salud de todas las personas. Reviste particular importancia para las personas expuestas al riesgo de infección, así como para las ya infectadas, que pueden evitar la transmisión del virus a otras y mantenerse sanas. Se pueden utilizar muchas estrategias en los establecimientos de atención de salud para optimizar la prevención del VIH, incluso la evaluación del riesgo de contraerla; la mejora del acceso a las pruebas de detección del virus; la prestación de servicios de asistencia a los pacientes infectados por el VIH  para revelar su estado serológico a sus parejas; el examen y el tratamiento de los pacientes con problemas de alcoholismo, uso de drogas e infecciones de transmisión sexual (ITS); y la provisión del mejor cuidado posible a las personas infectadas por el VIH, incluyendo acceso al tratamiento antirretroviral (ART) y consejería sobre la observancia del mismo.
<h4>¿Tienen los establecimientos algún papel en la detección de nuevas infecciones?</h4>
Los establecimientos de salud son sitios importantes para proporcionar acceso a mensajes sobre el examen de detección del VIH y la prevención del mismo, detectar nuevas infecciones y vincular a las personas infectadas con atención médica. En 2006, los CDC emitieron directrices para los proveedores de atención primaria de salud en las que recomendaron el acceso ampliado a las pruebas del VIH para todos los pacientes de 13 a 64 años de edad.<sup>1</sup> La provisión de servicios de pruebas VIH como parte ordinaria de la atención ha sido más productiva en las salas de urgencias y en las salas de trabajo de parto y de parto, <sup>2,3</sup> aunque los centros de salud comunitarios también han proporcionado nuevo y amplio acceso.<sup>4</sup> Los programas de pruebas del VIH también han demostrado ser eficaces para ayudar a las mujeres embarazadas a no transmitir el VIH a sus bebés.<sup>3</sup>

Una estrategia clave para ampliar las pruebas del VIH es una tecnología basada en el uso de pruebas rápidas.<sup>5</sup> Estas últimas permiten que los proveedores que las realizan entreguen los resultados en menos de una hora, aunque se necesita una prueba para confirmar un resultado positivo. Estas pruebas rápidas permiten que se puede planear atención de seguimiento apropiada antes de que el paciente salga del establecimiento de atención de salud.

Particularmente cuando primero se introduce la prueba del VIH, los proveedores en los establecimientos de salud necesitan aprender a integrar dichas pruebas a la atención regular, y remitir a los pacientes a servicios de apoyo complementarios, en caso de que sea necesario. Los proveedores también deben recibir capacitación sobre la forma de documentar los resultados de la prueba para asegurarse de que éstos se compartan con otros proveedores y para mantener la confidencialidad de la información de los clientes.

Los proveedores deben velar por que las personas infectadas por el VIH reciban la atención y el apoyo que necesitan. La vinculación a la atención es una parte importante, con frecuencia ignorada, de la integración de las pruebas del VIH al sistema de atención de salud. Las personas que apenas acaban de enterarse de que están infectadas a menudo necesitan mucho apoyo y ayuda para encontrar un proveedor del VIH, así como también hacer una cita y cumplirla. Los modelos de tratamiento intensivo de casos son prometedores para mejorar los vínculos de los pacientes recién diagnosticados con la atención médica.<sup>6</sup>
<h4>¿Qué otras estrategias de prevención surten efecto?</h4>
<strong>Evaluación del riesgo.</strong> La evaluación de comportamientos de riesgo de contraer el VIH debe ser una parte normal del registro de nuevos pacientes, independientemente de su estado serológico con respecto a ese virus. No todos los pacientes necesitan educación detallada en materia  de prevención del VIH. Sin embargo, los proveedores deben preguntarles a todos los pacientes sobre su comportamiento sexual, uso de preservativos, número de parejas sexuales y uso de alcohol y drogas ilícitas para evaluar el riesgo que tiene un paciente de contraer o transmitir el VIH. Estas preguntas rápidas pueden llevar a discusiones más prolongadas y a consejería sobre relaciones sexuales o prácticas de uso de alcohol y de drogas que sean más seguras.<sup>7</sup>

<strong>Tratamiento por uso de sustancias.</strong> La ayuda prestada a los pacientes para entrar a un programa de tratamiento del alcoholismo o de uso de drogas puede ser un instrumento eficaz de prevención del VIH <sup>8</sup> y puede ayudar a las personas a mantenerse saludables. Los proveedores pueden tener un profundo efecto en la vida de los pacientes al demostrar interés en los que usan drogas y alentar a los pacientes que estén dispuestos a entrar a un programa de tratamiento de alcohol o de drogas. Considerando que una recaída o relapso es común al tratar las adicciones, los proveedores de salud deben usar un enfoque no prejuicioso en el que no se critique a los pacientes.

<strong>Realización de pruebas de detección y tratamiento de ITS.</strong> Los proveedores deben alentar a las personas a realizarse pruebas de detección de ITS. También deben impartir educación sobre esas infecciones, recalcar el vínculo entre estas últimas y el VIH e instar a que las parejas a también se hagan un examen de detección.<sup>9</sup>
<h4>¿Cómo funciona la prevención con personas seropositivas en los establecimientos de salud?</h4>
<strong>Orientación en materia de prevención. </strong>Se ha demostrado que una breve sesión de orientación o consejería sobre prevención en cada consulta en los establecimientos de salud reduce la probabilidad de que las personas infectadas por el VIH transmitan ese virus a otras, particularmente si las intervenciones se adaptan a las subpoblaciones de pacientes infectados por el VIH.<sup>10</sup> Entre los mensajes importantes cabe citar los siguientes: ayudar a las personas a entender los riesgos relativos de sus actos y la eficacia de diferentes estrategias de prevención, como el uso de preservativos; revelar su estado de VIH a las parejas sexuales y las personas con las que usan drogas; y entender su responsabilidad con respecto a la prevención. Es  importante la capacitación formal de los proveedores para facilitar la aplicación de estos enfoques.<sup>11,12</sup>

<strong>Supresión del virus.</strong> Un componente singular del papel que desempeñan los establecimientos en la prevención del VIH consiste en ayudar a las personas infectadas a encontrar y observar un régimen ARV eficaz para mantener baja la carga viral. Algunas investigaciones han demostrado que el mantenimiento de la carga viral por debajo del umbral detectable a través de análisis de laboratorio puede ayudar a prevenir hasta un 60% de nuevos casos de ITS.<sup>13</sup>
<h4>¿Cómo se puede ampliar la capacidad de pre-vención del VIH en los establecimientos de salud?</h4>
<strong>Evaluación de riesgos.</strong> Es de suma importancia saber evaluar el riesgo de los pacientes para cualquier clase de actividad de prevención del VIH. Es de importancia crítica tener instrumentos de evaluación del riesgo y enseñar a los proveedores a utilizarlos.

<strong>Protocolos por escrito.</strong> Es importante asegurarse de establecer los procedimientos necesarios para orientar las actividades de realización de exámenes de detección en los establecimientos de salud.<sup>14</sup> Reviste importancia crítica tener un plan de prevención adaptado al tamaño del centro médico, el modelo de prestación de servicios, los tipos de proveedores y la población de pacientes.

<strong>Liderazgo.</strong> En los programas realizados con éxito en los centros médicos a menudo se han identificado líderes dentro del personal que cumplen la función de consejeros o de líderes de equipo para realizar una prevención positiva.<sup>15</sup>

<strong>Capacitación.</strong> La capacitación es el elemento fundamental de todos estos componentes de importancia. Puede facilitar la aceptación y compromiso de los proveedores de salud en los centros médicos y tener en cuenta o considerar las actitudes y creencias de los proveedores con respecto a la reducción del riesgo y la consejería.<sup>16</sup> La capacitación debe esbozar las responsabilidades del personal y preveer los cambios en el flujo de actividades de los centros médicos.<sup>17</sup>
<h4>¿Cuáles son los modelos eficaces para ser empleados en los establecimientos de salud?</h4>
Positive STEPs <sup>16</sup> es una intervención de capacitación para ayudar a los proveedores de atención del VIH a impartir consejería de prevención a sus pacientes. El modelo fue eficaz para mejorar las actitudes, el grado de comodidad y la auto eficacia de los proveedores, así como la frecuencia con que se ofrece orientación con fines de prevención.

Partnership for Health <sup>17</sup> es una intervención conductual eficaz de los CDC (EBI) para los proveedores en los centros médicos de atención del VIH. Se adiestra a los proveedores de atención médica para ofrecer una consejería breve sobre la reducción del riesgo a sus pacientes. Se capacita a todo el personal de los centros médicos para incorporar mensajes de prevención en dichos centros, y la consejería  se complementa con información escrita para todos los pacientes. Fue eficaz para reducir las relaciones sexuales sin protección en un 38% en los pacientes que tenían dos o más parejas.

Positive Choice <sup>18</sup> es un sistema interactivo de un médico en video. Com parte de este modelo, los pacientes de  los centros médicos de atención del VIH completaron una detallada evaluación electrónica de su riesgo y recibieron orientación individualizada sobre la reducción del riesgo a través de un médico en video que miraban en un laptop, y una hoja de trabajo impresa y de naturaleza didáctica. Los proveedores recibieron una hoja impresa con los riesgos reportados por los pacientes para su discusión durante la visita.

Consejería ofrecida por los proveedores.<sup>10,17</sup>  En un extenso proyecto federal de demostración, los breves mensajes de consejería dados por los proveedores de salud en los centros médicos fueron muy eficaces para reducir el riesgo para los pacientes con VIH, aunque también hubo beneficios en los programas realizados por especialistas en prevención y por pares infectados por el VIH.
<h4>¿Qué se necesita hacer?</h4>
Los proveedores necesitan capacitación más amplia y repetida sobre la forma de integrar la prevención del VIH a la atención que prestan. Todavía hay importantes percepciones erróneas entre los proveedores sobre quién debe realizarse la prueba del VIH y cuándo se debe poner en práctica la prueba rápida. Las actitudes, las creencias y la propia eficacia de los proveedores pueden determinar si abordan o no la prevención por medio de pruebas del VIH o de provisión de orientación sobre reducción del riesgo. Algunos métodos que mejoran el registro de la prevención del VIH por los proveedores exigen atención y más investigación.

Los dirigentes de los establecimientos de salud pueden introducir protocolos por escrito para orientar las prácticas de prevención del VIH, incluso las pruebas de detección en sus centros médicos. El establecimiento de protocolos, la documentación y las prácticas de garantía de la calidad pueden mejorar las prácticas de prueba y prevención en toda clase de establecimientos de salud.

<hr />

<h3>¿Quién lo dice?</h3>
1. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. <em>Morbidity and Mortality Weekly Report.</em> 2006;55:1-17.

2. Haukoos JS, Hopkins E, Byyny RL, et al. Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings. <em>Annals of Emergency Medicine</em>. 2008;51:303-309.

3. Tepper NK, Farr SL, Danner SP, et al. Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study.<em>American Journal of Obstetrics and Gynecology.</em> 2009;201:31-36.

4. Myers JJ, Modica C, Bernstein C, Kang M, McNamara K. Routine rapid HIV screening in six Community Health Centers serving populations at risk. <em>Journal of General Internal Medicine. </em>2009;24:1269–1274.

5. Branson BM. State of the art for diagnosis of HIV infection. <em>Clinical Infectious Diseases</em>. 2007;15:S221-225.

6. Christopoulos K, Koester K, Weiser S, et al. A comparative evaluation of the development and implementation of three emergency department HIV testing programs (forthcoming)

7. Schechtel J, Coates T, Mayer K, et al. HIV risk assessment: physician and patient communication. <em>Journal of General Internal Med.</em> 1997;12:722-723.

8. Bruce RD. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. <em>International Journal of Drug Policy.</em> 2010;21:122-124.

9. McClelland RS, Baeten JM. Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals. <em>Journal of Antimicrobial Chemotherapy</em>. 2006;57:163-166.

10. Myers JJ, Shade S, Dawson Rose C, et al. Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV. <em>AIDS and Behavior.</em> 2010;14:483-492.

11. Gilliam PP, Straub DM. Prevention with positives: A review of published research, 1998-2008. <em>Journal of the Association of Nurses in AIDS Care.</em> 2009;20:92-109.

12. Harder &amp; Co. Community Research. Prevention with positives: Best practices Guide. Prevention with Positives Workgroup. 2009.

13. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. <em>AIDS</em>. 2004;18:81-88.

14. Myers JJ, Steward, WT, Koester KA, et al. Written procedures enhance delivery of HIV “prevention with positives” counseling in primary health care settings. <em>Journal of AIDS</em>. 2004;37:S95-S100.

15. Koester KA, Maiorana A, Vernon K, et al. Implementation of HIV prevention interventions with people living with HIV/AIDS in clinical settings: Challenges and lessons learned. <em>AIDS and Behavior</em>. 2007;1:S17-S29.

16. Thrun M, Cook PF, Bradley-Springer LA, et al. Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs. <em>AIDS Education and Prevention.</em> 2009;21:55-66.

17. Richardson J, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment. <em>AIDS</em>. 2004;18:1179-1186.

18. Gilbert P, Ciccarone D, Gansky SA, et al. Interactive “Video Doctor” counseling reduces drug and sexual risk behaviors among HIV+ patients in diverse outpatient settings. <em>PLoS One</em>. 2008;3.

<hr />

Una publicación del Centro de Estudios para la Prevención del SIDA (CAPS) y el Instituto de Investigaciones sobre SIDA (ARI), Universidad de California en San Francisco (UCSF). Se autoriza la reproducción (citando a UCSF) más no la venta de copias este documento. También disponibles en inglés - www.prevention.ucsf.edu/pubs/FS/. Para recibir las Hojas de Datos por correo electrónico escriba a listserv@listserv.ucsf.edu con el mensaje “subscribe CAPSFS nombre apellido” ©UCSF 2010]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2011/04/establecimientossaludFS.pdf</url>
	</node>
	<node>
		<title>International</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What works best in HIV prevention globally?</h3>
<h4>what does HIV look like internationally?</h4>
With 39 million people living with HIV worldwide, the HIV/AIDS epidemic threatens every aspect of global economic development.<sup>1,2</sup> In 2005, over 4 million people were newly infected with HIV, and almost 3 million died of an AIDS-related illness. HIV/AIDS is among the top 10 causes of death in developing countries, and the leading cause of death in Sub-Saharan Africa.

Although Sub-Saharan Africa is the hardest-hit region, HIV is spreading into parts of Asia and Eastern Europe with alarming speed. HIV is transmitted primarily through three mechanisms: sexual intercourse (about 80% of infections worldwide);<sup>3</sup> exposure to infected blood or blood products,including injecting drug use; and transmission by HIV+ mothers to their newborns.

The international community recognizes the urgency of stopping the AIDS epidemic, yet funding, political will, accountability and human resources have fallen short of needs. Although known interventions could prevent nearly two-thirds of new infections projected to occur between 2002 and 2010, fewer than one in five people at high risk of infection have access to the most basic prevention services.<sup>4</sup>
<h4>how is prevention tailored?</h4>
Prevention studies and national experiences over the past 20 years strongly suggest that strategies are likely to be most effective when they are carefully tailored to the nature and stage of the epidemic in a specific country or community. Despite a limited amount of rigorous evaluation on prevention programs, evidence demonstrates that tailoring prevention strategies to a region’s epidemic profile is most effective and cost-effective.<sup>5</sup>
<ul>
 	<li><strong>Low-level epidemics</strong> occur in regions where the HIV prevalence in the general population is low (less than 1%) and the highest prevalence in a key population is also low (less than 5%). Key populations include sex workers, men who have sex with men (MSM) and injecting drug users (IDUs).</li>
 	<li><strong>Concentrated epidemics</strong> occur in regions where the HIV prevalence in the general population is less than 1% and the highest prevalence in a key population is more than 5%.</li>
 	<li><strong>Generalized low-level epidemics</strong> occur in regions where the HIV prevalence in the general population is 1%-10% and the highest prevalence in a key population is 5% or over.</li>
 	<li><strong>Generalized high-level epidemics</strong> occur in regions where the HIV prevalence in the general population is 10% or over and the highest prevalence in a key population is 5% or over.</li>
</ul>
The following activities are relevant across all epidemic profiles:
<ul>
 	<li>surveillance of risk behaviors, sexually transmitted infections (STIs) and HIV</li>
 	<li>school-based sex education</li>
 	<li>peer-based programs</li>
 	<li>information, education, and communication (IEC)</li>
 	<li>STI screening and treatment</li>
 	<li>voluntary counseling and testing (VCT)</li>
 	<li>harm reduction for IDUs</li>
 	<li>condom promotion, distribution and social marketing</li>
 	<li>blood safety practices</li>
 	<li>prevention of mother-to-child transmission (MTCT) and universal precautions</li>
</ul>
<h4>low-level epidemic</h4>
Providing widespread VCT, screening for STIs and postexposure prophylaxis may not be cost-effective in a low-level epidemic. In this setting, such as in the Middle East and North Africa, HIV/AIDS control strategies should emphasize:
<ul>
 	<li>individual-level interventions that target key populations</li>
 	<li>limited education through the mass media</li>
 	<li>prevention programs for HIV+ persons</li>
 	<li>VCT that is available to key populations with the highest levels of risk behavior and infection rates</li>
 	<li>MTCT prevention to known HIV+ mothers</li>
 	<li>addressing market inefficiencies in condom procurement and distribution—including strategies such as bulk purchases and incentives</li>
 	<li>responding to community attitudes toward sexual activity, as they may dictate people’s response to sex education materials.</li>
</ul>
<h4>concentrated epidemic</h4>
In a concentrated epidemic, as in East Asia and the Pacific, Europe and Central Asia, Latin America and the Caribbean, and South Asia, prevention priorities should include:
<ul>
 	<li>promotion of VCT among key populations</li>
 	<li>HIV screening of pregnant women, guided by individuals’ risk profiles</li>
 	<li>peer-based programs for key populations to educate individuals at risk, promote safer behaviors and distribute condoms</li>
 	<li>needle exchange and drug substitution programs for IDUs</li>
 	<li>STI screening and treatment for key risk groups</li>
 	<li>targeted distribution and promotion of condoms to key populations, linked to VCT and STI care.</li>
</ul>
Contextual factors—such as government acceptance of needle exchange programs, incarceration of drug users and harassment of sex workers—will likely have a major impact on the effectiveness of prevention efforts. HIV/AIDS is typically concentrated in socially or economically marginalized populations in concentrated epidemics, so attention to socioeconomic factors and to stigmatization of key populations will be vital.
<h4>generalized low-level epidemic</h4>
Here, as in some countries in Sub-Saharan Africa (Tanzania), targeted interventions must be maintained or strengthened. Interventions for broader populations must be aggressively implemented. Prevention priorities should include:
<ul>
 	<li>maintaining surveillance in the entire population, with a focus on young people</li>
 	<li>extending mass media IEC beyond basic education</li>
 	<li>providing routine VCT and STI screening and treatment beyond key populations</li>
 	<li>strengthened condom distribution to ensure universal access</li>
 	<li>offering HIV screening to all pregnant women</li>
 	<li>broadening peer approaches and targeted IEC to include all populations with higher rates of STIs and risk behavior.</li>
</ul>
Contextual factors remain critical, but population level factors now have greater priority. The most important is likely to be the status of women, especially with regard to their ability to control their sexual interactions, to negotiate VCT, to be protected from abuse and to have property rights following the death of a spouse.
<h4>generalized high-level epidemic</h4>
In a generalized high-level epidemic, such as in some countries in Sub-Saharan Africa (Botswana and Zimbabwe), an attack on all fronts is required. Prevention efforts should focus on broadly based, population-level interventions that can mobilize an entire society. Prevention should include:
<ul>
 	<li>offering routine, universal VCT and STI screening and universal treatment</li>
 	<li>distributing condoms free in all possible venues</li>
 	<li>providing VCT for couples seeking to have children</li>
 	<li>counseling pregnant women and new mothers to make informed choices for breastfeeding</li>
 	<li>implementing individual-level approaches to innovative mass strategies with accompanying evaluations of effectiveness</li>
 	<li>using the mass media as a tool for mobilizing society and changing social norms</li>
 	<li>using venues to reach large numbers of people for a range of interventions—workplaces, transit venues, political rallies, schools, universities and military camps</li>
</ul>
In a generalized high-level epidemic, contextual factors—such as poverty and the fragility of the health care infrastructure—will dramatically affect service provision at every level. The status of women becomes an overriding concern in this setting, requiring priority action to radically alter gender norms and reduce the economic, social, legal and physical vulnerability of girls and women.
<h4>what needs to be done?</h4>
The magnitude and seriousness of the global pandemic calls for action. The appropriate mix and distribution of prevention and treatment interventions depends on the stage of the epidemic in a given country and the context in which it occurs. In the absence of firm data to guide program objectives, national strategies may not accurately reflect the priorities dictated by the particular epidemic profile, resulting in highly inefficient investments in HIV/AIDS prevention and care. This waste undoubtedly exacerbates funding shortfalls and results in unnecessary HIV infections and premature deaths.

<hr />

<h3>Says who?</h3>
1. The information in this fact sheet is taken directly from the following chapter: Bertozzi S, Padian NS, Wegbreit J, et al. HIV/AIDS Prevention and Treatment. In: Disease Control Priorities in Developing Countries. April 2006.

2. UNAIDS (Joint United Nations Programme on HIV/AIDS). 2006 Report on the global AIDS epidemic.

3. Askew I, Berer M. The contribution of sexual and reproductive health services to the fight against HIV/AIDS: A review. Reproductive Health Matters. 2003;11:51–73.

4. Stover J, Bertozzi S, Gutierrez JP, et al. The global impact of scaling-up HIV/AIDS prevention programs in low- and middle-income countries. Science. 2006;311:1474-1476.

5. Wegbreit J, Bertozzi S, Demaria LM, et al. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS. 2006;20:1217-1235.

<hr />

<strong>Prepared by Nancy Padian PhD, Womens Global Health Imperative, UCSF; Stefano Bertozzi, PhD; Instituto Nacional de Salud Publica, Mexico</strong>

<strong>January 2007. Fact Sheet #62E</strong>

Special thanks to the following reviewers of this fact sheet: James Curran, Michael Merson, John Stover, Kwaku Yeboah.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©January 2007, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/internationalFS.pdf</url>
	</node>
	<node>
		<title>Mundial</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué sirve mejor para la prevención mundial del VIH?</h3>
<h4>¿cuál es el cuadro internacional del VIH?</h4>
Con más de 39 millones de personas viviendo con el VIH alrededor del mundo, la epidemia del VIH/SIDA es una amenaza para cada aspecto del desarrollo económico global.<sup>1,2</sup> En 2005, más de 4 millones de personas contrajeron el VIH y casi 3 millones murieron de enfermedades relacionadas con el SIDA.<sup>2</sup> El VIH/SIDA se ubica entre las primeras 10 causas de muerte en los países en vías de desarrollo y es la mayor causa de muerte en el África subsahariana.

Aunque el África subsahariana es la región más azotada por el VIH, el virus se va extendiendo con alarmante velocidad a partes de Asia y Europa occidental. El VIH tiene tres modos principales de transmisión: el coito (aproximadamente el 80 % de las infecciones en todo el mundo);<sup>3</sup> la exposición a sangre o productos sanguíneos infectados, lo cual incluye el consumo de drogas inyectables; y el contagio de una madre VIH+ a su recién nacido.

La comunidad internacional reconoce la urgencia de detener la epidemia del SIDA, pero faltan el financiamiento, la voluntad política, la responsabilidad social y los recursos humanos necesarios. Aunque intervenciones ya conocidas podrían evitar casi dos tercios de las infecciones nuevas proyectadas entre el año 2002 y el 2010, menos de una de cada cinco personas con alto riesgo de infectarse tiene acceso a los servicios más básicos de prevención.<sup>4</sup>
<h4>¿cómo se adecua la prevención?</h4>
Los estudios sobre la prevención y las experiencias nacionales durante los últimos 20 años sugieren fuertemente que las estrategias alcanzan su mayor eficacia cuando se adecuan cuidadosamente de acuerdo con las características y la etapa de la epidemia en el país o comunidad en cuestión. A pesar de las escasas evaluaciones rigorosas de programas de prevención, las evidencias demuestran que las estrategias adaptadas para reflejar el perfil epidémico regional son las más eficaces y costo-efectivas.<sup>5</sup>
<ul>
 	<li><strong>Las epidemias de bajo nivel</strong> ocurren en regiones con baja prevalencia del VIH en la población general (&lt; 1%) y también una reducida prevalencia máxima en una población clave (&lt; 5%). Las poblaciones clave incluyen los trabajadores sexuales, los hombres que tienen sexo con hombres (HSH) y los usuarios de drogas inyectables (UDI).</li>
 	<li><strong>Las epidemias concentradas</strong> se dan en regiones en donde la prevalencia del VIH en la población general es menos del 1% y la prevalencia máxima en una población clave excede el 5%.</li>
 	<li><strong>Las epidemias generalizadas de bajo nivel </strong>ocurren en regiones cuya prevalencia del VIH en la población general es del 1-10% y cuya prevalencia máxima en una población clave es del 5% o más.</li>
 	<li><strong>Las epidemias generalizadas de alto nivel </strong>suceden en regiones en donde la prevalencia del VIH en la población general es del 10% o más y la prevalencia máxima en una población clave es del 5% o mayor.</li>
</ul>
Las siguientes actividades son relevantes para todos los perfiles epidémicos:
<ul>
 	<li>Enseñanza sexual en las escuelas</li>
 	<li>Programas basados en la participación de pares</li>
 	<li>Información, enseñanza y comunicación (IEC)</li>
 	<li>Detección y tratamiento de ITS</li>
 	<li>Pruebas y consejería voluntarias (PCV)</li>
 	<li>Reducción de daños para los UDI</li>
 	<li>Vigilancia de las conductas riesgosas, las infecciones de transmisión sexual (ITS) y el VIH</li>
 	<li>Promoción y distribución de condones, junto con campañas de publicidad social</li>
 	<li>Prácticas de seguridad para evitar el contacto con sangre</li>
 	<li>Prevención de la transmisión madre-hijo (TMH) y uso de precauciones universales</li>
</ul>
<h4>epidemia de bajo nivel</h4>
La provisión amplia de PCV, detección de ITS y profilaxis postexposición podría no ser costo-efectiva en una epidemia de bajo nivel. En esta situación, como ocurre en Oriente Medio y en el Norte de África, las estrategias de control del VIH/SIDA deben enfatizar:
<ul>
 	<li>Intervención individual en poblaciones clave</li>
 	<li>Uso limitado de los medios masivos para difundir mensajes educativos</li>
 	<li>Programas de prevención para personas VIH+</li>
 	<li>PCV disponibles a las poblaciones con los mayores niveles de conducta riesgosa y tasas de infección</li>
 	<li>Prevención de la TMH entre madres identificadas como VIH+</li>
 	<li>Solución de las ineficiencias del mercado con respecto a la compra y distribución de condones, incluyendo estrategias como compras al por mayor e incentivos</li>
 	<li>Consideración de las actitudes comunitarias hacia la actividad sexual, ya que éstas pueden determinar sus reacciones a los materiales de enseñanza sexual.</li>
</ul>
<h4>epidemia concentrada</h4>
En una epidemia concentrada, como las que se dan en el Asia Occidental, el Pacífico, Europa, el Asia Central, América Latina, el Caribe y Surasia, las prioridades de prevención deben incluir:
<ul>
 	<li>Promoción de las PCV entre las poblaciones clave</li>
 	<li>Pruebas de VIH para mujeres embarazadas, según el perfil de riesgo individual</li>
 	<li>Programas de pares que informen a los individuos en riesgo, promuevan conductas más seguras y repartan condones entre poblaciones clave</li>
 	<li>Programas de intercambio de agujas y de sustitución de drogas para los UDI</li>
 	<li>Pruebas de detección y tratamiento de ITS para los grupos clave de riesgo</li>
</ul>
Distribución selectiva y promoción de condones entre poblaciones clave, vinculada a las PCV y al tratamiento de ITS.
Factores contextuales—tales como el grado de aceptación gubernamental de los programas de intercambio de jeringas, el encarcelamiento de los consumidores de drogas y el hostigamiento de los trabajadores sexuales—probablemente tendrán un efecto considerable sobre la eficacia de los esfuerzos de prevención. El VIH/SIDA se concentra por lo general en poblaciones social y económicamente marginadas en epidemias concentradas, lo cual precisa enfocar los factores socioeconómicos y la estigmatización de las poblaciones clave.
<h4>epidemia generalizada de bajo nivel</h4>
Aquí, al igual que en algunos países del África subsahariana, las intervenciones selectivas deberán mantenerse o reforzarse. Las intervenciones destinadas a poblaciones más amplias deberán implementarse en forma resolutiva. Entre las
prioridades de prevención deben figurar:
<ul>
 	<li>Mantener la vigilancia en la población entera, con enfoque en la juventud</li>
 	<li>Extender la IEC de los medios masivos más allá de la orientación básica</li>
 	<li>Ampliar la provisión habitual de las PCV y de la detección y tratamiento de ITS más allá de las poblaciones clave</li>
 	<li>Consolidar la distribución de condones para asegurar el acceso universal</li>
 	<li>Ofrecer pruebas de detección del VIH a toda mujer embarazada</li>
 	<li>Ampliar los métodos que involucren a pares y la IEC, con el fin de alcanzar a todas las poblaciones con tasas mayores de ITS y de conducta riesgosa.</li>
</ul>
Los factores contextuales siguen siendo críticos, pero actualmente imperan los aspectos poblacionales. El más importante
probablemente será la condición de la mujer, especialmente con respecto a su capacidad para controlar sus interacciones
sexuales, negociar las PCV, protegerse contra el abuso y tener derechos de propiedad como viuda.
<h4>epidemia generalizada de alto nivel</h4>
En una epidemia generalizada de alto nivel, tal como existe en algunos países del África subsahariana (Botswana y Zimbabwe), es preciso atacar en todos los frentes. Los esfuerzos de prevención deben centrarse en intervenciones de base amplia destinadas a poblaciones concretas y ser capaces de movilizar a la sociedad entera. La prevención debe abarcar:
<ul>
 	<li>La provisión universal y rutinaria de las PCV, detección de ITS y tratamiento de las mismas</li>
 	<li>La distribución gratuita de condones en todo lugar posible</li>
 	<li>La provisión de PCV para parejas que buscan tener hijos</li>
 	<li>Consejería para ayudar a las mujeres embarazadas y madres nuevas a tomar decisiones informadas sobre el amamantamiento</li>
 	<li>La transferencia de métodos individualizados a estrategias masivas innovadoras, acompañadas por evaluaciones de eficacia</li>
 	<li>La utilización de los medios masivos como herramienta para movilizar a la sociedad y modificar las normas sociales</li>
 	<li>El uso de espacios que permitan alcanzar a gran número de personas para diversas intervenciones—lugares de trabajo, centros de tránsito, movilizaciones políticas, escuelas, universidades y campamentos militares</li>
</ul>
En una epidemia generalizada de alto nivel, los factores contextuales como la pobreza y la fragilidad de la infraestructura
sanitaria afectarán en forma dramática a la prestación de servicios en todos los niveles. La condición de la mujer se convierte en una preocupación primordial en este ambiente y requiere de acción prioritaria con el fin de alterar radicalmente las normas de género y la vulnerabilidad económica, social, legal y física de las jóvenes y mujeres.
<h4>¿qué queda por hacer?</h4>
La magnitud y gravedad de la pandemia mundial son un llamado a la acción. La mezcla y distribución adecuada de
intervenciones de prevención y tratamiento depende de la etapa de la epidemia en el país en cuestión y del contexto en el que suceda. Sin datos firmes que orienten los objetivos programáticos, las estrategias nacionales tal vez no reflejen las
prioridades dictadas por el perfil epidémico determinado, generando así inversiones altamente ineficientes en la prevención y atención del VIH/SIDA. Tal derroche sin duda agrava la escasez de fondos y produce infecciones de VIH innecesarias así como muertes prematuras.

<hr />

<h3>¿Quién lo dice?</h3>
1. The information in this fact sheet is taken directly from the following chapter: Bertozzi S, Padian NS, Wegbreit J, et al. HIV/AIDS Prevention and Treatment. In: Disease Control Priorities in Developing Countries. April 2006.

2. UNAIDS (Joint United Nations Programme on HIV/AIDS). 2006 Report on the global AIDS epidemic.

3. Askew I, Berer M. The contribution of sexual and reproductive health services to the fight against HIV/AIDS: A review. Reproductive Health Matters. 2003;11:51–73.

4. Stover J, Bertozzi S, Gutierrez JP, et al. The global impact of scaling-up HIV/AIDS prevention programs in low- and middle-income countries. Science. 2006;311:1474-1476.

5. Wegbreit J, Bertozzi S, Demaria LM, et al. Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS. 2006;20:1217-1235.

<hr />

<strong>Preparado por Nancy Padian PhD*, Stefano Bertozzi,PhD**
*Womens Global Health Imperative, UCSF; **Instituto Nacional de Salud Publica, Mexico</strong>

<strong>Traducido por Rocky Schnaath</strong>

Mayo 2007. Hoja de Dato #62S]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/mundialFS.pdf</url>
	</node>
	<node>
		<title>Internet</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How does the Internet affect HIV prevention?</h3>
<h4>why the Internet?</h4>
The Internet has become a remarkable social networking tool where people who once were unlikely to meet in the physical world are now only a few key strokes away. It is not surprising that many persons with access to the Internet have used it to find love, companionship and sex.<sup>1</sup> In fact, using the Internet to find sexual partners is a widespread practice among men and women of all ages. About 16 million people say they have used websites to meet other people.<sup>2</sup>

Men who have sex with men (MSM)—whose sexual activities traditionally have been stigmatized—have benefited from the privacy of the Internet, with 40% of gay men reporting that they use the Internet to find sexual partners.<sup>3</sup> In online interviews, gay men reported that the Internet has helped them find social support, access resources safely and anonymously, and develop significant personal relationships.<sup>4</sup>

The Internet is important to the HIV prevention field. It is a powerful medium to deliver health and risk-reduction information. Many individuals who engage in risk-taking behaviors use the Internet to meet their sexual partners, and the Internet itself may facilitate such risk-taking behaviors.
<h4>does the Internet contribute to risk?</h4>
Whether or not the Internet’s unique qualities contribute to risk-taking behaviors is not fully understood. We know that people who use the Internet to meet sexual partners have been found to engage in more risky sexual behavior, be more likely to report a history of STDs, and have greater numbers of sexual partners than those who do not seek sexual partners online.<sup>3,5</sup> In fact, as early as 1999, outbreaks of syphilis among MSM were traced to users of specific chatrooms,<sup>6</sup> and there are also case reports of HIV transmission from sexual partners met online.<sup>7</sup>

It has been found, though, that men who engage in high-risk behaviors do so regardless of whether they meet their partners online or offline, such as in bars and clubs.<sup>8</sup>

Gay and bisexual men with “psychosocial vulnerabilities” (e.g., safer-sex burnout, depression, and social isolation) may be particularly prone to disengage, or avoid thinking about HIV, in the anonymity of a virtual world where they can meet sexual
partners for engaging in high-risk sexual behaviors.<sup>9</sup>

Using the Internet to meet partners outside one’s regular sexual network may also create an environment where sexual mixing between high-risk and low-risk persons occurs.<sup>10</sup> These new, expanded sexual networks can, in turn, increase the rate at which HIV and other STDs are transmitted.
<h4>can the Internet help in prevention?</h4>
Absolutely. The anonymity of online communication may make it easier to disclose HIV status or discuss safer sex and condom use before meeting in person.<sup>11</sup> A study of Latino MSM found they were significantly more likely to engage in sexual negotiation and serostatus disclosure on the Internet than in person. For HIV+ persons, disclosing HIV status online also helps avoid abuse, discrimination or rejection by partners.<sup>12</sup>

The Internet also provides a way to find sex partners who like the same things and are willing to take the same amount of risk. It may afford more opportunities to chat with a potential partner before having sex. In online ads, individuals can clearly state that they’re looking for partners who agree to safer sex (such as condom use), and they can more easily avoid meeting those who do not. Similarly, online sex-seeking allows HIV+ persons to disclose their status and find partners of the same serostatus (often called serosorting), especially if they intend not to use condoms.<sup>8</sup> Just like in the physical world, however, one cannot be fully trusted to give or even know their accurate HIV status, so serosorting may not be a foolproof HIV prevention strategy, and it also risks transmitting other STDs.
<h4>what’s being done?</h4>
Community-Based Organizations (CBOs), researchers, and health departments—occasionally with the support of online service providers—are using the Internet in creative ways to increase HIV-related awareness and knowledge, and to positively influence attitudes, beliefs, and behaviors. Researchers have used the Internet to recruit participants and to collect data. Internet-based programs have also been used to help people anonymously disclosure their HIV/STD status to past sexual partners.

Commonly, CBOs have used e-mail distribution lists or sent outreach workers into popular online meeting venues (such as chat rooms and hook-up sites) to promote their programs, answer questions, deliver educational and safer-sex materials, and encourage dialogue about HIV prevention. A handful of CBOs with dedicated funding created HIV-prevention websites tailored for their communities.<sup>13</sup>

Launched in 2002, PowerOn is a comprehensive site providing access to HIV/AIDS education, support, and referrals to 200 local prevention agencies for the gay, bisexual and transgender community in Seattle/King County, WA. Early PowerOn users showed particular interest in pages about Negotiating Safety Agreements and Putting on a Condom.<sup>14</sup>

Wrapp.net provides HIV prevention interventions and resources for MSM in the rural US. One NIMH-funded intervention presented a conversation between an HIV+ and an HIV- gay man who recently engaged in risk behavior. A randomized controlled trial found it was well accepted and improved participants’ HIV risk-reduction knowledge, safer-sex attitudes, beliefs about what will happen as a result of engaging in certain behaviors, and beliefs about how well they can perform a given task.<sup>15</sup>

Once computerized online interventions are developed, they can operate cost-effectively around the clock, can be easily modified whenever changes are necessary, and quality control standards can be readily established with little opportunity for human error. Community members with Internet access can use such programs at their convenience and with little risk to their personal privacy.

Many health departments are exploring using the Internet for partner notification, disclosure assistance and referrals.<sup>16</sup> InSPOT.org, developed by ISIS, Inc., is a website where men diagnosed with HIV /STDs can send electronic cards to sexual partners to inform them of a potential exposure, conveniently and without intervention by a provider. Cards can be sent anonymously, with or without a personal message. A survey of MSM in San Francisco found that 19% had heard of InSPOT, 5% of those used it to notify a partner and 4% received an e-card.

Popular website owners can also participate in HIV prevention and education activities. Craigslist.org agreed to add a health message and link to the San Francisco City Clinic website for users entering the “men seeking men” and the “casual encounters” pages. This addition did not result in a decline in the number of postings or visitors. Manhunt agreed to place ads on the dangers of crystal meth use and the rise in syphilis cases. Gay.com accepted a request to integrate sexual health
messages by linking to “Ask Dr. K,” a question-and-answer sexual-health forum.<sup>17</sup>
<h4>what needs to be done?</h4>
New interventions to address the HIV risks associated with the Internet need to be developed and evaluated. Programs that help people think about their motives for seeking partners online, and Web-based, health-related screening and referral tools may be promising approaches. It is crucial to conduct further evaluations of the efficacy of current online prevention programs before any such interventions and approaches can be deemed successful and worth replicating.

Social policies to help prevent Internet-facilitated HIV transmission are also necessary and may come from legislation or from voluntary changes enacted by website operators. Cooperative efforts between online providers, law makers, researchers, program planners and, most importantly, community members could create structural changes to prevent further Internet-facilitated HIV transmissions.<sup>18</sup>

Options for policy changes include: public-health warnings on websites; changes to the way hookup sites are advertised; encouraging research to measure behavior change from online interventions and the development of tools on dating or hookup sites that facilitate the discussion of HIV and safer sex; and incentives for website operators to cooperate with public-health and other HIV-prevention efforts.

<hr />

<h3>Says who?</h3>
1. Chiasson MA, Parsons JT, Tesoriero JM, et al. HIV behavioral research online.Journal of Urban Health. 2006;83:73-85.

2. Madden M, Lenhart A. Online dating. Report prepared by the Pew Internet and American Life Project. March 2006.

3. Liau A, Millett G, Marks G. Meta-analytic examination of online sex-seeking and sexual risk behavior among men who have sex with men. Sexually Transmitted Diseases. 2006;33:576-584.

4. Rebchook G, Curotto A, Kegeles S. Exploring the sexual behavior and Internet use of chatroom-using men who have sex with men through qualitative and quantitative research. Presented at the 2003 National HIV Prevention Conference, Atlanta, GA.

5. McFarlane M, Bull SS, Rietmeijer CA. The Internet as a newly emerging risk environment for sexually transmitted diseases. Journal of the American Medical Association. 2000;284:443-446.

6. Klausner JD, Wolf W, Fischer-Ponce L, et al. Tracing a syphilis outbreak through cyberspace. Journal of the American Medical Association. 2000;284:447-449.

7. Tashima K, Alt E, Harwell J, et al. Internet sex-seeking leads to acute HIV infection: a report of two cases. International Journal of STD and AIDS. 2003;14:285-286.

8. Bolding G, Davis M, Hart G, et al. Gay men who look for sex on the Internet: is there more HIV/STI risk with online partners? AIDS. 2005;19:961-968.

9. McKirnan D, Houston E, Tolou-Shams M. Is the Web the culprit? Cognitive escape and Internet sexual risk among gay and bisexual men. AIDS and Behavior. 2006.

10. Wohlfeiler D, Potterat JJ. Using gay men’s sexual networks to reduce sexually transmitted disease (STD)/human immunodeficiency virus (HIV) transmission. Sexually Transmitted Diseases. 2005;32:S48-52.

11. Carballo-Dieguez A, Miner M, Dolezal C, et al. Sexual negotiation, HIV-status disclosure, and sexual risk behavior among Latino men who use the internet to seek sex with other men. Archives of Sexual Behavior. 2006;35:473-481.

12. Davis M, Hart G, Bolding G, et al. Sex and the Internet: gay men, risk reduction and serostatus. Culture, Health and Sexuality. 2006;8:161-174.

13. Curotto A, Rebchook G, Kegeles S. Opening a virtual door into a vast real world: Community-based organizations are reaching out to at-risk MSM with creative, online programs. Paper presented at: STD/HIV Prevention and the Internet; August 27, 2003; Washington D.C.

14. Weldon JN. The Internet as a tool for delivering a comprehensive prevention intervention for MSM Internet sex seekers. Paper presented at: 2003 National HIV Prevention Conference; July 27-30, 2003, 2003; Atlanta, GA.
depts.washington.edu/poweron/

15. Bowen AM, Horvath K, Williams ML. A randomized control trial of Internet-delivered HIV prevention targeting rural MSM. Health Education Research. 2006.www.wrapp.net

16. Mimiaga MJ, Tetu A, Novak D, et al. Acceptability and utility of a partner notification system for sexually transmitted infection exposure using an internet-based, partner-seeking website for men who have sex with men. Presented at the International AIDS Conference, Toronto, Canada. 2006. Abstr #THPDC02.

17. Klausner JD, Levine DK, Kent CK. Internet-based site-specific interventions for syphilis prevention among gay and bisexual men. AIDS Care, 2004;16:964-970.

18. Levine D, Klausner JD. Lessons learned from tobacco control: A proposal for public health policy initiatives to reduce the consequences of high-risk sexual behavior among men who have sex with men and use the Internet. Sexuality Research and Social Policy. 2005;2:51-58.

<hr />

<strong>Prepared by Greg Rebchook PhD, Alberto Curotto PhD, CAPS and Deb Levine, ISIS</strong>

<strong>January 2007. Fact Sheet #63E</strong>

Special thanks to the following reviewers of this fact sheet: Anne Bowen, Cari Courtenay-Quirk, Jonathan Elford, Charles King, Jeff Klausner, Mary McFarlane, Greg Millett, Frank Strona.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©January 2007, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/InternetFS.pdf</url>
	</node>
	<node>
		<title>Red Internet</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo afecta la red Internet en la prevención del VIH?</h3>
<h4>¿por qué Internet?</h4>
Internet se ha convertido en una herramienta de conexión social que mediante unas pocas tecleadas une a personas que difícilmente se conocerían en el mundo físico. No es sorprendente que muchas personas con acceso a Internet la hayan usado para buscar amor, compañerismo y sexo.<sup>1</sup> De hecho, el uso de Internet para buscar parejas sexuales es una práctica amplia entre hombres y mujeres de todas las edades. Unas 16 millones de personas afirman haber visitado páginas web con el fin de conocer a otras personas.<sup>2</sup>

Los hombres que tienen sexo con hombres (HSH)— una conducta tradicionalmente estigmatizada— se han beneficiado de la privacidad que les ofrece Internet, y un 40 % de los hombres homosexuales informan que usan Internet para conocer a parejas sexuales.<sup>3</sup> En entrevistas realizadas en línea, los hombres gay afirmaron que Internet los ha ayudado a encontrar apoyo social, obtener recursos en forma segura y anónima y formar relaciones personales importantes.<sup>4</sup>

Internet es importante en el campo de la prevención del VIH. Es un medio poderoso para brindar información sobre la salud y la reducción de riesgos. Muchos individuos que participan en conductas de riesgo usan Internet para conocer a sus parejas sexuales, y es posible que Internet en sí facilite tales conductas riesgosas.
<h4>¿contribuye Internet al riesgo?</h4>
No se entiende completamente si las características únicas de Internet contribuyen a las conductas riesgosas o no. Se ha comprobado que las personas que usan Internet para conocer a parejas sexuales tienen conductas más riesgosas, más probabilidades de reportar antecedentes de ITS y mayores números de parejas sexuales que otras personas que no buscan parejas sexuales en línea.<sup>3,5</sup> De hecho, ya desde 1999, se detectaron brotes de sífilis entre HSH mediante rastreo a usuarios de ciertas salas de conversación.<sup>6</sup> También existen informes de casos de transmisión del VIH entre parejas sexuales que se conocieron en línea.<sup>7</sup>

Sin embargo, se ha encontrado que los hombres que participan en conductas de alto riesgo lo hacen independientemente de si conocieron a sus parejas en línea o de otra manera, como en un bar o club.<sup>8</sup>

Los hombres gay o bisexuales con “vulnerabilidades psicosociales” (p.ej., hartos de practicar el sexo seguro, deprimidos y socialmente aislados) pueden ser especialmente propensos a distanciarse emocionalmente, o a evitar pensar en el VIH, en el anonimato de un mundo virtual que les permite conocer a parejas con el fin de tener sexo de alto riesgo.<sup>9</sup>

El uso de Internet para conocer a parejas fuera de su red social habitual también puede crear un ambiente en el cual ocurre contacto sexual entre personas de alto riesgo y otras de bajo riesgo.<sup>10</sup> Las nuevas redes sexuales expandidas pueden, a su vez, aumentar la frecuencia de transmisión del VIH y otras ITS.
<h4>¿puede Internet ayudar en la prevención?</h4>
Absolutamente. El anonimato de la comunicación en línea puede facilitar la revelación de la condición de VIH o las conversaciones sobre el sexo más seguro y el uso de condones antes de conocerse personalmente. Un estudio de HSH latinos encontró que eran mucho más propensos a participar en la negociación sexual y de revelar su serocondición en Internet que en persona.<sup>11</sup> Para las personas VIH+, la revelación de su condición de VIH en línea también ayuda a evitar el abuso, la discriminación o el rechazo por parte de sus parejas.<sup>12</sup>

Internet también facilita la búsqueda de parejas sexuales que compartan los mismos gustos y estén dispuestas a correr el mismo nivel de riesgo. Este medio tal vez ofrece más oportunidades para charlar con una pareja potencial antes de tener sexo. En los anuncios en línea, uno puede exponer claramente que busca parejas que acepten practicar el sexo más seguro (como el uso de condones) y es más fácil evitar quienes no concuerden. Asimismo, la búsqueda sexual en línea permite que las personas VIH+ revelen su condición y encuentren parejas de la misma serocondición (a esto muchas veces se le llama seroselección), especialmente si no piensan usar condones.<sup>8</sup> Al igual que en el mundo físico, sin embargo, no es posible confiar completamente en que otro le diga o siquiera conozca su condición de VIH exacta, entonces la seroselección tal vez no sea una estrategia
infalible de prevención del VIH, y también conlleva el riesgo de transmitir otras ITS.
<h4>¿qué se está haciendo al respecto?</h4>
Las organizaciones comunitarias (CBOs), los investigadores y los departamentos de salud, a veces con el apoyo de los proveedores de servicios en línea, aprovechan Internet creativamente con el fin de aumentar la conciencia y los conocimientos sobre el VIH y para afectar en forma positiva las actitudes, creencias y conductas. Los investigadores han usado Internet para reclutar a participantes y recopilar datos. También se han usado Internet para ayudar a las personas a revelar en forma anónima su condición de VIH/ITS a sus parejas anteriores.

Las CBOs frecuentemente han usado listas de distribución de correo electrónico o han enviado a educadores que visitan sitios populares para charlar en línea (salas de conversación, sitios de ligue, etc.) para promover sus programas, contestar preguntas, informar sobre el sexo protegido y otros temas, y para fomentar el diálogo sobre la prevención del VIH. Unas cuantas CBOs con fondos dedicados a este fin crearon sitios web sobre la prevención del VIH.<sup>13</sup>

Lanzado en el 2002, PowerOn es un sitio integral que provee acceso a información, apoyo y recomendaciones a servicios relacionados con el VIH/SIDA a 200 organizaciones locales de prevención para la comunidad gay, bisexual y transgénero del condado de Seattle/King, WA. Los primeros usuarios de PowerOn indicaron especial interés en las páginas sobre la negociación de acuerdos de seguridad y para la colocación correcta del condón.<sup>14</sup>

Wrapp.net brinda intervenciones y recursos de prevención del VIH para HSH en las zonas rurales de EE.UU. Una intervención financiada por los NIMH presentó una conversación entre un hombre VIH+ y otro VIH- quienes acababan de participar en conducta riesgosa. Un ensayo controlado aleatorizado encontró que el sitio tenía buena acogida y que mejoró los conocimientos de los participantes con respecto a la reducción de riesgos del VIH, sus actitudes hacia el sexo más seguro, sus creencias sobre las consecuencias de ciertas conductas y sus creencias sobre su capacidad para efectuar ciertas tareas.<sup>15</sup>

Una vez creadas, las intervenciones en línea operan en forma económica las 24 horas del día, se pueden modificar fácilmente en el momento necesario y se pueden establecer normas de control de calidad con poca posibilidad de error humano. Personas con acceso a Internet pueden usar estos programas según su conveniencia y con poco riesgo a su intimidad personal.

Muchos departamentos de salud exploran las aplicaciones de Internet con respecto a notificación de parejas, ayuda para revelar la serocondición y remisiones a servicios relacionados.<sup>16</sup> InSPOT.org, creado por ISIS, Inc., es un sitio web en el cual, en forma conveniente y sin la intervención del proveedor médico, los hombres diagnosticados con VIH/ ITS pueden enviar tarjetas electrónicas a sus parejas sexuales para informarles de la posible exposición. Las tarjetas se pueden enviar en forma anónima, con o sin un mensaje personal.

Los propietarios de sitios web populares también pueden participar en la prevención del VIH. Craigslist.org aceptó agregar un mensaje informativo y un enlace al sitio web de la San Francisco City Clinic para usuarios que visiten las páginas sobre “hombres que buscan a hombres” y “encuentros casuales.” Esta añadidura no produjo una disminución en el número de comentarios colocados ni de visitantes. Manhunt aceptó colocar anuncios sobre los peligros del uso de la metanfetamina cristal y sobre el aumento en los casos de sífilis. Gay.com accedió a una petición de integrar mensajes de salud sexual por medio de un enlace con“Ask Dr. K,” un foro de preguntas y respuestas sobre la salud sexual.<sup>17</sup>
<h4>¿qué queda por hacer?</h4>
Es preciso crear y evaluar nuevas intervenciones que respondan a los riesgos de VIH vinculados con Internet. Los programas que ayuden a las personas a pensar en sus motivos para buscar parejas en línea y las herramientas de detección y remisión en Internet pueden ser abordajes prometedores. Es crucial realizar más evaluaciones sobre la eficacia de los actuales programas en línea antes de determinar que tales intervenciones sean meritorios de ser reproducidos.

También se necesitan políticas sociales para ayudar a evitar la transmisión del VIH facilitada por Internet; tales normas pueden lograrse por medios legislativos o por cambios voluntarios efectuados por los propietarios de sitios web. Las colaboraciones entre los proveedores de servicios en línea, los legisladores, los investigadores, los planificadores de programas y, de mayor importancia, los integrantes de la comunidad, podrían generar cambios estructurales que eviten más transmisiones de VIH facilitadas por Internet.<sup>18</sup>

Las opciones de cambios normativos abarcan: advertencias de salud pública en los sitios web; cambios en la forma en que se publicitan los sitios de ligue; la promoción de investigaciones que midan los cambios de conducta producidos por las intervenciones en línea y la creación de herramientas en los sitios de ligue y en los sitios para conocer parejas que faciliten las conversaciones sobre el VIH y el sexo más seguro; así como incentivos para los operadores de sitios web para que cooperen con a los esfuerzos de salud pública y de la prevención del VIH.

<hr />

<h3>¿Quién lo dice?</h3>
1. Chiasson MA, Parsons JT, Tesoriero JM, et al. HIV behavioral research online.Journal of Urban Health. 2006;83:73-85.

2. Madden M, Lenhart A. Online dating. Report prepared by the Pew Internet and American Life Project. March 2006.

3. Liau A, Millett G, Marks G. Meta-analytic examination of online sex-seeking and sexual risk behavior among men who have sex with men. Sexually Transmitted Diseases. 2006;33:576-584.

4. Rebchook G, Curotto A, Kegeles S. Exploring the sexual behavior and Internet use of chatroom-using men who have sex with men through qualitative and quantitative research. Presented at the 2003 National HIV Prevention Conference, Atlanta, GA.

5. McFarlane M, Bull SS, Rietmeijer CA. The Internet as a newly emerging risk environment for sexually transmitted diseases. Journal of the American Medical Association. 2000;284:443-446.

6. Klausner JD, Wolf W, Fischer-Ponce L, et al. Tracing a syphilis outbreak through cyberspace. Journal of the American Medical Association. 2000;284:447-449.

7. Tashima K, Alt E, Harwell J, et al. Internet sex-seeking leads to acute HIV infection: a report of two cases. International Journal of STD and AIDS. 2003;14:285-286.

8. Bolding G, Davis M, Hart G, et al. Gay men who look for sex on the Internet: is there more HIV/STI risk with online partners? AIDS. 2005;19:961-968.

9. McKirnan D, Houston E, Tolou-Shams M. Is the Web the culprit? Cognitive escape and Internet sexual risk among gay and bisexual men. AIDS and Behavior. 2006.

10. Wohlfeiler D, Potterat JJ. Using gay men’s sexual networks to reduce sexually transmitted disease (STD)/human immunodeficiency virus (HIV) transmission. Sexually Transmitted Diseases. 2005;32:S48-52.

11. Carballo-Dieguez A, Miner M, Dolezal C, et al. Sexual negotiation, HIV-status disclosure, and sexual risk behavior among Latino men who use the internet to seek sex with other men. Archives of Sexual Behavior. 2006;35:473-481.

12. Davis M, Hart G, Bolding G, et al. Sex and the Internet: gay men, risk reduction and serostatus. Culture, Health and Sexuality. 2006;8:161-174.

13. Curotto A, Rebchook G, Kegeles S. Opening a virtual door into a vast real world: Community-based organizations are reaching out to at-risk MSM with creative, online programs. Paper presented at: STD/HIV Prevention and the Internet; August 27, 2003; Washington D.C.

14. Weldon JN. The Internet as a tool for delivering a comprehensive prevention intervention for MSM Internet sex seekers. Paper presented at: 2003 National HIV Prevention Conference; July 27-30, 2003, 2003; Atlanta, GA.
depts.washington.edu/poweron/

15. Bowen AM, Horvath K, Williams ML. A randomized control trial of Internet-delivered HIV prevention targeting rural MSM. Health Education Research. 2006.www.wrapp.net

16. Mimiaga MJ, Tetu A, Novak D, et al. Acceptability and utility of a partner notification system for sexually transmitted infection exposure using an internet-based, partner-seeking website for men who have sex with men. Presented at the International AIDS Conference, Toronto, Canada. 2006. Abstr #THPDC02.

17. Klausner JD, Levine DK, Kent CK. Internet-based site-specific interventions for syphilis prevention among gay and bisexual men. AIDS Care, 2004;16:964-970.

18. Levine D, Klausner JD. Lessons learned from tobacco control: A proposal for public health policy initiatives to reduce the consequences of high-risk sexual behavior among men who have sex with men and use the Internet. Sexuality Research and Social Policy. 2005;2:51-58.

<hr />

<strong>Preparado por Greg Rebchook PhD*, Alberto Curotto PhD* and Deb Levine**
*CAPS, **ISIS</strong>

<strong>Traducido por Rocky Schnaat</strong>h

Mayo 2007. Hoja de Dato #63S]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/redInternetFS.pdf</url>
	</node>
	<node>
		<title>Prisons and jails</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of prisons and jails in HIV prevention?</h3>
<h4>Is prevention in prisons and jails important?</h4>
Absolutely. The US has the highest incarceration rate in the world, and the numbers keep growing.<sup>1</sup> In 2007, the US had over 2.4 million people in state, federal and local correctional facilities.<sup>2</sup> For the first time, more than 1 in every 100 adults in the US is confined in a jail or prison.<sup>1</sup>

Persons in prison and jail have higher rates of many diseases and health problems than the general population.<sup>3</sup> HIV rates among incarcerated persons are 2 ½ times higher than in the general population. In any given year, about 25% of all HIV+ persons in the US pass through a correctional facility.<sup>4</sup> Persons in prison and jail also have higher rates of STIs, tuberculosis and viral hepatitis, as well as substance abuse and mental illness.<sup>5</sup>

These high infection rates in prisons and jails in the US reflect the fact that the majority of persons who are incarcerated come from impoverished and disenfranchised communities with limited access to prevention, screening and treatment services.<sup>6</sup> These are the same neighborhoods with high rates of HIV, STIs and other infectious diseases.

Criminal justice and public health systems can work together to provide comprehensive prevention and treatment inside and outside facilities. Incarceration presents a window of opportunity for primary prevention, screening, treatment and establishing comprehensive, pro-active transitional linkages for persons approaching release and follow-up.
<h4>What is the HIV connection between prisons, jails and the community?</h4>
At least 95% of persons in prison are released into the community at some point.<sup>7</sup> The impact of incarceration and disease is not limited to the men and women being locked up, but extends to their families, partners and communities.

There is a mistaken belief that men and women acquire HIV inside, when in fact, the vast majority of HIV+ persons in prison and jail enter the criminal justice system HIV+.<sup>8,9</sup>

Persons with a history of mental illness, trauma or physical and sexual abuse, who do not have access to mental health services, may self-medicate with substance use. This combination puts them at increased risk for behaviors that may both lead to HIV and land them in jail or prison. Rates of mental health diagnoses for persons in jail and prison are 45-65%, while rates of substance abuse are as high as 75%.<sup>10</sup>
<h4>How does incarceration impact HIV risk?</h4>
Persons in prison and jail may engage in risk behaviors before, during and after incarceration. However, behavior during incarceration may be riskier for those who do not have access to condoms, clean syringes and other prevention tools. Sexual activity (both consensual and coerced), substance use, injecting and tattooing can all put individuals at risk for HIV/STIs and viral hepatitis.<sup>11</sup> In one study of incarcerated young men, 50% had used substances and 17% had consensual sex with men or women while confined.<sup>12</sup>

Release from correctional settings and re-entry into the community can be a stressful time and often carries higher risks than being incarcerated. Persons released from prison and jail may celebrate their release with HIV risk-related behaviors such as drinking, drug use and sex. Persons released with few resources often return to the same precarious environments where they were arrested. A study of persons formerly incarcerated in Washington found a high risk of drug overdose within the first two weeks of release.<sup>13</sup>

There is a misperception that incarcerated men are responsible for increasing rates of HIV/STIs. Imprisonment does affect HIV/STI rates in the community, but not from men getting infected on the inside and bringing it out to their female sexual partners once they are released. Instead, incarceration decreases the number of men in the community, which disrupts stable partnerships, changes the male-to-female ratio and promotes higher-risk concurrent, or overlapping, partnerships.<sup>14</sup>
<h4>What can be done inside?</h4>
Across the US, many HIV prevention agencies and public health departments are working with the criminal justice system to improve the health of persons who are incarcerated and their communities. Agencies can provide: peer-based prevention programs, including prevention with positives; harm reduction programs; quality health care; treatment for HIV/STIs; treatment for substance abuse and mental illness; links to community services pre-release; help with community reintegration post-release.<sup>10,15</sup>

<strong>Counseling, testing and treatment for HIV/STI/hepatitis/TB.</strong> Incarceration can be an opportunity for screening and treating a group of individuals with high risk behaviors. This should include comprehensive pre-test counseling with a consent process describing the implications of testing positive or negative, as these can have consequences within correctional facilities, such as limiting housing and work assignments, and restricting visiting privileges. It should also include providing treatment for those who test positive and prevention education to those who test positive and negative.

<strong>Mental health treatment.</strong> Persons in prison and jail have high rates of mental illness. Conditions in correctional settings such as overcrowding, violence and isolation have negative effects on mental health. Prisons and jails can help by providing assessment and effective treatment. Persons with mental illness who have committed minor offenses should be diverted to mental health services before or instead of prison or jail.<sup>16</sup>

<strong>Comprehensive substance abuse treatment. </strong>While many jails and prisons in the US offer detoxification, professional and peer counseling, self-help groups and drug and alcohol education, very few offer methadone maintenance. The capacity of effective substance abuse treatment programs falls far short of the need. The KEEP program, based in New York, NY, provides jail-based methadone treatment and dedicated treatment slots to released individuals in the community.<sup>17</sup>
<h4>What are transitional interventions?</h4>
Effective transitional interventions ensure that prevention and treatment services provided on the inside are continued on the outside. Many communities will have an increasing role in transitional planning with enactment of the Second Chance Act.<sup>18</sup>

Project START is the only intervention for incarcerated populations in the CDC’s Compendium of Evidence-Based Interventions. Project START is a client-centered, 6-session HIV, STI and hepatitis risk reduction intervention for persons being released from a correctional setting. Based in harm reduction, it uses a prevention case management model and motivational enhancement to encourage risk reduction. The first two sessions are pre-release and the last four are post-release. All sessions include facilitated referrals for housing, employment, substance abuse and mental health treatment, legal issues, and avoiding reincarceration. Research demonstrated that Project START was effective in reducing unprotected sex among young men after their release from prison.<sup>19</sup>

Project Bridge in Providence, RI, provides intensive case management for HIV+ persons being released from state prison. Enrollees receive 18 months of case management by a social worker and an outreach worker. Participants meet weekly for 12 weeks, then once a month, at a minimum. Project Bridge is effective in helping HIV+ persons obtain and maintain much needed post-release services. Research showed that despite high levels of addiction (97%) and mental illness (34%), participants received post-release medical care (95%), secured housing (46%), linked to mental health care (71%) and linked to addiction services (51%).<sup>20</sup>
<h4>What are next steps?</h4>
Effectively addressing HIV in prisons, jails and communities requires both effective prevention strategies (such as peer education, access to condoms, HIV counseling and testing) and effective structural and medical strategies. Some of the proven effective strategies and policies that can help reduce HIV/STIs in prisons and jails include: harm reduction programs (providing clean syringes);<sup>21</sup> substance abuse treatment;<sup>17</sup> mental health treatment;<sup>16</sup> STI/HIV treatment;<sup>5</sup> transitional discharge planning;<sup>19,20</sup> housing;<sup>5</sup> alternatives to incarceration;<sup>15</sup> and sentencing and parole reform.<sup>1</sup>

Collaboration between the criminal justice system (prison, jail, parole and probation) and the community public health system (social services, medical/health clinics, treatment programs, etc.) is essential, and there are several effective models. Building partnerships can help tackle public health issues while understanding the challenges of public safety and custody priorities. If we truly want to decrease rates of HIV, STIs and hepatitis in our communities, we have to work together to create a seamless continuum that will improve prevention, care and treatment both inside prisons and jails as well as in disproportionately affected communities.

<hr />

<h3>Says who?</h3>
1. PEW Center on the States. One in 31: The long reach of American corrections. March 2009.

2. West HC, Sabol WJ. Prisoners in 2007. Bureau of Justice Statistics Bulletin. 2008.

3. Maruschak L. HIV in Prisons, 2006. Bureau of Justice Statistics Bulletin. 2008.

4. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. American Journal of Public Health. 2002 ;92:1789-1794.

5. The Foundation for AIDS Research. HIV in correctional settings: implications for prevention and treatment policy. Issue Brief No 5, March 2008.

6. Golembeski C, Fullilove R. Criminal (in)justice in the city and its associated health consequences. American Journal of Public Health. 2005;95:1701–1706.

7. Hughes T, James Wilson D. Reentry trends in the United States. Bureau of Justice Statistics.

8. Vlahov D, Putnam S. From corrections to communities as an HIV priority. Journal of Urban Health. 2006;83:339-348.

9. Zack B, Kramer K. HIV prevention education in correctional settings. Project UNSHACKLE discussion paper. May 2008.

10. James DJ, Glaze LE. Mental health problems of prison and jail inmates. Bureau of Justice Statistics Special Report. September 2006.

11. HIV transmission among male inmates in a state prison system – Georgia, 1992-2005. Morbity and Mortality Weekly Report. 2006;55:421-426.

12. Seal DW, Margolis AD, Morrow KM, et al. Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates.AIDS and Behavior. 2008;12:27-40.

13. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison—a high risk of death for former inmates. New England Journal of Medicine. 2007;356:157-165.

14. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372:337-340.

15. Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. Journal of Urban Health. 2001;78:214-235.

16. World Health Organization. Mental health and prisons. 2005.

17. Tomasino V, Swanson AJ, Nolan J, et al. The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates. The Mount Sinai Journal of Medicine. 2001;68:14-20.

18. Second Chance Act.

19. Wolitski RJ, The Project START study group. Relative efficacy of a multi-session sexual risk-reduction intervention for young men released from prison in 4 states. American Journal of Public Health. 2006;96:1845-1861.

20. Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. Journal of Health Care for the Poor and Underserved. 2008;19:522-531.

21. Jürgens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infectious Diseases. 2009;9:57-66.

<hr />

<strong>Prepared by Barry Zack MPH and Katie Kramer MSW/MPH, The Bridging Group LLC</strong>

<strong>March 2009. Fact Sheet #13R</strong>

Special thanks to the following reviewers of this Fact Sheet: Tim Flanigan, Nick Freudenberg, Robert Fullilove, Robert Greifinger, Ted Hammett, Bob Hogg, Ralf Jürgens, Beth Justiniano, James Learned, Robin MacGowan, Alex Margolis, Dan O’Connell, Anthony Papa, Robin Pollini, Hugh Potter, Cristine Rodriguez, David Seal, Dan Wohlfeiler, Jeanne Woodford.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©March 2009, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revincarceratedFS.pdf</url>
	</node>
	<node>
		<title>Prisiones</title>
		<tax>1737</tax>
		<content><![CDATA[<h3><strong>¿Cuál es el papel de las prisiones y cárceles en la prevención del VIH?</strong></h3>
<strong>¿Es importante hacer prevención en las prisiones y cárceles?</strong>

Definitivamente. EE.UU. tiene la mayor proporción de personas encarceladas del mundo y la cifra sigue en aumento.<sup>1</sup> En el 2007 las instituciones correccionales estatales, federales y locales alojaban a 2.4 millones de reclusos.<sup>2</sup> Por primera vez más de uno de cada 100 adultos en EE.UU. se encuentra encarcelado.<sup>3</sup>

En comparación con la población general, los reclusos padecen más enfermedades y problemas de salud; sus tasas de VIH son 2 1/2 veces mayores. En cualquier año dado, un 25% de todas las personas VIH+ en EE.UU. pasa por una institución correccional.<sup>4</sup> Las personas encarceladas también tienen tasas más altas de ITS, tuberculosis y hepatitis viral, abuso de alcohol y drogas y enfermedad mental.<sup>5</sup>

Estas altas tasas de infección en las prisiones y cárceles estadounidenses reflejan el hecho de que la mayoría de los reclusos provienen de zonas pobres y marginadas con poco acceso a servicios de prevención y tratamiento<sup>6</sup> y con tasas altas de VIH, ITS y otras enfermedades infecciosas.

Los sistemas de justicia penal y de salud pública pueden colaborar para brindar servicios de prevención y tratamiento integrales dentro de estas instituciones y en la comunidad. El encarcelamiento les presenta una ventana de oportunidad para la realización de servicios primarios de prevención, detección y tratamiento así como el establecimiento de enlaces oportunos que faciliten la transición para reclusos con fecha de salida cercana.

<strong>¿Cuál es la conexión entre las prisiones/cárceles y la comunidad con respecto al VIH?</strong>

Por lo menos el 95% de los presos regresa a la comunidad en algún momento.<sup>7</sup> El impacto del encarcelamiento y de la enfermedad no se limita a los hombres y mujeres tras las rejas, sino que también repercute en su familias, parejas y comunidades.

Se cree erróneamente que el VIH se adquiere en la cárcel o prisión, pero en realidad casi todas las personas VIH+ se infectaron antes de entrar al sistema de justicia penal.<sup>8,9</sup> Las personas con antecedentes de enfermedad mental, trauma o abuso físico y sexual, y que no disponen de acceso a servicios de salud mental, pueden auto medicarse con alcohol o drogas. Esta combinación propicia conductas que puedan llevar tanto a la infección por VIH como al encarcelamiento. El 45-65% de los reclusos tiene un diagnóstico de salud mental y hasta el 75% consume drogas o alcohol.<sup>10</sup>

<strong>¿Cuál es el efecto del encarcelamiento sobre el riesgo de contraer el VIH?</strong>

Los reclusos pueden tener conductas riesgosas antes, durante y después de ser encarcelados. No obstante, la conducta durante el encarcelamiento puede conllevar un mayor riesgo si no tienen acceso a condónes, jeringas limpias y otras formas de prevención. La actividad sexual (tanto consensual como por coerción), el consumo de alcohol y drogas, la inyección de drogas y el tatuaje pueden poner a los individuos en riesgo de contraer el VIH, otras ITS y la hepatitis viral.<sup>11</sup> Un estudio con hombres jóvenes encontró que durante su encarcelamiento el 50% había consumido drogas/alcohol y el 17% había aceptado tener relaciones sexuales con hombres o mujeres.<sup>12</sup>

La salida de un entorno correccional y el regreso a la comunidad puede ser una etapa de transición estresante que muchas veces conlleva riesgos mayores que el propio encarcelamiento. Los reclusos recién liberados pueden festejar participando en conductas que aumentan su riesgo de contraer el VIH, como beber, drogarse y tener relaciones sexuales. En el estado de Washington un estudio de personas con historial de encarcelamiento encontró un alto riesgo de sobredosis de drogas durante las dos semanas siguientes a su puesta en libertad.<sup>13</sup>

Existe la percepción errónea de los hombres encarcelados como los responsables de aumentar las tasas de VIH/ITS. El encarcelamiento sí afecta las tasas de VIH/ITS en la comunidad, pero no porque los hombres contraigan estas enfermedades durante el encierro y posteriormente infecten a sus parejas sexuales femeninas cuando son liberados. En cambio, el encarcelamiento disminuye el número de hombres en la comunidad, lo cual perturba las relaciones de pareja estables, altera la proporción hombre-mujer y da lugar a relaciones de pareja concurrentes, o solapadas, de alto riesgo.<sup>14</sup>

<strong>¿Qué se puede hacer desde adentro?</strong>

A lo largo de EE.UU. muchas organizaciones de prevención del VIH y departamentos de salud pública colaboran con el sistema de justicia penal para fortalecer la salud de las personas encarceladas y la de sus comunidades. Las organizaciones pueden ofrecer: programas de pares para la prevención, incluyendo la prevención para personas positivas; reducción de daños; atención médica de alta calidad; tratamiento contra el VIH/ITS; tratamientos para la enfermedad mental y la cesación de alcohol y drogas; enlaces a servicios comunitarios previa liberación y ayuda posterior para reintegrarse en la comunidad.<sup>10,15</sup>

<strong>Consejería, pruebas y tratamiento para VIH/ITS/hepatitis/tuberculosis.</strong> El encarcelamiento puede ser una oportunidad para ofrecer pruebas de detección y tratamiento a un grupo de individuos con conductas de alto riesgo. Es importante incluir consejería integral previa a la prueba (con un proceso de consentimiento que describa las implicaciones de un resultado positivo o negativo), ya que éstos pueden tener consecuencias dentro de los centros de encarcelamiento, como la limitación de sus opciones de alojamiento, trabajo y privilegios de visita. También se debe proveer tratamiento para los que salgan positivos y orientación sobre la prevención para todos ya sea que resulten VIH positivos o negativos.

<strong>Tratamiento de salud mental.</strong> Las personas encarceladas tienen altas tasas de enfermedad mental. El aglomeramiento, la violencia, el aislamiento otras condiciones de los entornos correccionales perjudican la salud mental. Las prisiones y cárceles pueden ayudar brindando valoraciones clínicas y tratamientos eficaces. Se debe remitir a las personas con trastornos mentales que han cometido delitos menores a servicios de salud mental antes o en lugar de la prisión o cárcel.<sup>16</sup>

<strong>Tratamiento integral contra el abuso de alcohol y drogas.</strong> Aunque muchas cárceles y prisiones estadounidenses ofrecen desintoxicación, consejería de profesionales y de pares, grupos de auto ayuda y educación sobre las drogas y el alcohol, muy pocas ofrecen mantenimiento con metadona, por lo que la capacidad de servicio de los programas eficaces de tratamiento contra las drogas está muy lejos de satisfacer la necesidad. En la ciudad de Nueva York, NY, el programa KEEP brinda tratamiento con metadona durante el encarcelamiento y reserva espacios para que los individuos liberados continúen en tratamiento.<sup>17</sup>

<strong>¿Qué son las intervenciones de transición?</strong>

Las intervenciones de transición eficaces aseguran que los servicios de prevención y tratamiento proporcionados en las prisiones y cárceles tengan continuidad fuera de éstas. Al entrar en vigor la ley Second Chance Act, muchas comunidades jugarán un mayor papel en la planificación para la transición.<sup>17</sup>

El proyecto START es la única intervención del Compendium of Evidence-Based Interventions de los CDC destinada a poblaciones encarceladas. START se centra en los clientes (personas recién liberadas de una institución correccional) y les brinda una intervención de 6 sesiones con el fin de reducir su riesgo de VIH, ITS y hepatitis. Basándose en la reducción de daños, START emplea un modelo de prevención con manejo de casos y fomento de la motivación para estimular la reducción de riesgos. Las dos sesiones iniciales preceden a la puesta en libertad y las cuatro finales ocurren después de ésta. Todas incluyen coordinación de remisiones a servicios de vivienda, empleo, desintoxicación de drogas/alcohol, salud mental, jurídicos y prevención de futuros encarcelamientos. START tuvo eficacia para reducir las relaciones sexuales sin protección con jóvenes recién liberados de prisión.<sup>18</sup>

El proyecto Bridge en Providence, RI, ofrece manejo intensivo de casos para personas VIH+ que salen de la cárcel estatal, quienes son atendidos por un trabajador social y un promotor de salud durante 18 meses. Los participantes se reúnen con ellos una vez por semana durante 12 semanas, luego una vez al mes como mínimo. El proyecto Bridge ha logrado ayudar a personas VIH+ a conseguir y a mantener servicios primordiales después de su puesta en libertad. La investigación ha demostrado que a pesar de tener altos niveles de adicción (el 97%) y de enfermedad mental (el 34%), los participantes recibieron atención médica posterior a su liberación (el 95%), consiguieron vivienda (el 46%) y lograron acceso a servicios de salud mental (el 71%) y de adicción (el 51%).<sup>19</sup>

<strong>¿Qué queda por hacer?</strong>

Para triunfar contra el VIH en las prisiones, cárceles y comunidades se requieren estrategias de prevención eficaces (educación por pares, acceso a condones, consejería y pruebas de VIH, etc.) junto con otras estrategias médicas y de tipo estructural que sean exitosas. Algunas estrategias estructurales que han demostrado reducción de VIH/ITS en correccionales son: programas de reducción de daños (provisión de jeringas limpias);<sup>21</sup> tratamiento contra alcohol y drogas;<sup>17</sup> tratamiento de salud mental;<sup>16</sup> tratamiento contra ITS/VIH;<sup>5</sup> planes para la transición;<sup>19,20</sup> vivienda;<sup>5</sup> alternativas al encarcelamiento;<sup>15</sup> y reformas con respecto a las condenas y la libertad condicional.<sup>1</sup>

Es esencial la colaboración entre el sistema de justicia penal (prisión, cárcel, libertad a prueba y condena condicional) y el sistema comunitario de salud pública (servicios sociales y de salud, programas de tratamiento, etc.), y existen varios modelos eficaces. Los programas conjuntos pueden ayudar a resolver problemas de salud pública al tiempo que entienden los retos de priorización de la seguridad y custodia públicas. Si realmente pretendemos reducir las tasas de VIH, ITS y hepatitis en nuestras comunidades, nos incumbe unir fuerzas para crear un espectro continuo de servicios que mejore la prevención, la atención y el tratamiento tanto en las prisiones y cárceles como en las comunidades afectadas desproporcionadamente por el VIH.

<hr size="2" />

<h3><strong>¿Quién lo dice?</strong></h3>
1. PEW Center on the States. One in 31: The long reach of American corrections. March 2009.

2. West HC, Sabol WJ. Prisoners in 2007. Bureau of Justice Statistics Bulletin. 2008.

3. Maruschak L. HIV in Prisons, 2006. Bureau of Justice Statistics Bulletin. 2008.

4. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. American Journal of Public Health. 2002 ;92:1789-1794.

5. The Foundation for AIDS Research. HIV in correctional settings: implications for prevention and treatment policy. Issue Brief No 5, March 2008.

6. Golembeski C, Fullilove R. Criminal (in)justice in the city and its associated health consequences. American Journal of Public Health. 2005;95:1701–1706.

7. Hughes T, James Wilson D. Reentry trends in the United States. Bureau of Justice Statistics.

8. Vlahov D, Putnam S. From corrections to communities as an HIV priority. Journal of Urban Health. 2006;83:339-348.

9. Zack B, Kramer K. HIV prevention education in correctional settings. Project UNSHACKLE discussion paper. May 2008.

10. James DJ, Glaze LE. Mental health problems of prison and jail inmates. Bureau of Justice Statistics Special Report. September 2006.

11. HIV transmission among male inmates in a state prison system – Georgia, 1992-2005. Morbity and Mortality Weekly Report. 2006;55:421-426.

12. Seal DW, Margolis AD, Morrow KM, et al. Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates.AIDS and Behavior. 2008;12:27-40.

13. Binswanger IA, Stern MF, Deyo RA, et al. Release from prison—a high risk of death for former inmates. New England Journal of Medicine. 2007;356:157-165.

14. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372:337-340.

15. Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. Journal of Urban Health. 2001;78:214-235.

16. World Health Organization. Mental health and prisons. 2005.

17. Tomasino V, Swanson AJ, Nolan J, et al. The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates. The Mount Sinai Journal of Medicine. 2001;68:14-20.

18. Second Chance Act.

19. Wolitski RJ, The Project START study group. Relative efficacy of a multi-session sexual risk-reduction intervention for young men released from prison in 4 states. American Journal of Public Health. 2006;96:1845-1861.

20. Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. Journal of Health Care for the Poor and Underserved. 2008;19:522-531.

21. Jürgens R, Ball A, Verster A. Interventions to reduce HIV transmission related to injecting drug use in prison. Lancet Infectious Diseases. 2009;9:57-66.

<hr size="2" />

Una publicación del Centro de Estudios para la Prevención del SIDA (CAPS) y el Instituto de Investigaciones sobre SIDA (ARI), Universidad de California en San Francisco (UCSF). Se autoriza la reproducción (citando a UCSF) más no la venta de copias este documento. También disponibles en inglés. Para recibir las Hojas de Datos por correo electrónico escriba a listserv@listserv.ucsf.edu con el mensaje “subscribe CAPSFS nombre apellido” ©UCSF 2010]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revprisionesFS.pdf</url>
	</node>
	<node>
		<title>Rural</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are rural HIV prevention needs?</h3>
<h4>are rural populations at risk?</h4>
Over the years, rural areas, which represent roughly 20% of the US population, have consistently reported 5-8% of all US HIV cases.<sup>1</sup> Yet certain rural areas and populations are disproportionately affected—the South and African Americans in particular. There may not be an epidemic of rural HIV/AIDS cases but there are troubling hot spots.

The South comprises 68% of all AIDS cases among rural populations.<sup>2</sup> In 2000, the rate of new AIDS diagnoses was three times higher for the South than for other rural areas in the US.3 In certain areas of the South, the rate of HIV/AIDS diagnoses is almost as high in rural areas as in urban areas.<sup>3</sup>

African American men and women represent 50% of rural AIDS cases, Whites 37%, Latinos 9% and American Indian/Alaska Natives 2%.<sup>2</sup> African Americans and Latinos are disproportionately affected by HIV in rural areas: In the Northeast, African Americans and Latinos each represent 1% of the rural population, but 25% and 20% of the AIDS cases, respectively.<sup>3</sup>

Most rural AIDS cases (75%) occur among men.<sup>2</sup> However, rates among rural women are increasing, particularly among African American women. Heterosexual transmission accounts for most cases among rural women, whereas injection drug use is the most common transmission category for urban women.<sup>2</sup>

Among rural men, men who have sex with men (MSM) comprise approximately 60% of rural AIDS cases and injecting drug users (IDUs) about 20%.2 In 2000, in the rural South, 28.5% of men were infected through heterosexual contact.<sup>3</sup>
<h4>what are rural challenges?</h4>
In rural areas, HIV prevention and intervention programs have lagged behind urban programs, due to stigmatization of HIV and high risk groups, geographic factors and low overall HIV rates. These three factors combine to make it difficult, financially and practically, to implement rural HIV prevention programs.<sup>4</sup>

Geographic isolation can hinder access to preventive services for rural residents who have limited access to transportation. Rugged topography and long distances between towns can mean traveling several hours for medical care or social services. This can result in services that are not tailored to specific population needs and delays in delivery of services.<sup>5</sup>

In addition, isolation can lead to difficulty finding sexual partners and might lead to riskier behaviors when sexual encounters do occur. One study found that rural men are more likely to have sex on their first date than urban men, possibly due to long travel distances and concern that the next chance may be a long time away.<sup>6</sup>

A powerful stigma remains associated with both HIV/AIDS and homosexuality. Rural MSM may avoid stigma, social hostility and expected violence by hiding their sexuality and assimilating into the heterosexual culture. Rural venues where MSM openly socialize are scarce, resulting in some men seeking sex partners in public sex environments, through the Internet and by regularly traveling to higher seroprevalence areas.<sup>4</sup>

Rural residents are more likely to live in poverty and less likely to have health insurance than urban residents.<sup>7</sup> Without insurance, rural residents are less likely to seek medical care or social services. Rural areas have fewer healthcare providers with HIV expertise and rural HIV+ patients are less likely than urban patients to be on antiretroviral therapy.<sup>8</sup> There is limited funding for and access to substance abuse treatment services.

Poverty can also increase individual risk such as exchanging sex for money, shelter or drugs. In one study, Black women reported the most common reason for engaging in high risk behaviors was financial dependence on male partners.<sup>9</sup>
<h4>what puts rural populations at risk?</h4>
As with all populations, HIV risk depends not on where you live, but on whether you have unprotected sex or share needles with an HIV+ partner, and whether you have access to care, education and prevention services.

Rates of sexual partner change and concurrent relationships (having more than one sexual partner at a time) increase the risk of transmission of HIV. A study of rural African Americans with heterosexually transmitted HIV found that more than half had multiple partners, 40% had concurrent partners and 87% believed that their partner had sex with others during their relationship. Concurrency was associated with smoking crack cocaine and incarceration of a sex partner.<sup>10</sup>

Drug abuse is often seen as an urban problem, but it poses a significant problem in rural areas, methamphetamine in particular.<sup>11</sup> One report showed that rural youth are more likely to become substance abusers than urban youth: eighth graders in rural towns are 59% more likely than urban eighth graders to use methamphetamines.<sup>12</sup> Substance abuse contributes to risky behaviors such as engaging in unprotected sex, having multiple partners, sharing needles or exchanging sex for drugs.
<h4>what’s being done?</h4>
The Strong African American Families (SAAF) program is a 7-week prevention intervention designed for African American mothers and their 11-year-old children in rural Georgia. SAAF sought to strengthen parenting skills that would in turn promote positive self-pride and positive sexual body image in their children to help lower their sexual risk behaviors. Mothers reported an increase in targeted parenting behaviors, which increase self pride in their children. Youth reported less intention and willingness to engage in risky behaviors, and a reduction in risky sexual behavior.<sup>13</sup>

The Wyoming Rural AIDS Prevention Project (WRAPP) piloted an Internet-based intervention for rural MSM that used conversations between an “expert” HIV+ gay man and an “inexperienced” HIV- gay man to deliver basic HIV education and behavior change strategies. The 2 modules lasted 20 minutes and featured dialogues, interactive activities and graphics. Men who participated in the intervention reported increases in knowledge, safer sex outcome expectancies and self-efficacy.<sup>14</sup>

In rural Arkansas, collaboration between a CBO, the Department of Corrections, the Health Department and Addiction Treatment and Recovery Centers, helped to identify and recruit HIV+ clients engaging in risky sexual and drug-using behaviors. These clients enrolled in the Healthy Relationships Intervention and reported decreased unprotected sex and increased disclosure to family, friends and partners.<sup>15</sup>

In Mississippi, the Mobile Medical Clinic van travels to rural areas where people are at highest risk for HIV and syphilis, specifically focusing on African Americans. So that they are not seen as the “VD van,” they offer glucose, blood pressure and cholesterol screening. Before the clinic enters a community, they arrange for a local sponsoring organization, like a church or community representative, to ensure that there is support in the community for their presence. They have partnered with local agencies to perform clinical breast exams, PAP smears and dental sealant applications in youth.<sup>16</sup>
<h4>what needs to be done?</h4>
Because resources are limited in rural areas, prevention activities need to be targeted to populations at highest risk, including women and men who have sex with men, African Americans and Latinos, young persons, and alcohol and drug users. Recent immigrants and migrant workers may also be at high risk, especially along the US/Mexico border.<sup>4</sup>

It is critical to expand and improve care for HIV+ persons in rural areas and provide prevention education in medical settings. Rural healthcare providers need better training and support on HIV clinical care, delivering prevention messages, assessing risk behavior and cultural sensitivity and confidentiality issues.

<hr />

<h3>Says who?</h3>
1. Steinberg S, Fleming P. The geographic distribution of AIDS in the United States: is there a rural epidemic? Journal of Rural Health. 2000;16:11-19.

2. Centers for Disease Control and Prevention. HIV/AIDS surveillance in urban and nonurban areas. Slide set. *www.cdc.gov/hiv/graphics/rural-urban.htm

3. Hall HI, Li J, McKenna MT. HIV in predominantly rural areas of the United States. Journal of Rural Health. 2005;21:245-253.

4. Williams ML, Bowen AM, Horvath KJ. The social/sexual environment of gay men residing in a rural frontier state: implications for the development of HIV prevention programs. Journal of Rural Health. 2005;21:48-55.

5. Castañeda D. HIV/AIDS-related services for women and the rural community context. AIDS Care. 2000;12:549-565.

6. Horvath KJ, Bowen AM, Williams ML. Virtual and physical venues as contexts for HIV risk among rural men who have sex with men. Health Psychology. 2006;25:237-242.

7. National Rural Health Association. HIV/AIDS in rural America: Disproportionate impact on minority and multicultural populations. July 2004. *www.nrharural.org/advocacy/sub/issuepapers/HIVAids.pdf

8. Cohn SE, Berk ML, Berry SH, et al. The care of HIV-infected adults in rural areas of the United States. Journal of AIDS. 2001;28:385-392.

9. HIV transmission among Black women–North Carolina, 2004. Morbidity and Mortality Weekly Report. 2005;54:89-94. *www.cdc.gov/mmwr/preview/mmwrhtml/mm5404a2.htm

10. Adimora AA, Schoenbach VJ, Martinson FEA, et al. Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection. Journal of AIDS. 2003;34:423-429.

11. Kraman P. Drug abuse in America–Rural meth. Trends Alert. March 2004.
*csg-web.csg.org/pubs/Documents/TA0403RuralMeth.pdf

12. The National Center on Addiction and Substance Abuse. No place to hide: Substance abuse in mid-size cities and rural America. New York, New York: Columbia University. January 2000. *www.casacolumbia.org/absolutenm/articlefiles/379-no_place_to_hide_01-28-00.pdf

13. Brody GH, Murry VM, Gerrard M, et al. The Strong African American Families Program: translating research into prevention programming. Child Development. 2004;75:900-917. *www.cfr.uga.edu/html/saaf.php

14. Bowen A, Horvath K, Williams M. Randomized control trial of an Internet-delivered HIV knowledge intervention with MSM. Health Education and Research. In press. *www.wrapp.net

15. Smith AJ, Gaynor H. Advancing HIV prevention in rural Arkansas. Presented at the National HIV Prevention Conference, Atlanta, GA, 2005. Abstract #M1-C1802. *www.effectiveinterventions.org/interventions/healthy_relation.cfm

16. Prevention in rural communities: Mississippi’s Mobile Medical Clinic. NASTAD HIV Prevention Bulletin. March 2006. *www.msdh.state.ms.us/msdhsite/_static/14,0,150.php

*All websites accessed May 2006

<hr />

Prepared by Anne Bowen PhD*, Alan Gambrell MPubAff**, Pamela DeCarlo***

*University of Wyoming, **WordPortfolio, Inc., ***CAPS

<strong>May 2006 . Fact Sheet #26ER</strong>

Special thanks to the following reviewers of this Fact Sheet: James Anderson, Janet Arno, Keith Bletzer, Lucy Bradley-Springer, Angeline Bushy, Irene Hall, Rachel Kachur, Bronwen Lichtenstein, Deborah Preston, David Seal, Dale Stratford, Craig Thompson, Mohammad Torabi, Eric Wright.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © May 2006, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revruralFS.pdf</url>
	</node>
	<node>
		<title>Rurales</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuáles son las necesidades de prevención del VIH
en zonas rurales?</h3>
<h4>¿corren riesgo las poblaciones rurales?</h4>
Históricamente las áreas rurales, que representan el 20 % de la población de EE.UU., han reportado entre el 5 % y el 8 % de los casos de VIH en el país.<sup>1</sup> Pero ciertas zonas y poblaciones rurales están desproporcionadamente afectadas: el Sur y los afroamericanos en particular. Aunque no exista una epidemia rural, sí existen zonas críticas preocupantes.

El 68 % de los casos de SIDA en poblaciones rurales se da en el Sur.<sup>2</sup> En el 2000, la tasa de nuevos diagnósticos de SIDA en el Sur era tres veces mayor que en otras zonas rurales de EE.UU. En ciertas partes del Sur, la tasa de diagnósticos de VIH/SIDA de las zonas rurales casi alcanza la de las zonas urbanas.<sup>3</sup>

Las personas afroamericanas representan el 50 % de los casos de SIDA rurales, las caucásicas el 37 %, las latinas el 9 % y las indígenas americanas y nativas de Alaska el 2 %.<sup>2</sup> Los afroamericanos y los latinos están desproporcionadamente afectados por el VIH en áreas rurales: En el Noreste, estas mismas poblaciones representan cada una el 1 % de la población rural, pero el 25 % y el 20 % de los casos de SIDA, respectivamente.<sup>3</sup>

La mayoría de los casos de SIDA rurales (el 75 %) ocurre entre hombres.<sup>2</sup> Sin embargo, las tasas entre mujeres rurales van en aumento, especialmente entre las afroamericanas. Para las mujeres rurales VIH+, la causa principal es la transmisión heterosexual, mientras que la inyección de drogas es la causa más común entre las mujeres urbanas.<sup>2</sup>

Entre los hombres rurales, aquellos que tienen sexo con hombres (HSH), componen aproximadamente el 60 % de los casos de SIDA rurales y los usuarios de drogas inyectables (UDI) cerca del 20 %.<sup>2</sup> En el año 2000 en las zonas rurales del Sur, el 28.5 % de los hombres VIH+ se infectaron por contacto heterosexual.<sup>3</sup>
<h4>¿cuáles son los desafíos en las zonas rurales?</h4>
En las zonas rurales, los programas de intervención y prevención del VIH se han rezagado en comparación con los programas urbanos debido al estigma del VIH y de los grupos de alto riesgo, a factores geográficos y a la baja tasa general de VIH. Estos tres aspectos se combinan para crear obstáculos económicos y funcionales a la implementación de programas rurales de prevención del VIH.<sup>4</sup>

El aislamiento geográfico puede impedir el acceso a servicios preventivos para los habitantes rurales cuyo acceso al transporte es limitado. La topografía accidentada y las largas distancias entre poblados pueden requerir varias horas de viaje para recibir servicios médicos o sociales. Esto puede hacer que los servicios no se adapten a las necesidades de la población en cuestión y producir retrasos en la prestación de servicios.<sup>5</sup>

Otra consecuencia del aislamiento es la posible dificultad para encontrar parejas sexuales, lo cual podría llevar a conductas más riesgosas cuando los encuentros lleguen a darse. Un estudio descubrió que los hombres rurales son más propensos a tener sexo en la primera cita que los hombres urbanos, posiblemente por las largas distancias y por la inquietud de tener que esperar mucho tiempo hasta que se presente la próxima oportunidad.<sup>6</sup>

Todavía existe un fuerte estigma asociado con el VIH/SIDA y con la homosexualidad. Los HSH rurales pueden evitar el estigma, la hostilidad social y la violencia que conlleva si ocultan su sexualidad y se integran en la cultura heterosexual. Escasean locales rurales en donde los HSH socialicen abiertamente, por lo que algunos buscan parejas sexuales en lugares públicos de sexo anónimo, en Internet y en zonas lejanas de mayor seroprevalencia.<sup>4</sup>

En comparación con la población urbana, es más probable que los habitantes rurales vivan en la pobreza y que no tengan seguro médico.<sup>7</sup>  Sin esta cobertura, es menos probable que busquen servicios médicos o sociales. Las zonas rurales cuentan con menos proveedores médicos especializados en el VIH y los pacientes VIH+ rurales son menos propensos que sus homólogos urbanos a recibir terapia antirretroviral.<sup>8</sup> Los fondos y el acceso a los servicios de tratamiento del abuso de drogas y alcohol son limitados.

La pobreza también puede aumentar el riesgo individual al propiciar el intercambio de sexo por dinero, vivienda o drogas. En un estudio, las mujeres negras reportaron que sus conductas de alto riesgo se debían principalmente a la dependencia económica de un hombre.<sup>9</sup>
<h4>¿qué las hace vulnerables?</h4>
Al igual que toda población, el riesgo del VIH no depende del lugar donde uno vive, sino de la participación o no en el sexo sin protección o en el uso de jeringas compartidas con una pareja VIH+, y del acceso a servicios de atención, asesoramiento y prevención.

Las tasas de cambio de pareja sexual y de relaciones concurrentes (mantener más de una pareja sexual al mismo tiempo) aumentan el riesgo de transmisión del VIH. Un estudio de la población afroamericana rural que contrajo el VIH por vía heterosexual reveló que más de la mitad tenía parejas múltiples, el 40 % tenía parejas concurrentes y el 87 % creía que su pareja había tenido sexo con otra persona durante su relación. La concurrencia se asoció con fumar cocaína crack y con el encarcelamiento de una pareja sexual.<sup>10</sup>

El abuso de drogas muchas veces se ve como un problema urbano, pero también es significante en las zonas rurales, especialmente el uso de la metanfetamina.<sup>11</sup> Un informe demostró que los jóvenes rurales tienen mayor propensión al abuso de drogas que los jóvenes urbanos: los estudiantes rurales del octavo grado escolar son un 59% más propensos que sus homólogos urbanos al consumo de metanfetaminas.<sup>12</sup> El consumo de alcohol y drogas contribuye a conductas de riesgo tales como el sexo sin uso de protección, la multiplicidad de parejas, el uso de jeringas previamente usadas y el intercambio de sexo por drogas.
<h4>¿qué se está haciendo al respecto?</h4>
Strong African American Families (SAAF) es una intervención preventiva de 7 semanas diseñada para madres afroamericanas y sus hijos de 11 años de edad en la Georgia rural. La SAAF buscó fortalecer las habilidades de las madres para infundir a sus hijos una autoestima y una imagen corporal sexual de sí mismos positiva, y poder así reducir sus conductas sexuales de riesgo. Las madres reportaron una mayor participación en las actividades dirigidas a aumentar el amor propio de sus hijos. Los jóvenes reportaron menos intención y voluntad de participar en conductas riesgosas en general y una disminución de su participación en actividades sexuales de riesgo<sup>13</sup>.

El Wyoming Rural AIDS Prevention Project lanzó una intervención piloto de dos módulos a través de Internet para HSH rurales en la cual emplearon conversaciones entre un hombre gay VIH+ “experto” y otro hombre gay VIH- “con poca experiencia” para comunicar información y estrategias de cambio de conductas. Ambos módulos duraron 20 minutos e incluyeron diálogos, actividades interactivas y gráficos. Los participantes reportaron un aumento en conocimientos, en expectativas sobre la práctica del sexo más seguro y en la autoeficacia.<sup>14</sup>

En la Arkansas rural, una colaboración entre una organización comunitaria, el Departamento de Correcciones, el Departamento de Salud y los Addiction Treatment and Recovery Centers, sirvió para identificar y reclutar a personas VIH+ que practicaban conductas sexuales de riesgo y consumían en drogas. Dichas personas se inscribieron en la intervención Healthy Relationships y reportaron una disminución del sexo sin protección y un mayor nivel de revelación de su condición de VIH a familiares, amigos y parejas.<sup>15</sup>

En Mississippi, la camioneta de la Mobile Medical Clinic viaja a las áreas rurales de mayor riesgo de contraer VIH y sífilis, centrándose en la comunidad afroamericana. Para no ser vistos como “la camioneta de las enfermedades venéreas”, ofrecen pruebas de glucosa, presión arterial y colesterol. Antes de entrar en alguna comunidad, la clínica forma lazos con alguna organización, iglesia o representante local que los auspicie con el fin de ganarse el apoyo y la confianza de la comunidad. Han colaborado con organizaciones locales para brindar exámenes médicos de los senos, pruebas de Papanicolau y la aplicación de sellante dental para jóvenes.
<h4>¿qué queda por hacer?</h4>
Debido a la escasez de recursos en las zonas rurales, las actividades de prevención deben dirigirse hacia las poblaciones de mayor riesgo, entre ellas las mujeres y los hombres que tienen sexo con hombres, los afroamericanos, los latinos, los jóvenes y los consumidores de alcohol y drogas. Los inmigrantes recién llegados y los trabajadores itinerantes también podrían correr alto riesgo, especialmente a lo largo de la frontera entre EE.UU. y México.

Es esencial expandir y mejorar la atención para todas las personas VIH+ en las zonas rurales y brindar orientación sobre la prevención en los centros médicos. Los trabajadores de salud necesitan capacitación y apoyo en la atención clínica del VIH, la comunicación de mensajes de prevención, la evaluación de la conducta riesgosa, la sensibilidad cultural y la confidencialidad.

<hr />

<h3>¿Quién lo dice?</h3>
1. Steinberg S, Fleming P. The geographic distribution of AIDS in the United States: is there a rural epidemic? Journal of Rural Health. 2000;16:11-19.

2. Centers for Disease Control and Prevention. HIV/AIDS surveillance in urban and nonurban areas. Slide set. *www.cdc.gov/hiv/graphics/rural-urban.htm

3. Hall HI, Li J, McKenna MT. HIV in predominantly rural areas of the United States. Journal of Rural Health. 2005;21:245-253.

4. Williams ML, Bowen AM, Horvath KJ. The social/sexual environment of gay men residing in a rural frontier state: implications for the development of HIV prevention programs. Journal of Rural Health. 2005;21:48-55.

5. Castañeda D. HIV/AIDS-related services for women and the rural community context. AIDS Care. 2000;12:549-565.

6. Horvath KJ, Bowen AM, Williams ML. Virtual and physical venues as contexts for HIV risk among rural men who have sex with men. Health Psychology. 2006;25:237-242.

7. National Rural Health Association. HIV/AIDS in rural America: Disproportionate impact on minority and multicultural populations. July 2004. *www.nrharural.org/advocacy/sub/issuepapers/HIVAids.pdf

8. Cohn SE, Berk ML, Berry SH, et al. The care of HIV-infected adults in rural areas of the United States. Journal of AIDS. 2001;28:385-392.

9. HIV transmission among Black women–North Carolina, 2004. Morbidity and Mortality Weekly Report. 2005;54:89-94. *www.cdc.gov/mmwr/preview/mmwrhtml/mm5404a2.htm

10. Adimora AA, Schoenbach VJ, Martinson FEA, et al. Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection. Journal of AIDS. 2003;34:423-429.

11. Kraman P. Drug abuse in America–Rural meth. Trends Alert. March 2004.
*csg-web.csg.org/pubs/Documents/TA0403RuralMeth.pdf

12. The National Center on Addiction and Substance Abuse. No place to hide: Substance abuse in mid-size cities and rural America. New York, New York: Columbia University. January 2000. *www.casacolumbia.org/absolutenm/articlefiles/379-no_place_to_hide_01-28-00.pdf

13. Brody GH, Murry VM, Gerrard M, et al. The Strong African American Families Program: translating research into prevention programming. Child Development. 2004;75:900-917. *www.cfr.uga.edu/html/saaf.php

14. Bowen A, Horvath K, Williams M. Randomized control trial of an Internet-delivered HIV knowledge intervention with MSM. Health Education and Research. In press. *www.wrapp.net

15. Smith AJ, Gaynor H. Advancing HIV prevention in rural Arkansas. Presented at the National HIV Prevention Conference, Atlanta, GA, 2005. Abstract #M1-C1802. *www.effectiveinterventions.org/interventions/healthy_relation.cfm

16. Prevention in rural communities: Mississippi’s Mobile Medical Clinic. NASTAD HIV Prevention Bulletin. March 2006. *www.msdh.state.ms.us/msdhsite/_static/14,0,150.php

<hr />

<strong>Preparado por Anne Bowen PhD*, Alan Gambrell MPubAff**, Pamela DeCarlo***
*University of Wyoming, **WordPortfolio, Inc., ***CAPS</strong>

<strong>Traducción: Rocky Schnaath</strong>

Septiembre 2006. Hoja de Dato #26SR]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revruralesFS.pdf</url>
	</node>
	<node>
		<title>Acute infection</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of acute HIV infection in HIV prevention?</h3>
<h4>What is acute infection?</h4>
Acute HIV infection refers to the first stage of infection, the time immediately after a person is infected and before an antibody response to the infection develops. The second stage of infection is seroconversion, when a person develops HIV-specific antibodies. During acute HIV infection, there are high levels of virus since the antibody response has not yet developed.<sup>1,2</sup>

Determining acute HIV infection is critical for HIV prevention efforts. Conventional HIV tests do not detect acute infection, yet it is estimated that almost half of new HIV infections may occur when a person with acute infection unknowingly transmits HIV.<sup>3</sup>

There is no defined acute retroviral syndrome since there are many different symptoms associated with acute HIV infection. After an incubation period of 1 to 3 weeks, about 50% of persons with acute HIV infection develop headaches, sore throat, fever, muscle pain, anorexia, rash, and/or diarrhea.<sup>4</sup> The symptoms are generally mild and may span anywhere from days to weeks.

It is easy to overlook or miss the signs of acute HIV infection. Half of persons who are acutely infected will never notice any symptoms. Also, the symptoms of acute retroviral syndrome are similar for other common illnesses such as infectious mononucleosis and influenza, which means acute HIV infection often goes undiagnosed.<sup>4</sup>
<h4>How is acute infection detected?</h4>
Acute infection cannot be detected by most routinely used HIV tests. Conventional HIV tests detect HIV-specific antibodies in blood or oral fluids that are produced by the immune system during seroconversion. Therefore, a person who was infected very recently will receive an HIV-negative result using conventional HIV tests.

Nucleic acid amplification testing (NAAT) can detect acute HIV infection by looking for the presence of the virus.<sup>5</sup> Because NAAT is expensive to use for each individual specimen, many testing sites are combining HIV-negative blood specimens for testing. This NAAT pooling strategy makes screening for acute HIV infection feasible in settings with low disease incidence but high testing volume.<sup>6</sup>

Blood specimens with initial HIV-negative antibody results can be routinely screened using the pooled NAAT strategy to detect acute HIV infection. If a client has an HIV-negative antibody test but a positive NAAT result for the virus, it is important to have them come back to the clinic for follow-up counseling and repeat testing to confirm HIV infection.
<h4>How does it affect prevention?</h4>
The only way for persons to know that they are HIV+ and take precautions to prevent transmission is to be tested for HIV. However, with most routinely used HIV tests, it may take two months or more after initial infection to receive an HIV+ result. These two months are critical for HIV prevention: it is estimated that almost half of HIV transmissions occur when a person is in this acute HIV infection phase. During acute infection, there are high levels of HIV virus in the body,<sup>2,3</sup> and high viral load has been shown to be associated with increased risk of HIV transmission.<sup>7</sup>

If persons are at greatest infectivity during acute infection, it is likely that many persons are transmitting HIV unknowingly during this time. An acutely infected person who receives an HIV-negative antibody test result could be engaging in recommended HIV prevention practices, such as disclosing their status and only having sex or sharing injection equipment with HIV-negative persons, and yet still be transmitting HIV.

Persons with acute HIV infection may benefit from enhanced counseling focused on immediate risk reduction strategies and clarification about the conflicting test results. They should also be offered disclosure assistance and partner testing and counseling.<sup>8</sup>
<h4>Can acute infection be treated?</h4>
Treating HIV during the acute infection stage may boost the immune system and slow the progression of HIV disease. One study followed HIV+ persons who started highly active antiretroviral treatment (HAART) in the acute infection stage. These persons had significantly better viral load and CD4 counts, compared to HIV+ persons who began HAART at a later stage.<sup>9</sup>

Guidelines for treating HIV infection usually recommend that HIV+ persons who are asymptomatic and have low viral loads and strong CD4 counts should wait to begin HAART.<sup>10</sup> It is possible that initiating treatment during acute infection may be beneficial. However, starting HIV medications is a major decision: there are many side effects and toxicities and there are currently no long-term studies on the effectiveness of treatment for acute infection.<sup>11</sup>
<h4>What’s being done?</h4>
North Carolina has instituted the Screening and Tracing Active Transmission (STAT) program to identify and manage new HIV infections. As a part of STAT, all tests at publicly funded sites that return HIV-negative using standard testing are re-tested with NAAT. In 2003, NAAT detected an additional 23 cases of HIV infection, a 3.9% increase in the rate of HIV case identification. All 23 persons with acute infection were notified, 21 began HIV medical care, and 48 of their sexual partners received HIV testing, risk reduction counseling and referrals.<sup>6</sup>

In 2003, the San Francisco Department of Public Health began to screen for acute HIV infection among persons seeking HIV counseling and testing at the city STD clinic. In 2004, 11 cases of acute HIV infection were detected, reflecting an increase in HIV case detection of 8.8%. Program staff performed contact tracing and partner management for all persons newly diagnosed HIV+.<sup>8,12</sup>

At a hospital Urgent Care Center in Boston, MA, all patients who had symptoms of a viral illness and who reported risk factors for HIV infection were tested for acute HIV infection. Most patients (68%) agreed to be tested for HIV even though they came to the hospital with unrelated concerns. Of 499 patients tested in 2000, 5 had acute HIV infection and 6 had chronic infection. Of the 5 patients with acute HIV infection, 4 returned for their test results, were seen by an HIV physician or nurse and began antiretroviral therapy.<sup>13</sup>
<h4>What needs to be done?</h4>
Acute HIV infection is hard to detect and often goes undiagnosed.<sup>14</sup> Primary care physicians and healthcare workers at emergency rooms, urgent care and STD clinics need education and training on symptoms of acute HIV infection.<sup>15</sup> Clinicians with patients who show signs of viral illness such as influenza or mononucleosis should conduct quick risk assessments for HIV risk and provide referrals to testing and counseling sites as needed.

More HIV testing and counseling sites need to test for acute infection, especially in high prevalence areas and high risk settings such as STD clinics. To accomplish this, resources for training, technical assistance and funding need to increase for agencies that provide acute HIV infection testing. State and federal reimbursement protocols, as well as public and private insurance, need to be changed to encourage the use of NAAT.

Identifying persons with acute HIV infection can be an effective HIV prevention strategy, as it focuses on persons at greatest risk for transmission. Persons with acute infection may need enhanced post-test counseling, including referrals to: medical care; social services such as substance abuse and mental health treatment when appropriate and prevention programs for HIV+ persons. Acute infection is also a crucial time for identifying sex and drug use partners and offering disclosure assistance services such as partner notification, counseling, testing and referrals.<sup>2,16</sup>

<hr />

<h3>Says who?</h3>
1. Pilcher CD, Eron JJ, Galvin S, et al. Acute HIV revisited: new opportunities for treatment and prevention . Journal of Clinical Investigation. 2004;113:937-945.

2. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection . Nature and Medicine. 2003;9:847-852.

3. Wawer MJ, Gray RH, Sewankambo N, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda . Journal of Infectious Diseases. 2005;191:403-409.

4. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection . Annals of Internal Medicine. 1996;125:257-264.

5. Quinn TC, Brookmeyer R, Kline R, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence . AIDS. 2000;14:2751-2757.

6. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina . New England Journal of Medicine. 2005;352:1873-1883.

7. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine. 2000;342:921-929.

8. Klausner J, Kohn R, Nieri G, et al. A comprehensive HIV surveillance &amp; disease control program in a sentinel site: San Francisco municipal STD clinic, 2004. Presented at the National HIV Prevention Conference, Atlanta, GA, 2005. Abst # W0-L0405.

9. Hecht F, Wang L, Collier A, et al. Outcomes of HAART for acute/early HIV-1 infection after treatment discontinuation. Presented at the 12th Conference on Retroviruses and Opportunistic Infections. 2005. Abst# 568.

10. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Oct 2005.

11. Geise R, Maenza J, Celum CL. Clinical challenges and diagnostic approaches to recognizing acute human immunodeficiency virus infection . American Journal of Medicine. 2001;111:237-238.

12. Truong HM, McFarland W, Kellogg T, et al. Detection of acute HIV infection among STD clinic patients in San Francisco. Presented at the 13th Conference on Retro-viruses and Opportunistic Infections. 2006. Abst #914.

13. Pincus JM, Crosby SS, Losina E, et al. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center . Clinical Infectious Diseases. 2003;37:1699-1704.

14. Kuo AM, Haukoos JM, Witt MD, et al. Recognition of undiagnosed HIV infection: an evaluation of missed opportunities in a predominantly urban minority population . AIDS Patient Care and STDs. 2005;19:239-246.

15. Hightow L, MacDonald P, Boland M, et al. Missed opportunities for the diagnosis of acute infection: room for improvement. Presented at the 12th Conference on Retroviruses and Opportunis-tic Infections. 2005. Abst# 565.

16. Centers for Disease Control and Prevention. HIV transmission among black college student and non-student men who have sex with men– North Carolina, 2003 . Morbidity and Mortality Weekly Report. 2004;53:731-734.

<hr />

<strong>Prepared by Hong-Ha M. Truong, PhD, MS, MPH*; Christopher D. Pilcher MD**</strong>

<strong>*CAPS, *Gladstone Institute of Virology and Immunology, **University of North Carolina Chapel Hill</strong>

<strong>January 2006 . Fact Sheet #59E</strong>

Special thanks to the following reviewers of this Fact Sheet: Michael Busch, Andrew Forsyth, Karlissa Foy, Sabine Kinloch-de Loes, Mario Legault, Elizabeth Londoño, Willi McFarland, Jon Pincus, Elisabeth Puchhammer-Stöckl, Kathleen Sikkema.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 2006, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/acuteinfectionFS.pdf</url>
	</node>
	<node>
		<title>Infección aguda</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué papel juega la infección aguda en la prevención del VIH?</h3>
<h4>¿qué es la infección aguda?</h4>
El término infección aguda por VIH se refiere a la primera etapa de la infección, inmediatamente después de que una persona quede infectada y antes del desarrollo de una respuesta de los anticuerpos contra la infección. La segunda etapa de la infección es la seroconversión, cuando se forman anticuerpos específicos contra el VIH. Durante la infección aguda por VIH, existen altos niveles del virus ya que todavía no se ha desarrollado la respuesta de anticuerpos.<sup>1,2</sup>

Determinar si hay una infección aguda por VIH es un paso crítico en los esfuerzos de prevención. Las pruebas convencionales del VIH no detectan la infección aguda, pero se calcula que casi la mitad de las nuevas infecciones tal vez ocurren cuando una persona con infección aguda transmite el VIH sin saberlo.<sup>3</sup>

Todavía no existe una definición del síndrome retroviral agudo porque existen muchos síntomas asociados con la infección aguda por VIH. Al cabo de un periodo de incubación de entre 1 y 3 semanas, aproximadamente el 50% de las personas con infección aguda por VIH padecen dolor de cabeza, dolor de garganta, fiebre, dolor muscular, anorexia, salpullido o diarrea.<sup>4</sup> Los síntomas por lo general son leves y pueden durar días o semanas.

Es fácil pasar por alto o ignorar las señales de infección aguda. La mitad de las personas con infección aguda nunca percibirá síntoma alguno. Asimismo, los síntomas del síndrome retroviral agudo son similares a los de otras enfermedades comunes tales como la mononucleosis infecciosa y la influenza, por lo que muchas veces la infección aguda por VIH se queda sin diagnosticar.<sup>4</sup>
<h4>¿cómo se detecta la infección aguda?</h4>
La infección aguda no puede detectarse con la mayoría de las pruebas del VIH habituales, pues éstas detectan los anticuerpos específicos contra el VIH en la sangre o en las secreciones bucales producidos por el sistema inmunológico durante la seroconversión. Por lo tanto, una persona muy recién infectada obtendrá un resultado negativo en las pruebas convencionales del VIH.

La prueba de amplificación del ácido nucleico (PAAN) puede detectar la infección aguda por VIH buscando la presencia del virus.<sup>5</sup> Ya que es costoso aplicar la PAAN en cada muestra individual, muchos centros de pruebas combinan las muestras de sangre VIH negativas para analizarlas en conjunto. Esta estrategia de aplicar la PAAN conjuntamente hace factible la detección de la infección aguda en entornos con baja incidencia de enfermedad pero con un alto volumen de pruebas.<sup>6</sup>

Las muestras de sangre con resultados inicialmente negativos pueden ser analizadas de forma rutinaria usando la estrategia de aplicar la PAAN conjuntamente para detectar la infección aguda por VIH. Si un cliente tiene un resultado negativo en la prueba de anticuerpos de VIH pero un resultado positivo en la prueba PAAN para la detección del virus, es importante que regrese a la clínica para recibir consejería de seguimiento y repetir la prueba para confirmar la infección por VIH.
<h4>¿qué efectos tiene sobre la prevención?</h4>
La única manera de saber si uno es VIH+ y de tomar precauciones para evitar la transmisión es someterse a una prueba del VIH. Sin embargo, pueden pasar dos o más meses después de la infección inicial antes de que se produzca un resultado VIH+ con la mayoría de las pruebas de mayor uso en la actualidad. Estos dos meses son críticos en la prevención del VIH: se calcula que casi la mitad de las transmisiones del VIH sucede durante la etapa de infección aguda,<sup>1</sup> precisamente cuando existen altos niveles del virus en el cuerpo.<sup>2,3</sup> Se ha comprobado que una carga viral elevada está asociada con un mayor riesgo de transmisión del VIH.<sup>7</sup>

Si las personas se encuentran en auge de infeccionsidad durante la infección aguda, es probable que en esta etapa muchas transmitan el VIH sin saberlo. Una persona con infección aguda cuya prueba de anticuerpos resulte negativa puede transmitir el VIH aunque siga las prácticas recomendadas para evitarlo como revelar su condición o estatus de VIH, tener contacto sexual o compartir equipos de inyección de drogas únicamente con personas VIH -.

Las personas con infección aguda por VIH pueden beneficiarse de más consejería centrada en estrategias inmediatas de reducción de riesgos y de la aclaración de los resultados contradictorios de las pruebas. Es importante ofrecerles ayuda para revelar su condición así como pruebas y consejería para sus parejas.<sup>8</sup>
<h4>¿se puede tratar la infección aguda?</h4>
Tratar el VIH durante la etapa de infección aguda puede fortalecer el sistema inmunológico y retrasar la evolución de la enfermedad. Un estudio dio seguimiento a personas VIH+ que iniciaron la terapia antirretroviral altamente activa (TARAA o TARSA) durante la etapa de infección aguda. Sus niveles de carga viral y de células CD4 resultaron mucho mejores que las de otras personas VIH+ que iniciaron la TARAA en una etapa posterior.<sup>9</sup>

Los protocolos de tratamiento del VIH generalmente recomiendan que las personas VIH+ asintomáticas, con carga viral baja y con niveles de CD4 saludables esperen antes de iniciar la TARAA.<sup>10</sup> Es posible que sea beneficioso comenzar el tratamiento durante la infección aguda. No obstante, la decisión de empezar a tomar medicamentos contra el VIH es de suma importancia, pues tienen numerosos efectos secundarios y toxicidades y actualmente no existen estudios a largo plazo sobre la eficacia del tratamiento de la infección aguda.<sup>11</sup>
<h4>¿qué se está haciendo al respecto?</h4>
Carolina del Norte ha instituido un programa (Screening and Tracing Active Transmission– STAT) para identificar y tratar nuevas infecciones por VIH. Como parte del STAT y en centros financiados públicamente, toda prueba del VIH estándar que resulte negativa se vuelve a analizar aplicando la PAAN. En 2003, la PAAN detectó 23 casos adicionales de VIH, un aumento del 3.9% en la tasa de identificación de casos. Las 23 personas con infección aguda fueron notificadas, 21 iniciaron atención médica de VIH y 48 de sus parejas sexuales se hicieron la prueba del VIH y recibieron conserjería sobre reducción de riesgos y remisiones a otros servicios.<sup>6</sup>

En el 2003, el Departamento de Salud Pública de San Francisco empezó a hacer pruebas de detección de infección aguda por VIH entre las personas que acudieron a la clínica de ETS/ITS de la ciudad para recibir consejería y pruebas del VIH. En el 2004, se detectaron 11 casos de infección aguda por VIH, lo que refleja un aumento del 8.8% en la detección de casos de VIH. El personal del programa se encargo de contactar, notificar y manejar la situación con las parejas de todas las personas recién diagnosticadas con el virus.<sup>8,12</sup>

En un centro hospitalario de atención urgente en Boston, MA, todos los pacientes que tenían síntomas de una enfermedad viral y que reportaron factores de riesgo de infección por VIH se sometieron a una prueba para detectar la infección aguda por VIH. La mayoría de los pacientes (el 68%) aceptaron hacerse la prueba aunque habían acudido al hospital por otros problemas no relacionados con el VIH. De los 499 pacientes que se hicieron la prueba en el año 2000, a 5 se les encontró una infección aguda por VIH y 6 tenían infección crónica. De los 5 pacientes con infección aguda por VIH, 4 regresaron para recibir los resultados de la prueba, fueron evaluados por un médico o enfermera de VIH e iniciaron la terapia antirretroviral.<sup>13</sup>
<h4>¿qué queda por hacer?</h4>
La infección aguda por VIH es difícil de detectar y muchas veces se queda sin diagnosticar. Los médicos de atención primaria y los trabajadores de salud en salas de emergencia, centros de atención urgente y clínicas de ETS/ITS necesitan orientación y capacitación sobre los síntomas de la infección aguda por VIH. Los proveedores médicos con pacientes que muestran señales de enfermedad viral tales como la influenza o la mononucleosis deben hacerles una breve evaluación del riesgo de la infección por VIH y remitirlos a centros de consejería y pruebas del VIH según la necesidad.

Se necesitan más centros de consejería y pruebas del VIH que ofrezcan pruebas para detectar la infección aguda, especialmente en áreas de alta incidencia y en entornos de alto riesgo tales como las clínicas de ETS/ITS. Para lograr esto, es preciso ampliar los recursos de capacitación, asistencia técnica y financieros para las organizaciones que ofrecen pruebas de infección aguda por VIH. Para fomentar el uso de la prueba PAAN se necesitan cambios en los protocolos de reembolsos estatales y federales, así como en los seguros públicos y privados.

Identificar a las personas con infección aguda por VIH puede ser una estrategia eficaz de prevención del VIH, porque se enfoca en las personas con mayor riesgo de transmisión. Después de la prueba, las personas con infección aguda pueden necesitar consejería más extensa con remisiones a: atención médica, servicios sociales como el tratamiento para la drogadicción o el alcoholismo, servicios de salud mental y programas de prevención para personas VIH+. La infección aguda también es una etapa crítica para identificar a parejas sexuales y compañeros de consumo de drogas, como también lo es para ofrecer servicios de ayuda para la revelación, tales como la notificación, consejería, pruebas y remisión a servicios para las parejas.<sup>2,16</sup>

<hr />

<h3>¿quién lo dice?</h3>
1. Pilcher CD, Eron JJ, Galvin S, et al. Acute HIV revisited: new opportunities for treatment and prevention . Journal of Clinical Investigation. 2004;113:937-945.

2. Pope M, Haase AT. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection . Nature and Medicine. 2003;9:847-852.

3. Wawer MJ, Gray RH, Sewankambo N, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda . Journal of Infectious Diseases. 2005;191:403-409.

4. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection . Annals of Internal Medicine. 1996;125:257-264.

5. Quinn TC, Brookmeyer R, Kline R, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence . AIDS. 2000;14:2751-2757.

6. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina . New England Journal of Medicine. 2005;352:1873-1883.

7. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine. 2000;342:921-929.

8. Klausner J, Kohn R, Nieri G, et al. A comprehensive HIV surveillance &amp; disease control program in a sentinel site: San Francisco municipal STD clinic, 2004. Presented at the National HIV Prevention Conference, Atlanta, GA, 2005. Abst # W0-L0405.

9. Hecht F, Wang L, Collier A, et al. Outcomes of HAART for acute/early HIV-1 infection after treatment discontinuation. Presented at the 12th Conference on Retroviruses and Opportunistic Infections. 2005. Abst# 568.

10. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Oct 2005. aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

11. Geise R, Maenza J, Celum CL. Clinical challenges and diagnostic approaches to recognizing acute human immunodeficiency virus infection . American Journal of Medicine. 2001;111:237-238.

12. Truong HM, McFarland W, Kellogg T, et al. Detection of acute HIV infection among STD clinic patients in San Francisco. Presented at the 13th Conference on Retro-viruses and Opportunistic Infections. 2006. Abst #914.

13. Pincus JM, Crosby SS, Losina E, et al. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center . Clinical Infectious Diseases. 2003;37:1699-1704.

14. Kuo AM, Haukoos JM, Witt MD, et al. Recognition of undiagnosed HIV infection: an evaluation of missed opportunities in a predominantly urban minority population . AIDS Patient Care and STDs. 2005;19:239-246.

15. Hightow L, MacDonald P, Boland M, et al. Missed opportunities for the diagnosis of acute infection: room for improvement. Presented at the 12th Conference on Retroviruses and Opportunis-tic Infections. 2005. Abst# 565.

16. Centers for Disease Control and Prevention. HIV transmission among black college student and non-student men who have sex with men– North Carolina, 2003 . Morbidity and Mortality Weekly Report. 2004;53:731-734.

<hr />

<strong>Preparado por Hong-Ha M. Truong, PhD, MS, MPH*; Christopher D. Pilcher MD**</strong>

<strong>*CAPS, *Gladstone Institute of Virology and Immunology, **University of North Carolina Chapel Hill</strong>

<strong>Mayo 2006 . Fact Sheet #59S</strong>

Special thanks to the following reviewers of this Fact Sheet: Michael Busch, Andrew Forsyth, Karlissa Foy, Sabine Kinloch-de Loes, Mario Legault, Elizabeth Londoño, Willi McFarland, Jon Pincus, Elisabeth Puchhammer-Stöckl, Kathleen Sikkema.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/infeccionagudaFS.pdf</url>
	</node>
	<node>
		<title>Notificación de parejas</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>¿Qué papel juegan los servicios de notificación de parejas en la prevención del VIH?</h2>
<h3>¿por qué la notificación de parejas?</h3>
A más de 20 años del inicio de la epidemia y a pesar de los avances en conocimiento, tratamiento, y aceptación del VIH, la experiencia de recibir un diagnóstico VIH+ aún puede resultar traumática. La gente VIH+ debe asimilar la realidad de su propia infección al tiempo de preocuparse por la posible infección de parejas pasadas y futuras. Es difícil hablar con la pareja sobre el VIH, pues aunque puede controlarse, aún no tiene cura.

La ayuda con la notificación de parejas (conocida como servicios de asesoramiento y referencia para parejas o PCRS en inglés) es una serie de servicios voluntarios y confidenciales para personas VIH+ y para sus parejas sexuales y/o de inyección de drogas. Estos servicios son costo-efectivos y tienen un papel crítico tanto identificando individuos a mayor riesgo de infección como remitiendo oportunamente a servicios médicos a quienes estén infectados.

La mayoría de las personas VIH+ deciden por su cuenta si revelan o no su condición a sus parejas, pero muchas veces necesitan apoyo para hablar directamente con éstas o para que cuidadosa y confidencialmente lo haga un profesional. En un estudio, las personas que recibieron ayuda con la notificación triplicaron la probabilidad de informar a sus parejas sobre el riesgo contraído.

En años recientes, los programas de consejería y pruebas del VIH en los EE.UU. han cambiado de aplicar la prueba a todo mundo, a identificar y ofrecer pruebas a los más vulnerables a infectarse. En los sitios generales de pruebas del VIH cerca de un 1% resulta VIH+, comparado con el 8 al 39% que resulta de los programas de notificación de parejas.
<h3>¿qué es la notificación de parejas?</h3>
La notificación de parejas no siempre la efectúa un profesional médico; de hecho, puede realizarse de tres maneras:

Notificación personal- La persona infectada bajo la orientación de un consejero habla directamente con su pareja. La mayoría de las personas VIH+ prefieren este método.

Notificación dual- La persona informa a su pareja en presencia de un profesional de salud, quien apoya durante la conversación y sirve de recurso a la pareja notificada. Este método se usa rara vez y requiere de profesionales muy especializados.

Notificación por un profesional de salud (un tercero anónimo)- La persona elige que un profesional notifique a la pareja proporcionando los datos de contacto de la misma. Comúnmente, un proveedor de salud entrega la información a especialistas en intervención de enfermedades (EIE) quienes buscan y notifican a las parejas identificadas, manteniendo confidencialmente la identidad del notificante. Este método es el único que permite anonimato.

Para las parejas notificadas, los servicios de notificación incluyen: información sobre su exposición al VIH, consejería de prevención del VIH y pruebas, y si su resultado es positivo, remisión a una evaluación médica y a otros servicios pertinentes.
<h3>¿cómo funcionan estos servicios?</h3>
Se ofrecen cuando la persona recibe un resultado VIH+. No debe ofrecerse una sola vez, sino repetidamente según cambien las circunstancias de riesgo y las necesidades de la persona. El propósito es ayudar a las personas VIH+ a informar a sus compañeros sexuales y/o de inyección de drogas sobre una posible exposición al VIH.

La calidad y el uso de los servicios de notificación de parejas en EE.UU. pueden variar de estado a estado. Algunos están obligados a ofrecerlos por ley, otros por medio de programas de VIH/ITS o reciben remisiones de médicos, departamentos de salud o de sitios de pruebas.

Las organizaciones de servicios de VIH, los departamentos de salud y la mayoría de las clínicas y hospitales pueden notificar parejas. Las organizaciones de servicios pueden asesorar y apoyar en la notificación personal o dual, u obtener los datos de las parejas y proporcionarlos a los EIE para notificación. La mayoría de las notificaciones la realizan los departamentos de salud pues tienen la capacidad, el conocimiento, el personal y la protección contra demandas legales.

Una buena notificación depende de EIE con la capacitación, la experiencia y los conocimientos adecuados. Es importante que los EIE reciban apoyo y preparación continua así como evaluaciones periódicas de rendimiento para asegurar la calidad de sus servicios.
<h3>¿cuáles son las inquietudes al respecto?</h3>
Los mensajes de salud pública han exhortado a la notificación a toda pareja sexual y/o de inyección de drogas, pero esta notificación es difícil y compleja. Algunas personas VIH+ deciden no revelar su condición por temor al posible rechazo familiar o de la pareja, a menos oportunidades sexuales, a menos acceso a drogas o mayor riesgo de violencia física y sexual. Los programas de VIH deben aceptar que “no notificar” es también una opción válida.

Aunque por muchos años se han usado los servicios de los profesionales de salud para notificar sobre otras ITS, respecto al VIH existe un amplio rango en los índices aceptación de este tipo de notificación: En Carolina del Norte, el 87% de personas VIH+ recientemente diagnosticadas aceptó la notificación por un profesional, en Florida el 63.1%, en Los Ángeles, CA el 60%, en el Estado de Nueva York el 32.9%, en Seattle, WA el 32% y entre los recipientes de pruebas anónimas en San Francisco, CA el 3.1%. En Los Ángeles, las razones más comunes de rechazo de la notificación fueron: Pareja ya notificada (23.4%), no estar listo/a para revelar su condición (15.3%), abstinencia sexual (15%) y pareja anónima (11%).

La revelación de la condición de VIH a las parejas puede ser motivo de temor, pero también fuente de poder. En un estudio, los consumidores VIH+ de drogas inyectables que revelaron su condición encontraron un aumento en el apoyo social y en la intimidad con sus parejas, una reafirmación de su sentido de sí mismos y la oportunidad de compartir experiencias y sentimientos con sus parejas sexuales. Otro estudio de personas VIH+ y sus parejas que recibieron ayuda con la notificación encontró que el abuso emocional y la violencia física disminuyeron notablemente después de la notificación.
<h3>¿qué se está haciendo al respecto?</h3>
En Florida, los EIE brindan servicios de notificación de parejas para todo caso nuevo de VIH reportado. En el 2004, el 63.1% de las personas recién diagnosticadas con VIH aceptó la notificación de parejas por un profesional, con la consecuente identificación de 4,460 parejas sexuales o de inyección de drogas. De estas parejas, el 21.8% ya había resultado VIH + anteriormente. De las 2,518 personas notificadas, el 84.2% aceptó recibir consejería y pruebas; el 11.5% resultó VIH+.

El Departamento de Salud de Massachusetts lanzó un programa piloto de notificación de parejas “centrado en el cliente” el cual se integró a los servicios rutinarios de prevención, atención y apoyo. El programa requirió modificaciones importantes al modelo habitual de notificación de los EIE; se formaron vínculos estrechos entre los proveedores de servicios y los EIE para responder mejor a las necesidades de notificación de parejas mientras se protegía la confidencialidad.

California instituyó un programa de notificación voluntaria que incluye: Consejería y preparación para que las personas VIH+ revelen la información personalmente; notificación anónima por un tercero; consejería, pruebas y remisión a servicios para las parejas identificadas; y capacitación y asistencia técnica para profesionales médicos en centros públicos y privados. Cerca de un tercio de los pacientes optó por la notificación por un tercero y el 85% remitió a sus parejas. De las parejas localizadas, el 56% se hizo la prueba (la mitad nunca se la había hecho) y el 18% de todas las parejas resultó VIH+.
<h3>¿qué queda por hacer?</h3>
Las nuevas tecnologías de pruebas del VIH pueden ser útiles en los servicios de notificación. La prueba rápida mejorada es una herramienta invaluable para ofrecer pruebas a las parejas notificadas. La prueba de amplificación de ácido nucleico (NAAT, en inglés) puede determinar infecciones agudas, nuevas infecciones que no se detectan durante el periodo de ventana de otras pruebas. Combinando estas estrategias de pruebas con la notificación de parejas se podría identificar a personas recién infectadas y que éstas reciban atención y servicios inmediatamente.

Para que la notificación de parejas (especialmente la realizada por un tercero) funcione bien dentro de los servicios de VIH pueden requerirse de modificaciones extensivas al modelo tradicional de los EIE. El personal de prevención general de VIH puede capacitarse como EIE para ampliar el acceso y la confianza a éstos servicios. Los departamentos de salud pueden conectar más sus programas de VIH, ITS y con organizaciones externas.

Los servicios de notificación deben ofrecerse no sólo en el diagnóstico inicial del VIH, sino constantemente según cambien las circunstancias y las necesidades de las personas VIH+. No les corresponde a los profesionales de salud decidir si la persona necesita o desea ayuda para notificar a sus parejas; el apoyo y las opciones deben ofrecérsele independientemente de cuál sea su decisión en ese momento.

<strong>Preparado por Fern Orenstein MEd</strong>

<strong>CA STD Control Branch, Prevention Training Center</strong>

<strong>Septiembre 2005. Hoja #53SR</strong>

**********
<h1>¿quién lo dice?</h1>
1. Landis SE, Schoenbach VJ, Weber DJ, et al. Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. New England Journal of Medicine. 1992;326: 101-106.
2. Golden MR. Editorial: HIV partner notification, a neglected prevention intervention. Sexually Transmitted Diseases. 2002;29:472-475.
3. Varghese B, Peterman TA, Holtgrave DR. Cost-effectiveness of counseling and testing and partner notification: a decision analysis. AIDS. 1999;13:1745-1751.
4. Eckert V. Utilization of voluntary HIV partner counseling and referral services. California Office of AIDS &amp; STD Control Branch. Presented at the Statewide PCRS Conference, May 2004.
5. Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic – US, 2003. Morbidity and Mortality Weekly Report. 2003:52;329-332.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5215a1.htm (accessed April 2006).
6. HIV partner counseling and referral services guidance. Centers for Disease Control and Prevention. 1998. www.cdc.gov/hiv/pubs/pcrs.htm
7. Aldridge C, Randall L. Implementing partner counseling and referral services programs. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #TO-057.
8. Centers for Disease Control and Prevention. Partner counseling and referral services to identify persons with undiagnosed HIV–North Carolina, 2001. Morbidity and Mortality Weekly Report. 2003;52:1181-1184.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5248a4.htm(accessed April 2006).
9. George D. Partner counseling and referral services (PCRS): the Florida experience. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #M3-B1605.
10. Aynalem G, Hawkins K, Smith LV, et al. Who and why? Partner counseling and referral service refusal: implication for HIV infection prevention in Los Angeles. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #MP-036.
11. Birkhead G. HIV partner counseling and referral services in New York state. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #M3-B1603.
12. Golden MR. Partner notification: where do we stand and outstanding barriers. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #T3-D1302.
13. Schwarcz S, McFarland W, Delgado V, et al. Partner notification for persons recently infected with HIV: experience in San Francisco. Journal of Acquired Immune Deficiency Syndrome. 2001;28:403-404.
14. Parsons JT, Vanora J, Missildine W, et al. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Education and Prevention. 2004;16:459-475.
15. Kissinger PJ, Niccolai LM, Magnus M, et al. Partner notification for HIV and syphilis: effects on sexual behaviors and relationship stability. Sexually Transmitted Diseases. 2003;30:75-82.
16. Cranston K. Planning for HIV partner counseling and referral services in the third decade. Presented at the National HIV Prevention Conference, Atlanta, GA. 2005. Abst #T3-D1301.
17. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. New England Journal of Medicine. 2005;352:1873-1883.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Home testing</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Is the Role of HIV Testing at Home?</h3>
<h4>Is home HIV testing feasible?</h4>
Home-access testing for HIV met with virtually unanimous opposition when it was first proposed.<sup>1</sup> Today, the Centers for Disease Control (CDC), leading clinicians, gay activists and AIDS advocates have all endorsed home access testing.<sup>2</sup> The barriers to home access testing have not been technical, as feasibility studies have demonstrated.<sup>3</sup> Home testing has been possible for more than a decade.

Actually, “home testing” is a little misleading: customers don’t actually get on-the-spot results, the way they do with home test kits for glucose, cholesterol, blood pressure or pregnancy. The tests are really at-home “collection kits” to be purchased over the counter or through the mail. A test kit purchaser pricks his/her finger, puts a drop of blood on a piece of blotter paper, sends it off in the mail, then phones for results and counseling after a specified time.

In the spring of 1996, the Food and Drug Administration (FDA) approved the first HIV home collection test kit, Confide. The kit, sold by a subsidiary of Johnson &amp; Johnson, was later withdrawn from the market. The FDA later licensed Home Access HIV-1 Test System, manufactured by Home Access Health Corporation of Chicago. This remains the only home collection kit approved for sale by the FDA, although a dozen other unapproved home test kits have been advertised for sale in newspapers and via the Internet. The FDA cautions against the use of these unapproved test kits, which have not been fully evaluated and “do not have a documented history of delivering dependable results.”<sup>4</sup>
<h4>How is it different?</h4>
It’s an easy way for people to find out if they’re HIV infected. Traditionally, getting tested for HIV has meant a trip to a doctor or clinic, getting blood drawn, then returning for results and counseling. The new home testing kits save two trips to the doctor or clinic. It also makes testing accessible for people who live in rural areas, or inner cities where clinics are scarce, too busy, or a long bus ride away.

Home testing also affords privacy. Some people are afraid to visit a clinic or doctor’s office because they fear they will be recognized by neighbors, friends, or family. In a number of studies, at-risk individuals have expressed preference for anonymous systems of HIV testing.<sup>5</sup> Home testing has the potential for complete anonymity.

Offering another testing option is a step toward solving the national problem of inadequate HIV testing. An alarmingly high proportion of those at risk has not been tested for HIV.<sup>6</sup> Getting HIV test results becomes more and more important as means of bolstering the immune system and staving off opportunistic infections improve. Pregnant women are being encouraged to take voluntary HIV tests in light of studies showing that treating HIV-infected pregnant women with zidovudine (AZT) can reduce the rate of maternal/fetal transmission of HIV by two-thirds.<sup>7</sup>
<h4>Are the results reliable? private?</h4>
Millions of HIV antibody tests have been conducted using dried blood specimens.<sup>8</sup> Such testing is highly accurate when laboratory protocols for confirmatory testing and quality assurance mechanisms are followed. False positive results do occur in HIV testing, but at a very low rate. Some test kit blotters mailed to the lab may not have enough blood to test. In such situations, telephone counselors have been trained to advise customers when results are unclear or need further confirmation.

Each test comes with a unique identification number, which patients return to the lab with their blood samples. The lab never knows a name. When calling for results, patients identify themselves by this number alone.
<h4>Who will get tested at home?</h4>
Home access HIV testing may provide reassurance to the “worried well”-people for whom the risk of HIV infection may be quite remote, but are nevertheless seeking reassurance. If such individuals no longer rely on public sources of testing, resources may be freed up for more targeted interventions with those at highest risk.<sup>9</sup>

Sales of home test kits have not been quite as robust as might have been expected from surveys in which people expressed their attitudes and intentions regarding home testing. In its first year, Home Access Health’s sold 152,044 test kits; 148,039 people called to find out their results. The overall HIV seropositive rate was 0.9%.<sup>10</sup>

Beyond the denial and psychological barriers to seeking testing, many may find the $30-40 retail cost for home test kits prohibitive. Home test kit companies are working with a variety of public health and community agencies, selling kits at wholesale prices so that home access testing can become part of various prevention outreach strategies.
<h4>What are the concerns?</h4>
One concern is the adequacy of counseling. At a doctor’s office or clinic, test results are usually delivered in person. If a patient feels overwhelmed, or even suicidal, an expert is there to help. Companies selling home test kits make counselors available, but they will be miles away on the other end of a telephone. As one critic of home testing put it, “a 1-800 number can’t hug you when you’re crying."<sup>11</sup>

Yet for some people, the remoteness and anonymity afforded by telephone counseling makes it easier to reveal painful feelings or embarrassing information. There is a long tradition with telephone counseling in crisis intervention and suicide prevention.

Telephone counseling must be compared to the actual experiences of current HIV testing. For many, counseling is already inadequate or missing altogether. According to data from the National Health Interview Survey (NHIS), a third of those who were tested for HIV antibodies got their results by mail (16%) or telephone (17%).<sup>12</sup>

About 2.5 million tests are performed annually at publicly funded test sites. In 1995, 25% of people who tested positive and 33% who tested negative failed to return for their results.<sup>13</sup> In contrast, 97.4% of buyers of the home test kit called for test results.<sup>10</sup>

Another concern is potential abuse of home test kits. Some fear that employers, family members or health providers could send someone’s blood sample to be tested without the person’s knowledge. Laws already exist against testing without consent and discrimination on the basis of HIV status. These statutes need to be enforced; new legal protections may be needed once there is more experience with home test kits.
<h4>What are the limitations?</h4>
A positive HIV test result does not guarantee access to needed care. As the National Commission on AIDS wrote, “for many impoverished individuals gaining entry into a health care and social service system by means of a ticket stamped `HIV positive’ is still a cruel hoax.”  Nevertheless, this is no reason to discourage people from seeking testing. “The lack of good medical and social services for people with HIV infection is an argument for increasing those services, not denying people access to personal medical information.”<sup>15</sup>

HIV testing is not an end in itself. A comprehensive HIV prevention strategy uses multiple elements to protect as many people at risk of HIV infection as possible. The real challenge is to ensure that wherever people are tested they have access to follow-up counseling and care. If they are HIV positive they should receive care to stay healthy, and if they are HIV negative they should receive support to stay negative.

<hr />

<h3>Says who?</h3>
<ol>
 	<li>Anon. Banned at home: an FDA ruling on AIDS test. Time. 1989; April 18:26.</li>
 	<li>Leary WE. Government panel hears call for expanded AIDS testing. New York Times. 1994;June 23:A18.</li>
 	<li>Frank AP, Wandell MG, Headings MD, Conant MA, Woody G, Michel C. Anonymous HIV testing using home collection and telemedicine: a multicenter evaluation. Archives of Internal Medicine. 1997;157:309-314.</li>
 	<li>Center for Biologics Evaluation and Research, Food and Drug Administration (FDA). Testing yourself for HIV-1, the virus that causes AIDS–Home test system is available. 1997;July 25. Http://www.fda.gov/cber/infosheets/hiv-home.htm.</li>
 	<li>Hirano D, Gellert GA, Fleming K, et al. Anonymous HIV testing: the impact of availability on demand in Arizona. American Journal of Public Health. 1994;84:2008-2010.</li>
 	<li>Sweeney PA, Fleming PL, Karon JM, Ward JW. A minimum estimate of the number of living HIV infected persons confidentially tested in the United States. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 1997;Sept.-Oct., Toronto, Canada.</li>
 	<li>Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine. 1994;331:1173-1180.</li>
 	<li>Gwinn M, Redus MA, Granade TC. HIV-1 serologic test results for one million newborn dried-blood specimens: assay performance and implication for screening. Journal of Acquired Immune Deficiency Syndrome. 1992;5:505-12.</li>
 	<li>Valdiserri RO, Weber JT, Frey R, Trends in HIV seropositivity in publicly finded HIV counseling and testing programs: implications for prevention policy. American Journal of Preventive Medicine. 1998;14:31-42.</li>
 	<li>Home Access Health. http://www.homeaccess.com.</li>
 	<li>Ocamb K. Home HIV testing is near. POZ. 1994;June-July:48-52. (quoting Dennis Ouellet, LA Free Clinic).</li>
 	<li>Schoenborn CA, Marsh Sl, Hardy AM. AIDS knowledge and attitudes for 1992. Data from the National Health Interview Survey. Advance Data. 1994;243:1-15.</li>
 	<li>Centers for Disease Control. Update: HIV counseling and testing using rapid tests–United States. Morbidity and Mortality Weekly Report. 1998;47: 211-5.</li>
 	<li>National Commission on AIDS. Report of the Working Group on Social and Human Issues. Washington, DC: National Commission on AIDS, 1991.</li>
 	<li>Bayer R, Stryker J, Smith MD. Testing for HIV infection at home. New England Journal of Medicine. 1995;332: 1296-1299.</li>
</ol>

<hr />

<strong>Prepared by Jeff Stryker*
*CAPS</strong>

Updated August 1998. Fact Sheet #11Er

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Francisco should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © August 1998, University of California.
<h3></h3>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/hometestFS.pdf</url>
	</node>
	<node>
		<title>Prueba del VIH en casa</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Que papel juega hacerse la prueba del VIH en casa?</h3>
<h4>¿será factible el examen casero para la detección del VIH?</h4>
Cuando por primera vez se planteó la posibilidad de poner al alcance del público un estuche casero para la detección del VIH, esa se encontró con oposición unánime.<sup>1</sup> Hoy en día los Centros para el Control de Enfermedades (CDC, por sus siglas en Inglés), destacados miembros del sector salud, activistas “gay” y los defensores de la lucha contra el SIDA apoyan la idea del estuche casero para detectar el VIH.<sup>2</sup> Los estudios que se han hecho sobre la factibilidad de las pruebas caseros han demostrado que no hay barreras técnicas en su uso.<sup>3</sup> Se ha podido examinar en casa por mas de una década.

Realmente, el nombre “examen casero” tiende a mal interpretarse puesto que la persona no obtiene resultados inmediatos, a como sucede con los estuches caseros para detectar el nivel de glucosa, colesterol, presión arterial y el embarazo. En realidad las pruebas son “estuches para ser recolectados” que se pueden comprar sin receta médica en cualquier farmacia o por medio del correo. El comprador del estuche se pincha el dedo, deposita una gota de sangre en un pedazo de papel absorbente, lo envía por correo y luego llama por teléfono (después de un tiempo específico) para obtener los resultados.

En la primavera del 1996, la entidad encargada de administrar las medicinas y los alimentos de los EEUU (FDA), aprobó, Confide, el primer estuche casero para la detección del VIH. El estuche, que se vendió por una empresa filial de Johnson &amp; Johnson, y después fue retirado del mercado. El FDA después aprobó Home Access HIV-1 Test System, que esta manufacturado por la empresa Home Access Health Corporation en Chicago. Actualmente, este es el único estuche para prueba casera que ha sido aprobado por el FDA, aunque varios otros estuches no-aprobados han sido anunciados por vente en periódicos y en el Internet. El FDA previene contra el uso de estuches no-aprobados, que no han sido completamente evaluados y que “no tienen una historia documentada de entregar resultados confiables.”<sup>4</sup>
<h4>¿en qué forma es diferente?</h4>
Tradicionalmente, hacerse la prueba del VIH ha implicado tener que ir al doctor o a la clínica, sacarse sangre, y después regresar por los resultados y recibir apoyo psicológico. Con el nuevo examen casero se ahorrarían dos viajes. Este método hará posible que las personas que viven en áreas rurales o recónditas de la ciudad en donde las clínicas son escasas, con muchos pacientes o que impliquen un largo viaje en bus se hagan la prueba del VIH.

El examen casero también brinda privacidad. Algunas personas no van al doctor o a la clínica por temor a ser vistos por algún vecino, familiar o amigo. En un cantidad de estudios, los individuos que están a riesgo han expresado su preferencia por un sistema anónimo al hacerse la prueba.<sup>5</sup> El examen casero ofrece el potencial de ser totalmente anónimo.

Ofrecer otra opción para hacerse la prueba significa avanzar un paso hacia la resolución del problema nacional que enfrenta el sistema de hacerse el examen del VIH. Una proporción alarmantemente alta de aquellos que están a riesgo (más del 60%) todavía no se han hecho la prueba del VIH.<sup>6</sup> Obtener resultados del VIH se vuelve cada vez más y más importante ya que el sistema inmunológico necesita fortalecerse y mantener bajo control a las infecciones oportunistas. A las mujeres embarazadas se les anima a hacerse la prueba voluntaria del VIH ya que los estudios demuestran que al suministrárseles Zidovudine (AZT), este puede reducir en dos tercios la tasa de transmisión del VIH de madre a feto.<sup>7</sup>
<h4>¿los resultados, son confiables?</h4>
Millones de las pruebas realizadas para detectar la presencia de anticuerpos del VIH se han hecho por medio de una muestra de sangre seca.<sup>8</sup>  Este tipo de pruebas son bastante exactas, siempre y cuando se siga muy de cerca el protocolo de laboratorio en cuanto a la confirmación de la prueba y los mecanismos que lo garantizan.

Algunos de los estuches enviados al laboratorio para ser examinados puede que no contengan la cantidad de sangre necesaria para conducir la prueba. En estos casos, los consejeros telefónicos van a tener que ser entrenados para aconsejar al cliente cuando los resultados no estén claros o por si necesitan confirmación.
<h4>¿quiénes se harán la prueba en casa?</h4>
La accesibilidad del examen casero puede brindar mayor seguridad a aquellas personas que aunque el riesgo de infección con el VIH sea bastante remota, andan buscando como reasegurarse. Si estas personas ya no pueden contar con las fuentes públicas para hacerse la prueba, puede ser que estos recursos sean utilizados para poner en práctica mas intervenciones dirigidas a los que se encuentran a mayor riesgo.<sup>9</sup>

Las ventas de los estuches para prueba casera no han sido tan numerosas como se esperaba de acuerdo a los resultados obtenidos de encuestas sobre las intenciones acerca de pruebas caseras. En el primer ano de vente, Home Access Health vendió 152,044 estuches; 148,039 personas llamaron para obtener sus resultados. El índice de resultados seropositivos fue 0,9%.<sup>10</sup>

Además de la negación y otras barreras psicológicas, muchos encuentran el costo por menor de $30-$40 por estuche a ser imposible. Las empresas que manufacturan los estuches de prueba casera están trabajando con varias agencias de salud publica y comunitarias, vendiéndoles los estuches al mayor para que puedan utilizarlos en sus campanas de prevención.
<h4>¿cuál es la preocupación?</h4>
Una de las preocupaciones es lo adecuado del apoyo psicológico. En una clínica u oficina del Doctor, los resultados usualmente se entregan en persona. Si el paciente se siente sumamente abrumado por la noticia, hay un experto presente que le puede ayudar. Las compañías que venden el estuche casero también pondrán consejeros a la disposición, pero estos estarán a millas de distancia en la línea telefónica. A como lo expuso uno de los que critican el examen casero “el número 1-800 no te puede abrazar cuando lloras.”<sup>11</sup>

Para algunos, lo remoto y lo anónimo de la orientación por teléfono les permite revelar con mayor facilidad sentimientos de dolor o información embarazosa. Además, ya existe una larga tradición en cuanto intervenir por medio del teléfono en crisis y en la prevención del suicidio.

La propuesta de brindar apoyo psicológico por teléfono debería ser comparado con experiencias que actualmente ocurren al hacerse la prueba del VIH. Para muchos, la consejería ni es la adecuada, ni existe. De acuerdo a las datos arrojados por el National Health Interview Study (Estudio Nacional sobre la Salud), un tercio de aquellos que se hicieron la prueba del VIH obtuvieron los resultados por correo (16%) o por teléfono (17%). <sup>12</sup>

En los sitios públicos, se hacen cerca de 2,5 millones de pruebas anuales. En 1995, 25% de las personas que tuvieron resultados positivos y 33% de las personas que tuvieron resultados negativos, faltaron de regresar por sus resultados.<sup>13</sup> Por contraste, 97,4% de las personas que compraron estuches de prueba casera llamaron para obtener sus resultados.<sup>10</sup>

Otra de las preocupaciones es el potencial de abuso al que el estuche casero pudiera prestarse. Algunos temen que los patrones, familiares o proveedores al cuidado de salud puedan enviar muestras de sangre sin el consentimiento de la persona. Aunque ya existen leyes que protegen en caso de que se hagan sin el permiso de la persona ya sea por discriminación o por ser VIH positivos. Estos estatutos necesitan ser enforzados; nuevas leyes de protección deberán ser creadas a medida que se adquiere experiencia con el examen casero.
<h4>¿cuáles son las limitaciones?</h4>
Un resultado positivo a la prueba no garantiza el acceso a los cuidados de salud necesarios. A como lo escribió la Comisión Nacional del SIDA “Es muy cruel que muchos de los pobres crean que van a obtener acceso al sistema de salud y servicios sociales por medio de un diagnóstico VIH positivo.”<sup>14</sup> No obstante, esto no debería impedir que la gente busque como hacerse la prueba. “La falta de buenos servicios de salud y de servicios sociales para las personas infectadas con el VIH es argumento para incrementarlos, no para reducirlos.”<sup>15</sup>

Hacerse la prueba del VIH no necesariamente significa el final. El reto mas importante se el de lograr un acceso seguro a servicios de cuidados de salud y de apoyo psicológico continuo para todas aquellas personas que se hacen la prueba. Si estos resultan ser VIH positivos, deberían recibir los cuidados médicos necesarios para mantenerse saludables, y si el resultado es negativo deberán recibir el apoyo necesario para mantenerse negativos.

<hr />

<h4>¿quién lo dice?</h4>
<ol>
 	<li>Anon. Banned at home: an FDA ruling on AIDS test. Time. 1989; April 18:26.</li>
 	<li>Leary WE. Government panel hears call for expanded AIDS testing. New York Times. 1994;June 23:A18.</li>
 	<li>Frank AP, Wandell MG, Headings MD, Conant MA, Woody G, Michel C. Anonymous HIV testing using home collection and telemedicine: a multicenter evaluation. Archives of Internal Medicine. 1997;157:309-314.</li>
 	<li>Center for Biologics Evaluation and Research, Food and Drug Administration (FDA). Testing yourself for HIV-1, the virus that causes AIDS–Home test system is available. 1997;July 25. Http://www.fda.gov/cber/infosheets/hiv-home.htm.</li>
 	<li>Hirano D, Gellert GA, Fleming K, et al. Anonymous HIV testing: the impact of availability on demand in Arizona. American Journal of Public Health. 1994;84:2008-2010.</li>
 	<li>Sweeney PA, Fleming PL, Karon JM, Ward JW. A minimum estimate of the number of living HIV infected persons confidentially tested in the United States. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 1997;Sept.-Oct., Toronto, Canada.</li>
 	<li>Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New England Journal of Medicine. 1994;331:1173-1180.</li>
 	<li>Gwinn M, Redus MA, Granade TC. HIV-1 serologic test results for one million newborn dried-blood specimens: assay performance and implication for screening. Journal of Acquired Immune Deficiency Syndrome. 1992;5:505-12.</li>
 	<li>Valdiserri RO, Weber JT, Frey R, Trends in HIV seropositivity in publicly finded HIV counseling and testing programs: implications for prevention policy. American Journal of Preventive Medicine. 1998;14:31-42.</li>
 	<li>Home Access Health. http://www.homeaccess.com.</li>
 	<li>Ocamb K. Home HIV testing is near. POZ. 1994;June-July:48-52. (quoting Dennis Ouellet, LA Free Clinic).</li>
 	<li>Schoenborn CA, Marsh Sl, Hardy AM. AIDS knowledge and attitudes for 1992. Data from the National Health Interview Survey. Advance Data. 1994;243:1-15.</li>
 	<li>Centers for Disease Control. Update: HIV counseling and testing using rapid tests–United States. Morbidity and Mortality Weekly Report. 1998;47: 211-5.</li>
 	<li>National Commission on AIDS. Report of the Working Group on Social and Human Issues. Washington, DC: National Commission on AIDS, 1991.</li>
 	<li>Bayer R, Stryker J, Smith MD. Testing for HIV infection at home. New England Journal of Medicine. 1995;332: 1296-1299.</li>
</ol>

<hr />

<strong>Preparado por Jeff Stryker, Traducción Sandra Galvez
CAPS</strong>

Revisado Deciembre 1998. Hoja Informativa 11Sr.

Alentamos la reproducción de este documento; aunque, no se admite la venta de copias y UCSF deberá ser mencionada como fuente de esta información. Para obtener copias, llame por favor al National Prevention Information Network al 800/458-5231 o al Internet http://www.prevention.ucsf.edu o http://hiviniste.ucsf.edu/prevention. Estas hojas informativas están disponibles en ingles. Cualquier comentario o pregunta acerca de esta hoja informativa puede ser electrónicamente dirigido al FactsSheetM@psg.ucsf.edu. ©Deciembre 1998, University of California.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/prcasaFS.pdf</url>
	</node>
	<node>
		<title>Rapid testing</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How is rapid testing used in HIV prevention?</h3>
<h4>why rapid testing?</h4>
It is estimated that 25% of all HIV+ persons in the US do not know they’re infected.<sup>1</sup> Taking an HIV antibody test and knowing one’s HIV status are key to preventing the spread of HIV. Many persons who test HIV+ can access counseling, prevention education, support services and medical care to stay healthy and not progress to AIDS. HIV- persons can access counseling and education to remain HIV-. However, even when people choose to get tested, many never return for their results. In public test sites, up to 33% of clients who test HIV- and 25% who test HIV+ never return for their results.<sup>2</sup>

The rapid HIV test is a new, FDA-approved approach to HIV testing that addresses these issues. Conventional HIV testing has been conducted with needle blood draws or mouth swabs which are sent to a laboratory for analysis. Clients need to return to the test site 1-2 weeks later to find out their results. With rapid tests, clients can take the test, receive counseling, and find out their results all in one visit. This can help increase the number of persons who get tested and reduce the number of persons who don’t return for their results.<sup>3</sup>

Many government and non-governmental agencies are moving toward rapid testing instead of conventional testing. The Centers for Disease Control and Prevention’s (CDC) Strategic Plan for 2005 seeks to increase the number of HIV+ persons who know their HIV status from 70% to 95%—using rapid testing is an integral part of the plan.1 In California, the goal is to have 80% of all state-funded HIV test sites use rapid tests by the end of 2006.<sup>4</sup>
<h4>how is rapid testing done?</h4>
Rapid testing uses a finger stick, blood draw or mouth swab to collect samples. The test counselor places the sample in a tube with chemicals to process it, and can read the results in about 20 minutes. Counseling and risk reduction planning with the client can take place during the waiting time, or can be done before or after sample collection.

Within 20 minutes, most rapid tests will either be non-reactive—a negative test result—or reactive—a preliminary positive result. Currently, if a result shows preliminary positive, a second conventional blood or oral sample is required to confirm it. Final confirmation still takes 1-2 weeks. National data indicate that with rapid testing, 95% of clients who received a preliminary positive result returned for their confirmatory results.<sup>5</sup>

There are currently four FDA-approved rapid HIV tests in the US: Reveal, OraQuick, Multispot and Uni-Gold.<sup>6</sup> All tests are extremely accurate, with 99.6-100% sensitivity rates.<sup>7</sup> Only two of the tests—OraQuick and Uni-Gold—are Clinical Laboratory Improvement Amendment (CLIA) waived. OraQuick Advance uses a mouth swab and can be performed
in a wider range of settings and temperatures.

Rapid testing can be done in most clinical offices and in a large number of non-traditional health care and outreach settings such as mobile vans, storefronts, shelters, bathhouses,<sup>8</sup> labor and delivery clinics and emergency rooms. Testing in alternative venues can help increase testing among populations that are mobile or hard to reach, including migrant workers, homeless persons, adolescents and young adults.<sup>9</sup>

Rapid testing can change the way HIV testing is done. Most HIV test sites currently have counselors and separate phelobotomists who take the blood sample. With rapid testing, the test counselor can also take the sample and analyze it. However, in some rapid test sites, counselors do the consent and counseling and someone else still collects the sample.
<h4>is rapid testing rapid counseling?</h4>
No. One study found no difference in STD rates after counseling with rapid tests and conventional tests.<sup>10</sup> Rapid tests still allow for plenty of counseling time. Counselors have about 20 minutes between taking a sample and receiving the results to provide focused and specific counseling about the client’s real risks and possible exposure to HIV. Rapid testing counseling can be more intense due to the immediacy of getting results.<sup>11</sup>

Clients who receive a preliminary positive result and must return for their confirmation result may be more prepared to deal with their diagnosis. Clients often have had a week to think about what testing positive means and may be more emotionally prepared to listen to and digest referrals and options the counselors can provide.
<h4>can my agency/clinic offer it?</h4>
Agencies have several considerations to make before deciding to use rapid testing. The client flow will be different because counselors are involved with each client for longer periods of time than during conventional testing. Agencies have greater responsibility because they are handling blood or oral samples. To do this, most agencies must apply to the government for a CLIA certificate,<sup>12</sup> provide quality assurance, keep records and create documentation.

If test counselors are also conducting the test, they may need training to collect and process samples, run controls and track the tests. They will also need in-depth knowledge of referral resources for issues that may emerge in new, more focused HIV counseling sessions. Counselors typically may have concerns about the new testing procedures and counseling initially. After they’ve been trained and have provided a number of counseling sessions, they become more comfortable and often say they wished they had become involved in HIV rapid testing sooner.<sup>13</sup>

In some clinical settings it is easier to implement rapid testing because healthcare workers are used to taking samples, running controls and using universal precautions. However, clinicians may not be used to counseling when testing for HIV,<sup>14</sup> and may need training to develop stronger counseling skills and provide adequate referrals.
<h4>what’s being done?</h4>
The Metro Atlanta Women of Color Initiative (MAWOCI) brought rapid testing, prevention education and linkage to medical care to African American women in community settings such as churches, college campuses, homeless shelters and public housing. Staff were trained in HIV test counseling, rapid testing and condom demonstrations. To facilitate referrals, MAWOCI mapped local resources, forged alliances with agencies serving women of color and assessed capacity of HIV care doctors and clinics. More than 99% of women returned for confirmatory test results.<sup>15</sup>

The introduction of OraQuick in counseling and testing sites throughout the state of New Jersey resulted in an increased number of previously undiagnosed HIV cases as well as an increased number of patients receiving both their test results and posttest counseling. Within the first year, 10,429 patients received the rapid test. Of this group, 99.7% received their test results, compared to 65% before rapid testing.<sup>16</sup>

In Seattle, WA, the public health department routinely provides rapid testing to persons at high-risk in bathhouses, needle exchange sites and STD clinics. They made this decision after conducting research showing that more people received their test results with rapid testing and it was more cost-effective than conventional blood or oral fluid testing strategies.<sup>8</sup>

The Night Ministry in Chicago, IL, provides rapid testing in health outreach buses for homeless adults and youth and pregnant and parenting teens. The buses are staffed by a nurse, two HIV test counselors and a minister, and offer general health care, mental health services, STD and hepatitis C screening as well as coffee, cookies and condoms. For clients who test HIV+, the program offers bus cards, telephone calling cards and referrals to physicians experienced in providing HIV care.<sup>17</sup>
<h4>what is the future of rapid testing?</h4>
The future is now. Outside of the US, rapid testing is widely used and confirmatory tests are also done with rapid test, eliminating any waiting period for persons who test HIV+. Manufacturers have been slow to seek approval for tests in the US because the FDA has strict policies about licensing new HIV tests.

Rapid testing has been met with great enthusiasm in some areas and great trepidation in others. As federal and state governments increase requirements for rapid testing, resources for training, technical assistance and funding need to increase for the agencies that implement rapid testing. State and federal reimbursement protocols, as well as public and private insurance, need to be changed to encourage rapid testing.

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005. www.cdc.gov/hiv/partners/psp.htm (Accessed 4/20/06)

2. Kendrick SR, Kroc KA, Withum D, et al. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. Journal of AIDS. 2005;38:142-146.

3. Sullivan PS, Lansky A, Drake A. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. Journal of AIDS. 2004;35:511-518.

4. Dowling T. Outreach and prevention rapid HIV testing in non-clinical settings. Presented at the California Rapid Testing Conference. 2004.

5. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045-1051.

6. Reveal: www.reveal-hiv.com/ (Accessed 4/20/06)

OraQuick: www.abbottdiagnostics.com/Reagents_Tests/testdetail.cfm?test=oraquick (Accessed 4/20/06)

Uni-Gold: www.trinitybiotech.com/EN/index.asp (Accessed 4/20/06)

Multispot: www.bio-rad.com (Accessed 4/20/06)

7. Branson BM. Point-of-care rapid tests for HIV antibodies. Journal of Laboratory Medicine. 2003;27:288-295.

8. Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. Journal of AIDS. 2005;38:348-355.

9. Ellen JM, Bonu S, Arruda JS, et al. Comparison of clients of a mobile health van and a traditional STD clinic. Journal of AIDS. 2003;32:388-393.

10. Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sexually Transmitted Diseases. 2005;32:130-138.

11. Rapid HIV antibody testing. HIV Counselor Perspectives. 2003; 12:1-8.

12. Centers for Medicare and Medicaid Services. How to apply for a CLIA certificate, including foreign laboratories.http://www.cms.hhs.gov/CLIA/06_How_to_Apply_for_a_CLIA_Certificate,_Including_Foreign_Laboratories.asp(Accessed 4/20/06)

13. Birkhead GS, San Antonio-Gaddy ML, Richardson-Moore AL, et al. Effect of training and field experience on staff confidence and skills for rapid HIV testing in New York state. Presented at the International Conference on AIDS, Bangkok, Thailand. 2004. Abst #MoPeE4103.

14. Tao G, Branson BM, Anderson LA, et al. Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments? AIDS. 2003;17:1243-1247.

15. Thompson MA, Williams S, Williams K, et al. MAWOCI: a novel program providing transportable prevention education, rapid HIV testing, free CD4+ testing and linkage to medical care for women of color in Atlanta, GA. Presented at the 2003 National HIV Prevention Conference, Atlanta, GA. Abst #M1-G0502.

16. Cadoff EM. Rapid HIV testing increases detection rates and posttest counseling. Presented at the Annual Meeting of American College of Preventive Medicine. Feb 17, 2005. Poster 35.

17. Rapid HIV testing popular with Chicago CBO clients. AIDS Alert. February 2005.

18. Rapid testing for HIV: An issue brief. NASTAD HIV Prevention Update. September 2000.http://www.nastad.org/documents/public/pub_prevention/2001720September2000HVPreventionBulletin.pdf(Accessed 4/20/06)

<hr />

<strong>PREPARED BY TOM DONOHOE* AND JAY FOURNIER
*UCLA/PACIFIC AIDS EDUCATION AND TRAINING CENTER</strong>

<strong>May 2005 . Fact Sheet #58E</strong>

Special thanks to the following reviewers of this Fact Sheet: Bernard Branson, Marc Butlerys, Grant Colfax, Teri Dowling, Emily Erbelding, Shelley Facente, Keith Folger, Carol Galper, Cindy Getty, Patrick Keenan, Sally Liska, Rosa Solorio, Peter Shalit, Freya Speilberg, Deanna Sykes, Barbara Weiser.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © May 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/rapidtestingFS.pdf</url>
	</node>
	<node>
		<title>Prueba rápida</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo se aplica la prueba rápida en la prevención del VIH?</h3>
<h4>¿por qué se recomienda la prueba rápida?</h4>
Se calcula que el 25% de todas las personas VIH+ en EE.UU. ignoran que están infectadas. La clave para prevenir el VIH es hacerse una prueba de anticuerpos del VIH y enterarse si uno está infectado o no. Muchas personas con resultados VIH+ pueden recibir consejería, servicios de apoyo, educación preventiva y atención médica para mantenerse saludables e impedir el desarrollo del SIDA. Las personas seronegativas pueden tener acceso a consejería y educación sobre cómo permanecer VIH -. Aún cuando la gente se hace la prueba, muchos nunca regresan por sus resultados. En los lugares de pruebas que operan con fondos públicos, hasta un 33% de los pacientes que resultan VIH+ y un 25% de los negativos nunca regresan por sus resultados para saber si están infectados o no.

Autorizada por la Administración de Alimentos y Medicamentos (FDA siglas en inglés), la prueba rápida del VIH es una forma novedosa que confronta esta problemática. Las pruebas convencionales del VIH se realizan con extracciones de sangre con jeringa o tomas de muestras bucales que se envían al laboratorio para su análisis. Las personas deben regresar de 1 a 2 semanas después para obtener sus resultados. Con la prueba rápida se puede tomar la prueba, recibir consejería y obtener resultados en una sola visita. Esto puede ayudar a aumentar la cantidad de personas que se hacen la prueba y disminuir la cantidad de quienes no regresan por sus resultados.

Muchas organizaciones gubernamentales y no gubernamentales se están inclinando por el uso de la prueba rápida en lugar de la prueba convencional. El Plan Estratégico de los Centros para el Control y Prevención de las Enfermedades (CDC sus siglas en inglés) para el 2005 pretende incrementar al 95% la cantidad de personas que conocen su condición respecto al VIH, y el uso de la prueba rápida es una parte integral del plan. En California, la meta es que el 80% de los sitios financiados por el estado utilicen la prueba rápida para fines del 2006.
<h4>¿cómo se efectúa la prueba?</h4>
La prueba rápida puede hacer uso de un piquete de alfiler en el dedo, de la extracción de sangre con jeringa o de una almohadilla para obtener la muestra bucal. El técnico a cargo de la prueba coloca la muestra en un tubo de ensayo con sustancias químicas para procesarla. Los resultados se obtienen a los veinte minutos o menos. La consejería y la planeación para la reducción del riesgo con el paciente puede hacerse antes o después de obtener la muestra o durante el tiempo de espera.

En 20 minutos, la mayoría de las pruebas rápidas proporcionan ya sea resultados negativos (no hay reacción) o bien resultados positivos preliminares (sí hay reacción). En la actualidad, si el resultado preliminar es positivo, se toma una segunda muestra convencional de sangre o bucal para confirmarlo. La confirmación final sigue requiriendo de 1-2 semanas. Datos a nivel nacional indican que con la prueba rápida, el 95% de los pacientes con un resultado positivo preliminar regresaron por sus resultados confirmatorios.

En la actualidad, cuatro pruebas rápidas han sido autorizadas por la FDA en EE.UU.: Reveal, OraQuick, Multispot y Uni-Gold. Todas son extremadamente precisas, con tasas de sensibilidad de entre 99.6 y 100%. OraQuick Advance utiliza una muestra bucal y puede efectuarse en una gama más amplia de situaciones y temperaturas.

La prueba rápida puede realizarse en la mayoría de los consultorios clínicos y en muchos lugares donde se prestan servicios de salud alternativos y de promoción de la salud, como furgonetas [vans], tiendas, albergues para desamparados, baños públicos, clínicas de obstetricia y salas de urgencias. Realizar pruebas en lugares alternativos puede ayudar a incrementar este servicio entre las poblaciones móviles o difíciles de alcanzar incluyendo trabajadores migrantes, personas sin hogar, adolescentes y adultos jóvenes.
<h4>¿prueba rápida significa consejería rápida?</h4>
No. Un estudio no encontró diferencia en las tasas de enfermedades transmitidas sexualmente (ETS) al comparar la consejería de las pruebas rápidas y con la de las pruebas convencionales. La prueba rápida permite suficiente tiempo para la consejería. Un consejero tiene alrededor de 20 minutos mientras se toma la muestra y se obtiene el resultado para ofrecer una consejería enfocada y específica a los riesgos del paciente y su posible exposición al VIH. La consejería de la prueba rápida puede ser más intensa pues los resultados se obtienen de inmediato.

Las personas que reciben un resultado positivo preliminar deben regresar por sus resultados confirmatorios. Éstas podrían estar más preparadas para lidiar con su diagnóstico pues han tenido tiempo para pensar sobre su resultado positivo y quizá sean más receptivas a las recomendaciones y alternativas que se les ofrezcan.
<h4>¿puede mi organización/clínica ofrecerla?</h4>
Las organizaciones deben tomar varias cuestiones en cuenta antes de decidir utilizarla. El flujo de pacientes será diferente pues los consejeros están involucrados con cada persona durante periodos más prolongados que cuando se usa la prueba convencional. Existe una mayor responsabilidad debido a que están manipulando muestras de sangre y bucales, por lo que la mayoría de las organizaciones deben solicitar un certificado “CLIA” del gobierno, proporcionar garantías de calidad, mantener registros y generar documentos.

Si los consejeros también realizan la prueba, es posible que requieran capacitación para colectar y procesar las muestras, aplicar controles y darle seguimiento a las pruebas. También necesitarán conocer a fondo los recursos disponibles que puedan requerirse en estas nuevas sesiones de consejería que son aún más enfocadas. Al principio, los consejeros tienden a inquietarse un poco por los nuevos procedimientos de la prueba y la consejería, pero después de haber recibido capacitación y ofrecido algunas sesiones, se sienten más cómodos y reportan haber querido realizar esta prueba con anterioridad.

En algunas clínicas, es más fácil implementar la prueba rápida ya que el personal de atención médica está acostumbrados a tomar muestras, aplicar controles y tomar precauciones universales. Sin embargo el personal médico quizá no esté acostumbrado a dar consejería de la prueba del VIH y proveer referencias por lo que podría requerir capacitación para ello.
<h4>¿qué se está haciendo?</h4>
La organización Metro Atlanta Women of Color Initiative (MAWOCI) introdujo la prueba rápida, la educación preventiva y los vínculos con la atención médica para mujeres afroamericanas en lugares comunitarios como iglesias, planteles universitarios, albergues para personas sin hogar y unidades habitacionales para personas de bajos ingresos. Se capacitó al personal en cuanto a la consejería, la prueba rápida y para dar demostraciones sobre el uso del condón. Para referir más fácilmente a sus pacientes, MAWOCI ubicó recursos existentes en la zona, estableció alianzas con organizaciones que servían a mujeres de color y evaluó la capacidad de los médicos y las clínicas para atender a las personas VIH+ . Más del 99% de las mujeres regresaron para obtener sus resultados confirmatorios.

La introducción de OraQuick en lugares donde se aplicaba la prueba y se daba consejería en todo el estado de Nueva Jersey resultó en una cantidad mayor de casos de VIH previamente indiagnosticados y un aumento en la cantidad de pacientes que recibieron los resultados de sus pruebas y la consejería. En el primer año, 10,429 personas se hicieron la prueba rápida. De este grupo, el 99.7% obtuvo los resultados, comparado con un 65% que los obtuvo antes de la aplicación de la prueba rápida.

En Seattle, Washington, el Departamento de Salud Pública efectúa pruebas rápidas de manera rutinaria a personas de alto riesgo en baños públicos, sitios de intercambio de jeringas y clínicas de ETS. Ellos tomaron esta decisión después de realizar una investigación que mostró que la prueba rápida era más eficaz y más económica que otras estrategias de prueba convencionales que usaban muestras de sangre o fluidos bucales.

La organización The Night Ministry en Chicago, Illinois, ofrece la prueba rápida en autobuses para la promoción de la salud entre adultos y jóvenes sin hogar y adolescentes embarazadas y con hijos. Los autobuses cuentan con una enfermera, dos consejeros de la prueba del VIH y un ministro. Proporcionan atención médica general, servicios para la salud mental, pruebas de ETS así como café, galletas y condones. A las personas con resultados VIH+ les ofrecen tarjetas telefónicas, vales de transporte público y referencias a médicos especializados en el VIH.
<h4>¿cuál es el futuro de la prueba rápida?</h4>
El futuro es ahora. Fuera de los EE.UU., la prueba rápida se utiliza ampliamente y las pruebas confirmatorias también se hacen con una prueba rápida, eliminando el periodo de espera para las personas que resultan VIH+. Los fabricantes se han demorado en solicitar la autorización para dichas pruebas en los Estados Unidos debido a que la FDA tiene políticas muy estrictas para la concesión de permisos de nuevas pruebas para el VIH.

La prueba rápida ha sido recibida con gran entusiasmo en algunas áreas y con bastante aprehensión en otras. Conforme los gobiernos federales y estatales aumentan los requisitos para la prueba rápida; los recursos para la capacitación, la asistencia técnica y el financiamiento para las organizaciones que efectúan la prueba rápida necesitan también incrementarse. Los protocolos estatales y federales para los reembolsos, así como los seguros públicos y privados, necesitan modificarse para alentar el uso de la prueba rápida.

<hr />

<h4>¿quién lo dice?</h4>
1. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005. www.cdc.gov/hiv/partners/psp.htm (Accessed 4/20/06)

2. Kendrick SR, Kroc KA, Withum D, et al. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. Journal of AIDS. 2005;38:142-146.

3. Sullivan PS, Lansky A, Drake A. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. Journal of AIDS. 2004;35:511-518.

4. Dowling T. Outreach and prevention rapid HIV testing in non-clinical settings. Presented at the California Rapid Testing Conference. 2004.

5. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045-1051.

6. Reveal: www.reveal-hiv.com/ (Accessed 4/20/06)

OraQuick: www.abbottdiagnostics.com/Reagents_Tests/testdetail.cfm?test=oraquick (Accessed 4/20/06)

Uni-Gold: www.trinitybiotech.com/EN/index.asp (Accessed 4/20/06)

Multispot: www.bio-rad.com (Accessed 4/20/06)

7. Branson BM. Point-of-care rapid tests for HIV antibodies. Journal of Laboratory Medicine. 2003;27:288-295.

8. Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. Journal of AIDS. 2005;38:348-355.

9. Ellen JM, Bonu S, Arruda JS, et al. Comparison of clients of a mobile health van and a traditional STD clinic. Journal of AIDS. 2003;32:388-393.

10. Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sexually Transmitted Diseases. 2005;32:130-138.

11. Rapid HIV antibody testing. HIV Counselor Perspectives. 2003; 12:1-8.

12. Centers for Medicare and Medicaid Services. How to apply for a CLIA certificate, including foreign laboratories.http://www.cms.hhs.gov/CLIA/06_How_to_Apply_for_a_CLIA_Certificate,_Including_Foreign_Laboratories.asp(Accessed 4/20/06)

13. Birkhead GS, San Antonio-Gaddy ML, Richardson-Moore AL, et al. Effect of training and field experience on staff confidence and skills for rapid HIV testing in New York state. Presented at the International Conference on AIDS, Bangkok, Thailand. 2004. Abst #MoPeE4103.

14. Tao G, Branson BM, Anderson LA, et al. Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments? AIDS. 2003;17:1243-1247.

15. Thompson MA, Williams S, Williams K, et al. MAWOCI: a novel program providing transportable prevention education, rapid HIV testing, free CD4+ testing and linkage to medical care for women of color in Atlanta, GA. Presented at the 2003 National HIV Prevention Conference, Atlanta, GA. Abst #M1-G0502.

16. Cadoff EM. Rapid HIV testing increases detection rates and posttest counseling. Presented at the Annual Meeting of American College of Preventive Medicine. Feb 17, 2005. Poster 35.

17. Rapid HIV testing popular with Chicago CBO clients. AIDS Alert. February 2005.

18. Rapid testing for HIV: An issue brief. NASTAD HIV Prevention Update. September 2000.http://www.nastad.org/documents/public/pub_prevention/2001720September2000HVPreventionBulletin.pdf(Accessed 4/20/06)

<hr />

<strong>Preparado por TOM DONOHOE* y JAY FOURNIER
*UCLA/PACIFIC AIDS EDUCATION AND TRAINING CENTER</strong>
<strong>Traducción por David Sweet-Cordero</strong>

<strong>Mayo 2005. Hoja Informativa #58S</strong>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Rapid testing at the US/Mexico border</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of rapid testing for US-Mexico border and migrant populations?</h3>
<h4>why test for HIV?</h4>
Until recently, HIV rates in Mexico and among Mexican migrants in California appeared to be stable and relatively low; however, recent studies show that HIV may be expanding more aggressively in some populations, especially in border communities.<sup>1</sup> One study of 374 young Latino men who have sex with men (MSM) in the San Diego/Tijuana region found high rates of HIV: 19% in Tijuana and 35% in San Diego.<sup>2</sup> Another study of 1,068 pregnant women in labor in Tijuana found a 1.12% HIV rate.<sup>3</sup> Yet a study of 1,041 Mexican migrants at border crossing locations in Tijuana found a 0% HIV rate.<sup>4</sup>

Getting tested for HIV is key to preventing the spread of HIV. Persons who test HIV+ can access counseling, prevention education, support services and medical care to stay healthy and not progress to AIDS. HIV- persons can access counseling and education to remain HIV-. It is estimated that 31% of all HIV+ persons in the US do not know they’re infected.<sup>5</sup>

Border and migrant populations may be at great risk for HIV yet they are less likely to be tested for HIV or return for test results. Many do not have access to (or fear accessing) traditional healthcare systems, lack transportation and frequently change address.<sup>6</sup>
<h4>why rapid testing?</h4>
Even when people are able to test for HIV, many never return for their results. In public test sites, up to 33% of persons who test HIV- and 25% of persons who test HIV+ never return for their results.<sup>7</sup> This may be especially true for border and migrant populations because they may not have stable housing or legal status in the US.

The rapid HIV test is a new approach to HIV testing that helps address many of these issues. Conventional HIV testing has been done with needle blood draws or mouth swabs which are sent to a laboratory for analysis. Clients need to return to the test site 1-2 weeks later to find out their results. With rapid tests, clients can take the test, receive counseling, and find out their results all in one visit. This can help increase the number of persons who take an HIV test and reduce the number of persons who don’t return for their results.<sup>8</sup>

Rapid testing can be done in most clinics and in non-traditional healthcare and outreach settings such as mobile vans, bars, parks and health fairs. One study of seasonal farmworkers found that men and women were more likely to accept a free HIV test if it used a finger stick and they could get results in 30 minutes.<sup>9</sup>

Many government and non-governmental agencies are moving towards rapid testing instead of conventional testing. The Centers for Disease Control and Prevention’s (CDC) Strategic Plan for 2005 seeks to increase the number of people who know their HIV status to 95%—using rapid testing is an integral part of the plan.3 In California, the goal is to have 80% of all state-funded HIV test sites use rapid tests by the end of 2006.<sup>10</sup>
<h4>how is it done?</h4>
Rapid testing uses a finger stick, blood draw or mouth swab to collect samples. The test counselor places the sample in a tube with chemicals to process it, and can read the results in 20 minutes or less. Counseling and risk reduction planning with the client can take place during the waiting time, or can be done before or after sample collection.

There are four FDA-approved rapid HIV tests in the US: Reveal, OraQuick, Multispot and Uni-Gold.<sup>11</sup> All tests are extremely accurate, with 99.6-100% sensitivity rates.<sup>12</sup> OraQuick Advance uses a mouth swab and can be used in a wider range of settings and temperatures.

Rapid testing can change the way HIV testing is done. Most HIV test sites currently have counselors and separate phelobotomists who take the blood or oral sample. With rapid testing, the test counselor can also take the sample and analyze it, becoming counselor, technician and laboratory all in one. In some sites, test counselors do the consent and counseling and a separate staff person still collects the sample and reads the results.<sup>13</sup>

Within 20 minutes, the OraQuick Rapid test will either be non-reactive—a negative test result—or reactive—a preliminary positive result. Currently, if a result shows preliminary positive, a second conventional blood or oral sample is required to confirm it. Final confirmation still takes 1-2 weeks. National data indicate that with rapid testing, 95% of clients who received a preliminary positive result returned for their confirmatory results.
<h4>is rapid testing rapid counseling?</h4>
No. One study found no difference in STD rates after counseling with rapid tests and conventional tests.<sup>14</sup> Rapid testing still allows for plenty of counseling time. A counselor has about 20 minutes between taking a sample and receiving the results to provide focused and specific counseling about the client’s risks and possible exposure to HIV. Counseling can be more intense due to the immediacy of hearing results.<sup>15</sup>

Clients who receive a preliminary positive result and must return for their confirmation result may be more prepared to deal with their diagnosis. Clients often have had a week to think about what testing positive means and may be more emotionally prepared to listen to and digest referrals and options the counselors can provide.

Test counselors need in-depth knowledge of referral resources for client’s that may emerge in new, more focused HIV counseling sessions. Referrals should be specifically tailored to the needs of border and migrant populations, including basic needs such as healthcare, housing, legal assistance and jobs. Materials should be available in Spanish and counselors should have culturally-relevant knowledge and training in migrant and immigrant issues. Because many persons travel back and forth between the US and Mexico, referrals may need to focus on resources in both countries.

Counselors typically may have concerns about the new testing procedures and counseling initially, but after they’ve been trained and have provided a number of counseling sessions, they become more comfortable and often say they wished they had become involved in HIV rapid testing sooner.<sup>16</sup>
<h4>what’s being done?</h4>
Rapid testing is relatively new in most border settings. A 2003 survey of 85 border health centers (community and migrant health centers, tribal organizations and programs for homeless people, among others) found that 64 (75%) offered HIV testing. Of these, 45 also provided HIV medication and counseling services. None of the sites in any state offered rapid HIV testing.<sup>17</sup>

Currently, San Diego County offers rapid testing, prevention education and linkage to medical care along the Mexico/California border in various settings such as churches, homeless shelters, parks and beaches. Staff members underwent additional training on rapid testing and single-session HIV counseling. Since offering rapid testing at all anonymous test sites, client return rates have increased from 72% to 93%.<sup>18</sup>

La Fe CARE Center in El Paso, TX, offers rapid testing at their clinic and through a mobile van that visits gay bars, nightclubs and adult bookstores downtown. The mobile van has two counselors and uses the OraQuick Advanced mouth swab HIV test. The clinic uses the OraQuick finger stick HIV test. Clients prefer getting results quickly and not having a blood draw. Since offering rapid testing, the number of clients testing at La Fe has increased from 500 in 2002 to over 2000 currently.<sup>19</sup>
<h4>what is the future of rapid testing?</h4>
The future is now. Outside of the US, rapid testing is widely used and confirmatory tests are also done with rapid test, eliminating any waiting period for persons who test HIV+. Manufacturers have been slow to seek approval for tests in the US because the FDA has strict policies about licensing new HIV tests.

Rapid testing has been met with great enthusiasm in some areas and great trepidation in others. As federal and state governments increase requirements for rapid testing, resources for training, technical assistance and funding need to increase for the agencies that implement rapid testing. State and federal reimbursement protocols, as well as public and private insurance, need to be changed to encourage rapid testing.

It is not enough simply to offer HIV testing to Mexican and other immigrants. Persons who test positive will need quality HIV care and treatment, and persons at risk for HIV will need culturally specific education and prevention programs. Because many persons travel back and forth between the US and Mexico, bi-national cooperation is key in addressing these issues to improve public health in both countries.

<hr />

<h3>Says who?</h3>
1. Sanchez MA, Lemp GF, Magis-Rodriguez C, et al. The epidemiology of HIV among Mexican migrants and recent immigrants in California and Mexico. Journal of Acquired Immune Deficiency Syndromes. 2004;37:S204-S214.

2. Ruiz, JD. HIV prevalence, risk behaviors and access to care among young Latino MSM in San Diego, California and Tijuana, Mexico. Presented at the Binational Conference on HIV AIDS. Oakland, CA. 2002.

3. Viani RM, Araneta MR, Ruiz-Calderon J, et al. HIV-1 infection in a cohort of pregnant women in Baja California, Mexico: evidence of an emerging crisis? Presented at the International Conference on AIDS, Bangkok, Thailand. 2004. Abst #ThPeC7301.

4. Martinez-Donate AP, Rangell MG, Hovell MF, et al. HIV infection in mobile populations: the case of Mexican migrants to the US. Revista Panamaña de Salud Publica. 2005;17:26-29.

5. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005. www.cdc.gov/hiv/partners/psp.htm

6. Solorio MR, Currier J, Cunningham W. HIV health care services for Mexican migrants. Journal of Acquired Immune Deficiency Syndromes. 2004;37:S240-S251.

7. Kendrick SR, Kroc KA, Withum D, et al. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. Journal of AIDS. 2005;38:142-146.

8. Sullivan PS, Lansky A, Drake A. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. Journal of AIDS. 2004;35:511-518.

9. Fernandez MI, Collazo JB, Bowen GS, et al. Predictors of HIV testing and intention to test among Hispanic farmworkers in South Florida. Journal of Rural Health. 2005;2:56-64.

10. Dowling T. Outreach and prevention rapid HIV testing in non-clinical settings. Presented at the Rapid Testing Conference, California 2004.

11. Reveal: www.reveal-hiv.com/

OraQuick: www.abbottdiagnostics.com/Reagents_Tests/testdetail.cfm?test=oraquick

Uni-Gold:ww.trinitybiotech.com/EN/index.asp

Multispot: www.bio-rad.com

12. Branson BM. Point-of-care rapid tests for HIV antibodies. Journal of Laboratory Medicine. 2003;27:288-295.

13. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045-1051.

14. Metcalf CA, Douglas JM, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sexually Transmitted Diseases. 2005;32:130-138.

15. Rapid HIV antibody testing. HIV Counselor Perspectives. 2003;12:1-8.

16. Birkhead GS, San Antonio-Gaddy ML, Richardson-Moore AL, et al. Effect of training and field experience on staff confidence and skills for rapid HIV testing in New York state. Presented at the International Conference on AIDS, Bangkok, Thailand. 2004. Abst #MoPeE4103.

17. Donohoe TJ, Ribo A. Border “330″ clinics: a preliminary report on survey data and an inventory &amp; summary of HIV border services. Needs Assessment Report of Pacific AIDS Education and Training Center and Texas/ Oklahoma AIDS Education and Training Center. July 2003.

18. HIV, STD and Hepatitis Branch, San Diego County, CA. (619) 296-2120

19. La Fe CARE Center, El Paso, TX. (915) 534-7979

20. Rapid testing for HIV: an issue brief. NASTAD HIV Prevention Update. September 2000.

<hr />

<strong>PREPARED BY Tom Donohoe* and Jay Fournier
*UCLA/Pacific AIDS Education and Training Center</strong>

<strong>May 2005 . Fact Sheet #S58E</strong>

Special thanks to the following reviewers of this Fact Sheet: Denise Escandon Borntrager, Hector Carrillo, Carol Galper, Maria Teresa Hernández, Steve Trujillo, Rebecca Ramos, Octavio Vallejo, Rolando Viani.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@.ucsf.edu. © May 2005, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/borderrapidtestingFS.pdf</url>
	</node>
	<node>
		<title>Prueba rápida a la frontera</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el papel de las pruebas rápidas para la frontera EE.UU.- México y las poblaciones migrantes?</h3>
<h4>¿por qué hacer pruebas del VIH?</h4>
Hasta hace poco, las tasas de infección por VIH en México y entre los migrantes mexicanos en California parecían estables y relativamente bajas. Sin embargo, investigaciones recientes demuestran que el VIH podría estarse extendiendo más agresivamente en algunas poblaciones, especialmente en las comunidades fronterizas.<sup>1</sup> Un estudio entre 374 hombres latinos jóvenes que tienen sexo con hombres (HSH) de San Diego-Tijuana encontró tasas elevadas de VIH: 19% en Tijuana y 35% en San Diego.<sup>2</sup> Otro estudio en Tijuana con 1,068 mujeres embarazadas en trabajo de parto encontró una tasa de infección del 1.12%.<sup>3</sup> Sin embargo, otro estudio efectuado entre 1,041 migrantes mexicanos en puntos de cruce fronterizo en Tijuana encontró tasas de infección por VIH de 0%.<sup>4</sup>

Las pruebas del VIH son clave para prevenir el VIH. Las personas VIH+ pueden recibir consejería, servicios de educación preventiva y apoyo, y atención médica para mantenerse saludables e impedir el desarrollo del SIDA. Las personas VIH- pueden tener acceso a consejería y educación para permanecer seronegativos. El 31% de las personas VIH+ en EE.UU. ignoran que están infectadas.<sup>5</sup>

Las poblaciones fronterizas y migrantes pueden enfrentar un mayor riesgo de infección por VIH, pero tienen menor probabilidad de hacerse una prueba o regresar por sus resultados. Muchos no tienen acceso o tienen miedo de acceder los sistemas tradicionales de salud, no cuentan con medios de transporte y cambian de domicilio frecuentemente.<sup>6</sup>
<h4>¿por qué se recomienda la prueba rápida?</h4>
Aun cuando las personas pueden hacerse la prueba del VIH, muchos nunca regresan por sus resultados. En los lugares de pruebas que operan con fondos públicos, hasta el 33% de las personas que resultan VIH+ y un 25% de las que resultan VIH- nunca recogen sus resultados.<sup>7</sup> Esto podría ser especialmente cierto para las poblaciones fronterizas y migrantes pues no cuentan con vivienda estable ni permiso legal para permanecer en EE.UU.

La prueba rápida del VIH es una forma novedosa que confronta esta problemática. Las pruebas convencionales del VIH se realizan con extracciones de sangre con jeringa o tomas de muestras bucales que se envían al laboratorio para su análisis. Las personas deben regresar de 1 a 2 semanas después por sus resultados. Con la prueba rápida se puede tomar la prueba, recibir consejería y obtener resultados en una sola visita. Esto puede ayudar a aumentar la cantidad de personas que se hacen la prueba y disminuir la cantidad de quienes no regresan por sus resultados.<sup>8</sup>

Las pruebas rápidas se pueden hacer en la mayoría de las clínicas y en lugares alternativos de atención y promoción para la salud como furgonetas [vans], bares, parques y ferias de la salud. Un estudio entre trabajadores agrícolas temporaleros encontró que era más probable que los hombres y las mujeres aceptaran hacerse gratuitamente la prueba del VIH si se utilizaba un piquete de alfiler en el dedo y podían obtener sus resultados en 30 minutos.<sup>9</sup>

Muchas organizaciones gubernamentales y no gubernamentales se están inclinando por el uso de la prueba rápida en lugar de la prueba convencional. El Plan Estratégico de los CDC para el 2005 pretende incrementar al 95% la cantidad de personas que conocen su condición respecto al VIH, y el uso de la prueba rápida es una parte integral del plan.5 En California, la meta es que el 80% de los sitios financiados por el estado utilicen la prueba rápida para fines del 2006.<sup>10</sup>
<h4>¿cómo se efectúa la prueba?</h4>
La prueba rápida puede hacer uso de un piquete de alfiler en el dedo, de la extracción de sangre con jeringa o de una almohadilla para obtener la muestra bucal. El técnico a cargo de la prueba coloca la muestra en un tubo de ensayo con sustancias químicas para procesarla. Los resultados se obtienen en 20 minutos o menos. La consejería y la planeación para la reducción del riesgo con el paciente puede hacerse antes o después de obtener la muestra o durante el tiempo de espera.

En la actualidad, cuatro pruebas rápidas han sido autorizadas por la FDA en EE.UU.: Reveal, OraQuick, Multispot y Uni-Gold.<sup>11</sup> Todas son extremadamente precisas, con tasas de sensibilidad de entre 99.6 y 100%.<sup>12</sup> OraQuick Advance utiliza una muestra bucal y puede efectuarse en una gama más amplia de situaciones y temperaturas.

En 20 minutos, la mayoría de las pruebas rápidas proporcionan ya sea resultados negativos (no hay reacción) o bien resultados positivos preliminares (sí hay reacción). Si el resultado preliminar es positivo, se toma una segunda muestra convencional para confirmarlo. La confirmación final sigue requiriendo de 1-2 semanas. Datos a nivel nacional indican que con la prueba rápida, el 95% de los pacientes con un resultado positivo preliminar regresaron por sus resultados confirmatorios.<sup>13</sup>
<h4>¿la prueba rápida significa consejería rápida?</h4>
No. Un estudio no encontró diferencia en las tasas de enfermedades transmitidas sexualmente (ETS) al comparar la consejería de las pruebas rápidas y con la de las pruebas convencionales.<sup>14</sup> La prueba rápida permite suficiente tiempo para la consejería. Un consejero tiene alrededor de 20 minutos mientras se toma la muestra y se obtiene el resultado para ofrecer una consejería enfocada y específica a los riesgos del paciente y su posible exposición al VIH. La consejería de la prueba rápida puede ser más intensa pues los resultados se obtienen de inmediato.<sup>15</sup> Las personas que reciben un resultado positivo preliminar deben regresar por sus resultados confirmatorios. Estas podrían estar más preparadas para lidiar con su diagnóstico pues han tenido tiempo para pensar sobre su resultado positivo y quizá sean más receptivas a las recomendaciones y alternativas que se les ofrezcan.

Los consejeros necesitarán conocer a fondo las referencias a los recursos disponibles que estas sesiones más enfocadas puedan requerir. Dichas referencias deben ser específicas a las poblaciones fronterizas y migrantes, incluyendo las necesidades básicas como atención médica, vivienda, consejería jurídica y empleo. Se debe disponer de materiales impresos en español y los consejeros tener conocimiento y capacitación culturalmente relevante a la problemática de la migración e inmigración. Ya que muchas personas viajan entre EE.UU. y México, las referencias deben considerar recursos en ambos países.

Al principio, los consejeros tienden a inquietarse un poco por los nuevos procedimientos de la prueba y la consejería, pero después de haber recibido capacitación y ofrecido una serie de sesiones de consejería, se sienten más cómodos y reportan haber querido realizar esta prueba con anterioridad.<sup>16</sup>
<h4>¿qué se está haciendo?</h4>
La prueba rápida es algo relativamente nuevo en las zonas fronterizas. Una encuesta realizada en el 2003 entre 85 centros fronterizos de salud (centros de salud comunitarios y para migrantes, organizaciones de tribus indígenas y programas para personas desamparadas, entre otros) encontró que 64 centros (o sea, el 75%) realizaban la prueba del VIH. De estos, 45 también ofrecían medicamentos para el VIH y servicios de consejería. Ningún sitio en ningún estado fronterizo ofrecía la prueba rápida del VIH.<sup>17</sup>

En la actualidad, el condado de San Diego ofrece la prueba rápida, educación para la prevención y servicios de enlace con atención médica en varios lugares, como iglesias, albergues, parques y playas, a lo largo de la frontera entre México y California. Desde que comenzó a ofrecerse la prueba rápida en todos los sitios donde se hacía la prueba en forma anónima, la tasa de retorno de los pacientes aumentó del 72% al 93%.<sup>18</sup>

La FE CARE Center en El Paso, Texas, ofrece la prueba rápida en su clínica y a través de una camioneta que visita bares y centro nocturnos para gente gay y librerías para adultos en la zona centro. El vehículo tiene dos consejeros y utiliza la prueba rápida oral “OraQuick Advanced” para detectar el VIH. En clínica utilizan la prueba OraQuick de piquete en el dedo. Las personas prefieren obtener sus resultados rápidamente sin que se les extraiga sangre con una jeringa. Desde que se comenzó a ofrecer la prueba rápida, la cantidad de personas que se hacen la prueba en La Fe ha aumentado de 500 en 2002 a más de 2,000 en la actualidad.<sup>19</sup>
<h4>¿cuál es el futuro de la prueba rápida?</h4>
El futuro es ahora. Fuera de los EE.UU., la prueba rápida se utiliza ampliamente y las pruebas confirmatorias también se hacen con una prueba rápida, eliminado el periodo de espera para quienes que resultan VIH+. Los fabricantes se han demorado en solicitar la autorización para dichas pruebas en EE.UU. ya que la FDA tiene políticas muy estrictas. La prueba rápida ha sido recibida con gran entusiasmo en algunas áreas y con bastante aprehensión en otras. Conforme los gobiernos federales y estatales aumentan sus requisitos para la aplicación de esta prueba, los recursos para la capacitación, la asistencia técnica y el financiamiento para las organizaciones necesitan incrementarse para poder incentivar su uso.

No basta con simplemente ofrecer la prueba rápida para el VIH a los inmigrantes mexicanos y de otras procedencias. La prueba rápida puede facilitar un mejor monitoreo epidemiológico del VIH en las poblaciones migrantes y fronterizas, ofreciendo una perspectiva más clara de la magnitud de esta infección. Las personas con resultados VIH+ necesitarán atención médica y tratamientos de alta calidad; y las personas en riesgo de contraer el VIH necesitarán acudir a programas de educación y prevención que sean culturalmente específicos. Ya que muchas personas viajan entre EE.UU. y México, la cooperación binacional indispensable para abordar esta problemática y mejorar la salud pública en ambos países.

<hr />

<h4>¿quién lo dice?</h4>
1. Sanchez MA, Lemp GF, Magis-Rodriguez C, et al. The epidemiology of HIV among Mexican migrants and recent immigrants in California and Mexico. Journal of Acquired Immune Deficiency Syndromes. 2004;37:S204-S214.

2. Ruiz, JD. HIV prevalence, risk behaviors and access to care among young Latino MSM in San Diego, California and Tijuana, Mexico. Presented at the Binational Conference on HIV AIDS. Oakland, CA. 2002.

3. Viani RM, Araneta MR, Ruiz-Calderon J, et al. HIV-1 infection in a cohort of pregnant women in Baja California, Mexico: evidence of an emerging crisis? Presented at the International Conference on AIDS, Bangkok, Thailand. 2004. Abst #ThPeC7301.

4. Martinez-Donate AP, Rangell MG, Hovell MF et al. HIV infection in mobile populations: the case of Mexican migrants to the US. Revista Panamaña de Salud Publica. 2005;17:26-29.

5. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005. www.cdc.gov/hiv/partners/psp.htm

6. Solorio MR, Currier J, Cunningham W. HIV health care services for Mexican migrants. Journal of Acquired Immune Deficiency Syndromes. 2004;37:S240-S251.

7. Kendrick SR, Kroc KA, Withum D et al. Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. Journal of AIDS. 2005;38:142-146.

8. Sullivan PS, Lansky A, Drake A. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. Journal of AIDS. 2004;35:511-518.

9. Fernandez MI, Collazo JB, Bowen GS et al. Predictors of HIV testing and intention to test among Hispanic farmworkers in South Florida. Journal of Rural Health. 2005;2:56-64.

10. Dowling T. Outreach and prevention rapid HIV testing in non-clinical settings. Presented at the Rapid Testing Conference, California 2004.

11. Reveal: www.reveal-hiv.com/

OraQuick: www.abbottdiagnostics.com/Reagents_Tests/testdetail.cfm?test=oraquick

Uni-Gold:ww.trinitybiotech.com/EN/index.asp

Multispot: www.bio-rad.com

12. Branson BM. Point-of-care rapid tests for HIV antibodies. Journal of Laboratory Medicine. 2003;27:288-295.

13. Kassler WJ, Dillon BA, Haley C, et al. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045-1051.

14. Metcalf CA, Douglas JM, Malotte CK et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sexually Transmitted Diseases. 2005;32:130-138.

15. Rapid HIV antibody testing. HIV Counselor Perspectives. 2003;12:1-8.

16. Birkhead GS, San Antonio-Gaddy ML, Richardson-Moore AL, et al. Effect of training and field experience on staff confidence and skills for rapid HIV testing in New York state. Presented at the International Conference on AIDS, Bangkok, Thailand. 2004. Abst #MoPeE4103.

17. Donohoe TJ, Ribo A. Border “330″ clinics: a preliminary report on survey data and an inventory &amp; summary of HIV border services. Needs Assessment Report of Pacific AIDS Education and Training Center and Texas/ Oklahoma AIDS Education and Training Center. July 2003.

18. HIV, STD and Hepatitis Branch, San Diego County, CA. (619) 296-2120

19. La Fe CARE Center, El Paso, TX. (915) 534-7979

20. Rapid testing for HIV: an issue brief. NASTAD HIV Prevention Update. September 2000.

<hr />

<strong>Preparado por Tom Donohoe* y Jay Fournier
*UCLA/Pacific AIDS Education and Training Center. Traducción David Sweet-Cordero</strong>

<strong>Mayo 2005. Hoja Informativa #S58S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/rapidafronteraFS.pdf</url>
	</node>
	<node>
		<title>Mujeres negras</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan las mujeres negras para evitar el VIH?</h3>
<h4>¿Afecta el VIH a las mujeres negras?</h4>
Sí. Desde el inicio de la epidemia, el VIH ha azotado a los hombres y mujeres negros radicados en EE.UU. A pesar de componer sólo el 12% de la población femenina del país, en el 2006 las mujeres negras representaban el 61% de los casos nuevos entre mujeres.<sup>1</sup> Se diagnostica el VIH a mujeres negras con 15 veces más frecuencia que a mujeres caucásicas.<sup>1</sup>

Las mujeres negras también tienen altas tasas de infecciones transmitidas sexualmente (ITS), lo cual puede promover la transmisión del VIH. En el 2006, la tasa de clamidia entre mujeres negras era 7 veces mayor, la de gonorrea 14 veces mayor y la de sífilis 16 veces mayor que entre mujeres caucásicas.<sup>2</sup>

Estas cifras y estadísticas no terminan de revelar toda la riqueza y diversidad de las vidas de las mujeres negras, un grupo que abarca a oficinistas y obreras, cristianas y musulmanas, habitantes de áreas urbanas y de suburbios, descendientes de esclavos e inmigrantes caribeñas recién llegadas. Ellas trabajan, estudian, crían a sus familias, se enamoran. El VIH entre las mujeres negras no se debe exclusivamente a su conducta individual, sino a un sistema complejo de aspectos sociales, culturales, económicos, geográficos, religiosos y políticos los cuales se entrelazan para afectar a su salud.<sup>3</sup>
<h4>¿Cuáles de ellas corren riesgo de contraer el VIH?</h4>
Los principales factores de riesgo de contraer el VIH son: tener otra ITS que no sea el VIH, no protegerse durante las relaciones sexuales vaginales o anales con una persona VIH positiva e inyectarse drogas con equipos previamente usados por una persona VIH+. Otro riesgo es ignorar los riesgos de su pareja, por ejemplo, si él usa drogas inyectables o tiene otras parejas sexuales concurrentes, y desconocer su condición de VIH. De las mujeres negras infectadas por VIH en el 2005, el 80% se contagiaron por contacto heterosexual y él 18% por inyección de drogas.<sup>4</sup>

Las mujeres jóvenes y las adolescentes resultan excesivamente afectadas. En el 2004, el VIH fue la primera causa de muertes en mujeres negras de 25-34 años de edad.<sup>5</sup> Las adolescentes (13-19 años de edad) negras componían el 69% de los nuevos casos de SIDA en el 2006, mientras que su proporción de la población general de adolescentes en EE.UU. apenas alcanza el 16%.<sup>6</sup>
<h4>¿Qué aspectos influyen en el riesgo de contraer el VIH?</h4>
Al protegerse durante el sexo, muchas mujeres se preocupan más por evitar el embarazo que el VIH/ITS, y son menos propensas a combinar dos métodos de protección (por ejemplo: la pastilla anticonceptiva junto con el condón). Más jóvenes negras que caucásicas usan anticonceptivos implantados o inyectables (el parche, Norplant), por lo que es menos probable que usen condones los cuales las protegerían contra el VIH.<sup>7</sup> También es más común que las mujeres negras, especialmente las que viven en zonas de bajos ingresos, recurran a la esterilización para controlar la natalidad.<sup>8</sup>

La prevención del VIH muchas veces pasa a segundo plano para las mujeres que luchan para conseguir trabajo, alimentos, vivienda o cuidado infantil. La mayoría de los casos de VIH/SIDA en mujeres negras ocurren en los cascos urbanos y áreas rurales, donde abunda la pobreza y escasean empleos y vivienda.<sup>9</sup> Estas mujeres son más propensas a quedarse sin vivienda, tener sexo a cambio de dinero o alojamiento, consumir drogas (heroína, cocaína crack) y alcohol, depender de un hombre para su sustento y sufrir violencia o trauma. Todas estas condiciones minan la capacidad de la mujer para rechazar el sexo, usar condón y limpiar jeringas al inyectarse para protegerse contra el VIH.

Otro factor que aumenta el riesgo de contraer el VIH es la alta proporción de hombres afroamericanos encarcelados, lo cual merma su presencia en la comunidad desestabilizando así a las parejas y promoviendo la formación de relaciones de pareja concurrentes de mayor riesgo (tener más de una pareja sexual durante cierto tiempo y alternar entre una y otra pareja).<sup>10</sup>

La proporción de hombres en relación con mujeres es mucho menor entre afroamericanos que cualquier otro grupo étnico en EE.UU. El gran número de hombres negros muertos por enfermedades y actos de violencia así como encarcelados genera muchas secuelas en la comunidad, entre ellas el reducido número de candidatos a parejas. Esto lleva a que algunas mujeres con conductas de bajo riesgo se emparejen con hombres cuya conducta es de alto riesgo.<sup>3</sup>
<h4>¿Estarán enteradas las mujeres negras del riesgo que corren?</h4>
Al hacerse la prueba del VIH muchas mujeres negras responden que su categoría de transmisión es ninguna o desconocida, por lo que se ha inferido que ellas desconocen su riesgo de contraer el VIH. En comunidades negras existe una historia de relaciones sociales entre personas de alto riesgo y otras de menor riesgo,<sup>11</sup> lo cual aumenta sus posibilidades de conocer y salir con una pareja con antecedentes riesgosos. Al contrario, es posible que aun conociendo los riesgos, las mujeres negras los acepten más debido a este entretejimiento social.

Las mujeres negras reconocen el riesgo que corren, según lo evidencia la proporción de pruebas de VIH entre ellas en comparación con cualquier otro grupo racial. Casi los dos tercios (el 65%) de las mujeres negras de 15-44 años de edad se han hecho la prueba del VIH alguna vez, y dos veces más se sometieron a la prueba durante los últimos 12 meses que mujeres caucásicas (el 25% en comparación con el 13%).<sup>12</sup>

Debido a las tasas descomunales de ITS y VIH en su comunidad, los hombres y mujeres negros corren un riesgo mucho mayor de tener contacto con una persona infectada en comparación con otros grupos. Esto significa que aunque las mujeres negras practiquen menos conductas riesgosas que las mujeres caucásicas,<sup>3</sup> tienen que hacer mucho más que otras mujeres para lograr protegerse.<sup>3</sup>
<h4>¿Qué se está haciendo al respecto?</h4>
Once intervenciones han sido aprobadas por el CDC para mujeres y adolescentes negras en categoría de mejor o prometedora evidencia o forman parte del proyecto DEBI (Diffusion of Effective Behavioral Interventions).<sup>13</sup> Otras organizaciones a lo largo de EE.UU. también brindan servicios innovadores de prevención del VIH con y para mujeres negras y enfocados en la mujer íntegra como parte de una comunidad, sin limitarse únicamente a su conducta sexual o consumo de drogas.

Es importante apoyar a mujeres con parejas encarceladas. HOME (Health Options Mean Empowerment) capacitó a mujeres cuyas parejas masculinas estaban a punto de salir de la prisión estatal, capacitándolas para orientar a otras mujeres que visitaban a reclusos y también en la comunidad. HOME ofreció almuerzos grupales para mujeres mientras esperaban en la prisión antes de entrar a visitar a sus parejas; pláticas sobre la salud general (temas: diabetes, presión arterial, obesidad, dejar de fumar); la salud sexual–pláticas sobre el VIH/ITS; ferias de salud; y remisión a servicios en la comunidad y de apoyo para mujeres que visitan a sus compañeros encarcelados. Las participantes reportaron menos contactos sexuales sin protección, más pruebas de VIH y mejor comunicación con sus parejas sobre temas relacionados con el VIH.<sup>14</sup>

Un reciente ensayo grande implementado en varios lugares describió un programa para parejas afroamericanas VIH serodiscordantes, el Eban HIV/STD Risk Reduction Intervention, que ofrece 8 sesiones semanales de 2 horas para comentar los factores individuales, interpersonales y comunitarios que contribuyen en varios niveles a las conductas de riesgo del VIH. Cuatro sesiones se dedican a la comunicación, resolución de problemas y toma de decisiones sobre mayor protección durante el sexo dentro de la pareja. Las cuatro reuniones restantes abarcan cómo cambiar actitudes y normas entre pares, cómo eliminar el estigma de ser una pareja serodiscordante y cómo ampliar los apoyos para parejas en la comunidad.<sup>15</sup>

Para llegar a las mujeres negras en sus propias comunidades, muchas intervenciones de prevención del VIH se han ubicado en salones de belleza y de estética, que brindan un ambiente de confianza en donde recibir condones e información sobre el VIH. En el condado de Durham, NC, Project StraightTalk ha capacitado desde 1988 a peluqueros y esteticistas a informar a sus clientes sobre las ITS/VIH. El proyecto ofrece capacitaciones anuales, regala condones y materiales educativos a cada salón dos veces por mes y produce carteles individualizados para los salones.<sup>16</sup>
<h4>¿Qué queda por hacer?</h4>
El VIH seguirá azotando a la comunidad afroamericana a menos que los esfuerzos de prevención y atención se combinen con otros con el fin de eliminar las causas subyacentes de la enfermedad.<sup>3</sup> Las niñas, adolescentes y mujeres negras necesitan apoyos en su entorno social que les permitan desarrollar relaciones, familias, vecindarios y comunidades más fuertes y reducir su riesgo de contraer el VIH y otras enfermedades. Los programas de prevención del VIH destinados a sus compañeros pueden beneficiar tanto a las mujeres como a los hombres.

Las mujeres negras deben crear y dirigir programas eficaces de prevención del VIH que incluyan capacitación laboral, consejería para parejas, bancos de alimentos, asistencia de vivienda, servicios de salud mental, tratamiento de abuso de alcohol y drogas, y servicios familiares. El gobierno y otros organismos de subvención necesitan entender que todos estos aspectos forman parte íntegra de la prevención del VIH y por tanto deben ser subvencionados como tal.

<hr />

<h3>¿Quién lo dice?</h3>
1. CDC. Subpopulation Estimates from the HIV Incidence Surveillance System—United States, 2006. Morbidity and Mortality Weekly Report. 2008;57;985-989.

2. CDC. Sexually Transmitted Disease Surveillance, 2006. November 2007.

3. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372:337-340.

4. Rose MA, Telfair Sharpe T, Raleigh K, et al. An HIV/AIDS crisis among African American women: A summary for prevention and care in the 21st century. Journal of Women’s Health. 2008;17:321-324.

5. HIV/AIDS among women. Fact sheet prepared by the CDC. August 2008.

6. Black Americans and HIV/AIDS. Fact sheet by the Kaiser Family Foundation. October 2008.

7. Abma JC, Martinez GM, Mosher WD, et al. Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2002. Vital and Health Statistics. 2004;23.

8. Mosher WD, Deang LP, Bramlett MD. Community environment and women’s health outcomes: Contextual data. Vital and Health Statistics. 2003;23.

9. Fullilove RE. African Americans, health disparities and HIV/AIDS. Report prepared by the National Minority AIDS Council. November 2006.

10. Harawa N, Adimora A. Incarceration, African Americans and HIV: advancing a research agenda. Journal of the National Medical Association. 2008;100:57-62.

11. Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the Southern United States: sexual networks and social context.Sexually Transmitted Diseases. 2006;33:S39-S45.

12. Anderson JE, Chandra A, Mosher WD. HIV Testing in the United States, 2002. Advance Data for Vital and Health Statistics. 2005;363:16.

13. Centers for Disease Control and Prevention. Updated Compendium of Evidence-Based Interventions, 2007.

14. Grinstead O, Comfort M, McCartney K, et al. Bringing it home: design and implementation of an HIV/STD intervention for women visiting incarcerated men. AIDS Education and Prevention. 2008;20:285-300.

15. NIMH Multisite HIV/STD Prevention Trial for African American Couples Group. Eban HIV/STD Risk Reduction Intervention: Conceptual basis and procedures. Journal of AIDS. 2008;49:S15–S27.

16. Lewis YR, Shain L, Crouse Quinn S, et al. Building community trust: lessons from an STD/HIV peer educator program with African American barbers and beauticians. Health Promotion Practice. 2002;3:133-143.

<hr />

Una publicación del Centro de Estudios para la Prevención del SIDA (CAPS) y el Instituto de Investigaciones sobre SIDA (ARI), Universidad de California en San Francisco (UCSF). Se autoriza la reproducción (citando a UCSF) más no la venta de copias este documento. También disponibles en inglés. Para recibir las Hojas de Datos por correo electrónico escriba a listserv@listserv.ucsf.edu con el mensaje “subscribe CAPSFS nombre apellido” ©UCSF 2010]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/MujeresNegrasFS.pdf</url>
	</node>
	<node>
		<title>Mother-to-child transmission (MTCT)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Is Mother-to-Child HIV Transmission Preventable?</h3>
<strong>Prepared by Sarah A. Gutin, MPH*
*CAPS, Community Health Systems- School of Nursing, UCSF</strong>

<strong>Fact Sheet #34ER – September 2015</strong>

Special thanks to the following reviewers of this Fact Sheet: Yvette Cuca, Carol Dawson Rose, Shannon Weber

In 2012, there were 2.3 million new HIV infections globally<sup>1</sup>. A large proportion of people newly diagnosed with HIV worldwide are in their reproductive years and these men and women are likely to want children in the future<sup>2-4</sup>. Addressing the sexual and reproductive health and rights of this population is critical to addressing the spread of HIV because HIV infection in childbearing women is the main cause of HIV infection in children<sup>5</sup>. Treatment for those who are already infected is also central to stopping the spread of HIV to infants and to uninfected sexual partners.

<strong>How does transmission occur?</strong>

Perinatal transmission of HIV, also called vertical transmission, occurs when HIV is passed from an HIV-positive woman to her baby during pregnancy, labor and delivery or breastfeeding. For an HIV-positive woman not taking HIV medications, the chance of passing the virus to her child ranges from about 15 to 45% during pregnancy, labor and delivery. If she breastfeeds her infant, there is an additional 35 to 40% chance of transmission<sup>6</sup>.

<strong>Is the risk of perinatal transmission always the same?</strong>

No. Global societal and economic inequities create a wide gap between women in developing nations and women in developed nations with regard to HIV prevention, voluntary counseling and testing and access to drugs which treat HIV infection and can prevent perinatal transmission.

<strong>Developed countries</strong>- In many developed countries, pediatric HIV has been virtually eliminated<sup>7</sup>. In the US in 1994, the Public Health Service recommended HIV counseling and voluntary testing and AZT therapy for all pregnant women after the clinical trial known as “076” showed that AZT reduced rates of MTCT by two-thirds. Since then, a combination of interventions that includes treatment with ART to control the virus and make it undetectable, cesarean delivery, and avoidance of breastfeeding has helped further reduce perinatal transmission in the US, from an estimated 1,500 cases in 1992 to an estimated 162 perinatal infections in 2010<sup>8</sup>. Although the estimated number of perinatal HIV infections in the US continues to decline, women of color, especially black/African American women are disproportionately affected by HIV infection and as a result, perinatal HIV infection is highest among blacks/African Americans (63%), followed by Hispanics/Latinas (22%)<sup>8</sup>. Although effective interventions have led to a significant reduction in the number of perinatal infections in the US, <strong>perinatal</strong> transmission still occurs. To close the final gap, the CDC has proposed a new framework to eliminate mother-to-child HIV transmission (EMCT) in the US<sup>8</sup>. This framework focuses on key areas including: comprehensive reproductive health care (that includes both family planning (FP) and preconception care) and comprehensive case-finding  of pregnancies in HIV-infected women that is conducted through comprehensive clinical care  and case management services for women and infants; case review and community action; continuous quality research in prevention and long-term monitoring of HIV-exposed infants; and thorough data reporting for HIV surveillance at the state and local health department levels<sup>8,9</sup>.

<strong>Developing countries</strong>- Unfortunately, perinatal transmission of HIV continues to plague many developing countries despite recent prevention acceleration. In 2008, an estimated 1.4 million pregnant women in low and middle-income countries were living with HIV, of whom about 90% were in sub-Saharan African countries<sup>7</sup>. In 2012, UNAIDS reported that approximately 210,000 children became HIV infected<sup>1</sup>.

<strong>Can perinatal transmission of HIV be reduced?</strong>

Yes. Perinatal transmission encompasses a variety of highly effective interventions that have huge potential to improve maternal and child health. Advances in treatment and new classes of drugs have provided the opportunity to greatly reduce rates of perinatal transmission worldwide. Also, perinatal transmission can be reduced by preventing unintended pregnancies.  Preventing unintended pregnancies is one of the most effective ways to prevent HIV infection in infants and stop spread of the epidemic to children<sup>10</sup>. For that reason, preventing unintended pregnancies among women living with HIV and offering family planning to delay, space or end childbearing is one of the four WHO pillars in the comprehensive approach to preventing perinatal transmission<sup>7</sup>. However, we have still not addressed the root cause of perinatal transmission, mainly heterosexual HIV transmission. The best way to prevent perinatal HIV transmission is to prevent HIV transmission in the mother and father.

In order to reduce perinatal transmission, all pregnant women should have access to free or low-cost prenatal care and voluntary HIV testing and counseling. If a pregnant woman is HIV-positive, she should have access to lifelong ART to treat HIV and improve her own health and to decrease the chances of HIV infection in her infant. In June 2013, the WHO published updated guidelines on the diagnosis of HIV, the care of people living with HIV(PLHIV) and the use of ART for treating and preventing HIV infection<sup>1</sup>. In the US, the Department of Health and Human Services recommends that all HIV-infected pregnant women should be given ART during pregnancy to prevent perinatal transmission of HIV, regardless of whether ART is indicated for the woman’s own health<sup>11</sup>. Perinatal transmission can be reduced to less than 2% if a woman is on ART, has a low or undetectable viral load, follows the recommended treatment regimen and does not breastfeed<sup>7,8</sup>. Careful management during labor and delivery can also help reduce perinatal transmission, for example by avoiding unnecessary instrumentation and not prematurely rupturing membranes<sup>12</sup>.

Also, although universal prenatal HIV testing is the standard in the US, if prenatal care has not been provided, the patient has HIV, or her HIV status is undocumented, it is critical for hospitals to determine a laboring patient’s HIV status upon admission. Even without the use of ART during the pregnancy, the use of ART during labor and for the infant can reduce the risk of perinatal transmission to between 6 to 13%<sup>13</sup>. It is therefore recommended that rapid HIV testing be performed in Labor and Delivery units on pregnant women with no HIV test during their pregnancy or with risk factors for infection since their last test<sup>14</sup>.

In developing countries, perinatal transmission has been a priority since 1998, following the success of short-course zidovudine and single-dose nevirapine clinical trials<sup>7</sup>. In recent years, single-dose nevirapine as the primary antiretroviral medicine option for HIV-positive pregnant women to prevent transmission to their infants has been phased out, in favor of more effective and simplified triple ART regimens<sup>1</sup>.  The WHO now recommends that all pregnant and breastfeeding women with HIV, regardless of CD4 count or clinical stage, should initiate a triple ART regimen which should be maintained for the duration of perinatal transmission risk, which includes pregnancy, delivery and throughout the breastfeeding period (this is known as Option B). In countries were more than one percent of the population has HIV (these are known as generalized epidemics) and where there is often limited access to tests that indicate the severity of HIV illness (such as CD4 testing), limited partner testing, long duration of breastfeeding and high rates of fertility, the WHO recommends that women meeting treatment eligibility criteria should continue lifelong ART (this strategy is referred to as Option B+)<sup>12</sup>. There are many benefits to lifelong treatment for all pregnant and breastfeeding women and these include increased coverage of those needing ART for their own health, a reduction in the number of women stopping and starting ART during repeat pregnancies, early protection against perinatal transmission in future pregnancies, reduced risk of infecting a partner who is HIV-negative and decreased risk of medication failure or the development of resistance<sup>12</sup>.

The ultimate goal is to find the most effective and sustainable regimens for HIV treatment and the prevention of perinatal transmission worldwide. Economics, politics, poor infrastructure, access to healthcare and medications, stigma and cultural norms all pose significant challenges to providing this standard of care everywhere and not all PLHIV have equal access to treatment.

<strong>What are the barriers to the prevention of perinatal transmission?</strong>

Pregnant women face many difficult decisions, including decisions around HIV testing, treatment options and infant feeding. Understanding the barriers that women face and addressing barriers at various levels can help in realizing the full potential of prevention of perinatal transmission programs. A recent review article found that barriers to the prevention of perinatal transmission often fell into three broad categories that included the individual, their partners and community, and health systems<sup>15</sup>. At the individual level, studies suggest that a lower maternal education level, younger maternal age, and poor knowledge of HIV transmission and ART are associated with not receiving and/or not taking ART in order to treat and prevent the spread of HIV<sup>15</sup>.

Additionally, a woman’s male partner(s), extended family, greater community and health care setting all influence her decision and ability to take advantage of prevention of perinatal transmission programs. Many qualitative studies have found that stigma regarding HIV status and fear of disclosure to partners and family members is a major barrier to the uptake of perinatal prevention interventions<sup>15</sup>. Women living with HIV also continue to report that stigma and discrimination, especially in health care settings, continue to be a barrier to accessing adequate information and services<sup>1</sup>. In various studies, PLHIV have reported negative staff attitudes and this has been cited as a barrier to returning to facilities for care<sup>15</sup>.

In developing countries, health systems issues are also a barrier to greater prevention uptake. Key barriers that have been identified include a shortage of trained clinic staff, high patient volumes, long wait times, and brief and poor counseling sessions<sup>15</sup>. In addition, a lack of access or shortages of medications, including ART, as well as stock-outs of HIV test kits and condoms have been reported.  Poor access to healthcare overall (long distances to facilities) and poor integration of services also contributes to low ART uptake.

<strong>What about breastfeeding?</strong>

Breastfeeding is usually the healthiest choice for both infants and mothers. However, HIV transmission can occur during breastfeeding, with chances of transmission increasing the longer the infant is breastfed. In the countries with the highest perinatal HIV rates, it is estimated that more than half of the children newly infected with HIV acquire it during the breastfeeding period<sup>1</sup>. However, the risk of transmitting HIV to infants through breastfeeding is low in the presence of ART<sup>12</sup>. Therefore, providing ART to mothers throughout the breastfeeding period is a critical step needed to further reduce rates of perinatal transmission<sup>1</sup>. It is recommended that HIV-positive mothers do not breastfeed when formula feeding is safe, well accepted and readily available. In the US, both the Centers for Disease Control and Prevention and the American Academy of Pediatrics recommends that HIV-infected women refrain from breastfeeding regardless of their ART status to avoid postnatal transmission of HIV to their infants through breast milk<sup>16,17</sup>.

However, formula feeding requires clean water for mixing formula. Many women in developing countries do not have access to clean water or sanitation and cannot afford formula, and therefore cannot avoid breastfeeding. In developing countries where breastfeeding is the norm, formula feeding may also alert a woman’s family or community that she is HIV-positive, which may result in stigma or other negative repercussions. Therefore, the WHO recommends that when breastfeeding is unavoidable, mothers should take ART while breastfeeding and that infants should receive 6 weeks of prophylaxis with once-daily nevirapine<sup>12</sup>. The WHO further recommends that mothers known to be infected with HIV (and whose infants are HIV uninfected or of unknown status) should exclusively breastfeed for the first 6 months of life, introducing appropriate complementary foods thereafter, and continue breastfeeding for the first 12 months of life. It is recommended that breastfeeding should only stop when a nutritionally adequate and safe diet without breast-milk can be provided<sup>12</sup>. Access to ARVs during this extended breastfeeding period is critical<sup>12</sup>.

<strong>What’s being done?</strong>

<strong>Primary prevention of HIV among men and women of childbearing age: </strong>Various tools are now available to prevent HIV infections in men and women of childbearing age. Pre-exposure prophylaxis (PrEP), which is a special course of HIV treatment that aims to prevent people from becoming infected with HIV, has been found to protect against HIV-1 infection in heterosexual men and women and reduce HIV transmission by 67 to 75%<sup>18,19</sup>. PrEP is intended for people at-risk of becoming infected with HIV, for example in the case of couples where one partner is HIV-positive and the other is HIV-negative. In countries with generalized HIV epidemics, voluntary medical male circumcision for HIV-negative male partners in relationships with a positive partner has been shown to reduce the risk of HIV-acquisition in men by between 38% to 66%<sup>20</sup>. Using ART to decrease the chance of HIV transmission, a concept known as treatment as prevention, has also recently been found to be very efficacious, with studies in heterosexual populations showing that adherence to ART is very effective at preventing transmission of HIV to HIV-negative partners<sup>21-23</sup>. Couples-testing with treatment for infected partners in discordant partnerships is also a promising approach. Integrating couples counseling and partner testing into routine clinic and community services  can increase the number of couples in which the status of both partners is known and can help identifying sero-discordant couples<sup>24</sup>.

<strong>Preventing unintended pregnancies and Safer Conception Options: </strong>Preventing unintended pregnancies among women living with HIV (WLHIV) is a powerful prevention strategy. One study found that even modest reductions in the numbers of pregnancies among WLHIV could avert HIV-positive births at the same rates as the use of ART for PMTCT<sup>25</sup>. One targeted approach to strengthening FP programs is to integrate FP within HIV services. In Kenya, a recent cluster-randomized trial tried to determine whether integrating FP services into HIV care was associated with increased use of more effective contraceptive methods such as sterilization, IUDs, implants, injectables and oral contraceptives. Women seen at integrated sites were significantly more likely to use more effective methods of FP at the end of the study<sup>26</sup>. This makes the case for integrating FP within HIV care. Reducing the unmet need for FP will reduce new HIV infections among children and improve overall maternal and infant health.

For HIV-positive or serodiscordant couples who would like to have children, there are many options available to make conception safer. When offering preconception care, HIV-positive couples will have specific needs, many of which can be addressed during their routine HIV care. When offering preconception counseling for HIV-positive women, the CDC recommends that health care providers should discuss a variety of topics, including: reproductive options and actively assessing women’s pregnancy intentions on an ongoing basis; Counseling on safe sexual practices that prevent HIV transmission to sexual partners, protect women from acquiring sexually transmitted diseases, and reduce the potential to acquire more virulent or resistant strains of HIV;  Using ART to attain a stable, maximally suppressed maternal viral load prior to conception to decrease the risk of perinatal transmission and of HIV transmission to an uninfected partner; and encouraging sexual partners to receive counseling and HIV testing and, if infected, to seek appropriate HIV care<sup>11</sup>.

For couples who want to conceive, in which one or both are HIV-positive, the positive partner should be on ART and have achieved maximal suppression of HIV infection. ART for the positive partner may not be fully protective against sexual transmission of HIV and so the administration of PrEP for the HIV-negative partner may offer an additional tool to reduce the risk of transmission. For discordant couples, when the positive partner is a woman, the safest conception option is artificial insemination. In discordant couples where the positive partner is male,the safest conception option is the use of donor sperm from an HIV-uninfected male with artificial insemination. When the use of donor sperm is unacceptable, the use of sperm preparation techniques together with either intrauterine insemination or <em>in vitro </em>fertilization is an option<sup>11</sup>.

<strong>Preventing HIV transmission from WLHIV to infants:</strong> Increasing access to ART for WLHIV is critical to saving the lives of women and their children. The number of pregnant WLHIV receiving ART for their own health has increased from 25% in 2009 to 60% in 2012<sup>1</sup>. One of the greatest success stories has been in Malawi where a policy of providing lifelong ART to all pregnant and breastfeeding women (irrespective of CD4 count or clinical status– a strategy referred to as Option B+) was enacted in 2011. Since then, Malawi increased the estimated coverage of women in need of ART from 13% in 2009 to 86% in 2012. The implementation of Option B+ has resulted in a 748% increase in the number of pregnant and breastfeeding women starting ART, from 1,257 in the second quarter of 2011 to 10,663 in the third quarter of 2012<sup>27</sup>. As a result of Option B+, the perinatal transmission rate for women on ART is expected to be reduced, from approximately 40% without intervention to less than 5%. By decentralizing treatment services and offering lifelong HIV treatment to all pregnant and breastfeeding women, Malawi has been able to increase ART coverage both during pregnancy and the breastfeeding period<sup>1</sup>.

<strong>Providing treatment, care and support to WLHIV and their children and families:</strong>

Increasing access to ART for pregnant women living with HIV for their own health is critical to saving the lives of women and their children. Even developing countries, which at first lagged behind in reducing the number of children newly infected with HIV, have made great gains in recent years. In 2013, UNAIDS reported that in 7 high burden countries where access to treatment has increased, the rates of HIV transmission to children has fallen by 50% or more<sup>1</sup>.

<strong>What still needs to be done?</strong>

HIV is a preventable disease. Perinatal transmission is best prevented by effective, accessible and sustainable HIV prevention, access to HIV testing, early diagnosis and linkage to treatment programs for women, men and their children, access to family planning and abortion services to prevent unintended pregnancies, and access to an ongoing supply of ARVs to improve the health of women and their children. Structural interventions are also needed that increase access to health centers, improve health care infrastructure, provide food supplementation, and HIV treatments.

Women are the key to the HIV response and the number of women acquiring HIV has to be reduced. All women have a right to be treated for HIV infection, not simply because they are bearing a child. All women living with HIV who are eligible for ART need to have access to it. Unfortunately, too many women are still lost along the prevention cascade and never get the care or treatment they need and deserve. Providing women with access to high quality healthcare for themselves and their families, whether they are HIV-positive or not, is imperative.

<hr size="1" />

<h3><strong>Says who?</strong></h3>
1. UNAIDS. AIDS by the numbers. Geneva, Switzerland, 2013.

2. Kanniappan S, Jeyapaul MJ, Kalyanwala S. Desire for motherhood: exploring HIV-positive women’s desires, intentions and decision-making in attaining motherhood. AIDS care 2008;<strong>20</strong>(6):625-30 doi: 10.1080/09540120701660361[published Online First: Epub Date]|.

3. Beyeza-Kashesya J, Kaharuza F, Mirembe F, et al. The dilemma of safe sex and having children: challenges facing HIV sero-discordant couples in Uganda. African health sciences 2009;<strong>9</strong>(1):2-12

4. Cooper D, Moodley J, Zweigenthal V, et al. Fertility intentions and reproductive health care needs of people living with HIV in Cape Town, South Africa: implications for integrating reproductive health and HIV care services. AIDS and behavior 2009;<strong>13 Suppl 1</strong>:38-46 doi: 10.1007/s10461-009-9550-1[published Online First: Epub Date]|.

5. UNAIDS. We Can Prevent mothers fom dying and babies from becoming infected with HIV. Geneva, Switzerland, 2010.

6. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA : the journal of the American Medical Association 2000;<strong>283</strong>(9):1175-82

7. WHO. PMTCT Strategic Vision 2010-2015: Preventing mother-to-child transmission of HIV to reach the UNGASS and Millenium Development Goals. Geneva, Switzerland, 2010.

8. CDC. HIV Among Pregnant Women, Infants, and Children in the United States. Atlanta, 2012.

9. Nesheim S, Taylor A, Lampe MA, et al. A framework for elimination of perinatal transmission of HIV in the United States. Pediatrics 2012;<strong>130</strong>(4):738-44 doi: 10.1542/peds.2012-0194[published Online First: Epub Date]|.

10. Nakayiwa S, Abang B, Packel L, et al. Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS and behavior 2006;<strong>10</strong>(4 Suppl):S95-104 doi: 10.1007/s10461-006-9126-2[published Online First: Epub Date]|.

11. Department of Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. In: Bureau HA, ed. Washington, DC, 2014.

12. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. Geneva, Switzerland, 2013.

13. Kourtis AP, Lee FK, Abrams EJ, et al. Mother-to-child transmission of HIV-1: timing and implications for prevention. The Lancet infectious diseases 2006;<strong>6</strong>(11):726-32 doi: 10.1016/S1473-3099(06)70629-6[published Online First: Epub Date]|.

14. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control 2006;<strong>55</strong>(RR-14):1-17; quiz CE1-4

15. Gourlay A, Birdthistle I, Mburu G, et al. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society 2013;<strong>16</strong>(1):18588 doi: 10.7448/IAS.16.1.18588[published Online First: Epub Date]|.

16. American Academy of Pediatrics Committee on Pediatric A. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. Pediatrics 2008;<strong>122</strong>(5):1127-34 doi: 10.1542/peds.2008-2175[published Online First: Epub Date]|.

17. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Secondary Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf.

18. Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Current opinion in infectious diseases 2012;<strong>25</strong>(1):51-7 doi: 10.1097/QCO.0b013e32834ef5ef[published Online First: Epub Date]|.

19. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. The New England journal of medicine 2012;<strong>367</strong>(5):399-410 doi: 10.1056/NEJMoa1108524[published Online First: Epub Date]|.

20. Siegfried N, Muller M, Deeks JJ, et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. The Cochrane database of systematic reviews 2009(2):CD003362 doi: 10.1002/14651858.CD003362.pub2[published Online First: Epub Date]|.

21. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;<strong>375</strong>(9731):2092-8 doi: 10.1016/S0140-6736(10)60705-2[published Online First: Epub Date]|.

22. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England journal of medicine 2010;<strong>363</strong>(27):2587-99 doi: 10.1056/NEJMoa1011205[published Online First: Epub Date]|.

23. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England journal of medicine 2011;<strong>365</strong>(6):493-505 doi: 10.1056/NEJMoa1105243[published Online First: Epub Date]|.

24. Medley A, Baggaley R, Bachanas P, et al. Maximizing the impact of HIV prevention efforts: Interventions for couples. AIDS care 2013 doi: 10.1080/09540121.2013.793269[published Online First: Epub Date]|.

25. Sweat MD, O’Reilly KR, Schmid GP, et al. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. Aids 2004;<strong>18</strong>(12):1661-71

26. Grossman D, Onono M, Newmann SJ, et al. Integration of family planning services into HIV care and treatment in Kenya: a cluster-randomized trial. Aids 2013;<strong>27 Suppl 1</strong>:S77-85 doi: 10.1097/QAD.0000000000000035[published Online First: Epub Date]|.

27. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV–Malawi, July 2011-September 2012. MMWR. Morbidity and mortality weekly report 2013;<strong>62</strong>(8):148-51

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©2009, University of CA. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf. edu.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/11/MTCT-Revised-Sept-2015.pdf</url>
	</node>
	<node>
		<title>Transgender women</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are transgender women’s HIV prevention needs?</h3>
<h4>what does being transgender mean?</h4>
Transgender is an umbrella term for persons whose gender identity and expression does not conform to norms and expectations traditionally associated with their sex assigned at birth. Transgender persons may self-identify as transgender, female, male, trans-woman or -man, transsexual, cross-dresser, bigender, gender queer, gender questioning, MtF, FtM or one of many other transgender identities, and may express their genders in a variety of masculine, feminine and androgynous ways. Transgender persons may prefer and identify with certain terms and not others, so it is best to ask participants and clients what they prefer. For this fact sheet, we use the term transgender women.

The transgender community is diverse and more research is needed. From what we know, transgender women have higher rates of HIV and HIV-related risks than transgender men. While this fact sheet focuses on transgender women, we are developing other fact sheets on transgender men and the general transgender population.
<h4>is HIV a concern?</h4>
Unfortunately, yes. HIV is certainly not the only concern of transgender women, who face many physical, mental, social and economic disparities besides HIV. The stigma and discrimination experienced by many people merely for being transgender heightens risk behavior for transgender women. It is greater for transgender women of color, who experience stigma and discrimination due to ethnicity as well.<sup>1</sup>

A recent review of 29 studies of transgender women in the US, found they have been greatly impacted by the HIV epidemic. In four of the studies, 27.7% of transgender women tested HIV+, compared to 11.8% who self-reported HIV+ in the remaining 25 studies. This suggests that many transgender women may not be aware of their HIV status. The highest HIV rates were among African American transgender women (56.3%).2 In this review, a large percentage of transgender women reported engaging in unprotected receptive anal intercourse, multiple casual partners and sex work.<sup>2</sup>

Stigma, discrimination, racism as well as the social isolation and alienation from family that some transgender women encounter can lead to anxiety, depression as well as suicidal ideation and attempts. Stigma and abuse also make transgender women vulnerable to dropping out of school and homelessness at a young age, disrupting their education and employment careers. Some transgender women turn to sex work for survival, and some transgender women turn to substance use to cope with all of these life stresses.<sup>3</sup>

It is important to note that not all transgender women are at risk for HIV. Like many populations, those at greatest risk are more likely to be poor, homeless, young, people of color and sex workers. There are many transgender women who do not face the same degrees of risk.

Substance use immediately before and during sexual activity increases HIV risk. One study of transgender women in San Francisco, CA, found that their male sexual partners often used crack cocaine before sex to ease inhibitions and to maintain their fantasy, particularly during anal sex.<sup>4</sup>
<h4>who are partners of transgender women?</h4>
Transgender women may have sex with men, women and other transgender persons. Like many other women, transgender women face complicated power and gender dynamics in their sexual relationships. There is a perception that there are few people who are willing to be in committed relationships with transgender women, which compromises disclosure of HIV status, sexual negotiation and condom use. Some transgender women have sexual partners who provide a sense of love and acceptance, but who also request unsafe sexual behaviors.<sup>5</sup>

While transgender women have been considered a bridge group for transmission to men, it appears that the opposite could be true. In one online survey, Latino men who had sex with a transgender partner were more likely to be HIV+, reported a higher number of sexual partners, and were almost three times more likely to have had unprotected sex than Latino men who have sex with men who did not report sex with a transgender person.<sup>6</sup>

Men who have sex with transgender women challenge traditional sexual orientation categories often used in HIV prevention. These men may have sex with women, men and transgender women and may describe themselves as straight, bisexual or gay. Few have sex solely with transgender women.<sup>4,6,7</sup>
<h4>how are challenges addressed?</h4>
<strong>Education and employment.</strong> Finding and keeping jobs is a key step in reducing risk for transgender women. The Transgender Economic Empowerment Initiative (TEEI) provides training, employment and support for transgender individuals in San Francisco, CA. TEEI helps build job skills such as interviewing, coaching and resume building and has hosted job fairs. TEEI has a mentoring program for newly placed employees, and legal and technical services for employers to help make workplaces safe for transgenders.<sup>8</sup>

<strong>Training for healthcare providers.</strong> Quality, sensitive healthcare is important for transgender women. Despite their sincere concern to serve patients effectively, providers may have very little knowledge, experience, skills and therefore comfort with transgender patients. The Center of Excellence for Transgender HIV Health provides free training and consultations for health professionals.<sup>9</sup>

<strong>Mentoring.</strong> Youth and others who are transitioning need role models to help them envision a successful life for themselves. Unfortunately, transgender women struggle with the loss of potential role models due to marginalization and pressure to “pass.” This invisibility often leaves young transgender people looking to find community on the street, one of the few places where transgender women are visible, yet risks are high. Fortunately, an increasing number of transgender women are more open about their transgender identity, and public awareness is growing due to transgender community organizing and coalitions with the gay, lesbian, bisexual and other allied communities.<sup>10</sup>
<h4>what’s being done?</h4>
In Minnesota, All Gender Health incorporates HIV prevention efforts into comprehensive sexuality education for transgender persons. The program addresses HIV risk in context and covers topics such as coming out, resilience in the face of stigma and discrimination, dating and relationships, body image and sexual functioning, and community building and empowerment. The two-day, weekend workshops are led by professional and trained transgender women professional peer educators, combining education with live entertainment. Participants reported improved attitudes toward condom use, increased monogamy and decreased high risk behavior at 3-month follow-up.<sup>11</sup> All Gender Health is being adapted for online delivery.

In Hawaii, Kulia Na Mamo is a program developed and run by transgender women that provides job skills training, job referrals and a support group for working women. They developed an HIV, substance abuse and hepatitis prevention program for native Hawaiian transgender women.<sup>12</sup>

Although the CDC currently has no interventions for transgender populations in their Diffusion of Effective Behavioral Intervention (DEBI) program, a few have been informally or formally adapted. The Transitions Project provides technical assistance to numerous agencies adapting the DEBI projects SISTA and Mpowerment across the US.<sup>13</sup>

Bienestar in Los Angeles, CA, has adapted SISTA for Latina transgender women, as DIVAS (Destacadas Intervenciones Variadas Acerca del SIDA). The Life Foundation in Hawaii has another adaptation, TITA (T-girls Informing T-girls about Topics on AIDS).<sup>14</sup>
<h4>what still needs to be done?</h4>
To address the devastating effects of stigma and discrimination on transgender persons, large scale anti-stigma campaigns as well as anti-discrimination laws should be implemented across the country. Sensitivity training should be provided for healthcare workers, employers, service providers and researchers working with transgender women. Education and training for school officials—including teachers, principals and administrators—is key.

Sexual partners of transgender women should not be ignored. Recent studies show that many male partners of transgender women are at high risk for HIV.<sup>6</sup> More research is needed for them, as well as programs that work with transgender women and their partners together as a couple.

We need to do a better job counting and including transgender women in HIV surveillance. The CDC currently has plans to pilot a transgender category for HIV reporting as part of the National HIV Behavioral Surveillance System. Interventions that specifically address transgender persons should be added to the DEBI program. DEBIs that have been successfully adapted for the transgender population should be disseminated.

More research should be done with transgender youth to identify and develop strategies for HIV prevention for young adults coming out as transgender.<sup>15</sup> Structural interventions such as job training, housing and anti-discrimination laws need to be studied to see if they are effective and make a difference in transgender women’s lives.

<hr />

<h3>Says who?</h3>
1. Nemoto T, Sausa LA, Operario D, et al. Need for HIV/AIDS education and intervention for MTF transgenders: responding to the challenge. Journal of Homosexuality. 2006;51:183-202.

2. Herbst JH, Jacobs ED, Finlayson TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: A systematic review.AIDS and Behavior. 2008;12:1-17.

3. Bockting W, Avery E. Transgender health and HIV prevention: needs assessment studies from transgender communities across the United States. International Journal of Transgenderism. 2005;8.

4. Coan DL, Schrager W, Packer T. The role of male sexual partner in HIV infection among male-to-female transgendered individuals. International Journal of Transgenderism. 2005;8:21-30.

5. Melendez RM, Pinto R. ‘It’s really a hard life’: love, gender and HIV risk among male-to-female transgender persons.Culture, Health and Sexuality. 2007;9:233-245.

6. Bockting W, Miner M, Rosser BR. Latino men’s sexual behavior with transgender persons. Archives of Sexual Behavior. 2007;36:778-786.

7. Operario D, Burton J, Underhill K, et al. Men who have sex with transgender women: challenges to category-based HIV prevention. AIDS and Behavior. 2008;12:18-26.

8. Transgender Economic Empowerment Initiative

9. Center of Excellence for Transgender HIV Health

10. Bockting WO. Transgender identity and HIV: resilience in the face of stigma.FOCUS. 2008;23:1-4.

11. Bockting WO, Robinson BE, Forberg J, et al. Evaluation of a sexual health approach to reducing HIV/STD risk in the transgender community. AIDS Care. 2005;17:289-303.

12. Kulia Na Mamo

13. Transitions Project

14. Transitions Project Newsletter. Winter/Spring 2007.

15. Garofalo R, Deleon J, Osmer E, et al. Overlooked, misunderstood and at-risk: Exploring the lives and HIV risk of ethnic minority male-to-female transgender youth. Journal of Adolescent Health. 2006;38:230–236.

<strong>Transgender Resources</strong>
<ul>
 	<li>Center of Excellence for Transgender Health</li>
 	<li>Transgender Law Center</li>
 	<li>National Center for Transgender Equality</li>
 	<li>Transgender HIV/AIDS Services Best Practices Guidelines</li>
 	<li>World Professional Association for Transgender Health</li>
</ul>

<hr />

<strong>Prepared by JoAnne Keatley MSW* and Walter Bockting PhD**
*CAPS, Pacific AETC; **University of Minnesota</strong>

<strong>September 2008/Revised July 2015. Fact Sheet #41ER</strong>

Special thanks to the following reviewers of this fact sheet: Ashliana Hawelu-Fulgoni, Craig Hutchinson, Steve Levine, Micah Lubensky, Samuel Lurie, Rita Melendez, Don Operario, Jessica Xavier.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©September 2015, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2010/11/transgender-women-fact-sheet.pdf</url>
	</node>
	<node>
		<title>Woman</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are US women’s HIV prevention needs?</h3>
<h4>are women at risk?</h4>
Yes. HIV is taking an increasing toll on women and girls in the US. In 1985, women comprised 8% of all AIDS cases in the US, while by 2005, women made up 27% of all AIDS cases.

In 2005, women accounted for 30% of all new HIV infections. Of these, 60% occurred among African Americans, 19% among Whites, 19% among Hispanics, and 1% each among Asian/Pacific Islanders and American Indian/Alaska Natives.
<h4>who are women most affected by HIV?</h4>
African American and Hispanic women in particular are disproportionately affected by HIV/AIDS. Although African American and Hispanic women comprise only 23% of the total female population in the US, in 2005 they accounted for 79% of all new HIV infections (African American women: 60%, Hispanic women: 19%). Accordingly, in 2004 HIV infection was the leading cause of death for Black women (including African American women) aged 25-34 years.

Younger women are also affected by HIV/AIDS. In recent years, the largest number of HIV/AIDS diagnoses among women occured in women 15-39 years old. In 2005, young women represented 28% of AIDS cases among young men and women aged 20-24.
<h4>what places women at risk?</h4>
Most women are infected with HIV through heterosexual contact, especially women with injection drug using partners. In 2005, 80% of all new infections in women were from heterosexual contact. Women are more likely than men to acquire HIV via sexual intercourse, due to greater exposed surface area in the female genital tract.

Injection and non-injection drug use places women at an increased risk for HIV and is strongly linked to unsafe sexual practices. Approximately 20% of new HIV cases in women is related to injection drug use. Women who use crack cocaine may also be at high risk of sexual transmission of HIV, particularly if they sell or trade sex for drugs.

Sexually transmitted infections (STIs) other than HIV can increase the likelihood of getting or transmitting HIV. In the US, chlamydia and gonorrhea (both asymptomatic) are the most commonly reported STIs, with highest rates in women of color and young women and adolescents.

Sexual abuse (both childhood and adult) and domestic violence play a substantial role in placing women at risk for HIV infection. In the US, annually 2.1 million women are raped and 4 million become victims of domestic violence; of these women, more than 10,000 rape victims and 79,000 violence victims require hospitalization. Women who report early and chronic sexual abuse are seven times more likely to engage in HIV-related risk behaviors compared to women without trauma history.

Women disproportionately suffer from poverty, in particular women of color who are affected by HIV. Because of this, women are less likely than men to have health insurance and access to quality healthcare or prevention services. Approximately two-thirds of women with HIV in the US have an annual income of less than $10,000. Poverty can increase HIV risks such as exchanging sex for money, shelter, or drugs. In a survey of young and low-income women in California, women who reported sex work were more likely to have syphilis, herpes, hepatitis C, and a history of sexual abuse.

Abuse, violence and poverty can all lessen a woman’s power to negotiate condom use or choose safer partners. They also can lead to psychological distress, such as depression, anxiety and post-traumatic stress disorder (PTSD).

Having relationships that overlap in time (concurrent partners) can increase women’s risk of HIV transmission. Concurrency is more likely to occur among women who are not married, are young adults and are poor.
<h4>what can help?</h4>
<strong>Involving male partners.</strong> For women to protect themselves from HIV, they must not only rely on their own skills, attitudes, and behaviors regarding condom use, but also on those of their male partner. Often, men and women in relationships may find intimacy to be more important than protection against HIV. Involving women’s partners in HIV prevention programs can help strengthen intimacy and trust and improve sexual communication and negotiation, including asking about past and current partners.

<strong>Support from other women</strong>. Many prevention programs for women offer groups to reduce women’s isolation and allow women to support each other and normalize safer behaviors. Greater social support can increase self esteem and allow women to make healthier choices. A program in Washington DC helped build support and empowerment for HIV+ African American women by holding educational groups during shared meals and providing small gifts (along with condoms) as incentives or thank-yous.

<strong>Help with non-HIV factors.</strong> Women at risk for HIV face many behavioral and structural challenges beyond HIV: poverty and economic strain, unemployment, violence and unhealthy gender relations, migration, STIs, drug use, and caring for children and family members. HIV prevention programs for women should provide transportation, child care, nutritious food and compensation such as money, phone or store cards or gift packs. Programs should provide up-to-date referrals for employment, housing, medical care and mental health services trauma, abuse and depression.
<h4>what is being done?</h4>
Currently 17 women-specific interventions exist that have been approved by the CDC as best evidence or promising evidence or are part of the Diffusion of Effective Behavioral Interventions (DEBI) project: CHOICES, Communal Effectance-AIDS Prevention, Female and Culturally Specific Negotiation, Project FIO, Project SAFE, RAPP, SiHLE, SISTA, Sisters Saving Sisters, Sister to Sister, WHP, WiLLOW, Women’s Co-op, Condom Promotion, Insights, Safer Sex, and SEPA.

The Women’s Leadership and Community Planning project in San Francisco, offered a 2-day training for women with HIV in California who want to take greater leadership roles in state Planning Councils. At the training, women network with each other, as well as learn skills in public speaking, decision-making, and conflict management. Women stay in touch through monthly conference calls. After the first training, 6 of 13 women moved into leadership positions on their local or state Councils.

Respeto/Proteger: Respecting and Protecting our Relationships is an HIV prevention program for Latino teen mothers and fathers in Los Angeles, CA. Developed and tested with a community agency and academic researchers, the program recognizes risks young women face, including poverty, drug and alcohol use, history of STIs and physical or sexual abuse. The six-session intervention focuses on healing the wounded spirit and builds on feelings of maternal and paternal protectiveness using cultural and traditional teachings.
<h4>what needs to be done?</h4>
Because women are more likely to get HIV from their male partners, programs that target men (especially IDUs) will have a beneficial impact on women. Needle exchange and drug treatment strategies are critical. Public health agencies need to raise awareness about sexual abuse and domestic violence to not only help men and women develop the skills to prevent it, but also to curb its effect on the HIV epidemic. HIV testing campaigns that target women and women-friendly testing sites are also needed.

Behavioral and structural HIV prevention interventions for women continue to be necessary, given the lack of evidence from biomedical interventions (microbicides, vaccines). However, research needs to continue on how women can protect themselves with an accessible, affordable, comfortable and discrete tool for safer sex.

Although research has highlighted the subpopulations of women most affected by HIV/AIDS, it is even more important to translate and materialize study findings into tangible public health programs and effective policies. Interventions that address sexuality, family, culture, empowerment, self-esteem, and negotiating skills, as well as interventions located in varying community settings are especially valuable.

<hr />

<h3>Says who?</h3>
1. Kaiser Family Foundation. Women and HIV/AIDS in the United States. Policy Fact Sheet. July 2007.

2. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and Dependent Areas, 2005. HIV/AIDS Surveillance Report. 2007;17.

3. Centers for Disease Control and Prevention. HIV/AIDS fact sheet: HIV/AIDS among women. June 2007.

4. National Institute of Allergy and Infectious Diseases at National Institutes of Health. Research on HIV infection in women. 2006.

5. Theall KP, Sterk CE, Elifson KW, et al. Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence. Public Health Reports. 2003;118:415-424.

6. Sangani P, Rutherford G, Wilkinson D. Population-based interventions for reducing sexually transmitted infections, including HIV infection. Cochrane Database of Systematic Reviews. 2004; 2:CD001220.

7. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6-10.

8. Koenig LJ, Moore J. Women, violence, and HIV: A critical evaluation with implications for HIV services. Maternal and Child Health Journal. 2000;4:103-109.

9. Wyatt GE, Myers HF, Loeb TB. Women, trauma, and HIV: an overview. AIDS and Behavior. 2004;8:401-403.

10. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. New Engand Journal of Medicine. 1998;339:1897-1904.

11. Cohan DL, Kim A, Ruiz J, et al. Health indicators among low income women who report a history of sex work: the population based Northern California Young Women’s Survey. Sexually Transmitted Infections. 2005;81:428-433.

12. Adimora AA, Schoenbach VJ, Bonas DM, et al. Concurrent sexual partnerships among women in the United States. Epidemiology. 2002;13:320-327.

13. Prosper! The Women’s Collective, Washington DC.

14. Dworkin SL, Ehrhardt AA. Going beyond “ABC” to include “GEM”: critical reflections on progress in the HIV/AIDS epidemic. American Journal of Public Health. 2007;97:13-18.

15. Centers for Disease Control and Prevention. Updated Compendium of Evidence-Based Interventions, 2007.

16. Women’s Leadership and Community Planning project, CompassPoint, San Francisco, CA.

17. Lesser J, Koniak-Griffin D, Gonzalez-Figueroa E, et al. Childhood abuse history and risk behaviors among teen parents in a culturally rooted, couple-focused HIV prevention program. Journal of the Association of Nurses in AIDS Care. 2007;18:18-27.

18. Landovitz RJ. Recent efforts in biomedical prevention of HIV. Topics in HIV Medicine. 2007;15:99-103.

<hr />

<strong>Prepared by Roshan Rahnama, CAPS</strong>

<strong>April 2008. Fact Sheet #4ER</strong>

Special thanks to the following reviewers of this fact sheet: Abby Charles, Beth Freedman, Bridget Hughes, Winifred King, Linda Koening, Maureen Miller, Adeline Nyamathi, Nancy Padian, Kate Perkins, Gina Wingood, Gail Wyatt, Toni Young.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. To receive Fact Sheets via e-mail, send an e-mail to listserv@listserv.ucsf.edu with the message “subscribe CAPSFS first name last name.” ©April 2008, University of CA.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Mujeres</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan las mujeres en la prevención del VIH en EEUU?</h3>
<h4>¿corren riesgo de contraer el VIH?</h4>
Sí. El VIH afecta a cada vez más mujeres y muchachas en EEUU. En 1985, las mujeres componían el sólo el 8 % de los casos de SIDA en EEUU, en comparación con el 27 % en el año 2005.

Para el 2005, las mujeres ya representaban el 30 % de las nuevas infecciones por VIH, de las cuales el 60 % eran afroamericanas, el 19 % caucásicas, el 19 % hispanas y el 1 % asiáticas/isleñas del Pacífico e indígenas americanas/nativas de Alaska, respectivamente.
<h4>¿qué mujeres son más afectadas por el VIH?</h4>
El VIH/SIDA afecta desproporcionadamente a las mujeres afroamericanas y las hispanas. Aunque estos dos grupos componen sólo el 23 % de la población femenina de EEUU, en el año 2005 representaban el 79 % de los casos nuevos de infección por VIH (afroamericanas: 60 %, hispanas: 19 %). En el 2004 la infección por VIH fue la primera causa de muerte entre mujeres negras (incluidas las afroamericanas) entre 25 y 34 años de edad.

El VIH/SIDA también afecta a mujeres más jóvenes. En años recientes, el mayor número de diagnósticos de VIH/SIDA entre mujeres se dio en las que tenían entre 15 y 39 años de edad. En el 2005, las mujeres jóvenes representaban el 28 % de los casos de SIDA entre mujeres y hombres de 20 a 24 años de edad.
<h4>¿qué pone en riesgo a las mujeres?</h4>
La mayoría de las mujeres contraen el VIH por medio del contacto heterosexual, especialmente si su pareja se inyecta drogas. En el 2005, el 80 % de las nuevas infecciones entre mujeres se debían al contacto heterosexual. Las mujeres son más propensas que los hombres a adquirir el VIH durante el coito debido a que, dentro del tracto genital femenino, una mayor superficie queda expuesta.

El consumo de drogas (inyectables o no inyectables) aumenta el riesgo que corren las mujeres de contraer el VIH y está fuertemente vinculado a las prácticas sexuales riesgosas. Aproximadamente el 20 % de los nuevos casos femeninos de VIH se relaciona con el uso de drogas inyectables. Las consumidoras de cocaína en roca (crack) también pueden correr un riesgo elevado de transmisión del VIH, en particular si venden o intercambian el sexo por drogas.

Las infecciones de transmisión sexual (ITS) que no sean el VIH pueden aumentar las posibilidades de adquirir o de transmitir el VIH. En EEUU, la clamidia y la gonorrea (ambas infecciones asintomáticas) son las ITS que se reportan con mayor frecuencia, con las tasas más altas entre las mujeres no caucásicas, las mujeres jóvenes y las adolescentes.

El abuso sexual (en la niñez y en la edad adulta) y la violencia doméstica juegan un papel fundamental en aumentar el riesgo de contraer el VIH. Cada año 2.1 millones de mujeres son violadas y cuatro millones son víctimas de la violencia doméstica en EE.UU.; de estas mujeres, más de 10,000 mujeres violadas y 79,000 de las víctimas de abuso requieren hospitalización. Las mujeres que han sufrido abuso sexual desde temprana edad y en forma crónica son siete veces más propensas a participar en conductas que las ponen en riesgo de contraer el VIH que otras mujeres sin antecedentes de trauma.

Las mujeres sufren desproporcionadamente de la pobreza, en particular las mujeres no caucásicas con VIH, lo cual reduce sus posibilidades de tener seguro médico y acceso a servicios médicos o preventivos de alta calidad. En EEUU, unos dos tercios de las mujeres con VIH tienen ingresos anuales por debajo de $10,000. La pobreza puede aumentar los riesgos de VIH tales como el intercambio del sexo por dinero, alojamiento o drogas. Entre las mujeres jóvenes y de bajos ingresos encuestadas en California, las que afirmaron haber hecho trabajo sexual tenían tasas más altas de sífilis, herpes, hepatitis C y antecedentes de abuso sexual.

El abuso, la violencia y la pobreza pueden minar el poder de la mujer a la hora de negociar el uso de condones o de escoger parejas sexualmente más seguras. También pueden llevar a problemas psicológicos como la depresión, la ansiedad y el trastorno de estrés postraumático (PTSD en inglés).

Tener parejas concurrentes puede incrementar el riesgo de contraer el VIH y es más común entre las mujeres jóvenes solteras pobres.
<h4>¿qué se puede hacer para ayudar?</h4>
<strong>Involucrar a las parejas masculinas.</strong> Para poder protegerse contra el VIH, las mujeres no sólo dependen de sus propias habilidades, actitudes y conductas con respecto al uso de condones, sino también de las de sus compañeros sexuales. En muchas relaciones románticas la intimidad pesa más que la protección contra el VIH. La inclusión de los hombres en los programas de prevención del VIH puede profundizar la intimidad y confianza y mejorar la comunicación y negociación sexual incluyendo las preguntas sobre parejas sexuales anteriores y actuales.

<strong>Recibir el apoyo de otras mujeres.</strong> Muchos programas de prevención para mujeres ofrecen grupos para reducir el aislamiento y permitir el apoyo mutuo entre mujeres y la normalización de prácticas más seguras. Un aumento del apoyo social puede incrementar la autoestima y promover la toma de decisiones más saludables. Un programa en Washington, DC generó apoyo y empoderamiento para mujeres afroamericanas VIH+ por medio de pláticas educativas durante comidas comunales y la provisión de pequeños obsequios (junto con condones) a manera de incentivo o agradecimiento.

<strong>Ayudar con otros problemas no relacionados con el VIH. </strong>Las mujeres vulnerables al VIH encaran muchos desafíos conductuales y estructurales además del VIH: la pobreza y otras dificultades económicas, el desempleo, la violencia y las relaciones de pareja dañinas, la migración, las ITS, el uso de drogas y la necesidad de cuidar de niños y otros familiares. Los programas de prevención del VIH para mujeres deben brindarles transporte, cuidado infantil, alimentos nutritivos y remuneración en forma de comida, tarjetas telefónicas o de tiendas y paquetes de regalos. También deben ofrecer remisiones adecuadas y actualizadas para servicios de empleo, vivienda, atención médica y de salud mental en caso de trauma, abuso y depresión.
<h4>¿qué se está haciendo al respecto?</h4>
Actualmente existen 17 intervenciones para mujeres las cuales han sido reconocidas por los CDC como ejemplos de “las mejores evidencias” o “evidencias prometedoras” o bien que forman parte del proyecto <em>Diffusion of Effective Behavioral Interventions (DEBI): CHOICES, Communal Effectance-AIDS Prevention, Female and Culturally Specific Negotiation, Project FIO, Project SAFE, RAPP, SiHLE, SISTA, Sisters Saving Sisters, Sister to Sister, WHP, WiLLOW, Women’s Co-op, Condom Promotion, Insights, Safer Sex y SEPA</em>.

En San Francisco, el proyecto <em>Women’s Leadership and Community Planning</em>organiza una capacitación de dos días para mujeres con VIH en California que quieren asumir papeles de mayor liderazgo en los concilios de planificación estatal. En las jornadas de capacitación las mujeres forman redes de contacto, aprenden sobre la pronunciación de discursos, la toma de decisiones y el manejo de conflictos. Ellas se mantienen en contacto por medio de conferencias telefónicas mensuales. Después de la primera capacitación, 6 de las 13 asistentes pasaron a ocupar puestos de liderazgo en sus concilios locales o estatales.

<em>Respeto/Proteger: Respecting and Protecting our Relationships</em> es un programa de prevención del VIH para madres y padres adolescentes latinos en Los Ángeles, CA. Creado y probado conjuntamente por una organización comunitaria e investigadores académicos, el programa reconoce los riesgos que las adolescentes afrontan, como la pobreza, el uso de drogas y alcohol, y antecedentes de ITS, abuso físico o abuso sexual. La intervención consiste en seis sesiones destinadas a sanar el espíritu herido y cultivar los sentimientos de protección materna y paterna por medio de enseñanzas culturales tradicionales.
<h4>¿qué queda por hacer?</h4>
Los programas para los hombres (especialmente los UDIs) también beneficiarán a las mujeres. El intercambio de jeringas y el tratamiento para dejar las drogas son esenciales. Las agencias de salud pública necesitan aumentar la conciencia sobre el abuso sexual y la violencia domestica, no sólo para ayudar a los hombres y a las mujeres a aprender cómo evitarlas, sino también para mitigar sus efectos sobre la epidemia del VIH. También se necesitan campañas de detección del VIH dirigidas sólo a mujeres y sitios de pruebas donde las mujeres se sientan cómodas.

Dada la falta de evidencias de intervenciones biomédicas (microbicidas y vacunas) eficaces, persiste la necesidad de brindar intervenciones conductuales y estructurales de prevención del VIH para mujeres. Sin embargo, debe continuar la investigación sobre cómo las mujeres pueden protegerse utilizando una herramienta accesible, económica, cómoda y discreta.

Es importante trasladar y concretar los hallazgos de los estudios en programas tangibles de salud pública y en políticas eficaces. Son especialmente valiosas aquellas intervenciones que tomen en cuenta la sexualidad, la familia, la cultura, el empoderamiento, la autoestima y las habilidades de negociación, así como las intervenciones ubicadas en una variedad de ambientes comunitarios.

<hr />

<h3>¿Quién lo dice?</h3>
1. Kaiser Family Foundation. Women and HIV/AIDS in the United States. Policy Fact Sheet. July 2007.

2. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and Dependent Areas, 2005. HIV/AIDS Surveillance Report. 2007;17.

3. Centers for Disease Control and Prevention. HIV/AIDS fact sheet: HIV/AIDS among women. June 2007.

4. National Institute of Allergy and Infectious Diseases at National Institutes of Health. Research on HIV infection in women. 2006.

5. Theall KP, Sterk CE, Elifson KW, et al. Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence. Public Health Reports. 2003;118:415-424.

6. Sangani P, Rutherford G, Wilkinson D. Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database of Systematic Reviews. 2004; 2:CD001220.

7. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6-10.

8. Koenig LJ, Moore J. Women, violence, and HIV: A critical evaluation with implications for HIV services. Maternal and Child Health Journal. 2000;4:103-109.

9. Wyatt GE, Myers HF, Loeb TB. Women, trauma, and HIV: an overview. AIDS and Behavior. 2004;8:401-403.

10. Bozzette SA, Berry SH, Duan N, et al. The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. New Engand Journal of Medicine. 1998;339:1897-1904.

11. Cohan DL, Kim A, Ruiz J, et al. Health indicators among low income women who report a history of sex work: the population based Northern California Young Women’s Survey. Sexually Transmitted Infections. 2005;81:428-433.

12. Adimora AA, Schoenbach VJ, Bonas DM, et al. Concurrent sexual partnerships among women in the United States. Epidemiology. 2002;13:320-327.

13. Prosper! The Women’s Collective, Washington DC.

14. Dworkin SL, Ehrhardt AA. Going beyond “ABC” to include “GEM”: critical reflections on progress in the HIV/AIDS epidemic. American Journal of Public Health. 2007;97:13-18.

15. Centers for Disease Control and Prevention. Updated Compendium of Evidence-Based Interventions, 2007.

16. Women’s Leadership and Community Planning project, CompassPoint, San Francisco, CA.

17. Lesser J, Koniak-Griffin D, Gonzalez-Figueroa E, et al. Childhood abuse history and risk behaviors among teen parents in a culturally rooted, couple-focused HIV prevention program. Journal of the Association of Nurses in AIDS Care. 2007;18:18-27.

18. Landovitz RJ. Recent efforts in biomedical prevention of HIV. Topics in HIV Medicine. 2007;15:99-103.

<hr />

<strong>Preparado por Roshan Rahnama, MPH, CAPS</strong>

<strong>Traducido por Rocky Schnaat</strong>h

Septiembre 2008. Hoja de Dato #4SR]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Women who have sex with women (Lesbians)</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are Women Who Have Sex With Women’s HIV Prevention Needs?</h3>
<h4>Are women who have sex with women at risk for HIV?</h4>
HIV risk for women who have sex with women (WSW), like for all people, varies depending on what they do. Some WSW may shoot drugs, have sex with men, trade sex for money or drugs, be victims of rape or abuse, have sex with many partners or have artificial insemination.

It is important to remember that sexual identity and sexual behavior are not always similar; for example, women who identify as lesbian can also have sex with men, and not all WSW identify as lesbian or bisexual. In this fact sheet, the term “WSW” will cover all these categories, unless a more specific term or definition is offered.

Among injection drug users, WSW have higher HIV rates than do women who have sex with men only. A study of female injection drug users (IDUs) in 14 US cities found that, compared to heterosexual women, women who had a female sex partner were more likely to share syringes, to exchange sex for drugs or money, to be homeless and to seroconvert.<sup>1</sup>

Women who identify as lesbian or bisexual and have sex with men may be at high risk for HIV due to male partnering choices and low condom use. A study of lesbians and bisexual women in San Francisco, CA, found that 81% reported sex with men in the past 3 years. Of those women, 39% reported unprotected vaginal sex and 11% unprotected anal sex.<sup>2</sup> In a survey of lesbians and bisexual women in 16 small US cities, among women who were currently sexually active with a male partner, 39% reported sex with a gay/bisexual man and 20% sex with an IDU.<sup>3</sup>
<h4>Is female-to-female transmission possible?</h4>
From all we know, there is a small but still unspecified risk of HIV transmission associated with female-to-female sexual practices.<sup>4</sup> HIV is found in vaginal fluids and menstrual blood, but the amount of virus has not been adequately measured. Female-to-female sex can include a variety of activities, and the risk relative to all activities is still not known. It is thought that oral sex alone poses a relatively low risk,<sup>4</sup> and acts that may result in vaginal trauma, such as sharing sex toys without condoms or digital play with finger cuts or sharp nails, might pose higher risk.

To date, there have been no studies that have rigorously examined female-to-female sexual acts or cunnilingus as a risk for HIV transmission, but there are a number of reported cases of transmission.<sup>5</sup> Only one study has looked at HIV-discordant lesbian couples (where one woman is infected and the other isn’t). Although this study followed only 10 couples and only over a short period of time, they found no seroconversions.<sup>6</sup>
<h4>What are barriers to prevention?</h4>
Social, environmental and economic factors can be a barrier to prevention. WSW who are poor, drug addicted, lack adequate job training, are homeless or who fear violence may turn to prostitution or engage in sex with men for survival.<sup>4</sup> Attention to more immediate concerns of food, housing and addiction often takes priority over future concerns of HIV infection.

Expectations of heterosexuality and negative social or cultural attitudes towards homosexuality may serve to increase risk behaviors among some WSW. A study in San Francisco, CA, found that young lesbians engaged in high rates of alcohol and drug use, unprotected sex with men and sexual experimentation with young gay men as a way of coping with societal pressures.<sup>7</sup>

At-risk WSW are often invisible or not recognized within other groups such as crack-smokers and injection drug users, the homeless, commercial sex workers and prisoners. WSW who have sex with men may identify with different communities depending on the gender of their current sex partner. Prevention efforts should take this into account, and recognize that bisexual women may be most effectively reached through programs targeted to high risk heterosexual women.
<h4>What’s being done?</h4>
Prevention programs that focus specifically on WSW and HIV are still extremely limited, but the following projects have made a difference. The Lesbian AIDS Project (LAP) at GMHC in New York City, NY, provides multiple services to both HIV- and HIV+ WSW. LAP runs groups, safer sex workshops and a hotline. At-risk and HIV+ lesbians on staff provide education and outreach in the community including in women’s prisons and recovery settings.<sup>8</sup>

In San Francisco, CA, Lyon-Martin Women’s Health Services trained lesbians and bisexual women as peer educators to deliver safer sex information in women’s bars, dance clubs and sex clubs. Affectionately known as the “Safer Sex Sluts,” the peer educators are “dedicated to demolishing denial” by presenting skits, giving workshops and individual consultations and handing out condoms and lubricant.<sup>9</sup>

A community-based outreach project in Hollywood, CA, targeted street-based high-risk gay, bisexual, lesbian and transgender drug users. Based on a harm reduction model, the program provided support groups, peer counseling, referrals, prevention packages and hygiene kits.<sup>10</sup>

In Guatemala, a public space for lesbians, transvestites and gay/bisexual men opened to provide a safe environment for self-expression free of alcohol, sex and drugs. The Culture House sponsors creative workshops and classes in pottery, photography, literature, English and French, among others. They also sponsor conferences and round tables on issues such as violations of human rights, attitudes of the Catholic church towards gays and lesbians, staying HIV-negative and legal aspects of AIDS.<sup>11</sup>
<h4>What still needs to be done?</h4>
Definitive research on sexual practices, sexual risks, partnering choices and demographic characteristics of WSW are needed. Effective HIV prevention for WSW must take into account their sexual identity as well as their sexual behavior and drug use activity. Distinguishing WSW by their sexual identity may be crucial in targeting prevention messages.

Service providers and health care workers must be sensitized to the needs of WSW and be trained to conduct risk assessments that are not heterosexually biased. Many service providers assume that women who are HIV+ are exclusively heterosexual. If a woman says that she has had sex with a man, most will stop at that first question and don’t proceed to ask if she has also had sex with a woman. Likewise, if a woman reports injection drug use, many will not proceed to sexual behavior questions, assuming drug use is the main risk. This not only affects the care and education a WSW may receive, but also leads to poor documentation on risk behavior forms and inadequate reporting of WSW HIV rates.

As a group, WSW have been invisible in the Centers for Disease Control and Prevention (CDC) HIV classification system. While categories of risk groups for men include men who have sex with men, injecting drug use and heterosexual<sup>12</sup> contact, among others, there is no category for WSW. Efforts to more clearly identify WSW within the CDC’s current surveillance system are underway.<sup>13</sup> Information on the actual number of WSW among AIDS cases will bring to light the need for targeted prevention programs in this population.

The most effective prevention message for WSW is still unclear. Some groups contend that we need to focus on what’s causing HIV risk for the majority of WSW—drug use and sex with men—rather than focus on issues of female-to-female transmission. Education and outreach should focus on cleaning or using new needles and using condoms for anal and vaginal sex with men, but a clearer message regarding female-to-female sex must also be established.<sup>14</sup>

It is unconscionable that after 15 years of the HIV epidemic, HIV+ women still don’t have accurate information about risk in order to know what to do or not do sexually with their female partners. A comprehensive HIV prevention strategy uses a variety of elements to protect as many people at risk as possible. Accurate information on female-to-female sexual transmission and HIV incidence, as well as what factors influence risk taking among WSW, will be key to protecting women who have sex with women.

<hr />

<h3>Says who?</h3>
<ol>
 	<li>Young RM, Weissman G, Cohen JB. Assessing risk in the absence of information: HIV risk among women injection drug users who have sex with women. AIDS and Public Policy Journal. 1992;7:175-183.</li>
 	<li>Lemp GF, Jones M, Kellogg TA, et al. HIV seroprevalence and risk behaviors among lesbians and bisexual women in San Francisco. American Journal of Public Health. 1995;85: 1549-1552.</li>
 	<li>Norman AD, Perry MJ, Stevenson LY, et al. Lesbian and bisexual women in small cities-at risk for HIV? Public Health Reports. 1996;111:347-352.</li>
 	<li>Mays VM, Cochran SD, Pies C, et al. The risk of HIV infection for lesbians and other women who have sex with women: implications for HIV research, prevention, policy, and services. Women’s Health: Research on Gender, Behavior and Policy. 1996;2:119-139.</li>
 	<li>Kennedy MB, Scarlett MI, Duerr AC et al. Assessing HIV risk among women who have sex with women: scientific and communication issues. Journal of the American Medical Women’s Association. 1995;50:103-107.</li>
 	<li>Raiteri R. HIV transmission in HIV-discordant lesbian couples. Presented at the 11th International Conference on AIDS. Vancouver, BC. 1996. Abstract #Tu.C.2455.</li>
 	<li>Gómez CA, Garcia DR, Kegebein VJ, et al. Sexual identity versus sexual behavior: implications for HIV prevention strategies for women who have sex with women. Women’s Health: Research on Gender, Behavior and Policy. 1996;2:91-109.</li>
 	<li>Hollibaugh A. LAP Notes. Lesbian AIDS project at GMHC. 1994;2:12.
<ul>
 	<li>Contact: Io Cyrus, Lesbian AIDS Project (212) 337-3531</li>
</ul>
</li>
 	<li>Stevens PE. HIV prevention education for lesbians and bisexual women: a cultural analysis of a community intervention. Social Science in Medicine. 1994;39:1565-1578.
<ul>
 	<li>Contact: Lani Ka’ahumanu (415) 821-3534.</li>
</ul>
</li>
 	<li>Reback CJ, Watt K. Street drugs, street sex: community-based outreach to gay, bisexual, lesbian and transgender drug users. Presented at the 11th International Conference on AIDS. Vancouver, BC. 1996. Abstract #ThC4670,
<ul>
 	<li>Contact: Cathy Reback (213) 463-1601.</li>
</ul>
</li>
 	<li>Martinez LF, Mayorga R, Lorenzana A, et al. The Guatemalan Gay/bisexual and Lesbian Culture House: alternative activities fostering self-esteem, behavioral changes, and AIDS prevention. Presented at the 11th International Conference on AIDS. Vancouver, BC. 1996. Abstract #ThD363.</li>
 	<li>Warren N. Out of the question: obstacles to research on HIV and women who engage in sexual behaviors with women. SIECUS Report. 1993;October/ November:13-15.</li>
 	<li>Centers for Disease Control and Prevention. Report on lesbian HIV issues meeting. Decatur, GA; April 1995.</li>
 	<li>Gorna R. Lesbian safer sex: alarmist or inadequate? Presented at the 11th International Conference on AIDS. Vancouver, BC. 1996. Abstract #ThD244.
<ul>
 	<li>Contact: (in England) Robin Gorna, Terrence Higgins Trust (011) 44-171-831-0330.</li>
</ul>
</li>
</ol>

<hr />

<strong>Prepared by Pamela DeCarlo and Cynthia Gómez, PhD</strong>
January 1997. Fact Sheet #24E

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © January 1997, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/WSWFS.pdf</url>
	</node>
	<node>
		<title>Young women</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are young women’s HIV prevention needs?</h3>
<h4>Are young women at risk for HIV?</h4>
Yes. One in five people living with HIV in the US is under the age of 25. Forty percent of these young people are female, with a total of 10,111 young women in the US living with HIV.<sup>1</sup>

Patterns of HIV infection among young women and men differ considerably. Young women bear the weight of most infections, representing 57% of all HIV cases among 13-19 year-olds, in contrast to 35% of cases among 20-24 year-olds.<sup>1</sup>

Young African American women are significantly over-represented among HIV+ youth, comprising almost three-fourths (69%) of young women living with HIV. White young women comprise 23% of young women living with HIV, Latinas 6% and Asian/Pacific Islanders and American Indian/Alaska Natives each 1%.<sup>1</sup>

The reasons why young African American women in particular have such high rates of HIV and other sexually transmitted diseases (STDs) have not been adequately addressed in research. Economic and social inequalities increase young African American women’s vulnerability to HIV infection. Structural racism through discrimination in employment, housing, earning power and educational opportunity can affect their risk for HIV.<sup>2</sup>
<h4>What puts them at risk?</h4>
While many women face structural barriers that make them vulnerable to HIV, young women face specific barriers. Social and economic inequalities, gender violence, and social position as youth—combined with young women’s particular biological vulnerability—place young women at considerable risk for HIV infection.

Over half of all HIV cases among young women do not have an identified risk (they report no or unknown transmission risk), indicating that young women are not aware that they are being exposed to HIV. Of the reported HIV cases with identified risk among young women, 37% are due to heterosexual contact and 7% to injection drug use.<sup>1</sup>

Twenty-two percent of American children live in families below the poverty level, almost twice the rate in any other industrialized country. Poverty contributes to an environment of high risk for young women, such as being homeless and/or trading sex for money or shelter.<sup>3</sup>

Sexual transmission of HIV and other STDs from men to young women is easier than to older women due to young women’s developing genital tract. A young woman’s genital tract has a thin single layer of cells that does not transition to a thick multi-layer wall until women are in their early 20s.<sup>4</sup>

Young women have high rates of STDs, and active STDs can facilitate transmission of HIV. In the US, 15-19 year-old women have the highest rates of gonorrhea and chlamydia. African American women aged 15-19 have gonorrhea rates 24 times higher than young white women.<sup>5</sup>

Sharing needles and drug preparation equipment is greater among young female IDUs, despite injecting no more than young males. Also, overlapping sexual and injection partnerships have been found to be a key factor in increased injection risk in females.<sup>6</sup>

One quarter (26%) of lesbian, gay, bisexual, and transgender youth are forced out of their homes upon disclosure of their sexuality. Living on the streets places young women at risk of HIV infection due to exposure through rape, survival sex and injecting drug use.<sup>7</sup>

Personal histories of physical and sexual abuse and trauma increase vulnerability to high-risk drug use and sexual behavior. A study of young IDUs in Vancouver, Canada, found that those who were HIV+ were more likely to be female, have a history of sexual abuse, engage in survival sex, inject heroin daily and have numerous lifetime sexual partners.<sup>8</sup>

HIV+ young women (age 13-19) are more likely than their HIV- counterparts to have older sex partners and to use condoms less frequently with them.<sup>9</sup> Partnering with older men has perceived and actual benefits for young women, such as financial and emotional security, escape from their current living situation and high status among peers. Older male partners may also present risks, as they are more likely to have had multiple sex partners and be HIV/STD infected, and less likely to use condoms.<sup>10</sup>
<h4>What are facilitators to prevention?</h4>
HIV prevention with young women is about so much more than HIV, and must consider the social and economic context of these youths’ lives. Supporting young women as agents of well-being and change in their own lives and in their communities is the foundation of thoughtful HIV prevention.

Family and community are important support systems that can protect young women from HIV risk. For example, one study found that young African American women who are involved in community-based Black social organizations are less likely to engage in risky sexual behaviors and more likely to talk to their parents about sexuality and HIV.<sup>11</sup>
<h4>What’s being done?</h4>
The Center for Young Women’s Development is a peer-run organization in San Francisco, CA that promotes self-sufficiency, community safety, and youth advocacy among young women aged 14-18 who are involved in the juvenile justice and foster care systems and/or have lived on the streets. The Center provides employment, leadership and training for them to educate others in their community. Equipped with the knowledge and opportunity to train others, these young women are more likely to incorporate these skills into their own lives.<sup>12</sup>

Sisters for Life, in Washington, DC, is a mentoring program for African American girls aged 9-14 serving three public housing communities in Alexandria, VA. The program builds the life skills of girls, supporting their efforts to develop into healthy, responsible adults who avoid HIV infection, substance abuse and STDs. Sisters for Life promotes academic accomplishments as well as self-worth and self-esteem. It addresses risks surrounding HIV/AIDS indirectly, concentrating on supporting the girls as maturing youth and addressing high-risk behaviors in the larger context of the girls’ lives.<sup>13</sup>

De Madre a Hija: Protegiendo Nuestra Salud (From Mother to Daughter: Protecting Our Health) is an intergenerational HIV prevention initiative for Latina women. This pilot intervention targets Spanish-speaking Latina mothers of adolescents. It focuses on improving mother-daughter communication across generational and cultural barriers, improving sexual knowledge and comfort, understanding risk, examining gender/sex role attitudes, and building risk reduction skills for both mother and daughter.<sup>14</sup>
<h4>What more needs to be done?</h4>
“I want to be able to speak my own language but still be understood.” (Nelly Valesco, 10/16/76 – 10/06/96)

Young women must be involved in the planning, design and implementation of HIV prevention programs. In order to be effective, HIV prevention with young women must be conducted within the social and economic context in which they are becoming infected. Because they often experience economic and social disadvantages, education and job training/opportunities are important components of prevention programs. HIV prevention programs that promote community building and involvement can be effective. Programs should incorporate communication and negotiation skills (especially with older men), general sexual and reproductive health information and mental health issues such as healing histories of trauma and abuse.

HIV prevention for young women should include access or referrals to STD prevention and treatment, pregnancy prevention and needle exchange services. Programs for hard-to-reach young women who can be most at risk for HIV should be implemented in venues outside of schools, such as youth shelters, shopping malls, detention facilities and recreation/community centers. HIV and other STDs are less of a problem for young women when they are given the skills and opportunities to support themselves.

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. US HIV and AIDS cases reported through June 2001 Midyear edition. 2002;13(1).

2. Zierler S, Krieger N. Reframing women’s risk: social inequalities and HIV infection. Annual Review of Public Health. 1997;18:401-436.

3. Prilleltensky I, Nelson G. Promoting Child and Family Wellness: Priorities for Psychological and Social Interventions. Journal of Community Applied and Social Psychology. 2000;10:86.

4. Reid E, Bailey M. Young Women: Silence, Susceptibility and the HIV Epidemic. UNDP HIV and Development Programme, Issue Paper No. 12, 2001.

5. Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1996.Atlanta, GA: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, 1997.

6. Evans JE, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco(The UFO Study) (in press).

7. Clifton CE. The young and the restless. Positively Aware. March/April 2001.http://www.thebody.com/tpan/marapr_01/young.php

8. Miller CL, Spittal PM, LaLiberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal Of Acquired Immune Deficiency Syndromes. 2002;30:335-341.

9. Sturdevant MS, Belzer M, Weissman G, et al. The relationship of unsafe sexual behavior and the characteristics of sexual partners of HIV infected and HIV uninfected adolescent females. Journal of Adolescent Health. 2001;29:S64-71.

10. Harper GW, Bangi AK, Doll M, et al. Older male sex partners present increased HIV risk for low-income female adolescents: economic, social and cultural influences. Presented at the International Conference on AIDS, July 2002,Barcelona, Spain. #ThPeE7789.

11. Crosby RA, DiClemente RJ, Wingood GM, et al. Participation by African-American adolescent females in social organizations: associations with HIV-protective behaviors. Ethnicity and Disease. 2002;12:186-192.

12. Center for Young Women’s Development. www.cywd.org

13. AIDS Action Committee. What Works in HIV Prevention for Youth. Chapter 4: What Is Working in Local Communities. 2001.http://www.thebody.com/aac/youth_prev/chapter4.php

14. Gómez CA, Gómez-Mandic C. Intergenerational HIV Prevention Initiative forLatina Women. Presented at the UCSF Center for AIDS Prevention Studies Conference. April, 2002./sites/prevention.ucsf.edu/files/uploads/ppt/Mandicppt_files/frame.htm

<hr />

<strong>Prepared by Sonja Mackenzie, MS, CAPS</strong>

<strong>October 2002. Fact Sheet #45E</strong>

Special thanks to the following reviewers of this Fact Sheet: Moher Downing, Cynthia Gomez, Gary Harper, Kayla Jackson, Jen Lee, Beverly Saunders Biddle, Kimberly Page Shafer.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © October 2002, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/youngwomenFS.pdf</url>
	</node>
	<node>
		<title>Mujeres jóvenes</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan las mujeres jóvenes para la prevención del VIH?</h3>
<h4>¿corren riesgo las mujeres jóvenes?</h4>
Sí. Una de cada cinco personas con VIH en EE.UU. es menor de 25 años. El 40% de estos jóvenes son mujeres con un total de 10,111 jovencitas en EE.UU. viviendo con VIH.<sup>1</sup>

Los patrones de infección entre las jóvenes son muy diferentes a los de los jóvenes. Las jovencitas representan una mayoría de un 57% de todos los casos de VIH entre personas de 13 a 19 años de edad, en contraste con el 35% de los casos entre personas de 20 a 24 años.<sup>1</sup>

Entre las jóvenes VIH+, predominan desproporcionadamente las afroamericanas, que componen casi las tres cuartas partes (69%) de las mujeres jóvenes viviendo con VIH. El 23% de éstas son blancas, el 6% son latinas y las asiáticas/de las islas del Pacífico, y las indígenas/nativas de Alaska componen el 1% respectivamente.<sup>1</sup>

No se ha realizado suficiente investigación sobre las razones por las cuales las jóvenes afroamericanas en particular tienen tasas tan altas de VIH y de otras enfermedades transmitidas sexualmente (ETS). Las desigualdades económicas y sociales aumentan su vulnerabilidad a la infección por VIH. El racismo estructural (que conduce a la discriminación en el empleo, la vivienda, los salarios y las oportunidades educativas) puede promover su riesgo de contraer el VIH.<sup>2</sup>
<h4>¿qué las pone en riesgo?</h4>
Muchas mujeres encuentran obstáculos estructurales que las hacen vulnerables al VIH, pero las jóvenes se enfrentan a otras barreras específicas. Las desigualdades sociales y económicas, la violencia y su posición social como persona joven, en combinación con la vulnerabilidad particular de la mujer joven, ponen a las jovencitas en un riesgo considerable de contraer el VIH.

Más de la mitad de todos los casos de VIH entre mujeres jóvenes no se atribuye a ningún riesgo identificado (ellas reportan un riesgo desconocido o ninguno), lo cual indica que ellas no se dan cuenta de que se exponen al VIH. De los casos de VIH reportados entre mujeres jóvenes con un riesgo identificado, el 37% se debe al contacto heterosexual y el 7% al uso de drogas inyectables.<sup>1</sup>

El 22% de los niños en EE.UU. vive en familias con ingresos por debajo del índice de pobreza, casi el doble de la tasa de pobreza de cualquier otro país industrializado. La pobreza contribuye a crear un ambiente de alto riesgo para las mujeres jóvenes, por ejemplo, la falta de vivienda o la necesidad de tener sexo a cambio de dinero o alojamiento.<sup>3</sup>

El VIH y otras ETS se transmiten más fácilmente del hombre a la mujer joven que a la mujer mayor, pues los órganos genitales de la joven aún se encuentran en desarrollo. Durante la juventud, el aparato genital tiene sólo una capa delgada de células, la cual no se convierte en barrera gruesa (con la formación de capas adicionales) sino hasta un poco después de los 20 años de edad.<sup>4</sup>

Las mujeres jóvenes tienen tasas altas de ETS. Una ETS activa puede facilitar la transmisión del VIH. En EE.UU., las mujeres de 15-19 años de edad tienen las tasas más altas de gonorrea y clamidia. Las afroamericanas de 15-19 años tienen tasas de gonorrea 24 veces mayores que las jóvenes blancas.<sup>5</sup>

Aunque las mujeres jóvenes usuarias de drogas inyectables (UDI) no se inyecten más que los hombres jóvenes UDI, es más frecuente que ellas compartan jeringas y equipos de preparación de drogas. Entre mujeres la práctica de compartir materiales de inyección de drogas con su pareja sexual es un factor clave en el aumento del riesgo al inyectarse.<sup>6</sup>

La cuarta parte (26%) de los jóvenes gays, lesbianas, bisexuales y transexuales son corridos de su casa al revelar su sexualidad. La vida en la calle pone a las mujeres jóvenes en peligro de contraer el VIH al exponerlas a la violación, al sexo por sobrevivencia y al uso de drogas inyectables.<sup>7</sup>

Haber sufrido abuso y trauma físico y sexual en el pasado aumenta la vulnerabilidad al uso riesgoso de drogas y a la actividad sexual sin protección. Un estudio de jóvenes UDI en Vancouver, Canadá encontró que quienes eran VIH+ tendían a: ser mujeres, haber sufrido abuso sexual, tener sexo a cambio de drogas, inyectarse diariamente heroína y haber tenido muchas parejas sexuales.<sup>8</sup>

Las adolescentes (de 13 a 19 años de edad) VIH+ son más propensas que las VIH- a tener parejas sexuales mayores y a un uso infrecuente de condones ellos.<sup>9</sup> Tener un compañero sexual mayor ofrece beneficios aparentes y reales para las mujeres jóvenes, tales como la seguridad económica y emocional, la capacidad de salir de su situación de vivienda actual, y el respeto de sus compañeras. Los compañeros mayores también pueden presentar un riesgo, pues es más probable que ellos hayan tenido varias parejas sexuales y por lo tanto estén infectados por VIH u otra ETS. Ellos también son menos propensos a usar condones.<sup>10</sup>
<h4>¿qué es lo que ayuda en la prevención?</h4>
La prevención del VIH entre mujeres jóvenes abarca mucho más que el VIH, y deberá tomar en cuenta el contexto social y económico de la vida de estas jóvenes. La base de una prevención del VIH bien pensada, consiste en apoyar a las jóvenes para que sean agentes del bienestar y del cambio en su propia vida y en su comunidad.

La familia y la comunidad son sistemas de apoyo importantes que pueden proteger a las jovencitas contra el riesgo del VIH. Por ejemplo, un estudio reveló que las jóvenes afroamericanas que participan en organizaciones sociales de la comunidad negra son menos propensas a participar en actividades sexuales riesgosas y más propensas a hablar con sus padres sobre la sexualidad y el VIH.<sup>11</sup>
<h4>¿qué se está haciendo al respecto?</h4>
El Center for Young Women’s Development (Centro para el Desarrollo de la Mujer Joven) es una organización dirigida por mujeres jóvenes en San Francisco, CA. que promueve la autosuficiencia, la seguridad comunitaria y la defensa de los derechos de la juventud entre chicas de 14 a 18 años de edad que están involucradas en los sistemas de justicia juvenil o de crianza temporal, o que han vivido en la calle. El centro les brinda empleo, liderazgo y capacitación para que ellas orienten a otras personas en su comunidad. Una vez que tengan los conocimientos y la oportunidad de capacitar a otros, es más probable que estas mujeres jóvenes incorporen estas habilidades a su propia vida.<sup>12</sup>

Sisters for Life (Hermanas de por Vida), en Washington, DC, es un programa de mentoras para afroamericanas de 9-14 años de edad en tres comunidades de vivienda pública en Alexandria, VA. El programa fortalece las habilidades prácticas de las jovencitas al apoyar sus esfuerzos por llegar a ser adultas sanas y responsables que eviten la infección por VIH, el uso de drogas y alcohol y las ETS. Sisters for Life promueve tanto los logros académicos como el amor propio y la autoestima. El programa abarca el VIH/SIDA en forma indirecta, centrándose en apoyar a las muchachas como jóvenes en vías de maduración y en enfocar las conductas de alto riesgo dentro del contexto más amplio de la vida de cada jovencita.<sup>13</sup>

De Madre a Hija: Protegiendo Nuestra Salud, es una iniciativa intergeneracional de prevención del VIH entre mujeres latinas. Este programa piloto se destina a las madres hispanohablantes de adolescentes. Su enfoque es ayudar a las participantes a mejorar la comunicación madre-hija por encima de barreras generacionales y culturales, aumentar sus conocimientos sobre el sexo y su confianza para hablar del tema, entender los riesgos para la salud, examinar actitudes sobre los papeles masculinos y femeninos y aumentar las habilidades tanto de las madres como de las hijas para reducir riesgos.<sup>14</sup>
<h4>¿qué queda por hacer?</h4>
“Quiero hablar en mi propio idioma y saber que me entenderán.” (Nelly Valesco, 10/16/76 – 10/06/96)

Las jóvenes deben ser incluidas en la planificación, diseño y puesta en práctica de los programas de prevención del VIH. Para tener buenos resultados, la prevención del VIH entre mujeres jóvenes deberá realizarse dentro del contexto social y económico en el cual ellas se infectan. Ya que muchas veces ellas tienen desventajas económicas y sociales, las oportunidades educativas y de capacitación laboral son componentes importantes de los programas de prevención. Los programas de prevención del VIH que involucren y fortalezcan a la comunidad pueden lograr cambios positivos. Estos programas deben incorporar información sobre la buena comunicación y la negociación (especialmente con hombres mayores), la salud general y reproductiva, así como ayuda para superar los efectos del trauma o abuso y otras necesidades de salud mental.

La prevención del VIH entre las mujeres jóvenes debe incluir acceso o referencias a servicios de prevención y tratamiento de ETS, prevención del embarazo e intercambio de jeringas. Es necesario ofrecer programas para las jóvenes con quienes es difícil establecer contacto y que pueden correr un mayor riesgo de contraer el VIH. Éstos servicios deben ofrecerse en lugares fuera de la escuela, tales como albergues para jóvenes, centros comerciales, centros de detención y centros recreativos o comunitarios. El VIH y otras ETS dejan de ser una gran amenaza para las mujeres jóvenes cuando ellas han adquirido las destrezas y se les han ofrecido oportunidades de apoyarse a sí mismas.

<hr />

<h4>¿quién lo dice?</h4>
1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. US HIV and AIDS cases reported through June 2001 Midyear edition. 2002;13(1).

2. Zierler S, Krieger N. Reframing women’s risk: social inequalities and HIV infection. Annual Review of Public Health. 1997;18:401-436.

3. Prilleltensky I, Nelson G. Promoting Child and Family Wellness: Priorities for Psychological and Social Interventions. Journal of Community Applied and Social Psychology. 2000;10:86.

4. Reid E, Bailey M. Young Women: Silence, Susceptibility and the HIV Epidemic. UNDP HIV and Development Programme, Issue Paper No. 12, 2001.

5. Division of STD Prevention. Sexually Transmitted Disease Surveillance, 1996.Atlanta, GA: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, 1997.

6. Evans JE, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco(The UFO Study) (in press).

7. Clifton CE. The young and the restless. Positively Aware. March/April 2001.http://www.thebody.com/tpan/marapr_01/young.html

8. Miller CL, Spittal PM, LaLiberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal Of Acquired Immune Deficiency Syndromes. 2002;30:335-341.

9. Sturdevant MS, Belzer M, Weissman G, et al. The relationship of unsafe sexual behavior and the characteristics of sexual partners of HIV infected and HIV uninfected adolescent females. Journal of Adolescent Health. 2001;29:S64-71.

10. Harper GW, Bangi AK, Doll M, et al. Older male sex partners present increased HIV risk for low-income female adolescents: economic, social and cultural influences. Presented at the International Conference on AIDS, July 2002,Barcelona, Spain. #ThPeE7789.

11. Crosby RA, DiClemente RJ, Wingood GM, et al. Participation by African-American adolescent females in social organizations: associations with HIV-protective behaviors. Ethnicity and Disease. 2002;12:186-192.

12. Center for Young Women’s Development. www.cywd.org

13. AIDS Action Committee. What Works in HIV Prevention for Youth. Chapter 4: What Is Working in Local Communities. 2001.http://www.thebody.com/aac/youth_prev/chapter4.html

14. Gómez CA, Gómez-Mandic C. Intergenerational HIV Prevention Initiative forLatina Women. Presented at the UCSF Center for AIDS Prevention Studies Conference. April, 2002./sites/prevention.ucsf.edu/files/uploads/ppt/Mandicppt_files/frame.htm

<hr />

<h3><strong>Preparado por Sonja Mackenzie, MS, CAPS</strong></h3>
<strong>Traducción Rocky Schnaath</strong>

<strong>Octubre 2002. Hoja Informativa 45S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/mujeresjovenesFS.pdf</url>
	</node>
	<node>
		<title>Abstinence</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Should we teach only abstinence in sexuality education?</h3>
<h4>Why all the fuss?</h4>
Schools have become a battleground in the nation’s culture wars. In the fight over the hearts, minds-and libidos-of our nation’s teenagers, the latest skirmish involves sex education. The question is not whether education about sexuality belongs in the schools (there is well nigh universal accord on this score),<sup>1</sup> but rather, how to approach the topic. “Just say no” is the answer, at least according to a growing number of champions of “abstinence only” curricula. Abstinence-only approaches include discussions of values, character building and refusal skills, while avoiding specific discussions of contraception or safer sex.

<strong>Comprehensive sexuality education</strong> begins with abstinence but also acknowledges that many teenagers will choose to have sex and thus need to be aware of the consequences and how to protect themselves. Such programs include instruction in safe sex behavior, including use of condoms and other contraceptives.<sup>2</sup>

<strong>The abstinence-only sex education movement</strong> has been propelled by the persistent but mistaken belief that comprehensive sexuality education itself somehow seduces teenagers into sexual activity. By this reasoning it follows that schools should either ignore the issue or discuss sexuality only in terms of fear and disease. The casualties in this war are teenagers themselves, denied information about how to prevent pregnancy or sexually transmitted diseases in the highly likely event that they have sexual intercourse.
<h4>Policy developments</h4>
Abstinence-only proponents got a big boost when, as part of the federal welfare reform legislation, Congress earmarked $50 million dollars per year for the next five years for abstinence-only school programs. Eight specific criteria have been established for programs, including the mandate that their “exclusive purpose” be teaching the “social, psychological and health gains” to be realized from abstinence. The block grant requires 75 percent matching funds from other public or private sources, for an annual total of more than $87 million.<sup>3</sup>

Every state in the union applied for the federal abstinence funding. Some expect to use it only for children in early grades or for media campaigns, a strategy which avoids putting a teacher in the position of being unable to answer a question about birth control or barrier methods of protection from high school students.<sup>4</sup>
<h4>Abstinence for whom? until when?</h4>
Abstinence-only curricula typically seek to encourage abstinence from sexual activity until marriage. In support of this goal, abstinence proponents use arguments that fly in the face of both science and human experience. The federal abstinence provisions include the statement: “Sexual activity outside the context of marriage is likely to have harmful psychological and physical effects.” This conclusion is as unsubstantiated as it is startling, in light of the statistic that 93 percent of American men and 80 percent of American women between ages 18 and 59 were not virgins on their wedding night.<sup>4</sup>

In the debate over the role for abstinence in sexuality education, little pain is taken to avoid the distinction, for example, between abstinence for 12 or 13-year olds versus 17 or 18-year-olds. Few could argue with a near exclusive focus on abstinence for young children. For older teens, sexuality education needs to be relevant for the substantial share of adolescents who choose to have sex. Two thirds (66%) of American high school seniors have had sex.<sup>5</sup>

Pleas to abstain from sex until marriage must also be considered in light of the current average age at which Americans first tie the knot (approximately 24 for women and 26 for men).<sup>6</sup> Moreover, the exhortations to avoid sex until marriage have little, if any, meaning for gay teens.
<h4>Great expectations?</h4>
The sex education debate sometimes grows so heated as to lose a sense of proportion. Great expectations are heaped on school-based programs. Most teaching is assessed by measuring its impact on knowledge rather than behavior outside of the classroom.<sup>7</sup> It is a tall order to establish the relationship between classroom sex education and changes in behaviors such as delays in initiating intercourse or increases in contraceptive use. Classroom instruction must be factored into the conflicting mix of influences from peers, parents, churches and a media barrage of pro-sex messages.

If all young people had safe and secure lives, a “just say no” message by itself might be useful. But for most, risk taking is part of a constellation of internal and external influences. A 1995 national survey reported that 16% of girls whose first intercourse was before age 16 reported that initiation of intercourse was not voluntary. School-based programs by definition also fail to reach many of those at highest risk, such as “runaway” or “throwaway” youth.<sup>9</sup>

<strong>Abstinence-only or abstinence plus?</strong>

The best sex education begins with abstinence as a starting point, both encouraging it for young people who are not ready for sex and supporting those who choose it for whatever reason. Abstinence-only proponents have criticized more comprehensive approaches for focusing only on “plumbing,” sending “mixed messages” and ignoring values. Clearly, the best sex education programs address more than the biology of sex and risk (although kids are owed the basic facts on how their bodies work and how to protect themselves against unintended pregnancy and sexually transmitted diseases).

So far, abstinence-only programs have failed to meet scientific tests of proven effectiveness. A recent review found only six published studies in the peer-reviewed literature examining abstinence-only programs.<sup>10</sup> None was found effective, in part due to poor evaluation; one was clearly ineffective. If the federal government is going to fund approaches absent any proof of significant program effects, state officials who accept federal dollars should insist that the programs be thoroughly and rigorously evaluated.

The new quarter billion dollar federal program for abstinence-only teaching furthers a religious and political, not a public health agenda.<sup>11</sup> Political agendas and discomfort with teen sexuality obstruct the ability to conduct research on which programs work best in preventing HIV and unintended pregnancies. It is not enough to agree on what adults would like young people to hear. Delivery of politically palatable-rather than effective-curricula may serve the interest of adults, but will cheat many young people.
<h4>What really works?</h4>
For all their antipathy, abstinence-only advocates and comprehensive sexuality education proponents share common goals: the prevention of unintended pregnancies, HIV and other STDs. A number of comprehensive sex education curricula examined in rigorous studies have achieved modest delays in sexual intercourse, reductions in number of partners, and increases in contraceptive use. A national review outlined a variety of elements of effective programs: tailoring to the age and experience of the audience; focus on risky sexual behavior; sound theoretical foundation; provision of basic facts about avoiding risks of unprotected sex; acknowledgement of social pressures to have sex; and practice in communication, negotiation and refusal skills.<sup>10</sup>

The guardians of quality education, including teachers, parents, school boards, and legislators have a duty to consider more than the leanings of one advocacy group or another. Credible, objective evidence about the ability of specific programs to achieve their goals is essential. Decision makers need to separate value questions from questions of effectiveness in sex education, and find the common ground.
<h3>Says who?</h3>
Kaiser Family Foundation. The Kaiser Survey on Americans and AIDS/HIV. Menlo Park, CA: 1998.

2. National Institutes of Health. Interventions to Prevent HIV Risk Behaviors. Consensus Development Conference Statement . Washington, D.C.:1997; Feb. 11-13.

3. Block Grant Guidance for the Abstinence Education Provision of the 1996 Welfare Law P.L. 104-193. For more information, contact: Department of Health and Human Services, PHS/HRSA/MCHB/OD/CB-18-20, 5600 Fishers Lane, Rockville, MD 20857, (301) 443-0205.

4. Associated Press. Sex education that teaches abstinence wins support. New York Times. July 23,1997;A19.

5. Centers for Disease Control and Prevention. Youth risk behavior surveillance-United States , 1995. Morbidity and Mortality Weekly Report. 1996;45(No. SS-4):1-86.

6. The Alan Guttmacher Institute. Sex and America’s Teenagers. New York, 1994. http://www.agi-usa.org/

7. Kirby D. Sex and HIV/AIDS education in schools . British Medical Journal. 1995;311:403.

8. National Center for Health Statistics. National Survey of Family Growth, cycle IV : 1990 telephone reinterview. Hyattsville, MD: US Department. of Health and Human Services; 1995.

9. Rotheram-Borus MJ, Koopman C, Haignere C, et al. Reducing HIV risk behaviors among runaway adolescents . Journal of the American Medical Association. 1991;266:1237-1241.

10. Kirby D. No Easy Answers: Research Findings on Programs to Reduce Teen Pregnancy . Washington, DC: National Campaign to Prevent Teen Pregnancy; 1997.

11. Ehrhardt AA. Our view of adolescent sexuality-a focus on risk behavior without the developmental context . American Journal of Public Health. 1996;86:1523-1525.

<strong>Resources:</strong>

The Alan Guttmacher Institute
120 Wall Street
New York, NY 10005
(212) 248-1111
http://www.agi-usa.org/

Centers for Disease Control and Prevention
Division of Adolescent and School Health
4770 Buford Highway, NE MS-29
Chamblee, GA 30341
(770) 488-3251
http://www.cdc.gov/nccdphp/dash/

Sexuality Information and Education Council of the United States (SIECUS)
130 West 42nd Street, Suite 350
New York, NY 10036
(212) 819-9770.
http://www.siecus.org

National School Boards Association
1680 Duke Street
Alexandria, VA 22314
(703) 838-6722
Contact: Brenda Z. Greene
http://www.nsba.org

<hr>
<strong>Prepared by Chris Collins* and Jeff Stryker*
*CAPS, UCSF</strong>

September 1997. Fact Sheet #30E

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to FactsSheetM@psg.ucsf.edu. © September 1997, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/abstinenceFS.pdf</url>
	</node>
	<node>
		<title>Abstinencia</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Debemos enseñar “solo-abstinencia” en la educación sexual?</h3>
<h4>¿por qué tanto alboroto?</h4>
Las escuelas se han convertido en el campo de batalla cultural de la nación. En la lucha por conquistar el corazón, mente — y líbidos — de nuestra juventud, la última contienda incluye la educación sexual. La pregunta no radica en que si la escuela es el lugar apropiado para enseñar educación sexual (en esto todos estamos de acuerdo),<sup>1</sup> más bien es, como abordar el tema. Con solo decir “no” se soluciona el problema, al menos esto es lo que cree una cantidad creciente de campeones del currículum basado en solo-abstinencia. Con la abstinencia se trata el tema de los valores morales, se contruye el carácter y se aprende a decir “no”, siempre y cuando se evite el tema de los anticonceptivos o el sexo seguro.

<strong>Una educación sexual completa</strong> comienza con la abstinencia, pero además toma en cuenta que muchos jóvenes van a decidir tener sexo, por lo tanto tienen que saber las consecuencias y la manera de protegerse a si mismos. Estos programas incluyen la instrucción sobre el comportamiento sexual seguro, incluyendo el uso del condón y de otros anticonceptivos.<sup>2</sup>

<strong>El movimiento de educación sexual basado en solo-abstinencia</strong> tiene su origen en la constante y errada creencia de que una educación sexual completa de alguna forma induce a la juventud a iniciar la actividad sexual. A causa de este razonamiento, las escuelas deben ignorar el tema o relacionar la sexualidad con el temor y la enfermedad. En esta guerra los perdedores siguen siendo los jóvenes, ya que se les niega información sobre como evitar los embarazos o las enfermedades de transmisión sexual en caso de que tengan relaciones sexuales, lo cual es muy probable.
<h4>políticas en desarrollo</h4>
Los proponentes de solo-abstinencia obtuvieron su mayor logro cuando como parte de la ley de Reforma Federal de Bienestar Social, el congreso designó 50 millones de dólares anuales por cinco años consecutivos a programas de solo-abstinencia en las escuelas. Existen ocho elementos específicos que estos programas deben cumplir, uno de estos mandatos es que el “propósito exclusivo” del programa sea el de demostrar la ganancia social, psicológica y de salud que se obtiene por medio de la abstinencia. Este tipo de fondos requiere que se recaude el 75% de la cantidad otorgada a través de fuentes públicas o privadas, para un total de $87 millones de dólares anuales.<sup>3</sup>
<h4>abstinencia, ¿para quién? y ¿Hasta cuándo?</h4>
Generalmente, el currículum de solo-abstinencia promueve abstenerse de la actividad sexual hasta el matrimonio. Para lograr esta meta, los proponentes de la abstinencia usan argumentos que pasan por alto ante la ciencia y la experiencia del ser humano. Una de las provisiones federales en cuanto a la abstinencia establece que la actividad sexual fuera del matrimonio puede ocasionar daños físicos y psicológicos. Esta conclusión resulta tan carente de validez como sorprendente si tomamos en cuenta las estadísticas que señalan que el 93 por ciento de los hombres y el 80 por ciento de las mujeres entre los 18 y 59 años de edad no eran vírgenes en su noche de bodas.<sup>4</sup>

En el debate acerca del papel que desempeña la abstinencia en la educación sexual, poco se hace para lograr la distinción, por ejemplo, entre los programas de abstinencia para los de 12 a 13 anõs versus los de 17 o 18 años. Todos están de acuerdo que la abstinencia se les debe enseñar a niños pequeños. Para los adolescentes mayores, la educación sexual debe ser relevante a la cantidad sustancial de adolescentes que deciden tener relaciones sexuales. Dos tercios (66%) de los adolescentes en su último año escolar han tenido relaciones sexuales.<sup>5</sup>

Al pedir la abstinencia sexual hasta el matrimonio, se debe tomar en cuenta el promedio actual de las edades en que los Norteamericanos contraen matrimonio por primera vez (aproximadamente 24 años en la mujer y 26 para el hombre).<sup>6</sup> Es más, pedirles a los hombres gay que eviten el sexo hasta el matrimonio, tiene poco significado, si acaso lo tiene.
<h4>¿grandes expectativas?</h4>
El debate sobre la educación sexual, algunas veces crece a niveles fuera de proporción. La mayor parte de la enseñanza se determina midiendo el impacto que el programa ha tenido en el conocimiento, en vez de en la conducta adoptada una vez fuera del salón de clases.<sup>7</sup>  Es imperante establecer la relación entre las clases de educación sexual en el salón de clases y los cambios de conducta tales como el retraso del inicio de las relaciones sexuales o el incremento en el uso de los anticonceptivos. La enseñanza en los salones de clase debe tomar en cuenta la mezcla de influencias de los compañeros(as), de la iglesia , y de una ráfaga de mensajes publicitarios que promueven el sexo.

Si todos tuviéramos una vida sana y segura, el simple mensaje de “solo di no” pudiera ser útil. Pero para la mayoría arriesgar forma parte de una constelación de influencias externas e internas. Una encuesta a nivel nacional reveló que el 16% de las chicas que tuvieron su primera relación sexual antes de cumplir los 16 años fue involuntaria.<sup>8</sup>  Los programas con base en las escuelas, por definición, fracasan en alcanzar a aquellos jóvenes que corren mayores riesgos, tales como los que han huído de sus casas y los que son echados de sus casas.<sup>9</sup>
<h4>¿solo-abstinencia o abstinencia y algo más?</h4>
La mejor educación sexual tiene como punto de partida la abstinencia, promoviéndola entre aquellos que no están listos para tener sexo y apoyando a aquellos que por cualquier razón deciden abstenerse. Claramente, los mejores programas de educación sexual van más allá de la biología del riesgo y del sexo (aún faltaría explicar el funcionamiento básico del cuerpo humano y como protegerse a si mismos de los embarazos no planeados y de las ETS).

Hasta hoy, los programas de solo-abstinencia no han podido demostrar cientificamente su efectividad. Un estudio realizado recientemente, encontró que solamente se ha publicado la literatura de seis estudios en revistas evaluadas por expertos en la materia, en los cuales se examinaba la efectividad de los programas de solo-abstinencia.<sup>10</sup>  Ninguno de estos programas demostró ser efectivo, en parte debido al inadecuado método de la evaluación; uno de estos era claramente ineficaz.

El nuevo cuarto de billón de dólares asignado a programas federales de solo-abstinencia, más que una agenda de salud pública parece más bien política y religiosa.<sup>11</sup>  Las agendas políticas y la incomodidad del tema de la sexualidad en la juventud obstruyen la habilidad de conducir investigaciones sobre cuales programas son los que funcionan mejor en la prevención del VIH y de los embarazos no planeados. Proclamar currículums agradables al paladar político-en vez de efectivo- puede servir el interés de los adultos, pero defraudar el de muchos jóvenes.
<h4>¿qué es lo que realmente funciona?</h4>
A pesar de todo, los que abogan por una educación sexual basada en solo-abstinencia y los proponentes de una educación sexual completa, tienen algunas metas en común: la prevención de los embarazos no planeados, evitar la infección con VIH y de otras ETS. Una buena cantidad de curriculums sobre educación sexual completa que fueron examinados a través de rigurosos estudios han logrado un modesto retraso en el inicio de las relaciones sexuales, una reducción en la cantidad de parejas; y un aumento en el uso de anticonceptivos. En una revisión a nivel nacional se señalaron varios elementos de programas eficaces: fueron diseñados de acuerdo a la edad y experiencia de la audiencia; con un enfoque en el comportamiento sexual de riesgo; con una base teórica razonable; ofreciendo información básica sobre como evitar el riesgo de tener sexo sin protección; hacerles notar que la sociedad los empuja a tener sexo; practicar la comunicación, la negociación y las formas de decir no.<sup>10</sup>

Los encargados de mantener una educación de calidad, incluyendo a maestros, padres de familia, miembros de juntas directivas escolares, y legisladores tienen el deber de ir más allá de querer favorecer a un grupo sobre otro. Para lograr cumplir las metas específicas de un programa que dice ser efectivo es esencial que la evidencia sea creíble y objetiva. Cuando se trata del tema de la sexualidad es necesario que los que toman las decisiones separen las preguntas sobre valores morales de las de efectividad y encontrar un terreno común.

<hr />

<h4>¿quién lo dice?</h4>
Kaiser Family Foundation. The Kaiser Survey on Americans and AIDS/HIV. Menlo Park, CA: 1998.

2. National Institutes of Health. Interventions to Prevent HIV Risk Behaviors. Consensus Development Conference Statement . Washington, D.C.:1997; Feb. 11-13.

3. Block Grant Guidance for the Abstinence Education Provision of the 1996 Welfare Law P.L. 104-193. For more information, contact: Department of Health and Human Services, PHS/HRSA/MCHB/OD/CB-18-20, 5600 Fishers Lane, Rockville, MD 20857, (301) 443-0205.

4. Associated Press. Sex education that teaches abstinence wins support. New York Times. July 23,1997;A19.

5. Centers for Disease Control and Prevention. Youth risk behavior surveillance-United States , 1995. Morbidity and Mortality Weekly Report. 1996;45(No. SS-4):1-86.

6. The Alan Guttmacher Institute. Sex and America’s Teenagers. New York, 1994. http://www.agi-usa.org/

7. Kirby D. Sex and HIV/AIDS education in schools . British Medical Journal. 1995;311:403.

8. National Center for Health Statistics. National Survey of Family Growth, cycle IV : 1990 telephone reinterview. Hyattsville, MD: US Department. of Health and Human Services; 1995.

9. Rotheram-Borus MJ, Koopman C, Haignere C, et al. Reducing HIV risk behaviors among runaway adolescents . Journal of the American Medical Association. 1991;266:1237-1241.

10. Kirby D. No Easy Answers: Research Findings on Programs to Reduce Teen Pregnancy . Washington, DC: National Campaign to Prevent Teen Pregnancy; 1997.

11. Ehrhardt AA. Our view of adolescent sexuality-a focus on risk behavior without the developmental context . American Journal of Public Health. 1996;86:1523-1525.

<strong>Recursos:</strong>

The Alan Guttmacher Institute 120 Wall Street, New York, NY 10005, (212) 248-1111. http://www.agi-usa.org/

Centers for Disease Control and Prevention, Division of Adolescent and School Health, 4770 Buford Highway, NE MS-29, Chamblee, GA 30341, (770) 488-3251.http://www.cdc.gov/nccdphp/dash/

Sexuality Information and Education Council of the United States (SIECUS), 130 West 42nd Street, Suite 350, New York, NY 10036, (212) 819-9770.http://www.siecus.org

National School Boards Association, 1680 Duke Street, Alexandria, VA 22314, (703) 838-6722. Contact: Brenda Z. Greene. http://www.nsba.org

<hr />

<strong>Preparado por Chris Collins* y Jeff Stryker*, Traducción Romy Benard-Rodríguez*
*CAPS</strong>

Abril 1998. Hoja Informativa 30S.

versión en PDF]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/abstinenciaFS.pdf</url>
	</node>
	<node>
		<title>Adolescents</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are Adolescents’ HIV Prevention Needs?</h3>
<h4>Can adolescents get HIV?</h4>
Unfortunately, yes. HIV infection is increasing most rapidly among young people. Half of all new infections in the US occur in people younger than 25. From 1994 to 1997, 44% of all HIV infections among young people aged 13-24 occurred among females, and 63% among African-Americans. While the number of new AIDS cases is declining among all age groups, there has not been a comparable decline in the number of new HIV infections among young people.<sup>1</sup>

Unprotected sexual intercourse puts young people at risk not only for HIV, but for other sexually transmitted diseases (STDs) and unintended pregnancy. Currently, adolescents are experiencing skyrocketing rates of STDs. Every year three million teens, or almost a quarter of all sexually experienced teens, will contract an STD. Chlamydia and gonorrhea are more common among teens than among older adults.<sup>2</sup>

Some sexually-active young African-American and Latina women are at especially high risk for HIV infection, especially those from poorer neighborhoods. A study of disadvantaged out-of-school youth in the US Job Corps found that young African-American women had the highest rate of HIV infection, and that women 16-18 years old had 50% higher rates of infection than young men.<sup>3</sup> Another study of African-American and Latina adolescent females found that young women with older boyfriends (3 years older or more) are at higher risk for HIV.<sup>4</sup>
<h4>What puts adolescents at risk?</h4>
Adolescence is a developmental period marked by discovery and experimentation that comes with a myriad of physical and emotional changes. Sexual behavior and/or drug use are often a part of this exploration. During this time of growth and change, young people get mixed messages. Teens are urged to remain abstinent while surrounded by images on television, movies and magazines of glamorous people having sex, smoking and drinking. Double standards exist for girls-who are expected to remain virgins-and boys-who are pressured to prove their manhood through sexual activity and aggressiveness. And in the name of culture, religion or morality, young people are often denied access to information about their bodies and health risks that can help keep them safe.<sup>5</sup>

A recent national survey of teens in school showed that from 1991 to 1997, the prevalence of sexually activity decreased 15% for male students, 13% for White students and 11% for African-American students. However, sexual experience among female students and Latino students did not decrease. Condom use increased 23% among sexually active students. However, only about half of sexually active students (57%) used condoms during their last sexual intercourse.<sup>6</sup>

Not all adolescents are equally at risk for HIV infection. Teens are not a homogenous group, and various subgroups of teens participate in higher rates of unprotected sexual activity and substance use, making them especially vulnerable to HIV and other STDs. These include teens who are gay/exploring same-sex relationships, drug users, juvenile offenders, school dropouts, runaways, homeless or migrant youth. These youth are often hard to reach for prevention and education efforts since they may not attend school on a regular basis, and have limited access to health care and service-delivery systems.<sup>7</sup>
<h4>Can education help?</h4>
Yes. Schools are an important venue for educating teenagers on many kinds of health risks, including HIV, STD and unintended pregnancy. Across the US and around the world, studies have shown that sexuality education for children and young people does not encourage increased sexual activity and does help young people remain abstinent longer. Effective educational programs have focused curricula, have clear messages about risks of unprotected sex and how to avoid risks, teach and practice communication skills, address social and media influences, and encourage openness in discussing sexuality.<sup>8</sup> In addition, HIV prevention programs that are carefully targeted to adolescents can be highly cost effective.<sup>9</sup>
<h4>Are schools the only answer?</h4>
No. Young people need to get prevention messages in lots of different ways and in lots of different settings. Schools alone can’t do the job. In the US, many schools are being hampered by laws and funding that prohibit comprehensive sexuality education. The federal government earmarked $50 million per year for school-based abstinence-only programs which emphasize values, character building and refusal skills, but do not discuss contraception or safer sex.<sup>10</sup> Although abstinence programs are effective at delaying the onset of sexual activity, they typically do not decrease rates of sexual risk activity among adolescents the way that safer sex interventions do.<sup>11</sup>

Youth who are not in school have higher frequencies of behaviors that put them at risk for HIV/STDs, and are less accessible by prevention efforts. A national survey of youth aged 12-19 found that 9% were out-of-school. Out-of-school youth were significantly more likely than in-school youth to have had sexual intercourse, had four or more sex partners, and had used alcohol, marijuana and cocaine.<sup>12</sup> More intensive STD/HIV and substance abuse prevention programs should be aimed at out-of-school youth or youth at risk for dropping out of school.

Programs targeting hard-to-reach adolescents at high risk for HIV are necessary in many different venues outside of schools. Programs based in venues such as residential child care facilities, alternative schools and youth detention centers are needed. Peer educators can use an empowerment-oriented approach targeted to youth aged 12-17 to teach about preventing HIV and STDs, and to mobilize and link resources for young people through social and community networks.<sup>13</sup>

Families play an important role in helping teenagers avoid risk behaviors. Frank discussions between parents and adolescent children about condoms can lead teens to adopt behaviors that will prevent them from getting HIV and other STDs. Research has shown that when mothers talked about and answered questions about condom use with their adolescents prior to sexual debut, the adolescents reported greater condom use at first intercourse and most recent intercourse, as well as greater lifetime condom use.<sup>14</sup>

The WEHO Lounge in Los Angeles, CA, is a coffee house and HIV testing and information center located between two of the busiest gay discos in town. It offers free confidential oral HIV testing, weekly community forums, peer counseling, drug adherence support groups, free condom distribution and a comprehensive youth and HIV resource library. The Lounge also sells coffee drinks. By placing this resource in the community and adapting it to the needs and habits of young gay men, the program has been highly successful with clients.<sup>15</sup>

Project VIDA in Chicago, IL, a community-based service organization, provides HIV prevention for high-risk urban Latina females, ages 12-24. Project VIDA incorporates empowerment and self-care themes into peer-facilitated street/community outreach and group interventions. They act on the belief that it is impossible to separate HIV risks from other cultural, environmental, interpersonal, and intrapsychic stressors that Latina youths face; and that coping skills can help manage the perplexities of these challenges.<sup>16</sup>
<h4>What needs to be done?</h4>
HIV prevention programs for adolescents must consider the developmental needs and abilities of this age group. Programs should focus on contextual factors that lead young people to engage in higher rates of sexual activity and lower rates of condom use, such as low self-esteem, depression, substance use, gang activity, stress of living in turbulent urban environments, or boredom/restlessness related to unemployment.

Any program for adolescents should be interesting, fun and interactive, and involve youth in the planning and implementation. This is especially true for out-of-the-mainstream youth and youth from diverse cultures. Programs for hard-to-reach youth who are most at risk for HIV infection should be implemented in venues outside of schools, such as runaway/homeless youth shelters, shopping malls, detention facilities and recreation/community centers. Adolescents not only need correct information and practice in self-protective skills, but also easy access to condoms in order to keep themselves risk-free.

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. Young people at risk-epidemic shifts further toward young women and minorities. Fact sheet prepared by the CDC. July 1998.

2. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1996.

3. Valleroy LA, MacKellar DA, Karon JM, et al. HIV infection in disadvantaged out-of-school youth: prevalence for US Job Corps entrants, 1990 through 1996 . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;19:67-73.

4. Miller KS, Clark LF, Moore JS. Sexual initiation with older male partners and subsequent HIV risk behavior among female adolescents . Family Planning Perspectives. 1997;29:212-214.

5. UNAIDS. Force for Change: World AIDS Campaign with Young People . Report prepared by UNAIDS, The Joint United Nations Programme on HIV/AIDS for World AIDS Day 1998.

6. Centers for Disease Control and Prevention. Trends in sexual risk behaviors among high school students-United States, 1991-1997 . Morbidity and Mortality Weekly Report. 1998;47:749-752.

7. Rotheram-Borus MJ, Mahler KA, Rosario M. AIDS prevention with adolescents . AIDS Education and Prevention. 1995;7:320-336.

8. UNAIDS. Impact of HIV and sexual health education on the sexual behavior of young people: a review update . Report prepared by UNAIDS, The Joint United Nations Programme on HIV/AIDS for World AIDS Day 1997.

9. Pinkerton SD, Cecil H, Holtgrave D.R. HIV/STD prevention interventions for adolescents: cost-effectiveness considerations . Journal of HIV/AIDS Prevention and Education for Adolescents and Children. 1998;2:5-31.

10. Associated Press. Sex education that teaches abstinence wins support. New York Times. July 23,1997:A19.

11. Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African-American adolescents: a randomized controlled trial . Journal of the American Medical Association. 1998;279:1529-1536.

12. Centers for Disease Control and Prevention. Health risk behaviors among adolescents who do and do not attend school-United States, 1992 . Morbidity and Mortality Weekly Report. 1994;43:129-132.

13. Zibalese-Crawford M. A creative approach to HIV/AIDS programs for adolescents . Social Work in Health Care. 1997;25:73-88.

14. Miller KS, Levin ML, Whitaker DJ, et al. Patterns of condom use among adolescents: the impact of mother-adolescent communication . American Journal of Public Health. 1998;88:1542-1544.

15. Weinstein M, Farthing C, Portillo T, et al. Taking it to the streets: HIV testing, treatment information and outreach in a Los Angeles neighborhood coffee house. Presented at the 12th World AIDS Conference, Geneva, Switzerland; 1998. Abstract #43125.

16. Harper GW, Contreras R, Vess L, et al. Improving community-based HIV prevention for young Latina women. Presented at the Biennial Meeting of the Society for Community Research and Action, New Haven, CT; June,1999.

<hr />

<h3><strong>Prepared by Gary W. Harper, PhD MPH* and Pamela DeCarlo**
*Department of Psychology, DePaul University, **CAPS</strong></h3>
April 1999. Fact Sheet #9ER

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 1999, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/adolescentFS.pdf</url>
	</node>
	<node>
		<title>Adolescentes</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué necesitan los adolescentes en la prevención del VIH?</h3>
<h4>¿pueden contraer los adolescentes el VIH?</h4>
Desafortunadamente, sí. Los casos de infección del VIH se incrementan más aceleradamente en los jóvenes. La mitad de todos los casos de VIH se presentan en personas menores de 25 años. De todos los casos de VIH de 1994-1997 en jóvenes de 13-24 años, 44% eran mujeres y 63% Afro-Americanos. Mientras la cifra de nuevos casos de SIDA se reduce en los diferentes grupos de edad, no se ha observado una reducción comparable en la cantidad de nuevas infecciones en los jóvenes.<sup>1</sup>

Las relaciones sexuales implican riesgo para un joven, no solo del VIH, sino además para otras Enfermedades de Transmisión Sexual (ETS) y los embarazos no planeados. Actualmente, los adolescentes experimentan tasas alarmantes de ETS. Cada año, tres millones de jovenes entre los 13 y 18 años-es decir, un cuarto de todos con experiencia sexual-contraerán alguna ETS. La clamidia y la gonorrea ocurren con mayor frecuencia entre la juventud que en personas mayores.<sup>2</sup>

En especial, algunas jóvenes Afro-Americanas y Latinas sexualmente activas corren mayor riesgo de infectarse con VIH, especialmente aquellas que provienen de barrios pobres. En un estudio de desertores escolares jóvenes en el “U.S. Job Corps” se descubrió que las jóvenes Afro-Americanas tenían mayores tasas de infección con VIH y que los índices de infección entre las mujeres entre los 16 y 18 años era mayor a las de los hombres jóvenes en un 50%.<sup>3</sup> Otro estudio de mujeres adolescentes Afro-Americanas y Latinas reveló que las jóvenes con novios mayores que ellas (3 años mayor o más) corren mayor riesgo de infectarse con el VIH.<sup>4</sup>
<h4>¿cómo se exponen al riesgo?</h4>
La adolescencia es un período de desarrollo marcado por la curiosidad y la experimentación acompañada de una miríada de cambios emocionales. La conducta sexual y/o el uso de drogas suelen formar parte de esta exploración. Durante esta etapa de crecimiento y cambios, los jóvenes reciben mensajes contradictorios. Por un lado a la juventud se le exhorta a abstenerse sexualmente mientras se les satura de imágenes glamorosas de personajes de cine y televisión teniendo sexo, fumando y tomando. Este doble estándar existe para las chicas-de las que se espera se conserven vírgenes-y los chicos-con la presión de demostrar su hombría por medio de la agresividad y la actividad sexual. En nombre de la cultura, la religión y la moralidad, a la juventud suele negársele el derecho a estar informados sobre el funcionamiento de su cuerpo y los riesgos para la salud para poder protetegerse mejor.<sup>5</sup>

Un reciente sondeo a nivel nacional con jóvenes reveló que de 1991 a 1997, la prevalencia de la actividad sexual disminuyó en un 15% para los estudiantes masculinos, 13% en estudiantes blancos y 11% en estudiantes Afro-Americanos. Sin embargo no se presentó reducción alguna respecto a la experiencia sexual en estudiantes femeninas o en Latinos. Hubo un incremento del uso del condón del 23% en estudiantes sexualmente activos. Sin embargo, solo cerca de la mitad de los estudiantes sexualmente activos usaron condones durante su última relación sexual.<sup>6</sup>

No todos los adolescentes corren el mismo riesgo de infectarse con VIH. La juventud no es un grupo homogéneo, por lo tanto, dentro de esa categoría existen subgrupos que participan en mayor cantidad de actividades sexuales sin protección y abusan de las drogas, lo cual les vuelve más vulnerables al VIH y otras ETS. Esto incluye a jóvenes homosexuales o que experimentan relaciones con personas del mismo sexo, usuarios de drogas, delincuentes juveniles, desertores escolares, vagabundos, desamparados o jóvenes inmigrantes. Alcanzar a este grupo de jóvenes con actividades de prevención se dificulta debido a que no asisten a la escuela regularmente y tienen acceso limitado al sistema de salud u otros servicios similares.<sup>7</sup>
<h4>¿puede ayudar la educación?</h4>
Si. Las escuelas son un sitio ideal para que los jóvenes aprendan a conocer los riesgos para la salud, incluyendo el VIH, las ETS y los embarazos no planeados. A nivel nacional y global se ha comprobado, por medio de estudios, que la educación sexual a niños y jóvenes no estimula el incremento en la actividad sexual y sí ayuda a la juventud a abstenerse por más tiempo. Los programas educativos exitosos utilizan un curriculó y mensajes claros sobre los riesgos del sexo sin protección y las formas de evitar el riesgo, enseñan y practican la comunicación, tratan el tema de la influencia de la sociedad y de los medios de comunicación, y promueven que se hable del tema de la sexualidad abiertamente.<sup>8</sup> Adicionalmente, los programas de prevención para adolescentes dirigidos cuidadosamente pueden ser muy efectivos a nivel de costo.<sup>9</sup>
<h4>¿sólo en la escuela se encuentra la solución?</h4>
No. La juventud necesita recibir mensajes de prevención de formas diversas y en sitios diferentes. Las escuelas por si solas no pueden realizar esta tarea. En los EEUU, a muchas escuelas se les prohibe el uso de fondos federales si utilizan un currículo abierto en cuanto a la sexualidad. El gobierno federal asignó $50 millones anuales a aquellas escuelas cuyos programas están basados en la abstinencia-sin tocar el tema de los anticonceptivos o el sexo seguro.<sup>10</sup> Aunque es cierto que los programas de abstinencia logran retrasar el inicio de la actividad sexual, en general, no reducen la cantidad de actividades sexuales de riesgo de la forma en que lo logran las intervenciones basadas en el sexo seguro.<sup>11</sup>

Los jóvenes que no asisten a la escuela con mayor frecuencia presentan conductas que les pone a riesgo de contraer VIH/ETS, y tienen menor acceso a programas de prevención. Un sondeo nacional con jóvenes entre los 12 y 19 años de edad reveló que el 9% no asistían a la escuela. Los desertores escolares estuvieron significativamente más propensos a haber tenido relaciones sexuales que los que sí asistían, tenían 4 o más parejas sexuales y habían experimentado con el alcohol, marihuana y cocaína.<sup>12</sup> Deberían crearse programas de prevención más intensivos para los desertores escolares y los que están en riesgo de desertar.

Es necesario que los programas dirigidos a los adolescentes que no tienen una vida estable se lleven a cabo en los sitios que ellos frecuentan tales como en centros de detención juvenil y escuelas alternativas. La instrucción impartida por miembros de este mismo grupo puede utilizar el método del empoderamiento, enseñar sobre prevención de VIH, ETS, además de movilizar y anexar recursos para los jóvenes por medio de organizaciones comunitarias y sociales.<sup>13</sup>

El apoyo familiar para que los jóvenes eviten caer en conductas de riesgo es de incalculable valor. Las conversaciones francas sobre condones entre padres e hijos adolescentes puede conducir a los jóvenes a adoptar conductas que les prevendrán de contraer el VIH y otras ETS. Cuando las madres hablan y contestan preguntas sobre el uso del condón previo al iniciamiento sexual, los adolescentes han reportado el uso del condón la primera y última vez que tuvieron sexo, así como un mayor uso del condón durante el transcurso de sus vidas.<sup>14</sup>

En Los Angeles, CA, el “WEHO Lounge” es una cafetería y centro de detección e información de VIH localizado entre dos discotecas “gay.” Ofrece pruebas orales de detección del VIH confidenciales, foros comunitarios semanales, consejería impartida por miembros de este grupo, distribución gratuita de condones y una biblioteca juvenil con recursos relacionados al VIH. Este “Lounge” tambien vende cafés. Al colocar este recurso en la comunidad y adaptarlo a la necesidad y hábitos de los hombres jóvenes “gay”, el programa ha tenido un exito fenomenal.<sup>15</sup>

El Proyecto VIDA de Chicago, IL, una organización que provee servicios a la comunidad, conduce prevención del VIH a mujeres Latinas entre los 12 y 24 años en riesgo de infección. VIDA recluta y conduce intervenciones dirigidas por miembros de este mismo grupo en las que se incorporan temas como el empoderamiento y la autoestima. Ellos actúan en la creencia de que es imposible separar los riesgos de contraer VIH de las presiones culturales, ambientales, interpersonales e intrasíquicas que enfrentan las jóvenes Latinas; y que es posible vencer estos obstáculos aprendido a manejar situaciones difíciles.<sup>16</sup>
<h4>¿qué queda por hacer?</h4>
Los programas de prevención para adolescentes deben tomar en cuenta las necesidades y habilidades que presenta la edad de este grupo. Los programas deben tener un enfoque en los factores contextuales que contribuyen a que los jóvenes participen en mayor cantidad de actividades sexuales y bajos índices en el uso del condón, tales como la baja auto-estima, la depresión, el uso de drogas, actividades de pandillas, la presión de vivir en ambientes urbanos turbulentos o aburridos ocasionados por la falta de empleo.

Cualquier programa para adolescentes debe ser interesante, divertido e interactivo, debe incluir la opinión de los jóvenes en cuanto al diseño e implementación. Esto se aplica especialmente a jóvenes de otras culturas que no forman parte de la gran mayoría. Los programas para jóvenes inestables que corren el riesgo de contraer VIH deben implementarse en otros locales aparte de la escuela, tales como casas de refugio para jóvenes sin hogar o que se han escapado de ellos, centros comerciales, centros de detención, y centros comunitarios. No basta con que los jóvenes reciban la información adecuada ni con practicar las habilidades de auto-protección, es también necesario facilitar el acceso a los condones para poder mantenerles libres de riesgo.

<hr />

<h4>¿quién lo dice?</h4>
1. Centers for Disease Control and Prevention. Young people at risk-epidemic shifts further toward young women and minorities. Fact sheet prepared by the CDC. July 1998.

2. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1996.

3. Valleroy LA, MacKellar DA, Karon JM, et al. HIV infection in disadvantaged out-of-school youth: prevalence for US Job Corps entrants, 1990 through 1996 . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998;19:67-73.

4. Miller KS, Clark LF, Moore JS. Sexual initiation with older male partners and subsequent HIV risk behavior among female adolescents . Family Planning Perspectives. 1997;29:212-214.

5. UNAIDS. Force for Change: World AIDS Campaign with Young People . Report prepared by UNAIDS, The Joint United Nations Programme on HIV/AIDS for World AIDS Day 1998.

6. Centers for Disease Control and Prevention. Trends in sexual risk behaviors among high school students-United States, 1991-1997 . Morbidity and Mortality Weekly Report. 1998;47:749-752.

7. Rotheram-Borus MJ, Mahler KA, Rosario M. AIDS prevention with adolescents . AIDS Education and Prevention. 1995;7:320-336.

8. UNAIDS. Impact of HIV and sexual health education on the sexual behavior of young people: a review update . Report prepared by UNAIDS, The Joint United Nations Programme on HIV/AIDS for World AIDS Day 1997.

9. Pinkerton SD, Cecil H, Holtgrave D.R. HIV/STD prevention interventions for adolescents: cost-effectiveness considerations . Journal of HIV/AIDS Prevention and Education for Adolescents and Children. 1998;2:5-31.

10. Associated Press. Sex education that teaches abstinence wins support. New York Times. July 23,1997:A19.

11. Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African-American adolescents: a randomized controlled trial . Journal of the American Medical Association. 1998;279:1529-1536.

12. Centers for Disease Control and Prevention. Health risk behaviors among adolescents who do and do not attend school-United States, 1992 . Morbidity and Mortality Weekly Report. 1994;43:129-132.

13. Zibalese-Crawford M. A creative approach to HIV/AIDS programs for adolescents . Social Work in Health Care. 1997;25:73-88.

14. Miller KS, Levin ML, Whitaker DJ, et al. Patterns of condom use among adolescents: the impact of mother-adolescent communication . American Journal of Public Health. 1998;88:1542-1544.

15. Weinstein M, Farthing C, Portillo T, et al. Taking it to the streets: HIV testing, treatment information and outreach in a Los Angeles neighborhood coffee house. Presented at the 12th World AIDS Conference, Geneva, Switzerland; 1998. Abstract #43125.

16. Harper GW, Contreras R, Vess L, et al. Improving community-based HIV prevention for young Latina women. Presented at the Biennial Meeting of the Society for Community Research and Action, New Haven, CT; June,1999.

<hr />

<h3><strong>Preparado por Gary Harper, PhD MPH* y Pamela DeCarlo**, Traducción Romy Benard Rodríguez**
*Departamento de Psicología, Universidad DePaul, **CAPS</strong></h3>
Septiembre 1999. Hoja Informativa 9SR.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/adolescentesFS.pdf</url>
	</node>
	<node>
		<title>Family</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What is the role of the family in HIV prevention?</h3>
<h4>Why families?</h4>
Families have great influence over a person, and that influence can last a lifetime. Even people who are no longer or never were in touch with their family are influenced by their absence. One half of all persons with HIV became infected during adolescence or early adulthood (ages 15-24). Working with families as early as possible in children’s lives helps solidify healthy behaviors and relationships, thus preventing risk before it happens.

HIV prevention has traditionally focused on the individual and not the family. Yet families can have both positive and negative impact on sexual and drug using behaviors that put a person at risk for HIV. Families are important determinants of adolescent sexual behavior, can affect men and women as they “come out” as gay and lesbian and can affect injection drug users (IDUs) as they gain and lose ties to family throughout the years.

For this fact sheet, families are defined as the people you grew up with: fathers, mothers, uncles, aunts, cousins, grandparents or foster parents. Many families have strong ties with the community as well, making the community a strong influence. We will not be discussing families of choice, such as intimate social networks.
<h4>How do families affect risk behavior?</h4>
Families can help protect themselves and their children from risky sexual and drug using behaviors. Family connectedness and parent child communication are key for ensuring healthy behaviors.<sup>1</sup> Likewise, when families are not connected and adolescents feel they can’t talk to the adults in their lives, there is a greater risk of unhealthy behavior.

Adolescents who feel connected to their families and perceive their parents as caring are more likely to postpone their sexual debut, use contraception, have fewer pregnancies and fewer children.<sup>2,3</sup> Two key aspects of parenting that are influential to adolescents are their beliefs that their parents know who they spend time with, and know where they are when they’re not at home or at school.<sup>1</sup>

In families with strong religious values and an emphasis on marriage and having children, young gay men can have a hard time coming out to their parents. Young men may fear that having a gay son could cause the family shame, or that they will disappoint their parents by not getting married and having children.<sup>4</sup> This can lead to internalized shame and low self esteem which contribute to risky behavior.

A child who grows up in a family where high stress, alcoholism, substance use and domestic violence are the norm, may repeat that behavior as an adult. Many alcohol and substance abusers have a family history of alcoholism and substance abuse and high levels of domestic violence. In addition, family members sometimes are the ones who give young people their first puff of marijuana, first taste of alcohol or first injection of drugs.<sup>5</sup>

Family childhood physical abuse, sexual abuse and neglect often lead to risky sexual behavior and drug use in adolescence and adulthood. One study of persons who left methadone maintenance found that 36% had experienced sexual abuse as a child, 60% physical abuse, 57% emotional abuse, 66% child physical neglect and 25% all four experiences. Persons with a history of childhood abuse reported more sexual partners and those with physical neglect were more likely to be HIV+.<sup>6</sup>
<h4>W hat puts families at risk?</h4>
Families that have problems often produce children who have problems. Stress, poverty, violence and substance abuse in families leads to less family cohesion, less communication and less tolerance. As a result, teens experience more abuse, neglect and risky drug use and sexual behavior. Neighborhoods with few job opportunities and high levels of drug use and violence have a negative impact on teenage sexual behavior.<sup>7</sup>

Work and feeling overworked can greatly affect family life. At every economic level, work-related stress negatively impacts family cohesion and communication. When parents have long work hours and feel burned out by their jobs, they don’t have enough time for themselves or their families.<sup>8</sup>
<h4>What’s being done?</h4>
The Collaborative HIV Prevention and Adolescent Mental Health Project is a family-based preventive intervention. The program is based on the needs of urban African American youth and their families living in neighborhoods with high HIV infection rates. It seeks to 1) address pre-adolescent behavior, 2) target specific child, parent, and family factors in preventing HIV risk exposure and 3) address high HIV infection rates through a family-based approach. The program offers multiple family groups, a pre-adolescent component, an adolescent component, and stresses the importance of community collaboration.<sup>9</sup>

Family to Family is a structural intervention that strengthens family functioning and the bonds that connect families to each other. Designed to address a broad range of social issues, the program seeks to increase family communication in a community with high rates of violence, drug abuse and HIV infection. The program uses family groups and life coping skills to address issues such as forgiveness, communication, responsibility, teamwork, family traditions, and household management.<sup>10</sup>

While many schools and community agencies have begun to offer risk reduction programs for gay/lesbian/bisexual/transgender (GLBT) youth, there are few programs to help GLBT children and their parents. Groups such as Parents, Families &amp; Friends of Lesbians &amp; Gays (PFLAG) offer support and education.<sup>11</sup>

In San Francisco, CA, a coalition of agencies serving Latino gay and bisexual men started a media campaign to address family cohesion. In their research they found that women were overwhelmingly identified as a source of support: mothers, sisters, aunts and cousins. The campaign “Families Change, Families Grow/Las Familias Cambian, Las Familias Crecen,” used posters showing a mother hugging her adult son’s boyfriend with the caption, “Mom got to know my boyfriend, now there’s a place for him too.”

Keepin’ it R.E.A.L.!, a program for adolescents and their mothers, works to increase parental knowledge about HIV and sexuality issues and increase comfort discussing these issues with their children. The program gave mothers and teens a chance to interact and bond, as well as gave mothers a chance to communicate with each other. Women in the program were more likely to talk to their adolescents about sex. School classes that give homework assignments for students to talk to their parents about sexual topics can be effective. The assignments are required, and parents don’t have to go anywhere, but can talk to their children at home.
<h4>What still needs to be done?</h4>
Families need support to increase communication and build strong bonds as early as possible. Many HIV prevention programs acknowledge that families play a large role in determining risk behavior, but few programs offer interventions for families. In addition to supporting persons who are already engaged in risky behaviors, programs should support family members so that risk behavior doesn’t have cause to start.

To establish open communication and solidify family bonds, special care must be taken to encourage gay and lesbian youth to talk about their sexuality, especially in families with strong values regarding the importance of marriage and bearing children. Gays and lesbians are prohibited by law from marrying, may not wish to have children and are often prohibited from adopting children. Community institutions such as churches and schools can work with prevention programs to educate their members and instill tolerance and acceptance of diverse sexual identities.

Too often, communities hardest hit by drug use, crime and poverty also have the highest rates of HIV and the lowest rates of family and community support. However, negative outside influences can often be overcome with the help of a strong family. Family strengthening programs, parenting centers and hotlines are needed. Well monitored recreational activities and community centers are also necessary so that parents can know their children will be safe when not at home.

<hr />

<h3>Says who?</h3>
1. DiClemente RJ, Wingood GM, Crosby R, et al. Parental monitoring: Association with adolescents’ risk behaviors. Pediatrics. 2001;107:1363-1368.
2. Resnick MD, Bearman PS, Blum RW, et al. Protecting adolescents from harm: Findings from the National Longitudinal Study on Adolescent Health. Journal of the American Medical Association. 1997; 278:823-32.
3. Kirby D. Emerging Answers: Research Findings on Programs to Reduce Teen Pregnancy, Washington, DC: National Campaign to Prevent Teen Pregnancy, 2001.
4. Newman BS, Muzzonigro PG. The effects of traditional family values on the coming out process of gay male adolescents. Adolescence.1993;28:213-216.
5. Hampton RL, Senatore V, Gullotta TP, editors. Substance abuse, family violence and child welfare. Thousand Oaks, CA: Sage Publications; 1998.
6. Kang SY, Deren S, Goldstein MF. Relationships between childhood abuse and neglect experience and HIV risk behaviors among methadone treatment drop-outs. Child Abuse and Neglect. 2002;26:1275-1289.
7. Averett SL, Rees D, Argys LM. The impact of government policies and neighborhood characteristics on teenage sexual activity and contraceptive use.American Journal of Public Health. 2002; 92:1773-1778.
8. Gallinsky, E. Ask the children: A breakthrough study that reveals how to succeed at work and parenting. Quill Publications. 2000.
9. Madison SM, McKay MM, Paikoff R, et al. Basic research and community collaboration: Necessary ingredients for the development of a family-based HIV prevention program. AIDS Education and Prevention. 2000;12:281.
10. Fullilove RE, Green L, Fullilove MT. The Family to Family program: A structural intervention with implications for the prevention of HIV/AIDS and other community epidemics. AIDS. 2000;14S1:S63-S67.
11. PFLAG. www.pflag.org
12. Freedman B. Great HIV prevention campaigns are not just born. CAPS Exchange. 2000. prevention.ucsf.edu/uploads/CEsummer2000.pdf
13. DiIorio C, Resnicow K, Dudley WN, et al. Social cognitive factors associated with mother-adolescent communication about sex. Health Communications.2000;5:41-51.
14. Kirby D, Miller BC. Interventions designed to promote parent-teen communication about sexuality. New Directions for Child and Adolescent Development. 2002;97:93-110.

<strong>Prepared by Lesley Green*, Bob Fullilove*, Pamela DeCarlo**
*Community Research Group, Columbia University, **CAPS</strong>

<strong>April 2003. Fact Sheet #49E</strong>

Special thanks to the following reviewers of this Fact Sheet: Roberta Downing, Beth Freedman, Doug Kirby, Mary McKay, Lydia O’Donnell, Birdy Paikoff, Pam Woody.

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © April 2003, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/familyFS.pdf</url>
	</node>
	<node>
		<title>Familia</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cuál es el papel de la familia en la prevención del VIH?</h3>
<h4>¿por qué la familia?</h4>
La familia tiene una gran influencia sobre los individuos que puede durar toda la vida. Incluso aquellos que ya no mantienen contacto con su familia, o que nunca lo tuvieron, también están afectados por su ausencia. La mitad de todas las personas con VIH se infectó durante la
adolescencia o al entrar en la edad adulta (entre los 15 y 24 años). Las intervenciones dirigidas a las familias lo antes posible en la vida de los niños ayudan a asentar prácticas y relaciones saludables que los mantienen alejados de los riesgos.

Para los fines de esta hoja informativa, la familia se define como aquellos individuos con quienes la persona haya crecido: el padre, la madre, los tíos, las tías, los primos, los abuelos o los padres de crianza temporal. Muchas familias también tienen lazos fuertes con la comunidad, la cual se convierte en otra influencia poderosa. No comentaremos sobre las familias de elección, tales como las redes sociales íntimas.
<h4>¿cómo influye la familia?</h4>
La estructura familiar ayuda a la familia, y particularmente a los hijos, a protegerse de conductas riesgosas sexuales y de consumo de drogas. La unidad familiar y la comunicación entre padres e hijos son fundamentales para asegurar conductas saludables.<sup>1</sup> Asimismo, cuando existe poca unidad familiar y poca confianza para hablar con los adultos en su vida, los jóvenes están más propensos a participar en actividades riesgosas.

Los adolescentes que se sienten unidos a su familia y perciben que sus padres están atentos a sus necesidades tienden a postergar la iniciación sexual, a protegerse contra el embarazo y a tener menos embarazos e hijos.<sup>2,3</sup> Dos aspectos clave de la paternidad que influyen en la conducta de los adolescentes son la convicción de que sus padres saben con quiénes andan y adónde van cuando no están en la escuela o en casa.<sup>1</sup>

Los jóvenes homosexuales pueden tener muchas dificultades para revelar su identidad si sus familias tienen fuertes creencias religiosas que acentúan la importancia del matrimonio y la reproducción. Los jovencitos pueden temer que sus padres se avergüencen de tener un hijo homosexual o que se decepcionen si no se casan y tienen hijos.<sup>4</sup> Esto puede conducir a la interiorización del sentimiento de vergüenza y a la disminución del amor propio, lo cual contribuye a las prácticas arriesgadas.

Un niño que crece en una familia en la cual el estrés, el alcoholismo, el uso de drogas y la violencia doméstica son habituales puede repetir estos comportamientos al llegar a la edad adulta. Muchos alcohólicos y usuarios de drogas tienen antecedentes familiares de alcoholismo y drogadicción, así como altos niveles de violencia doméstica. Además, a veces son los familiares mismos quienes ofrecen a los jóvenes la primera fumada de marihuana, el primer trago de alcohol o la primera inyección de drogas.<sup>5</sup>

El maltrato físico, el abuso sexual y el descuido muchas veces llevan a prácticas sexuales riesgosas y al uso de drogas durante la adolescencia y la edad adulta. Un estudio de personas que abandonaron el mantenimiento con metadona encontró que durante su niñez el 36% fueron víctimas de abuso sexual, el 60% de maltrato físico, el 57% de maltrato emocional, el 66% de descuido y el 25% de las cuatro experiencias. Las personas con antecedentes de maltrato durante la niñez reportaron un mayor número de parejas sexuales y aquellas que fueron descuidadas tenían más probabilidades de ser VIH positivas.<sup>6</sup>
<h4>¿qué pone a las familias en riesgo?</h4>
Con frecuencia, las familias que tienen problemas producen niños con problemas. La tensión emocional, la pobreza, la violencia y el abuso de drogas en la familia disminuyen la unidad, comunicación y tolerancia entre la familia. Consecuentemente, estos jóvenes sufren más maltrato y descuido, y participan más en prácticas riesgosas sexuales y de uso de drogas. Los barrios en donde hay pocas oportunidades de trabajo y altos niveles de consumo de drogas y violencia perjudican la conducta sexual de los jóvenes.<sup>7</sup>

El trabajo y el cansancio debido al exceso de trabajo pueden tener un efecto considerable sobre la vida familiar. En todos los niveles económicos, el estrés laboral debilita la unidad y comunicación familiar. Cuando los padres trabajan jornadas largas y se sienten abrumados por el trabajo, no tienen tiempo para sí mismos ni para su familia.<sup>8</sup>
<h4>¿qué se está haciendo al respecto?</h4>
El Collaborative HIV Prevention and Adolescent Mental Health Project es una intervención centrada en la familia, concretamente en las necesidades de los jóvenes afroamericanos y sus familias que viven en barrios urbanos con altas tasas de infección por VIH. El programa busca 1) abordar temas sobre conducta preadolescente, 2) concentrarse en factores relacionados con el niño, los padres y la familia y 3) emplear métodos que tomen en cuenta e involucren a la familia para reducir las altas tasas de infección por VIH. El programa ofrece grupos familiares, servicios para adolescentes y preadolescentes y enfatiza la importancia de la colaboración comunitaria.<sup>9</sup>

Family to Family es una intervención estructural que fortalece la función de la familia y los lazos familiares. Diseñado para responder a una amplia gama de problemas sociales, el programa busca aumentar la comunicación familiar en una comunidad con altas tasas de violencia, abuso de drogas e infección por VIH. Por medio de grupos familiares y orientación sobre cómo afrontar los retos de la vida, el programa abarca temas como el perdón, la comunicación, la responsabilidad, el trabajo en equipo, las tradiciones familiares y el manejo del hogar.<sup>10</sup>

Mientras que muchas escuelas y organizaciones comunitarias han empezado a ofrecer programas de reducción de daños para jóvenes gay/lesbianas/bisexuales/transexuales, existen pocos servicios que ayuden a sus padres. Grupos como Parents, Families &amp; Friends of Lesbians &amp; Gays (PFLAG) les ofrecen apoyo y orientación.<sup>11</sup>

En San Francisco, CA, una coalición de organizaciones que sirven a hombres latinos gay y bisexuales lanzó una campaña en los medios de comunicación sobre la unidad familiar. Al investigar sobre el tema, la coalición encontró que las mujeres fueron identificadas de manera abrumadora como fuentes de apoyo: madres, hermanas, tías y primas. La campaña, “Las familias cambian, las familias crecen”, empleó carteles que mostraban a una madre que abraza al novio de su hijo, con el título: “Mamá conoció a mi novio, así que ya hay lugar para él también.”<sup>12</sup>

Keepin’ it R.E.A.L.!, un programa para adolescentes y sus madres, aumenta los conocimientos de los padres sobre el VIH y la sexualidad así como su confianza para comentar estos temas con sus hijos. El programa brindó a las madres y a los jóvenes oportunidades de convivencia y acercamiento. Las madres también pudieron platicar unas con otras, y después del programa estaban más propensas a entablar una conversación con sus hijos adolescentes sobre el sexo.<sup>13</sup> Las tareas escolares que piden que los estudiantes hablen con sus padres sobre temas sexuales pueden producir buenos resultados. Las tareas, que son obligatorias, permiten que los padres tengan la conversación con sus hijos sin tener que salir de casa.<sup>14</sup>
<h4>¿qué queda por hacer?</h4>
Aunque muchos programas de prevención del VIH reconocen que las familias juegan un papel importante con respecto a las prácticas riesgosas, pocos ofrecen intervenciones para familias. Además de apoyar a las personas que ya practican conductas arriesgadas, los
programas deben apoyar a las familias para impedir las causas subyacentes que llevan a los adolescentes a ponerse en riesgo.

Para establecer la comunicación abierta y solidificar la unión familiar, es necesario poner atención especial en alentar a los jóvenes gays y lesbianas a hablar sobre su sexualidad, especialmente en aquellas familias con fuertes creencias sobre la importancia del matrimonio y la reproducción. Se prohíbe a los homosexuales y lesbianas casarse; no todos desean tener hijos y frecuentemente se les prohíbe adoptarlos. Las instituciones comunitarias como las iglesias y las escuelas pueden colaborar con los programas de prevención para conscientizar a sus miembros e inculcarles la tolerancia y la aceptación de identidades sexuales no tradicionales.

Con demasiada frecuencia, las mismas comunidades que han sido más afectadas por el uso de drogas, la delincuencia y la pobreza también tienen las mayores tasas de VIH y los menores niveles de apoyo familiar y comunitario. No obstante, las influencias externas negativas muchas veces se pueden superar con la ayuda de una familia unida. Se necesitan programas que fortalezcan a las familias, centros para padres de familia y líneas de ayuda telefónica, así como actividades recreativas y centros comunitarios con supervisión adecuada para que los padres sepan que sus hijos están protegidos cuando están fuera de la casa.

<hr />

<h4>¿quién lo dice?</h4>
1. DiClemente RJ, Wingood GM, Crosby R, et al. Parental monitoring: Association with adolescents’ risk behaviors. Pediatrics. 2001;107:1363-1368.
2. Resnick MD, Bearman PS, Blum RW, et al. Protecting adolescents from harm: Findings from the National Longitudinal Study on Adolescent Health. Journal of the American Medical Association. 1997; 278:823-32.
3. Kirby D. Emerging Answers: Research Findings on Programs to Reduce Teen Pregnancy, Washington, DC: National Campaign to Prevent Teen Pregnancy, 2001. www.teenpregnancy.org/product/pdf/emergingSumm.pdf
4. Newman BS, Muzzonigro PG. The effects of traditional family values on the coming out process of gay male adolescents. Adolescence.1993;28:213-216.
5. Hampton RL, Senatore V, Gullotta TP, editors. Substance abuse, family violence and child welfare. Thousand Oaks, CA: Sage Publications; 1998.
6. Kang SY, Deren S, Goldstein MF. Relationships between childhood abuse and neglect experience and HIV risk behaviors among methadone treatment drop-outs. Child Abuse and Neglect. 2002;26:1275-1289.
7. Averett SL, Rees D, Argys LM. The impact of government policies and neighborhood characteristics on teenage sexual activity and contraceptive use.American Journal of Public Health. 2002; 92:1773-1778.
8. Gallinsky, E. Ask the children: A breakthrough study that reveals how to succeed at work and parenting. Quill Publications. 2000.
9. Madison SM, McKay MM, Paikoff R, et al. Basic research and community collaboration: Necessary ingredients for the development of a family-based HIV prevention program. AIDS Education and Prevention. 2000;12:281.
10. Fullilove RE, Green L, Fullilove MT. The Family to Family program: A structural intervention with implications for the prevention of HIV/AIDS and other community epidemics. AIDS. 2000;14S1:S63-S67.
11. PFLAG. www.pflag.org
12. Freedman B. Great HIV prevention campaigns are not just born. CAPS Exchange. 2000. prevention.ucsf.edu/uploads/CEsummer2000.pdf
13. DiIorio C, Resnicow K, Dudley WN, et al. Social cognitive factors associated with mother-adolescent communication about sex. Health Communications.2000;5:41-51.
14. Kirby D, Miller BC. Interventions designed to promote parent-teen communication about sexuality. New Directions for Child and Adolescent Development. 2002;97:93-110.

<hr />

<strong>Preparado por Lesley Green*, Bob Fullilove*, Pamela DeCarlo**
*Community Research Group, Columbia University, **CAPS</strong>

<strong>Traducción Rocky Schnaath</strong>

<strong>Septiembre 2003. Hoja Informativa 49S</strong>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/familiaFS.pdf</url>
	</node>
	<node>
		<title>Parents and children</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Why is communication important?</h3>
Sexual activity begins early for many teens. Almost four of ten (37%) 9th graders have had intercourse, and nearly seven of ten (66%) have had intercourse by 12th grade.<sup>1</sup>

Every year three million teens, or almost a quarter (1 out of 4) of all sexually experienced teens, will contract a sexually transmitted disease (STD). Chlamydia is more common among teens than among older men and women, and teens have higher rates of gonorrhea than men and women aged 20-44.<sup>2</sup>

The HIV epidemic in the US is increasingly becoming an epidemic of the young. One fourth of all new HIV infections in the US occur in people under the age of 22, and one half of all new infections occur in people under age 25.<sup>3</sup>
<blockquote><strong>“I want my daughter to be prepared [for sex and puberty]. I was taken by surprise.” Parent</strong></blockquote>
In spite of these staggering statistics, many parents are unaware of or in denial about their children’s sexual experience. A study of mothers and their adolescent children found that 70% of the mothers believed their sons were virgins, but only 44% of sons actually were (had not yet engaged in sexual intercourse). With daughters, 82% of mothers thought they were virgins, and only 70% of daughters actually were.<sup>4</sup>
<h3>Are parents and their kids talking?</h3>
Unfortunately, not enough. A survey of pre-adolescents and their parents in a high HIV seroprevalence neighborhood found that parents overestimate how much they talk about HIV. Kids remembered less than one-fourth of HIV discussions parents said occurred. They were most likely to remember talks with the parent that were private.<sup>5</sup>

Parents often think they’re talking to their kids about AIDS, but may be discussing medical facts and not necessarily sexuality or safer sex. A national survey found that mothers of children aged 11 and older rated themselves “unsatisfactory” on talking about issues such as: how to tell when youth are ready to be sexually active (38%), preventing HIV (40%), sexual orientation (47%) and how to use a condom (73%).<sup>6</sup>
<blockquote><strong>“I think it’s sad I can’t talk to my mom about it-but it’s her loss. I can always go other places. I think that is a lot of the problem, because when you go `other places’ sometimes you get the wrong information.” Teen</strong></blockquote>
<h3>What is the role of parents?</h3>
Parents can influence their children’s actions. At-risk youth in five cities took part in an HIV prevention marketing initiative. They reported that parents exerted substantial influence on sexual behavior in three ways: by communicating with them, by acting as role models and by providing direct supervision.<sup>7</sup>

Contrary to popular opinion, children do look to their parents for guidance. Kids often want to talk to their parents about HIV-related issues, but may find it difficult to do so.<sup>8</sup> Kids may worry that parents’ disapproval and fears will prevent honest discussion, or that parents lack correct information about HIV.
<blockquote><strong>“I want my boys to be respectful of others and learn to develop a relationship with a person before having sex with them.” Parent</strong></blockquote>
Children learn from parents by watching what they do as well as hearing what they say. Whether parents answer, don’t answer, or get angry at childrens’ questions can show children how to deal with difficult issues. Discussions about healthy relationships should start early and grow more sophisticated as children mature. Early talks with young children about naming body parts accurately, learning how to say no, and taking health precautions can set the stage for later education in HIV prevention and sexuality.
<h3>What are barriers to communication?</h3>
Talking about issues of sexuality with their children can be a difficult experience for many adults. When many of today’s adults were children, their parents didn’t talk about sexuality and other topics with them. Today’s parents may want to take a different approach with their own children, but have no experience to guide them.
<blockquote><strong>“We didn’t talk about these things when we grew up so I’m not always used to it. I try, and I laugh…the kids are more comfortable with [talking about sex] than I am.” Parent</strong></blockquote>
Youth need to carve out their own autonomy during adolescence. As young people begin to separate from their parents, they may be more resistant to parental advice.

Parents may have unfounded concerns about talking to their kids, such as the fear that talking about sex will increase curiosity and cause them to experiment prematurely, or that giving information about birth control is a green light for kids to have intercourse. Some parents fear that talking about homosexuality might influence a child’s sexual orientation. In fact, open discussion with parents can help postpone sexual activity, protect from risky behavior and support the healthy sexual socialization of youth.<sup>9</sup>
<h3>What’s working?</h3>
In Los Angeles, CA, a program addressing newly arrived immigrant parents found that involving churches and health providers, providing culturally sensitive presenters in the parents’ language, and scheduling meetings during the evenings all helped to attract parents to meetings.<sup>10</sup> Parenting and communicating classes often attract more parents than classes specifically addressing HIV, especially in religious communities.

Peer education among parents has been effective. “Talking With Kids About AIDS” trains volunteers to conduct workshops with parents and guardians in a variety of community settings. Parents learn about HIV, practice communication and risk reduction skills and complete homework assignments to discuss HIV with their children. The program significantly enhances parents’ ability to initiate talks with their children.<sup>11</sup>
<blockquote><strong>“Parents need to inform and guide (and get involved) with their kids more! I think it will help tremendously.” Teen</strong></blockquote>
In Virginia, parent educators were trained to lead HIV information programs for parents of elementary, middle and high school students. These parents also served as resource persons for their community. Word-of-mouth recommendations from parents have been effective in attracting other parents. Parent participants reported they were more likely to talk to their children about HIV/AIDS if they felt knowledgeable on the subject.<sup>12</sup>

The Fast Road/El Camino Rapido is a training program for migrant families and educators to help families discuss healthy relationships, practice communication skills, and focus on HIV prevention. The program uses cartoon videos in English and Spanish and drawings with bubbles for spoken words and thoughts. Parents work with other parents and with their children to fill in the blanks and help stimulate discussion.
<h3>What needs to be done?</h3>
Parent-child communication often has not been a focus of HIV prevention efforts. However, programs that involve all family members, children and adults, in educating about sexuality, values and family life, can be very effective. Programs that are most effective must involve parents and youth in program design and staffing. A comprehensive HIV prevention strategy uses many elements to protect as many people at risk for HIV as possible. Given what is at stake, family members and prevention educators must work together to ensure the future health and safety of our children.

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. Youth risk behavior surveillance-United States 1995 . Morbidity and Mortality Weekly Report. 1996;45:64.

2. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases . Washington, DC: National Academy Press; 1996.

3. Rosenberg PS, Biggar RJ, Goedert JJ. Declining age at HIV infection in the United States (letter). New England Journal of Medicine. 1994;330:789-790.

Miller K. Data from the Family adolescent risk behavior and communication study. Personal communication, Centers for Disease Control and Prevention; 1997.

Krauss BJ, Goldsamt L, Pierre-Louis M. How pre-adolescents and their parents talk about HIV in a high HIV seroprevalence neighborhood. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract ThD4878.

Mothers’ Voices. Mothers speak out on preventing and curing AIDS. Survey conducted by EDK Associates. 1997.

Kennedy MG, Bye L, Rosenbaum J, et al. Focus group theme that will shape participatory social marketing interventions in 5 cities. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract TuD2882.

Heft L, Faigeles B, Hall TL. Where are the parents in HIV education? Adolescents want their parents to talk about HIV. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract ThC4431.
<ul>
 	<li>Contact: Lisa Heft (415) 487-8088.</li>
</ul>
Leland NL, Barth RP. Characteristics of adolescents who have attempted to avoid HIV and who have communicated with parents about sex. Journal of Adolescent Research. 1993;8:58-76.

Baker C, Rich R, Wulf K. Strategies to involve newly-arrived immigrant parents in HIV education. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract TuD2794.
<ul>
 	<li>Contact: Claudia Baker (213) 625-6429.</li>
</ul>
Tiffany J. HIV/AIDS education for parents and guardians: talking with kids about AIDS. Presented at the 9th International Conference on AIDS, Berlin, Germany. 1993. Abstract PO-D13-3716.
<ul>
 	<li>Contact: Jennifer Tiffany (607) 255-1942.</li>
</ul>
Rankin DL. When “just say no” isn’t enough: parents educating parents about AIDS. Presented at the National Conference on Women and HIV, Los Angeles, CA. 1997. Abstract P2.37.
<ul>
 	<li>Contact: Daphne Long Rankin (804) 828-2210.</li>
</ul>
The Fast Road/El Camino Rapido.
<ul>
 	<li>Contact: Angela Branz-Spail (800) 580-0740.
http:// www.speakeasy.org/plaintalk/</li>
</ul>
<strong>Parent/Child Resources:</strong>

Advocates for Youth
1025 Vermont Avenue NW
Washington, DC 20005
(202) 347-5700
http://eos.atmos.washington.edu/~robert/Advocates/

American Red Cross
AIDS Education Office
8111 Gate-house Road
Falls Church, VA 22042
http://www.redcross.org

Mothers’ Voices
165 West 46th Street, Suite 701
New York, NY 10036
(888) MVOICES
http://www.mvoices.org

National AIDS Clearinghouse
PO Box 6003
Rockville, MD 20849-6003
(800) 458-5231
http://www.cdcnac.org

Planned Parenthood
(800) 230-7526
http://www.igc.apc.org/ ppfa/

Sexuality Information and Education Council of the US
130 West 42nd Street, Suite 350
New York, NY 10036
(212) 819-9770
http://www.siecus.org

<hr />

<strong>Prepared by Lisa Heft*, Ann Kurth**, Pamela DeCarlo***
*San Francisco AIDS Foundation, **Mothers’ Voices, ***CAPS</strong>

September 1997. Fact Sheet #28E

<hr />

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National AIDS Clearinghouse at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 1997, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/parentFS.pdf</url>
	</node>
	<node>
		<title>Padres e hijos</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Cómo hablan padres e hijos sobre el VIH?</h3>
<h4>¿por qué es importante la comunicación?</h4>
La actividad sexual empieza a temprana edad para muchos jóvenes. De cada 10 estudiantes del noveno grado casi cuatro (37%) han tenido relaciones sexuales, y de cada 10 estudiantes, casi 7 (66%) han tenido relaciones sexuales al llegar al doceavo grado.<sup>1</sup>

Cada año tres millones de jóvenes, es decir, casi un cuarto de los jóvenes que han experimentado con el sexo, van a padecer de alguna Enfermedad de Transmisión Sexual (ETS). Clamidia es la enfermedad más común entre la juventud que entre adultos. Los jóvenes tienen índices más altos de gonorrea que los adultos de 20-44 años de edad.<sup>2</sup>

El VIH se convierte cada vez más en la epidemia de la juventud. Un cuarto de todas las nuevas infecciones en los EEUU ocurre entre personas menores de 22 años y la mitad de todas las nuevas infecciones ocurren entre personas menores de 25 años.<sup>3</sup>
<blockquote><strong>“Quiero que mi hija esté preparada [para la pubertad y el sexo]. A mi me tomó por sorpresa.” -Padre de familia</strong></blockquote>
A pesar de estas escalofriantes estadísticas, muchos padres no saben o no quieren aceptar que sus hijos pueden estar experimentando con el sexo. Un estudio a madres con hijos adolescentes reveló que el 70% de las mamás creían que sus hijos varones eran vírgenes (todavía no habían tenido relaciones sexuales) cuando sólo el 44% de ellos lo eran. Con respecto a las hijas, el 82% de las madres creyó que todavía eran vírgenes cuando en realidad sólo el 70% lo eran.<sup>4</sup>
<h4>¿están hablando los padres con sus hijos?</h4>
Desafortunadamente, no lo suficiente. Una encuesta a padres de familia con hijos pre- adolescentes de un vecindario con alta seroprevalencia encontró que los padres de familia tienen la impresión de hablar mucho sobre el VIH. Los hijos, por el contrario, dicen haber tenido menos de un cuarto de las pláticas que los padres dijeron tener.<sup>5</sup>

A menudo, los padres creen estar hablando con sus hijos sobre el SIDA, cuando probablemente están hablando del aspecto médico y no necesariamente sobre la sexualidad o el sexo seguro. Una encuesta a nivel nacional reveló que las madres con hijos mayores de 11 años dijeron no estar satisfechas al tratar temas tales: como explicar cuando un(a) jóven está listo para llevar una vida sexual activa, la prevención del VIH, la orientación sexual y el uso del condón.<sup>6</sup>
<blockquote><strong>“Es muy triste, para mi, pensar que no puedo hablar con mi mamá acerca de esto-ella se lo pierde. Siempre existen otros lugares. Yo creo que esta es la parte más grave del problema, porque cuando uno va a otros lugares, algunas veces recibe la información equivocada.” -Un jóven</strong></blockquote>
<h4>¿cuál es el papel de los padres?</h4>
Los padres pueden influir en las acciones de sus hijos. En cinco ciudades se llevó a cabo una iniciativa de mercadeo sobre prevención del VIH con jóvenes de alto riesgo. Estos reportaron que sus padres ejercieron una influencia sustancial sobre el comportamiento sexual en tres formas: comunicándose con ellos, dándoles el ejemplo, y supervisándolos directamente.<sup>7</sup>

Contrario a la opinión popular, los jóvenes sí quieren tener a sus padres como guía. A los jóvenes les gustaría hablar más a menudo con sus padres sobre temas relacionados con el VIH, sin embargo, esto puede resultar un poco difícil.<sup>8</sup>
<blockquote><strong>“Yo quiero que mis hijos varones sepan respetar a los demás y que primero conozcan a fondo a la persona antes de tener relaciones sexuales.” -Padre de familia</strong></blockquote>
Los hijos aprenden observando y escuchando a sus padres. La manera en que los padres de familia reaccionan ante las preguntas de sus hijos (al contestar, al no contestar, enojado) es la forma en que ellos aprenden a reaccionar ante las situaciones difíciles. Las pláticas sobre las relaciones sanas deben comenzar a temprana edad y evolucionar en la medida en que los hijos maduran. Hablar con los hijos desde pequeños, darles el nombre apropiado a las diferentes partes del cuerpo, enseñarles a como decir no, y tomar las precauciones de salud necesarias puede ser el trampolín de su futura educación sobre la sexualidad y la prevención del VIH.
<h4>¿cuáles son las barreras?</h4>
Hablar sobre el tema de la sexualidad con los hijos puede ser una experiencia a veces difícil para el adulto. Cuando muchos de los adultos de hoy eran niños, sus padres no les hablaron de sexo o de otros temas. Los padres de hoy supondrían hacer lo contrario con sus hijos, pero carecen de la experiencia para guiar a los hijos.
<blockquote><strong>“Nosotros no hablábamos de estas cosas cuando estábamos creciendo, por eso casi no acostumbro hacerlo. Yo trato, y me da risa…los niños se sienten más cómodos con eso [hablando de sexo] que yo.” -Padre de familia</strong></blockquote>
Muchos padres tienen el concepto equivocado de que hablar de sexo con sus hijos puede despertar la curiosidad ocasionando la experiencia sexual prematura o que darles información sobre el control de la natalidad o anticonceptivos es darles luz verde para empezar las relaciones sexuales. Algunos padres creen que el hecho de hablar sobre la homosexualidad podría influir en la orientación sexual del hijo(a). De hecho, la plática honesta entre padres e hijos puede contribuir al retraso de la actividad sexual, evitar las conductas de riesgo y promover la socialización sexual sana en la juventud.<sup>9</sup>
<h4>¿qué es lo que funciona?</h4>
En los Angeles, CA, un programa que trataba a padres recién emigrados a los EEUU descubrió que al lograr la participación de la iglesia, de los proveedores de salud, usando presentadores que entienden la cultura y que hablan el idioma de los padres, y teniendo las reuniones<sup>10</sup> por las noches fue lo que ayudó a atraer a los padres a las reuniones. Muchas veces, se logra atraer a más padres cuando se ofrecen clases de cómo criar y communicarse con los hijos que cuando se ofrecen clases específicamente sobre VIH, especialmente en comunidades religiosas.

La educación impartida entre padres de familia ha sido eficaz. El folleto “Hablando del SIDA con Nuestros Hijos” capacita voluntarios para dirigir talleres para padres y tutores en las diferentes comunidades. Los padres aprenden sobre el VIH, practican la comunicación y las formas en que se puede reducir el riesgo y tienen, además, que hacer tareas que los preparan a hablar del VIH con sus hijos.<sup>11</sup>
<blockquote><strong>“Los padres necesitan informar y guíar más a sus hijos! Yo pienso que esta es una ayuda tremenda.” -Un joven</strong></blockquote>
En Virginia, los padres educadores fueron entrenados con el fin de dirigir programas de información del VIH para padres de familia con hijos en la escuela primaria (1-6), media (7-9), y superior (10-12). Estos padres sirvieron, además, como fuente de información en su comunidad. Se ha logrado la participación de otros padres por las recomendaciones que corren de boca en boca. Los padres participantes reportaron que habría más posibilidades de hablar con sus hijos sobre el SIDA si tuvieran conocimiento del tema.<sup>12</sup>

El programa de entrenamiento “El Camino Rápido” sirve a las familias emigrantes. Este programa tiene educadores que enseñan a las familias a platicar sobre las relaciones sanas y a mejorar la comunicación con el fin de prevenir el VIH. El programa usa videos con dibujos animados en inglés y español. Estos dibujos tienen una especie de círculos vacíos para los pensamientos y las palabras. Los padres trabajan entre sí y con sus hijos para completar los espacios en blanco, ayudando así a estimular la plática.<sup>13</sup>
<h4>¿qué queda por hacer?</h4>
La comunicación entre el padre o la madre y sus hijos no ha estado incluída en los esfuerzos de prevención. Sin embargo, los programas que involucran a todos los miembros de la familia pueden ser muy eficaces. Los programas más exitosos deben incluir a jóvenes y a padres de familia en el diseño del programa y en la selección del personal. Un programa de prevención completo utiliza muchos elementos para proteger del VIH a la mayor cantidad de personas posible. Dados los hechos, tanto los miembros de la familia como los educadores de prevención deberían trabajar en conjunto para asegurar la salud y la seguridad de nuestro niños en el futuro.

<hr />

<h4>¿quién lo dice?</h4>
1. Centers for Disease Control and Prevention. Youth risk behavior surveillance-United States 1995 . Morbidity and Mortality Weekly Report. 1996;45:64.

2. Eng TR, Butler WT, eds. The Hidden Epidemic: Confronting Sexually Transmitted Diseases . Washington, DC: National Academy Press; 1996.

3. Rosenberg PS, Biggar RJ, Goedert JJ. Declining age at HIV infection in the United States (letter). New England Journal of Medicine. 1994;330:789-790.

Miller K. Data from the Family adolescent risk behavior and communication study. Personal communication, Centers for Disease Control and Prevention; 1997.

Krauss BJ, Goldsamt L, Pierre-Louis M. How pre-adolescents and their parents talk about HIV in a high HIV seroprevalence neighborhood. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract ThD4878.

Mothers’ Voices. Mothers speak out on preventing and curing AIDS. Survey conducted by EDK Associates. 1997.

Kennedy MG, Bye L, Rosenbaum J, et al. Focus group theme that will shape participatory social marketing interventions in 5 cities. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract TuD2882.

Heft L, Faigeles B, Hall TL. Where are the parents in HIV education? Adolescents want their parents to talk about HIV. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract ThC4431.
<ul>
 	<li>Contacto: Lisa Heft (415) 487-8088.</li>
</ul>
Leland NL, Barth RP. Characteristics of adolescents who have attempted to avoid HIV and who have communicated with parents about sex. Journal of Adolescent Research. 1993;8:58-76.

Baker C, Rich R, Wulf K. Strategies to involve newly-arrived immigrant parents in HIV education. Presented at the 11th International Conference on AIDS, Vancouver BC. 1997. Abstract TuD2794.
<ul>
 	<li>Contacto: Claudia Baker (213) 625-6429.</li>
</ul>
Tiffany J. HIV/AIDS education for parents and guardians: talking with kids about AIDS. Presented at the 9th International Conference on AIDS, Berlin, Germany. 1993. Abstract PO-D13-3716.
<ul>
 	<li>Contacto: Jennifer Tiffany (607) 255-1942.</li>
</ul>
Rankin DL. When “just say no” isn’t enough: parents educating parents about AIDS. Presented at the National Conference on Women and HIV, Los Angeles, CA. 1997. Abstract P2.37.
<ul>
 	<li>Contacto: Daphne Long Rankin (804) 828-2210.</li>
</ul>
The Fast Road/El Camino Rapido.
<ul>
 	<li>Contacto: Angela Branz-Spail (800) 580-0740.
http:// www.speakeasy.org/plaintalk/</li>
</ul>
<strong>Recursos para Padres e hijos:</strong>

Advocates for Youth
1025 Vermont Avenue NW
Washington, DC 20005
(202) 347-5700
http://eos.atmos.washington.edu/~robert/Advocates/

American Red Cross
AIDS Education Office
8111 Gate-house Road
Falls Church, VA 22042
http://www.redcross.org

Mothers’ Voices
165 West 46th Street, Suite 701
New York, NY 10036
(888) MVOICES
http://www.mvoices.org

National AIDS Clearinghouse
PO Box 6003
Rockville, MD 20849-6003
(800) 458-5231
http://www.cdcnac.org

Planned Parenthood
(800) 230-7526
http://www.igc.apc.org/ ppfa/

Sexuality Information and Education Council of the US
130 West 42nd Street, Suite 350
New York, NY 10036
(212) 819-9770
http://www.siecus.org

<hr />

<strong>Preparado por Lisa Heft*, Ann Kurth**, Pamela DeCarlo***, Tradución Romy Benard Rodríguez***
*San Francisco AIDS Foundation, **Mothers’ Voices, ***CAPS</strong>

Deciembre 1997. Hoja Informativa 28S.]]></content>
		
		<type>
			6
		</type>
			<url>https://web.archive.org/web/20161029012945//sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/hijosFS.pdf</url>
	</node>
	<node>
		<title>Sex education</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What works best in sex/HIV education?</h3>
<h4>why sex/HIV education?</h4>
Sex and HIV education programs have multiple goals: to decrease unintended pregnancy, to decrease STDs including HIV and to improve sexual health among youth. In 2005, almost two-thirds (63%) of all high school seniors in the US had engaged in sex, yet only 21% of all female students used birth control pills before their last sex and only 70% of males used a condom during their last sexual intercourse.<sup>1</sup> In 2000, 8.4% of 15-19 year old girls became pregnant, producing one of the highest teen pregnancy rates in the western industrial world.<sup>1</sup> Persons aged 15-24 had 9.1 million new cases of STDs in 2000 and made up almost half of all new STD cases in the US.<sup>3</sup>

There are numerous factors affecting adolescent sexual behavior and use of protection. Some of these factors have little to do with sex, such as growing up in disadvantaged communities, having little attachment to parents or failing at school. Other factors are sexual in nature, such as beliefs, values, perceptions of peer norms, attitudes and skills involving sexual behavior and using condoms or contraception.<sup>4</sup> It is these sexual factors that sex/HIV education programs can potentially affect, thereby impacting behavior. Sex/HIV education programs alone cannot totally reduce sexual risk-taking, but they can be an effective part of a more comprehensive initiative.
<h4>do sex/HIV education programs work?</h4>
Yes. Some sex/HIV education programs delay initiation of intercourse, reduce the frequency of sex, reduce the number of sexual partners and increase use of condoms or other forms of contraception. Also, research indicates that sex/HIV education programs–even those that encourage condom and contraceptive use–do not increase sexual activity. In a recent review, almost two-thirds of the programs evaluated within the US significantly improved one or more of these behaviors. The results were even more positive in developing countries. Thus, many programs are effective, but others may not be and communities should implement either those programs that have been demonstrated to be effective or those programs that incorporate common characteristics of effective programs.<sup>5</sup>
<h4>can effective programs be replicated?</h4>
Yes. Several curricula have been implemented and evaluated up to five times in different states and consistently produced positive changes in sexual behavior when implemented as designed. One of them was even replicated in more than 80 CBOs and found to be effective.<sup>6</sup> However, when the curricula are greatly shortened, when condom lessons are cut, or when programs designed for the community are implemented in the classroom, they are less likely to significantly change behavior.
<h4>which curricula are most likely to significantly change behavior?</h4>
<ul>
 	<li>In a randomized trial of young women, SiHLE (sistering, informing, healing, living, and empowering) significantly increased condom use, reduced the pregnancy rate and reduced the STD rate.<sup>7</sup></li>
 	<li>In four different studies, Reducing the Risk delayed the initiation of sex and/or increased condom use for up to 18 months.<sup>8,9</sup></li>
 	<li>In a randomized trial, Safer Choices delayed sex among some youth and increased condom and contraceptive use among sexually active youth over a 31 month period.<sup>10</sup></li>
 	<li>Finally, in multiple randomized trials, Making Proud Choices<sup>11</sup> and Becoming a Responsible Teen<sup>12</sup> increased condom use for at least one year.</li>
</ul>
These and other effective programs share 17 characteristics that contribute to their success. Characteristics are divided into development, the curriculum itself, and implementation.
<h4>how are effective programs developed?</h4>
Effective programs can be developed by teams of people with backgrounds in psychosocial theory, adolescent sexual behavior, curriculum design, community culture and/or teaching sex/HIV education. They review local data on teens’ sexual behavior, pregnancy rates and STD rates and often conduct focus groups with teens and interviews with adults. Using a logic model framework, they identify the behaviors they want to change, the risk and protective factors affecting them and activities that would change them. They then design activities consistent with community values and resources and finally pilot-test and revise the curricula.
<h4>what do effective curricula look like?</h4>
Effective curricula really focus on reducing unintended pregnancy, STD/HIV or both. They do this by emphasizing the consequences of unintended pregnancy, STDs or HIV, and the risk of experiencing them; by giving a very clear message about sexual behavior; and by discussing situations that might lead to sex and how to avoid or get out of those situations.

Particularly important are the behavioral messages. Effective curricula most commonly emphasize that abstinence is the safest and best approach and encourage condom/contraceptive use for those having sex. Sometimes other values, such as being proud, being responsible, respecting yourself, sticking to your limits and remaining in control, are also emphasized, and are clearly linked to particular behaviors.

Effective curricula incorporate activities, instructional methods and behavioral messages that are appropriate to the youths’ culture, developmental age, gender and sexual experience. All actively involve youth to help them personalize the information.
<ul>
 	<li>To increase basic knowledge about risks of teen sex and methods of avoiding intercourse or using protection, effective programs can use: short lectures, class discussions, competitive games, skits or videos and flip charts or pamphlets.</li>
 	<li>To address risk, programs can use: data on the incidence or prevalence of pregnancy or STD/HIV among youth and their consequences, class discussions, HIV+ speakers, and simulations such as the STD handshake.</li>
 	<li>To change individual values and peer norms about abstinence and condom use, programs can use: clear behavioral messages, forced choice value exercises, peer surveys/voting, peer role plays, discussions of effectiveness of condoms and visits to drug stores or clinics where condoms are sold or distributed.</li>
 	<li>To build skills to help avoid unwanted or unprotected sex and insist on and use condoms or contraception, programs can use: role playing including describing the skills, modeling the skills and repeated individual practice role playing the skills.</li>
 	<li>To use condoms properly, youth can practice opening the package and putting a condom over their fingers, or talking through all the steps for using condoms.</li>
</ul>
<h4>how are effective programs implemented?</h4>
When effective programs are implemented, they typically obtain necessary support from appropriate authorities, select educators with desirable traits and train them, implement activities to recruit and retain youth if needed, and implement the curricula with fidelity. Programs can be effective with either adult or peer educators.
<h4>what needs to be done?</h4>
Policy makers should fund and encourage the implementation of sex/HIV education programs that have been demonstrated to be effective. If a new program is used, it should have the common characteristics of effective programs. Untested programs should be evaluated for effectiveness. Although programs should be implemented everywhere, they especially should be implemented in the locations and among populations where youth are at highest risk for HIV, STDs and unplanned pregnancy.

In order for evidence-based sex/HIV education programs to be implemented broadly, they should have support from appropriate authorities such as directors of youth-serving organizations, school districts, principals and teachers. Staff or teachers conducting programs should be trained and supported to implement programs with fidelity. This includes allowing enough time in the classroom or organization to deliver the program.

<hr />

<strong>Says who?</strong>

1. Centers for Disease Control and Prevention. Youth risk behavior surveillance – United States, 2005. Surveillance Summaries. June 9, 2006.

2. Alan Guttmacher Institute. U.S. teenage pregnancy statistics: Overall trends, trends by race and ethnicity and state-by-state information. New York: The Alan Guttmacher Institute, 2004.

3. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6-10.

4. Kirby D, Lepore G, Ryan J. Sexual risk and protective factors: Factors affecting teen sexual behavior, pregnancy, childbearing and sexually transmitted disease: Which are important? Which can you change? Washington DC: National Campaign to Prevent Teen Pregnancy. 2005.

5. Kirby D, Laris BA, Rolleri L. Sex and HIV education programs for youth: Their impact and important characteristics. Washington DC: Family Health International, 2006.

6. Jemmott III, JB. Effectiveness of an HIV/STD risk-reduction intervention implemented by nongovernmental organizations: A randomized controlled trial among adolescents. Presented at the American Psychological Association Annual Conference. Washington DC: August, 2005.

7. DiClemente RJ, Wingood GM, Harrington KF, et al. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. Journal of the American Medical Association. 2004;292:171-179.

8. Kirby D, Barth RP, Leland N, et al. Reducing the risk: Impact of a new curriculum on sexual risk-taking. Family Planning Perspectives. 1991;23:253-263.

9. Hubbard BM, Giese ML, Rainey J. A replication of Reducing the Risk, a theory-based sexuality curriculum for adolescents. Journal of School Health. 1998;68:243-247.

10. Kirby DB, Baumler E, Coyle KK, et al. The “Safer Choices” intervention: its impact on the sexual behaviors of different subgroups of high school students. Journal of Adolescent Health. 2004;35:442-452.

11. Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex: A randomized trial of HIV sexual risk-reduction interventions for young African-American adolescents. Journal of the American Medical Association. 1998;279:1529-1536.

12. St. Lawrence JS, Brasfield TL, Jefferson KW, et al. Cognitive-behavioral intervention to reduce African American adolescents’ risk for HIV infection. Journal of Consulting and Clinical Psychology. 1995;63:221-237.

*All websites accessed July 2006

<hr />

<strong>Prepared By Douglas Kirby PhD, ETR Associates</strong>

<strong>September 2006 . Fact Sheet #10ER</strong>

Special thanks to the following reviewers of this Fact Sheet: Forrest L. Alton, Suzan Boyd, Karin Coyle, Glenn Dodd, Polly Edwards, Erin Johnson, Barbara Richardson-Todd, John Santelli, William Smith, Katherine Suellentrop, Mary Martha Wilson, Paulina Zamudio.

Reproduction of this text is encouraged; however, copies may not be sold, and the Center for AIDS Prevention Studies at the University of California San Franciso should be cited as the source of this information. For additional copies of this and other HIV Prevention Fact Sheets, please call the National Prevention Information Network at 800/458-5231. Comments and questions about this Fact Sheet may be e-mailed to CAPS.web@ucsf.edu. © September 2006, University of California]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/pubs/FS/pdf/revsexedFS.pdf</url>
	</node>
	<node>
		<title>Educación sexual</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>¿Qué sirve mejor en la enseñanza sobre la sexualidad y el VIH?</h2>
<h3>¿por qué la enseñanza sobre la sexualidad y el VIH?</h3>
Los programas educativos sobre la sexualidad y el VIH tienen varias metas: disminuir los embarazos no planeados, reducir las enfermedades de transmisión sexual (ETS) incluyendo la del VIH y mejorar la salud sexual de los jóvenes. En 2005 en los EE.UU., el 63% de todos los alumnos del último año de preparatoria (high school) habían tenido relaciones sexuales, pero sólo el 21 % de las alumnas usaron pastillas anticonceptivas antes del último coito y sólo el 70 % de los varones usaron condón en el último coito.<sup>1</sup> En el 2000, el 8.4 % de las chicas entre 15 y 19 años se embarazaron, produciendo una de las tasas más altas de embarazo adolescente en el mundo occidental industrializado.<sup>2</sup> Casi la mitad de los nuevos casos de ETS en EE.UU. del año 2000 (9.1 millones) se presentaron en jóvenes entre los 15 y los 24 años de edad.<sup>3</sup>

Algunos de los numerosos factores que influyen en la conducta sexual y el uso de protección entre los adolescentes tienen poco que ver con las relaciones sexuales, por ejemplo: la crianza en una comunidad desfavorecida, la falta de apego a los padres o el fracaso escolar. Otros factores de naturaleza sexual como las creencias, los valores, las percepciones de normas de los pares, las actitudes y habilidades relacionadas con la conducta sexual y con el uso del condón o de anticonceptivos,<sup>4</sup> son factores en los que los programas de enseñanza potencialmente pueden incidir para generar cambios de conducta. Estos programas no pueden por sí solos eliminar las conductas sexuales riesgosas, pero sí pueden ser una pieza eficaz dentro de una iniciativa integral.
<h3>¿sirven los programas de enseñanza?</h3>
Sí. Algunos programas retrasan el inicio de las relaciones sexuales, disminuyen la frecuencia de las relaciones sexuales, limitan el número de parejas sexuales y aumentan el uso del condón u otro anticonceptivo. Además hay investigaciones que demuestran que los programas de enseñanza sobre la sexualidad/VIH (incluyendo los que promueven el uso de condones y otros anticonceptivos) no aumentan la actividad sexual. En una revisión reciente en EE.UU de programas que han sido evaluados, casi dos tercios mejoraron considerablemente una o más de estas prácticas.<sup>5</sup> Los resultados fueron aun más positivos en países en vías de desarrollo. Si bien muchos programas son eficaces, otros pueden no serlo; las comunidades deben implementar ya sea los programas con eficacia comprobada o los que incorporen las características comunes de los programas eficaces.<sup>5</sup>
<h3>¿es posible replicar programas eficaces?</h3>
Sí. Varios currículos implementados y evaluados hasta cinco veces en varios estados de EE.UU. con frecuencia produjeron cambios positivos en la conducta sexual al realizarse tal y como fueron diseñados. De hecho, uno de estos programas fue replicado en más de 80 organizaciones comunitarias y su eficacia quedó comprobada.<sup>6</sup> Sin embargo, cuando se recortan mucho los currículos, cuando se eliminan las lecciones sobre el condón o cuando los programas diseñados para lugares de la comunidad se llevan a cabo en el aula escolar, se reduce la probabilidad de producir cambios importantes en la conducta.
<h3>¿qué currículos logran cambios importantes en la conducta?</h3>
<ul>
 	<li>En un ensayo aleatorizado de mujeres jóvenes, el programa SiHLE (las siglas en inglés para hermanar, informar, curar, vivir, empoderar) aumentó considerablemente el uso del condón y redujo la incidencia de embarazos y de ETS.<sup>7</sup></li>
 	<li>En cuatro estudios diferentes, Reducing the Risk logró durante 18 meses bien un retraso en la iniciación de relaciones sexuales o un aumento en el uso del condón.<sup>8,9</sup></li>
 	<li>En otro ensayo aleatorizado, Safer Choices retrasó la iniciación del sexo entre algunos jóvenes y aumentó el uso de condones y otros anticonceptivos entre jóvenes sexualmente activos a lo largo de 31 meses.<sup>10</sup></li>
 	<li>Finalmente, en varios ensayos aleatorizados, Making Proud Choices<sup>11</sup> y Becoming a Responsible Teen<sup>12</sup> aumentaron durante un año el uso de condones.</li>
</ul>
Estos y otros programas eficaces comparten 17 características que contribuyen a su éxito, las cuales se agrupan bajo el desarrollo, el currículo en sí y la implementación.<sup>5</sup>
<h3>¿cómo se desarrollan programas eficaces?</h3>
Los programas eficaces se pueden desarrollar por equipos de personas con formación en teoría psicosocial, conducta sexual adolescente, diseño de currículos, cultura comunitaria y/o enseñanza sobre la sexualidad y el VIH. El equipo examina los datos locales sobre la conducta sexual adolescente, las tasas de embarazo y de ETS, y muchas veces realiza grupos de focales con jóvenes y entrevistas con adultos. También utiliza el marco de un modelo lógico para identificar las prácticas que desea modificar, los factores de riesgo y los factores protectores que las afectan, así como las actividades que las harían cambiar. Posteriormente el equipo diseña actividades coherentes con los valores y recursos comunitarios. Finalmente el equipo realiza pruebas piloto y ajusta los currículos.
<h3>¿en qué consisten currículos eficaces?</h3>
Los currículos eficaces se centran en reducir los embarazos no deseados, las ETS, el VIH o ambos al enfatizar las consecuencias y los peligros que éstos conllevan, presentar un mensaje claro sobre la conducta sexual y comentar las situaciones que pueden llevar a las relaciones sexuales y cómo evitarlas.

Los mensajes conductuales son de suma importancia. Los currículos eficaces por lo general enfatizan la abstinencia como el método más eficaz e inocuo (que no daña), y motivan a los jóvenes que ya tienen relaciones sexuales a usar condones y anticonceptivos. A veces se hace hincapié en otros valores (como el orgullo propio, la responsabilidad, el auto respeto, la capacidad de no exceder los límites y la de controlarse) que claramente están vinculados con ciertas conductas en particular.
Los currículos eficaces incorporan actividades, métodos docentes y mensajes conductuales que reflejan la cultura, la edad madurativa, el género y la experiencia sexual de los jóvenes. Todos involucran activamente a los jóvenes para ayudarles a personalizar la información.
<ul>
 	<li><strong>Para aumentar los conocimientos básicos sobre los riesgos </strong>que conlleva las prácticas sexuales en la adolescencia y sobre métodos para evitar el coito o para usar protección, los programas eficaces pueden emplear: discursos breves, diálogos en clase, juegos competitivos, parodias o dramatizaciones breves, videos y rotafolios o folletos.</li>
 	<li><strong>Para aclarar los riesgos</strong>, los programas pueden emplear datos sobre la incidencia o la prevalencia del embarazo o de ETS/VIH entre los jóvenes (junto con las consecuencias), diálogos en clase, oradores VIH+ y simulaciones.</li>
 	<li><strong>Para modificar los valores individuales y las normas entre pares</strong> con respecto a la abstinencia y al uso del condón, los programas pueden emplear: mensajes conductuales nítidos, ejercicios de elección obligatoria de valores, encuestas o votación entre pares, de juegos de interpretación de roles, conversaciones sobre la eficacia de los condones y visitas a farmacias o clínicas que los venden o regalan.</li>
 	<li><strong>Para fomentar las habilidades</strong> necesarias para evitar el sexo no deseado o desprotegido y para insistir en el uso de condones o anticonceptivos, se puede emplear juegos de rol que describan, demuestren y permitan que todos practiquen estas habilidades.</li>
 	<li>Los jóvenes pueden practicar <strong>el uso correcto del condón</strong> abriendo el paquete y deslizando el condón sobre los dedos, o bien describiendo cada paso en el uso del condón.</li>
</ul>
<h3>¿cómo se implementan programas?</h3>
Cuando los programas eficaces se implementan, por lo general obtienen el apoyo necesario de las autoridades correspondientes, seleccionan y capacitan a los educadores con las características deseadas, realizan las actividades necesarias para reclutar y retener a participantes jóvenes y se apegan fielmente a los currículos. Los programas pueden ser eficaces tanto con educadores adultos como con educadores pares.
<h3>¿qué queda por hacer?</h3>
Los legisladores deben financiar y promover la implementación de programas de enseñanza con eficacia comprobada sobre la sexualidad y el VIH. Cualquier programa nuevo necesita incluir las características comunes de los programas eficaces.<sup>5</sup> Los programas cuya eficacia no se ha comprobado deben ser evaluados.

Para implementar ampliamente los programas con evidencia científica de eficacia para la enseñanza sobre la sexualidad y el VIH, debe contarse con el apoyo de las autoridades correspondientes, tales como directores de organizaciones para jóvenes, distritos escolares, directores de escuela y maestros. El personal o los maestros que realizan los programas deben recibir capacitación y apoyo con el fin de impartir los programas con fidelidad; esto supone apartar el tiempo suficiente en la clase o en la organización para poder brindar el programa.

<hr />

<h3>¿Quién lo dice?</h3>
1. Centers for Disease Control and Prevention. Youth risk behavior surveillance – United States, 2005. Surveillance Summaries. June 9, 2006.

2. Alan Guttmacher Institute. U.S. teenage pregnancy statistics: Overall trends, trends by race and ethnicity and state-by-state information. New York: The Alan Guttmacher Institute, 2004.

3. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6-10.

4. Kirby D, Lepore G, Ryan J. Sexual risk and protective factors: Factors affecting teen sexual behavior, pregnancy, childbearing and sexually transmitted disease: Which are important? Which can you change? Washington DC: National Campaign to Prevent Teen Pregnancy. 2005.

5. Kirby D, Laris BA, Rolleri L. Sex and HIV education programs for youth: Their impact and important characteristics. Washington DC: Family Health International, 2006.

6. Jemmott III, JB. Effectiveness of an HIV/STD risk-reduction intervention implemented by nongovernmental organizations: A randomized controlled trial among adolescents. Presented at the American Psychological Association Annual Conference. Washington DC: August, 2005.

7. DiClemente RJ, Wingood GM, Harrington KF, et al. Efficacy of an HIV prevention intervention for African American adolescent girls: a randomized controlled trial. Journal of the American Medical Association. 2004;292:171-179.

8. Kirby D, Barth RP, Leland N, et al. Reducing the risk: Impact of a new curriculum on sexual risk-taking. Family Planning Perspectives. 1991;23:253-263.

9. Hubbard BM, Giese ML, Rainey J. A replication of Reducing the Risk, a theory-based sexuality curriculum for adolescents. Journal of School Health. 1998;68:243-247.

10. Kirby DB, Baumler E, Coyle KK, et al. The “Safer Choices” intervention: its impact on the sexual behaviors of different subgroups of high school students. Journal of Adolescent Health. 2004;35:442-452.

11. Jemmott JB, Jemmott LS, Fong GT. Abstinence and safer sex: A randomized trial of HIV sexual risk-reduction interventions for young African-American adolescents. Journal of the American Medical Association. 1998;279:1529-1536.

12. St. Lawrence JS, Brasfield TL, Jefferson KW, et al. Cognitive-behavioral intervention to reduce African American adolescents’ risk for HIV infection. Journal of Consulting and Clinical Psychology. 1995;63:221-237.

<hr />

Preparado por Douglas Kirby PhD, ETR Associates

Traducido por Rocky Schnaath

<strong>Enero 2007. Hoja de Dato #10SR</strong>

Se autoriza la reproducción (citando a UCSF) mas no la venta de copias este documento. También disponibles en inglés. Para recibir las Hojas de Datos por correo electrónico escriba a <a href="mailto:listserv@listserv.ucsf.edu">listserv@listserv.ucsf.edu</a> con el mensaje “subscribe CAPSFS nombre apellido” ©Enero 2007, UCSF.	]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/espanol/hojas/pdf/revensenanzaFS.pdf</url>
	</node>
	<node>
		<title>Couples-Based Voluntary Counseling and Testing and HIV Prevention in South Africa</title>
		<tax>1737</tax>
		<content><![CDATA[This project has two primary aims:
<ol>
 	<li>Identify barriers and facilitators for heterosexual couples pertaining to utilizing couples-based voluntary counseling and testing (CBVCT) in Soweto, South Africa</li>
 	<li>Identify relationship-based predictors of HIV risk behavior in couples (e.g., communication, intimacy, commitment, etc.).</li>
</ol>
The study is comprised of two phases. The first phase was qualitative in nature, and focused on obtaining information from men and women regarding their relationships and their perceptions and attitudes about couples-based testing for HIV. Both individual interviews and focus groups were conducted (N=48, 16 couples in individual interviews and eight couples in focus groups). Data collection was completed for this phase in February of 2006.

The second phase was a cross-sectional quantitative study of predictors of HIV risk behavior and of utilizing couples-based testing among a sample of 220 couples. The survey included questions about relationship dynamics, such as trust and communication, as well as social norms regarding HIV testing. This project finished data collection in December of 2008. The research is based at the Chris Hani Baragwanath Hospital and the Perinatal HIV Research Unit at the University of the Witwatersrand in Johannesburg, South Africa.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Darbes_L-CouplesBasedVCTPrevinSAfrica2009.pdf</url>
	</node>
	<node>
		<title>Couples in Context: An RCT of Couples-Based HIV Prevention Intervention</title>
		<tax>1737</tax>
		<content><![CDATA[This project has two primary aims: 1. Identify barriers and facilitators for heterosexual couples pertaining to utilizing couples-based voluntary counseling and testing (CBVCT) in Soweto, South Africa 2. Identify relationship-based predictors of HIV risk behavior in couples (e.g., communication, intimacy, commitment, etc.). The study is comprised of two phases. The first phase was qualitative in nature, and focused on obtaining information from men and women regarding their relationships and their perceptions and attitudes about couples-based testing for HIV. Both individual interviews and focus groups were conducted (N=48, 16 couples in individual interviews and eight couples in focus groups). Data collection was completed for this phase in February of 2006. The second phase was a cross-sectional quantitative study of predictors of HIV risk behavior and of utilizing couples-based testing among a sample of 220 couples. The survey included questions about relationship dynamics, such as trust and communication, as well as social norms regarding HIV testing. This project finished data collection in December of 2008. The research is based at the Chris Hani Baragwanath Hospital and the Perinatal HIV Research Unit at the University of the Witwatersrand in Johannesburg, South Africa.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Darbes.-Couples-in-Context-an-RCT-of-Couples-Based-HIV-Prevention-Intervention.pdf</url>
	</node>
	<node>
		<title>Developing a Comprehensive Couples-Based Intervention in South Africa</title>
		<tax>1737</tax>
		<content><![CDATA[This project conducted in-depth qualitative interviews with couples (n=20) key informants (n=12), and focus groups (n=4) regarding the feasibility and acceptability of a comprehensive couples-based intervention. Key issues were explored to determine potential interest for intervention content. The research is based at the Chris Hani Baragwanath Hospital and the Perinatal HIV Research Unit at the University of the Witwatersrand in Johannesburg, South Africa.

The primary aims of the project were to:
<ul>
 	<li>Determine the ideal components of an integrated package delivering comprehensive HIV and reproductive health services to heterosexual couples in Soweto, South Africa.</li>
 	<li>Explore the feasibility and acceptability of such a program via in-depth interviews with potential target audience members and key informants.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Darbes_L-DevelopCompBased.pdf</url>
	</node>
	<node>
		<title>Family-Based HIV Voluntary Counseling and Testing in Patients at Risk for Tuberculosis</title>
		<tax>1737</tax>
		<content><![CDATA[This study tests the efficacy of an intervention utilizing HIV rapid testing and integration of HIV Voluntary Counseling and Testing (VCT) into Tuberculosis (TB) evaluation and home-based VCT for family members, to overcome identified logistical and psychological barriers to HIV VCT among new TB patients and their family members.

The specific aims of the study are:
<ol>
 	<li>To determine the uptake of and barriers to HIV VCT among a cross-sectional sample of 2,000 TB evaluation patients offered same-day results HIV counseling and testing at the Uganda National TB and Leprosy Programme outpatient TB clinic at Old Mulago Hospital in Kampala, Uganda</li>
 	<li>To conduct a randomized trial of HIV VCT among 600 households comparing VCT uptake between home-based VCT and TB clinic-based VCT for family and household members of TB evaluation patients</li>
 	<li>To investigate the effectiveness of home-based and TB clinic-based VCT in linking HIV+ persons to HIV medical care and social support</li>
</ol>
Through this study’s dissemination plan and the proposed policy and community forums, information on a successful model could be made rapidly available to key stakeholders responsible for setting national policy and local HIV/AIDS control programs.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Charlebois_E-FamilyVCTinPatientsRiskofTB2009.pdf</url>
	</node>
	<node>
		<title>Identifying Opportunities for HIV Prevention with Female Migrants in Kenya</title>
		<tax>1737</tax>
		<content><![CDATA[This 5-year research program addresses a neglected topic of HIV prevention research: HIV risks to female migrants in sub-Saharan Africa. The research uses mixed quantitative and ethnographic methods to investigate how migration and mobility facilitate women’s risks of acquiring and transmitting HIV infection.

The first phase of the research in Kisumu, Kenya aims to
<ul>
 	<li>Describe women’s patterns of migration and mobility, and the spatial and social features of the common destinations of female migrants</li>
 	<li>Identify the social, environmental and structural aspects of women’s migration which render it particularly hazardous vis-à-vis HIV risks</li>
 	<li>Describe HIV-related beliefs, attitudes and sexual risk behaviors among female migrants The ultimate aim of this research is to develop and test a multi-level HIV prevention intervention with female migrants in western Kenya.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>https://designactioncollective.harvestapp.com/client/estimates/450028287967fe0726bdce7aa76d4e787f39027e</url>
	</node>
	<node>
		<title>MAMAS Study: Effects of HIV/AIDS Stigma on Use of Services by Pregnant Women in Kenya</title>
		<tax>1737</tax>
		<content><![CDATA[The Maternity in Migori and AIDS Stigma Study (MAMAS Study) aims to understand the effects of HIV/AIDS stigma on service use by pregnant women in rural Kenya, and to use the knowledge gained to develop stigma reduction interventions for this vulnerable group. The research plan includes a prospective study of women who use antenatal care (ANC) services at clinics in Migori and Rongo Districts in Nyanza Province, Kenya, as well as qualitative research to elucidate the potential role of HIV/AIDS stigma as a barrier to health service use among women in the community who do not use ANC services.

The MAMAS prospective study includes interviews with childbearing women at their first ANC visit, during late pregnancy, and after the birth. Around 1800 pregnant women who come to ten clinics for their first ANC visit and do not yet know their HIV status are being interviewed before their first visit to assess their perceptions of HIV/AIDS stigma, uptake of HIV testing, and other variables.

A subsample of these women (n=900) are re-interviewed during their last month of pregnancy and then again at six weeks postpartum to assess changes in perceptions and experiences of stigma, number of ANC visits completed, place of delivery, postpartum checkups, and enrollment in HIV care and treatment.

The qualitative research component will consist of in-depth interviews with:
<ul>
 	<li>Women who did not use maternity services for a recent pregnancy</li>
 	<li>Traditional birth attendants</li>
 	<li>Community health workers</li>
 	<li>Male partners of women who did not use maternity services</li>
</ul>
The final step will be to integrate the findings from the quantitative and qualitative data and use them to guide the development of an intervention to reduce HIV/AIDS stigma that adversely affects pregnant women in Kenya.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Turan_J-MAMAS2009.pdf</url>
	</node>
	<node>
		<title>Positive Prevention in Mozambique</title>
		<tax>1737</tax>
		<content><![CDATA[Facilitated by The Twinning Center, the UCSF School of Nursing has partnered with the Ministry of Health in Mozambique in order to adapt, pilot, and implement an US evidence-based Positive Prevention (PP) intervention within rural Mozambique. The purpose of this project is to develop a PP intervention that will effectively address the needs of people living with HIV (PLHIV) in Mozambique through advancing understanding among healthcare providers, counseling and testing staff, and peer educators.

Beginning in 2006, this intervention is taking place in two sites in Maputo Province in Mozambique. The first site focuses on building healthcare provider skills around effective risk assessment and prevention messages for their HIV-infected patients. The second site focuses on implementing similar needs assessment and prevention messages within one community–based Voluntary counseling and testing center and an accompanying peer support group. Collaboration among US and Mozambican partners (including healthcare providers, counseling and testing counselors, and PLHIV peer counselors) has guided the development of this PP intervention. The intervention currently includes case studies developed by Mozambican partners and a peer-led support group with enhanced one-to-one risk reduction counseling by counselors and PLHIV peers. Case studies are used in each setting to illustrate concepts such as assessment of transmission risk, behavioral risk reduction approaches, encouragement of partner testing and disclosure, prevention of mother-to-child transmission, and family planning.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Dawson_C-PosPrevMozambique2009.pdf</url>
	</node>
	<node>
		<title>Project Accept: …Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand</title>
		<tax>1737</tax>
		<content><![CDATA[UCSF is one site of an NIMH-funded multi-site, international efficacy trial of a behavioral intervention to reduce the incidence of HIV infection. Collaborating international sites teamed with US sites are: Zimbabwe (S. Morin, UCSF PI), South Africa (T. Coates, UCLA PI), Tanzania (M. Sweat, Johns Hopkins University PI) and Thailand (D. Celantano, Johns Hopkins University PI). In this prevention trial, 34 communities in Africa (Tanzania, Zimbabwe, and South Africa) and 14 communities in Thailand will be randomized to either a community-based HIV voluntary counseling and testing (CBVCT) intervention or clinic-based standard VCT (SVCT).

The intervention has three major strategies:
<ol>
 	<li>To make VCT more available in community settings</li>
 	<li>To engage the community through outreach and community mobilization</li>
 	<li>To provide post-test support services</li>
</ol>
These strategies are designed to change community norms and reduce risk for HIV among all community members, irrespective of whether they participated directly in the intervention. Thus, we plan a community-level sampling approach as opposed to a cohort design to evaluate outcomes.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Morin_S-ProjectAccept2009.pdf</url>
	</node>
	<node>
		<title>Project PROMOTE: Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa — Data and Statistics Core</title>
		<tax>1737</tax>
		<content><![CDATA[The overarching goal of this program project (P01) is to evaluate novel and strategic interventions to reduce the burden of malaria and improve HIV outcomes among children and pregnant women, the populations most affected by the overlap of these diseases. We hypothesize that treatment with HIV protease inhibitors (PIs) will lower the incidence of malaria and consequent morbidity in HIV+ children and pregnant women compared to those treated with standard antiretroviral treatment. This hypothesis is based on the appreciation that malaria parasites and HIV express biochemically similar proteases and the observation that HIV PIs exert potent in vitro antimalarial activity. We hypothesize that in HIV- children, chemopreventive therapy will offer strong protection against malaria without increased malarial morbidity after discontinuation of the intervention. We hypothesize that intermittent or chronic antimalarial and PI-based antiretroviral therapy will select for drug resistant parasites, and that different drugs will offer different selective pressures.

Four interlinked studies to test these three hypotheses comprise our P01 projects:
<ol>
 	<li>Protease inhibitors for the prevention of malaria in HIV-infected children</li>
 	<li>Protease inhibitors to reduce malaria morbidity in HIV-infected pregnant women</li>
 	<li>Chemopreventive therapy for malaria in HIV-uninfected infants and children</li>
 	<li>Selection of drug resistant malaria parasites by antimalarial and HIV therapies</li>
</ol>
The projects will enroll a total of 1600 participants and be implemented by a multidisciplinary, multinational team in Tororo, Uganda, a site of high malaria transmission. The Administrative and Data and Statistics Cores will support the four projects. CAPS will spearhead the Data and Statistics Core for this P01.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Charlebois_E-ProjectPromote2009.pdf</url>
	</node>
	<node>
		<title>Project REAC: Prevalence and Duration of False-Positive HIV Test Results in Acute Malaria</title>
		<tax>1737</tax>
		<content><![CDATA[The HIV and malaria epidemics inflict the greatest harm in sub-Saharan Africa and overlap significantly. We have recently identified an interaction between acute malaria and false positive HIV EIA test results. This project will investigate this interaction in three of the most common rapid EIA HIV tests used in sub-Saharan Africa among a cohort of 450 HIV-uninfected children aged 2-17 years being followed longitudinally for malaria in Kampala, Uganda as part of a larger, parent study. Children will be HIV counseled and tested once at baseline. For those who test HIV-negative we will retest blood samples at the time of first new malaria diagnosis using samples already being collected for the parent study, and again as blood is collected for the parent study for a period of up to 180 days. The study will be conducted at the MU/UCSF Malaria Clinic in Kampala, Uganda. The study clinic is located within the Mulago Hospital Complex, the primary referral hospital in Uganda.

The aims of the study are to:
<ul>
 	<li>Determine the prevalence of false positive HIV EIA test results in children with uncomplicated malaria.</li>
 	<li>Estimate the duration of false positive HIV EIA test results in children with uncomplicated malaria.</li>
 	<li>Compare the positive predictive value, sensitivity and specificity of serial rapid HIV testing algorithms to parallel rapid HIV testing algorithms in children with uncomplicated malaria.</li>
 	<li>Identify risk factors and predictors of false positive HIV EIA test results in children with malaria.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Charlebois_E-ProjectREAC2009.pdf</url>
	</node>
	<node>
		<title>Qualitative Study of HIV Prevalence Patterns among Youth in Botswana</title>
		<tax>1737</tax>
		<content><![CDATA[Three recent independent national datasets suggest that the rate of new HIV infections in Botswana appears to be declining, as evidenced by decreased prevalence among pregnant women aged 15-49. However, it is still uncertain why these declines have been observed and the extent to which behavioral changes (e.g., monogamy, condom use) have been causally associated with the decline. The goal of this study is to use qualitative research methods to lend additional depth to existing surveillance data that suggest that HIV prevalence among young people in Botswana is declining.

Focus group discussions and individual in-depth interviews are conducted with
<ul>
 	<li>Local youth service providers</li>
 	<li>Youth between the ages of 18-24</li>
 	<li>Adult key informants in three districts selected for regional diversity and variation of trends in HIV prevalence</li>
</ul>
By gathering information from young people and key informants who provide health-related services to young Batswana, we will gain valuable insight into the behavioral and contextual factors that may assist in explaining the observed decreases in HIV prevalence. Qualitative methods will allow us to explore the meanings and variations of the sexual experiences of young Batswana. This work may also lead to the development of innovative behavior change strategies to help support the decreased spread of HIV in Botswana.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Rutherford_G-QualitStudyHIVPrevelYouthBotswana2009.pdf</url>
	</node>
	<node>
		<title>Reducing New Infections in the NW Province of South Africa</title>
		<tax>1737</tax>
		<content><![CDATA[South Africa is the country most impacted by HIV in the world—of 49 million people, 5.6 million are infected with HIV. In 2011 the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Centers for Disease Control and Prevention (CDC) responded to the epidemic crisis by stepping up prevention partnerships across South Africa through support for comprehensive HIV/TB prevention programs.

The International Training and Education Center for Health in South Africa (I-TECH) was awarded funds to partner with the North West Province Department of Health (NWDOH), Empowerment Concepts, the University of California San Francisco’s Center for AIDS Prevention Studies, LifeLine and Soul City to develop, implement, and evaluate a comprehensive HIV prevention program in the province. Comprehensive prevention packages incorporate biomedical, behavioral and structural interventions, recognizing there is no silver bullet to prevent HIV but “that the optimal set of interventions implemented with quality and to scale can significantly reduce HIV incidence.” UCSF has supported this work by conducting a situational analysis, to tailor the programming to the local context; providing technical assistance in programming components; creating an infrastructure for community engagement through community working groups; supporting quality assurance, monitoring and evaluation; and leading an impact assessment of the project.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Lippman.-Reducing-New-Infections-in-the-NW-Province-of-South-Africa.pdf</url>
	</node>
	<node>
		<title>Risk Reduction for HIV Serodiscordant Couples Attempting Conception</title>
		<tax>1737</tax>
		<content><![CDATA[The goal of this study is to develop a preliminary understanding of the social and cultural context in which HIV serodiscordant couples in Kenya are making the decision to become pregnant.

The specific aims of this study are:
<ul>
 	<li>To explore the motivations for conception, understanding the risk of HIV transmission, and the decisionmaking process of serodiscordant couples desiring pregnancy.</li>
 	<li>To assess the acceptability of:</li>
 	<li>Limiting unprotected intercourse to the fertile window in a woman’s cycle to reduce the number of episodes of unprotected sex per month.</li>
 	<li>Providing the HIV- partner with antiretroviral medication to take prior to unprotected intercourse to reduce the risk of HIV transmission.</li>
 	<li>Starting antiretroviral medication in the HIV+ partner, regardless of immune status and clinical staging to reduce genital tract viral shedding and possibly HIV transmission.</li>
 	<li>Sperm washing to isolate spermatozoa from semen of HIV+ men, followed by intrauterine insemination using the prepared sperm in order to achieve pregnancy while preventing HIV transmission.</li>
</ul>
The study tool will consist of a structured questionnaire, followed by an in-depth interview. Fifteen discordant couples of reproductive age who express a general desire to have children in the future will be recruited from an existing AIDS care program in Kisumu, Kenya. Findings from this study will be used to design an investigation to determine the uptake and acceptability of these potential HIV prevention strategies.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Brubaker_S-RiskReducSerodiscorcouplesConception2009.pdf</url>
	</node>
	<node>
		<title>South Africa Health Monitoring Study (SAHMS)</title>
		<tax>1737</tax>
		<content><![CDATA[To continue UCSF’s commitment in helping the CDC’s Global AIDS Program (GAP) achieve its goals in GAP countries and regions, this project will strengthen local capacity, as well as collect vital data on the HIV epidemic among Sex Workers (SW) in South Africa.

To this end this project has 4 objectives:
<ol>
 	<li>To estimate the prevalence of HIV and syphilis, and associated risk behaviors among female sex workers in Johannesburg, Cape Town, and Durban, South Africa.</li>
 	<li>To estimate the population size and distribution of SW’s at these three locations.</li>
 	<li>To identify and assess determinants of access and utilization of health and social welfare programs in South Africa among sex workers.</li>
 	<li>To enhance the national capacity to conduct Integrated Bio-Behavioral Surveillance (IBBS) for key populations in South Africa as a key component of a strengthened second generation national HIV surveillance system.</li>
</ol>
This study is the first of its kind in South Africa and will be conducted in Johannesburg, Durban, and Cape Town. We will use key informant interviews, focus group discussions, and mapping as an initial Formative Assessment to guide the implementation of a more in-depth IBBS.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/CAPS_One-Pager_SAHMS_11-14-12.pdf</url>
	</node>
	<node>
		<title>Strategies for Promoting Male Circumcision through Voluntary Counseling and Testing in Rural Sub-Saharan African Communities</title>
		<tax>1737</tax>
		<content><![CDATA[This project is designed to assess logistical and sociocultural challenges involved in promoting male circumcision (MC) as a method of HIV prevention. The project took place in two sites: Mutoko, a rural district in the Mashonaland East Province of Zimbabwe and Vulindlela, a rural district in the province of KwaZulu-Natal, in South Africa. These communities are high HIV prevalence, resource-limited environments where MC is not traditionally practiced. The goal of this study is to better understand how to incorporate the concept of MC into broader HIV prevention planning for sub-Saharan Africa. Sixteen in-depth interviews were conducted with eight traditional, political, and religious leaders and health care providers key informants at each site. Eight focus group discussions (four focus groups per site) were conducted with community members separated by age and gender: younger men, younger women (ages 18-24 years); older men, older women (25 years and older).]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Morin_S-MaleCircVCTSubSahaAfrica2009.pdf</url>
	</node>
	<node>
		<title>Toward Understanding Community Mobilization for HIV Prevention in the African Context</title>
		<tax>1737</tax>
		<content><![CDATA[Increasingly HIV prevention specialists are focusing efforts on community social mobilization (CSM) strategies as a powerful and sustainable means of combating the HIV epidemic.

This study aims to
<ul>
 	<li>Develop a conceptual definition of CSM, including exploration of dimensions of CSM appropriate to the context of rural South Africa. We will conduct focus group discussions with young men and women and in-depth-interviews with community leaders in order to adapt and refine prior work conceptualizing the definition and dimensions of CSM to fit the rural South African context.</li>
 	<li>Generate context-specific items that capture dimensions of CSM and evaluate the properties of the new community mobilization measure. We will generate a pool of items measuring the dimensions of CSM, pilot test the items among 100 young people, conduct exit surveys, and evaluate the scale properties in order to refine the measure for use in a large scale survey.</li>
 	<li>Test the measure of CSM in the large scale community survey of young people aged 18-35 years (1,200 people in 25 communities) being implemented in the study entitled “Effects of cash transfer and community mobilization in young South African women.” The scale performance will be evaluated for reliability and validity using both item response modeling and confirmatory factor analysis in a large sample.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Lippman_CommunityMobilization_2010.pdf</url>
	</node>
	<node>
		<title>AIDS Stigma and Gender: Health Consequences in Urban India</title>
		<tax>1737</tax>
		<content><![CDATA[This study is a collaboration between UCSF, UC Davis, the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore and the TATA Institute of Social Sciences (TISS), Mumbai. The field sites are located in Bangalore and Mumbai, two large Indian cities situated in high HIV prevalence states.

The study is designed to:
<ul>
 	<li>Examine the nature, extent, and context of AIDS stigma and discrimination by gender, at multiple levels, among people coming into contact with urban health care systems, including: people living with HIV/AIDS, healthcare staff and the general population of patients seeking healthcare in outpatient settings.</li>
 	<li>Measure the health-relevant consequences of AIDS stigma and discrimination among both perpetrators and targets of stigma. These include the influence of stigma on HIV testing, on disclosure, on treatment seeking, and on willingness to provide care and treatment.</li>
 	<li>Develop a culturally-specific theoretical understanding of AIDS stigma and health in urban India as well as measures of AIDS stigma that can be used to evaluate future stigma reduction policies and programs in healthcare and community settings among victims and perpetrators.</li>
 	<li>Develop empirically-based programs and policy recommendations to reduce AIDS-related stigma and discrimination in urban Indian healthcare settings and to disseminate these.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Ekstrand_M-AIDStigmasndGender2009.pdf</url>
	</node>
	<node>
		<title>ASHA Improving Health and Nutrition of Indian Women with AIDS and their Children</title>
		<tax>1737</tax>
		<content><![CDATA[The overall goal of this study is to enhance the physical and mental health of rural Indian women living with AIDS and their children. We will achieve these goals through the use of trained village women as Accredited Social Health Activists (ASHA) to enhance the health of women and children through improved ART adherence, CD4 levels, and physical and mental health. This Indo-US collaboration between University of California, Los Angeles, University of California, San Francisco and All India Institutes of Medical Sciences (AIIMS) builds on our previous work with rural women living with AIDS and our successful ASHA program.

Specific objectives include:
<ul>
 	<li>Using a 2x2 factorial design, we plan to assess the effects of nutrition training and/or food supplements on primary outcomes for rural women living with AIDS in improving body composition and immune status (CD4 levels) as assessed at 6-, 12- and 18-month follow-up.</li>
 	<li>Examining the effects of the program arms and their interaction on adherence to ART, psychological health, nutritional adequacy, and lipid profile over time.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/ASHA-Nutrition-Summary_CAPS_website_FINAL.pdf</url>
	</node>
	<node>
		<title>Reducing AIDS Stigma among Health Professionals in South India (The DriSti Study)</title>
		<tax>1737</tax>
		<content><![CDATA[This study brings together researchers from the University of California, San Francisco; Research Triangle Institute in Washington DC; St. John’s National Academy of Health Sciences in Bangalore, India; and the All India Institute of Medical Sciences in New Delhi, India to evaluate the efficacy of a promising intervention designed to reduce HIV stigma among Indian health professionals. The intervention builds on results of our previous research, identifying prevalence and drivers of stigma and discrimination in Indian healthcare settings among PLHIV, health care providers and uninfected patients.

Specifically, the study will:
<ol>
 	<li>Adapt our pilot-tested 3-session stigma reduction intervention for partial tablet-based delivery to increase its long-term sustainability in health care settings. The two tablet-administered sessions of the intervention use interactive touch screen methodology and video vignettes tailored to situations likely to be encountered by Indian nurses and ward attendants. The third session focuses on skills-building in a group format and is co-facilitated by a PLHIV.</li>
 	<li>Evaluate the efficacy of the intervention in 24 hospitals in North and South India on:
<ol>
 	<li>behavioral manifestations of HIV stigma, including endorsement of coercive policies, behavioral intentions to discriminate, and non/stigmatizing provider-patient interactions.</li>
 	<li>the factors underlying stigma proposed by our conceptual model and targeted in the intervention modules, including fears and misconceptions regarding casual transmission (instrumental stigma), and negative attitudes toward marginalized, vulnerable groups (symbolic stigma).</li>
</ol>
</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/EKSTRAND-DRISTI-summary-for-CAPS-site-me-9-22-14_aes-me.pdf</url>
	</node>
	<node>
		<title>Improving Mental Health through Integration with Primary Care in Rural Karnataka</title>
		<tax>1737</tax>
		<content><![CDATA[The overall goal of this study is to improve screening, diagnoses and treatment of Common Mental Disorders among individuals with dual mental illness and cardiovascular disease diagnoses in rural South India. The multi-level intervention uses a collaborative care model that will be tested in a cluster RCT and includes low-cost, evidence-based sustainable strategies targeting multiple chronic diseases. This five-year study is being conducted in collaboration with our colleagues at St. John’s National Academy of Health Sciences in Bangalore and the Karnataka State government.

Specific objectives include:
<ul>
 	<li>Train community health outreach workers (ASHAs) to conduct community-based screening of depression, anxiety, type-2 diabetes and CVD risk factors during community health fairs to examine: a) whether this increases subsequent diagnoses in the Primary Health Clinics (PHC) of patients diagnosed with co-morbid mental health and chronic disease; and b) whether such patients are as likely to remain in treatment, compared to the standard PHC-based screening.</li>
 	<li>Implement and evaluate the effects of providing staff training in the collaborative care model of integrated mental health (depression, anxiety) and cardiovascular disease (hypertension, diabetes, CVD) to PHC staff and compare them to control PHC staff with respect to: a) knowledge and clinical skills using clinical patient vignettes; and b) perceived satisfaction reported by clinic patients in intervention and control PHCs.</li>
 	<li>Evaluate the effects of our multi-level integrated clinic and community-based intervention for co-morbid primary care patients compared to the enhanced standard non-integrated treatment services in a cRCT with 50 participating PHC, with regard to both mental and physical health outcomes at post-intervention, 6 and 12 month follow up.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/EKSTRAND-Mental-Health-Summary_CAPS_website_FINAL.pdf</url>
	</node>
	<node>
		<title>Cambodian Young Women’s Health Study</title>
		<tax>1737</tax>
		<content><![CDATA[This multidisciplinary study includes epidemiological research on prevalence and incidence of HIV, chlamydia, gonorrhea, and human papillomavirus (HPV), as well as rates of drug use including amphetamine-type stimulants (ATS) among young women in Phnom Penh, Cambodia working in the sex and entertainment service sectors and who have multiple sexual partners. Medical anthropology and psychological experts will assess cultural mediators of risk and preventive behaviors, including uptake of HPV vaccine. This is the second wave of this prospective study.

YWHS is a collaboration between CWDA, a small, women-run NGO, and the NCHADS. Using a community participatory approach, CWDA will conduct qualitative research recruitment of study participants, and ensure that retention of study participants is maintained at high rates through follow up within established communitybased networks in Phnom Penh. NCHADS clinical staff including health care and HIV counseling staff will assess biological outcomes, risk and provide ongoing HIV prevention and treatment access.

The study will:
<ul>
 	<li>Enroll 300 women aged 15-29 who report more than two sexual partners within the past month or engaging in transactional sex within the past three months.</li>
 	<li>Screen the women for HIV, STD and HPV infections.</li>
 	<li>Administer a behavioral interview on demographics, sexual risk and drug-use behaviors.</li>
 	<li>Assess ATS use using urine screening.</li>
 	<li>Conduct HPV testing and gynecological assessments to assess HPV infection, cytology and cervical disease. All consenting participants will be followed prospectively for up to two years with quarterly follow-up visits. Recruitment and follow-up strategies will be monitored in preparation for future larger prevention research studies including HIV vaccine, microbicide, and chemoprophylaxis trials.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Page_K-CambodianYoungWomen2009.pdf</url>
	</node>
	<node>
		<title>Context and Correlates of Health Behaviors in South India</title>
		<tax>1737</tax>
		<content><![CDATA[This five-year study is being conducted in collaboration with three Indian NGOs: YRGCARE in Chennai, Tamil Nadu, SHADOWS in Chirala, Andhra Pradesh, and Shelter in Calicut, Kerala. The overall goal is to obtain a better understanding of HIV risk-taking in the context of alcohol consumption among male migrant workers and female sex workers in South India through formative work as well as qualitative and qualitative interviews. A secondary goal of this project is to develop and pilot-test a risk reduction intervention among these two groups.

Specific objectives include:
<ul>
 	<li>Conduct qualitative interviews with our target populations to examine patterns of alcohol consumption and sexual risk-taking, and the relationship between these behaviors and individual, interpersonal and contextual factors.</li>
 	<li>Develop and administer a quantitative survey to measure the prevalence and patterns of sexual risk-taking and alcohol consumption, as well as related individual interpersonal and contextual factors in the two target populations.</li>
 	<li>Develop, implement and pilot test a risk-reduction intervention to reduce HIV risk-taking in the context of alcohol use among South Indian female sex workers and male migrant workers.</li>
 	<li>Develop research capacity in two NGOs serving vulnerable populations in these areas, using a previously successful scale-up model in collaboration with YRGCARE, Chennai.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Ekstrand_M-ContextanCorrelaSIndia2009.pdf</url>
	</node>
	<node>
		<title>Formative Research to Assess HIV Risk among MSM in Nepal</title>
		<tax>1737</tax>
		<content><![CDATA[<img class="alignright size-full wp-image-4827" src="/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/Screen-Shot-2016-12-09-at-4.54.43-PM.png" alt="" width="248" height="247" />This study aims to meet the need for in-depth formative research to develop an evidence-based and theorydriven HIV prevention intervention with MSM in Nepal. The study will be conducted in collaboration with the Blue Diamond Society, the only CBO currently serving MSM in Nepal.

We will conduct five interviews with key informants who are service providers knowledgeable about HIV risk among MSM to identify sub-populations of MSM, gather initial HIV risk data, assist in the refinement of an interview guide for MSM and assess feasibility of a larger study. Based on this data, we will conduct in-depth interviews with 20 MSM to explore identity, sexual networks, risk perception and stigma. Finally, we will conduct interviews with five key informants who are leaders in HIV prevention among MSM in Nepal and South Asia. These last interviews will help the research team develop relationships with leaders in South Asian MSM HIV prevention and assess feasibility for a larger study.

We will engage community members at the beginning and end of this study for their input and engagement as potential community advisory board members in a future study.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Wilson_E-HIVRiskamongMSMinNepal2009.pdf</url>
	</node>
	<node>
		<title>HIV Prevention Intervention for HIV-Positive Men in China</title>
		<tax>1737</tax>
		<content><![CDATA[In China, sexual transmission has become the major driving force behind the HIV epidemic, accounting for more than half (52%) of the estimated 700,000 people currently living with HIV. Men who have sex with men (MSM) may contribute to the rapid acceleration of the epidemic throughout China. Studies with Chinese MSM have documented an increasing HIV prevalence, a high HIV incidence, and high rates of unprotected intercourse and sexually transmitted infections (e.g., syphilis) known to facilitate sexual transmission of HIV. Moreover, our work found that HIV-transmission risk behavior is highly prevalent among HIV-positive MSM in China. Nonetheless, no HIV prevention interventions have targeted HIV-positive Chinese MSM. Several interventions have demonstrated efficacy in reducing sexual risk behaviors among HIV-positive MSM in the U.S. Adapting such interventions for HIV-positive MSM in China would help accelerate the process of developing an efficacious intervention for this risk group. The proposed three-year study (R34) will adapt and pilot-test currently available evidence-based behavioral interventions to reduce HIV-transmission risk behavior among HIV-positive MSM in Chongqing, China. This study will be implemented in five phases, guided by Wainberg et al.’s intervention adaptation model.

In Step 1, we will identify core components of efficacious interventions (e.g., key theoretical constructs, intervention messages, delivery modes) through the review of the literature.

In Step 2, we will explore cultural, psychosocial, and contextual factors associated with sexual risk behaviors and generate ideas for intervention strategies for HIV-positive MSM by conducting 15 key informant interviews with individuals knowledgeable about HIV-positive MSM and 30 in-depth interviews with HIV-positive MSM.

In Step 3, we will adapt efficacious interventions through reviewing the core elements of efficacious interventions identified in Step 1 and collating those elements with qualitative data collected in Step 2 with an intervention adaptation working group of 10 health professionals and MSM lay workers who serve HIV-positive MSM.

In Step 4, we will pilot-test the adapted intervention with 16 HIV-positive MSM and refine the intervention if necessary.

In Step 5, we will test the feasibility of implementing and assessing the intervention refined in Step 4 by conducting the intervention with 50 HIV-positive MSM and having these 50 men complete baseline and 3- month surveys.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Choi.-HIV-Prevention-Intervention-for-HIV-Positive-Men-in-China.pdf</url>
	</node>
	<node>
		<title>Influence of Stigma and Discrimination on HIV Risk among Men in China</title>
		<tax>1737</tax>
		<content><![CDATA[This is a three-phase study to identify the specific mechanisms by which MSM stigma affect sexual risk behaviors among MSM in Beijing, China.

In Phase 1, we will explore the range of management strategies used to cope with MSM stigma via 30 in-depth qualitative interviews with MSM.

In Phase 2, we will develop, using Phase 1 qualitative data and adapting existing quantitative scales, culturally-relevant measures of explanatory constructs of interest (e.g., MSM stigma management) to establish reliability and validity (N=170).

In Phase 3, we will examine potential mediators (e.g., stigma management strategies, psychological distress, sexual contexts/situations) that explain how MSM stigma are linked to sexual risk for HIV with a respondent-driven sample of 500 MSM who will complete baseline and two follow-up assessments at 6 and 12 months.

We will also conduct 20 in-depth qualitative individual interviews with a subset of men selected from the Phase-3 participants to examine the acceptability of potential intervention components to address the link between MSM stigma and HIV risk.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Choi_China-Stigma-MSM_2010.pdf</url>
	</node>
	<node>
		<title>Understanding the HIV Risk and Protective Behaviors of Young Business Process Outsourcing Center Employees in the Philippines</title>
		<tax>1737</tax>
		<content><![CDATA[This project focuses on the HIV prevention needs of young adults employed in business process outsourcing (BPO) centers in the Philippines. The BPO industry is projected to create 303,000 new jobs by 2010, with the total BPO workforce reaching 1.1 million in the Philippines. The overall goal of the proposed project is to utilize qualitative research methods to gain a better understanding of the complexity of sexual risk and protective behaviors of these young adults. Since no specific HIV workplace interventions are currently implemented in the Philippines, the proposed research will help describe how to best address the unique health needs of young BPO employees.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Bangi_A-RiskBehaYoungBizPeoplePhilippines2009.pdf</url>
	</node>
	<node>
		<title>Assessing the Feasibility of Conducting a Randomized Community Trial of the Encontros Intervention Model among Sex Workers in Brazil (Lippman, S)</title>
		<tax>1737</tax>
		<content><![CDATA[This study will determine the feasibility of conducting a CRCT of a promising multi-component intervention among sex workers in Brazil. Determining study feasibility includes documenting local interest and input from key stakeholders and carrying out an analysis of costs to implement a large intervention trial. This study combines qualitative interviewing of key stakeholders (n=20) and modeling of sample size projections and costs to outline:
<ul>
 	<li> Intervention design</li>
 	<li> Study logistics</li>
 	<li>Study ethics</li>
 	<li>Study location</li>
 	<li>In-country collaborators</li>
 	<li>Strategies for community participation</li>
 	<li>Costs</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Lippman_Brazil_2010.pdf</url>
	</node>
	<node>
		<title>Application of Weighted Time-Series to Address Bias in Evaluation of Clinic- and Community-Level Research</title>
		<tax>1737</tax>
		<content><![CDATA[This study will use simulation to develop, test and apply new analytic methods (weighted time-series) for evaluation of community-level interventions. It will then compare results using weighted time-series and conventional methods within the context of a clinic-level intervention to provide family-centered HIV care, voluntary counseling and testing (VCT) and prevention services at Family AIDS Care and Education Services (FACES), a community-based organization in Kenya. Because FACES includes observational data on virtually all patients in care at participating clinics, it provides an excellent platform to evaluate the effectiveness of this intervention using both cohort and time-series methods. The results of this study will be used to seek funding to test the broader application of these methods in both community- and clinic-level interventions. The specific aims of the proposed project are:
<ul>
 	<li>To provide the rationale and framework for applying weighted time-series to serial cross-sectional data.</li>
 	<li>To use simulation (created data) to apply and test the use of weighted time-series in a setting where the distribution of demographic characteristics and the health status of the population changes over time.</li>
 	<li>To use existing clinical data to compare the effect of introducing family-centered HIV care, VCT and prevention services on the transmission of HIV among the families served by participating clinics using cohort analysis, time-series analysis and weighted time-series.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Shade_S-WeightedTimeSeriestoAddressBias2009.pdf</url>
	</node>
	<node>
		<title>Improving Self-Reports about High-Risk Sexual Behavior</title>
		<tax>1737</tax>
		<content><![CDATA[In this study we will conduct an experiment to test the effectiveness of an innovative method of administering a survey interview--conversational interviewing--in reducing respondents’ reporting errors in their responses to sexual behavior questions common in HIV/AIDS research. In studies comparing conversational interviewing to standardized interviewing, conversational interviewing resulted in remarkable improvements in respondents’ understanding of the intended meaning of survey questions and in the accuracy of respondents’ answers. The standardized method of administering survey questions states that if respondents request clarification regarding the meaning of a survey item, interviewers are instructed to read the question again, and if confusion persists, say, “Whatever it means to you.” In contrast, the conversational interviewing method maintains the basic structure of the survey interview but adds procedures to allow interviewers to assist respondents to understand survey questions that are posing difficulties. We will use a mixed method design (n=200) to (1) conduct an experiment comparing conversational interviewing to standard interviewing in a sexual behavior survey; and (2) conduct an in-depth debriefing interview immediately after the survey interview is completed to identify the types of comprehension issues that occurred in the interview.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Binson_Conversational-Interviewing_2010.pdf</url>
	</node>
	<node>
		<title>AIDS Policy Research Center</title>
		<tax>1737</tax>
		<content><![CDATA[UCSF, the San Francisco AIDS Foundation (SFAF), and Project Inform have created an AIDS Policy Research Center (APRC) to conduct timely research to help policymakers, planning councils and community organizations address the HIV epidemic in the State of California. The center is supported with funds from the California HIV/AIDS Research Program (CHRP). The work of the APRC includes both a Rapid Response Core and a set of planned research projects.

The purpose of the Rapid Response Core is to:
<ul>
 	<li>Identify HIV-related policy issues affecting California</li>
 	<li>Develop specific research questions and to design studies that answer critical questions of relevance to pressing policy issues</li>
 	<li>Collect and analyze research data</li>
 	<li>Relay findings back to policymakers and other individuals involved in the formulation of policies</li>
</ul>
The planned research projects focus on:
<ul>
 	<li>Modeling costs to the State under healthcare reform</li>
 	<li>An evaluation of medical homes</li>
 	<li>A model of care recently endorsed by the California Visioning Change Initiative</li>
 	<li>Estimating funding to the state and its cities under a reauthorization of the Ryan White Program anticipated in the next several years</li>
</ul>
Research conducted at the APRC is guided by an external Policy Research Advisory Committee (PRAC) that guarantees regular and ongoing communication between the scientific investigators and community partners. The PRAC consists of approximately 10 individuals from non-governmental and community-based HIV/AIDS organizations, public health offices, and clinical care and prevention services programs throughout the State of California.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Morin_APRC_2010.pdf</url>
	</node>
	<node>
		<title>Evaluation of Patient and Provider Perspectives on Routine HIV Screening in Emergency Departments</title>
		<tax>1737</tax>
		<content><![CDATA[Routine HIV screening in all health facilities has been recommended by the CDC as a critical strategy to reach undiagnosed HIV patients in order to facilitate linkage to care and enhance HIV prevention efforts. Offering HIV testing in hospital emergency departments is viewed as a particularly important mechanism to reach patients who may not have health insurance or access to regular medical care. To address this issue, the California State Office of AIDS will be launching a program to expand HIV screening in three San Francisco Bay Area hospital emergency departments including: Alameda County Medical Center-Highland Hospital, Alta Bates Summit Medical Center and San Francisco General Hospital. This project will evaluate the implementation process of Routine Testing for HIV in each Emergency Department.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Lane_T-EvalofPatientProviderRoutERScreen2009.pdf</url>
	</node>
	<node>
		<title>Evaluation of Patient Perspectives on Routine HIV Screening in Health Care Settings</title>
		<tax>1737</tax>
		<content><![CDATA[In collaboration with investigators at the Francois-Xavier Bagnoud Center at the University of Medicine and Dentistry of New Jersey, we are developing and pilot testing a set of evaluation tools for use by clinical sites implementing routine HIV screening in primary care settings in accord with updated guidelines released by the CDC in 2006. The tools will help staff in these settings to assess:
<ul>
 	<li>Patient and provider preferences</li>
 	<li>Satisfaction and attitudes with respect to CDC recommended practice, including opt-out screening</li>
 	<li>Patients’ perceptions of their ability to decline testing</li>
 	<li>Sufficiency and effectiveness of methods used to impart information prior to testing</li>
 	<li>Acceptability of different methods for providing test results Development of the patient assessment tool has been accomplished in two steps.</li>
</ul>
In the first, we conducted interviews with patients who were routinely tested for HIV in the Kansas City Free Clinic. Results from the first phase were used to develop a quantitative assessment of patient attitudes, reactions and acceptance of new models for HIV screening and prevention and their outcomes in terms of patient care. In the second step, this assessment will be validated through administration to as many as 450 patients seen in three sites nationally, one emergency room and two primary care settings (one seeing primarily privately insured patients, the other publicly-insured ones). The provider tool was developed and tested at San Francisco General Hospital. Findings from this project will be collected in a toolkit of clinical evaluation instruments and protocols for assessing patient experiences and outcomes associated with the enhanced screening projects. The toolkit will be disseminated through tailored technical assistance provided through the Health Resources and Services Administration’s (HRSA) AIDS Education and Training Centers program.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Myers_J-EvalPatientProviderRoutineScreenHCset2009.pdf</url>
	</node>
	<node>
		<title>Formative Study of the Role of Gender, Ethnicity and Sexual Orientation in the Provision of Prevention Counseling with HIV+ Patients</title>
		<tax>1737</tax>
		<content><![CDATA[We will conduct formative research to inform the design of a discrete choice experiment (DCE) that will quantitatively assess the relative importance of gender, ethnicity and sexual orientation in providers’ decisions to provide Prevention with Positives (PWP) counseling. In the DCE, providers will be presented a variety of scenarios in which factors that impact provision of PWP counseling are varied. Information from their responses will be used to quantitatively assess the relative impact of each of the factors included in the scenarios on providers’ decisions to provide PWP counseling. This study involves three critical steps:
<ol>
 	<li>To develop preliminary versions of the questions to be used in clinical scenarios that involve decisions to offer HIV prevention counseling to an HIV+ patient.</li>
 	<li>To pilot test the preliminary questions and scenarios with a sample of 20 providers of HIV care in order to finalize the language used in the scenarios.</li>
 	<li>To obtain preliminary information from the 20 provider interviews on responses to DCE scenarios in order to estimate the number of scenarios and participants required.</li>
</ol>
The first aim will be accomplished by convening three focus groups of key informants with expertise of relevance to PWP counseling. Investigators will present broad outlines of potential scenarios and will ask informants to critique and help refine language that will become part of the information presented in the scenarios, of the questions to be asked during the scenarios, and of the potential response options. For the second and third aims, we will conduct 20 formative interviews with HIV providers in the greater San Francisco Bay Area. Specifically, we will employ cognitive interviewing techniques, in which we present the scenarios, questions, and potential answer options to participants, and ask them to explain their understanding of the items and the thinking that goes into their selection of a response.

Providers will also complete a short assessment of their beliefs about clinical care and about their personal characteristics (e.g., race/ethnicity, gender, sexual orientation, professional training). Information from the cognitive interviews will be used to finalize response options, scenarios and sample size to be used in a full DCE study.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Shade_S-GenderEthnicitySexualinProvCouns2009.pdf</url>
	</node>
	<node>
		<title>Health Information Technology Evaluation Center (HITEC)</title>
		<tax>1737</tax>
		<content><![CDATA[HITEC is the evaluation center for the HRSA Special Projects of National Significance (SPNS) Information Technology Networks of Care Initiative. Six demonstration sites are implementing electronic network systems to interconnect providers at different care locations. The goal of these systems is to promote health information exchange to improve the delivery, continuity, and quality of care to people living with HIV/AIDS who receive services in publicly-funded settings. Using a mixed methods design, HITEC seeks to answer the following questions:
<ul>
 	<li>What are the barriers and facilitators to the implementation of health information electronic network systems among sites serving people living with or affected by HIV/AIDS?</li>
 	<li>What characteristics of electronic network systems are associated with improved care?</li>
 	<li>Are there patients for whom this works better?</li>
 	<li>How do electronic network systems improve continuity across sites?</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Myers_J-HITEC2009.pdf</url>
	</node>
	<node>
		<title>Severity of Need: California Health Care Financing and Policy Research Initiative [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[The Ryan White HIV/AIDS Treatment Modernization Act (a reauthorization of the original Ryan White CARE Act) changed the formulas used to distribute funding to states and cities in the US. The case counts used to allocate the awards shifted from using only AIDS cases to using both HIV (non-AIDS) and AIDS cases. In addition, federal agencies have been charged with developing a Severity of Need Index, which eventually may be used in formula award allocations to weight HIV/AIDS case data by factors thought to impact the variable cost of treatment around the nation. In this project, we have responsibility for developing models that simulate the distribution of formula awards in order to understand how changes to the Ryan White Program formulas impact funding nationwide—and, in particular, California and its cities.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/Morin_SeverityofNeed2009.pdf</url>
	</node>
	<node>
		<title>Using Technology to Streamline Client Data Collection and Improve HIV Test Counseling</title>
		<tax>1737</tax>
		<content><![CDATA[This pilot study will determine the acceptability and translatability of PalmPal, an innovative structural intervention we designed to improve the process of HIV test counseling. PalmPal is a ten minute risk assessment questionnaire that is self administered by the client using a handheld computer just prior to the test session. The proposed study will recruit a representative sample of 40 test clients from three test clinics to conduct six focus groups. The study will address two main research questions:
<ol>
 	<li>Is PalmPal usable and acceptable across a variety of test client populations?</li>
 	<li>What are clients’ perceptions about the potential of PalmPal to enhance the testing process?</li>
</ol>
To address the first question, participants will complete the PalmPal questionnaire at the start of the focus group. To address the second question, the focus group discussions will explore client experiences with a range of counseling strategies and the ways that PalmPal might enhance the session. The demographic, risk, and testing characteristics of participants collected on the PalmPal device will provide valuable context for interpreting participant comments about testing preferences and experiences from the focus group discussion. The proposed study will lay the groundwork for two future research proposals:
<ol>
 	<li>To expand the scope of the PalmPal intervention to include targeted prevention education for test clients</li>
 	<li>To test the effectiveness of PalmPal as a structural intervention both by itself and combined with face-to-face test counseling</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Sheon_N-PalmPal2009.pdf</url>
	</node>
	<node>
		<title>AIDS Education and Training Centers’ HIV Recommendations Training Initiative</title>
		<tax>1737</tax>
		<content><![CDATA[Six Pacific AIDS Education and Training Center (PAETC) local performance sites (LPSs) will target medical settings for activities to promote and support expanded HIV testing, per the 2006 Centers for Disease Control and Prevention Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. This decentralized model provides services based on an understanding of the local epidemic and local health care delivery services.

The Hawai’i, Nevada and Arizona AETCs will each work with one hospital-based labor and delivery department to implement rapid HIV testing with women presenting in labor with no prenatal care or documented HIV test result. The East Bay and San Francisco AETCs will each work with one community health center (CHC) or public health clinic to implement opt-out HIV testing when feasible, given state laws and regulations, for primary care clients between the ages of 13 and 64. The University of California Los Angeles AETC will identify and target four CHCs in Los Angeles to expand HIV testing with primary care patients.

All targeted health care settings will serve a majority of minorities, primarily Latinos and African Americans in California, Arizona and Nevada, and Pacific Islanders in Hawai’i. The LPSs will use a technical assistance model that includes identification of key decision-makers, support to implement clinic policies and procedures, and accompanying staff training.

The San Francisco AETC will develop a binder of resource materials to support implementation in CHC settings. Materials will consist of:
<ul>
 	<li>Federal guidelines and recommendations for testing and initial diagnosis</li>
 	<li>Sample protocols, policies and procedures</li>
 	<li>Fact sheets</li>
 	<li>Staff training materials</li>
 	<li>Patient education materials</li>
 	<li>State regulations on testing and reporting</li>
 	<li>References and resources</li>
</ul>
The LPSs that work with labor and delivery settings will use PAETC’s resources and reference manual developed for our current California Office of AIDS-supported Rapid Testing in Labor and Delivery program. Level I and II training will be provided to physicians, nurses, nurse practitioners, physician assistants, and pharmacists.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Reyes_M-AETCRecsTrainingInitiative2009.pdf</url>
	</node>
	<node>
		<title>AIDS Education Training Centers’ National Evaluation Center [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[The AIDS Education and Training Centers’ National Evaluation Center (AETC NEC) provides evaluation development and technical support to the national AIDS Education and Training program, a network of 11 regional centers conducting targeted, multidisciplinary education and training programs for health care providers treating persons living with HIV/AIDS. Through a national network of more than 130 local performance sites (LPSs) and four national centers, the AETCs target training to providers who serve minority populations, the homeless, rural communities, incarcerated persons, community and migrant health centers, and Ryan White Program-funded sites. As one of the national centers, the AETC NEC’s mission is to provide leadership in the development, design, testing and dissemination of effective evaluation models for determining the effect that AETC clinical education and training programs have on increasing trainee knowledge and skills and improving clinical practice.

In collaboration with HRSA/HAB, the specific aims for the Center are:
<ul>
 	<li>Aim 1 (Development): Design and conduct rigorous evaluation research across AETC regions and national centers that will measure the effectiveness and impact of training and education on clinical practice; uncover barriers and challenges to applying new knowledge and skills; and have maximum impact on evaluation practice and policy across the AETC network.</li>
 	<li>Aim 2 (Capacity Building): Stimulate innovative evaluation projects and ensure scientific excellence by developing, designing and implementing outcome evaluation projects collaboratively in each region across the AETC network, as well as the organizational capacity to ensure integrity and quality of evaluation research.</li>
 	<li>Aim 3 (Replication): Enhance evaluation across the network by adapting proven methods for measuring AETC clinical training outcomes and applying them across local performance sites, regions and national centers.</li>
 	<li>Aim 4 (Support): Provide methodological (both quantitative and qualitative) evaluation research design consultation and technical support to AETC regional and national centers as they implement innovative tools and best practices for measuring training outcomes.</li>
 	<li>Aim 5 (Dissemination): Disseminate findings from evaluation projects so that they have optimum impact on further HIV clinical education and training programs.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Myers_J-AETCNEC2009.pdf</url>
	</node>
	<node>
		<title>Capacity Building Assistance Project [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[UCSF has a long and successful history of delivering Capacity Building Assistance (CBA) to Community-based Organizations (CBO), going back to the beginning of the epidemic. We provide information dissemination services, training, and technical assistance (TA), including the facilitation of peer-to-peer learning. Our CBA providers are also experienced at helping CBOs use social media in their prevention efforts.

The purpose of our CBA project is to <strong>increase the capacity of the HIV prevention workforce at CBOs to optimize the planning, implementation, and maintenance of interventions and strategies for HIP</strong>. By doing so, UCSF will further the HIV prevention goals and objectives outlined in the <em>National HIV/AIDS Strategy</em>.

Our Capacity Building Assistance (CBA) team includes <strong>expert CBA providers</strong> from UCSF’s Center for AIDS Prevention Studies (CAPS), Center of Excellence for Transgender Health (CoE), and Alliance Health Project (AHP—formerly AIDS Health Project). Additionally, we collaborate with the Bridging Group.

We have the experience and expertise to provide HIP-related CBA services to CBOs to <strong>improve their capacity to conduct HIV testing, prevention with HIV-positive individuals, and prevention with high-risk HIV-negative individuals</strong>, especially:
<ul>
 	<li>Gay/bisexual/and other men who have sex with men</li>
 	<li>Transgender women</li>
 	<li>Communities of color</li>
 	<li>Incarcerated populations</li>
 	<li>Injection drug users</li>
</ul>
While we can assist CBOs implementing and adapting a broad variety of evidence-based HIV prevention approaches, our team has <strong>specialized expertise</strong> on the following interventions and public health strategies:
<ul>
 	<li><a href="https://web.archive.org/web/20161029004643/http://mpowerment.org/" target="_blank">The Mpowerment Project</a> (MP)</li>
 	<li>Personalized Cognitive Counseling (PCC)</li>
 	<li>Couples HIV Testing and Counseling (CHTC)</li>
 	<li>Healthy Relationships (HR)</li>
 	<li>Social Network Strategy for Counseling, Testing, and Referral (SNS)</li>
 	<li><a href="https://web.archive.org/web/20161029004643/https://www.effectiveinterventions.org/HighImpactPrevention/Interventions/ProjectSTART.aspx" target="_blank">Project START</a></li>
 	<li><a href="https://web.archive.org/web/20161029004643/http://www.thebridginggroup.com/" target="_blank">The Bridging Group</a></li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/resources/capacity-building-assistance-cba/</url>
	</node>
	<node>
		<title>Center of Excellence for Transgender HIV Prevention</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			1
		</type>
			<url>http://www.transhealth.ucsf.edu/</url>
	</node>
	<node>
		<title>Evaluation and Technical Assistance Center (ETAC) for the SPNS Culturally Appropriate Interventions of Outreach, Access and Retention among Latino/a Populations Initiative</title>
		<tax>1737</tax>
		<content><![CDATA[The Evaluation and Technical Assistance Center (ETAC) at UCSF will provide leadership and support to demonstration sites implementing interventions to enhance HIV testing and diagnosis among out-of-care Latina/os, and to link and retain these populations in high quality HIV care. Over the course of the five year Initiative, the ETAC will:
<ol>
 	<li>provide technical assistance (TA) to the demonstration sites regarding the development of innovative models for providing HIV and support services, as well as TA regarding methodological (both quantitative and qualitative) research design;</li>
 	<li>conduct a rigorous multi-site evaluation of the implementation and outcomes of all interventions and the multi-site cohort as a whole; and</li>
 	<li>lead and coordinate the efforts for publication and dissemination of findings and lessons learned from the Initiative.</li>
</ol>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Myers-and-Steward.-HRSA-SPNS-ETAC.pdf</url>
	</node>
	<node>
		<title>Local Evaluation Online (LEO)</title>
		<tax>1737</tax>
		<content><![CDATA[Through this project CAPS is partnering with the California Office of AIDS (OA) to provide on-going support for the Local Evaluation On-Line (LEO) system in California. LEO is a web-based information system that enables California’s prevention providers to systematically collect and access information that is critical to effectively prevent HIV infection. It provides primarily process monitoring and client-based evaluation data on a number of intervention activities (e.g., individual or group-level), and eventually it will provide data on how these local interventions are affecting HIV infection rates in the area being served. LEO combines all of the OA HIV prevention data-based systems into one integrated system. Our team will assist with the implementation process.

Currently, our team provides programmatic technical assistance, including the use of data for evaluation of local programs’ effectiveness. We assist the OA staff on the development and implementation of HIV Education and Prevention Scopes of Work between the OA and the Local Health Jurisdictions, including assistance with the development of their LEO data-system and reviewing and approving interventions in the LEO system. Additionally, our evaluation and prevention scientists are currently analyzing LEO system data to learn more about the epidemic in California, as well as how effectively local and statewide efforts are at addressing the epidemic.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Morin_S-LEO2009.pdf</url>
	</node>
	<node>
		<title>Rapid HIV Testing in Labor and Delivery in California</title>
		<tax>1737</tax>
		<content><![CDATA[This three-year capacity building project targets labor and delivery departments in 120 California hospitals to implement HIV rapid testing with women presenting in labor with no previous documented HIV test or prenatal care. These women may be the hardest-to-reach populations who prefer to avoid contact with the health care system, such as migrant women, undocumented women, drug-addicted women, women who engage in sex work, and women with a child protective services history. Project components include:
<ul>
 	<li>Curriculum development to train labor and delivery staff</li>
 	<li>Development of materials (such as sample policies, procedures, patient education materials, consent forms, etc.) to support implementation of rapid testing</li>
 	<li>Staff training</li>
 	<li>On-going technical assistance to ensure policies are followed and antiretroviral prophylaxis medications are readily available when needed</li>
</ul>
The project uses a decentralized model, with implementation activities based at PAETC’s 11 local performance sites in California with oversight and management from PAETC’s Central Office at UCSF. This project is supported by a contract with the California State Office of AIDS, with CDC funds.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Reyes_M-RTLD2009.pdf</url>
	</node>
	<node>
		<title>Transgender Evaluation and Technical Assistance Center (TETAC)</title>
		<tax>1737</tax>
		<content><![CDATA[]]></content>
		
		<type>
			1
		</type>
			<url>http://transhealth.ucsf.edu/trans?page=programs-tetac</url>
	</node>
	<node>
		<title>Transitions Project</title>
		<tax>1737</tax>
		<content><![CDATA[The Transitions Project provides capacity building assistance (CBA) and technical assistance to community-based organizations (CBOs) and health departments throughout the US to promote knowledgeable, sensitive, and effective HIV/AIDS prevention for transgender communities of color and HIV+ transgender people. The project particularly focuses on young transgender women of color. The goals of the Transitions Project are:
<ul>
 	<li>To improve healthcare providers’ awareness around issues that impact trans health and access to healthcare.</li>
 	<li>To expand the capacities of HIV/AIDS prevention organizations in order to serve trans clients more effectively.</li>
 	<li>To increase transgender-specific resources in community-based health promotion programs.</li>
 	<li>To promote community building and networking among trans and gender-variant persons and allied service providers and advocates.</li>
 	<li>To help adapt evidence-based interventions that were originally developed for other populations so that they are culturally appropriate and relevant to young trans women of color.</li>
</ul>
The Transitions Team is available for consultation, training, capacity-building and technical assistance throughout the United States.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Kegeles_S-Transitions2009.pdf</url>
	</node>
	<node>
		<title>Cochrane Review Group on HIV/AIDS [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[The Cochrane Collaborative Review Group on HIV Infection and AIDS (Cochrane HIV/AIDS Group) is one of 52 Collaborative Review Groups of the Cochrane Collaboration. The Cochrane HIV/AIDS Group, with editorial bases at the University of California, San Francisco (UCSF), and the South African Medical Research Council (MRC), Cape Town, South Africa, brings together individuals from around the world who share an interest in preparing, disseminating, and updating systematic reviews of rigorous HIV/AIDS prevention, treatment, palliative care and pain management research as well as enhancing the science of evidence-based health care. As of this writing in February 2009, we have 53 completed systematic reviews and 50 reviews in progress in all areas of HIV prevention, treatment, palliative care, and health care services. About 30 of the reviews in progress are at advanced stages of completion. We work very closely with our satellite editorial base at the South Africa Cochrane Centre, and have developed a mentoring program with them to assist new authors in sub-Saharan Africa. This helps African researchers to learn the process of conducting a systematic review, and helps us to be sure that the reviews we are conducting are relevant to the areas of the world most impacted by the AIDS pandemic. We have also helped to re-establish the Cochrane Sexually Transmitted Diseases Group in Porto Alegre, Brazil, with Dr. Mauro Ramos of the Centro por Estudos de AIDS/DST do Rio Grande do Sul (CEARGS). We work with policy makers at the national and international levels to disseminate the results of our reviews, and have produced documents used by the Council on Foreign Relations, the Institute of Medicine, South Africa’s Treatment Action Coalition, South Africa’s MRC (at a national level), the US State Department, the World Health Organization, and various other national and international non-governmental organizations]]></content>
		
		<type>
			1
		</type>
			<url>http://hiv.cochrane.org/</url>
	</node>
	<node>
		<title>Eastern Caribbean Community Access Project: Increasing Access to HIV/AIDS Services through Evidence-Based Programming</title>
		<tax>1737</tax>
		<content><![CDATA[In collaboration with the Caribbean HIV/AIDS Alliance and Intrahealth, CAPS is working in four Eastern Caribbean countries to enhance the response to the HIV/AIDS epidemic. The USAID-funded Eastern Caribbean Community Action Project (EC-CAP) supports prevention, development and use of strategic information, roll-out of community-based counseling and testing, and provision of care services (palliative and home based care). As one of three partners, the CAPS team’s specific aims are:
<ol>
 	<li>To identify the barriers and facilitators to access and delivery of HIV prevention, testing, and treatment services (Antigua-Barbuda, Barbados, St. Vincent-Grenadines)</li>
 	<li>To assess the feasibility and acceptability of prevention interventions for different population groups at risk for HIV (St Kitts-Nevis, Barbados)</li>
 	<li>To provide technical support and capacity building to improve regional, country and programmatic monitoring and evaluation (M&amp;E) systems for assessing the quality and impact of HIV services (all countries)</li>
</ol>
CAPS is providing specific expertise and technical support to design a series of special studies to:
<ul>
 	<li>Describe HIV risk and health seeking behavior</li>
 	<li>Conduct studies on implementation and scale-up community-based HIV counseling and testing</li>
 	<li>Train local prevention providers on monitoring and evaluation systems, data use and program planning</li>
 	<li>Provide local organizations with technical assistance in strategic information, package findings and recommendations of the evaluations into best practice publications</li>
 	<li>Disseminate the publications at the international, regional, and national level</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Myers_J-ECCAP2009.pdf</url>
	</node>
	<node>
		<title>Global AIDS Program</title>
		<tax>1737</tax>
		<content><![CDATA[Since 2002, the Institute for Global Health (IGH) has helped CDC’s Global AIDS Program (GAP) to achieve its goals in GAP countries and regions. UCSF faculty and staff have provided technical assistance in several broad component areas including surveillance, monitoring and evaluation, technical and scientific writing, literature digests and reviews, and research design. Our overall goal is to assist GAP to assist countries and regions to reduce HIV transmission, to improve HIV/AIDS care and treatment and to collect and use data to manage national programs effectively and allocate resources rationally, all in a way that builds long-term capacity and sustainability.

Beginning in 2009, we plan to build upon these activities, including:
<ul>
 	<li>Development of guideline and resource documents</li>
 	<li>Provision of regional training opportunities for country and regional offices</li>
 	<li>A series of other technical assistance and capacity-building activities, such as:
<ul>
 	<li>Surveillance training</li>
 	<li>Monitoring and evaluation</li>
 	<li>Evidence-based HIV prevention strategies</li>
 	<li>Laboratory quality assessment</li>
 	<li>Systems strengthening to address the human resource needs for provision of high-quality HIV treatment and care</li>
</ul>
</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Rutherford_G-GAP2009.pdf</url>
	</node>
	<node>
		<title>Strengthening Capacity to Deliver HIV Research Counseling and Testing in International Biomedical Prevention and Treatment Trials</title>
		<tax>1737</tax>
		<content><![CDATA[In this project we will develop, pilot and evaluate a curriculum for improving HIV research counseling and testing (HRCT) skills among staff working in international prevention and treatment clinical trials. Guided by an assessment of acceptability and feasibility among clinicians and counselors, we are developing a novel self-directed learning (SDL) curriculum including a DVD/e-Learning approach and an enhanced component for training supervisors to support on-going HRCT (train the mentors or TOM).

The SDL curriculum and the TOM will be piloted with a sample of trial sites in Peru and South Africa. To measure the relative effectiveness of the two training conditions (SDL alone and SDL plus TOM and supervisor support) we will use an on-line tool able to detect changes in trainee knowledge and competency to conduct risk reduction counseling before and after the training.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Myers_J-StrengthCapacityHIVCinIntlBiomedtrials2009.pdf</url>
	</node>
	<node>
		<title>Mpowerment Evaluation and Monitoring (MEM)</title>
		<tax>1737</tax>
		<content><![CDATA[The aim of this project is to better understand the capacity of CBOs to conduct outcome monitoring of the Mpowerment Project (MP) for the purpose of improving their implementation of the intervention. To this end, we will collaborate with the Centers for Disease Control and Prevention (CDC) and the three CBOs funded under the CDC FOA 09-947 to participate in this project. We will do this by:
<ul>
 	<li>Assisting the CDC and the three CBOs to assess the feasibility of conducting outcome monitoring of the MP by collecting individual-, program-, and community-level data during a 30-month project period</li>
 	<li>Providing expert technical assistance related to the implementation and outcome monitoring of the MP in the form of consultations with the CDC</li>
 	<li>Conducting site visits at each of the three CBOs during their community assessment data collection phase</li>
 	<li>Conducting reviews of the community-level assessment data that CBOs will collect once annually</li>
 	<li>Providing input on the quality of the outcome monitoring data collected by the three CBOs, highlighting ways outcome monitoring data can be used to improve implementation of the MP</li>
 	<li>Assisting the CDC in interpreting, summarizing, and reporting the findings of the outcome monitoring activities described above to both the CBOs and the CDC</li>
 	<li>Drafting a comprehensive report of the project’s findings, with recommendations for the CDC and the CBOs regarding future implementation and outcome monitoring of the MP</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Rebchook_MEM_2010.pdf</url>
	</node>
	<node>
		<title>Oakland Community Research Consortium</title>
		<tax>1737</tax>
		<content><![CDATA[CAPS and the AIDS Project East Bay (APEB) will build a coalition of health sciences investigators at UCSF, community-based organizations that serve the African American community, and community members to answer significant scientific STI/HIV research questions.

We aim to:
<ul>
 	<li>Develop a research coalition to identify significant research questions and design, implement and disseminate appropriate and scientifically-rigorous research projects that address STI/HIV health disparities in the African American community</li>
 	<li>Increase the capacity of the members of the research coalition to participate in community collaborative research projects through relationship building activities, specialized trainings and forums</li>
 	<li>Develop an electronic infrastructure to support, grow and ensure sustainability of the coalition and activities by archiving coalition trainings and forums, facilitating communication among coalition members, and providing a forum for support and problem-solving among the subgroups of the coalition</li>
 	<li>Stimulate and develop innovative research by providing funding to conduct pilot research that will yield data for collaborative presentations at national conferences and provide preliminary data for use by academic and CBO researchers when submitting future R01 grant proposals to NIH.</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2010/Lightfoot_ResearchConsortium_2010.pdf</url>
	</node>
	<node>
		<title>TRIP 2: Putting Community-Level HIV Prevention Research into Practice [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[=The Mpowerment Project is a model HIV prevention program that has been specifically designed to address the needs of young gay and bisexual men. Read about the newest adaptations to MP to address HIV prevention for men living with HIV and the use of PrEP, in what we are calling <a href="https://web.archive.org/web/20161029004428/http://mpowerment.org/downloads/MP+Handout.pdf">MP+</a>.

Learn how the Mpowerment Project <a title="how the Mpowerment Project fits into the National HIV/AIDS Strategy" href="https://web.archive.org/web/20161029004428/http://www.mpowerment.org/downloads/national_hiv_aids_strategy_MP_email.pdf" type="application/pdf">fits into the National HIV/AIDS Strategy here</a> (pdf), find out <a href="https://web.archive.org/web/20161029004428/http://mpowerment.org/project-overview">more about the Project</a>, or read some of the <a href="https://web.archive.org/web/20161029004428/http://mpowerment.org/research-papers">research papers</a> on the Project's effectiveness.]]></content>
		
		<type>
			1
		</type>
			<url>http://mpowerment.org/</url>
	</node>
	<node>
		<title>HIV Transmission Cluster Analysis to Inform Prevention</title>
		<tax>1737</tax>
		<content><![CDATA[This research will evaluate <a href="https://projectreporter.nih.gov/project_info_description.cfm?aid=9102264&amp;icde=32502367">how high-risk clusters and current prevention strategies affect HIV transmission patterns</a>. There are a number of potential drivers of the epidemic, including substance use, undiagnosed infections and high number of sexual partners. However, it still remains unclear which drivers contribute to the epidemic with HIV transmission as the biological outcome. The study aims to characterize HIV clusters and correlates associated with transmission. Phylogenetic analysis will be performed to assess transmission clusters. Qualitative interviews will be conducted to describe the psychosocial and behavioral contexts associated with transmission.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/Truong.-HIV-Transmission-Cluster-Analysis-to-Inform-Prevention.pdf</url>
	</node>
	<node>
		<title>CAPS/Fogarty International Traineeships in AIDS Prevention Studies (I-TAPS) [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[We sponsor four types of training:

1. An intensive eight-week course in designing and conducting AIDS prevention research In our prevention research course, trainees develop a study protocol for implementation in their home countries. Subsequently, we provide assistance to obtain funding to field these pilot studies, and provide continued technical assistance from a CAPS faculty mentor.

2. A six-week writing sabbatical/scientific manuscript preparation workshop Scientists who complete data collection can return to CAPS for a scientific writing workshop, in which we provide statistical support and faculty consultation for preparation of a scientific manuscript. In some cases, we also allow for individual writing sabbaticals; trainees receive similar support and consultation. The scientific writing workshop is open both to returning scholars who attended our research methods courses, and to other international collaborators who are ready to complete scientific manuscripts.

3. A nine-month advanced research traineeship In our advanced research traineeship, visiting scientists prepare grant proposals for the US National Institutes of Health, on which the trainee is the principal investigator.

4. Formal graduate study We also serve as a “portal of entry” for the AIDS International Research and Training Program at UC Berkeley for MPH and PhD degrees in epidemiology (Arthur Reingold, PI).]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Rutherford_G-ITAPS2009.pdf</url>
	</node>
	<node>
		<title>Dyadic Processes in the Patient-Provider Relationship</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this project is to (1) provide expanded mentoring of early career clinician- researchers in patient oriented research (POR), and (2) extend his current research program to the study of patient-provider dyads, which will be studied through the integration of research tools into electronic health records (EHR) systems. Dr. Johnson's trainees have emerged as research clinicians interested in conducting POR. There is a critical need for a better understanding of how the patient-provider relationship influences health outcomes and how these relationships can be augmented to improve outcomes. Much of the existing research on this topic is limited to a single perspective of the patient-provider relationship, but seldom do studies attempt to understand the relationship and its implications simultaneously from the patients and providers. Understanding how to measure and analyze the relationship from these two sides is a critical step in developing an effective model for interventions. Further, it is clear that medical informatics will become an increasingly central base of healthcare delivery in the United States and developing world. The proposed research emphasizes the contextual role of EHRs and other technologies (such as email, patient access to online information portals, etc) on the patient-provider dyads, with an emphasis on decisional balance preferences. Therefore, the candidate seeks to bridge these areas through gaining expertise in medical informatics, provider relations, dyadic data analysis, and international collaborative research to remain on the cutting edge of this rapidly evolving field. The K24 support would insure sufficient time to pursue this natural progression of his research while protecting time to devote to mentoring future clinician investigators in POR. The plans for development, research, and mentoring were designed to complement each other and to create a synergistic effect of mentoring and research in a new direction of POR. The proposed mentoring, research, and career development activities actively leverage existing infrastructure, resources and training initiatives provided by NIH, including the candidate's active research program, the Center for AIDS Prevention Studies (CAPS), the Center for AIDS Research (CFAR), and the Clinical and Translational Science Institute (CTSI) at UCSF.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Johnson.-Dyadic-Processes-in-the-Patient-Provider-Relationship.pdf</url>
	</node>
	<node>
		<title>ICOHRTA Brazilian Scientists Program [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[This project is an extension of the International Traineeships in AIDS Prevention Studies Program (I-TAPS) through a partnership with the Centro de Estudos de AIDS do Rio Grande do Sul (CEARGS) in Porto Alegre, Brazil and with the Universidade Federale do Bahia (UFBA) in Salvador, and funded by the Fogarty International Center. It is aimed at training Brazilian scientists, as well as scientists from other lusophone countries, in AIDS prevention research, with a focus on epidemiological and behavioral studies. In-country training at CEARGS and UFBA are conducted in Portuguese. Our Brazilian collaborators work in conjunction with the Brazilian Ministry of Health, UNAIDS, CDC, and other partners to identify trainees from all across Brazil. The main goal is to provide self-sufficiency for research scientists, capable of designing and implementing AIDS prevention research, independently or in collaboration with US investigators.

This project began in 2001 and was renewed for 2006-2011. In the first funding cycle, training of Brazilian scientists was supported both at CAPS and in Brazil. In the current funding cycle, we continue to recruit and support Brazilian scientists at CAPS, but supported through other sources. We also have had two Brazilian scientists join us at CAPS as advanced research trainees, preparing grant applications to the NIH on which the trainee is the principal investigator. Our primary focus of our ICOHRTA funding is on in-country training, and an expansion of this training to reach scientists in previously underserved parts of the country.

At CEARGS in Porto Alegre in the south of Brazil, 168 Brazilian scientists have been trained since 2002 in several short courses on clinical research methods, basic epidemiology, data management and analysis, and scientific writing. A distance learning component was added at the end of 2005, enabling scientists from all over Brazil to attend the basic clinical research methods trainings through teleconferencing, and a distance learning scientific writing module is also under development.

In the current funding cycle, a second training site, in addition to CEARGS, has been established at UFBA, in order to attract scientists from the north and northeast of Brazil. The first training course at UFBA in research methods took place in the fall of 2007 and trained 16 scientists from the region. Several of these scientists are in the process of fielding pilot research projects developed at this training.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Rutherford_G-ICOHRTA2009.pdf</url>
	</node>
	<node>
		<title>Training Program for Scientists Doing Research to Reduce HIV Health Disparities [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[The Collaborative HIV Prevention Research in Minority Communities Program was developed to address the simultaneous overrepresentation of communities of color among those with HIV and under-representation of researchers of color at the National Institutes of Health. The program is designed to help scientists develop their programs of research and obtain significant research funding.

The 27-month program has the following elements:
<ul>
 	<li>Small grant funding</li>
 	<li>Structured summer program</li>
 	<li>Individualized long-term research collaboration</li>
 	<li>Access to behavioral science expertise</li>
 	<li>Internal peer review of all products</li>
</ul>]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/NeilandsBinson-VP2009.pdf</url>
	</node>
	<node>
		<title>Traineeships in AIDS Prevention Studies (TAPS) [summary]</title>
		<tax>1737</tax>
		<content><![CDATA[The Traineeships in AIDS Prevention Studies (TAPS) program trains scientists for academic and public health careers. TAPS has been in existence since 1989 and has trained nearly 100 scientists focusing on various aspects of HIV/AIDS prevention, both domestically and internationally. The graduates of the program hold positions at universities around the US, at the CDC, NIH, several foundations, and health departments in California and in San Francisco in particular. The program supports 12 postdoctoral fellows with diverse backgrounds, including physicians (OB/GYNs, pediatricians, infectious disease specialists and internists), epidemiologists, psychologists, sociologists, anthropologists, and so forth. About half of the 12 focus on biomedical or epidemiological issues and half focus on social, behavioral and policy research.

To apply to TAPS, candidates must have a PhD, MD, or equivalent doctorate degree. At the end of the two- or three-year program each trainee has: completed an MPH degree or its equivalent; taken advanced courses in research methods, statistics and other topics relevant to their major fields of interest; participated in and led numerous seminars on research topics; designed several research protocols; completed at least one significant research project under the direction of a faculty mentor; made several presentations at national or international meetings; learned how to write a grant proposal; and submitted several papers for publication.

Academic Preparation - The MPH Requirement Trainees without an MPH or its equivalent matriculate into a relevant track at the UC Berkeley School of Public Health. Such training or its equivalent represents a very important part of the overall traineeship program. Public health training provides trainees with a thorough grounding in biometrics skills, and in the art and science of disease prevention and control. Equally important to the acquisition of specific skills and knowledge, such training provides physicians and social and behavioral scientists with both the time and intellectual environment they will need if they are to broaden their perspective from one which focuses primarily on the characteristics and problems of individuals to one which also gives major attention to the community and how it affects individuals.

Academic Preparation at UCSF - UCSF provides a wealth of formal and informal educational opportunities related to AIDS. Early during the first year of the traineeship the Program Directors and mentor review with each trainee his or her overall educational needs that are to be met during the two- or three-year period and may recommend the Training in Clinical Research (TICR) courses, the Advanced Training in Clinical Epidemiology (ATCR), or individual courses in statistics or specific research methods, such as qualitative research. Every trainee is required to take a course in the ethical conduct of research during their fellowship. The intent is that every trainee, in addition to having excellent qualifications in his or her basic discipline, research methods and public health, also has a solid grounding in research ethics and the basics of HIV infection and AIDS. Moreover, whatever their area of special interest, e.g., medicine, social sciences, behavioral science, epidemiology or policy, trainees should be reasonably well acquainted with the fundamentals of the other areas. The traineeship experience should provide breadth as well as depth.

Commitment to Diversity - Applicants from communities of color, particularly those from groups underrepresented in the health sciences, are especially welcome to apply to TAPS. The TAPS directors have a strong commitment, both through their research and through their mentoring and selection of fellows, to training people of color to work on disparity issues in HIV in the US.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/research/portfolio/2009/Kegeles_S-TAPS2009.pdf</url>
	</node>
	<node>
		<title>Substance Use and HIV Prevention Research in Minority Communities Training Program</title>
		<tax>1737</tax>
		<content><![CDATA[The Substance Use and HIV Prevention Research in Minority Communities training program addresses the urgent need for culturally-competent prevention research in racial and ethnic minority communities targeting the intersection of substance use and HIV. The program offers research education and mentoring to social and behavioral prevention scientists who have cultural expertise regarding minority communities and who are initiating innovative programs of research that focus on substance use and HIV-risk-and-prevention topics. This five-year project will provide educational, mentoring and technical assistance to facilitate the development and continuation of innovative substance use and HIV-prevention research in racial and ethnic minority populations by early-career research scientists from the continental United States and Puerto Rico. The program will accomplish these goals via an intensive summer program housed at the Center for AIDS Prevention Studies (CAPS) at the University of California, San Francisco along with cyber-mentoring during the regular academic year. The program's aims are to: 1) assist visiting scientists in identifying and refining innovative theories, concepts, and ideas into clearly articulated programs of research in substance use and HIV-risk prevention; 2) increase the capacity of visiting scientists to conduct multidisciplinary prevention research that targets the links between substance use and other HIV-risk behaviors in racial and ethnic minority communities; 3) provide funding to conduct pilot research that will yield data for presentations at substance use-focused national conferences and provide preliminary data for grant proposals to NIDA; and 4) provide education, mentoring, and technical assistance in the development and submission of research grants to NIDA that focus on substance use, HIV-risk behavior, and HIV prevention. In collaboration with program faculty mentors, visiting scientists will design pilot studies, which they will conduct during the following academic year, and return to CAPS for a second summer to analyze data from their pilot studies. Findings from the pilot studies will be reported at a national substance use research-focused conference, enabling the scientists to obtain extramural feedback on their work and to network with national and international leaders in substance use research and HIV-prevention research. By the third summer the visiting scientist will have obtained extensive feedback on that proposal, revised it, and submitted it for extramural review. The third summer will provide an opportunity to work with faculty mentors in responding to NIH reviewers' comments, further refining the proposal for resubmission, and, for proposals funded on the first submission, providing guidance in the implementation and management of the funded study. During the academic years between the summer training institutes, the program will use cyber-mentoring to support visiting scientists in completing their pilot studies and grant proposals, while providing additional seminars for topics identified by the visiting scientists (e.g., substance use syndemics, sampling hidden populations). The guidance provided by the collaborative research experiences and opportunities for interdisciplinary networking will result in a substantial increase in high quality substance use and HIV-prevention research by scientists studying minority populations in the U.S.]]></content>
		
		<type>
			1
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/old-site/uploads/2010/10/Lightfoot.-Substance-Use-and-HIV-Prevention-Research-in-Minority-Communities-training-program.pdf</url>
	</node>
	<node>
		<title>Hermanos de Luna y Sol</title>
		<tax>1737</tax>
		<content><![CDATA[<h3><img class="size-full wp-image-1451 alignnone" title="hermanos de luna y sol" src="/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2011/01/hermanos-de-luna-y-sol.gif" alt="" width="156" height="220" /></h3>
<h3>An Empowerment HIV Prevention Program for Spanish-Speaking Latino Gay/Bisexual Men</h3>
Latino gay/bisexual men in the U.S. have been highly and <a href="https://web.archive.org/web/20161029015526//sites/prevention.ucsf.edu/files/hermanos-de-luna-y-sol/research-on-latino-gaybisexual-men">disproportionately affected</a> by the AIDS epidemic. The program "Hermanos de Luna y Sol" (HLS) was designed as a culturally-appropriate HIV risk-reduction intervention that targets <a href="https://web.archive.org/web/20161029015529//sites/prevention.ucsf.edu/files/hermanos-de-luna-y-sol/target-audience">immigrant, Spanish-speaking gay/bisexual men</a> in the San Francisco, CA Mission district.

The aims of the program are the following:
<ul>
 	<li>Provide experiences of social support, social belonging, and enhanced self-esteem in the context of a Latino gay identity and community;</li>
 	<li>Promote critical awareness of social and cultural forces that impact and shape participant's social and sexual lives'</li>
 	<li>Increase participant's sexual self-knowledge, with particular emphasis on sexual contexts and situations of personal vulnerability that limit participants' ability to practice safer sex, and:</li>
 	<li>Facilitate community involvement and activism to support a sense of increased personal agency and self-efficacy (instead of fatalism and victimization) in response to oppressive social forces in participants' lives.</li>
</ul>
Based on <a href="https://web.archive.org/web/20161029015526//sites/prevention.ucsf.edu/files/hermanos-de-luna-y-sol/research-on-latino-gaybisexual-men">research findings</a> about Latino gay/bisexual men, Bandura's theory of self-regulation, and principles of empowerment education, HLS aims to intervene in a culturally-appropriate manner with four factors that weaken the enactment of safer sex intentions:
<ul>
 	<li>low self-esteem</li>
 	<li>perceptions of low sexual control</li>
 	<li>lack of social support</li>
 	<li>fatalism regarding inevitability of HIV infection</li>
</ul>
By providing opportunities for group reflection and critical self-observation within the domain of sexuality, by providing a network of peer social support for the practice of safer sex, and sponsoring activities that support self-esteem and pride for being Latino and gay/bisexual, the program intervenes with and attempts to modify factors that promote HIV risk behavior in this particular population.
<h2>Intervention</h2>
HLS consists of three types of interrelated interventions. Please see detailed descriptions of the <a href="https://web.archive.org/web/20161029015522//sites/prevention.ucsf.edu/files/hermanos-de-luna-y-sol/intervention">program activities</a>.
<ol>
 	<li>Bar outreach and recruitment activities;</li>
 	<li>Six-week initial <a href="https://web.archive.org/web/20161029015456//sites/prevention.ucsf.edu/files/hermanos-de-luna-y-sol/group-meetings">discussion workshops</a> with structured sessions designed to promote self-esteem, social support and sexual self-regulation; and</li>
 	<li>A set of follow-up resources and activities targeted to the maintenance of safer sex behavior over time, including participation in ongoing peer support groups, specialized workshops and retreats, and access to individual risk reduction counseling services.</li>
</ol>
<a href="https://web.archive.org/web/20161029015532//sites/prevention.ucsf.edu/files/hermanos-de-luna-y-sol/testimonials">Testimonies of participants' reactions to the program</a>
<h2>Research</h2>
We are conducting an ongoing evaluation of the program, including quantitative data on participants' satisfaction and the program's impact on self-esteem, social support, self-efficacy, perceptions of sexual control, and safer sex behavior.

Please see the <a href="/sites/prevention.ucsf.edu/files/library/evaluation/">latest report of the program evaluation for HLS</a> from January 1, 2001.

Also, San Francisco State University's César E. Chávez Institute has <a title="Hermanos de Luna y Sol" href="http://cci.sfsu.edu/hls" target="_blank">more information</a> about Hermanos de Luna y Sol.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Condom use Among Hispanics - Female</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Hispanic Condom Use Study 1991
Questionnaire for Use with Females</h3>
<pre>TIME AT BEGINNING:  ______________

Many of the questions we will be asking relate to sexual matters and it is
 possible that you may feel a bit uncomfortable.  But please remember that
 your responses are completely confidential and that you may indicate if there
 are any questions you do not wish to answer.

I would like to ask you some general questions about AIDS. Your answer can be
 "yes," "probably yes," "probably no," or "no."

1.  Do you think it's possible to get the AIDS virus from a mosquito bite?
  Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(06)

2.  Do you think it's possible to get the AIDS virus by sitting on a public
 toilet?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(07)

3.  Do you think AIDS is a problem only for homosexuals and drug addicts?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(08)

4.  Do you think it's possible to know by appearance if a person has the AIDS
 virus?  

	1   Yes	2   Probably Yes	3   Probably No	4   No	(09)

5.  Have you personally known someone who had AIDS or was infected with the
 AIDS virus?

	1   Yes	2   Probably Yes	3   Probably No	4   No	

			8  DON'T KNOW	(10)

6.  How often do you worry that you might get the virus that causes AIDS?
  Would you say very often, often, sometimes, or never?
	(11)
	1   Very often	2   Often	3   Sometimes	4   Never

I'll be asking some questions about condoms or rubbers. 

7. Would you like me to use the word "condom" or "rubber?"

		4   CONDOM	5   RUBBER	(12)

		6  NO PREFERENCE (USE "CONDOM")

The following items ask for information about how condoms/rubbers are used.
  If you have never used condoms/rubbers, your answers are still important to
 us.

8.  Do you think vaseline is a good lubricant or cream for condoms/rubbers?

	1    YES	0    NO   	8   DOESN'T KNOW	(13)

9.  Do you think a condom/rubber should be unrolled before putting it on a
 man's penis?

	1    YES	0    NO   	8   DOESN'T KNOW	(14)

Now we would like to ask you some questions about your experiences with
 condoms/rubbers and other sexual activities.  I will be using the word
 "partner" to refer to the person with whom one has sex.  This information is
 very important for our study.  Each person has different sexual experiences,
 so some questions may not apply to you. 

10.  How often do you carry a condom/rubber with you?  Would you say
 always, sometimes, hardly ever, or never?
	(15)
	1   Always	2   Sometimes	3   Hardly ever	4   Never

11.  Have you ever had sex with a  partner who used condoms/rubbers?

	1    YES	0    NO    [GO TO Q 15]	9   RA	(16)

12.  Have you ever used condoms/rubbers to avoid a pregnancy?

	1    YES	0    NO   	9   RA	(17)

13.  Have you ever used condoms/rubbers to avoid diseases?

	1    YES	0    NO   	9   RA	(18)

14.  How did you get condoms/rubbers? 

[IF RESPONDENT GIVES MORE THAN ONE ANSWER, ASK WHERE SHE HAS BOUGHT
 THEM OR GOTTEN THEM MORE OFTEN AND CIRCLE ONLY THAT RESPONSE]

		[DO NOT READ RESPONSES]

______ BOUGHT THEM	ASK:	Where?		

	1	PHARMACY OR DRUG STORE
	2	RESTROOM VENDING MACHINES
	3	SUPERMARKET
	9	RA
				(19)

______ GIVEN TO THEM  	ASK:	Where?  

	4	AT A HEALTH CENTER
	5	ON THE STREET
	6	BY A FRIEND/RELATIVE
	7	FROM A PARTNER
	8	ELSEWHERE  __________________________
	9	RA

15.  In these questions we'll talk about a steady sex partner.  A steady sex
 partner is a person one has sex with in an ongoing relationship and might be a
 spouse. 

	Imagine that you will have sex with a husband or steady partner in the next
 30 days.  How often do you think your partner would use condoms/rubbers?
  Would you say always, more than half the time, half the time, less than half
 the time, or never?

IF RESPONDENT SAYS NOT APPLICABLE, SAY:  "Even if you don't know, please
 try to guess."

	1	Always	(20)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	RA

16. Imagine that you will have sex with a person other than a steady partner
 in the next 30 days.  How often do you think that partner would use
 condoms/rubbers?

IF RESPONDENT SAYS NOT APPLICABLE, SAY:  "Even if you don't know, please
 try to guess."

	1	Always	(21)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	RA

17.  Have you had sex at least once in the past 12 months, that is, since
[THIS MONTH] of 1990?

	1    YES [GO TO Q19]	0    NO [GO TO Q18]	9   RA [GO TO Q18]	(22)

18.  Have you had sex at least once in the last 5 years?

	1    YES [GO TO Q19]	0    NO [GO TO Q26]	9   RA [GO TO Q26]	(23)

19. As I said, some questions may not apply to you.  If a question does not
 apply to you, please let me know.

	When you had sex with your husband or steady partner in the last 12 months,
 how often did he use condoms/rubbers?  Would you say always, more than
 half the time, half the time, less than half the time, or never?

	1	Always	(24)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	6	NO MALE PARTNER [GO TO Q26]
	7	NO STEADY PARTNER
	8	NO SEX PAST 12 MONTHS [GO TO Q26]
	9 	RA

20.  When you had sex with a man other than your husband or steady partner in
 the last 12 months, how often did that partner use condoms/rubbers?

	1	Always	(25)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	7	NO CASUAL PARTNER
	8	NO MALE PARTNER  [GO TO Q26]
	9 	RA

			BLANK	(26-28)

23.  How many men have you had sex with in the last 12 months in total?

	___  ___  NUMBER OF MEN 				(29-30)
		[90 OR MORE = 90]

		99	RA

IF Q23 IS  00, GO TO Q26

24.  In the last 12 months, how often did you drink alcoholic beverages before
 having sex?  Would you say always, more than half the time, half the time,
 less than half the time, or never?

	1	Always	(31)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	RA

25.  In the last 12 months, how often did you use drugs before having sex?

	1	Always	(32)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	RA

26.  Do you think you're going to have sex in the next 30 days?  Would you say
 yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(33)

27.  Is it possible to know beforehand if you're going to have sex? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(34)

In the following questions I am going to ask your opinions about the use of
 condoms or rubbers.  If you have never had sex or if you have never used a
 condom/rubber, please answer the questions trying to imagine how you would
 feel in each case.

28.  Do you think condoms/rubbers are only for men having sex with female
 prostitutes?  Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(35)

29.  Do you think it's difficult to find places to buy condoms/rubbers?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(36)

			BLANK	(37)

31.  Would you ask a partner to use a condom/rubber even if you had been
 drinking alcoholic beverages or using drugs?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(38)

32.  Would you be able to ask a partner to use a condom/rubber if you thought
 he was having sex with someone else?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(39)

33.  Would you be able to refuse to have sex if your partner didn't want to use
 a condom/rubber?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(40)

34. Imagine that your partner used a condom/rubber the next time you had sex.

Would you feel less sexual pleasure than if he didn't use one?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(41)

35.  If your partner used a condom/rubber, would sex last longer than if he
 didn't use one?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(42)

36. If your partner used a condom, would you feel guilty?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(43)

37. If a condom/rubber were used, would you feel an emotional barrier with
 your sex partner? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(44)

38. Do you think the condom/rubber would cause a burning sensation?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(45)

39. Do you think putting on a condom/rubber would interrupt sex?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(46)

40. Do you think sex would be cleaner than if your partner didn't use a
 condom/rubber?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(47)

Continue to imagine that your partner used a condom/rubber the next time you
 had sex

41.  Do you think the condom/rubber would feel uncomfortable or too tight to
 your partner?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(48)

42. Do you think the condom/rubber might come off inside you? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(49)

43. Do you think the condom/rubber might break?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(50)

44. If your partner used a condom/rubber, do you think you might get cancer?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(51)

45.  If your partner used a condom/rubber, do you think you would get
 pregnant?

	1   Yes	2   Probably Yes	3   Probably No	4   No	9   RA	(52)

46. If your partner used a condom/rubber, would it be more difficult for him
 to ejaculate or come than if he didn't use one? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(53)

47. If your partner used a condom/rubber, would it be more difficult for him
 to keep an erection than if he didn't use one?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(54)

In the following questions we'll talk about two types of partners: steady sex
 partners and casual sex partners.  As you recall, a steady sex partner is a
 person one has sex with in an ongoing relationship. A casual sex partner
 refers to a person one doesn't know very well and has sex with only once or a
 few times.

48. Would you be able to ask a steady partner to use a condom/rubber?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(55)

49. Would you be able to ask a casual partner to use a condom/rubber?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(56)

Imagine that you were going to have sex with a casual partner and he used a
 condom/rubber.

50. Do you think you could get a venereal disease such as gonorrhea or
 syphilis?

Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(57)

51. If this casual partner used a condom/rubber, do you think you could get the
 virus that causes AIDS?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(58)

52. If this casual partner used a condom/rubber, would you worry less about
 giving a steady partner a disease such as syphilis, gonorrhea or AIDS? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(59)

Imagine that you asked a steady partner to use a condom/rubber the next time
 you had sex,

53. Would it lead the steady partner to think you had had sex with someone
 else?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(60)

54.  If you asked a steady partner to use condoms/rubbers, do you think he
 would get angry?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(61)

55. Would a casual partner get angry?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(62)

56.  If you asked a steady partner to use condoms/rubbers, do you think he
 would get violent?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(63)

57. Would a casual partner get violent?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(64)

58. If you asked a steady partner to use a condom/rubber, do you think he
 would refuse to have sex with you?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(65)

59. Would a casual partner refuse to have sex with you?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(66)

60. Imagine that you carried condoms/rubbers in your pocket or purse.  Do you
 think that your women friends would think badly of you?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(67)

			9   RA

61. If you had condoms/rubbers with you, would a casual partner respect you
 more than if you didn't have them?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(68)

62. If you had condoms/rubbers with you, would men think you're willing to
 have sex with someone you just met?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(69)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 3	(05)

In the following questions we want to know how much you would be bothered
 by some things that could happen to a person who used condoms/rubbers.
 These questions may seem repetitive but they are very important and we
 would appreciate your patience.

The responses can be "A lot" "Somewhat" or "Very little" 

63. How much would it bother you to feel less pleasure during sex?  Would it
 bother you a lot, somewhat or very little?

		1   A lot	2   Somewhat	3    Very little	(06)

64. How much would it bother you to feel a burning sensation in your sex
 organs?

		1   A lot	2   Somewhat	3    Very little	(07)

65. How much would it bother you to interrupt sex?

		1   A lot	2   Somewhat	3    Very little	(08)

66. How much would it bother you  to feel guilty?

		1   A lot	2   Somewhat	3    Very little	(09)

67. How much would it bother you  to have a condom/rubber that feels
 uncomfortable or too tight to your partner?

		1   A lot	2   Somewhat	3    Very little	(10)

68.  How much would it bother you if a condom/rubber came off inside you?

		1   A lot	2   Somewhat	3    Very little	(11)

69. How much would it bother you  if a condom/rubber broke?

		1   A lot	2   Somewhat	3    Very little	(12)

70. How much would it bother you  if you felt an emotional barrier with your
 partner?

		1   A lot	2   Somewhat	3    Very little	(13)

			 	BLANK	(14)

72. How much would it bother you  if your partner had trouble ejaculating?

		1   A lot	2   Somewhat	3    Very little	(15)

73. How much would it bother you  if your partner had trouble keeping an
 erection?	

		1   A lot	2   Somewhat	3    Very little	(16)

74. How much would it bother you to get a venereal disease like gonorrhea or
 syphilis?	

		1   A lot	2   Somewhat	3    Very little	(17)

75. How much would it bother you  to have a steady partner think you had had
 sex with someone else?		

		1   A lot	2   Somewhat	3    Very little	(18)

76. How much would it bother you  to have a steady partner get angry?

		1   A lot	2   Somewhat	3    Very little	(19)

77.  How much would it bother you  to have a casual partner get angry?

		1   A lot	2   Somewhat	3    Very little	(20)

78.  How much would it bother you  to have a steady partner refuse to have
 sex with you?	

		1   A lot	2   Somewhat	3    Very little	(21)

79.  How much would it bother you  to have a casual partner refuse to have
sex with you?	

		1   A lot	2   Somewhat	3    Very little	(22)

80. How much would it bother you  to have your women friends think badly
of you?

		1   A lot	2   Somewhat	3    Very little	(23)

81. Now, please tell me, how much would you like to have a casual partner
 respect you more?  Would you say a lot, somewhat or very little?

		6   A lot	5   Somewhat	4    Very little	(24)

82. How much would you like not having to worry about giving a steady
 partner a disease like syphilis, gonorrhea or AIDS?

		6   A lot	5   Somewhat	4    Very little	(25)

83. How much would you like to have sex feel cleaner?

		6   A lot	5   Somewhat	4    Very little	(26)

For the following items, first tell me if you would like it or dislike it,
then tell me how much you would like or dislike it.

84.  Would you like or dislike getting pregnant now?  How much, a lot,
 somewhat or very little?

	like it:	6   A lot	5   Somewhat	4    Very little	(27)

	dislike it:	1   A lot	2   Somewhat	3    Very little

85. Would you like or dislike having sex last longer?  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(28)

	dislike it:	1   A lot	2   Somewhat	3    Very little

86. Would you like or dislike having men think you're willing to have sex
with someone you just met?  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(29)

	dislike it:	1   A lot	2   Somewhat	3    Very little

87. Would you like or dislike using a condom/rubber with a steady partner?
  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(30)

	dislike it:	1   A lot	2   Somewhat	3    Very little

88. Would you like or dislike using a condom/rubber with a casual partner?
  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(31)

	dislike it:	1   A lot	2   Somewhat	3    Very little

89.  Would you like or dislike carrying a condom/rubber with you?
How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(32)

	dislike it:	1   A lot	2   Somewhat	3    Very little

90. How many of your closest women friends do you think carry condoms
with them?

  Would you say almost all, more than half, half, less than half or almost
 none?

[IF THE PERSON DOESN'T KNOW, SAY: "Even if you don't know, please try
to guess"]

			(33)
	1   Almost 	2   More	3   Half	4   Less	5   Almost
	all	than half		than half	None

						7   NO FRIENDS [GO TO Q93]

91. How many of your closest women friends do you think use
 condoms/rubbers when they have sex with a steady partner?
			(34)
	1   Almost 	2   More	3   Half	4   Less	5   Almost
	all	than half		than half	None

92. How many of your closest women friends do you think use
 condoms/rubbers when they have sex with a casual partner?
			(35)
	1   Almost 	2   More	3   Half	4   Less	5   Almost
	all	than half		than half	None

					7   NO FRIENDS HAVE CASUAL PARTNERS

93. Try to imagine how comfortable you would feel in the following
 situations.

	How comfortable would you feel buying a condom/rubber?  Would you feel
 very comfortable, somewhat comfortable, somewhat uncomfortable or very
 uncomfortable?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(36)
	comfortable	comfortable	uncomfortable	uncomfortable	

94. How comfortable would you feel asking a steady partner to use a
 condom/rubber?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(37)
	comfortable	comfortable	uncomfortable	uncomfortable	

95. How comfortable would you feel  asking a casual partner to use a
 condom/rubber?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(38)
	comfortable	comfortable	uncomfortable	uncomfortable	

96. How comfortable would you feel  watching your partner put on a
 condom/rubber?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(39)
	comfortable	comfortable	uncomfortable	uncomfortable	

97. How comfortable would you feel  putting a condom/rubber on your
 partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(40)
	comfortable	comfortable	uncomfortable	uncomfortable	

98. How comfortable would you feel  having a steady partner use a
 condom/rubber?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(41)
	comfortable	comfortable	uncomfortable	uncomfortable	

99. How comfortable would you feel having a casual partner use a
 condom/rubber?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(42)
	comfortable	comfortable	uncomfortable	uncomfortable	

100. How comfortable would you feel  being naked in front of a sex partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(43)
	comfortable	comfortable	uncomfortable	uncomfortable	

101. How comfortable would you feel having sex with the lights on?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(44)
	comfortable	comfortable	uncomfortable	uncomfortable	

102. How comfortable would you feel  having sex with a new partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(45)
	comfortable	comfortable	uncomfortable	uncomfortable	

Now I'd like to ask you...

103. Do you have any children?

	00    NO	YES  How many?      ___ ___	(46-47)

104.		BLANK	(48)

IF NECESSARY, ASK:  Do you have a husband or steady partner?

YES [GO TO Q105]			NO  [GO TO Q111]

105. Are you pregnant? 

	1	YES 	[GO TO Q. 111]	(49)
	0	NO
	7	HE/SHE CANNOT HAVE CHILDREN  [GO TO Q111]
	8	DON'T KNOW
	9	RA

106. Are you trying to get pregnant?

	1	YES 	[GO TO Q. 111]	(50)
	0	NO
	7	HE/SHE CANNOT HAVE CHILDREN  [GO TO Q111]
	9	RA

IF Q103 ABOVE IS 00, GO TO Q108

107. Have you given birth in the last 3 months?

	1	YES 	[GO TO Q. 111]	(51)
	0	NO
	7	HE/SHE CANNOT HAVE CHILDREN  [GO TO Q111]
	9	RA

108. Have you or your steady partner used some form of birth control
other than condoms/rubbers in the last 12 months?

	YES &gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;[IF  THE ANSWER IS YES]    Which kind?	(52)
			[CIRCLE ALL THAT APPLY]
	1    PILL
	0   NO	2    IUD
	3    DIAPHRAGM
		4    SPONGE/FOAM/JELLY
	5    DOUCHE
	9   RA	6    WITHDRAWAL
		7    ABORTION
			8    OTHER ____________________

IF ANSWER IS YES, GO TO Q111

109. Is there a reason why your partner is unable to have children either
due to an operation or some other cause?

	1	YES 	[GO TO Q. 111]	(53)
	0	NO
	8	DON'T KNOW
	9	RA

110. Is there a reason why you are unable to have children either due
to an operation or some other cause?

	1	YES 		(54)
	0	NO
	8	DON'T KNOW
	9	RA

111. Now I'm going to ask you some questions about how you have been
feeling during the last seven days.   Since [ TODAY'S DAY OF THE WEEK]
of last week 

     Were you bothered by things that usually don't bother you?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(55)
			How many days during the past week?

		[DO NOT READ RESPONSES]

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

112. Did you feel like not eating or was your appetite poor?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(56)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

113. Did you feel like you couldn't shake off the blues even with the help
of family and friends?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(57)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

114. Did you feel depressed?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(58)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

115. Did you feel as if your life had been a failure?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(59)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

116. Did you feel afraid?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(60)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

117. Was your sleep restless?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(61)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

118. Did you feel lonely?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(62)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

119. Did you feel sad?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(63)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

120. Did you have crying spells?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(64)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

IF NON-HISPANIC, GO TO Q128

IF HISPANIC, CONTINUE BELOW

121. Now, please tell me, where were you born?

	1    USA	[GO TO THE FOLLOWING QUESTION]	(65)
	2    PUERTO RICO	[GO TO Q. 123]
	3    MEXICO	[GO TO Q. 123]
	4    REPUBLICA DOMINICANA	[GO TO Q. 123]
	5    COLOMBIA	[GO TO Q. 123]
	6    CENTRAL AMERICA	[GO TO Q. 123]
	7    SOUTH AMERICA, (NO COLOMBIA)	[GO TO Q. 123]
	8    SPAIN OR CUBA	[GO TO Q. 123]
	9    OTHER _______________________  [GO TO THE FOLLOWING QUESTION]

FOR HISPANICS BORN IN THE U.S. OR COUNTRIES LISTED AS 9 ABOVE

122.  The families of the majority of people living in the United States
come from other countries. Where is your family from?

[DO NOT READ ALTERNATIVES  IF RESPONSE IS MORE THAN ONE COUNTRY,
 ASK:]"Which country is the majority of your family from or which country
do you feel closest to?"  [CIRCLE ONLY ONE]

	2    PUERTO RICO	(66)
	3    MEXICO
	4    REPUBLICA DOMINICANA
	5    COLOMBIA
	6    CENTRAL AMERICA
	7    SOUTH AMERICA, (NO COLOMBIA)
	8    CUBA

123. How long have you lived in the United States?

	___ ___    YEARS [LESS THAN A YEAR = ONE YEAR{01}]	(67-68)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 4	(05)

124. In general what language do you read and speak?  Would you say
Spanish only, Spanish more than English, both equally, English more than
 Spanish, or English only?
		(06)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

125. What language do you usually speak at home?
		(07)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

126. In which language do you usually think?
		(08)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

127. What language do you usually speak with your friends?
		(09)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

ASK EVERYONE

128. How many years of formal education have you completed?

	___ ___ YEARS	(10-11)

129. Are you:
	1	Married or living with your partner	(12)
	2	Single
	3	Separated or divorced
	4	Widowed

130. What is your religion?  __________________________
	(13)
	1	CATHOLIC
	2	CHRISTIAN OTHER THAN CATHOLIC
	3	OTHER: (SPECIFY: ________________)
	4	NONE

131. How important is religion in your life?  Would you say...
	(14)
	1   	Extremely important
	2   	Very important
	3   	Important
	4   	Somewhat important
	5   	Not important at all

132.  How many years have you been employed in a full time or part time
job, excluding housework in your own home?

	___ ___    YEARS [LESS THAN A YEAR = ONE YEAR{01}]	(15-16)

133. Would you say that you live in a town, city, suburb of a city, or a
rural area?

	1   TOWN  	2   CITY	3   SUBURB	4   RURAL AREA	(17)

134. Could you please give me your Zip Code?

		__ __ __ __ __    ZIP CODE	(18-22)
		[99998 &gt;&gt; DK        99999 &gt;&gt; RA]

135. Tell me when I get to the category that best describes your family
 income for 1990.  [IF LIVING ALONE, ASK FOR PERSONAL INCOME]

	[READ THE RESPONSES]

		1	Less than $10,000	(23)
		2	$10,001 to 20,000
		3	$20,001 to 40,000
		4	More than $40,000
		8	DON'T KNOW
		9	RA

As I already explained, your phone number was chosen at random.  To avoid
 calling your house again, could you please tell me if there is another
 telephone number in your house?

	[IF THE ANSWER IS YES]   What is it?__________________

	Is there more than one number?

		OTHER NUMBER(S) ________________________

136. 	NUMBER OF TELEPHONE LINES     _________	(24)
		[INCLUDING THE ONE BEING CALLED]

IF NON HISPANIC, GO TO PARAGRAPH BEGINNING:
'This is all for now."

IF HISPANIC, CONTINUE BELOW

137. In the future, it is possible that we will do a study of sexual attitudes
 and behavior among Hispanic adolescents.  The questions will be very
 different from the ones you just answered and will be appropriate for
 adolescents.    To include an adolescent in that study not only would we need
 the adolescent's consent but also the permission of a parent or guardian.

Is there an adolescent in this house who is 15, 16 or 17 years old?

	YES  How many?  _____	NO  0  [GO TO END]	(25)

Could you give me the name of the parent or guardian who could give
 permission to interview the adolescent, if we do call?

	____________________________________________________

138.  Could you give me the names of the adolescent(s)?

	___________________________________________

	ASK IF UNCLEAR:     NUMBER OF FEMALES ______	(26)

This is all for now.  My supervisor may call you back to validate that this
 interview was completed.  Thank you for your help with this interview.
If you would like any further information about AIDS or AIDS prevention,
you can call this number             1-800-342-2437       [AIDS].  Would you like me to
 repeat that number?   The call is free and you don't have to give your name.

Again, thank you very much!

__________________________________________________________________

TIME AT THE END OF INTERVIEW:___________

139. 		LENGTH OF INTERVIEW [ IN MINUTES]   ___ ___	(27-28)

140. LANGUAGE OF INTERVIEW:	0    ENGLISH	(29)

141. LANGUAGE CHOICE:

 	1    RESPONDENT   	0       RANDOMLY BY INTERVIEWER	(30)

142. INTERVIEWER'S NAME:_________________________ [ ___ ___ ___ ]	(31-33)

DATE OF INTERVIEW:_____________________________

INTERVIEW TERMINATED BEFORE COMPLETION

	1  YES   	0  NO	(34)

	[IF THE ANSWER IS YES] __ __ __  ITEM NUMBER	(35-37)

IS RESPONDENT A MEMBER OF HOUSEHOLD?

	1  YES	0  NO	(38)</pre>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Condom use Among Hispanics - Male</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>Hispanic Condom Use Study 1991
Questionnaire for Use with Males</h2>
<pre>TIME AT BEGINNING:  ______________

Many of the questions we will be asking relate to sexual matters and it is
 possible that you may feel a bit uncomfortable.  But please remember that your
 responses are completely confidential and that you may indicate if there are
 any questions you do not wish to answer.

I would like to ask you some general questions about AIDS. Your answer can be
 "yes," "probably yes," "probably no," or "no."

1.  Do you think it's possible to get the AIDS virus from a mosquito bite?
Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(06)

2.  Do you think it's possible to get the AIDS virus by sitting on a public toilet?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(07)

3.  Do you think AIDS is a problem only for homosexuals and drug addicts?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(08)

4.  Do you think it's possible to know by appearance if a person has the AIDS
 virus?  

	1   Yes	2   Probably Yes	3   Probably No	4   No	(09)

5.  Have you personally known someone who had AIDS or was infected with
the AIDS virus?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(10)

		              8  DON'T KNOW	

6.  How often do you worry that you might get the virus that causes AIDS?
  Would you say very often, often, sometimes, or never?
	(11)
	1   Very often	2   Often	3   Sometimes	4   Never

I'll be asking some questions about condoms or rubbers. 

7. Would you like me to use the word "condom" or "rubber?"

		4   CONDOM	5   RUBBER	(12)

		6  NO PREFERENCE (USE "CONDOM")

The following items ask for information about how condoms/rubbers are used.
  If you have never used condoms/rubbers, your answers are still important
to us.

8.  Do you think vaseline is a good lubricant or cream for condoms/rubbers?

	1    YES	0    NO   	8   DOESN'T KNOW	(13)

9.  Do you think a condom/rubber should be unrolled before putting it on a
man's penis?

	1    YES	0    NO   	8   DOESN'T KNOW	(14)

Now we would like to ask you some questions about your experiences with
 condoms/rubbers and other sexual activities.  I will be using the word
 "partner" to refer to the person with whom one has sex.  This information is
 very important for our study.  Each person has different sexual experiences,
so some questions may not apply to you. 

10.  How often do you carry a condom/rubber with you?  Would you say always,
 sometimes, hardly ever, or never?

	1   Always	2   Sometimes	3   Hardly ever	4   Never   (15)

11. Have you ever used condoms/rubbers?      

	1    YES	0    NO    [GO TO Q 15]	9   RA	(16)

12.  Have you ever used condoms/rubbers to avoid a pregnancy?

	1    YES	0    NO   	9   RA	(17)

13.  Have you ever used condoms/rubbers to avoid diseases?

	1    YES	0    NO   	9   RA	(18)

14.  How did you get condoms/rubbers? 

[IF RESPONDENT GIVES MORE THAN ONE ANSWER, ASK WHERE HE HAS BOUGHT
 THEM OR GOTTEN THEM MORE OFTEN AND CIRCLE ONLY THAT RESPONSE]

		[DO NOT READ RESPONSES]

______ BOUGHT THEM	ASK:	Where?   		

	1	PHARMACY OR DRUG STORE
	2	RESTROOM VENDING MACHINES
	3	SUPERMARKET
	9	RA
				(19)

______ GIVEN TO THEM	ASK:	Where? 

	4	AT A HEALTH CENTER
	5	ON THE STREET
	6	BY A FRIEND/RELATIVE
	7	FROM A PARTNER
	8	ELSEWHERE  __________________________
	9	RA

15.  In these questions we'll talk about a steady sex partner.  A steady sex
 partner is a person one has sex with in an ongoing relationship and might be
a spouse. 

	Imagine that you will have sex with a wife or steady partner in the next 30
 days.  How often do you think you would use condoms/rubbers?  Would you say
 always, more than half the time, half the time, less than half the time, or
 never?

[IF RESPONDENT SAYS NOT APPLICABLE, SAY:  "Even if you don't know, please
try to guess."]

	1	Always	(20)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	RA

16. Imagine that you will have sex with a partner other than a steady partner
in the next 30 days.  How often do you think you would use condoms/rubbers?

[IF RESPONDENT SAYS NOT APPLICABLE, SAY:  "Even if you don't know, please
try to guess."]

	1	Always	(21)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	RA

17.  Have you had sex at least once in the past 12 months, that is, since
[THIS MONTH] of 1990?

	1    YES [GO TO Q19]	0    NO [GO TO Q18]	9   RA [GO TO Q18]	(22)

18.  Have you had sex at least once in the last 5 years?

	1    YES [GO TO Q19]	0    NO [GO TO Q26]	9   RA [GO TO Q26]	(23)

19. As I said, some questions may not apply to you.  If a question does not apply
 to you, please let me know.

	When you had sex with your wife or steady partner in the last 12 months, how
 often did you use condoms/rubbers?  Would you say always, more than half the
 time, half the time, less than half the time, or never?

	1	Always	(24)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	7	NO STEADY PARTNER
	8	NO SEX PAST 12 MONTHS [GO TO Q26]
	9 	RA

20.  When you had sex with a woman other than your wife or steady partner in
 the last 12 months, how often did you use condoms/rubbers? 

	1	Always	(25)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	7	NO CASUAL PARTNER
	8	NO FEMALE PARTNER [GO TO Q22]
	9 	RA

21.  How many women have you had sex with in the last 12 months in total?

	___  ___  NUMBER OF WOMEN 				(26-27)
		[90 OR MORE = 90]	99	RA	

22.  If you had sex with any male partner in the last 12 months, how often
were condoms/rubbers used?  Would you say always, more than half the time,
 half the time, less than half the time, or never?

	1	Always	(28)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	7	NO SEX WITH MALE PARTNER [GO TO Q24]
	8	NO SEX AT ALL [GO TO Q26]
	9 	REFUSED TO ANSWER

23.  How many men have you had sex with in the last 12 months in total?

	___  ___  NUMBER OF MEN 				(29-30)
		[90 OR MORE = 90]

		98	NO SEX AT ALL [GO TO Q26]
		99	RA

IF Q21 AND Q23 ARE  00, GO TO Q26

24.  In the last 12 months, how often did you drink alcoholic beverages before
 having sex? Would you say always, more than half the time, half the time, less
 than half the time, or never?

	1	Always	(31)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	7	NO SEX LAST 12 MONTHS [GO TO Q26]
	9 	REFUSED TO ANSWER

25.  In the last 12 months, how often did you use drugs before having sex?

	1	Always	(32)
	2	More than half the time
	3	Half the time
	4	Less than half the time
	5	Never
	9 	REFUSED TO ANSWER

26.  Do you think you're going to have sex in the next 30 days?  Would you say
 yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(33)

27.  Is it possible to know beforehand if you're going to have sex? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(34)

In the following questions I am going to ask your opinions about the use of
 condoms/rubbers.  If you have never had sex or if you have never used a
 condom/rubber, please answer the questions trying to imagine how you would
 feel in each case.

28.  Do you think condoms/rubbers are only for men having sex with female
 prostitutes?  Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(35)

29.  Do you think it's difficult to find places to buy condoms/rubbers?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(36)

30.  Would you use a condom/rubber even if you had to stop to buy them or look
 for them?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(37)

31.  Would you use a condom/rubber even if you had been drinking alcoholic
 beverages or using drugs?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(38)

			BLANK	(39)

33.  Would you be able to refuse to have sex if your partner didn't want you to
 use a condom/rubber?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(40)

34. Imagine that you used a condom/rubber the next time you had sex.

Would you feel less sexual pleasure than if you didn't use one?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(41)

35. If you used a condom/rubber, would sex last longer than if you didn't use
 one?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(42)

36. If you used a condom/rubber, would you feel guilty?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(43)

37. If you used a condom/rubber, would you feel an emotional barrier with
your sex partner? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(44)

38. Do you think the condom/rubber would cause a burning sensation?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(45)

39. Do you think putting on a condom/rubber would interrupt sex?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(46)

40. Do you think sex would be cleaner than if you didn't use a condom/rubber?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(47)

Continue to imagine that you used a condom/rubber the next time you had sex

41.  Do you think the condom/rubber would feel uncomfortable or too tight?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(48)

42.  Do you think the condom/rubber might come off inside your partner?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(49)

43. Do you think the condom/rubber might break?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(50)

44. If you used a condom/rubber, do you think you might get cancer?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(51)

45. If you used a condom/rubber, do you think a female partner would get
 pregnant? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	9   RA	(52)

46. If you used a condom/rubber, would it be more difficult for you to
ejaculate or come than if you didn't use one?  

	1   Yes	2   Probably Yes	3   Probably No	4   No	(53)

47. If you used a condom/rubber, would it be more difficult for you to keep an
 erection than if you didn't use one?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(54)

In the following questions we'll talk about two types of partners: steady sex
 partners and casual sex partners.  As you recall, a steady sex partner is a
 person one has sex with in an ongoing relationship. A casual sex partner refers
 to a person one doesn't know very well and has sex with only once or a few
 times.

48. Would you be able to use a condom/rubber with a steady partner?
Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(55)

49. Would you be able to use a condom/rubber with a casual partner?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(56)

Imagine that you were going to have sex with a casual partner and you used
a condom/rubber

50. Do you think you could get a venereal disease such as gonorrhea or
syphilis?
Would you say yes, probably yes, probably no, or no?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(57)

51. If you used a condom/rubber with this casual partner, do you think you
could get the virus that causes AIDS?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(58)

52. If you used a condom/rubber with this casual partner, would you worry
less about giving a steady partner a disease such as syphilis, gonorrhea or
 AIDS? 

	1   Yes	2   Probably Yes	3   Probably No	4   No	(59)

Imagine that you insisted on using a condom/rubber the next time you had sex
 with a steady partner,

53. Would it lead the steady partner to think you had had sex with someone
 else?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(60)

54. If you insisted on using condoms/rubbers, do you think a steady partner
 would get angry?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(61)

55. Would a casual partner get angry?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(62)

				BLANK	(63-64)

58. If you insisted on using a condom/rubber, do you think a steady partner
 would refuse to have sex with you?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(65)

59. Would a casual partner refuse to have sex with you?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(66)

60. Imagine that you carried condoms/rubbers in your pocket or wallet.
Do you think that your men friends would think badly of you?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(67)

			9  RA	

61. If you had condoms/rubbers with you, would a casual partner respect you
 more than if you didn't have them?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(68)

62. If a woman has condoms/rubbers with her, do you think she is willing to
 have sex with someone she just met?

	1   Yes	2   Probably Yes	3   Probably No	4   No	(69)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 3	(05)

In the following questions we want to know how much you would be bothered
by some things that could happen to a person who used condoms/rubbers.
These questions may seem repetitive but they are very important and we
would appreciate your patience.

The responses can be "A lot" "Somewhat" or "Very little" 

63. How much would it bother you to feel less pleasure during sex?  Would it
 bother you a lot, somewhat or very little?

		1   A lot	2   Somewhat	3    Very little	(06)

64. How much would it bother you to feel a burning sensation in your sex
 organs?

		1   A lot	2   Somewhat	3    Very little	(07)

65. How much would it bother you  to interrupt sex?

		1   A lot	2   Somewhat	3    Very little	(08)

66. How much would it bother you  to feel guilty?

		1   A lot	2   Somewhat	3    Very little	(09)

67. How much would it bother you  to have a condom/rubber that feels
 uncomfortable or too tight?

		1   A lot	2   Somewhat	3    Very little	(10)

68. How much would it bother you if a condom/rubber came off inside your
 partner?

		1   A lot	2   Somewhat	3    Very little	(11)

69. How much would it bother you  if a condom/rubber broke?

		1   A lot	2   Somewhat	3    Very little	(12)

70. How much would it bother you  if you felt an emotional barrier with your
 partner?

		1   A lot	2   Somewhat	3    Very little	(13)

				BLANK	(14)

72. How much would it bother you  if you had trouble ejaculating?

		1   A lot	2   Somewhat	3    Very little	(15)

73. How much would it bother you  if you had trouble keeping an erection?	

		1   A lot	2   Somewhat	3    Very little	(16)

74. How much would it bother you to get a venereal disease like gonorrhea
or syphilis?	

		1   A lot	2   Somewhat	3    Very little	(17)

75. How much would it bother you  to have a steady partner think you had had
 sex with someone else?	

		1   A lot	2   Somewhat	3    Very little	(18)

76. How much would it bother you  to have a steady partner get angry?

		1   A lot	2   Somewhat	3    Very little	(19)

77. How much would it bother you  to have a casual partner get angry?

		1   A lot	2   Somewhat	3    Very little	(20)

78. How much would it bother you  to have a steady partner refuse to have
sex with you?

		1   A lot	2   Somewhat	3    Very little	(21)

79. How much would it bother you  to have a casual partner refuse to have
sex with you?

		1   A lot	2   Somewhat	3    Very little	(22)

80. How much would it bother you  to have your men friends think badly of you?

		1   A lot	2   Somewhat	3    Very little	(23)

81. Now, please tell me, how much would you like to have a casual partner
 respect you more?  Would you say a lot, somewhat, or very little?

		6   A lot	5   Somewhat	4    Very little	(24)

82. How much would you like not having to worry about giving a steady partner
 a disease like syphilis, gonorrhea or AIDS?

		6   A lot	5   Somewhat	4    Very little	(25)

83. How much would you like to have sex feel cleaner?

		6   A lot	5   Somewhat	4    Very little	(26)

For the following items, first tell me if you would like it or dislike it, then
tell me how much you would like or dislike it.

84.  Would you like or dislike having a female sex partner get pregnant now?
  How much, a lot, somewhat or very little?

	like it:	6   A lot	5   Somewhat	4    Very little	(27)

	dislike it:	1   A lot	2   Somewhat	3    Very little

85. Would you like or dislike having sex last longer?  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(28)

	dislike it:	1   A lot	2   Somewhat	3    Very little

		BLANK	(29)

87. Would you like or dislike using a condom/rubber with a steady partner?
  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(30)

	dislike it:	1   A lot	2   Somewhat	3    Very little

88. Would you like or dislike using a condom/rubber with a casual partner?
  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(31)

	dislike it:	1   A lot	2   Somewhat	3    Very little

89. Would you like or dislike carrying a condom/rubber with you?  How much?

	like it:	6   A lot	5   Somewhat	4    Very little	(32)

	dislike it:	1   A lot	2   Somewhat	3    Very little

90. How many of your closest men friends do you think carry condoms with
 them?
  Would you say almost all, more than half, half, less than half or almost none?

[IF THE PERSON DOESN'T KNOW, SAY: "Even if you don't know, please try to
 guess"]

			(33)
	1   Almost 	2   More	3   Half	4   Less	5   Almost
	all	than half		than half	None

					7   NO FRIENDS [GO TO Q93]

91. How many of your closest men friends do you think use condoms/rubbers
 when they have sex with a steady partner?
			(34)
	1   Almost 	2   More	3   Half	4   Less	5   Almost
	all	than half		than half	None

92. How many of your closest men friends do you think use condoms/rubbers
 when they have sex with a casual partner?
			(35)
	1   Almost 	2   More	3   Half	4   Less	5   Almost
	all	than half		than half	None

					7 NO FRIENDS HAVE CASUAL PARTNERS

93. Try to imagine how comfortable you would feel in the following situations.

	How comfortable would you feel buying a condom/rubber?  Would you feel very
 comfortable, somewhat comfortable, somewhat uncomfortable or very
 uncomfortable?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(36)
	comfortable	comfortable	uncomfortable	uncomfortable	

94.  How comfortable would you feel insisting on using a condom/rubber
with a steady partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(37)
	comfortable	comfortable	uncomfortable	uncomfortable	

95. How comfortable would you feel  insisting on using a condom/rubber with a casual partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(38)
	comfortable	comfortable	uncomfortable	uncomfortable	

96. How comfortable would you feel  putting on a condom/rubber?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(39)
	comfortable	comfortable	uncomfortable	uncomfortable	

97.  How comfortable would you feel  having a condom/rubber put on you?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(40)
	comfortable	comfortable	uncomfortable	uncomfortable	

98. How comfortable would you feel  using a condom/rubber with a steady
 partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(41)
	comfortable	comfortable	uncomfortable	uncomfortable	

99. How comfortable would you feel  using a condom/rubber with a casual
 partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(42)
	comfortable	comfortable	uncomfortable	uncomfortable	

100. How comfortable would you feel  being naked in front of a sex partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(43)
	comfortable	comfortable	uncomfortable	uncomfortable	

101. How comfortable would you feel having sex with the lights on?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(44)
	comfortable	comfortable	uncomfortable	uncomfortable	

102. How comfortable would you feel having sex with a new partner?

	1   Very 	2   Somewhat	3   Somewhat	4   Very	(45)
	comfortable	comfortable	uncomfortable	uncomfortable	

Now I'd like to ask you:

103. Do you have any children?

	00    NO	YES   How many?     ___ ___	(46-47)

104. Have you been circumcised?

	1    YES	0    NO 	8    DON'T KNOW	9    RA	(48)

IF NECESSARY, ASK:  Do you have a wife or steady partner who is a woman?

YES [GO TO Q105]			NO  [GO TO Q111]

105. Is your wife or steady partner pregnant? 

	1	YES 	[GO TO Q. 111]	(49)
	0	NO
	7	HE/SHE CANNOT HAVE CHILDREN  [GO TO Q111]
	8	DON'T KNOW
	9	RA

106. Is she trying to get pregnant?

	1	YES 	[GO TO Q. 111]	(50)
	0	NO
	7	HE/SHE CANNOT HAVE CHILDREN  [GO TO Q111]
	9	RA

107. Has she given birth in the last 3 months?

	1	YES 	[GO TO Q. 111]	(51)
	0	NO
	7	HE/SHE CANNOT HAVE CHILDREN  [GO TO Q111]
	9	RA

108. Have you or your steady partner used some form of birth control other
than condoms/rubbers in the last 12 months?

	YES &gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;[IF  THE ANSWER IS YES]    Which kind?	(52)
			[CIRCLE ALL THAT APPLY]
	1    PILL
	0   NO	2    IUD
	3    DIAPHRAGM
		4    SPONGE/FOAM/JELLY
	5    DOUCHE
	9   RA	6    WITHDRAWAL
		7    ABORTION
			8    OTHER ___________________

IF ANSWER IS YES, GO TO Q111

109. Is there a reason why your partner is unable to have children either due
to an operation or some other cause?

	1	YES 	[GO TO Q. 111]	(53)
	0	NO
	8	DON'T KNOW
	9	RA

110. Is there a reason why you are unable to have children either due to an
 operation or some other cause?

	1	YES 		(54)
	0	NO
	8	DON'T KNOW
	9	RA

111. Now I'm going to ask you some questions about how you have been feeling
 during the last seven days.   Since [ TODAY'S DAY OF THE WEEK] of last week 

	Were you bothered by things that usually don't bother you?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(55)
			How many days during the past week?

		[DO NOT READ RESPONSES]

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

112. Did you feel like not eating or was your appetite poor?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(56)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

113. Did you feel like you couldn't shake off the blues even with the help of
 family and friends?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(57)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

114. Did you feel depressed?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(58)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

115. Did you feel as if your life had been a failure?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(59)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

116. Did you feel afraid?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(60)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

117. Was your sleep restless?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(61)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

118. Did you feel lonely?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(62)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

119. Did you feel sad?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(63)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

120. Did you have crying spells?

	O    NO		[IF THE ANSWER IS YES, SAY]:	(64)
			How many days during the past week?

			1     1-2 DAYS	2     3-4 DAYS	3     5-7 DAYS

IF NON-HISPANIC, GO TO Q128

IF HISPANIC, CONTINUE BELOW

121. Now, please tell me, where were you born?

	1    USA	[GO TO THE FOLLOWING QUESTION]	(65)
	2    PUERTO RICO	[GO TO Q. 123]
	3    MEXICO	[GO TO Q. 123]
	4    REPUBLICA DOMINICANA	[GO TO Q. 123]
	5    COLOMBIA	[GO TO Q. 123]
	6    CENTRAL AMERICA	[GO TO Q. 123]
	7    SOUTH AMERICA, (NO COLOMBIA)	[GO TO Q. 123]
	8    SPAIN OR CUBA	[GO TO Q. 123]
	9    OTHER _______________________  [GO TO THE FOLLOWING QUESTION]

FOR HISPANICS BORN IN THE U.S. OR COUNTRIES LISTED IN 9 ABOVE

122.  The families of the majority of people living in the United States come
 from other countries. Where is your family from?

[DO NOT READ ALTERNATIVES  IF RESPONSE IS MORE THAN ONE COUNTRY,
 ASK:]"Which country is the majority of your family from or which country do
 you feel closest to?"  [CIRCLE ONLY ONE]

	2    PUERTO RICO	(66)
	3    MEXICO
	4    REPUBLICA DOMINICANA
	5    COLOMBIA
	6    CENTRAL AMERICA
	7    SOUTH AMERICA, (NO COLOMBIA)
	8    SPAIN OR CUBA

123. How long have you lived in the United States?

	___ ___    YEARS [LESS THAN A YEAR = ONE YEAR{01}]	(67-68)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 4	(05)

124. In general what language do you read and speak?  Would you say Spanish
 only, Spanish more than English, both equally, English more than Spanish, or
 English only?
		(06)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

125. What language do you usually speak at home?
	(07)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

126. In which language do you usually think?
	(08)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

127. What language do you usually speak with your friends?
	(09)

	1   Spanish	2   Spanish more 	3   Both 	4   English more	5   English
	only	than English	equally	than Spanish	only

ASK EVERYONE

128. How many years of formal education have you completed?

	___ ___ YEARS	(10-11)

129. Are you:
	1	Married or living with your partner	(12)
	2	Single
	3	Separated or divorced
	4	Widowed

130. What is your religion?  __________________________
	(13)
	1	CATHOLIC
	2	CHRISTIAN OTHER THAN CATHOLIC
	3	OTHER: (SPECIFY: ________________)
	4	NONE

131. How important is religion in your life?  Would you say:
	(14)
	1   	Extremely important
	2   	Very important
	3   	Important
	4   	Somewhat important
	5   	Not important at all
							BLANK	(15-16)

133. Would you say that you live in a town, city, suburb of a city, or a rural
 area?

	1   TOWN  	2   CITY	3   SUBURB	4   RURAL AREA	(17)

134. Could you please give me your Zip Code?

		__ __ __ __ __    ZIP CODE	(18-22)
		[99998 &gt;&gt; DK        99999 &gt;&gt; RA]

135. Tell me when I get to the category that best describes your family
income for 1990.  [IF LIVING ALONE, ASK FOR PERSONAL INCOME]

	[READ RESPONSES]

		1	Less than $10,000	(23)
		2	$10,001 to 20,000
		3	$20,001 to 40,000
		4	More than $40,000
		8	DON'T KNOW
		9	RA

As I already explained, your phone number was chosen at random.  To avoid
 calling your house again, could you please tell me if there is another
telephone number in your house?

	[IF THE ANSWER IS YES]   What is it?__________________

	Is there more than one number?

		OTHER NUMBER(S) ________________________

136. 	NUMBER OF TELEPHONE LINES _______	(24)
		[INCLUDING THE ONE BEING CALLED]

IF NON HISPANIC, GO TO PARAGRAPH BEGINNING:
'This is all for now."

IF HISPANIC, CONTINUE BELOW

137. In the future, it is possible that we will do a study of sexual attitudes
and behavior among Hispanic adolescents.  The questions will be very different
 from the ones you just answered and will be appropriate for adolescents.
To include an adolescent in that study not only would we need the adolescent's
 consent but also the permission of a parent or guardian. 

Is there an adolescent in this house who is 15, 16 or 17 years old?

	YES  How many?  _____	NO  0  [GO TO END]	(25)

Could you give me the name of the parent or guardian who could give permission
 to interview the adolescent, if we do call?

	____________________________________________________

138.  Could you give me the name(s) of the adolescent(s)?

	___________________________________________

	ASK IF UNCLEAR:     NUMBER OF FEMALES______	(26)

This is all for now.  My supervisor may call you back to validate that this
 interview was completed.  Thank you for your help with this interview.
If you would like any further information about AIDS or AIDS prevention, you
 can call this number             1-800-342-2437       [AIDS]. Would you like me to repeat
that number?   The call is free and you don't have to give your name.

Again, thank you very much!

__________________________________________________________

TIME AT THE END OF INTERVIEW:___________

139. 	LENGTH OF INTERVIEW [ IN MINUTES]   ___ ___	(27-28)

140. LANGUAGE OF INTERVIEW:	0    ENGLISH	(29)

141. LANGUAGE CHOICE:

 	1    RESPONDENT   	0       RANDOMLY BY INTERVIEWER	(30)

142. INTERVIEWER'S NAME:_________________________ [ ___ ___ ___ ]	(31-33)

DATE OF INTERVIEW:_____________________________

INTERVIEW TERMINATED BEFORE COMPLETION

	1  YES   	0  NO	(34)

	[IF THE ANSWER IS YES] __ __ __  ITEM NUMBER	(35-37)

IS RESPONDENT A MEMBER OF HOUSEHOLD?

	1  YES	0  NO	(38)</pre>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Condom use Among Hispanics - Mujeres</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Estudio del Uso de Condones 1991
Entrevista Para Mujeres</h3>
<pre>HORA AL EMPEZAR LA ENTREVISTA: __________________

Muchas de las preguntas que le vamos a hacer son de índole sexual y es
 posible que se pueda sentir un poco incómoda. Le recuerdo que sus
 respuestas se guardarán completamente confidenciales y que me
 puede indicar cualquier pregunta que no quiera contestar.

Quisiera hacerle unas preguntas generales acerca del SIDA.  Sus respuestas
 pueden ser "sí" "probablemente sí," "probablemente no," o "no." 

1. Cree que es posible contraer el virus del SIDA de una picada o
 piquete de mosquito?  Diría que sí, probablemente
 sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(06)

2. Cree que es posible contraer el virus del SIDA al sentarse en un
 baño público?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(07)

3. Cree que el SIDA es un problema sólo de los homosexuales y
 drogadictos?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(08)

4. Cree que es posible saber por la apariencia si una persona tiene el
 virus del SIDA?  

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(09)

5. Ha conocido personalmente a alguien que tuviera SIDA o estuviera
 infectado con el virus del SIDA?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	

			8    NO SABE	(10)

6. Con qué frecuencia le preocupa el que pudiera contagiarse
 del virus que causa el SIDA?

Diría que muy frecuentemente, frecuentemente, a veces, o nunca?
		(11)
	1   Muy	2   Frecuentemente	3   A veces	4   Nunca
	Frecuentemente

Ahora le voy a preguntar acerca de los preservativos o condones.  

7. Prefiere que usemos la palabra "preservativo" o "condón?"   

	1	PRESERVATIVO	2     CONDON 	(12)

	3	NO TIENE PREFERENCIA (USE "PRESERVATIVO")

Las siguientes preguntas se refieren al uso de los preservativos/condones. Si
 nunca los ha usado, de todas maneras nos interesan sus respuestas.

8. Cree que la vaselina es buena como crema o lubricante para los
 preservativos/condones?

	1    SI	0    NO   	8    NO SABE	(13)

9. Cree que hay que desenrrollar el preservativo/condón antes
 de ponérselo al  pene?

	1    SI	0    NO   	8    NO SABE			(14)

Ahora quisiera hacerle algunas preguntas acerca de sus experiencias con
 preservativos/condones y otras actividades sexuales.  Usaré la
 palabra "compañero sexual" para referirme a la persona con quien se
 tiene relaciones sexuales.  Esta información es muy importante para
 nuestro estudio.  Cada persona tiene diferentes experiencias sexuales, de
 modo que algunas preguntas pueden no serle relevantes.

10. Con qué frecuencia lleva preservativos/condones consigo?
  Diría que siempre, a veces, casi nunca, o nunca?

	1   Siempre	2   A veces	3   Casi nunca	4   Nunca	(15)

11. Alguna vez ha tenido relaciones sexuales con un compañero
 sexual que usó preservativos/condones?

	1    SI			(16)
	0    NO  [PASE A LA P.15]
	9    RA

12. Alguna vez ha usado preservativos/condones para evitar un
 embarazo?

	1    SI	0    NO   	9    RA	(17)

13. Alguna vez ha usado preservativos/condones para evitar
 enfermedades?

	1    SI	0    NO   	9    RA	(18)

14. Cómo consiguió los preservativos/condones?
[NO LEA LAS RESPUESTAS]

[MARQUE UNA SOLA RESPUESTA]

[SI LA ENTREVISTADA DA MAS DE UNA RESPUESTA, PREGUNTE DONDE LOS
 OBTUVO CON MAS FRECUENCIA E INDIQUE ESA RESPUESTA SOLAMENTE]

______ LOS COMPRO   PREGUNTE:	Dónde?

	1	FARMACIA O DRUG STORE
	2	BAÑO PUBLICO [VENDING MACHINES]
	3	SUPERMERCADO
	9	RA
				(19)
_____ SE LOS REGALARON	PREGUNTE:	Dónde? 

	4	EN UNA CLINICA
	5	EN LA CALLE
	6	UN AMIGO/PARIENTE
	7	UN COMPAÑERO SEXUAL
	8	EN OTRO LUGAR _____________
	9	RA

15. En las siguientes preguntas, hablaremos de un compañero sexual
 habitual que se refiere a una persona con quien usualmente se comparte la
 vida sexual y podría ser un esposo.  

Imagínese que tuviera relaciones sexuales con un esposo o
 compañero sexual habitual en los próximos 30 días,
 Con qué frecuencia cree que usaría
 preservativos/condones ese compañero?  Diría que
 siempre, más de la mitad de las veces, la mitad de las veces, menos
 de la mitad de las veces, o nunca?

[SI LA ENTREVISTADA DICE QUE NO ES APLICABLE, DIGA: "Aunque no sepa,
 conteste lo que se imagine."]

	1	Siempre	(20)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

16. Imagínese que tuviera relaciones sexuales con una persona que no
 es su compañero habitual en los próximos 30 días,
 Con qué frecuencia cree que usaría
 preservativos/condones esa persona? [SI LA ENTREVISTADA DICE QUE NO ES
 APLICABLE, DIGA: "Aunque no sepa, conteste lo que se imagine."]

	1	Siempre	(21)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

17. Durante los últimos 12 meses, o sea desde [ESTE MES] de
 1990, ha tenido relaciones sexuales alguna vez?

	1	SI	[PASE A LA P. 19]	0	NO 	[PASE A LA P.18]	(22)

	9	RA 	[PASE A LA P.18]

18. Durante los últimos cinco años ha tenido relaciones
 sexuales alguna vez?

	1	SI	[PASE A LA P. 19]	0	NO 	[PASE A LA P.26]	(23)

	9	RA 	[PASE A LA P.26]

19. Como ya se explicó algunas de las preguntas tal vez no son
 relevantes a usted. Si no tienen aplicación para usted por favor
 indíquelo.

Durante los últimos 12 meses, cuando tuvo relaciones sexuales con su
 esposo o compañero habitual, Con qué frecuencia
 usó preservativos/condones su compañero?
  Diría que siempre, más de la mitad de las veces, la
 mitad de las veces, menos de la mitad de las veces, o nunca?

	1	Siempre	(24)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	6	NO COMPAÑERO HOMBRE [PASE A LA P. 26]
	7	NO COMPAÑERO HABITUAL
	8	NO RELACIONES SEXUALES EN LOS ULTIMOS 12 MESES  [PASE A LA P. 26]
	9	RA

20. Durante los últimos 12 meses, cuando tuvo relaciones sexuales con
 algún hombre diferente de su esposo o compañero habitual,
 Con qué frecuencia usó preservativos/condones ese
 compañero?

	1	Siempre	(25)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	7	NO COMPAÑERO CASUAL
	8	NO RELACIONES SEXUALES  [PASE A LA P. 26]
	9	RA

			BLANK	(26-28)

23. Durante los últimos 12 meses, Con cuántos
 hombres en total ha tenido relaciones sexuales?

	______  NUMERO DE HOMBRES [90  O MAS  = 90]	99	RA	(29-30)

SI LA RESPUESTA A LA PREGUNTA ANTERIOR ES  00, PASE A LA P. 26

24. Durante los últimos 12 meses, Con qué frecuencia
 tomó bebidas alcoholicas antes de tener relaciones sexuales?
   Diría que siempre, más de la mitad de las veces, la
 mitad de las veces, menos de la mitad de las veces, o nunca?

	1	Siempre	(31)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

25. Durante los últimos 12 meses, Con qué frecuencia
 usó drogas antes de tener relaciones sexuales?		

	1	Siempre	(32)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

26. Cree que va a tener relaciones sexuales en los próximos 30
 días?  Diría que sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(33)

27. Es posible saber de antemano si va a tener relaciones sexuales?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(34)

En las siguientes preguntas le voy a pedir sus opiniones acerca del uso de los
 preservativos/condones. Si nunca ha tenido relaciones sexuales o nunca ha
 usado un preservativo/condón por favor conteste imaginándose
 como se sentiría en cada caso.

28. Cree que el preservativo/condón es sólo para las
 relaciones sexuales de hombres con prostitutas?  Diría que
 sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(35)

29. Cree que es difícil encontrar donde comprar
 preservativos/condones?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(36)

	BLANK	(37)

31. Le pediría a un compañero sexual que usara un
 preservativo/condón aunque usted hubiera estado tomando bebidas
 alcohólicas o usando drogas?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(38)

32. Se sentiría capaz de pedirle a un compañero que
 usara un preservativo/condón si pensara que está teniendo
 relaciones sexuales con otra persona?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(39)

33. Se sentiría capaz de rehusarse a tener relaciones sexuales
 si su compañero no quisiera usar un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(40)

34. Imagínese que la próxima vez que tuviera relaciones
 sexuales su compañero usara un preservativo/condón.
  Sentiría usted menos placer sexual que si no lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(41)

35. Si su compañero sexual usara un preservativo/condón,
 durarían más tiempo las relaciones sexuales que si no
 lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(42)

36. Si su compañero sexual usara un preservativo/condón,
 Se sentiría culpable usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(43)

37. Si se usara un preservativo/condón, Sentiría una
 barrera emocional con su
	compañero sexual?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(44)

38. Cree que el preservativo/condón le produciría una
 sensación de ardor?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(45)

39. Cree que se interrumpiría el acto sexual al ponerse su
 compañero un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(46)

40. Cree que las relaciones sexuales serían más
 limpias que si no usara su compañero un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(47)

Continue imaginándose que la próxima vez que tuviera
 relaciones sexuales su compañero usara un preservativo/condón.

41. Cree que el preservativo/condón se le haría
 incómodo o apretado a su compañero sexual?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(48)

42.  Cree que podría quedarse el preservativo/condón
 dentro de usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(49)

43. Cree que el preservativo/condón podría romperse?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(50)

44. Si su compañero sexual usara un preservativo/condón,
 Cree que podría contraer cáncer usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(51)

45. Si su compañero sexual usara un preservativo/condón,
 Cree que quedaría embarazada?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(52)

		9   RA				

46. Si su compañero sexual usara un preservativo/condón,
 Se le haría más difícil eyacular o acabar que
 si no lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(53)

47. Si su compañero usara un preservativo/condón, Se
 le haría más difícil mantener una erección que
 si no lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(54)

En las siguientes preguntas, hablaremos de dos tipos de compañero
 sexual: el compañero sexual habitual y el compañero sexual
 casual.  Como ya le explicamos, compañero sexual habitual se refiere a
 una persona con quien usualmente se comparte la vida sexual.
  Compañero sexual casual se refiere a una persona poco conocida con
 quien uno tiene relaciones sexuales una o pocas veces.

48. Se sentiría capaz de pedirle a un compañero sexual
 habitual que use un preservativo/condón?

Diría que sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(55)

49. Se sentiría capaz de pedirle a un compañero sexual
 casual que use un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(56)

Imagínese que fuera a tener relaciones sexuales con un
 compañero sexual casual y que él usara un
 preservativo/condón

50. Cree que podría contraer una enfermedad venérea
 como sífilis o gonorrhea?
Diría que sí, probablemente sí, probablemente
 no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(57)

51.  Cree que podría contraer el virus que causa el SIDA si
 este compañero casual usara un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(58)

52. Si este compañero casual usara un preservativo/condón, se
 preocuparía usted menos de infectar a un compañero habitual
 con una enfermedad como sífilis, gonorrea o SIDA?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(59)

Imagínese que  la próxima vez que tenga relaciones sexuales
 con un compañero sexual habitual le pidiera que usara un preservativo/condón:

53. Le haría creer al compañero habitual que usted
 había tenido relaciones sexuales con otra persona?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(60)

54. Si le pidiera a un compañero habitual que usara
 preservativos/condones, Cree que se enojaría?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(61)

55. Se enojaría un compañero casual ?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(62)

56. Si le pidiera a un compañero habitual que usara
 preservativos/condones, Se pondría violento?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(63)

57. Se pondría violento un compañero casual?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(64)

58. Si le pidiera a un compañero habitual que usara
 preservativos/condones, cree que se rehusaría a tener
 relaciones sexuales con usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(65)

59. Se rehusaría a tener relaciones sexuales con usted un
 compañero casual ?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(66)

60. Imaginese que usted llevara preservativos/condones en un bolsillo o en
 una bolsa o una cartera.  Cree que sus amigas pensarían mal de usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No     9  RA	(67)

61. Si usted llevara preservativos/condones consigo, Cree que un
 compañero casual sentiría más respeto por usted que si no los llevara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(68)

62. Si llevara preservativos/condones consigo, pensarían los
 hombres que está dispuesta a tener relaciones sexuales con un recién conocido?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(69)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 3	(05)

En las siguientes preguntas queremos saber que tanto le molestarían
 cosas que podrían sucederle a una persona que usara
 preservativos/condones.  Estas preguntas le pueden parecer un poco
 repetidas, pero son muy importantes y le agradecemos su paciencia.  Las
 respuestas pueden ser "Mucho"  "Algo" o "Muy poco."

63. Qué tanto le molestaría sentir menos placer
 sexual?  Diría que le molestaría mucho, algo, o muy poco?
		1   Mucho	2   Algo	3    Muy poco	(06)

64. Qué tanto le molestaría sentir ardor en los organos
 sexuales?

		1   Mucho	2   Algo	3    Muy poco	(07)

65. Qué tanto le molestaría  interrumpir el acto
 sexual?

		1   Mucho	2   Algo	3    Muy poco	(08)

66. Qué tanto le molestaría  sentirse culpable?

		1   Mucho	2   Algo	3    Muy poco	(09)

67. Qué tanto le molestaría que un
 preservativo/condón le fuera incómodo o le apretara mucho
 	  a su compañero?
		1   Mucho	2   Algo	3    Muy poco	(10)

68. Qué tanto le molestaría  que un
 preservativo/condón se quedara dentro de usted?

		1   Mucho	2   Algo	3    Muy poco	(11)

69. Qué tanto le molestaría  que un
 preservativo/condón se rompiera?

		1   Mucho	2   Algo	3    Muy poco	(12)

70. Qué tanto le molestaría sentir una barrera
 emocional con su compañero?

		1   Mucho	2   Algo	3    Muy poco	(13)

				BLANK	(14)

72. Qué tanto le molestaría  que su compañero
 tuviera dificultad para eyacular o acabar? 

		1   Mucho	2   Algo	3    Muy poco	(15)

73. Qué tanto le molestaría  que su compañero
 tuviera dificultad para mantener la erección?

		1   Mucho	2   Algo	3    Muy poco	(16)

74. Qué tanto le molestaría contraer una enfermedad
 venérea, como la gonorrea o el sífilis?

		1   Mucho	2   Algo	3    Muy poco	(17)

75. Qué tanto le molestaría  que su compañero
 habitual pensara que había tenido relaciones sexuales con otra persona?

		1   Mucho	2   Algo	3    Muy poco	(18)

76. Qué tanto le molestaría que un compañero
 habitual se sintiera enojada?

		1   Mucho	2   Algo	3    Muy poco	(19)

77. Qué tanto le molestaría que un compañero
 casual se sintiera enojada?

		1   Mucho	2   Algo	3    Muy poco	(20)

78. Qué tanto le molestaría  que un compañero
 habitual se rehusara a tener relaciones sexuales?

		1   Mucho	2   Algo	3    Muy poco	(21)

79. Qué tanto le molestaría  que un compañero
 casual se rehusara a tener relaciones sexuales?

		1   Mucho	2   Algo	3    Muy poco	(22)

80. Qué tanto le molestaría  que sus amigas pensaran
 mal de usted?

		1   Mucho	2   Algo	3    Muy poco	(23)

81. Ahora por favor dígame, qué tanto le gustaría que un
 compañero casual sintiera más respeto por usted?
  Diría que mucho, algo, o muy poco?

		6   Mucho	5   Algo	4    Muy poco	(24)

82. Qué tanto le gustaría no tener que preocuparse de
 darle a su compañero habitual una enfermedad como sífilis,
 gonorrea o SIDA?
		6   Mucho	5   Algo	4    Muy poco	(25)

83. Qué tanto le gustaría que las relaciones sexuales
 fueran mas limpias a causa del
preservativo/condón?

		6   Mucho	5   Algo	4    Muy poco	(26)

Para las siguientes preguntas, primero dígame si le gustaría o
 le molestaría y luego dígame cuanto le gustaría o le
 molestaría:

84. Le gustaría o le molestaría quedar embarazada
 ahora?  Qué tanto:  Mucho, algo o muy poco?

	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(27)

	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

85. Le gustaría o le molestaría que las relaciones
 sexuales duraran más?  Qué tanto?
	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(28)
	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

86. Le gustaría o le molestaría que los hombres pensaran que
 está dispuesta a tener relaciones sexuales con un recién
 conocido? Qué tanto?
	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(29)
	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

87. Le gustaría o le molestaría usar un
 preservativo/condón con un compañero habitual?  Qué tanto?
	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(30)
	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

88. Le gustaría o le molestaría usar un
 preservativo/condón con un compañero casual?
Qué tanto?
	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(31)
	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

89. Le gustaría o le molestaría llevar un
 preservativo/condón consigo?
Qué tanto?
	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(32)
	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

90. De sus amigas más cercanas, Cuántas cree que
 llevan preservativos/condones consigo?  Diría que casi todas,
 mas de la mitad, la mitad, menos de la mitad, o casi ninguna?

[SI NO SABE, DIGA:  "Aunque no sepa con seguridad, conteste lo que se
 imagine"]

	1   Casi 	2   Más de	3   La Mitad	4   Menos de	5   Casi	(33)
	Todas	la Mitad		la mitad	Ninguna

				 7   NO TIENE NINGUNA AMIGA [PASE A LA P.93]

91. De sus amigas más cercanas, Cuántas cree que usan
 preservativos/condones cuando tienen relaciones sexuales con un
 compañero habitual?

	1   Casi 	2   Más de	3   La Mitad	4   Menos de	5   Casi	(34)
	Todas	la Mitad		la mitad	Ninguna

92. De sus amigas más cercanas, Cuántas cree que usan
 preservativos/condones cuando tienen relaciones sexuales con un
 compañero casual?  

	1   Casi 	2   Más de	3   La Mitad	4   Menos de	5   Casi	(35)
	Todas	la Mitad		la mitad	Ninguna
				 7   NINGUNA AMIGA TIENE C. CASUAL 				 

93.  Trate de imaginarse que tan cómoda se sentiría en las
 siguientes situaciones.

Qué tan cómoda se sentiría al comprar un
 preservativo/condón?  Diría que muy cómoda,
 algo cómoda, algo incómoda, o muy incómoda?

	1   Muy 	2   Algo	3   Algo	4   Muy	(36)
	cómoda	cómoda	incómoda	incómoda	

94. Qué tan cómoda se sentiría al pedirle a un
 compañero habitual que use un
	 preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(37)
	cómoda	cómoda	incómoda	incómoda	

95. Qué tan cómoda se sentiría  al pedirle a un
 compañero casual que use un preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(38)
	cómoda	cómoda	incómoda	incómoda	

96. Qué tan cómoda se sentiría  al ver a su
 compañero ponerse un preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(39)
	cómoda	cómoda	incómoda	incómoda	

97. Qué tan cómoda se sentiría  al ponerle un
 preservativo/condón a su compañero?

	1   Muy 	2   Algo	3   Algo	4   Muy	(40)
	cómoda	cómoda	incómoda	incómoda	

98. Qué tan cómoda se sentiría si un
 compañero habitual usara un preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(41)
	cómoda	cómoda	incómoda	incómoda	

99. Qué tan cómoda se sentiría  si un
 compañero casual usara un preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(42)
	cómoda	cómoda	incómoda	incómoda	

100. Qué tan cómoda se sentiría al estar
 desnuda frente a un compañero sexual?

	1   Muy 	2   Algo	3   Algo	4   Muy	(43)
	cómoda	cómoda	incómoda	incómoda	

101. Qué tan cómoda se sentiría  al tener
 relaciones sexuales con la luz prendida?

	1   Muy 	2   Algo	3   Algo	4   Muy	(44)
	cómoda	cómoda	incómoda	incómoda	

102. Qué tan cómoda se sentiría al tener
 relaciones sexuales con un compañero nuevo?

	1   Muy 	2   Algo	3   Algo	4   Muy	(45)
	cómoda	cómoda	incómoda	incómoda	

Ahora, quisiera preguntarle...
103. Tiene hijos?
	(46-47)
		  (00) NO  	 SI       Cuántos?____ ____
				                     BLANK	(48)

SI ES NECESARIO:  Tiene esposo o un compañero habitual?

SI&gt;&gt;&gt;[PASE A LA P. 105] 		NO&gt;&gt;&gt;[PASE A LA P. 111]

105. Está embarazada? 

	1	SI 	[PASE A LA P. 111]	(49)
	0	NO
	7	EL/ELLA NO PUEDE TENER HIJOS [PASE A LA P. 111]
	8	NO SABE
	9	RA

106. Está intentando quedar embarazada?

	1	SI 	[PASE A LA P. 111]	(50)
	0	NO
	7	EL/ELLA NO PUEDE TENER HIJOS [PASE A LA P. 111]
	8	NO SABE
	9	RA

IF Q103 ABOVE IS 00, GO TO Q108

107. Ha dado a luz durante los últimos tres meses?

	1	SI 	[PASE A LA P. 111]	(51)
	0	NO
	7	EL/ELLA NO PUEDE TENER HIJOS [PASE A LA P. 111]
	8	NO SABE
	9	RA

108. Aparte de preservativos/condones, Ha usado usted o su
 compañero habitual algún método para evitar tener
 hijos en los últimos 12 meses?

	SI   &gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;[SI LA RESPUESTA ES SI]  Qué clase?	(52)
			[ANOTE TODAS LAS QUE SE APLIQUEN]
	1  PASTILLA/LA PILDORA
	0   NO	2  DIU
	3  DIAFRAGMA
		4  ESPONJA/JALEA/ESPUMA
	5  LAVADO
	9   RA	6  RETIRARSE
			7  ABORTO
			8  OTRO ____________________

SI LA RESPUESTA ES SI, PASE A LA P. 111

109.  Hay alguna razón por la cual su compañero
 habitual no pueda tener hijos, ya sea por operación o cualquier otra
 causa?

	1	SI 	[PASE A LA P. 111]	(53)
	0	NO
	8	NO SABE
	9	RA

110. Hay alguna razón por la cual no pueda tener hijos, ya sea
 por operación o cualquier otra causa?

	1	SI 		(54)
	0	NO
	8	NO SABE
	9	RA

111. Ahora le voy a hacer algunas preguntas acerca de cómo se ha
 sentido en los últimos siete días.  Desde el [DIA DE LA
SEMANA DE HOY] de la semana pasada.

Le molestaron cosas que por lo general no le molestan?

	0   NO	[SI LA RESPUESTA ES SI, DIGA]:	(55)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

112. Se sintió sin ganas de comer o tuvo mal apetito?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(56)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

113. Sintió que no podía quitarse de encima la
tristeza ni aún con el apoyo de su familia y amigos?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(57)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

114. Se sentió deprimida?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(58)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

115. Sintió que su vida había sido un fracaso?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(59)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

116. Se sintió con miedo?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(60)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

117. Tuvo sueño inquieto?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(61)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

118. Se ha sentido sola?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(62)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

119. Se sintió triste?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(63)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

120. Pasó ratos llorando?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(64)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

121. Ahora, me podría decir, Dónde nació?

	1	ESTADOS UNIDOS  	[PASE A LA SIGUIENTE PREGUNTA]	(65)
	2	PUERTO RICO  	[PASE A LA P.123]
	3	MEXICO   		[PASE A LA P.123]
	4 	REPUBLICA DOMINICANA	[PASE A LA P.123]
	5	COLOMBIA	[PASE A LA P.123]
	6	CENTRO AMERICA	[PASE A LA P.123]
	7	SUR AMERICA,(NO COLOMBIA)	[PASE A LA P.123]
	8	CUBA/ESPAÑA	[PASE A LA P.123]
	9	OTRO ______________	[PASE A LA SIGUIENTE PREGUNTA]

PARA LOS QUE NACIERON EN LOS ESTADOS UNIDOS
O CUALQUIER OTRO PAIS APUNTADO ARRIBA COMO #9

122.  Las familias de la mayoría de las personas que viven en los
 Estados Unidos provienen de otros países.
 De dónde viene su familia?

			[NO LEA LAS ALTERNATIVAS] 

[SI RESPONDE DICIENDO MAS DE UN PAIS, PREGUNTE:  "De cuál
 país proviene la mayoría de su familia o por cuál
 país siente mas cariño o apego?"]
[MARQUE SOLAMENTE UNO]

	2	PUERTO RICO	(66)
	3	MEXICO
	4	REPUBLICA DOMINICANA
	5	COLOMBIA
	6	CENTRO AMERICA
	7	SUR AMERICA, (NO COLOMBIA)
	8	CUBA

123. Cuánto tiempo ha vivido en los Estados Unidos?

	___ ___    AÑOS [MENOS DE UN AÑO = UN AÑO {01}]	(67-68)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 4	(05)

124. Por lo general, Qué idioma lee y habla usted?
  Diría que sólo español, más
 español que inglés, ambos por igual, más inglés
 que español o sólo inglés?
	(06)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español
	inglés

125.  Por lo general, Qué idioma habla en su casa?
	(07)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

126. Por lo general, En qué idioma piensa?
	(08)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

127. Por lo general, Qué idioma habla con sus amigos?
	(09)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

128. Cuántos años de educación formal ha completado?
			____  ____  AÑOS	(10-11)

129. Está usted:
	1	casada  o viviendo con su compañero,	(12)
	2	soltera,
	3	separada o divorciada, o
	4	viuda?

130. Cuál es su religión?________________________

	1	CATOLICA	(13)
	2	CRISTIANA [NO CATOLICA]
	3	OTRA: (ESPECIFIQUE.. _________)
	4	NINGUNA

131. Qué tan importante es la religión en su vida?
  Diría que es:	

	1	sumamente importante	(14)
	2	muy importante
	3	importante
	4 	algo importante
	5	nada importante

132. Cúantos años tiene de estar empleada, de tiempo
 completo o de tiempo parcial, sin incluir trabajo en su casa?

	_____  AÑOS  	(15-16)

133. Diría que vive en un pueblo, una ciudad, en los
 alrededores de una ciudad o en un área rural?

	1	PUEBLO	(17)
	2	CIUDAD
	3	ALREDEDORES
	4	RURAL

134. Podría decirme cual es su código postal o zip code?

		___ ___ ___ ___ ___	(18-22)

		99998	DK          99999	RA	

135. Por favor dígame dentro de qué categoría caen los
 ingresos de su familia  para el año 1990: [SI VIVE SOLO, "sus ingresos
 personales"]

	1	menos de $10,000	(23)
	2	entre $10,001 y $20,000
	3	entre $20,001 y $40,000
	4	más de $40,000
	8	NO SABE
	9	RA

136. Como ya le expliqué su número de teléfono se
 escogió al azar o a la suerte.  Para no volver a llamar a esta casa,
 Me podría decir si hay otro número de teléfono
 que pertenece a su casa?  

	[SI LA RESPUESTA ES SI]   Cuál es?__________________

	Hay otro más?	NUMEROS TELEFONICOS

		______________________________
		______________________________
		______________________________

	CUANTOS TELEFONOS SON?    ______	(24)
	[INCLUYENDO EL QUE SE ESTA LLAMANDO]

137.  En el futuro, es posible que hagamos un estudio de las actitudes y
 conductas sexuales de los adolescentes Hispanos o Latinos.  Será un
 estudio bastante diferente a éste y adecuado a los intereses y
 sensibilidad de los adolescentes.  Para incluir a un adolescente en ese
 estudio no sólo se necesitaría el consentimiento de ese o esa
 adolescente sino también el permiso de uno de los padres o
 guardián

Hay algún adolescente en esta casa que tenga 15, 16, o 17 años de edad?

	SI (Cuantos son?) ______	NO	  0   [PASE AL FINAL]	(25)

	Podría darme el nombre del padre, la madre o el
 guardián que podría dar el permiso para entrevistar al/a los
  adolescente(s), si le volviéramos a llamar?

	_________________________________

138.  Podría darme el/los nombre(s) del/de los adolescente(s)?

	_____________________________________________________

					_____ MUJERES 	(26)

Hemos terminado.  Tal vez reciba una llamada de mi supervisor para verificar
 mi trabajo.  Muchísimas gracias por su ayuda.  Si desea recibir
 más información sobre el SIDA o su prevención puede
 llamar, gratis y sin dar su nombre al              1-800-344-7432      .

Quiere que le repita el número?. . . .  De nuevo, ¡muchísimas gracias!

__________________________________________________________

139. TIME AT THE END OF INTERVIEW:  ________________________

	CUANTO TIEMPO TARDO LA ENTREVISTA  [EN MINUTOS]   ___ ___	(27-28)

140. LANGUAGE OF INTERVIEW:	1     SPANISH	(29)

141. LANGUAGE CHOICE: 

		1      RESPONDENT 	         0       RANDOMLY BY INTERVIEWER	(30)

142. INTERVIEWER'S NAME:_________________________ [ ___ ___ ___ ]	(31-33)

DATE OF INTERVIEW:_____________________________

INTERVIEW TERMINATED BEFORE COMPLETION:

	1    SI	0    NO	(34)

		[SI LA RESPUESTA ES SI]: __ __ __  ITEM NUMBER 	(35-37)

IS RESPONDENT A MEMBER OF HOUSEHOLD?          	(38)

		1  YES	0  NO</pre>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Condom use Among Hispanics - Hombres</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Estudio del Uso de Condones 1991
Entrevista Para Hombres</h3>
<pre>HORA AL EMPEZAR LA ENTREVISTA: __________________

Muchas de las preguntas que le vamos a hacer son de índole sexual y es
 posible que se pueda sentir un poco incómodo. Le recuerdo que sus
 respuestas se guardarán completamente confidenciales y que me
 puede indicar cualquier pregunta que no quiera contestar.

Quisiera hacerle unas preguntas generales acerca del SIDA.  Sus respuestas
 pueden ser "sí" "probablemente sí," "probablemente no," o "no." 

1. Cree que es posible contraer el virus del SIDA de una picada o
 piquete de mosquito?
	Diría que sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(06)

2. Cree que es posible contraer el virus del SIDA al sentarse en un
 baño público?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(07)

3. Cree que el SIDA es un problema sólo de los homosexuales y
 drogadictos?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(08)

4. Cree que es posible saber por la apariencia si una persona tiene el
 virus del SIDA?  

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(09)

5. Ha conocido personalmente a alguien que tuviera SIDA o estuviera
 infectado con el virus del SIDA?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(10)

			8    NO SABE	

6. Con qué frecuencia le preocupa el que pudiera contagiarse
 del virus que causa el SIDA?
Diría que muy frecuentemente, frecuentemente, a veces, o nunca?
		(11)
	1   Muy	2   Frecuentemente	3   A veces	4   Nunca
	Frecuentemente

 Ahora le voy a preguntar acerca de los preservativos o condones.  

7. Prefiere que usemos la palabra "preservativo" o "condón?"   

	1	PRESERVATIVO	2     CONDON 	(12)

	3	NO TIENE PREFERENCIA (USE "PRESERVATIVO")

Las siguientes preguntas se refieren al uso de los preservativos/condones.
Si nunca los ha usado, de todas maneras nos interesan sus respuestas.

8. Cree que la vaselina es buena como crema o lubricante para los
 preservativos/condones?

	1    SI	0    NO   	8    NO SABE	(13)

9 Cree que hay que desenrrollar el preservativo/condón antes
 de ponérselo al pene?

	1    SI	0    NO   	8    NO SABE	(14)

Ahora quisiera hacerle algunas preguntas acerca de sus experiencias con
 preservativos/condones y otras actividades sexuales.  Usaré la
 palabra "compañera sexual" para referirme a la persona con quien se
 tiene relaciones sexuales.  Esta información es muy importante para
 nuestro estudio.  Cada persona tiene diferentes experiencias sexuales, de
 modo que algunas preguntas pueden no serle relevantes.

10. Con qué frecuencia lleva preservativos/condones consigo?
  Diría que siempre, a veces, casi nunca, o nunca?

	1   Siempre	2   A veces	3   Casi nunca	4   Nunca	(15)

11. Ha usado preservativos/condones alguna vez en su vida?

	1	SI			(16)
	0	NO	[PASE A LA P.15]
	9	RA

12. Alguna vez ha usado preservativos/condones para evitar un
 embarazo?

	1	SI	0	NO	9	RA	(17)

13. Alguna vez ha usado preservativos/condones para evitar
 enfermedades?

	1	SI	0	NO	9	RA	(18)

14. Cómo consiguió los preservativos/condones?
 [NO LEA LAS RESPUESTAS]

[MARQUE UNA SOLA RESPUESTA]

[SI EL ENTREVISTADO DA MAS DE UNA RESPUESTA, PREGUNTE DONDE LOS
 OBTUVO CON MAS FRECUENCIA E INDIQUE ESA RESPUESTA SOLAMENTE]

______ LOS COMPRO   PREGUNTE:	Dónde?

	1	FARMACIA O DRUG STORE
	2	BAÑO PUBLICO [VENDING MACHINES]
	3	SUPERMERCADO
	9	RA
				(19)
_____ SE LOS REGALARON	PREGUNTE:	Dónde? 

	4	EN UNA CLINICA
	5	EN LA CALLE
	6	UN AMIGO/PARIENTE
	7	UNA COMPAÑERA SEXUAL
	8	EN OTRO LUGAR _____________
	9	RA

15. En las siguientes preguntas, hablaremos de una compañera sexual
 habitual que se refiere a una persona con quien usualmente se comparte la
 vida sexual y podría ser una esposa.  

Imagínese que tuviera relaciones sexuales con una esposa o
 compañera sexual habitual en los próximos 30 días.
  Con qué frecuencia cree que usaría
 preservativos/condones?   Diría que siempre, más de
 la mitad de las veces, la mitad de las veces, menos de la mitad de las veces,
 o nunca?
[SI EL ENTREVISTADO DICE QUE NO ES APLICABLE, DIGA: "Aunque no sepa,
 conteste lo que se imagine."]

	1	Siempre	(20)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

16. Imagínese que tuviera relaciones sexuales con una persona que no
 es su compañera habitual en los próximos 30 días,
 Con qué frecuencia cree que usaría
 preservativos/condones?
    [SI EL ENTREVISTADO DICE QUE NO ES APLICABLE, DIGA: "Aunque no sepa,
 conteste lo que se imagine."]

	1	Siempre	(21)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

17. Durante los últimos 12 meses, o sea desde [ESTE MES] de
 1990, ha tenido relaciones sexuales alguna vez?

	1	SI  [PASE A LA P.19]	0	NO [PASE A LA P.18]	(22)

	9	RA  [PASE A LA P.18]

18. Durante los últimos cinco años ha tenido relaciones
 sexuales alguna vez?

	1	SI  [PASE A LA P.19]	0	NO [PASE A LA P.26]	(23)

	9	RA  [PASE A LA P.26]

19. Como ya se explicó, algunas de las preguntas tal vez no son
 relevantes a usted. Si no tienen aplicación para usted por favor
 indíquelo.

Durante los últimos 12 meses, cuando tuvo relaciones sexuales con su
 esposa o compañera habitual, Con qué frecuencia
 usó preservativos/condones?  Diría que siempre,
 más de la mitad de las veces, la mitad de las veces, menos de la
 mitad de las veces, o nunca?  

	1	Siempre	(24)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	7	NO COMPAÑERA HABITUAL
	8	NO RELACIONES SEXUALES EN LOS ULTIMOS 12 MESES [PASE A LA P. 26]
	9	RA

20. Durante los últimos 12 meses, cuando tuvo relaciones sexuales
con una mujer diferente de su esposa o compañera sexual habitual
 Con qué frecuencia usó preservativos/condones? 

	1	Siempre	(25)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	7	NO COMPAÑERA CASUAL
	8	NO RELACIONES CON MUJER [PASE A LA P. 22]
	9	RA

21. Durante los últimos 12 meses, Con cuántas
 mujeres en total ha tenido relaciones sexuales?

	___  ___  NUMERO DE MUJERES 				(26-27)
		[90  0 MAS = 90]	99	RA	

22. Durante los últimos 12 meses, si tuvo relaciones sexuales con
 algún hombre, Con qué frecuencia usó
 preservativos/condones?  Diría que siempre, más de
 la mitad de las veces, la mitad de las veces, menos de la mitad de las veces,
 o nunca?

	1	Siempre	(28)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	7	NO RELACIONES CON HOMBRES [PASE A LA P. 24]
	8	NO HA TENIDO RELACIONES SEXUALES [PASE A LA P. 26]
	9	RA

23. Durante los últimos 12 meses, Con cuántos
 hombres en total ha tenido relaciones sexuales?

	___  ___  NUMERO DE HOMBRES 				(29-30)
		[90  0 MAS = 90]	

		98	NO HA TENIDO RELACIONES SEXUALES [PASE A LA P. 26]
		99	RA

SI NO RELACIONES SEXUALES EN AÑO PASADO, PASE A LA P. 26

24. Durante los últimos 12 meses, Con qué frecuencia
 tomó bebidas alcohólicas antes de tener relaciones sexuales?
  Diría que siempre, más de la mitad de las veces, la
 mitad de las veces, menos de la mitad de las veces, o nunca?

	1	Siempre	(31)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

25. Durante los últimos 12 meses, Con qué frecuencia
 usó drogas antes de tener relaciones sexuales?

	1	Siempre	(32)
	2	Más de la mitad de las veces
	3	La mitad de las veces
	4	Menos de la mitad de las veces
	5	Nunca
	9	RA

26. Cree que va a tener relaciones sexuales en los próximos 30
 días?  Diría que sí, probablemente sí,
 probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(33)

27. Es posible saber de antemano si va a tener relaciones sexuales?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(34)

En las siguientes preguntas le voy a pedir sus opiniones acerca del uso de los
 preservativos/condones. Si nunca ha tenido relaciones sexuales o nunca ha
 usado un preservativo/condón por favor conteste imaginándose
 como se sentiría en cada caso.

28. Cree que el preservativo/condón es sólo para las
 relaciones sexuales de hombres con prostitutas?  Diría que
 sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(35)

29. Cree que es difícil encontrar donde comprar
 preservativos/condones?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(36)

30. Usaría un preservativo/condón aunque tuviera que
 detenerse para comprar o buscarlo?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(37)

31. Usaría un preservativo/condón aunque hubiera
 estado tomando bebidas alcohólicas o usando drogas?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(38)

	BLANK	(39)

33. Se sentiría capaz de rehusarse a tener relaciones sexuales
 si su compañera no quisiera que usara un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(40)

34. Imagínese que la próxima vez que tuviera relaciones
 sexuales usara un preservativo/condón.  Sentiría
 menos placer sexual que si no lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(41)

35. Si usara un preservativo/condón, Durarían
 más tiempo las relaciones sexuales que si no lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(42)

36. Si usara un preservativo/condón, Se sentiría
 culpable?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(43)

37. Si usara un preservativo/condón Sentiría una
 barrera emocional con su compañera sexual?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(44)

38. Cree que el preservativo/condón le produciría una
 sensación de ardor?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(45)

39. Cree que se interrumpiría el acto sexual al ponerse un
 preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(46)

40. Cree que las relaciones sexuales serían más
 limpias que si no usara un preservativo/condón?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(47)

Continue imaginándose que la próxima vez que tuviera
 relaciones sexuales usara un preservativo/condón.

41. Cree que el preservativo/condón se le haría
 incómodo o apretado?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(48)

42. Cree que podría quedarse el preservativo/condón
 dentro de su compañera sexual?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(49)

43. Cree que el preservativo/condón podría romperse?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(50)

44. Si usara un preservativo/condón, Cree que podría
 contraer cáncer?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(51)

45.  Si usara un preservativo/condón, Cree que su
 compañera sexual quedaría embarazada?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(52)

		9   RA				

46. Si usara un preservativo/condón, Se le haría
 más difícil eyacular o acabar que si no lo usara? 

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(53)

47. Si usara un preservativo/condón, Se le haría
 más difícil mantener una erección que si no lo usara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(54)

En las siguientes preguntas, hablaremos de dos tipos de compañera
 sexual: la compañera sexual habitual y la compañera sexual
 casual.  Como ya le explicamos, compañera sexual habitual se refiere a
 una persona con quien usualmente se comparte la vida sexual.
  Compañera sexual casual se refiere a una persona poco conocida con
 quien uno tiene relaciones sexuales una o pocas veces.

48.Se sentiría capaz de usar un preservativo/condón
 con una compañera sexual habitual? Diría que
 sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(55)

49. Se sentiría capaz de usar un preservativo/condón
 con una compañera sexual casual?  

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(56)

Imagínese que fuera a tener relaciones sexuales con una
 compañera sexual casual y que usara un preservativo/condón

50. Cree que podría contraer una enfermedad venérea
 como sífilis o gonorrea?

Diría que sí, probablemente sí, probablemente no, o no?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(57)

51. Cree que podría contraer el virus que causa el SIDA si
 usara un preservativo/condón con esta compañera casual?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(58)

52. Si usara un preservativo/condón con esta compañera casual,
 Se preocuparía menos de infectar a una compañera
 habitual con una enfermedad como sífilis, gonorrea o SIDA?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(59)

Imagínese que la próxima vez que tenga relaciones sexuales
 con una compañera sexual habitual usted insistiera en usar un
 preservativo/condón

53. Le haría creer a la compañera habitual que usted
 había tenido relaciones sexuales con otra persona?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(60)

54. Si insistiera en usar preservativos/condones, cree que una
 compañera habitual se enojaría?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(61)

55. Se enojaría una compañera casual ?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(62)

				BLANK	(63-64)

58. Si insistiera en usar un preservativo/condón, Cree que una
 compañera habitual se rehusaría a tener relaciones sexuales
 con usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(65)

59. Se rehusaría a tener relaciones sexuales con usted una
 compañera casual ?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(66)

60. Imaginese que llevara preservativos/condones en una billetera o en el
 bolsillo. Cree que sus amigos pensarían mal de usted?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No 	(67)

		9   RA

61. Si llevara preservativos/condones consigo, Cree que una
 compañera casual sentiría más respeto por usted que si
 no los llevara?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(68)

62. Si una mujer llevara preservativos/condones consigo
 Pensaría usted que está dispuesta a tener relaciones
 sexuales con un recién conocido?

	1   Sí	2   Probablemente Sí	3   Probablemente No	4   No	(69)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 3	(05)

En las siguientes preguntas queremos saber que tanto le molestarían
 cosas que podrían sucederle a una persona que usara
 preservativos/condones.  Estas preguntas le pueden parecer un poco
 repetidas, pero son muy importantes y le agradecemos su paciencia.

Las respuestas pueden ser "Mucho"  "Algo" o "Muy poco"

63. Qué tanto le molestaría sentir menos placer
 sexual?
Diría que le molestaría mucho, algo, o muy poco?

		1   Mucho	2   Algo	3    Muy poco	(06)

64. Qué tanto le molestaría sentir ardor en los
 órganos sexuales?

		1   Mucho	2   Algo	3    Muy poco	(07)

65. Qué tanto le molestaría  interrumpir el acto
 sexual?

		1   Mucho	2   Algo	3    Muy poco	(08)

66. Qué tanto le molestaría  sentirse culpable?

		1   Mucho	2   Algo	3    Muy poco	(09)

67. Qué tanto le molestaría que un
 preservativo/condón se sintiera incómodo o apretado?

		1   Mucho	2   Algo	3    Muy poco	(10)

68.Qué tanto le molestaría  que el
 preservativo/condón se quedara dentro de su compañera?

		1   Mucho	2   Algo	3    Muy poco	(11)

69. Qué tanto le molestaría  que un
 preservativo/condón se rompiera?

		1   Mucho	2   Algo	3    Muy poco	(12)

70. Qué tanto le molestaría sentir una barrera
 emocional con su compañera?

		1   Mucho	2   Algo	3    Muy poco	(13)

				BLANK	(14)

72. Qué tanto le molestaría  tener dificultades para
 eyacular o acabar?

		1   Mucho	2   Algo	3    Muy poco	(15)

73. Qué tanto le molestaría  tener dificultades para
 mantener la erección?

		1   Mucho	2   Algo	3    Muy poco	(16)

74. Qué tanto le molestaría contraer una enfermedad
 venérea, como la gonorrea o el sífilis?

		1   Mucho	2   Algo	3    Muy poco	(17)

75. Qué tanto le molestaría que su compañera
 habitual pensara que había tenido relaciones sexuales con otra
 persona?

		1   Mucho	2   Algo	3    Muy poco	(18)

76. Qué tanto le molestaría  que una compañera
 habitual se sintiera enojada?

		1   Mucho	2   Algo	3    Muy poco	(19)

77. Qué tanto le molestaría  que una compañera
 casual se sintiera enojada?

		1   Mucho	2   Algo	3    Muy poco	(20)

78. Qué tanto le molestaría que una compañera
 habitual se rehusara a tener relaciones sexuales?

		1   Mucho	2   Algo	3    Muy poco	(21)

79. Qué tanto le molestaría  que una compañera
 casual se rehusara a tener relaciones sexuales?

		1   Mucho	2   Algo	3    Muy poco	(22)

80. Qué tanto le molestaría  que sus amigos pensaran
 mal de usted?

		1   Mucho	2   Algo	3    Muy poco	(23)

81. Ahora por favor dígame, Qué tanto le
 gustaría que una compañera casual sintiera mas respeto por
 usted?  Diría que mucho, algo, o muy poco?

		6   Mucho	5   Algo	4    Muy poco	(24)

82. Qué tanto le gustaría no tener que preocuparse de
 darle a su compañera habitual una enfermedad como sífilis,
 gonorrea o SIDA?

		6   Mucho	5   Algo	4    Muy poco	(25)

83. Qué tanto le gustaría que las relaciones sexuales
 fueran mas limpias a causa del 	preservativo/condón?

		6   Mucho	5   Algo	4    Muy poco	(26)

Para las siguientes preguntas, primero dígame si le gustaría o
 le molestaría y luego dígame cuanto le gustaría o le
 molestaría:

84. Le gustaría o le molestaría que una
 compañera sexual quedara embarazada ahora?

	Qué tanto:  Mucho, algo o muy poco?

	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(27)

	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

85. Le gustaría o le molestaría que las relaciones
 sexuales duraran más?

Qué tanto?

	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(28)

	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

			Blank	(29)

87. Le gustaría o le molestaría usar un
 preservativo/condón con una compañera habitual?
   Qué tanto?

	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(30)

	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

88. Le gustaría o le molestaría usar un
 preservativo/condón con una compañera casual?

	Qué tanto?

	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(31)

	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

89. Le gustaría o le molestaría llevar un
 preservativo/condón consigo?   Qué tanto?

	le gustaría:	6   Mucho	5   Algo	4    Muy poco	(32)

	le molestaría:	1   Mucho	2   Algo	3    Muy poco	

90. De sus amigos más cercanos, Cuántos cree que
 llevan preservativos/condones consigo?  Diría que casi todos,
 más de la mitad, la mitad, menos de la mitad, o casi ninguno?

 [SI NO SABE, DIGA:  "Aunque no sepa con seguridad,  conteste lo que se
 imagine]    

	1   Casi 	2   Más de	3   La Mitad	4   Menos de	5   Casi	(33)
	Todos	la Mitad		la mitad	Ninguno
				7  NO TIENE NINGUN AMIGO [PASE A LA P.93]

91. De sus amigos más cercanos, Cuántos cree que usan
 preservativos/condones cuando tienen relaciones sexuales con una
 compañera habitual?

	1   Casi 	2   Más de	3   La Mitad	4   Menos de	5   Casi	(34)
	Todos	la Mitad		la mitad	Ninguno

92. De sus amigos más cercanos, Cuántos cree que usan
 preservativos/condones cuando tienen relaciones sexuales con una
 compañera casual?  

	1   Casi 	2   Más de	3   La Mitad	4   Menos de	5   Casi	(35)
	Todos	la Mitad		la mitad	Ninguno
				7   NINGUN AMIGO TIENE COMPAÑERA. CASUAL

93.  Trate de imaginarse que tan cómodo se sentiría en las
 siguientes situaciones.

Qué tan cómodo se sentiría al comprar un
 preservativo/condón?

	Diría que muy cómodo, algo cómodo, algo
 incómodo, o muy incómodo?

	1   Muy 	2   Algo	3   Algo	4   Muy	(36)
	cómodo	cómodo	incómodo	incómodo	

94. Qué tan cómodo se sentiría al insistir en
 usar un preservativo/condón con una compañera habitual?

	1   Muy 	2   Algo	3   Algo	4   Muy	(37)
	cómodo	cómodo	incómodo	incómodo	

95. Qué tan cómodo se sentiría  al insistir en
 usar un preservativo/condón con una compañera casual?

	1   Muy 	2   Algo	3   Algo	4   Muy	(38)
	cómodo	cómodo	incómodo	incómodo	

96. Qué tan cómodo se sentiría  al ponerse un
 preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(39)
	cómodo	cómodo	incómodo	incómodo	

97. Qué tan cómodo se sentiría cuando le ponen
 un preservativo/condón?

	1   Muy 	2   Algo	3   Algo	4   Muy	(40)
	cómodo	cómodo	incómodo	incómodo	

98. Qué tan cómodo se sentiría al usar un
 preservativo/condón con una compañera habitual?

	1   Muy 	2   Algo	3   Algo	4   Muy	(41)
	cómodo	cómodo	incómodo	incómodo	

99. Qué tan cómodo se sentiría  al usar un
 preservativo/condón con una compañera casual?

	1   Muy 	2   Algo	3   Algo	4   Muy	(42)
	cómodo	cómodo	incómodo	incómodo	

100. Qué tan cómodo se sentiría  al estar
 desnudo frente a una compañera sexual?

	1   Muy 	2   Algo	3   Algo	4   Muy	(43)
	cómodo	cómodo	incómodo	incómodo	

101.Qué tan cómodo se sentiría al tener
 relaciones sexuales con la luz prendida?

	1   Muy 	2   Algo	3   Algo	4   Muy	(44)
	cómodo	cómodo	incómodo	incómodo	

102. Qué tan cómodo se sentiría  al tener
 relaciones sexuales con una compañera nueva?

	1   Muy 	2   Algo	3   Algo	4   Muy	(45)
	cómodo	cómodo	incómodo	incómodo	

Ahora, quisiera preguntarle...

103. Tiene hijos?
	(46-47)
		(00) NO  	SI	Cuántos? ___ ___

104. Le han hecho la circuncisión a usted?

	1    SI	0    NO 	8   NO SABE	9    RA	(48)

SI ES NECESARIO:  Tiene esposa o una compañera habitual?

SI&gt;&gt;&gt;[PASE A LA P. 105] 		NO&gt;&gt;&gt;[PASE A LA P. 111]

105. Está embarazada su esposa o compañera habitual? 

	1	SI 	[PASE A LA P.111]	(49)
	0	NO
	7	EL/ELLA NO PUEDE TENER HIJOS [ PASE A LA P. 111]
	8	NO SABE
	9	RA

106. Está intentando quedar embarazada?

	1	SI 	[PASE A LA P. 111]	(50)
	0	NO
	7	EL/ELLA NO PUEDE TENER HIJOS [ PASE A LA P. 111]
	9	RA

107. Ha dado a luz durante los últimos tres meses?

	1	SI 	[PASE A LA P. 111]	(51)
	0	NO
	7	EL/ELLA NO PUEDE TENER HIJOS [ PASE A LA P. 111]
	9	RA

108. Aparte de preservativos/condones, Ha usado usted o su
 compañera habitual algún método para evitar tener
 hijos en los últimos 12 meses?

	SI   &gt;&gt;&gt;&gt;&gt;&gt;&gt;&gt;[SI LA RESPUESTA ES SI]  Qué clase?	(52)
			[ANOTE TODAS LAS QUE SE APLIQUEN]
	1  PASTILLA/LA PILDORA
	0   NO	2  DIU
	3  DIAFRAGMA
		4  ESPONJA/JALEA/ESPUMA
	5  LAVADO
	9   RA	6  RETIRARSE
			7  ABORTO
			8  OTRO __________________

SI LA RESPUESTA ES SI, PASE A LA P. 111

109.  Hay alguna razón por la cual su compañera
 habitual no pueda tener hijos, ya sea por operación o cualquier otra
 causa?

	1	SI 	[PASE A LA P. 111]	(53)
	0	NO
	8	NO SABE
	9	RA

110. Hay alguna razón por la cual usted no pueda tener hijos,
 ya sea por operación	o cualquier otra causa?

	1	SI 		(54)
	0	NO
	8	NO SABE
	9	RA

111. Ahora le voy a hacer algunas preguntas acerca de cómo se ha
 sentido en los últimos siete días.  Desde el [DIA DE LA SEMANA
 DE HOY] de la semana pasada,  Le molestaron cosas que por lo general
 no le molestan?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(55)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

112. Se sintió sin ganas de comer o tuvo mal apetito?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(56)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

113. Sintió que no podía quitarse de encima la tristeza
 ni aún con el apoyo de su familia y amigos?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(57)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

114. Se sentió deprimido?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(58)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

115. Sintió que su vida había sido un fracaso?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(59)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

116. Se sintió con miedo?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(60)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

117. Tuvo sueño inquieto?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(61)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

118. Se ha sentido solo?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(62)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

119. Se sintió triste?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(63)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

120. Pasó ratos llorando?

	O   NO	[SI LA RESPUESTA ES SI, DIGA]:	(64)
		Cuántos días durante la semana pasada?

			1     1-2 DIAS	2     3-4 DIAS	3     5-7 DIAS

121. Ahora, me podría decir, Dónde nació?

	1	ESTADOS UNIDOS  	[PASE A LA SIGUIENTE PREGUNTA]	(65)
	2	PUERTO RICO  	[PASE A LA P.123]
	3	MEXICO   		[PASE A LA P.123]
	4 	REPUBLICA DOMINICANA	[PASE A LA P.123]
	5	COLOMBIA	[PASE A LA P.123]
	6	CENTRO AMERICA	[PASE A LA P.123]
	7	SUR AMERICA,( NO COLOMBIA)	[PASE A LA P.123]
	8	CUBA/ESPAÑA	[PASE A LA P.123]
	9	OTRO ______________	[PASE A LA SIGUIENTE PREGUNTA]

PARA LOS QUE NACIERON EN LOS ESTADOS UNIDOS O CUALQUIER OTRO PAIS APUNTADO ARRIBA COMO #9	

122.  Las familias de la mayoría de las personas que viven en los
 Estados Unidos provienen de otros países.    De dónde
 viene su familia?

[NO LEA LAS ALTERNATIVAS] 

[SI RESPONDE DICIENDO MAS DE UN PAIS, PREGUNTE:  "De cuál
 país proviene la mayoría de su familia o por cuál país siente mas cariño o apego?"]

		[MARQUE SOLAMENTE UNO]

	2	PUERTO RICO	(66)
	3	MEXICO
	4 	REPUBLICA DOMINICANA
	5	COLOMBIA
	6	CENTRO AMERICA
	7	SUR AMERICA, (NO COLOMBIA)
	8	CUBA

123. Cuánto tiempo ha vivido en los Estados Unidos?

	___ ___    AÑOS [MENOS DE UN AÑO = UN AÑO {01}]	(67-68)

		Respondent ID __ __ __ __.
		(01-04)
		Card = 4	(05)

124. Por lo general, Qué idioma lee y habla usted?
  Diría que sólo español, más español
que inglés, ambos por igual, más ingles que español o
 sólo inglés?
	(06)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

125.  Por lo general, Qué idioma habla en su casa?
	(07)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

126. Por lo general, En qué idioma piensa?
	(08)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

127. Por lo general,  Qué idioma habla con sus amigos?
	(09)
	1   Sólo 	2   Español más 	3   Ambos	4   Inglés más	5   Sólo
	español	que inglés	por igual	que español	inglés

128. Cuántos años de educación formal ha
 completado?
	(10-11)
	___________AÑOS

129. Está usted:
	1	casado  o viviendo con su compañera?	(12)
	2	soltero?
	3	separado o divorciado? o
	4	viudo?

130. Cuál es su religión?________________________

	1	CATOLICA	(13)
	2	CRISTIANA [NO CATOLICA]
	3	OTRA: (ESPECIFIQUE... _________)
	4	NINGUNA

131. Qué tan importante es la religión en su vida?
  Diría que es	

	1   	sumamente importante	(14)
	2   	muy importante
	3   	importante
	4   	algo importante
	5   	nada importante

			BLANK	(15-16)

133. Diría que vive en un pueblo, una ciudad, en los
 alrededores de una ciudad o un área rural?

	1	PUEBLO	(17)
	2	CIUDAD
	3	ALREDEDORES
	4	RURAL

134. Podría decirme Cual es su código postal o zip
 code?

		___ ___ ___ ___ ___	(18-22)

		9 9 9 9 8	DK
		9 9 9 9 9	RA	

135. Por favor dígame dentro de qué categoría
 caen los ingresos de su familia  para el año 1990? [SI VIVE SOLO,  "sus
 ingresos personales"  ]

	[LEA LAS ALTERNATIVAS]

	1	menos de $10,000	(23)
	2	entre $10,001 y $20,000
	3	entre $20,001 y $40,000
	4	más de $40,000
	8	NO SABE
	9	RA

136. Como ya le expliqué, su número de teléfono se
 escogió al azar o a la suerte.  Para no volver a llamar a esta casa,
 Me podría decir si hay otro número de teléfono
 que pertenece a su casa?  

	[SI LA RESPUESTA ES SI]	 Cuál es?__________________

	Hay otro más?	NUMEROS TELEFONICOS
		______________________________
		______________________________
		______________________________

	NUMERO DE LINEAS TELEFONICAS    ________	(24)
	[INCLUYENDO EL QUE SE ESTA LLAMANDO]

137.  En el futuro, es posible que hagamos un estudio de las actitudes y
 conductas sexuales de los adolescentes Hispanos o Latinos.  Será un
 estudio bastante diferente a éste y adecuado a los intereses y
 sensibilidad de los adolescentes.  Para incluir a un adolescente en ese
 estudio no sólo se necesitaría el consentimiento de ese o esa
 adolescente sino también el permiso de uno de los padres o
 guardián

Hay algún adolescente en esta casa que tenga 15, 16, o 17 años de edad?

	SI (Cuantos son?) ______	NO	  0   [PASE AL FINAL]	(25)

	Podría darme el nombre del padre, la madre o el
 guardián que podría dar el permiso para entrevistar al/a los
  adolescente(s), si le volviéramos a llamar?

	_________________________________

138.  Podría darme el/los nombre(s) del/de los adolescente(s)?

	_____________________________________________________
					_____ MUJERES 	(26)

Hemos terminado.  Tal vez reciba una llamada de mi supervisor para verificar
 mi trabajo.  Muchísimas gracias por su ayuda.  Si desea recibir
 más información sobre el SIDA o su prevención puede
 llamar, gratis y sin dar su nombre al              1-800-344-7432      .

Quiere que le repita el número?		

De nuevo, ¡muchísimas gracias!
__________________________________________________________

139. TIME AT THE END OF INTERVIEW:________________________

	CUANTO TIEMPO TARDO LA ENTREVISTA  [EN MINUTOS]   ___ ___	(27-28)

140. LANGUAGE OF INTERVIEW:	1	SPANISH	(29)

141. LANGUAGE CHOICE: 

		1	RESPONDENT 	0	RANDOMLY BY INTERVIEWER	(30)

142. INTERVIEWER'S NAME:_________________________ [ ___ ___ ___ ]	(31-33)

DATE OF INTERVIEW:_____________________________

INTERVIEW TERMINATED BEFORE COMPLETION:

	1    SI	0    NO	(34)

		[SI LA RESPUESTA ES SI]: __ __ __  ITEM NUMBER 	(35-37)
		
	IS RESPONDENT A MEMBER OF HOUSEHOLD?	(38)
		1  YES	0    NO</pre>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Condom Use Among Hispanic Men</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Marin, Barbara VanOss; Gomez, Cynthia A.; Tschann, Jeanne M.
<em>Public Health Reports</em> v108, n6 (Nov-Dec, 1993):742-750</h3>
COPYRIGHT U.S. Department of Health and Human Services 1993

<span style="font-size: large;">E</span>ffective and culturally appropriate strategies for promoting condom use within the Hispanic community in the United States are needed urgently because of Hispanics' high prevalence of infection with human immunodeficiency virus (HIV) and other sexually transmitted diseases (STD).

Hispanics are overrepresented disproportionately in statistics on STD and acquired immunodeficiency syndrome (AIDS). HIV infection is currently the sixth leading cause of death among Hispanic adults, although it is not among the first 10 causes of death among non-Hispanic whites. The already high levels of HIV infection in the Hispanic community mean that rates will increase unless successful preventive measures, such as the promotion of condom use, are employed more effectively.

HIV risk behavior is difficult to change. In one study, despite individual counseling of patients following HIV testing, 23 percent of those STD seronegative and 15 percent of those STD seropositive had a new exposure to STD in less than 12 months following counseling. To create effective and culturally appropriate promotion campaigns for condom use by Hispanics at risk, the beliefs, attitudes, and behaviors that are associated with consistent condom use for the community need to be better identified and understood.

Most of the information about condom use among Hispanics has come from studies of married women. Those studies focused on simple demographic predictors of condom use behavior, rather than identification of complex psychological mechanisms that could improve the understanding and effectiveness of condom promotion efforts. Studies of condom use rarely distinguish between use with a primary sexual partner and use with a secondary sexual partner, despite the many differences in those relationships that could affect the likelihood or ability to use condoms.

We designed a study of condom use by Hispanics with a sample of sufficient size and representation to assess predictors of the frequency of condom use by men with their secondary female sexual partners and to assess differences among specific Hispanic subgroups, as for example, Puerto Ricans and Mexican Americans.
<h3><a name="method"></a></h3>
<strong>Sampling.</strong> The 1991 telephone survey employed a modified Mitofsky- Waksberg sampling technique to identify Hispanic household in nine States that had concentrations of Hispanics ranging from 5 percent to 38 percent in the Northeast (NY, NJ, MA, and CT) and Southwest (CA, AZ, CO, NM, and TX). Hispanics in those States comprise 77 percent of all Hispanics in the country.

In the first stage of sampling, 143,984 telephone number hundred- series groups were randomly generated from working telephone area codes and prefixes for the 9 States. A hundred-series group consists of an area code, plus a 3-digit prefix, plus the next 2 digits, plus all 100 possible combinations of numbers for the last 2 digits. Computer matching of Spanish surnames with telephone directory information identified 27,574 hundred-series groups (19 percent) that contained at least 1 Spanish- surnamed household. We did not sample hundred-series groups with no listed Spanish surnames, because we assume that the number of Hispanic households would be extremely low.

Subsequently, 12,078 telephone numbers were randomly generated from those 27574 hundred-series groups by a stratification procedure that oversampled the hundred series with the most Spanish surnames to increase the probability of reaching Hispanic households. Because the Northeast has a smaller Hispanic population that the Southwest, higher sampling fractions also were assigned to the Northeast to allow for reliable extrapolation of results to all Hispanics in that area. Calls to the 12078 numbers produced 372 Hispanic households, although not all households include an eligible respondent.

In the second stage of sampling, the hundred-series groups in which those 372 Hispanic households appeared were treated as Primary Sampling Units, and additional telephone numbers from these groups were computer generated. Hundred-series groups were noted in which at least 1 additional Hispanic household was identified in the first 20 numbers called. Those hundred-series groups were called at a higher rate to increase the probability of finding eligible Hispanics. We made at least six attempts during various days and hours to reach unanswered telephone numbers.

<strong>Procedures.</strong> The screening procedure involved identifying the ethnicity, sex, and age of household members. Potential respondents were asked "Do you, or any of the members of your household, consider yourselves to be Latinos or Hispanics?" An eligible Hispanic respondent in the household was selected randomly, using the Kish method. Interviews were bilingual men and women.

Prior experience of the telephone survey research organization that conducted the interviews had indicated that Hispanic women have difficulty answering questions on sexuality if interviewed by a man. Accordingly, the survey procedures called for only women to interview women respondents. Interviewers were experienced and received specific training on how to ask the question used in this project. Respondents were interviewed in the language of their choice. Interviews were conducted between March and July of 1991.
<table style="width: 300px;" border="1">
<tbody>
<tr>
<td colspan="2"><strong>Table 1.</strong> Characteristics of 361 Hispanic men, 18--49 years old, in 9 States, reporting secondary female sexual partners in the prior 12 months, in response to a telephone survey, 1991</td>
</tr>
<tr>
<td><strong>Characteristics</strong></td>
<td><strong>Percent</strong></td>
</tr>
<tr>
<td><strong>Age (in years):</strong></td>
<td></td>
</tr>
<tr>
<td>18-25</td>
<td>47.8</td>
</tr>
<tr>
<td>26-32</td>
<td>23.9</td>
</tr>
<tr>
<td>33-40</td>
<td>17.5</td>
</tr>
<tr>
<td>41-49</td>
<td>10.8</td>
</tr>
<tr>
<td><strong>Marital status:</strong></td>
<td></td>
</tr>
<tr>
<td>Married</td>
<td>31.0</td>
</tr>
<tr>
<td>Not married</td>
<td>69.0</td>
</tr>
<tr>
<td><strong>Education:</strong></td>
<td></td>
</tr>
<tr>
<td>Less than high school</td>
<td>30.5</td>
</tr>
<tr>
<td>High school graduate</td>
<td>27.4</td>
</tr>
<tr>
<td>Some College</td>
<td>28.8</td>
</tr>
<tr>
<td>College graduate</td>
<td>13.3</td>
</tr>
<tr>
<td><strong>Income:</strong></td>
<td></td>
</tr>
<tr>
<td>Less than $10,000</td>
<td>21.9</td>
</tr>
<tr>
<td>$10,001 to $20,000</td>
<td>32.7</td>
</tr>
<tr>
<td>$20,001 to $40,000</td>
<td>26.6</td>
</tr>
<tr>
<td>More than $40,000</td>
<td>14.4</td>
</tr>
<tr>
<td>Refused to answer</td>
<td>4.4</td>
</tr>
<tr>
<td><strong>Acculturation:</strong></td>
<td></td>
</tr>
<tr>
<td>Low</td>
<td>34.6</td>
</tr>
<tr>
<td>Medium</td>
<td>35.7</td>
</tr>
<tr>
<td>High</td>
<td>29.6</td>
</tr>
<tr>
<td><strong>Origin:</strong></td>
<td></td>
</tr>
<tr>
<td>Mexican</td>
<td>37.4</td>
</tr>
<tr>
<td>Puerto Rican</td>
<td>23.5</td>
</tr>
<tr>
<td>Dominican</td>
<td>15.8</td>
</tr>
<tr>
<td>Other</td>
<td>23.3</td>
</tr>
</tbody>
</table>
<strong>Instrument.</strong> The survey instrument was based on more than 100 open- ended interview and 2 focus groups with Hispanics in San Francisco, held to identify Hispanic men's perceptions of the consequences of condom use with primary and secondary sexual partners, difficulties with condom use, and normative aspects of condom use. The instrument was developed originally in Spanish and a back-translation procedure was used to assure that the English version was equivalent in meaning. Both the Spanish and English versions were pretested with at least 20 persons.

The final version of the interview required an average of 24 minutes to complete. Most interview questions had four or five-level Likert-type response scales. The reported reliabilities were for the sample of 361 Hispanic men, reporting 1 or more secondary female sexual partners, who responded to the question on condom use with a secondary partner or partners.

<em>Frequency of using and carrying condoms.</em> The extent of condom use with a secondary sexual partner was assessed by the question, "When you had sex with someone other than your wife or primary partner in the last 12 months, how often did you use condoms?" The extent of carrying condoms was assessed by the question, "How often do you carry a condom with you?" Each item was recorded using a five-point response scale from "always" to "never."

<em>Self-efficacy to use condoms.</em> Four questions were developed to assess perceived ability to use condoms:
<ul>
 	<li>"Would you be able to refuse sex if you partner didn't want you to use a condom?"</li>
 	<li>"Would you use condoms even if you had to stop to buy them or look for them?"</li>
 	<li>"Would you use condoms even if you had been drinking or using drugs?" and,</li>
 	<li>"Would you be able to use a condom with a secondary partner?"</li>
</ul>
The self-efficacy score was the mean of the four items on a four- point yes-no response scale with higher scores meaning higher efficacy (alpha = 0.55). Those with greater self-efficacy to use condoms were expected to use them more consistently with secondary partners that did those who scored lower.

<em>Negative beliefs about condoms. </em>Sixteen items measured beliefs about the consequences of using condoms. Beliefs included "the condom might break," "the condom might come off inside your partner," and "you would feel less sexual pleasure." Responses were "yes" "probably yes," "probably no," and "no" (alpha = 0.70).

<em>Depression scale</em>. Ten of the 20 items of the Center of Epidemiologic Studies Depression Scale (CES-D) were selected for the questionnaire, based on their factor loading for Hispanics (alpha = 0.88). The items measure sadness in the 7 days prior to the interview and have been shown to assess depression in community samples<a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/marinarticle.php#refs">.</a> We expected those men who reported the most depressive symptoms to report more risky behaviors than those who reported the least depressive symptoms. The scale score was a continuous variable ranging from 0 to 30, with high scores meaning more depressive symptoms.

<em>Sexual comfort.</em> Three items were used to assess sexual comfort: being naked in front of a partner, having sex with the lights on, and having sex with a new partner. The sexual comfort score was the mean of the three items on a four-point scale ranging from "very comfortable" to "very uncomfortable" (alpha = 0.62). Persons with high levels of sexual comfort have been shown to exhibit sexual behavior that is more self-protective than persons with low levels of sexual comfort.

<em>Number of friends using or carrying condoms.</em> Two items assessed the proportion of the respondent's close friends who carried condoms and used them with secondary partners, a measure of perceived normative condom use behavior among peers. Responses ranged on a five-point scale from "almost all" to "almost none."

<em>Myths about HIV transmission.</em> A measure of beliefs about the casual transmission of HIV was computed by adding responses to three items, such as the likelihood of getting HIV from using public toilets. Total scores could range from 3 to 12, with higher scores representing less accurate beliefs.

<em>Demographics.</em> Age, education, marital status, and ethnic origin were determined for each respondent.

<em>Acculturation.</em> Acculturation, the process by which a person learns a new culture, was assessed using four language-related items. That scale has been previously shown to have good reliability and validity. Mean scores ranged from 1 to 5, with higher scores indicating more use of English, hence higher levels of acculturation (alpha = 0.90).

<em>Other variables. </em>Positive attitude toward condom use with a secondary partner was measured with a six-level Likert-type scale ranging from "dislike a lot" to "like a lot." Knowing someone with HIV infection or AIDS and previous use of condoms to prevent disease were assessed through single items with "yes" or "no" responses.
<h3><a name="analysis"></a></h3>
Ordinary least squares regression with all variables entered simultaneously was used to identify predictors of frequency of condom use with secondary female sexual partners. The analysis was conducted for the 361 Hispanic men who reported more than 1 female sexual partners in the previous 12 months. Additional regressions were conducted to identify predictors of selected variables that were significantly related to frequency of condom use in the initial analysis.

The results are reported as betas, a standardized regression coefficient reflecting the association between the predictor and the outcome, taking into account all other variables in the equation. Thus, effects of all psychosocial variables are adjusted for the demographic variables of ethnicity (Puerto Rican, Dominican, Mexican, or other Hispanic), age, marital status, education, income, and acculturation. All analyses were unweighted, because analysis indicated that sampling probability weights were uncorrelated (P &gt; 0.20) to any of the outcome variables. Predictor variables showed low correlation between them, with the highest correlation of 0.32 between acculturation and education. Acculturation had a small correlation with several demographic variables, but most psychological predictor variables were uncorrelated.
<h3><a name="results"></a></h3>
<strong>Response rate.</strong> A response rate in survey sampling may be defined as the ration of the number of questionnaires completed for eligible elements to the number of eligible elements in the sample. The response rate was calculated by multiplying the proportion of households screened for eligibility by the proportion of eligible respondents who completed the interview. As in all telephone samples, certain telephone numbers (for example, those of businesses, facsimile machines, and nonhouseholds) were not eligible for enumeration. After those were eliminated, the age and sex of the adults in the household were determined for 67.1 percent of eligible telephone numbers (households or undetermined status). Also 86.4 percent of those contacted, and who met the survey criteria, provided complete interview. Multiplying those two proportions, a response rate of 58.0 percent for the entire sample was obtained. That rate compares well with other telephone surveys, since only six call-back attempts could be made because of budget constraints. Only 4.2 percent of eligible Hispanics refused to be interviewed. Another 4.7 percent broke off interviews before completion. The remaining 4.7 percent of eligible Hispanics who did not provide completed interviews were persons who could not be contacted after the initial contact.
<table style="width: 300px;" border="1">
<tbody>
<tr>
<td colspan="2"><strong>Table 2.</strong> Predictors(1) of frequency of condom use with secondary sexual partners by 361 Hispanic men, 18-49 years old, in response to a telephone survey, 1991</td>
</tr>
<tr>
<td><strong>Predictor variables</strong></td>
<td><strong>Beta</strong>(2)</td>
</tr>
<tr>
<td>Carrying condoms</td>
<td>(3)0.32</td>
</tr>
<tr>
<td>Self-efficacy to use condoms</td>
<td>(3)0.22</td>
</tr>
<tr>
<td>Friends use condoms</td>
<td>(4)0.14</td>
</tr>
<tr>
<td>Positive attitude towards condom use</td>
<td>(5)0.12</td>
</tr>
<tr>
<td>Depressive symptoms</td>
<td>(5)0.10</td>
</tr>
<tr>
<td>Knowing someone with HIV or AIDS</td>
<td>(5)0.10</td>
</tr>
<tr>
<td colspan="2">(1) Variables entered in the analysis, but not significantly associated with frequency of condom use with a secondary sexual partner, included age, marital status, acculturation, ethnic subgroup, education, income, myths about HIV transmission, sexual comfort, substance use prior to sexual activity, and negative beliefs about condoms.
(2) Beta is a standardized regression coefficient reflecting the association between the predictor and outcome, taking into account all other variables in the equation. High betas, regardless of sign, indicate stronger prediction than low betas.
(3) P &lt; 0.001. (4) P &lt; 0.01. (5) P &lt; 0.05.
NOTE: [R sup. 2] = 0.35, P &lt; 0.001.</td>
</tr>
</tbody>
</table>
<strong>Sample.</strong> There were 361 Hispanic men ages 18--49 years who reported having a secondary female sexual partner in the 12 months prior to the interview, including 5 men who also reported 1 for more male sexual partners. Those 361 men were 37 percent of all Hispanic men interviewed. Demographic characteristics of the 361 men are shown in table 1. More than two-thirds were unmarried, almost half were younger than 25 years, more than two-thirds had a high school diploma or better, more than half had incomes of $20,000 or less, and the men were evenly distributed by acculturation categories. Because of purposeful oversampling in the Northeast, almost 40 percent of the sample were either Puerto Rican or Dominican, with an equal percentage of Mexican origin, compared with the 1990 census, in which more than 60 percent of Hispanics were of Mexican origin. Hispanic men with a secondary female sexual partner were more likely than those with a single partner to be unmarried, ages 18--24 years, less acculturated, and living in the northeastern United States (data not shown).

In the unweighted analyses, 60.1 percent of the 361 men reported "always" using condoms with secondary partners in the 12 months before the interview. Analysis weighted by sampling probability adjusted the prevalence of consistent condom use downward to 49.0 percent.

The results of the least squares regression analysis are shown in table 2. Six variables were identified as the best combination of predictors of frequency of condom use with a secondary partner among the 361 Hispanic men reporting a secondary female sexual partner. Those variables were greater frequency of carrying condoms, higher self-efficacy to use condoms, positive attitude toward condom use with a secondary partner, having friends who used condoms with a secondary partner, personally knowing a person with AIDS or HIV, and fewer depressive symptoms. The multiple R for that equation was 0.588, which means those predictors account for a substantial proportion (35 percent) of the variance in frequency of condom use with secondary partners.

Table 3 presents the results of separate regression analyses of three significant predictors of secondary condom use: carrying condoms, attitude toward condom use with a secondary partner, and self-efficacy to use condoms. We were able to explore those variables in more detail because we had additional predictors for each. Frequency of carrying condoms was predicted by the variables of having a positive attitude toward carrying condoms, having used condoms to prevent disease, being unmarried, having friends who carried condoms, knowing a person with AIDS or HIV, having greater sexual comfort, and having lower levels of acculturation. Together they account for 34 percent of the variance of that measure.
<table style="width: 300px;" border="1">
<tbody>
<tr>
<td colspan="2"><strong>Table 3.</strong> Predictors of condom carrying, positive attitude about use, and self-efficacy to use, among 361 Hispanic men 18-49 years old, with secondary sexual partners, in response to a telephone survey, 1991</td>
</tr>
<tr>
<td><strong>Variable</strong></td>
<td><strong>Beta</strong></td>
</tr>
<tr>
<td colspan="2"><strong>Carrying condoms:</strong>(1)</td>
</tr>
<tr>
<td>Positive attitude about condom carrying</td>
<td>(2)0.31</td>
</tr>
<tr>
<td>Previously used condoms to prevent disease</td>
<td>(2)0.20</td>
</tr>
<tr>
<td>Not married</td>
<td>(3)0.14</td>
</tr>
<tr>
<td>Friends carry condoms</td>
<td>(3)0.13</td>
</tr>
<tr>
<td>Knowing someone with HIV or AIDS</td>
<td>(4)0.11</td>
</tr>
<tr>
<td>Sexual comfort</td>
<td>(4)0.11</td>
</tr>
<tr>
<td>Acculturation</td>
<td>(4)-0.11</td>
</tr>
<tr>
<td colspan="2">[R.sup.2] = 0.34, P &lt; 0.001</td>
</tr>
<tr>
<td colspan="2"><strong>Positive attitude about condom use:</strong>(5)</td>
<td></td>
</tr>
<tr>
<td>Acculturation</td>
<td>(2)-0.21</td>
</tr>
<tr>
<td>Sexual comfort</td>
<td>(3)0.17</td>
</tr>
<tr>
<td>Depressive symptoms</td>
<td>(3)-0.13</td>
</tr>
<tr>
<td>Negative beliefs about condoms</td>
<td>(4)-0.13</td>
</tr>
<tr>
<td>Ever used condoms</td>
<td>(4)0.12</td>
</tr>
<tr>
<td colspan="2">[R.sup.2 = 0.14, P &lt; 0.001</td>
</tr>
<tr>
<td colspan="2"><strong>Self-efficacy to use condoms:</strong>(6)</td>
</tr>
<tr>
<td>Ever used condoms</td>
<td>(2)0.28</td>
</tr>
<tr>
<td>Sexual comfort</td>
<td>(2)0.28</td>
</tr>
<tr>
<td>Negative beliefs about condoms</td>
<td>(4)-0.11</td>
</tr>
<tr>
<td colspan="2">[R.sup.2] = 0.28, P &lt; 0.001</td>
</tr>
<tr>
<td colspan="2">(1) Variables that were not significantly predictive of carrying condoms included age, ethnic subgroup, education, income, ever having used condoms, believing it is possible to know beforehand if you are going to have sex, belief that a casual partner would respect you more if you had condoms with you, myths about HIV transmission, depression, and belief that you were going to have sex in the next 30 days.
(2) P &lt; 0.001, (3) P &lt; 0.01, (4) P &lt; 0.05.
(5) Variables that were unrelated to positive attitude toward condom use included age, marital status, ethnic subgroup, education, income, HIV transmission knowledge, and knowing someone with AIDS or HIV.
(6) Variables that were unrelated to self-efficacy to use condoms include age, marital status, acculturation, ethnic subgroup, education, income, depression, substance use before sex, HIV myths, knowing a person with AIDS, and knowing how to use condoms.
NOTE: HIV = human immunodeficiency virus infection. AIDS = acquired immunodeficiency syndrome.</td>
</tr>
</tbody>
</table>
A more positive attitude toward condom use with a secondary partner was significantly predicted by lower acculturation, more sexual comfort, fewer depressive symptoms, less negative beliefs about the consequences of condom use with a secondary partner, and having ever used condoms. Together they explain 14 percent of the variance of that variable. High levels of sexual comfort, having ever used condoms, and fewer negative beliefs about the consequences of condom use with a secondary partner were significantly related to self-efficacy to use condoms with a secondary partner, explaining 28 percent of the variance of that variable.
<h3><a name="discussion"></a></h3>
Key psychosocial predictors explained a substantial portion (35 percent) of the frequency of condom use with secondary sexual partners in the 12 months prior to the interview. More frequent condom use with secondary partners for these Hispanic men was associated with more frequently carrying condoms, greater self-efficacy to use condoms, having friends who also used condoms with secondary partners, a positive attitude toward condom use with a secondary partner, a lack of depressive symptoms, and personally knowing someone who had HIV and AIDS. The data suggest that behavioral factors, the social environment, culture, and psychological symptoms may play an important role in whether Hispanic men consistently use condoms with secondary sexual partners. Given the large proportion (almost 40 percent) of Hispanic men who reported multiple female partners in the previous year and the high prevalence of STD and HIV infection in the Hispanic community, those factors deserve careful consideration.

<strong>Behavioral factors. </strong>Two behavioral factors emerged as particularly important in the study: carrying condoms and self-efficacy to use condoms. In the sample, carrying condoms appears to be an indicators of preparedness for safe sex with a secondary partner and also of greater experience with condoms. Health care providers who wish to increase Hispanic men's use of condoms with secondary sexual partners should focus specifically on increasing the behavior of carrying condoms.

Self-efficacy to use condoms strongly predicted actual use with a secondary partner, and was in turn strongly predicted by prior use of condoms. That was not surprising, since feelings of self-efficacy generally are produced by practice. Health care providers in STD or family planning clinics, who see Hispanic male patients should teach techniques of proper condom use, such as avoiding the use of oil-based lubricants and leaving a reservoir for semen at the tip.

Hispanic men should be encouraged to handle condoms and to practice putting on one before attempting to do so during a sexual encounter. Men should be asked to consider how to overcome related difficulties, such as having to stop to buy condoms or to look for them, using them even if they had been drinking or using drugs, and learning how to insist on condom use with a partner who does not want them to use one. These barriers to condom use with a secondary partner, which were the basis of the self-efficacy measure in the study, should be specifically discussed. Video presentations or self-instructional approaches should be developed that incorporate modeling of appropriate condom behaviors. When feasible, role playing and instructive feedback may be used to prepare men.

The relationship between risky sexual behavior and the use of alcohol has been debated since it was first described. We found no relationship between the frequency of condom use and the use of drugs of alcohol before sex. However, self-efficacy to use condoms (which did predict greater condom use) included the perception that one could use condoms even after drinking or using drugs. Thus, actual frequency of alcohol or drug use before sex may be less important factors to assess for intervention than a person's perceived self-efficacy to use condoms, even under the influence of alcohol or drugs.

<strong>Social environment. </strong>The social environment affects condom use. Three factors appear particularly important: marital status, personal knowledge of someone with HIV or AIDS, and having friends who use condoms with secondary partners. A substantial minority (18 percent) of the married Hispanic men in the sample had multiple female sexual partners in the prior year. Unmarried men, with no marital partner who might question condom carrying, were more likely to carry condoms than were married men. Other research has found the same association between condom carrying and marital status among Hispanic men.

Personally knowing someone with HIV or AIDS was a predictor of more condom carrying and more use of condoms with a secondary partner. That suggests that health care providers should assess and emphasize a Hispanic man's personal vulnerability to HIV from sexual risk behaviors and previous STD. The results confirm the wisdom of many community programs that utilize persons with HIV to reach and motivate the community.

Having friends who carry condoms and use them with secondary partners were circumstances predictive of both carrying and using condoms. That was not surprising, given the importance of normative influences on sexual behavior. The findings suggest the importance of mass media and community level approaches to condom promotion, as well as approaches to promote normative changes within subgroups. Increased availability of condoms in vending machines can reduce embarrassment associated with buying condoms and increase the perception that "everybody" uses condoms.

<strong>Culture.</strong> Hispanic culture may contribute to high-risk sexual activity. One way is the common idea that sexuality is embarrassing and not to be discussed either with one's children or with one's sexual partner. In this study, comfort with sexuality was an important predictor of self-efficacy to use condoms, accounting for a substantial amount of the variance, as well as predicting greater frequency of condom carrying and a positive attitude toward condoms. Other research has found among Hispanic men an association between carrying condoms and sexual discomfort, measured as embarrassment in buying condoms.

We measured sexual comfort as comfort with commonplace aspects of sexuality, such as being naked in front of a partner or having sex with lights on. Fisher and coworkers have shown that comfort with sexuality is associated with various sexual self-care behaviors, such as breast self-examination and engaging in behaviors to prevent STD. As hypothesized by Fisher, some persons who feel discomfort with sexuality may avoid sex entirely, but those who are uncomfortable yet have multiple partners will be less likely to plan for sex, including condom buying and using. Those who are comfortable may be more likely to engage in nonpenetrative and generally safer forms of sex.

The issue of comfort with sexuality needs to be addressed in a culturally appropriate manner by health care providers. Initially, comfort with condom use should be the focus, emphasizing carrying condoms, practicing their use, and practical skills needed for their use. The patient's basic information, such as knowing the names for body parts and sexual acts, should not be assumed. A Hispanic man in one focus group wondered if oral sex ("sexo oral") meant "sex by the hour"; another thought a woman's vaginal lubrication meant she had "ejaculated;" and several believed masturbation causes physical harm. Further work on the components and amelioration of sexual discomfort clearly is needed among Hispanics.

If anthropological research is correct in suggesting a dichotomy in many Hispanics' minds between "good" women (a wife or mother) and "bad" women (a prostitute or easy conquest), changing the concept that only "bad" women enjoy sex could lead to more enjoyable sex with one's primary partner. Work is needed on the relationships between the beliefs many Hispanic men hold about what it means to be a man (low perceptions of sexual control, associating positive values with sexual behavior risk- taking, and needs for multiple sexual partners) and the sexual behaviors that many Hispanic men demonstrate.

<strong>Psychological symptoms.</strong> Depressive symptoms in the week before the interview were associated with low rates of use of condoms with secondary partners in the previous year and negative attitudes toward condom use with a secondary partner. While those findings might appear to be surprising, people who are depressed are less likely, for example, to be able to quit smoking and are more likely to relapse from methadone maintenance<a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/marinarticle.php#refs">.</a> Depressed persons may perceive themselves as having less to live for, thus evaluating risk behavior as unimportant, or they may be preoccupied with significant life problems that appear more important than an unprotected sexual encounter. For Hispanics, and possibly for other ethnic groups as well, health care providers and staff members of STD clinics may want to assess depressive symptoms to identify those patients who are more likely to have repeated STD exposures. Care providers can then design more comprehensive clinical interventions for them, focusing on depression prevention.

<strong>Demographic variables.</strong> We found no differences in predictors of condom use with secondary partners between Hispanic men in the Northeast and Southwest United States or between ethnic subgroups, education, income, or age groups, despite having sufficient power to detect such differences. Thus, recommendations made in this report are not limited to a particular subgroup of Hispanic men.

Less acculturated men were more likely than the more highly acculturated to carry condoms and to report a positive attitude toward condom use, although they were no more likely than more acculturated men to actually use them. Those positive attitudes and behaviors suggest that less acculturated Hispanic men are quite open to condom use with secondary partners. Certainly, in Latin America, condoms are seen as useful primarily outside primary relationships.

The data have the usual limitations of sexual behavior research, being self-reports that could not practically or ethically be validated. They are also cross-sectional in nature, with current measures of psychosocial variables being used to predict reports of past behavior. Thus, while the study provides useful information about the associations between variables, conclusions should not be drawn about causation or prediction. The generalizability of the sample is limited by the lack of telephones in some Hispanic households, although the absence of effects for income on relationships found in the research suggests that the limitation may be minimal. Some potential respondents were lost because of our inability to make more than six followup calls to a telephone number because of cost factors. We were told by the interviews that some respondents broke off the interview, or refused to participate, because of their fundamentalist religious beliefs.
<h3><a name="conclusions"></a></h3>
Programs and providers promoting condom use with secondary partners should attend to behavioral factors, the social environment, cultural issues, and psychological symptoms. Specifically, they should recommend that Hispanic men carry condoms; should teach specific skills, such as how to use condoms even under difficult conditions; should lower sexual discomfort by providing basic information about sex in a sex-positive climate; and should pay particular attention to those men who may be emotionally troubled. Emphasizing personal vulnerability to HIV, especially for men with STD, and pointing out that "most men" use condoms with secondary partners is useful.

<hr />

<h3><a name="refs"></a></h3>
[1] Syphilis and congenital syphilis--United States, 1985--1988. MMWR Morb Mortal Wkly Rep 37: 486-489, Aug. 19, 1988.
[2] Continuing increase in infectious syphilis--United States. MMWR Morb Mortal Wkly Rep 37: 35- 38, Jan. 29, 1988.
[3] Schmid, G. P., Sanders, L. L., Blount, J. H., and Alexander, E. R.: Chancroid in the United States: reestablishment of an old disease. JAMA 258: 3265-3268, Dec. 11, 1987.
[4] Selik, R. M., Castro, K. G., and Pappaioanou, M.: Racial/ethnic differences in risk of AIDS. Am J Public Health 78: 1539-1545, 1988.
[5] National Center for Health Statistics: Advance report of final mortality statistics, 1989. Vol. 40, No. 8, Supp 2. DHHS Publication No. (PHS) 92-1120, Hyattsville, MD, 1992.
[6] Rietmeijer, C. A. M., Krebs, J. W., Feorino, P. M., and Judson, F. N.: Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA 259: 1851-1853, Mar. 25, 1988.
[7] Zenilman, J., et al.: Effect of HIV posttest counseling on STD incidence. JAMA 267: 843-845, Feb. 12, 1992.
[8] Mosher, W. D. and Bachrach, C. A.: Contraceptive use, United States, 1992. Vital Health Stat
[23] No. 12. DHHS Publication No. (PHS) 86-1988. National Center for Health Statistics, Hyattsville, MD, 1986.
[9] Forrest, J., and Singh, S.: The sexual and reproductive behavior of American women, 1982-1988. Fam Plann Perspect 22: 206-214 (1990).
[10] Waksberg, J.: Sampling methods for random digit dialing. J Am Stat Assoc 73: 40-46 (1978).
[11] Kish, L.: Survey sampling. John Wiley and Sons, New York, NY, 1965.
[12] Marin G., and Marin, B.: Research with Hispanic populations. Sage Press, Newbury Park, CA, 1991.
[13] Bandura, A.: Self- efficacy: toward a unifying theory of behavioral change. Psychol Rev 84: 191-215 (1977).
[14] Bandura, A.: Social foundations of though and action: a social cognitive theory. Prentice-Hall, Englewood Cliffs, NJ, 1986.
[15]Radloff, L. S.: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1: 385-401 (1977).
[16] Guarnaccia, P. J., Angel, R., and Worobey, J. L.: The factor structure of the CES-D in the Hispanic Health and Nutrition Examination Survey: The influences of ethnicity, gender and language. Soc Sci Med 29: 85-94 (1989).
[17] Myers, J. K., and Weissman, M. M.: Use of a self-report symptom scale to detect depression in a community sample. Am J Psychol 137: 1081-1084 (1980).
[18] Weissman, M. M., et al.: Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106- 203-214 (1977).
[19] Fisher, W., Byrne, D., White, L., and Kelley, K.: Erotophobia-erotophilia as a dimension of personality. J Sex Res 26: 123-151 (1988).
[20] Marin, G., et al.: Development of a short acculturation scale for Hispanics. Hispanic J. Behav Sci 9: 183-205 (1987).
[21] Kalton, G.: Introduction to survey sampling. Sage Publications, Newbury Park, CA, 1983
[22] Bandura, A.: Perceived self- efficacy in the exercise of control over AIDS infection. Evaluation Prog Plann 13: 9-17 (1990).
[23] Bolton, R., Vincke, J., Mark, R., and Dennehy, E.: Alcohol and risky sex: in search of an elusive connection. Med Anthropol 14: 323-363 (1992).
[24] Stall, R., et al.: Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: the AIDS Behavioral Research Project. Health Ed Q 13: 359-371 (1986).
[25] Marin, B. V., Gomez, C. A., and Hearst, N.: Multiple heterosexual partners and condom use among Hispanics and Non-Hispanic whites. Fam Plan Perspect 25: 170-174 (1993).
[26] Marin, B. V., and Marin, G.: Predictors of condom accessibility among Hispanics in San Francisco. Am J Public Health 82: 592-595 (1992).
[27] Joseph, J. G., et al.: Magnitude and determinants of behavioral risk reduction: longitudinal analysis of a cohort at risk for AIDS. Psychol Health 1: 73-96 (1987).
[28] Kelly, J., et al.: HIV risk behavioral reduction following intervention with key opinion leaders of population: an experimental analysis. Am J Public Health 81: 168-171 (1991).
[29] Pavich, E. G.: A Chicano perspective on Mexican culture and sexuality. J. Social Work Human Sexuality 4: 47-65 (1986).
[30] Burgos, N. M., and Diaz Perez, Y. I.: An exploration of human sexuality and the Puerto Rican culture. J. Social Work Human Sexuality 4: 135-150 (1986).
[31] Diaz, R. M.: Latino gay men and the psychocultural barriers to AIDS prevention. In A plague of our own: the impact of the AIDS epidemic on the lesbian and gay communities, edited by M. Levine, J. Gagnon, and P. Nardi. University of Chicago, Chicago, IL. In press, 1993.
[32] Anda, R. F., et al.: Depression and the dynamics of smoking: a national perspective. JAMA 264: 1541-1545, Sept. 26, 1990.
[33] Batki, S., Sorensen, J., Gibson, D., and Maude-Griffen, P.: HIV-infected drug users in methadone treatment: outcome and psychological correlates--a preliminary report. In Problems of drug dependence 1989: proceedings of the 51st annual scientific meeting of the Committee on the Problems of Drug Dependence, edited by L. Harris. NIDA Research Monograph Series No. 95. U.S. Government Printing Office, Washington DC, 1988, pp. 405-406.
[34] Batki, S., Sorensen, J., Faltz, G., and Madover, S.: Psychiatric aspects of treatment of IV drug abusers with AIDS. Hosp Community Psychiatry 39: 439-411 (1989).
[35] Lewinshon, P. M., Munoz, R. F., Youngren, M. A., and Zeiss, A. M.: Control your depression (revised edition). Prentice Hall, New York, NY. 1986.
[36] Bailey, J., Lopez- Escobar, G., and Estrada, A.: A Colombian view of the condom. Stud Fam Plann 4: 60-64 (1973).

The authors are associated with the University of California, San Francisco, School of Medicine. Dr. Marin and Dr. Gomez are with the Department of Epidemiology and Biostatistics and with the Center of AIDS Prevention Studies. Dr. Marin is an Associate Adjunct Professor and Dr. Gomez is an Associate Specialist. Dr. Tschann is Assistant Adjunct Professor with the Graduate Program in Health Psychology, Department of Psychiatry.

Rolando Juarez, of the Center for AIDS Prevention Studies, provided date analysis services; Dr. Thomas Piazza, of the Survey Research Center, University of California, Berkeley, suggested the sampling approach. The telephone survey was carried out by Communication Technologies, Inc., San Francisco, whose interviews collected the data.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Hispanic Condom Use Study: Description and Explanation of Questionnaire</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Instrument</h3>
The survey instrument was based on more than 100 open- ended interview and 2 focus groups with Hispanics in San Francisco, held to identify Hispanic men's perceptions of the consequences of condom use with primary and secondary sexual partners, difficulties with condom use, and normative aspects of condom use. The instrument was developed originally in Spanish and a back-translation procedure was used to assure that the English version was equivalent in meaning. Both the Spanish and English versions were pretested with at least 20 persons.

The final version of the interview required an average of 24 minutes to complete. Most interview questions had four or five-level Likert-type response scales. The reported reliabilities were for the sample of 361 Hispanic men, reporting 1 or more secondary female sexual partners, who responded to the question on condom use with a secondary partner or partners.

<strong>Frequency of using and carrying condoms.</strong>

The extent of condom use with a secondary sexual partner was assessed by the question, "When you had sex with someone other than your wife or primary partner in the last 12 months, how often did you use condoms?" The extent of carrying condoms was assessed by the question, "How often do you carry a condom with you?" Each item was recorded using a five-point response scale from "always" to "never."

<em>Self-efficacy to use condoms.</em> Four questions were developed to assess perceived ability to use condoms:
<ul>
 	<li>"Would you be able to refuse sex if you partner didn't want you to use a condom?"</li>
 	<li>"Would you use condoms even if you had to stop to buy them or look for them?"</li>
 	<li>"Would you use condoms even if you had been drinking or using drugs?" and,</li>
 	<li>"Would you be able to use a condom with a secondary partner?"</li>
</ul>
The self-efficacy score was the mean of the four items on a four- point yes-no response scale with higher scores meaning higher efficacy (alpha = 0.55). Those with greater self-efficacy to use condoms were expected to use them more consistently with secondary partners that did those who scored lower.

<strong>Negative beliefs about condoms.</strong>

Sixteen items measured beliefs about the consequences of using condoms. Beliefs included "the condom might break," "the condom might come off inside your partner," and "you would feel less sexual pleasure." Responses were "yes" "probably yes," "probably no," and "no" (alpha = 0.70).

<strong>Depression scale</strong>.

Ten of the 20 items of the Center of Epidemiologic Studies Depression Scale (CES-D) were selected for the questionnaire, based on their factor loading for Hispanics (alpha = 0.88). The items measure sadness in the 7 days prior to the interview and have been shown to assess depression in community samples<a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/marinarticle.php#refs">.</a> We expected those men who reported the most depressive symptoms to report more risky behaviors than those who reported the least depressive symptoms. The scale score was a continuous variable ranging from 0 to 30, with high scores meaning more depressive symptoms.

<strong>Sexual comfort.</strong>

Three items were used to assess sexual comfort: being naked in front of a partner, having sex with the lights on, and having sex with a new partner. The sexual comfort score was the mean of the three items on a four-point scale ranging from "very comfortable" to "very uncomfortable" (alpha = 0.62). Persons with high levels of sexual comfort have been shown to exhibit sexual behavior that is more self-protective than persons with low levels of sexual comfort.

<strong>Number of friends using or carrying condoms.</strong>

Two items assessed the proportion of the respondent's close friends who carried condoms and used them with secondary partners, a measure of perceived normative condom use behavior among peers. Responses ranged on a five-point scale from "almost all" to "almost none."

<strong>Myths about HIV transmission.</strong>

A measure of beliefs about the casual transmission of HIV was computed by adding responses to three items, such as the likelihood of getting HIV from using public toilets. Total scores could range from 3 to 12, with higher scores representing less accurate beliefs.

<strong>Demographics.</strong>

Age, education, marital status, and ethnic origin were determined for each respondent.

<strong>Acculturation.</strong>

Acculturation, the process by which a person learns a new culture, was assessed using four language-related items. That scale has been previously shown to have good reliability and validity. Mean scores ranged from 1 to 5, with higher scores indicating more use of English, hence higher levels of acculturation (alpha = 0.90).

<strong>Other variables.</strong>

Positive attitude toward condom use with a secondary partner was measured with a six-level Likert-type scale ranging from "dislike a lot" to "like a lot." Knowing someone with HIV infection or AIDS and previous use of condoms to prevent disease were assessed through single items with "yes" or "no" responses.

<hr />

This text is excerpted from the article <a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/marinarticle.php">"Condom use among Hispanic men with secondary female sexual partners."</a> Marin, Barbara VanOss; Gomez, Cynthia A.; Tschann, Jeanne M.; <em>Public Health Reports</em> v108, n6 (Nov-Dec, 1993):742-750.

COPYRIGHT U.S. Department of Health and Human Services 1993]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Married &amp; Unmarried Latinos</title>
		<tax>1737</tax>
		<content><![CDATA[<table border="0">
<tbody>
<tr>
<td valign="top" height="654">
<h3><span style="font-size: 11px; font-weight: normal;">The questionnaires for unmarried Latino women and men were used in a random digit dial telephone survey of 1500 Latinos in ten states in the U.S. These states contain 90% of all Latinos living in the continental U.S. The survey was designed to assess risk for HIV due to sexual behaviors as well as the variables that might predict sexual behaviors such as condom use. The potential predictors measured include homophobia, self-efficacy to use condoms, sexual comfort, sexual coercion, and traditional gender role beliefs. Publications based on this data set include:</span></h3>
<blockquote>Marín B.V., Gomez, C. (1999). Latinos and HIV: Cultural Issues in AIDS. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS knowledge base. Third Edition. Lippincott Williams &amp; Wilkins, Philadelphia, (Chapter 8; pp 917-924).

Marín, B.V.; Gonzalez, F.J.; Gomez, C. "Unmarried Latino Men Who Report Sex With Men: Psychocultural and Demographic Characteristics." AIDS and Behavior, 2(3):203-212, 1998.

Marín, B.V., Tschann, J., Gomez, C., Gregorich, S.E. (1998). Self efficacy to use condoms in unmarried Latino adults. American Journal of Community Psychology. 26(1), 53-71.

Marin, BV, Gomez, C, Tschann, J, &amp; Gregorich, S.E. (1997). Condom use in unmarried Latino men: A test of cultural constructs. Health Psychology. 16(5), 458-467.

Marin, BV. (1997). Cultural Issues in HIV Prevention for Latinos: Should we be changing gender roles. In Oskamp, S. &amp; Thompson, S. (Eds.) Safer Sex in the 90s: Understanding and Preventing HIV Risk Behavior.

Marín, B.V., Gómez, C.A . (1996). Latino Culture and Sex: Implications for HIV Prevention. In J. Garcia &amp; M.C. Zea (Eds.) Psychological Interventions and Research with Latino Populations, Meedham Heights, MA: Allyn and Bacon (pp. 73-93).</blockquote>
For permission to use the data set of 1500 Latino adults, please contact Dr. Barbara Marin at: <a href="mailto:bmarin@psg.ucsf.edu">bmarin@psg.ucsf.edu</a></td>
</tr>
</tbody>
</table>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Healthy Oakland Teens (HOT)</title>
		<tax>1737</tax>
		<content><![CDATA[<strong><span style="color: red;">NOTE: The HOT Project ended in 1995. For a list of more recent, effective school-based sexuality/HIV education programs, please see:</span></strong>
<ul>
 	<li><a href="http://pub.etr.org/pages.aspx?docid=135" target="_blank">ETR Associates' Evidence-Based Programs</a></li>
 	<li><a href="http://www.cdc.gov/hiv/topics/research/prs/subset-best-evidence-interventions.htm#link2" target="_blank">CDC's Best Evidence Interventions</a></li>
 	<li>CDC's DEBI programs for youth: <a href="http://www.effectiveinterventions.org/go/interventions/clear" target="_blank">CLEAR</a>, <a href="http://www.effectiveinterventions.org/go/interventions/focus-on-youth--impact" target="_blank">Focus on Youth</a>, <a href="http://www.effectiveinterventions.org/go/interventions/street-smart" target="_blank">Street Smart</a>, <a href="http://www.effectiveinterventions.org/go/interventions/together-learning-choices" target="_blank">TLC</a></li>
</ul>
The Center for AIDS Prevention Studies began providing innovative HIV prevention education in Oakland, CA in 1989. The Healthy Oakland Teens Project (HOT) began in the fall of 1992 at an urban, ethnically diverse junior high school. The project's goal was to reduce <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/healthy-oakland-teens-hot/risks/">adolescents' risk</a> for HIV infection by using peer role models to advocate for responsible decision making, healthy values and norms, and improved communication skills. The HOT program was very <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/healthy-oakland-teens-hot/successes/">successful</a>.

<img src="/sites/prevention.ucsf.edu/files/uploads/projects/HOT/images/hotphoto.jpeg" alt="" width="113" height="131" align="middle" /> Melanie Buccat teaches her classmates about safe sex

The HOT program educated ninth grade students during a one semester, daily class to become HIV <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/healthy-oakland-teens-hot/peer-helpers/">peer helpers</a> for seventh grade students. After extensive training, the ninth grade peer helpers delivered weekly interactive sessions in seventh grade science classes, focusing on <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/healthy-oakland-teens-hot/values/">values</a>, decision-making, communication, and prevention skills. The program trained 30 ninth grade peer helpers who in turn taught 300 seventh graders each year.

<img src="/sites/prevention.ucsf.edu/files/uploads/projects/HOT/images/hot7&amp;9.jpeg" alt="" width="131" height="113" align="middle" /> A seventh grader and ninth grader in the HOT program.

Each semester the peers designed their own <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/healthy-oakland-teens-hot/logos/">group logo</a> which was printed on T-shirts worn enthusiastically by the peer helpers.

During eighth grade, the students received two "booster" sessions - a reminder of what they learned in seventh grade. HIV-positive young people visited each eighth grade classroom helping the students realize that HIV infection does happen to teenagers. The eighth graders also saw a theater presentation, Secrets, sponsored by the Kaiser Permanente Medical Center, which tells the story of a high school student who becomes infected with HIV.
<h2><a name="curriculum"></a>Curriculum</h2>
<strong><span style="color: red;">NOTE: The HOT Project ended in 1995. For a list of more recent, effective school-based sexuality/HIV education programs, please see:</span></strong>
<ul>
 	<li><a href="http://pub.etr.org/pages.aspx?docid=135" target="_blank">ETR Associates' Evidence-Based Programs</a></li>
 	<li><a href="http://www.cdc.gov/hiv/topics/research/prs/subset-best-evidence-interventions.htm#link2" target="_blank">CDC's Best Evidence Interventions</a></li>
 	<li>CDC's DEBI programs for youth: <a href="http://www.effectiveinterventions.org/go/interventions/clear" target="_blank">CLEAR</a>, <a href="http://www.effectiveinterventions.org/go/interventions/focus-on-youth--impact" target="_blank">Focus on Youth</a>, <a href="http://www.effectiveinterventions.org/go/interventions/street-smart" target="_blank">Street Smart</a>, <a href="http://www.effectiveinterventions.org/go/interventions/together-learning-choices" target="_blank">TLC</a></li>
</ul>
Our entire HOT curriculum is available.
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/HOT/pdf/HealthyOaklandTeensPeercurriculum.pdf">Peer curriculum</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/HOT/pdf/HealthyOaklandTeensAdult.pdf">Adult Curriculum</a></li>
</ul>
<h2>Evaluation</h2>
Our evaluation instruments are also available.
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOT%20survey.pdf">Teen knowledge, attitude, behavior, belief (KABB) questionnaire</a></li>
 	<li>Adult evaluation of peer educators <em>(sorry, unavailable)</em></li>
 	<li>Student evaluation of peer educators <em>(sorry, unavailable)</em></li>
</ul>
<h2>Staff</h2>
Meet our <a href="/sites/prevention.ucsf.edu/files/healthy-oakland-teens-hot/staff">staff</a>.

For more information about the Healthy Oakland Teens Project, please write to:

Maria Ekstrand
Project Director
Center for AIDS Prevention Studies
Maria.Ekstrand@ucsf.edu]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Healthy Oakland Teens</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>Healthy Oakland Teens Description and Explanation of Study Instrument</h2>

<hr />

A questionnaire based on findings from earlier surveys was developed and pilot tested on junior high school students. The content and wording of the survey was modified based on pilot study results and participant feedback and used in the present study to assess demographic characteristics, HIV/AIDS/STD-related knowledge, attitudes, and beliefs, sexual behaviors and drug and alcohol use. The final instrument included 102 items at pretest and 97 items at follow-up, and required approximately 40 minutes to complete. The instrument contained the following sections that were used to develop scales.

<strong>Sexual behaviors </strong>were assessed including dating, kissing, deep kissing, breast touching, and genital touching. These individual-item measures were dichotomous assessments for lifetime behaviors and for practices during the past two months. Those students who had experienced sexual intercourse were asked about their lifetime and prior two months practice of vaginal, anal, and oral sex.

<strong>Demographics</strong>, including gender, age, ethnicity, and the primary language spoken at home were measured. Socioeconomic status was assessed by examining the proportion of students who participated in the school district's free lunch program.

An <strong>AIDS -related knowledge</strong> score was created by adding the number of correct answers to 11 true-false questions regarding AIDS transmission, general medical aspects of AIDS, and knowledge of preventive behaviors. Examples of items included, "Only people who look sick can spread the AIDS virus," "A person can get the AIDS virus even if he or she has sexual intercourse just one time without a condom," and "Birth control pills prevent a woman from getting the AIDS virus." (scale range 0 to 11, seventh grade baseline mean=7.9, Cronbach's alpha=.64).

The perceived costs and benefits of preventive behaviors scale combines statements about the <strong>negative and positive aspects of condom use</strong>. Examples of items include "It would really bother me to stop having sexual intercourse to put on a condom," "Condoms would be too much trouble to use," and "Condoms slip off easily." Responses are in the Likert format ranging from "definitely" to "definitely not" (range 0 to 21, seventh-grade baseline mean=11.1, Cronbach's alpha=.43; for negative aspect items only, six items, Cronbach's alpha=.47). We decided to retain this scale even though it has a relatively low reliability, since perceived barriers have previously been shown to be related to sexual behaviors and were specifically targeted in our intervention.

The perceived peer norms scale used the CDC's national survey of adolescent AIDS-related attitudes (CDC, 1988). This scale measures the <strong>perceived prevalence of risk behaviors among the friends of adolescents</strong>, using Likert response options. Examples of items include, "How many of your friends do you think have had sexual intercourse?" and "How many of your friends think condoms are too much trouble to use?" A high score indicates that friends are believed to have the lowest risk behaviors and attitudes regarding condom use (five items, range 0 to 20, seventh grade baseline mean=15.1, Cronbach's alpha =.62)

The <strong>attitudes regarding sexually active students</strong> scale consists of three statements referring to sexually active boys and girls (for a total of six statements), "Having sexual intercourse makes a boy (a girl) popular," "Having sexual intercourse at my age is a `cool' thing for a boy (a girl) to do," and "Having sexual intercourse with someone besides his (her) steady partner makes a boy (a girl) 'cool' or popular." Students responded on a 4 point Likert format scale ranging from "strongly agree" to "strongly disagree." (Six item scale, range 0 to 18, seventh-grade baseline mean=13.5, Cronbach's alpha=.88)

The <strong>partner norms</strong> scale combines three items regarding attitudes toward a sexual partner who suggested using a condom, (i.e. "If the person I was about to have sex with suggested using a condom, I would feel like that person cared about me,"), (3 items, range 0 to 9, seventh grade baseline mean=7.3, standardized Cronbach's alpha=.69)

The <strong>self-efficacy</strong> scale measures confidence in one's ability to refuse unsafe situations or use of a condom in appropriate situations. Examples of items include "I would refuse to have sexual intercourse without a condom," and "I would use a condom even if I were drunk or high." A high score reflects the strongest refusal and condom use self-efficacy (range 0-15, seventh grade baseline mean=11.2, Cronbach's alpha=.62)

<strong>Alcohol consumption</strong>. Students were asked at what age they had consumed their first drink (open-ended), their frequency of drinking and their frequency of getting "really drunk" (7 response categories ranging from "never" to "almost every day"). Questions about marijuana smoking included the age at first use, frequency of use, and frequency of getting "really high." These questions used the same format as for alcohol consumption.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Voluntary HIV Counseling and Testing Efficacy Study</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Is HIV Counseling and Testing Effective for Prevention?</h3>
While voluntary HIV counseling and testing has been demonstrated to be useful for care and support, the effectiveness of counseling and testing for prevention has not been conclusively demonstrated <a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/c&amp;teffective.php#1">[1-6]</a>. There have been very few studies of the effectiveness of counseling and testing for prevention, and even fewer randomized trials [7-8], despite repeated calls for controlled studies<a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/c&amp;teffective.php#1">[1,6,9]</a>. While speculation continues regarding the potential usefulness of counseling and testing despite its relatively high cost, there are currently insufficient data to determine either the efficacy or the true cost of the intervention in relationship to the number of infections that could be prevented by it (cost-effectiveness).

Arguments in favor of more widespread HIV testing and counseling include that counseling and testing provides an opportunity for education and behavior change, and that knowledge of serostatus allows individuals to plan, make important life decisions and to seek care and support <a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/c&amp;teffective.php#10">[10]</a>. On the other hand, HIV counseling and testing is an expensive intervention compared to health education and other potentially effective prevention strategies. In addition, there are potentially negative social consequences of counseling and testing including family and relationship disruption, sexual violence, stigma and discrimination <a href="/sites/prevention.ucsf.edu/files/uploads/projects/VCT/c&amp;teffective.php#11">[11-12]</a>.

The Voluntary HIV Counseling and Testing Efficacy Study was a clinical trial conducted in 1995-1997 to test the effectiveness and consequences of Voluntary HIV Counseling and Testing for the prevention of new HIV infections. This is an important policy issue, particularly in countries where health care resources are limited. More specifically the purpose of the study was to determine if counseling and testing, whether given to individuals or couples, might be effective in reducing risk behavior for the sexual transmission of HIV.
<h3><a name="1">References</a></h3>
[1] Higgins DL, Galavotti C, O'Reilly K, et al. Evidence for the Effects of HIV Antibody Counseling and Testing on Risk Behaviors. JAMA 1991; 266:2419-2429.

[2] DeZoysa I, Phillips KA, Kamenga MC, et al. Role of HIV counseling and testing in changing risk behavior in developing countries. AIDS 1995: S95-S101.

[3] Landis SE, Earp JL, Koch GG. Impact of HIV Testing and Counseling on subsequent sexual behavior. AIDS Education and Prevention; 1992; 4:61-70.

[4] Zenilman JM, Erickson B, Fox R, Reichart CA, Hook III EW. Effect of HIV posttest Counseling on STD incidence. JAMA 1992; 267:843-845.

[5] Otten Jr MW, Zaidi AA, Wroten JE, Witte JJ, Peterman TA. Changes in Sexually Transmitted Disease Rates after HIV Testing and Posttest Counseling, Miami 1988 to 1989. American Journal of Public Health 1993; 83:529-533.

[6] Beardsell S. Should wider HIV testing be encouraged on the grounds of HIV prevention? AIDS Care 1994; 6:5-19.

[7] Wenger NS, Linn LS, Epstein M, Shapiro MF. Reduction of High-Risk Sexual Behavior among Heterosexuals Undergoing HIV Antibody Testing: A Randomized Clinical Trial. American Journal of Public Health 1991; 81:1580-1585.

[8] Wenger NS, Greenberg JM, Hilborne LH, Kusseling F, Mangotich M, Shapiro MF. Effect of HIV Antibody Testing and AIDS Education on Communication about HIV Risk and Sexual Behavior. Annuals of Internal Medicine 1992; 117:905-911.

[9] Phillips KA &amp; Coates TJ. HIV counselling and testing: research and policy issues. AIDS Care 1995; 7:115-124.

<a name="10">[10]</a> Müller O, Barugahare L, Schwartländer B, et al. HIV prevalence, attitudes and behaviour in clients of a confidential HIV testing and counselling centre in Uganda. AIDS 1992; 6:869-874.

<a name="11">[11] </a>Colebunders R &amp; Ndumbe P. Priorities for HIV testing in developing countries? The Lancet 1993; 342:601-602.

[12] van der Straten A, King R, Grinstead O, Serufilira A, Allen S. Couple communication, sexual coercion and HIV risk reduction in Kigali, Rwanda. AIDS 1995; 9:935-944.]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Qualitative interview instrument</title>
		<tax>1737</tax>
		<content><![CDATA[<h4>While you are setting up your equipment, getting the consent form, etc. take note of the surroundings for your field notes.</h4>
<h2><a name="test"></a></h2>
<h3><a name="experience"></a></h3>
<strong>1.	I’d like you to think back to the last time you got an HIV test. Take a minute to remember everything you can about it and then tell me the whole story. Starting from what led up to the test, why you went to get it, where it was done and then how you felt afterwards?</strong>

If they have never tested, skip to question # 6:

Let interviewee describe the episode. Listen for answers to each of the following questions. Once interviewee's story is told, probe for any questions not answered.

<span style="text-decoration: underline;">Content Areas for HIV Testing:</span>

<span style="text-decoration: underline;">Motivation</span>:
including why they decided to test, whether strictly voluntary, coerced or mandatory testing (prison, hospital), where they found out about testing/test site

<span style="text-decoration: underline;">Location: </span>
Where was the test site?

<span style="text-decoration: underline;">Procedures: </span>
Describe the actual test? (blood/Orasure)
Who administered?
How was the counseling?
What was discussed in counseling? (Probe for discussion of risk behaviors, results, follow-up appointment)
How did you feel after you left?

<span style="text-decoration: underline;">Confidentiality</span>: <em>avoid using the words "confidential" or "anonymous" </em>
Were you concerned about privacy at all? (Probe for name or number given, familiar test site, familiar test counselor/administrator)

<span style="text-decoration: underline;">Waiting Period: </span>
How was the waiting period?
Tell me about any changes that occurred during this time period.
Did you talk to anyone about HIV and/or the test during the waiting period?

<span style="text-decoration: underline;">Results: </span>
When did you go back for results?
IF didn’t get results ask why. If had another test where did get results, what was different this time?
Where did you go for results?
Who gave them? (probe for familiarity with results counselor)
How was the result explained/presented to you?
What were your results?
Was this the result you were expecting? Why?
How did you feel after receiving the results?
What was discussed after you received the results? (probe for discussions around risk, 6 month window period, referrals given, IF NEGATIVE — ways to stay negative, any plans made to stay negative)
Was talking to them useful/helpful?
Did you just want to get out of there?
Who did you share your results with?

<strong>2.	How did this compare to other tests you’ve had, did you like it or not? Was it typical of other tests?</strong>

<strong>3.	After this HIV test, did anything change in your life? </strong><em>(drug use, sex, views on risk)</em>

<strong>If yes, explain what changed.
If NO ask:</strong>

<strong>4.	Have you ever had an HIV test that caused you to change your beliefs or behaviors? If yes, please explain what changed. <em>(Probe for what aspect of C&amp;T caused the change; i.e. was it the risk assessment counseling, or receiving the test results)</em></strong>

<strong>5.	Is there anything [else] that caused you to change your beliefs or behaviors? <em>(i.e. drug use, sex, views on risk)</em></strong> If yes, please explain what it was, <span style="text-decoration: underline;"><strong>and</strong></span> what changed.

<strong>6.	Have you ever thought about testing/or been approached about testing? What happened? How did you hear about it? Why did you decide not to test? What do you think would happen if you did test?</strong>
<h3><a name="repeat"></a></h3>
<strong>Now I’d like to ask you a few more general questions about HIV testing.</strong>

If they have already discussed their testing pattern above skip 1,2 &amp; 3.

<strong>1.	How many times have you tested in your life?</strong>

<strong>2.	How often do you test?</strong>

<strong>3.	Do you test regularly? If so, why?</strong>

<strong> </strong>

<strong> </strong>

<strong> </strong>
<h2><strong><a name="daily"></a></strong></h2>
<strong>This next section is very general. We are just trying to get a sense of people’s everyday lives.</strong>

<strong>1.	Describe yesterday. What did you do when you got up in the morning until you went to bed?</strong>

<strong> </strong>

<span style="text-decoration: underline;">Content Areas for Daily Life: </span>
Location(s)
Who respondent interacted with during the day
Drug Use
Resources: eating, getting money
Time frames (what time did they get up, what time to bed, etc.)

<strong>2.	How, in any way, was this different from a typical day?</strong>
<h2><a name="drug"></a></h2>
<strong>I have a couple general questions about drugs and then I’d like to ask you more specifically about the last time you used.</strong>

<strong>1.	What kinds of drugs do you use now?</strong> <em>Probe for all drugs, including alcohol and those used sporadically</em>

<strong>2.	When do you use and how much?</strong> Ask for each drug mentioned above

<strong>3.	Can you describe to me what happened the last time you used. Tell me the whole story from when it began until where you think it ended. I’d like to know who you were with, what you used, etc.</strong>

Let interviewee describe the episode. Listen for answers to each of the following questions. Once interviewee's story is told, probe for any questions not answered.

<span style="text-decoration: underline;">Content Areas for Drug Narrative:</span>

In this section we want to get at settings, people, and social and physical conditions which shape use; decisions and rules, spoken and tacit.

<span style="text-decoration: underline;">Before Using: </span>
How were you feeling/What kind of mood were you in?
What was going on at the time?

<span style="text-decoration: underline;">Buying and preparing: </span>
Time and place.
How were drugs procured? Who got them?
Who paid?
How did you get money for the drugs/buy in?
If didn’t have money, how did you get your portion?
Who was there? What are your relationships with these people?
Who prepared drugs, how?
How were drugs measured? <strong>Probe for using ONE syringe to divide up drugs into other syringes— was the loader’s syringe new or used; were receivers’ syringes new or used. </strong>
Who or what determined how much each person got?

<span style="text-decoration: underline;">Taking: </span>
How did you take the drugs (inject self, injected by another person, smoke, snort)
Where did you get the (pipe, works)? Whose (rigs, pipe) did you use?
Who went first (second, third, etc.) and why?

<span style="text-decoration: underline;">Afterwards: </span>
How did you feel, what did you do afterwards?
Did you need any other drugs to come down?

<strong>4.	How, in any way, was this different from your usual experience using?</strong>

<strong>5.	How does your drug use fit into your sex life?
</strong><em>How does your drug use impact your sex life? Probe for drugs used before, during and after sex.</em>
<h2><a name="sex"></a></h2>
<h3><a name="relation"></a></h3>
Let me ask you a few general questions about your relationships.

<strong>1.	Do you currently have a steady partner(s) (girlfriend, boyfriend, husband, wife, etc.)? If so, tell me about her/him or them?</strong>

<strong> </strong>

Individual characteristics of their partner. (age, gender, and ethnicity).
Relationship with this partner (duration and nature of relationship, where/when/how met partner; main, casual, paying or exchange)
Probe around past sexual experiences with this partner.
What attracted you to her/him? What did you like about her/him? (if appropriate)
<h3><a name="unprotected"></a></h3>
Now I would like to ask some personal questions about your sexual behavior. We realize that this is a very personal subject, but your answers are very important to our research. Your answers will remain completely confidential and remember names will not be attached to any of this information.

<strong>1.	I would like to talk about the last time you had sex with someone without a condom. When was that?</strong>

NOTE: This includes when a condom broke and when there was dipping.

<strong>2.	Could you think back now and try to remember as much as you can about that time, and tell me the story of how it happened? Try to remember when it happened, who you were with, what you were doing and how you felt.</strong>

Let interviewee describe the episode. Listen for answers to each of the following questions. Once Interviewee's story is told, probe for any questions not answered.

<span style="text-decoration: underline;"><em>Content Areas for Sexual Interactions:</em></span>

<em>Sexual partner:
Individual characteristics of this sex partner. (age, gender, and ethnicity).
Relationship with this partner (duration and nature of relationship, where/when/how met partner; main, casual, paying or exchange)
Past sexual experiences with this partner
What attracted you to him/her? (if appropriate)</em>

<em><span style="text-decoration: underline;">Before Sex: </span>
What was going on at that time?
How did it happen? (When did it happen?, who initiated?, where were you?)
How were you feeling? (Were you expecting to have sex? Did either one of you talk about it first? What were you hoping to get out of it?)</em>

<em><span style="text-decoration: underline;">Sexual Events: </span>
What happened? (types of sex: anal, oral, vaginal, mutual masturbation, digital, etc.)
What determined the kinds of sex you had? (active vs. passive roles, verbal vs. nonverbal c	communication, payment, consent, etc.) <strong>
How did you make a decision to NOT use a condom?/Why didn’t you use condoms? </strong>
Birth control method of any kind used</em>

<em><span style="text-decoration: underline;">Using (Drugs): </span>
Drugs or alcohol used by you or this sex partner before, during or after having sex. (Injected drugs/non-injected drugs/alcohol; levels of intoxication)
What did using have to do with this sexual encounter? (sex/drug exchanges, drugs enhancing sex, sex enhancing drug, etc.)</em>

<em><span style="text-decoration: underline;">HIV/AIDS:</span>
Issue of HIV ever discussed (Your status? Partner’s status? If so, how? Before or after sex?)
If not discussed, then what did you believe (or assume)? Before or after sex?
How did knowing or not knowing your partner’s HIV status affect having sex this time.</em>

<em><span style="text-decoration: underline;">After Sex: </span>
Thinking back over this particular experience, is there anything that you would have wanted to happen differently? Tell me about that.
Generalizability - Typical or unusual compared to most of other sexual interactions
Relationship potential - Someone you wanted to see again? To have sex with again?</em>

<strong><em>3.	How was this different from your usual experience having sex without a condom?</em></strong>

<strong><em>4.	How was this different from the last time you had sex WITH a condom?</em></strong>

<em><strong>5.	Thinking about when you have sex in general, what makes it easier to use condoms/protection with your partners? </strong>(Probes: nature of relationship; how long they knew their partner; serostatus)</em>

<em><strong>6.	Thinking about when you have sex in general, what are some of the reasons you haven’t used condoms/protection?</strong></em>

<em><strong>7.	How are these situations (using a condom verses not using a condom) different.</strong></em>

<em><strong>8.	How is having sex with your "steady partner" </strong>(whatever term interviewee uses) </em>different from having sex with others, such as casual partners, one-night stands or tricks?]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Adherence Abstracts</title>
		<tax>1737</tax>
		<content><![CDATA[<h2>Adherence to Combination Therapy in AIDS Clinical Trials (1997)</h2>
<h5>Chesney, M., Ickovics J., for the Recruitment, Adherence and Retention Committee of the ACTG (1997). Presented at the Annual Meeting of the AIDS Clinical Trials Group, July 1997,Washington, D.C.</h5>
The Recruitment, Adherence and Retention Subcommittee of the AIDS Clinical Trials Group administered two questionnaires to 76 patients on combination therapy from 10 clinic AIDS Clinical Trials Units during May and June of 1997 (results were presented at the July, 1997 ACTG meeting by Drs. Margaret Chesney and Jeannette Ickovics). Eighty percent of the respondents were male, 30% were persons of color, the mean age was 40 years, 41 % were college graduates and the mean income was US$ 25,000. Of the 76 patients, 41% reported missing at least one dose "yesterday" (i.e., the day before completing the survey). Fourteen percent reported missing at least one dose the "day before yesterday." When these two days were examined together, a total of 18% of the patients missed at least one dose in the last two days. When asked about the last two weeks, 36% reported missing at least one dose. These data probably underestimate the problem because most of these patients were relatively new to their regimens. Adherence research indicates that adherence is better early on in the course of treatment and declines with time.

The report of the ACTG survey also provided preliminary findings on some of the variables that are associated with or 'predict' nonadherence. These variables are important because they suggest ways that individuals who may have difficulties with adherence could be identified. The intent of studies finding such "predictors" is not to characterize persons who might not be prescribed medication but rather, to identify persons who may need additional assistance and to provide information that could be used to maximize the effectiveness of the assistance.

The ACTG survey identified two predictors of nonadherence. The first of these was the frequency of alcohol intake, with a higher frequency associated with skipped doses. The average number of drinks per month among those who did not report skipping medication was 9, whereas the average number of drinks per month among those who reported skipping medication was 17. The second variable significantly associated with non adherence was "working outside the home for pay' " Specifically, 59% of the adherent survey respondents worked outside the home, the prevalence of working outside the home was significantly higher, at 85%, among those who are nonadherent. This latter variable is consistent with the data indicating that among the reasons for missing medications is being away from home and busy with other daily activities.

A primary purpose of this survey was to test the feasibility of the two instruments: the baseline and the adherence follow-up questionnaires. The questionnaires took an average of 10 minutes each to complete and 89% and 93% thought the lengths of each (respectively) were fine. Ninety-six and 99% of the patients said that they thought others would be willing to complete the two instruments, respectively.

<span style="color: #999999;">Feb 01, 1998</span>
<h2>Adherence and Effectiveness of Protease Inhibitors in Clinical Practice</h2>
Abstract of Presentation from the 5th Conference on Retroviruses and Opportunistic Infections February 1-5, 1998, Chicago, ILHECHT FM<sup>1</sup>, COLFAX G<sup>2</sup>, SWANSON M<sup>1</sup>, CHESNEY MA<sup>1</sup>

<sup><strong>1</strong></sup><strong>University of California San Francisco, CA and <sup>2</sup>Department of Public Health, SF CA</strong>

<strong>Background:</strong>

Adherence to protease inhibitor containing regimens for HIV infection is thought to be a important factor in determining the effectiveness of treatment, but there is limited data linking adherence to virologic outcomes.

We measured adherence to protease inhibitor (PI) regimens in a public hospital clinic setting, and determined the association between adherence and undetectable HIV viremia.

<strong>Methods:</strong>

In 1-97 and 2-97 we surveyed patients at half of all clinic sessions at the San Francisco General Hospital AIDS clinic. Adherence was measured using a self-administered questionnaire that was reviewed by a trained interviewer for completeness. The questionnaire asked how many doses of protease inhibitors had been missed in each of the past 3 days. Patients were also asked if they took less pills than their doctor told them to take at each dose. A composite adherence measure was produced by calculating the proportion of recommended medication actually taken by patients in the prior 3 days, accounting for both missed and reduced doses.

HIV-1 plasma RNA was measured by the bDNA test (Chiron, limit of detection 500 copies/ml), using measurements requested by physicians the day of the interview or the first measure performed after the interview.

<strong>Results:</strong>

<strong>Table 1: Patient Characteristics (n=135)</strong>
<table style="width: 427px;" border="1" cellspacing="2" cellpadding="3">
<tbody>
<tr>
<th valign="TOP" width="29%"><span style="font-family: Arial;">Characteristic</span></th>
<th valign="TOP" width="26%"><span style="font-family: Arial;">Number</span></th>
<th valign="TOP" width="45%"><span style="font-family: Arial;">Percent</span></th>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Male</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">123</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">91.1 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Race</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">White</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">90</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">67.2 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">African American</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">20</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">14.9 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Latino</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">15</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">11.2 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Median age (years)</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">39.8 years</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">Range 27.0-59.5 years</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">HIV Risk</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">MSM*</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">93</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">68.9 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">IDU*</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">12</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">8.9 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">MSM/IDU</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">11</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">8.1 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Other</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">7</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">14.1 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Baseline CD4**</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">0-100</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">49</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">36.6 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">101-200</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">29</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">21.6 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">201-500</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">39</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">29.1 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">&gt; 500</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">2</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">1.5 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Unknown</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">16</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">11.9 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Baseline median VL (n=61)</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">16060 copies/ul</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Protease Inhibitor</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Saquinavir</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">17</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">13.1 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Indinavir</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">80</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">61.5 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Ritonavir</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">24</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">18.5 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Nelfinavir</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">2</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">1.5 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Saquinavir/Ritonavir</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">7</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">5.4 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Duration of PI Tx</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">205 days</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">Range 60-624 days</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">Adherence to PI Tx</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">100% adherent</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">98</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">72.6 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">80-99% adherent</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">10</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">7.4 %</span></td>
</tr>
<tr>
<td valign="TOP" width="29%" height="13"><span style="font-family: Arial;">&lt; 80% adherent</span></td>
<td valign="TOP" width="26%" height="13"><span style="font-family: Arial;">27</span></td>
<td valign="TOP" width="45%" height="13"><span style="font-family: Arial;">20.0 %</span></td>
</tr>
</tbody>
</table>
* MSM=Men having sex with men and IDU=Injection drug use
** Before starting treatment with protease inhibitors.

<em>Patients: </em>388 patients agreed to fill out the survey (response rate 72%). Of these, 183 had taken protease inhibitors. Of the 183, 135 had taken protease inhibitors for more than 2 months at the time of the interview, and provided a medical record number to match laboratory data with the questionnaire. Overall, 41% of patients had detectable viremia.

<strong>Figure 1: Proportion of Patients with Undetectable Viremia by Adherence</strong>

<em>Multivariate predictors of undetectable viremia:</em> In a multiple logistic regression model controlling for CD4 count prior to beginning PI treatment, type of protease inhibitor, and whether new or changed reverse transcriptase inhibitors were started with the PI, adherence was associated with non-detectable viremia, OR=4.7, 95% CI 1.1 ñ 20.6.

<strong>Conclusions</strong>

(1) The proportion of patients with undetectable viremia was nearly twice as high in patients who reported taking 100% of their recommended protease inhibitor medication in a 3 day period, compared with patients taking less than 80% of medication. Adherence to protease inhibitor treatment is an important predictor of reaching undetectable viremia in clinical practice.

(2) While self-reported adherence is likely underestimate missed doses, a simple self-report measure identifies clinically important non-adherence.

(3) Nearly half our pts had detectable viremia. This is higher than reported in several clinical trials of protease inhibitor regimens, and suggest that the effectiveness of protease inhibitor regimens in clinical practice may be lower than the efficacy of these treatments established in clinical trial settings.

Frederick M. Hecht, MD
UCSF AIDS Program
San Francisco General Hospital
995 Potrero Ave, Ward 84
San Francisco, CA, 94110
Phone:             (415) 476-4082       x.431
Fax: (415) 476-6953
rhecht@sfaids.ucsf.edu]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Middle School Pregnancy/STD/HIV Prevention Program</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Description and Explanation of Study Instrument</h3>

<hr />

Barbara Marín and Cynthia Gomez at the Center for AIDS Prevention Studies at UCSF and Karin Coyle and Doug Kirby at ETR Associates developed this questionnaire as part of an evaluation study.
<h3>Sample:</h3>
The questionnaire was used in a study to evaluate the impact of a middle school pregnancy/STD/HIV prevention program. The sample included students from 19 San Jose middle schools, each with a substantial percentage of Hispanic students. Students were surveyed in the 6th, 7th, 8th and 9th grades (1997-2000). The 6th grade sample included about 2,800 students; more than 80% of these students were surveyed in the 8th grade; more than 60% in the 9th grade. About half the students were in the control group and about half in the intervention group. The sample is ethnically diverse, and includes a large proportion of Hispanic students (about 50%).
<h3>Questionnaire:</h3>
The questionnaire included a large number of questions about sexuality, including questions on the following topics: existence of a boyfriend/girlfriend and age difference of that boy/girlfriend, knowledge about sexual topics, self-efficacy to avoid various sexual behaviors, norms about various sexual behaviors, perceptions of peer behaviors, opportunity to have sex, pressures to have sex, pre-coital sexual behaviors, various measures of sexual behavior, attempts to pressure someone else to have sex, and reasons to have and not to have sex.
<ul>
 	<li><a href="https://web.archive.org/web/20161029004809/http:/prevention.ucsf.edu/uploads/tools/surveys/pdf/marinschoolquest.pdf">Student health questionnaire</a></li>
 	<li><a href="https://web.archive.org/web/20161029004809/http:/prevention.ucsf.edu/uploads/tools/surveys/pdf/encuestamarin.pdf">Encuesta de salud estudiantil</a></li>
</ul>
Data from the 6th grade questionnaire have been presented in:

Marín, B.V., Coyle, K., Gomez, C., Carvajal, S. , Kirby, D. (2000) Older Boyfriends and Girlfriends Increase Risk of Sexual Initiation in Young Adolescents. Journal of Adolescent Health, 27: 409-418.]]></content>
		
		<type>
			6
		</type>
			<url>https://web.archive.org/web/20161029013628//sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/marinschoolquest.pdf</url>
	</node>
	<node>
		<title>Prevention Services for HIV+ Patients Methods</title>
		<tax>1737</tax>
		<content><![CDATA[These surveys have been designed and tested by CAPS scientists and are made available for use by HIV prevention program planners and designers.

<hr /><strong><span style="color: red;">Warning:</span> </strong>Survey needs vary from population to population and project to project. Please consider carefully the needs of your particular intervention before using one of these instruments.

We encourage researchers and service providers to use these instruments, adapting and modifying as you see fit. Please cite CAPS as the source in any presented or published work, and, if the instruments were modified in any way from their original (as downloaded from the CAPS Web site) please note that in any presentations.

<hr />
<h2>Instruments for Prevention Services for HIV+ Patients</h2>
The following exit survey instruments were developed to assess frequency and variation of prevention services as reported by HIV positive patients at Ryan White-funded clinics across the US.
<h3>Reliability and Validity</h3>
This instrument is in a preliminary stage. Therefore, reliability, validity, and scoring systems are not available. The instrument was not designed to have psychometric properties that would enable its use outside of the immediate research setting of the study for which it was designed; however, it is posted in case that provides a platform for other researchers to develop new instruments.
<h3>Methods</h3>
Exit surveys were conducted in 16 Ryan White funded clinics across the country to 618 HIV-infected patients as they left routine visits with their primary care providers. The inclusion criteria were HIV-positive status, patient at the HIV primary care clinic, and able to provide informed consent. The number of patients surveyed ranged from 9 to 69 (mean=39) depending on the patient volume at each clinic and the number of patients who agreed to be surveyed within one-week field visits. Fifty-six (9%) of the exit interviews were conducted in Spanish and the remainder in English. These surveys were anonymous and pre-coded with participant identification codes. Participants received a $10.00 stipend for their participation in this 20 minutes survey. Participants were either recruited directly by interviewers from UCSF or referred by clinic staff, depending on the setting and the confidentiality procedures at each clinic.

The exit surveys were formatted using Teleforms and faxed into a database housed on a web server.
<h3>Computer Based techniques for quantitative data collection for RWPP</h3>
A standardized data management system was used to collect, transfer, store, and edit data for the duration of this project. All components of the data system either read or wrote to a Microsoft SQL Server database. The survey instrument was modified to be machine readable using Cardiff Teleform Software, and all scannable forms were manually filled in by interviewers at the time of the interview, submitted via fax, and identified and evaluated by Teleform Reader. A data verifier then correctly entered any data in fields that the software had difficulty reading. A data querying component, consisting of a custom-written Visual Basic program, then queried the database for problems and generated a table with a record of each problem found. Quantitative interviewers underwent group and individual training to access data queries and modify errors made in survey collection. An audit trail was automatically created for each change made to any field in the database. The final SQL database was then directly read by SAS (Statistical Analysis Software) via an ODBC connection for data analysis. These methods of quality control and assurance ensured data that was of high caliber and timely.]]></content>
        <type>
		</type>
        <url>
        </url>
	</node>	
	<node>
		<title>HOME (Prevention for Women with Incarcerated Partners)</title>
		<tax>1737</tax>
		<content><![CDATA[Please see the <a href="/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/HOMES2C.pdf">Science-to-Community Report</a> on HOME.

Women with incarcerated partners are at particular risk for HIV infection. Their partners are over five times more likely than men in the general population to be HIV+. Incarcerated men also have a high incidence of injection drug use. Women with incarcerated partners are primarily low-income women of color for whom racism, poverty and sexism contribute to increased HIV risk and whose life stressors are exacerbated by their partners' imprisonment.
<h2>Program</h2>
The purpose of the HOME project is to design and test an intervention to reduce HIV risk among women whose male partner is being released from San Quentin State Prison. This study is funded by the National Institute of Nursing Research (NINR). The 12-month HOME intervention ran from February 2005 through January 2006. Weekly activities addressing HIV and STD prevention, women's health, and population-specific topics such as parole information were held at a center for visitors directly outside of the gates of San Quentin.

Eleven women who visit incarcerated men were trained as peer educators and were closely involved with project staff in facilitating weekly activities. We collected data during the intervention period using the same quantitative surveys used in our formative research. We also are comparing participants in two cross-sectional surveys, one conducted immediately prior to the launch of the intervention and one conducted immediately after the intervention left the field. Finally, we conducted longitudinal qualitative interviews with the project peer educators.
<h2>Formative research</h2>
Prior to developing HOME, we conducted several studies with women with incarcerated partners. Based on information gathered in focus groups and pilot studies, we developed an HIV prevention intervention that addresses the specific needs of women with incarcerated partners and facilitates their utilization of community services. This intervention was a peer-led HIV education workshop that provided HIV information, facilitated supportive relationships between visitors and provided referrals as needed. This program and its evaluation are described in a published article (Comfort M, Grinstead OA, Faigeles B, Zack B. Reducing HIV risk among women visiting their incarcerated male partners.<em>Criminal Justice and Behavior</em>, 2000, Vol 21, p. 57-71).

We also conducted a series of cross-sectional surveys of women leaving the prison after visiting. These descriptive surveys showed that women visitors are most often low income women of color and that the majority of visitors are raising children. Survey results also indicated that women are spending a large portion of their income on visiting, phone calls and other costs of maintaining their relationship with an incarcerated man. (Grinstead O, Faigeles B, Bancroft C, Zack B. The financial cost of maintaining relationships with incarcerated men: results from a survey of women prison visitors. <em>Journal of African American Men</em>. 2001.)<a name="video"></a>
<h2>Videotape</h2>
<img src="/sites/prevention.ucsf.edu/files/uploads/projects/Centerforce/images/Inside-Out-medium-res.jpg" alt="Inside Out logo" width="238" height="193" align="textTop" />

In response to our findings that many women are unaware of or minimize the risk of having an incarcerated partner, we created the videotape "Inside/Out: Real Stories of Men and Women and Life After Incarceration." This 17 minute video presents real stories of four women whose partners have been incarcerated and five men who have served time. The video explores the challenges faced by women after their partners are released from prison. Inside/Out focuses on the health risks in prison and highlights the need for honest communication around health issues when planning for the future. The accompanying discussion guide is designed to draw women with incarcerated partners and other at-risk women into a discussion about the risks of partner incarceration and other partner risk issues.

To order a copy of Inside/Out, please visit the <a href="http://www.centerforce.org/materials/index.html" target="_blank">Centerforce web site</a>.
<h2>Research findings</h2>
In an effort to deepen our understanding of how circumstances of forced separation and the interdiction of physical contact affect women's sexual behavior, we investigated the development and maintenance of heterosexual couples' intimacy when the male partner is incarcerated. We recognize that correctional control extends to these women's bodies, both when they are within the facility's walls visiting their mates and when they are at home striving to remain connected to absent men. Using our formative qualitative interviews with 20 women who visit their incarcerated partners and 13 correctional officers who interact with prison visitors, we examined how institutional constraints such as the regulation of women's apparel, the prohibition of physical contact, and the lack of forums for privacy result in couples forging alternative "spaces" in which their relationships occur. Romantic scripts, the build-up of sexual tension during the incarceration period and conditions of parole promote unprotected sexual intercourse and other HIV/STD risk behavior following release from prison. (Comfort M, Grinstead O, McCartney K, Bourgois P, Knight K. You cannot do nothing in this damn place": sex and intimacy among couples with an incarcerated male partner. J Sex Res. 2005 Feb;42(1):3-12.)
<ul>
 	<li>Please see the <a href="/sites/prevention.ucsf.edu/files/uploads/pubs/reports/pdf/HOMES2C.pdf">Science-to-Community Report</a> on HOME.</li>
 	<li>See the <a href="/sites/prevention.ucsf.edu/files/uploads/conference/2005/ppt/HOME.ppt">slide show presentation on HOME</a> from the 2005 CAPS Community Briefing.</li>
</ul>
<h2>Instruments</h2>
The following research instruments were used for the HOME study.
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOMELongitudinalbaseline.2.1.05.pdf">Longitudinal survey - baseline</a> (We administered these to women visiting their incarcerated partners at the prison under study. Women completed the baseline while their partner was incarcerated and they completed the follow-up 30 days after their partner was released from custody.)</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOMELBFUfieldversion.pdf">Longitudinal survey - follow-up</a></li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/HOMECross-sectionalsurveyFinal2006.pdf">Cross-sectional survey</a> (We administered this survey to women visiting incarcerated men at the prison under study before our intervention began and after our intervention ended to measure community impact.)</li>
</ul>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Enhancing Prevention with Positives Evaluation Center (EPPEC)</title>
		<tax>1737</tax>
		<content><![CDATA[<strong><span style="color: #ff0000;">NOTE: This study has ended.</span></strong>

The <strong>Enhancing Prevention with Positives Evaluation Center (EPPEC)</strong> is a technical assistance and evaluation center for <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/enhancing-prevention-with-positives-evaluation-center-eppec/eppec-sites/ ">15 demonstration sites </a>funded by the Special Projects of National Significance (SPNS) program of the Health Resources and Services Administration (HRSA). The 15 demonstration sites work with EPPEC and the SPNS program at HRSA to implement and evaluate HIV prevention interventions with HIV-infected patients in primary health care settings. A multidisciplinary team led by the UCSF AIDS Policy Research Center is carrying out the project. Each of the participating sites reports client, provider, organizational setting and intervention characteristics, as well as the results of behavior change surveys and other core measures.

What is unique about this project is that each of the 15 sites is implementing a different intervention specifically tailored to the local client population and environment. Interventions range from brief counseling delivered by primary care providers during regular visits to individual risk reduction counseling delivered by prevention specialists, and to peer-led group sessions. Some sites are using a combination of models and several sites are delivering intervention services in more than one clinical setting.

The specific aims for EPPEC are:
<ol>
 	<li><a href="/sites/prevention.ucsf.edu/files/resources/project-websites/enhancing-prevention-with-positives-evaluation-center-eppec/evaluation/">Evaluation: </a>To facilitate and conduct evaluation research that will have maximum impact on practice and policy of HIV prevention across 15 demonstration sites.</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/resources/project-websites/enhancing-prevention-with-positives-evaluation-center-eppec/technical-assistance/">Technical Assistance: </a>To provide methodological (both quantitative and qualitative) research design and technical assistance on the development of behaviorally based interventions, assist sites in design of data collection and management systems, and provide a central database for measurement of outcomes.</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/resources/project-websites/enhancing-prevention-with-positives-evaluation-center-eppec/dissemination/">Dissemination: </a>To synthesize and disseminate findings from demonstration projects to maximize their impact on further prevention research, practices and policies.</li>
 	<li>Capacity: To stimulate innovative projects, scientific excellence, and organizational capacity to ensure integrity of research and sound fiscal operations.</li>
</ol>
EPPEC is working to analyze, synthesize and disseminate findings from demonstration projects so that they have optimum impact on further prevention research, practices and policies.
<h2><a name="findings"></a>Findings</h2>
Nearing the end of the interventions at the demonstration sites, analysis of quantitative baseline data indicates that providers of primary care and support services in HIV clinical settings have a potential role in HIV prevention. Providers are more likely to deliver PwP if they feel responsible for doing so; providers are less likely to deliver PwP if they express prevention fatalism, the belief that no matter how much counseling is delivered, some HIV+ patients will still infect others. Among all HIV+ patients enrolled in the study–MSM, MSW and women–stimulant use is associated with risk.

Through analysis of pre-implementation qualitative data collected through interviews with project staff and interventionists at the demonstration sites we identified the following common elements to successfully implement complex behavioral interventions in clinical settings:
<ul>
 	<li>Internal leadership and authority to overcome resistance and foster interest and motivation on the
part of clinical providers and clinic staff,</li>
 	<li>Shared belief in importance, need, viability, and appropriateness of PwP in clinical setting,</li>
 	<li>Adequate attention to creating flow between clinic practice and intervention,</li>
 	<li>Ongoing training within the clinic that can address clinician and staff needs as prevention programs become a regular part of the care.</li>
</ul>
Successful implementation depends on the complementary fit between the intervention model and the clinical setting. Assessing the feasibility of whether or not a clinic has the support of providers, staff and patients–as well as the financial resources–is the first step in determining the potential success of implementing an intervention. Developing interventions that resonate with the patient population and the clinical environment will lead to great willingness from and meaningful experience for participants.

Please see the following articles for more detail:
<ul>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/EPPEC/pdf/KoesterPwPAIDSBehav.pdf">Implementation of HIV Prevention Interventions with People Living with HIV/AIDS in Clinical Settings: Challenges and Lessons Learned</a>. AIDS and Behavior, 2007</li>
 	<li><a href="/sites/prevention.ucsf.edu/files/uploads/projects/EPPEC/pdf/StewardFatalismAIDSBehav.pdf">Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings</a>. AIDS and Behavior, 2006</li>
 	<li><a href="http://www.ask.hrsa.gov/detail.cfm?PubID=HAB00430%20" target="_blank">Order a copy</a> of the Special Supplement to <em>AIDS and Behavior </em>with all the EPPEC articles.</li>
</ul>
<h2>Staff</h2>
Meet the <a href="/sites/prevention.ucsf.edu/files/resources/project-websites/enhancing-prevention-with-positives-evaluation-center-eppec/staff/">EPPEC staff </a>.

HRSA-SPNS funding for EPPEC began in October 2002 and will continue until September 2007. The funding for the 15 demonstration project sites began in October 2003 and will continue until September 2007.

For more information, please contact:

Jennifer Bie, Project Assistant
Center for AIDS Prevention Studies
50 Beale Street, Suite 1300
San Francisco, CA 94105
415/597-9213 - fax
415/597-9285 - phone
<a href="mailto:jennifer.bie@ucsf.edu"> jennifer.bie at ucsf.edu</a>]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Coping Self-Efficacy Scale - Scoring</title>
		<tax>1737</tax>
		<content><![CDATA[<em><em>The Coping Self-Efficacy Scale (CSES)</em></em> is a 26-item measure of perceived self-efficacy for coping with challenges and threats.  The scale items were developed by several of the authors (Margaret Chesney, Susan Folkman, and Jonelle Taylor) by creating sample items based upon stress and coping theory and the Ways of Coping Questionnaire, with consultation from Dr. Albert Bandura of Stanford University.  Items were refined based on pilot testing for face validity both with staff at the Center for AIDS Prevention Studies at the University of California, San Francisco, and with a sample of HIV-infected participants.

Respondents are asked, “When things aren’t going well for you, or when you’re having problems, how confident or certain are you that you can do the following:”   They are then asked to rate on an 11-point scale the extent to which they believe they could perform behaviors important to adaptive coping.  Anchor points on the scale are 0 (‘cannot do at all’), 5 (‘moderately certain can do’) and 10 (‘certain can do’).

An overall CSES score is created by summing the item ratings (α = .95; scale mean = 137.4, <em><em>SD</em></em> = 45.6)<a name="FN2"></a><a name="FN3"></a>.  Our standard scoring rule with summated rating scale scores is that respondents must answer at least 80% of the scale items.  For respondents missing an item or items, we estimate an individual’s score for the missing item(s) by adding in their mean for the items that they answered for each item that they skipped, resulting in a “corrected sum.”]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/uploads/tools/surveys/pdf/CopingSelf-EfficacyScale.pdf</url>
	</node>
	<node>
		<title>Superinfección</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿Qué sabemos acerca de la superinfección por VIH?</h3>
revisado 5/06
<h4>¿qué son la infección dual, la coinfección y la superinfección?</h4>
La infección dual ocurre cuando una persona está infectada por dos o más cepas del VIH. Dicha persona puede haber adquirido ambas cepas simultáneamente de una pareja con infección dual o bien de varias parejas. Una cepa diferente del virus es aquella que se distingue genéticamente de la primera en un árbol “familiar” o filogenético.

A la adquisición de distintas cepas del VIH de varias parejas muchas veces se le llama coinfección, si todas las cepas del virus fueron adquiridas anteriormente a la seroconversión, es decir, mucho antes de que se reconozca la presencia de cualquier infección por VIH.

Se llama superinfección a la adquisición de distintas cepas del VIH de varias parejas si el segundo virus se adquiere después de la seroconversión, o sea, cuando la primera cepa del virus ya se encuentra establecida.<sup>1</sup> La superinfección y la reinfección significan lo mismo.

Las infecciones duales pueden manifestarse de forma secuencial, lo cual puede hacer que la coinfección se parezca a la superinfección. Puede ser que las infecciones duales de expresión secuencial (IDES) ocurran porque las respuestas inmunológicas contra el virus predominante permiten la manifestación de otras cepas del virus presentes en el cuerpo. También pueden suceder cambios aleatorios en poblaciones de virus que evolucionan, lo cual puede parecerse a la superinfección aunque ambas cepas hayan estado presentes desde el principio.
<h4>¿por qué es importante la superinfección?</h4>
La superinfección tiene importancia porque podría provocar la resistencia medicamentosa en personas VIH+, y tal vez lleve a un avance más rápido de la enfermedad.<sup>2,3</sup> La investigación sobre el momento en que puede darse o no darse la superinfección podría identificar tipos de respuestas inmunológicas que protejan contra la infección, guiando así el diseño de vacunas contra el VIH.

Muchas personas VIH+ que tienen parejas VIH+ preguntan sobre la superinfección. Los funcionarios de salud pública necesitan información sobre la superinfección para poder ayudar a las personas a entender los posibles riesgos del contacto sexual sin protección entre personas VIH+, sin infundirles temores injustificados que perjudiquen su relación de pareja y la revelación de su condición de VIH a parejas potenciales.
<h4>¿puede producirse la superinfección?</h4>
Muchos científicos creen que la superinfección puede suceder. La investigación en monos indica que puede darse la superinfección con otros virus parecidos al VIH.<sup>4,5</sup> Las dieciséis personas con IDES (superinfección aparente) que han sido identificadas en la literatura científica, incluyen consumidores de drogas en Asia, mujeres en África y hombres en Europa y en EE.UU. Los análisis de laboratorio en algunos de estos informes sugieren que el segundo virus que apareció dichas personas no estuvo presente con anterioridad en la infección, lo cual sugiere la superinfección. La sensibilidad de estos análisis de laboratorio es limitada y las parejas causantes de la infección no han sido identificadas, por lo que no se puede saber con certeza en qué momento se adquirió el segundo virus.
<h4>¿quiénes corren el mayor riesgo?</h4>
El 95% de los casos aparentes de superinfección han ocurrido durante los primeros tres años de infección.<sup>6-9</sup> Estudios han detectado pruebas de superinfección entre el 2% y el 5% de las personas durante el primer año de infección. El tratamiento intermitente de las infecciones agudas o recientes por VIH puede prolongar la susceptibilidad a la superinfección.<sup>10,11</sup>

En cambio, los estudios realizados en personas con infecciones de más largo plazo no han encontrado evidencia alguna de superinfección. Un estudio no dio con ningún caso al cabo de 1,072 años-persona de observación.<sup>12</sup> Otro no reveló ninguno después de 215 años-persona de observación de consumidores de drogas intravenosas.<sup>13</sup> Un tercer estudio no encontró caso alguno tras 233 años-persona y 20,859 exposiciones por contacto sexual sin protección.<sup>14</sup>

Es posible que las personas con una carga viral muy baja sean más susceptibles a la superinfección. Las respuestas inmunológicas antivirales y la interferencia viral son menores en personas con carga viral baja, por lo que la superinfección puede ocurrir con más frecuencia en esta población.<sup>15</sup> Se necesita más investigación al respecto para confirmarlo.
<h2>¿es malo tener más de un virus?</h2>
La infección dual puede perjudicar la salud de las personas VIH+. Los individuos superinfectados pueden tener una carga viral más alta y un recuento de CD4 más bajo, lo cual acelera la evolución de la enfermedad.<sup>2,3</sup> Esta evolución puede acelerarse después de la aparición de un segundo virus.<sup>1</sup>

La superinfección también puede afectar el tratamiento del VIH, ya que ésta aumenta la probabilidad de resistencia medicamentosa.<sup>16</sup> Las personas VIH+ con infección dual pueden no responder tan bien a los medicamentos antirretrovirales actuales por tener cepas de virus resistentes.
<h4>¿qué nos falta por conocer?</h4>
Todavía falta mucho por aprender sobre la superinfección. Primero, necesitamos saber con más seguridad si la superinfección realmente ocurre o no entre las personas VIH+. No se ha documentado ningún caso definitivo de superinfección, para lo cual sería necesario poder vincular el momento de la segunda infección con el inicio de una relación sexual nueva.

Segundo, necesitamos entender cómo y cuándo se da la superinfección. Entre los investigadores se va creando consenso sobre la idea de que las personas VIH+ en la primera etapa de infección -y durante el primer año en particular- pueden correr un mayor riesgo de superinfección que otras personas VIH+ con infección crónica.<sup>17</sup> También debemos determinar si las personas con una carga viral suprimida durante el tratamiento son susceptibles a la superinfección.

Tercero, es preciso saber cómo proteger al individuo contra la superinfección. Si ésta ocurre rara vez o únicamente en la etapa de infección reciente, es importante determinar los mecanismos que hacen a una persona VIH+ inmune de adquirir un segundo virus. Sería importante saber si la exposición a diferentes cepas virales podría brindar inmunidad protectora contra la superinfección.<sup>18</sup>

Finalmente, debemos continuar actualizando y divulgando datos científicos sobre la superinfección, sus causas y consecuencias tanto a las personas VIH+ como a los profesionales médicos que las atienden.
<h4>¿qué podemos recomendar actualmente?</h4>
La consejería sobre la superinfección debe de basarse en un entendimiento de las relaciones sexuales del individuo. Antes de ofrecerle asesoría acerca de la superinfección, el consejero debe saber si el individuo está en una relación de pareja continua con una persona VIH+, si la persona busca habitualmente a otras personas VIH+ para tener sexo sin protección, y si revela su condición de VIH+ a parejas potenciales. Estos antecedentes deben guiar la conversación sobre los riesgos y beneficios del contacto sexual entre parejas VIH+. Si el consejero no tiene tiempo suficiente para considerar estos aspectos personales, sería mejor que se limitara a decir: “Hay una falta información sobre la superinfección. Si de hecho ocurre, lo más probable es que se dé en los primeros años después de contraer la primera infección. Después, es raro que ocurra.”

Se sabe aun menos sobre la superinfección causada al compartir jeringas, pero cabe esperar el mismo patrón de alto riesgo inicial seguido de un riesgo menor durante la etapa de infección crónica. Sin embargo, ya que los consumidores de drogas intravenosas corren un alto riesgo de infección por hepatitis C al inyectarse con jeringas previamente usadas, es importante enfatizar los esfuerzos para obtener equipos esterilizados de los programas de intercambio de jeringas.

Los interesados deben ser remitidos a los estudios de investigación actuales con el fin de reducir las considerables lagunas de información.<sup>19</sup>

Las personas con varias parejas sexuales, o cuyas parejas tienen varias parejas sexuales, deben recibir asesoría sobre los riesgos de contraer otras infecciones de transmisión sexual. Se les debe recomendar vacunarse contra la hepatitis B y hacerse pruebas periódicas de detección de sífilis.

<hr />

<h2>¿quién lo dice?</h2>
1. Smith DM, Richman DD, Little SJ. HIV superinfection . Journal of Infectious Diseases. 2005;192:438-444.

2. Gottlieb GS, Nickle DC, Jensen MA, et al. Dual HIV-1 infection associated with rapid disease progression . The Lancet. 2004;363:610-622.

3. Grobler J, Gray CM, Rademeyer C, et al. Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype c-infected female sex workers . Journal of Infectious Diseases. 2004;190:1355-9.

4. Otten RA, Ellenberger DL, Adams DR, et al. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina model . Journal of Infectious Diseases. 1999;180:673-84.

5. Fultz PN, Srinivasan A, Greene CR, et al. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus . Journal of Virology. 1987;61:4026-4029.

6. Angel JB, Hu YW, Kravcik S, et al. Virological evaluation of the ‘Ottawa case’ indicates no evidence for HIV-1 superinfection . AIDS. 2004;18:331-334.

7. Smith DM, Wong JK, Hightower GK, et al. Incidence of HIV superinfection following primary infection . Journal of the American Medical Association. 2004;292:1177-1178.

8. Hu DJ, Subbarao S, Vanichseni S, et al. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand . AIDS. 2005;19:303-308.

9. Grant R, McConnell J, Marcus J, et al. High frequency of apparent HIV-1 superinfection in a seroconverter cohort. 12th Conference on Retroviruses and Opportunistic Infections. 2005. Abst #287.

10. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus . Nature. 2002;420:434-439.

11. Jost S, Bernard M, Kaiser L, et al. A patient with HIV-1 super-infection . New England Journal of Medicine. 2002;347:731-736.

12. Gonzales MJ, Delwart E, Rhee SY, et al. Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation . Journal of Infectious Diseases. 2003;188:397-405.

13. Tsui R, Herring BL, Barbour JD, et al. Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure . Journal of Virology. 2004;78:94-103.

14. Grant R, McConnell J, Herring B, et al. No superinfection among seroconcordant couples after well-defined exposure. International Conference on AIDS, Bangkok, Thailand, 2004. Abst #ThPeA6949.

15. Marcus J, McConnell J, Liegler T, et al. Highly divergent viral lineages in blood DNA appear frequently during suppressive therapy in persons exposed to superinfection. 13th Conference on Retroviruses and Opportunistic Infections. 2006. Abst #297.

16. Smith DM, Wong JK, High-tower GK, et al. HIV drug resistance acquired through superinfection . AIDS. 2005;19:1251-1256.16. Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity. AIDS. 2004;18:1513-1520.

17. Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity . AIDS. 2004;18:1513-1520.

18. McConnell J, Liu Y, Kreis C, et al. Broad neutralization of HIV-1 variants in couples without evidence of systemic superinfection. 13th Conference on Retroviruses and Opportunistic Infections. 2006. Abst #92.

19. HIV+ persons who have HIV+ partners residing or visiting San Francisco can call the Positive Partners Study 1-415-734-4878.

<hr />

<strong>Preparado por Robert M. Grant MD, J. Jeff McConnell MA Gladstone Institute of Virology and Immunology, UCSF</strong>

<strong>Traducción: Rocky Schnaath</strong>

Mayo 2006. Hoja Informativo #56SR]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Mujeres transgénero</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>¿qué necesitan las personas transgénero de masculino a femenino (MAF) para prevenir el VIH?</h3>
<h4>¿qué significa ser transgénero?</h4>
Transgénero es un término amplio que se refiere a las personas que no pueden o no quieren conformarse con las normas sociales asociadas a su sexo físico.<sup>1</sup> Estas personas poseen una identidad, expresión o comportamientos que no se relacionan tradicionalmente con su sexo de nacimiento. Las personas transgénero tienen diferentes grados o niveles de “transformación genérica” y viven conforme al género que han escogido autoidentificándose ya sea como: mujeres, hombres, transmujeres, transhombres, transexuales sin operarse, transexuales preoperadas, transexuales operados u operadas (reasignación sexual quirúrgica) o transvestistas, entre otras identidades. Estos términos varían según la región y la época.

Esta hoja informativa se concentra en las personas transgénero de Masculino a Femenino (MAF) debido a que tienen mayores índices de riesgo de infección por VIH que las de Femenino a Masculino.
<h4>¿tienen riesgos las MAF?</h4>
Sí. Las MAF tienen un alto riesgo de infección por VIH. En 1997 las tasas de infección de MAF en San Francisco fueron de un 35% y de un 22% en 1998 en Los Angeles.<sup>2,3</sup> Un estudio realizado en Atlanta con trabajadoras sexuales MAF encontró que un 68% eran VIH positivas.4 Las tasas de infección entre las MAF continúan en aumento. Se estima que el porcentaje de nuevas infecciones varía entre el 3% y el 8% anual.<sup>3,5</sup> Las MAF Afroamericanas tienen un índice de infección más alto que otros grupos étnicos y raciales.<sup>2-5</sup>

El uso de drogas inyectables también es común entre las MAF y eso las pone aún más a riesgo. En un estudio realizado en San Francisco, el 18% de las participantes respondieron que habían usado drogas inyectables durante los últimos seis meses y la mitad de éstas compartieron sus jeringas.<sup>2</sup> Las MAF pueden también inyectarse hormonas para afeminar sus cuerpos. El riesgo de infección por el uso de hormonas inyectadas varía regionalmente. En Nueva York se reporta un riesgo mayor que en San Francisco debido a las diferencias en el acceso a las hormonas y a jeringas apropiadas.<sup>2,6</sup> En San Francisco, los programas de intercambio de jeringas ofrecen jeringas adecuadas para la inyección de hormonas y clínicas ofrecen terapia hormonal gratis o de bajo costo.
<h4>¿qué pone a las MAF en riesgo?</h4>
La transfobia o sea la estigmatización social generalizada hacia las MAF, aumenta enormemente su riesgo de infección. Esta intensa estigmatización las marginaliza socialmente y redunda en que se les niegue oportunidades de educación, empleo y vivienda.<sup>7,8</sup> También les crea múltiples barreras para el acceso a los servicios de salud. Esta marginalización disminuye la autoestima de las MAF, incrementa la probabilidad de que se prostituyan para sobrevivir y reduce sus posibilidades de practicar sexo protegido.<sup>9</sup> Todo esto se refleja en las altas tazas de MAF de infección por el VIH y otras enfermedades de transmisión sexual, uso de drogas e intentos de suicidio.

Las MAF tienen relaciones sexuales principalmente con hombres y de forma anal receptiva, lo cual, también aumenta su riesgo.<sup>2,3,10</sup> Algunas MAF que son trabajadoras sexuales no usan condones si sus clientes les ofrecen más dinero;8 sin embargo, algunos estudios han demostrado que la mayoría de las prácticas sexuales sin protección no ocurren con sus clientes sino con sus parejas.<sup>3</sup>
<h4>¿cuáles son las barreras a la prevención?</h4>
La pobreza, la baja autoestima, la depresión, el rechazo, el aislamiento y la falta de poder son factores psicosociales que las propias MAF han citado como barreras para la reducción de riesgos respecto al VIH y al uso de drogas. Por ejemplo, muchas MAF dicen que el sexo sin protección reafirma su identidad con el género femenino y aumenta su autoestima.<sup>10,11</sup>

Para muchas MAF asegurar empleo y vivienda es más imperante que prevenir el VIH. Estas necesidades deben ser atendidas para que los esfuerzos de prevención sean eficaces.<sup>11</sup>

Muchas MAF no acuden a los servicios de prevención del VIH o de salud debido a la falta de sensibilidad de los proveedores de salud<sup>11,12</sup> o bien porque tienen miedo de ser descubiertas como transgénero.<sup>13</sup> Debido a la transfobia, algunos programas de prevención para las MAF han tenido dificultades para alquilar un local.
<h4>¿qué se está haciendo?</h4>
El proyecto “Transgender Resources and Neighborhood Space (TRANS)” del Centro de Estudios para la Prevención del SIDA en San Francisco, CA, imparte talleres para las MAF sobre el abuso de drogas, el VIH, el sexo comercial, cómo cuidarse a sí mismas y cómo sobrevivir al medio. Ofrece también un centro donde las MAF pueden descansar, bañarse y socializar. Todas las actividades son facilitadas por promotores de salud. Este proyecto colabora con un programa de la agencia Walden House para que las MAF con adicción a las drogas se recuperen, el cual les ofrece una terapia más amplia, consejería, programas de mentores y adiestramiento sobre las destrezas indispensables para subsistir de acuerdo a las necesidades de las propias MAF.<sup>14</sup>

El Programa de Sexualidad Humana (PHS por sus siglas en inglés) de la Universidad de Minnesota desarrolló y evaluó un proyecto comunal para las MAF basado en el modelo de Creencias sobre la Salud (Health Belief) y en el erotismo del sexo con protección. Aunque fue bien recibido, las participantes reafirmaron la necesidad de una perspectiva más amplia que incorpore todos los aspectos de la salud ya que eran más importantes sus preocupaciones sobre el género que sobre el VIH. Ahora el PHS ofrece talleres sobre “Salud para todos los géneros” basados en un modelo de salud sexual que ubica los riesgos del VIH en el contexto de la vida de las participantes y toca temas como la estigmatización, los encuentros románticos, el desempeño sexual, el abuso de sustancias y la violencia. El programa combina la educación con el entretenimiento, y presenta a MAF que son celebridades y profesionales de la salud.<sup>15</sup>

El programa “Transgender Harm Reduction” en West Hollywood, CA, tiene promotores de salud y de alcance para MAF de alto riesgo que viven tanto en las calles como en los suburbios. También cuenta con talleres para desarrollar destrezas, mentoría y adiestramiento laboral. Los talleres incluyen temas sobre higiene y arreglo personal, legalización y documentación, cuidado de la salud y terapia hormonal y reducción del riesgo para contraer el VIH. El programa maneja de manera implícita la importancia de aumentar la autoestima para poder adoptar comportamientos más seguros.<sup>16</sup>

Desde 1993, “Gender Identity Support Services for Transgenders (GISST)” en Boston, MA, ha prestado servicios a las personas VIH- y VIH+. GISST provee educación sobre el SIDA, pruebas de VIH, tratamientos para evitar el consumo del alcohol y las drogas, consejería, adiestramiento laboral, destrezas para socializar, consejería sobre la aceptación social y la identidad de género. Patrocinan almuerzos sobre temas como la cirugía y las hormonas, con invitados especiales, videos o con personas transgénero que comparten sus experiencias.<sup>17</sup>
<h4>¿qué más hay por hacer ?</h4>
El temor social y la intolerancia hacia MAF limitan enormemente a muchas de ellas para que tengan una vida sana. Algunas ciudades y estados han decretado leyes contra la discriminación de personas transgénero para la vivienda y el empleo. Las entidades sin dichas legislaciones deben de considerar tenerlas. Estos cambios se han producido gracias al activismo y la intervención de las personas transgénero.

Se debe desarrollar y evaluar programas de pares (peer based) para las MAF que incluyan: 1) trabajo de promoción de salud para las prostitutas que trabajan en las noches y las madrugadas; 2) programas de intercambio de jeringas apropiadas para la inyección de hormonas; 3) intervenciones individuales y grupales sobre las barreras psicosociales para la prevención del VIH. Contratar y adiestrar a MAF en programas de prevención, no sólo proveería una fuente de empleo muy necesitada, sino que ofrecería programas de prevención del VIH apropiados culturalmente.<sup>12</sup>

Si la terapia hormonal se hace más accesible, se podría motivar a las MAF a que utilicen los servicios de salud, en los que a su vez, podrían obtener información para la prevención del VIH. Estas intervenciones pueden ser más eficaces si se combinan con programas de empleo, vivienda y educación. Los esfuerzos de prevención deben incluir a las parejas y amigos de las MAF.

Las MAF no han sido incluidas en los sistemas de clasificación del VIH del CDC (Centro para el Control y Prevención de Enfermedades). Aparecen como hombres que tienen sexo con hombres o como mujeres heterosexuales. Se deben incluir categorías específicas para las personas transgénero en todos los formularios federales y locales para recaudar datos.

Hay una necesidad enorme de adiestramientos sobre comunidad transgénero que sensibilicen a todos los proveedores de servicios públicos como médicos, enfermeras, personal de las clínicas (recepcionistas), la policía y los empleados de los servicios de emergencias (paramédicos, bomberos). Abogar para aumentar el acceso a servicios de salud y realizar investigaciones, trabajo político y educación que sean culturalmente apropiados, se han citado como factores que mejoran la salud de las personas transgénero.<sup>18</sup>

<hr />

<h3>¿Quién lo dice?</h3>
1. Gender Education and Advocacy. Gender Variance: A Primer. 2001. www.gender.org/ resources/dge/gea01004.pdf

2. Clements-Nolle K, Marx R, Guzman R, et al. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons in San Francisco: Implications for public health intervention. American Journal of Public Health. 2001;91:915-921.

3. Simon PA, Reback CJ, Bemis CC. HIV prevalence and incidence among male-to-female transsexuals receiving HIV prevention services in Los Angeles County (letter). AIDS. 2000;14: 2953-2955.

4. Elifson KW, Boles J, Posey E, et al. Male transvestite prostitutes and HIV risk. American Journal of Public Health. 1993;83:260-262.

5. Kellogg TA, Clements-Nolle K, McFarland W, et al. Incidence of Human Immunodeficiency Virus (HIV) among male-to-female transgendered persons in San Francisco. Journal of the Acquired Immune Deficiency Syndromes. in press.

6. McGowan CK. Transgender needs assessment. The HIV Prevention Planning Unit of the New York City Department of Health. December 1999.

7. Green J. Investigation into Discrimination against Transgendered People: A Report by the Human Rights Commission, City and County of San Francisco. 1994;1:8-10 &amp; 43-52.

8. Nemoto T, Luke, D, Mamo L, et al. HIV risk behaviors among maleto-female transgenders in comparison with homosexual or bisexual males and heterosexual females. AIDS Care.1999;11:297-312.

9. Bockting WO, Robinson BE, Rosser BR. Transgender HIV prevention: a qualitative needs assessment. AIDS Care. 1998;10:505-525.

10. Boles J, Elifson KW. The social organization of transvestite prostitution and AIDS. Social Science and Medicine. 1994;39:85-93.

11. Clements-Nolle K, Wilkinson W, Kitano K. HIV Prevention and Health Service Needs of the Transgender Community in San Francisco. In W. Bockting &amp; S Kirk editors: Transgender and HIV: Risks, prevention and care. Binghampton, NY: The Haworth Press, Inc. 2001; in press.

12. Feinberg L. Trans health crisis: for us it’s life or death. American Journal of Public Health. 2001;91:897-900.

13. Xavier J. The Washington Transgender Needs Assessment Survey. Administration for HIV &amp; AIDS, District of Columbia Government. 2000.

14. UCSF CAPS, Health Studies for People of Color. Contact Joanne Keatley 415/476-2364.

15. Bockting WO, Rosser S, Coleman E. Transgender HIV prevention: a model education workshop. Journal of the Gay and Lesbian Medical Association. 2000;4:175-183. http://www.med.umn.edu/fp/ AGH.htm

16. Reback K, Lombardi EL. HIV risk behaviors of male-to-female transgenders in a communitybased harm reduction program. International Journal of Transgenderism. 1999;3:1+2.

17. Hope Mason T, Connors MM, Kammerer CA. Transgenders and HIV risks: needs assessment. Prepared by the Massachusetts Department of Public Health, HIV/AIDS Bureau. August 1995. GISST: 617/720-3413.

18. Lombardi E. Enhancing transgender health care. American Journal of Public Health. 2001;91:869-872.

<strong>PREPARADO POR JOANNE KEATLEY, MSW* Y KRISTEN CLEMENTS-NOLLE, MPH**, TRADUCIÓN MATEO RUTHERFORD Y ROY ROJAS *CAPS, **SF DEPARTAMENTO DE SALUD PÚBLICA</strong>

<hr />

Se autoriza la reproducción (citando a UCSF) mas no la venta de copias este documento. Para obtener copias llame al National Prevention Information Network al 800/458-5231 o visite www.prevention.ucsf.edu También disponibles en inglés. Comentarios o preguntas pueden dirigirse a: CAPSWeb@psg.ucsf.edu ©Enero 2002, UCSF.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2016/12/transgeneroFS.pdf</url>
	</node>
	<node>
		<title>CAPS Brochure (2016)</title>
		<tax>1737</tax>
		<content><![CDATA[The Center for AIDS Prevention Studies (CAPS) at University of California San Francisco (UCSF) is a productive, vibrant, and innovative organization committed to conducting cutting-edge, high-impact HIV prevention research. It is the largest research center in the world devoted to social, behavioral, and policy-based approaches to HIV prevention.

<a href="/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/01/CAPS-Brochure-Rev4-Final-0831.pdf" target="_blank" rel="noopener noreferrer">Download full brochure PDF here.</a>]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/01/CAPS-Brochure-Rev4-Final-0831.pdf</url>
	</node>
	<node>
		<title>Project STYLE (“Strength Through Youth Livin’ Empowered”)</title>
		<tax>1737</tax>
		<content><![CDATA[Young Black men who have sex with men (MSM) have high rates of HIV infection and are less likely to receive HIV treatment than men of other racial groups. Men who have sex with men (MSM) represented 82% of all new HIV infections in 2015, and 92% among males ages 13-24.  New infections increased 26% among young MSM between 2008 and 2011, largely driven by an increase from 3,762 diagnoses in 2008 to 4,619 diagnoses among in 2011 among young Black MSM.  Fortunately<span style="text-decoration: line-through;">,</span> by 2014, rates of new HIV diagnoses among Black MSM stabilized, increasing less than 1%, and HIV diagnoses among young Black MSM men declined 2%. However, young Black MSM are still seven times more likely to be unaware of their HIV infection, compared to young MSM of other ethnic or racial groups.

Researchers have identified multiple reasons that affect linkage to and engagement in healthcare among people living with HIV. Barriers to care occur at different social levels and include: individual (e.g., stigma), interpersonal (e.g., medical mistrust), social/ community level (e.g., lack of social support), and structural (e.g., lack of insurance or transportation to physician) issues.

The University of California, San Francisco PRC is collaborating with a local CBO that is implementing an adaptation of “Strength Through Youth Livin’ Empowered” (STYLE), which has shown to be effective in improving engagement in HIV healthcare among young Black and Latino MSM living with HIV. The local STYLE adaptation is called “M+” and addresses HIV-related health disparities among African Americans.  STYLE seeks to diagnose, engage, and retain black MSM, prioritizing young MSM, living with HIV in primary healthcare services in Alameda County, California and adjacent counties.

<strong>Project Identifier</strong> “Strength Through Youth Livin’ Empowered” (STYLE)

<strong>Funding Source</strong> PRC Program

<strong>Project Status</strong> Active

<strong>Host Institution</strong> University of California, San Francisco

<strong>Health Topics</strong> HIV/AIDS &amp; STD prevention | Sexual health

<strong>Research setting:</strong> City/Town |Medical or clinical site

<strong>Race or ethnicity</strong> African American or Black

<strong>Gender</strong> Males

<strong>Age group</strong> Adolescents (12-17 years) | Young adults (18-24 years) |Adults (25+)

<strong>Contact Information Center</strong>
UCSF Prevention Research Center
3333 California Street, Suite 1300
San Francisco, CA 94143

<strong>Principal Investigator and PRC Director</strong>
Marguerita Lightfoot
Phone: 415-502-1000 ext. 17160 (vm only)
<a class="tp-link-policy" href="mailto:marguerita.lightfoot@ucsf.edu">marguerita.lightfoot@ucsf.edu</a>]]></content>
		
		<type>
			1
		</type>
			<url>https://www.cdc.gov/prc/center-descriptions/center/university-california-sanfrancisco.htm</url>
	</node>
	<node>
		<title>SIP14-013 Understanding barriers to colorectal cancer screening in South Asians</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Project Director/Lead Investigator</strong>: Ma Somsouk (UCSF PI); Susan L. Ivey (UCB Project Director/Co-PI); Scarlett Lin Gomez (CPIC Project Director/Co-PI); Marguerita Lightfoot, PhD (UCSF PRC PI)

<strong>Specific Aim 1</strong>: We will conduct a community-based participatory research (CBPR) study to better understand specific patient attitudes and knowledge about cancer; knowledge about colorectal cancer prevention and detection; acceptability of different modalities of colorectal screening (stool-based testing versus endoscopic testing); barriers and facilitators to screening; access and use of health services; and health information seeking behavior. Building upon existing community-academic partnerships, we will:
<ul>
 	<li><em>Sub-Aim 1: </em>Convene a CAB of patients, family members, and providers from local South Asian communities to provide input and guidance during all phases of the study. All focus group and interview domains and questions will be reviewed by community advisors prior to use.</li>
 	<li><em>Sub-Aim 2: </em>Conduct 8 focus groups (FGs) among South Asian men and women (e.g., Asian Indian, Pakistani, and Bangladeshi groups in the San Francisco Bay area) to understand patient perceptions of cancer, cancer risks, and colorectal screening modalities.</li>
 	<li><em>Sub-Aim 3: </em>Conduct a series of 10 interviews with local community providers and cancer experts to understand contextual and system-level factors in cancer prevention strategies and how they may affect low adherence to CRC screening in South Asian men and women, and to assess relevant interventions, strategies, and messages for improving uptake of colorectal cancer screening among South Asian men and women.</li>
</ul>
<strong>Specific Aim 2</strong>: We will apply novel classification techniques to analysis of existing population based data to identify subgroups of South Asians at highest risk of low adherence to CRC screening and late stage diagnosis, for informing targeted community interventions, communication strategies, and messaging to reach South Asian populations. We will:
<ul>
 	<li><em>Sub-Aim 1: </em>Incorporate guidance from the CAB on key factors to consider in CRC screening. CAB input will inform the design of the analysis of existing population-based data and the interpretation of the results.</li>
 	<li><em>Sub-Aim 2: </em>Use population-based California Cancer Registry data from 1988-2012 to assess prevalence of advanced CRC among South Asian ethnic groups and apply recursive partitioning to identify high-risk populations with high proportions of advanced disease.</li>
 	<li><em>Sub-Aim 3: </em>Use contemporary state-level data (California Health Interview Survey data 2001–2009) to assess trends in CRC screening among South Asians and identify highrisk populations with low adherence to CRC screening guidelines, focusing on insurance coverage, use of other types of preventive services, length of US residence, limited English proficiency, and health literacy measures.</li>
</ul>
<strong>Specific Aim 3: </strong>Exploratory: Using findings from Aims 1-2, targeted literature review, and with guidance from the community advisory board, we will identify relevant, ethnic-specific community interventions and communication strategies, including key health messages about CRC screening, tailored to South Asian American target audiences, accounting for differing preferences for type of screening test, primary care versus specialty care access, health literacy levels, and differing language, gender, and cultural needs. We will also assess the feasibility of the interventions and strategies identified, in preparation for next steps of designing tailored interventions, strategies, and messages to better engage South Asian patients in the uptake of colorectal screening modalities.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>Community Mobilization to Improve the HIV/AIDS Continuum of Care Among Black Men</title>
		<tax>1737</tax>
		<content><![CDATA[HIV rates are at catastrophic levels Among young Black Men who have sex with Men (YBMSM). A study in 21 US cities found that 21% of YBMSM aged 18-29 were HIV+, compared to 9% of Latino and 7% of white young MSM (YMSM), and these disparities are worsening. YBMSM are more likely to be HIV-infected, less likely to be aware of their HIV-infection, and less likely to disclose that they are HIV-infected, relative to Men of other ethnic/racial groups. HIV+ YBMSM are also less likely than white MSM to be in treatment for HIV and to have undetectable viral loads (VLs). When HIV+ individuals achieve an undetectable VL, their own health improves, and they are also less infectious to others.

Getting to that point, however, requires that HIV+ individuals: (1) know their HIV status; (2) link to HIV Care; (3) stay in Care over time; (4) begin appropriate treatment; and (5) adhere to antiretroviral therapy (ART). We refer to these steps as engagement in the HIV Care Continuum (CC). While these approaches have great potential to reduce HIV incidence, it is estimated that only 25% of HIV+ people in the US have engaged in the CC to the point of having undetectable VLs. Research suggests that HIV+ YBMSM engage in the CC far less than others. A community-level intervention (CLI) to build and mobilize communities of YBMSM to support HIV+ Men to engage in the CC, decrease psychosocial barriers and increase psychosocial facilitators to engage in the CC within those communities may be an efficacious approach to prevent HIV transmission and Improve health outcomes for YBMSM.

This proposal will test the efficacy of such a CLI model, called United Black Element+ (UBE+). UBE+ will be an adaptation of a current CLI, called UBE. UBE has already engaged hundreds of YBMSM in Dallas TX, and it diffuses support for HIV Prevention and creates positive social norms around reducing rates of unprotected sex and increasing regular HIV testing by building an empowered, mobilized YBMSM Community.

UBE+ will be an adaptation and extension of UBE designed to increase YBMSM's engagement in the CC. the aims of this project are: (1) to adapt and expand UBE into UBE+, a multilevel intervention that includes a new focus on increasing engagement in the CC Among HIV+YBMSM, including targeting psychosocial barriers and facilitators to engaging in the CC that are experienced in this Community (e.g., HIV stigma and social support); (2) to implement UBE+ in Dallas for 3 years in collaboration with a local AIDS Service Organization currently implementing UBE, the Dallas County Health Department, and the Texas Department of State Health Services' (TDSHS) HIV-STD Program; and (3) to evaluate the efficacy of UBE+ in increasing engagement in the CC in Dallas (utilizing Houston as a control Community) using 2 independent methods: (a) a longitudinal cohort of HIV+ YBMSM providing data on engagement in Care, and experiences of psychosocial and logistic barriers and facilitators to engagement in Care; and (b) public health data that the TDSHS independently collects on HIV+ YBMSM's engagement in the CC.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=9144450&amp;icde=32501890</url>
	</node>
	<node>
		<title>CRUSH: Connecting Resources for Urban Sexual Health</title>
		<tax>1737</tax>
		<content><![CDATA[The East Bay AIDS Center (EBAC) and the UCSF Center for AIDS Prevention Studies (CAPS) will work together to fight the HIV epidemic in California by meeting the need for high quality health care for young MSM of color in the eastern San Francisco Bay Area.

The CRUSH (Connecting Resources for Urban Sexual Health) project will improve access to state-of-the art health care by combining cutting-edge research at CAPS and compassionate and welcoming services at EBAC.

<a href="/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/04/CRUSH-Lessons-Learned-2.pdf">Download this two-page Lessons Learned [PDF] here.</a>]]></content>
		
		<type>
			1
		</type>
			<url>http://www.crush510.org/</url>
	</node>
	<node>
		<title>Development and Validation of a Multidimensional Index of Engagement in HIV Care</title>
		<tax>1737</tax>
		<content><![CDATA[Less than half of individuals living with HIV in the United States are receiving ongoing Care, and only one- quarter have an undetectable Viral Load. The National HIV/AIDS Strategy prioritizes Care and treatment of HIV- infected individuals, yet improvement in Care retention rates is clearly needed. Research on HIV Care has used attendance at primary Care appointments to assess whether Patients are in Care. While Medical visits are necessary, they are not sufficient and do not necessarily reflect a patient's level of Engagement. Engagement in Care is about the patient experience and interactions with providers and the Care site.

We propose to create a patient-centered Index of Engagement in HIV Care that will be framed within a model of Health Care Empowerment, which refers to participation in Care in a way that is engaged, informed, collaborative, committed, and tolerant of uncertainty. We will create the Index through a collaborative process of consensus- building with Patients, providers, and Research experts using iterative online Delphi Surveys and in-person focus groups. We will then translate these narrative findings into scale items and develop them further through cognitive interviewing with Patients.

We will validate the Index by administering i to a sample of Patients undergoing the Patient Reported Outcomes within the CFAR Network of Integrated Clinical Systems (CNICS) and examining retrospective, cross-sectional, and prospective Appointment and Viral Load Data. The resulting Index of Engagement in HIV Care will have implications for both Clinical Care and Research, identifying Patients who are at risk fo poor Clinical outcomes and providing a metric by which to develop and evaluate interventions aiming to improve Engagement in Care.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=9109456&amp;icde=32502145</url>
	</node>
	<node>
		<title>Development of a Couple-Based Mobile Health Intervention</title>
		<tax>1737</tax>
		<content><![CDATA[Compared to other racial/ethnic groups in the US, black men who have sex with men (MSM), once diagnosed, are less likely to be optimally engaged in HIV care and treatment. This undermines the promise of recent prevention approaches for reducing the disproportionate effects of HIV/AIDS on Black communities, emphasizing the urgency for increased Research focus and Intervention Development. Understanding HIV care engagement in the context of the dyad may be part of a comprehensive effort to addressing multilevel influences on HIV care engagement outcomes that are unique to HIV+ black MSM towards achieving the maximum public Health benefit of treatment-as-prevention. However, the scarcity of dyad-level Research limits our understanding of couple dynamics involved in HIV care engagement to inform Intervention Development targeting the couple, underscoring the need for Couple-Based studies of relational dynamics important to the HIV care engagement of the HIV+ partner(s).

Mobile technology-based strategies (mHealth) offer tremendous potential as an acceptable, feasible, and effective Intervention platform for enhancing HIV care engagement among HIV+ black MSM in couples by facilitating couple dynamics optimal to HIV care engagement. Further, mHealth offers potential in addressing limitations in previous Intervention Research with couples, one of which is the dissipation of Intervention effects over time due to absence of booster sessions.

Therefore, the aims of the study are to: elucidate the effects of couple dynamics on HIV care engagement among partnered synthesize the quantitative and qualitative (mixed methods) outcomes from Aim 1 to identify the issues the Intervention will target, and to iteratively determine core components of a couple-based Intervention for HIV+ black MSM (Aim 2); and develop a novel, technology-based Intervention prototype for enhancing HIV care engagement among HIV+ black MSM in couples (Aim 3). HIV+ black MSM (Aim 1); The overall objective of this application is to achieve a better understanding of the couple dynamics involved in HIV care engagement among HIV+ Black men in same-sex relationships. The end goal is the Development of an mHealth tool that targets couple dynamics important to enhancing HIV care engagement. Through these aims, I will acquire additional Training necessary for my career Development in (a) theory and mixed methods for conducting Couple-Based Research, (b) formative Research in Intervention Development, and (c) prototype design. These

Research and career Development activities will build the foundation to my becoming an independent, NIH-funded investigator with skills to conduct Couple-Based Intervention Research that is part of a comprehensive effort in HIV prevention integrating advances in technology and Behavioral Medicine to reduce racial/ethnic disparities in HIV.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=9041684&amp;icde=32502261</url>
	</node>
	<node>
		<title>HSIL Outcome Study (HOST) - AMC supplement</title>
		<tax>1737</tax>
		<content><![CDATA[This randomized phase III trial compares topical or ablative treatment with active monitoring in preventing anal cancer in patients with human immunodeficiency virus (HIV) and high-grade squamous intraepithelial lesions (HSIL). Anal HSIL is tissue in the anal canal that has been damaged by infection with human papillomavirus (HPV) and is at risk for turning into anal cancer. It is not yet known if treating HSIL is more effective than active monitoring in preventing patients from developing anal cancer.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>Identity, Stress, and Health in Three Cohorts of Lesbians, Gay Men, and Bisexuals (LGB)</title>
		<tax>1737</tax>
		<content><![CDATA[The Generation study is the first long-term, five year study to examine the health and well-being across three generations of lesbians, gay men, and bisexuals (LGB). Investigators in the Generations study will use both qualitative and quantitative methods, asking about LGB people’s sense of identity and identification with the LGB community, stressors and challenges they experience, resilience and sources of strength, and health and well-being.

An innovative quantitative survey procedure will identify Black, Latino, and White LGB individuals in the United States. Respondents will participate in the study over a 5-year period to detect changes in the social environment as people age. The qualitative portion of the study will collect narrative life histories of Black, Latino, White, and Asian LGB individuals living in urban and non-urban regions of New York, California, and Arizona.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>Mentoring and Empowerment in the Context of HIV Care</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this K24 application is to support the continuation and proposed expansions of Dr. Mallory Johnson's programs of Mentoring and patient-oriented research (POR) in social and behavioral approaches to optimizing engagement in HIV Care among drug-using populations. the candidate proposes new Mentoring, new research, and additional Training to build competency in Drug abuse research, HCV and liver disease, and advanced research methodologies. the proposed plan for Mentoring expands his current Mentoring program in new directions, including an innovative grand Mentoring program, new sources of mentees, development of online team-based Mentoring tools, and scholarship in best practices of Mentoring. These plans emphasize the importance of addressing challenges to successful transition to independence during periods of budgetary constraint through the leveraging and strategic use of data, Infrastructure, and expertise available through existing NIH-funded research networks, Training programs, and Funding mechanisms.

Three aims for new research are proposed, which will provide data for future interventions to improve health Care Empowerment and Clinical outcomes for populations at risk for suboptimal engagement in HIV Care, including HIV-infected substance users (men, women, and transgender women) and HIV/HCV co-infected women. These POR activities will be conducted within the Infrastructure of the Women's Interagency Health Study (WIHS), the CFAR Network of Integrated Clinical Systems (CNICS) and a cohort of transgender women led by one of the candidate's mentees. the overriding theme of the new POR is to investigate the challenges of engagement in Care and uptake, persistence, and adherence, to antiretroviral therapy (ART) among populations at greatest risk for poor treatment outcomes. These POR activities will involve active participation by mentees and will Complement their development plans and transitions to independence. All of the new aims will be framed in the Model of Health Care Empowerment and will provide preliminary data for subsequent observational and interventional studies of engagement in Care.

Through the efficient leveraging of existing resources, collaborations, data, and affiliations with NIH-funded networks, the overarching goal of this application is to support the development of early career Investigators, new mentors, and to provide opportunities for my own training/competency-building, and to catalyze new projects in the area of engagement in HIV Care among at- risk populations.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=9095270&amp;icde=32503264</url>
	</node>
	<node>
		<title>Fall/Winter 2016 [E-Newsletter]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>NIMH re-funds CAPS for another five years &amp; CAPS 30th Anniversary!</h3>
Welcome to our 2nd quarterly e-newsletter! This issue highlights new research projects from <b>CAPS VII,the CAPS 30th Anniversary Celebration,</b> and <b>NIMH re-funding for another 5 years</b>. Updates include our newly funded research, updated fact sheet on stigma, the launch of the new CAPS/PRC website, awards, and new staff!

In this issue:
<ol>
 	<li>CAPS 30th Anniversary</li>
 	<li>NIMH re-funds CAPS for 5 years</li>
 	<li>New California Projects</li>
 	<li>New International Projects</li>
 	<li>Featured: Updated fact sheet on stigma and HIV prevention</li>
 	<li>New website launch</li>
 	<li>Announcements</li>
</ol>]]></content>
		
		<type>
			6
		</type>
			<url>http://myemail.constantcontact.com/Fall-Winter-2016-E-Newsletter---CAPS-re-funded-by-NIMH-.html?soid=1114093349314&amp;aid=Da2rdT2V_eU</url>
	</node>
	<node>
		<title>Multilevel HIV Prevention Intervention for Young African American Men</title>
		<tax>1737</tax>
		<content><![CDATA[HIV prevalence and incidence rates have reached catastrophic levels among Young black Men who have sex with Men (YBMSM), ages 18-29. The goal of this project is to determine the efficacy of a Multilevel, theory- based Intervention, calld United Black Element (UBE), in reducing YBMSM's sexual risk behavior and increasing the frequency of HIV testing. Although based on the Mpowerment Project, a cost-effective HIV Prevention Intervention that has been shown to be efficacious in reducing the rate of unprotected sex among Young MSM, UBE has been extensively adapted to the socioeconomic, cultural, and social context of YBMSM's lives.

Through the Development of an empowered, mobilized YBMSM community, UBE creates positive social norms around HIV Prevention that are diffused throughout diverse social networks. We began work to launch and begin testing the efficacy of UBE in Dallas and Houston, TX with CDC funding; Dallas was randomized to the Intervention condition. Large cities were chosen since that is where the majority of YBMSM reside, and testing a community mobilization approach in such a setting is critical in considering how to translate it to practice. It took longer than anticipated to fully implement UBE because of community capacity issues, but UBE is now fully implemented and is reaching into diverse social networks of Dallas YBMSM. The CDC funding that supported the Intervention and baseline assessments has ended, and the Texas State Health Department is now funding UBE at a local organization with which we are collaborating.

In the proposed mixed methods project, we have an extraordinary opportunity to study the impact of this Intervention without having to start up or cover the costs of the Intervention. Thus, the aims of this mixed methods project are to: 1) Analyze public health data and conduct 3 additional annual cross-sectional Surveys of YBMSM in Dallas and Houston using venue-based sampling to determine the efficacy of UBE in: (a) reducing unprotected anal sex; (b) increasing recent HIV testing; (c) modifying psychosocial mediating variables that may be causally related to HIV risk reduction; and (d) changing psychosocial factors related to positive mental health and wellbeing; 2) Determine how community changes occur during implementation of UBE by examining when changes in the psychosocial mediating variables, sexual risk behavior and HIV testing take place and if changes in sexual risk behavior and testing continue to improve, remain the same, or decrease over time; 3) Explore how UBE penetrates diverse YBMSM subcommunities in Dallas, and how this Multilevel Intervention impacts individual, interpersonal, and social level factors related t risk behavior and testing. Using ethnography, we will follow a longitudinal cohort while the Intervention is being fully implemented. 4) Examine the potential integration of biomedical HIV Prevention methods into UBE through administering and analyzing quantitative data from the survey and qualitative data from the interviews.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=8885899&amp;icde=32503871</url>
	</node>
	<node>
		<title>Networked Home HIV Testing</title>
		<tax>1737</tax>
		<content><![CDATA[In California and locally in Alameda County, HIV disproportionately impacts African American and Latino men who have sex with men (MSM). This study will develop and test an innovative strategy to identify MSM who are unaware of their status, have them test for HIV and for those that are positive, link them to HIV care and services. The proposed intervention will have MSM, called “seeds,” reach out to their social networks and recruit their peers to take an HIV test using a self-test kit. Seeds will be trained to deliver prevention messages that encourage their friends and peers who are at risk for HIV to take the HIV self-test. The seeds provide support through the testing process and if the peer is found to be positive, they will assist in linking the peer to HIV care and services.

The use of the self-test kit has the potential to overcome many of the structural barriers to testing, such as stigma, discrimination, homophobia, privacy concerns, lack of access to care, mistrust of medical providers and wait times in clinical settings. This intervention strategy also has the potential to reach young MSM who don’t normally test, by accessing this hard-to-reach population in a place where testing can occur immediately and the men are in control of the process. The study aims to examine how well the proposed intervention identifies MSM who had been undiagnosed and how well the intervention links HIV positive MSM to care.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>New Challenges in HIV Prevention for Gay Male Couples</title>
		<tax>1737</tax>
		<content><![CDATA[As HIV research and prevention efforts increasingly target gay men in relationships, situational factors such as couple serostatus and agreements about sex become central to examinations of risk. Discordant gay couples are of particular interest because the risk of HIV infection is seemingly near-at-hand. Yet, little is known about their sexual behaviors, agreements about sex, and safer sex efforts.

The present study utilized longitudinal semi-structured, qualitative interviews to explore these issues among 12 discordant couples. Findings show that nearly every couple had agreements about reducing the likelihood of HIV transmission from one partner to the other. Negotiating these agreements involved establishing a level of acceptable risk, determining condom use, and employing other risk-reduction techniques, such as seropositioning and withdrawal.

For half of the couples, these agreements did not involve using condoms; only two couples reported consistent condom use. Despite forgoing condoms, however, none reported seroconversion over the course of data collection. Additional issues are raised where long-term HIV prevention is concerned. Future prevention efforts with discordant couples should work with, rather than fight against, the couple’s decision to use condoms and endeavor to complement and accentuate their other safer sex efforts.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>Pilot of Culturally Tailored Mpowerment for HIV Prevention</title>
		<tax>1737</tax>
		<content><![CDATA[HIV in Lebanon and the Middle East is predominantly among men who have sex with men (MSM), and rates of HIV and sexual risk behavior are on the rise among young MSM (YMSM), driven in part by increased freedom of expression, social tolerance in areas such as Beirut, an influx of migration attributed to MSM refugees coming from war torn Iraq and Syria, and a flourishing sex tourism industry. At a time of political and societa upheaval across MENA, with no substantial HIV prevention programs for MSM anywhere in the region, Lebanon and MENA may be at risk for a critical surge in HIV infection in this vulnerable population. This context presents a great opportunity for an intervention like Mpowerment (MP) to make a critical impact.

MP is an evidence-based community-level, structural, social and behavioral HIV prevention intervention developed for YMSM. It combines strategies for individual and community empowerment and mobilization, self-affirmation, sexual self-knowledge, and the creation of supportive social environments for YMSM. It has been widely disseminated in the U.S., but it has never been used in a Muslim-dominant setting;hence, the need for formative research to help us understand how to best tailor MP for this much understudied cultural setting that is not well understood. The gay community in Beirut has grown significantly in recent years with regard to organization, development and advocacy, making it ready to take on and be successful with a community driven intervention like MP.

This 5-year project will culturally adapt and pilot MP for YMSM (age 18-29) in Beirut. Phase 1 will involve extensive formative research including innovative peer ethnography and focus groups to better understand the social networks of YMSM and how they communicate about HIV and sexual health with each other, and elicit feedback on how to culturally adapt the MP program for Beirut. In Phase 2 we will pilot specific MP components and adapt the intervention manual. Phase 3 will consist of a 2-year pilot implementation and controlled evaluation of MP to assess intervention effects on community levels of sexual risk behavior and HIV testing. Cohorts of 200 YMSM in each of Beirut and the comparison community of Jounieh will be used to evaluate intervention effects.

This study is innovative in being the first implementation and evaluation of any psychosocial sexual health intervention for MSM in all of MENA, and the first study of the social network-driven MP program that will use social network (SN) methodology for evaluating and adapting the intervention. It will have impact by providing pioneering data to broaden the field's understanding of the cultural underpinnings of HIV risk behavior and how to intervene to promote HIV prevention among a highrisk group (YMSM) in a cultural setting in which very little prior work has been done. The goal of this research is to establish an evidence-based model for HIV prevention and sexual health promotion with YMSM in the Middle East and other Muslim-dominant countries.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=9043200&amp;icde=32505565</url>
	</node>
	<node>
		<title>Relationship Factors and HIV Treatment Adherence</title>
		<tax>1737</tax>
		<content><![CDATA[This competing renewal application builds upon the success of our project "Relationship Factors and HIV Treatment Adherence" (R01NR010187) also known as the "Duo Project". The parent grant has been successful thus far and the process and findings have informed the aims of this renewal application. Being in a primary Relationship is generally accepted as resulting in logistic and emotional support that provides health- promoting benefits. However, there is evidence that being in a primary Relationship may result in behaviors, emotions, and conflict that may hinder Adherence to prescribed Treatment regimens. Framing our work in Social Control Theory while using dyadic data analysis and maintaining the couple as the unit of analysis will maximize our understanding of how couple interactions affect Adherence. Our work to date has documented associations between partner dynamics and Adherence and has suggested the importance of studying couples over time to best understand the dynamic interplay of Relationship Factors and ART Adherence.

We are therefore now proposing to extend the work through mixed qualitative, quantitative and randomized controlled trial (RCT) methodologies. The current Phase 3 study is a cross-sectional investigation of male couples to test hypotheses of the interrelationships among individual-level variables (e.g., beliefs about Treatment efficacy, substance use, and Adherence self-efficacy) and couple-level variables (e.g., Relationship satisfaction, conflict, and adherence-specific partner support), and medication Adherence and clinical variables. To optimize the contribution to the Adherence and social Relationship literature, we propose to follow these couples with repeat assessments at 6, 12, 18 and 24 months to test longitudinal hypotheses. We will purposefully select couples for in-depth qualitative interviews to further contextualize our findings and to inform interventions. Finally, we will develop and pilot a couples-based intervention, Duo PACT (Partnership Adherence Commitment Therapy), with 32 couples (equally randomized to intervention or assessment only control) to determine feasibility, satisfaction, and to inform effect size estimates for a larger trial of the intervention. Three well- validated self-report instruments will measure Adherence to ART in all participants, and we will also use MEMS caps monitoring with those in the intervention to pilot procedures for a subsequent larger RCT. Clinical status will be assessed by ultrasensitive viral load and CD4 count assays. Significance.

Findings will have clinical implications for the detection of Adherence problems and the further development, evaluation, and dissemination of interventions to improve Adherence within the couple Relationship. Study findings will also have theoretical implications for the function of social control in the context of Adherence to HIV medications within non-traditional relationships and across different serostatus configurations.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=8663078&amp;icde=32580291</url>
	</node>
	<node>
		<title>SHEROES: Culturally relevant sexual risk reduction among high risk transgender women</title>
		<tax>1737</tax>
		<content><![CDATA[The purpose of this study is to assess the feasibility and acceptability of <strong>SHEROES</strong>, a theory-driven, culturally grounded intervention to reduce sexual risk behavior among male-to-female transgender women (transwomen) at risk for HIV acquisition or transmission. HIV prevalence estimates among this population are markedly higher than estimates for other at-risk groups, and transwomen also experience severe stigma, discrimination, alienation, poverty, and victimization. Despite elevated risk for HIV, the rates of HIV testing among transwomen are much lower than other at-risk groups, and our team's research with transwomen living with HIV indicates unique barriers to treatment uptake and antiretroviral medication adherence, which puts them at elevated risk of poor HIV-related clinical outcomes, including morbidity, mortality, and transmission of HIV to uninfected partners. There is a dire need for rigorously-evaluated interventions designed specifically to meet the unique needs of transwomen.

To address this need, we developed 'Sheroes,' a group-based intervention that addresses the unifying lived experiences of HIV-positive, HIV-negative, and unknown status high-risk transwomen. <strong>SHEROES</strong> was designed in close collaboration with the transgender community and is grounded in our team's innovative Model of Gender Affirmation. While a number of investigators have observed an intense need for (and often lack of access to) gender affirmation among transgender individuals, its relationship to high-risk behavior has rarely been directly investigated. This study is a pilot randomized controlled trial (RCT) comparing the <strong>SHEROES</strong> intervention to a time- and attention-matched film-based control condition. From a projected 223 to be screened, 60 self-identified transwomen who are at least 18 years of age, of any HIV status, and reporting unprotected receptive and/or insertive anal intercourse (UAI) in the past 3 months will be stratified by HIV status and randomized to receive the 5-session <strong>SHEROES</strong> intervention or a time- and attention- matched control group. Follow-up assessments will be conducted at 3 and 6 months post-randomization.

While this pilot study is not powered for a formal test of outcomes or effect size estimation, we will collect data on our primary and secondary outcomes of interest to determine feasibility and acceptability of data collection and to explore our hypotheses via preliminary analyses. We hypothesize that following intervention exposure relative to control group, <strong>SHEROES</strong> participants will report a lower mean number of unprotected sexual partners. Moreover, we will test the secondary/exploratory hypotheses that <strong>SHEROES</strong> participants will report a) higher HIV testing rates (for HIV-negative transwomen at baseline); b) higher STI testing rates (for all serostatus transwomen), and c) higher HIV medical appointment attendance and ART readiness or ART use and adherence (for HIV-positive transwomen). An additional secondary/exploratory aim is to examine mediators/mechanisms of change based on the Model of Gender Affirmation (e.g., need for gender affirmation, self-objectification) and moderators of the intervention (e.g., HIV status, drug use).]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_details.cfm?aid=8892262&amp;icde=32580424</url>
	</node>
	<node>
		<title>Technology to connect at-risk youth to testing</title>
		<tax>1737</tax>
		<content><![CDATA[Among the numerous health disparities disproportionately burdening people of color, HIV/AIDS is Among the highest. In the African American community the HIV/AIDS epidemic is one of the most urgent public health issues. In order to address the health disparity in HIV/AIDS, detection of HIV in the African American community is crucial. the benefits for early detection of HIV include potentially prolonged duration and quality of life for those living with the virus. HIV testing has also been proposed as a HIV preventive strategy. Detection of HIV has a number of potential preventive benefits, including reduced Transmission Risk behaviors by those infected9 and reduced viral load by those taking antiretroviral medications, whereby potentially reducing Transmission. the proposed study makes a significant public health impact by developing and pilot testing an innovative strategy to increase the number of high-risk adolescents receiving HIV screening.

In response to PA-09-146 (Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials [r34]), we propose a pilot study to examine the acceptability and feasibility of a peer-driven, HIV-testing campaign. Peer education and outreach strategies have been successful at reducing sexual Risk behavior and increasing the use of health resources in adolescents and other at-risk groups, including adults residing in census tracts where STI rates are high. A potential vehicle for outreach to adolescents is socially interactive technologies (e.g., text messages). the proposed study makes a scientific impact in examining the effectiveness of messaging diffused through the social network of adolescents. A total of 100 current patients at an urban adolescent health clinic serving predominately African Americans will be recruited to disseminate at least 5 text messages to friends they believe are sexually active. Youth will be provided with a brief guide to help them develop their messages. the youth generated text messages will encourage their friends to Visit the clinic and get tested. the specific aims of this project are to: Aim 1: Develop protocols and a theory-informed message guide for a peer-driven text message intervention for adolescents recruited from an adolescent health clinic. Aim 2: Examine the acceptability and feasibility of sending text messages related to obtaining HIV/STI testing. We will obtain participant feedback and examine the recruitment rate, number of youth failing to meet inclusion criteria, number of youth verified to have sent text messages, and number of text messages sent. We will also obtain feedback from the clinic providers regarding impact on patient and services flow, provider reactions, and impact on clinical Visit. Aim 3: Preliminarily examine the efficacy of a youth generated messaging intervention to increase the: 1) number of high-risk youth seeking services and 2) clinic volume as measured by: a) number of new patients at clinic, b) increase in rate of new patient appointments, and c) number of STI tests conducted.

If successful, the proposed study will significantly contribute to the field of HI prevention by examining the acceptability, feasibility and potential impact of an innovative strategy for delivering messages to high-risk youth, which encourage connection with the healthcare system and screening for HIV. This trial will fill a critical need to improve the sexual health outcomes of high-risk African American youth and lay the groundwork for a subsequent R01 proposal with a larger sample and that would include control sites.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=8464044&amp;icde=32580501</url>
	</node>
	<node>
		<title>Technology-based adaptive treatment strategies for antiretroviral adherence1</title>
		<tax>1737</tax>
		<content><![CDATA[The Achilles heel of successful HIV treatment is adherence to antiretroviral (ARV) therapy, as non-adherence remains one of the strongest predictors of progression to AIDS and death. The recognition of the supportive role of technology for ARV adherence by the U.S. Department of Health and Human Services underscores the importance of the need for stronger evidence of the effectiveness of these interventions. As a result, several studies have examined the efficacy of electronic reminder devices on ARV adherence. However, most of these studies have not revealed clinically significant improvements in adherence; which may be because they have primarily investigated the role of a single method, irrespective of patient-specific reasons for non-adherence. Thus, instead of using tailored Technology-based methods to address distinct non-adherence reasons, most studies compel the participant to "fit" the technology.

Therefore, to most effectively use technology to improve adherence, customized interventions that focus on the patients' specific non-adherence reasons need to be considered. With protected time, training, and mentoring during this K23 career development award, I propose to acquire the skills needed to address these issues and to achieve my long-term career goal of becoming an independent clinical researcher. My training to date has provided me with a strong and basic foundation of research and affirmed my decision of becoming a clinical investigator. However, I require further training in the use of technology and Informatics to improve ARV adherence, conducting focus groups and advanced training in qualitative research, designing and implementing behavioral interventions, advanced training in biostatistics, and creating and testing rules for adaptive treatment strategies. I have identified Dr. Mallory Johnson as my primary mentor, who is an expert in the area of treatment adherence and has an outstanding record of mentorship. Drs. Nicolas Sheon, Ida Sim, Michael Silverberg, and Eric Vittinghoff will serve as co-mentors.

Through mentorship and training, I plan to pursue four interconnected career goals: 1) become an expert in Technology-based methods of improving ARV adherence; 2) acquire expertise in adaptive treatment strategies; 3) become proficient in the use of mixed methods (qualitative and quantitative) research for the design and evaluation of behavioral interventions; and 4) move the field of clinical pharmacy forward by researching evidence-based HIV clinical pharmacist-led initiatives in advancing HIV care. The overarching objective of my research is to identify and develop individually-tailored Technology-based approaches that have the potential to overcome specific reasons for non-adherence in HIV+ youth. The advanced training I will receive during this K23 award will fill the gaps in my knowledge and enable me to successfully compete for an R34 grant to conduct a pilot study of Technology-based adaptive interventions to improve adherence in young HIV+ men and women; which will lead to an R01 to evaluate the efficacy of this Intervention.]]></content>
		
		<type>
			1
		</type>
			<url>https://projectreporter.nih.gov/project_info_description.cfm?aid=9057134&amp;icde=32580830</url>
	</node>
	<node>
		<title>SIP14-026 Cognitive Interviews of Executive Directors of Food Banks to Inform Improved Distribution of Healthy Foods</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Project Director/Lead Investigator</strong>: Hilary Seligman, MD (UCSF PI); Kirsten Bibbins-Domingo, PhD (Co-PI); Dean Schillinger, MD (Co-PI); Elaine Waxman, PhD (Co-PI); Michelle Marshall (Co-PI);  Marguerita Lightfoot, PhD (UCSF PRC PI)

&nbsp;

<em>Coordinating Center Aim 1: </em><u>Identify critical gaps </u>in nutrition policy research, and insure that cost-effective and time-efficient projects are conducted to fill those gaps

<em>Coordinating Center Aim 2: </em><u>Disseminate findings broadly </u>and <u>engage external and non-traditional stakeholders</u> by employing multiple communication channels

<em>Coordinating Center Aim 3: </em><u>Facilitate translation of effective policies into local communities </u>by leveraging the infrastructure of the Working Groups and our engagement with varied stakeholders

&nbsp;

CVP faculty and staff, under the leadership of Dr. Hilary Seligman, bring a unique skill set to the coordination of CDC’s nutrition policy through <a href="http://nopren.org/">NOPREN</a>:
<ul>
 	<li>Depth of expertise working with community groups and county and state health departments, with a particular focus on nutrition policy, diabetes prevention, and health disparities.</li>
 	<li>Infrastructure and experience in leading and coordinating trans-disciplinary, multi-site programs for research and evaluation.</li>
 	<li>Deep skill in all phases of policy and implementation research, from intervention design, evaluation, and implementation; to dissemination; to sophisticated modeling of policy interventions.</li>
 	<li>Experience directing state public health programs in chronic disease prevention and control.</li>
 	<li>Expertise in the health consequences of poor nutrition and poverty, informed by our continued work as primary care physicians at an urban, safety net hospital run by the local health department.</li>
</ul>
As a Collaborating Member Center, we will continue our longstanding collaboration with a national network of food banks (<em>Feeding </em>America) to answer a critical nutrition policy research question: <u>how can we leverage the</u> <u>infrastructure and enormous capacity of the existing food bank system to support national nutrition priorities in</u> <u>low-income communities? </u>We will answer this question by completing the following Aims:

&nbsp;

<em>Project Aim 1</em>: Systematically interview Executive Directors of food banks across the US to rigorously examine <u>barriers to and opportunities for distribution of healthier foods </u>(particularly fresh vegetables and fruits)

<em>Project Aim 2: </em><u>Establish policies and goals </u>for the distribution of healthier foods by food banks, create and <u>nationally disseminate </u>the first toolkit to assist in implementation, and <u>monitor policy success at the level of the</u> <u>food bank</u>

<em>Project Aim 3</em>: Create a protocol for <u>monitoring policy success at the level of the individual </u>by measuring client dietary intake over time]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>SIP14-012 Mailing FIT kits to improve colorectal cancer screening, a partnership with San Francisco Department of Public Health</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Project Director/Lead Investigator</strong>: Ma Somsouk, MD (UCSF PI); Uri Ladabaum (Stanford Co-PI); Eric Vittinghoff (Co-I); Ellen Chen (Co-I);  Marguerita Lightfoot, PhD (UCSF PRC PI)
<h3>Research Findings Summary</h3>
This study enrolled more than 9,500 patients - men and women ages 50-75 - from six clinics in the San Francisco Health Network. About half of them received routine care, while the other half were mailed a stool sample test kit called (FIT). The FIT kit is a non-invasive colon cancer screening that checks for blood in the stool as a possible sign of colon cancer. Results show that mailing the FIT kits increased the number of patients who completed the screening from 21% to 49%. Participants who did not speak English, or who had done a FIT test before, were more likely to complete the test. Common barriers to participants returning the FIT kits were forgetting, not understanding, not wanting to test, or other health problems, which may be addressed during follow-up calls.

<strong><a href="/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/09/2017-09-PRC-UCSF-Somsouk.pdf">Download PowerPoint PDF summarizing the study here.</a></strong>

&nbsp;

<strong>Specific Aim 1: To determine if centralized panel management with mailed fecal immunochemical tests (FIT) outreach improves uptake of CRC screening compared with usual care. </strong>In collaboration with primary care providers, we will leverage the EHR system to identify asymptomatic patients not up-to-date with CRC screening. Patients will be randomized 1:1, stratified by clinic and race to mailed FIT outreach versus usual care. The primary outcome will be the difference between groups in completion rates of FIT tests at one-year from randomization. Secondary outcomes include the FIT completion rate 28 days after mailing, reasons for incomplete tests, FIT test positivity, colonoscopy completion rates and pathology findings, and the programmatic efficacy of the delivery model over time on proportion of patients up-to-date with CRC screening. Other outcomes include the CRC-specific mortality, incidence, and stage in those receiving usual care versus mailed FIT.

<strong>Specific Aim 2: To determine if the mailed outreach program can be used to improve other health maintenance practices. </strong>We hypothesize that a centralized panel model program supporting CRC screening could also be used to improve other health maintenance efforts. Among patients appropriate for screening, patients will be randomized to receive information about age-appropriate health maintenance measures (e.g., mammogram, vaccinations).

<strong>Specific Aim 3: To describe and compare the cost and effectiveness of the centralized panel management for mailed FIT versus usual care. </strong>We hypothesize that the administrative cost and utilization of FIT kits will drive cost up, but will be balanced by increased uptake of CRC screening. Adapting previously developed decision analytic models with Markov processes12-18, the cost and effectiveness of mailed FIT outreach versus usual care will be examined. Outcomes reported include implementation and operational cost of the outreach program (e.g., personnel, capital expenditure, and colonoscopy utilization), cost per clinical outcome (e.g., patient screened, cancer diagnosed, quality-adjusted life year), and performance incentives needed to break even.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>SIP16-003 Small Media Interventions to Increase Colorectal Cancer Screening among Chinese Americans</title>
		<tax>1737</tax>
		<content><![CDATA[<strong>Project Director/Lead Investigator</strong>: Tung Nguyen, MD (UCSF PI); Janice Y. Tsoh, PhD (Co-PI); Angela Sun (Subcontract Co-PI); Kent Woo (Subcontract Co-PI);  Marguerita Lightfoot, PhD (UCSF PRC PI)

Through an innovative approach that links community organizations that have cultural and linguistic expertise to healthcare systems that have many Chinese American patients, we will test the effect of combining these small media materials and a mailed patient reminder on the rate of screening for colorectal cancer screening among Chinese Americans in this <strong>S</strong>mall <strong>M</strong>edia <strong>I</strong>nterventions for <strong>L</strong>imited <strong>E</strong>nglish <strong>S</strong>peakers (<strong>SMILES</strong>) project. The <strong>Specific Aims </strong>are to:

<strong>Aim 1: </strong>Develop English and Chinese (Cantonese and Mandarin) small print and electronic media materials to promote colorectal cancer screening among Chinese Americans;

<strong>Aim 2: </strong>Compare the efficacy of a combination of mailed patient reminder and small print and electronic media versus usual care among Chinese American patients who are not up-to-date for colorectal cancer screening recruited from 3 healthcare systems in a randomized controlled trial; and

<strong>Aim 3: </strong>Describe the factors that affect the clinical-community linkages between healthcare systems and community organizations to reduce colorectal cancer screening disparities among Chinese American patients.

The team, which consists of bilingual bicultural UCSF researchers and 2 community organizations, the Chinese Community Health Resource Center and NICOS Chinese Health Coalition, has been working together since 2000. Our bilingual colorectal cancer brochures, booklet, flipchart, and videos have been developed rigorously and tested in studies with Chinese Americans. In Aim 1, we will revise these materials with input from Chinese American patients to create a print booklet and an audio-visual version that can be accessed through a mobile application and website. All print materials will be available in written English, traditional Chinese, and simplified Chinese while all videos will be available in English, Cantonese, and Mandarin.

For Aim 2, we will work with 3 healthcare systems to identify eligible Chinese American patients who are not up-to-date for colorectal cancer screening. They will be randomized into an immediate intervention or control (delayed intervention) arm. The immediate intervention arm will receive 2 mailings separated by 1 month. Each mailing will include a reminder from the primary care physician that the patient is overdue for screening, the booklet, and links to the mobile application and website. Both arms will receive usual care. The main outcome will be receipt of colorectal cancer screening as documented by the electronic health record 6 months later. After the outcome has been collected, the control participants will receive 1 mailing of the same materials.

For Aim 3, we will conduct interviews at the beginning of the project with leaders of the 3 healthcare systems and 2 community organizations to assess expectations about barriers and benefits of clinical-community linkages and ways to address them. We will interview them at the end of the study to identify what worked and did not work. We will interview leaders of other healthcare systems to identify barriers and benefits to participation as well as potential facilitators and solutions. Our strong community-academic team has the environment, resources, and experience to carry out this innovative study using the most methodologically rigorous approach. Upon study completion, we will utilize our extensive local, regional, and national networks to disseminate the findings of the SMILES project and the small media materials to ensure the greatest possible impact on the reduction of colorectal cancer screening disparities among Chinese Americans.]]></content>
		
		<type>
			1
		</type>
			<url></url>
	</node>
	<node>
		<title>National Black HIV/AIDS Awareness Day — February 7, 2017 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with African Americans and helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing at 415-514-4590 or Daryl.Mangosing@ucsf.edu

<em>This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core.</em>
<h4>Acronyms</h4>
<strong>MSM</strong>: Men who have sex with men

<strong>PI</strong>: Principal Investigator (lead researcher on the study)]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>National Youth HIV/AIDS Awareness Day — April 10, 2017 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with Youth or young adults as well as helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing via phone at 1-415-514-4590 or email at <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

<em>This brochure was prepared by the<a href="/sites/prevention.ucsf.edu/files/about/caps-structure-and-cores/community-engagement-ce-core/" target="_blank"> CAPS Community Engagement (CE) Core</a>, which is previously known as the Technology and Information Exchange (TIE) Core.</em>
<h3>Acronyms</h3>
<strong>MSM</strong>: Men who have sex with men
<strong>PI</strong>: Principal Investigator (lead researcher on the study)]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Pre-exposure prophylaxis (PrEP) - 2017</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How can Pre-Exposure Prophylaxis (PrEP) help in HIV prevention?</h3>
<strong>Prepared by Pamela DeCarlo and Kimberly Koester, CAPS/PRC/CHPRC</strong>

<strong>Community Engagement (CE) Core | May 2017</strong>
<h4>What is PrEP?</h4>
Pre-Exposure Prophylaxis (PrEP) is an HIV prevention method for people who do not have HIV but are concerned about getting HIV. Currently, PrEP involves taking one pill (Truvada) a day on a consistent basis.[1] Clinical guidelines for PrEP recommend that people be tested for HIV and kidney function before starting medication. While on medication, people should be tested and treated for sexually transmitted infections (STIs) every 3 months, for HIV every 6 months, and for kidney function as indicated.[1] Anyone newly diagnosed with an STI or HIV should be offered treatment.
<h4>Does PrEP work?</h4>
Yes! PrEP can work to prevent transmission of HIV, when the medication is taken consistently every day. Daily PrEP reduces the risk of getting HIV from sex by more than 90%. Among people who inject drugs, it reduces the risk by more than 49%.[2] A Kaiser Permanente study followed 972 patients over 3 years and found that no HIV infections occurred among those who took PrEP; however, 2 infections occurred in individuals who stopped taking PrEP after losing health insurance coverage.[3] At Magnet, a community clinic in San Francisco, CA, there have been no new HIV infections among 1,196 patients enrolled in their PrEP program.[4] PrEP may work differently to prevent transmission through vaginal sex than through anal sex. In the iPrEX clinical trial, protection from anal transmission was achieved taking the medication 4-5 times a week.[5] A clinical trial with cisgender women found that taking the pill 6-7 times a week provided protection from vaginal transmission.[6]
<h4>Is PrEP safe?</h4>
Absolutely. Most of the people who take PrEP do not experience side effects. For those people who do, the side effects are generally mild and go away within a month. The most common side effects are nausea, digestive problems, kidney issues and bone loss. One study found that taking PrEP generally was safer than taking aspirin.[7]
<h4>How else can PrEP help?</h4>
<strong>PrEP can provide mental health benefits.</strong> Several studies and many PrEP service providers report that PrEP use appears to decrease HIV-related stress and anxiety as well as increase the potential for greater intimacy and sexual pleasure. In fact, some people stated that after starting PrEP, they were able to have sex without the fear of HIV for the first time in their lives. Others felt hope for the future and optimistic about their love lives.[8,9]

<strong>PrEP can increase self-efficacy.</strong> PrEP is the first reliable method for HIV prevention that provides people with a relatively easy way to take an active role in preventing HIV. It does not require telling, showing or negotiating with partners, and does not need to be used during sexual activity.[10]

<strong>PrEP can facilitate access to healthcare.</strong> Many PrEP programs are serving young, healthy people—populations that otherwise may not access healthcare or health insurance. Because PrEP involves frequent laboratory testing and prescription medication, programs are training PrEP navigators to help patients sign up for insurance coverage, pay for medication, find a medical provider, encourage medication and appointment adherence, and access other social services that can help with staying healthy.
<h4>How can PrEP access be improved?</h4>
<strong>Remove structural barriers.</strong> Like most medications and behavioral prevention efforts, PrEP only works if it is taken as prescribed. It appears that many people accessing PrEP are highly motivated to take the pill, and that structural issues, not individual level issues, may be bigger barriers to adherence. Some of these barriers include being unable to pay for PrEP and clinical/laboratory services, problems finding providers that will prescribe PrEP in a nonjudgmental manner, difficulty attending clinic every 3 months, as well as concerns related to having experienced and perceived HIV-related stigma.

<strong>Reduce costs.</strong> PrEP medications cost $1200 - $1500 per month. Most insurance, including Medicaid, will cover PrEP, but some insurance plans have high co-pays and out-of-pocket expenses. Changing jobs or health care plans can often result in a gap in insurance when people may not be able to afford PrEP. Some states and Gilead, manufacturer of Truvada, have medication assistance programs to help offset these costs.[11]

<strong>Increase use of PrEP navigators.</strong> PrEP navigators work in a variety of public and private health care settings to connect people to PrEP services and gain access to insurance and other programs to pay for PrEP.

<strong>Increase provider comfort and knowledge.</strong> Some healthcare providers are unaware of HIV pre-exposure prophylaxis or are uncomfortable prescribing PrEP for their patients. Providers may have misconceptions about the efficacy of PrEP, or assume that their patients will not be adherent.[12] Prejudice and bias around race, gender, sexuality, age, condom use and drug use may make providers unlikely to offer and/or prescribe PrEP to some patients. One study found that providers were most willing to prescribe PrEP to MSM with an HIV+ partner, and less likely to prescribe to heterosexuals and people who inject drugs.[13]

<strong>Address health disparities.</strong> While PrEP use increased over 500% between 2013 and 2015, disparities exist. Current use only covers a small percentage all the people who could benefit from PrEP, and PrEP uptake has been low among African Americans, Latinos, women and young adults.[14]
<h4>What's being done?</h4>
There are a variety of places such as, primary care clinics, STD and HIV clinics, family planning clinics, pharmacies and websites as well as a variety of providers such as physicians, nurse practitioners and pharmacists, offering PrEP services.

Many service agencies across the US have created PrEP programs to help those who want and need PrEP, with a focus on underserved communities such as Black and Latino gay men, transgender women and youth. Some of these agencies include Callen-Lorde Community Health Center, Chicago PrEP Working Group, HIVE, Philly FIGHT, and Houston Area Community Services.[15]

In Seattle, WA, the Kelley-Ross community pharmacies have implemented One-Step PrEP, a program where patients can meet with a pharmacist, be screened and prescribed PrEP, get follow-up lab tests and pick up prescriptions all in one place. Kelley-Ross also helps navigate insurance, and 98% of their patients pay $0 for their medication.

Several programs are delivering PrEP via telehealth, such as Nurx.com (available in 11 states). People interested in PrEP sign up on the website by answering a few key questions that are reviewed by a doctor. Clients are then directed to a local lab to seek HIV, STI and kidney testing. Once labs are reviewed by a Nurx doctor, PrEP medications are either delivered to their door or can be picked up at a local pharmacy.

Because finding a provider who knows about PrEP can be challenging, three services pleasePrEPme.org, pleasePrEPme. global and PrEPlocator.org offer a directory of public and private PrEP providers. You can search for providers that accept uninsured patients and for navigation services.
<h4>What needs to be done?</h4>
When new medications are introduced to the general public, health disparities are often highlighted, as underserved populations may be unaware of, unable to access and be suspicious of new medications. PrEP presents an opportunity to address and reduce these disparities.

While many healthcare providers have championed PrEP for their patients, providers also can be a major stumbling block. Successful PrEP providers are likely to engage in shared decision-making with their patients, providing accurate information about PrEP, and trust that their patients will be positioned to make the best decisions about their own health.

New medications and methods for delivering and monitoring PrEP that can lower barriers to access are being developed and tested. These include new, longer-lasting medications; drugs delivered via injection, vaginal and rectal microbicides and vaginal rings; and self-screening for HIV and STIs.[16]

With the changing landscape of healthcare and policy in the US, we need continued advocacy for PrEP access and funding.

<hr />

<h3><strong>Says Who?</strong></h3>
<ol>
 	<li>CDC. Preexposure prophylaxis for the prevention of HIV infections in the United States—2014: a clinical practice guideline. Atlanta, GA: US Department of Health and Human Services, CDC, US Public Health Service; 2014. CDC fact sheet for providers</li>
 	<li>CDC. PrEP 101 Consumer Info Sheet. 2016.</li>
 	<li>Volk JE, Marcus JL, Phengrasamy T, et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. <em>Clin Infect Dis</em>. 2015;61:1601-1603.</li>
 	<li>Gibson S, Crouch P-C, Hecht J, et al. Eliminating barriers to increase uptake of PrEP in a communitybased clinic in San Francisco. 21st International AIDS Conference. July 2016. Durban, South Africa. Abstract FRAE0104.</li>
 	<li>Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-Tenofovir concentrations and preexposure prophylaxis efficacy in men who have sex with men. <em>Science Trans Med. </em>2012:4;151-</li>
 	<li>Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. <em>N Engl J Med</em>. 2012;367:399-410.</li>
 	<li>Kojima N, Klausner JD. Is emtricitabine-tenofovir disoproxil fumarate pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection safer than aspirin? <em>Open Forum Infect Dis</em>. 2016 Jan 6;3(1):ofv221.</li>
 	<li>Koester K, Amico RK, Gilmore H, et al. Risk, safety and sex among male PrEP users: time for a new understanding. <em>Culture, Health &amp; Sexuality</em>. 2017.</li>
 	<li>Golub SA, Radix A, Hilley A, et al. Developing and implementing a PrEP demonstration/ implementation hybrid in a community-based health center. 11th International Conference on HIV Treatment and Prevention Adherence, May 9-11, 2016, Fort Lauderdale, FL. ADH9_OA409.</li>
 	<li>Seidman D, Weber S. Integrating PrEP for HIV prevention into women’s health care in the United States. <em>Obstetrics and Gyn</em>. 2016;127:37-43.</li>
 	<li>CDC. Paying for PrEP. 2015.</li>
 	<li>Elion R, Coleman M. The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. <em>Curr Opin HIV AIDS</em>. 2016;11:67-73.</li>
 	<li>Adams LM, Balderson BH. HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report. <em>AIDS Care</em>. 2016;8:1154-1158.</li>
 	<li>Bush S, Magnuson D, Rawlings MK, et al. Racial characteristics of FTC/TDF for Pre-exposure Prophylaxis(PrEP) users in the US #265. ICAAC 2016. Boston, MA; June 16-20, 2016.</li>
 	<li><a href="http://hivprepsummit.org/index.php/prepresources/">http://hivprepsummit.org/index.php/prepresources/</a></li>
 	<li>Mayer KH. PrEP 2016: What will it take to generate demand, increase access, and accelerate uptake? 11th International Conference on HIV Treatment and Prevention Adherence, May 2016, Fort Lauderdale, FL. ADH11.</li>
</ol>

<hr />

Special thanks to the following reviewers of this Fact Sheet: Leah Adams, Pierre Crouch, Rick Elion, Nathan Fecik, Jayne Gagliano, Barbara Green-Ajufo, Colleen Kelley, Jeffry Klausner, Daryl Mangosing, Alan McCord, Karishma Oza, Rupa Patel, Jim Pickett, Rebecca Sedillo, Dominika Seidman, Aaron Siegler, Jill Tregor, Jonathan Volk, Shannon Weber.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Many Fact Sheets are also available in Spanish. ©2017, University of CA. Comments and questions about this Fact Sheet may be e-mailed to <a href="mailto:CAPS.web@ucsf.edu">CAPS.web@ucsf.edu</a>. This publication is a product of a Prevention Research Center and was supported by Cooperative Agreement Number 5U48DP004998 from the Centers for Disease Control and Prevention.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/08/RevPrEPFSfinal_CHPRC_final.pdf</url>
	</node>
	<node>
		<title>National HIV Testing Day – June 27, 2017 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[This brochure lists research focusing on HIV testing and helpful resources produced by CAPS/PRC.

You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Use the materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects.</li>
</ul>
Lead researchers (PIs) are listed for each study. Questions? Comments?

Contact Daryl Mangosing at 415-514-4590 or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

This brochure was prepared by the <a href="/sites/prevention.ucsf.edu/files/about/caps-structure-and-cores/community-engagement-ce-core/"><strong>Community Engagement (CE) Core</strong></a>, previously known as the Technology and Information Exchange (TIE) Core: “Tying research and community together.”]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/06/2017-National-HIV-Testing-Day-booklet.pdf</url>
	</node>
	<node>
		<title>Opioid Use (pain pills) - 2017</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>How do prescription pain pills (opioids) affect HIV?</h3>
<strong>Prepared by Kathleen Clanon, MD and Pamela DeCarlo </strong>

<strong>Community Engagement (CE) Core | July 2017</strong>
<h4>Are prescription opioids a concern?</h4>
Yes. Prescription pain pills (opioids) such as oxycodone, hydrocodone and methadone have helped millions of people effectively manage chronic pain. But for some, opioids have become a complex, tangled web of misuse and abuse that has led to dramatic increases in addiction, overdose, hepatitis B and C infection, and potentially, HIV infection in the US.[1]

Prescription opioids sold in the US more than doubled from 2001 to 2015, yet there has not been a decrease in the amount of pain reported. The amount of oxycodone and hydrocodone alone tripled from 2000 to 2015. Healthcare providers wrote 259 million prescriptions for opioid painkillers in 2012—enough for every adult in the US.[2]

The CDC recommends that prescription opioids should not be considered first-line or routine therapy for chronic pain.[3]
<h4>Why are prescription opioids a concern?</h4>
<strong>People often don’t know the risk involved in taking prescribed opioids.</strong> Opioids make people feel good, the side effects often are not bothersome, and patients tend to think that doctors would not prescribe something that is dangerous. Patients may not understand they can become physically dependent on them, and providers may not understand or adequately explain this. People being prescribed opioids should ask their providers if opioids are really the safest way to manage their pain.

<strong>Overdose.</strong> From 2000 to 2014, nearly half a million people died from drug overdoses, and more than 60% of drug overdose deaths involve an opioid. Every day, 46 people in the US die from prescription opioid overdose.[2]

<strong>Opioids are highly addictive.</strong> As many as 25% of people using opioids long-term struggle with opioid dependence.[4] And people become dependent on them extremely quickly. The chances of chronic use begin to increase as early as after the third day taken, and rise rapidly with each day after.[5]
<h4>What is their effect on HIV?</h4>
<strong>Potential negative effects on PLWH.</strong> For people living with HIV (PLWH), long-term opioid use may lead to depression, can trigger relapse, and actually can increase chronic pain.[6]

<strong>Increased risk behavior.</strong> Like alcohol and other drugs, prescription opioids can interfere with judgment and decision-making, and can result in users doing things they wouldn’t do when not in an altered state. People using opioids may have lowered inhibitions and be less likely to use condoms and more likely to share syringes, behaviors that increase the risk of transmitting and acquiring HIV as well as hepatitis C (HCV) and hepatitis B.[7]

<strong>Transition to injecting and heroin.</strong> The epidemic of prescription opioid misuse has resulted in a large population of people who are new to injecting. Almost 80% of new heroin users report using prescription opioids prior to heroin.[8]
<h4>What are concerns for PLWH?</h4>
<strong>Long-term opioid use.</strong> Chronic pain occurs in as many as 85% of PLWH and many use prescription opioids to manage their pain. Side effects from long-term and regular use of opioids include: decreased libido and testosterone, depression, neurological and heart rhythm problems. Repeated use of opiate pain medicines can, in fact, heighten—instead of alleviate—chronic pain in PLWH.[6]

<strong>Opioid misuse.</strong> Problematic prescription opioid use may be common among PLWH especially persons with a history of substance use, mental health issues, and poor adherence to ART. One study of PLWH prescribed opioids found that 62% had problematic use.[9]

<strong>Relapse and overdose.</strong> For PLWH with a history of alcohol and drug abuse, opioids may cause relapse. Accidental overdose is common, especially when opioids are combined with alcohol or benzodiazepines (such as Valium and Xanax), or with anti-depression and seizure medications.[3]

<strong>HIV healthcare.</strong> For many HIV providers, the unique factors in HIV care can influence whether they adopt federal guidelines for prescribing opioids. For example, goals such as retaining patients in HIV care or being an ally with patients, may be seen as more important than conservative opioid prescribing guidelines. Specialized training on opioid prescribing may be warranted for HIV providers.[10]
<h4>What are concerns for person at risk for HIV?</h4>
<strong>Lack of safer injecting knowledge and programs.</strong> The opioid epidemic has led to an increase in people who inject drugs (PWID). These new injectors tend to be mostly White, live in rural and suburban areas, have little knowledge of safe injecting practices or HCV and HIV risks, and have little or no access to education or services for injectors, such as syringe access programs.[11] This creates the potential for rapid spread of HIV once introduced into communities.

<strong>Hepatitis C.</strong> Currently, HCV infection is a major concern for injectors, especially among young adults and those living in small towns and rural areas in the US who inject opioids. In 2013, 30,000 new cases of HCV occurred, and 28 states reported increases in HCV infections. This was an increase of more than 150% from 2010 to 2013.[11]

<strong>Potential rapid spread of HIV.</strong> In 2015, the first HIV outbreak associated with injecting prescription opioids occurred in rural Indiana. HIV infection spread quickly in this small community, with 135 people testing positive, and 80% of those reporting dissolving and injecting tablets of oxymorphone.[12]
<h4>What needs to be done?</h4>
While opioid prescriptions, use, addiction and overdose have skyrocketed in the past few years, federal, state and local agencies have responded with guidelines, regulations and programs to promote safety. In 2016, the CDC issued guidelines intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, to improve the safety and effectiveness of pain treatment, and to reduce the risks associated with long-term opioid therapy, including addiction, overdose, and death.[3]

<strong>Healthcare providers</strong>

<em>Non-opioid pain management.</em> Providers working with PLWH should consider age, gender, socioeconomic status, current mental health, and substance use, as addressing pain without looking at these may have limited success. As the CDC recommends that opioids should not be a first-line therapy for chronic pain, providers should consider non-opioid means of managing pain. PLWH may get relief from pain with cognitive behavioral therapy, physical therapy, hypnosis or medical marijuana.[13]

<em>Overdose prevention.</em> If providers and patients wish to use opioids, providers should discuss and provide written materials on the risks of dependence and overdose, and consider co-prescribing naloxone to reverse potentially fatal overdose.

<strong>People living with HIV</strong>

PLWH who are prescribed opioids by their doctor should discuss any concerns and ask about non-opioid pain relief methods. If prescribed an opioid, they should use it for shortest period of time possible and be aware that dependence can happen right away, within 3 days of use.[5] PLWH who have been taking opioids for a long time should talk to their doctor about weaning off, or reducing their use.

<strong>Policymakers</strong>

We know how to prevent HIV, and we have multiple effective HIV prevention interventions. The HIV outbreak among rural PWID in Indiana has shown what can happen when states and local communities do not invest in prevention. We need to make a serious commitment to expanding education; harm reduction services such as syringe access programs; overdose prevention including access to naloxone; and drug treatment.[14]

Despite years of scientific evidence of their need, cost-effectiveness and effectiveness, there exist political and legislative barriers to implementing programs for PWID. We need to support, protect and expand existing laws and programs for the health and wellbeing of people who use and misuse prescription opioids, including PWID and their partners.

<hr />

<h3><strong>Says Who?</strong></h3>
<ol>
 	<li>RTI International. Opioids In America: A complex crisis. A comprehensive response. <a href="http://www.rti.org/sites/default/files/brochures/rti_opioids_in_america.pdf">www.rti.org/sites/default/files/brochures/rti_opioids_in_america.pdf</a></li>
 	<li>CDC. Opioid painkiller prescribing: Where you live makes a difference. CDC Vital Signs. July 2014. <a href="http://www.cdc.gov/vitalsigns/opioid-prescribing">www.cdc.gov/vitalsigns/opioid-prescribing</a></li>
 	<li>Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR. 2016;65:1-49.</li>
 	<li>CDC. Injury prevention and control: Opioid overdose. Drug overdose deaths in the United States continue to increase in 2015. <a href="http://www.cdc.gov/drugoverdose/epidemic/">www.cdc.gov/drugoverdose/epidemic/</a></li>
 	<li>Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use — United States, 2006–2015. MMWR. 2017;66:265–269. <a href="http://dx.doi.org/10.15585/mmwr.mm6610a1">http://dx.doi.org/10.15585/mmwr.mm6610a1</a></li>
 	<li>Liu B, Liu X, Tang SJ. Interactions of opioids and HIV infection in the pathogenesis of chronic pain. Front Microbiol. 2016;7:103.</li>
 	<li>Zule WA, Oramasionwu C, Evon D, et al. Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users. Am J Drug Alcohol Abuse. 2016;42:689-697.</li>
 	<li>Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71(7):821-826.</li>
 	<li>Turner AN, Maierhofer C, Funderburg NT, et al. High levels of self-reported prescription opioid use by HIV-positive individuals. AIDS Care. 2016;28:1559-1565.</li>
 	<li>Starrels JL, Peyser D, Haughton L, et al. When human immunodeficiency virus (HIV) treatment goals conflict with guideline-based opioid prescribing: A qualitative study of HIV treatment providers. Subst Abus. 2016;37:148-153.</li>
 	<li>National Institute on Drug Abuse. Prescription opioids and heroin. NIDA Research Report Series. 2015. <a href="http://www.drugabuse.gov/publications/research-reports/prescription-opioids-heroin">www.drugabuse.gov/publications/research-reports/prescription-opioids-heroin</a></li>
 	<li>Conrad C,  Bradley HM,  Broz D, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone — Indiana, 2015. MMWR. 2015;64:443-444. <a href="http://www.cdc.gov/mmWr/preview/mmwrhtml/mm6416a4.htm">www.cdc.gov/mmWr/preview/mmwrhtml/mm6416a4.htm</a></li>
 	<li>Merlin JS. Chronic pain in patients with HIV infection: What clinicians need to know. Topics in Antiviral Medicine. 2015;23:120-124.</li>
 	<li>Raymond D. Injecting opana: Indiana’s HIV outbreak and America’s opioid epidemic. Harm Reduction Coalition. March 2015. <a href="http://harmreduction.org/blog/injecting-opana-indianas-hiv-outbreak-and-americas-opioid-epidemic/">http://harmreduction.org/blog/injecting-opana-indianas-hiv-outbreak-and-americas-opioid-epidemic/</a></li>
</ol>

<hr />

Special thanks to the following reviewers of this Fact Sheet: Rachel Anderson, Emily Behar, Neisha Becton, Holvis Delgadillo, Linda Gowing, Barbara Green-Ajufo, Renata Henry, Daryl Mangosing, Savannah O’Neill. Kathleen Clanon is affiliated with the Alameda County Health Care Services Agency.

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Many Fact Sheets are available in Spanish. ©2017, University of CA. Comments and questions about this Fact Sheet may be e-mailed to <a href="mailto:CAPS.web@ucsf.edu">CAPS.web@ucsf.edu</a>. This publication is a product of a Prevention Research Center and was supported by Cooperative Agreement Number 5U48DP004998 from the Centers for Disease Control and Prevention.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/07/OpioidFSfinal.pdf</url>
	</node>
	<node>
		<title>Black Men - 2017</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What are Black Men’s HIV Prevention Needs?</h3>
<strong>Prepared by Bob Haas &amp; Barbara Green-Ajufo, DrPH, MPH</strong>

<strong>Community Engagement (CE) Core | August 2017</strong>
<h4>Who are black men?</h4>
In the U.S., Black men include different ethnic groups from the African Diaspora. They are friends and diverse family members: fathers, grandfathers, husbands, partners, brothers, uncles, sons, nephews, and cousins. They are colleagues working in professional and blue-collar jobs. They also represent different sexual orientations, have diverse spiritual and religious beliefs, and speak different languages, among having other demographic differences.
<h4>Why is HIV a concern among black men?</h4>
HIV is a health emergency among Black men of every age and sexual orientation. In 2015, 33% of HIV infections diagnosed in the U.S. were among Black men. They were diagnosed eight times more than white men and two times more than Hispanic men.[1] One in every twenty Black men will be diagnosed with HIV in their lifetime. Among the general population of men, Black men have a higher risk of HIV, noted by the differences below that will continue if current trends are not reversed.[2-4]
<ul>
 	<li>Men who have sex with men (MSM): black (1 in 2); general MSM population (1 in 6)</li>
 	<li>Injection drug users (IDU): black men (1 in 9); general male IDU population (1 in 36)</li>
 	<li>Heterosexual men: black (1 in 86); general heterosexual male population (1 in 473)</li>
</ul>
Among MSM, Black MSM (BMSM) – including gay and bisexual men – are more likely than others to be diagnosed with HIV (39% in 2015).[5] Young Black MSM (YBMSM) are most at risk. Seventy-five percent of all BMSM diagnosed with HIV in 2015 were ≤ age 34 – split equally between those aged 13-24 (37.7%) and aged 25-34 (37.3%).[6]

Many studies have shown that BMSM’s engagement in unprotected “condomless” anal intercourse (UAI) and number of sexual partners are similar to or less than MSM of other race or ethnic groups. However, BMSM are more likely to be diagnosed with HIV. This finding is true for different populations of BMSM.[7-10] In one study, YBMSM were nine times more likely to be living with HIV than white participants with similar risks.[7]

The demand for and awareness of PrEP – a proven biomedical intervention – is lower for BMSM than white MSM (WMSM).[11] From January 2012 to September 2015, 74% of the PrEP prescriptions in the U.S. were to whites, 12% to Latinos, and 10% to African Americans.[12]
<h4>What are HIV risk factors for black men?</h4>
Many factors affect Black men’s risk of HIV infection.

<strong>Stigma and Discrimination</strong> – When Black men experience stigma or discrimination, they are less likely to use PrEP [13] or disclose their HIV status.[14] Moreover, discrimination-related traumas, based on being gay, black or living with HIV, are associated with greater UAI.[15] High HIV infection rates, racist attitudes of non-Black gay men, and social networks and environments where gay men gather have been found to stigmatize and isolate BMSM from other MSM.[16]

<strong>HIV Care Continuum Disparities</strong> – Poor retention of Black men in health care is deeply rooted in discriminatory practices of the medical system towards the Black community.[17] Consequently, BMSM are less likely than WMSM to know their HIV status, more likely to be diagnosed later, and less likely to stay engaged in care and on treatment.[18-19]

<strong>Poverty</strong> – Discrimination and reduced access to and retention in quality education are reasons that Black men experience more unemployment or are underemployed, compared to white men.[20] Consequently, Black men are more likely to be living in poverty, which usually means reduced access to quality health care.[20] HIV rate increases 3.0 to 5.5 times with increasing neighborhood poverty level from &lt; 10% (low poverty) to more than 30% (very high poverty level).[21-22] For Black individuals living with HIV, poverty is associated with lower levels of engagement in HIV care.[23]

<strong>Sexual Trauma</strong> – Sexual abuse and assault rates are high among MSM and are related to greater risks of HIV infection. In the EXPLORE Study, 39% of MSM reported childhood sexual assault; Black participants were more likely to have a history of assault than no history of assault.[24-25]

<strong>Sexually Transmitted Diseases (STDs)</strong> – Having an STD can increase the chances of a person transmitting or becoming infected with HIV.[26] STD and HIV disparities in the Black community increase the likelihood of HIV transmission.[27-29]

<strong>Social networks and sex with men of their race</strong> – The high HIV rate among BMSM and their preference for sex with MSM of their same race increase the chances of BMSM having a sexual partner that is living with HIV. A review of studies found that at least 29% of BMSM in networks having sexual contact were living with HIV and 47% of men living with HIV in these networks did not know their status.[30]
<h4>What is being done?</h4>
Research findings for black men of diverse ages, sexual orientations, and HIV serostatus, discussed below, have been shown to reduce sexual risk behaviors and increase engagement in HIV care.[31]

<strong>Randomized Comparison Group Interventions</strong>: Two studies, Many Men Many Voices (3MV) and Brothers to Brothers, report positive findings for either a reduction in number of UAI occurrences with casual partners, number of any unprotected insertive anal intercourse, number of male sex partners, and/or a greater likelihood to test for HIV.

<strong>Pre- Post-Test/Repeated Survey Interventions</strong>: Black MSM who participated in D-up! Connect with Pride, BRUTHAS, Motivational Interviewing (MI), or Special Projects of National Significance (SPNS) interventions report improved outcomes, compared to those with limited or no participation. Studies found either a reduction in any UAI at different times during the intervention, a reduction in occurrences of UAI with main partners, reduced number of sexual partners, greater condom use with main partners, reduced number of high-risk sexual encounters with female sex partners, and/or a reduction in sex under the influence of drugs. Different studies also reported improvements in social support, self-esteem, and loneliness, as well as improved likelihood of HIV counseling and testing, return for test results, and fewer missed HIV medical visits. For one study, as the number of hours spent attending case management meetings increased, the time in HIV care increased.

<strong>Blended Pre- Post-Test and Control Group</strong>: Young MSM of color who participated in STYLE (Strength Through Youth Livin’ Empowered) reported 83% retention in care, and the chances of attending a clinic visit was greater for the STYLE participants than non-participants (2.58, 95% CI 1.34-4.98).
<h4>What still needs to be done?</h4>
HIV prevention targeting Black men should not simply address high-risk sexual behaviors but also societal and structural issues. We need policies that will prevent new infections and add to our understanding of Black/White HIV infection disparities, including the role of structural interventions.[32-33]. We need to combine behavioral and biomedical interventions; abandon a “one size fits all” approach; address high STD rates, traumatic events and structural and access barriers; and, consider the intersection of health and social conditions.

The need to address stigma – including ones that are unapparent – must not be lost. For example, data must be presented with background, community perspective, and accurate explanation. HIV disclosure must include strategies to help partners and family members receive information that their loved one is gay or living with HIV. Broad implementation of successful interventions in areas where HIV is highest for Black men is necessary.

<hr />

<h4>Says who?</h4>
1. CDC. HIV among Afr. Americans. Feb 2017.
2. Gavett G. Timeline: 30 Yrs. of AIDS in Blk. Americans. KQED Frontline. Jul 10, 2012.
3. Hess K, et al. Est. lifetime risk of dx of HIV infect in the U.S. CROI 2016. Boston, abstract 52.
4. CDC. Lifetime risk of HIV dx. Feb 2016.
5. CDC. HIV in the U.S.: At A Glance. Dec 2, 2016.
6. CDC. HIV among Afr. Am. gay and bisexual men. Jul 2016.
7. Millett GA, et al. Greater Risk for HIV Infect of Blk MSM: Lit Rev. AJPH. Jun 2006;96(6):1007-19.
8. Millet GA, et al. Disparities in HIV Infect among Blk and Wht MSM: Meta-Analysis. AIDS. Oct 1 2007;21(15):2083-91.
9. Magnus M, et al. Elevated HIV Prev. Despite Lower Rates of Sexual Risk Behav among Blk MSM in DC. AIDS Patient Care STDS. Oct 2010;24(10): 615–22.
10. Maulsby C, et al. HIV among Blk MSM in the U.S.: Lit. Rev. AIDS and Behav Jan 2014;18(1):10-25.
11. Cohen SE, et al. Response to race and PH impact potential of PrEP in the U.S. J Acquir Immune Defic Syndr. Sep 1 2015;70(1):e33-e35.
12. Highleyman L. PrEP use rising in U.S. but large racial disparities remain. nam aidsmap. Jun 24, 2016.
13. Chaill S, et al. Stigma, med mistrust, and racism affect PrEP awareness and uptake in Blk compared to Wht MSM in Jackson, MS and Boston, MA. AIDS Care, 2017.
14. Overstreet NM, et al. Internalized stigma and HIV status disclosure among HIV-pos MSM. AIDS Care 2013;25 4, 466-471.
15. Fields EL, et al. Assoc. of Discrimination-Related Trauma with Sexual Risk among HIV-Pos Afr. Am. MSM. AJPH. May 2013;103(5):875-80.
16. Raymond HF, et al. Racial Mixing and HIV Risk among MSM. AIDS Behav Aug 2009;13(4):630-37.
17. Lisa Eaton, et al. Role of Stigma and Med Mistrust in Routine Hlth Care Engagement of MSM. AJPH. Feb 2015;105(2): e75–e82.
18. Levy ME, et al. Understand Structural Barriers to Accessing HIV Test &amp; Prev Servs among Blk MSM in the U.S. AIDS Behav. 2014 May; 18(5): 972–996.
19. Christopoulos KA, et al. Link and Retention in HIV Care among MSM in the U.S. Clin Infect Dis. 2011 Jan 15; 52(Suppl 2): S214–S222.
20. Ethnic and Racial Minorities and SES. Factsheet. APA. http://www.apa.org/pi/ses/resources/publications/factsheet-erm.pdf
21. Alameda Co. CA eHARS data (2008-2012). Verbal communication with Nina Murgai, Dir, HIV/AIDS Surv Unit.
22. Wiewel EW, et al. Assoc bwt Neighborhood Poverty and HIV Dx among Males and Females in NYC, 2010-2011. PH Rep. Mar-Apr 2016;131(2):290-302.
23. Lechtenberg RJ, et al. Poverty, Race, Engagement: Diff Assoc with Retention in Care among PLWH in Alameda Co. UCSF CFAR HIV Hlth Disparities Symposium, Mar 24, 2017.
24. Mimiaga MM, et al. Child Sexual Abuse Assoc with HIV Risk–Taking Behav and Infect among MSM in the EXPLORE Study. J Acquir Immune Defic Syndr. 2009 Jul 1:51(3):340-348.
25. Millett GA, et al. Rev of HIV epidemics in Blk MSM across African diaspora. Lancet. Jul 28 – Aug 3;380(9839):411-23.
26. CDC. STDs and HIV – CDC Factsheet. Nov 17, 2015.
27. CDC. 2015 STDs Surveillance – STDs in Racial and Ethnic Minorities. Jan 23, 2017.
28. Scott HM, et al. Racial/ethnic and sexual behav disparities in rates of STIs, SF (1999-2008). BMC Pub Hlth. Jun 6, 2010;10:315.
29. Pathela P, et al. MSM have higher risk for newly dx HIV and syphilis compared with heterosexual men in NYC. J Acquir Immune Defic Syndr. Dec 1, 2011;58(4):408-16.
30. Hurt CB, et al. Invest Sexual Network of Blk MSM: Implications for Transmission and Prev of HIV Infect in U.S. J Acquir Immune Defic Syndr. Dec 1, 2012;61(4):515-21.
31. Maulsby C, et al. Rev of HIV Interv for Blk MSM. BMC Pub Hlth. 2013;13:625.
32. Peterson, JL, et al. Soc. discrimination and resiliency not assoc with differ in HIV infect in blk and wht MSM. JAIDS 2014:66;538-543.
33. Sullivan PS, et al. Understand racial HIV/STI disparities in blk and wht MSM. PLoS One 2014;9: e90514.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Emily Arnold, Jesse Brooks, Lorenzo Hinojosa, Loren Jones, Micah Lubensky, Daryl Mangosing, Janet Myers, Nasheedah Bynes-Muhammad, Rob Newells, John Peterson, Greg Rebchook, Andrew Reynolds, and Wilson Vincent

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. ©2017, University of CA. Comments and questions about this Fact Sheet may be e-mailed to <a href="mailto:CAPS.web@ucsf.edu">CAPS.web@ucsf.edu</a>. This publication is a product of a Prevention Research Center and was supported by Cooperative Agreement Number <strong>5U48DP004998</strong> from the Centers for Disease Control and Prevention.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2017/09/BlackMenFS_2017_final.pdf</url>
	</node>
	<node>
		<title>National Gay Men&#039;s HIV/AIDS Awareness Day – September 27, 2017 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[This brochure lists research focusing on HIV testing and helpful resources produced by CAPS/PRC.

You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Use the materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects.</li>
</ul>
Lead researchers (PIs) are listed for each study. Questions? Comments?

Contact Daryl Mangosing at 415 502-1000 ext. 44590 (vm only) or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

This brochure was prepared by the <a href="/sites/prevention.ucsf.edu/files/about/caps-structure-and-cores/community-engagement-ce-core/"><strong>Community Engagement (CE) Core</strong></a>, previously known as the Technology and Information Exchange (TIE) Core: “Tying research and community together.”]]></content>
		
		<type>
			6
		</type>
			<url></url>
	</node>
	<node>
		<title>Spring Summer 2017 [E-Newsletter]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Health disparities and HIV/AIDS</h3>
<b>Health disparities </b>exist across race/ethnic, gender, sexual orientation, socioeconomic and/or geographically defined population groups. This e-newsletter features CAPS/PRC research that discusses and addresses health disparities among impacted groups that are living with or at risk of acquiring HIV/AIDS.

Shout out to our <a href="/sites/prevention.ucsf.edu/files/news/shout-out-to-our-ucsf-visiting-professors-for-summer-2017-2-first-year-professors-8-returning/">Visiting Professors for summer 2017</a> ! We welcomed two first-year professors and welcomed back eight returning professors who all improved their programs of HIV-related health disparities research.
<div><b>In This Issue</b></div>
<ol>
 	<li>Local projects</li>
 	<li>National projects</li>
 	<li>International projects</li>
 	<li>Fact sheets on PrEP and Opioid Use</li>
 	<li>National HIV/AIDS Awareness Days: Research and Resources booklets</li>
 	<li>Announcements</li>
</ol>]]></content>
		
		<type>
			6
		</type>
			<url>http://myemail.constantcontact.com/Spring-Summer-2017-E-Newsletter---Health-Disparities.html?soid=1114093349314&amp;aid=6be5Z5Jb3sk</url>
	</node>
	<node>
		<title>Heterosexual Men - 2018</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>What Are Heterosexual Men’s HIV Prevention Needs?</h3>
<strong>Prepared by Joshua Middleton and Reverend William Francis</strong>

<strong>Community Engagement (CE) Core | March 2018</strong>
<h4>Heterosexual men are affected by HIV</h4>
HIV is a concern for heterosexual men, as almost 14% of new male HIV cases in 2016 occurred among heterosexuals, through sex with a woman (9.5%) and injecting drug use (3.9%). Most of those cases were among Black (63%) and Latino (22%) men, and men living in the Southeast (62%) and Northeast (19%) of the US.[1]

These statistics, however, may not give us an accurate picture of HIV among heterosexual men. Because sexuality is complex, some heterosexually-identified men may have sex with men, but still identify as straight.[2] The CDC tracks HIV infections through means of infection, not by a person’s identity. Therefore, a heterosexual man who tells his healthcare provider he ever had a sexual encounter with a man is categorized under “men who have sex with men,” and if he says he has ever injected a drug, is categorized under “people who inject drugs (PWID).”

Because of this, heterosexual men are seldom mentioned or addressed in the world of HIV prevention, care and research—where men are classified based on federal guidance and misconceptions, and not on men’s own identity.[3] This may be helpful for tracking the HIV epidemic, but it hampers service organizations who want to serve straight men who are at risk for or living with HIV, because funding for programs is linked to mode of transmission.
<h4>Fighting stigma</h4>
<strong>Misunderstanding, discrimination and HIV stigma.</strong> Heterosexual men may be reluctant to access testing and education programs at HIV-related organizations because they are concerned they might be labeled as gay or in the closet. Heterosexual men living with HIV can feel excluded from HIV clinics that brand their sites as safe and inclusive spaces for gay and bisexual men, which may be less about homophobia, and more about wanting a safe space for connection with and support from their community.[4]

<strong>HIV criminalization.</strong> Straight men often are blamed for the HIV epidemic among heterosexual women, and may carry guilt, shame and fear of criminal charges. Between 2008 and 2016 in the US, there were 279 cases of HIV criminalization. This occurs when a person is prosecuted for not disclosing their HIV status to a partner. The majority of prosecutions are of heterosexual men.[5]

<strong>Religion.</strong> Religion is an important part of many heterosexual men’s lives, yet sometimes the church may be the place where they are exposed to the beliefs that HIV is a punishment from God, and homosexuality and sex outside of marriage are sins.[6] These religious views may deter open dialogue around HIV, such as HIV testing and prevention, or disclosing HIV status.
<h4>Holistic approach</h4>
Addressing issues that impact heterosexual men as a whole person—body, mind and spirit—can be more effective than addressing HIV transmission mode. Health inequalities and structural barriers, not necessarily sexual risk taking behaviors, make men more likely to contract HIV and less likely to seek and have access to HIV programs.[3]

<strong>Family, relationships and intimacy.</strong> It is important for heterosexual men to explore their identity as a father, a romantic partner and a member of a family unit.[7] Men view intimacy in many different ways, including being able to communicate with their partner, being transparent and comfortable expressing their feelings, spending quality time with their partners, and having healthy and satisfying sexual lives.[8] Men and boys may need support developing communication skills with their partners.

<strong>Social injustice and resilience.</strong> The largest proportion of heterosexual HIV cases occur among Black men in the Southeast. This is also true for other race/ethnic groups except American Indian/Alaska Native where the largest number is in the West. The second largest number of cases among Black, Latino, and White men occur in the Northeast US. Latino men, the second largest race/ethnic group with HIV also are most affected in the South and Northeast US. Black and Latino men also face disproportionate rates of unemployment, racism, incarceration and lack of education, which can be more pressing issues to contend with than HIV and healthcare. Despite these challenges, many Black men have supportive communities, are highly resilient and persevere. HIV prevention and care services can support Black men by partnering with educational and vocational services to bolster men’s efforts to survive and thrive amid their adversities.[8]

<strong>Incarceration and post-incarceration services.</strong> Programs for heterosexual men should address the impact of incarceration on men, their partners, family and community. Sex with men, sexual assault and injection drug use are risks while incarcerated. People living with HIV (PLWH) may face treatment interruption both in prison and jail, and upon release—which can increase their viral loads and infectivity. Programs can provide education and risk reduction for men affected by incarceration,[9] as well as support finding employment, healthcare and housing upon release.[3]
<h4>Quality healthcare</h4>
<strong>Talking about health.</strong> Many men don’t feel comfortable talking about their sexual health and behaviors with their doctors, and doctors typically don’t ask these questions. Cultural male stereotypes and seeing the bulk of health services and promotions focused on women, hamper men’s willingness to seek out health care services, including HIV testing.[10] Healthcare providers need to take a proactive role engaging men, and provide a non-judgmental, safe environment where men can feel free and safe to talk about their sexual health.

<strong>HIV testing.</strong> Providers and clinics need greater awareness that heterosexual men can be at risk for HIV, and should offer all men HIV testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). Half of heterosexual men living with HIV were diagnosed 5 years or more after they were infected, later than any other population. Providers should talk to men of every age about HIV and HIV risk reduction, and let them know that HIV testing is a part of routine healthcare.[11]

<strong>HIV treatment and PrEP.</strong> PLWH who are on antiretroviral treatment and have undetectable viral loads do not transmit the virus to their partners.[5] PrEP, a medication for people who do not have HIV, can be used by men and women to protect themselves from HIV safely. These medical breakthroughs can help heterosexual men avoid HIV transmission, safely have children, reduce stress and worry, and increase trust and sexual pleasure in relationships.
<h4>Resources and programs</h4>
There has been resistance in the HIV community to track, fund, research and provide HIV services for heterosexual men, perhaps due to the focus on the mode of transmission and reluctance to acknowledge men’s own heterosexual identity.[3] For example, for the past five years there have been more new HIV cases from heterosexual transmission than from injecting drug use transmission among men,[1] yet programs and services for PWID far outnumber those for straight men.

Programs for heterosexual men should collaborate with mainstream organizations, as straight men are less likely to use HIV-specific services. Programs should reach out to places where straight men go, such as the grocery store, gym, barbershops, sporting events, clubs, churches, colleges, vocational services. Heterosexual men prefer to hear messages from other straight men in community locations.[12]

Programs, providers and researchers can do a better job of supporting Black men’s strengths and stop highlighting weaknesses. Increasing HIV testing, education, care and treatment, including PrEP for heterosexual men, can help address HIV. Increasing quality education, job and housing opportunities, as well as providing safe spaces for Black men that foster social support can also address HIV.[7]
<h4>Making a difference</h4>
It is time to recognize and fully address HIV among heterosexual men. Organizations, health departments and clinics should consider the needs of heterosexual men when planning their budgets, and include men in program planning, service delivery, research and policymaking. Straight men can help fight stigma and invisibility by speaking up, disclosing their status, working in HIV organizations and taking their place at the table to advocate for funding and programs.

"Until we all come together, HIV is not going to end." -Rev. Francis

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016. November 2017; vol. 28.
2. Carrillo H, Hoffman A. From MSM to heteroflexibilities: Non-exclusive straight male identities and their implications for HIV prevention and health promotion. Global Public Health. 2016;11:923-36.
3. Bowleg L, Raj A. Shared communities, structural contexts, and HIV risk: prioritizing the HIV risk and prevention needs of Black heterosexual men. American Journal of Public Health. 2012;102:S173-S177.
4. Kou N, Djiometio JN, Agha A, et al. Examining the health and health service utilization of heterosexual men with HIV: a community-informed scoping review. AIDS Care. 2017;29:552-558.
5. Halkitis PM, Pomeranz JL. It’s time to repeal HIV criminalization laws. Huffington Post. August 1, 2017.
6. Wilson PA,  Wittlin NM, Muñoz-Laboy M, et al. Ideologies of Black churches in New York City and the public health crisis of HIV among Black men who have sex with men. Global Public Health. 2011;6: S227–S242.
7. Abrahams C, Jones D, Viera A, et al. The forgotten population in HIV prevention: Heterosexual Black/African American men: Key findings and strategies. Harm Reduction Coalition position paper. December 2009.
8. Teti M, Martin AE, Ranade R, et al. “I’m a keep rising. I’m a keep going forward, regardless”: Exploring Black men’s resilience amid sociostructural challenges and stressors. Qualitative Health Research. 2012; 22:524–533.
9. Valera P, Chang Y, Lian Z. HIV risk inside US prisons: A systematic review of risk reduction interventions conducted in US prisons. AIDS Care, 2017;29:943-952.
10. Marcell AV, Morgan AR, Sanders R. The socioecology of sexual and reproductive health care use among young urban minority males. Journal of Adolescent Health. 2017;60:402-410.
11. CDC. HIV testing. CDC National HIV Surveillance System, 2015.
12. Murray A, Toledo L, Brown EE, et al. “We as Black men have to encourage each other:» Facilitators and barriers associated with HIV testing among Black/African American men in rural Florida. Journal of Health Care for the Poor and Underserved. 2017;28:487-498.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Tony Antoniou, Lisa Bowleg, Derek Canas, Hector Carrillo, Todd Genre, Barbara Green Ajufo, Davina Jones, Steve Kogan, Steven Lamm, Daryl Mangosing, Arik Marcell, Ashley Murray, Bob Siedle-Khan, Michelle Teti, Pamela Valera, Bill Woods

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. ©2018, University of CA. Comments and questions about this Fact Sheet may be e-mailed to <a href="mailto:CAPS.web@ucsf.edu">CAPS.web@ucsf.edu</a>. This publication is a product of a Prevention Research Center and was supported by Cooperative Agreement Number <strong>5U48DP004998</strong> from the Centers for Disease Control and Prevention.]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2018/03/HeteroMenFS2018_final.pdf</url>
	</node>
	<node>
		<title>National Black HIV/AIDS Awareness Day — February 7, 2018 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with African Americans and helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing at 415-502-1000 ext. 17163 (vm only) or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

<em>This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core.</em>
<h4>Acronyms</h4>
<strong>MSM</strong>: Men who have sex with men

<strong>PI</strong>: Principal Investigator (lead researcher on the study)

<strong>CO-I</strong>: Co-Investigator (contributing researcher or research partner)]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2018/02/2018-NBHAAD_final.pdf</url>
	</node>
	<node>
		<title>National Youth HIV/AIDS Awareness Day — April 10, 2018 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with youth or young adults, as well as helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing at 415-502-1000 ext. 17163 (vm only) or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

<em>This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core.</em>
<h4>Acronyms</h4>
<strong>MSM</strong>: Men who have sex with men

<strong>PI</strong>: Principal Investigator (lead researcher on the study)

<strong>CO-I</strong>: Co-Investigator (contributing researcher or research partner)]]></content>
		
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2018/04/2018-NYHAAD-1.pdf</url>
	</node>
    <node>
        <title>Heterosexual Men - 2018</title>
		<content><![CDATA[<h3>What Are Heterosexual Men’s HIV Prevention Needs?</h3>
<strong>Prepared by Joshua Middleton and Reverend William Francis</strong>

<strong>Community Engagement (CE) Core | March 2018</strong>
<h4>Heterosexual men are affected by HIV</h4>
HIV is a concern for heterosexual men, as almost 14% of new male HIV cases in 2016 occurred among heterosexuals, through sex with a woman (9.5%) and injecting drug use (3.9%). Most of those cases were among Black (63%) and Latino (22%) men, and men living in the Southeast (62%) and Northeast (19%) of the US.[1]

These statistics, however, may not give us an accurate picture of HIV among heterosexual men. Because sexuality is complex, some heterosexually-identified men may have sex with men, but still identify as straight.[2] The CDC tracks HIV infections through means of infection, not by a person’s identity. Therefore, a heterosexual man who tells his healthcare provider he ever had a sexual encounter with a man is categorized under “men who have sex with men,” and if he says he has ever injected a drug, is categorized under “people who inject drugs (PWID).”

Because of this, heterosexual men are seldom mentioned or addressed in the world of HIV prevention, care and research—where men are classified based on federal guidance and misconceptions, and not on men’s own identity.[3] This may be helpful for tracking the HIV epidemic, but it hampers service organizations who want to serve straight men who are at risk for or living with HIV, because funding for programs is linked to mode of transmission.
<h4>Fighting stigma</h4>
<strong>Misunderstanding, discrimination and HIV stigma.</strong> Heterosexual men may be reluctant to access testing and education programs at HIV-related organizations because they are concerned they might be labeled as gay or in the closet. Heterosexual men living with HIV can feel excluded from HIV clinics that brand their sites as safe and inclusive spaces for gay and bisexual men, which may be less about homophobia, and more about wanting a safe space for connection with and support from their community.[4]

<strong>HIV criminalization.</strong> Straight men often are blamed for the HIV epidemic among heterosexual women, and may carry guilt, shame and fear of criminal charges. Between 2008 and 2016 in the US, there were 279 cases of HIV criminalization. This occurs when a person is prosecuted for not disclosing their HIV status to a partner. The majority of prosecutions are of heterosexual men.[5]

<strong>Religion.</strong> Religion is an important part of many heterosexual men’s lives, yet sometimes the church may be the place where they are exposed to the beliefs that HIV is a punishment from God, and homosexuality and sex outside of marriage are sins.[6] These religious views may deter open dialogue around HIV, such as HIV testing and prevention, or disclosing HIV status.
<h4>Holistic approach</h4>
Addressing issues that impact heterosexual men as a whole person—body, mind and spirit—can be more effective than addressing HIV transmission mode. Health inequalities and structural barriers, not necessarily sexual risk taking behaviors, make men more likely to contract HIV and less likely to seek and have access to HIV programs.[3]

<strong>Family, relationships and intimacy.</strong> It is important for heterosexual men to explore their identity as a father, a romantic partner and a member of a family unit.[7] Men view intimacy in many different ways, including being able to communicate with their partner, being transparent and comfortable expressing their feelings, spending quality time with their partners, and having healthy and satisfying sexual lives.[8] Men and boys may need support developing communication skills with their partners.

<strong>Social injustice and resilience.</strong> The largest proportion of heterosexual HIV cases occur among Black men in the Southeast. This is also true for other race/ethnic groups except American Indian/Alaska Native where the largest number is in the West. The second largest number of cases among Black, Latino, and White men occur in the Northeast US. Latino men, the second largest race/ethnic group with HIV also are most affected in the South and Northeast US. Black and Latino men also face disproportionate rates of unemployment, racism, incarceration and lack of education, which can be more pressing issues to contend with than HIV and healthcare. Despite these challenges, many Black men have supportive communities, are highly resilient and persevere. HIV prevention and care services can support Black men by partnering with educational and vocational services to bolster men’s efforts to survive and thrive amid their adversities.[8]

<strong>Incarceration and post-incarceration services.</strong> Programs for heterosexual men should address the impact of incarceration on men, their partners, family and community. Sex with men, sexual assault and injection drug use are risks while incarcerated. People living with HIV (PLWH) may face treatment interruption both in prison and jail, and upon release—which can increase their viral loads and infectivity. Programs can provide education and risk reduction for men affected by incarceration,[9] as well as support finding employment, healthcare and housing upon release.[3]
<h4>Quality healthcare</h4>
<strong>Talking about health.</strong> Many men don’t feel comfortable talking about their sexual health and behaviors with their doctors, and doctors typically don’t ask these questions. Cultural male stereotypes and seeing the bulk of health services and promotions focused on women, hamper men’s willingness to seek out health care services, including HIV testing.[10] Healthcare providers need to take a proactive role engaging men, and provide a non-judgmental, safe environment where men can feel free and safe to talk about their sexual health.

<strong>HIV testing.</strong> Providers and clinics need greater awareness that heterosexual men can be at risk for HIV, and should offer all men HIV testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). Half of heterosexual men living with HIV were diagnosed 5 years or more after they were infected, later than any other population. Providers should talk to men of every age about HIV and HIV risk reduction, and let them know that HIV testing is a part of routine healthcare.[11]

<strong>HIV treatment and PrEP.</strong> PLWH who are on antiretroviral treatment and have undetectable viral loads do not transmit the virus to their partners.[5] PrEP, a medication for people who do not have HIV, can be used by men and women to protect themselves from HIV safely. These medical breakthroughs can help heterosexual men avoid HIV transmission, safely have children, reduce stress and worry, and increase trust and sexual pleasure in relationships.
<h4>Resources and programs</h4>
There has been resistance in the HIV community to track, fund, research and provide HIV services for heterosexual men, perhaps due to the focus on the mode of transmission and reluctance to acknowledge men’s own heterosexual identity.[3] For example, for the past five years there have been more new HIV cases from heterosexual transmission than from injecting drug use transmission among men,[1] yet programs and services for PWID far outnumber those for straight men.

Programs for heterosexual men should collaborate with mainstream organizations, as straight men are less likely to use HIV-specific services. Programs should reach out to places where straight men go, such as the grocery store, gym, barbershops, sporting events, clubs, churches, colleges, vocational services. Heterosexual men prefer to hear messages from other straight men in community locations.[12]

Programs, providers and researchers can do a better job of supporting Black men’s strengths and stop highlighting weaknesses. Increasing HIV testing, education, care and treatment, including PrEP for heterosexual men, can help address HIV. Increasing quality education, job and housing opportunities, as well as providing safe spaces for Black men that foster social support can also address HIV.[7]
<h4>Making a difference</h4>
It is time to recognize and fully address HIV among heterosexual men. Organizations, health departments and clinics should consider the needs of heterosexual men when planning their budgets, and include men in program planning, service delivery, research and policymaking. Straight men can help fight stigma and invisibility by speaking up, disclosing their status, working in HIV organizations and taking their place at the table to advocate for funding and programs.

"Until we all come together, HIV is not going to end." -Rev. Francis

<hr />

<h3>Says who?</h3>
1. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016. November 2017; vol. 28.
2. Carrillo H, Hoffman A. From MSM to heteroflexibilities: Non-exclusive straight male identities and their implications for HIV prevention and health promotion. Global Public Health. 2016;11:923-36.
3. Bowleg L, Raj A. Shared communities, structural contexts, and HIV risk: prioritizing the HIV risk and prevention needs of Black heterosexual men. American Journal of Public Health. 2012;102:S173-S177.
4. Kou N, Djiometio JN, Agha A, et al. Examining the health and health service utilization of heterosexual men with HIV: a community-informed scoping review. AIDS Care. 2017;29:552-558.
5. Halkitis PM, Pomeranz JL. It’s time to repeal HIV criminalization laws. Huffington Post. August 1, 2017.
6. Wilson PA,  Wittlin NM, Muñoz-Laboy M, et al. Ideologies of Black churches in New York City and the public health crisis of HIV among Black men who have sex with men. Global Public Health. 2011;6: S227–S242.
7. Abrahams C, Jones D, Viera A, et al. The forgotten population in HIV prevention: Heterosexual Black/African American men: Key findings and strategies. Harm Reduction Coalition position paper. December 2009.
8. Teti M, Martin AE, Ranade R, et al. “I’m a keep rising. I’m a keep going forward, regardless”: Exploring Black men’s resilience amid sociostructural challenges and stressors. Qualitative Health Research. 2012; 22:524–533.
9. Valera P, Chang Y, Lian Z. HIV risk inside US prisons: A systematic review of risk reduction interventions conducted in US prisons. AIDS Care, 2017;29:943-952.
10. Marcell AV, Morgan AR, Sanders R. The socioecology of sexual and reproductive health care use among young urban minority males. Journal of Adolescent Health. 2017;60:402-410.
11. CDC. HIV testing. CDC National HIV Surveillance System, 2015.
12. Murray A, Toledo L, Brown EE, et al. “We as Black men have to encourage each other:» Facilitators and barriers associated with HIV testing among Black/African American men in rural Florida. Journal of Health Care for the Poor and Underserved. 2017;28:487-498.

<hr />

Special thanks to the following reviewers of this Fact Sheet: Tony Antoniou, Lisa Bowleg, Derek Canas, Hector Carrillo, Todd Genre, Barbara Green Ajufo, Davina Jones, Steve Kogan, Steven Lamm, Daryl Mangosing, Arik Marcell, Ashley Murray, Bob Siedle-Khan, Michelle Teti, Pamela Valera, Bill Woods

Reproduction of this text is encouraged; however, copies may not be sold, and the University of California San Francisco should be cited as the source. Fact Sheets are also available in Spanish. ©2018, University of CA. Comments and questions about this Fact Sheet may be e-mailed to <a href="mailto:CAPS.web@ucsf.edu">CAPS.web@ucsf.edu</a>. This publication is a product of a Prevention Research Center and was supported by Cooperative Agreement Number <strong>5U48DP004998</strong> from the Centers for Disease Control and Prevention.]]></content>
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2018/03/HeteroMenFS2018_final.pdf</url>
	</node>
	<node>
		<title>National Black HIV/AIDS Awareness Day — February 7, 2018 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with African Americans and helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing at 415-502-1000 ext. 17163 (vm only) or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

<em>This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core.</em>
<h4>Acronyms</h4>
<strong>MSM</strong>: Men who have sex with men

<strong>PI</strong>: Principal Investigator (lead researcher on the study)

<strong>CO-I</strong>: Co-Investigator (contributing researcher or research partner)]]>
        </content>
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2018/02/2018-NBHAAD_final.pdf</url>
	</node>
	<node>
		<title>National Youth HIV/AIDS Awareness Day — April 10, 2018 [booklet]</title>
		<tax>1737</tax>
		<content><![CDATA[<h3>Research &amp; Resources</h3>
This brochure lists research projects with youth or young adults, as well as helpful resources produced by CAPS/PRC. You might use it to:
<ul>
 	<li>Stay up-to-date on research and learn what we found out from research</li>
 	<li>Provide materials in trainings/presentations</li>
 	<li>Advocate for services/funding</li>
 	<li>Write grants</li>
 	<li>Develop new or modify existing HIV prevention programs</li>
 	<li>Evaluate current programs</li>
 	<li>Connect with CAPS/PRC to develop new projects. Lead researchers (PIs) are listed for each study. Contact us below to connect.</li>
</ul>
Questions? Comments? Contact Daryl Mangosing at 415-502-1000 ext. 17163 (vm only) or <a href="mailto:Daryl.Mangosing@ucsf.edu">Daryl.Mangosing@ucsf.edu</a>

<em>This brochure was prepared by the CAPS Community Engagement (CE) Core, which is previously known as the Technology and Information Exchange (TIE) Core.</em>
<h4>Acronyms</h4>
<strong>MSM</strong>: Men who have sex with men

<strong>PI</strong>: Principal Investigator (lead researcher on the study)

<strong>CO-I</strong>: Co-Investigator (contributing researcher or research partner)]]></content>
		<type>
			6
		</type>
			<url>/sites/prevention.ucsf.edu/files/wordpress/wp-content/uploads/2018/04/2018-NYHAAD-1.pdf</url>
	</node>
</nodes>